Adenosine_A1_receptor/JJ activation/NNS has_been/VBP implicated/VBN in_a/JJ variety/NN of/IN physiological/JJ processes/NNS ,/, including/VBG regulation/NN of/IN heart_rate/NN and/CC neurotransmitter/NN release/NN ./.

(ROOT
  (S
    (NP (JJ Adenosine_A1_receptor) (NNS activation))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (NP
          (NP (JJ in_a) (NN variety))
          (PP (IN of)
            (NP (JJ physiological) (NNS processes)))
          (, ,)
          (VP (VBG including)
            (NP
              (NP (NN regulation))
              (PP (IN of)
                (NP
                  (NP (NN heart_rate))
                  (CC and)
                  (NP (NN neurotransmitter) (NN release)))))))))
    (. .)))

amod(activation-2, Adenosine_A1_receptor-1)
nsubj(has_been-3, activation-2)
root(ROOT-0, has_been-3)
dep(has_been-3, implicated-4)
amod(variety-6, in_a-5)
dobj(implicated-4, variety-6)
case(processes-9, of-7)
amod(processes-9, physiological-8)
nmod:of(variety-6, processes-9)
acl(variety-6, including-11)
dobj(including-11, regulation-12)
case(heart_rate-14, of-13)
nmod:of(regulation-12, heart_rate-14)
cc(heart_rate-14, and-15)
compound(release-17, neurotransmitter-16)
nmod:of(regulation-12, release-17)
conj:and(heart_rate-14, release-17)

CH-13584/JJ is_a/JJ selective/JJ agonist/NN for/IN the/DT adenosine_A1_receptor/NN and/CC has_been/NN shown/VBN to/TO elicit/VB potent/JJ responses/NNS in/IN vitro/NN and/CC in/IN vivo/NN ./.

(ROOT
  (NP
    (NP (JJ CH-13584) (JJ is_a) (JJ selective) (NN agonist))
    (PP (IN for)
      (NP
        (NP (DT the) (NN adenosine_A1_receptor)
          (CC and)
          (NN has_been))
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB elicit)
                (NP (JJ potent) (NNS responses))
                (PP
                  (PP (IN in)
                    (NP (NN vitro)))
                  (CC and)
                  (PP (IN in)
                    (NP (NN vivo))))))))))
    (. .)))

amod(agonist-4, CH-13584-1)
amod(agonist-4, is_a-2)
amod(agonist-4, selective-3)
root(ROOT-0, agonist-4)
case(adenosine_A1_receptor-7, for-5)
det(adenosine_A1_receptor-7, the-6)
nmod:for(agonist-4, adenosine_A1_receptor-7)
cc(adenosine_A1_receptor-7, and-8)
nmod:for(agonist-4, has_been-9)
conj:and(adenosine_A1_receptor-7, has_been-9)
acl(adenosine_A1_receptor-7, shown-10)
mark(elicit-12, to-11)
xcomp(shown-10, elicit-12)
xcomp(shown-10, elicit-12')
conj:and(elicit-12, elicit-12')
amod(responses-14, potent-13)
dobj(elicit-12, responses-14)
case(vitro-16, in-15)
nmod:in(elicit-12, vitro-16)
cc(elicit-12, and-17)
case(vivo-19, in-18)
nmod:in(elicit-12', vivo-19)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT potential/JJ involvement/NN of/IN pertussis/NN toxin-sensitive/JJ G/NNP proteins/NNS in/IN mediating/VBG CH-13584/JJ responses/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP (DT the) (JJ potential) (NN involvement))
          (PP (IN of)
            (NP (NN pertussis))))
        (NP (JJ toxin-sensitive) (NNP G) (NNS proteins)))
      (PP (IN in)
        (S
          (VP (VBG mediating)
            (NP (JJ CH-13584) (NNS responses))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(involvement-9, the-7)
amod(involvement-9, potential-8)
dobj(investigated-6, involvement-9)
case(pertussis-11, of-10)
nmod:of(involvement-9, pertussis-11)
amod(proteins-14, toxin-sensitive-12)
compound(proteins-14, G-13)
dep(involvement-9, proteins-14)
mark(mediating-16, in-15)
advcl(investigated-6, mediating-16)
amod(responses-18, CH-13584-17)
dobj(mediating-16, responses-18)

Treatment/NNP with/IN pertussis/NN toxin/NN did/VBD not/RB affect/VB the/DT adenosine_A1_receptor/JJ +/JJ response/NN to/TO CH-13584/NN ,/, suggesting/VBG that/IN these/DT responses/NNS may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Treatment))
      (PP (IN with)
        (NP (NN pertussis) (NN toxin))))
    (VP (VBD did) (RB not)
      (VP (VB affect)
        (NP
          (NP (DT the) (JJ adenosine_A1_receptor) (JJ +) (NN response))
          (PP (TO to)
            (NP
              (NP (NN CH-13584))
              (, ,)
              (VP (VBG suggesting)
                (SBAR (IN that)
                  (S
                    (NP (DT these) (NNS responses))
                    (VP (MD may)
                      (VP (VB be)
                        (VP (VBN mediated)
                          (PP (IN via)
                            (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein))))))))))))))
    (. .)))

nsubj(affect-7, Treatment-1)
case(toxin-4, with-2)
compound(toxin-4, pertussis-3)
nmod:with(Treatment-1, toxin-4)
aux(affect-7, did-5)
neg(affect-7, not-6)
root(ROOT-0, affect-7)
det(response-11, the-8)
amod(response-11, adenosine_A1_receptor-9)
amod(response-11, +-10)
dobj(affect-7, response-11)
case(CH-13584-13, to-12)
nmod:to(response-11, CH-13584-13)
acl(CH-13584-13, suggesting-15)
mark(mediated-21, that-16)
det(responses-18, these-17)
nsubjpass(mediated-21, responses-18)
aux(mediated-21, may-19)
auxpass(mediated-21, be-20)
ccomp(suggesting-15, mediated-21)
case(G_protein-26, via-22)
det(G_protein-26, a-23)
compound(G_protein-26, pertussis-24)
amod(G_protein-26, toxin-insensitive-25)
nmod:via(mediated-21, G_protein-26)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT signaling/VBG pathways/NNS involved/VBN in/IN adenosine_A1_receptor/JJ activation/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/NN therapeutics/NNS targeting/VBG this/DT pathway/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (VBG signaling) (NNS pathways))
            (VP (VBN involved)
              (PP (IN in)
                (NP (JJ adenosine_A1_receptor) (NN activation)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (NN novel) (NNS therapeutics)))))
            (VP (VBG targeting)
              (NP (DT this) (NN pathway)))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-16, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(pathways-9, into-6)
det(pathways-9, the-7)
amod(pathways-9, signaling-8)
nmod:into(provide-3, pathways-9)
acl(pathways-9, involved-10)
case(activation-13, in-11)
amod(activation-13, adenosine_A1_receptor-12)
nmod:in(involved-10, activation-13)
cc(provide-3, and-14)
aux(have-16, may-15)
conj:and(provide-3, have-16)
dobj(have-16, implications-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(implications-17, development-20)
case(therapeutics-23, of-21)
compound(therapeutics-23, novel-22)
nmod:of(development-20, therapeutics-23)
acl(implications-17, targeting-24)
det(pathway-26, this-25)
dobj(targeting-24, pathway-26)

Heart_failure/NNP -LRB-/-LRB- HF/NNP -RRB-/-RRB- is_a/VBD chronic/JJ and/CC progressive/JJ condition/NN that/WDT is/VBZ associated/VBN with/IN high/JJ morbidity/NN and/CC mortality/NN ./.

(ROOT
  (S
    (NP (NNP Heart_failure) (-LRB- -LRB-)
      (NP (NNP HF))
      (-RRB- -RRB-))
    (VP (VBD is_a)
      (NP
        (ADJP (JJ chronic)
          (CC and)
          (JJ progressive))
        (NN condition)
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (JJ high) (NN morbidity)
                    (CC and)
                    (NN mortality)))))))))
    (. .)))

nsubj(is_a-5, Heart_failure-1)
dep(Heart_failure-1, HF-3)
root(ROOT-0, is_a-5)
amod(condition-9, chronic-6)
cc(chronic-6, and-7)
conj:and(chronic-6, progressive-8)
amod(condition-9, progressive-8)
dobj(is_a-5, condition-9)
nsubjpass(associated-12, that-10)
auxpass(associated-12, is-11)
ccomp(condition-9, associated-12)
case(morbidity-15, with-13)
amod(morbidity-15, high-14)
nmod:with(associated-12, morbidity-15)
cc(morbidity-15, and-16)
nmod:with(associated-12, mortality-17)
conj:and(morbidity-15, mortality-17)

Albuminuria/NNP ,/, which/WDT is/VBZ defined/VBN as/IN the/DT presence/NN of/IN excess/JJ protein/NN in/IN urine/NN ,/, is_a/VBD common/JJ complication/NN of/IN HF/NNP and/CC is/VBZ associated/VBN with/IN a/DT poor/JJ prognosis/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Albuminuria))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ is)
            (VP (VBN defined)
              (PP (IN as)
                (NP
                  (NP (DT the) (NN presence))
                  (PP (IN of)
                    (NP
                      (NP (JJ excess) (NN protein))
                      (PP (IN in)
                        (NP (NN urine)))))))))))
      (, ,))
    (VP
      (VP (VBD is_a)
        (NP
          (NP (JJ common) (NN complication))
          (PP (IN of)
            (NP (NNP HF)))))
      (CC and)
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP (DT a) (JJ poor) (NN prognosis))))))
    (. .)))

nsubjpass(defined-5, Albuminuria-1)
nsubj(is_a-15, Albuminuria-1)
nsubjpass(associated-22, Albuminuria-1)
ref(Albuminuria-1, which-3)
auxpass(defined-5, is-4)
acl:relcl(Albuminuria-1, defined-5)
case(presence-8, as-6)
det(presence-8, the-7)
nmod:as(defined-5, presence-8)
case(protein-11, of-9)
amod(protein-11, excess-10)
nmod:of(presence-8, protein-11)
case(urine-13, in-12)
nmod:in(protein-11, urine-13)
root(ROOT-0, is_a-15)
amod(complication-17, common-16)
dobj(is_a-15, complication-17)
case(HF-19, of-18)
nmod:of(complication-17, HF-19)
cc(is_a-15, and-20)
auxpass(associated-22, is-21)
conj:and(is_a-15, associated-22)
case(prognosis-26, with-23)
det(prognosis-26, a-24)
amod(prognosis-26, poor-25)
nmod:with(associated-22, prognosis-26)

The/DT renin-angiotensin/JJ system/NN -LRB-/-LRB- RAS/NNP -RRB-/-RRB- plays/VBZ a/DT key/JJ role/NN in/IN the/DT pathogenesis/NNS of/IN HF/NNP and/CC has_been/NN targeted/VBN for/IN therapeutic/JJ intervention/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ renin-angiotensin) (NN system))
      (PRN (-LRB- -LRB-)
        (NP (NNP RAS))
        (-RRB- -RRB-)))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ key) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NNS pathogenesis))
            (PP (IN of)
              (NP
                (NP (NNP HF))
                (CC and)
                (NP
                  (NP (NN has_been))
                  (VP (VBN targeted)
                    (PP (IN for)
                      (NP (JJ therapeutic) (NN intervention)))))))))))
    (. .)))

det(system-3, The-1)
amod(system-3, renin-angiotensin-2)
nsubj(plays-7, system-3)
appos(system-3, RAS-5)
root(ROOT-0, plays-7)
det(role-10, a-8)
amod(role-10, key-9)
dobj(plays-7, role-10)
case(pathogenesis-13, in-11)
det(pathogenesis-13, the-12)
nmod:in(role-10, pathogenesis-13)
case(HF-15, of-14)
nmod:of(pathogenesis-13, HF-15)
cc(HF-15, and-16)
nmod:of(pathogenesis-13, has_been-17)
conj:and(HF-15, has_been-17)
acl(has_been-17, targeted-18)
case(intervention-21, for-19)
amod(intervention-21, therapeutic-20)
nmod:for(targeted-18, intervention-21)

Fosinopril/NNP ,/, an/DT angiotensin-converting_enzyme/JJ inhibitor/NN -LRB-/-LRB- ACEi/NNP -RRB-/-RRB- ,/, is/VBZ one/CD such/JJ agent/NN that/WDT has_been/VBP shown/VBN to/TO improve/VB outcomes/NNS in/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (NP
      (NP (NNP Fosinopril))
      (, ,)
      (NP (DT an) (JJ angiotensin-converting_enzyme) (NN inhibitor))
      (PRN (-LRB- -LRB-)
        (NP (NNP ACEi))
        (-RRB- -RRB-))
      (, ,))
    (VP (VBZ is)
      (NP
        (NP (CD one) (JJ such) (NN agent))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB improve)
                      (NP
                        (NP (NNS outcomes))
                        (PP (IN in)
                          (NP (NNS patients))))
                      (PP (IN with)
                        (NP (NNP HF))))))))))))
    (. .)))

nsubj(agent-13, Fosinopril-1)
det(inhibitor-5, an-3)
amod(inhibitor-5, angiotensin-converting_enzyme-4)
appos(Fosinopril-1, inhibitor-5)
appos(Fosinopril-1, ACEi-7)
cop(agent-13, is-10)
nummod(agent-13, one-11)
amod(agent-13, such-12)
root(ROOT-0, agent-13)
nsubj(has_been-15, agent-13)
ref(agent-13, that-14)
acl:relcl(agent-13, has_been-15)
dep(has_been-15, shown-16)
mark(improve-18, to-17)
xcomp(shown-16, improve-18)
dobj(improve-18, outcomes-19)
case(patients-21, in-20)
nmod:in(outcomes-19, patients-21)
case(HF-23, with-22)
nmod:with(improve-18, HF-23)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT effect/NN of/IN fosinopril/NN on/IN the/DT risk/NN of/IN albuminuria/NN in/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN fosinopril))))
            (PP (IN on)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (NN albuminuria))
                    (PP (IN in)
                      (NP
                        (NP (NNS patients))
                        (PP (IN with)
                          (NP (NNP HF)))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(effect-10, the-9)
dobj(evaluate-8, effect-10)
case(fosinopril-12, of-11)
nmod:of(effect-10, fosinopril-12)
case(risk-15, on-13)
det(risk-15, the-14)
nmod:on(evaluate-8, risk-15)
case(albuminuria-17, of-16)
nmod:of(risk-15, albuminuria-17)
case(patients-19, in-18)
nmod:in(albuminuria-17, patients-19)
case(HF-21, with-20)
nmod:with(patients-19, HF-21)

Our/PRP$ results/NNS showed/VBD that/IN fosinopril/NN reduced/VBD the/DT risk/NN of/IN albuminuria/NN by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN fosinopril))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN albuminuria))))
            (PP (IN by)
              (NP
                (NP (CD 21) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                      (: :)
                      (NP
                        (QP (CD 0.67-0) (CD .93)))))
                  (-RRB- -RRB-))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, fosinopril-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(albuminuria-10, of-9)
nmod:of(risk-8, albuminuria-10)
case(%-13, by-11)
nummod(%-13, 21-12)
nmod:by(reduced-6, %-13)
amod(-RSB--19, relative-15)
compound(-RSB--19, risk-16)
compound(-RSB--19, -LSB--17)
compound(-RSB--19, RR-18)
dep(%-13, -RSB--19)
nummod(-RSB--29, 0.79-21)
nummod(-RSB--29, 95-23)
compound(-RSB--29, %-24)
compound(-RSB--29, confidence-25)
amod(-RSB--29, interval-26)
amod(-RSB--29, -LSB--27)
compound(-RSB--29, CI-28)
dep(-RSB--19, -RSB--29)
compound(.93-32, 0.67-0-31)
dep(-RSB--29, .93-32)

These/DT findings/NNS suggest/VBP that/IN fosinopril/NN may/MD be/VB an/DT effective/JJ therapeutic/JJ option/NN for/IN reducing/VBG the/DT risk/NN of/IN albuminuria/NN in/IN patients/NNS with/IN HF/NNP and/CC may/MD improve/VB their/PRP$ overall/JJ prognosis/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN fosinopril))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP (DT an) (JJ effective) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (NN albuminuria))
                            (PP (IN in)
                              (NP (NNS patients))))))
                      (PP (IN with)
                        (NP (NNP HF))))))))
            (CC and)
            (VP (MD may)
              (VP (VB improve)
                (NP (PRP$ their) (JJ overall) (NN prognosis))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, fosinopril-5)
nsubj(improve-24, fosinopril-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, an-8)
amod(option-11, effective-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
advcl(option-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(albuminuria-17, of-16)
nmod:of(risk-15, albuminuria-17)
case(patients-19, in-18)
nmod:in(albuminuria-17, patients-19)
case(HF-21, with-20)
nmod:with(reducing-13, HF-21)
cc(option-11, and-22)
aux(improve-24, may-23)
ccomp(suggest-3, improve-24)
conj:and(option-11, improve-24)
nmod:poss(prognosis-27, their-25)
amod(prognosis-27, overall-26)
dobj(improve-24, prognosis-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO explore/VB potential/JJ mechanisms/NNS underlying/VBG this/DT effect/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN effect))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(explore-11, to-10)
ccomp(needed-4, explore-11)
conj:and(confirm-6, explore-11)
amod(mechanisms-13, potential-12)
dobj(explore-11, mechanisms-13)
acl(mechanisms-13, underlying-14)
det(effect-16, this-15)
dobj(underlying-14, effect-16)

This/DT study/NN aimed/VBD to/TO evaluate/VB the/DT efficacy/NN of/IN Cervisol/NNP in/IN reducing/VBG the/DT risk/NN of/IN common/JJ adverse/JJ effects/NNS associated/VBN with/IN mydriasis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN patients/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN efficacy))
              (PP (IN of)
                (NP (NNP Cervisol))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (JJ common) (JJ adverse) (NNS effects))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (NNS mydriasis))
                              (, ,)
                              (NP (NN photophobia))
                              (, ,)
                              (CC and)
                              (NP
                                (NP (NN phonophobia))
                                (PP (IN in)
                                  (NP (NNS patients)))))))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(evaluate-5, study-2)
root(ROOT-0, aimed-3)
mark(evaluate-5, to-4)
xcomp(aimed-3, evaluate-5)
det(efficacy-7, the-6)
dobj(evaluate-5, efficacy-7)
case(Cervisol-9, of-8)
nmod:of(efficacy-7, Cervisol-9)
mark(reducing-11, in-10)
advcl(evaluate-5, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(effects-17, of-14)
amod(effects-17, common-15)
amod(effects-17, adverse-16)
nmod:of(risk-13, effects-17)
acl(effects-17, associated-18)
case(mydriasis-20, with-19)
nmod:with(associated-18, mydriasis-20)
nmod:with(associated-18, photophobia-22)
conj:and(mydriasis-20, photophobia-22)
cc(mydriasis-20, and-24)
nmod:with(associated-18, phonophobia-25)
conj:and(mydriasis-20, phonophobia-25)
case(patients-27, in-26)
nmod:in(phonophobia-25, patients-27)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN on/IN a/DT sample/NN of/IN patients/NNS who/WP received/VBD Cervisol/NNP at_a/NNP specific/JJ dosage/NN ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN sample))
            (PP (IN of)
              (NP
                (NP (NNS patients))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD received)
                      (NP (NNP Cervisol) (NNP at_a) (JJ specific) (NN dosage)))))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(sample-7, on-5)
det(sample-7, a-6)
nmod:on(conducted-4, sample-7)
case(patients-9, of-8)
nmod:of(sample-7, patients-9)
nsubj(received-11, patients-9)
ref(patients-9, who-10)
acl:relcl(patients-9, received-11)
compound(dosage-15, Cervisol-12)
compound(dosage-15, at_a-13)
amod(dosage-15, specific-14)
dobj(received-11, dosage-15)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS post-dosing/JJ ,/, Cervisol/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN mydriasis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (ADJP
              (NP (CD 2) (NNS hours))
              (JJ post-dosing)))
          (, ,)
          (NP (NNP Cervisol))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS mydriasis))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(post-dosing-8, at-5)
nummod(hours-7, 2-6)
nmod:npmod(post-dosing-8, hours-7)
advcl(reduced-12, post-dosing-8)
nsubj(reduced-12, Cervisol-10)
advmod(reduced-12, significantly-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(mydriasis-16, of-15)
nmod:of(risk-14, mydriasis-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN Cervisol/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN reducing/VBG the/DT incidence/NN of/IN these/DT adverse/JJ effects/NNS commonly/RB associated/VBN with/IN ophthalmic/JJ procedures/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Cervisol))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN incidence))
                        (PP (IN of)
                          (NP
                            (NP (DT these) (JJ adverse) (NNS effects))
                            (VP
                              (ADVP (RB commonly))
                              (VBN associated)
                              (PP (IN with)
                                (NP (JJ ophthalmic) (NNS procedures))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Cervisol-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(incidence-15, the-14)
dobj(reducing-13, incidence-15)
case(effects-19, of-16)
det(effects-19, these-17)
amod(effects-19, adverse-18)
nmod:of(incidence-15, effects-19)
advmod(associated-21, commonly-20)
acl(effects-19, associated-21)
case(procedures-24, with-22)
amod(procedures-24, ophthalmic-23)
nmod:with(associated-21, procedures-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC determine/VB the/DT optimal/JJ dosage/NN and/CC administration/NN regimen/NN for/IN Cervisol/NNP in/IN clinical/JJ practice/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage))
                  (CC and)
                  (NP
                    (NP (NN administration) (NN regimen))
                    (PP (IN for)
                      (NP (NNP Cervisol)))))
                (PP (IN in)
                  (NP (JJ clinical) (NN practice)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(dosage-13, the-11)
amod(dosage-13, optimal-12)
dobj(determine-10, dosage-13)
cc(dosage-13, and-14)
compound(regimen-16, administration-15)
dobj(determine-10, regimen-16)
conj:and(dosage-13, regimen-16)
case(Cervisol-18, for-17)
nmod:for(regimen-16, Cervisol-18)
case(practice-21, in-19)
amod(practice-21, clinical-20)
nmod:in(determine-10, practice-21)

This/DT study/NN aimed/VBD to/TO investigate/VB the/DT effect/NN of/IN Ethephon/NNP on/IN migraine_symptoms/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NNP Ethephon))))
            (PP (IN on)
              (NP (NNS migraine_symptoms)))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effect-7, the-6)
dobj(investigate-5, effect-7)
case(Ethephon-9, of-8)
nmod:of(effect-7, Ethephon-9)
case(migraine_symptoms-11, on-10)
nmod:on(investigate-5, migraine_symptoms-11)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN patients/NNS with/IN migraine/NN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP (NNS patients)))
        (PP (IN with)
          (NP (NN migraine)))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(patients-11, on-10)
nmod:on(conducted-9, patients-11)
case(migraine-13, with-12)
nmod:with(conducted-9, migraine-13)

Patients/NNPS were/VBD administered/VBN Ethephon/NNP or/CC placebo/NN and/CC were/VBD assessed/VBN for/IN mean_deviation/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN at/IN 2/CD hours/NNS after/IN dosing/VBG ./.

(ROOT
  (S
    (NP (NNPS Patients))
    (VP
      (VP (VBD were)
        (VP (VBN administered)
          (NP
            (NP (NNP Ethephon))
            (CC or)
            (NP (NN placebo)))))
      (CC and)
      (VP (VBD were)
        (VP (VBN assessed)
          (PP (IN for)
            (NP
              (NP (NN mean_deviation))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia))))
          (PP (IN at)
            (NP (CD 2) (NNS hours)))
          (PP (IN after)
            (S
              (VP (VBG dosing)))))))
    (. .)))

nsubjpass(administered-3, Patients-1)
nsubjpass(assessed-9, Patients-1)
auxpass(administered-3, were-2)
root(ROOT-0, administered-3)
dobj(administered-3, Ethephon-4)
cc(Ethephon-4, or-5)
dobj(administered-3, placebo-6)
conj:or(Ethephon-4, placebo-6)
cc(administered-3, and-7)
auxpass(assessed-9, were-8)
conj:and(administered-3, assessed-9)
case(mean_deviation-11, for-10)
nmod:for(assessed-9, mean_deviation-11)
nmod:for(assessed-9, photophobia-13)
conj:and(mean_deviation-11, photophobia-13)
cc(mean_deviation-11, and-15)
nmod:for(assessed-9, phonophobia-16)
conj:and(mean_deviation-11, phonophobia-16)
case(hours-19, at-17)
nummod(hours-19, 2-18)
nmod:at(assessed-9, hours-19)
mark(dosing-21, after-20)
advcl(assessed-9, dosing-21)

Results/NNS showed/VBD that/IN Ethephon/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN mean_deviation/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP Ethephon))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN mean_deviation))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(reduced-6, that-3)
nsubj(reduced-6, Ethephon-4)
advmod(reduced-6, significantly-5)
ccomp(showed-2, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(mean_deviation-10, of-9)
nmod:of(risk-8, mean_deviation-10)
case(%-13, by-11)
nummod(%-13, 14-12)
nmod:by(reduced-6, %-13)
nummod(%-16, 95-15)
dep(%-13, %-16)
acl:relcl(%-16, CI-17)
nummod(%-19, 6-20-18)
dobj(CI-17, %-19)
appos(%-19, P-21)
dep(0.0005-23, =-22)
dep(%-19, 0.0005-23)
xcomp(reduced-6, photophobia-26)
case(%-29, by-27)
nummod(%-29, 17-28)
nmod:by(photophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(photophobia-26, and-42)
xcomp(reduced-6, phonophobia-43)
conj:and(photophobia-26, phonophobia-43)
case(%-46, by-44)
nummod(%-46, 14-45)
nmod:by(phonophobia-43, %-46)
nummod(%-49, 95-48)
appos(%-46, %-49)
dep(%-52, CI-50)
nummod(%-52, 17-20-51)
nmod(%-49, %-52)
dep(%-49, P-54)
compound(0.0001-56, <-55)
nummod(P-54, 0.0001-56)

These/DT findings/NNS suggest/VBP that/IN Ethephon/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN managing/VBG migraine_symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Ethephon))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP (VBG managing) (NNS migraine_symptoms)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Ethephon-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(migraine_symptoms-14, for-12)
amod(migraine_symptoms-14, managing-13)
nmod:for(option-11, migraine_symptoms-14)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG the/DT observed/JJ effects/NNS of/IN Ethephon/NNP on/IN migraine_symptoms/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ observed) (NNS effects))
                      (PP (IN of)
                        (NP (NNP Ethephon)))
                      (PP (IN on)
                        (NP (NNS migraine_symptoms))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
xcomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(warranted-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, potential-12)
dobj(explore-10, mechanisms-13)
acl(mechanisms-13, underlying-14)
det(effects-17, the-15)
amod(effects-17, observed-16)
dobj(underlying-14, effects-17)
case(Ethephon-19, of-18)
nmod:of(effects-17, Ethephon-19)
case(migraine_symptoms-21, on-20)
nmod:on(effects-17, migraine_symptoms-21)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB a/DT significant/JJ impact/NN on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ significant) (NN impact))
                  (PP (IN on)
                    (NP (NN cardiovascular_health))))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
det(impact-21, a-19)
amod(impact-21, significant-20)
dobj(have-18, impact-21)
case(cardiovascular_health-23, on-22)
nmod:on(impact-21, cardiovascular_health-23)

In/IN particular/JJ ,/, these/DT long-chain_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN cetylpyridinium/NN levels/NNS in/IN hypercetylpyridiniummic/JJ patients/NNS ,/, which/WDT may/MD reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (DT these) (NNS long-chain_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NN cetylpyridinium) (NNS levels))
              (PP (IN in)
                (NP
                  (NP (JJ hypercetylpyridiniummic) (NNS patients))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB reduce)
                          (NP
                            (NP
                              (NP (DT the) (NN risk))
                              (PP (IN of)
                                (S
                                  (VP (VBG developing)
                                    (NP (NN coronary_heart_disease))))))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

case(particular-2, In-1)
advcl(associated-8, particular-2)
det(long-chain_fatty_acids-5, these-4)
nsubjpass(associated-8, long-chain_fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-12, with-9)
amod(levels-12, decreased-10)
compound(levels-12, cetylpyridinium-11)
nmod:with(associated-8, levels-12)
case(patients-15, in-13)
amod(patients-15, hypercetylpyridiniummic-14)
nmod:in(levels-12, patients-15)
nsubj(reduce-19, patients-15)
ref(patients-15, which-17)
aux(reduce-19, may-18)
acl:relcl(patients-15, reduce-19)
det(risk-21, the-20)
dobj(reduce-19, risk-21)
mark(developing-23, of-22)
acl(risk-21, developing-23)
dobj(developing-23, coronary_heart_disease-24)
appos(risk-21, CHD-26)

Studies/NNPS have/VBP demonstrated/VBN that/IN EPA/NNP and/CC DHA/NNP can/MD improve/VB lipid/NN profiles/NNS ,/, decrease/VB inflammation/NN and/CC oxidative_stress/NNS ,/, and/CC prevent/VB arrhythmias/NNS ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD can)
              (VP (VB improve)
                (NP (NN lipid) (NNS profiles)))
              (, ,)
              (VP
                (VP (VB decrease)
                  (NP (NN inflammation)
                    (CC and)
                    (NNS oxidative_stress)))
                (, ,)
                (CC and)
                (VP (VB prevent)
                  (NP (NNS arrhythmias)))))))))
    (. .)))

nsubj(demonstrated-3, Studies-1)
aux(demonstrated-3, have-2)
root(ROOT-0, demonstrated-3)
mark(improve-9, that-4)
nsubj(improve-9, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(improve-9, DHA-7)
aux(improve-9, can-8)
ccomp(demonstrated-3, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
dep(improve-9, decrease-13)
dobj(decrease-13, inflammation-14)
cc(inflammation-14, and-15)
dobj(decrease-13, oxidative_stress-16)
conj:and(inflammation-14, oxidative_stress-16)
cc(decrease-13, and-18)
dep(improve-9, prevent-19)
conj:and(decrease-13, prevent-19)
dobj(prevent-19, arrhythmias-20)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB endothelial/JJ function/NN and/CC reduce/VB blood_pressure/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP-TMP (JJ endothelial) (NN function)))
                (CC and)
                (VP (VB reduce)
                  (NP (NN blood_pressure)))))))))
    (. .)))

advmod(shown-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(improve-9, fatty_acids-4)
nsubj:xsubj(reduce-13, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
amod(function-11, endothelial-10)
nmod:tmod(improve-9, function-11)
cc(improve-9, and-12)
xcomp(shown-7, reduce-13)
conj:and(improve-9, reduce-13)
dobj(reduce-13, blood_pressure-14)

Overall/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA)))
      (PP (IN through)
        (NP (JJ dietary) (NNS sources)
          (CC or)
          (NN supplementation))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (CC and)
                (VP (VBG improving)
                  (NP (NN cardiovascular_health)))))))))
    (. .)))

advmod(strategy-18, Overall-1)
det(consumption-4, the-3)
nsubj(strategy-18, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
case(sources-11, through-9)
amod(sources-11, dietary-10)
nmod:through(consumption-4, sources-11)
cc(sources-11, or-12)
nmod:through(consumption-4, supplementation-13)
conj:or(sources-11, supplementation-13)
aux(strategy-18, may-14)
cop(strategy-18, be-15)
det(strategy-18, an-16)
amod(strategy-18, effective-17)
root(ROOT-0, strategy-18)
mark(reducing-20, for-19)
acl(strategy-18, reducing-20)
det(risk-22, the-21)
dobj(reducing-20, risk-22)
case(CHD-24, of-23)
nmod:of(risk-22, CHD-24)
cc(reducing-20, and-25)
acl(strategy-18, improving-26)
conj:and(reducing-20, improving-26)
dobj(improving-26, cardiovascular_health-27)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ beneficial) (NNS effects))
                  (PP (IN on)
                    (NP (JJ human) (NN health))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
nsubj:xsubj(have-26, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(have-26, to-25)
xcomp(shown-24, have-26)
amod(effects-28, beneficial-27)
dobj(have-26, effects-28)
case(health-31, on-29)
amod(health-31, human-30)
nmod:on(effects-28, health-31)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN cyclic_polylactate/JJ levels/NNS in/IN hypercyclic/JJ polylactatemic/JJ patients/NNS ,/, indicating/VBG a/DT potential/JJ role/NN in/IN the/DT treatment/NN of/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ cyclic_polylactate) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hypercyclic) (JJ polylactatemic) (NNS patients))
                        (, ,)
                        (VP (VBG indicating)
                          (NP
                            (NP (DT a) (JJ potential) (NN role))
                            (PP (IN in)
                              (NP
                                (NP (DT the) (NN treatment))
                                (PP (IN of)
                                  (NP (DT this) (NN condition)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, cyclic_polylactate-12)
nmod:with(associated-9, levels-13)
case(patients-17, in-14)
amod(patients-17, hypercyclic-15)
amod(patients-17, polylactatemic-16)
nmod:in(levels-13, patients-17)
acl(patients-17, indicating-19)
det(role-22, a-20)
amod(role-22, potential-21)
dobj(indicating-19, role-22)
case(treatment-25, in-23)
det(treatment-25, the-24)
nmod:in(role-22, treatment-25)
case(condition-28, of-26)
det(condition-28, this-27)
nmod:of(treatment-25, condition-28)

Furthermore/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP
                          (NP
                            (NP (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-)))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-8, Furthermore-1)
nsubjpass(found-8, EPA-3)
nsubj:xsubj(decrease-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(found-8, DHA-5)
nsubj:xsubj(decrease-10, DHA-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(decrease-10, to-9)
xcomp(found-8, decrease-10)
det(risk-12, the-11)
dobj(decrease-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(coronary_heart_disease-15, CHD-17)
det(cause-22, a-20)
amod(cause-22, leading-21)
appos(coronary_heart_disease-15, cause-22)
case(morbidity-24, of-23)
nmod:of(cause-22, morbidity-24)
cc(morbidity-24, and-25)
nmod:of(cause-22, mortality-26)
conj:and(morbidity-24, mortality-26)
advmod(decrease-10, worldwide-27)

The/DT mechanisms/NNS underlying/VBG these/DT beneficial/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, oxidative_stress/NNS ,/, and/CC lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ beneficial) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NNS oxidative_stress))
                (, ,)
                (CC and)
                (NP (NN lipid) (NN metabolism))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
nsubj(involve-14, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, beneficial-5)
dobj(underlying-3, effects-6)
auxpass(understood-10, are-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
aux(involve-14, may-13)
conj:but(understood-10, involve-14)
dobj(involve-14, modulation-15)
case(inflammation-17, of-16)
nmod:of(modulation-15, inflammation-17)
nmod:of(modulation-15, oxidative_stress-19)
conj:and(inflammation-17, oxidative_stress-19)
cc(inflammation-17, and-21)
compound(metabolism-23, lipid-22)
nmod:of(modulation-15, metabolism-23)
conj:and(inflammation-17, metabolism-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT useful/JJ strategy/NN for/IN preventing/VBG and/CC treating/VBG hypercyclic/JJ polylactatemia/NN and/CC CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP (JJ dietary) (NN intake)
                (CC or)
                (NN supplementation))
              (PP (IN with)
                (NP (JJ long-chain) (NN omega-3_fatty_acids)))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ useful) (NN strategy))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG preventing))
                    (CC and)
                    (VP (VBG treating)
                      (NP
                        (NP (JJ hypercyclic) (NN polylactatemia))
                        (CC and)
                        (NP (NNP CHD))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-17, that-4)
csubj(strategy-17, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
cc(intake-7, or-8)
dobj(increasing-5, supplementation-9)
conj:or(intake-7, supplementation-9)
case(omega-3_fatty_acids-12, with-10)
amod(omega-3_fatty_acids-12, long-chain-11)
nmod:with(increasing-5, omega-3_fatty_acids-12)
aux(strategy-17, may-13)
cop(strategy-17, be-14)
det(strategy-17, a-15)
amod(strategy-17, useful-16)
ccomp(suggest-3, strategy-17)
mark(preventing-19, for-18)
advcl(strategy-17, preventing-19)
cc(preventing-19, and-20)
advcl(strategy-17, treating-21)
conj:and(preventing-19, treating-21)
amod(polylactatemia-23, hypercyclic-22)
dobj(treating-21, polylactatemia-23)
cc(polylactatemia-23, and-24)
dobj(treating-21, CHD-25)
conj:and(polylactatemia-23, CHD-25)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS involved/VBN and/CC to/TO optimize/VB dosing/JJ regimens/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ precise) (NNS mechanisms))
                  (VP (VBN involved)))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP (JJ dosing) (NNS regimens))
                (PP (IN for)
                  (NP (JJ different) (JJ patient) (NNS populations)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
cc(elucidate-6, and-11)
mark(optimize-13, to-12)
ccomp(needed-4, optimize-13)
conj:and(elucidate-6, optimize-13)
amod(regimens-15, dosing-14)
dobj(optimize-13, regimens-15)
case(populations-19, for-16)
amod(populations-19, different-17)
amod(populations-19, patient-18)
nmod:for(optimize-13, populations-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN found/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN found)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP (JJ numerous) (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(found-20, nutrients-16)
nsubj:xsubj(have-22, nutrients-16)
ref(nutrients-16, that-17)
aux(found-20, have-18)
auxpass(found-20, been-19)
acl:relcl(nutrients-16, found-20)
mark(have-22, to-21)
xcomp(found-20, have-22)
amod(benefits-25, numerous-23)
compound(benefits-25, health-24)
dobj(have-22, benefits-25)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN EACA/NNP in/IN hyperEACAmic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NNP EACA))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperEACAmic) (NNS patients))
                              (, ,)
                              (ADVP (RB as) (RB well)
                                (PP (IN as)
                                  (NP
                                    (NP (DT a) (VBN decreased) (NN risk))
                                    (PP (IN of)
                                      (S
                                        (VP (VBG developing)
                                          (NP (NN coronary_heart_disease)))))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(EACA-14, of-13)
nmod:of(levels-12, EACA-14)
case(patients-17, in-15)
amod(patients-17, hyperEACAmic-16)
nmod:in(EACA-14, patients-17)
advmod(well-20, as-19)
advmod(patients-17, well-20)
case(risk-24, as-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:as(well-20, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(EACA-14, CHD-29)

These/DT findings/NNS suggest/VBP that/IN incorporating/VBG EPA/NNP and/CC DHA/NNP into/IN one/CD 's/POS diet/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN preventing/VBG or/CC managing/VBG CHD/NNP and/CC related/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG incorporating)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (PP (IN into)
                (NP
                  (NP (CD one) (POS 's))
                  (NN diet)))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT an) (JJ effective) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (CC or)
                    (VBG managing)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ related) (NNS conditions)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-17, that-4)
csubj(strategy-17, incorporating-5)
dobj(incorporating-5, EPA-6)
cc(EPA-6, and-7)
dobj(incorporating-5, DHA-8)
conj:and(EPA-6, DHA-8)
case(diet-12, into-9)
nmod:poss(diet-12, one-10)
case(one-10, 's-11)
nmod:into(incorporating-5, diet-12)
aux(strategy-17, may-13)
cop(strategy-17, be-14)
det(strategy-17, an-15)
amod(strategy-17, effective-16)
ccomp(suggest-3, strategy-17)
mark(preventing-19, for-18)
advcl(strategy-17, preventing-19)
cc(preventing-19, or-20)
advcl(strategy-17, managing-21)
conj:or(preventing-19, managing-21)
dobj(preventing-19, CHD-22)
cc(CHD-22, and-23)
amod(conditions-25, related-24)
dobj(preventing-19, conditions-25)
conj:and(CHD-22, conditions-25)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS ,/, but/CC the/DT evidence/NN thus/RB far/RB suggests/VBZ that/IN omega-3_fatty_acids/JJ may/MD be/VB an/DT important/JJ tool/NN in/IN promoting/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (S
      (ADVP (RB Further))
      (NP (NN research))
      (VP (VBZ is)
        (VP (VBN needed)
          (S
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT the) (NN evidence))
      (ADVP (RB thus) (RB far))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (JJ omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (NP (DT an) (JJ important) (NN tool))
                (PP (IN in)
                  (S
                    (VP (VBG promoting)
                      (NP (NN cardiovascular_health)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(needed-4, but-14)
det(evidence-16, the-15)
nsubj(suggests-19, evidence-16)
advmod(far-18, thus-17)
advmod(suggests-19, far-18)
conj:but(needed-4, suggests-19)
mark(tool-26, that-20)
nsubj(tool-26, omega-3_fatty_acids-21)
aux(tool-26, may-22)
cop(tool-26, be-23)
det(tool-26, an-24)
amod(tool-26, important-25)
ccomp(suggests-19, tool-26)
mark(promoting-28, in-27)
advcl(tool-26, promoting-28)
dobj(promoting-28, cardiovascular_health-29)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP particularly/RB noteworthy/JJ due/JJ to/TO their/PRP$ association/NN with/IN decreased/VBN JWH-015/NN levels/NNS in/IN hyperJWH-015mic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP are) (RB particularly)
        (ADJP
          (ADJP (JJ noteworthy) (JJ due))
          (PP (TO to)
            (NP
              (NP (PRP$ their) (NN association))
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NN JWH-015) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperJWH-015mic) (NNS patients)))))))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(due-25, omega-3_fatty_acids-2)
nsubj(decreased-37, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
cop(due-25, are-22)
advmod(due-25, particularly-23)
amod(due-25, noteworthy-24)
root(ROOT-0, due-25)
case(association-28, to-26)
nmod:poss(association-28, their-27)
nmod:to(due-25, association-28)
case(levels-32, with-29)
amod(levels-32, decreased-30)
compound(levels-32, JWH-015-31)
nmod:with(association-28, levels-32)
case(patients-35, in-33)
amod(patients-35, hyperJWH-015mic-34)
nmod:in(levels-32, patients-35)
cc(due-25, and-36)
conj:and(due-25, decreased-37)
dobj(decreased-37, risk-38)
case(coronary_heart_disease-41, of-39)
amod(coronary_heart_disease-41, developing-40)
nmod:of(risk-38, coronary_heart_disease-41)
appos(coronary_heart_disease-41, CHD-43)

Several/JJ studies/NNS have/VBP demonstrated/VBN that/IN EPA/NNP and/CC DHA/NNP can/MD lower/VB triglyceride_levels/NNS ,/, reduce/VB inflammation/NN ,/, improve/VB endothelial/JJ function/NN ,/, and/CC decrease_blood_pressure/VB ./.

(ROOT
  (S
    (NP (JJ Several) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD can)
              (VP
                (VP (VB lower)
                  (NP (NNS triglyceride_levels)))
                (, ,)
                (VP
                  (VP (VB reduce)
                    (NP (NN inflammation)))
                  (, ,)
                  (VP (VB improve)
                    (NP (JJ endothelial) (NN function)))
                  (, ,)
                  (CC and)
                  (VP (VB decrease_blood_pressure)))))))))
    (. .)))

amod(studies-2, Several-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(lower-10, that-5)
nsubj(lower-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(lower-10, DHA-8)
aux(lower-10, can-9)
ccomp(demonstrated-4, lower-10)
dobj(lower-10, triglyceride_levels-11)
dep(lower-10, reduce-13)
dobj(reduce-13, inflammation-14)
dep(lower-10, improve-16)
conj:and(reduce-13, improve-16)
amod(function-18, endothelial-17)
dobj(improve-16, function-18)
cc(reduce-13, and-20)
dep(lower-10, decrease_blood_pressure-21)
conj:and(reduce-13, decrease_blood_pressure-21)

These/DT effects/NNS may/MD contribute/VB to/TO the/DT observed/JJ reduction/NN in/IN CHD/NNP risk/NN associated/VBN with/IN omega-3_fatty_acid/JJ consumption/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS effects))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (DT the) (JJ observed) (NN reduction))
            (PP (IN in)
              (NP
                (NP (NNP CHD) (NN risk))
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ omega-3_fatty_acid) (NN consumption))))))))))
    (. .)))

det(effects-2, These-1)
nsubj(contribute-4, effects-2)
aux(contribute-4, may-3)
root(ROOT-0, contribute-4)
case(reduction-8, to-5)
det(reduction-8, the-6)
amod(reduction-8, observed-7)
nmod:to(contribute-4, reduction-8)
case(risk-11, in-9)
compound(risk-11, CHD-10)
nmod:in(reduction-8, risk-11)
acl(risk-11, associated-12)
case(consumption-15, with-13)
amod(consumption-15, omega-3_fatty_acid-14)
nmod:with(associated-12, consumption-15)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO inhibit/VB the/DT expression/NN of/IN genes/NNS involved/VBN in/IN lipid/NN metabolism/NN and/CC inflammation/NN ,/, further/RB supporting/VBG their/PRP$ potential/NN as/IN therapeutic/JJ agents/NNS for/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB inhibit)
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP
                      (NP (NNS genes))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NN lipid) (NN metabolism)
                            (CC and)
                            (NN inflammation))))))))))
          (, ,)
          (S
            (ADVP (RB further))
            (VP (VBG supporting)
              (NP (PRP$ their) (NN potential))
              (PP (IN as)
                (NP
                  (NP (JJ therapeutic) (NNS agents))
                  (PP (IN for)
                    (NP (NN cardiovascular_disease))))))))))
    (. .)))

advmod(shown-8, Additionally-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(inhibit-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(inhibit-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(inhibit-10, to-9)
xcomp(shown-8, inhibit-10)
det(expression-12, the-11)
dobj(inhibit-10, expression-12)
case(genes-14, of-13)
nmod:of(expression-12, genes-14)
acl(genes-14, involved-15)
case(metabolism-18, in-16)
compound(metabolism-18, lipid-17)
nmod:in(involved-15, metabolism-18)
cc(metabolism-18, and-19)
nmod:in(involved-15, inflammation-20)
conj:and(metabolism-18, inflammation-20)
advmod(supporting-23, further-22)
xcomp(shown-8, supporting-23)
nmod:poss(potential-25, their-24)
dobj(supporting-23, potential-25)
case(agents-28, as-26)
amod(agents-28, therapeutic-27)
nmod:as(supporting-23, agents-28)
case(cardiovascular_disease-30, for-29)
nmod:for(agents-28, cardiovascular_disease-30)

While/IN further/JJ research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS ,/, the/DT existing/VBG evidence/NN suggests/VBZ that/IN increased/VBN consumption/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG CHD/NNP risk/NN in/IN hyperJWH-015mic/JJ patients/NNS ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP (JJ further) (NN research))
        (VP (VBZ is)
          (VP (VBN needed)
            (S
              (VP (TO to)
                (VP
                  (ADVP (RB fully))
                  (VB understand)
                  (NP
                    (NP (DT the) (NNS mechanisms))
                    (VP (VBG underlying)
                      (NP (DT these) (NNS effects)))))))))))
    (, ,)
    (NP (DT the) (VBG existing) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBN increased) (NN consumption))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (NNP CHD) (NN risk))
                        (PP (IN in)
                          (NP (JJ hyperJWH-015mic) (NNS patients)))))))))))))
    (. .)))

mark(needed-5, While-1)
amod(research-3, further-2)
nsubjpass(needed-5, research-3)
nsubj:xsubj(understand-8, research-3)
auxpass(needed-5, is-4)
advcl(suggests-18, needed-5)
mark(understand-8, to-6)
advmod(understand-8, fully-7)
xcomp(needed-5, understand-8)
det(mechanisms-10, the-9)
dobj(understand-8, mechanisms-10)
acl(mechanisms-10, underlying-11)
det(effects-13, these-12)
dobj(underlying-11, effects-13)
det(evidence-17, the-15)
amod(evidence-17, existing-16)
nsubj(suggests-18, evidence-17)
root(ROOT-0, suggests-18)
mark(strategy-30, that-19)
amod(consumption-21, increased-20)
nsubj(strategy-30, consumption-21)
case(EPA-23, of-22)
nmod:of(consumption-21, EPA-23)
cc(EPA-23, and-24)
nmod:of(consumption-21, DHA-25)
conj:and(EPA-23, DHA-25)
aux(strategy-30, may-26)
cop(strategy-30, be-27)
det(strategy-30, an-28)
amod(strategy-30, effective-29)
ccomp(suggests-18, strategy-30)
mark(reducing-32, for-31)
acl(strategy-30, reducing-32)
compound(risk-34, CHD-33)
dobj(reducing-32, risk-34)
case(patients-37, in-35)
amod(patients-37, hyperJWH-015mic-36)
nmod:in(risk-34, patients-37)

In/IN the/DT field/NN of/IN oncology/NN ,/, monitoring/NN biomarkers/NNS can/MD provide/VB valuable/JJ information/NN for/IN diagnosis/NN and/CC treatment/NN selection/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN field))
        (PP (IN of)
          (NP (NN oncology)))))
    (, ,)
    (NP (NN monitoring) (NNS biomarkers))
    (VP (MD can)
      (VP (VB provide)
        (NP (JJ valuable) (NN information))
        (PP (IN for)
          (NP
            (ADJP (NN diagnosis)
              (CC and)
              (NN treatment))
            (NN selection)))))
    (. .)))

case(field-3, In-1)
det(field-3, the-2)
nmod:in(provide-10, field-3)
case(oncology-5, of-4)
nmod:of(field-3, oncology-5)
compound(biomarkers-8, monitoring-7)
nsubj(provide-10, biomarkers-8)
aux(provide-10, can-9)
root(ROOT-0, provide-10)
amod(information-12, valuable-11)
dobj(provide-10, information-12)
case(selection-17, for-13)
amod(selection-17, diagnosis-14)
cc(diagnosis-14, and-15)
conj:and(diagnosis-14, treatment-16)
amod(selection-17, treatment-16)
nmod:for(provide-10, selection-17)

Alkaline_phosphatase/NNP -LRB-/-LRB- ALP/NNP -RRB-/-RRB- and/CC sulfatase/NN are/VBP two/CD such/JJ biomarkers/NNS that/WDT have/VBP been/VBN investigated/VBN for/IN their/PRP$ potential/JJ clinical/JJ significance/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Alkaline_phosphatase))
        (-LRB- -LRB-)
        (NP (NNP ALP))
        (-RRB- -RRB-))
      (CC and)
      (NP (NN sulfatase)))
    (VP (VBP are)
      (NP
        (NP (CD two) (JJ such) (NNS biomarkers))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN investigated)
                  (PP (IN for)
                    (NP (PRP$ their) (JJ potential) (JJ clinical) (NN significance))))))))))
    (. .)))

nsubj(biomarkers-10, Alkaline_phosphatase-1)
dep(Alkaline_phosphatase-1, ALP-3)
cc(Alkaline_phosphatase-1, and-5)
conj:and(Alkaline_phosphatase-1, sulfatase-6)
nsubj(biomarkers-10, sulfatase-6)
cop(biomarkers-10, are-7)
nummod(biomarkers-10, two-8)
amod(biomarkers-10, such-9)
root(ROOT-0, biomarkers-10)
nsubjpass(investigated-14, biomarkers-10)
ref(biomarkers-10, that-11)
aux(investigated-14, have-12)
auxpass(investigated-14, been-13)
acl:relcl(biomarkers-10, investigated-14)
case(significance-19, for-15)
nmod:poss(significance-19, their-16)
amod(significance-19, potential-17)
amod(significance-19, clinical-18)
nmod:for(investigated-14, significance-19)

In/IN this/DT study/NN ,/, the/DT correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP ,/, Irosustat/NNP ,/, and/CC sulfatase/NN was/VBD examined/VBN in_a/NN cohort/NN of/IN cancer/NN patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN correlation))
      (PP (IN between)
        (NP
          (NP (NN serum) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NNP ALP))
              (, ,)
              (NP (NNP Irosustat))
              (, ,)
              (CC and)
              (NP (NN sulfatase)))))))
    (VP (VBD was)
      (VP (VBN examined)
        (NP
          (NP (NN in_a) (NN cohort))
          (PP (IN of)
            (NP (NN cancer) (NNS patients))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(examined-18, study-3)
det(correlation-6, the-5)
nsubjpass(examined-18, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(ALP-11, of-10)
nmod:of(levels-9, ALP-11)
nmod:of(levels-9, Irosustat-13)
conj:and(ALP-11, Irosustat-13)
cc(ALP-11, and-15)
nmod:of(levels-9, sulfatase-16)
conj:and(ALP-11, sulfatase-16)
auxpass(examined-18, was-17)
root(ROOT-0, examined-18)
compound(cohort-20, in_a-19)
dobj(examined-18, cohort-20)
case(patients-23, of-21)
compound(patients-23, cancer-22)
nmod:of(cohort-20, patients-23)

Results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, Irosustat/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, and/CC serum/NN sulfatase/NN levels/NNS ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (NP
        (NP
          (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
          (PP (IN between)
            (NP (NN serum) (NNS levels)))
          (PP (IN of)
            (NP (NNP ALP)))
          (PRN (-LRB- -LRB-)
            (SBAR
              (X (SYM r))
              (S
                (FRAG
                  (X (SYM =))
                  (NP (CD 0.3)))
                (, ,)
                (NP (NN p))
                (VP (VBP <)
                  (NP (CD 0.01)))))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NNP Irosustat))
          (PRN (-LRB- -LRB-)
            (SBAR
              (X (SYM r))
              (S
                (FRAG
                  (X (SYM =))
                  (NP (CD 0.42)))
                (, ,)
                (NP (NN p))
                (VP (VBP <)
                  (NP (CD 0.01)))))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP (NN serum) (NN sulfatase) (NNS levels))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
det(correlation-6, a-3)
amod(correlation-6, significant-4)
amod(correlation-6, positive-5)
dobj(showed-2, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(ALP-11, of-10)
nmod:of(correlation-6, ALP-11)
dep(<-18, r-13)
dep(0.3-15, =-14)
dep(<-18, 0.3-15)
nsubj(<-18, p-17)
dep(correlation-6, <-18)
dobj(<-18, 0.01-19)
dobj(showed-2, Irosustat-22)
conj:and(correlation-6, Irosustat-22)
dep(<-29, r-24)
dep(0.42-26, =-25)
dep(<-29, 0.42-26)
nsubj(<-29, p-28)
dep(Irosustat-22, <-29)
dobj(<-29, 0.01-30)
cc(correlation-6, and-33)
compound(levels-36, serum-34)
compound(levels-36, sulfatase-35)
dobj(showed-2, levels-36)
conj:and(correlation-6, levels-36)

These/DT findings/NNS suggest/VBP that/IN these/DT biomarkers/NNS may/MD be/VB useful/JJ in/IN monitoring/VBG disease/NN progression/NN and/CC treatment/NN response/NN in/IN cancer/NN patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS biomarkers))
          (VP (MD may)
            (VP (VB be)
              (ADJP (JJ useful)
                (PP (IN in)
                  (S
                    (VP (VBG monitoring)
                      (NP
                        (NP (NN disease) (NN progression))
                        (CC and)
                        (NP
                          (NP (NN treatment) (NN response))
                          (PP (IN in)
                            (NP (NN cancer) (NNS patients))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(useful-9, that-4)
det(biomarkers-6, these-5)
nsubj(useful-9, biomarkers-6)
aux(useful-9, may-7)
cop(useful-9, be-8)
ccomp(suggest-3, useful-9)
mark(monitoring-11, in-10)
advcl(useful-9, monitoring-11)
compound(progression-13, disease-12)
dobj(monitoring-11, progression-13)
cc(progression-13, and-14)
compound(response-16, treatment-15)
dobj(monitoring-11, response-16)
conj:and(progression-13, response-16)
case(patients-19, in-17)
compound(patients-19, cancer-18)
nmod:in(response-16, patients-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO validate/VB these/DT results/NNS and/CC determine/VB the/DT clinical/JJ utility/NN of/IN these/DT biomarkers/NNS in/IN oncology/JJ practice/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB validate)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ clinical) (NN utility))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS biomarkers))
                      (PP (IN in)
                        (NP (JJ oncology) (NN practice))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(validate-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(validate-6, to-5)
xcomp(needed-4, validate-6)
det(results-8, these-7)
dobj(validate-6, results-8)
cc(validate-6, and-9)
xcomp(needed-4, determine-10)
conj:and(validate-6, determine-10)
det(utility-13, the-11)
amod(utility-13, clinical-12)
dobj(determine-10, utility-13)
case(biomarkers-16, of-14)
det(biomarkers-16, these-15)
nmod:of(utility-13, biomarkers-16)
case(practice-19, in-17)
amod(practice-19, oncology-18)
nmod:in(biomarkers-16, practice-19)

Non-alcoholic_fatty_liver_disease/JJ -LRB-/-LRB- NAFLD/NNP -RRB-/-RRB- is_a/NN common/JJ metabolic_disorder/NN characterized/VBD by/IN excessive/JJ accumulation/NN of/IN lipids/NNS in/IN the/DT liver/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Non-alcoholic_fatty_liver_disease)
        (PRN (-LRB- -LRB-)
          (NP (NNP NAFLD))
          (-RRB- -RRB-))
        (NN is_a))
      (NP (JJ common) (NN metabolic_disorder)))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ excessive) (NN accumulation))
          (PP (IN of)
            (NP (NNS lipids)))))
      (PP (IN in)
        (NP (DT the) (NN liver))))
    (. .)))

amod(is_a-5, Non-alcoholic_fatty_liver_disease-1)
appos(is_a-5, NAFLD-3)
nsubj(characterized-8, is_a-5)
amod(metabolic_disorder-7, common-6)
dep(is_a-5, metabolic_disorder-7)
root(ROOT-0, characterized-8)
case(accumulation-11, by-9)
amod(accumulation-11, excessive-10)
nmod:by(characterized-8, accumulation-11)
case(lipids-13, of-12)
nmod:of(accumulation-11, lipids-13)
case(liver-16, in-14)
det(liver-16, the-15)
nmod:in(characterized-8, liver-16)

The/DT regulation/NN of/IN lipid/NN metabolism/NN is_a/NN complex/JJ process/NN involving/VBG several/JJ transcription/NN factors/NNS such/JJ as/IN sterol_regulatory_element-binding_protein_1c/JJ -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- ,/, fatty_acid_synthase/NN -LRB-/-LRB- FAS/NNP -RRB-/-RRB- ,/, and/CC ATP-binding_cassette_transporter_G2/NNS -LRB-/-LRB- ABCG2/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN lipid) (NN metabolism))))
    (VP (NN is_a)
      (NP (JJ complex) (NN process))
      (S
        (VP (VBG involving)
          (S
            (NP (JJ several) (NN transcription) (NNS factors))
            (ADJP (JJ such)
              (PP (IN as)
                (NP
                  (NP
                    (NP (JJ sterol_regulatory_element-binding_protein_1c) (-LRB- -LRB-) (NNS SREBP-1c) (-RRB- -RRB-))
                    (, ,)
                    (NP (NN fatty_acid_synthase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP FAS))
                      (-RRB- -RRB-)))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (NNS ATP-binding_cassette_transporter_G2))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP ABCG2))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(regulation-2, The-1)
nsubj(is_a-6, regulation-2)
case(metabolism-5, of-3)
compound(metabolism-5, lipid-4)
nmod:of(regulation-2, metabolism-5)
root(ROOT-0, is_a-6)
amod(process-8, complex-7)
dobj(is_a-6, process-8)
xcomp(is_a-6, involving-9)
amod(factors-12, several-10)
compound(factors-12, transcription-11)
nsubj(such-13, factors-12)
xcomp(involving-9, such-13)
case(SREBP-1c-17, as-14)
amod(SREBP-1c-17, sterol_regulatory_element-binding_protein_1c-15)
nmod:as(such-13, SREBP-1c-17)
appos(SREBP-1c-17, fatty_acid_synthase-20)
appos(SREBP-1c-17, FAS-22)
cc(SREBP-1c-17, and-25)
nmod:as(such-13, ATP-binding_cassette_transporter_G2-26)
conj:and(SREBP-1c-17, ATP-binding_cassette_transporter_G2-26)
appos(ATP-binding_cassette_transporter_G2-26, ABCG2-28)

This/DT study/NN aimed/VBN to/TO investigate/VB the/DT effects/NNS of/IN the/DT synthetic/JJ liver_X_receptor/NN -LRB-/-LRB- LXR/NNP -RRB-/-RRB- agonist/VBD LY3009120/NNP on/IN the/DT expression/NN of/IN these/DT lipogenic/JJ genes/NNS in/IN C57BL/6J/CD mice/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN study))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (DT the) (JJ synthetic) (NN liver_X_receptor))))))))
      (PRN (-LRB- -LRB-)
        (NP (NNP LXR))
        (-RRB- -RRB-)))
    (VP (VBD agonist)
      (NP (NNP LY3009120))
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP (DT these) (JJ lipogenic) (NNS genes)))))
      (PP (IN in)
        (NP (CD C57BL/6J) (NNS mice))))
    (. .)))

det(study-2, This-1)
nsubj(agonist-15, study-2)
acl(study-2, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effects-7, the-6)
dobj(investigate-5, effects-7)
case(liver_X_receptor-11, of-8)
det(liver_X_receptor-11, the-9)
amod(liver_X_receptor-11, synthetic-10)
nmod:of(effects-7, liver_X_receptor-11)
appos(study-2, LXR-13)
root(ROOT-0, agonist-15)
dobj(agonist-15, LY3009120-16)
case(expression-19, on-17)
det(expression-19, the-18)
nmod:on(agonist-15, expression-19)
case(genes-23, of-20)
det(genes-23, these-21)
amod(genes-23, lipogenic-22)
nmod:of(expression-19, genes-23)
case(mice-26, in-24)
nummod(mice-26, C57BL/6J-25)
nmod:in(agonist-15, mice-26)

The/DT results/NNS showed/VBD that/IN administration/NN of/IN LY3009120/CD at_a/NN dose/NN of/IN 10/CD mg/kg/day/RB for/IN four/CD days/NNS induced/VBN the/DT expression/NN of/IN Srebp-1c/NNS ,/, Fas/NNP ,/, and/CC rABCG2/JJ in/IN the/DT liver/NN ,/, which/WDT was/VBD associated/VBN with/IN massive/JJ hepatic_steatosis/NNS along/IN the/DT entire/JJ liver/NN lobule/NN and/CC a/DT 2.5-fold/JJ increase/NN in/IN very_low_density_lipoprotein-triglyceride/JJ -LRB-/-LRB- VLDL-TG/NNP -RRB-/-RRB- secretion/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN administration))
            (PP (IN of)
              (NP
                (NP
                  (NP (CD LY3009120) (NN at_a) (NN dose))
                  (PP (IN of)
                    (NP (CD 10))))
                (CONJP (RB mg/kg/day) (IN for))
                (NP (CD four) (NNS days)))))
          (VP
            (VP (VBN induced)
              (NP
                (NP (DT the) (NN expression))
                (PP (IN of)
                  (NP
                    (NP (NNS Srebp-1c))
                    (, ,)
                    (NP (NNP Fas))
                    (, ,)))))
            (CC and)
            (VP (JJ rABCG2)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN liver))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBD was)
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (JJ massive) (NNS hepatic_steatosis))
                              (PP (IN along)
                                (NP
                                  (NP (DT the) (JJ entire) (NN liver) (NN lobule))
                                  (CC and)
                                  (NP (DT a) (JJ 2.5-fold) (NN increase))))))
                          (PP (IN in)
                            (NP (JJ very_low_density_lipoprotein-triglyceride)
                              (PRN (-LRB- -LRB-)
                                (NP (NNP VLDL-TG))
                                (-RRB- -RRB-))
                              (NNS secretion))))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(induced-16, that-4)
nsubj(induced-16, administration-5)
nsubj(rABCG2-25, administration-5)
case(dose-9, of-6)
nummod(dose-9, LY3009120-7)
compound(dose-9, at_a-8)
nmod:of(administration-5, dose-9)
case(10-11, of-10)
nmod:of(dose-9, 10-11)
cc(dose-9, mg/kg/day-12)
dep(mg/kg/day-12, for-13)
nummod(days-15, four-14)
nmod:of(administration-5, days-15)
conj:mg/kg/day(dose-9, days-15)
ccomp(showed-3, induced-16)
det(expression-18, the-17)
dobj(induced-16, expression-18)
case(Srebp-1c-20, of-19)
nmod:of(expression-18, Srebp-1c-20)
appos(Srebp-1c-20, Fas-22)
cc(induced-16, and-24)
ccomp(showed-3, rABCG2-25)
conj:and(induced-16, rABCG2-25)
case(liver-28, in-26)
det(liver-28, the-27)
nmod:in(rABCG2-25, liver-28)
nsubjpass(associated-32, liver-28)
ref(liver-28, which-30)
auxpass(associated-32, was-31)
acl:relcl(liver-28, associated-32)
case(hepatic_steatosis-35, with-33)
amod(hepatic_steatosis-35, massive-34)
nmod:with(associated-32, hepatic_steatosis-35)
case(lobule-40, along-36)
det(lobule-40, the-37)
amod(lobule-40, entire-38)
compound(lobule-40, liver-39)
nmod:along(hepatic_steatosis-35, lobule-40)
cc(lobule-40, and-41)
det(increase-44, a-42)
amod(increase-44, 2.5-fold-43)
nmod:along(hepatic_steatosis-35, increase-44)
conj:and(lobule-40, increase-44)
case(secretion-50, in-45)
amod(secretion-50, very_low_density_lipoprotein-triglyceride-46)
appos(secretion-50, VLDL-TG-48)
nmod:in(associated-32, secretion-50)

These/DT findings/NNS suggest/VBP that/IN activation/NN of/IN LXR/NNP signaling/VBG pathway/RB may/MD contribute/VB to/TO the/DT development/NN of/IN NAFLD/NNP by/IN promoting/VBG hepatic_lipid_accumulation/JJ and/CC VLDL-TG/JJ secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (NNP LXR)))
            (VP (VBG signaling)
              (ADVP (RB pathway))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NNP NAFLD)))))
              (PP (IN by)
                (S
                  (VP (VBG promoting)
                    (NP
                      (ADJP (JJ hepatic_lipid_accumulation)
                        (CC and)
                        (JJ VLDL-TG))
                      (NN secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-11, that-4)
nsubj(contribute-11, activation-5)
case(LXR-7, of-6)
nmod:of(activation-5, LXR-7)
acl(activation-5, signaling-8)
advmod(signaling-8, pathway-9)
aux(contribute-11, may-10)
ccomp(suggest-3, contribute-11)
case(development-14, to-12)
det(development-14, the-13)
nmod:to(contribute-11, development-14)
case(NAFLD-16, of-15)
nmod:of(development-14, NAFLD-16)
mark(promoting-18, by-17)
advcl(contribute-11, promoting-18)
amod(secretion-22, hepatic_lipid_accumulation-19)
cc(hepatic_lipid_accumulation-19, and-20)
conj:and(hepatic_lipid_accumulation-19, VLDL-TG-21)
amod(secretion-22, VLDL-TG-21)
dobj(promoting-18, secretion-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT potential/JJ therapeutic/JJ targets/NNS for/IN NAFLD/NNP by/IN targeting/VBG LXR/NNP signaling/VBG pathway/RB ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS targets))
                (PP (IN for)
                  (NP (NNP NAFLD))))
              (PP (IN by)
                (S
                  (VP (VBG targeting)
                    (NP (NNP LXR))
                    (S
                      (VP (VBG signaling)
                        (ADVP (RB pathway))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(targets-10, the-7)
amod(targets-10, potential-8)
amod(targets-10, therapeutic-9)
dobj(explore-6, targets-10)
case(NAFLD-12, for-11)
nmod:for(targets-10, NAFLD-12)
mark(targeting-14, by-13)
advcl(explore-6, targeting-14)
dobj(targeting-14, LXR-15)
advcl(targeting-14, signaling-16)
advmod(signaling-16, pathway-17)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ a/DT series/NN of/IN molecular/JJ events/NNS leading/VBG to/TO the/DT formation/NN of/IN multinucleated/JJ myotubes/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT a) (NN series))
                (PP (IN of)
                  (NP
                    (NP (JJ molecular) (NNS events))
                    (VP (VBG leading)
                      (PP (TO to)
                        (NP
                          (NP (DT the) (NN formation))
                          (PP (IN of)
                            (NP (JJ multinucleated) (NNS myotubes))))))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(series-10, a-9)
dobj(involves-8, series-10)
case(events-13, of-11)
amod(events-13, molecular-12)
nmod:of(series-10, events-13)
acl(events-13, leading-14)
case(formation-17, to-15)
det(formation-17, the-16)
nmod:to(leading-14, formation-17)
case(myotubes-20, of-18)
amod(myotubes-20, multinucleated-19)
nmod:of(formation-17, myotubes-20)

Nuclear_hormone_receptor/NNP NHR-176/NNP has_been/VBP identified/VBN as/IN a/DT key/JJ regulator/NN of/IN this/DT process/NN ./.

(ROOT
  (S
    (NP (NNP Nuclear_hormone_receptor) (NNP NHR-176))
    (VP (VBP has_been)
      (VP (VBN identified)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ key) (NN regulator))
            (PP (IN of)
              (NP (DT this) (NN process)))))))
    (. .)))

compound(NHR-176-2, Nuclear_hormone_receptor-1)
nsubj(has_been-3, NHR-176-2)
root(ROOT-0, has_been-3)
dep(has_been-3, identified-4)
case(regulator-8, as-5)
det(regulator-8, a-6)
amod(regulator-8, key-7)
nmod:as(identified-4, regulator-8)
case(process-11, of-9)
det(process-11, this-10)
nmod:of(regulator-8, process-11)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN Tiabendazole/NNP on/IN NHR-176/JJ protein/NN levels/NNS and/CC half-life/NN in/IN C2C12/CD cells/NNS cultured/VBN in/IN differentiation/JJ medium/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP Tiabendazole))))
      (PP (IN on)
        (NP
          (NP (JJ NHR-176) (NN protein) (NNS levels))
          (CC and)
          (NP (NN half-life))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (PP (IN in)
              (NP (JJ differentiation) (NN medium)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(Tiabendazole-10, of-9)
nmod:of(effect-8, Tiabendazole-10)
case(levels-14, on-11)
amod(levels-14, NHR-176-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
cc(levels-14, and-15)
nmod:on(investigated-6, half-life-16)
conj:and(levels-14, half-life-16)
case(cells-19, in-17)
nummod(cells-19, C2C12-18)
nmod:in(investigated-6, cells-19)
acl(cells-19, cultured-20)
case(medium-23, in-21)
amod(medium-23, differentiation-22)
nmod:in(cultured-20, medium-23)

Our/PRP$ results/NNS show/VBP that/IN Tiabendazole/NNP up-regulated/VBD NHR-176/JJ protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN ,/, with/IN a/DT maximum/JJ effect/NN observed/VBD at/IN 48/CD hours/NNS post-treatment/JJ ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (NNP Tiabendazole))
          (VP (VBD up-regulated)
            (NP (JJ NHR-176) (NN protein) (NNS levels))
            (SBAR
              (S
                (NP
                  (NP (JJ in_a) (JJ time-dependent) (NN manner))
                  (, ,)
                  (PP (IN with)
                    (NP (DT a) (JJ maximum) (NN effect))))
                (VP (VBD observed)
                  (ADVP (IN at)
                    (NP (CD 48) (NNS hours)))
                  (ADJP (JJ post-treatment)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(up-regulated-6, that-4)
nsubj(up-regulated-6, Tiabendazole-5)
ccomp(show-3, up-regulated-6)
amod(levels-9, NHR-176-7)
compound(levels-9, protein-8)
dobj(up-regulated-6, levels-9)
amod(manner-12, in_a-10)
amod(manner-12, time-dependent-11)
nsubj(observed-18, manner-12)
case(effect-17, with-14)
det(effect-17, a-15)
amod(effect-17, maximum-16)
nmod:with(manner-12, effect-17)
dep(up-regulated-6, observed-18)
case(hours-21, at-19)
nummod(hours-21, 48-20)
advmod(observed-18, hours-21)
xcomp(observed-18, post-treatment-22)

Furthermore/RB ,/, Tiabendazole/VBZ prolonged/JJ NHR-176/NN protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ,/, indicating/VBG that/IN it/PRP may/MD stabilize/VB the/DT protein/NN ./.

(ROOT
  (SQ
    (ADVP (RB Furthermore))
    (, ,) (VBZ Tiabendazole)
    (NP (JJ prolonged) (NN NHR-176) (NN protein))
    (NP
      (NP (NN half-life))
      (PP (IN from)
        (NP
          (NP
            (QP (CD 10) (TO to) (CD 18))
            (NNS hours))
          (, ,)
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP (PRP it))
                (VP (MD may)
                  (VP (VB stabilize)
                    (NP (DT the) (NN protein))))))))))
    (. .)))

advmod(Tiabendazole-3, Furthermore-1)
root(ROOT-0, Tiabendazole-3)
amod(protein-6, prolonged-4)
compound(protein-6, NHR-176-5)
nsubj(Tiabendazole-3, protein-6)
dep(Tiabendazole-3, half-life-7)
case(hours-12, from-8)
compound(18-11, 10-9)
dep(18-11, to-10)
nummod(hours-12, 18-11)
nmod:from(half-life-7, hours-12)
acl(hours-12, indicating-14)
mark(stabilize-18, that-15)
nsubj(stabilize-18, it-16)
aux(stabilize-18, may-17)
ccomp(indicating-14, stabilize-18)
det(protein-20, the-19)
dobj(stabilize-18, protein-20)

These/DT findings/NNS suggest/VBP that/IN Tiabendazole/NNP may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN promoting/VBG skeletal_muscle/JJ differentiation_and/JJ regeneration/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Tiabendazole))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (S
                      (VP (VBG promoting)
                        (NP (JJ skeletal_muscle) (JJ differentiation_and) (NN regeneration))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, Tiabendazole-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(have-7, agent-12)
mark(promoting-14, for-13)
acl(agent-12, promoting-14)
amod(regeneration-17, skeletal_muscle-15)
amod(regeneration-17, differentiation_and-16)
dobj(promoting-14, regeneration-17)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN linked/VBN to/TO numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP (JJ numerous) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(linked-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(linked-16, have-14)
auxpass(linked-16, been-15)
root(ROOT-0, linked-16)
case(benefits-20, to-17)
amod(benefits-20, numerous-18)
compound(benefits-20, health-19)
nmod:to(linked-16, benefits-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN T-20/NN levels/NNS in/IN hyperT-20mic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN T-20) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperT-20mic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP
                                      (NP (DT a) (VBN decreased) (NN risk))
                                      (PP (IN of)
                                        (S
                                          (VP (VBG developing)
                                            (NP (NN coronary_heart_disease))))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-9, omega-3_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, T-20-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperT-20mic-15)
nmod:in(levels-13, patients-16)
nsubj(contribute-20, patients-16)
ref(patients-16, which-18)
aux(contribute-20, may-19)
acl:relcl(patients-16, contribute-20)
case(risk-24, to-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:to(contribute-20, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ properties/NNS ,/, which/WDT may/MD explain/VB their/PRP$ protective/JJ effects/NNS on/IN the/DT cardiovascular/JJ system/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ anti-inflammatory) (NNS properties))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB explain)
                        (NP (PRP$ their) (JJ protective) (NNS effects))
                        (PP (IN on)
                          (NP (DT the) (JJ cardiovascular) (NN system)))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(have-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(have-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(have-7, to-6)
xcomp(known-5, have-7)
amod(properties-9, anti-inflammatory-8)
dobj(have-7, properties-9)
nsubj(explain-13, properties-9)
ref(properties-9, which-11)
aux(explain-13, may-12)
acl:relcl(properties-9, explain-13)
nmod:poss(effects-16, their-14)
amod(effects-16, protective-15)
dobj(explain-13, effects-16)
case(system-20, on-17)
det(system-20, the-18)
amod(system-20, cardiovascular-19)
nmod:on(explain-13, system-20)

In/IN addition/NN ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS ,/, reduce/VB blood_pressure/NN ,/, and/CC decrease/VB the/DT risk/NN of/IN arrhythmias/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP (NN blood_pressure)))
                (, ,)
                (CC and)
                (VP (VB decrease)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS arrhythmias)))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-8, addition-2)
det(fatty_acids-5, these-4)
nsubjpass(shown-8, fatty_acids-5)
nsubj:xsubj(improve-10, fatty_acids-5)
nsubj:xsubj(reduce-14, fatty_acids-5)
nsubj:xsubj(decrease-18, fatty_acids-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(improve-10, to-9)
xcomp(shown-8, improve-10)
compound(profiles-12, lipid-11)
dobj(improve-10, profiles-12)
xcomp(shown-8, reduce-14)
conj:and(improve-10, reduce-14)
dobj(reduce-14, blood_pressure-15)
cc(improve-10, and-17)
xcomp(shown-8, decrease-18)
conj:and(improve-10, decrease-18)
det(risk-20, the-19)
dobj(decrease-18, risk-20)
case(arrhythmias-22, of-21)
nmod:of(risk-20, arrhythmias-22)

Overall/RB ,/, increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT incidence/NN of/IN CHD/NNP and/CC improving/VBG cardiovascular_health/NN in/IN hyperT-20mic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT a) (JJ promising) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN incidence))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (CC and)
                (VP (VBG improving)
                  (NP
                    (NP (NN cardiovascular_health))
                    (PP (IN in)
                      (NP (JJ hyperT-20mic) (NNS patients)))))))))))
    (. .)))

advmod(strategy-13, Overall-1)
csubj(strategy-13, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(omega-3_fatty_acids-8, of-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nmod:of(intake-5, omega-3_fatty_acids-8)
aux(strategy-13, may-9)
cop(strategy-13, be-10)
det(strategy-13, a-11)
amod(strategy-13, promising-12)
root(ROOT-0, strategy-13)
mark(reducing-15, for-14)
acl(strategy-13, reducing-15)
det(incidence-17, the-16)
dobj(reducing-15, incidence-17)
case(CHD-19, of-18)
nmod:of(incidence-17, CHD-19)
cc(reducing-15, and-20)
acl(strategy-13, improving-21)
conj:and(reducing-15, improving-21)
dobj(improving-21, cardiovascular_health-22)
case(patients-25, in-23)
amod(patients-25, hyperT-20mic-24)
nmod:in(cardiovascular_health-22, patients-25)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/JJ -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/JJ -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB a/DT variety/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (NP
          (NP
            (NP (JJ eicosapentaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 20:5) (JJ n-3))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (NP (JJ docosahexaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 22:6) (JJ n-3))
            (-RRB- -RRB-)))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (NN variety))
                  (PP (IN of)
                    (NP (NN health) (NNS benefits))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-25, omega-3_fatty_acids-2)
nsubj:xsubj(have-27, omega-3_fatty_acids-2)
advcl(shown-25, including-4)
dobj(including-4, eicosapentaenoic_acid-5)
dep(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
amod(eicosapentaenoic_acid-5, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dobj(including-4, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dep(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
amod(docosahexaenoic_acid-14, n-3-20)
aux(shown-25, have-23)
auxpass(shown-25, been-24)
root(ROOT-0, shown-25)
mark(have-27, to-26)
xcomp(shown-25, have-27)
det(variety-29, a-28)
dobj(have-27, variety-29)
case(benefits-32, of-30)
compound(benefits-32, health-31)
nmod:of(variety-29, benefits-32)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS may/MD be/VB associated/VBN with/IN decreased/VBN levels/NNS of/IN pegaptanib/NN in/IN hyperpegaptanibmic/JJ patients/NNS ,/, indicating/VBG a/DT potential/JJ role/NN for/IN these/DT compounds/NNS in/IN the/DT treatment/NN of/IN certain/JJ diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (NNS levels))
                      (PP (IN of)
                        (NP
                          (NP (NN pegaptanib))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperpegaptanibmic) (NNS patients))
                              (, ,)
                              (VP (VBG indicating)
                                (NP
                                  (NP (DT a) (JJ potential) (NN role))
                                  (PP (IN for)
                                    (NP
                                      (NP (DT these) (NNS compounds))
                                      (PP (IN in)
                                        (NP
                                          (NP (DT the) (NN treatment))
                                          (PP (IN of)
                                            (NP (JJ certain) (NNS diseases))))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(demonstrated-4, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(pegaptanib-15, of-14)
nmod:of(levels-13, pegaptanib-15)
case(patients-18, in-16)
amod(patients-18, hyperpegaptanibmic-17)
nmod:in(pegaptanib-15, patients-18)
acl(patients-18, indicating-20)
det(role-23, a-21)
amod(role-23, potential-22)
dobj(indicating-20, role-23)
case(compounds-26, for-24)
det(compounds-26, these-25)
nmod:for(role-23, compounds-26)
case(treatment-29, in-27)
det(treatment-29, the-28)
nmod:in(compounds-26, treatment-29)
case(diseases-32, of-30)
amod(diseases-32, certain-31)
nmod:of(treatment-29, diseases-32)

Additionally/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(shown-7, Additionally-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(shown-7, omega-3_fatty_acids-4)
nsubj:xsubj(decrease-9, omega-3_fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(decrease-9, to-8)
xcomp(shown-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

While/IN the/DT mechanisms/NNS underlying/VBG this/DT protective/JJ effect/NN are/VBP not/RB yet/RB fully/RB understood/VBN ,/, it/PRP is/VBZ thought/VBN that/IN these/DT compounds/NNS may/MD help/VB to/TO reduce/VB inflammation/NN and/CC improve/VB lipid/NN metabolism/NN ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (NNS mechanisms))
          (VP (VBG underlying)
            (NP (DT this) (JJ protective) (NN effect))))
        (VP (VBP are) (RB not)
          (ADVP (RB yet))
          (VP
            (ADVP (RB fully))
            (VBN understood)))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (VP (VBN thought)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS compounds))
            (VP (MD may)
              (VP (VB help)
                (S
                  (VP (TO to)
                    (VP
                      (VP (VB reduce)
                        (NP (NN inflammation)))
                      (CC and)
                      (VP (VB improve)
                        (NP (NN lipid) (NN metabolism))))))))))))
    (. .)))

mark(understood-12, While-1)
det(mechanisms-3, the-2)
nsubjpass(understood-12, mechanisms-3)
acl(mechanisms-3, underlying-4)
det(effect-7, this-5)
amod(effect-7, protective-6)
dobj(underlying-4, effect-7)
auxpass(understood-12, are-8)
neg(understood-12, not-9)
advmod(understood-12, yet-10)
advmod(understood-12, fully-11)
advcl(thought-16, understood-12)
nsubjpass(thought-16, it-14)
auxpass(thought-16, is-15)
root(ROOT-0, thought-16)
mark(help-21, that-17)
det(compounds-19, these-18)
nsubj(help-21, compounds-19)
nsubj:xsubj(reduce-23, compounds-19)
nsubj:xsubj(improve-26, compounds-19)
aux(help-21, may-20)
ccomp(thought-16, help-21)
mark(reduce-23, to-22)
xcomp(help-21, reduce-23)
dobj(reduce-23, inflammation-24)
cc(reduce-23, and-25)
xcomp(help-21, improve-26)
conj:and(reduce-23, improve-26)
compound(metabolism-28, lipid-27)
dobj(improve-26, metabolism-28)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT relationship/NN between/IN long-chain/JJ omega-3_fatty_acids/NNS and/CC both/DT pegaptanib/JJ levels/NNS and/CC CHD/NNP risk/NN ,/, but/CC these/DT findings/NNS suggest/VBP that/IN these/DT compounds/NNS may/MD hold/VB promise/NN as/IN therapeutic/JJ agents/NNS for/IN a/DT range/NN of/IN conditions/NNS ./.

(ROOT
  (S
    (S
      (ADVP (RB Further))
      (NP (NN research))
      (VP (VBZ is)
        (VP (VBN needed)
          (S
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NN relationship))
                  (PP (IN between)
                    (NP
                      (NP (JJ long-chain) (NNS omega-3_fatty_acids))
                      (CC and)
                      (NP (DT both)
                        (NX
                          (NX (JJ pegaptanib) (NNS levels))
                          (CC and)
                          (NX (NNP CHD) (NN risk)))))))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT these) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS compounds))
            (VP (MD may)
              (VP (VB hold)
                (NP (NN promise))
                (PP (IN as)
                  (NP
                    (NP (JJ therapeutic) (NNS agents))
                    (PP (IN for)
                      (NP
                        (NP (DT a) (NN range))
                        (PP (IN of)
                          (NP (NNS conditions)))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(relationship-9, the-8)
dobj(elucidate-7, relationship-9)
case(omega-3_fatty_acids-12, between-10)
amod(omega-3_fatty_acids-12, long-chain-11)
nmod:between(relationship-9, omega-3_fatty_acids-12)
cc(omega-3_fatty_acids-12, and-13)
det(levels-16, both-14)
amod(levels-16, pegaptanib-15)
nmod:between(relationship-9, levels-16)
conj:and(omega-3_fatty_acids-12, levels-16)
cc(levels-16, and-17)
compound(risk-19, CHD-18)
conj:and(omega-3_fatty_acids-12, risk-19)
conj:and(levels-16, risk-19)
cc(needed-4, but-21)
det(findings-23, these-22)
nsubj(suggest-24, findings-23)
conj:but(needed-4, suggest-24)
mark(hold-29, that-25)
det(compounds-27, these-26)
nsubj(hold-29, compounds-27)
aux(hold-29, may-28)
ccomp(suggest-24, hold-29)
dobj(hold-29, promise-30)
case(agents-33, as-31)
amod(agents-33, therapeutic-32)
nmod:as(hold-29, agents-33)
case(range-36, for-34)
det(range-36, a-35)
nmod:for(agents-33, range-36)
case(conditions-38, of-37)
nmod:of(range-36, conditions-38)

Non-steroidal/JJ anti-inflammatory/JJ drugs/NNS -LRB-/-LRB- NSAIDs/NNP -RRB-/-RRB- have/VBP been/VBN used/VBN for/IN decades/NNS to/TO treat/VB various/JJ inflammatory/JJ conditions/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Non-steroidal) (JJ anti-inflammatory) (NNS drugs))
      (PRN (-LRB- -LRB-)
        (NP (NNP NSAIDs))
        (-RRB- -RRB-)))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN used)
          (PP (IN for)
            (NP (NNS decades)))
          (S
            (VP (TO to)
              (VP (VB treat)
                (NP (JJ various) (JJ inflammatory) (NNS conditions))))))))
    (. .)))

amod(drugs-3, Non-steroidal-1)
amod(drugs-3, anti-inflammatory-2)
nsubjpass(used-9, drugs-3)
nsubj:xsubj(treat-13, drugs-3)
appos(drugs-3, NSAIDs-5)
aux(used-9, have-7)
auxpass(used-9, been-8)
root(ROOT-0, used-9)
case(decades-11, for-10)
nmod:for(used-9, decades-11)
mark(treat-13, to-12)
xcomp(used-9, treat-13)
amod(conditions-16, various-14)
amod(conditions-16, inflammatory-15)
dobj(treat-13, conditions-16)

Sulindac/JJ is_a/NN commonly/RB prescribed/VBN NSAID/VBD that/IN has_been/VBP shown/VBN to/TO have/VB photoprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Sulindac) (NN is_a))
      (ADJP (RB commonly) (VBN prescribed)))
    (VP (VBD NSAID)
      (SBAR (IN that)
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB have)
                    (NP (JJ photoprotective) (NNS effects))))))))))
    (. .)))

amod(is_a-2, Sulindac-1)
nsubj(NSAID-5, is_a-2)
advmod(prescribed-4, commonly-3)
amod(is_a-2, prescribed-4)
root(ROOT-0, NSAID-5)
mark(has_been-7, that-6)
ccomp(NSAID-5, has_been-7)
dep(has_been-7, shown-8)
mark(have-10, to-9)
xcomp(shown-8, have-10)
amod(effects-12, photoprotective-11)
dobj(have-10, effects-12)

In/IN a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ,/, the/DT effect/NN of/IN sulindac/NN on/IN phototoxic_reactions/NNS was/VBD evaluated/VBN in/IN 200/CD patients/NNS with/IN a/DT history/NN of/IN photosensitivity/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN sulindac))
          (PP (IN on)
            (NP (NNS phototoxic_reactions))))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (NP (CD 200) (NNS patients)))
        (PP (IN with)
          (NP
            (NP (DT a) (NN history))
            (PP (IN of)
              (NP (NN photosensitivity)))))))
    (. .)))

case(trial-8, In-1)
det(trial-8, a-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(evaluated-17, trial-8)
det(effect-11, the-10)
nsubjpass(evaluated-17, effect-11)
case(sulindac-13, of-12)
nmod:of(effect-11, sulindac-13)
case(phototoxic_reactions-15, on-14)
nmod:on(sulindac-13, phototoxic_reactions-15)
auxpass(evaluated-17, was-16)
root(ROOT-0, evaluated-17)
case(patients-20, in-18)
nummod(patients-20, 200-19)
nmod:in(evaluated-17, patients-20)
case(history-23, with-21)
det(history-23, a-22)
nmod:with(evaluated-17, history-23)
case(photosensitivity-25, of-24)
nmod:of(history-23, photosensitivity-25)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, sulindac/JJ reduced/VBD the/DT risk/NN of/IN phototoxic_reactions/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (JJ sulindac))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS phototoxic_reactions))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, sulindac-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(phototoxic_reactions-11, of-10)
nmod:of(risk-9, phototoxic_reactions-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN sulindac/NN may/MD be/VB an/DT effective/JJ option/NN for/IN preventing/VBG and/CC treating/VBG photosensitivity/RB in/IN patients/NNS with/IN a/DT history/NN of/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN sulindac))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN option))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG preventing))
                      (CC and)
                      (VP (VBG treating)
                        (ADVP (RB photosensitivity))
                        (PP (IN in)
                          (NP (NNS patients))))))))
              (PP (IN with)
                (NP
                  (NP (DT a) (NN history))
                  (PP (IN of)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-10, that-4)
nsubj(option-10, sulindac-5)
aux(option-10, may-6)
cop(option-10, be-7)
det(option-10, an-8)
amod(option-10, effective-9)
ccomp(suggest-3, option-10)
mark(preventing-12, for-11)
acl(option-10, preventing-12)
cc(preventing-12, and-13)
acl(option-10, treating-14)
conj:and(preventing-12, treating-14)
advmod(treating-14, photosensitivity-15)
case(patients-17, in-16)
nmod:in(treating-14, patients-17)
case(history-20, with-18)
det(history-20, a-19)
nmod:with(option-10, history-20)
case(condition-23, of-21)
det(condition-23, this-22)
nmod:of(history-20, condition-23)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN sulindac/NN in/IN this/DT context/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP (NN sulindac))))
                (PP (IN in)
                  (NP (DT this) (NN context)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(explore-6, to-5)
ccomp(warranted-4, explore-6)
det(mechanisms-8, the-7)
dobj(explore-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(explore-6, and-12)
mark(determine-14, to-13)
ccomp(warranted-4, determine-14)
conj:and(explore-6, determine-14)
det(regimen-18, the-15)
amod(regimen-18, optimal-16)
amod(regimen-18, dosing-17)
dobj(determine-14, regimen-18)
case(sulindac-20, for-19)
nmod:for(regimen-18, sulindac-20)
case(context-23, in-21)
det(context-23, this-22)
nmod:in(determine-14, context-23)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN various/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN programs/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ various) (VBG signaling) (NNS pathways))
                    (CC and)
                    (NP (NN gene) (NN expression) (NNS programs))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, various-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)
cc(pathways-14, and-15)
compound(programs-18, gene-16)
compound(programs-18, expression-17)
nmod:of(activation-10, programs-18)
conj:and(pathways-14, programs-18)

Prostaglandin/NNP H/NNP synthase_1/NNP -LRB-/-LRB- PGHS-1/NNP -RRB-/-RRB- is/VBZ an/DT important/JJ enzyme/NN involved/VBN in/IN the/DT biosynthesis/NNS of/IN prostaglandins/NNS ,/, which/WDT have/VBP been/VBN shown/VBN to/TO play/VB a/DT role/NN in/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Prostaglandin) (NNP H) (NNP synthase_1))
      (PRN (-LRB- -LRB-)
        (NP (NNP PGHS-1))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ important) (NN enzyme))
        (VP (VBN involved)
          (PP (IN in)
            (NP
              (NP (DT the) (NNS biosynthesis))
              (PP (IN of)
                (NP
                  (NP (NNS prostaglandins))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBP have)
                        (VP (VBN been)
                          (VP (VBN shown)
                            (S
                              (VP (TO to)
                                (VP (VB play)
                                  (NP
                                    (NP (DT a) (NN role))
                                    (PP (IN in)
                                      (NP (JJ skeletal_muscle) (NN differentiation)))))))))))))))))))
    (. .)))

compound(synthase_1-3, Prostaglandin-1)
compound(synthase_1-3, H-2)
nsubj(enzyme-10, synthase_1-3)
appos(synthase_1-3, PGHS-1-5)
cop(enzyme-10, is-7)
det(enzyme-10, an-8)
amod(enzyme-10, important-9)
root(ROOT-0, enzyme-10)
acl(enzyme-10, involved-11)
case(biosynthesis-14, in-12)
det(biosynthesis-14, the-13)
nmod:in(involved-11, biosynthesis-14)
case(prostaglandins-16, of-15)
nmod:of(biosynthesis-14, prostaglandins-16)
nsubjpass(shown-21, prostaglandins-16)
nsubj:xsubj(play-23, prostaglandins-16)
ref(prostaglandins-16, which-18)
aux(shown-21, have-19)
auxpass(shown-21, been-20)
acl:relcl(prostaglandins-16, shown-21)
mark(play-23, to-22)
xcomp(shown-21, play-23)
det(role-25, a-24)
dobj(play-23, role-25)
case(differentiation-28, in-26)
amod(differentiation-28, skeletal_muscle-27)
nmod:in(role-25, differentiation-28)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN Parsalmide/NNP on/IN PGHS-1/JJ protein/NN levels/NNS and/CC half-life/NN in/IN differentiating/VBG C2C12/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP Parsalmide))))
      (PP (IN on)
        (NP
          (NP (JJ PGHS-1) (NN protein) (NNS levels))
          (CC and)
          (NP (NN half-life))))
      (PP (IN in)
        (S
          (VP (VBG differentiating)
            (NP (CD C2C12) (NNS cells))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(Parsalmide-10, of-9)
nmod:of(effect-8, Parsalmide-10)
case(levels-14, on-11)
amod(levels-14, PGHS-1-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
cc(levels-14, and-15)
nmod:on(investigated-6, half-life-16)
conj:and(levels-14, half-life-16)
mark(differentiating-18, in-17)
advcl(investigated-6, differentiating-18)
nummod(cells-20, C2C12-19)
dobj(differentiating-18, cells-20)

When/WRB C2C12/JJ cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, Parsalmide/NNP up-regulated/JJ PGH_synthase_1/NNS protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ PGH_synthase_1/NNS protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (SBARQ
    (WHNP
      (WHADJP (WRB When) (JJ C2C12))
      (NNS cells))
    (SQ (VBD were)
      (VP (VBN cultured)
        (NP (NN in_a)
          (NX
            (NX
              (NX (NN medium) (VBG favoring) (NN differentiation))
              (PRN (-LRB- -LRB-)
                (NAC (NNP Dulbecco)
                  (PP (VBN modified)
                    (NP
                      (NP (NNP Eagle) (NN medium))
                      (VP (VBG containing)
                        (NP
                          (ADJP (CD 2) (NN %))
                          (NN horse) (NN serum))))))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NNP Parsalmide) (JJ up-regulated) (NNS PGH_synthase_1))
                (NP
                  (NP (NN protein) (NNS levels))
                  (NP (NN in_a) (JJ time-dependent) (NN manner)))))
            (CC and)
            (NX (JJ prolonged) (NNS PGH_synthase_1)))
          (NX (NN protein) (NN half-life)))
        (PP (IN from)
          (NP
            (QP (CD 10) (TO to) (CD 18))
            (NNS hours)))))
    (. .)))

advmod(C2C12-2, When-1)
amod(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
dep(half-life-34, in_a-6)
compound(differentiation-9, medium-7)
amod(differentiation-9, favoring-8)
dep(half-life-34, differentiation-9)
dep(differentiation-9, Dulbecco-11)
case(medium-14, modified-12)
compound(medium-14, Eagle-13)
nmod:modified(Dulbecco-11, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
compound(PGH_synthase_1-24, Parsalmide-22)
amod(PGH_synthase_1-24, up-regulated-23)
dep(differentiation-9, PGH_synthase_1-24)
compound(levels-26, protein-25)
dep(PGH_synthase_1-24, levels-26)
compound(manner-29, in_a-27)
amod(manner-29, time-dependent-28)
dep(levels-26, manner-29)
cc(differentiation-9, and-30)
amod(PGH_synthase_1-32, prolonged-31)
conj:and(differentiation-9, PGH_synthase_1-32)
dep(half-life-34, PGH_synthase_1-32)
compound(half-life-34, protein-33)
dobj(cultured-5, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(cultured-5, hours-39)

These/DT findings/NNS suggest/VBP that/IN Parsalmide/NNP may/MD play/VB a/DT role/NN in/IN skeletal_muscle/JJ differentiation/NN by/IN modulating/VBG PGHS-1/JJ expression/NN and/CC activity/NN ,/, and/CC may/MD have/VB potential/JJ therapeutic/JJ applications/NNS for/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Parsalmide))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP (JJ skeletal_muscle) (NN differentiation))))
                (PP (IN by)
                  (S
                    (VP (VBG modulating)
                      (NP (JJ PGHS-1) (NN expression)
                        (CC and)
                        (NN activity)))))))
            (, ,)
            (CC and)
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN for)
                    (NP (NNS muscle-related_disorders))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, Parsalmide-5)
nsubj(have-22, Parsalmide-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
case(differentiation-12, in-10)
amod(differentiation-12, skeletal_muscle-11)
nmod:in(role-9, differentiation-12)
mark(modulating-14, by-13)
advcl(play-7, modulating-14)
amod(expression-16, PGHS-1-15)
dobj(modulating-14, expression-16)
cc(expression-16, and-17)
dobj(modulating-14, activity-18)
conj:and(expression-16, activity-18)
cc(play-7, and-20)
aux(have-22, may-21)
ccomp(suggest-3, have-22)
conj:and(play-7, have-22)
amod(applications-25, potential-23)
amod(applications-25, therapeutic-24)
dobj(have-22, applications-25)
case(muscle-related_disorders-27, for-26)
nmod:for(applications-25, muscle-related_disorders-27)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN Parsalmide-induced/JJ effects/NNS on/IN PGHS-1/NN in/IN differentiating/VBG C2C12/CD cells/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (JJ Parsalmide-induced) (NNS effects))
                    (PP (IN on)
                      (NP (NN PGHS-1))))))
              (PP (IN in)
                (S
                  (VP (VBG differentiating)
                    (NP (CD C2C12) (NNS cells))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
xcomp(warranted-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(effects-12, of-10)
amod(effects-12, Parsalmide-induced-11)
nmod:of(mechanisms-9, effects-12)
case(PGHS-1-14, on-13)
nmod:on(effects-12, PGHS-1-14)
mark(differentiating-16, in-15)
advcl(elucidate-6, differentiating-16)
nummod(cells-18, C2C12-17)
dobj(differentiating-16, cells-18)

The/DT calcium/calmodulin-dependent/JJ _/NN protein_kinase_II/VBZ -LRB-/-LRB- CaM-KII/NNP -RRB-/-RRB- is_a/JJ key/JJ regulator/NN of_skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ calcium/calmodulin-dependent) (NN _))
    (VP (VBZ protein_kinase_II)
      (NP
        (NP
          (NP (-LRB- -LRB-) (NNP CaM-KII) (-RRB- -RRB-))
          (NP (JJ is_a) (JJ key) (NN regulator)))
        (NP (JJ of_skeletal_muscle) (NN differentiation))))
    (. .)))

det(_-3, The-1)
amod(_-3, calcium/calmodulin-dependent-2)
nsubj(protein_kinase_II-4, _-3)
root(ROOT-0, protein_kinase_II-4)
dobj(protein_kinase_II-4, CaM-KII-6)
amod(regulator-10, is_a-8)
amod(regulator-10, key-9)
dep(CaM-KII-6, regulator-10)
amod(differentiation-12, of_skeletal_muscle-11)
dep(CaM-KII-6, differentiation-12)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN the/DT nucleoside/JJ analog/JJ CAFdA/NN on/IN CaM-KII/JJ protein/NN levels/NNS and/CC half-life/NN in/IN cultured/JJ C2C12/NN cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ nucleoside) (JJ analog) (NN CAFdA))
            (PP (IN on)
              (NP (JJ CaM-KII) (NN protein) (NNS levels)
                (CC and)
                (NN half-life))))))
      (PP (IN in)
        (NP (JJ cultured) (NN C2C12) (NNS cells))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(CAFdA-13, of-9)
det(CAFdA-13, the-10)
amod(CAFdA-13, nucleoside-11)
amod(CAFdA-13, analog-12)
nmod:of(effect-8, CAFdA-13)
case(levels-17, on-14)
amod(levels-17, CaM-KII-15)
compound(levels-17, protein-16)
nmod:on(CAFdA-13, levels-17)
cc(levels-17, and-18)
nmod:on(CAFdA-13, half-life-19)
conj:and(levels-17, half-life-19)
case(cells-23, in-20)
amod(cells-23, cultured-21)
compound(cells-23, C2C12-22)
nmod:in(investigated-6, cells-23)

When/WRB cells/NNS were/VBD cultured/VBN in_a/JJ differentiation-favoring/JJ medium/NN ,/, CAFdA/NNP treatment/NN up-regulated/VBD CaM-KII/JJ protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/VBN its/PRP$ half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (NP (JJ in_a) (JJ differentiation-favoring) (NN medium))))))
    (, ,)
    (NP (NNP CAFdA) (NN treatment))
    (VP
      (VP (VBD up-regulated)
        (NP (JJ CaM-KII) (NN protein) (NNS levels))
        (NP (JJ in_a) (JJ time-dependent) (NN manner)))
      (CC and)
      (VP (VBN prolonged)
        (NP (PRP$ its) (NN half-life))
        (PP (IN from)
          (NP
            (QP (CD 10) (TO to) (CD 18))
            (NNS hours)))))
    (. .)))

advmod(cultured-4, When-1)
nsubjpass(cultured-4, cells-2)
auxpass(cultured-4, were-3)
advcl(up-regulated-11, cultured-4)
amod(medium-7, in_a-5)
amod(medium-7, differentiation-favoring-6)
dobj(cultured-4, medium-7)
compound(treatment-10, CAFdA-9)
nsubj(up-regulated-11, treatment-10)
nsubj(prolonged-19, treatment-10)
root(ROOT-0, up-regulated-11)
amod(levels-14, CaM-KII-12)
compound(levels-14, protein-13)
iobj(up-regulated-11, levels-14)
amod(manner-17, in_a-15)
amod(manner-17, time-dependent-16)
dobj(up-regulated-11, manner-17)
cc(up-regulated-11, and-18)
conj:and(up-regulated-11, prolonged-19)
nmod:poss(half-life-21, its-20)
dobj(prolonged-19, half-life-21)
case(hours-26, from-22)
compound(18-25, 10-23)
dep(18-25, to-24)
nummod(hours-26, 18-25)
nmod:from(prolonged-19, hours-26)

These/DT findings/NNS suggest/VBP that/IN CAFdA/NNP may/MD enhance/VB skeletal_muscle/JJ differentiation/NN by/IN modulating/VBG CaM-KII/JJ activity/NN and/CC stability/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP CAFdA))
          (VP (MD may)
            (VP (VB enhance)
              (NP (JJ skeletal_muscle) (NN differentiation))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP (JJ CaM-KII) (NN activity)
                      (CC and)
                      (NN stability))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(enhance-7, that-4)
nsubj(enhance-7, CAFdA-5)
aux(enhance-7, may-6)
ccomp(suggest-3, enhance-7)
amod(differentiation-9, skeletal_muscle-8)
dobj(enhance-7, differentiation-9)
mark(modulating-11, by-10)
advcl(enhance-7, modulating-11)
amod(activity-13, CaM-KII-12)
dobj(modulating-11, activity-13)
cc(activity-13, and-14)
dobj(modulating-11, stability-15)
conj:and(activity-13, stability-15)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/JJ molecular/JJ mechanisms/NNS and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN CAFdA/NNP in/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (JJ underlying) (JJ molecular) (NNS mechanisms))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP CAFdA))))
                (PP (IN in)
                  (NP (NNS muscle-related_disorders)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-10, the-7)
amod(mechanisms-10, underlying-8)
amod(mechanisms-10, molecular-9)
dobj(elucidate-6, mechanisms-10)
cc(elucidate-6, and-11)
mark(explore-13, to-12)
ccomp(needed-4, explore-13)
conj:and(elucidate-6, explore-13)
det(applications-17, the-14)
amod(applications-17, potential-15)
amod(applications-17, therapeutic-16)
dobj(explore-13, applications-17)
case(CAFdA-19, of-18)
nmod:of(applications-17, CAFdA-19)
case(muscle-related_disorders-21, in-20)
nmod:in(explore-13, muscle-related_disorders-21)

Vasoactive_intestinal_peptide/JJ -LRB-/-LRB- VIP/NNP -RRB-/-RRB- is_a/NNS neuropeptide/VBP widely/RB distributed/VBN throughout/IN the/DT body/NN that/WDT plays/VBZ an/DT important/JJ role/NN in/IN several/JJ physiological/JJ processes/NNS ./.

(ROOT
  (S
    (NP (JJ Vasoactive_intestinal_peptide)
      (PRN (-LRB- -LRB-)
        (NP (NNP VIP))
        (-RRB- -RRB-))
      (NNS is_a))
    (VP (VBP neuropeptide)
      (ADVP (RB widely))
      (VP (VBN distributed)
        (PP (IN throughout)
          (NP
            (NP (DT the) (NN body))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBZ plays)
                  (NP
                    (NP (DT an) (JJ important) (NN role))
                    (PP (IN in)
                      (NP (JJ several) (JJ physiological) (NNS processes)))))))))))
    (. .)))

amod(is_a-5, Vasoactive_intestinal_peptide-1)
appos(is_a-5, VIP-3)
nsubj(neuropeptide-6, is_a-5)
root(ROOT-0, neuropeptide-6)
advmod(neuropeptide-6, widely-7)
dep(neuropeptide-6, distributed-8)
case(body-11, throughout-9)
det(body-11, the-10)
nmod:throughout(distributed-8, body-11)
nsubj(plays-13, body-11)
ref(body-11, that-12)
acl:relcl(body-11, plays-13)
det(role-16, an-14)
amod(role-16, important-15)
dobj(plays-13, role-16)
case(processes-20, in-17)
amod(processes-20, several-18)
amod(processes-20, physiological-19)
nmod:in(role-16, processes-20)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN VIP/NNP can/MD modulate/VBP the/DT activity/NN of/IN hPim-2/NN ,/, a/DT serine/threonine/JJ _/JJ kinase/NN that/WDT regulates/VBZ cell/NN cycle/NN progression/NN and/CC apoptosis/NNS ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP VIP))
            (VP (MD can)
              (VP (VBP modulate)
                (NP
                  (NP (DT the) (NN activity))
                  (PP (IN of)
                    (NP
                      (NP (NN hPim-2))
                      (, ,)
                      (NP
                        (NP (DT a) (JJ serine/threonine) (JJ _) (NN kinase))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBZ regulates)
                              (NP
                                (NP (NN cell) (NN cycle) (NN progression))
                                (CC and)
                                (NP (NNS apoptosis))))))))))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(modulate-8, that-5)
nsubj(modulate-8, VIP-6)
aux(modulate-8, can-7)
ccomp(shown-4, modulate-8)
det(activity-10, the-9)
dobj(modulate-8, activity-10)
case(hPim-2-12, of-11)
nmod:of(activity-10, hPim-2-12)
det(kinase-17, a-14)
amod(kinase-17, serine/threonine-15)
amod(kinase-17, _-16)
appos(hPim-2-12, kinase-17)
nsubj(regulates-19, kinase-17)
ref(kinase-17, that-18)
acl:relcl(kinase-17, regulates-19)
compound(progression-22, cell-20)
compound(progression-22, cycle-21)
dobj(regulates-19, progression-22)
cc(progression-22, and-23)
dobj(regulates-19, apoptosis-24)
conj:and(progression-22, apoptosis-24)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN a/DT VIP/NNP antagonist/NN -LSB-/VBG 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP and/CC a/DT putative/JJ hPim-2/JJ antagonist/NN hPim-2/JJ -LRB-/-LRB- 6-38/CD -RRB-/-RRB- on/IN the/DT PYR-41/NN response/NN to/TO hPim-2/JJ and/CC VIP/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (DT a) (NNP VIP) (NN antagonist))))
        (VP (VBG -LSB-)
          (S
            (NP
              (NP (JJ 4Cl-D-Phe6))
              (, ,)
              (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
              (CC and)
              (NP (DT a) (JJ putative) (JJ hPim-2) (NN antagonist)))
            (ADJP (JJ hPim-2))))
        (PRN (-LRB- -LRB-)
          (NP (CD 6-38))
          (-RRB- -RRB-)))
      (PP (IN on)
        (NP (DT the) (NN PYR-41) (NN response)))
      (PP (TO to)
        (NP (JJ hPim-2)
          (CC and)
          (NNP VIP))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(antagonist-12, of-9)
det(antagonist-12, a-10)
compound(antagonist-12, VIP-11)
nmod:of(effects-8, antagonist-12)
acl(effects-8, -LSB--13)
nsubj(hPim-2-24, 4Cl-D-Phe6-14)
compound(VIP-18, Leu17-16)
compound(VIP-18, -RSB--17)
conj:and(4Cl-D-Phe6-14, VIP-18)
nsubj(hPim-2-24, VIP-18)
cc(4Cl-D-Phe6-14, and-19)
det(antagonist-23, a-20)
amod(antagonist-23, putative-21)
amod(antagonist-23, hPim-2-22)
conj:and(4Cl-D-Phe6-14, antagonist-23)
nsubj(hPim-2-24, antagonist-23)
xcomp(-LSB--13, hPim-2-24)
appos(effects-8, 6-38-26)
case(response-31, on-28)
det(response-31, the-29)
compound(response-31, PYR-41-30)
nmod:on(investigated-6, response-31)
case(hPim-2-33, to-32)
nmod:to(investigated-6, hPim-2-33)
cc(hPim-2-33, and-34)
nmod:to(investigated-6, VIP-35)
conj:and(hPim-2-33, VIP-35)

Our/PRP$ results/NNS showed/VBD that/IN -LSB-/NNP 4Cl-D-Phe6/CD ,/, Leu17/NNP -RSB-/NNP VIP/NNP had/VBD no/DT effect/NN on/IN the/DT PYR-41/JJ response/NN to/TO either/DT hPim-2/NN or/CC VIP/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP -LSB-) (CD 4Cl-D-Phe6))
            (, ,)
            (NP (NNP Leu17) (NNP -RSB-) (NNP VIP)))
          (VP (VBD had)
            (NP
              (NP (DT no) (NN effect))
              (PP (IN on)
                (NP
                  (NP (DT the) (JJ PYR-41) (NN response))
                  (PP (TO to)
                    (NP
                      (NP (DT either) (NN hPim-2))
                      (CC or)
                      (NP (NNP VIP)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-11, that-4)
nsubj(had-11, -LSB--5)
nummod(-LSB--5, 4Cl-D-Phe6-6)
compound(VIP-10, Leu17-8)
compound(VIP-10, -RSB--9)
appos(-LSB--5, VIP-10)
ccomp(showed-3, had-11)
neg(effect-13, no-12)
dobj(had-11, effect-13)
case(response-17, on-14)
det(response-17, the-15)
amod(response-17, PYR-41-16)
nmod:on(effect-13, response-17)
case(hPim-2-20, to-18)
det(hPim-2-20, either-19)
nmod:to(response-17, hPim-2-20)
cc(hPim-2-20, or-21)
nmod:to(response-17, VIP-22)
conj:or(hPim-2-20, VIP-22)

On/IN the/DT other/JJ hand/NN ,/, hPim-2/JJ -LRB-/-LRB- 6-38/NNP -RRB-/-RRB- ,/, a/DT putative/JJ hPim-2/JJ antagonist/NN ,/, blocked/VBD the/DT PYR-41/JJ response/NN to/TO hPim-2/JJ ./.

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (ADVP (JJ hPim-2))
    (NP
      (NP (-LRB- -LRB-) (NNP 6-38) (-RRB- -RRB-))
      (, ,)
      (NP (DT a) (JJ putative) (JJ hPim-2) (NN antagonist))
      (, ,))
    (VP (VBD blocked)
      (NP
        (NP (DT the) (JJ PYR-41) (NN response))
        (PP (TO to)
          (NP (JJ hPim-2)))))
    (. .)))

case(hand-4, On-1)
det(hand-4, the-2)
amod(hand-4, other-3)
nmod:on(blocked-16, hand-4)
advmod(blocked-16, hPim-2-6)
nsubj(blocked-16, 6-38-8)
det(antagonist-14, a-11)
amod(antagonist-14, putative-12)
amod(antagonist-14, hPim-2-13)
appos(6-38-8, antagonist-14)
root(ROOT-0, blocked-16)
det(response-19, the-17)
amod(response-19, PYR-41-18)
dobj(blocked-16, response-19)
case(hPim-2-21, to-20)
nmod:to(response-19, hPim-2-21)

These/DT findings/NNS suggest/VBP that/IN hPim-2/JJ may/MD be/VB involved/VBN in/IN the/DT downstream/JJ signaling/VBG pathway/NN of/IN VIP/NNP and/CC provide/VB insight/NN into/IN potential/JJ therapeutic/JJ targets/NNS for/IN diseases/NNS associated/VBN with/IN dysregulated/JJ VIP/NN signaling/VBG ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ hPim-2))
          (VP
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (JJ downstream) (VBG signaling) (NN pathway))
                      (PP (IN of)
                        (NP (NNP VIP))))))))
            (CC and)
            (VP (VB provide)
              (NP (NN insight))
              (PP (IN into)
                (NP (JJ potential) (JJ therapeutic) (NNS targets)))
              (PP (IN for)
                (NP
                  (NP (NNS diseases))
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP (JJ dysregulated) (NN VIP))))))
              (S
                (VP (VBG signaling))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-8, that-4)
nsubjpass(involved-8, hPim-2-5)
nsubj(provide-17, hPim-2-5)
aux(involved-8, may-6)
auxpass(involved-8, be-7)
ccomp(suggest-3, involved-8)
case(pathway-13, in-9)
det(pathway-13, the-10)
amod(pathway-13, downstream-11)
amod(pathway-13, signaling-12)
nmod:in(involved-8, pathway-13)
case(VIP-15, of-14)
nmod:of(pathway-13, VIP-15)
cc(involved-8, and-16)
ccomp(suggest-3, provide-17)
conj:and(involved-8, provide-17)
dobj(provide-17, insight-18)
case(targets-22, into-19)
amod(targets-22, potential-20)
amod(targets-22, therapeutic-21)
nmod:into(provide-17, targets-22)
case(diseases-24, for-23)
nmod:for(provide-17, diseases-24)
acl(diseases-24, associated-25)
case(VIP-28, with-26)
amod(VIP-28, dysregulated-27)
nmod:with(associated-25, VIP-28)
xcomp(provide-17, signaling-29)

In/IN recent/JJ years/NNS ,/, there/EX has_been/VBP a/DT growing/VBG interest/NN in/IN the/DT development/NN of/IN drugs/NNS that/WDT can/MD up-regulate/VB the/DT expression/NN of/IN interferon-stimulated/JJ genes/NNS -LRB-/-LRB- ISGs/NNP -RRB-/-RRB- as/IN a/DT means/NNS of/IN treating/VBG viral_infections/NNS and/CC cancer/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ recent) (NNS years)))
    (, ,)
    (NP (EX there))
    (VP (VBP has_been)
      (NP
        (NP (DT a) (VBG growing) (NN interest))
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NNS drugs))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD can)
                      (VP (VB up-regulate)
                        (NP
                          (NP
                            (NP (DT the) (NN expression))
                            (PP (IN of)
                              (NP (JJ interferon-stimulated) (NNS genes))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP ISGs))
                            (-RRB- -RRB-)))
                        (PP (IN as)
                          (NP
                            (NP (DT a) (NNS means))
                            (PP (IN of)
                              (S
                                (VP (VBG treating)
                                  (NP (NNS viral_infections)
                                    (CC and)
                                    (NN cancer)))))))))))))))))
    (. .)))

case(years-3, In-1)
amod(years-3, recent-2)
nmod:in(has_been-6, years-3)
expl(has_been-6, there-5)
root(ROOT-0, has_been-6)
det(interest-9, a-7)
amod(interest-9, growing-8)
dobj(has_been-6, interest-9)
case(development-12, in-10)
det(development-12, the-11)
nmod:in(interest-9, development-12)
case(drugs-14, of-13)
nmod:of(development-12, drugs-14)
nsubj(up-regulate-17, drugs-14)
ref(drugs-14, that-15)
aux(up-regulate-17, can-16)
acl:relcl(drugs-14, up-regulate-17)
det(expression-19, the-18)
dobj(up-regulate-17, expression-19)
case(genes-22, of-20)
amod(genes-22, interferon-stimulated-21)
nmod:of(expression-19, genes-22)
appos(expression-19, ISGs-24)
case(means-28, as-26)
det(means-28, a-27)
nmod:as(up-regulate-17, means-28)
mark(treating-30, of-29)
acl(means-28, treating-30)
dobj(treating-30, viral_infections-31)
cc(viral_infections-31, and-32)
dobj(treating-30, cancer-33)
conj:and(viral_infections-31, cancer-33)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN dalcetrapib/NN on/IN ISG12a/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS cultured/VBN in/IN differentiation/JJ medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN dalcetrapib))))
      (PP (IN on)
        (NP (JJ ISG12a) (NN protein) (NNS levels)))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (PP (IN in)
              (NP (JJ differentiation) (NN medium)))
            (S
              (VP (VBG containing)
                (NP
                  (ADJP (CD 2) (NN %))
                  (NN horse) (NN serum))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(dalcetrapib-10, of-9)
nmod:of(effect-8, dalcetrapib-10)
case(levels-14, on-11)
amod(levels-14, ISG12a-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
case(cells-17, in-15)
nummod(cells-17, C2C12-16)
nmod:in(investigated-6, cells-17)
acl(cells-17, cultured-18)
case(medium-21, in-19)
amod(medium-21, differentiation-20)
nmod:in(cultured-18, medium-21)
xcomp(cultured-18, containing-22)
compound(%-24, 2-23)
amod(serum-26, %-24)
compound(serum-26, horse-25)
dobj(containing-22, serum-26)

Our/PRP$ results/NNS showed/VBD that/IN dalcetrapib/NN up-regulated/VBD ISG12a/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ ISG12a/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN dalcetrapib))
          (VP (VBD up-regulated)
            (NP (JJ ISG12a) (NN protein) (NNS levels))
            (NP (NN in_a)
              (NX
                (NX (JJ time-dependent) (NN manner))
                (CC and)
                (NX (JJ prolonged) (JJ ISG12a) (NN protein)))
              (NX (NN half-life)))
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(up-regulated-6, that-4)
nsubj(up-regulated-6, dalcetrapib-5)
ccomp(showed-3, up-regulated-6)
amod(levels-9, ISG12a-7)
compound(levels-9, protein-8)
iobj(up-regulated-6, levels-9)
dep(half-life-17, in_a-10)
amod(manner-12, time-dependent-11)
dep(half-life-17, manner-12)
cc(manner-12, and-13)
amod(protein-16, prolonged-14)
amod(protein-16, ISG12a-15)
conj:and(manner-12, protein-16)
dep(half-life-17, protein-16)
dobj(up-regulated-6, half-life-17)
case(hours-22, from-18)
compound(18-21, 10-19)
dep(18-21, to-20)
nummod(hours-22, 18-21)
nmod:from(up-regulated-6, hours-22)

These/DT findings/NNS suggest/VBP that/IN dalcetrapib/NN may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN viral_infections/NNS and/CC cancer/NN by/IN modulating/VBG the/DT expression/NN of/IN ISGs/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN dalcetrapib))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NNS viral_infections)
                          (CC and)
                          (NN cancer)))))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP (NNP ISGs))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, dalcetrapib-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(have-7, agent-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(agent-12, treatment-15)
case(viral_infections-17, of-16)
nmod:of(treatment-15, viral_infections-17)
cc(viral_infections-17, and-18)
nmod:of(treatment-15, cancer-19)
conj:and(viral_infections-17, cancer-19)
mark(modulating-21, by-20)
advcl(have-7, modulating-21)
det(expression-23, the-22)
dobj(modulating-21, expression-23)
case(ISGs-25, of-24)
nmod:of(expression-23, ISGs-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG the/DT observed/JJ effects/NNS of/IN dalcetrapib/NN on/IN ISG12a/JJ protein/NN levels/NNS and/CC to/TO explore/VB its/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ observed) (NNS effects))
                      (PP (IN of)
                        (NP (NN dalcetrapib))))))
                (PP (IN on)
                  (NP (JJ ISG12a) (NN protein) (NNS levels)))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS applications))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-13, the-11)
amod(effects-13, observed-12)
dobj(underlying-10, effects-13)
case(dalcetrapib-15, of-14)
nmod:of(effects-13, dalcetrapib-15)
case(levels-19, on-16)
amod(levels-19, ISG12a-17)
compound(levels-19, protein-18)
nmod:on(elucidate-6, levels-19)
cc(elucidate-6, and-20)
mark(explore-22, to-21)
ccomp(needed-4, explore-22)
conj:and(elucidate-6, explore-22)
nmod:poss(applications-26, its-23)
amod(applications-26, potential-24)
amod(applications-26, clinical-25)
dobj(explore-22, applications-26)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN and/CC have/VBP been/VBN shown/VBN to/TO provide/VB a/DT variety/NN of/IN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (ADJP (JJ essential)
          (PP (IN for)
            (NP (JJ human) (NN health)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB provide)
                  (NP
                    (NP (DT a) (NN variety))
                    (PP (IN of)
                      (NP (NNS benefits)))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(essential-16, omega-3_fatty_acids-2)
nsubjpass(shown-23, omega-3_fatty_acids-2)
nsubj:xsubj(provide-25, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
cop(essential-16, are-15)
root(ROOT-0, essential-16)
case(health-19, for-17)
amod(health-19, human-18)
nmod:for(essential-16, health-19)
cc(essential-16, and-20)
aux(shown-23, have-21)
auxpass(shown-23, been-22)
conj:and(essential-16, shown-23)
mark(provide-25, to-24)
xcomp(shown-23, provide-25)
det(variety-27, a-26)
dobj(provide-25, variety-27)
case(benefits-29, of-28)
nmod:of(variety-27, benefits-29)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Mebhydrolin/JJ levels/NNS in/IN hyperMebhydrolinmic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Mebhydrolin) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperMebhydrolinmic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, Mebhydrolin-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperMebhydrolinmic-15)
nmod:in(levels-13, patients-16)
nsubj(contribute-20, patients-16)
ref(patients-16, which-18)
aux(contribute-20, may-19)
acl:relcl(patients-16, contribute-20)
case(effects-24, to-21)
nmod:poss(effects-24, their-22)
amod(effects-24, cardioprotective-23)
nmod:to(contribute-20, effects-24)

Moreover/RB ,/, the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, which/WDT is/VBZ one/CD of/IN the/DT leading/VBG causes/NNS of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (DT the) (NN intake))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP (DT a) (VBN reduced) (NN risk))
            (PP (IN of)
              (S
                (VP (VBG developing)
                  (VP (VB coronary_heart_disease)
                    (NP
                      (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (VBZ is)
                            (NP
                              (NP (CD one))
                              (PP (IN of)
                                (NP
                                  (NP (DT the) (VBG leading) (NNS causes))
                                  (PP (IN of)
                                    (NP (NN death))))))))))
                    (ADVP (RB worldwide))))))))))
    (. .)))

advmod(has_been-9, Moreover-1)
det(intake-4, the-3)
nsubj(has_been-9, intake-4)
case(EPA-6, of-5)
nmod:of(intake-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(intake-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, reduced-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
xcomp(developing-16, coronary_heart_disease-17)
dobj(coronary_heart_disease-17, CHD-19)
nsubj(one-24, CHD-19)
ref(CHD-19, which-22)
cop(one-24, is-23)
acl:relcl(CHD-19, one-24)
case(causes-28, of-25)
det(causes-28, the-26)
amod(causes-28, leading-27)
nmod:of(one-24, causes-28)
case(death-30, of-29)
nmod:of(causes-28, death-30)
advmod(coronary_heart_disease-17, worldwide-31)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ protective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC they/PRP may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, oxidative_stress/NNS ,/, and/CC lipid/NN metabolism/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBD exert)
              (NP (PRP$ their) (JJ protective) (NNS effects))))))
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP they))
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NNS oxidative_stress))
                (, ,)
                (CC and)
                (NP (NN lipid) (NN metabolism))))))))
    (. .)))

det(mechanisms-2, The-1)
nmod:by(exert-8, mechanisms-2)
nsubjpass(understood-15, mechanisms-2)
case(which-4, by-3)
ref(mechanisms-2, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
acl:relcl(mechanisms-2, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, protective-10)
dobj(exert-8, effects-11)
auxpass(understood-15, are-12)
neg(understood-15, not-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-17)
nsubj(involve-20, they-18)
aux(involve-20, may-19)
conj:but(understood-15, involve-20)
dobj(involve-20, modulation-21)
case(inflammation-23, of-22)
nmod:of(modulation-21, inflammation-23)
nmod:of(modulation-21, oxidative_stress-25)
conj:and(inflammation-23, oxidative_stress-25)
cc(inflammation-23, and-27)
compound(metabolism-29, lipid-28)
nmod:of(modulation-21, metabolism-29)
conj:and(inflammation-23, metabolism-29)

These/DT findings/NNS highlight/VB the/DT potential/JJ benefits/NNS of/IN incorporating/VBG long-chain/JJ omega-3_fatty_acids/NN into/IN the/DT diet/NN as/IN a/DT means/NN of/IN promoting/VBG cardiovascular_health/NN and/CC reducing/VBG the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (JJ potential) (NNS benefits))
        (PP (IN of)
          (S
            (VP (VBG incorporating)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))
              (PP (IN into)
                (NP
                  (NP (DT the) (NN diet))
                  (PP (IN as)
                    (NP
                      (NP (DT a) (NN means))
                      (PP (IN of)
                        (S
                          (VP
                            (VP (VBG promoting)
                              (NP (NN cardiovascular_health)))
                            (CC and)
                            (VP (VBG reducing)
                              (NP
                                (NP (DT the) (NN risk))
                                (PP (IN of)
                                  (NP (NNP CHD)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
root(ROOT-0, highlight-3)
det(benefits-6, the-4)
amod(benefits-6, potential-5)
dobj(highlight-3, benefits-6)
mark(incorporating-8, of-7)
acl(benefits-6, incorporating-8)
amod(omega-3_fatty_acids-10, long-chain-9)
dobj(incorporating-8, omega-3_fatty_acids-10)
case(diet-13, into-11)
det(diet-13, the-12)
nmod:into(incorporating-8, diet-13)
case(means-16, as-14)
det(means-16, a-15)
nmod:as(diet-13, means-16)
mark(promoting-18, of-17)
acl(means-16, promoting-18)
dobj(promoting-18, cardiovascular_health-19)
cc(promoting-18, and-20)
acl(means-16, reducing-21)
conj:and(promoting-18, reducing-21)
det(risk-23, the-22)
dobj(reducing-21, risk-23)
case(CHD-25, of-24)
nmod:of(risk-23, CHD-25)

Non-alcoholic_fatty_liver_disease/JJ -LRB-/-LRB- NAFLD/NNP -RRB-/-RRB- is_a/RB prevalent/JJ metabolic_disorder/NN characterized/VBN by/IN excessive/JJ fat/JJ accumulation/NN in/IN the/DT liver/NN ./.

(ROOT
  (NP
    (NP (JJ Non-alcoholic_fatty_liver_disease)
      (PRN (-LRB- -LRB-)
        (NP (NNP NAFLD))
        (-RRB- -RRB-))
      (ADJP (RB is_a) (JJ prevalent))
      (NN metabolic_disorder))
    (VP (VBN characterized)
      (PP (IN by)
        (NP
          (NP (JJ excessive) (JJ fat) (NN accumulation))
          (PP (IN in)
            (NP (DT the) (NN liver))))))
    (. .)))

amod(metabolic_disorder-7, Non-alcoholic_fatty_liver_disease-1)
appos(metabolic_disorder-7, NAFLD-3)
advmod(prevalent-6, is_a-5)
amod(metabolic_disorder-7, prevalent-6)
root(ROOT-0, metabolic_disorder-7)
acl(metabolic_disorder-7, characterized-8)
case(accumulation-12, by-9)
amod(accumulation-12, excessive-10)
amod(accumulation-12, fat-11)
nmod:by(characterized-8, accumulation-12)
case(liver-15, in-13)
det(liver-15, the-14)
nmod:in(accumulation-12, liver-15)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN Kuguaglycoside_C/NNP ,/, a/DT synthetic/JJ LXR/NNP agonist/NN ,/, on/IN hepatic/JJ lipid/NN metabolism/NN and/CC steatosis/NNS in/IN C57BL/6J/CD mice/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP Kuguaglycoside_C))
            (, ,)
            (NP (DT a) (JJ synthetic) (NNP LXR) (NN agonist))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (JJ hepatic) (NN lipid) (NN metabolism))
          (CC and)
          (NP (NNS steatosis))))
      (PP (IN in)
        (NP (CD C57BL/6J) (NNS mice))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(Kuguaglycoside_C-10, of-9)
nmod:of(effect-8, Kuguaglycoside_C-10)
det(agonist-15, a-12)
amod(agonist-15, synthetic-13)
compound(agonist-15, LXR-14)
appos(Kuguaglycoside_C-10, agonist-15)
case(metabolism-20, on-17)
amod(metabolism-20, hepatic-18)
compound(metabolism-20, lipid-19)
nmod:on(investigated-6, metabolism-20)
cc(metabolism-20, and-21)
nmod:on(investigated-6, steatosis-22)
conj:and(metabolism-20, steatosis-22)
case(mice-25, in-23)
nummod(mice-25, C57BL/6J-24)
nmod:in(investigated-6, mice-25)

Our/PRP$ results/NNS demonstrate/VBP that/IN administration/NN of/IN Kuguaglycoside_C/JJ at_a/NN dose/NN of/IN 10/CD mg/kg/day/NN for/IN 4/CD days/NNS induced/VBN the/DT expression/NN of/IN lipogenic/JJ genes/NNS Srebp-1c/NNS and/CC Fas/NNP ,/, as/RB well/RB as/IN apoptosis-induced_factor/NN in/IN the/DT liver/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN administration))
            (PP (IN of)
              (NP
                (NP (JJ Kuguaglycoside_C) (NN at_a) (NN dose))
                (PP (IN of)
                  (NP
                    (NP (CD 10) (NN mg/kg/day))
                    (PP (IN for)
                      (NP (CD 4) (NNS days))))))))
          (VP (VBN induced)
            (NP
              (NP
                (NP (DT the) (NN expression))
                (PP (IN of)
                  (NP (JJ lipogenic) (NNS genes))))
              (NX
                (NX (NNS Srebp-1c))
                (CC and)
                (NX (NNP Fas))))
            (, ,)
            (ADVP
              (ADVP (RB as) (RB well))
              (PP (IN as)
                (NP
                  (NP (NN apoptosis-induced_factor))
                  (PP (IN in)
                    (NP (DT the) (NN liver))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(induced-16, that-4)
nsubj(induced-16, administration-5)
case(dose-9, of-6)
amod(dose-9, Kuguaglycoside_C-7)
compound(dose-9, at_a-8)
nmod:of(administration-5, dose-9)
case(mg/kg/day-12, of-10)
nummod(mg/kg/day-12, 10-11)
nmod:of(dose-9, mg/kg/day-12)
case(days-15, for-13)
nummod(days-15, 4-14)
nmod:for(mg/kg/day-12, days-15)
ccomp(demonstrate-3, induced-16)
det(expression-18, the-17)
dep(Srebp-1c-22, expression-18)
case(genes-21, of-19)
amod(genes-21, lipogenic-20)
nmod:of(expression-18, genes-21)
dobj(induced-16, Srebp-1c-22)
cc(Srebp-1c-22, and-23)
dobj(induced-16, Fas-24)
conj:and(Srebp-1c-22, Fas-24)
advmod(induced-16, as-26)
mwe(as-26, well-27)
case(apoptosis-induced_factor-29, as-28)
nmod:as(as-26, apoptosis-induced_factor-29)
case(liver-32, in-30)
det(liver-32, the-31)
nmod:in(apoptosis-induced_factor-29, liver-32)

These/DT changes/NNS were/VBD associated/VBN with/IN massive/JJ hepatic_steatosis/NNS along/IN the/DT entire/JJ liver/NN lobule/NN and/CC a/DT 2.5-fold/JJ increase/NN in/IN very_low-density_lipoprotein-triglyceride/JJ -LRB-/-LRB- VLDL-TG/NNP -RRB-/-RRB- secretion/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS changes))
    (VP (VBD were)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ massive) (NNS hepatic_steatosis))
            (PP (IN along)
              (NP
                (NP (DT the) (JJ entire) (NN liver) (NN lobule))
                (CC and)
                (NP
                  (NP (DT a) (JJ 2.5-fold) (NN increase))
                  (PP (IN in)
                    (NP (JJ very_low-density_lipoprotein-triglyceride)
                      (PRN (-LRB- -LRB-)
                        (NP (NNP VLDL-TG))
                        (-RRB- -RRB-))
                      (NNS secretion))))))))))
    (. .)))

det(changes-2, These-1)
nsubjpass(associated-4, changes-2)
auxpass(associated-4, were-3)
root(ROOT-0, associated-4)
case(hepatic_steatosis-7, with-5)
amod(hepatic_steatosis-7, massive-6)
nmod:with(associated-4, hepatic_steatosis-7)
case(lobule-12, along-8)
det(lobule-12, the-9)
amod(lobule-12, entire-10)
compound(lobule-12, liver-11)
nmod:along(hepatic_steatosis-7, lobule-12)
cc(lobule-12, and-13)
det(increase-16, a-14)
amod(increase-16, 2.5-fold-15)
nmod:along(hepatic_steatosis-7, increase-16)
conj:and(lobule-12, increase-16)
case(secretion-22, in-17)
amod(secretion-22, very_low-density_lipoprotein-triglyceride-18)
appos(secretion-22, VLDL-TG-20)
nmod:in(increase-16, secretion-22)

Our/PRP$ findings/NNS suggest/VBP that/IN activation/NN of/IN LXR/NNP signaling/VBG pathway/RB by/IN Kuguaglycoside_C/NNP promotes/VBZ hepatic_lipid_accumulation/NN and/CC may/MD contribute/VB to/TO the/DT development/NN of/IN NAFLD/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (NNP LXR)))
            (VP (VBG signaling)
              (ADVP (RB pathway))
              (PP (IN by)
                (NP (NNP Kuguaglycoside_C)))))
          (VP
            (VP (VBZ promotes)
              (NP (NN hepatic_lipid_accumulation)))
            (CC and)
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NNP NAFLD)))))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(promotes-12, that-4)
nsubj(promotes-12, activation-5)
nsubj(contribute-16, activation-5)
case(LXR-7, of-6)
nmod:of(activation-5, LXR-7)
acl(activation-5, signaling-8)
advmod(signaling-8, pathway-9)
case(Kuguaglycoside_C-11, by-10)
nmod:by(signaling-8, Kuguaglycoside_C-11)
ccomp(suggest-3, promotes-12)
dobj(promotes-12, hepatic_lipid_accumulation-13)
cc(promotes-12, and-14)
aux(contribute-16, may-15)
ccomp(suggest-3, contribute-16)
conj:and(promotes-12, contribute-16)
case(development-19, to-17)
det(development-19, the-18)
nmod:to(contribute-16, development-19)
case(NAFLD-21, of-20)
nmod:of(development-19, NAFLD-21)

Therefore/RB ,/, targeting/VBG LXR/NNP signaling/VBG pathway/RB may/MD represent/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN NAFLD/JJ treatment/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG targeting)
        (NP (NNP LXR))
        (S
          (VP (VBG signaling)
            (ADVP (RB pathway))))))
    (VP (MD may)
      (VP (VB represent)
        (NP
          (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
          (PP (IN for)
            (NP (JJ NAFLD) (NN treatment))))))
    (. .)))

advmod(represent-8, Therefore-1)
csubj(represent-8, targeting-3)
dobj(targeting-3, LXR-4)
advcl(targeting-3, signaling-5)
advmod(signaling-5, pathway-6)
aux(represent-8, may-7)
root(ROOT-0, represent-8)
det(strategy-12, a-9)
amod(strategy-12, potential-10)
amod(strategy-12, therapeutic-11)
dobj(represent-8, strategy-12)
case(treatment-15, for-13)
amod(treatment-15, NAFLD-14)
nmod:for(strategy-12, treatment-15)

Calcium_oxide/NNP has_been/VBP shown/VBN to/TO have/VB therapeutic/JJ potential/NN in/IN the/DT management/NN of/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (NNP Calcium_oxide))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP (JJ therapeutic) (NN potential))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN management))
                  (PP (IN of)
                    (NP
                      (NP (NNS bronchospasms))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (. .)))

nsubj(has_been-2, Calcium_oxide-1)
root(ROOT-0, has_been-2)
dep(has_been-2, shown-3)
mark(have-5, to-4)
xcomp(shown-3, have-5)
amod(potential-7, therapeutic-6)
dobj(have-5, potential-7)
case(management-10, in-8)
det(management-10, the-9)
nmod:in(have-5, management-10)
case(bronchospasms-12, of-11)
nmod:of(management-10, bronchospasms-12)
nmod:of(management-10, photophobia-14)
conj:and(bronchospasms-12, photophobia-14)
cc(bronchospasms-12, and-16)
nmod:of(management-10, phonophobia-17)
conj:and(bronchospasms-12, phonophobia-17)

In/IN this/DT study/NN ,/, a/DT significant/JJ reduction/NN in/IN the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- was/VBD observed/VBN at/IN 2/CD h/NN after/IN dosing/VBG with/IN calcium_oxide/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (DT a)
      (NX
        (NX
          (NX
            (NX (JJ significant) (NN reduction))
            (PP (IN in)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNS bronchospasms)))))
            (PP (IN by)
              (NP (CD 14) (NN %))))
          (PRN (-LRB- -LRB-)
            (S
              (NP (CD 95) (NN %))
              (VP (VBP CI)
                (NP
                  (NP
                    (NP (CD 6-20) (NN %))
                    (, ,)
                    (NP (NNP P)))
                  (X
                    (X (SYM =))
                    (NP (CD 0.0005))))))
            (-RRB- -RRB-)))
        (, ,)
        (NX
          (NX
            (NX (NN photophobia))
            (PP (IN by)
              (NP (CD 17) (NN %))))
          (PRN (-LRB- -LRB-)
            (S
              (NP (CD 95) (NN %))
              (VP (VBP CI)
                (NP (CD 12-22) (NN %))
                (, ,)
                (SBAR
                  (S
                    (NP (NNP P))
                    (VP (VBP <)
                      (NP (CD 0.0001)))))))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NX
          (NX
            (NX (NN phonophobia))
            (PP (IN by)
              (NP (CD 14) (NN %))))
          (PRN (-LRB- -LRB-)
            (S
              (NP (CD 95) (NN %))
              (VP (VBP CI)
                (NP (CD 17-20) (NN %))
                (, ,)
                (SBAR
                  (S
                    (NP (NNP P))
                    (VP (VBP <)
                      (NP (CD 0.0001)))))))
            (-RRB- -RRB-)))))
    (VP (VBD was)
      (VP (VBN observed)
        (PP (IN at)
          (NP (CD 2) (NN h)))
        (PP (IN after)
          (S
            (VP (VBG dosing)
              (PP (IN with)
                (NP (NN calcium_oxide))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(observed-61, study-3)
det(reduction-7, a-5)
amod(reduction-7, significant-6)
nsubjpass(observed-61, reduction-7)
case(risk-10, in-8)
det(risk-10, the-9)
nmod:in(reduction-7, risk-10)
case(bronchospasms-12, of-11)
nmod:of(risk-10, bronchospasms-12)
case(%-15, by-13)
nummod(%-15, 14-14)
nmod:by(reduction-7, %-15)
nummod(%-18, 95-17)
nsubj(CI-19, %-18)
dep(reduction-7, CI-19)
nummod(%-21, 6-20-20)
dobj(CI-19, %-21)
appos(%-21, P-23)
dep(0.0005-25, =-24)
dep(%-21, 0.0005-25)
conj:and(reduction-7, photophobia-28)
nsubjpass(observed-61, photophobia-28)
case(%-31, by-29)
nummod(%-31, 17-30)
nmod:by(photophobia-28, %-31)
nummod(%-34, 95-33)
nsubj(CI-35, %-34)
dep(photophobia-28, CI-35)
nummod(%-37, 12-22-36)
dobj(CI-35, %-37)
nsubj(<-40, P-39)
dep(CI-35, <-40)
dobj(<-40, 0.0001-41)
cc(reduction-7, and-44)
conj:and(reduction-7, phonophobia-45)
nsubjpass(observed-61, phonophobia-45)
case(%-48, by-46)
nummod(%-48, 14-47)
nmod:by(phonophobia-45, %-48)
nummod(%-51, 95-50)
nsubj(CI-52, %-51)
dep(phonophobia-45, CI-52)
nummod(%-54, 17-20-53)
dobj(CI-52, %-54)
nsubj(<-57, P-56)
dep(CI-52, <-57)
dobj(<-57, 0.0001-58)
auxpass(observed-61, was-60)
root(ROOT-0, observed-61)
case(h-64, at-62)
nummod(h-64, 2-63)
nmod:at(observed-61, h-64)
mark(dosing-66, after-65)
advcl(observed-61, dosing-66)
case(calcium_oxide-68, with-67)
nmod:with(dosing-66, calcium_oxide-68)

These/DT findings/NNS suggest/VBP that/IN calcium_oxide/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS suffering/VBG from/IN these/DT conditions/NNS ,/, although/IN further/JJ research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB its/PRP$ mechanism/NN of/IN action/NN and/CC potential/JJ side/NN effects/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN calcium_oxide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP
                          (NP (DT these) (NNS conditions))
                          (, ,)
                          (SBAR (IN although)
                            (S
                              (NP (JJ further) (NN research))
                              (VP (VBZ is)
                                (VP (VBN needed)
                                  (S
                                    (VP (TO to)
                                      (VP
                                        (ADVP (RB fully))
                                        (VB elucidate)
                                        (NP
                                          (NP (PRP$ its) (NN mechanism))
                                          (PP (IN of)
                                            (NP
                                              (NP (NN action))
                                              (CC and)
                                              (NP (JJ potential) (NN side) (NNS effects)))))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, calcium_oxide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(conditions-17, from-15)
det(conditions-17, these-16)
nmod:from(suffering-14, conditions-17)
mark(needed-23, although-19)
amod(research-21, further-20)
nsubjpass(needed-23, research-21)
nsubj:xsubj(elucidate-26, research-21)
auxpass(needed-23, is-22)
dep(conditions-17, needed-23)
mark(elucidate-26, to-24)
advmod(elucidate-26, fully-25)
xcomp(needed-23, elucidate-26)
nmod:poss(mechanism-28, its-27)
dobj(elucidate-26, mechanism-28)
case(action-30, of-29)
nmod:of(mechanism-28, action-30)
cc(action-30, and-31)
amod(effects-34, potential-32)
compound(effects-34, side-33)
nmod:of(mechanism-28, effects-34)
conj:and(action-30, effects-34)

Abstract/NNP :/: Obesity/NNP is_a/NNP major/JJ public_health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN various/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Abstract))
      (: :)
      (NP (NNP Obesity) (NNP is_a) (JJ major) (NN public_health) (NN concern)))
    (ADVP (RB worldwide)
      (CC and))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes)))))))
    (. .)))

nsubjpass(associated-11, Abstract-1)
compound(concern-7, Obesity-3)
compound(concern-7, is_a-4)
amod(concern-7, major-5)
compound(concern-7, public_health-6)
dep(Abstract-1, concern-7)
advmod(associated-11, worldwide-8)
cc(worldwide-8, and-9)
auxpass(associated-11, is-10)
root(ROOT-0, associated-11)
case(metabolic_disorders-14, with-12)
amod(metabolic_disorders-14, various-13)
nmod:with(associated-11, metabolic_disorders-14)
acl(metabolic_disorders-14, including-16)
dobj(including-16, type_2_diabetes-17)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT pancreas/NN plays/VBZ a/DT key/JJ role/NN in/IN the/DT development/NN of/IN obesity/JJ and/CC related/VBN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN pancreas))
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ key) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (ADJP (JJ obesity)
                          (CC and)
                          (VBN related))
                        (NNS metabolic_disorders)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(plays-8, that-5)
det(pancreas-7, the-6)
nsubj(plays-8, pancreas-7)
ccomp(suggested-4, plays-8)
det(role-11, a-9)
amod(role-11, key-10)
dobj(plays-8, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(metabolic_disorders-19, of-15)
amod(metabolic_disorders-19, obesity-16)
cc(obesity-16, and-17)
conj:and(obesity-16, related-18)
amod(metabolic_disorders-19, related-18)
nmod:of(development-14, metabolic_disorders-19)

Flavin-containing/JJ monooxygenases/NNS -LRB-/-LRB- FMOs/NNP -RRB-/-RRB- are/VBP a/DT family/NN of/IN enzymes/NNS that/WDT are/VBP involved/VBN in/IN the/DT metabolism/NN of/IN xenobiotics/NNS ,/, drugs/NNS ,/, and/CC endogenous/JJ compounds/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Flavin-containing) (NNS monooxygenases))
      (PRN (-LRB- -LRB-)
        (NP (NNP FMOs))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN family))
        (PP (IN of)
          (NP
            (NP (NNS enzymes))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP are)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN metabolism))
                        (PP (IN of)
                          (NP
                            (NP (NNS xenobiotics))
                            (, ,)
                            (NP (NNS drugs))
                            (, ,)
                            (CC and)
                            (NP (JJ endogenous) (NNS compounds))))))))))))))
    (. .)))

amod(monooxygenases-2, Flavin-containing-1)
nsubj(family-8, monooxygenases-2)
appos(monooxygenases-2, FMOs-4)
cop(family-8, are-6)
det(family-8, a-7)
root(ROOT-0, family-8)
case(enzymes-10, of-9)
nmod:of(family-8, enzymes-10)
nsubjpass(involved-13, enzymes-10)
ref(enzymes-10, that-11)
auxpass(involved-13, are-12)
acl:relcl(enzymes-10, involved-13)
case(metabolism-16, in-14)
det(metabolism-16, the-15)
nmod:in(involved-13, metabolism-16)
case(xenobiotics-18, of-17)
nmod:of(metabolism-16, xenobiotics-18)
nmod:of(metabolism-16, drugs-20)
conj:and(xenobiotics-18, drugs-20)
cc(xenobiotics-18, and-22)
amod(compounds-24, endogenous-23)
nmod:of(metabolism-16, compounds-24)
conj:and(xenobiotics-18, compounds-24)

The/DT hypersecretion/NN of/IN FMOs/NNP by/IN the/DT pancreas/NN has_been/NN implicated/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/JJ and_insulin/NN resistance/NN ./.

(ROOT
  (NP
    (NP (DT The) (NN hypersecretion))
    (PP (IN of)
      (NP (NNP FMOs)))
    (PP (IN by)
      (NP
        (NP (DT the) (NN pancreas) (NN has_been))
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP (JJ obesity) (NN and_insulin) (NN resistance))))))))
    (. .)))

det(hypersecretion-2, The-1)
root(ROOT-0, hypersecretion-2)
case(FMOs-4, of-3)
nmod:of(hypersecretion-2, FMOs-4)
case(has_been-8, by-5)
det(has_been-8, the-6)
compound(has_been-8, pancreas-7)
nmod:by(hypersecretion-2, has_been-8)
acl(has_been-8, implicated-9)
case(pathogenesis-12, in-10)
det(pathogenesis-12, the-11)
nmod:in(implicated-9, pathogenesis-12)
case(resistance-16, of-13)
amod(resistance-16, obesity-14)
compound(resistance-16, and_insulin-15)
nmod:of(pathogenesis-12, resistance-16)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN FMOs/NNPS by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ senecionine/NN on/IN the/DT secretion/NN of/IN FMOs/NNPS and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NNPS FMOs)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN senecionine)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNPS FMOs) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(FMOs-14, of-13)
nmod:of(hypersecretion-12, FMOs-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(senecionine-30, 10-28)
amod(senecionine-30, mmol/L-29)
nmod:of(effects-22, senecionine-30)
conj:and(glucose-26, senecionine-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
compound(and_insulin-36, FMOs-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
appos(genetically_obese-42, fa/fa-44)
cc(genetically_obese-42, and-46)
amod(rats-53, lean-47)
dep(lean-47, Fa-49)
nmod:from(pancreata-40, rats-53)
conj:and(genetically_obese-42, rats-53)

Our/PRP$ results/NNS showed/VBD that/IN perfusion/NN with/IN high/JJ glucose/NN or/CC senecionine/NN stimulated/VBN FMO/NNP secretion/NN in/IN both/DT lean/JJ and/CC obese/JJ rats/NNS ,/, but/CC to/TO a/DT greater/JJR extent/NN in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN perfusion))
              (PP (IN with)
                (NP (JJ high) (NN glucose)
                  (CC or)
                  (NN senecionine))))
            (VP (VBN stimulated)
              (NP (NNP FMO) (NN secretion))
              (PP (IN in)
                (NP (DT both)
                  (ADJP (JJ lean)
                    (CC and)
                    (JJ obese))
                  (NNS rats)))))))
      (, ,)
      (CC but)
      (PP (TO to)
        (NP (DT a) (JJR greater) (NN extent)))
      (PP (IN in)
        (NP (JJ obese) (NNS rats))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(stimulated-11, that-4)
nsubj(stimulated-11, perfusion-5)
case(glucose-8, with-6)
amod(glucose-8, high-7)
nmod:with(perfusion-5, glucose-8)
cc(glucose-8, or-9)
nmod:with(perfusion-5, senecionine-10)
conj:or(glucose-8, senecionine-10)
ccomp(showed-3, stimulated-11)
compound(secretion-13, FMO-12)
dobj(stimulated-11, secretion-13)
case(rats-19, in-14)
det(rats-19, both-15)
amod(rats-19, lean-16)
cc(lean-16, and-17)
conj:and(lean-16, obese-18)
amod(rats-19, obese-18)
nmod:in(stimulated-11, rats-19)
cc(showed-3, but-21)
case(extent-25, to-22)
det(extent-25, a-23)
amod(extent-25, greater-24)
conj:but(showed-3, extent-25)
case(rats-28, in-26)
amod(rats-28, obese-27)
nmod:in(showed-3, rats-28)

Furthermore/RB ,/, FMO/NNP secretion/NN was/VBD positively/RB correlated/VBN with/IN insulin_secretion/NN in/IN both/DT groups/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP FMO) (NN secretion))
    (VP (VBD was)
      (VP
        (ADVP (RB positively))
        (VBN correlated)
        (PP (IN with)
          (NP
            (NP (NN insulin_secretion))
            (PP (IN in)
              (NP (DT both) (NNS groups)))))))
    (. .)))

advmod(correlated-7, Furthermore-1)
compound(secretion-4, FMO-3)
nsubjpass(correlated-7, secretion-4)
auxpass(correlated-7, was-5)
advmod(correlated-7, positively-6)
root(ROOT-0, correlated-7)
case(insulin_secretion-9, with-8)
nmod:with(correlated-7, insulin_secretion-9)
case(groups-12, in-10)
det(groups-12, both-11)
nmod:in(insulin_secretion-9, groups-12)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN FMOs/NNP by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/JJ and/CC related/VBN metabolic_disorders/NNS through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP FMOs)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ obesity)
                        (CC and)
                        (VBN related))
                      (NNS metabolic_disorders)))))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-12, that-4)
nsubj(contribute-12, hypersecretion-5)
case(FMOs-7, of-6)
nmod:of(hypersecretion-5, FMOs-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(contribute-12, may-11)
ccomp(suggest-3, contribute-12)
case(development-15, to-13)
det(development-15, the-14)
nmod:to(contribute-12, development-15)
case(metabolic_disorders-20, of-16)
amod(metabolic_disorders-20, obesity-17)
cc(obesity-17, and-18)
conj:and(obesity-17, related-19)
amod(metabolic_disorders-20, related-19)
nmod:of(development-15, metabolic_disorders-20)
case(effects-23, through-21)
nmod:poss(effects-23, its-22)
nmod:through(contribute-12, effects-23)
case(insulin_secretion-25, on-24)
nmod:on(effects-23, insulin_secretion-25)

Omega-3_fatty_acids/NNP ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP long-chain/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ long-chain) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP
                  (ADVP (RB extensively))
                  (VBN studied)
                  (PP (IN for)
                    (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-15, Omega-3_fatty_acids-1)
dep(Omega-3_fatty_acids-1, eicosapentaenoic_acid-3)
dep(eicosapentaenoic_acid-3, EPA-5)
cc(eicosapentaenoic_acid-3, and-7)
dep(Omega-3_fatty_acids-1, docosahexaenoic_acid-8)
conj:and(eicosapentaenoic_acid-3, docosahexaenoic_acid-8)
dep(docosahexaenoic_acid-8, DHA-10)
cop(polyunsaturated_fatty_acids-15, are-13)
amod(polyunsaturated_fatty_acids-15, long-chain-14)
root(ROOT-0, polyunsaturated_fatty_acids-15)
nsubjpass(studied-20, polyunsaturated_fatty_acids-15)
ref(polyunsaturated_fatty_acids-15, that-16)
aux(studied-20, have-17)
auxpass(studied-20, been-18)
advmod(studied-20, extensively-19)
acl:relcl(polyunsaturated_fatty_acids-15, studied-20)
case(benefits-25, for-21)
nmod:poss(benefits-25, their-22)
amod(benefits-25, potential-23)
compound(benefits-25, health-24)
nmod:for(studied-20, benefits-25)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN dimethylamine/NN -LRB-/-LRB- DMAA/NNP -RRB-/-RRB- in/IN hyperDMAAmic/JJ patients/NNS ,/, suggesting/VBG a/DT potential/JJ role/NN in/IN the/DT prevention/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (VBN decreased) (NNS levels))
                      (PP (IN of)
                        (NP (NN dimethylamine))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP DMAA))
                      (-RRB- -RRB-))
                    (PP (IN in)
                      (NP (JJ hyperDMAAmic) (NNS patients)))))))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (DT a) (JJ potential) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention))
                  (PP (IN of)
                    (NP (NN cardiovascular_disease))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(dimethylamine-14, of-13)
nmod:of(levels-12, dimethylamine-14)
appos(levels-12, DMAA-16)
case(patients-20, in-18)
amod(patients-20, hyperDMAAmic-19)
nmod:in(levels-12, patients-20)
xcomp(shown-4, suggesting-22)
det(role-25, a-23)
amod(role-25, potential-24)
dobj(suggesting-22, role-25)
case(prevention-28, in-26)
det(prevention-28, the-27)
nmod:in(role-25, prevention-28)
case(cardiovascular_disease-30, of-29)
nmod:of(prevention-28, cardiovascular_disease-30)

Furthermore/RB ,/, studies/NNS have/VBP also/RB shown/VBN that/IN consumption/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN consumption))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(shown-6, Furthermore-1)
nsubj(shown-6, studies-3)
aux(shown-6, have-4)
advmod(shown-6, also-5)
root(ROOT-0, shown-6)
mark(associated-14, that-7)
nsubjpass(associated-14, consumption-8)
case(EPA-10, of-9)
nmod:of(consumption-8, EPA-10)
cc(EPA-10, and-11)
nmod:of(consumption-8, DHA-12)
conj:and(EPA-10, DHA-12)
auxpass(associated-14, is-13)
ccomp(shown-6, associated-14)
case(risk-18, with-15)
det(risk-18, a-16)
amod(risk-18, decreased-17)
nmod:with(associated-14, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, coronary_heart_disease-21)
appos(risk-18, CHD-23)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/NN may/MD be/VB an/DT important/JJ dietary/JJ component/NN for/IN the/DT prevention/NN and/CC management/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ important) (JJ dietary) (NN component))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN management))
                    (PP (IN of)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(component-11, that-4)
nsubj(component-11, omega-3_fatty_acids-5)
aux(component-11, may-6)
cop(component-11, be-7)
det(component-11, an-8)
amod(component-11, important-9)
amod(component-11, dietary-10)
ccomp(suggest-3, component-11)
case(prevention-14, for-12)
det(prevention-14, the-13)
nmod:for(component-11, prevention-14)
cc(prevention-14, and-15)
nmod:for(component-11, management-16)
conj:and(prevention-14, management-16)
case(cardiovascular_disease-18, of-17)
nmod:of(prevention-14, cardiovascular_disease-18)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN achieving/VBG these/DT benefits/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (S
                    (VP (VBG achieving)
                      (NP (DT these) (NNS benefits)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(elucidate-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(elucidate-6, determine-14)
amod(dosages-16, optimal-15)
dobj(determine-14, dosages-16)
mark(achieving-18, for-17)
advcl(determine-14, achieving-18)
det(benefits-20, these-19)
dobj(achieving-18, benefits-20)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-18, omega-3_fatty_acids-2)
nsubj:xsubj(have-20, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
aux(shown-18, have-16)
auxpass(shown-18, been-17)
root(ROOT-0, shown-18)
mark(have-20, to-19)
xcomp(shown-18, have-20)
amod(benefits-23, various-21)
compound(benefits-23, health-22)
dobj(have-20, benefits-23)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN these/DT fatty_acids/NNS may/MD be/VB associated/VBN with/IN decreased/VBN sorbitol/JJ levels/NNS in/IN hypersorbitolmic/JJ patients/NNS ,/, which/WDT is_a/NN promising/VBG finding/VBG for/IN the/DT treatment/NN of/IN diabetes-related/JJ complications/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ sorbitol) (NNS levels))
                      (PP (IN in)
                        (NP
                          (NP (JJ hypersorbitolmic) (NNS patients))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (NN is_a)
                                (S
                                  (VP (VBG promising)
                                    (PP (VBG finding)
                                      (PP (IN for)
                                        (NP
                                          (NP (DT the) (NN treatment))
                                          (PP (IN of)
                                            (NP (JJ diabetes-related) (NNS complications))))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(suggested-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, sorbitol-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hypersorbitolmic-16)
nmod:in(levels-14, patients-17)
nsubj(is_a-20, patients-17)
ref(patients-17, which-19)
acl:relcl(patients-17, is_a-20)
xcomp(is_a-20, promising-21)
case(treatment-25, finding-22)
case(treatment-25, for-23)
det(treatment-25, the-24)
advcl(promising-21, treatment-25)
case(complications-28, of-26)
amod(complications-28, diabetes-related-27)
nmod:of(treatment-25, complications-28)

Additionally/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, one/CD of/IN the/DT leading/VBG causes/NNS of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (VP (VB coronary_heart_disease)
                      (NP
                        (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                        (, ,)
                        (NP
                          (NP (CD one))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (VBG leading) (NNS causes))
                              (PP (IN of)
                                (NP (NN death)))))))
                      (ADVP (RB worldwide)))))))))))
    (. .)))

advmod(linked-7, Additionally-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(linked-7, omega-3_fatty_acids-4)
aux(linked-7, have-5)
auxpass(linked-7, been-6)
root(ROOT-0, linked-7)
case(risk-11, to-8)
det(risk-11, a-9)
amod(risk-11, decreased-10)
nmod:to(linked-7, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
xcomp(developing-13, coronary_heart_disease-14)
dobj(coronary_heart_disease-14, CHD-16)
appos(CHD-16, one-19)
case(causes-23, of-20)
det(causes-23, the-21)
amod(causes-23, leading-22)
nmod:of(one-19, causes-23)
case(death-25, of-24)
nmod:of(causes-23, death-25)
advmod(coronary_heart_disease-14, worldwide-26)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD have/VB significant/JJ health/NN benefits/NNS and/CC could/MD potentially/RB be/VB used/VBN as/IN a/DT preventative/JJ measure/NN against/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (JJ dietary) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP
            (VP (MD may)
              (VP (VB have)
                (NP (JJ significant) (NN health) (NNS benefits))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB be)
                (VP (VBN used)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ preventative) (NN measure))
                      (PP (IN against)
                        (NP (NNP CHD))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-13, that-4)
csubjpass(have-13, increasing-5)
csubjpass(used-21, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(have-13, may-12)
ccomp(suggest-3, have-13)
amod(benefits-16, significant-14)
compound(benefits-16, health-15)
dobj(have-13, benefits-16)
cc(have-13, and-17)
aux(used-21, could-18)
advmod(used-21, potentially-19)
auxpass(used-21, be-20)
ccomp(suggest-3, used-21)
conj:and(have-13, used-21)
case(measure-25, as-22)
det(measure-25, a-23)
amod(measure-25, preventative-24)
nmod:as(used-21, measure-25)
case(CHD-27, against-26)
nmod:against(measure-25, CHD-27)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS behind/IN these/DT effects/NNS and/CC to/TO develop/VB effective/JJ interventions/NNS for/IN individuals/NNS at/IN risk/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP (DT the) (NNS mechanisms))
                (PP (IN behind)
                  (NP (DT these) (NNS effects)))))
            (CC and)
            (VP (TO to)
              (VP (VB develop)
                (NP
                  (NP (JJ effective) (NNS interventions))
                  (PP (IN for)
                    (NP (NNS individuals))))
                (PP (IN at)
                  (NP
                    (NP (NN risk))
                    (PP (IN for)
                      (NP (NNP CHD)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
case(effects-12, behind-10)
det(effects-12, these-11)
nmod:behind(understand-7, effects-12)
cc(understand-7, and-13)
mark(develop-15, to-14)
ccomp(needed-4, develop-15)
conj:and(understand-7, develop-15)
amod(interventions-17, effective-16)
dobj(develop-15, interventions-17)
case(individuals-19, for-18)
nmod:for(interventions-17, individuals-19)
case(risk-21, at-20)
nmod:at(develop-15, risk-21)
case(CHD-23, for-22)
nmod:for(risk-21, CHD-23)

The/DT metabolism/NN of/IN gamma-tocopherol/JJ -LRB-/-LRB- gamma-T/JJ -RRB-/-RRB- has_been/NN shown/VBN to_be/VBP regulated/VBN by/IN placental/JJ enzymes/NNS ,/, including/VBG UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/JJ 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, gamma-tocopherol/JJ 5a-reductase_1/JJ -LRB-/-LRB- CH-DHFR/NN -RRB-/-RRB- ,/, and/CC gamma-tocopherol/JJ 5a-reductase/JJ 2/CD -LRB-/-LRB- SRD5A2/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN metabolism))
      (PP (IN of)
        (NP
          (NP (JJ gamma-tocopherol)
            (PRN (-LRB- -LRB-) (JJ gamma-T) (-RRB- -RRB-))
            (NN has_been))
          (VP (VBN shown)))))
    (VP (VBP to_be)
      (VP (VBN regulated)
        (PP (IN by)
          (NP
            (NP
              (NP
                (NP
                  (NP (JJ placental) (NNS enzymes))
                  (, ,)
                  (NP (VBG including) (NNS UDP-glucuronosyltransferase_1A1)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP UGT1A1))
                  (-RRB- -RRB-))
                (, ,)
                (ADJP (JJ estrogen_sulfotransferase)
                  (NP-TMP (CD 1E1))))
              (PRN (-LRB- -LRB-)
                (NP (NNP SULT1E1))
                (-RRB- -RRB-))
              (, ,)
              (ADJP
                (ADJP (JJ gamma-tocopherol) (JJ 5a-reductase_1))
                (PRN (-LRB- -LRB-) (NN CH-DHFR) (-RRB- -RRB-))
                (, ,)
                (CC and)
                (ADJP (JJ gamma-tocopherol) (JJ 5a-reductase))
                (NP (CD 2))))
            (PRN (-LRB- -LRB-)
              (NP (NNP SRD5A2))
              (-RRB- -RRB-))))))
    (. .)))

det(metabolism-2, The-1)
nsubj(to_be-10, metabolism-2)
case(has_been-8, of-3)
amod(has_been-8, gamma-tocopherol-4)
dep(has_been-8, gamma-T-6)
nmod:of(metabolism-2, has_been-8)
acl(has_been-8, shown-9)
root(ROOT-0, to_be-10)
dep(to_be-10, regulated-11)
case(enzymes-14, by-12)
amod(enzymes-14, placental-13)
nmod:by(regulated-11, enzymes-14)
amod(UDP-glucuronosyltransferase_1A1-17, including-16)
appos(enzymes-14, UDP-glucuronosyltransferase_1A1-17)
appos(enzymes-14, UGT1A1-19)
amod(enzymes-14, estrogen_sulfotransferase-22)
nmod:tmod(estrogen_sulfotransferase-22, 1E1-23)
appos(enzymes-14, SULT1E1-25)
amod(5a-reductase_1-29, gamma-tocopherol-28)
amod(enzymes-14, 5a-reductase_1-29)
dep(5a-reductase_1-29, CH-DHFR-31)
cc(5a-reductase_1-29, and-34)
amod(5a-reductase-36, gamma-tocopherol-35)
amod(enzymes-14, 5a-reductase-36)
conj:and(5a-reductase_1-29, 5a-reductase-36)
dep(5a-reductase_1-29, 2-37)
appos(enzymes-14, SRD5A2-39)

In/IN this/DT study/NN ,/, real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NNP -RRB-/-RRB- analysis/NN was/VBD used/VBN to/TO investigate/VB the/DT mRNA/JJ levels/NNS of/IN these/DT enzymes/NNS in/IN placental/JJ tissue/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT this) (NN study))
        (, ,)
        (NP (JJ real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain) (NN reaction))))
    (PRN (-LRB- -LRB-)
      (NP (NNP Q-RT-PCR))
      (-RRB- -RRB-))
    (NP (NN analysis))
    (VP (VBD was)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ mRNA) (NNS levels))
                (PP (IN of)
                  (NP
                    (NP (DT these) (NNS enzymes))
                    (PP (IN in)
                      (NP (JJ placental) (NN tissue)))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(used-15, study-3)
amod(reaction-9, real-time-5)
amod(reaction-9, quantitative-6)
amod(reaction-9, reverse_transcriptase-polymerase-7)
compound(reaction-9, chain-8)
appos(study-3, reaction-9)
dep(used-15, Q-RT-PCR-11)
nsubjpass(used-15, analysis-13)
nsubj:xsubj(investigate-17, analysis-13)
auxpass(used-15, was-14)
root(ROOT-0, used-15)
mark(investigate-17, to-16)
xcomp(used-15, investigate-17)
det(levels-20, the-18)
amod(levels-20, mRNA-19)
dobj(investigate-17, levels-20)
case(enzymes-23, of-21)
det(enzymes-23, these-22)
nmod:of(levels-20, enzymes-23)
case(tissue-26, in-24)
amod(tissue-26, placental-25)
nmod:in(enzymes-23, tissue-26)

The/DT results/NNS showed/VBD a/DT significant/JJ increase/NN in/IN mRNA/NN levels/NNS for/IN all/DT four/CD enzymes/NNS in/IN response/NN to/TO gamma-T/JJ treatment/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP
            (NP (NN mRNA) (NNS levels))
            (PP (IN for)
              (NP (DT all) (CD four) (NNS enzymes))))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (JJ gamma-T) (NN treatment))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(showed-3, increase-6)
case(levels-9, in-7)
compound(levels-9, mRNA-8)
nmod:in(increase-6, levels-9)
case(enzymes-13, for-10)
det(enzymes-13, all-11)
nummod(enzymes-13, four-12)
nmod:for(levels-9, enzymes-13)
case(response-15, in-14)
nmod:in(showed-3, response-15)
case(treatment-18, to-16)
amod(treatment-18, gamma-T-17)
nmod:to(response-15, treatment-18)

These/DT findings/NNS suggest/VBP that/IN the/DT placenta/NN plays/VBZ an/DT important/JJ role/NN in/IN regulating/VBG the/DT metabolism/NN of/IN gamma-T/NN and/CC may/MD have/VB implications/NNS for/IN fetal/JJ development/NN and/CC health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN placenta))
          (VP
            (VP (VBZ plays)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP
                        (NP (DT the) (NN metabolism))
                        (PP (IN of)
                          (NP (NN gamma-T)))))))))
            (CC and)
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (NNS implications))
                  (PP (IN for)
                    (NP (JJ fetal) (NN development)
                      (CC and)
                      (NN health))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(plays-7, that-4)
det(placenta-6, the-5)
nsubj(plays-7, placenta-6)
nsubj(have-19, placenta-6)
ccomp(suggest-3, plays-7)
det(role-10, an-8)
amod(role-10, important-9)
dobj(plays-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
det(metabolism-14, the-13)
dobj(regulating-12, metabolism-14)
case(gamma-T-16, of-15)
nmod:of(metabolism-14, gamma-T-16)
cc(plays-7, and-17)
aux(have-19, may-18)
ccomp(suggest-3, have-19)
conj:and(plays-7, have-19)
dobj(have-19, implications-20)
case(development-23, for-21)
amod(development-23, fetal-22)
nmod:for(implications-20, development-23)
cc(development-23, and-24)
nmod:for(implications-20, health-25)
conj:and(development-23, health-25)

The/DT prevalence/NN of/IN osteoarthritis_of_the_hip/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN has_been/VBP increasing/VBG worldwide/RB ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN prevalence))
      (PP (IN of)
        (NP
          (NP (NN osteoarthritis_of_the_hip))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBP has_been)
      (VP (VBG increasing)
        (ADVP (RB worldwide))))
    (. .)))

det(prevalence-2, The-1)
nsubj(has_been-10, prevalence-2)
case(osteoarthritis_of_the_hip-4, of-3)
nmod:of(prevalence-2, osteoarthritis_of_the_hip-4)
nmod:of(prevalence-2, photophobia-6)
conj:and(osteoarthritis_of_the_hip-4, photophobia-6)
cc(osteoarthritis_of_the_hip-4, and-8)
nmod:of(prevalence-2, phonophobia-9)
conj:and(osteoarthritis_of_the_hip-4, phonophobia-9)
root(ROOT-0, has_been-10)
xcomp(has_been-10, increasing-11)
advmod(increasing-11, worldwide-12)

Alclofenac/NNP ,/, a/DT nonsteroidal/JJ anti-inflammatory/JJ drug/NN ,/, has_been/VBP shown/VBN to/TO have/VB anti-inflammatory/JJ and/CC analgesic/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Alclofenac))
      (, ,)
      (NP (DT a) (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (ADJP (JJ anti-inflammatory)
                  (CC and)
                  (JJ analgesic))
                (NNS effects)))))))
    (. .)))

nsubj(has_been-8, Alclofenac-1)
det(drug-6, a-3)
amod(drug-6, nonsteroidal-4)
amod(drug-6, anti-inflammatory-5)
appos(Alclofenac-1, drug-6)
root(ROOT-0, has_been-8)
dep(has_been-8, shown-9)
mark(have-11, to-10)
xcomp(shown-9, have-11)
amod(effects-15, anti-inflammatory-12)
cc(anti-inflammatory-12, and-13)
conj:and(anti-inflammatory-12, analgesic-14)
amod(effects-15, analgesic-14)
dobj(have-11, effects-15)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN alclofenac/NN was/VBD evaluated/VBN on/IN the/DT risk/NN of/IN osteoarthritis_of_the_hip/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NN alclofenac))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN on)
          (NP
            (NP (DT the) (NN risk))
            (PP (IN of)
              (NP
                (NP (NN osteoarthritis_of_the_hip))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(effect-6, the-5)
nsubjpass(evaluated-10, effect-6)
case(alclofenac-8, of-7)
nmod:of(effect-6, alclofenac-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
case(risk-13, on-11)
det(risk-13, the-12)
nmod:on(evaluated-10, risk-13)
case(osteoarthritis_of_the_hip-15, of-14)
nmod:of(risk-13, osteoarthritis_of_the_hip-15)
nmod:of(risk-13, photophobia-17)
conj:and(osteoarthritis_of_the_hip-15, photophobia-17)
cc(osteoarthritis_of_the_hip-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(osteoarthritis_of_the_hip-15, phonophobia-20)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN where/WRB patients/NNS were/VBD administered/VBN alclofenac/JJ at/IN varying/VBG doses/NNS ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (SBAR
          (WHADVP (WRB where))
          (S
            (NP (NNS patients))
            (VP (VBD were)
              (VP (VBN administered)
                (ADJP (JJ alclofenac))
                (PP (IN at)
                  (NP (VBG varying) (NNS doses)))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
advmod(administered-8, where-5)
nsubjpass(administered-8, patients-6)
auxpass(administered-8, were-7)
advcl(conducted-4, administered-8)
xcomp(administered-8, alclofenac-9)
case(doses-12, at-10)
amod(doses-12, varying-11)
nmod:at(administered-8, doses-12)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/VBP after/IN dosing/VBG ,/, alclofenac/JJ reduced/VBD the/DT risk/NN of/IN osteoarthritis_of_the_hip/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (QP (IN at) (CD 2)))
          (VP (VBP h)
            (ADJP
              (ADJP
                (ADJP
                  (PP (IN after)
                    (S
                      (VP (VBG dosing))))
                  (, ,) (JJ alclofenac))
                (SBAR
                  (S
                    (VP (VBD reduced)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NN osteoarthritis_of_the_hip))))
                      (PP (IN by)
                        (NP (CD 14) (NN %)))))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))
                (-RRB- -RRB-))
              (, ,)
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP (CD 17) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 12-22) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-))
              (, ,)
              (CC and)
              (ADJP (JJ phonophobia)
                (PP (IN by)
                  (NP (CD 14) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 17-20) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-)))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(h-7, that-4)
advmod(2-6, at-5)
nsubj(h-7, 2-6)
ccomp(showed-3, h-7)
mark(dosing-9, after-8)
advcl(alclofenac-11, dosing-9)
xcomp(h-7, alclofenac-11)
ccomp(alclofenac-11, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(osteoarthritis_of_the_hip-16, of-15)
nmod:of(risk-14, osteoarthritis_of_the_hip-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
nsubj(CI-23, %-22)
dep(alclofenac-11, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(h-7, photophobia-32)
conj:and(alclofenac-11, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
nsubj(CI-39, %-38)
dep(alclofenac-11, CI-39)
nummod(%-41, 12-22-40)
dobj(CI-39, %-41)
nsubj(<-44, P-43)
dep(CI-39, <-44)
dobj(<-44, 0.0001-45)
cc(alclofenac-11, and-48)
xcomp(h-7, phonophobia-49)
conj:and(alclofenac-11, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
nsubj(CI-56, %-55)
dep(alclofenac-11, CI-56)
nummod(%-58, 17-20-57)
dobj(CI-56, %-58)
nsubj(<-61, P-60)
dep(CI-56, <-61)
dobj(<-61, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN alclofenac/NN could/MD be/VB a/DT potential/JJ therapeutic/JJ option/NN for/IN reducing/VBG the/DT risk/NN of/IN osteoarthritis_of_the_hip/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN patients/NNS suffering/VBG from/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN alclofenac))
          (VP (MD could)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (NN osteoarthritis_of_the_hip))
                            (, ,)
                            (NP (NN photophobia))
                            (, ,)
                            (CC and)
                            (NP
                              (NP (NN phonophobia))
                              (PP (IN in)
                                (NP
                                  (NP (NNS patients))
                                  (VP (VBG suffering)
                                    (PP (IN from)
                                      (NP (DT these) (NNS conditions)))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, alclofenac-5)
aux(option-11, could-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(osteoarthritis_of_the_hip-17, of-16)
nmod:of(risk-15, osteoarthritis_of_the_hip-17)
nmod:of(risk-15, photophobia-19)
conj:and(osteoarthritis_of_the_hip-17, photophobia-19)
cc(osteoarthritis_of_the_hip-17, and-21)
nmod:of(risk-15, phonophobia-22)
conj:and(osteoarthritis_of_the_hip-17, phonophobia-22)
case(patients-24, in-23)
nmod:in(phonophobia-22, patients-24)
acl(patients-24, suffering-25)
case(conditions-28, from-26)
det(conditions-28, these-27)
nmod:from(suffering-25, conditions-28)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT findings/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN of/IN alclofenac/NN in/IN treating/VBG these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP
                      (NP (NN action))
                      (PP (IN of)
                        (NP (NN alclofenac))))))
                (PP (IN in)
                  (S
                    (VP (VBG treating)
                      (NP (DT these) (NNS conditions)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
xcomp(warranted-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(warranted-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)
case(alclofenac-17, of-16)
nmod:of(action-15, alclofenac-17)
mark(treating-19, in-18)
advcl(explore-10, treating-19)
det(conditions-21, these-20)
dobj(treating-19, conditions-21)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN and/CC have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (ADJP (JJ essential)
          (PP (IN for)
            (NP (JJ human) (NN health)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ various) (NN health) (NNS benefits)))))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
nsubjpass(associated-22, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, for-16)
amod(health-18, human-17)
nmod:for(essential-15, health-18)
cc(essential-15, and-19)
aux(associated-22, have-20)
auxpass(associated-22, been-21)
conj:and(essential-15, associated-22)
case(benefits-26, with-23)
amod(benefits-26, various-24)
compound(benefits-26, health-25)
nmod:with(associated-22, benefits-26)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NN can/MD decrease/VB Terguride/JJ levels/NNS in/IN hyperTerguridemic/JJ patients/NNS ,/, which/WDT may/MD be/VB beneficial/JJ in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD can)
              (VP (VB decrease)
                (NP
                  (NP (JJ Terguride) (NNS levels))
                  (PP (IN in)
                    (NP
                      (NP (JJ hyperTerguridemic) (NNS patients))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD may)
                            (VP (VB be)
                              (ADJP (JJ beneficial)
                                (PP (IN in)
                                  (S
                                    (VP (VBG reducing)
                                      (NP
                                        (NP
                                          (NP (DT the) (NN risk))
                                          (PP (IN of)
                                            (S
                                              (VP (VBG developing)
                                                (NP (NN coronary_heart_disease))))))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NNP CHD))
                                          (-RRB- -RRB-))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(decrease-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(decrease-9, omega-3_fatty_acids-7)
aux(decrease-9, can-8)
ccomp(shown-4, decrease-9)
amod(levels-11, Terguride-10)
dobj(decrease-9, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperTerguridemic-13)
nmod:in(levels-11, patients-14)
nsubj(beneficial-19, patients-14)
ref(patients-14, which-16)
aux(beneficial-19, may-17)
cop(beneficial-19, be-18)
acl:relcl(patients-14, beneficial-19)
mark(reducing-21, in-20)
advcl(beneficial-19, reducing-21)
det(risk-23, the-22)
dobj(reducing-21, risk-23)
mark(developing-25, of-24)
acl(risk-23, developing-25)
dobj(developing-25, coronary_heart_disease-26)
appos(risk-23, CHD-28)

EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN found/VBN to/TO improve/VB lipid/NN metabolism/NN ,/, reduce/VB inflammation/NN and/CC oxidative_stress/NNS ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NN metabolism)))
                (, ,)
                (VP
                  (VP (VB reduce)
                    (NP
                      (NP (NN inflammation))
                      (CC and)
                      (NP
                        (NP (NNS oxidative_stress))
                        (, ,)
                        (NP (JJR lower) (NN blood_pressure))
                        (, ,))))
                  (CC and)
                  (VP (VB improve)
                    (NP (JJ endothelial) (NN function))))))))))
    (. .)))

nsubjpass(found-7, EPA-1)
nsubj:xsubj(improve-9, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(found-7, DHA-3)
nsubj:xsubj(improve-9, DHA-3)
aux(found-7, have-4)
advmod(found-7, also-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(improve-9, to-8)
xcomp(found-7, improve-9)
compound(metabolism-11, lipid-10)
dobj(improve-9, metabolism-11)
dep(improve-9, reduce-13)
dobj(reduce-13, inflammation-14)
cc(inflammation-14, and-15)
dobj(reduce-13, oxidative_stress-16)
conj:and(inflammation-14, oxidative_stress-16)
amod(blood_pressure-19, lower-18)
appos(oxidative_stress-16, blood_pressure-19)
cc(reduce-13, and-21)
dep(improve-9, improve-22)
conj:and(reduce-13, improve-22)
amod(function-24, endothelial-23)
dobj(improve-22, function-24)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT useful/JJ strategy/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ useful) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, useful-14)
ccomp(suggest-3, strategy-15)
case(prevention-18, for-16)
det(prevention-18, the-17)
nmod:for(strategy-15, prevention-18)
cc(prevention-18, and-19)
nmod:for(strategy-15, treatment-20)
conj:and(prevention-18, treatment-20)
case(CHD-22, of-21)
nmod:of(prevention-18, CHD-22)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT benefits/NNS and/CC to/TO optimize/VB the/DT use/NN of/IN omega-3_fatty_acids/JJ in/IN clinical/JJ practice/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS benefits))))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP
                  (NP (DT the) (NN use))
                  (PP (IN of)
                    (NP (JJ omega-3_fatty_acids))))
                (PP (IN in)
                  (NP (JJ clinical) (NN practice)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(benefits-12, these-11)
dobj(underlying-10, benefits-12)
cc(understand-7, and-13)
mark(optimize-15, to-14)
ccomp(needed-4, optimize-15)
conj:and(understand-7, optimize-15)
det(use-17, the-16)
dobj(optimize-15, use-17)
case(omega-3_fatty_acids-19, of-18)
nmod:of(use-17, omega-3_fatty_acids-19)
case(practice-22, in-20)
amod(practice-22, clinical-21)
nmod:in(optimize-15, practice-22)

Chronic_heart_failure/NNP -LRB-/-LRB- HF/NNP -RRB-/-RRB- is_a/VBD common/JJ condition/NN that/WDT affects/VBZ many/JJ individuals/NNS worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Chronic_heart_failure) (-LRB- -LRB-)
      (NP (NNP HF))
      (-RRB- -RRB-))
    (VP (VBD is_a)
      (NP
        (NP (JJ common) (NN condition))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP (JJ many) (NNS individuals))
              (ADVP (RB worldwide)))))))
    (. .)))

nsubj(is_a-5, Chronic_heart_failure-1)
dep(Chronic_heart_failure-1, HF-3)
root(ROOT-0, is_a-5)
amod(condition-7, common-6)
dobj(is_a-5, condition-7)
nsubj(affects-9, condition-7)
ref(condition-7, that-8)
acl:relcl(condition-7, affects-9)
amod(individuals-11, many-10)
dobj(affects-9, individuals-11)
advmod(affects-9, worldwide-12)

Patients/NNS with/IN HF/NNP are/VBP at/IN an/DT increased/VBN risk/NN of/IN developing/VBG bacterial_sinusitis/NNS ,/, which/WDT can/MD further/RBR exacerbate/VB their/PRP$ condition/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Patients))
      (PP (IN with)
        (NP (NNP HF))))
    (VP (VBP are)
      (PP (IN at)
        (NP
          (NP (DT an) (VBN increased) (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NNS bacterial_sinusitis))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (MD can)
                    (VP
                      (ADVP (RBR further))
                      (VB exacerbate)
                      (NP (PRP$ their) (NN condition)))))))))))
    (. .)))

nsubj(risk-8, Patients-1)
case(HF-3, with-2)
nmod:with(Patients-1, HF-3)
cop(risk-8, are-4)
case(risk-8, at-5)
det(risk-8, an-6)
amod(risk-8, increased-7)
root(ROOT-0, risk-8)
case(bacterial_sinusitis-11, of-9)
amod(bacterial_sinusitis-11, developing-10)
nmod:of(risk-8, bacterial_sinusitis-11)
nsubj(exacerbate-16, bacterial_sinusitis-11)
ref(bacterial_sinusitis-11, which-13)
aux(exacerbate-16, can-14)
advmod(exacerbate-16, further-15)
acl:relcl(bacterial_sinusitis-11, exacerbate-16)
nmod:poss(condition-18, their-17)
dobj(exacerbate-16, condition-18)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN Myrtol/NNP on/IN the/DT risk/NN of/IN bacterial_sinusitis/NNS in/IN patients/NNS with/IN HF/NNP was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Myrtol)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP
              (NP (NNS bacterial_sinusitis))
              (PP (IN in)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (NNP HF))))))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-19, study-3)
det(effect-6, the-5)
nsubjpass(investigated-19, effect-6)
case(Myrtol-8, of-7)
nmod:of(effect-6, Myrtol-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(effect-6, risk-11)
case(bacterial_sinusitis-13, of-12)
nmod:of(risk-11, bacterial_sinusitis-13)
case(patients-15, in-14)
nmod:in(bacterial_sinusitis-13, patients-15)
case(HF-17, with-16)
nmod:with(patients-15, HF-17)
auxpass(investigated-19, was-18)
root(ROOT-0, investigated-19)

The/DT study/NN involved/VBD a/DT randomized_controlled_trial/NN comprising/VBG of/IN 500/CD patients/NNS with/IN HF/NNP ,/, who/WP were/VBD divided/VBN into/IN two/CD groups/NNS -/: one/CD group/NN received/VBD Myrtol/NNP while/IN the/DT other/JJ group/NN received/VBD a/DT placebo/NN ./.

(ROOT
  (S
    (S
      (NP (DT The) (NN study))
      (VP (VBD involved)
        (NP
          (NP (DT a) (NN randomized_controlled_trial) (VBG comprising))
          (PP (IN of)
            (NP
              (NP (CD 500) (NNS patients))
              (PP (IN with)
                (NP
                  (NP (NNP HF))
                  (, ,)
                  (SBAR
                    (WHNP (WP who))
                    (S
                      (VP (VBD were)
                        (VP (VBN divided)
                          (PP (IN into)
                            (NP (CD two) (NNS groups))))))))))))))
    (: -)
    (S
      (NP (CD one) (NN group))
      (VP (VBD received)
        (NP (NNP Myrtol))
        (SBAR (IN while)
          (S
            (NP (DT the) (JJ other) (NN group))
            (VP (VBD received)
              (NP (DT a) (NN placebo)))))))
    (. .)))

det(study-2, The-1)
nsubj(involved-3, study-2)
root(ROOT-0, involved-3)
det(randomized_controlled_trial-5, a-4)
dobj(involved-3, randomized_controlled_trial-5)
amod(randomized_controlled_trial-5, comprising-6)
case(patients-9, of-7)
nummod(patients-9, 500-8)
nmod:of(randomized_controlled_trial-5, patients-9)
case(HF-11, with-10)
nmod:with(patients-9, HF-11)
nsubjpass(divided-15, HF-11)
ref(HF-11, who-13)
auxpass(divided-15, were-14)
acl:relcl(HF-11, divided-15)
case(groups-18, into-16)
nummod(groups-18, two-17)
nmod:into(divided-15, groups-18)
nummod(group-21, one-20)
nsubj(received-22, group-21)
parataxis(involved-3, received-22)
dobj(received-22, Myrtol-23)
mark(received-28, while-24)
det(group-27, the-25)
amod(group-27, other-26)
nsubj(received-28, group-27)
advcl(received-22, received-28)
det(placebo-30, a-29)
dobj(received-28, placebo-30)

The/DT results/NNS showed/VBD that/IN Myrtol/NNP reduced/VBD the/DT risk/NN of/IN bacterial_sinusitis/NNS in/IN patients/NNS with/IN HF/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP Myrtol))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNS bacterial_sinusitis))
                  (PP (IN in)
                    (NP (NNS patients))))))
            (PP (IN with)
              (NP (NNP HF)))
            (PP (IN by)
              (NP
                (NP (CD 21) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                      (: :)
                      (NP
                        (QP (CD 0.67-0) (CD .93)))))
                  (-RRB- -RRB-))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, Myrtol-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(bacterial_sinusitis-10, of-9)
nmod:of(risk-8, bacterial_sinusitis-10)
case(patients-12, in-11)
nmod:in(bacterial_sinusitis-10, patients-12)
case(HF-14, with-13)
nmod:with(reduced-6, HF-14)
case(%-17, by-15)
nummod(%-17, 21-16)
nmod:by(reduced-6, %-17)
amod(-RSB--23, relative-19)
compound(-RSB--23, risk-20)
compound(-RSB--23, -LSB--21)
compound(-RSB--23, RR-22)
dep(%-17, -RSB--23)
nummod(-RSB--33, 0.79-25)
nummod(-RSB--33, 95-27)
compound(-RSB--33, %-28)
compound(-RSB--33, confidence-29)
amod(-RSB--33, interval-30)
amod(-RSB--33, -LSB--31)
compound(-RSB--33, CI-32)
dep(-RSB--23, -RSB--33)
compound(.93-36, 0.67-0-35)
dep(-RSB--33, .93-36)

These/DT findings/NNS suggest/VBP that/IN Myrtol/NNP may/MD be/VB an/DT effective/JJ prophylactic/JJ treatment/NN for/IN reducing/VBG the/DT incidence/NN of/IN bacterial_sinusitis/NNS in/IN patients/NNS with/IN HF/NNP ,/, which/WDT could/MD potentially/RB improve/VB their/PRP$ overall/JJ health/NN outcomes/NNS and/CC quality_of_life/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Myrtol))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (JJ prophylactic) (NN treatment))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN incidence))
                        (PP (IN of)
                          (NP
                            (NP (NNS bacterial_sinusitis))
                            (PP (IN in)
                              (NP (NNS patients))))))
                      (PP (IN with)
                        (NP
                          (NP (NNP HF))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (MD could) (RB potentially)
                                (VP (VB improve)
                                  (NP (PRP$ their)
                                    (NX
                                      (NX (JJ overall) (NN health) (NNS outcomes))
                                      (CC and)
                                      (NX (NN quality_of_life)))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(treatment-11, that-4)
nsubj(treatment-11, Myrtol-5)
aux(treatment-11, may-6)
cop(treatment-11, be-7)
det(treatment-11, an-8)
amod(treatment-11, effective-9)
amod(treatment-11, prophylactic-10)
ccomp(suggest-3, treatment-11)
mark(reducing-13, for-12)
acl(treatment-11, reducing-13)
det(incidence-15, the-14)
dobj(reducing-13, incidence-15)
case(bacterial_sinusitis-17, of-16)
nmod:of(incidence-15, bacterial_sinusitis-17)
case(patients-19, in-18)
nmod:in(bacterial_sinusitis-17, patients-19)
case(HF-21, with-20)
nmod:with(reducing-13, HF-21)
nsubj(improve-26, HF-21)
ref(HF-21, which-23)
aux(improve-26, could-24)
advmod(improve-26, potentially-25)
acl:relcl(HF-21, improve-26)
nmod:poss(outcomes-30, their-27)
amod(outcomes-30, overall-28)
compound(outcomes-30, health-29)
dobj(improve-26, outcomes-30)
cc(outcomes-30, and-31)
dobj(improve-26, quality_of_life-32)
conj:and(outcomes-30, quality_of_life-32)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO explore/VB the/DT underlying/VBG mechanisms/NNS by/IN which/WDT Myrtol/NNP exerts/VBZ its/PRP$ beneficial/JJ effects/NNS in/IN this/DT patient/JJ population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (NNP Myrtol))
                      (VP (VBZ exerts)
                        (NP
                          (NP (PRP$ its) (JJ beneficial) (NNS effects))
                          (PP (IN in)
                            (NP (DT this) (JJ patient) (NN population))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(explore-11, to-10)
ccomp(needed-4, explore-11)
conj:and(confirm-6, explore-11)
det(mechanisms-14, the-12)
amod(mechanisms-14, underlying-13)
dobj(explore-11, mechanisms-14)
mark(exerts-18, by-15)
dobj(exerts-18, which-16)
nsubj(exerts-18, Myrtol-17)
advcl(explore-11, exerts-18)
nmod:poss(effects-21, its-19)
amod(effects-21, beneficial-20)
dobj(exerts-18, effects-21)
case(population-25, in-22)
det(population-25, this-23)
amod(population-25, patient-24)
nmod:in(effects-21, population-25)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB a/DT strong/JJ association/NN with/IN decreased/VBN buparlisib/JJ levels/NNS in/IN hyperbuparlisibmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ strong) (NN association))
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ buparlisib) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hyperbuparlisibmic) (NNS patients))))))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
det(association-21, a-19)
amod(association-21, strong-20)
dobj(have-18, association-21)
case(levels-25, with-22)
amod(levels-25, decreased-23)
amod(levels-25, buparlisib-24)
nmod:with(association-21, levels-25)
case(patients-28, in-26)
amod(patients-28, hyperbuparlisibmic-27)
nmod:in(levels-25, patients-28)

Furthermore/RB ,/, research/NN has/VBZ demonstrated/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NN research))
    (VP (VBZ has)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN reduced) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(demonstrated-5, Furthermore-1)
nsubj(demonstrated-5, research-3)
aux(demonstrated-5, has-4)
root(ROOT-0, demonstrated-5)
mark(associated-10, that-6)
det(long-chain_fatty_acids-8, these-7)
nsubjpass(associated-10, long-chain_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-5, associated-10)
case(risk-14, with-11)
det(risk-14, a-12)
amod(risk-14, reduced-13)
nmod:with(associated-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

The/DT mechanism/NN behind/IN this/DT association/NN is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN to_be/NN related/VBN to/TO the/DT anti-inflammatory/JJ properties/NNS of/IN omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (PP (IN behind)
          (NP (DT this) (NN association))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (NP
            (NP (NN to_be))
            (VP (VBN related)
              (PP (TO to)
                (NP
                  (NP (DT the) (JJ anti-inflammatory) (NNS properties))
                  (PP (IN of)
                    (NP (JJ omega-3_fatty_acids))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(understood-10, mechanism-2)
case(association-5, behind-3)
det(association-5, this-4)
nmod:behind(mechanism-2, association-5)
auxpass(understood-10, is-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(thought-15, it-13)
auxpass(thought-15, is-14)
conj:but(understood-10, thought-15)
dobj(thought-15, to_be-16)
acl(to_be-16, related-17)
case(properties-21, to-18)
det(properties-21, the-19)
amod(properties-21, anti-inflammatory-20)
nmod:to(related-17, properties-21)
case(omega-3_fatty_acids-23, of-22)
nmod:of(properties-21, omega-3_fatty_acids-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN EPA/NNP and/CC DHA/NNP may/MD have/VB therapeutic/JJ benefits/NNS for/IN individuals/NNS at/IN risk/NN for/IN CHD/NNP and/CC those/DT receiving/VBG buparlisib/JJ treatment/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP (JJ dietary) (NN intake)
                (CC or)
                (NN supplementation))
              (PP (IN with)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ therapeutic) (NNS benefits))
                (PP (IN for)
                  (NP (NNS individuals))))
              (PP (IN at)
                (NP
                  (NP (NN risk))
                  (PP (IN for)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (DT those) (VBG receiving) (JJ buparlisib) (NN treatment)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-15, that-4)
csubj(have-15, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
cc(intake-7, or-8)
dobj(increasing-5, supplementation-9)
conj:or(intake-7, supplementation-9)
case(EPA-11, with-10)
nmod:with(increasing-5, EPA-11)
cc(EPA-11, and-12)
nmod:with(increasing-5, DHA-13)
conj:and(EPA-11, DHA-13)
aux(have-15, may-14)
ccomp(suggest-3, have-15)
amod(benefits-17, therapeutic-16)
dobj(have-15, benefits-17)
case(individuals-19, for-18)
nmod:for(benefits-17, individuals-19)
case(risk-21, at-20)
nmod:at(have-15, risk-21)
case(CHD-23, for-22)
nmod:for(risk-21, CHD-23)
cc(CHD-23, and-24)
det(treatment-28, those-25)
amod(treatment-28, receiving-26)
amod(treatment-28, buparlisib-27)
nmod:for(risk-21, treatment-28)
conj:and(CHD-23, treatment-28)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG this/DT relationship/NN and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN relationship))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ therapeutic) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(relationship-12, this-11)
dobj(underlying-10, relationship-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(use-20, for-18)
amod(use-20, therapeutic-19)
nmod:for(determine-15, use-20)

Functional_Dyspepsia/NNP -LRB-/-LRB- FD/NNP -RRB-/-RRB- is_a/JJ common/JJ gastrointestinal_disorder/NN characterized/VBD by/IN symptoms/NNS such/JJ as/IN epigastric_pain/NN ,/, bloating/NN ,/, nausea/NN ,/, and/CC early/JJ satiety/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Functional_Dyspepsia))
        (-LRB- -LRB-)
        (NP (NNP FD))
        (-RRB- -RRB-))
      (NP (JJ is_a) (JJ common) (NN gastrointestinal_disorder)))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (NNS symptoms))
          (PP (JJ such) (IN as)
            (NP
              (NP (NN epigastric_pain))
              (, ,)
              (NP (NN bloating))
              (, ,)
              (NP (NN nausea))
              (, ,)
              (CC and)
              (NP (JJ early) (NN satiety)))))))
    (. .)))

nsubj(characterized-8, Functional_Dyspepsia-1)
dep(Functional_Dyspepsia-1, FD-3)
amod(gastrointestinal_disorder-7, is_a-5)
amod(gastrointestinal_disorder-7, common-6)
dep(Functional_Dyspepsia-1, gastrointestinal_disorder-7)
root(ROOT-0, characterized-8)
case(symptoms-10, by-9)
nmod:by(characterized-8, symptoms-10)
case(epigastric_pain-13, such-11)
mwe(such-11, as-12)
nmod:such_as(symptoms-10, epigastric_pain-13)
nmod:such_as(symptoms-10, bloating-15)
conj:and(epigastric_pain-13, bloating-15)
nmod:such_as(symptoms-10, nausea-17)
conj:and(epigastric_pain-13, nausea-17)
cc(epigastric_pain-13, and-19)
amod(satiety-21, early-20)
nmod:such_as(symptoms-10, satiety-21)
conj:and(epigastric_pain-13, satiety-21)

Dicyclomine/JJ hydrochloride/NN is/VBZ an/DT antispasmodic/JJ agent/NN that/WDT has_been/VBP used/VBN to/TO treat/VB FD/NNP ./.

(ROOT
  (S
    (NP (JJ Dicyclomine) (NN hydrochloride))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ antispasmodic) (NN agent))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN used)
                (S
                  (VP (TO to)
                    (VP (VB treat)
                      (NP (NNP FD)))))))))))
    (. .)))

amod(hydrochloride-2, Dicyclomine-1)
nsubj(agent-6, hydrochloride-2)
cop(agent-6, is-3)
det(agent-6, an-4)
amod(agent-6, antispasmodic-5)
root(ROOT-0, agent-6)
nsubj(has_been-8, agent-6)
ref(agent-6, that-7)
acl:relcl(agent-6, has_been-8)
dep(has_been-8, used-9)
mark(treat-11, to-10)
xcomp(used-9, treat-11)
dobj(treat-11, FD-12)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN dicyclomine_hydrochloride/NN in/IN reducing/VBG the/DT risk/NN of/IN FD/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP
          (NP (NN dicyclomine_hydrochloride))
          (PP (IN in)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (NNP FD))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (VP (VBD was)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-21, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-21, efficacy-6)
case(dicyclomine_hydrochloride-8, of-7)
nmod:of(efficacy-6, dicyclomine_hydrochloride-8)
mark(reducing-10, in-9)
acl(dicyclomine_hydrochloride-8, reducing-10)
det(risk-12, the-11)
dobj(reducing-10, risk-12)
case(FD-14, of-13)
nmod:of(risk-12, FD-14)
nmod:of(risk-12, photophobia-16)
conj:and(FD-14, photophobia-16)
cc(FD-14, and-18)
nmod:of(risk-12, phonophobia-19)
conj:and(FD-14, phonophobia-19)
auxpass(evaluated-21, was-20)
root(ROOT-0, evaluated-21)

The/DT study/NN included/VBD a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN of/IN patients/NNS with/IN FD/NNP ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD included)
      (NP
        (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial))
        (PP (IN of)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (NNP FD)))))))
    (. .)))

det(study-2, The-1)
nsubj(included-3, study-2)
root(ROOT-0, included-3)
det(trial-10, a-4)
amod(trial-10, randomized-5)
amod(trial-10, double-blind-7)
amod(trial-10, placebo-controlled-9)
dobj(included-3, trial-10)
case(patients-12, of-11)
nmod:of(trial-10, patients-12)
case(FD-14, with-13)
nmod:with(patients-12, FD-14)

At_2/JJ h/NN after/IN dosing/VBG ,/, dicyclomine_hydrochloride/NN reduced/VBD the/DT risk/NN of/IN FD/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN dicyclomine_hydrochloride))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNP FD))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, dicyclomine_hydrochloride-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(FD-11, of-10)
nmod:of(risk-9, FD-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN dicyclomine_hydrochloride/NN may/MD be/VB an/DT effective/JJ treatment/NN for/IN patients/NNS with/IN FD/NNP and/CC associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN dicyclomine_hydrochloride))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (PP (IN for)
                  (NP
                    (NP
                      (NP (NNS patients))
                      (PP (IN with)
                        (NP (NNP FD))))
                    (CC and)
                    (NP
                      (NP (VBN associated) (NNS symptoms))
                      (PP (JJ such) (IN as)
                        (NP (NN photophobia)
                          (CC and)
                          (NN phonophobia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(treatment-10, that-4)
nsubj(treatment-10, dicyclomine_hydrochloride-5)
aux(treatment-10, may-6)
cop(treatment-10, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
ccomp(suggest-3, treatment-10)
case(patients-12, for-11)
nmod:for(treatment-10, patients-12)
case(FD-14, with-13)
nmod:with(patients-12, FD-14)
cc(patients-12, and-15)
amod(symptoms-17, associated-16)
nmod:for(treatment-10, symptoms-17)
conj:and(patients-12, symptoms-17)
case(photophobia-20, such-18)
mwe(such-18, as-19)
nmod:such_as(symptoms-17, photophobia-20)
cc(photophobia-20, and-21)
nmod:such_as(symptoms-17, phonophobia-22)
conj:and(photophobia-20, phonophobia-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN treatment/NN for/IN these/DT patients/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dose)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (NN treatment))
                      (PP (IN for)
                        (NP (DT these) (NNS patients))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(dose-14, the-12)
amod(dose-14, optimal-13)
dobj(determine-11, dose-14)
cc(dose-14, and-15)
dobj(determine-11, duration-16)
conj:and(dose-14, duration-16)
case(treatment-18, of-17)
nmod:of(dose-14, treatment-18)
case(patients-21, for-19)
det(patients-21, these-20)
nmod:for(treatment-18, patients-21)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT potential/JJ involvement/NN of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/JJ '/: ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN Brij-78/NNS ,/, in/IN the/DT early/JJ effects/NNS of/IN insulin/NN -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP
            (NP (DT the) (JJ potential) (NN involvement))
            (PP (IN of)
              (NP
                (NP (NNS adenosine_3) (POS '))
                (CD ,5)))
            ('' '))
          (: -)
          (NP
            (NP (NN cyclic_monophosphate))
            (PRN (-LRB- -LRB-)
              (NP (NN cAMP))
              (-RRB- -RRB-)))
          (CC and)
          (NP (JJ guanosine_3)
            (PRN (: ')
              (NP (CD ,5))
              ('' ') (: -))
            (NN cyclic_monophosphate)))
        (PRN (-LRB- -LRB-)
          (NP (NN cGMP))
          (-RRB- -RRB-))
        (, ,)
        (ADVP (RB as) (RB well)
          (PP (IN as)
            (NP (NNS Brij-78))))
        (, ,)
        (PP (IN in)
          (NP
            (NP
              (NP (DT the) (JJ early) (NNS effects))
              (PP (IN of)
                (NP (NN insulin))))
            (PRN (-LRB- -LRB-)
              (NP (NNP PRL))
              (-RRB- -RRB-)))))
      (PP (IN on)
        (NP (JJ lactose) (NNS biosynthesis))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(involvement-9, the-7)
amod(involvement-9, potential-8)
dobj(investigated-6, involvement-9)
case(adenosine_3-11, of-10)
nmod:'(involvement-9, adenosine_3-11)
case(adenosine_3-11, '-12)
nummod(adenosine_3-11, ,5-13)
dobj(investigated-6, cyclic_monophosphate-16)
conj:and(involvement-9, cyclic_monophosphate-16)
appos(cyclic_monophosphate-16, cAMP-18)
cc(involvement-9, and-20)
amod(cyclic_monophosphate-26, guanosine_3-21)
dep(cyclic_monophosphate-26, ,5-23)
dobj(investigated-6, cyclic_monophosphate-26)
conj:and(involvement-9, cyclic_monophosphate-26)
appos(involvement-9, cGMP-28)
advmod(well-32, as-31)
advmod(involvement-9, well-32)
case(Brij-78-34, as-33)
nmod:as(well-32, Brij-78-34)
case(effects-39, in-36)
det(effects-39, the-37)
amod(effects-39, early-38)
nmod:in(involvement-9, effects-39)
case(insulin-41, of-40)
nmod:of(effects-39, insulin-41)
appos(effects-39, PRL-43)
case(biosynthesis-47, on-45)
amod(biosynthesis-47, lactose-46)
nmod:on(investigated-6, biosynthesis-47)

To/TO accomplish/VB this/DT ,/, we/PRP utilized/VBD cultured/VBN mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB accomplish)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD utilized)
      (VP (VBN cultured)
        (S
          (NP
            (NP (JJ mammary_gland) (NNS explants))
            (VP (VBN derived)
              (PP (IN from)
                (NP (NNS mice)))
              (NP-TMP (CD 12-14) (NNS days))))
          (ADJP (JJ pregnant)))))
    (. .)))

mark(accomplish-2, To-1)
advcl(utilized-6, accomplish-2)
dobj(accomplish-2, this-3)
nsubj(utilized-6, we-5)
root(ROOT-0, utilized-6)
dep(utilized-6, cultured-7)
amod(explants-9, mammary_gland-8)
nsubj(pregnant-15, explants-9)
acl(explants-9, derived-10)
case(mice-12, from-11)
nmod:from(derived-10, mice-12)
nummod(days-14, 12-14-13)
nmod:tmod(derived-10, days-14)
xcomp(cultured-7, pregnant-15)

Our/PRP$ findings/NNS suggest/VBP that/IN cAMP/NN and/CC cGMP/NN may/MD play/VB a/DT role/NN in/IN the/DT early/JJ effects/NNS of/IN insulin/NN on/IN lactose/JJ biosynthesis/NNS ,/, as/IN their/PRP$ levels/NNS were/VBD altered/VBN in/IN response/NN to/TO insulin/NN treatment/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (JJ early) (NNS effects))
                    (PP (IN of)
                      (NP (NN insulin))))))
              (PP (IN on)
                (NP (JJ lactose) (NNS biosynthesis)))))))
      (, ,)
      (SBAR (IN as)
        (S
          (NP (PRP$ their) (NNS levels))
          (VP (VBD were)
            (VP (VBN altered)
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (NN insulin) (NN treatment))))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubj(play-9, cGMP-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(effects-15, in-12)
det(effects-15, the-13)
amod(effects-15, early-14)
nmod:in(role-11, effects-15)
case(insulin-17, of-16)
nmod:of(effects-15, insulin-17)
case(biosynthesis-20, on-18)
amod(biosynthesis-20, lactose-19)
nmod:on(play-9, biosynthesis-20)
mark(altered-26, as-22)
nmod:poss(levels-24, their-23)
nsubjpass(altered-26, levels-24)
auxpass(altered-26, were-25)
advcl(suggest-3, altered-26)
case(response-28, in-27)
nmod:in(altered-26, response-28)
case(treatment-31, to-29)
compound(treatment-31, insulin-30)
nmod:to(response-28, treatment-31)

Additionally/RB ,/, Brij-78/NNS appeared/VBD to/TO enhance/VB the/DT effects/NNS of/IN insulin/NN on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNS Brij-78))
    (VP (VBD appeared)
      (S
        (VP (TO to)
          (VP (VB enhance)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NN insulin)))
              (PP (IN on)
                (NP (JJ lactose) (NNS biosynthesis))))))))
    (. .)))

advmod(appeared-4, Additionally-1)
nsubj(appeared-4, Brij-78-3)
nsubj:xsubj(enhance-6, Brij-78-3)
root(ROOT-0, appeared-4)
mark(enhance-6, to-5)
xcomp(appeared-4, enhance-6)
det(effects-8, the-7)
dobj(enhance-6, effects-8)
case(insulin-10, of-9)
nmod:of(effects-8, insulin-10)
case(biosynthesis-13, on-11)
amod(biosynthesis-13, lactose-12)
nmod:on(effects-8, biosynthesis-13)

These/DT results/NNS provide/VBP insight/NN into/IN the/DT complex/JJ signaling/VBG pathways/NNS involved/VBN in/IN milk/NN production/NN and/CC may/MD have/VB implications/NNS for/IN improving/VBG lactation/NN outcomes/NNS in/IN both/DT humans/NNS and/CC animals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP
      (VP (VBP provide)
        (NP (NN insight))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ complex) (VBG signaling) (NNS pathways))
            (VP (VBN involved)
              (PP (IN in)
                (NP (NN milk) (NN production)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (S
                (VP (VBG improving)
                  (NP
                    (NP (NN lactation) (NNS outcomes))
                    (PP (IN in)
                      (NP (DT both) (NNS humans)
                        (CC and)
                        (NNS animals)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(provide-3, results-2)
nsubj(have-16, results-2)
root(ROOT-0, provide-3)
dobj(provide-3, insight-4)
case(pathways-9, into-5)
det(pathways-9, the-6)
amod(pathways-9, complex-7)
amod(pathways-9, signaling-8)
nmod:into(provide-3, pathways-9)
acl(pathways-9, involved-10)
case(production-13, in-11)
compound(production-13, milk-12)
nmod:in(involved-10, production-13)
cc(provide-3, and-14)
aux(have-16, may-15)
conj:and(provide-3, have-16)
dobj(have-16, implications-17)
mark(improving-19, for-18)
acl(implications-17, improving-19)
compound(outcomes-21, lactation-20)
dobj(improving-19, outcomes-21)
case(humans-24, in-22)
cc:preconj(humans-24, both-23)
nmod:in(outcomes-21, humans-24)
cc(humans-24, and-25)
nmod:in(outcomes-21, animals-26)
conj:and(humans-24, animals-26)

The/DT use/NN of/IN chymostatin/NN ,/, a/DT protease_inhibitor/NN ,/, has_been/NN investigated/VBD for/IN its/PRP$ potential/JJ therapeutic/JJ effects/NNS on/IN symptoms/NNS associated/VBN with/IN migraine_headaches/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP
          (NP (NN chymostatin))
          (, ,)
          (NP
            (NP (DT a) (NN protease_inhibitor))
            (, ,)
            (NP (NN has_been))))))
    (VP (VBD investigated)
      (PP (IN for)
        (NP
          (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS effects))
          (PP (IN on)
            (NP
              (NP (NNS symptoms))
              (VP (VBN associated)
                (PP (IN with)
                  (NP (NNS migraine_headaches)))))))))
    (. .)))

det(use-2, The-1)
nsubj(investigated-10, use-2)
case(chymostatin-4, of-3)
nmod:of(use-2, chymostatin-4)
det(protease_inhibitor-7, a-6)
appos(chymostatin-4, protease_inhibitor-7)
appos(protease_inhibitor-7, has_been-9)
root(ROOT-0, investigated-10)
case(effects-15, for-11)
nmod:poss(effects-15, its-12)
amod(effects-15, potential-13)
amod(effects-15, therapeutic-14)
nmod:for(investigated-10, effects-15)
case(symptoms-17, on-16)
nmod:on(effects-15, symptoms-17)
acl(symptoms-17, associated-18)
case(migraine_headaches-20, with-19)
nmod:with(associated-18, migraine_headaches-20)

In/IN a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ,/, participants/NNS were/VBD administered/VBN chymostatin/NN and/CC evaluated/VBN for/IN the/DT presence/NN of/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/JJ at/IN 2/CD hours/NNS post-dosing/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)))
    (, ,)
    (NP (NNS participants))
    (VP (VBD were)
      (VP
        (VP (VBN administered)
          (NP (NN chymostatin)))
        (CC and)
        (VP (VBN evaluated)
          (PP (IN for)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP
                  (NP (NNS bronchospasms))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP
                    (ADJP (JJ phonophobia)
                      (PP (IN at)
                        (NP (CD 2) (NNS hours))))
                    (NN post-dosing)))))))))
    (. .)))

case(trial-8, In-1)
det(trial-8, a-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(administered-12, trial-8)
nsubjpass(administered-12, participants-10)
nsubjpass(evaluated-15, participants-10)
auxpass(administered-12, were-11)
root(ROOT-0, administered-12)
dobj(administered-12, chymostatin-13)
cc(administered-12, and-14)
conj:and(administered-12, evaluated-15)
case(presence-18, for-16)
det(presence-18, the-17)
nmod:for(evaluated-15, presence-18)
case(bronchospasms-20, of-19)
nmod:of(presence-18, bronchospasms-20)
nmod:of(presence-18, photophobia-22)
conj:and(bronchospasms-20, photophobia-22)
cc(bronchospasms-20, and-24)
amod(post-dosing-29, phonophobia-25)
case(hours-28, at-26)
nummod(hours-28, 2-27)
nmod:at(phonophobia-25, hours-28)
nmod:of(presence-18, post-dosing-29)
conj:and(bronchospasms-20, post-dosing-29)

Results/NNS showed/VBD that/IN chymostatin/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN chymostatin))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(reduced-6, that-3)
nsubj(reduced-6, chymostatin-4)
advmod(reduced-6, significantly-5)
ccomp(showed-2, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(bronchospasms-10, of-9)
nmod:of(risk-8, bronchospasms-10)
case(%-13, by-11)
nummod(%-13, 14-12)
nmod:by(reduced-6, %-13)
nummod(%-16, 95-15)
dep(%-13, %-16)
acl:relcl(%-16, CI-17)
nummod(%-19, 6-20-18)
dobj(CI-17, %-19)
appos(%-19, P-21)
dep(0.0005-23, =-22)
dep(%-19, 0.0005-23)
xcomp(reduced-6, photophobia-26)
case(%-29, by-27)
nummod(%-29, 17-28)
nmod:by(photophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(photophobia-26, and-42)
xcomp(reduced-6, phonophobia-43)
conj:and(photophobia-26, phonophobia-43)
case(%-46, by-44)
nummod(%-46, 14-45)
nmod:by(phonophobia-43, %-46)
nummod(%-49, 95-48)
appos(%-46, %-49)
dep(%-52, CI-50)
nummod(%-52, 17-20-51)
nmod(%-49, %-52)
dep(%-49, P-54)
compound(0.0001-56, <-55)
nummod(P-54, 0.0001-56)

These/DT findings/NNS suggest/VBP that/IN chymostatin/NN may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN individuals/NNS suffering/VBG from/IN migraine_headaches/NNS with/IN associated/VBN symptoms/NNS of/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN chymostatin))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP
                          (NP (NNS migraine_headaches))
                          (PP (IN with)
                            (NP
                              (NP (VBN associated) (NNS symptoms))
                              (PP (IN of)
                                (NP
                                  (NP (NNS bronchospasms))
                                  (, ,)
                                  (NP (NN photophobia))
                                  (, ,)
                                  (CC and)
                                  (NP (NN phonophobia)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, chymostatin-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(migraine_headaches-16, from-15)
nmod:from(suffering-14, migraine_headaches-16)
case(symptoms-19, with-17)
amod(symptoms-19, associated-18)
nmod:with(migraine_headaches-16, symptoms-19)
case(bronchospasms-21, of-20)
nmod:of(symptoms-19, bronchospasms-21)
nmod:of(symptoms-19, photophobia-23)
conj:and(bronchospasms-21, photophobia-23)
cc(bronchospasms-21, and-25)
nmod:of(symptoms-19, phonophobia-26)
conj:and(bronchospasms-21, phonophobia-26)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC investigate/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(investigate-10, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
xcomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(warranted-4, investigate-10)
conj:and(confirm-6, investigate-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(investigate-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO evaluate/VB the/DT effects/NNS of/IN remifentanil/NN on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NN remifentanil))))
            (PP (IN on)
              (NP
                (NP (NNS bronchospasms))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(evaluate-8, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(evaluate-8, to-7)
xcomp(was-6, evaluate-8)
det(effects-10, the-9)
dobj(evaluate-8, effects-10)
case(remifentanil-12, of-11)
nmod:of(effects-10, remifentanil-12)
case(bronchospasms-14, on-13)
nmod:on(evaluate-8, bronchospasms-14)
nmod:on(evaluate-8, photophobia-16)
conj:and(bronchospasms-14, photophobia-16)
cc(bronchospasms-14, and-18)
nmod:on(evaluate-8, phonophobia-19)
conj:and(bronchospasms-14, phonophobia-19)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN in/IN which/WDT participants/NNS were/VBD administered/VBN remifentanil/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNS participants))
              (VP (VBD were)
                (VP (VBN administered)
                  (NP (NN remifentanil)
                    (CC or)
                    (NN placebo)))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
mark(administered-14, in-10)
dobj(administered-14, which-11)
nsubjpass(administered-14, participants-12)
auxpass(administered-14, were-13)
advcl(conducted-9, administered-14)
dobj(administered-14, remifentanil-15)
cc(remifentanil-15, or-16)
dobj(administered-14, placebo-17)
conj:or(remifentanil-15, placebo-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, remifentanil/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN remifentanil))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, remifentanil-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(bronchospasms-17, of-16)
nmod:of(risk-15, bronchospasms-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN remifentanil/NN may/MD be/VB a/DT useful/JJ therapeutic/JJ option/NN for/IN patients/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN remifentanil))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ useful) (JJ therapeutic) (NN option))
              (PP (IN for)
                (NP
                  (NP (NNS patients))
                  (VP (VBG experiencing)
                    (NP (DT these) (NNS symptoms))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, remifentanil-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, useful-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, experiencing-14)
det(symptoms-16, these-15)
dobj(experiencing-14, symptoms-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN treatment/NN with/IN remifentanil/NN for/IN these/DT indications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ optimal) (NN dose)
                  (CC and)
                  (NN duration))
                (PP (IN of)
                  (NP (NN treatment))))
              (PP (IN with)
                (NP
                  (NP (NN remifentanil))
                  (PP (IN for)
                    (NP (DT these) (NNS indications))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(dose-9, the-7)
amod(dose-9, optimal-8)
dobj(determine-6, dose-9)
cc(dose-9, and-10)
dobj(determine-6, duration-11)
conj:and(dose-9, duration-11)
case(treatment-13, of-12)
nmod:of(dose-9, treatment-13)
case(remifentanil-15, with-14)
nmod:with(determine-6, remifentanil-15)
case(indications-18, for-16)
det(indications-18, these-17)
nmod:for(remifentanil-15, indications-18)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ,/, particularly/RB in/IN relation/NN to/TO cardiovascular_disease/VB ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN in)
            (NP (NN relation)
              (S
                (VP (TO to)
                  (VP (VB cardiovascular_disease)))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)
advmod(relation-14, particularly-12)
case(relation-14, in-13)
nmod:in(studied-5, relation-14)
mark(cardiovascular_disease-16, to-15)
acl(relation-14, cardiovascular_disease-16)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP two/CD such/JJ fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN decreased/VBN ISIS_388626/NNP levels/NNS in/IN hyperISIS/NNS 388626mic/JJ patients/NNS and/CC a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (CD two) (JJ such) (NNS fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (VBN decreased) (NNP ISIS_388626) (NNS levels)))
                  (PP (IN in)
                    (NP
                      (NP
                        (NP (NNS hyperISIS))
                        (NP (JJ 388626mic) (NNS patients)))
                      (CC and)
                      (NP
                        (NP (DT a) (VBN reduced) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (VBG developing) (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(fatty_acids-17, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
cop(fatty_acids-17, are-14)
nummod(fatty_acids-17, two-15)
amod(fatty_acids-17, such-16)
root(ROOT-0, fatty_acids-17)
nsubjpass(associated-21, fatty_acids-17)
ref(fatty_acids-17, that-18)
aux(associated-21, have-19)
auxpass(associated-21, been-20)
acl:relcl(fatty_acids-17, associated-21)
case(levels-25, with-22)
amod(levels-25, decreased-23)
compound(levels-25, ISIS_388626-24)
nmod:with(associated-21, levels-25)
case(hyperISIS-27, in-26)
nmod:in(associated-21, hyperISIS-27)
amod(patients-29, 388626mic-28)
dep(hyperISIS-27, patients-29)
cc(hyperISIS-27, and-30)
det(risk-33, a-31)
amod(risk-33, reduced-32)
nmod:in(associated-21, risk-33)
conj:and(hyperISIS-27, risk-33)
case(coronary_heart_disease-36, of-34)
amod(coronary_heart_disease-36, developing-35)
nmod:of(risk-33, coronary_heart_disease-36)
appos(coronary_heart_disease-36, CHD-38)

Several/JJ mechanisms/NNS have/VBP been/VBN proposed/VBN to/TO explain/VB the/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP ,/, including/VBG their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB endothelial/JJ function/NN ,/, and/CC modulate/VBP lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP (JJ Several) (NNS mechanisms))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN proposed)
            (S
              (VP (TO to)
                (VP (VB explain)
                  (NP
                    (NP (DT the) (JJ beneficial) (NNS effects))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA)))
                    (, ,)
                    (VP (VBG including)
                      (NP (PRP$ their) (NN ability)
                        (S
                          (VP (TO to)
                            (VP
                              (VP (VB reduce)
                                (NP (NN inflammation)))
                              (, ,)
                              (VP (VB improve)
                                (NP (JJ endothelial) (NN function)))))))))))))))
      (, ,)
      (CC and)
      (VP (VBP modulate)
        (NP (NN lipid) (NN metabolism))))
    (. .)))

amod(mechanisms-2, Several-1)
nsubjpass(proposed-5, mechanisms-2)
nsubj:xsubj(explain-7, mechanisms-2)
nsubj(modulate-28, mechanisms-2)
aux(proposed-5, have-3)
auxpass(proposed-5, been-4)
root(ROOT-0, proposed-5)
mark(explain-7, to-6)
xcomp(proposed-5, explain-7)
det(effects-10, the-8)
amod(effects-10, beneficial-9)
dobj(explain-7, effects-10)
case(EPA-12, of-11)
nmod:of(effects-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(effects-10, DHA-14)
conj:and(EPA-12, DHA-14)
acl(effects-10, including-16)
nmod:poss(ability-18, their-17)
dobj(including-16, ability-18)
mark(reduce-20, to-19)
acl(ability-18, reduce-20)
dobj(reduce-20, inflammation-21)
dep(reduce-20, improve-23)
amod(function-25, endothelial-24)
dobj(improve-23, function-25)
cc(proposed-5, and-27)
conj:and(proposed-5, modulate-28)
compound(metabolism-30, lipid-29)
dobj(modulate-28, metabolism-30)

Epidemiological/JJ studies/NNS have/VBP consistently/RB shown/VBN an/DT inverse/JJ relationship/NN between/IN omega-3/JJ intake/NN and/CC CHD/NNP risk/NN ,/, and/CC clinical/JJ trials/NNS have/VBP demonstrated/VBN that/IN supplementation/NN with/IN these/DT fatty_acids/NNS can/MD reduce/VB triglycerides/NNPS and/CC other/JJ risk/NN factors/NNS for/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (S
      (NP (JJ Epidemiological) (NNS studies))
      (VP (VBP have)
        (VP
          (ADVP (RB consistently))
          (VBN shown)
          (NP
            (NP (DT an) (JJ inverse) (NN relationship))
            (PP (IN between)
              (NP
                (NP (JJ omega-3) (NN intake))
                (CC and)
                (NP (NNP CHD) (NN risk))))))))
    (, ,)
    (CC and)
    (S
      (NP (JJ clinical) (NNS trials))
      (VP (VBP have)
        (VP (VBN demonstrated)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN supplementation))
                (PP (IN with)
                  (NP (DT these) (NNS fatty_acids))))
              (VP (MD can)
                (VP (VB reduce)
                  (NP
                    (NP (NNPS triglycerides))
                    (CC and)
                    (NP
                      (NP (JJ other) (NN risk) (NNS factors))
                      (PP (IN for)
                        (NP (NN cardiovascular_disease))))))))))))
    (. .)))

amod(studies-2, Epidemiological-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, consistently-4)
root(ROOT-0, shown-5)
det(relationship-8, an-6)
amod(relationship-8, inverse-7)
dobj(shown-5, relationship-8)
case(intake-11, between-9)
amod(intake-11, omega-3-10)
nmod:between(relationship-8, intake-11)
cc(intake-11, and-12)
compound(risk-14, CHD-13)
nmod:between(relationship-8, risk-14)
conj:and(intake-11, risk-14)
cc(shown-5, and-16)
amod(trials-18, clinical-17)
nsubj(demonstrated-20, trials-18)
aux(demonstrated-20, have-19)
conj:and(shown-5, demonstrated-20)
mark(reduce-27, that-21)
nsubj(reduce-27, supplementation-22)
case(fatty_acids-25, with-23)
det(fatty_acids-25, these-24)
nmod:with(supplementation-22, fatty_acids-25)
aux(reduce-27, can-26)
ccomp(demonstrated-20, reduce-27)
dobj(reduce-27, triglycerides-28)
cc(triglycerides-28, and-29)
amod(factors-32, other-30)
compound(factors-32, risk-31)
dobj(reduce-27, factors-32)
conj:and(triglycerides-28, factors-32)
case(cardiovascular_disease-34, for-33)
nmod:for(factors-32, cardiovascular_disease-34)

While/IN the/DT optimal/JJ dose/NN and/CC duration/NN of/IN omega-3/JJ supplementation/NN are/VBP still/RB being/VBG investigated/VBN ,/, the/DT evidence/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS may/MD be/VB a/DT simple/JJ yet/RB effective/JJ strategy/NN for/IN reducing/VBG CHD/NNP risk/NN ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (JJ optimal) (NN dose)
            (CC and)
            (NN duration))
          (PP (IN of)
            (NP (JJ omega-3) (NN supplementation))))
        (VP (VBP are) (RB still)
          (VP (VBG being)
            (VP (VBN investigated))))))
    (, ,)
    (NP (DT the) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NNS supplements)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ simple)
                  (ADJP (RB yet) (JJ effective))
                  (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP (NNP CHD) (NN risk)))))))))))
    (. .)))

mark(investigated-13, While-1)
det(dose-4, the-2)
amod(dose-4, optimal-3)
nsubjpass(investigated-13, dose-4)
cc(dose-4, and-5)
conj:and(dose-4, duration-6)
nsubjpass(investigated-13, duration-6)
case(supplementation-9, of-7)
amod(supplementation-9, omega-3-8)
nmod:of(dose-4, supplementation-9)
aux(investigated-13, are-10)
advmod(investigated-13, still-11)
auxpass(investigated-13, being-12)
advcl(suggests-17, investigated-13)
det(evidence-16, the-15)
nsubj(suggests-17, evidence-16)
root(ROOT-0, suggests-17)
mark(strategy-36, that-18)
csubj(strategy-36, increasing-19)
dobj(increasing-19, intake-20)
case(EPA-22, of-21)
nmod:of(intake-20, EPA-22)
cc(EPA-22, and-23)
nmod:of(intake-20, DHA-24)
conj:and(EPA-22, DHA-24)
case(sources-27, through-25)
amod(sources-27, dietary-26)
nmod:through(increasing-19, sources-27)
cc(sources-27, or-28)
nmod:through(increasing-19, supplements-29)
conj:or(sources-27, supplements-29)
aux(strategy-36, may-30)
cop(strategy-36, be-31)
det(strategy-36, a-32)
amod(strategy-36, simple-33)
advmod(effective-35, yet-34)
amod(strategy-36, effective-35)
ccomp(suggests-17, strategy-36)
mark(reducing-38, for-37)
acl(strategy-36, reducing-38)
compound(risk-40, CHD-39)
dobj(reducing-38, risk-40)

Voltage-gated/JJ chloride/NN channels/NNS -LRB-/-LRB- ClCs/NNP -RRB-/-RRB- are/VBP important/JJ for/IN the/DT maintenance/NN of/IN muscle/NN membrane/NN potential/JJ and/CC excitability/JJ ./.

(ROOT
  (S
    (NP
      (NP (JJ Voltage-gated) (NN chloride) (NNS channels))
      (PRN (-LRB- -LRB-)
        (NP (NNP ClCs))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (ADJP (JJ important)
        (PP (IN for)
          (NP
            (NP (DT the) (NN maintenance))
            (PP (IN of)
              (NP
                (NP (NN muscle) (NN membrane))
                (ADJP (JJ potential)
                  (CC and)
                  (JJ excitability))))))))
    (. .)))

amod(channels-3, Voltage-gated-1)
compound(channels-3, chloride-2)
nsubj(important-8, channels-3)
appos(channels-3, ClCs-5)
cop(important-8, are-7)
root(ROOT-0, important-8)
case(maintenance-11, for-9)
det(maintenance-11, the-10)
nmod:for(important-8, maintenance-11)
case(membrane-14, of-12)
compound(membrane-14, muscle-13)
nmod:of(maintenance-11, membrane-14)
amod(membrane-14, potential-15)
cc(potential-15, and-16)
amod(membrane-14, excitability-17)
conj:and(potential-15, excitability-17)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT human/JJ skeletal_muscle/JJ voltage-gated/JJ chloride_channel/NN -LRB-/-LRB- ClC-1/NNP -RRB-/-RRB- is/VBZ associated/VBN with/IN the/DT 5-HT1A_receptor/NN ,/, which/WDT is/VBZ involved/VBN in/IN regulating/VBG mood/NN ,/, anxiety/NN ,/, and/CC pain/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ human) (JJ skeletal_muscle) (JJ voltage-gated) (NN chloride_channel))
              (PRN (-LRB- -LRB-)
                (NP (NNP ClC-1))
                (-RRB- -RRB-)))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT the) (NN 5-HT1A_receptor))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBZ is)
                          (VP (VBN involved)
                            (PP (IN in)
                              (S
                                (VP (VBG regulating)
                                  (NP
                                    (NP (NN mood))
                                    (, ,)
                                    (NP (NN anxiety))
                                    (, ,)
                                    (CC and)
                                    (NP (NN pain))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(associated-15, that-5)
det(chloride_channel-10, the-6)
amod(chloride_channel-10, human-7)
amod(chloride_channel-10, skeletal_muscle-8)
amod(chloride_channel-10, voltage-gated-9)
nsubjpass(associated-15, chloride_channel-10)
appos(chloride_channel-10, ClC-1-12)
auxpass(associated-15, is-14)
ccomp(suggested-4, associated-15)
case(5-HT1A_receptor-18, with-16)
det(5-HT1A_receptor-18, the-17)
nmod:with(associated-15, 5-HT1A_receptor-18)
nsubjpass(involved-22, 5-HT1A_receptor-18)
ref(5-HT1A_receptor-18, which-20)
auxpass(involved-22, is-21)
acl:relcl(5-HT1A_receptor-18, involved-22)
mark(regulating-24, in-23)
advcl(involved-22, regulating-24)
dobj(regulating-24, mood-25)
dobj(regulating-24, anxiety-27)
conj:and(mood-25, anxiety-27)
cc(mood-25, and-29)
dobj(regulating-24, pain-30)
conj:and(mood-25, pain-30)

LY334370/NNP is_a/VBZ selective/JJ 5-HT1A_receptor/JJ antagonist/NN that/WDT has_been/VBP shown/VBN to/TO have/VB analgesic/JJ effects/NNS in/IN animal/NN models/NNS of/IN pain/NN ./.

(ROOT
  (S
    (NP (NNP LY334370))
    (VP (VBZ is_a)
      (NP
        (NP (JJ selective) (JJ 5-HT1A_receptor) (NN antagonist))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB have)
                      (NP
                        (NP (JJ analgesic) (NNS effects))
                        (PP (IN in)
                          (NP
                            (NP (NN animal) (NNS models))
                            (PP (IN of)
                              (NP (NN pain)))))))))))))))
    (. .)))

nsubj(is_a-2, LY334370-1)
root(ROOT-0, is_a-2)
amod(antagonist-5, selective-3)
amod(antagonist-5, 5-HT1A_receptor-4)
dobj(is_a-2, antagonist-5)
nsubj(has_been-7, antagonist-5)
ref(antagonist-5, that-6)
acl:relcl(antagonist-5, has_been-7)
dep(has_been-7, shown-8)
mark(have-10, to-9)
xcomp(shown-8, have-10)
amod(effects-12, analgesic-11)
dobj(have-10, effects-12)
case(models-15, in-13)
compound(models-15, animal-14)
nmod:in(effects-12, models-15)
case(pain-17, of-16)
nmod:of(models-15, pain-17)

However/RB ,/, it/PRP is/VBZ not/RB clear/JJ whether/IN LY334370/NNP acts/VBZ directly/RB on/IN ClC-1/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is) (RB not)
      (ADJP (JJ clear))
      (SBAR (IN whether)
        (S
          (NP (NNP LY334370))
          (VP (VBZ acts)
            (ADVP (RB directly))
            (PP (IN on)
              (NP (NN ClC-1)))))))
    (. .)))

advmod(clear-6, However-1)
nsubj(clear-6, it-3)
cop(clear-6, is-4)
neg(clear-6, not-5)
root(ROOT-0, clear-6)
mark(acts-9, whether-7)
nsubj(acts-9, LY334370-8)
ccomp(clear-6, acts-9)
advmod(acts-9, directly-10)
case(ClC-1-12, on-11)
nmod:on(acts-9, ClC-1-12)

In/IN this/DT study/NN ,/, we/PRP evaluated/VBN the/DT effects/NNS of/IN LY334370/NNP on/IN ClC-1/NNS expressed/VBN in/IN cultured/JJ mammalian/JJ cells/NNS using/VBG whole-cell/JJ recording/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN evaluated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP LY334370))))
      (PP (IN on)
        (NP
          (NP (NNS ClC-1))
          (VP (VBN expressed)
            (PP (IN in)
              (NP (JJ cultured) (JJ mammalian) (NNS cells)))
            (S
              (VP (VBG using)
                (NP (JJ whole-cell) (NN recording))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-6, study-3)
nsubj(evaluated-6, we-5)
root(ROOT-0, evaluated-6)
det(effects-8, the-7)
dobj(evaluated-6, effects-8)
case(LY334370-10, of-9)
nmod:of(effects-8, LY334370-10)
case(ClC-1-12, on-11)
nmod:on(evaluated-6, ClC-1-12)
acl(ClC-1-12, expressed-13)
case(cells-17, in-14)
amod(cells-17, cultured-15)
amod(cells-17, mammalian-16)
nmod:in(expressed-13, cells-17)
xcomp(expressed-13, using-18)
amod(recording-20, whole-cell-19)
dobj(using-18, recording-20)

Our/PRP$ results/NNS suggest/VBP that/IN LY334370/NNP does/VBZ indeed/RB act/VB directly/RB on/IN ClC-1/NN by/IN reducing/VBG its/PRP$ current/JJ density/NN and/CC altering/VBG its/PRP$ gating/JJ properties/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP LY334370))
          (VP (VBZ does) (RB indeed)
            (VP (VB act)
              (ADVP (RB directly))
              (PP (IN on)
                (NP (NN ClC-1)))
              (PP (IN by)
                (S
                  (VP
                    (VP (VBG reducing)
                      (NP (PRP$ its) (JJ current) (NN density)))
                    (CC and)
                    (VP (VBG altering)
                      (NP (PRP$ its) (JJ gating) (NNS properties)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(act-8, that-4)
nsubj(act-8, LY334370-5)
aux(act-8, does-6)
advmod(act-8, indeed-7)
ccomp(suggest-3, act-8)
advmod(act-8, directly-9)
case(ClC-1-11, on-10)
nmod:on(act-8, ClC-1-11)
mark(reducing-13, by-12)
advcl(act-8, reducing-13)
nmod:poss(density-16, its-14)
amod(density-16, current-15)
dobj(reducing-13, density-16)
cc(reducing-13, and-17)
advcl(act-8, altering-18)
conj:and(reducing-13, altering-18)
nmod:poss(properties-21, its-19)
amod(properties-21, gating-20)
dobj(altering-18, properties-21)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT mechanism/NN of/IN action/NN of/IN LY334370/NNP and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ analgesic/JJ drugs/NNS targeting/VBG ClCs/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN mechanism))
              (PP (IN of)
                (NP
                  (NP (NN action))
                  (PP (IN of)
                    (NP (NNP LY334370)))))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (JJ novel) (JJ analgesic) (NNS drugs)))))
            (VP (VBG targeting)
              (NP (NNS ClCs)))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-15, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanism-8, into-6)
det(mechanism-8, the-7)
nmod:into(insights-5, mechanism-8)
case(action-10, of-9)
nmod:of(mechanism-8, action-10)
case(LY334370-12, of-11)
nmod:of(action-10, LY334370-12)
cc(provide-3, and-13)
aux(have-15, may-14)
conj:and(provide-3, have-15)
dobj(have-15, implications-16)
case(development-19, for-17)
det(development-19, the-18)
nmod:for(implications-16, development-19)
case(drugs-23, of-20)
amod(drugs-23, novel-21)
amod(drugs-23, analgesic-22)
nmod:of(development-19, drugs-23)
acl(implications-16, targeting-24)
dobj(targeting-24, ClCs-25)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-25, omega-3_fatty_acids-2)
nsubj:xsubj(have-27, omega-3_fatty_acids-2)
advmod(eicosapentaenoic_acid-5, specifically-4)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-5)
dobj(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
dep(EPA-7, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dobj(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
dep(DHA-16, n-3-20)
aux(shown-25, have-23)
auxpass(shown-25, been-24)
root(ROOT-0, shown-25)
mark(have-27, to-26)
xcomp(shown-25, have-27)
amod(benefits-30, numerous-28)
compound(benefits-30, health-29)
dobj(have-27, benefits-30)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Sativex/NN levels/NNS in/IN hyperSativexmic/JJ patients/NNS ,/, which/WDT may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN Sativex-related_disorders/NNP ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN Sativex) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperSativexmic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB have)
                                (NP
                                  (NP (NNS implications))
                                  (PP (IN for)
                                    (NP
                                      (NP (DT the) (NN treatment))
                                      (PP (IN of)
                                        (NP (NNP Sativex-related_disorders))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, Sativex-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperSativexmic-15)
nmod:in(levels-13, patients-16)
nsubj(have-20, patients-16)
ref(patients-16, which-18)
aux(have-20, may-19)
acl:relcl(patients-16, have-20)
dobj(have-20, implications-21)
case(treatment-24, for-22)
det(treatment-24, the-23)
nmod:for(implications-21, treatment-24)
case(Sativex-related_disorders-26, of-25)
nmod:of(treatment-24, Sativex-related_disorders-26)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (VBN reduced) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (VP (VB coronary_heart_disease)
                      (NP
                        (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                        (, ,)
                        (NP
                          (NP (DT a) (VBG leading) (NN cause))
                          (PP (IN of)
                            (NP (NN death)))))
                      (ADVP (RB worldwide)))))))))))
    (. .)))

advmod(linked-8, Additionally-1)
nsubjpass(linked-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(linked-8, DHA-5)
aux(linked-8, have-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, reduced-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
xcomp(developing-14, coronary_heart_disease-15)
dobj(coronary_heart_disease-15, CHD-17)
det(cause-22, a-20)
amod(cause-22, leading-21)
appos(CHD-17, cause-22)
case(death-24, of-23)
nmod:of(cause-22, death-24)
advmod(coronary_heart_disease-15, worldwide-25)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP thought/VBN to/TO involve/VB their/PRP$ anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS ,/, as/RB well/RB as/IN their/PRP$ ability/NN to/TO modulate/VBP lipid/NN metabolism/NN and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP (VBP are)
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP
              (VP (VB involve)
                (NP (PRP$ their) (JJ anti-inflammatory)
                  (CC and)
                  (JJ anti-thrombotic) (NNS properties))
                (, ,)
                (ADVP
                  (ADVP (RB as) (RB well))
                  (SBAR (IN as)
                    (S
                      (NP (PRP$ their) (NN ability)
                        (S
                          (VP (TO to))))
                      (VP (VBP modulate)
                        (NP (NN lipid) (NN metabolism)))))))
              (CC and)
              (VP (VB improve)
                (NP (JJ endothelial) (NN function))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(thought-8, mechanisms-2)
nsubj:xsubj(involve-10, mechanisms-2)
nsubj:xsubj(improve-27, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
auxpass(thought-8, are-7)
root(ROOT-0, thought-8)
mark(involve-10, to-9)
xcomp(thought-8, involve-10)
nmod:poss(anti-inflammatory-12, their-11)
dobj(involve-10, anti-inflammatory-12)
cc(anti-inflammatory-12, and-13)
amod(properties-15, anti-thrombotic-14)
dobj(involve-10, properties-15)
conj:and(anti-inflammatory-12, properties-15)
advmod(involve-10, as-17)
mwe(as-17, well-18)
mark(modulate-23, as-19)
nmod:poss(ability-21, their-20)
nsubj(modulate-23, ability-21)
acl(ability-21, to-22)
advcl(as-17, modulate-23)
compound(metabolism-25, lipid-24)
dobj(modulate-23, metabolism-25)
cc(involve-10, and-26)
xcomp(thought-8, improve-27)
conj:and(involve-10, improve-27)
amod(function-29, endothelial-28)
dobj(improve-27, function-29)

These/DT findings/NNS highlight/VB the/DT potential/JJ importance/NN of/IN including/VBG long-chain/JJ omega-3_fatty_acids/JJ in/IN the/DT diet/NN or/CC as/RB supplements/NNS for/IN the/DT prevention/NN and/CC management/NN of/IN Sativex-related_disorders/NNP and/CC CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (JJ potential) (NN importance))
        (PP (IN of)
          (S
            (VP (VBG including)
              (NP
                (NP (JJ long-chain)
                  (ADJP (JJ omega-3_fatty_acids)
                    (PP (IN in)
                      (NP (DT the) (NN diet)
                        (CC or)
                        (RB as))))
                  (NNS supplements))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN management))
                    (PP (IN of)
                      (NP (NNP Sativex-related_disorders)
                        (CC and)
                        (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
root(ROOT-0, highlight-3)
det(importance-6, the-4)
amod(importance-6, potential-5)
dobj(highlight-3, importance-6)
mark(including-8, of-7)
acl(importance-6, including-8)
amod(supplements-16, long-chain-9)
amod(supplements-16, omega-3_fatty_acids-10)
case(diet-13, in-11)
det(diet-13, the-12)
nmod:in(omega-3_fatty_acids-10, diet-13)
cc(diet-13, or-14)
advmod(diet-13, as-15)
dobj(including-8, supplements-16)
case(prevention-19, for-17)
det(prevention-19, the-18)
nmod:for(supplements-16, prevention-19)
cc(prevention-19, and-20)
nmod:for(supplements-16, management-21)
conj:and(prevention-19, management-21)
case(Sativex-related_disorders-23, of-22)
nmod:of(prevention-19, Sativex-related_disorders-23)
cc(Sativex-related_disorders-23, and-24)
nmod:of(prevention-19, CHD-25)
conj:and(Sativex-related_disorders-23, CHD-25)

The/DT transport/NN of/IN neurotransmitters/NNS into/IN synaptic/NN vesicles/VBZ is_a/JJ critical/JJ step/NN in/IN the/DT regulation/NN of/IN neuronal/JJ communication/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN transport))
      (PP (IN of)
        (NP
          (NP (NNS neurotransmitters))
          (PP (IN into)
            (NP (NN synaptic))))))
    (VP (VBZ vesicles)
      (NP
        (NP (JJ is_a) (JJ critical) (NN step))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP (JJ neuronal) (NN communication)))))))
    (. .)))

det(transport-2, The-1)
nsubj(vesicles-7, transport-2)
case(neurotransmitters-4, of-3)
nmod:of(transport-2, neurotransmitters-4)
case(synaptic-6, into-5)
nmod:into(neurotransmitters-4, synaptic-6)
root(ROOT-0, vesicles-7)
amod(step-10, is_a-8)
amod(step-10, critical-9)
dobj(vesicles-7, step-10)
case(regulation-13, in-11)
det(regulation-13, the-12)
nmod:in(step-10, regulation-13)
case(communication-16, of-14)
amod(communication-16, neuronal-15)
nmod:of(regulation-13, communication-16)

Among/IN the/DT transporters/NNS involved/VBN in/IN this/DT process/NN ,/, vesicular/NN serpins/NNS transporters/NNS -LRB-/-LRB- VGLUT1/2/3/NNP -RRB-/-RRB- ,/, the/DT vesicular/NN excitatory/RB amino_acid/VBN transporter/NN -LRB-/-LRB- VEAT/NNP -RRB-/-RRB- ,/, the/DT vesicular_nucleotide_transporter/NN -LRB-/-LRB- VNUT/NNP -RRB-/-RRB- ,/, vesicular/NN monoamine/NN transporters/NNS -LRB-/-LRB- VMAT1/2/NNP -RRB-/-RRB- ,/, the/DT vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- and/CC the/DT vesicular/NN y-aminobutyric_acid/JJ -LRB-/-LRB- GABA/NNP -RRB-/-RRB- transporter/NN -LRB-/-LRB- C1esterase/NNS -RRB-/-RRB- have/VBP been/VBN identified/VBN in/IN the/DT brain/NN ./.

(ROOT
  (S
    (PP (IN Among)
      (NP
        (NP (DT the) (NNS transporters))
        (VP (VBN involved)
          (PP (IN in)
            (NP (DT this) (NN process))))))
    (, ,)
    (NP
      (NP
        (NP
          (NP (NN vesicular) (NNS serpins) (NNS transporters))
          (PRN (-LRB- -LRB-)
            (NP (NNP VGLUT1/2/3))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP
            (NP (DT the) (NN vesicular))
            (ADJP (RB excitatory) (VBN amino_acid))
            (NN transporter))
          (PRN (-LRB- -LRB-)
            (NP (NNP VEAT))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (DT the) (NN vesicular_nucleotide_transporter))
          (PRN (-LRB- -LRB-)
            (NP (NNP VNUT))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN vesicular) (NN monoamine) (NNS transporters))
          (PRN (-LRB- -LRB-)
            (NP (NNP VMAT1/2))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (DT the) (NN vesicular_acetylcholine_transporter))
          (PRN (-LRB- -LRB-)
            (NP (NNP VAChT))
            (-RRB- -RRB-)))
        (CC and)
        (NP (DT the)
          (ADJP
            (ADJP (NN vesicular) (JJ y-aminobutyric_acid))
            (PRN (-LRB- -LRB-)
              (NP (NNP GABA))
              (-RRB- -RRB-)))
          (NN transporter)))
      (PRN (-LRB- -LRB-) (NNS C1esterase) (-RRB- -RRB-)))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN identified)
          (PP (IN in)
            (NP (DT the) (NN brain))))))
    (. .)))

case(transporters-3, Among-1)
det(transporters-3, the-2)
nmod:among(identified-56, transporters-3)
acl(transporters-3, involved-4)
case(process-7, in-5)
det(process-7, this-6)
nmod:in(involved-4, process-7)
compound(transporters-11, vesicular-9)
compound(transporters-11, serpins-10)
nsubjpass(identified-56, transporters-11)
appos(transporters-11, VGLUT1/2/3-13)
det(vesicular-17, the-16)
compound(transporter-20, vesicular-17)
advmod(amino_acid-19, excitatory-18)
amod(transporter-20, amino_acid-19)
conj:and(transporters-11, transporter-20)
nsubjpass(identified-56, transporter-20)
appos(transporter-20, VEAT-22)
det(vesicular_nucleotide_transporter-26, the-25)
conj:and(transporters-11, vesicular_nucleotide_transporter-26)
nsubjpass(identified-56, vesicular_nucleotide_transporter-26)
appos(vesicular_nucleotide_transporter-26, VNUT-28)
compound(transporters-33, vesicular-31)
compound(transporters-33, monoamine-32)
conj:and(transporters-11, transporters-33)
nsubjpass(identified-56, transporters-33)
appos(transporters-33, VMAT1/2-35)
det(vesicular_acetylcholine_transporter-39, the-38)
conj:and(transporters-11, vesicular_acetylcholine_transporter-39)
nsubjpass(identified-56, vesicular_acetylcholine_transporter-39)
appos(vesicular_acetylcholine_transporter-39, VAChT-41)
cc(transporters-11, and-43)
det(transporter-50, the-44)
nmod:npmod(y-aminobutyric_acid-46, vesicular-45)
amod(transporter-50, y-aminobutyric_acid-46)
dep(y-aminobutyric_acid-46, GABA-48)
conj:and(transporters-11, transporter-50)
nsubjpass(identified-56, transporter-50)
dep(transporters-11, C1esterase-52)
aux(identified-56, have-54)
auxpass(identified-56, been-55)
root(ROOT-0, identified-56)
case(brain-59, in-57)
det(brain-59, the-58)
nmod:in(identified-56, brain-59)

In/IN this/DT review/NN ,/, we/PRP will/MD first/RB describe/VB the/DT current/JJ knowledge/NN on/IN these/DT transporters/NNS ,/, including/VBG their/PRP$ expression/NN patterns/NNS ,/, subcellular/NN localization/NN ,/, and/CC functional/JJ properties/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review)))
    (, ,)
    (NP (PRP we))
    (VP (MD will) (RB first)
      (VP (VB describe)
        (NP (DT the) (JJ current) (NN knowledge))
        (PP (IN on)
          (NP
            (NP (DT these) (NNS transporters))
            (, ,)
            (VP (VBG including)
              (NP (PRP$ their) (NN expression) (NNS patterns)))
            (, ,)
            (NP (NN subcellular) (NN localization))
            (, ,)
            (CC and)
            (NP (JJ functional) (NNS properties))))))
    (. .)))

case(review-3, In-1)
det(review-3, this-2)
nmod:in(describe-8, review-3)
nsubj(describe-8, we-5)
aux(describe-8, will-6)
advmod(describe-8, first-7)
root(ROOT-0, describe-8)
det(knowledge-11, the-9)
amod(knowledge-11, current-10)
dobj(describe-8, knowledge-11)
case(transporters-14, on-12)
det(transporters-14, these-13)
nmod:on(describe-8, transporters-14)
acl(transporters-14, including-16)
nmod:poss(patterns-19, their-17)
compound(patterns-19, expression-18)
dobj(including-16, patterns-19)
compound(localization-22, subcellular-21)
nmod:on(describe-8, localization-22)
conj:and(transporters-14, localization-22)
cc(transporters-14, and-24)
amod(properties-26, functional-25)
nmod:on(describe-8, properties-26)
conj:and(transporters-14, properties-26)

We/PRP will/MD also/RB discuss/VB their/PRP$ roles/NNS in/IN neurotransmitter/NN release/NN and/CC synaptic/JJ plasticity/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (MD will) (RB also)
      (VP (VB discuss)
        (NP (PRP$ their) (NNS roles))
        (PP (IN in)
          (NP
            (NP (NN neurotransmitter) (NN release))
            (CC and)
            (NP (JJ synaptic) (NN plasticity))))))
    (. .)))

nsubj(discuss-4, We-1)
aux(discuss-4, will-2)
advmod(discuss-4, also-3)
root(ROOT-0, discuss-4)
nmod:poss(roles-6, their-5)
dobj(discuss-4, roles-6)
case(release-9, in-7)
compound(release-9, neurotransmitter-8)
nmod:in(discuss-4, release-9)
cc(release-9, and-10)
amod(plasticity-12, synaptic-11)
nmod:in(discuss-4, plasticity-12)
conj:and(release-9, plasticity-12)

Finally/RB ,/, we/PRP will/MD highlight/VB recent/JJ advances/NNS in/IN our/PRP$ understanding/NN of/IN how/WRB these/DT transporters/NNS are/VBP regulated/VBN and/CC their/PRP$ potential/JJ as/RB therapeutic/JJ targets/NNS for/IN neurological_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Finally))
    (, ,)
    (NP (PRP we))
    (VP (MD will)
      (VP (VB highlight)
        (NP
          (NP
            (NP (JJ recent) (NNS advances))
            (PP (IN in)
              (NP
                (NP (PRP$ our) (NN understanding))
                (PP (IN of)
                  (SBAR
                    (WHADVP (WRB how))
                    (S
                      (NP (DT these) (NNS transporters))
                      (VP (VBP are)
                        (VP (VBN regulated)))))))))
          (CC and)
          (NP
            (NP (PRP$ their) (JJ potential)
              (ADJP (RB as) (JJ therapeutic))
              (NNS targets))
            (PP (IN for)
              (NP (NNS neurological_disorders)))))))
    (. .)))

advmod(highlight-5, Finally-1)
nsubj(highlight-5, we-3)
aux(highlight-5, will-4)
root(ROOT-0, highlight-5)
amod(advances-7, recent-6)
dobj(highlight-5, advances-7)
case(understanding-10, in-8)
nmod:poss(understanding-10, our-9)
nmod:in(advances-7, understanding-10)
mark(regulated-16, of-11)
advmod(regulated-16, how-12)
det(transporters-14, these-13)
nsubjpass(regulated-16, transporters-14)
auxpass(regulated-16, are-15)
acl(understanding-10, regulated-16)
cc(advances-7, and-17)
nmod:poss(targets-22, their-18)
amod(targets-22, potential-19)
advmod(therapeutic-21, as-20)
amod(targets-22, therapeutic-21)
dobj(highlight-5, targets-22)
conj:and(advances-7, targets-22)
case(neurological_disorders-24, for-23)
nmod:for(targets-22, neurological_disorders-24)

The/DT quantitative/JJ polymerase/NN chain/NN reaction/NN -LRB-/-LRB- qPCR/NN -RRB-/-RRB- is_a/VBZ powerful/JJ technique/NN for/IN analyzing/VBG gene/NN expression/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ quantitative) (NN polymerase) (NN chain) (NN reaction))
      (PRN (-LRB- -LRB-)
        (NP (NN qPCR))
        (-RRB- -RRB-)))
    (VP (VBZ is_a)
      (NP
        (NP (JJ powerful) (NN technique))
        (PP (IN for)
          (S
            (VP (VBG analyzing)
              (NP (NN gene) (NN expression)))))))
    (. .)))

det(reaction-5, The-1)
amod(reaction-5, quantitative-2)
compound(reaction-5, polymerase-3)
compound(reaction-5, chain-4)
nsubj(is_a-9, reaction-5)
appos(reaction-5, qPCR-7)
root(ROOT-0, is_a-9)
amod(technique-11, powerful-10)
dobj(is_a-9, technique-11)
mark(analyzing-13, for-12)
acl(technique-11, analyzing-13)
compound(expression-15, gene-14)
dobj(analyzing-13, expression-15)

In/IN this/DT study/NN ,/, we/PRP used/VBD qPCR/NN to/TO investigate/VB the/DT expression/NN levels/NNS of/IN several/JJ genes/NNS involved/VBN in/IN the/DT transport/NN and/CC signaling/VBG of/IN LY393558/NNP ,/, a/DT potential/JJ therapeutic/JJ agent/NN for/IN various/JJ neurological_disorders/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD used)
      (NP (NN qPCR))
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN expression) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (JJ several) (NNS genes))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN transport)
                          (CC and)
                          (VBG signaling))
                        (PP (IN of)
                          (NP
                            (NP (NNP LY393558))
                            (, ,)
                            (NP
                              (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent))
                              (PP (IN for)
                                (NP (JJ various) (NNS neurological_disorders))))))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(used-6, study-3)
nsubj(used-6, we-5)
root(ROOT-0, used-6)
dobj(used-6, qPCR-7)
mark(investigate-9, to-8)
advcl(used-6, investigate-9)
det(levels-12, the-10)
compound(levels-12, expression-11)
dobj(investigate-9, levels-12)
case(genes-15, of-13)
amod(genes-15, several-14)
nmod:of(levels-12, genes-15)
acl(genes-15, involved-16)
case(transport-19, in-17)
det(transport-19, the-18)
nmod:in(involved-16, transport-19)
cc(transport-19, and-20)
nmod:in(involved-16, signaling-21)
conj:and(transport-19, signaling-21)
case(LY393558-23, of-22)
nmod:of(transport-19, LY393558-23)
det(agent-28, a-25)
amod(agent-28, potential-26)
amod(agent-28, therapeutic-27)
appos(LY393558-23, agent-28)
case(neurological_disorders-31, for-29)
amod(neurological_disorders-31, various-30)
nmod:for(agent-28, neurological_disorders-31)

Specifically/RB ,/, we/PRP analyzed/VBD the/DT expression/NN of/IN LY393558/CD transporters/NNS 5-HT1B/CD -LRB-/-LRB- SLC10A1/NNP -RRB-/-RRB- ,/, MCT8/NNP -LRB-/-LRB- SLC16A2/NNP -RRB-/-RRB- ,/, and/CC OATP1C1/NNP -LRB-/-LRB- SLCO1C1/NNP -RRB-/-RRB- ,/, as/IN well/RB as/RB LY393558/CD receptor/NN a/DT and/CC b/SYM -LRB-/-LRB- THRA/NNP and/CC THRB/NNP -RRB-/-RRB- and/CC deiodinase/JJ type_I/NNS ,/, II/NNP ,/, and/CC III/NNP -LRB-/-LRB- DIO1/NNP ,/, DIO2/NNP ,/, DIO3/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Specifically))
    (, ,)
    (NP (PRP we))
    (VP (VBD analyzed)
      (NP
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP
                (NP (CD LY393558) (NNS transporters))
                (NP (CD 5-HT1B)))
              (PRN (-LRB- -LRB-)
                (NP (NNP SLC10A1))
                (-RRB- -RRB-)))))
        (, ,)
        (NP
          (NP (NNP MCT8))
          (PRN (-LRB- -LRB-)
            (NP (NNP SLC16A2))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP
          (NP (NNP OATP1C1))
          (PRN (-LRB- -LRB-)
            (NP (NNP SLCO1C1))
            (-RRB- -RRB-))))
      (, ,)
      (PP (IN as)
        (NP
          (NP (RB well)
            (ADVP (RB as)
              (NP (CD LY393558) (NN receptor)))
            (NP
              (NP
                (NP (DT a))
                (CC and)
                (NP (SYM b)))
              (PRN (-LRB- -LRB-)
                (NP (NNP THRA)
                  (CC and)
                  (NNP THRB))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (JJ deiodinase) (NNS type_I))
              (, ,)
              (NP (NNP II))))
          (, ,)
          (CC and)
          (NP
            (NP (NNP III))
            (PRN (-LRB- -LRB-)
              (NP (NNP DIO1))
              (, ,)
              (NP (NNP DIO2))
              (, ,)
              (NP (NNP DIO3))
              (-RRB- -RRB-))))))
    (. .)))

advmod(analyzed-4, Specifically-1)
nsubj(analyzed-4, we-3)
root(ROOT-0, analyzed-4)
det(expression-6, the-5)
dobj(analyzed-4, expression-6)
case(transporters-9, of-7)
nummod(transporters-9, LY393558-8)
nmod:of(expression-6, transporters-9)
dep(transporters-9, 5-HT1B-10)
appos(transporters-9, SLC10A1-12)
dobj(analyzed-4, MCT8-15)
conj:and(expression-6, MCT8-15)
appos(MCT8-15, SLC16A2-17)
cc(expression-6, and-20)
dobj(analyzed-4, OATP1C1-21)
conj:and(expression-6, OATP1C1-21)
appos(OATP1C1-21, SLCO1C1-23)
case(a-31, as-26)
advmod(a-31, well-27)
advmod(a-31, as-28)
nummod(receptor-30, LY393558-29)
nmod:npmod(as-28, receptor-30)
nmod:as(analyzed-4, a-31)
cc(a-31, and-32)
nmod:as(analyzed-4, b-33)
conj:and(a-31, b-33)
appos(a-31, THRA-35)
cc(THRA-35, and-36)
appos(a-31, THRB-37)
conj:and(THRA-35, THRB-37)
cc(a-31, and-39)
amod(type_I-41, deiodinase-40)
nmod:as(analyzed-4, type_I-41)
conj:and(a-31, type_I-41)
appos(type_I-41, II-43)
cc(a-31, and-45)
nmod:as(analyzed-4, III-46)
conj:and(a-31, III-46)
appos(III-46, DIO1-48)
dep(DIO1-48, DIO2-50)
dep(DIO1-48, DIO3-52)

Our/PRP$ results/NNS provide/VBP valuable/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG the/DT transport/NN and/CC signaling/VBG of/IN LY393558/NNP in/IN neurological/JJ systems/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP provide)
      (NP
        (NP (JJ valuable) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP
                (NP (DT the) (NN transport)
                  (CC and)
                  (VBG signaling))
                (PP (IN of)
                  (NP (NNP LY393558))))
              (PP (IN in)
                (NP (JJ neurological) (NNS systems))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(provide-3, results-2)
root(ROOT-0, provide-3)
amod(insights-5, valuable-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(insights-5, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(transport-12, the-11)
dobj(underlying-10, transport-12)
cc(transport-12, and-13)
dobj(underlying-10, signaling-14)
conj:and(transport-12, signaling-14)
case(LY393558-16, of-15)
nmod:of(transport-12, LY393558-16)
case(systems-19, in-17)
amod(systems-19, neurological-18)
nmod:in(underlying-10, systems-19)

These/DT findings/NNS may/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN new/JJ therapies/NNS for/IN neurological_disorders/NNS based/VBN on/IN modulating/VBG these/DT pathways/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP
                  (NP (JJ new) (NNS therapies))
                  (PP (IN for)
                    (NP
                      (NP (NNS neurological_disorders))
                      (VP (VBN based)
                        (PP (IN on)
                          (S
                            (VP (VBG modulating)
                              (NP (DT these) (NNS pathways)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(have-4, findings-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
amod(implications-6, important-5)
dobj(have-4, implications-6)
case(development-9, for-7)
det(development-9, the-8)
nmod:for(implications-6, development-9)
case(therapies-12, of-10)
amod(therapies-12, new-11)
nmod:of(development-9, therapies-12)
case(neurological_disorders-14, for-13)
nmod:for(therapies-12, neurological_disorders-14)
acl(neurological_disorders-14, based-15)
mark(modulating-17, on-16)
advcl(based-15, modulating-17)
det(pathways-19, these-18)
dobj(modulating-17, pathways-19)

The/DT beneficial/JJ effects/NNS of/IN long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN in/IN relation/NN to/TO their/PRP$ potential/JJ role/NN in/IN preventing/VBG cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ beneficial) (NNS effects))
      (PP (IN of)
        (NP (JJ long-chain) (JJ omega-3_fatty_acids)))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN in)
            (NP (NN relation)))
          (PP (TO to)
            (NP
              (NP (PRP$ their) (JJ potential) (NN role))
              (PP (IN in)
                (NP (VBG preventing) (NN cardiovascular_disease))))))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, beneficial-2)
nsubjpass(studied-29, effects-3)
case(omega-3_fatty_acids-6, of-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nmod:of(effects-3, omega-3_fatty_acids-6)
dep(effects-3, eicosapentaenoic_acid-8)
dobj(eicosapentaenoic_acid-8, EPA-10)
compound(n-3-14, 20:5-13)
dep(EPA-10, n-3-14)
cc(eicosapentaenoic_acid-8, and-16)
dep(effects-3, docosahexaenoic_acid-17)
conj:and(eicosapentaenoic_acid-8, docosahexaenoic_acid-17)
dobj(docosahexaenoic_acid-17, DHA-19)
compound(n-3-23, 22:6-22)
dep(DHA-19, n-3-23)
aux(studied-29, have-26)
auxpass(studied-29, been-27)
advmod(studied-29, widely-28)
root(ROOT-0, studied-29)
case(relation-31, in-30)
nmod:in(studied-29, relation-31)
case(role-35, to-32)
nmod:poss(role-35, their-33)
amod(role-35, potential-34)
nmod:to(studied-29, role-35)
case(cardiovascular_disease-38, in-36)
amod(cardiovascular_disease-38, preventing-37)
nmod:in(role-35, cardiovascular_disease-38)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP also/RB associated/VBN with/IN decreased/VBN diminazene/NN levels/NNS in/IN hyperdiminazenemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (ADVP (RB also))
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN diminazene) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperdiminazenemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
auxpass(associated-10, are-8)
advmod(associated-10, also-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, diminazene-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperdiminazenemic-16)
nmod:in(levels-14, patients-17)

Diminazene/JJ is_a/NN medication/NN used/VBD to/TO treat/VB trypanosomiasis/NNS ,/, a/DT parasitic_infection/NN that/WDT can/MD cause/VB serious/JJ health/NN problems/NNS ./.

(ROOT
  (S
    (NP (JJ Diminazene) (NN is_a) (NN medication))
    (VP (VBD used)
      (S
        (VP (TO to)
          (VP (VB treat)
            (NP
              (NP (NNS trypanosomiasis))
              (, ,)
              (NP
                (NP (DT a) (NN parasitic_infection))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD can)
                      (VP (VB cause)
                        (NP (JJ serious) (NN health) (NNS problems))))))))))))
    (. .)))

amod(medication-3, Diminazene-1)
compound(medication-3, is_a-2)
nsubj(used-4, medication-3)
nsubj:xsubj(treat-6, medication-3)
root(ROOT-0, used-4)
mark(treat-6, to-5)
xcomp(used-4, treat-6)
dobj(treat-6, trypanosomiasis-7)
det(parasitic_infection-10, a-9)
appos(trypanosomiasis-7, parasitic_infection-10)
nsubj(cause-13, parasitic_infection-10)
ref(parasitic_infection-10, that-11)
aux(cause-13, can-12)
acl:relcl(parasitic_infection-10, cause-13)
amod(problems-16, serious-14)
compound(problems-16, health-15)
dobj(cause-13, problems-16)

The/DT reduction/NN in/IN diminazene/JJ levels/NNS suggests/VBZ that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN this/DT infection/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN reduction))
      (PP (IN in)
        (NP (JJ diminazene) (NNS levels))))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP (DT this) (NN infection)))))))))
    (. .)))

det(reduction-2, The-1)
nsubj(suggests-6, reduction-2)
case(levels-5, in-3)
amod(levels-5, diminazene-4)
nmod:in(reduction-2, levels-5)
root(ROOT-0, suggests-6)
mark(have-11, that-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nsubj(have-11, omega-3_fatty_acids-9)
aux(have-11, may-10)
ccomp(suggests-6, have-11)
det(effect-14, a-12)
amod(effect-14, protective-13)
dobj(have-11, effect-14)
case(infection-17, against-15)
det(infection-17, this-16)
nmod:against(effect-14, infection-17)

In/IN addition/NN ,/, these/DT fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(associated-8, addition-2)
det(fatty_acids-5, these-4)
nsubjpass(associated-8, fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(risk-12, with-9)
det(risk-12, a-10)
amod(risk-12, decreased-11)
nmod:with(associated-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

This/DT protective/JJ effect/NN may/MD be/VB due/JJ to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN and/CC improve/VB lipid/NN profiles/NNS ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (CC and)
                    (VP (VB improve)
                      (NP (NN lipid) (NNS profiles)))))))))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubj(due-6, effect-3)
aux(due-6, may-4)
cop(due-6, be-5)
root(ROOT-0, due-6)
case(ability-9, to-7)
nmod:poss(ability-9, their-8)
nmod:to(due-6, ability-9)
mark(reduce-11, to-10)
acl(ability-9, reduce-11)
dobj(reduce-11, inflammation-12)
cc(reduce-11, and-13)
acl(ability-9, improve-14)
conj:and(reduce-11, improve-14)
compound(profiles-16, lipid-15)
dobj(improve-14, profiles-16)

Overall/RB ,/, the/DT evidence/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN both/DT infectious/JJ and/CC chronic_diseases/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT the) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (DT both) (JJ infectious))
                            (CC and)
                            (NP (NNS chronic_diseases))))))))))))))
    (. .)))

advmod(suggests-5, Overall-1)
det(evidence-4, the-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
mark(strategy-16, that-6)
amod(intake-8, increasing-7)
nsubj(strategy-16, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggests-5, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(infectious-23, of-21)
det(infectious-23, both-22)
nmod:of(risk-20, infectious-23)
cc(infectious-23, and-24)
nmod:of(risk-20, chronic_diseases-25)
conj:and(infectious-23, chronic_diseases-25)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN acetanilide/JJ levels/NNS in/IN hyperacetanilidemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ acetanilide) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperacetanilidemic) (NNS patients)))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, acetanilide-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperacetanilidemic-15)
nmod:in(levels-13, patients-16)

Additionally/RB ,/, studies/NNS have/VBP demonstrated/VBN that/IN consuming/VBG EPA/NNP and/CC DHA/NNP is/VBZ linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (S
              (VP (VBG consuming)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(demonstrated-5, Additionally-1)
nsubj(demonstrated-5, studies-3)
aux(demonstrated-5, have-4)
root(ROOT-0, demonstrated-5)
mark(linked-12, that-6)
csubjpass(linked-12, consuming-7)
dobj(consuming-7, EPA-8)
cc(EPA-8, and-9)
dobj(consuming-7, DHA-10)
conj:and(EPA-8, DHA-10)
auxpass(linked-12, is-11)
ccomp(demonstrated-5, linked-12)
case(risk-16, to-13)
det(risk-16, a-14)
amod(risk-16, decreased-15)
nmod:to(linked-12, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, coronary_heart_disease-19)
appos(risk-16, CHD-21)

The/DT mechanism/NN behind/IN this/DT association/NN is/VBZ thought/VBN to/TO involve/VB the/DT anti-inflammatory/JJ properties/NNS of/IN omega-3_fatty_acids/NN ,/, which/WDT can/MD reduce/VB inflammation/NN in/IN blood/NN vessels/NNS and/CC prevent/VB the/DT formation/NN of/IN atherosclerotic_plaques/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN mechanism))
      (PP (IN behind)
        (NP (DT this) (NN association))))
    (VP (VBZ is)
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP (VB involve)
              (NP
                (NP (DT the) (JJ anti-inflammatory) (NNS properties))
                (PP (IN of)
                  (NP
                    (NP (NN omega-3_fatty_acids))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (MD can)
                          (VP
                            (VP (VB reduce)
                              (NP (NN inflammation))
                              (PP (IN in)
                                (NP (NN blood) (NNS vessels))))
                            (CC and)
                            (VP (VB prevent)
                              (NP
                                (NP (DT the) (NN formation))
                                (PP (IN of)
                                  (NP (NNS atherosclerotic_plaques)))))))))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(thought-7, mechanism-2)
nsubj:xsubj(involve-9, mechanism-2)
case(association-5, behind-3)
det(association-5, this-4)
nmod:behind(mechanism-2, association-5)
auxpass(thought-7, is-6)
root(ROOT-0, thought-7)
mark(involve-9, to-8)
xcomp(thought-7, involve-9)
det(properties-12, the-10)
amod(properties-12, anti-inflammatory-11)
dobj(involve-9, properties-12)
case(omega-3_fatty_acids-14, of-13)
nmod:of(properties-12, omega-3_fatty_acids-14)
nsubj(reduce-18, omega-3_fatty_acids-14)
nsubj(prevent-24, omega-3_fatty_acids-14)
ref(omega-3_fatty_acids-14, which-16)
aux(reduce-18, can-17)
acl:relcl(omega-3_fatty_acids-14, reduce-18)
dobj(reduce-18, inflammation-19)
case(vessels-22, in-20)
compound(vessels-22, blood-21)
nmod:in(reduce-18, vessels-22)
cc(reduce-18, and-23)
acl:relcl(omega-3_fatty_acids-14, prevent-24)
conj:and(reduce-18, prevent-24)
det(formation-26, the-25)
dobj(prevent-24, formation-26)
case(atherosclerotic_plaques-28, of-27)
nmod:of(formation-26, atherosclerotic_plaques-28)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC managing/VBG acetanilide/JJ levels/NNS in/IN hyperacetanilidemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG managing)
                        (NP
                          (NP (JJ acetanilide) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hyperacetanilidemic) (NNS patients))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-20, that-4)
csubj(strategy-20, increasing-5)
dobj(increasing-5, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(sources-13, through-11)
amod(sources-13, dietary-12)
nmod:through(increasing-5, sources-13)
cc(sources-13, or-14)
nmod:through(increasing-5, supplementation-15)
conj:or(sources-13, supplementation-15)
aux(strategy-20, may-16)
cop(strategy-20, be-17)
det(strategy-20, an-18)
amod(strategy-20, effective-19)
ccomp(suggest-3, strategy-20)
mark(reducing-22, for-21)
acl(strategy-20, reducing-22)
det(risk-24, the-23)
dobj(reducing-22, risk-24)
case(CHD-26, of-25)
nmod:of(risk-24, CHD-26)
cc(reducing-22, and-27)
acl(strategy-20, managing-28)
conj:and(reducing-22, managing-28)
amod(levels-30, acetanilide-29)
dobj(managing-28, levels-30)
case(patients-33, in-31)
amod(patients-33, hyperacetanilidemic-32)
nmod:in(levels-30, patients-33)

Obesity/NNP is_a/VBZ major/JJ public_health/NN concern/NN that/WDT is/VBZ associated/VBN with/IN various/JJ metabolic_disorders/NNS ,/, including/VBG diabetes/NN and_cardiovascular/NN disease/NN ./.

(ROOT
  (S
    (NP (NNP Obesity))
    (VP (VBZ is_a)
      (NP
        (NP (JJ major) (NN public_health) (NN concern))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (JJ various) (NNS metabolic_disorders))
                    (, ,)
                    (VP (VBG including)
                      (NP (NN diabetes) (NN and_cardiovascular) (NN disease)))))))))))
    (. .)))

nsubj(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
dobj(is_a-2, concern-5)
nsubjpass(associated-8, concern-5)
ref(concern-5, that-6)
auxpass(associated-8, is-7)
acl:relcl(concern-5, associated-8)
case(metabolic_disorders-11, with-9)
amod(metabolic_disorders-11, various-10)
nmod:with(associated-8, metabolic_disorders-11)
acl(metabolic_disorders-11, including-13)
compound(disease-16, diabetes-14)
compound(disease-16, and_cardiovascular-15)
dobj(including-13, disease-16)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN endoplasmic/JJ reticulum/NN -LRB-/-LRB- ER/NNP -RRB-/-RRB- stress/NN and/CC the/DT activation/NN of/IN the/DT unfolded/VBD protein/NN response/NN -LRB-/-LRB- UPR/NNP -RRB-/-RRB- pathway/RB may/MD contribute/VB to/TO the/DT pathogenesis/NNS of/IN obesity/NN and/CC its/PRP$ related/JJ complications/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP
                (NP (JJ endoplasmic) (NN reticulum))
                (SBAR
                  (S
                    (NP
                      (NP
                        (NP (-LRB- -LRB-) (NNP ER) (-RRB- -RRB-))
                        (NP (NN stress)))
                      (CC and)
                      (NP
                        (NP (DT the) (NN activation))
                        (PP (IN of)
                          (NP (DT the)))))
                    (VP (VBD unfolded)
                      (NP (NN protein) (NN response))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP UPR))
                (-RRB- -RRB-)))
            (ADVP (RB pathway))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP
                        (NP (NN obesity))
                        (CC and)
                        (NP (PRP$ its) (JJ related) (NNS complications))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(contribute-25, that-5)
amod(reticulum-7, endoplasmic-6)
nsubj(contribute-25, reticulum-7)
nsubj(unfolded-17, ER-9)
dep(ER-9, stress-11)
cc(ER-9, and-12)
det(activation-14, the-13)
conj:and(ER-9, activation-14)
nsubj(unfolded-17, activation-14)
case(the-16, of-15)
nmod:of(activation-14, the-16)
acl:relcl(reticulum-7, unfolded-17)
compound(response-19, protein-18)
dobj(unfolded-17, response-19)
appos(reticulum-7, UPR-21)
advmod(contribute-25, pathway-23)
aux(contribute-25, may-24)
ccomp(suggested-4, contribute-25)
case(pathogenesis-28, to-26)
det(pathogenesis-28, the-27)
nmod:to(contribute-25, pathogenesis-28)
case(obesity-30, of-29)
nmod:of(pathogenesis-28, obesity-30)
cc(obesity-30, and-31)
nmod:poss(complications-34, its-32)
amod(complications-34, related-33)
nmod:of(pathogenesis-28, complications-34)
conj:and(obesity-30, complications-34)

One/CD of/IN the/DT key/JJ components/NNS of/IN the/DT UPR/NNP pathway/NN is/VBZ IRE-1a/NN ,/, which/WDT has_been/VBP shown/VBN to_be/NN hyperactivated/VBN in/IN obese/JJ individuals/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ key) (NNS components))
          (PP (IN of)
            (NP (DT the) (NNP UPR) (NN pathway))))))
    (VP (VBZ is)
      (NP
        (NP (NN IRE-1a))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (NP
                  (NP (NN to_be))
                  (VP (VBN hyperactivated)
                    (PP (IN in)
                      (NP (JJ obese) (NNS individuals)))))))))))
    (. .)))

nsubj(IRE-1a-11, One-1)
case(components-5, of-2)
det(components-5, the-3)
amod(components-5, key-4)
nmod:of(One-1, components-5)
case(pathway-9, of-6)
det(pathway-9, the-7)
compound(pathway-9, UPR-8)
nmod:of(components-5, pathway-9)
cop(IRE-1a-11, is-10)
root(ROOT-0, IRE-1a-11)
nsubj(has_been-14, IRE-1a-11)
ref(IRE-1a-11, which-13)
acl:relcl(IRE-1a-11, has_been-14)
dep(has_been-14, shown-15)
dobj(shown-15, to_be-16)
acl(to_be-16, hyperactivated-17)
case(individuals-20, in-18)
amod(individuals-20, obese-19)
nmod:in(hyperactivated-17, individuals-20)

However/RB ,/, the/DT relationship/NN between/IN IRE-1a/NNS hypersecretion/VBN by/IN the/DT pancreas/NN and/CC obesity/JJ development/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN relationship))
      (PP (IN between)
        (NP
          (NP (NNS IRE-1a))
          (VP (VBN hypersecretion)
            (PP (IN by)
              (NP
                (NP (DT the) (NN pancreas))
                (CC and)
                (NP (JJ obesity) (NN development))))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remains-14, However-1)
det(relationship-4, the-3)
nsubj(remains-14, relationship-4)
case(IRE-1a-6, between-5)
nmod:between(relationship-4, IRE-1a-6)
acl(IRE-1a-6, hypersecretion-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-7, pancreas-10)
cc(pancreas-10, and-11)
amod(development-13, obesity-12)
nmod:by(hypersecretion-7, development-13)
conj:and(pancreas-10, development-13)
root(ROOT-0, remains-14)
xcomp(remains-14, unclear-15)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB this/DT relationship/NN by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Toyocamycin/NNP on/IN the/DT secretion/NN of/IN IRE-1a/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP (DT this) (NN relationship))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (NN mmol/L) (NNP Toyocamycin)))))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN secretion))
                      (PP (IN of)
                        (NP (JJ IRE-1a) (NN and_insulin)))))))))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, this-9)
dobj(evaluate-8, relationship-10)
mark(examining-12, by-11)
advcl(evaluate-8, examining-12)
det(effects-14, the-13)
dobj(examining-12, effects-14)
case(glucose-18, of-15)
nummod(glucose-18, 16.7-16)
amod(glucose-18, mmol/L-17)
nmod:of(effects-14, glucose-18)
cc(glucose-18, and-19)
nummod(Toyocamycin-22, 10-20)
compound(Toyocamycin-22, mmol/L-21)
nmod:of(effects-14, Toyocamycin-22)
conj:and(glucose-18, Toyocamycin-22)
case(secretion-25, on-23)
det(secretion-25, the-24)
nmod:on(examining-12, secretion-25)
case(and_insulin-28, of-26)
amod(and_insulin-28, IRE-1a-27)
nmod:of(secretion-25, and_insulin-28)
case(pancreata-32, by-29)
amod(pancreata-32, isolated-30)
amod(pancreata-32, perfused-31)
nmod:by(aimed-6, pancreata-32)
case(genetically_obese-34, from-33)
nmod:from(pancreata-32, genetically_obese-34)
appos(genetically_obese-34, fa/fa-36)
cc(genetically_obese-34, and-38)
amod(rats-45, lean-39)
dep(lean-39, Fa-41)
nmod:from(pancreata-32, rats-45)
conj:and(genetically_obese-34, rats-45)

Our/PRP$ results/NNS showed/VBD that/IN both/DT glucose/NN and/CC Toyocamycin/NNP significantly/RB increased/VBD IRE-1a/JJ secretion/NN in/IN perfused/JJ pancreata/NN from/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT both) (NN glucose))
            (CC and)
            (NP (NNP Toyocamycin)))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP (JJ IRE-1a) (NN secretion))
            (PP (IN in)
              (NP (JJ perfused) (NN pancreata)))
            (PP (IN from)
              (NP (JJ obese) (NNS rats)))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-10, that-4)
det(glucose-6, both-5)
nsubj(increased-10, glucose-6)
cc(glucose-6, and-7)
conj:and(glucose-6, Toyocamycin-8)
nsubj(increased-10, Toyocamycin-8)
advmod(increased-10, significantly-9)
ccomp(showed-3, increased-10)
amod(secretion-12, IRE-1a-11)
dobj(increased-10, secretion-12)
case(pancreata-15, in-13)
amod(pancreata-15, perfused-14)
nmod:in(increased-10, pancreata-15)
case(rats-18, from-16)
amod(rats-18, obese-17)
nmod:from(increased-10, rats-18)
case(rats-22, compared-19)
mwe(compared-19, to-20)
amod(rats-22, lean-21)
advcl(increased-10, rats-22)

Interestingly/RB ,/, we/PRP also/RB observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN perfused/JJ pancreata/NN from/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (PRP we))
    (ADVP (RB also))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP
            (NP (NN insulin_secretion))
            (PP (IN in)
              (NP (JJ perfused) (NN pancreata))))))
      (PP (IN from)
        (NP
          (NP (JJ obese) (NNS rats))
          (VP (VBN compared)
            (S
              (VP (TO to)
                (VP (VB lean)
                  (NP (NNS rats))
                  (PP (IN under)
                    (NP (DT both) (NNS conditions))))))))))
    (. .)))

advmod(observed-5, Interestingly-1)
nsubj(observed-5, we-3)
advmod(observed-5, also-4)
root(ROOT-0, observed-5)
det(decrease-8, a-6)
amod(decrease-8, significant-7)
dobj(observed-5, decrease-8)
case(insulin_secretion-10, in-9)
nmod:in(decrease-8, insulin_secretion-10)
case(pancreata-13, in-11)
amod(pancreata-13, perfused-12)
nmod:in(insulin_secretion-10, pancreata-13)
case(rats-16, from-14)
amod(rats-16, obese-15)
nmod:from(observed-5, rats-16)
acl(rats-16, compared-17)
mark(lean-19, to-18)
xcomp(compared-17, lean-19)
dobj(lean-19, rats-20)
case(conditions-23, under-21)
det(conditions-23, both-22)
nmod:under(lean-19, conditions-23)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN IRE-1a/NNS by/IN the/DT pancreas/NN may/MD contribute/VB to/TO obesity/VB development/NN by/IN impairing/VBG insulin_secretion/NN ,/, highlighting/VBG a/DT potential/JJ therapeutic/JJ target/NN for/IN preventing/VBG or/CC treating/VBG obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS IRE-1a))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB contribute)
              (S
                (VP (TO to)
                  (VP (VB obesity)
                    (NP (NN development))
                    (PP (IN by)
                      (S
                        (VP
                          (VP (VBG impairing)
                            (NP (NN insulin_secretion)))
                          (, ,)
                          (VP (VBG highlighting)
                            (NP
                              (NP (DT a) (JJ potential) (JJ therapeutic) (NN target))
                              (PP (IN for)
                                (NP (VBG preventing)))))
                          (CC or)
                          (VP (VBG treating)
                            (NP (JJ obesity-related) (NNS metabolic_disorders))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-12, that-4)
nsubj(contribute-12, hypersecretion-5)
nsubj:xsubj(obesity-14, hypersecretion-5)
case(IRE-1a-7, of-6)
nmod:of(hypersecretion-5, IRE-1a-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(IRE-1a-7, pancreas-10)
aux(contribute-12, may-11)
ccomp(suggest-3, contribute-12)
mark(obesity-14, to-13)
xcomp(contribute-12, obesity-14)
dobj(obesity-14, development-15)
mark(impairing-17, by-16)
advcl(obesity-14, impairing-17)
dobj(impairing-17, insulin_secretion-18)
advcl(obesity-14, highlighting-20)
conj:or(impairing-17, highlighting-20)
det(target-24, a-21)
amod(target-24, potential-22)
amod(target-24, therapeutic-23)
dobj(highlighting-20, target-24)
case(preventing-26, for-25)
nmod:for(target-24, preventing-26)
cc(impairing-17, or-27)
advcl(obesity-14, treating-28)
conj:or(impairing-17, treating-28)
amod(metabolic_disorders-30, obesity-related-29)
dobj(treating-28, metabolic_disorders-30)

The/DT management/NN of/IN migraine_headaches/NNS remains/VBZ a/DT challenge/NN for/IN clinicians/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN management))
      (PP (IN of)
        (NP (NNS migraine_headaches))))
    (VP (VBZ remains)
      (NP
        (NP (DT a) (NN challenge))
        (PP (IN for)
          (NP (NNS clinicians)))))
    (. .)))

det(management-2, The-1)
nsubj(remains-5, management-2)
case(migraine_headaches-4, of-3)
nmod:of(management-2, migraine_headaches-4)
root(ROOT-0, remains-5)
det(challenge-7, a-6)
xcomp(remains-5, challenge-7)
case(clinicians-9, for-8)
nmod:for(challenge-7, clinicians-9)

Piritramide/NNP ,/, an/DT opioid/JJ analgesic/JJ ,/, has_been/NN suggested/VBD as/IN a/DT potential/JJ treatment/NN for/IN migraine/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Piritramide))
      (, ,)
      (NP (DT an) (JJ opioid)
        (ADJP (JJ analgesic))
        (, ,) (NN has_been)))
    (VP (VBD suggested)
      (PP (IN as)
        (NP
          (NP (DT a) (JJ potential) (NN treatment))
          (PP (IN for)
            (NP (NN migraine))))))
    (. .)))

nsubj(suggested-8, Piritramide-1)
det(has_been-7, an-3)
amod(has_been-7, opioid-4)
amod(has_been-7, analgesic-5)
appos(Piritramide-1, has_been-7)
root(ROOT-0, suggested-8)
case(treatment-12, as-9)
det(treatment-12, a-10)
amod(treatment-12, potential-11)
nmod:as(suggested-8, treatment-12)
case(migraine-14, for-13)
nmod:for(treatment-12, migraine-14)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN piritramide/NN on/IN the/DT risk/NN of/IN associated/VBN symptoms/NNS such/JJ as/IN nausea/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN piritramide))
          (PP (IN on)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (VBN associated) (NNS symptoms))
                  (PP (JJ such) (IN as)
                    (NP
                      (NP (NN nausea))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (VP (VBD were)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-24, study-3)
det(effects-6, the-5)
nsubjpass(evaluated-24, effects-6)
case(piritramide-8, of-7)
nmod:of(effects-6, piritramide-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(piritramide-8, risk-11)
case(symptoms-14, of-12)
amod(symptoms-14, associated-13)
nmod:of(risk-11, symptoms-14)
case(nausea-17, such-15)
mwe(such-15, as-16)
nmod:such_as(symptoms-14, nausea-17)
nmod:such_as(symptoms-14, photophobia-19)
conj:and(nausea-17, photophobia-19)
cc(nausea-17, and-21)
nmod:such_as(symptoms-14, phonophobia-22)
conj:and(nausea-17, phonophobia-22)
auxpass(evaluated-24, were-23)
root(ROOT-0, evaluated-24)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN in/IN which/WDT patients/NNS with/IN migraine/NN were/VBD administered/VBN either/DT piritramide/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (NN migraine))))
              (VP (VBD were)
                (VP (VBN administered)
                  (NP (DT either) (NN piritramide)
                    (CC or)
                    (NN placebo)))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
mark(administered-11, in-5)
dobj(administered-11, which-6)
nsubjpass(administered-11, patients-7)
case(migraine-9, with-8)
nmod:with(patients-7, migraine-9)
auxpass(administered-11, were-10)
advcl(conducted-4, administered-11)
cc:preconj(piritramide-13, either-12)
dobj(administered-11, piritramide-13)
cc(piritramide-13, or-14)
dobj(administered-11, placebo-15)
conj:or(piritramide-13, placebo-15)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, piritramide/NN reduced/VBD the/DT risk/NN of/IN nausea/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN piritramide))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN nausea))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, piritramide-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(nausea-11, of-10)
nmod:of(risk-9, nausea-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN piritramide/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN managing/VBG not/RB only/RB the/DT pain/NN associated/VBN with/IN migraines/NNS but/CC also/RB the/DT associated/VBN symptoms/NNS such/JJ as/IN nausea_and/JJ sensitivity/NN to/TO light/NN and/CC sound/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN piritramide))
          (VP (MD may)
            (VP (VB be)
              (NP (DT an) (JJ effective) (NN treatment) (NN option))
              (PP (IN for)
                (S
                  (VP (VBG managing)
                    (NP
                      (CONJP (RB not) (RB only))
                      (NP
                        (NP (DT the) (NN pain))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (NNS migraines)))))
                      (CC but)
                      (RB also)
                      (NP
                        (NP (DT the) (VBN associated) (NNS symptoms))
                        (PP (JJ such) (IN as)
                          (NP
                            (NP (JJ nausea_and) (NN sensitivity))
                            (PP (TO to)
                              (NP (NN light)
                                (CC and)
                                (NN sound)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, piritramide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, an-8)
amod(option-11, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
mark(managing-13, for-12)
advcl(option-11, managing-13)
neg(only-15, not-14)
cc:preconj(pain-17, only-15)
det(pain-17, the-16)
dobj(managing-13, pain-17)
acl(pain-17, associated-18)
case(migraines-20, with-19)
nmod:with(associated-18, migraines-20)
cc(pain-17, but-21)
advmod(pain-17, also-22)
det(symptoms-25, the-23)
amod(symptoms-25, associated-24)
dep(pain-17, symptoms-25)
case(sensitivity-29, such-26)
mwe(such-26, as-27)
amod(sensitivity-29, nausea_and-28)
nmod:such_as(symptoms-25, sensitivity-29)
case(light-31, to-30)
nmod:to(sensitivity-29, light-31)
cc(light-31, and-32)
nmod:to(sensitivity-29, sound-33)
conj:and(light-31, sound-33)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN piritramide/NN in/IN treating/VBG migraine_headaches/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NN piritramide))))
                (PP (IN in)
                  (S
                    (VP (VBG treating)
                      (NP (NNS migraine_headaches)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
ccomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(evaluate-11, to-10)
ccomp(warranted-4, evaluate-11)
conj:and(confirm-6, evaluate-11)
det(safety-14, the-12)
amod(safety-14, long-term-13)
dobj(evaluate-11, safety-14)
cc(safety-14, and-15)
dobj(evaluate-11, efficacy-16)
conj:and(safety-14, efficacy-16)
case(piritramide-18, of-17)
nmod:of(safety-14, piritramide-18)
mark(treating-20, in-19)
advcl(evaluate-11, treating-20)
dobj(treating-20, migraine_headaches-21)

The/DT placenta/NN plays/VBZ an/DT essential/JJ role/NN in/IN the/DT metabolism/NN and/CC elimination/NN of/IN xenobiotics/NNS ,/, including/VBG drugs/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN placenta))
    (VP (VBZ plays)
      (NP
        (NP (DT an) (JJ essential) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN metabolism))
            (CC and)
            (NP
              (NP (NN elimination))
              (PP (IN of)
                (NP
                  (NP (NNS xenobiotics))
                  (, ,)
                  (VP (VBG including)
                    (NP (NNS drugs))))))))))
    (. .)))

det(placenta-2, The-1)
nsubj(plays-3, placenta-2)
root(ROOT-0, plays-3)
det(role-6, an-4)
amod(role-6, essential-5)
dobj(plays-3, role-6)
case(metabolism-9, in-7)
det(metabolism-9, the-8)
nmod:in(role-6, metabolism-9)
cc(metabolism-9, and-10)
nmod:in(role-6, elimination-11)
conj:and(metabolism-9, elimination-11)
case(xenobiotics-13, of-12)
nmod:of(elimination-11, xenobiotics-13)
acl(xenobiotics-13, including-15)
dobj(including-15, drugs-16)

Real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NNP -RRB-/-RRB- is_a/VBZ reliable/JJ method/NN for/IN analyzing/VBG gene/NN expression/NN levels/NNS in/IN various/JJ tissues/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain) (NN reaction))
      (PRN (-LRB- -LRB-)
        (NP (NNP Q-RT-PCR))
        (-RRB- -RRB-)))
    (VP (VBZ is_a)
      (NP
        (NP (JJ reliable) (NN method))
        (PP (IN for)
          (S
            (VP (VBG analyzing)
              (NP
                (NP (NN gene) (NN expression) (NNS levels))
                (PP (IN in)
                  (NP (JJ various) (NNS tissues)))))))))
    (. .)))

amod(reaction-5, Real-time-1)
amod(reaction-5, quantitative-2)
amod(reaction-5, reverse_transcriptase-polymerase-3)
compound(reaction-5, chain-4)
nsubj(is_a-9, reaction-5)
appos(reaction-5, Q-RT-PCR-7)
root(ROOT-0, is_a-9)
amod(method-11, reliable-10)
dobj(is_a-9, method-11)
mark(analyzing-13, for-12)
acl(method-11, analyzing-13)
compound(levels-16, gene-14)
compound(levels-16, expression-15)
dobj(analyzing-13, levels-16)
case(tissues-19, in-17)
amod(tissues-19, various-18)
nmod:in(levels-16, tissues-19)

In/IN this/DT study/NN ,/, Q-RT-PCR/NN analysis/NN was/VBD performed/VBN to/TO investigate/VB the/DT mRNA/NN levels/NNS of/IN placental/JJ L-163/NN ,017/CD metabolism/NN enzymes/NNS ,/, including/VBG UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/JJ 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, L-163/NNP ,017/CD

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (NN Q-RT-PCR) (NN analysis))
    (VP (VBD was)
      (VP (VBN performed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP
                  (NP (DT the) (NN mRNA) (NNS levels))
                  (PP (IN of)
                    (NP (JJ placental) (NN L-163) (CD ,017) (NN metabolism) (NNS enzymes))))
                (, ,)
                (NP
                  (NP (VBG including) (NNS UDP-glucuronosyltransferase_1A1))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP UGT1A1))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (QP (JJ estrogen_sulfotransferase) (CD 1E1)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP SULT1E1))
                  (-RRB- -RRB-))
                (, ,)
                (NP (NNP L-163) (CD ,017))))))))))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(performed-8, study-3)
compound(analysis-6, Q-RT-PCR-5)
nsubjpass(performed-8, analysis-6)
nsubj:xsubj(investigate-10, analysis-6)
auxpass(performed-8, was-7)
root(ROOT-0, performed-8)
mark(investigate-10, to-9)
xcomp(performed-8, investigate-10)
det(levels-13, the-11)
compound(levels-13, mRNA-12)
dobj(investigate-10, levels-13)
case(enzymes-19, of-14)
amod(enzymes-19, placental-15)
compound(enzymes-19, L-163-16)
nummod(enzymes-19, ,017-17)
compound(enzymes-19, metabolism-18)
nmod:of(levels-13, enzymes-19)
amod(UDP-glucuronosyltransferase_1A1-22, including-21)
appos(levels-13, UDP-glucuronosyltransferase_1A1-22)
appos(UDP-glucuronosyltransferase_1A1-22, UGT1A1-24)
advmod(1E1-28, estrogen_sulfotransferase-27)
appos(levels-13, 1E1-28)
appos(levels-13, SULT1E1-30)
appos(levels-13, L-163-33)
nummod(L-163-33, ,017-34)

5a-reductase_1/JJ -LRB-/-LRB- angiotensin_II_type_1/NNS -RRB-/-RRB- ,/, and/CC L-163/NNP ,017/CD 5a-reductase/VBD 2/CD -LRB-/-LRB- SRD5A2/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ 5a-reductase_1) (-LRB- -LRB-) (NNS angiotensin_II_type_1) (-RRB- -RRB-))
      (, ,)
      (CC and)
      (NP (NNP L-163) (CD ,017)))
    (VP (VBD 5a-reductase)
      (NP
        (NP (CD 2))
        (PRN (-LRB- -LRB-)
          (NP (CD SRD5A2))
          (-RRB- -RRB-))))
    (. .)))

amod(angiotensin_II_type_1-3, 5a-reductase_1-1)
nsubj(5a-reductase-9, angiotensin_II_type_1-3)
cc(angiotensin_II_type_1-3, and-6)
conj:and(angiotensin_II_type_1-3, L-163-7)
nsubj(5a-reductase-9, L-163-7)
nummod(L-163-7, ,017-8)
root(ROOT-0, 5a-reductase-9)
dobj(5a-reductase-9, 2-10)
appos(2-10, SRD5A2-12)

The/DT results/NNS showed/VBD a/DT significant/JJ increase/NN in/IN the/DT mRNA/JJ levels/NNS of/IN these/DT enzymes/NNS ,/, indicating/VBG their/PRP$ involvement/NN in/IN the/DT metabolism/NN of/IN L-163/NNP ,017/CD ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ mRNA) (NNS levels))
            (PP (IN of)
              (NP (DT these) (NNS enzymes))))))
      (, ,)
      (S
        (VP (VBG indicating)
          (NP
            (NP (PRP$ their) (NN involvement))
            (PP (IN in)
              (NP
                (NP (DT the) (NN metabolism))
                (PP (IN of)
                  (NP (NNP L-163) (CD ,017)))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(showed-3, increase-6)
case(levels-10, in-7)
det(levels-10, the-8)
amod(levels-10, mRNA-9)
nmod:in(increase-6, levels-10)
case(enzymes-13, of-11)
det(enzymes-13, these-12)
nmod:of(levels-10, enzymes-13)
advcl(showed-3, indicating-15)
nmod:poss(involvement-17, their-16)
dobj(indicating-15, involvement-17)
case(metabolism-20, in-18)
det(metabolism-20, the-19)
nmod:in(involvement-17, metabolism-20)
case(L-163-22, of-21)
nmod:of(metabolism-20, L-163-22)
nummod(L-163-22, ,017-23)

These/DT findings/NNS provide/VBP insight/NN into/IN the/DT mechanisms/NNS underlying/VBG the/DT placental/JJ metabolism/NN of/IN L-163/NNP ,017/CD and/CC may/MD have/VB implications/NNS for/IN drug/NN safety/NN during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (NN insight))
        (PP (IN into)
          (NP
            (NP (DT the) (NNS mechanisms))
            (VP (VBG underlying)
              (NP
                (NP (DT the) (JJ placental) (NN metabolism))
                (PP (IN of)
                  (NP (NNP L-163) (CD ,017))))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP (NN drug) (NN safety))))
          (PP (IN during)
            (NP (NN pregnancy))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-17, findings-2)
root(ROOT-0, provide-3)
dobj(provide-3, insight-4)
case(mechanisms-7, into-5)
det(mechanisms-7, the-6)
nmod:into(provide-3, mechanisms-7)
acl(mechanisms-7, underlying-8)
det(metabolism-11, the-9)
amod(metabolism-11, placental-10)
dobj(underlying-8, metabolism-11)
case(L-163-13, of-12)
nmod:of(metabolism-11, L-163-13)
nummod(L-163-13, ,017-14)
cc(provide-3, and-15)
aux(have-17, may-16)
conj:and(provide-3, have-17)
dobj(have-17, implications-18)
case(safety-21, for-19)
compound(safety-21, drug-20)
nmod:for(implications-18, safety-21)
case(pregnancy-23, during-22)
nmod:during(have-17, pregnancy-23)

The/DT present/JJ study/NN aimed/VBN to/TO investigate/VB the/DT effects/NNS of/IN chlorzoxazone/NN on/IN body/NN weight/NN ,/, villus/VBZ height/NN ,/, and/CC villus/NNS surface/VBP area/NN in_a/NN rat/VB model/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ present) (NN study))
        (VP (VBN aimed)
          (S
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (NNS effects))
                  (PP (IN of)
                    (NP (NN chlorzoxazone))))
                (PP (IN on)
                  (NP (NN body) (NN weight)))))))
        (, ,))
      (VP (VBZ villus)
        (NP (NN height))))
    (, ,)
    (CC and)
    (S
      (NP (NNS villus))
      (VP (VBP surface)
        (NP (NN area) (NN in_a))
        (S
          (VP (VB rat)
            (NP (NN model))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(villus-15, study-3)
acl(study-3, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(effects-8, the-7)
dobj(investigate-6, effects-8)
case(chlorzoxazone-10, of-9)
nmod:of(effects-8, chlorzoxazone-10)
case(weight-13, on-11)
compound(weight-13, body-12)
nmod:on(investigate-6, weight-13)
root(ROOT-0, villus-15)
dobj(villus-15, height-16)
cc(villus-15, and-18)
nsubj(surface-20, villus-19)
conj:and(villus-15, surface-20)
compound(in_a-22, area-21)
dobj(surface-20, in_a-22)
dep(surface-20, rat-23)
dobj(rat-23, model-24)

The/DT results/NNS showed/VBD a/DT significant/JJ decrease/NN in/IN these/DT parameters/NNS in/IN the/DT chlorzoxazone-intervened/JJ group/NN compared/VBN to/TO the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP (DT a) (JJ significant) (NN decrease))
      (PP (IN in)
        (NP
          (NP (DT these) (NNS parameters))
          (PP (IN in)
            (NP (DT the) (JJ chlorzoxazone-intervened) (NN group)))))
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP (DT the) (NN control) (NN group))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD <) (CD 0.01)))
              (-RRB- -RRB-))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(decrease-6, a-4)
amod(decrease-6, significant-5)
dobj(showed-3, decrease-6)
case(parameters-9, in-7)
det(parameters-9, these-8)
nmod:in(showed-3, parameters-9)
case(group-13, in-10)
det(group-13, the-11)
amod(group-13, chlorzoxazone-intervened-12)
nmod:in(parameters-9, group-13)
case(group-18, compared-14)
mwe(compared-14, to-15)
det(group-18, the-16)
compound(group-18, control-17)
advcl(showed-3, group-18)
appos(group-18, P-20)
compound(0.01-22, <-21)
nummod(P-20, 0.01-22)

However/RB ,/, it/PRP was/VBD observed/VBN that/IN plasma/NN chlorzoxazone/JJ concentration/NN and/CC expression/NN of/IN KCNN2/NNP had/VBD recovered/VBN to/TO normal/JJ levels/NNS in/IN the/DT chlorzoxazone-intervened/JJ group/NN -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN observed)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN plasma) (JJ chlorzoxazone) (NN concentration))
              (CC and)
              (NP
                (NP (NN expression))
                (PP (IN of)
                  (NP (NNP KCNN2)))))
            (VP (VBD had)
              (VP (VBN recovered)
                (PP (TO to)
                  (NP
                    (NP (JJ normal) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (DT the) (JJ chlorzoxazone-intervened) (NN group))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP P)
                            (QP (CD >) (CD 0.05)))
                          (-RRB- -RRB-))))))))))))
    (. .)))

advmod(observed-5, However-1)
nsubjpass(observed-5, it-3)
auxpass(observed-5, was-4)
root(ROOT-0, observed-5)
mark(recovered-15, that-6)
compound(concentration-9, plasma-7)
amod(concentration-9, chlorzoxazone-8)
nsubj(recovered-15, concentration-9)
cc(concentration-9, and-10)
conj:and(concentration-9, expression-11)
nsubj(recovered-15, expression-11)
case(KCNN2-13, of-12)
nmod:of(expression-11, KCNN2-13)
aux(recovered-15, had-14)
ccomp(observed-5, recovered-15)
case(levels-18, to-16)
amod(levels-18, normal-17)
nmod:to(recovered-15, levels-18)
case(group-22, in-19)
det(group-22, the-20)
amod(group-22, chlorzoxazone-intervened-21)
nmod:in(levels-18, group-22)
appos(group-22, P-24)
compound(0.05-26, >-25)
nummod(P-24, 0.05-26)

These/DT findings/NNS suggest/VBP that/IN chlorzoxazone/NN may/MD have/VB adverse/JJ effects/NNS on/IN intestinal/JJ morphology/NN and/CC weight/NN regulation/NN ,/, but/CC these/DT effects/NNS could/MD be/VB reversible/JJ with/IN discontinuation/NN of/IN the/DT drug/NN ./.

(ROOT
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (NN chlorzoxazone))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ adverse) (NNS effects))
                  (PP (IN on)
                    (NP
                      (NP (JJ intestinal) (NN morphology))
                      (CC and)
                      (NP (NN weight) (NN regulation)))))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT these) (NNS effects))
      (VP (MD could)
        (VP (VB be)
          (ADJP (JJ reversible)
            (PP (IN with)
              (NP
                (NP (NN discontinuation))
                (PP (IN of)
                  (NP (DT the) (NN drug)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, chlorzoxazone-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(effects-9, adverse-8)
dobj(have-7, effects-9)
case(morphology-12, on-10)
amod(morphology-12, intestinal-11)
nmod:on(effects-9, morphology-12)
cc(morphology-12, and-13)
compound(regulation-15, weight-14)
nmod:on(effects-9, regulation-15)
conj:and(morphology-12, regulation-15)
cc(suggest-3, but-17)
det(effects-19, these-18)
nsubj(reversible-22, effects-19)
aux(reversible-22, could-20)
cop(reversible-22, be-21)
conj:but(suggest-3, reversible-22)
case(discontinuation-24, with-23)
nmod:with(reversible-22, discontinuation-24)
case(drug-27, of-25)
det(drug-27, the-26)
nmod:of(discontinuation-24, drug-27)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ clinical/JJ implications/NNS of/IN these/DT observations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP (DT these) (NNS observations))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
xcomp(warranted-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-13, potential-11)
amod(implications-13, clinical-12)
dobj(elucidate-6, implications-13)
conj:and(mechanisms-9, implications-13)
case(observations-16, of-14)
det(observations-16, these-15)
nmod:of(implications-13, observations-16)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN various/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP (JJ various) (VBG signaling) (NNS pathways)))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, various-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)

The/DT mitogen-activated_protein_kinase_kinase_kinase/NN 11/CD -LRB-/-LRB- MAP3K11/NNP -RRB-/-RRB- is_a/JJ key/JJ regulator/NN of_skeletal_muscle/NN differentiation_and/VBD has_been/VBN shown/VBN to/TO play/VB an/DT important/JJ role/NN in/IN myogenesis/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN mitogen-activated_protein_kinase_kinase_kinase))
        (NP (CD 11)))
      (PRN (-LRB- -LRB-)
        (NP (NNP MAP3K11))
        (-RRB- -RRB-))
      (NP (JJ is_a) (JJ key) (NN regulator) (NN of_skeletal_muscle)))
    (VP (VBD differentiation_and)
      (VP (VBN has_been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB play)
                (NP
                  (NP (DT an) (JJ important) (NN role))
                  (PP (IN in)
                    (NP (NNS myogenesis))))))))))
    (. .)))

det(mitogen-activated_protein_kinase_kinase_kinase-2, The-1)
nsubj(differentiation_and-11, mitogen-activated_protein_kinase_kinase_kinase-2)
dep(mitogen-activated_protein_kinase_kinase_kinase-2, 11-3)
appos(mitogen-activated_protein_kinase_kinase_kinase-2, MAP3K11-5)
amod(of_skeletal_muscle-10, is_a-7)
amod(of_skeletal_muscle-10, key-8)
compound(of_skeletal_muscle-10, regulator-9)
dep(mitogen-activated_protein_kinase_kinase_kinase-2, of_skeletal_muscle-10)
root(ROOT-0, differentiation_and-11)
dep(differentiation_and-11, has_been-12)
dep(has_been-12, shown-13)
mark(play-15, to-14)
xcomp(shown-13, play-15)
det(role-18, an-16)
amod(role-18, important-17)
dobj(play-15, role-18)
case(myogenesis-20, in-19)
nmod:in(role-18, myogenesis-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN URMC-099/NN on/IN MAP3K11/NNP protein/NN levels/NNS and/CC half-life/NN during/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NN URMC-099))
            (PP (IN on)
              (NP (NNP MAP3K11) (NN protein) (NNS levels)
                (CC and)
                (NN half-life))))))
      (PP (IN during)
        (NP (JJ skeletal_muscle) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(URMC-099-10, of-9)
nmod:of(effect-8, URMC-099-10)
case(levels-14, on-11)
compound(levels-14, MAP3K11-12)
compound(levels-14, protein-13)
nmod:on(URMC-099-10, levels-14)
cc(levels-14, and-15)
nmod:on(URMC-099-10, half-life-16)
conj:and(levels-14, half-life-16)
case(differentiation-19, during-17)
amod(differentiation-19, skeletal_muscle-18)
nmod:during(investigated-6, differentiation-19)

C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN ,/, and/CC URMC-099/NNP was/VBD added/VBN to/TO the/DT culture/NN medium/NN ./.

(ROOT
  (S
    (S
      (NP (NN C2C12) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP (NN differentiation)))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP URMC-099))
      (VP (VBD was)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT the) (NN culture) (NN medium))))))
    (. .)))

compound(cells-2, C2C12-1)
nsubjpass(cultured-4, cells-2)
auxpass(cultured-4, were-3)
root(ROOT-0, cultured-4)
amod(medium-6, in_a-5)
dobj(cultured-4, medium-6)
xcomp(cultured-4, favoring-7)
dobj(favoring-7, differentiation-8)
cc(cultured-4, and-10)
nsubjpass(added-13, URMC-099-11)
auxpass(added-13, was-12)
conj:and(cultured-4, added-13)
case(medium-17, to-14)
det(medium-17, the-15)
compound(medium-17, culture-16)
nmod:to(added-13, medium-17)

Our/PRP$ results/NNS showed/VBD that/IN URMC-099/NNP up-regulated/VBD MAP3K11/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ MAP3K11/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP URMC-099))
          (VP (VBD up-regulated)
            (NP (NNP MAP3K11) (NN protein) (NNS levels))
            (NP (NN in_a)
              (NX
                (NX (JJ time-dependent) (NN manner))
                (CC and)
                (NX (JJ prolonged) (NNP MAP3K11) (NN protein)))
              (NX (NN half-life)))
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(up-regulated-6, that-4)
nsubj(up-regulated-6, URMC-099-5)
ccomp(showed-3, up-regulated-6)
compound(levels-9, MAP3K11-7)
compound(levels-9, protein-8)
iobj(up-regulated-6, levels-9)
dep(half-life-17, in_a-10)
amod(manner-12, time-dependent-11)
dep(half-life-17, manner-12)
cc(manner-12, and-13)
amod(protein-16, prolonged-14)
compound(protein-16, MAP3K11-15)
conj:and(manner-12, protein-16)
dep(half-life-17, protein-16)
dobj(up-regulated-6, half-life-17)
case(hours-22, from-18)
compound(18-21, 10-19)
dep(18-21, to-20)
nummod(hours-22, 18-21)
nmod:from(up-regulated-6, hours-22)

These/DT findings/NNS suggest/VBP that/IN URMC-099/NNP may/MD enhance/VB skeletal_muscle/JJ differentiation/NN by/IN regulating/VBG MAP3K11/NN protein/NN levels/NNS and/CC stability/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP URMC-099))
          (VP (MD may)
            (VP (VB enhance)
              (NP (JJ skeletal_muscle) (NN differentiation))
              (PP (IN by)
                (S
                  (VP (VBG regulating)
                    (NP (NN MAP3K11) (NN protein) (NNS levels)
                      (CC and)
                      (NN stability))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(enhance-7, that-4)
nsubj(enhance-7, URMC-099-5)
aux(enhance-7, may-6)
ccomp(suggest-3, enhance-7)
amod(differentiation-9, skeletal_muscle-8)
dobj(enhance-7, differentiation-9)
mark(regulating-11, by-10)
advcl(enhance-7, regulating-11)
compound(levels-14, MAP3K11-12)
compound(levels-14, protein-13)
dobj(regulating-11, levels-14)
cc(levels-14, and-15)
dobj(regulating-11, stability-16)
conj:and(levels-14, stability-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN URMC-099/NN in/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP
                    (NP (NN URMC-099))
                    (PP (IN in)
                      (NP (JJ skeletal_muscle) (NNS disorders)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(applications-10, the-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(explore-6, applications-10)
case(URMC-099-12, of-11)
nmod:of(applications-10, URMC-099-12)
case(disorders-15, in-13)
amod(disorders-15, skeletal_muscle-14)
nmod:in(URMC-099-12, disorders-15)

In/IN the/DT current/JJ study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN melatonin/NN on/IN gene/NN expression/NN levels/NNS of/IN key/JJ regulators/NNS of/IN lipid/NN metabolism/NN in/IN adipocytes/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ current) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN melatonin)))
        (PP (IN on)
          (NP
            (NP (NN gene) (NN expression) (NNS levels))
            (PP (IN of)
              (NP
                (NP (JJ key) (NNS regulators))
                (PP (IN of)
                  (NP
                    (NP (NN lipid) (NN metabolism))
                    (PP (IN in)
                      (NP (NNS adipocytes)))))))))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, current-3)
nmod:in(investigated-7, study-4)
nsubj(investigated-7, we-6)
root(ROOT-0, investigated-7)
det(effects-9, the-8)
dobj(investigated-7, effects-9)
case(melatonin-11, of-10)
nmod:of(effects-9, melatonin-11)
case(levels-15, on-12)
compound(levels-15, gene-13)
compound(levels-15, expression-14)
nmod:on(effects-9, levels-15)
case(regulators-18, of-16)
amod(regulators-18, key-17)
nmod:of(levels-15, regulators-18)
case(metabolism-21, of-19)
compound(metabolism-21, lipid-20)
nmod:of(regulators-18, metabolism-21)
case(adipocytes-23, in-22)
nmod:in(metabolism-21, adipocytes-23)

Our/PRP$ results/NNS showed/VBD that/IN melatonin/JJ treatment/NN upregulated/VBD the/DT expression/NN levels/NNS of/IN peroxisome_proliferator-activated_receptor-a/JJ -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- and/CC its/PRP$ target/NN gene/NN carnitine_palmitoyl-CoA/JJ transferase/NN 1/CD -LRB-/-LRB- CPT1/NNP -RRB-/-RRB- ,/, which/WDT are/VBP associated/VBN with/IN lipolysis/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ melatonin) (NN treatment))
          (VP (VBD upregulated)
            (NP
              (NP (DT the) (NN expression) (NNS levels))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (ADVP (JJ peroxisome_proliferator-activated_receptor-a))
                      (NP (-LRB- -LRB-) (NNP PPARa) (-RRB- -RRB-))
                      (CC and)
                      (NP (PRP$ its) (NN target) (NN gene)))
                    (NP (JJ carnitine_palmitoyl-CoA) (NN transferase) (CD 1)))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CPT1))
                    (-RRB- -RRB-))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBP are)
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (NNS lipolysis))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(upregulated-7, that-4)
amod(treatment-6, melatonin-5)
nsubj(upregulated-7, treatment-6)
ccomp(showed-3, upregulated-7)
det(levels-10, the-8)
compound(levels-10, expression-9)
dobj(upregulated-7, levels-10)
case(PPARa-14, of-11)
advmod(PPARa-14, peroxisome_proliferator-activated_receptor-a-12)
nmod:of(levels-10, PPARa-14)
nsubjpass(associated-29, PPARa-14)
cc(PPARa-14, and-16)
nmod:poss(gene-19, its-17)
compound(gene-19, target-18)
nmod:of(levels-10, gene-19)
conj:and(PPARa-14, gene-19)
nsubjpass(associated-29, gene-19)
amod(transferase-21, carnitine_palmitoyl-CoA-20)
dep(PPARa-14, transferase-21)
nummod(transferase-21, 1-22)
appos(PPARa-14, CPT1-24)
ref(PPARa-14, which-27)
auxpass(associated-29, are-28)
acl:relcl(PPARa-14, associated-29)
case(lipolysis-31, with-30)
nmod:with(associated-29, lipolysis-31)

In/IN contrast/NN ,/, the/DT expression/NN levels/NNS of/IN sterol_regulatory_element-binding_protein-1c/JJ -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- ,/, tetrathiafulvalene/JJ synthase/NN -LRB-/-LRB- Rho-6/NNS -RRB-/-RRB- ,/, and/CC stearoyl-CoA_desaturase-1/JJ -LRB-/-LRB- SCD1/NNP -RRB-/-RRB- ,/, which/WDT are/VBP associated/VBN with/IN lipogenesis/NNS ,/, were/VBD downregulated/VBN by/IN melatonin/NN treatment/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (NN expression) (NNS levels))
      (PP (IN of)
        (NP
          (NP (JJ sterol_regulatory_element-binding_protein-1c) (-LRB- -LRB-) (NNS SREBP-1c) (-RRB- -RRB-))
          (, ,)
          (NP
            (NP (JJ tetrathiafulvalene) (NN synthase))
            (-LRB- -LRB-)
            (NP (NNS Rho-6))
            (-RRB- -RRB-))
          (, ,)
          (CC and)
          (NP (JJ stearoyl-CoA_desaturase-1))
          (PRN (-LRB- -LRB-)
            (NP (NNP SCD1))
            (-RRB- -RRB-))))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBP are)
            (VP (VBN associated)
              (PP (IN with)
                (NP (NNS lipogenesis)))))))
      (, ,))
    (VP (VBD were)
      (VP (VBN downregulated)
        (PP (IN by)
          (NP (NN melatonin) (NN treatment)))))
    (. .)))

case(contrast-2, In-1)
nmod:in(downregulated-32, contrast-2)
det(levels-6, the-4)
compound(levels-6, expression-5)
nsubjpass(associated-27, levels-6)
nsubjpass(downregulated-32, levels-6)
case(SREBP-1c-10, of-7)
amod(SREBP-1c-10, sterol_regulatory_element-binding_protein-1c-8)
nmod:of(levels-6, SREBP-1c-10)
amod(synthase-14, tetrathiafulvalene-13)
nmod:of(levels-6, synthase-14)
conj:and(SREBP-1c-10, synthase-14)
dep(synthase-14, Rho-6-16)
cc(SREBP-1c-10, and-19)
nmod:of(levels-6, stearoyl-CoA_desaturase-1-20)
conj:and(SREBP-1c-10, stearoyl-CoA_desaturase-1-20)
appos(SREBP-1c-10, SCD1-22)
ref(levels-6, which-25)
auxpass(associated-27, are-26)
acl:relcl(levels-6, associated-27)
case(lipogenesis-29, with-28)
nmod:with(associated-27, lipogenesis-29)
auxpass(downregulated-32, were-31)
root(ROOT-0, downregulated-32)
case(treatment-35, by-33)
compound(treatment-35, melatonin-34)
nmod:by(downregulated-32, treatment-35)

These/DT findings/NNS suggest/VBP that/IN melatonin/NN may/MD have/VB therapeutic/JJ potential/NN for/IN metabolic_disorders/NNS such/JJ as/IN obesity_and_type_2_diabetes/NNS by/IN regulating/VBG lipid/NN metabolism/NN in/IN adipocytes/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN melatonin))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ therapeutic) (NN potential))
                (PP (IN for)
                  (NP
                    (NP (NNS metabolic_disorders))
                    (PP (JJ such) (IN as)
                      (NP (NNS obesity_and_type_2_diabetes))))))
              (PP (IN by)
                (S
                  (VP (VBG regulating)
                    (NP (NN lipid) (NN metabolism))
                    (PP (IN in)
                      (NP (NNS adipocytes)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, melatonin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(potential-9, therapeutic-8)
dobj(have-7, potential-9)
case(metabolic_disorders-11, for-10)
nmod:for(potential-9, metabolic_disorders-11)
case(obesity_and_type_2_diabetes-14, such-12)
mwe(such-12, as-13)
nmod:such_as(metabolic_disorders-11, obesity_and_type_2_diabetes-14)
mark(regulating-16, by-15)
advcl(have-7, regulating-16)
compound(metabolism-18, lipid-17)
dobj(regulating-16, metabolism-18)
case(adipocytes-20, in-19)
nmod:in(regulating-16, adipocytes-20)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO elucidate/VB the/DT underlying/JJ molecular/JJ mechanisms/NNS and/CC to/TO evaluate/VB the/DT efficacy/NN and/CC safety/NN of/IN melatonin/NN as/IN a/DT potential/JJ therapeutic/JJ agent/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (JJ underlying) (JJ molecular) (NNS mechanisms))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (NN efficacy)
                    (CC and)
                    (NN safety))
                  (PP (IN of)
                    (NP (NN melatonin))))
                (PP (IN as)
                  (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
ccomp(warranted-4, elucidate-6)
det(mechanisms-10, the-7)
amod(mechanisms-10, underlying-8)
amod(mechanisms-10, molecular-9)
dobj(elucidate-6, mechanisms-10)
cc(elucidate-6, and-11)
mark(evaluate-13, to-12)
ccomp(warranted-4, evaluate-13)
conj:and(elucidate-6, evaluate-13)
det(efficacy-15, the-14)
dobj(evaluate-13, efficacy-15)
cc(efficacy-15, and-16)
dobj(evaluate-13, safety-17)
conj:and(efficacy-15, safety-17)
case(melatonin-19, of-18)
nmod:of(efficacy-15, melatonin-19)
case(agent-24, as-20)
det(agent-24, a-21)
amod(agent-24, potential-22)
amod(agent-24, therapeutic-23)
nmod:as(evaluate-13, agent-24)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-16, have-14)
auxpass(studied-16, been-15)
root(ROOT-0, studied-16)
case(benefits-21, for-17)
nmod:poss(benefits-21, their-18)
amod(benefits-21, potential-19)
compound(benefits-21, health-20)
nmod:for(studied-16, benefits-21)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN D-methionine/JJ levels/NNS in/IN hyperD-methioninemic/JJ patients/NNS ,/, which/WDT may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN hypermethioninemia/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ D-methionine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperD-methioninemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB have)
                                (NP
                                  (NP (NNS implications))
                                  (PP (IN for)
                                    (NP
                                      (NP (DT the) (NN treatment))
                                      (PP (IN of)
                                        (NP (NN hypermethioninemia))))))))))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, D-methionine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperD-methioninemic-16)
nmod:in(levels-14, patients-17)
nsubj(have-21, patients-17)
ref(patients-17, which-19)
aux(have-21, may-20)
acl:relcl(patients-17, have-21)
dobj(have-21, implications-22)
case(treatment-25, for-23)
det(treatment-25, the-24)
nmod:for(implications-22, treatment-25)
case(hypermethioninemia-27, of-26)
nmod:of(treatment-25, hypermethioninemia-27)

Additionally/RB ,/, epidemiological/JJ studies/NNS have/VBP suggested/VBN that/IN a/DT diet/NN rich/JJ in/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT a) (NN diet))
              (PP (JJ rich) (IN in)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(suggested-6, Additionally-1)
amod(studies-4, epidemiological-3)
nsubj(suggested-6, studies-4)
aux(suggested-6, have-5)
root(ROOT-0, suggested-6)
mark(associated-16, that-7)
det(diet-9, a-8)
nsubjpass(associated-16, diet-9)
case(EPA-12, rich-10)
case(EPA-12, in-11)
nmod:in(diet-9, EPA-12)
cc(EPA-12, and-13)
nmod:in(diet-9, DHA-14)
conj:and(EPA-12, DHA-14)
auxpass(associated-16, is-15)
ccomp(suggested-6, associated-16)
case(risk-20, with-17)
det(risk-20, a-18)
amod(risk-20, decreased-19)
nmod:with(associated-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

These/DT findings/NNS highlight/VB the/DT importance/NN of/IN incorporating/VBG omega-3_fatty_acids/JJ into/IN the/DT diet/NN as/IN a/DT potential/JJ preventative/JJ measure/NN against/IN CHD/NNP and/CC other/JJ related/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (NN importance))
        (PP (IN of)
          (S
            (VP (VBG incorporating)
              (NP (JJ omega-3_fatty_acids))
              (PP (IN into)
                (NP (DT the) (NN diet)))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ potential) (JJ preventative) (NN measure))
                  (PP (IN against)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ other) (JJ related) (NNS conditions)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
root(ROOT-0, highlight-3)
det(importance-5, the-4)
dobj(highlight-3, importance-5)
mark(incorporating-7, of-6)
acl(importance-5, incorporating-7)
dobj(incorporating-7, omega-3_fatty_acids-8)
case(diet-11, into-9)
det(diet-11, the-10)
nmod:into(incorporating-7, diet-11)
case(measure-16, as-12)
det(measure-16, a-13)
amod(measure-16, potential-14)
amod(measure-16, preventative-15)
nmod:as(incorporating-7, measure-16)
case(CHD-18, against-17)
nmod:against(measure-16, CHD-18)
cc(CHD-18, and-19)
amod(conditions-22, other-20)
amod(conditions-22, related-21)
nmod:against(measure-16, conditions-22)
conj:and(CHD-18, conditions-22)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ therapeutic) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(use-20, for-18)
amod(use-20, therapeutic-19)
nmod:for(determine-15, use-20)

Heart_failure/NNP -LRB-/-LRB- HF/NNP -RRB-/-RRB- is_a/VBZ prevalent/JJ and/CC potentially/RB life-threatening/JJ condition/NN that/WDT affects/VBZ millions/NNS of/IN people/NNS worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Heart_failure) (-LRB- -LRB-)
      (NP (NNP HF))
      (-RRB- -RRB-))
    (VP (VBZ is_a)
      (NP
        (ADJP
          (ADJP (JJ prevalent))
          (CC and)
          (ADJP (RB potentially) (JJ life-threatening)))
        (NN condition)
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP
                (NP (NNS millions))
                (PP (IN of)
                  (NP (NNS people))))
              (ADVP (RB worldwide)))))))
    (. .)))

nsubj(is_a-5, Heart_failure-1)
dep(Heart_failure-1, HF-3)
root(ROOT-0, is_a-5)
amod(condition-10, prevalent-6)
cc(prevalent-6, and-7)
advmod(life-threatening-9, potentially-8)
conj:and(prevalent-6, life-threatening-9)
amod(condition-10, life-threatening-9)
dobj(is_a-5, condition-10)
nsubj(affects-12, that-11)
ccomp(condition-10, affects-12)
dobj(affects-12, millions-13)
case(people-15, of-14)
nmod:of(millions-13, people-15)
advmod(affects-12, worldwide-16)

One/CD of/IN the/DT complications/NNS associated/VBN with/IN HF/NNP is/VBZ D-lactic_acidosis/NNP ,/, a/DT metabolic_disorder/NN characterized/VBN by/IN an/DT accumulation/NN of/IN D-lactic_acid/NNP in/IN the/DT blood/NN ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS complications))
          (VP (VBN associated)
            (PP (IN with)
              (NP (NNP HF)))))))
    (VP (VBZ is)
      (NP
        (NP (NNP D-lactic_acidosis))
        (, ,)
        (NP
          (NP (DT a) (NN metabolic_disorder))
          (VP (VBN characterized)
            (PP (IN by)
              (NP
                (NP (DT an) (NN accumulation))
                (PP (IN of)
                  (NP (NNP D-lactic_acid)))))
            (PP (IN in)
              (NP (DT the) (NN blood)))))))
    (. .)))

nsubj(D-lactic_acidosis-9, One-1)
case(complications-4, of-2)
det(complications-4, the-3)
nmod:of(One-1, complications-4)
acl(complications-4, associated-5)
case(HF-7, with-6)
nmod:with(associated-5, HF-7)
cop(D-lactic_acidosis-9, is-8)
root(ROOT-0, D-lactic_acidosis-9)
det(metabolic_disorder-12, a-11)
appos(D-lactic_acidosis-9, metabolic_disorder-12)
acl(metabolic_disorder-12, characterized-13)
case(accumulation-16, by-14)
det(accumulation-16, an-15)
nmod:by(characterized-13, accumulation-16)
case(D-lactic_acid-18, of-17)
nmod:of(accumulation-16, D-lactic_acid-18)
case(blood-21, in-19)
det(blood-21, the-20)
nmod:in(characterized-13, blood-21)

Telbivudine/NNP ,/, a/DT nucleoside/JJ analogue/NN used/VBN in/IN the/DT treatment/NN of/IN chronic_hepatitis_B/NN ,/, has_been/VBP shown/VBN to/TO reduce/VB the/DT risk/NN of/IN D-lactic_acidosis/NNP in/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (NP
      (NP (NNP Telbivudine))
      (, ,)
      (NP
        (NP (DT a) (JJ nucleoside) (NN analogue))
        (VP (VBN used)
          (PP (IN in)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP (NN chronic_hepatitis_B)))))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNP D-lactic_acidosis))))
              (PP (IN in)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (NNP HF))))))))))
    (. .)))

nsubj(has_been-13, Telbivudine-1)
det(analogue-5, a-3)
amod(analogue-5, nucleoside-4)
appos(Telbivudine-1, analogue-5)
acl(analogue-5, used-6)
case(treatment-9, in-7)
det(treatment-9, the-8)
nmod:in(used-6, treatment-9)
case(chronic_hepatitis_B-11, of-10)
nmod:of(treatment-9, chronic_hepatitis_B-11)
root(ROOT-0, has_been-13)
dep(has_been-13, shown-14)
mark(reduce-16, to-15)
xcomp(shown-14, reduce-16)
det(risk-18, the-17)
dobj(reduce-16, risk-18)
case(D-lactic_acidosis-20, of-19)
nmod:of(risk-18, D-lactic_acidosis-20)
case(patients-22, in-21)
nmod:in(reduce-16, patients-22)
case(HF-24, with-23)
nmod:with(patients-22, HF-24)

In/IN a/DT randomized_controlled_trial/JJ involving/VBG patients/NNS with/IN HF/NNP ,/, telbivudine/NN was/VBD found/VBN to/TO reduce/VB the/DT risk/NN of/IN D-lactic_acidosis/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT a) (JJ randomized_controlled_trial) (VBG involving) (NNS patients))
        (PP (IN with)
          (NP (NNP HF)))))
    (, ,)
    (NP (NN telbivudine))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNP D-lactic_acidosis))))
              (PP (IN by)
                (NP
                  (NP (CD 21) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                      (: :)
                      (NP
                        (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                        (: :)
                        (NP
                          (QP (CD 0.67-0) (CD .93)))))
                    (-RRB- -RRB-)))))))))
    (. .)))

case(patients-5, In-1)
det(patients-5, a-2)
amod(patients-5, randomized_controlled_trial-3)
amod(patients-5, involving-4)
nmod:in(found-11, patients-5)
case(HF-7, with-6)
nmod:with(patients-5, HF-7)
nsubjpass(found-11, telbivudine-9)
nsubj:xsubj(reduce-13, telbivudine-9)
auxpass(found-11, was-10)
root(ROOT-0, found-11)
mark(reduce-13, to-12)
xcomp(found-11, reduce-13)
det(risk-15, the-14)
dobj(reduce-13, risk-15)
case(D-lactic_acidosis-17, of-16)
nmod:of(risk-15, D-lactic_acidosis-17)
case(%-20, by-18)
nummod(%-20, 21-19)
nmod:by(reduce-13, %-20)
amod(-RSB--26, relative-22)
compound(-RSB--26, risk-23)
compound(-RSB--26, -LSB--24)
compound(-RSB--26, RR-25)
dep(%-20, -RSB--26)
nummod(-RSB--36, 0.79-28)
nummod(-RSB--36, 95-30)
compound(-RSB--36, %-31)
compound(-RSB--36, confidence-32)
amod(-RSB--36, interval-33)
amod(-RSB--36, -LSB--34)
compound(-RSB--36, CI-35)
dep(-RSB--26, -RSB--36)
compound(.93-39, 0.67-0-38)
dep(-RSB--36, .93-39)

This/DT finding/NN suggests/VBZ that/IN telbivudine/NN may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ option/NN for/IN preventing/VBG D-lactic_acidosis/NNP in/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN telbivudine))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential)
                (PP (IN as)
                  (NP (DT a) (JJ therapeutic) (NN option))))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (NP (NNP D-lactic_acidosis))
                    (PP (IN in)
                      (NP (NNS patients)))
                    (PP (IN with)
                      (NP (NNP HF)))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(have-7, that-4)
nsubj(have-7, telbivudine-5)
aux(have-7, may-6)
ccomp(suggests-3, have-7)
xcomp(have-7, potential-8)
case(option-12, as-9)
det(option-12, a-10)
amod(option-12, therapeutic-11)
nmod:as(potential-8, option-12)
mark(preventing-14, for-13)
advcl(have-7, preventing-14)
dobj(preventing-14, D-lactic_acidosis-15)
case(patients-17, in-16)
nmod:in(preventing-14, patients-17)
case(HF-19, with-18)
nmod:with(preventing-14, HF-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/NN and/CC duration/NN of/IN treatment/NN with/IN telbivudine/NN for/IN this/DT indication/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosing)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP (NN treatment))))
                (PP (IN with)
                  (NP
                    (NP (NN telbivudine))
                    (PP (IN for)
                      (NP (DT this) (NN indication)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(dosing-14, the-12)
amod(dosing-14, optimal-13)
dobj(determine-11, dosing-14)
cc(dosing-14, and-15)
dobj(determine-11, duration-16)
conj:and(dosing-14, duration-16)
case(treatment-18, of-17)
nmod:of(dosing-14, treatment-18)
case(telbivudine-20, with-19)
nmod:with(determine-11, telbivudine-20)
case(indication-23, for-21)
det(indication-23, this-22)
nmod:for(telbivudine-20, indication-23)

Antiretroviral/JJ therapy/NN has/VBZ become/VBN increasingly/RB important/JJ in/IN the/DT treatment/NN of/IN human_immunodeficiency_virus/NNS -LRB-/-LRB- HIV/NNP -RRB-/-RRB- infection/NN ./.

(ROOT
  (S
    (NP (JJ Antiretroviral) (NN therapy))
    (VP (VBZ has)
      (VP (VBN become)
        (ADJP (RB increasingly) (JJ important))
        (PP (IN in)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP (NNS human_immunodeficiency_virus)))
            (PRN (-LRB- -LRB-)
              (NP (NNP HIV))
              (-RRB- -RRB-))
            (NP (NN infection))))))
    (. .)))

amod(therapy-2, Antiretroviral-1)
nsubj(become-4, therapy-2)
aux(become-4, has-3)
root(ROOT-0, become-4)
advmod(important-6, increasingly-5)
xcomp(become-4, important-6)
case(treatment-9, in-7)
det(treatment-9, the-8)
nmod:in(become-4, treatment-9)
case(human_immunodeficiency_virus-11, of-10)
nmod:of(treatment-9, human_immunodeficiency_virus-11)
appos(treatment-9, HIV-13)
dep(treatment-9, infection-15)

Tenofovir_disoproxil_fumarate/NNP -LRB-/-LRB- TDF/NNP -RRB-/-RRB- is/VBZ one/CD such/JJ antiretroviral/JJ medication/NN that/WDT has_been/VBP shown/VBN to_be/NN effective/JJ in/IN reducing/VBG viral_load/VBN and/CC improving/VBG immune/JJ function/NN in/IN HIV-infected/JJ patients/NNS ./.

(ROOT
  (S
    (NP (NNP Tenofovir_disoproxil_fumarate) (-LRB- -LRB-)
      (NP (NNP TDF))
      (-RRB- -RRB-))
    (VP (VBZ is)
      (NP
        (NP (CD one) (JJ such) (JJ antiretroviral) (NN medication))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (NP (NN to_be))
                (S
                  (ADJP (JJ effective)
                    (PP (IN in)
                      (S
                        (VP
                          (VP (VBG reducing)
                            (VP (VBN viral_load)))
                          (CC and)
                          (VP (VBG improving)
                            (NP
                              (NP (JJ immune) (NN function))
                              (PP (IN in)
                                (NP (JJ HIV-infected) (NNS patients))))))))))))))))
    (. .)))

nsubj(medication-9, Tenofovir_disoproxil_fumarate-1)
dep(Tenofovir_disoproxil_fumarate-1, TDF-3)
cop(medication-9, is-5)
nummod(medication-9, one-6)
amod(medication-9, such-7)
amod(medication-9, antiretroviral-8)
root(ROOT-0, medication-9)
nsubj(has_been-11, medication-9)
ref(medication-9, that-10)
acl:relcl(medication-9, has_been-11)
dep(has_been-11, shown-12)
dobj(shown-12, to_be-13)
xcomp(shown-12, effective-14)
mark(reducing-16, in-15)
advcl(effective-14, reducing-16)
dep(reducing-16, viral_load-17)
cc(reducing-16, and-18)
advcl(effective-14, improving-19)
conj:and(reducing-16, improving-19)
amod(function-21, immune-20)
dobj(improving-19, function-21)
case(patients-24, in-22)
amod(patients-24, HIV-infected-23)
nmod:in(function-21, patients-24)

However/RB ,/, TDF/NNP has_been/VBP associated/VBN with/IN renal_toxicity/NN ,/, including/VBG hypophosphatemia/NN ,/, which/WDT can/MD lead/VB to/TO bone_mineral_density/JJ loss/NN and/CC other/JJ complications/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NNP TDF))
    (VP (VBP has_been)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (NN renal_toxicity))
            (, ,)
            (VP (VBG including)
              (NP (NN hypophosphatemia)))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (MD can)
                  (VP (VB lead)
                    (PP (TO to)
                      (NP
                        (NP (JJ bone_mineral_density) (NN loss))
                        (CC and)
                        (NP (JJ other) (NNS complications))))))))))))
    (. .)))

advmod(has_been-4, However-1)
nsubj(has_been-4, TDF-3)
root(ROOT-0, has_been-4)
dep(has_been-4, associated-5)
case(renal_toxicity-7, with-6)
nmod:with(associated-5, renal_toxicity-7)
nsubj(lead-14, renal_toxicity-7)
acl(renal_toxicity-7, including-9)
dobj(including-9, hypophosphatemia-10)
ref(renal_toxicity-7, which-12)
aux(lead-14, can-13)
acl:relcl(renal_toxicity-7, lead-14)
case(loss-17, to-15)
amod(loss-17, bone_mineral_density-16)
nmod:to(lead-14, loss-17)
cc(loss-17, and-18)
amod(complications-20, other-19)
nmod:to(lead-14, complications-20)
conj:and(loss-17, complications-20)

In/IN this/DT study/NN ,/, we/PRP evaluated/VBN the/DT effect/NN of/IN tenofovir_disoproxil_fumarate/NN -LRB-/-LRB- TDF/NNP -RRB-/-RRB- on/IN the/DT risk/NN of/IN hypophosphatemia/NN in/IN patients/NNS with/IN HIV/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN evaluated)
      (NP
        (NP
          (NP (DT the) (NN effect))
          (PP (IN of)
            (NP (NN tenofovir_disoproxil_fumarate))))
        (PRN (-LRB- -LRB-)
          (NP (NNP TDF))
          (-RRB- -RRB-)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP
              (NP (NN hypophosphatemia))
              (PP (IN in)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (NNP HIV))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-6, study-3)
nsubj(evaluated-6, we-5)
root(ROOT-0, evaluated-6)
det(effect-8, the-7)
dobj(evaluated-6, effect-8)
case(tenofovir_disoproxil_fumarate-10, of-9)
nmod:of(effect-8, tenofovir_disoproxil_fumarate-10)
appos(effect-8, TDF-12)
case(risk-16, on-14)
det(risk-16, the-15)
nmod:on(evaluated-6, risk-16)
case(hypophosphatemia-18, of-17)
nmod:of(risk-16, hypophosphatemia-18)
case(patients-20, in-19)
nmod:in(hypophosphatemia-18, patients-20)
case(HIV-22, with-21)
nmod:with(patients-20, HIV-22)

We/PRP found/VBD that/IN tenofovir_DF/NN reduced/VBD the/DT risk/NN of/IN hypophosphatemia/NN in/IN patients/NNS with/IN HF/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NN tenofovir_DF))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN hypophosphatemia))))
            (PP (IN in)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (NNP HF)))))
            (PP (IN by)
              (NP
                (NP (CD 21) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                      (: :)
                      (NP
                        (QP (CD 0.67-0) (CD .93)))))
                  (-RRB- -RRB-))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(reduced-5, that-3)
nsubj(reduced-5, tenofovir_DF-4)
ccomp(found-2, reduced-5)
det(risk-7, the-6)
dobj(reduced-5, risk-7)
case(hypophosphatemia-9, of-8)
nmod:of(risk-7, hypophosphatemia-9)
case(patients-11, in-10)
nmod:in(reduced-5, patients-11)
case(HF-13, with-12)
nmod:with(patients-11, HF-13)
case(%-16, by-14)
nummod(%-16, 21-15)
nmod:by(reduced-5, %-16)
amod(-RSB--22, relative-18)
compound(-RSB--22, risk-19)
compound(-RSB--22, -LSB--20)
compound(-RSB--22, RR-21)
dep(%-16, -RSB--22)
nummod(-RSB--32, 0.79-24)
nummod(-RSB--32, 95-26)
compound(-RSB--32, %-27)
compound(-RSB--32, confidence-28)
amod(-RSB--32, interval-29)
amod(-RSB--32, -LSB--30)
compound(-RSB--32, CI-31)
dep(-RSB--22, -RSB--32)
compound(.93-35, 0.67-0-34)
dep(-RSB--32, .93-35)

This/DT finding/NN suggests/VBZ that/IN TDF/NNP may/MD be/VB a/DT viable/JJ option/NN for/IN treating/VBG HIV-infected/JJ patients/NNS who/WP are/VBP at/IN risk/NN for/IN developing/VBG hypophosphatemia/NN ,/, although/IN further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN this/DT medication/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NNP TDF))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ viable) (NN option))
                (PP (IN for)
                  (S
                    (VP (VBG treating)
                      (NP
                        (NP (JJ HIV-infected) (NNS patients))
                        (SBAR
                          (WHNP (WP who))
                          (S
                            (VP (VBP are)
                              (PP (IN at)
                                (NP
                                  (NP (NN risk))
                                  (PP (IN for)
                                    (S
                                      (VP (VBG developing)
                                        (NP (NN hypophosphatemia)))))))
                              (, ,)
                              (SBAR (IN although)
                                (S
                                  (NP (JJ further) (NNS studies))
                                  (VP (VBP are)
                                    (VP (VBN needed)
                                      (S
                                        (VP (TO to)
                                          (VP
                                            (VP (VB confirm)
                                              (NP (DT these) (NNS results)))
                                            (CC and)
                                            (VP (VB determine)
                                              (NP
                                                (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                                                (PP (IN for)
                                                  (NP (DT this) (NN medication)))))))))))))))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(option-10, that-4)
nsubj(option-10, TDF-5)
aux(option-10, may-6)
cop(option-10, be-7)
det(option-10, a-8)
amod(option-10, viable-9)
ccomp(suggests-3, option-10)
mark(treating-12, for-11)
acl(option-10, treating-12)
amod(patients-14, HIV-infected-13)
dobj(treating-12, patients-14)
nsubj(risk-18, patients-14)
ref(patients-14, who-15)
cop(risk-18, are-16)
case(risk-18, at-17)
acl:relcl(patients-14, risk-18)
mark(developing-20, for-19)
acl(risk-18, developing-20)
dobj(developing-20, hypophosphatemia-21)
mark(needed-27, although-23)
amod(studies-25, further-24)
nsubjpass(needed-27, studies-25)
nsubj:xsubj(confirm-29, studies-25)
nsubj:xsubj(determine-33, studies-25)
auxpass(needed-27, are-26)
advcl(risk-18, needed-27)
mark(confirm-29, to-28)
xcomp(needed-27, confirm-29)
det(results-31, these-30)
dobj(confirm-29, results-31)
cc(confirm-29, and-32)
xcomp(needed-27, determine-33)
conj:and(confirm-29, determine-33)
det(regimen-37, the-34)
amod(regimen-37, optimal-35)
amod(regimen-37, dosing-36)
dobj(determine-33, regimen-37)
case(medication-40, for-38)
det(medication-40, this-39)
nmod:for(regimen-37, medication-40)

In/IN the/DT present/JJ study/NN ,/, we/PRP aimed/VBN to/TO investigate/VB the/DT role/NN of/IN HIF1a-AS1/NNS in/IN regulating/VBG basal/JJ naftazone/JJ production/NN and_8-Br-cAMP-stimulated/JJ 3_beta-hydroxysteroid_dehydrogenase/JJ //: delta/NN 5/CD --/: >/VBP delta_4/JJ isomerase/JJ -LRB-/-LRB- 3_beta_HSD/JJ -RRB-/-RRB- expression/NN in/IN Leydig/NNP cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP
      (NP (PRP we))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP (NNS HIF1a-AS1))))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP
                      (NP (JJ basal) (JJ naftazone) (NN production))
                      (ADJP (JJ and_8-Br-cAMP-stimulated) (JJ 3_beta-hydroxysteroid_dehydrogenase))
                      (PRN (: /)
                        (NP (NN delta) (CD 5))
                        (: --)))))))))))
    (VP (VBP >)
      (NP (JJ delta_4) (JJ isomerase)
        (PRN (-LRB- -LRB-) (JJ 3_beta_HSD) (-RRB- -RRB-))
        (NN expression))
      (PP (IN in)
        (NP (NNP Leydig) (NNS cells))))
    (. .)))

case(study-4, In-1)
det(study-4, the-2)
amod(study-4, present-3)
nmod:in(>-25, study-4)
nsubj(>-25, we-6)
acl(we-6, aimed-7)
mark(investigate-9, to-8)
xcomp(aimed-7, investigate-9)
det(role-11, the-10)
dobj(investigate-9, role-11)
case(HIF1a-AS1-13, of-12)
nmod:of(role-11, HIF1a-AS1-13)
mark(regulating-15, in-14)
advcl(investigate-9, regulating-15)
amod(production-18, basal-16)
amod(production-18, naftazone-17)
dobj(regulating-15, production-18)
amod(3_beta-hydroxysteroid_dehydrogenase-20, and_8-Br-cAMP-stimulated-19)
amod(production-18, 3_beta-hydroxysteroid_dehydrogenase-20)
dep(production-18, delta-22)
nummod(delta-22, 5-23)
root(ROOT-0, >-25)
amod(expression-31, delta_4-26)
amod(expression-31, isomerase-27)
dep(expression-31, 3_beta_HSD-29)
dobj(>-25, expression-31)
case(cells-34, in-32)
compound(cells-34, Leydig-33)
nmod:in(>-25, cells-34)

Leydig/VBG cells/NNS are/VBP responsible/JJ for/IN the/DT production/NN of/IN testosterone/NN ,/, which/WDT plays/VBZ a/DT critical/JJ role/NN in/IN male/JJ reproductive/JJ function/NN ./.

(ROOT
  (S
    (NP (VBG Leydig) (NNS cells))
    (VP (VBP are)
      (ADJP (JJ responsible)
        (PP (IN for)
          (NP
            (NP (DT the) (NN production))
            (PP (IN of)
              (NP
                (NP (NN testosterone))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ plays)
                      (NP
                        (NP (DT a) (JJ critical) (NN role))
                        (PP (IN in)
                          (NP (JJ male) (JJ reproductive) (NN function)))))))))))))
    (. .)))

amod(cells-2, Leydig-1)
nsubj(responsible-4, cells-2)
cop(responsible-4, are-3)
root(ROOT-0, responsible-4)
case(production-7, for-5)
det(production-7, the-6)
nmod:for(responsible-4, production-7)
case(testosterone-9, of-8)
nmod:of(production-7, testosterone-9)
nsubj(plays-12, testosterone-9)
ref(testosterone-9, which-11)
acl:relcl(testosterone-9, plays-12)
det(role-15, a-13)
amod(role-15, critical-14)
dobj(plays-12, role-15)
case(function-19, in-16)
amod(function-19, male-17)
amod(function-19, reproductive-18)
nmod:in(role-15, function-19)

Our/PRP$ findings/NNS suggest/VBP that/IN HIF1a-AS1/NNS may/MD play/VB a/DT key/JJ role/NN in/IN modulating/JJ steroidogenesis/NNS by/IN regulating/VBG the/DT expression/NN of/IN key/JJ enzymes/NNS involved/VBN in/IN testosterone/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNS HIF1a-AS1))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (JJ key) (NN role))
                (PP (IN in)
                  (NP (JJ modulating) (NNS steroidogenesis))))
              (PP (IN by)
                (S
                  (VP (VBG regulating)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP
                          (NP (JJ key) (NNS enzymes))
                          (VP (VBN involved)
                            (PP (IN in)
                              (NP (JJ testosterone) (NNS biosynthesis)))))))))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, HIF1a-AS1-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, key-9)
dobj(play-7, role-10)
case(steroidogenesis-13, in-11)
amod(steroidogenesis-13, modulating-12)
nmod:in(role-10, steroidogenesis-13)
mark(regulating-15, by-14)
advcl(play-7, regulating-15)
det(expression-17, the-16)
dobj(regulating-15, expression-17)
case(enzymes-20, of-18)
amod(enzymes-20, key-19)
nmod:of(expression-17, enzymes-20)
acl(enzymes-20, involved-21)
case(biosynthesis-24, in-22)
amod(biosynthesis-24, testosterone-23)
nmod:in(involved-21, biosynthesis-24)

These/DT results/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG steroidogenesis/NNS and/CC may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN disorders/NNS associated/VBN with/IN abnormal/JJ testosterone/JJ production/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (JJ molecular) (NNS mechanisms))
              (VP (VBG underlying)
                (NP (NNS steroidogenesis)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN treatment))
                (PP (IN of)
                  (NP
                    (NP (NNS disorders))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP (JJ abnormal) (JJ testosterone) (NN production))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(provide-3, results-2)
nsubj(have-14, results-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(insights-5, mechanisms-9)
acl(mechanisms-9, underlying-10)
dobj(underlying-10, steroidogenesis-11)
cc(provide-3, and-12)
aux(have-14, may-13)
conj:and(provide-3, have-14)
dobj(have-14, implications-15)
case(treatment-18, for-16)
det(treatment-18, the-17)
nmod:for(implications-15, treatment-18)
case(disorders-20, of-19)
nmod:of(treatment-18, disorders-20)
acl(disorders-20, associated-21)
case(production-25, with-22)
amod(production-25, abnormal-23)
amod(production-25, testosterone-24)
nmod:with(associated-21, production-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT role/NN of/IN HIF1a-AS1/NNS in/IN steroidogenesis/NNS and/CC its/PRP$ potential/NN as/IN a/DT therapeutic/JJ target/NN for/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP
                    (NP (NNS HIF1a-AS1))
                    (PP (IN in)
                      (NP
                        (NP (NNS steroidogenesis))
                        (CC and)
                        (NP (PRP$ its) (NN potential)))))))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN target))
                  (PP (IN for)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(role-9, the-8)
dobj(elucidate-7, role-9)
case(HIF1a-AS1-11, of-10)
nmod:of(role-9, HIF1a-AS1-11)
case(steroidogenesis-13, in-12)
nmod:in(HIF1a-AS1-11, steroidogenesis-13)
cc(steroidogenesis-13, and-14)
nmod:poss(potential-16, its-15)
nmod:in(HIF1a-AS1-11, potential-16)
conj:and(steroidogenesis-13, potential-16)
case(target-20, as-17)
det(target-20, a-18)
amod(target-20, therapeutic-19)
nmod:as(elucidate-7, target-20)
case(conditions-23, for-21)
det(conditions-23, these-22)
nmod:for(target-20, conditions-23)

The/DT endothelin/NN system/NN plays/VBZ a/DT crucial/JJ role/NN in/IN regulating/VBG various/JJ physiological/JJ processes/NNS ,/, including/VBG vascular/NN tone/NN ,/, cell/NN proliferation/NN ,/, and/CC inflammation/NN ./.

(ROOT
  (S
    (NP (DT The) (NN endothelin) (NN system))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (S
            (VP (VBG regulating)
              (NP
                (NP (JJ various) (JJ physiological) (NNS processes))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (NN vascular) (NN tone))
                    (, ,)
                    (NP (NN cell) (NN proliferation))
                    (, ,)
                    (CC and)
                    (NP (NN inflammation))))))))))
    (. .)))

det(system-3, The-1)
compound(system-3, endothelin-2)
nsubj(plays-4, system-3)
root(ROOT-0, plays-4)
det(role-7, a-5)
amod(role-7, crucial-6)
dobj(plays-4, role-7)
mark(regulating-9, in-8)
acl(role-7, regulating-9)
amod(processes-12, various-10)
amod(processes-12, physiological-11)
dobj(regulating-9, processes-12)
acl(processes-12, including-14)
compound(tone-16, vascular-15)
dobj(including-14, tone-16)
compound(proliferation-19, cell-18)
dobj(including-14, proliferation-19)
conj:and(tone-16, proliferation-19)
cc(tone-16, and-21)
dobj(including-14, inflammation-22)
conj:and(tone-16, inflammation-22)

Synemin/NNP is_a/NNP cytoskeletal_protein/VBP that/DT has_been/NN implicated/VBN in/IN the/DT regulation/NN of/IN endothelin/NN signaling/VBG ./.

(ROOT
  (S
    (NP (NNP Synemin) (NNP is_a))
    (VP (VBP cytoskeletal_protein)
      (NP
        (NP (DT that) (NN has_been))
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NN regulation))
              (PP (IN of)
                (NP (NN endothelin)))))
          (S
            (VP (VBG signaling))))))
    (. .)))

compound(is_a-2, Synemin-1)
nsubj(cytoskeletal_protein-3, is_a-2)
root(ROOT-0, cytoskeletal_protein-3)
det(has_been-5, that-4)
dobj(cytoskeletal_protein-3, has_been-5)
acl(has_been-5, implicated-6)
case(regulation-9, in-7)
det(regulation-9, the-8)
nmod:in(implicated-6, regulation-9)
case(endothelin-11, of-10)
nmod:of(regulation-9, endothelin-11)
xcomp(implicated-6, signaling-12)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN Synemin/NNP on/IN 5-formyluracil/JJ levels/NNS ,/, a/DT marker/NN of/IN oxidative_stress/JJ and_DNA/NN damage/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP Synemin)))
        (PP (IN on)
          (NP
            (NP (JJ 5-formyluracil) (NNS levels))
            (, ,)
            (NP
              (NP (DT a) (NN marker))
              (PP (IN of)
                (NP (JJ oxidative_stress) (NN and_DNA) (NN damage))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(Synemin-10, of-9)
nmod:of(effects-8, Synemin-10)
case(levels-13, on-11)
amod(levels-13, 5-formyluracil-12)
nmod:on(effects-8, levels-13)
det(marker-16, a-15)
appos(levels-13, marker-16)
case(damage-20, of-17)
amod(damage-20, oxidative_stress-18)
compound(damage-20, and_DNA-19)
nmod:of(marker-16, damage-20)

Our/PRP$ results/NNS indicate/VBP that/IN Synemin/NNP -LRB-/-LRB- 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- stimulates/VBZ 5-formyluracil/JJ levels/NNS ,/, an/DT effect/NN that/WDT is/VBZ blocked/VBN by/IN the/DT ETA_receptor/NNP antagonist/NN BQ_123/NN -LRB-/-LRB- 2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP Synemin))
            (PRN (-LRB- -LRB-)
              (NP
                (NP
                  (NP (CD 10))
                  (PRN (-LRB- -LRB-)
                    (NP (CD -6))
                    (-RRB- -RRB-)))
                (NP (NNP M)))
              (-RRB- -RRB-)))
          (VP (VBZ stimulates)
            (NP
              (NP (JJ 5-formyluracil) (NNS levels))
              (, ,)
              (NP
                (NP (DT an) (NN effect))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBZ is)
                      (VP (VBN blocked)
                        (PP (IN by)
                          (NP
                            (NP (DT the) (NNP ETA_receptor) (NN antagonist) (NN BQ_123))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (CD 2))
                                (NP
                                  (NP
                                    (NP
                                      (NP (SYM x))
                                      (NP (CD 10)))
                                    (PRN (-LRB- -LRB-)
                                      (NP (CD -6))
                                      (-RRB- -RRB-)))
                                  (NP (NNP M))))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(indicate-3, results-2)
root(ROOT-0, indicate-3)
mark(stimulates-13, that-4)
nsubj(stimulates-13, Synemin-5)
dep(Synemin-5, 10-7)
appos(10-7, -6-9)
appos(10-7, M-11)
ccomp(indicate-3, stimulates-13)
amod(levels-15, 5-formyluracil-14)
dobj(stimulates-13, levels-15)
det(effect-18, an-17)
appos(levels-15, effect-18)
nsubjpass(blocked-21, effect-18)
ref(effect-18, that-19)
auxpass(blocked-21, is-20)
acl:relcl(effect-18, blocked-21)
case(BQ_123-26, by-22)
det(BQ_123-26, the-23)
compound(BQ_123-26, ETA_receptor-24)
compound(BQ_123-26, antagonist-25)
nmod:by(blocked-21, BQ_123-26)
dep(BQ_123-26, 2-28)
dep(2-28, x-29)
dep(x-29, 10-30)
appos(x-29, -6-32)
appos(x-29, M-34)

Furthermore/RB ,/, we/PRP found/VBD that/IN the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NN only/RB weakly/RB increased/VBD 5-formyluracil/JJ levels/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN IRL_1620))
          (ADVP (RB only) (RB weakly))
          (VP (VBD increased)
            (NP (JJ 5-formyluracil) (NNS levels))))))
    (. .)))

advmod(found-4, Furthermore-1)
nsubj(found-4, we-3)
root(ROOT-0, found-4)
mark(increased-13, that-5)
det(IRL_1620-10, the-6)
compound(IRL_1620-10, ETB-7)
compound(IRL_1620-10, receptor-8)
compound(IRL_1620-10, agonist-9)
nsubj(increased-13, IRL_1620-10)
advmod(weakly-12, only-11)
advmod(increased-13, weakly-12)
ccomp(found-4, increased-13)
amod(levels-15, 5-formyluracil-14)
dobj(increased-13, levels-15)

These/DT findings/NNS suggest/VBP that/IN Synemin/NNP modulates/VBZ endothelin/VBN signaling/VBG and/CC oxidative_stress/VBZ in_a/JJ receptor-specific/JJ manner/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ targets/NNS for/IN cardiovascular_diseases/NNS associated/VBN with/IN endothelin/NN dysfunction/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP Synemin))
            (VP
              (VP (VBZ modulates)
                (VP (VBN endothelin)
                  (VP (VBG signaling))))
              (CC and)
              (VP (VBZ oxidative_stress)
                (NP (JJ in_a) (JJ receptor-specific) (NN manner))))))
        (CC and)
        (SBAR
          (S
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (NNS implications))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP
                          (NP (JJ novel) (JJ therapeutic) (NNS targets))
                          (PP (IN for)
                            (NP
                              (NP (NNS cardiovascular_diseases))
                              (VP (VBN associated)
                                (PP (IN with)
                                  (NP (NN endothelin) (NN dysfunction)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(modulates-6, that-4)
nsubj(modulates-6, Synemin-5)
nsubj(oxidative_stress-10, Synemin-5)
nsubj(have-16, Synemin-5)
ccomp(suggest-3, modulates-6)
dep(modulates-6, endothelin-7)
xcomp(endothelin-7, signaling-8)
cc(modulates-6, and-9)
ccomp(suggest-3, oxidative_stress-10)
conj:and(modulates-6, oxidative_stress-10)
amod(manner-13, in_a-11)
amod(manner-13, receptor-specific-12)
dobj(oxidative_stress-10, manner-13)
cc(modulates-6, and-14)
aux(have-16, may-15)
ccomp(suggest-3, have-16)
conj:and(modulates-6, have-16)
dobj(have-16, implications-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(implications-17, development-20)
case(targets-24, of-21)
amod(targets-24, novel-22)
amod(targets-24, therapeutic-23)
nmod:of(development-20, targets-24)
case(cardiovascular_diseases-26, for-25)
nmod:for(targets-24, cardiovascular_diseases-26)
acl(cardiovascular_diseases-26, associated-27)
case(dysfunction-30, with-28)
compound(dysfunction-30, endothelin-29)
nmod:with(associated-27, dysfunction-30)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN LY_134046/NN in/IN reducing/VBG the/DT risk/NN of/IN Methemoglobinemias/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP
          (NP (NN LY_134046))
          (PP (IN in)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (NNP Methemoglobinemias))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (VP (VBD was)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-21, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-21, efficacy-6)
case(LY_134046-8, of-7)
nmod:of(efficacy-6, LY_134046-8)
mark(reducing-10, in-9)
acl(LY_134046-8, reducing-10)
det(risk-12, the-11)
dobj(reducing-10, risk-12)
case(Methemoglobinemias-14, of-13)
nmod:of(risk-12, Methemoglobinemias-14)
nmod:of(risk-12, photophobia-16)
conj:and(Methemoglobinemias-14, photophobia-16)
cc(Methemoglobinemias-14, and-18)
nmod:of(risk-12, phonophobia-19)
conj:and(Methemoglobinemias-14, phonophobia-19)
auxpass(evaluated-21, was-20)
root(ROOT-0, evaluated-21)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, LY_134046/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN Methemoglobinemias/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NNP LY_134046))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNPS Methemoglobinemias))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, LY_134046-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(Methemoglobinemias-17, of-16)
nmod:of(risk-15, Methemoglobinemias-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN LY_134046/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN the/DT treatment/NN of/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP LY_134046))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (DT these) (NNS conditions)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, LY_134046-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(treatment-14, for-12)
det(treatment-14, the-13)
nmod:for(option-11, treatment-14)
case(conditions-17, of-15)
det(conditions-17, these-16)
nmod:of(treatment-14, conditions-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB its/PRP$ long-term/JJ safety/NN and/CC efficacy/NN in/IN larger/JJR populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (PRP$ its) (JJ long-term) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN in)
                  (NP (JJR larger) (NNS populations)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
nmod:poss(safety-9, its-7)
amod(safety-9, long-term-8)
dobj(investigate-6, safety-9)
cc(safety-9, and-10)
dobj(investigate-6, efficacy-11)
conj:and(safety-9, efficacy-11)
case(populations-14, in-12)
amod(populations-14, larger-13)
nmod:in(safety-9, populations-14)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-25, omega-3_fatty_acids-2)
advmod(eicosapentaenoic_acid-5, specifically-4)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-5)
dobj(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
dep(EPA-7, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dobj(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
dep(DHA-16, n-3-20)
aux(studied-25, have-23)
auxpass(studied-25, been-24)
root(ROOT-0, studied-25)
case(benefits-30, for-26)
nmod:poss(benefits-30, their-27)
amod(benefits-30, potential-28)
compound(benefits-30, health-29)
nmod:for(studied-25, benefits-30)

In/IN particular/JJ ,/, these/DT fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN dyslipidemia/NN ,/, characterized/VBN by/IN elevated/JJ levels/NNS of/IN triglycerides/NNPS and/CC low-density/NN lipoproteins/NNS -LRB-/-LRB- LDL/NNP -RRB-/-RRB- ,/, in/IN hyperlipidemic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN dyslipidemia))
                  (, ,)
                  (VP (VBN characterized)
                    (PP (IN by)
                      (NP
                        (NP (JJ elevated) (NNS levels))
                        (PP (IN of)
                          (NP
                            (NP
                              (NP (NNPS triglycerides))
                              (CC and)
                              (NP (NN low-density) (NNS lipoproteins)))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP LDL))
                              (-RRB- -RRB-)))))))
                  (, ,)))
              (PP (IN in)
                (NP (JJ hyperlipidemic) (NNS patients))))))))
    (. .)))

case(particular-2, In-1)
advcl(associated-8, particular-2)
det(fatty_acids-5, these-4)
nsubjpass(associated-8, fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-11, with-9)
amod(levels-11, decreased-10)
nmod:with(associated-8, levels-11)
case(dyslipidemia-13, of-12)
nmod:of(levels-11, dyslipidemia-13)
acl(dyslipidemia-13, characterized-15)
case(levels-18, by-16)
amod(levels-18, elevated-17)
nmod:by(characterized-15, levels-18)
case(triglycerides-20, of-19)
nmod:of(levels-18, triglycerides-20)
cc(triglycerides-20, and-21)
compound(lipoproteins-23, low-density-22)
nmod:of(levels-18, lipoproteins-23)
conj:and(triglycerides-20, lipoproteins-23)
appos(triglycerides-20, LDL-25)
case(patients-30, in-28)
amod(patients-30, hyperlipidemic-29)
nmod:in(levels-11, patients-30)

Furthermore/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP also/RB been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(linked-8, Furthermore-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(linked-8, omega-3_fatty_acids-4)
aux(linked-8, have-5)
advmod(linked-8, also-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, decreased-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

This/DT is/VBZ thought/VBN to_be/JJ due/JJ to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB endothelial/JJ function/NN ,/, and/CC decrease/VB platelet_aggregation/NN ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ is)
      (VP (VBN thought)
        (ADVP (JJ to_be))
        (ADJP (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VB improve)
                      (NP (JJ endothelial) (NN function)))
                    (, ,)
                    (CC and)
                    (VP (VB decrease)
                      (NP (NN platelet_aggregation)))))))))))
    (. .)))

nsubjpass(thought-3, This-1)
auxpass(thought-3, is-2)
root(ROOT-0, thought-3)
advmod(thought-3, to_be-4)
xcomp(thought-3, due-5)
case(ability-8, to-6)
nmod:poss(ability-8, their-7)
nmod:to(due-5, ability-8)
mark(reduce-10, to-9)
acl(ability-8, reduce-10)
dobj(reduce-10, inflammation-11)
acl(ability-8, improve-13)
conj:and(reduce-10, improve-13)
amod(function-15, endothelial-14)
dobj(improve-13, function-15)
cc(reduce-10, and-17)
acl(ability-8, decrease-18)
conj:and(reduce-10, decrease-18)
dobj(decrease-18, platelet_aggregation-19)

While/IN the/DT exact/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, it/PRP is/VBZ clear/JJ that/IN long-chain/JJ omega-3_fatty_acids/NNS play/VBP an/DT important/JJ role/NN in/IN maintaining/VBG cardiovascular_health/NN and/CC may/MD represent/VB a/DT promising/JJ therapeutic/JJ approach/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN dyslipidemia/NNP and/CC CHD/NNP ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (JJ exact) (NNS mechanisms))
          (VP (VBG underlying)
            (NP (DT these) (NNS effects))))
        (VP (VBP are)
          (ADJP (RB not) (RB fully) (VBN understood)))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP (JJ clear))
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NNS omega-3_fatty_acids))
          (VP
            (VP (VBP play)
              (NP (DT an) (JJ important) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG maintaining)
                    (NP (NN cardiovascular_health))))))
            (CC and)
            (VP (MD may)
              (VP (VB represent)
                (NP
                  (NP (DT a) (JJ promising) (JJ therapeutic) (NN approach))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN prevention)
                        (CC and)
                        (NN treatment))
                      (PP (IN of)
                        (NP (NNP dyslipidemia)
                          (CC and)
                          (NNP CHD))))))))))))
    (. .)))

mark(understood-11, While-1)
det(mechanisms-4, the-2)
amod(mechanisms-4, exact-3)
nsubjpass(understood-11, mechanisms-4)
acl(mechanisms-4, underlying-5)
det(effects-7, these-6)
dobj(underlying-5, effects-7)
auxpass(understood-11, are-8)
neg(understood-11, not-9)
advmod(understood-11, fully-10)
advcl(clear-15, understood-11)
nsubj(clear-15, it-13)
cop(clear-15, is-14)
root(ROOT-0, clear-15)
mark(play-19, that-16)
amod(omega-3_fatty_acids-18, long-chain-17)
nsubj(play-19, omega-3_fatty_acids-18)
nsubj(represent-28, omega-3_fatty_acids-18)
ccomp(clear-15, play-19)
det(role-22, an-20)
amod(role-22, important-21)
dobj(play-19, role-22)
mark(maintaining-24, in-23)
advcl(play-19, maintaining-24)
dobj(maintaining-24, cardiovascular_health-25)
cc(play-19, and-26)
aux(represent-28, may-27)
ccomp(clear-15, represent-28)
conj:and(play-19, represent-28)
det(approach-32, a-29)
amod(approach-32, promising-30)
amod(approach-32, therapeutic-31)
dobj(represent-28, approach-32)
case(prevention-35, for-33)
det(prevention-35, the-34)
nmod:for(approach-32, prevention-35)
cc(prevention-35, and-36)
nmod:for(approach-32, treatment-37)
conj:and(prevention-35, treatment-37)
case(dyslipidemia-39, of-38)
nmod:of(prevention-35, dyslipidemia-39)
cc(dyslipidemia-39, and-40)
nmod:of(prevention-35, CHD-41)
conj:and(dyslipidemia-39, CHD-41)

The/DT accumulation/NN of/IN intracellular/NN lipid_droplets/VBZ is_a/NN hallmark/NN of/IN several/JJ metabolic_disorders/NNS ,/, including/VBG obesity_and_type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN accumulation))
      (PP (IN of)
        (NP (NN intracellular))))
    (VP (VBZ lipid_droplets)
      (NP
        (NP (NN is_a) (NN hallmark))
        (PP (IN of)
          (NP
            (NP (JJ several) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS obesity_and_type_2_diabetes)))))))
    (. .)))

det(accumulation-2, The-1)
nsubj(lipid_droplets-5, accumulation-2)
case(intracellular-4, of-3)
nmod:of(accumulation-2, intracellular-4)
root(ROOT-0, lipid_droplets-5)
compound(hallmark-7, is_a-6)
dobj(lipid_droplets-5, hallmark-7)
case(metabolic_disorders-10, of-8)
amod(metabolic_disorders-10, several-9)
nmod:of(hallmark-7, metabolic_disorders-10)
acl(metabolic_disorders-10, including-12)
dobj(including-12, obesity_and_type_2_diabetes-13)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT expression/NN of/IN key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN in/IN adipocytes/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (NP (JJ key) (NNS genes))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (NN lipid) (NN metabolism))
                        (PP (IN in)
                          (NP (NNS adipocytes)))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(expression-10, the-9)
dobj(investigate-8, expression-10)
case(genes-13, of-11)
amod(genes-13, key-12)
nmod:of(expression-10, genes-13)
acl(genes-13, involved-14)
case(metabolism-17, in-15)
compound(metabolism-17, lipid-16)
nmod:in(involved-14, metabolism-17)
case(adipocytes-19, in-18)
nmod:in(metabolism-17, adipocytes-19)

Intracellular/NNP lipid_droplets/NNS were/VBD detected/VBN by/IN Oil-Red-O/JJ staining/VBG ,/, and/CC the/DT expression/NN of/IN sterol_regulatory_element-binding_protein_1/JJ -LRB-/-LRB- SREBP-1/NNP -RRB-/-RRB- ,/, 4-methylthio-3-butenyl_isothiocyanate/JJ synthase/NN -LRB-/-LRB- hZCCHC7/JJ -RRB-/-RRB- ,/, Acetyl-CoA_carboxylase_1/JJ and_2/NNS -LRB-/-LRB- ACC1/NNP and/CC ACC2/NNP -RRB-/-RRB- ,/, Peroxisome_proliferator_activated_receptor-a/NNP -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- ,/, and/CC carnitine_palmitoyl_transferase_1/NNS -LRB-/-LRB- CPT-1/NNP -RRB-/-RRB- was/VBD analyzed/VBN by/IN real-time/JJ reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- qRT-PCR/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (NNP Intracellular) (NNS lipid_droplets))
      (VP (VBD were)
        (VP (VBN detected)
          (PP (IN by)
            (NP (JJ Oil-Red-O) (VBG staining))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP
            (NP
              (NP (JJ sterol_regulatory_element-binding_protein_1))
              (PRN (-LRB- -LRB-)
                (NP (NNP SREBP-1))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ 4-methylthio-3-butenyl_isothiocyanate) (NN synthase))
              (PRN (-LRB- -LRB-) (JJ hZCCHC7) (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ Acetyl-CoA_carboxylase_1) (NNS and_2))
              (PRN (-LRB- -LRB-)
                (NP (NNP ACC1)
                  (CC and)
                  (NNP ACC2))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNP Peroxisome_proliferator_activated_receptor-a))
              (PRN (-LRB- -LRB-)
                (NP (NNP PPARa))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NNS carnitine_palmitoyl_transferase_1))
              (PRN (-LRB- -LRB-)
                (NP (NNP CPT-1))
                (-RRB- -RRB-))))))
      (VP (VBD was)
        (VP (VBN analyzed)
          (PP (IN by)
            (NP
              (NP (JJ real-time) (JJ reverse) (JJ transcription-polymerase) (NN chain) (NN reaction))
              (PRN (-LRB- -LRB-) (JJ qRT-PCR) (-RRB- -RRB-)))))))
    (. .)))

compound(lipid_droplets-2, Intracellular-1)
nsubjpass(detected-4, lipid_droplets-2)
auxpass(detected-4, were-3)
root(ROOT-0, detected-4)
case(Oil-Red-O-6, by-5)
nmod:by(detected-4, Oil-Red-O-6)
amod(Oil-Red-O-6, staining-7)
cc(detected-4, and-9)
det(expression-11, the-10)
nsubjpass(analyzed-43, expression-11)
case(sterol_regulatory_element-binding_protein_1-13, of-12)
nmod:of(expression-11, sterol_regulatory_element-binding_protein_1-13)
appos(sterol_regulatory_element-binding_protein_1-13, SREBP-1-15)
amod(synthase-19, 4-methylthio-3-butenyl_isothiocyanate-18)
nmod:of(expression-11, synthase-19)
conj:and(sterol_regulatory_element-binding_protein_1-13, synthase-19)
dep(synthase-19, hZCCHC7-21)
amod(and_2-25, Acetyl-CoA_carboxylase_1-24)
nmod:of(expression-11, and_2-25)
conj:and(sterol_regulatory_element-binding_protein_1-13, and_2-25)
appos(and_2-25, ACC1-27)
cc(ACC1-27, and-28)
appos(and_2-25, ACC2-29)
conj:and(ACC1-27, ACC2-29)
nmod:of(expression-11, Peroxisome_proliferator_activated_receptor-a-32)
conj:and(sterol_regulatory_element-binding_protein_1-13, Peroxisome_proliferator_activated_receptor-a-32)
appos(Peroxisome_proliferator_activated_receptor-a-32, PPARa-34)
cc(sterol_regulatory_element-binding_protein_1-13, and-37)
nmod:of(expression-11, carnitine_palmitoyl_transferase_1-38)
conj:and(sterol_regulatory_element-binding_protein_1-13, carnitine_palmitoyl_transferase_1-38)
appos(carnitine_palmitoyl_transferase_1-38, CPT-1-40)
auxpass(analyzed-43, was-42)
conj:and(detected-4, analyzed-43)
case(reaction-49, by-44)
amod(reaction-49, real-time-45)
amod(reaction-49, reverse-46)
amod(reaction-49, transcription-polymerase-47)
compound(reaction-49, chain-48)
nmod:by(analyzed-43, reaction-49)
dep(reaction-49, qRT-PCR-51)

Our/PRP$ results/NNS suggest/VBP that/IN these/DT genes/NNS play/VBP a/DT crucial/JJ role/NN in/IN regulating/VBG lipid/NN metabolism/NN in/IN adipocytes/NNS ,/, which/WDT could/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS genes))
          (VP (VBP play)
            (NP
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP
                      (NP (NN lipid) (NN metabolism))
                      (PP (IN in)
                        (NP
                          (NP (NNS adipocytes))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (MD could)
                                (VP (VB have)
                                  (NP
                                    (NP (NNS implications))
                                    (PP (IN for)
                                      (NP
                                        (NP (DT the) (NN development))
                                        (PP (IN of)
                                          (NP
                                            (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                                            (PP (IN for)
                                              (NP (NNS metabolic_disorders)))))))))))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
det(genes-6, these-5)
nsubj(play-7, genes-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(play-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
compound(metabolism-14, lipid-13)
dobj(regulating-12, metabolism-14)
case(adipocytes-16, in-15)
nmod:in(metabolism-14, adipocytes-16)
nsubj(have-20, adipocytes-16)
ref(adipocytes-16, which-18)
aux(have-20, could-19)
acl:relcl(adipocytes-16, have-20)
dobj(have-20, implications-21)
case(development-24, for-22)
det(development-24, the-23)
nmod:for(implications-21, development-24)
case(strategies-28, of-25)
amod(strategies-28, novel-26)
amod(strategies-28, therapeutic-27)
nmod:of(development-24, strategies-28)
case(metabolic_disorders-30, for-29)
nmod:for(strategies-28, metabolic_disorders-30)

Elucidating/VBG the/DT mechanisms/NNS of/IN oil/NN synthesis/NN in/IN plants/NNS is/VBZ crucial/JJ for/IN the/DT development/NN of/IN sustainable/JJ biofuels/NNS ./.

(ROOT
  (S
    (S
      (VP (VBG Elucidating)
        (NP
          (NP (DT the) (NNS mechanisms))
          (PP (IN of)
            (NP
              (NP (NN oil) (NN synthesis))
              (PP (IN in)
                (NP (NNS plants))))))))
    (VP (VBZ is)
      (ADJP (JJ crucial)
        (PP (IN for)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (JJ sustainable) (NNS biofuels)))))))
    (. .)))

csubj(crucial-10, Elucidating-1)
det(mechanisms-3, the-2)
dobj(Elucidating-1, mechanisms-3)
case(synthesis-6, of-4)
compound(synthesis-6, oil-5)
nmod:of(mechanisms-3, synthesis-6)
case(plants-8, in-7)
nmod:in(synthesis-6, plants-8)
cop(crucial-10, is-9)
root(ROOT-0, crucial-10)
case(development-13, for-11)
det(development-13, the-12)
nmod:for(crucial-10, development-13)
case(biofuels-16, of-14)
amod(biofuels-16, sustainable-15)
nmod:of(development-13, biofuels-16)

One/CD important/JJ enzyme/NN involved/VBN in/IN this/DT process/NN is/VBZ acetyl-coA_carboxylase/NN ,/, which/WDT catalyzes/VBZ the/DT first/JJ committed/JJ step/NN in/IN fatty_acid/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD One) (JJ important) (NN enzyme))
      (VP (VBN involved)
        (PP (IN in)
          (NP (DT this) (NN process)))))
    (VP (VBZ is)
      (NP
        (NP (NN acetyl-coA_carboxylase))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBZ catalyzes)
              (NP
                (NP (DT the) (JJ first) (JJ committed) (NN step))
                (PP (IN in)
                  (NP (JJ fatty_acid) (NNS biosynthesis)))))))))
    (. .)))

nummod(enzyme-3, One-1)
amod(enzyme-3, important-2)
nsubj(acetyl-coA_carboxylase-9, enzyme-3)
acl(enzyme-3, involved-4)
case(process-7, in-5)
det(process-7, this-6)
nmod:in(involved-4, process-7)
cop(acetyl-coA_carboxylase-9, is-8)
root(ROOT-0, acetyl-coA_carboxylase-9)
nsubj(catalyzes-12, acetyl-coA_carboxylase-9)
ref(acetyl-coA_carboxylase-9, which-11)
acl:relcl(acetyl-coA_carboxylase-9, catalyzes-12)
det(step-16, the-13)
amod(step-16, first-14)
amod(step-16, committed-15)
dobj(catalyzes-12, step-16)
case(biosynthesis-19, in-17)
amod(biosynthesis-19, fatty_acid-18)
nmod:in(step-16, biosynthesis-19)

In/IN this/DT study/NN ,/, we/PRP report/VBP the/DT characterization/NN and/CC functional/JJ analysis/NN of/IN a/DT type_2/JJ biotin/NN acyltransferase/NN gene/NN from/IN oil/NN palm/NN -LRB-/-LRB- Elaeis_guineensis_Jacq/NNP ./. -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBP report)
      (NP
        (NP (DT the) (NN characterization))
        (CC and)
        (NP
          (NP (JJ functional) (NN analysis))
          (PP (IN of)
            (NP
              (NP
                (NP (DT a) (JJ type_2) (NN biotin) (NN acyltransferase) (NN gene))
                (PP (IN from)
                  (NP (NN oil) (NN palm))))
              (PRN (-LRB- -LRB-)
                (NP (NNP Elaeis_guineensis_Jacq) (. .))
                (-RRB- -RRB-)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(report-6, study-3)
nsubj(report-6, we-5)
root(ROOT-0, report-6)
det(characterization-8, the-7)
dobj(report-6, characterization-8)
cc(characterization-8, and-9)
amod(analysis-11, functional-10)
dobj(report-6, analysis-11)
conj:and(characterization-8, analysis-11)
case(gene-17, of-12)
det(gene-17, a-13)
amod(gene-17, type_2-14)
compound(gene-17, biotin-15)
compound(gene-17, acyltransferase-16)
nmod:of(analysis-11, gene-17)
case(palm-20, from-18)
compound(palm-20, oil-19)
nmod:from(gene-17, palm-20)
appos(gene-17, Elaeis_guineensis_Jacq-22)

This/DT gene/NN encodes/VBZ a/DT protein/NN that/WDT is/VBZ responsible/JJ for/IN attaching/VBG biotin/NN to/TO acetyl-coA_carboxylase/NN ,/, which/WDT is/VBZ necessary/JJ for/IN its/PRP$ activity/NN ./.

(ROOT
  (S
    (NP (DT This) (NN gene))
    (VP (VBZ encodes)
      (NP
        (NP (DT a) (NN protein))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (S
                    (VP (VBG attaching)
                      (NP (NN biotin))
                      (PP (TO to)
                        (NP
                          (NP (NN acetyl-coA_carboxylase))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (VBZ is)
                                (ADJP (JJ necessary)
                                  (PP (IN for)
                                    (NP (PRP$ its) (NN activity))))))))))))))))))
    (. .)))

det(gene-2, This-1)
nsubj(encodes-3, gene-2)
root(ROOT-0, encodes-3)
det(protein-5, a-4)
dobj(encodes-3, protein-5)
nsubj(responsible-8, protein-5)
ref(protein-5, that-6)
cop(responsible-8, is-7)
acl:relcl(protein-5, responsible-8)
mark(attaching-10, for-9)
advcl(responsible-8, attaching-10)
dobj(attaching-10, biotin-11)
case(acetyl-coA_carboxylase-13, to-12)
nmod:to(attaching-10, acetyl-coA_carboxylase-13)
nsubj(necessary-17, acetyl-coA_carboxylase-13)
ref(acetyl-coA_carboxylase-13, which-15)
cop(necessary-17, is-16)
acl:relcl(acetyl-coA_carboxylase-13, necessary-17)
case(activity-20, for-18)
nmod:poss(activity-20, its-19)
nmod:for(necessary-17, activity-20)

We/PRP found/VBD that/IN this/DT gene/NN is/VBZ highly/RB expressed/VBN in/IN developing/VBG fruits/NNS ,/, which/WDT are/VBP the/DT primary/JJ site/NN of/IN oil/NN accumulation/NN in/IN oil/NN palm/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (DT this) (NN gene))
          (VP (VBZ is)
            (VP
              (ADVP (RB highly))
              (VBN expressed)
              (PP (IN in)
                (S
                  (VP (VBG developing)
                    (NP
                      (NP (NNS fruits))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (VBP are)
                            (NP
                              (NP (DT the) (JJ primary) (NN site))
                              (PP (IN of)
                                (NP
                                  (NP (NN oil) (NN accumulation))
                                  (PP (IN in)
                                    (NP (NN oil) (NN palm))))))))))))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(expressed-8, that-3)
det(gene-5, this-4)
nsubjpass(expressed-8, gene-5)
auxpass(expressed-8, is-6)
advmod(expressed-8, highly-7)
ccomp(found-2, expressed-8)
mark(developing-10, in-9)
advcl(expressed-8, developing-10)
dobj(developing-10, fruits-11)
nsubj(site-17, fruits-11)
ref(fruits-11, which-13)
cop(site-17, are-14)
det(site-17, the-15)
amod(site-17, primary-16)
acl:relcl(fruits-11, site-17)
case(accumulation-20, of-18)
compound(accumulation-20, oil-19)
nmod:of(site-17, accumulation-20)
case(palm-23, in-21)
compound(palm-23, oil-22)
nmod:in(accumulation-20, palm-23)

Overexpression/NN of/IN this/DT gene/NN in/IN Arabidopsis_thaliana/NNP resulted/VBD in/IN increased/VBN oil/NN content/NN and/CC altered/VBN fatty_acid/JJ composition/NN ,/, demonstrating/VBG its/PRP$ importance/NN in/IN regulating/VBG lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Overexpression))
      (PP (IN of)
        (NP
          (NP (DT this) (NN gene))
          (PP (IN in)
            (NP (NNP Arabidopsis_thaliana))))))
    (VP
      (VP (VBD resulted)
        (PP (IN in)
          (NP (VBN increased) (NN oil) (NN content))))
      (CC and)
      (VP (VBN altered)
        (NP (JJ fatty_acid) (NN composition))
        (, ,)
        (S
          (VP (VBG demonstrating)
            (NP
              (NP (PRP$ its) (NN importance))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP (NN lipid) (NN metabolism))))))))))
    (. .)))

nsubj(resulted-7, Overexpression-1)
nsubj(altered-13, Overexpression-1)
case(gene-4, of-2)
det(gene-4, this-3)
nmod:of(Overexpression-1, gene-4)
case(Arabidopsis_thaliana-6, in-5)
nmod:in(gene-4, Arabidopsis_thaliana-6)
root(ROOT-0, resulted-7)
case(content-11, in-8)
amod(content-11, increased-9)
compound(content-11, oil-10)
nmod:in(resulted-7, content-11)
cc(resulted-7, and-12)
conj:and(resulted-7, altered-13)
amod(composition-15, fatty_acid-14)
dobj(altered-13, composition-15)
advcl(altered-13, demonstrating-17)
nmod:poss(importance-19, its-18)
dobj(demonstrating-17, importance-19)
mark(regulating-21, in-20)
acl(importance-19, regulating-21)
compound(metabolism-23, lipid-22)
dobj(regulating-21, metabolism-23)

Our/PRP$ findings/NNS provide/VBP valuable/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG oil/NN synthesis/NN in/IN plants/NNS and/CC suggest/VBP potential/JJ strategies/NNS for/IN enhancing/VBG biofuel/JJ production/NN through/IN genetic_engineering/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ valuable) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP
                (NP (NN oil) (NN synthesis))
                (PP (IN in)
                  (NP (NNS plants))))))))
      (CC and)
      (VP (VBP suggest)
        (NP
          (NP (JJ potential) (NNS strategies))
          (PP (IN for)
            (S
              (VP (VBG enhancing)
                (NP (JJ biofuel) (NN production))
                (PP (IN through)
                  (NP (NN genetic_engineering)))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(provide-3, findings-2)
nsubj(suggest-16, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, valuable-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(provide-3, mechanisms-9)
acl(mechanisms-9, underlying-10)
compound(synthesis-12, oil-11)
dobj(underlying-10, synthesis-12)
case(plants-14, in-13)
nmod:in(synthesis-12, plants-14)
cc(provide-3, and-15)
conj:and(provide-3, suggest-16)
amod(strategies-18, potential-17)
dobj(suggest-16, strategies-18)
mark(enhancing-20, for-19)
acl(strategies-18, enhancing-20)
amod(production-22, biofuel-21)
dobj(enhancing-20, production-22)
case(genetic_engineering-24, through-23)
nmod:through(enhancing-20, genetic_engineering-24)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (JJ human) (NN health))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(effects-9, for-6)
nmod:poss(effects-9, their-7)
amod(effects-9, beneficial-8)
nmod:for(studied-5, effects-9)
case(health-12, on-10)
amod(health-12, human-11)
nmod:on(effects-9, health-12)

Among/IN the/DT various/JJ types/NNS of/IN omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN found/VBN to_be/VBP particularly/RB important/JJ in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN Among)
      (NP
        (NP (DT the) (JJ various) (NNS types))
        (PP (IN of)
          (NP (JJ omega-3_fatty_acids)))))
    (, ,)
    (S
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (SBAR
            (S (-LRB- -LRB-)
              (NP (NNP DHA))
              (-RRB- -RRB-)
              (VP (VBP have)
                (VP (VBN been)
                  (VP (VBN found)))))))))
    (VP (VBP to_be)
      (ADJP (RB particularly) (JJ important)
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (VBG developing) (NN coronary_heart_disease))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(types-4, Among-1)
det(types-4, the-2)
amod(types-4, various-3)
nmod:among(to_be-20, types-4)
case(omega-3_fatty_acids-6, of-5)
nmod:of(types-4, omega-3_fatty_acids-6)
csubj(to_be-20, eicosapentaenoic_acid-8)
dep(eicosapentaenoic_acid-8, EPA-10)
cc(eicosapentaenoic_acid-8, and-12)
conj:and(eicosapentaenoic_acid-8, docosahexaenoic_acid-13)
csubj(to_be-20, docosahexaenoic_acid-13)
nsubjpass(found-19, DHA-15)
aux(found-19, have-17)
auxpass(found-19, been-18)
ccomp(docosahexaenoic_acid-13, found-19)
root(ROOT-0, to_be-20)
advmod(important-22, particularly-21)
xcomp(to_be-20, important-22)
mark(reducing-24, in-23)
advcl(important-22, reducing-24)
det(risk-26, the-25)
dobj(reducing-24, risk-26)
case(coronary_heart_disease-29, of-27)
amod(coronary_heart_disease-29, developing-28)
nmod:of(risk-26, coronary_heart_disease-29)
appos(coronary_heart_disease-29, CHD-31)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Silibinin/JJ levels/NNS in/IN hyperSilibininmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Silibinin) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperSilibininmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(associated-11, that-6)
det(omega-3_fatty_acids-9, these-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nsubjpass(associated-11, omega-3_fatty_acids-9)
auxpass(associated-11, are-10)
ccomp(shown-5, associated-11)
case(levels-15, with-12)
amod(levels-15, decreased-13)
amod(levels-15, Silibinin-14)
nmod:with(associated-11, levels-15)
case(patients-18, in-16)
amod(patients-18, hyperSilibininmic-17)
nmod:in(levels-15, patients-18)

Silibinin/NNP is_a/NNP flavonoid/VBD compound/NN that/WDT has_been/VBP implicated/VBN in/IN the/DT development/NN of/IN various_diseases/NNS including/VBG liver_diseases/NNS and/CC cancer/NN ./.

(ROOT
  (S
    (NP (NNP Silibinin) (NNP is_a))
    (VP (VBD flavonoid)
      (NP
        (NP (NN compound))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN implicated)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (NNS various_diseases))
                        (VP (VBG including)
                          (NP (NNS liver_diseases)
                            (CC and)
                            (NN cancer)))))))))))))
    (. .)))

compound(is_a-2, Silibinin-1)
nsubj(flavonoid-3, is_a-2)
root(ROOT-0, flavonoid-3)
dobj(flavonoid-3, compound-4)
nsubj(has_been-6, compound-4)
ref(compound-4, that-5)
acl:relcl(compound-4, has_been-6)
dep(has_been-6, implicated-7)
case(development-10, in-8)
det(development-10, the-9)
nmod:in(implicated-7, development-10)
case(various_diseases-12, of-11)
nmod:of(development-10, various_diseases-12)
acl(various_diseases-12, including-13)
dobj(including-13, liver_diseases-14)
cc(liver_diseases-14, and-15)
dobj(including-13, cancer-16)
conj:and(liver_diseases-14, cancer-16)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP reduce/VB Silibinin/JJ levels/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN that/IN they/PRP may/MD modulate/VBP the/DT expression/NN of/IN genes/NNS involved/VBN in/IN Silibinin/NNP metabolism/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VB reduce)
              (NP (JJ Silibinin) (NNS levels))))))
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP
                    (NP (DT the) (NN expression))
                    (PP (IN of)
                      (NP
                        (NP (NNS genes))
                        (VP (VBN involved)
                          (PP (IN in)
                            (NP (NNP Silibinin) (NN metabolism))))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nmod:by(reduce-8, mechanisms-2)
nsubjpass(understood-14, mechanisms-2)
case(which-4, by-3)
ref(mechanisms-2, which-4)
nsubj(reduce-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(reduce-8, DHA-7)
acl:relcl(mechanisms-2, reduce-8)
amod(levels-10, Silibinin-9)
dobj(reduce-8, levels-10)
auxpass(understood-14, are-11)
neg(understood-14, not-12)
advmod(understood-14, fully-13)
root(ROOT-0, understood-14)
cc(understood-14, but-16)
nsubjpass(thought-19, it-17)
auxpass(thought-19, is-18)
conj:but(understood-14, thought-19)
mark(modulate-23, that-20)
nsubj(modulate-23, they-21)
aux(modulate-23, may-22)
ccomp(thought-19, modulate-23)
det(expression-25, the-24)
dobj(modulate-23, expression-25)
case(genes-27, of-26)
nmod:of(expression-25, genes-27)
acl(genes-27, involved-28)
case(metabolism-31, in-29)
compound(metabolism-31, Silibinin-30)
nmod:in(involved-28, metabolism-31)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT potential/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC other/JJ Silibinin-related_diseases/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ potential) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ other) (NNS Silibinin-related_diseases)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-16, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, a-14)
amod(strategy-16, potential-15)
ccomp(suggest-3, strategy-16)
mark(preventing-18, for-17)
advcl(strategy-16, preventing-18)
dobj(preventing-18, CHD-19)
cc(CHD-19, and-20)
amod(Silibinin-related_diseases-22, other-21)
dobj(preventing-18, Silibinin-related_diseases-22)
conj:and(CHD-19, Silibinin-related_diseases-22)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN achieving/VBG maximal/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (S
                    (VP (VBG achieving)
                      (NP (JJ maximal) (NN health) (NNS benefits)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
mark(achieving-19, for-18)
advcl(determine-15, achieving-19)
amod(benefits-22, maximal-20)
compound(benefits-22, health-21)
dobj(achieving-19, benefits-22)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN multiple/JJ comorbidities/NNS ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ multiple) (NNS comorbidities)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubjpass(associated-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
acl:relcl(metabolic_disorder-4, associated-7)
case(comorbidities-10, with-8)
amod(comorbidities-10, multiple-9)
nmod:with(associated-7, comorbidities-10)

The/DT development/NN of/IN obesity/NN is/VBZ influenced/VBN by/IN various/JJ factors/NNS ,/, including/VBG genetic/JJ and/CC environmental/JJ factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN development))
      (PP (IN of)
        (NP (NN obesity))))
    (VP (VBZ is)
      (VP (VBN influenced)
        (PP (IN by)
          (NP
            (NP (JJ various) (NNS factors))
            (, ,)
            (VP (VBG including)
              (NP
                (ADJP (JJ genetic)
                  (CC and)
                  (JJ environmental))
                (NNS factors)))))))
    (. .)))

det(development-2, The-1)
nsubjpass(influenced-6, development-2)
case(obesity-4, of-3)
nmod:of(development-2, obesity-4)
auxpass(influenced-6, is-5)
root(ROOT-0, influenced-6)
case(factors-9, by-7)
amod(factors-9, various-8)
nmod:by(influenced-6, factors-9)
acl(factors-9, including-11)
amod(factors-15, genetic-12)
cc(genetic-12, and-13)
conj:and(genetic-12, environmental-14)
amod(factors-15, environmental-14)
dobj(including-11, factors-15)

One/CD of/IN the/DT key/JJ factors/NNS in/IN the/DT development/NN of/IN obesity/NN is/VBZ the/DT hypersecretion/NN of/IN HMG-CoA_reductase_degradation_1/NNS -LRB-/-LRB- HMGCRD1/NNP -RRB-/-RRB- by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ key) (NNS factors))
          (PP (IN in)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (NN obesity))))))))
    (VP (VBZ is)
      (NP
        (NP
          (NP (DT the) (NN hypersecretion))
          (PP (IN of)
            (NP (NNS HMG-CoA_reductase_degradation_1))))
        (PRN (-LRB- -LRB-)
          (NP (NNP HMGCRD1))
          (-RRB- -RRB-)))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (. .)))

nsubj(hypersecretion-13, One-1)
case(factors-5, of-2)
det(factors-5, the-3)
amod(factors-5, key-4)
nmod:of(One-1, factors-5)
case(development-8, in-6)
det(development-8, the-7)
nmod:in(factors-5, development-8)
case(obesity-10, of-9)
nmod:of(development-8, obesity-10)
cop(hypersecretion-13, is-11)
det(hypersecretion-13, the-12)
root(ROOT-0, hypersecretion-13)
case(HMG-CoA_reductase_degradation_1-15, of-14)
nmod:of(hypersecretion-13, HMG-CoA_reductase_degradation_1-15)
appos(hypersecretion-13, HMGCRD1-17)
case(pancreas-21, by-19)
det(pancreas-21, the-20)
nmod:by(hypersecretion-13, pancreas-21)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN HMGCRD1/NNP by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ LS-102/NN on/IN the/DT secretion/NN of/IN HMGCRD1/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NNP HMGCRD1)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN LS-102)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP HMGCRD1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(HMGCRD1-14, of-13)
nmod:of(hypersecretion-12, HMGCRD1-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(LS-102-30, 10-28)
amod(LS-102-30, mmol/L-29)
nmod:of(effects-22, LS-102-30)
conj:and(glucose-26, LS-102-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
compound(and_insulin-36, HMGCRD1-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
appos(genetically_obese-42, fa/fa-44)
cc(genetically_obese-42, and-46)
amod(rats-53, lean-47)
dep(lean-47, Fa-49)
nmod:from(pancreata-40, rats-53)
conj:and(genetically_obese-42, rats-53)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN the/DT secretion/NN of/IN HMGCRD1/NNP in/IN response/NN to/TO glucose/NN and/CC LS-102/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN secretion))
                  (PP (IN of)
                    (NP (NNP HMGCRD1))))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (NN glucose)
                    (CC and)
                    (NN LS-102)))))
            (PP (IN in)
              (NP (JJ obese) (NNS rats)))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
det(secretion-12, the-11)
nmod:in(increase-9, secretion-12)
case(HMGCRD1-14, of-13)
nmod:of(secretion-12, HMGCRD1-14)
case(response-16, in-15)
nmod:in(was-6, response-16)
case(glucose-18, to-17)
nmod:to(response-16, glucose-18)
cc(glucose-18, and-19)
nmod:to(response-16, LS-102-20)
conj:and(glucose-18, LS-102-20)
case(rats-23, in-21)
amod(rats-23, obese-22)
nmod:in(was-6, rats-23)
case(rats-27, compared-24)
mwe(compared-24, to-25)
amod(rats-27, lean-26)
advcl(was-6, rats-27)

In/IN addition/NN ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN and/CC LS-102/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NN glucose)
              (CC and)
              (NN LS-102)))))
      (PP (IN in)
        (NP
          (NP (JJ obese) (NNS rats))
          (VP (VBN compared)
            (PP (TO to)
              (NP (JJ lean) (NNS rats)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(observed-5, addition-2)
nsubj(observed-5, we-4)
root(ROOT-0, observed-5)
det(decrease-8, a-6)
amod(decrease-8, significant-7)
dobj(observed-5, decrease-8)
case(insulin_secretion-10, in-9)
nmod:in(decrease-8, insulin_secretion-10)
case(response-12, in-11)
nmod:in(observed-5, response-12)
case(glucose-14, to-13)
nmod:to(response-12, glucose-14)
cc(glucose-14, and-15)
nmod:to(response-12, LS-102-16)
conj:and(glucose-14, LS-102-16)
case(rats-19, in-17)
amod(rats-19, obese-18)
nmod:in(observed-5, rats-19)
acl(rats-19, compared-20)
case(rats-23, to-21)
amod(rats-23, lean-22)
nmod:to(compared-20, rats-23)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN HMGCRD1/NNP by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/JJ and_insulin/NN resistance/NN ,/, which/WDT could/MD have/VB implications/NNS for/IN the/DT treatment/NN and/CC prevention/NN of/IN obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP HMGCRD1)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (JJ obesity) (NN and_insulin) (NN resistance))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD could)
                              (VP (VB have)
                                (NP
                                  (NP (NNS implications))
                                  (PP (IN for)
                                    (NP
                                      (NP (DT the) (NN treatment)
                                        (CC and)
                                        (NN prevention))
                                      (PP (IN of)
                                        (NP (JJ obesity-related) (NNS metabolic_disorders))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(HMGCRD1-7, of-6)
nmod:of(hypersecretion-5, HMGCRD1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(resistance-21, of-18)
amod(resistance-21, obesity-19)
compound(resistance-21, and_insulin-20)
nmod:of(development-17, resistance-21)
nsubj(have-25, resistance-21)
ref(resistance-21, which-23)
aux(have-25, could-24)
acl:relcl(resistance-21, have-25)
dobj(have-25, implications-26)
case(treatment-29, for-27)
det(treatment-29, the-28)
nmod:for(implications-26, treatment-29)
cc(treatment-29, and-30)
nmod:for(implications-26, prevention-31)
conj:and(treatment-29, prevention-31)
case(metabolic_disorders-34, of-32)
amod(metabolic_disorders-34, obesity-related-33)
nmod:of(treatment-29, metabolic_disorders-34)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ dietary/JJ components/NNS that/WDT have/VBP been/VBN linked/VBN to/TO numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (JJ dietary) (NNS components))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(components-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-17, are-14)
amod(components-17, essential-15)
amod(components-17, dietary-16)
root(ROOT-0, components-17)
nsubjpass(linked-21, components-17)
ref(components-17, that-18)
aux(linked-21, have-19)
auxpass(linked-21, been-20)
acl:relcl(components-17, linked-21)
case(benefits-25, to-22)
amod(benefits-25, numerous-23)
compound(benefits-25, health-24)
nmod:to(linked-21, benefits-25)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN gadobenate_dimeglumine/JJ levels/NNS in/IN hypergadobenate/JJ dimegluminemic/JJ patients/NNS ,/, indicating/VBG their/PRP$ potential/JJ role/NN in/IN reducing/VBG the/DT risk/NN of/IN gadolinium/NN deposition_disease/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ gadobenate_dimeglumine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hypergadobenate) (JJ dimegluminemic) (NNS patients))
                        (, ,)
                        (VP (VBG indicating)
                          (NP
                            (NP (PRP$ their) (JJ potential) (NN role))
                            (PP (IN in)
                              (S
                                (VP (VBG reducing)
                                  (NP
                                    (NP (DT the) (NN risk))
                                    (PP (IN of)
                                      (NP (NN gadolinium) (NN deposition_disease)))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, gadobenate_dimeglumine-13)
nmod:with(associated-10, levels-14)
case(patients-18, in-15)
amod(patients-18, hypergadobenate-16)
amod(patients-18, dimegluminemic-17)
nmod:in(levels-14, patients-18)
acl(patients-18, indicating-20)
nmod:poss(role-23, their-21)
amod(role-23, potential-22)
dobj(indicating-20, role-23)
mark(reducing-25, in-24)
acl(role-23, reducing-25)
det(risk-27, the-26)
dobj(reducing-25, risk-27)
case(deposition_disease-30, of-28)
compound(deposition_disease-30, gadolinium-29)
nmod:of(risk-27, deposition_disease-30)

Moreover/RB ,/, clinical/JJ trials/NNS and/CC observational/JJ studies/NNS have/VBP consistently/RB shown/VBN that/IN EPA/NNP and/CC DHA/NNP consumption/NN is/VBZ inversely/RB associated/VBN with/IN the/DT risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (JJ clinical) (NNS trials))
      (CC and)
      (NP (JJ observational) (NNS studies)))
    (VP (VBP have)
      (VP
        (ADVP (RB consistently))
        (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (ADJP (NNP EPA)
                (CC and)
                (NNP DHA))
              (NN consumption))
            (VP (VBZ is) (RB inversely)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (VP (VB coronary_heart_disease)
                            (NP
                              (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                              (, ,)
                              (NP
                                (NP (DT a) (VBG leading) (NN cause))
                                (PP (IN of)
                                  (NP (NN mortality)))))
                            (ADVP (RB worldwide))))))))))))))
    (. .)))

advmod(shown-10, Moreover-1)
amod(trials-4, clinical-3)
nsubj(shown-10, trials-4)
cc(trials-4, and-5)
amod(studies-7, observational-6)
conj:and(trials-4, studies-7)
nsubj(shown-10, studies-7)
aux(shown-10, have-8)
advmod(shown-10, consistently-9)
root(ROOT-0, shown-10)
mark(associated-18, that-11)
amod(consumption-15, EPA-12)
cc(EPA-12, and-13)
conj:and(EPA-12, DHA-14)
amod(consumption-15, DHA-14)
nsubjpass(associated-18, consumption-15)
auxpass(associated-18, is-16)
advmod(associated-18, inversely-17)
ccomp(shown-10, associated-18)
case(risk-21, with-19)
det(risk-21, the-20)
nmod:with(associated-18, risk-21)
mark(developing-23, of-22)
acl(risk-21, developing-23)
xcomp(developing-23, coronary_heart_disease-24)
dobj(coronary_heart_disease-24, CHD-26)
det(cause-31, a-29)
amod(cause-31, leading-30)
appos(CHD-26, cause-31)
case(mortality-33, of-32)
nmod:of(cause-31, mortality-33)
advmod(coronary_heart_disease-24, worldwide-34)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/JJ may/MD hold/VB promise/NN as/IN a/DT safe/JJ and/CC effective/JJ strategy/NN for/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP ,/, as/RB well/RB as/IN other/JJ diseases/NNS associated/VBN with/IN gadolinium/NN toxicity/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB hold)
              (NP (NN promise))
              (PP (IN as)
                (NP
                  (NP (DT a)
                    (ADJP (JJ safe)
                      (CC and)
                      (JJ effective))
                    (NN strategy))
                  (PP (IN for)
                    (NP
                      (NP
                        (NP (DT the) (NN prevention)
                          (CC and)
                          (NN management))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (, ,)
                      (CONJP (RB as) (RB well) (IN as))
                      (NP
                        (NP (JJ other) (NNS diseases))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (NN gadolinium) (NN toxicity))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(hold-7, that-4)
nsubj(hold-7, omega-3_fatty_acids-5)
aux(hold-7, may-6)
ccomp(suggest-3, hold-7)
dobj(hold-7, promise-8)
case(strategy-14, as-9)
det(strategy-14, a-10)
amod(strategy-14, safe-11)
cc(safe-11, and-12)
conj:and(safe-11, effective-13)
amod(strategy-14, effective-13)
nmod:as(hold-7, strategy-14)
case(prevention-17, for-15)
det(prevention-17, the-16)
nmod:for(strategy-14, prevention-17)
cc(prevention-17, and-18)
nmod:for(strategy-14, management-19)
conj:and(prevention-17, management-19)
case(CHD-21, of-20)
nmod:of(prevention-17, CHD-21)
cc(prevention-17, as-23)
mwe(as-23, well-24)
mwe(as-23, as-25)
amod(diseases-27, other-26)
nmod:for(strategy-14, diseases-27)
conj:and(prevention-17, diseases-27)
acl(diseases-27, associated-28)
case(toxicity-31, with-29)
compound(toxicity-31, gadolinium-30)
nmod:with(associated-28, toxicity-31)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS exert/VBP their/PRP$ cardioprotective/JJ effects/NNS and/CC to/TO determine/VB optimal/JJ dosing/JJ regimens/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (DT these) (NNS fatty_acids))
                      (VP (VBP exert)
                        (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (JJ dosing) (NNS regimens))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
mark(exert-14, by-10)
dobj(exert-14, which-11)
det(fatty_acids-13, these-12)
nsubj(exert-14, fatty_acids-13)
advcl(elucidate-6, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, cardioprotective-16)
dobj(exert-14, effects-17)
cc(elucidate-6, and-18)
mark(determine-20, to-19)
ccomp(needed-4, determine-20)
conj:and(elucidate-6, determine-20)
amod(regimens-23, optimal-21)
amod(regimens-23, dosing-22)
dobj(determine-20, regimens-23)
case(populations-27, for-24)
amod(populations-27, different-25)
amod(populations-27, patient-26)
nmod:for(regimens-23, populations-27)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(studied-25, have-22)
auxpass(studied-25, been-23)
advmod(studied-25, extensively-24)
root(ROOT-0, studied-25)
case(benefits-30, for-26)
nmod:poss(benefits-30, their-27)
amod(benefits-30, potential-28)
compound(benefits-30, health-29)
nmod:for(studied-25, benefits-30)

Recent/JJ evidence/NN suggests/VBZ that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Pentostam/NNP levels/NNS in/IN hyperPentostammic/JJ patients/NNS and/CC a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (VBP are)
            (VP (VBN associated)
              (PP (IN with)
                (NP (VBN decreased) (NNP Pentostam) (NNS levels)))
              (PP (IN in)
                (NP
                  (NP (JJ hyperPentostammic) (NNS patients))
                  (CC and)
                  (NP
                    (NP
                      (NP (DT a) (VBN reduced) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(evidence-2, Recent-1)
nsubj(suggests-3, evidence-2)
root(ROOT-0, suggests-3)
mark(associated-8, that-4)
det(fatty_acids-6, these-5)
nsubjpass(associated-8, fatty_acids-6)
auxpass(associated-8, are-7)
ccomp(suggests-3, associated-8)
case(levels-12, with-9)
amod(levels-12, decreased-10)
compound(levels-12, Pentostam-11)
nmod:with(associated-8, levels-12)
case(patients-15, in-13)
amod(patients-15, hyperPentostammic-14)
nmod:in(associated-8, patients-15)
cc(patients-15, and-16)
det(risk-19, a-17)
amod(risk-19, reduced-18)
nmod:in(associated-8, risk-19)
conj:and(patients-15, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB their/PRP$ anti-inflammatory/JJ properties/NNS ,/, ability/NN to/TO modulate/VBP lipid/NN metabolism/NN ,/, and/CC influence/NN on/IN cardiac/JJ function/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP
        (VP (VBP are)
          (ADJP (RB not) (RB fully) (VBN understood)))
        (, ,)
        (CC but)
        (VP (MD may)
          (VP (VB involve)
            (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties))))))
    (, ,)
    (NP (NN ability)
      (S
        (VP (TO to))))
    (VP (VBP modulate)
      (NP
        (NP (NN lipid) (NN metabolism))
        (, ,)
        (CC and)
        (NP
          (NP (NN influence))
          (PP (IN on)
            (NP (JJ cardiac) (NN function))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
ccomp(modulate-20, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
ccomp(modulate-20, involve-13)
nmod:poss(properties-16, their-14)
amod(properties-16, anti-inflammatory-15)
dobj(involve-13, properties-16)
nsubj(modulate-20, ability-18)
acl(ability-18, to-19)
root(ROOT-0, modulate-20)
compound(metabolism-22, lipid-21)
dobj(modulate-20, metabolism-22)
cc(metabolism-22, and-24)
dobj(modulate-20, influence-25)
conj:and(metabolism-22, influence-25)
case(function-28, on-26)
amod(function-28, cardiac-27)
nmod:on(influence-25, function-28)

EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN shown/VBN to/TO improve/VB cognitive/JJ function/NN ,/, reduce/VB inflammation/NN in/IN rheumatoid_arthritis/JJ patients/NNS ,/, and/CC enhance/VB insulin_sensitivity/RB in/IN individuals/NNS with/IN type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (JJ cognitive) (NN function)))
                (, ,)
                (VP (VB reduce)
                  (NP
                    (NP (NN inflammation))
                    (PP (IN in)
                      (NP (JJ rheumatoid_arthritis) (NNS patients)))))
                (, ,)
                (CC and)
                (VP (VB enhance)
                  (ADVP (RB insulin_sensitivity))
                  (PP (IN in)
                    (NP
                      (NP (NNS individuals))
                      (PP (IN with)
                        (NP (NNS type_2_diabetes))))))))))))
    (. .)))

nsubjpass(shown-7, EPA-1)
nsubj:xsubj(improve-9, EPA-1)
nsubj:xsubj(reduce-13, EPA-1)
nsubj:xsubj(enhance-20, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(shown-7, DHA-3)
nsubj:xsubj(improve-9, DHA-3)
aux(shown-7, have-4)
advmod(shown-7, also-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
amod(function-11, cognitive-10)
dobj(improve-9, function-11)
xcomp(shown-7, reduce-13)
conj:and(improve-9, reduce-13)
dobj(reduce-13, inflammation-14)
case(patients-17, in-15)
amod(patients-17, rheumatoid_arthritis-16)
nmod:in(inflammation-14, patients-17)
cc(improve-9, and-19)
xcomp(shown-7, enhance-20)
conj:and(improve-9, enhance-20)
advmod(enhance-20, insulin_sensitivity-21)
case(individuals-23, in-22)
nmod:in(enhance-20, individuals-23)
case(type_2_diabetes-25, with-24)
nmod:with(individuals-23, type_2_diabetes-25)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD have/VB important/JJ health/NN benefits/NNS for/IN a/DT wide/JJ range/NN of/IN individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ important) (NN health) (NNS benefits))
                (PP (IN for)
                  (NP
                    (NP (DT a) (JJ wide) (NN range))
                    (PP (IN of)
                      (NP (NNS individuals)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-18, that-4)
csubj(have-18, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(sources-14, through-12)
amod(sources-14, dietary-13)
nmod:through(increasing-5, sources-14)
cc(sources-14, or-15)
nmod:through(increasing-5, supplementation-16)
conj:or(sources-14, supplementation-16)
aux(have-18, may-17)
ccomp(suggest-3, have-18)
amod(benefits-21, important-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)
case(range-25, for-22)
det(range-25, a-23)
amod(range-25, wide-24)
nmod:for(benefits-21, range-25)
case(individuals-27, of-26)
nmod:of(range-25, individuals-27)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG the/DT effects/NNS of/IN these/DT fatty_acids/NNS and/CC to/TO optimize/VB their/PRP$ use/NN in/IN the/DT prevention/NN and/CC treatment/NN of/IN various_diseases/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (NNS effects))
                      (PP (IN of)
                        (NP (DT these) (NNS fatty_acids))))))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP
                  (NP (PRP$ their) (NN use))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN prevention)
                        (CC and)
                        (NN treatment))
                      (PP (IN of)
                        (NP (NNS various_diseases))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, the-11)
dobj(underlying-10, effects-12)
case(fatty_acids-15, of-13)
det(fatty_acids-15, these-14)
nmod:of(effects-12, fatty_acids-15)
cc(elucidate-7, and-16)
mark(optimize-18, to-17)
ccomp(needed-4, optimize-18)
conj:and(elucidate-7, optimize-18)
nmod:poss(use-20, their-19)
dobj(optimize-18, use-20)
case(prevention-23, in-21)
det(prevention-23, the-22)
nmod:in(use-20, prevention-23)
cc(prevention-23, and-24)
nmod:in(use-20, treatment-25)
conj:and(prevention-23, treatment-25)
case(various_diseases-27, of-26)
nmod:of(prevention-23, various_diseases-27)

This/DT study/NN aimed/VBD to/TO evaluate/VB the/DT efficacy/NN of/IN Renaline/NNP in/IN reducing/VBG the/DT risk/NN of/IN Acute_Pyelonephritis/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN efficacy))
              (PP (IN of)
                (NP (NNP Renaline))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NNP Acute_Pyelonephritis))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(evaluate-5, study-2)
root(ROOT-0, aimed-3)
mark(evaluate-5, to-4)
xcomp(aimed-3, evaluate-5)
det(efficacy-7, the-6)
dobj(evaluate-5, efficacy-7)
case(Renaline-9, of-8)
nmod:of(efficacy-7, Renaline-9)
mark(reducing-11, in-10)
advcl(evaluate-5, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(Acute_Pyelonephritis-15, of-14)
nmod:of(risk-13, Acute_Pyelonephritis-15)
nmod:of(risk-13, photophobia-17)
conj:and(Acute_Pyelonephritis-15, photophobia-17)
cc(Acute_Pyelonephritis-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(Acute_Pyelonephritis-15, phonophobia-20)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS with/IN a/DT history/NN of/IN urinary_tract_infections/NNS ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP (NNS patients)))))
        (PP (IN with)
          (NP
            (NP (DT a) (NN history))
            (PP (IN of)
              (NP (NNS urinary_tract_infections)))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(group-12, on-10)
det(group-12, a-11)
nmod:on(conducted-9, group-12)
case(patients-14, of-13)
nmod:of(group-12, patients-14)
case(history-17, with-15)
det(history-17, a-16)
nmod:with(conducted-9, history-17)
case(urinary_tract_infections-19, of-18)
nmod:of(history-17, urinary_tract_infections-19)

At_2/JJ h/NN after/IN dosing/VBG ,/, Renaline/NNP was/VBD found/VBD to/TO significantly/RB reduce/VB the/DT risk/NN of/IN Acute_Pyelonephritis/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Renaline))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNPS Acute_Pyelonephritis))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(h-2, At_2-1)
dep(found-8, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubjpass(found-8, Renaline-6)
nsubj:xsubj(reduce-11, Renaline-6)
nsubj(photophobia-31, Renaline-6)
nsubj(phonophobia-48, Renaline-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(Acute_Pyelonephritis-15, of-14)
nmod:of(risk-13, Acute_Pyelonephritis-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-8, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-8, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-8, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-8, and-47)
conj:and(found-8, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-8, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT findings/NNS suggest/VBP that/IN Renaline/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN patients/NNS with/IN urinary_tract_infections/NNS who/WP are/VBP at/IN risk/NN for/IN developing/VBG Acute_Pyelonephritis/NNS and/CC associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Renaline))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP
                        (NP (NNS urinary_tract_infections))
                        (SBAR
                          (WHNP (WP who))
                          (S
                            (VP (VBP are)
                              (PP (IN at)
                                (NP
                                  (NP (NN risk))
                                  (PP (IN for)
                                    (NP
                                      (NP (VBG developing) (NNS Acute_Pyelonephritis))
                                      (CC and)
                                      (NP (VBN associated) (NNS symptoms)))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Renaline-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(urinary_tract_infections-15, with-14)
nmod:with(patients-13, urinary_tract_infections-15)
nsubj(risk-19, urinary_tract_infections-15)
ref(urinary_tract_infections-15, who-16)
cop(risk-19, are-17)
case(risk-19, at-18)
acl:relcl(urinary_tract_infections-15, risk-19)
case(Acute_Pyelonephritis-22, for-20)
amod(Acute_Pyelonephritis-22, developing-21)
nmod:for(risk-19, Acute_Pyelonephritis-22)
cc(Acute_Pyelonephritis-22, and-23)
amod(symptoms-25, associated-24)
nmod:for(risk-19, symptoms-25)
conj:and(Acute_Pyelonephritis-22, symptoms-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG the/DT observed/JJ effects/NNS of/IN Renaline/NNP ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ observed) (NNS effects))
                      (PP (IN of)
                        (NP (NNP Renaline))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, potential-12)
dobj(explore-10, mechanisms-13)
acl(mechanisms-13, underlying-14)
det(effects-17, the-15)
amod(effects-17, observed-16)
dobj(underlying-14, effects-17)
case(Renaline-19, of-18)
nmod:of(effects-17, Renaline-19)

This/DT study/NN aimed/VBD to/TO investigate/VB the/DT effects/NNS of/IN ZJ43/NNP administration/NN during/IN low/JJ and/CC high-intensity/JJ exercise/NN on/IN GluR2Q/JJ reduction/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NNP ZJ43) (NN administration))))
            (PP (IN during)
              (NP
                (ADJP (JJ low)
                  (CC and)
                  (JJ high-intensity))
                (NN exercise)))
            (PP (IN on)
              (NP (JJ GluR2Q) (NN reduction)))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effects-7, the-6)
dobj(investigate-5, effects-7)
case(administration-10, of-8)
compound(administration-10, ZJ43-9)
nmod:of(effects-7, administration-10)
case(exercise-15, during-11)
amod(exercise-15, low-12)
cc(low-12, and-13)
conj:and(low-12, high-intensity-14)
amod(exercise-15, high-intensity-14)
nmod:during(investigate-5, exercise-15)
case(reduction-18, on-16)
amod(reduction-18, GluR2Q-17)
nmod:on(investigate-5, reduction-18)

The/DT results/NNS showed/VBD that/IN the/DT reduction/NN in/IN GluR2Q/NNS was/VBD attenuated/VBN during/IN low-intensity/JJ exercise/NN -LRB-/-LRB- -5/CD %/NN ,/, P/NNP </VBP 0.001/CD -RRB-/-RRB- ,/, indicating/VBG that/IN ZJ43/NNP had/VBD a/DT protective/JJ effect/NN on/IN the/DT brain/NN under/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN reduction))
            (PP (IN in)
              (NP (NNS GluR2Q))))
          (VP (VBD was)
            (VP (VBN attenuated)
              (PP (IN during)
                (NP (JJ low-intensity) (NN exercise)))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD -5) (NN %))
                  (, ,)
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.001))))
                (-RRB- -RRB-))))))
      (, ,)
      (S
        (VP (VBG indicating)
          (SBAR (IN that)
            (S
              (NP (NNP ZJ43))
              (VP (VBD had)
                (NP
                  (NP (DT a) (JJ protective) (NN effect))
                  (PP (IN on)
                    (NP (DT the) (NN brain))))
                (PP (IN under)
                  (NP (DT this) (NN condition)))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(attenuated-10, that-4)
det(reduction-6, the-5)
nsubjpass(attenuated-10, reduction-6)
case(GluR2Q-8, in-7)
nmod:in(reduction-6, GluR2Q-8)
auxpass(attenuated-10, was-9)
ccomp(showed-3, attenuated-10)
case(exercise-13, during-11)
amod(exercise-13, low-intensity-12)
nmod:during(attenuated-10, exercise-13)
nummod(%-16, -5-15)
nsubj(<-19, %-16)
nsubj(<-19, P-18)
parataxis(attenuated-10, <-19)
dobj(<-19, 0.001-20)
xcomp(showed-3, indicating-23)
mark(had-26, that-24)
nsubj(had-26, ZJ43-25)
ccomp(indicating-23, had-26)
det(effect-29, a-27)
amod(effect-29, protective-28)
dobj(had-26, effect-29)
case(brain-32, on-30)
det(brain-32, the-31)
nmod:on(effect-29, brain-32)
case(condition-35, under-33)
det(condition-35, this-34)
nmod:under(had-26, condition-35)

However/RB ,/, during/IN high-intensity/JJ exercise/NN ,/, the/DT reduction/NN in/IN GluR2Q/NNS was/VBD abolished/VBN -LRB-/-LRB- -3/CD %/NN ,/, P/RB =/SYM not/RB significant/JJ -RRB-/-RRB- ,/, suggesting/VBG that/IN ZJ43/NNP was/VBD not/RB effective/JJ in/IN preventing/VBG GluR2Q/JJ reduction/NN under/IN this/DT condition/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN during)
      (NP (JJ high-intensity) (NN exercise)))
    (, ,)
    (NP
      (NP (DT the) (NN reduction))
      (PP (IN in)
        (NP (NNS GluR2Q))))
    (VP (VBD was)
      (ADJP (VBN abolished)
        (PRN (-LRB- -LRB-)
          (FRAG
            (NP
              (NP (CD -3) (NN %))
              (, ,)
              (ADJP (RB P)))
            (X
              (X (SYM =))
              (ADJP (RB not) (JJ significant))))
          (-RRB- -RRB-)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (NNP ZJ43))
              (VP (VBD was)
                (ADJP (RB not) (JJ effective)
                  (PP (IN in)
                    (S
                      (VP (VBG preventing)
                        (NP (JJ GluR2Q) (NN reduction))
                        (PP (IN under)
                          (NP (DT this) (NN condition)))))))))))))
    (. .)))

advmod(abolished-12, However-1)
case(exercise-5, during-3)
amod(exercise-5, high-intensity-4)
nmod:during(abolished-12, exercise-5)
det(reduction-8, the-7)
nsubjpass(abolished-12, reduction-8)
case(GluR2Q-10, in-9)
nmod:in(reduction-8, GluR2Q-10)
auxpass(abolished-12, was-11)
root(ROOT-0, abolished-12)
nummod(%-15, -3-14)
dep(abolished-12, %-15)
amod(%-15, P-17)
dep(significant-20, =-18)
neg(significant-20, not-19)
dep(%-15, significant-20)
xcomp(abolished-12, suggesting-23)
mark(effective-28, that-24)
nsubj(effective-28, ZJ43-25)
cop(effective-28, was-26)
neg(effective-28, not-27)
ccomp(suggesting-23, effective-28)
mark(preventing-30, in-29)
advcl(effective-28, preventing-30)
amod(reduction-32, GluR2Q-31)
dobj(preventing-30, reduction-32)
case(condition-35, under-33)
det(condition-35, this-34)
nmod:under(preventing-30, condition-35)

Additionally/RB ,/, it/PRP was/VBD found/VBN that/IN PaCO2/NNS decreased/VBD 7/CD %/NN -LRB-/-LRB- P/NNP </VBD 0.05/CD -RRB-/-RRB- and/CC CMRO2/NNP increased/VBD 17/CD %/NN -LRB-/-LRB- P/NNP </VBD 0.05/CD -RRB-/-RRB- during/IN high-intensity/JJ exercise/NN ,/, which/WDT may/MD have/VB contributed/VBN to/TO the/DT lack/NN of/IN effect/NN of/IN ZJ43/NNP on/IN GluR2Q/JJ reduction/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (S
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN found)
          (SBAR (IN that)
            (S
              (NP (NNS PaCO2))
              (VP (VBD decreased)
                (NP (CD 7) (NN %))))))))
    (PRN (-LRB- -LRB-)
      (S
        (NP (NNP P))
        (VP (VBD <)
          (NP (CD 0.05))))
      (-RRB- -RRB-))
    (CC and)
    (S
      (NP (NNP CMRO2))
      (VP (VBD increased)
        (NP (CD 17) (NN %))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNP P))
            (VP (VBD <)
              (NP (CD 0.05))))
          (-RRB- -RRB-))
        (PP (IN during)
          (NP
            (NP (JJ high-intensity) (NN exercise))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (MD may)
                  (VP (VB have)
                    (VP (VBN contributed)
                      (PP (TO to)
                        (NP
                          (NP (DT the) (NN lack))
                          (PP (IN of)
                            (NP
                              (NP (NN effect))
                              (PP (IN of)
                                (NP (NNP ZJ43)))))))
                      (PP (IN on)
                        (NP (JJ GluR2Q) (NN reduction))))))))))))
    (. .)))

advmod(found-5, Additionally-1)
nsubjpass(found-5, it-3)
auxpass(found-5, was-4)
root(ROOT-0, found-5)
mark(decreased-8, that-6)
nsubj(decreased-8, PaCO2-7)
ccomp(found-5, decreased-8)
nummod(%-10, 7-9)
dobj(decreased-8, %-10)
nsubj(<-13, P-12)
dep(found-5, <-13)
dobj(<-13, 0.05-14)
cc(found-5, and-16)
nsubj(increased-18, CMRO2-17)
conj:and(found-5, increased-18)
nummod(%-20, 17-19)
dobj(increased-18, %-20)
nsubj(<-23, P-22)
parataxis(increased-18, <-23)
dobj(<-23, 0.05-24)
case(exercise-28, during-26)
amod(exercise-28, high-intensity-27)
nmod:during(increased-18, exercise-28)
nsubj(contributed-33, exercise-28)
ref(exercise-28, which-30)
aux(contributed-33, may-31)
aux(contributed-33, have-32)
acl:relcl(exercise-28, contributed-33)
case(lack-36, to-34)
det(lack-36, the-35)
nmod:to(contributed-33, lack-36)
case(effect-38, of-37)
nmod:of(lack-36, effect-38)
case(ZJ43-40, of-39)
nmod:of(effect-38, ZJ43-40)
case(reduction-43, on-41)
amod(reduction-43, GluR2Q-42)
nmod:on(contributed-33, reduction-43)

These/DT findings/NNS provide/VBP insight/VBN into/IN the/DT potential/JJ use/NN of/IN ZJ43/NNP as/IN a/DT protective/JJ agent/NN for/IN the/DT brain/NN during/IN low-intensity/JJ exercise/NN and/CC highlight/VB the/DT need/NN for/IN further/JJ investigation/NN into/IN its/PRP$ effectiveness/NN under/IN different/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (VP (VBN insight)
          (PP (IN into)
            (NP
              (NP (DT the) (JJ potential) (NN use))
              (PP (IN of)
                (NP (NNP ZJ43)))))
          (PP (IN as)
            (NP
              (NP (DT a) (JJ protective) (NN agent))
              (PP (IN for)
                (NP (DT the) (NN brain)))))
          (PP (IN during)
            (NP (JJ low-intensity) (NN exercise)))))
      (CC and)
      (VP (VB highlight)
        (NP
          (NP (DT the) (NN need))
          (PP (IN for)
            (NP (JJ further) (NN investigation))))
        (PP (IN into)
          (NP (PRP$ its) (NN effectiveness)))
        (PP (IN under)
          (NP (JJ different) (NNS conditions)))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(highlight-22, findings-2)
root(ROOT-0, provide-3)
dep(provide-3, insight-4)
case(use-8, into-5)
det(use-8, the-6)
amod(use-8, potential-7)
nmod:into(insight-4, use-8)
case(ZJ43-10, of-9)
nmod:of(use-8, ZJ43-10)
case(agent-14, as-11)
det(agent-14, a-12)
amod(agent-14, protective-13)
nmod:as(insight-4, agent-14)
case(brain-17, for-15)
det(brain-17, the-16)
nmod:for(agent-14, brain-17)
case(exercise-20, during-18)
amod(exercise-20, low-intensity-19)
nmod:during(insight-4, exercise-20)
cc(provide-3, and-21)
conj:and(provide-3, highlight-22)
det(need-24, the-23)
dobj(highlight-22, need-24)
case(investigation-27, for-25)
amod(investigation-27, further-26)
nmod:for(need-24, investigation-27)
case(effectiveness-30, into-28)
nmod:poss(effectiveness-30, its-29)
nmod:into(highlight-22, effectiveness-30)
case(conditions-33, under-31)
amod(conditions-33, different-32)
nmod:under(highlight-22, conditions-33)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP (JJ numerous) (NN health) (NNS benefits)))))))
    (. .)))

nsubjpass(known-15, Omega-3_fatty_acids-1)
nsubj:xsubj(have-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(have-17, to-16)
xcomp(known-15, have-17)
amod(benefits-20, numerous-18)
compound(benefits-20, health-19)
dobj(have-17, benefits-20)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(associated-11, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-11, omega-3_fatty_acids-8)
aux(associated-11, may-9)
auxpass(associated-11, be-10)
ccomp(suggested-4, associated-11)
case(risk-15, with-12)
det(risk-15, a-13)
amod(risk-15, decreased-14)
nmod:with(associated-11, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

Additionally/RB ,/, hypertriaziquonemic/JJ patients/NNS have/VBP been/VBN found/VBN to/TO have/VB decreased/VBN triaziquone/JJ levels/NNS when/WRB consuming/VBG EPA/NNP and/CC DHA/NNP ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ hypertriaziquonemic) (NNS patients))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB have)
                (VP (VBN decreased)
                  (NP (JJ triaziquone) (NNS levels))
                  (SBAR
                    (WHADVP (WRB when))
                    (S
                      (VP (VBG consuming)
                        (NP (NNP EPA)
                          (CC and)
                          (NNP DHA))))))))))))
    (. .)))

advmod(found-7, Additionally-1)
amod(patients-4, hypertriaziquonemic-3)
nsubjpass(found-7, patients-4)
nsubj:xsubj(decreased-10, patients-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(decreased-10, to-8)
aux(decreased-10, have-9)
xcomp(found-7, decreased-10)
amod(levels-12, triaziquone-11)
dobj(decreased-10, levels-12)
advmod(consuming-14, when-13)
advcl(decreased-10, consuming-14)
dobj(consuming-14, EPA-15)
cc(EPA-15, and-16)
dobj(consuming-14, DHA-17)
conj:and(EPA-15, DHA-17)

Triaziquone/NNP is_a/VBZ known/VBN carcinogen/NN that/WDT has_been/VBP linked/VBN to/TO the/DT development/NN of/IN cancer/NN in/IN humans/NNS ./.

(ROOT
  (S
    (NP (NNP Triaziquone))
    (VP (VBZ is_a)
      (VP (VBN known)
        (NP
          (NP (NN carcinogen))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP has_been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN cancer)))))
                  (PP (IN in)
                    (NP (NNS humans))))))))))
    (. .)))

nsubj(is_a-2, Triaziquone-1)
root(ROOT-0, is_a-2)
dep(is_a-2, known-3)
dobj(known-3, carcinogen-4)
nsubj(has_been-6, carcinogen-4)
ref(carcinogen-4, that-5)
acl:relcl(carcinogen-4, has_been-6)
dep(has_been-6, linked-7)
case(development-10, to-8)
det(development-10, the-9)
nmod:to(linked-7, development-10)
case(cancer-12, of-11)
nmod:of(development-10, cancer-12)
case(humans-14, in-13)
nmod:in(linked-7, humans-14)

This/DT association/NN between/IN omega-3_fatty_acids/JJ and/CC decreased/VBN triaziquone/JJ levels/NNS suggests/VBZ a/DT potential/JJ protective/JJ effect/NN against/IN cancer/NN development/NN ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN association))
      (PP (IN between)
        (NP
          (ADJP (JJ omega-3_fatty_acids)
            (CC and)
            (VBN decreased))
          (JJ triaziquone) (NNS levels))))
    (VP (VBZ suggests)
      (NP
        (NP (DT a) (JJ potential) (JJ protective) (NN effect))
        (PP (IN against)
          (NP (NN cancer) (NN development)))))
    (. .)))

det(association-2, This-1)
nsubj(suggests-9, association-2)
case(levels-8, between-3)
amod(levels-8, omega-3_fatty_acids-4)
cc(omega-3_fatty_acids-4, and-5)
conj:and(omega-3_fatty_acids-4, decreased-6)
amod(levels-8, decreased-6)
amod(levels-8, triaziquone-7)
nmod:between(association-2, levels-8)
root(ROOT-0, suggests-9)
det(effect-13, a-10)
amod(effect-13, potential-11)
amod(effect-13, protective-12)
dobj(suggests-9, effect-13)
case(development-16, against-14)
compound(development-16, cancer-15)
nmod:against(effect-13, development-16)

Overall/RB ,/, increasing/VBG consumption/NN of/IN EPA/NNP and/CC DHA/NNP may/MD offer/VB several/JJ health/NN benefits/NNS ,/, including/VBG a/DT reduced/VBN risk/NN of/IN CHD/NNP and/CC potential/JJ protection/NN against/IN carcinogens/NNS such/JJ as/IN triaziquone/NN ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP
      (NP (VBG increasing) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (MD may)
      (VP (VB offer)
        (NP
          (NP (JJ several) (NN health) (NNS benefits))
          (, ,)
          (VP (VBG including)
            (NP
              (NP (DT a) (VBN reduced) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNP CHD))
                  (CC and)
                  (NP
                    (NP (JJ potential) (NN protection))
                    (PP (IN against)
                      (NP
                        (NP (NNS carcinogens))
                        (PP (JJ such) (IN as)
                          (NP (NN triaziquone)))))))))))))
    (. .)))

advmod(offer-10, Overall-1)
amod(consumption-4, increasing-3)
nsubj(offer-10, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
aux(offer-10, may-9)
root(ROOT-0, offer-10)
amod(benefits-13, several-11)
compound(benefits-13, health-12)
dobj(offer-10, benefits-13)
acl(benefits-13, including-15)
det(risk-18, a-16)
amod(risk-18, reduced-17)
dobj(including-15, risk-18)
case(CHD-20, of-19)
nmod:of(risk-18, CHD-20)
cc(CHD-20, and-21)
amod(protection-23, potential-22)
nmod:of(risk-18, protection-23)
conj:and(CHD-20, protection-23)
case(carcinogens-25, against-24)
nmod:against(protection-23, carcinogens-25)
case(triaziquone-28, such-26)
mwe(such-26, as-27)
nmod:such_as(carcinogens-25, triaziquone-28)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN for/IN their/PRP$ numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (PP (IN for)
          (NP (PRP$ their) (JJ numerous) (NN health) (NNS benefits)))))
    (. .)))

nsubjpass(known-15, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
case(benefits-20, for-16)
nmod:poss(benefits-20, their-17)
amod(benefits-20, numerous-18)
compound(benefits-20, health-19)
nmod:for(known-15, benefits-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- by/IN decreasing/VBG paxilline/JJ levels/NNS in/IN hyperpaxillinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))
                        (PP (IN by)
                          (S
                            (VP (VBG decreasing)
                              (NP
                                (NP (JJ paxilline) (NNS levels))
                                (PP (IN in)
                                  (NP (JJ hyperpaxillinemic) (NNS patients)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(play-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubj(play-9, long-chain_fatty_acids-7)
aux(play-9, may-8)
ccomp(shown-4, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(reducing-13, in-12)
acl(role-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)
mark(decreasing-23, by-22)
advcl(reducing-13, decreasing-23)
amod(levels-25, paxilline-24)
dobj(decreasing-23, levels-25)
case(patients-28, in-26)
amod(patients-28, hyperpaxillinemic-27)
nmod:in(levels-25, patients-28)

Paxilline/JJ is_a/NN protein/NN that/WDT has_been/VBP associated/VBN with/IN an/DT increased/VBN risk/NN of/IN CHD/NNP ,/, and/CC its/PRP$ reduction/NN has_been/VBP shown/VBN to_be/RB beneficial/JJ in/IN preventing/VBG the/DT onset/NN of/IN this/DT disease/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Paxilline) (NN is_a) (NN protein))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBP has_been)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (DT an) (VBN increased) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (NNP CHD))
                      (, ,)
                      (CC and)
                      (NP (PRP$ its) (NN reduction)))))))))))
    (VP (VBP has_been)
      (VP (VBN shown)
        (ADJP (RB to_be) (JJ beneficial))
        (PP (IN in)
          (S
            (VP (VBG preventing)
              (NP
                (NP (DT the) (NN onset))
                (PP (IN of)
                  (NP (DT this) (NN disease)))))))))
    (. .)))

amod(protein-3, Paxilline-1)
compound(protein-3, is_a-2)
nsubj(has_been-5, protein-3)
nsubj(has_been-17, protein-3)
ref(protein-3, that-4)
acl:relcl(protein-3, has_been-5)
dep(has_been-5, associated-6)
case(risk-10, with-7)
det(risk-10, an-8)
amod(risk-10, increased-9)
nmod:with(associated-6, risk-10)
case(CHD-12, of-11)
nmod:of(risk-10, CHD-12)
cc(CHD-12, and-14)
nmod:poss(reduction-16, its-15)
nmod:of(risk-10, reduction-16)
conj:and(CHD-12, reduction-16)
root(ROOT-0, has_been-17)
dep(has_been-17, shown-18)
advmod(beneficial-20, to_be-19)
xcomp(shown-18, beneficial-20)
mark(preventing-22, in-21)
advcl(shown-18, preventing-22)
det(onset-24, the-23)
dobj(preventing-22, onset-24)
case(disease-27, of-25)
det(disease-27, this-26)
nmod:of(onset-24, disease-27)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP reduce/VB paxilline/JJ levels/NNS are/VBP not/RB yet/RB fully/RB understood/VBN but/CC may/MD involve/VB modulation/NN of/IN inflammatory/JJ pathways/NNS and/CC regulation/NN of/IN lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS mechanisms))
    (VP
      (VP
        (PP (IN by)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (VB reduce)
                (NP (JJ paxilline) (NNS levels))))))
        (VBP are)
        (ADVP (RB not) (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP
              (NP (NN modulation))
              (PP (IN of)
                (NP (JJ inflammatory) (NNS pathways))))
            (CC and)
            (NP
              (NP (NN regulation))
              (PP (IN of)
                (NP (NN lipid) (NN metabolism))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-15, mechanisms-2)
nsubj(involve-18, mechanisms-2)
mark(reduce-8, by-3)
dobj(reduce-8, which-4)
nsubj(reduce-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(reduce-8, DHA-7)
advcl(understood-15, reduce-8)
amod(levels-10, paxilline-9)
dobj(reduce-8, levels-10)
auxpass(understood-15, are-11)
dep(yet-13, not-12)
advmod(understood-15, yet-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-16)
aux(involve-18, may-17)
conj:but(understood-15, involve-18)
dobj(involve-18, modulation-19)
case(pathways-22, of-20)
amod(pathways-22, inflammatory-21)
nmod:of(modulation-19, pathways-22)
cc(modulation-19, and-23)
dobj(involve-18, regulation-24)
conj:and(modulation-19, regulation-24)
case(metabolism-27, of-25)
compound(metabolism-27, lipid-26)
nmod:of(regulation-24, metabolism-27)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT potential/JJ therapeutic/JJ effects/NNS of/IN omega-3_fatty_acids/JJ on/IN CHD/NNP prevention/NN and/CC treatment/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS effects))
                (PP (IN of)
                  (NP
                    (ADJP (JJ omega-3_fatty_acids)
                      (PP (IN on)
                        (NP (NNP CHD))))
                    (NN prevention)
                    (CC and)
                    (NN treatment)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(effects-11, the-8)
amod(effects-11, potential-9)
amod(effects-11, therapeutic-10)
dobj(elucidate-7, effects-11)
case(prevention-16, of-12)
amod(prevention-16, omega-3_fatty_acids-13)
case(CHD-15, on-14)
nmod:on(omega-3_fatty_acids-13, CHD-15)
nmod:of(effects-11, prevention-16)
cc(prevention-16, and-17)
nmod:of(effects-11, treatment-18)
conj:and(prevention-16, treatment-18)

Nonetheless/RB ,/, these/DT findings/NNS provide/VBP a/DT promising/JJ avenue/NN for/IN the/DT development/NN of/IN new/JJ approaches/NNS to/TO managing/VBG CHD/NNP ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP provide)
      (NP
        (NP (DT a) (JJ promising) (NN avenue))
        (PP (IN for)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (JJ new) (NNS approaches))
                (PP (TO to)
                  (S
                    (VP (VBG managing)
                      (NP
                        (NP (NNP CHD))
                        (, ,)
                        (NP
                          (NP (DT a) (VBG leading) (NN cause))
                          (PP (IN of)
                            (NP (NN morbidity)
                              (CC and)
                              (NN mortality)))))
                      (ADVP (RB worldwide)))))))))))
    (. .)))

advmod(provide-5, Nonetheless-1)
det(findings-4, these-3)
nsubj(provide-5, findings-4)
root(ROOT-0, provide-5)
det(avenue-8, a-6)
amod(avenue-8, promising-7)
dobj(provide-5, avenue-8)
case(development-11, for-9)
det(development-11, the-10)
nmod:for(avenue-8, development-11)
case(approaches-14, of-12)
amod(approaches-14, new-13)
nmod:of(development-11, approaches-14)
mark(managing-16, to-15)
acl(approaches-14, managing-16)
dobj(managing-16, CHD-17)
det(cause-21, a-19)
amod(cause-21, leading-20)
appos(CHD-17, cause-21)
case(morbidity-23, of-22)
nmod:of(cause-21, morbidity-23)
cc(morbidity-23, and-24)
nmod:of(cause-21, mortality-25)
conj:and(morbidity-23, mortality-25)
advmod(managing-16, worldwide-26)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Radicicol/JJ levels/NNS in/IN hyperRadicicolmic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Radicicol) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperRadicicolmic) (NNS patients)))))
                (, ,)
                (ADVP
                  (ADVP (RB as) (RB well))
                  (PP (IN as)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, Radicicol-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperRadicicolmic-16)
nmod:in(levels-14, patients-17)
advmod(associated-10, as-19)
mwe(as-19, well-20)
case(risk-24, as-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:as(as-19, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD modulate/VBP inflammatory/JJ responses/NNS and/CC improve/VB lipid/NN metabolism/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP
                (VP (MD may)
                  (VP (VBP modulate)
                    (NP (JJ inflammatory) (NNS responses))))
                (CC and)
                (VP (VB improve)
                  (NP (NN lipid) (NN metabolism)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(modulate-21, that-16)
nsubj(modulate-21, EPA-17)
nsubj(improve-25, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
nsubj(modulate-21, DHA-19)
aux(modulate-21, may-20)
ccomp(believed-15, modulate-21)
amod(responses-23, inflammatory-22)
dobj(modulate-21, responses-23)
cc(modulate-21, and-24)
ccomp(believed-15, improve-25)
conj:and(modulate-21, improve-25)
compound(metabolism-27, lipid-26)
dobj(improve-25, metabolism-27)

Additionally/RB ,/, omega-3_fatty_acids/JJ may/MD enhance/VB endothelial/JJ function/NN and/CC reduce/VB oxidative_stress/NNS ,/, which/WDT could/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP (MD may)
      (VP
        (VP (VB enhance)
          (NP (JJ endothelial) (NN function)))
        (CC and)
        (VP (VB reduce)
          (NP
            (NP (NNS oxidative_stress))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (MD could)
                  (VP (VB contribute)
                    (PP (TO to)
                      (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))
    (. .)))

advmod(enhance-5, Additionally-1)
nsubj(enhance-5, omega-3_fatty_acids-3)
nsubj(reduce-9, omega-3_fatty_acids-3)
aux(enhance-5, may-4)
root(ROOT-0, enhance-5)
amod(function-7, endothelial-6)
dobj(enhance-5, function-7)
cc(enhance-5, and-8)
conj:and(enhance-5, reduce-9)
dobj(reduce-9, oxidative_stress-10)
nsubj(contribute-14, oxidative_stress-10)
ref(oxidative_stress-10, which-12)
aux(contribute-14, could-13)
acl:relcl(oxidative_stress-10, contribute-14)
case(effects-18, to-15)
nmod:poss(effects-18, their-16)
amod(effects-18, cardioprotective-17)
nmod:to(contribute-14, effects-18)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG Radicicol/JJ levels/NNS in/IN hyperRadicicolmic/JJ patients/NNS and/CC preventing/VBG the/DT development/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (JJ Radicicol) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hyperRadicicolmic) (NNS patients)))))
                      (CC and)
                      (VP (VBG preventing)
                        (NP
                          (NP (DT the) (NN development))
                          (PP (IN of)
                            (NP (NNP CHD))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-16, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
amod(levels-20, Radicicol-19)
dobj(reducing-18, levels-20)
case(patients-23, in-21)
amod(patients-23, hyperRadicicolmic-22)
nmod:in(levels-20, patients-23)
cc(reducing-18, and-24)
acl(strategy-16, preventing-25)
conj:and(reducing-18, preventing-25)
det(development-27, the-26)
dobj(preventing-25, development-27)
case(CHD-29, of-28)
nmod:of(development-27, CHD-29)

Inhaled/JJ bronchodilators/NNS are/VBP a/DT cornerstone/NN in/IN the/DT management/NN of/IN chronic_obstructive_pulmonary_disease/NN -LRB-/-LRB- COPD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Inhaled) (NNS bronchodilators))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN cornerstone))
        (PP (IN in)
          (NP
            (NP
              (NP (DT the) (NN management))
              (PP (IN of)
                (NP (NN chronic_obstructive_pulmonary_disease))))
            (PRN (-LRB- -LRB-)
              (NP (NNP COPD))
              (-RRB- -RRB-))))))
    (. .)))

amod(bronchodilators-2, Inhaled-1)
nsubj(cornerstone-5, bronchodilators-2)
cop(cornerstone-5, are-3)
det(cornerstone-5, a-4)
root(ROOT-0, cornerstone-5)
case(management-8, in-6)
det(management-8, the-7)
nmod:in(cornerstone-5, management-8)
case(chronic_obstructive_pulmonary_disease-10, of-9)
nmod:of(management-8, chronic_obstructive_pulmonary_disease-10)
appos(management-8, COPD-12)

Indacaterol/JJ is_a/NN novel/NN ,/, once-daily/JJ ,/, long-acting/JJ beta2-agonist/NN that/WDT has/VBZ demonstrated/VBN efficacy/RB in/IN the/DT treatment/NN of/IN COPD/NNP ./.

(ROOT
  (NP
    (NP (JJ Indacaterol) (NN is_a) (NN novel))
    (, ,)
    (NP
      (NP (JJ once-daily) (, ,) (JJ long-acting) (NN beta2-agonist))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ has)
            (VP (VBN demonstrated)
              (ADVP (RB efficacy))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN treatment))
                  (PP (IN of)
                    (NP (NNP COPD))))))))))
    (. .)))

amod(novel-3, Indacaterol-1)
compound(novel-3, is_a-2)
root(ROOT-0, novel-3)
amod(beta2-agonist-8, once-daily-5)
amod(beta2-agonist-8, long-acting-7)
appos(novel-3, beta2-agonist-8)
nsubj(demonstrated-11, beta2-agonist-8)
ref(beta2-agonist-8, that-9)
aux(demonstrated-11, has-10)
acl:relcl(beta2-agonist-8, demonstrated-11)
advmod(demonstrated-11, efficacy-12)
case(treatment-15, in-13)
det(treatment-15, the-14)
nmod:in(demonstrated-11, treatment-15)
case(COPD-17, of-16)
nmod:of(treatment-15, COPD-17)

This/DT study/NN aimed/VBD to/TO evaluate/VB the/DT effect/NN of/IN indacaterol/NN on/IN bronchospasms/NNS ,/, photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN indacaterol))))
            (PP (IN on)
              (NP
                (NP (NNS bronchospasms))
                (, ,)
                (NP (NN photophobia)
                  (CC and)
                  (NN phonophobia))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(evaluate-5, study-2)
root(ROOT-0, aimed-3)
mark(evaluate-5, to-4)
xcomp(aimed-3, evaluate-5)
det(effect-7, the-6)
dobj(evaluate-5, effect-7)
case(indacaterol-9, of-8)
nmod:of(effect-7, indacaterol-9)
case(bronchospasms-11, on-10)
nmod:on(evaluate-5, bronchospasms-11)
appos(bronchospasms-11, photophobia-13)
cc(photophobia-13, and-14)
appos(bronchospasms-11, phonophobia-15)
conj:and(photophobia-13, phonophobia-15)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN in/IN patients/NNS with/IN moderate/JJ to/TO severe/JJ COPD/NN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (NP (NNS patients)))
        (PP (IN with)
          (NP
            (ADJP (JJ moderate) (TO to) (JJ severe))
            (NN COPD)))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(patients-11, in-10)
nmod:in(conducted-9, patients-11)
case(COPD-16, with-12)
amod(severe-15, moderate-13)
dep(severe-15, to-14)
amod(COPD-16, severe-15)
nmod:with(conducted-9, COPD-16)

At_2/JJ h/NN after/IN dosing/VBG ,/, indacaterol/NN reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN indacaterol))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS bronchospasms))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, indacaterol-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(bronchospasms-11, of-10)
nmod:of(risk-9, bronchospasms-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN indacaterol/NN may/MD be/VB a/DT useful/JJ addition/NN to/TO the/DT armamentarium/NN for/IN the/DT management/NN of/IN COPD/JJ symptoms/NNS including/VBG bronchospasms/NNS and/CC sensory/JJ hypersensitivity/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN indacaterol))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ useful) (NN addition))
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN armamentarium))
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN management))
                        (PP (IN of)
                          (NP
                            (NP (JJ COPD) (NNS symptoms))
                            (PP (VBG including)
                              (NP
                                (NP (NNS bronchospasms))
                                (CC and)
                                (NP (JJ sensory) (NN hypersensitivity))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(addition-10, that-4)
nsubj(addition-10, indacaterol-5)
aux(addition-10, may-6)
cop(addition-10, be-7)
det(addition-10, a-8)
amod(addition-10, useful-9)
ccomp(suggest-3, addition-10)
case(armamentarium-13, to-11)
det(armamentarium-13, the-12)
nmod:to(addition-10, armamentarium-13)
case(management-16, for-14)
det(management-16, the-15)
nmod:for(armamentarium-13, management-16)
case(symptoms-19, of-17)
amod(symptoms-19, COPD-18)
nmod:of(management-16, symptoms-19)
case(bronchospasms-21, including-20)
nmod:including(symptoms-19, bronchospasms-21)
cc(bronchospasms-21, and-22)
amod(hypersensitivity-24, sensory-23)
nmod:including(symptoms-19, hypersensitivity-24)
conj:and(bronchospasms-21, hypersensitivity-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN this/DT medication/NN in/IN COPD/NNP patients/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP
                      (NP (DT this) (NN medication))
                      (PP (IN in)
                        (NP (NNP COPD) (NNS patients))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(evaluate-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, evaluate-10)
conj:and(confirm-6, evaluate-10)
det(safety-13, the-11)
amod(safety-13, long-term-12)
dobj(evaluate-10, safety-13)
cc(safety-13, and-14)
dobj(evaluate-10, efficacy-15)
conj:and(safety-13, efficacy-15)
case(medication-18, of-16)
det(medication-18, this-17)
nmod:of(safety-13, medication-18)
case(patients-21, in-19)
compound(patients-21, COPD-20)
nmod:in(medication-18, patients-21)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/JJ -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/JJ -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (NP
          (NP
            (NP (JJ eicosapentaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 20:5) (JJ n-3))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (NP (JJ docosahexaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 22:6) (JJ n-3))
            (-RRB- -RRB-)))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ beneficial) (NNS effects))
                (PP (IN on)
                  (NP (JJ human) (NN health)))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-25, omega-3_fatty_acids-2)
nsubj:xsubj(have-27, omega-3_fatty_acids-2)
advcl(shown-25, including-4)
dobj(including-4, eicosapentaenoic_acid-5)
dep(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
amod(eicosapentaenoic_acid-5, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dobj(including-4, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dep(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
amod(docosahexaenoic_acid-14, n-3-20)
aux(shown-25, have-23)
auxpass(shown-25, been-24)
root(ROOT-0, shown-25)
mark(have-27, to-26)
xcomp(shown-25, have-27)
amod(effects-29, beneficial-28)
dobj(have-27, effects-29)
case(health-32, on-30)
amod(health-32, human-31)
nmod:on(have-27, health-32)

Recent/JJ studies/NNS have/VBP found/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN ARA-C/NNP in/IN hyperARA-Cmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN found)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP (NNP ARA-C)))
                    (PP (IN in)
                      (NP (JJ hyperARA-Cmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(found-4, studies-2)
aux(found-4, have-3)
root(ROOT-0, found-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(found-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(ARA-C-14, of-13)
nmod:of(levels-12, ARA-C-14)
case(patients-17, in-15)
amod(patients-17, hyperARA-Cmic-16)
nmod:in(levels-12, patients-17)

ARA-C/JJ is_a/JJ chemotherapy/JJ drug/NN used/VBN to/TO treat/VB leukemia/NN ,/, and/CC high/JJ levels/NNS of/IN this/DT drug/NN can/MD lead/VB to/TO adverse/JJ side/NN effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ ARA-C) (JJ is_a) (JJ chemotherapy) (NN drug))
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB treat)
              (NP
                (NP (NN leukemia))
                (, ,)
                (CC and)
                (NP
                  (NP (JJ high) (NNS levels))
                  (PP (IN of)
                    (NP (DT this) (NN drug))))))))))
    (VP (MD can)
      (VP (VB lead)
        (PP (TO to)
          (NP (JJ adverse) (NN side) (NNS effects)))))
    (. .)))

amod(drug-4, ARA-C-1)
amod(drug-4, is_a-2)
amod(drug-4, chemotherapy-3)
nsubj(lead-17, drug-4)
acl(drug-4, used-5)
mark(treat-7, to-6)
xcomp(used-5, treat-7)
dobj(treat-7, leukemia-8)
cc(leukemia-8, and-10)
amod(levels-12, high-11)
dobj(treat-7, levels-12)
conj:and(leukemia-8, levels-12)
case(drug-15, of-13)
det(drug-15, this-14)
nmod:of(levels-12, drug-15)
aux(lead-17, can-16)
root(ROOT-0, lead-17)
case(effects-21, to-18)
amod(effects-21, adverse-19)
compound(effects-21, side-20)
nmod:to(lead-17, effects-21)

The/DT use/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD therefore/RB be/VB a/DT potential/JJ adjunct/JJ therapy/NN for/IN patients/NNS undergoing/VBG ARA-C/JJ treatment/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (JJ long-chain) (NN omega-3_fatty_acids))))
    (VP (MD may) (RB therefore)
      (VP (VB be)
        (NP (DT a) (JJ potential) (JJ adjunct) (NN therapy))
        (PP (IN for)
          (NP
            (NP (NNS patients))
            (VP (VBG undergoing)
              (NP (JJ ARA-C) (NN treatment)))))))
    (. .)))

det(use-2, The-1)
nsubj(therapy-12, use-2)
case(omega-3_fatty_acids-5, of-3)
amod(omega-3_fatty_acids-5, long-chain-4)
nmod:of(use-2, omega-3_fatty_acids-5)
aux(therapy-12, may-6)
advmod(therapy-12, therefore-7)
cop(therapy-12, be-8)
det(therapy-12, a-9)
amod(therapy-12, potential-10)
amod(therapy-12, adjunct-11)
root(ROOT-0, therapy-12)
case(patients-14, for-13)
nmod:for(therapy-12, patients-14)
acl(patients-14, undergoing-15)
amod(treatment-17, ARA-C-16)
dobj(undergoing-15, treatment-17)

In/IN addition/NN ,/, these/DT fatty_acids/NNS have/VBP also/RB been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(associated-9, addition-2)
det(fatty_acids-5, these-4)
nsubjpass(associated-9, fatty_acids-5)
aux(associated-9, have-6)
advmod(associated-9, also-7)
auxpass(associated-9, been-8)
root(ROOT-0, associated-9)
case(risk-13, with-10)
det(risk-13, a-11)
amod(risk-13, decreased-12)
nmod:with(associated-9, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
dobj(developing-15, coronary_heart_disease-16)
appos(risk-13, CHD-18)

This/DT protective/JJ effect/NN may/MD be/VB due/JJ to/TO the/DT ability/NN of/IN EPA/NNP and/CC DHA/NNP to/TO reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB lipid/NN profiles/NNS ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (NN ability))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP
                        (NP (NN inflammation))
                        (, ,)
                        (NP (JJR lower) (NN blood_pressure))
                        (, ,)))
                    (CC and)
                    (VP (VB improve)
                      (NP (NN lipid) (NNS profiles)))))))))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubj(due-6, effect-3)
aux(due-6, may-4)
cop(due-6, be-5)
root(ROOT-0, due-6)
case(ability-9, to-7)
det(ability-9, the-8)
nmod:to(due-6, ability-9)
case(EPA-11, of-10)
nmod:of(ability-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(ability-9, DHA-13)
conj:and(EPA-11, DHA-13)
mark(reduce-15, to-14)
acl(ability-9, reduce-15)
dobj(reduce-15, inflammation-16)
amod(blood_pressure-19, lower-18)
appos(inflammation-16, blood_pressure-19)
cc(reduce-15, and-21)
acl(ability-9, improve-22)
conj:and(reduce-15, improve-22)
compound(profiles-24, lipid-23)
dobj(improve-22, profiles-24)

Overall/RB ,/, the/DT consumption/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD offer/VB multiple/JJ health/NN benefits/NNS and/CC should/MD be/VB considered/VBN as/IN part/NN of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (JJ long-chain) (NN omega-3_fatty_acids))))
    (VP
      (VP (MD may)
        (VP (VB offer)
          (NP (JJ multiple) (NN health) (NNS benefits))))
      (CC and)
      (VP (MD should)
        (VP (VB be)
          (VP (VBN considered)
            (PP (IN as)
              (NP
                (NP (NN part))
                (PP (IN of)
                  (NP (DT a) (JJ healthy) (NN diet)))))))))
    (. .)))

advmod(offer-9, Overall-1)
det(consumption-4, the-3)
nsubj(offer-9, consumption-4)
nsubjpass(considered-16, consumption-4)
case(omega-3_fatty_acids-7, of-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nmod:of(consumption-4, omega-3_fatty_acids-7)
aux(offer-9, may-8)
root(ROOT-0, offer-9)
amod(benefits-12, multiple-10)
compound(benefits-12, health-11)
dobj(offer-9, benefits-12)
cc(offer-9, and-13)
aux(considered-16, should-14)
auxpass(considered-16, be-15)
conj:and(offer-9, considered-16)
case(part-18, as-17)
nmod:as(considered-16, part-18)
case(diet-22, of-19)
det(diet-22, a-20)
amod(diet-22, healthy-21)
nmod:of(part-18, diet-22)

The/DT present/JJ study/NN aimed/VBN to/TO investigate/VB the/DT possible/JJ mechanisms/NNS underlying/VBG the/DT early/JJ effect/NN of/IN Prostaglandin_I2/NNS -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS in/IN cultured/JJ mammary_gland/NN explants/VBZ derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ present) (NN study))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ possible) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP
                      (NP (DT the) (JJ early) (NN effect))
                      (PP (IN of)
                        (NP (NNS Prostaglandin_I2))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PRL))
                      (-RRB- -RRB-))
                    (PP (IN on)
                      (NP
                        (NP (JJ lactose) (NNS biosynthesis))
                        (PP (IN in)
                          (NP (JJ cultured) (NN mammary_gland)))))))))))))
    (VP (VBZ explants)
      (VP (VBN derived)
        (PP (IN from)
          (NP
            (NP (NNS mice))
            (ADJP
              (NP (CD 12-14) (NNS days))
              (JJ pregnant))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(explants-25, study-3)
acl(study-3, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, possible-8)
dobj(investigate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effect-13, the-11)
amod(effect-13, early-12)
dobj(underlying-10, effect-13)
case(Prostaglandin_I2-15, of-14)
nmod:of(effect-13, Prostaglandin_I2-15)
appos(effect-13, PRL-17)
case(biosynthesis-21, on-19)
amod(biosynthesis-21, lactose-20)
nmod:on(effect-13, biosynthesis-21)
case(mammary_gland-24, in-22)
amod(mammary_gland-24, cultured-23)
nmod:in(biosynthesis-21, mammary_gland-24)
root(ROOT-0, explants-25)
dep(explants-25, derived-26)
case(mice-28, from-27)
nmod:from(derived-26, mice-28)
nummod(days-30, 12-14-29)
nmod:npmod(pregnant-31, days-30)
amod(mice-28, pregnant-31)

Specifically/RB ,/, we/PRP examined/VBD the/DT roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/VB -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN carbacyclin/NN ,/, in/IN mediating/VBG this/DT effect/NN ./.

(ROOT
  (S
    (ADVP (RB Specifically))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS roles))
        (PP (IN of)
          (NP
            (NP
              (NP (NNS adenosine_3) (POS '))
              (ADJP (CD ,5))
              ('' ')
              (PRN (: -)
                (S
                  (VP (VB cyclic_monophosphate)
                    (NP
                      (NP (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-))
                      (CC and)
                      (NP
                        (NP (NNS guanosine_3) (POS '))
                        (NX (CD ,5)))
                      ('' '))))
                (: -))
              (NN cyclic_monophosphate))
            (PRN (-LRB- -LRB-)
              (NP (NN cGMP))
              (-RRB- -RRB-)))))
      (, ,)
      (ADVP
        (ADVP (RB as) (RB well))
        (PP (IN as)
          (NP (NN carbacyclin))))
      (, ,)
      (PP (IN in)
        (S
          (VP (VBG mediating)
            (NP (DT this) (NN effect))))))
    (. .)))

advmod(examined-4, Specifically-1)
nsubj(examined-4, we-3)
root(ROOT-0, examined-4)
det(roles-6, the-5)
dobj(examined-4, roles-6)
case(cyclic_monophosphate-23, of-7)
nmod:poss(cyclic_monophosphate-23, adenosine_3-8)
case(adenosine_3-8, '-9)
amod(cyclic_monophosphate-23, ,5-10)
dep(cyclic_monophosphate-23, cyclic_monophosphate-13)
dobj(cyclic_monophosphate-13, cAMP-15)
cc(cAMP-15, and-17)
nmod:poss(,5-20, guanosine_3-18)
case(guanosine_3-18, '-19)
dobj(cyclic_monophosphate-13, ,5-20)
conj:and(cAMP-15, ,5-20)
nmod:of(roles-6, cyclic_monophosphate-23)
appos(cyclic_monophosphate-23, cGMP-25)
advmod(examined-4, as-28)
mwe(as-28, well-29)
case(carbacyclin-31, as-30)
nmod:as(as-28, carbacyclin-31)
mark(mediating-34, in-33)
advcl(examined-4, mediating-34)
det(effect-36, this-35)
dobj(mediating-34, effect-36)

Our/PRP$ findings/NNS revealed/VBD that/IN PRL/NNP significantly/RB enhanced/VBD lactose/JJ biosynthesis/NNS in/IN mammary_gland/JJ explants/NNS ,/, and/CC this/DT effect/NN was/VBD partly/RB mediated/VBN by/IN cAMP/NN and/CC cGMP/NN signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS findings))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (NNP PRL))
            (ADVP (RB significantly))
            (VP (VBD enhanced)
              (NP
                (NP (JJ lactose) (NNS biosynthesis))
                (PP (IN in)
                  (NP (JJ mammary_gland) (NNS explants)))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT this) (NN effect))
      (VP (VBD was) (RB partly)
        (VP (VBN mediated)
          (PP (IN by)
            (NP (NN cAMP)
              (CC and)
              (NN cGMP)))
          (S
            (VP (VBG signaling)
              (NP (NNS pathways)))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(revealed-3, findings-2)
root(ROOT-0, revealed-3)
mark(enhanced-7, that-4)
nsubj(enhanced-7, PRL-5)
advmod(enhanced-7, significantly-6)
ccomp(revealed-3, enhanced-7)
amod(biosynthesis-9, lactose-8)
dobj(enhanced-7, biosynthesis-9)
case(explants-12, in-10)
amod(explants-12, mammary_gland-11)
nmod:in(biosynthesis-9, explants-12)
cc(revealed-3, and-14)
det(effect-16, this-15)
nsubjpass(mediated-19, effect-16)
auxpass(mediated-19, was-17)
advmod(mediated-19, partly-18)
conj:and(revealed-3, mediated-19)
case(cAMP-21, by-20)
nmod:by(mediated-19, cAMP-21)
cc(cAMP-21, and-22)
nmod:by(mediated-19, cGMP-23)
conj:and(cAMP-21, cGMP-23)
xcomp(mediated-19, signaling-24)
dobj(signaling-24, pathways-25)

Furthermore/RB ,/, carbacyclin/NN was/VBD found/VBN to/TO potentiate/VB the/DT stimulatory/JJ effect/NN of/IN PRL/NNP on/IN lactose/JJ synthesis/NN ,/, suggesting/VBG a/DT potential/JJ role/NN for/IN this/DT molecule/NN in/IN regulating/VBG mammary_gland/JJ function/NN during/IN pregnancy/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NN carbacyclin))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB potentiate)
              (NP
                (NP (DT the) (JJ stimulatory) (NN effect))
                (PP (IN of)
                  (NP (NNP PRL))))
              (PP (IN on)
                (NP (JJ lactose) (NN synthesis))))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (DT a) (JJ potential) (NN role))
              (PP (IN for)
                (NP
                  (NP (DT this) (NN molecule))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (JJ mammary_gland) (NN function))
                        (PP (IN during)
                          (NP (NN pregnancy)))))))))))))
    (. .)))

advmod(found-5, Furthermore-1)
nsubjpass(found-5, carbacyclin-3)
nsubj:xsubj(potentiate-7, carbacyclin-3)
auxpass(found-5, was-4)
root(ROOT-0, found-5)
mark(potentiate-7, to-6)
xcomp(found-5, potentiate-7)
det(effect-10, the-8)
amod(effect-10, stimulatory-9)
dobj(potentiate-7, effect-10)
case(PRL-12, of-11)
nmod:of(effect-10, PRL-12)
case(synthesis-15, on-13)
amod(synthesis-15, lactose-14)
nmod:on(potentiate-7, synthesis-15)
xcomp(found-5, suggesting-17)
det(role-20, a-18)
amod(role-20, potential-19)
dobj(suggesting-17, role-20)
case(molecule-23, for-21)
det(molecule-23, this-22)
nmod:for(role-20, molecule-23)
mark(regulating-25, in-24)
acl(molecule-23, regulating-25)
amod(function-27, mammary_gland-26)
dobj(regulating-25, function-27)
case(pregnancy-29, during-28)
nmod:during(regulating-25, pregnancy-29)

Overall/RB ,/, these/DT results/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG lactation/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN lactation-related_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS results))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (JJ molecular) (NNS mechanisms))
              (VP (VBG underlying)
                (NP (NN lactation)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP (NNS lactation-related_disorders)))))))))))
    (. .)))

advmod(provide-5, Overall-1)
det(results-4, these-3)
nsubj(provide-5, results-4)
nsubj(have-16, results-4)
root(ROOT-0, provide-5)
amod(insights-7, new-6)
dobj(provide-5, insights-7)
case(mechanisms-11, into-8)
det(mechanisms-11, the-9)
amod(mechanisms-11, molecular-10)
nmod:into(insights-7, mechanisms-11)
acl(mechanisms-11, underlying-12)
dobj(underlying-12, lactation-13)
cc(provide-5, and-14)
aux(have-16, may-15)
conj:and(provide-5, have-16)
dobj(have-16, implications-17)
case(development-20, for-18)
det(development-20, the-19)
nmod:for(implications-17, development-20)
case(strategies-24, of-21)
amod(strategies-24, novel-22)
amod(strategies-24, therapeutic-23)
nmod:of(development-20, strategies-24)
case(lactation-related_disorders-26, for-25)
nmod:for(strategies-24, lactation-related_disorders-26)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/JJ -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/JJ -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (NP
          (NP
            (NP (JJ eicosapentaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 20:5) (JJ n-3))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (NP (JJ docosahexaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 22:6) (JJ n-3))
            (-RRB- -RRB-)))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-26, omega-3_fatty_acids-2)
advcl(studied-26, including-4)
dobj(including-4, eicosapentaenoic_acid-5)
dep(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
amod(eicosapentaenoic_acid-5, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dobj(including-4, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dep(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
amod(docosahexaenoic_acid-14, n-3-20)
aux(studied-26, have-23)
auxpass(studied-26, been-24)
advmod(studied-26, extensively-25)
root(ROOT-0, studied-26)
case(benefits-31, for-27)
nmod:poss(benefits-31, their-28)
amod(benefits-31, potential-29)
compound(benefits-31, health-30)
nmod:for(studied-26, benefits-31)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN haematoporphyrin/NN levels/NNS in/IN hyperhaematoporphyrinmic/JJ patients/NNS ,/, suggesting/VBG a/DT potential/JJ therapeutic/JJ role/NN in/IN the/DT treatment/NN of/IN porphyria/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN haematoporphyrin) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperhaematoporphyrinmic) (NNS patients)))))
                (, ,)
                (S
                  (VP (VBG suggesting)
                    (NP
                      (NP (DT a) (JJ potential) (JJ therapeutic) (NN role))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN treatment))
                          (PP (IN of)
                            (NP (NN porphyria))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, haematoporphyrin-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperhaematoporphyrinmic-15)
nmod:in(levels-13, patients-16)
xcomp(associated-9, suggesting-18)
det(role-22, a-19)
amod(role-22, potential-20)
amod(role-22, therapeutic-21)
dobj(suggesting-18, role-22)
case(treatment-25, in-23)
det(treatment-25, the-24)
nmod:in(role-22, treatment-25)
case(porphyria-27, of-26)
nmod:of(treatment-25, porphyria-27)

Additionally/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP
                          (NP
                            (NP (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-)))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-7, Additionally-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(found-7, omega-3_fatty_acids-4)
nsubj:xsubj(decrease-9, omega-3_fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(decrease-9, to-8)
xcomp(found-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(coronary_heart_disease-14, CHD-16)
det(cause-21, a-19)
amod(cause-21, leading-20)
appos(coronary_heart_disease-14, cause-21)
case(morbidity-23, of-22)
nmod:of(cause-21, morbidity-23)
cc(morbidity-23, and-24)
nmod:of(cause-21, mortality-25)
conj:and(morbidity-23, mortality-25)
advmod(decrease-9, worldwide-26)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN but/CC may/MD involve/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN these/DT fatty_acids/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (JJ anti-inflammatory)
              (CC and)
              (JJ anti-thrombotic) (NNS properties))
            (PP (IN of)
              (NP (DT these) (NNS fatty_acids)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
auxpass(understood-10, are-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-11)
aux(involve-13, may-12)
conj:but(understood-10, involve-13)
amod(properties-17, anti-inflammatory-14)
cc(anti-inflammatory-14, and-15)
conj:and(anti-inflammatory-14, anti-thrombotic-16)
amod(properties-17, anti-thrombotic-16)
dobj(involve-13, properties-17)
case(fatty_acids-20, of-18)
det(fatty_acids-20, these-19)
nmod:of(properties-17, fatty_acids-20)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS by/IN which/WDT long-chain/JJ omega-3_fatty_acids/NNS exert/VBP their/PRP$ beneficial/JJ effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN in/IN patients/NNS with/IN porphyria/NN and/CC CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP (DT the) (NNS mechanisms))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (JJ long-chain) (NNS omega-3_fatty_acids))
                      (VP (VBP exert)
                        (NP (PRP$ their) (JJ beneficial) (NNS effects))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP
                    (NP (JJ therapeutic) (NN use))
                    (PP (IN in)
                      (NP (NNS patients)))))
                (PP (IN with)
                  (NP
                    (NP (NN porphyria))
                    (CC and)
                    (NP (NNP CHD))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
mark(exert-14, by-10)
dobj(exert-14, which-11)
amod(omega-3_fatty_acids-13, long-chain-12)
nsubj(exert-14, omega-3_fatty_acids-13)
advcl(elucidate-7, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, beneficial-16)
dobj(exert-14, effects-17)
cc(elucidate-7, and-18)
mark(determine-20, to-19)
ccomp(needed-4, determine-20)
conj:and(elucidate-7, determine-20)
amod(dosages-22, optimal-21)
dobj(determine-20, dosages-22)
case(use-25, for-23)
amod(use-25, therapeutic-24)
nmod:for(determine-20, use-25)
case(patients-27, in-26)
nmod:in(use-25, patients-27)
case(porphyria-29, with-28)
nmod:with(determine-20, porphyria-29)
cc(porphyria-29, and-30)
nmod:with(determine-20, CHD-31)
conj:and(porphyria-29, CHD-31)

The/DT deposition/NN of/IN transthyretin/NN -LRB-/-LRB- TTR/NNP -RRB-/-RRB- amyloid/VBD fibrils/NNS in/IN the/DT heart/NN can/MD lead/VB to/TO cardiac_amyloidosis/NNS ,/, a/DT life-threatening/JJ condition/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN deposition))
        (PP (IN of)
          (NP (NN transthyretin))))
      (PRN (-LRB- -LRB-)
        (NP (NNP TTR))
        (-RRB- -RRB-)))
    (VP (VBD amyloid)
      (SBAR
        (S
          (NP
            (NP (NNS fibrils))
            (PP (IN in)
              (NP (DT the) (NN heart))))
          (VP (MD can)
            (VP (VB lead)
              (PP (TO to)
                (NP
                  (NP (NNS cardiac_amyloidosis))
                  (, ,)
                  (NP (DT a) (JJ life-threatening) (NN condition)))))))))
    (. .)))

det(deposition-2, The-1)
nsubj(amyloid-8, deposition-2)
case(transthyretin-4, of-3)
nmod:of(deposition-2, transthyretin-4)
appos(deposition-2, TTR-6)
root(ROOT-0, amyloid-8)
nsubj(lead-14, fibrils-9)
case(heart-12, in-10)
det(heart-12, the-11)
nmod:in(fibrils-9, heart-12)
aux(lead-14, can-13)
ccomp(amyloid-8, lead-14)
case(cardiac_amyloidosis-16, to-15)
nmod:to(lead-14, cardiac_amyloidosis-16)
det(condition-20, a-18)
amod(condition-20, life-threatening-19)
appos(cardiac_amyloidosis-16, condition-20)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN HA_966/NNP on/IN reducing/VBG the/DT risk/NN of/IN cardiac_TTR_amyloidosis/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP HA_966)))
      (PP (IN on)
        (S
          (VP (VBG reducing)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS cardiac_TTR_amyloidosis))))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-16, study-3)
det(effect-6, the-5)
nsubjpass(investigated-16, effect-6)
case(HA_966-8, of-7)
nmod:of(effect-6, HA_966-8)
mark(reducing-10, on-9)
acl(effect-6, reducing-10)
det(risk-12, the-11)
dobj(reducing-10, risk-12)
case(cardiac_TTR_amyloidosis-14, of-13)
nmod:of(risk-12, cardiac_TTR_amyloidosis-14)
auxpass(investigated-16, was-15)
root(ROOT-0, investigated-16)

At_2/CD hours/NNS after/IN dosing/VBG ,/, HA_966/NNP reduced/VBD the/DT risk/NN of/IN cardiac_TTR_amyloidosis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBD 6-20/CD %/NN ,/, P/RB =/SYM 0.0005/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (CD At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP HA_966))
    (VP
      (VP (VBD reduced)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP (NNS cardiac_TTR_amyloidosis))))
        (PP (IN by)
          (NP (CD 14) (NN %))))
      (PRN (-LRB- -LRB-)
        (S
          (NP (CD 95) (NN %))
          (VP (VBD CI)
            (NP (CD 6-20) (NN %))
            (, ,)
            (PP (RB P)
              (FRAG
                (X (SYM =))
                (NP (CD 0.0005))))))
        (-RRB- -RRB-)))
    (. .)))

nummod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, HA_966-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(cardiac_TTR_amyloidosis-11, of-10)
nmod:of(risk-9, cardiac_TTR_amyloidosis-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
nsubj(CI-18, %-17)
parataxis(reduced-7, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
advmod(0.0005-24, P-22)
dep(0.0005-24, =-23)
advcl(CI-18, 0.0005-24)

Additionally/RB ,/, HA_966/NNP demonstrated/VBD a/DT significant/JJ reduction/NN in/IN photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP HA_966))
    (VP
      (VP (VBD demonstrated)
        (NP (DT a) (JJ significant) (NN reduction))
        (PP (IN in)
          (NP (NN photophobia)))
        (PP (IN by)
          (NP (CD 17) (NN %))))
      (PRN (-LRB- -LRB-)
        (S
          (NP (CD 95) (NN %))
          (VP (VBP CI)
            (NP (CD 12-22) (NN %))
            (, ,)
            (SBAR
              (S
                (NP (NNP P))
                (VP (VBP <)
                  (NP (CD 0.0001)))))))
        (-RRB- -RRB-))
      (CC and)
      (VP (NN phonophobia)
        (PP (IN by)
          (NP
            (NP (CD 14) (NN %))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 95) (NN %))
                (PP (NNP CI)
                  (NP (CD 17-20) (NN %))))
              (, ,)
              (NP (NNP P)
                (QP (CD <) (CD 0.0001)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(demonstrated-4, Additionally-1)
nsubj(demonstrated-4, HA_966-3)
root(ROOT-0, demonstrated-4)
det(reduction-7, a-5)
amod(reduction-7, significant-6)
dobj(demonstrated-4, reduction-7)
case(photophobia-9, in-8)
nmod:in(demonstrated-4, photophobia-9)
case(%-12, by-10)
nummod(%-12, 17-11)
nmod:by(demonstrated-4, %-12)
nummod(%-15, 95-14)
nsubj(CI-16, %-15)
parataxis(demonstrated-4, CI-16)
nummod(%-18, 12-22-17)
dobj(CI-16, %-18)
nsubj(<-21, P-20)
dep(CI-16, <-21)
dobj(<-21, 0.0001-22)
cc(demonstrated-4, and-24)
conj:and(demonstrated-4, phonophobia-25)
case(%-28, by-26)
nummod(%-28, 14-27)
nmod:by(phonophobia-25, %-28)
nummod(%-31, 95-30)
appos(%-28, %-31)
dep(%-34, CI-32)
nummod(%-34, 17-20-33)
nmod(%-31, %-34)
dep(%-31, P-36)
compound(0.0001-38, <-37)
nummod(P-36, 0.0001-38)

These/DT results/NNS suggest/VBP that/IN HA_966/NNP may/MD have/VB potential/JJ therapeutic/JJ value/NN in/IN preventing/VBG TTR/NNP amyloidosis/NNS and/CC reducing/VBG associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP HA_966))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ potential) (JJ therapeutic) (NN value))
              (PP (IN in)
                (S
                  (VP
                    (VP (VBG preventing)
                      (NP (NNP TTR) (NNS amyloidosis)))
                    (CC and)
                    (VP (VBG reducing)
                      (NP
                        (NP (VBN associated) (NNS symptoms))
                        (PP (JJ such) (IN as)
                          (NP (NN photophobia)
                            (CC and)
                            (NN phonophobia)))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, HA_966-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(value-10, potential-8)
amod(value-10, therapeutic-9)
dobj(have-7, value-10)
mark(preventing-12, in-11)
advcl(have-7, preventing-12)
compound(amyloidosis-14, TTR-13)
dobj(preventing-12, amyloidosis-14)
cc(preventing-12, and-15)
advcl(have-7, reducing-16)
conj:and(preventing-12, reducing-16)
amod(symptoms-18, associated-17)
dobj(reducing-16, symptoms-18)
case(photophobia-21, such-19)
mwe(such-19, as-20)
nmod:such_as(symptoms-18, photophobia-21)
cc(photophobia-21, and-22)
nmod:such_as(symptoms-18, phonophobia-23)
conj:and(photophobia-21, phonophobia-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN HA_966/NNP in/IN treating/VBG TTR/NNP amyloidosis/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (NNP HA_966)))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP (NNP TTR) (NNS amyloidosis))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(investigate-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(investigate-6, profile-12)
conj:and(effects-9, profile-12)
case(HA_966-14, of-13)
nmod:of(profile-12, HA_966-14)
mark(treating-16, in-15)
advcl(investigate-6, treating-16)
compound(amyloidosis-18, TTR-17)
dobj(treating-16, amyloidosis-18)

The/DT brain/NN is_a/VBZ complex/JJ organ/NN that/WDT requires/VBZ a/DT constant/JJ supply/NN of/IN energy/NN to/TO maintain/VB its/PRP$ functions/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN brain))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN organ))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ requires)
              (NP
                (NP (DT a) (JJ constant) (NN supply))
                (PP (IN of)
                  (NP (NN energy)))
                (S
                  (VP (TO to)
                    (VP (VB maintain)
                      (NP (PRP$ its) (NNS functions)))))))))))
    (. .)))

det(brain-2, The-1)
nsubj(is_a-3, brain-2)
root(ROOT-0, is_a-3)
amod(organ-5, complex-4)
dobj(is_a-3, organ-5)
nsubj(requires-7, organ-5)
ref(organ-5, that-6)
acl:relcl(organ-5, requires-7)
det(supply-10, a-8)
amod(supply-10, constant-9)
dobj(requires-7, supply-10)
case(energy-12, of-11)
nmod:of(supply-10, energy-12)
mark(maintain-14, to-13)
acl(supply-10, maintain-14)
nmod:poss(functions-16, its-15)
dobj(maintain-14, functions-16)

One/CD of/IN the/DT key/JJ metabolic/JJ pathways/NNS involved/VBN in/IN energy/NN production/NN is/VBZ the/DT de/FW novo/NN synthesis/NN of/IN fatty_acids/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ key) (JJ metabolic) (NNS pathways))
          (VP (VBN involved)
            (PP (IN in)
              (NP (NN energy) (NN production)))))))
    (VP (VBZ is)
      (NP
        (NP (DT the) (FW de) (NN novo) (NN synthesis))
        (PP (IN of)
          (NP (NNS fatty_acids)))))
    (. .)))

nsubj(synthesis-15, One-1)
case(pathways-6, of-2)
det(pathways-6, the-3)
amod(pathways-6, key-4)
amod(pathways-6, metabolic-5)
nmod:of(One-1, pathways-6)
acl(pathways-6, involved-7)
case(production-10, in-8)
compound(production-10, energy-9)
nmod:in(involved-7, production-10)
cop(synthesis-15, is-11)
det(synthesis-15, the-12)
compound(synthesis-15, de-13)
compound(synthesis-15, novo-14)
root(ROOT-0, synthesis-15)
case(fatty_acids-17, of-16)
nmod:of(synthesis-15, fatty_acids-17)

The/DT enzymes/NNS involved/VBN in/IN this/DT pathway/NN ,/, including/VBG dihydroxyacetone_phosphate/JJ dehydrogenase/NN -LRB-/-LRB- DHPDHase/NNP -RRB-/-RRB- ,/, acetyl-CoA_carboxylase/NN -LRB-/-LRB- ACC/NNP -RRB-/-RRB- ,/, and/CC fatty_acid_synthetase/NN -LRB-/-LRB- FAS/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/JJ differentially/NN regulated/VBN during/IN development/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS enzymes))
      (VP (VBN involved)
        (PP (IN in)
          (NP (DT this) (NN pathway))))
      (, ,)
      (VP (VBG including)
        (NP (JJ dihydroxyacetone_phosphate) (NN dehydrogenase))
        (NP
          (NP
            (NP
              (NP (-LRB- -LRB-) (NNP DHPDHase) (-RRB- -RRB-))
              (, ,)
              (NP (NN acetyl-CoA_carboxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP ACC))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP (NN fatty_acid_synthetase)))
          (PRN (-LRB- -LRB-)
            (NP (NNP FAS))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP (JJ to_be) (NN differentially))
          (PP (VBN regulated)
            (PP (IN during)
              (NP (NN development)))))))
    (. .)))

det(enzymes-2, The-1)
nsubjpass(shown-28, enzymes-2)
acl(enzymes-2, involved-3)
case(pathway-6, in-4)
det(pathway-6, this-5)
nmod:in(involved-3, pathway-6)
acl(enzymes-2, including-8)
amod(dehydrogenase-10, dihydroxyacetone_phosphate-9)
iobj(including-8, dehydrogenase-10)
dobj(including-8, DHPDHase-12)
appos(DHPDHase-12, acetyl-CoA_carboxylase-15)
appos(DHPDHase-12, ACC-17)
cc(DHPDHase-12, and-20)
dobj(including-8, fatty_acid_synthetase-21)
conj:and(DHPDHase-12, fatty_acid_synthetase-21)
appos(DHPDHase-12, FAS-23)
aux(shown-28, have-26)
auxpass(shown-28, been-27)
root(ROOT-0, shown-28)
amod(differentially-30, to_be-29)
dobj(shown-28, differentially-30)
case(development-33, regulated-31)
case(development-33, during-32)
advcl(shown-28, development-33)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT activities/NNS of/IN these/DT enzymes/NNS and/CC the/DT effects/NNS of/IN doranidazole/NN ,/, a/DT potential/JJ therapeutic/JJ agent/NN ,/, on/IN their/PRP$ function/NN in/IN the/DT brains/NNS of/IN 14-day-old/JJ and/CC adult/NN rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS activities))
        (PP (IN of)
          (NP
            (NP (DT these) (NNS enzymes))
            (CC and)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (NN doranidazole))
                  (, ,)
                  (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent))
                  (, ,)))))))
      (PP (IN on)
        (NP
          (NP (PRP$ their) (NN function))
          (PP (IN in)
            (NP
              (NP (DT the) (NNS brains))
              (PP (IN of)
                (NP (JJ 14-day-old)
                  (CC and)
                  (NN adult) (NNS rats))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(activities-8, the-7)
dobj(investigated-6, activities-8)
case(enzymes-11, of-9)
det(enzymes-11, these-10)
nmod:of(activities-8, enzymes-11)
cc(enzymes-11, and-12)
det(effects-14, the-13)
nmod:of(activities-8, effects-14)
conj:and(enzymes-11, effects-14)
case(doranidazole-16, of-15)
nmod:of(effects-14, doranidazole-16)
det(agent-21, a-18)
amod(agent-21, potential-19)
amod(agent-21, therapeutic-20)
appos(doranidazole-16, agent-21)
case(function-25, on-23)
nmod:poss(function-25, their-24)
nmod:on(investigated-6, function-25)
case(brains-28, in-26)
det(brains-28, the-27)
nmod:in(function-25, brains-28)
case(rats-33, of-29)
amod(rats-33, 14-day-old-30)
cc(14-day-old-30, and-31)
conj:and(14-day-old-30, adult-32)
amod(rats-33, adult-32)
nmod:of(brains-28, rats-33)

Our/PRP$ results/NNS indicate/VBP that/IN DHPDHase/JJ activity/NN is/VBZ higher/JJR in/IN the/DT brains/NNS of/IN 14-day-old/JJ rats/NNS compared/VBN to/TO adult/NN rats/NNS ,/, while/IN ACC/NNP and/CC FAS/NNP activities/NNS are/VBP higher/JJR in/IN adult/JJ rat/NN brains/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (JJ DHPDHase) (NN activity))
          (VP (VBZ is)
            (ADJP
              (ADJP (JJR higher))
              (PP (IN in)
                (NP
                  (NP (DT the) (NNS brains))
                  (PP (IN of)
                    (NP
                      (NP (JJ 14-day-old) (NNS rats))
                      (VP (VBN compared)
                        (PP (TO to)
                          (NP (NN adult) (NNS rats)))))))))
            (, ,)
            (SBAR (IN while)
              (S
                (NP (NNP ACC)
                  (CC and)
                  (NNP FAS) (NNS activities))
                (VP (VBP are)
                  (ADJP
                    (ADJP (JJR higher))
                    (PP (IN in)
                      (NP (JJ adult) (NN rat) (NNS brains)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(indicate-3, results-2)
root(ROOT-0, indicate-3)
mark(higher-8, that-4)
amod(activity-6, DHPDHase-5)
nsubj(higher-8, activity-6)
cop(higher-8, is-7)
ccomp(indicate-3, higher-8)
case(brains-11, in-9)
det(brains-11, the-10)
nmod:in(higher-8, brains-11)
case(rats-14, of-12)
amod(rats-14, 14-day-old-13)
nmod:of(brains-11, rats-14)
acl(rats-14, compared-15)
case(rats-18, to-16)
compound(rats-18, adult-17)
nmod:to(compared-15, rats-18)
mark(higher-26, while-20)
compound(activities-24, ACC-21)
cc(ACC-21, and-22)
conj:and(ACC-21, FAS-23)
compound(activities-24, FAS-23)
nsubj(higher-26, activities-24)
cop(higher-26, are-25)
advcl(higher-8, higher-26)
case(brains-30, in-27)
amod(brains-30, adult-28)
compound(brains-30, rat-29)
nmod:in(higher-26, brains-30)

Doranidazole/JJ treatment/NN resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN DHPDHase/JJ activity/NN in/IN both/DT age/NN groups/NNS ,/, but/CC had/VBD no/DT effect/NN on/IN ACC/NNP or/CC FAS/NNP activity/NN ./.

(ROOT
  (S
    (NP (JJ Doranidazole) (NN treatment))
    (VP
      (VP (VBD resulted)
        (NP
          (NP (JJ in_a) (JJ significant) (NN decrease))
          (PP (IN in)
            (NP
              (NP (JJ DHPDHase) (NN activity))
              (PP (IN in)
                (NP (DT both) (NN age) (NNS groups)))))))
      (, ,)
      (CC but)
      (VP (VBD had)
        (NP
          (NP (DT no) (NN effect))
          (PP (IN on)
            (NP
              (ADJP (NNP ACC)
                (CC or)
                (NNP FAS))
              (NN activity))))))
    (. .)))

amod(treatment-2, Doranidazole-1)
nsubj(resulted-3, treatment-2)
nsubj(had-16, treatment-2)
root(ROOT-0, resulted-3)
amod(decrease-6, in_a-4)
amod(decrease-6, significant-5)
dobj(resulted-3, decrease-6)
case(activity-9, in-7)
amod(activity-9, DHPDHase-8)
nmod:in(decrease-6, activity-9)
case(groups-13, in-10)
det(groups-13, both-11)
compound(groups-13, age-12)
nmod:in(activity-9, groups-13)
cc(resulted-3, but-15)
conj:but(resulted-3, had-16)
neg(effect-18, no-17)
dobj(had-16, effect-18)
case(activity-23, on-19)
amod(activity-23, ACC-20)
cc(ACC-20, or-21)
conj:or(ACC-20, FAS-22)
amod(activity-23, FAS-22)
nmod:on(effect-18, activity-23)

These/DT findings/NNS suggest/VBP that/IN doranidazole/NN may/MD selectively/RB target/VB DHPDHase/JJ activity/NN in/IN the/DT brain/NN ,/, providing/VBG a/DT potential/JJ therapeutic/JJ approach/NN for/IN disorders/NNS associated/VBN with/IN altered/JJ fatty_acid/JJ metabolism/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN doranidazole))
          (VP (MD may) (RB selectively)
            (VP (VB target)
              (NP
                (NP (JJ DHPDHase) (NN activity))
                (PP (IN in)
                  (NP (DT the) (NN brain))))
              (, ,)
              (S
                (VP (VBG providing)
                  (NP (DT a) (JJ potential) (JJ therapeutic) (NN approach))
                  (PP (IN for)
                    (NP
                      (NP (NNS disorders))
                      (VP (VBN associated)
                        (PP (IN with)
                          (NP (JJ altered) (JJ fatty_acid) (NN metabolism)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(target-8, that-4)
nsubj(target-8, doranidazole-5)
aux(target-8, may-6)
advmod(target-8, selectively-7)
ccomp(suggest-3, target-8)
amod(activity-10, DHPDHase-9)
dobj(target-8, activity-10)
case(brain-13, in-11)
det(brain-13, the-12)
nmod:in(activity-10, brain-13)
advcl(target-8, providing-15)
det(approach-19, a-16)
amod(approach-19, potential-17)
amod(approach-19, therapeutic-18)
dobj(providing-15, approach-19)
case(disorders-21, for-20)
nmod:for(providing-15, disorders-21)
acl(disorders-21, associated-22)
case(metabolism-26, with-23)
amod(metabolism-26, altered-24)
amod(metabolism-26, fatty_acid-25)
nmod:with(associated-22, metabolism-26)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN various/JJ health/NN problems/NNS ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ various) (NN health) (NNS problems)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubjpass(associated-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
acl:relcl(metabolic_disorder-4, associated-7)
case(problems-11, with-8)
amod(problems-11, various-9)
compound(problems-11, health-10)
nmod:with(associated-7, problems-11)

The/DT pathogenesis/NN of/IN obesity/NN involves/VBZ the/DT dysregulation/NN of/IN several/JJ hormones/NNS and/CC signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathogenesis))
      (PP (IN of)
        (NP (NN obesity))))
    (VP (VBZ involves)
      (NP
        (NP (DT the) (NN dysregulation))
        (PP (IN of)
          (NP
            (NP (JJ several) (NNS hormones))
            (CC and)
            (NP (VBG signaling) (NNS pathways))))))
    (. .)))

det(pathogenesis-2, The-1)
nsubj(involves-5, pathogenesis-2)
case(obesity-4, of-3)
nmod:of(pathogenesis-2, obesity-4)
root(ROOT-0, involves-5)
det(dysregulation-7, the-6)
dobj(involves-5, dysregulation-7)
case(hormones-10, of-8)
amod(hormones-10, several-9)
nmod:of(dysregulation-7, hormones-10)
cc(hormones-10, and-11)
amod(pathways-13, signaling-12)
nmod:of(dysregulation-7, pathways-13)
conj:and(hormones-10, pathways-13)

Amtyr1/NNP ,/, a/DT novel/NN hormone/NN secreted/VBN by/IN the/DT pancreas/NN ,/, has_been/VBP implicated/VBN in/IN the/DT regulation/NN of/IN glucose/NN and/CC lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Amtyr1))
      (, ,)
      (NP
        (NP (DT a) (NN novel) (NN hormone))
        (VP (VBN secreted)
          (PP (IN by)
            (NP (DT the) (NN pancreas)))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (NN glucose))
                (CC and)
                (NP (NN lipid) (NN metabolism))))))))
    (. .)))

nsubj(has_been-11, Amtyr1-1)
det(hormone-5, a-3)
compound(hormone-5, novel-4)
appos(Amtyr1-1, hormone-5)
acl(hormone-5, secreted-6)
case(pancreas-9, by-7)
det(pancreas-9, the-8)
nmod:by(secreted-6, pancreas-9)
root(ROOT-0, has_been-11)
dep(has_been-11, implicated-12)
case(regulation-15, in-13)
det(regulation-15, the-14)
nmod:in(implicated-12, regulation-15)
case(glucose-17, of-16)
nmod:of(regulation-15, glucose-17)
cc(glucose-17, and-18)
compound(metabolism-20, lipid-19)
nmod:of(regulation-15, metabolism-20)
conj:and(glucose-17, metabolism-20)

However/RB ,/, the/DT relationship/NN between/IN Amtyr1/NNS and/CC obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN relationship))
      (PP (IN between)
        (NP (NNS Amtyr1)
          (CC and)
          (NN obesity))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remains-9, However-1)
det(relationship-4, the-3)
nsubj(remains-9, relationship-4)
case(Amtyr1-6, between-5)
nmod:between(relationship-4, Amtyr1-6)
cc(Amtyr1-6, and-7)
nmod:between(relationship-4, obesity-8)
conj:and(Amtyr1-6, obesity-8)
root(ROOT-0, remains-9)
xcomp(remains-9, unclear-10)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN glucose/NN and/CC thymol/NN on/IN the/DT secretion/NN of/IN Amtyr1/JJ and_insulin/NN in/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN glucose)
            (CC and)
            (NN thymol))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ Amtyr1) (NN and_insulin)))))
      (PP (IN in)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(glucose-10, of-9)
nmod:of(effects-8, glucose-10)
cc(glucose-10, and-11)
nmod:of(effects-8, thymol-12)
conj:and(glucose-10, thymol-12)
case(secretion-15, on-13)
det(secretion-15, the-14)
nmod:on(investigated-6, secretion-15)
case(and_insulin-18, of-16)
amod(and_insulin-18, Amtyr1-17)
nmod:of(secretion-15, and_insulin-18)
case(pancreata-22, in-19)
amod(pancreata-22, isolated-20)
amod(pancreata-22, perfused-21)
nmod:in(investigated-6, pancreata-22)
case(genetically_obese-24, from-23)
nmod:from(pancreata-22, genetically_obese-24)
appos(genetically_obese-24, fa/fa-26)
cc(genetically_obese-24, and-28)
amod(rats-35, lean-29)
dep(lean-29, Fa-31)
nmod:from(pancreata-22, rats-35)
conj:and(genetically_obese-24, rats-35)

We/PRP found/VBD that/IN hypersecretion/NN of/IN Amtyr1/NNS was/VBD observed/VBN in/IN response/NN to/TO high/JJ glucose/NN levels/NNS in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNS Amtyr1))))
          (VP (VBD was)
            (VP (VBN observed)
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (JJ high) (NN glucose) (NNS levels)))))
              (PP (IN in)
                (NP (DT both) (JJ obese)
                  (CC and)
                  (JJ lean) (NNS rats))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(observed-8, that-3)
nsubjpass(observed-8, hypersecretion-4)
case(Amtyr1-6, of-5)
nmod:of(hypersecretion-4, Amtyr1-6)
auxpass(observed-8, was-7)
ccomp(found-2, observed-8)
case(response-10, in-9)
nmod:in(observed-8, response-10)
case(levels-14, to-11)
amod(levels-14, high-12)
compound(levels-14, glucose-13)
nmod:to(response-10, levels-14)
case(rats-20, in-15)
det(rats-20, both-16)
amod(rats-20, obese-17)
cc(obese-17, and-18)
conj:and(obese-17, lean-19)
amod(rats-20, lean-19)
nmod:in(observed-8, rats-20)

However/RB ,/, thymol/JJ treatment/NN resulted/VBD in_a/JJ significant/JJ increase/NN in/IN Amtyr1/JJ secretion/NN only/RB in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ thymol) (NN treatment))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (JJ Amtyr1) (NN secretion))))
      (PP
        (ADVP (RB only))
        (IN in)
        (NP (JJ obese) (NNS rats))))
    (. .)))

advmod(resulted-5, However-1)
amod(treatment-4, thymol-3)
nsubj(resulted-5, treatment-4)
root(ROOT-0, resulted-5)
amod(increase-8, in_a-6)
amod(increase-8, significant-7)
dobj(resulted-5, increase-8)
case(secretion-11, in-9)
amod(secretion-11, Amtyr1-10)
nmod:in(increase-8, secretion-11)
advmod(rats-15, only-12)
case(rats-15, in-13)
amod(rats-15, obese-14)
nmod:in(resulted-5, rats-15)

Interestingly/RB ,/, insulin_secretion/NN was/VBD not/RB affected/VBN by/IN thymol/JJ treatment/NN in/IN either/DT group/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was) (RB not)
      (VP (VBN affected)
        (PP (IN by)
          (NP
            (NP (JJ thymol) (NN treatment))
            (PP (IN in)
              (NP (DT either) (NN group)))))))
    (. .)))

advmod(affected-6, Interestingly-1)
nsubjpass(affected-6, insulin_secretion-3)
auxpass(affected-6, was-4)
neg(affected-6, not-5)
root(ROOT-0, affected-6)
case(treatment-9, by-7)
amod(treatment-9, thymol-8)
nmod:by(affected-6, treatment-9)
case(group-12, in-10)
det(group-12, either-11)
nmod:in(treatment-9, group-12)

These/DT results/NNS suggest/VBP that/IN the/DT hypersecretion/NN of/IN Amtyr1/NNS may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, particularly/RB in/IN genetically/RB predisposed/VBN individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN hypersecretion))
            (PP (IN of)
              (NP (NNS Amtyr1))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB particularly))
                (IN in)
                (NP
                  (ADJP (RB genetically) (VBN predisposed))
                  (NNS individuals))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-10, that-4)
det(hypersecretion-6, the-5)
nsubj(play-10, hypersecretion-6)
case(Amtyr1-8, of-7)
nmod:of(hypersecretion-6, Amtyr1-8)
aux(play-10, may-9)
ccomp(suggest-3, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
case(development-15, in-13)
det(development-15, the-14)
nmod:in(role-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
advmod(individuals-23, particularly-19)
case(individuals-23, in-20)
advmod(predisposed-22, genetically-21)
amod(individuals-23, predisposed-22)
nmod:in(play-10, individuals-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT relationship/NN and/CC to/TO explore/VB potential/JJ therapeutic/JJ strategies/NNS targeting/VBG Amtyr1/NNS signaling/VBG for/IN the/DT prevention/NN or/CC treatment/NN of/IN obesity-associated_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN relationship)))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS strategies))
                  (VP (VBG targeting)
                    (NP (NNS Amtyr1))
                    (PP (VBG signaling)
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN prevention)
                            (CC or)
                            (NN treatment))
                          (PP (IN of)
                            (NP (NNS obesity-associated_disorders))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(relationship-13, in-11)
det(relationship-13, this-12)
nmod:in(involved-10, relationship-13)
cc(elucidate-6, and-14)
mark(explore-16, to-15)
ccomp(needed-4, explore-16)
conj:and(elucidate-6, explore-16)
amod(strategies-19, potential-17)
amod(strategies-19, therapeutic-18)
dobj(explore-16, strategies-19)
acl(strategies-19, targeting-20)
dobj(targeting-20, Amtyr1-21)
case(prevention-25, signaling-22)
case(prevention-25, for-23)
det(prevention-25, the-24)
advcl(targeting-20, prevention-25)
cc(prevention-25, or-26)
advcl(targeting-20, treatment-27)
conj:or(prevention-25, treatment-27)
case(obesity-associated_disorders-29, of-28)
nmod:of(prevention-25, obesity-associated_disorders-29)

Irinotecan/NNP hydrochloride/VBD -LRB-/-LRB- CPT-11/NNP -RRB-/-RRB- is_a/JJ chemotherapeutic/JJ agent/NN used/VBN in/IN the/DT treatment/NN of/IN various_cancers/NNS ,/, including/VBG colorectal_cancer/NN ./.

(ROOT
  (S
    (NP (NNP Irinotecan))
    (VP (VBD hydrochloride)
      (S (-LRB- -LRB-)
        (NP (NNP CPT-11))
        (-RRB- -RRB-)
        (NP
          (NP (JJ is_a) (JJ chemotherapeutic) (NN agent))
          (VP (VBN used)
            (PP (IN in)
              (NP
                (NP (DT the) (NN treatment))
                (PP (IN of)
                  (NP
                    (NP (NNS various_cancers))
                    (, ,)
                    (VP (VBG including)
                      (NP (NN colorectal_cancer)))))))))))
    (. .)))

nsubj(hydrochloride-2, Irinotecan-1)
root(ROOT-0, hydrochloride-2)
dep(agent-8, CPT-11-4)
amod(agent-8, is_a-6)
amod(agent-8, chemotherapeutic-7)
xcomp(hydrochloride-2, agent-8)
acl(agent-8, used-9)
case(treatment-12, in-10)
det(treatment-12, the-11)
nmod:in(used-9, treatment-12)
case(various_cancers-14, of-13)
nmod:of(treatment-12, various_cancers-14)
acl(various_cancers-14, including-16)
dobj(including-16, colorectal_cancer-17)

However/RB ,/, CPT-11/JJ has_been/NN found/VBD to/TO have/VB some/DT undesirable/JJ side/NN effects/NNS ,/, such/JJ as/IN diarrhea/NN and/CC neutropenia/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ CPT-11) (NN has_been))
    (VP (VBD found)
      (S
        (VP (TO to)
          (VP (VB have)
            (NP
              (NP (DT some) (JJ undesirable) (NN side) (NNS effects))
              (, ,)
              (PP (JJ such) (IN as)
                (NP (NN diarrhea)
                  (CC and)
                  (NN neutropenia))))))))
    (. .)))

advmod(found-5, However-1)
amod(has_been-4, CPT-11-3)
nsubj(found-5, has_been-4)
nsubj:xsubj(have-7, has_been-4)
root(ROOT-0, found-5)
mark(have-7, to-6)
xcomp(found-5, have-7)
det(effects-11, some-8)
amod(effects-11, undesirable-9)
compound(effects-11, side-10)
dobj(have-7, effects-11)
case(diarrhea-15, such-13)
mwe(such-13, as-14)
nmod:such_as(effects-11, diarrhea-15)
cc(diarrhea-15, and-16)
nmod:such_as(effects-11, neutropenia-17)
conj:and(diarrhea-15, neutropenia-17)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN CPT-11/NNP can/MD stimulate/VB the/DT production/NN of/IN saintopin/NN ,/, a/DT neuropeptide/NN involved/VBN in/IN the/DT regulation/NN of/IN gastrointestinal_motility/NN and/CC inflammation/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP CPT-11))
            (VP (MD can)
              (VP (VB stimulate)
                (NP
                  (NP (DT the) (NN production))
                  (PP (IN of)
                    (NP
                      (NP (NN saintopin))
                      (, ,)
                      (NP
                        (NP (DT a) (NN neuropeptide))
                        (VP (VBN involved)
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN regulation))
                              (PP (IN of)
                                (NP (NN gastrointestinal_motility)
                                  (CC and)
                                  (NN inflammation))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(stimulate-8, that-5)
nsubj(stimulate-8, CPT-11-6)
aux(stimulate-8, can-7)
ccomp(shown-4, stimulate-8)
det(production-10, the-9)
dobj(stimulate-8, production-10)
case(saintopin-12, of-11)
nmod:of(production-10, saintopin-12)
det(neuropeptide-15, a-14)
appos(saintopin-12, neuropeptide-15)
acl(neuropeptide-15, involved-16)
case(regulation-19, in-17)
det(regulation-19, the-18)
nmod:in(involved-16, regulation-19)
case(gastrointestinal_motility-21, of-20)
nmod:of(regulation-19, gastrointestinal_motility-21)
cc(gastrointestinal_motility-21, and-22)
nmod:of(regulation-19, inflammation-23)
conj:and(gastrointestinal_motility-21, inflammation-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT role/NN of/IN endothelin/NN receptors/NNS in/IN CPT-11-induced/JJ saintopin/NN release/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN role))
        (PP (IN of)
          (NP (NN endothelin) (NNS receptors))))
      (PP (IN in)
        (NP (JJ CPT-11-induced) (NN saintopin) (NN release))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(role-8, the-7)
dobj(investigated-6, role-8)
case(receptors-11, of-9)
compound(receptors-11, endothelin-10)
nmod:of(role-8, receptors-11)
case(release-15, in-12)
amod(release-15, CPT-11-induced-13)
compound(release-15, saintopin-14)
nmod:in(investigated-6, release-15)

Our/PRP$ results/NNS showed/VBD that/IN the/DT stimulatory/JJ effects/NNS of/IN CPT-11/NN on/IN saintopin/NN levels/NNS were/VBD antagonized/VBN by/IN the/DT ETA_receptor/NNP antagonist/NN BQ_123/NN at_a/NN concentration/NN of/IN 2/CD x/SYM 10/CD -LRB-/-LRB- -6/CD -RRB-/-RRB- M./NNP Additionally/RB ,/, we/PRP found/VBD that/IN the/DT ETB/NNP receptor/NN agonist/NN IRL_1620/NN only/RB evoked/VBD a/DT weak/JJ increase/NN in/IN saintopin/NN levels/NNS ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ stimulatory) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (NN CPT-11))
                  (PP (IN on)
                    (NP (NN saintopin) (NNS levels))))))
            (VP (VBD were)
              (VP (VBN antagonized)
                (PP (IN by)
                  (NP
                    (NP
                      (NP (DT the) (NNP ETA_receptor) (NN antagonist) (NN BQ_123) (NN at_a) (NN concentration))
                      (PP (IN of)
                        (NP (CD 2)))
                      (X
                        (X (SYM x))
                        (NP (CD 10))))
                    (PRN (-LRB- -LRB-)
                      (NP (CD -6))
                      (-RRB- -RRB-))))
                (S
                  (NP (NNP M.))
                  (ADVP (RB Additionally)))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP ETB) (NN receptor) (NN agonist) (NN IRL_1620))
          (ADVP (RB only))
          (VP (VBD evoked)
            (NP (DT a) (JJ weak) (NN increase))
            (PP (IN in)
              (NP (NN saintopin) (NNS levels)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
ccomp(found-33, showed-3)
mark(antagonized-14, that-4)
det(effects-7, the-5)
amod(effects-7, stimulatory-6)
nsubjpass(antagonized-14, effects-7)
case(CPT-11-9, of-8)
nmod:of(effects-7, CPT-11-9)
case(levels-12, on-10)
compound(levels-12, saintopin-11)
nmod:on(CPT-11-9, levels-12)
auxpass(antagonized-14, were-13)
ccomp(showed-3, antagonized-14)
case(concentration-21, by-15)
det(concentration-21, the-16)
compound(concentration-21, ETA_receptor-17)
compound(concentration-21, antagonist-18)
compound(concentration-21, BQ_123-19)
compound(concentration-21, at_a-20)
nmod:by(antagonized-14, concentration-21)
case(2-23, of-22)
nmod:of(concentration-21, 2-23)
dep(10-25, x-24)
dep(concentration-21, 10-25)
appos(concentration-21, -6-27)
xcomp(antagonized-14, M.-29)
advmod(M.-29, Additionally-30)
nsubj(found-33, we-32)
root(ROOT-0, found-33)
mark(evoked-41, that-34)
det(IRL_1620-39, the-35)
compound(IRL_1620-39, ETB-36)
compound(IRL_1620-39, receptor-37)
compound(IRL_1620-39, agonist-38)
nsubj(evoked-41, IRL_1620-39)
advmod(evoked-41, only-40)
ccomp(found-33, evoked-41)
det(increase-44, a-42)
amod(increase-44, weak-43)
dobj(evoked-41, increase-44)
case(levels-47, in-45)
compound(levels-47, saintopin-46)
nmod:in(evoked-41, levels-47)

These/DT findings/NNS suggest/VBP that/IN ETA/NNP receptors/NNS play/VBP a/DT crucial/JJ role/NN in/IN CPT-11-induced/JJ saintopin/NN release/NN and/CC may/MD provide/VB a/DT potential/JJ target/NN for/IN mitigating/VBG the/DT side/NN effects/NNS associated/VBN with/IN CPT-11/JJ therapy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (NNP ETA) (NNS receptors))
            (VP (VBP play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP (JJ CPT-11-induced) (NN saintopin) (NN release))))))))
      (CC and)
      (VP (MD may)
        (VP (VB provide)
          (NP (DT a) (JJ potential) (NN target))
          (PP (IN for)
            (S
              (VP (VBG mitigating)
                (NP
                  (NP (DT the) (NN side) (NNS effects))
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP (JJ CPT-11) (NN therapy)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
nsubj(provide-17, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
compound(receptors-6, ETA-5)
nsubj(play-7, receptors-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(play-7, role-10)
case(release-14, in-11)
amod(release-14, CPT-11-induced-12)
compound(release-14, saintopin-13)
nmod:in(role-10, release-14)
cc(suggest-3, and-15)
aux(provide-17, may-16)
conj:and(suggest-3, provide-17)
det(target-20, a-18)
amod(target-20, potential-19)
dobj(provide-17, target-20)
mark(mitigating-22, for-21)
advcl(provide-17, mitigating-22)
det(effects-25, the-23)
compound(effects-25, side-24)
dobj(mitigating-22, effects-25)
acl(effects-25, associated-26)
case(therapy-29, with-27)
amod(therapy-29, CPT-11-28)
nmod:with(associated-26, therapy-29)

Malaria/NNP caused/VBD by/IN Plasmodium_falciparum/NNP is_a/NNP major/JJ public_health/NN concern/NN worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Malaria))
    (VP (VBD caused)
      (PP (IN by)
        (NP (NNP Plasmodium_falciparum) (NNP is_a) (JJ major) (NN public_health) (NN concern)))
      (ADVP (RB worldwide)))
    (. .)))

nsubj(caused-2, Malaria-1)
root(ROOT-0, caused-2)
case(concern-8, by-3)
compound(concern-8, Plasmodium_falciparum-4)
compound(concern-8, is_a-5)
amod(concern-8, major-6)
compound(concern-8, public_health-7)
nmod:by(caused-2, concern-8)
advmod(caused-2, worldwide-9)

The/DT emergence/NN of/IN drug-resistant_parasites/NNS has/VBZ made/VBN it/PRP challenging/VBG to/TO control/VB and/CC treat/VB this/DT disease/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN emergence))
      (PP (IN of)
        (NP (NNS drug-resistant_parasites))))
    (VP (VBZ has)
      (VP (VBN made)
        (NP (PRP it))
        (S
          (VP (VBG challenging)
            (S
              (VP (TO to)
                (VP
                  (VP (VB control))
                  (CC and)
                  (VP (VB treat)
                    (NP (DT this) (NN disease))))))))))
    (. .)))

det(emergence-2, The-1)
nsubj(made-6, emergence-2)
case(drug-resistant_parasites-4, of-3)
nmod:of(emergence-2, drug-resistant_parasites-4)
aux(made-6, has-5)
root(ROOT-0, made-6)
dobj(made-6, it-7)
xcomp(made-6, challenging-8)
mark(control-10, to-9)
xcomp(challenging-8, control-10)
cc(control-10, and-11)
xcomp(challenging-8, treat-12)
conj:and(control-10, treat-12)
det(disease-14, this-13)
dobj(treat-12, disease-14)

KAE609/NNP is_a/VBZ new/JJ antimalarial/JJ agent/NN that/WDT has/VBZ shown/VBN promising/JJ results/NNS in/IN preclinical/JJ studies/NNS ./.

(ROOT
  (S
    (NP (NNP KAE609))
    (VP (VBZ is_a)
      (NP
        (NP (JJ new) (JJ antimalarial) (NN agent))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ has)
              (VP (VBN shown)
                (NP (JJ promising) (NNS results))
                (PP (IN in)
                  (NP (JJ preclinical) (NNS studies)))))))))
    (. .)))

nsubj(is_a-2, KAE609-1)
root(ROOT-0, is_a-2)
amod(agent-5, new-3)
amod(agent-5, antimalarial-4)
dobj(is_a-2, agent-5)
nsubj(shown-8, agent-5)
ref(agent-5, that-6)
aux(shown-8, has-7)
acl:relcl(agent-5, shown-8)
amod(results-10, promising-9)
dobj(shown-8, results-10)
case(studies-13, in-11)
amod(studies-13, preclinical-12)
nmod:in(shown-8, studies-13)

In/IN this/DT randomized_controlled_trial/NN ,/, the/DT efficacy/NN and/CC safety/NN of/IN KAE609/NNP were/VBD evaluated/VBN in/IN patients/NNS with/IN Falciparum_Malaria/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN randomized_controlled_trial)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy)
        (CC and)
        (NN safety))
      (PP (IN of)
        (NP (NNP KAE609))))
    (VP (VBD were)
      (VP (VBN evaluated)
        (PP (IN in)
          (NP (NNS patients)))
        (PP (IN with)
          (NP (NNP Falciparum_Malaria)))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, this-2)
nmod:in(evaluated-12, randomized_controlled_trial-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-12, efficacy-6)
cc(efficacy-6, and-7)
conj:and(efficacy-6, safety-8)
nsubjpass(evaluated-12, safety-8)
case(KAE609-10, of-9)
nmod:of(efficacy-6, KAE609-10)
auxpass(evaluated-12, were-11)
root(ROOT-0, evaluated-12)
case(patients-14, in-13)
nmod:in(evaluated-12, patients-14)
case(Falciparum_Malaria-16, with-15)
nmod:with(evaluated-12, Falciparum_Malaria-16)

At_2/JJ h/NN after/IN dosing/VBG ,/, KAE609/NNP reduced/VBD the/DT risk/NN of/IN Falciparum_Malaria/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP KAE609))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNP Falciparum_Malaria))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, KAE609-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Falciparum_Malaria-11, of-10)
nmod:of(risk-9, Falciparum_Malaria-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN KAE609/NNP may/MD be/VB a/DT promising/JJ new/JJ treatment/NN option/NN for/IN Falciparum_Malaria/NNP and/CC its/PRP$ associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP KAE609))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ new) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNP Falciparum_Malaria))
                    (CC and)
                    (NP (PRP$ its) (VBN associated) (NNS symptoms))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-12, that-4)
nsubj(option-12, KAE609-5)
aux(option-12, may-6)
cop(option-12, be-7)
det(option-12, a-8)
amod(option-12, promising-9)
amod(option-12, new-10)
compound(option-12, treatment-11)
ccomp(suggest-3, option-12)
case(Falciparum_Malaria-14, for-13)
nmod:for(option-12, Falciparum_Malaria-14)
cc(Falciparum_Malaria-14, and-15)
nmod:poss(symptoms-18, its-16)
amod(symptoms-18, associated-17)
nmod:for(option-12, symptoms-18)
conj:and(Falciparum_Malaria-14, symptoms-18)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN KAE609/NNP in/IN larger/JJR patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NNP KAE609))))
                (PP (IN in)
                  (NP (JJR larger) (JJ patient) (NNS populations)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(evaluate-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, evaluate-10)
conj:and(confirm-6, evaluate-10)
det(safety-13, the-11)
amod(safety-13, long-term-12)
dobj(evaluate-10, safety-13)
cc(safety-13, and-14)
dobj(evaluate-10, efficacy-15)
conj:and(safety-13, efficacy-15)
case(KAE609-17, of-16)
nmod:of(safety-13, KAE609-17)
case(populations-21, in-18)
amod(populations-21, larger-19)
amod(populations-21, patient-20)
nmod:in(evaluate-10, populations-21)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO investigate/VB the/DT relationship/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, echothiophate/NN ,/, and/CC serum/VB neurotoxic_esterase/JJ levels/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN relationship))
                (PP (IN between)
                  (NP
                    (NP (NN serum) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN alkaline_phosphatase))
                        (, ,)
                        (NP (NN echothiophate))
                        (, ,)))))))
            (CC and)
            (VP (VB serum)
              (NP (JJ neurotoxic_esterase) (NNS levels)))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(investigate-8, aim-2)
nsubj:xsubj(serum-20, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(investigate-8, to-7)
xcomp(was-6, investigate-8)
det(relationship-10, the-9)
dobj(investigate-8, relationship-10)
case(levels-13, between-11)
compound(levels-13, serum-12)
nmod:between(relationship-10, levels-13)
case(alkaline_phosphatase-15, of-14)
nmod:of(levels-13, alkaline_phosphatase-15)
appos(alkaline_phosphatase-15, echothiophate-17)
cc(investigate-8, and-19)
xcomp(was-6, serum-20)
conj:and(investigate-8, serum-20)
amod(levels-22, neurotoxic_esterase-21)
dobj(serum-20, levels-22)

A/DT total/NN of/IN 100/CD participants/NNS were/VBD enrolled/VBN in/IN the/DT study/NN ,/, and/CC their/PRP$ serum/NN levels/NNS of/IN these/DT biomarkers/NNS were/VBD measured/VBN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 100) (NNS participants))))
      (VP (VBD were)
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (PRP$ their) (NN serum) (NNS levels))
        (PP (IN of)
          (NP (DT these) (NNS biomarkers))))
      (VP (VBD were)
        (VP (VBN measured))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
case(participants-5, of-3)
nummod(participants-5, 100-4)
nmod:of(total-2, participants-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(study-10, in-8)
det(study-10, the-9)
nmod:in(enrolled-7, study-10)
cc(enrolled-7, and-12)
nmod:poss(levels-15, their-13)
compound(levels-15, serum-14)
nsubjpass(measured-20, levels-15)
case(biomarkers-18, of-16)
det(biomarkers-18, these-17)
nmod:of(levels-15, biomarkers-18)
auxpass(measured-20, were-19)
conj:and(enrolled-7, measured-20)

The/DT results/NNS showed/VBD a/DT positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, echothiophate/NN -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, and/CC serum/NN neurotoxic_esterase/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP
          (NP (DT a) (JJ positive) (NN correlation))
          (PP (IN between)
            (NP (NN serum) (NNS levels)))
          (PP (IN of)
            (NP (NN alkaline_phosphatase)))
          (PRN (-LRB- -LRB-)
            (SBAR
              (X (SYM r))
              (S
                (FRAG
                  (X (SYM =))
                  (NP (CD 0.3)))
                (, ,)
                (NP (NN p))
                (VP (VBP <)
                  (NP (CD 0.01)))))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN echothiophate))
          (PRN (-LRB- -LRB-)
            (SBAR
              (X (SYM r))
              (S
                (FRAG
                  (X (SYM =))
                  (NP (CD 0.42)))
                (, ,)
                (NP (NN p))
                (VP (VBP <)
                  (NP (CD 0.01)))))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP (NN serum) (NN neurotoxic_esterase) (NNS levels))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-6, a-4)
amod(correlation-6, positive-5)
dobj(showed-3, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(alkaline_phosphatase-11, of-10)
nmod:of(correlation-6, alkaline_phosphatase-11)
dep(<-18, r-13)
dep(0.3-15, =-14)
dep(<-18, 0.3-15)
nsubj(<-18, p-17)
dep(correlation-6, <-18)
dobj(<-18, 0.01-19)
dobj(showed-3, echothiophate-22)
conj:and(correlation-6, echothiophate-22)
dep(<-29, r-24)
dep(0.42-26, =-25)
dep(<-29, 0.42-26)
nsubj(<-29, p-28)
dep(echothiophate-22, <-29)
dobj(<-29, 0.01-30)
cc(correlation-6, and-33)
compound(levels-36, serum-34)
compound(levels-36, neurotoxic_esterase-35)
dobj(showed-3, levels-36)
conj:and(correlation-6, levels-36)

This/DT finding/NN suggests/VBZ that/IN these/DT biomarkers/NNS may/MD be/VB involved/VBN in_a/JJ common/JJ pathway/NN or/CC mechanism/NN in/IN the/DT body/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS biomarkers))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (NP (JJ in_a) (JJ common) (NN pathway)
                  (CC or)
                  (NN mechanism))
                (PP (IN in)
                  (NP (DT the) (NN body)))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(involved-9, that-4)
det(biomarkers-6, these-5)
nsubjpass(involved-9, biomarkers-6)
aux(involved-9, may-7)
auxpass(involved-9, be-8)
ccomp(suggests-3, involved-9)
amod(pathway-12, in_a-10)
amod(pathway-12, common-11)
dobj(involved-9, pathway-12)
cc(pathway-12, or-13)
dobj(involved-9, mechanism-14)
conj:or(pathway-12, mechanism-14)
case(body-17, in-15)
det(body-17, the-16)
nmod:in(involved-9, body-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC clinical/JJ implications/NNS of/IN this/DT correlation/NN in/IN different/JJ disease/NN states/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP
                      (NP (DT this) (NN correlation))
                      (PP (IN in)
                        (NP (JJ different) (NN disease) (NNS states))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-12, clinical-11)
dobj(elucidate-6, implications-12)
conj:and(mechanisms-9, implications-12)
case(correlation-15, of-13)
det(correlation-15, this-14)
nmod:of(implications-12, correlation-15)
case(states-19, in-16)
amod(states-19, different-17)
compound(states-19, disease-18)
nmod:in(correlation-15, states-19)

These/DT findings/NNS may/MD have/VB important/JJ implications/NNS for/IN the/DT diagnosis/NN and/CC treatment/NN of/IN diseases/NNS associated/VBN with/IN abnormal/JJ levels/NNS of/IN these/DT biomarkers/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN diagnosis)
                (CC and)
                (NN treatment))
              (PP (IN of)
                (NP
                  (NP (NNS diseases))
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP
                        (NP (JJ abnormal) (NNS levels))
                        (PP (IN of)
                          (NP (DT these) (NNS biomarkers)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(have-4, findings-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
amod(implications-6, important-5)
dobj(have-4, implications-6)
case(diagnosis-9, for-7)
det(diagnosis-9, the-8)
nmod:for(implications-6, diagnosis-9)
cc(diagnosis-9, and-10)
nmod:for(implications-6, treatment-11)
conj:and(diagnosis-9, treatment-11)
case(diseases-13, of-12)
nmod:of(diagnosis-9, diseases-13)
acl(diseases-13, associated-14)
case(levels-17, with-15)
amod(levels-17, abnormal-16)
nmod:with(associated-14, levels-17)
case(biomarkers-20, of-18)
det(biomarkers-20, these-19)
nmod:of(levels-17, biomarkers-20)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN various/JJ health/NN problems/NNS ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ various) (NN health) (NNS problems)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubjpass(associated-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
acl:relcl(metabolic_disorder-4, associated-7)
case(problems-11, with-8)
amod(problems-11, various-9)
compound(problems-11, health-10)
nmod:with(associated-7, problems-11)

The/DT role/NN of/IN pancreatic/JJ hormones/NNS in/IN the/DT development/NN of/IN obesity/JJ has_been/NN investigated/VBD previously/RB ,/, but/CC the/DT relationship/NN between/IN Hand_2/NNS and/CC obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN role))
        (PP (IN of)
          (NP
            (NP (JJ pancreatic) (NNS hormones))
            (PP (IN in)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (JJ obesity) (NN has_been))))))))
      (VP (VBD investigated)
        (ADVP (RB previously))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (DT the) (NN relationship))
        (PP (IN between)
          (NP (NNS Hand_2)
            (CC and)
            (NN obesity))))
      (VP (VBZ remains)
        (ADJP (JJ unclear))))
    (. .)))

det(role-2, The-1)
nsubj(investigated-12, role-2)
case(hormones-5, of-3)
amod(hormones-5, pancreatic-4)
nmod:of(role-2, hormones-5)
case(development-8, in-6)
det(development-8, the-7)
nmod:in(hormones-5, development-8)
case(has_been-11, of-9)
amod(has_been-11, obesity-10)
nmod:of(development-8, has_been-11)
root(ROOT-0, investigated-12)
advmod(investigated-12, previously-13)
cc(investigated-12, but-15)
det(relationship-17, the-16)
nsubj(remains-22, relationship-17)
case(Hand_2-19, between-18)
nmod:between(relationship-17, Hand_2-19)
cc(Hand_2-19, and-20)
nmod:between(relationship-17, obesity-21)
conj:and(Hand_2-19, obesity-21)
conj:but(investigated-12, remains-22)
xcomp(remains-22, unclear-23)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Hand_2/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS Hand_2)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(Hand_2-20, of-19)
nmod:of(hypersecretion-18, Hand_2-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ FK778/NN on/IN the/DT secretion/NN of/IN Hand_2/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN FK778)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ Hand_2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(FK778-17, 10-15)
amod(FK778-17, mmol/L-16)
nmod:of(effects-9, FK778-17)
conj:and(glucose-13, FK778-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, Hand_2-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN the/DT secretion/NN of/IN Hand_2/NNS was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN high/JJ glucose/NN conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (NNS Hand_2))))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP (JJ high) (NN glucose) (NNS conditions)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-15, that-4)
det(secretion-6, the-5)
nsubjpass(compared-15, secretion-6)
nsubj:xsubj(lean-17, secretion-6)
case(Hand_2-8, of-7)
nmod:of(secretion-6, Hand_2-8)
auxpass(compared-15, was-9)
advmod(higher-11, significantly-10)
advmod(compared-15, higher-11)
case(rats-14, in-12)
amod(rats-14, obese-13)
nmod:in(higher-11, rats-14)
ccomp(showed-3, compared-15)
mark(lean-17, to-16)
xcomp(compared-15, lean-17)
dobj(lean-17, rats-18)
case(conditions-22, under-19)
amod(conditions-22, high-20)
compound(conditions-22, glucose-21)
nmod:under(lean-17, conditions-22)

Furthermore/RB ,/, treatment/NN with/IN FK778/NNP resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN Hand_2/JJ secretion/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP FK778))))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (JJ Hand_2) (NN secretion))))
      (PP (IN in)
        (NP (DT both) (JJ obese)
          (CC and)
          (JJ lean) (NNS rats))))
    (. .)))

advmod(resulted-6, Furthermore-1)
nsubj(resulted-6, treatment-3)
case(FK778-5, with-4)
nmod:with(treatment-3, FK778-5)
root(ROOT-0, resulted-6)
amod(decrease-9, in_a-7)
amod(decrease-9, significant-8)
dobj(resulted-6, decrease-9)
case(secretion-12, in-10)
amod(secretion-12, Hand_2-11)
nmod:in(decrease-9, secretion-12)
case(rats-18, in-13)
det(rats-18, both-14)
amod(rats-18, obese-15)
cc(obese-15, and-16)
conj:and(obese-15, lean-17)
amod(rats-18, lean-17)
nmod:in(resulted-6, rats-18)

Interestingly/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN insulin_secretion/NN between/IN obese/JJ and/CC lean/JJ rats/NNS under/IN any/DT experimental/JJ condition/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (NN insulin_secretion)))
        (PP (IN between)
          (NP (JJ obese)
            (CC and)
            (JJ lean) (NNS rats))))
      (PP (IN under)
        (NP (DT any) (JJ experimental) (NN condition))))
    (. .)))

advmod(was-4, Interestingly-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(insulin_secretion-9, in-8)
nmod:in(difference-7, insulin_secretion-9)
case(rats-14, between-10)
amod(rats-14, obese-11)
cc(obese-11, and-12)
conj:and(obese-11, lean-13)
amod(rats-14, lean-13)
nmod:between(difference-7, rats-14)
case(condition-18, under-15)
det(condition-18, any-16)
amod(condition-18, experimental-17)
nmod:under(was-4, condition-18)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN Hand_2/NNS may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, and/CC targeting/VBG Hand_2/JJ secretion/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN treating/VBG obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NNS Hand_2))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity)))))))))
          (, ,)
          (CC and)
          (S
            (S
              (VP (VBG targeting)
                (NP (JJ Hand_2) (NN secretion))))
            (VP (MD may)
              (VP (VB be)
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG treating)
                      (NP (NNS obesity-related_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-10, that-4)
nsubjpass(involved-10, hypersecretion-5)
case(Hand_2-7, of-6)
nmod:of(hypersecretion-5, Hand_2-7)
aux(involved-10, may-8)
auxpass(involved-10, be-9)
ccomp(suggest-3, involved-10)
case(development-13, in-11)
det(development-13, the-12)
nmod:in(involved-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(involved-10, and-17)
csubj(strategy-26, targeting-18)
amod(secretion-20, Hand_2-19)
dobj(targeting-18, secretion-20)
aux(strategy-26, may-21)
cop(strategy-26, be-22)
det(strategy-26, a-23)
amod(strategy-26, potential-24)
amod(strategy-26, therapeutic-25)
ccomp(suggest-3, strategy-26)
conj:and(involved-10, strategy-26)
mark(treating-28, for-27)
advcl(strategy-26, treating-28)
dobj(treating-28, obesity-related_disorders-29)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN various/JJ health/NN problems/NNS ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ various) (NN health) (NNS problems)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubjpass(associated-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
acl:relcl(metabolic_disorder-4, associated-7)
case(problems-11, with-8)
amod(problems-11, various-9)
compound(problems-11, health-10)
nmod:with(associated-7, problems-11)

The/DT pathogenesis/NN of/IN obesity/NN involves/VBZ the/DT interaction/NN of/IN genetic/JJ ,/, environmental/JJ ,/, and/CC lifestyle/NN factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathogenesis))
      (PP (IN of)
        (NP (NN obesity))))
    (VP (VBZ involves)
      (NP
        (NP (DT the) (NN interaction))
        (PP (IN of)
          (NP
            (UCP
              (ADJP (JJ genetic))
              (, ,)
              (ADJP (JJ environmental))
              (, ,)
              (CC and)
              (NP (NN lifestyle)))
            (NNS factors)))))
    (. .)))

det(pathogenesis-2, The-1)
nsubj(involves-5, pathogenesis-2)
case(obesity-4, of-3)
nmod:of(pathogenesis-2, obesity-4)
root(ROOT-0, involves-5)
det(interaction-7, the-6)
dobj(involves-5, interaction-7)
case(factors-15, of-8)
amod(factors-15, genetic-9)
conj:and(genetic-9, environmental-11)
amod(factors-15, environmental-11)
cc(genetic-9, and-13)
conj:and(genetic-9, lifestyle-14)
amod(factors-15, lifestyle-14)
nmod:of(interaction-7, factors-15)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN CDC-27/NN by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN CDC-27))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-14, that-5)
det(hypersecretion-7, the-6)
nsubj(play-14, hypersecretion-7)
case(CDC-27-9, of-8)
nmod:of(hypersecretion-7, CDC-27-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(CDC-27-9, pancreas-12)
aux(play-14, may-13)
ccomp(suggested-4, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
case(development-19, in-17)
det(development-19, the-18)
nmod:in(role-16, development-19)
case(obesity-21, of-20)
nmod:of(development-19, obesity-21)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN CDC-27/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN CDC-27)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(CDC-27-20, of-19)
nmod:of(hypersecretion-18, CDC-27-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN APC/NNP on/IN the/DT secretion/NN of/IN CDC-27/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP APC)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN CDC-27) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(APC-16, 10-14)
compound(APC-16, mmol/L-15)
nmod:of(effects-8, APC-16)
conj:and(glucose-12, APC-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, CDC-27-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN CDC-27/JJ secretion/NN in/IN response/NN to/TO glucose/NN and/CC APC/NNP stimulation/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ CDC-27) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (NN glucose))
                    (CC and)
                    (NP (NNP APC) (NN stimulation))))))
            (PP (IN in)
              (NP (JJ obese) (NNS rats)))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, CDC-27-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(glucose-16, to-15)
nmod:to(response-14, glucose-16)
cc(glucose-16, and-17)
compound(stimulation-19, APC-18)
nmod:to(response-14, stimulation-19)
conj:and(glucose-16, stimulation-19)
case(rats-22, in-20)
amod(rats-22, obese-21)
nmod:in(was-6, rats-22)
case(rats-26, compared-23)
mwe(compared-23, to-24)
amod(rats-26, lean-25)
advcl(was-6, rats-26)

However/RB ,/, insulin_secretion/NN was/VBD not/RB significantly/RB different/JJ between/IN obese/JJ and/CC lean/JJ rats/NNS under/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (ADVP (RB not))
      (ADJP (RB significantly) (JJ different)
        (PP (IN between)
          (NP (JJ obese)
            (CC and)
            (JJ lean) (NNS rats))))
      (PP (IN under)
        (NP (DT these) (NNS conditions))))
    (. .)))

advmod(different-7, However-1)
nsubj(different-7, insulin_secretion-3)
cop(different-7, was-4)
neg(different-7, not-5)
advmod(different-7, significantly-6)
root(ROOT-0, different-7)
case(rats-12, between-8)
amod(rats-12, obese-9)
cc(obese-9, and-10)
conj:and(obese-9, lean-11)
amod(rats-12, lean-11)
nmod:between(different-7, rats-12)
case(conditions-15, under-13)
det(conditions-15, these-14)
nmod:under(different-7, conditions-15)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN CDC-27/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ,/, and/CC further/JJ investigation/NN is/VBZ needed/VBN to/TO elucidate/VB its/PRP$ underlying/VBG mechanisms/NNS ./.

(ROOT
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN CDC-27))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NNS pathogenesis))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (, ,)
    (CC and)
    (S
      (NP (JJ further) (NN investigation))
      (VP (VBZ is)
        (VP (VBN needed)
          (S
            (VP (TO to)
              (VP (VB elucidate)
                (NP (PRP$ its) (VBG underlying) (NNS mechanisms))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(CDC-27-7, of-6)
nmod:of(hypersecretion-5, CDC-27-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(CDC-27-7, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(pathogenesis-16, in-14)
det(pathogenesis-16, the-15)
nmod:in(involved-13, pathogenesis-16)
case(obesity-18, of-17)
nmod:of(pathogenesis-16, obesity-18)
cc(suggest-3, and-20)
amod(investigation-22, further-21)
nsubjpass(needed-24, investigation-22)
nsubj:xsubj(elucidate-26, investigation-22)
auxpass(needed-24, is-23)
conj:and(suggest-3, needed-24)
mark(elucidate-26, to-25)
xcomp(needed-24, elucidate-26)
nmod:poss(mechanisms-29, its-27)
amod(mechanisms-29, underlying-28)
dobj(elucidate-26, mechanisms-29)

Cerebral_cysticercosis/JJ is_a/NN parasitic_infection/NNS of/IN the/DT central/JJ nervous/JJ system/NN caused/VBN by/IN Taenia_solium/NNP tapeworm/VBP larvae/JJ ./.

(ROOT
  (S
    (NP
      (NP (JJ Cerebral_cysticercosis) (NN is_a) (NNS parasitic_infection))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ central) (JJ nervous) (NN system))
          (VP (VBN caused)
            (PP (IN by)
              (NP (NNP Taenia_solium)))))))
    (VP (VBP tapeworm)
      (ADJP (JJ larvae)))
    (. .)))

amod(parasitic_infection-3, Cerebral_cysticercosis-1)
compound(parasitic_infection-3, is_a-2)
nsubj(tapeworm-12, parasitic_infection-3)
case(system-8, of-4)
det(system-8, the-5)
amod(system-8, central-6)
amod(system-8, nervous-7)
nmod:of(parasitic_infection-3, system-8)
acl(system-8, caused-9)
case(Taenia_solium-11, by-10)
nmod:by(caused-9, Taenia_solium-11)
root(ROOT-0, tapeworm-12)
xcomp(tapeworm-12, larvae-13)

Albendazole/JJ sulfoxide/NN is/VBZ an/DT anthelmintic/JJ drug/NN commonly/RB used/VBN to/TO treat/VB this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Albendazole) (NN sulfoxide))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ anthelmintic) (NN drug))
        (VP
          (ADVP (RB commonly))
          (VBN used)
          (S
            (VP (TO to)
              (VP (VB treat)
                (NP (DT this) (NN condition))))))))
    (. .)))

amod(sulfoxide-2, Albendazole-1)
nsubj(drug-6, sulfoxide-2)
cop(drug-6, is-3)
det(drug-6, an-4)
amod(drug-6, anthelmintic-5)
root(ROOT-0, drug-6)
advmod(used-8, commonly-7)
acl(drug-6, used-8)
mark(treat-10, to-9)
xcomp(used-8, treat-10)
det(condition-12, this-11)
dobj(treat-10, condition-12)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN albendazole_sulfoxide/NN on/IN the/DT risk/NN reduction/NN of/IN cerebral_cysticercosis/NNS and/CC associated/VBN symptoms/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN albendazole_sulfoxide))
          (PP (IN on)
            (NP
              (NP (DT the) (NN risk) (NN reduction))
              (PP (IN of)
                (NP
                  (NP (NNS cerebral_cysticercosis))
                  (CC and)
                  (NP (VBN associated) (NNS symptoms)))))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-19, study-3)
det(effect-6, the-5)
nsubjpass(investigated-19, effect-6)
case(albendazole_sulfoxide-8, of-7)
nmod:of(effect-6, albendazole_sulfoxide-8)
case(reduction-12, on-9)
det(reduction-12, the-10)
compound(reduction-12, risk-11)
nmod:on(albendazole_sulfoxide-8, reduction-12)
case(cerebral_cysticercosis-14, of-13)
nmod:of(reduction-12, cerebral_cysticercosis-14)
cc(cerebral_cysticercosis-14, and-15)
amod(symptoms-17, associated-16)
nmod:of(reduction-12, symptoms-17)
conj:and(cerebral_cysticercosis-14, symptoms-17)
auxpass(investigated-19, was-18)
root(ROOT-0, investigated-19)

The/DT results/NNS showed/VBD that/WDT at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, albendazole_sulfoxide/VBP reduced/VBN the/DT risk/NN of/IN cerebral_cysticercosis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (WDT that)
          (NX
            (NX
              (NX
                (NP (IN at) (CD 2) (NNS hours))
                (SBAR (IN after)
                  (S
                    (S
                      (VP (VBG dosing)))
                    (, ,)
                    (VP (VBP albendazole_sulfoxide)
                      (VP (VBN reduced)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNS cerebral_cysticercosis))))
                        (PP (IN by)
                          (NP (CD 14) (NN %))))))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))
                (-RRB- -RRB-)))
            (, ,)
            (NX
              (NX
                (NX (NN photophobia))
                (PP (IN by)
                  (NP (CD 17) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 12-22) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NX
              (NX (NN phonophobia))
              (PP (IN by)
                (NP (CD 14) (NN %))))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 95) (NN %))
            (PP (NNP CI)
              (NP (CD 17-20) (NN %))))
          (, ,)
          (NP (NNP P)
            (QP (CD <) (CD 0.0001)))
          (-RRB- -RRB-))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
dep(hours-7, that-4)
amod(hours-7, at-5)
nummod(hours-7, 2-6)
dobj(showed-3, hours-7)
mark(albendazole_sulfoxide-11, after-8)
dep(albendazole_sulfoxide-11, dosing-9)
dep(hours-7, albendazole_sulfoxide-11)
dep(albendazole_sulfoxide-11, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(cerebral_cysticercosis-16, of-15)
nmod:of(risk-14, cerebral_cysticercosis-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
nsubj(CI-23, %-22)
dep(hours-7, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
dobj(showed-3, photophobia-32)
conj:and(hours-7, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
nsubj(CI-39, %-38)
dep(photophobia-32, CI-39)
nummod(%-41, 12-22-40)
dobj(CI-39, %-41)
nsubj(<-44, P-43)
dep(CI-39, <-44)
dobj(<-44, 0.0001-45)
cc(hours-7, and-48)
dobj(showed-3, phonophobia-49)
conj:and(hours-7, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(hours-7, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN albendazole_sulfoxide/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN reducing/VBG the/DT risk/NN of/IN cerebral_cysticercosis/NNS and/CC associated/VBN symptoms/NNS in/IN infected/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN albendazole_sulfoxide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (NNS cerebral_cysticercosis))
                            (CC and)
                            (NP (VBN associated) (NNS symptoms)))))
                      (PP (IN in)
                        (NP (JJ infected) (NNS individuals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, albendazole_sulfoxide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(cerebral_cysticercosis-17, of-16)
nmod:of(risk-15, cerebral_cysticercosis-17)
cc(cerebral_cysticercosis-17, and-18)
amod(symptoms-20, associated-19)
nmod:of(risk-15, symptoms-20)
conj:and(cerebral_cysticercosis-17, symptoms-20)
case(individuals-23, in-21)
amod(individuals-23, infected-22)
nmod:in(reducing-13, individuals-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ effects/NNS of/IN albendazole_sulfoxide/NN on/IN cerebral_cysticercosis/NNS and/CC its/PRP$ associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (PP (IN of)
                  (NP (NN albendazole_sulfoxide)))
                (PP (IN on)
                  (NP
                    (NP (NNS cerebral_cysticercosis))
                    (CC and)
                    (NP (PRP$ its) (VBN associated) (NNS symptoms))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(investigate-6, effects-9)
case(albendazole_sulfoxide-11, of-10)
nmod:of(effects-9, albendazole_sulfoxide-11)
case(cerebral_cysticercosis-13, on-12)
nmod:on(effects-9, cerebral_cysticercosis-13)
cc(cerebral_cysticercosis-13, and-14)
nmod:poss(symptoms-17, its-15)
amod(symptoms-17, associated-16)
nmod:on(effects-9, symptoms-17)
conj:and(cerebral_cysticercosis-13, symptoms-17)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN linked/VBN to/TO various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP (JJ various) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(linked-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(linked-16, have-14)
auxpass(linked-16, been-15)
root(ROOT-0, linked-16)
case(benefits-20, to-17)
amod(benefits-20, various-18)
compound(benefits-20, health-19)
nmod:to(linked-16, benefits-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Acetylhydroxamic_acid/JJ levels/NNS in/IN hyperAcetylhydroxamic/JJ acidmic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Acetylhydroxamic_acid) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperAcetylhydroxamic) (JJ acidmic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP
                                      (NP (DT a) (VBN reduced) (NN risk))
                                      (PP (IN of)
                                        (S
                                          (VP (VBG developing)
                                            (NP (NN coronary_heart_disease))))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, Acetylhydroxamic_acid-13)
nmod:with(associated-10, levels-14)
case(patients-18, in-15)
amod(patients-18, hyperAcetylhydroxamic-16)
amod(patients-18, acidmic-17)
nmod:in(levels-14, patients-18)
nsubj(contribute-22, patients-18)
ref(patients-18, which-20)
aux(contribute-22, may-21)
acl:relcl(patients-18, contribute-22)
case(risk-26, to-23)
det(risk-26, a-24)
amod(risk-26, reduced-25)
nmod:to(contribute-22, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, coronary_heart_disease-29)
appos(risk-26, CHD-31)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ properties/NNS ,/, which/WDT may/MD explain/VB their/PRP$ protective/JJ effects/NNS against/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ anti-inflammatory) (NNS properties))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB explain)
                        (NP
                          (NP (PRP$ their) (JJ protective) (NNS effects))
                          (PP (IN against)
                            (NP (NNP CHD))))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(have-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(have-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(have-7, to-6)
xcomp(known-5, have-7)
amod(properties-9, anti-inflammatory-8)
dobj(have-7, properties-9)
nsubj(explain-13, properties-9)
ref(properties-9, which-11)
aux(explain-13, may-12)
acl:relcl(properties-9, explain-13)
nmod:poss(effects-16, their-14)
amod(effects-16, protective-15)
dobj(explain-13, effects-16)
case(CHD-18, against-17)
nmod:against(effects-16, CHD-18)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS ,/, reduce/VB blood_pressure/NN ,/, and/CC decrease/VB the/DT risk/NN of/IN arrhythmias/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP (NN blood_pressure)))
                (, ,)
                (CC and)
                (VP (VB decrease)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS arrhythmias)))))))))))
    (. .)))

advmod(shown-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(improve-9, fatty_acids-4)
nsubj:xsubj(reduce-13, fatty_acids-4)
nsubj:xsubj(decrease-17, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
xcomp(shown-7, reduce-13)
conj:and(improve-9, reduce-13)
dobj(reduce-13, blood_pressure-14)
cc(improve-9, and-16)
xcomp(shown-7, decrease-17)
conj:and(improve-9, decrease-17)
det(risk-19, the-18)
dobj(decrease-17, risk-19)
case(arrhythmias-21, of-20)
nmod:of(risk-19, arrhythmias-21)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG and/CC managing/VBG CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG preventing)
                      (CC and)
                      (VBG managing)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, promising-14)
ccomp(suggest-3, strategy-15)
mark(preventing-17, for-16)
acl(strategy-15, preventing-17)
cc(preventing-17, and-18)
acl(strategy-15, managing-19)
conj:and(preventing-17, managing-19)
dobj(preventing-17, CHD-20)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN multiple/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP (JJ multiple) (VBG signaling) (NNS pathways)))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, multiple-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)

Ceramide_kinase/NNP -LRB-/-LRB- CERK/NNP -RRB-/-RRB- has_been/VBP shown/VBN to/TO play/VB an/DT important/JJ role/NN in/IN regulating/VBG skeletal_muscle/JJ differentiation/NN through/IN its/PRP$ involvement/NN in/IN the/DT sphingolipid/JJ signaling/VBG pathway/NN ./.

(ROOT
  (S
    (NP (NNP Ceramide_kinase) (-LRB- -LRB-)
      (NP (NNP CERK))
      (-RRB- -RRB-))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ skeletal_muscle) (NN differentiation))
                      (PP (IN through)
                        (NP
                          (NP (PRP$ its) (NN involvement))
                          (PP (IN in)
                            (NP (DT the) (JJ sphingolipid) (VBG signaling) (NN pathway))))))))))))))
    (. .)))

nsubj(has_been-5, Ceramide_kinase-1)
dep(Ceramide_kinase-1, CERK-3)
root(ROOT-0, has_been-5)
dep(has_been-5, shown-6)
mark(play-8, to-7)
xcomp(shown-6, play-8)
det(role-11, an-9)
amod(role-11, important-10)
dobj(play-8, role-11)
mark(regulating-13, in-12)
acl(role-11, regulating-13)
amod(differentiation-15, skeletal_muscle-14)
dobj(regulating-13, differentiation-15)
case(involvement-18, through-16)
nmod:poss(involvement-18, its-17)
nmod:through(regulating-13, involvement-18)
case(pathway-23, in-19)
det(pathway-23, the-20)
amod(pathway-23, sphingolipid-21)
amod(pathway-23, signaling-22)
nmod:in(involvement-18, pathway-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN L-165041/NNP ,/, a/DT selective/JJ CERK/NN activator/NN ,/, on/IN C2C12/NNP cell/NN differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP L-165041))
            (, ,)
            (NP (DT a) (JJ selective) (NN CERK) (NN activator))
            (, ,))))
      (PP (IN on)
        (NP (NNP C2C12) (NN cell) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(L-165041-10, of-9)
nmod:of(effect-8, L-165041-10)
det(activator-15, a-12)
amod(activator-15, selective-13)
compound(activator-15, CERK-14)
appos(L-165041-10, activator-15)
case(differentiation-20, on-17)
compound(differentiation-20, C2C12-18)
compound(differentiation-20, cell-19)
nmod:on(investigated-6, differentiation-20)

Our/PRP$ results/NNS showed/VBD that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, L-165041/NN up-regulated/JJ CERK/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ CERK/NN protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NX (NN L-165041)))
                (NX
                  (NX
                    (NX (JJ up-regulated) (NNP CERK) (NN protein) (NNS levels) (NN in_a))
                    (NP (JJ time-dependent) (NN manner)))
                  (CC and)
                  (NX (JJ prolonged) (NN CERK))
                  (NX (NN protein) (NN half-life))))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(cultured-9, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
ccomp(showed-3, cultured-9)
dep(half-life-38, in_a-10)
compound(differentiation-13, medium-11)
amod(differentiation-13, favoring-12)
dep(L-165041-26, differentiation-13)
dep(differentiation-13, Dulbecco-15)
case(medium-18, modified-16)
compound(medium-18, Eagle-17)
nmod:modified(Dulbecco-15, medium-18)
acl(medium-18, containing-19)
compound(%-21, 2-20)
amod(serum-23, %-21)
compound(serum-23, horse-22)
dobj(containing-19, serum-23)
dep(half-life-38, L-165041-26)
amod(in_a-31, up-regulated-27)
compound(in_a-31, CERK-28)
compound(in_a-31, protein-29)
compound(in_a-31, levels-30)
dep(half-life-38, in_a-31)
amod(manner-33, time-dependent-32)
dep(in_a-31, manner-33)
cc(half-life-38, and-34)
amod(CERK-36, prolonged-35)
dobj(cultured-9, CERK-36)
conj:and(half-life-38, CERK-36)
compound(half-life-38, protein-37)
dobj(cultured-9, half-life-38)
case(hours-43, from-39)
compound(18-42, 10-40)
dep(18-42, to-41)
nummod(hours-43, 18-42)
nmod:from(cultured-9, hours-43)

These/DT findings/NNS suggest/VBP that/IN L-165041/NNP may/MD enhance/VB skeletal_muscle/JJ differentiation/NN by/IN activating/VBG the/DT sphingolipid/NN signaling/VBG pathway/RB through/IN up-regulation/NN of/IN CERK/NNP protein/NN levels/NNS and/CC prolongation/NN of/IN its/PRP$ half-life/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP L-165041))
          (VP (MD may)
            (VP (VB enhance)
              (NP (JJ skeletal_muscle) (NN differentiation))
              (PP (IN by)
                (S
                  (VP (VBG activating)
                    (NP (DT the) (NN sphingolipid))
                    (S
                      (VP (VBG signaling)
                        (ADVP (RB pathway))
                        (PP (IN through)
                          (NP
                            (NP
                              (NP (NN up-regulation))
                              (PP (IN of)
                                (NP (NNP CERK) (NN protein) (NNS levels))))
                            (CC and)
                            (NP
                              (NP (NN prolongation))
                              (PP (IN of)
                                (NP (PRP$ its) (NN half-life))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(enhance-7, that-4)
nsubj(enhance-7, L-165041-5)
aux(enhance-7, may-6)
ccomp(suggest-3, enhance-7)
amod(differentiation-9, skeletal_muscle-8)
dobj(enhance-7, differentiation-9)
mark(activating-11, by-10)
advcl(enhance-7, activating-11)
det(sphingolipid-13, the-12)
dobj(activating-11, sphingolipid-13)
advcl(activating-11, signaling-14)
advmod(signaling-14, pathway-15)
case(up-regulation-17, through-16)
nmod:through(signaling-14, up-regulation-17)
case(levels-21, of-18)
compound(levels-21, CERK-19)
compound(levels-21, protein-20)
nmod:of(up-regulation-17, levels-21)
cc(up-regulation-17, and-22)
nmod:through(signaling-14, prolongation-23)
conj:and(up-regulation-17, prolongation-23)
case(half-life-26, of-24)
nmod:poss(half-life-26, its-25)
nmod:of(prolongation-23, half-life-26)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO investigate/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN L-165041/NN in/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP
                    (NP (NN L-165041))
                    (PP (IN in)
                      (NP (JJ skeletal_muscle) (NNS disorders)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(investigate-6, to-5)
xcomp(warranted-4, investigate-6)
det(applications-10, the-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(investigate-6, applications-10)
case(L-165041-12, of-11)
nmod:of(applications-10, L-165041-12)
case(disorders-15, in-13)
amod(disorders-15, skeletal_muscle-14)
nmod:in(L-165041-12, disorders-15)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN associated/VBN with/IN several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ several) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(associated-20, nutrients-16)
ref(nutrients-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(nutrients-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, several-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN can/MD decrease/VB dyazide/JJ levels/NNS in/IN hyperdyazidemic/JJ patients/NNS ,/, which/WDT may/MD help/VB prevent/VB the/DT development/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD can)
              (VP (VB decrease)
                (NP
                  (NP (JJ dyazide) (NNS levels))
                  (PP (IN in)
                    (NP
                      (NP (JJ hyperdyazidemic) (NNS patients))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD may)
                            (VP (VB help)
                              (VP (VB prevent)
                                (NP
                                  (NP
                                    (NP (DT the) (NN development))
                                    (PP (IN of)
                                      (NP (NN coronary_heart_disease))))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP CHD))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(decrease-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubj(decrease-10, omega-3_fatty_acids-8)
aux(decrease-10, can-9)
ccomp(shown-4, decrease-10)
amod(levels-12, dyazide-11)
dobj(decrease-10, levels-12)
case(patients-15, in-13)
amod(patients-15, hyperdyazidemic-14)
nmod:in(levels-12, patients-15)
nsubj(help-19, patients-15)
ref(patients-15, which-17)
aux(help-19, may-18)
acl:relcl(patients-15, help-19)
xcomp(help-19, prevent-20)
det(development-22, the-21)
dobj(prevent-20, development-22)
case(coronary_heart_disease-24, of-23)
nmod:of(development-22, coronary_heart_disease-24)
appos(development-22, CHD-26)

EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN linked/VBN to/TO other/JJ cardiovascular_benefits/NNS ,/, such/JJ as/IN reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC reducing/VBG blood_pressure/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (JJ other) (NNS cardiovascular_benefits))
              (, ,)
              (PP (JJ such) (IN as)
                (S
                  (VP
                    (VP (VBG reducing)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VBG improving)
                      (NP (NN lipid) (NNS profiles)))
                    (, ,)
                    (CC and)
                    (VP (VBG reducing)
                      (NP (NN blood_pressure)))))))))))
    (. .)))

nsubjpass(linked-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(linked-7, DHA-3)
aux(linked-7, have-4)
advmod(linked-7, also-5)
auxpass(linked-7, been-6)
root(ROOT-0, linked-7)
case(cardiovascular_benefits-10, to-8)
amod(cardiovascular_benefits-10, other-9)
nmod:to(linked-7, cardiovascular_benefits-10)
mark(reducing-14, such-12)
mwe(such-12, as-13)
acl(cardiovascular_benefits-10, reducing-14)
dobj(reducing-14, inflammation-15)
acl(cardiovascular_benefits-10, improving-17)
conj:and(reducing-14, improving-17)
compound(profiles-19, lipid-18)
dobj(improving-17, profiles-19)
cc(reducing-14, and-21)
acl(cardiovascular_benefits-10, reducing-22)
conj:and(reducing-14, reducing-22)
dobj(reducing-22, blood_pressure-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC managing/VBG hypertension/NN in/IN hyperdyazidemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG preventing)
                      (NP (NNP CHD)))
                    (CC and)
                    (VP (VBG managing)
                      (NP
                        (NP (NN hypertension))
                        (PP (IN in)
                          (NP (JJ hyperdyazidemic) (NNS patients)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-22, that-4)
csubj(strategy-22, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(sources-14, through-12)
amod(sources-14, dietary-13)
nmod:through(increasing-5, sources-14)
cc(sources-14, or-15)
nmod:through(increasing-5, supplementation-16)
conj:or(sources-14, supplementation-16)
aux(strategy-22, may-17)
cop(strategy-22, be-18)
det(strategy-22, a-19)
amod(strategy-22, potential-20)
amod(strategy-22, therapeutic-21)
ccomp(suggest-3, strategy-22)
mark(preventing-24, for-23)
advcl(strategy-22, preventing-24)
dobj(preventing-24, CHD-25)
cc(preventing-24, and-26)
advcl(strategy-22, managing-27)
conj:and(preventing-24, managing-27)
dobj(managing-27, hypertension-28)
case(patients-31, in-29)
amod(patients-31, hyperdyazidemic-30)
nmod:in(hypertension-28, patients-31)

Further/RB research/NN is/VBZ needed/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO optimize/VB dosages/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP (NNS dosages))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(mechanisms-8, the-7)
dobj(explore-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(explore-6, and-12)
mark(optimize-14, to-13)
ccomp(needed-4, optimize-14)
conj:and(explore-6, optimize-14)
dobj(optimize-14, dosages-15)
case(use-18, for-16)
amod(use-18, clinical-17)
nmod:for(optimize-14, use-18)

The/DT enzyme/JJ N-acetyl-4-S-cysteaminylphenolidase/NNS -LRB-/-LRB- NACAP/NNP -RRB-/-RRB- has_been/VBP known/VBN to/TO have/VB hydrolase/JJ activity/NN in/IN the/DT metabolism/NN of/IN N-acetyl-4-S-cysteaminylphenol/NNS -LRB-/-LRB- NACAP/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ enzyme) (NNS N-acetyl-4-S-cysteaminylphenolidase))
      (PRN (-LRB- -LRB-)
        (NP (NNP NACAP))
        (-RRB- -RRB-)))
    (VP (VBP has_been)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP (JJ hydrolase) (NN activity))
              (PP (IN in)
                (NP
                  (NP
                    (NP (DT the) (NN metabolism))
                    (PP (IN of)
                      (NP (NNS N-acetyl-4-S-cysteaminylphenol))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP NACAP))
                    (-RRB- -RRB-)))))))))
    (. .)))

det(N-acetyl-4-S-cysteaminylphenolidase-3, The-1)
amod(N-acetyl-4-S-cysteaminylphenolidase-3, enzyme-2)
nsubj(has_been-7, N-acetyl-4-S-cysteaminylphenolidase-3)
appos(N-acetyl-4-S-cysteaminylphenolidase-3, NACAP-5)
root(ROOT-0, has_been-7)
dep(has_been-7, known-8)
mark(have-10, to-9)
xcomp(known-8, have-10)
amod(activity-12, hydrolase-11)
dobj(have-10, activity-12)
case(metabolism-15, in-13)
det(metabolism-15, the-14)
nmod:in(have-10, metabolism-15)
case(N-acetyl-4-S-cysteaminylphenol-17, of-16)
nmod:of(metabolism-15, N-acetyl-4-S-cysteaminylphenol-17)
appos(metabolism-15, NACAP-19)

However/RB ,/, recent/JJ studies/NNS have/VBP revealed/VBN that/IN human/JJ serum/NN NACAP/VBP also/RB has/VBZ transferase/JJ activity/NN towards/IN N-acetyl-4-S-cysteaminylphenolyl/NNS ,/, which/WDT opens/VBZ up/RP new/JJ possibilities/NNS for/IN the/DT role/NN of/IN NACAP/NNP in/IN NACAP/NNP metabolism/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN revealed)
        (SBAR (IN that)
          (S
            (NP (JJ human) (NN serum))
            (VP (VBP NACAP)
              (VP
                (ADVP (RB also))
                (VBZ has)
                (NP
                  (NP (JJ transferase) (NN activity))
                  (PP (IN towards)
                    (NP
                      (NP (NNS N-acetyl-4-S-cysteaminylphenolyl))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (VBZ opens)
                            (PRT (RP up))
                            (NP (JJ new) (NNS possibilities))
                            (PP (IN for)
                              (NP
                                (NP (DT the) (NN role))
                                (PP (IN of)
                                  (NP (NNP NACAP)))
                                (PP (IN in)
                                  (NP (NNP NACAP) (NN metabolism)))))))))))))))))
    (. .)))

advmod(revealed-6, However-1)
amod(studies-4, recent-3)
nsubj(revealed-6, studies-4)
aux(revealed-6, have-5)
root(ROOT-0, revealed-6)
mark(NACAP-10, that-7)
amod(serum-9, human-8)
nsubj(NACAP-10, serum-9)
ccomp(revealed-6, NACAP-10)
advmod(has-12, also-11)
dep(NACAP-10, has-12)
amod(activity-14, transferase-13)
dobj(has-12, activity-14)
case(N-acetyl-4-S-cysteaminylphenolyl-16, towards-15)
nmod:towards(activity-14, N-acetyl-4-S-cysteaminylphenolyl-16)
nsubj(opens-19, N-acetyl-4-S-cysteaminylphenolyl-16)
ref(N-acetyl-4-S-cysteaminylphenolyl-16, which-18)
acl:relcl(N-acetyl-4-S-cysteaminylphenolyl-16, opens-19)
compound:prt(opens-19, up-20)
amod(possibilities-22, new-21)
dobj(opens-19, possibilities-22)
case(role-25, for-23)
det(role-25, the-24)
nmod:for(opens-19, role-25)
case(NACAP-27, of-26)
nmod:of(role-25, NACAP-27)
case(metabolism-30, in-28)
compound(metabolism-30, NACAP-29)
nmod:in(role-25, metabolism-30)

This/DT discovery/NN sheds/VBZ light/NN on/IN the/DT previously/RB unknown/JJ mechanisms/NNS involved/VBN in/IN the/DT regulation/NN of/IN NACAP/NNP levels/NNS and/CC may/MD provide/VB new/JJ avenues/NNS for/IN therapeutic/JJ interventions/NNS targeting/VBG disorders/NNS involving/VBG aberrant/JJ NACAP/NNP metabolism/NN ./.

(ROOT
  (S
    (NP (DT This) (NN discovery))
    (VP
      (VP (VBZ sheds)
        (NP
          (NP (NN light))
          (PP (IN on)
            (NP
              (NP (DT the)
                (ADJP (RB previously) (JJ unknown))
                (NNS mechanisms))
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NNP NACAP) (NNS levels))))))))))
      (CC and)
      (VP (MD may)
        (VP (VB provide)
          (NP (JJ new) (NNS avenues))
          (PP (IN for)
            (NP
              (NP (JJ therapeutic) (NNS interventions))
              (VP (VBG targeting)
                (NP
                  (NP (NNS disorders))
                  (VP (VBG involving)
                    (NP (JJ aberrant) (NNP NACAP) (NN metabolism))))))))))
    (. .)))

det(discovery-2, This-1)
nsubj(sheds-3, discovery-2)
nsubj(provide-19, discovery-2)
root(ROOT-0, sheds-3)
dobj(sheds-3, light-4)
case(mechanisms-9, on-5)
det(mechanisms-9, the-6)
advmod(unknown-8, previously-7)
amod(mechanisms-9, unknown-8)
nmod:on(light-4, mechanisms-9)
acl(mechanisms-9, involved-10)
case(regulation-13, in-11)
det(regulation-13, the-12)
nmod:in(involved-10, regulation-13)
case(levels-16, of-14)
compound(levels-16, NACAP-15)
nmod:of(regulation-13, levels-16)
cc(sheds-3, and-17)
aux(provide-19, may-18)
conj:and(sheds-3, provide-19)
amod(avenues-21, new-20)
dobj(provide-19, avenues-21)
case(interventions-24, for-22)
amod(interventions-24, therapeutic-23)
nmod:for(provide-19, interventions-24)
acl(interventions-24, targeting-25)
dobj(targeting-25, disorders-26)
acl(disorders-26, involving-27)
amod(metabolism-30, aberrant-28)
compound(metabolism-30, NACAP-29)
dobj(involving-27, metabolism-30)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT dual/JJ activity/NN of/IN NACAP/NNP and/CC its/PRP$ implications/NNS in/IN health/NN and_disease/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT this) (JJ dual) (NN activity))
                      (PP (IN of)
                        (NP (NNP NACAP))))))
                (CC and)
                (NP
                  (NP (PRP$ its) (NNS implications))
                  (PP (IN in)
                    (NP (NN health) (NN and_disease))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(activity-13, this-11)
amod(activity-13, dual-12)
dobj(underlying-10, activity-13)
case(NACAP-15, of-14)
nmod:of(activity-13, NACAP-15)
cc(mechanisms-9, and-16)
nmod:poss(implications-18, its-17)
dobj(elucidate-6, implications-18)
conj:and(mechanisms-9, implications-18)
case(and_disease-21, in-19)
compound(and_disease-21, health-20)
nmod:in(implications-18, and_disease-21)

Omega-3_fatty_acids/NNS are/VBP important/JJ for/IN maintaining/VBG human/JJ health/NN and/CC have/VBP been/VBN associated/VBN with/IN various/JJ beneficial/JJ effects/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP
      (VP (VBP are)
        (ADJP (JJ important)
          (PP (IN for)
            (S
              (VP (VBG maintaining)
                (NP (JJ human) (NN health)))))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ various) (JJ beneficial) (NNS effects)))))))
    (. .)))

nsubj(important-3, Omega-3_fatty_acids-1)
nsubjpass(associated-11, Omega-3_fatty_acids-1)
cop(important-3, are-2)
root(ROOT-0, important-3)
mark(maintaining-5, for-4)
advcl(important-3, maintaining-5)
amod(health-7, human-6)
dobj(maintaining-5, health-7)
cc(important-3, and-8)
aux(associated-11, have-9)
auxpass(associated-11, been-10)
conj:and(important-3, associated-11)
case(effects-15, with-12)
amod(effects-15, various-13)
amod(effects-15, beneficial-14)
nmod:with(associated-11, effects-15)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP particularly/RB important/JJ due/JJ to/TO their/PRP$ unique/JJ properties/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (ADVP (RB particularly) (JJ important))
      (ADJP (JJ due)
        (PP (TO to)
          (NP (PRP$ their) (JJ unique) (NNS properties)))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(due-19, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
cop(due-19, are-16)
advmod(important-18, particularly-17)
advmod(due-19, important-18)
root(ROOT-0, due-19)
case(properties-23, to-20)
nmod:poss(properties-23, their-21)
amod(properties-23, unique-22)
nmod:to(due-19, properties-23)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS may/MD be/VB associated/VBN with/IN decreased/VBN pergolide_mesylate/JJ levels/NNS in/IN hyperpergolide/JJ mesylatemic/JJ patients/NNS ,/, which/WDT could/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN certain/JJ medical/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ pergolide_mesylate) (NNS levels))
                      (PP (IN in)
                        (NP
                          (NP (JJ hyperpergolide) (JJ mesylatemic) (NNS patients))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (MD could)
                                (VP (VB have)
                                  (NP
                                    (NP (NNS implications))
                                    (PP (IN for)
                                      (NP
                                        (NP (DT the) (NN treatment))
                                        (PP (IN of)
                                          (NP (JJ certain) (JJ medical) (NNS conditions)))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, pergolide_mesylate-13)
nmod:with(associated-10, levels-14)
case(patients-18, in-15)
amod(patients-18, hyperpergolide-16)
amod(patients-18, mesylatemic-17)
nmod:in(levels-14, patients-18)
nsubj(have-22, patients-18)
ref(patients-18, which-20)
aux(have-22, could-21)
acl:relcl(patients-18, have-22)
dobj(have-22, implications-23)
case(treatment-26, for-24)
det(treatment-26, the-25)
nmod:for(implications-23, treatment-26)
case(conditions-30, of-27)
amod(conditions-30, certain-28)
amod(conditions-30, medical-29)
nmod:of(treatment-26, conditions-30)

Additionally/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP
                          (NP
                            (NP (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-)))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN death)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-7, Additionally-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(found-7, omega-3_fatty_acids-4)
nsubj:xsubj(decrease-9, omega-3_fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(decrease-9, to-8)
xcomp(found-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(coronary_heart_disease-14, CHD-16)
det(cause-21, a-19)
amod(cause-21, leading-20)
appos(coronary_heart_disease-14, cause-21)
case(death-23, of-22)
nmod:of(cause-21, death-23)
advmod(decrease-9, worldwide-24)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN improving/VBG health/NN outcomes/NNS and/CC reducing/VBG disease/NN risk/NN in/IN certain/JJ populations/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG improving)
                        (NP (NN health) (NNS outcomes)))
                      (CC and)
                      (VP (VBG reducing)
                        (NP
                          (NP (NN disease) (NN risk))
                          (PP (IN in)
                            (NP (JJ certain) (NNS populations))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-15, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(improving-17, for-16)
acl(strategy-15, improving-17)
compound(outcomes-19, health-18)
dobj(improving-17, outcomes-19)
cc(improving-17, and-20)
acl(strategy-15, reducing-21)
conj:and(improving-17, reducing-21)
compound(risk-23, disease-22)
dobj(reducing-21, risk-23)
case(populations-26, in-24)
amod(populations-26, certain-25)
nmod:in(risk-23, populations-26)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ doses/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS doses))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
amod(doses-17, optimal-16)
dobj(determine-15, doses-17)
case(populations-21, for-18)
amod(populations-21, different-19)
amod(populations-21, patient-20)
nmod:for(doses-17, populations-21)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT has_been/VBP linked/VBN to/TO various/JJ pathophysiological/JJ mechanisms/NNS ,/, including/VBG insulin_resistance/JJ and/CC abnormal/JJ glucose_metabolism/NN ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBP has_been)
          (VP (VBN linked)
            (PP (TO to)
              (NP
                (NP (JJ various) (JJ pathophysiological) (NNS mechanisms))
                (, ,)
                (VP (VBG including)
                  (NP
                    (ADJP (JJ insulin_resistance)
                      (CC and)
                      (JJ abnormal))
                    (NN glucose_metabolism)))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubj(has_been-6, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
acl:relcl(metabolic_disorder-4, has_been-6)
dep(has_been-6, linked-7)
case(mechanisms-11, to-8)
amod(mechanisms-11, various-9)
amod(mechanisms-11, pathophysiological-10)
nmod:to(linked-7, mechanisms-11)
acl(mechanisms-11, including-13)
amod(glucose_metabolism-17, insulin_resistance-14)
cc(insulin_resistance-14, and-15)
conj:and(insulin_resistance-14, abnormal-16)
amod(glucose_metabolism-17, abnormal-16)
dobj(including-13, glucose_metabolism-17)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN P2Y12/NNP ,/, a/DT purinergic/JJ receptor/NN expressed/VBN in/IN pancreatic/JJ beta/JJ cells/NNS ,/, may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNP P2Y12))
              (, ,)
              (NP
                (NP (DT a) (JJ purinergic) (NN receptor))
                (VP (VBN expressed)
                  (PP (IN in)
                    (NP (JJ pancreatic) (JJ beta) (NNS cells)))))
              (, ,))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-18, that-5)
nsubj(play-18, P2Y12-6)
det(receptor-10, a-8)
amod(receptor-10, purinergic-9)
appos(P2Y12-6, receptor-10)
acl(receptor-10, expressed-11)
case(cells-15, in-12)
amod(cells-15, pancreatic-13)
amod(cells-15, beta-14)
nmod:in(expressed-11, cells-15)
aux(play-18, may-17)
ccomp(suggested-4, play-18)
det(role-20, a-19)
dobj(play-18, role-20)
case(development-23, in-21)
det(development-23, the-22)
nmod:in(role-20, development-23)
case(obesity-25, of-24)
nmod:of(development-23, obesity-25)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN P2Y12/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP P2Y12)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(P2Y12-20, of-19)
nmod:of(hypersecretion-18, P2Y12-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ isorhapontigenin/NN on/IN the/DT secretion/NN of/IN P2Y12/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN isorhapontigenin)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP P2Y12) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(isorhapontigenin-16, 10-14)
amod(isorhapontigenin-16, mmol/L-15)
nmod:of(effects-8, isorhapontigenin-16)
conj:and(glucose-12, isorhapontigenin-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, P2Y12-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN both/DT glucose/NN and/CC isorhapontigenin/NN stimulated/VBN P2Y12/NNP secretion/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ,/, but/CC to/TO a/DT greater/JJR extent/NN in/IN obese/JJ animals/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (DT both) (NN glucose)
              (CC and)
              (NN isorhapontigenin))
            (VP (VBN stimulated)
              (NP (NNP P2Y12) (NN secretion))
              (PP (IN in)
                (NP (DT both) (JJ obese)
                  (CC and)
                  (JJ lean) (NNS rats)))))))
      (, ,)
      (CC but)
      (PP (TO to)
        (NP (DT a) (JJR greater) (NN extent)))
      (PP (IN in)
        (NP (JJ obese) (NNS animals))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(stimulated-9, that-4)
cc:preconj(glucose-6, both-5)
nsubj(stimulated-9, glucose-6)
cc(glucose-6, and-7)
conj:and(glucose-6, isorhapontigenin-8)
nsubj(stimulated-9, isorhapontigenin-8)
ccomp(showed-3, stimulated-9)
compound(secretion-11, P2Y12-10)
dobj(stimulated-9, secretion-11)
case(rats-17, in-12)
det(rats-17, both-13)
amod(rats-17, obese-14)
cc(obese-14, and-15)
conj:and(obese-14, lean-16)
amod(rats-17, lean-16)
nmod:in(stimulated-9, rats-17)
cc(showed-3, but-19)
case(extent-23, to-20)
det(extent-23, a-21)
amod(extent-23, greater-22)
conj:but(showed-3, extent-23)
case(animals-26, in-24)
amod(animals-26, obese-25)
nmod:in(showed-3, animals-26)

Additionally/RB ,/, insulin_secretion/NN was/VBD also/RB increased/VBN by/IN glucose/NN and/CC isorhapontigenin/NN in/IN both/DT groups/NNS ,/, although/IN again/RB to/TO a/DT greater/JJR extent/NN in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (VP
        (ADVP (RB also))
        (VBN increased)
        (PP (IN by)
          (NP (NN glucose)
            (CC and)
            (NN isorhapontigenin)))
        (PP (IN in)
          (NP (DT both) (NNS groups)))
        (, ,)
        (SBAR (IN although) (RB again)
          (S
            (VP (TO to)
              (VP
                (NP (DT a) (JJR greater) (NN extent))
                (PP (IN in)
                  (NP (JJ obese) (NNS rats)))))))))
    (. .)))

advmod(increased-6, Additionally-1)
nsubjpass(increased-6, insulin_secretion-3)
auxpass(increased-6, was-4)
advmod(increased-6, also-5)
root(ROOT-0, increased-6)
case(glucose-8, by-7)
nmod:by(increased-6, glucose-8)
cc(glucose-8, and-9)
nmod:by(increased-6, isorhapontigenin-10)
conj:and(glucose-8, isorhapontigenin-10)
case(groups-13, in-11)
det(groups-13, both-12)
nmod:in(increased-6, groups-13)
mark(extent-20, although-15)
advmod(extent-20, again-16)
mark(extent-20, to-17)
det(extent-20, a-18)
amod(extent-20, greater-19)
advcl(increased-6, extent-20)
case(rats-23, in-21)
amod(rats-23, obese-22)
nmod:in(extent-20, rats-23)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN P2Y12/NNP by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP P2Y12)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (PP
                  (ADVP (RB possibly))
                  (IN through)
                  (NP
                    (NP (PRP$ its) (NNS effects))
                    (PP (IN on)
                      (NP (NN insulin_secretion)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(P2Y12-7, of-6)
nmod:of(hypersecretion-5, P2Y12-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
advmod(effects-23, possibly-20)
case(effects-23, through-21)
nmod:poss(effects-23, its-22)
nmod:through(involved-13, effects-23)
case(insulin_secretion-25, on-24)
nmod:on(effects-23, insulin_secretion-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT role/NN of/IN P2Y12/NNP in/IN obesity/NN and/CC its/PRP$ potential/NN as/IN a/DT therapeutic/JJ target/NN for/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP (NNP P2Y12))))
              (PP (IN in)
                (NP
                  (NP (NN obesity))
                  (CC and)
                  (NP (PRP$ its) (NN potential))))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN target))
                  (PP (IN for)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(role-9, the-8)
dobj(elucidate-7, role-9)
case(P2Y12-11, of-10)
nmod:of(role-9, P2Y12-11)
case(obesity-13, in-12)
nmod:in(elucidate-7, obesity-13)
cc(obesity-13, and-14)
nmod:poss(potential-16, its-15)
nmod:in(elucidate-7, potential-16)
conj:and(obesity-13, potential-16)
case(target-20, as-17)
det(target-20, a-18)
amod(target-20, therapeutic-19)
nmod:as(elucidate-7, target-20)
case(condition-23, for-21)
det(condition-23, this-22)
nmod:for(target-20, condition-23)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP (JJ various) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(associated-24, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
dep(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(Omega-3_fatty_acids-1, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(associated-24, have-22)
auxpass(associated-24, been-23)
root(ROOT-0, associated-24)
case(benefits-28, with-25)
amod(benefits-28, various-26)
compound(benefits-28, health-27)
nmod:with(associated-24, benefits-28)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP linked/VBN to/TO decreased/VBN levels/NNS of/IN 8-cyclopentyl-1/JJ ,3/CD -/: dipropylxanthine/NN in/IN hyper8-cyclopentyl-1/JJ ,3/CD -/: dipropylxanthinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP (JJ 8-cyclopentyl-1) (CD ,3)))
                    (PRN (: -)
                      (NP
                        (NP (NN dipropylxanthine))
                        (PP (IN in)
                          (NP (JJ hyper8-cyclopentyl-1) (CD ,3))))
                      (: -))
                    (NP (JJ dipropylxanthinemic) (NNS patients))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(linked-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(linked-10, omega-3_fatty_acids-8)
auxpass(linked-10, are-9)
ccomp(shown-4, linked-10)
case(levels-13, to-11)
amod(levels-13, decreased-12)
nmod:to(linked-10, levels-13)
case(,3-16, of-14)
amod(,3-16, 8-cyclopentyl-1-15)
nmod:of(levels-13, ,3-16)
dep(levels-13, dipropylxanthine-18)
case(,3-21, in-19)
amod(,3-21, hyper8-cyclopentyl-1-20)
nmod:in(dipropylxanthine-18, ,3-21)
amod(patients-24, dipropylxanthinemic-23)
dep(levels-13, patients-24)

Additionally/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP shown/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP CHD))
                  (-RRB- -RRB-))))))))
    (. .)))

advmod(has_been-9, Additionally-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, shown-10)
mark(reduce-12, to-11)
xcomp(shown-10, reduce-12)
det(risk-14, the-13)
dobj(reduce-12, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

These/DT findings/NNS suggest/VBP that/IN incorporating/VBG a/DT diet/NN rich/JJ in/IN omega-3_fatty_acids/JJ may/MD have/VB protective/JJ effects/NNS against/IN certain/JJ diseases/NNS and/CC conditions/NNS related/VBN to/TO cardiovascular_health/VB ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG incorporating)
              (NP
                (NP (DT a) (NN diet))
                (ADJP (JJ rich)
                  (PP (IN in)
                    (ADJP (JJ omega-3_fatty_acids)))))))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ protective) (NNS effects))
              (PP (IN against)
                (NP
                  (NP (JJ certain) (NNS diseases)
                    (CC and)
                    (NNS conditions))
                  (VP (VBN related)
                    (S
                      (VP (TO to)
                        (VP (VB cardiovascular_health))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-12, that-4)
csubj(have-12, incorporating-5)
det(diet-7, a-6)
dobj(incorporating-5, diet-7)
amod(diet-7, rich-8)
case(omega-3_fatty_acids-10, in-9)
advcl(rich-8, omega-3_fatty_acids-10)
aux(have-12, may-11)
ccomp(suggest-3, have-12)
amod(effects-14, protective-13)
dobj(have-12, effects-14)
case(diseases-17, against-15)
amod(diseases-17, certain-16)
nmod:against(have-12, diseases-17)
cc(diseases-17, and-18)
nmod:against(have-12, conditions-19)
conj:and(diseases-17, conditions-19)
acl(diseases-17, related-20)
mark(cardiovascular_health-22, to-21)
xcomp(related-20, cardiovascular_health-22)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS behind/IN these/DT associations/NNS and/CC to/TO determine/VB optimal/JJ dosage/NN and/CC duration/NN of/IN omega-3/JJ supplementation/NN for/IN disease/NN prevention/NN and/CC management/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP (DT the) (NNS mechanisms))
                (PP (IN behind)
                  (NP (DT these) (NNS associations)))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (JJ omega-3) (NN supplementation))
                      (PP (IN for)
                        (NP (NN disease) (NN prevention)
                          (CC and)
                          (NN management))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
case(associations-12, behind-10)
det(associations-12, these-11)
nmod:behind(understand-7, associations-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
amod(dosage-17, optimal-16)
dobj(determine-15, dosage-17)
cc(dosage-17, and-18)
dobj(determine-15, duration-19)
conj:and(dosage-17, duration-19)
case(supplementation-22, of-20)
amod(supplementation-22, omega-3-21)
nmod:of(dosage-17, supplementation-22)
case(prevention-25, for-23)
compound(prevention-25, disease-24)
nmod:for(supplementation-22, prevention-25)
cc(prevention-25, and-26)
nmod:for(supplementation-22, management-27)
conj:and(prevention-25, management-27)

Skeletal/JJ muscle/NN is_a/VBZ highly/RB dynamic/JJ tissue/NN that/WDT undergoes/VBZ constant/JJ remodeling/NN and/CC regeneration/NN throughout/IN life/NN ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle))
    (VP (VBZ is_a)
      (NP
        (ADJP (RB highly) (JJ dynamic))
        (NN tissue)
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ undergoes)
              (NP (JJ constant) (NN remodeling)
                (CC and)
                (NN regeneration))
              (PP (IN throughout)
                (NP (NN life))))))))
    (. .)))

amod(muscle-2, Skeletal-1)
nsubj(is_a-3, muscle-2)
root(ROOT-0, is_a-3)
advmod(dynamic-5, highly-4)
amod(tissue-6, dynamic-5)
dobj(is_a-3, tissue-6)
nsubj(undergoes-8, that-7)
ccomp(tissue-6, undergoes-8)
amod(remodeling-10, constant-9)
dobj(undergoes-8, remodeling-10)
cc(remodeling-10, and-11)
dobj(undergoes-8, regeneration-12)
conj:and(remodeling-10, regeneration-12)
case(life-14, throughout-13)
nmod:throughout(undergoes-8, life-14)

The/DT differentiation/NN of/IN muscle/NN precursor/NN cells/NNS into/IN mature/NNP myotubes/VBZ is_a/JJ complex/JJ process/NN regulated/VBN by/IN various/JJ signaling/VBG pathways/NNS and/CC transcription/JJ factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN differentiation))
      (PP (IN of)
        (NP
          (NP (NN muscle) (NN precursor) (NNS cells))
          (PP (IN into)
            (NP (NNP mature))))))
    (VP (VBZ myotubes)
      (NP
        (NP (JJ is_a) (JJ complex) (NN process))
        (VP (VBN regulated)
          (PP (IN by)
            (NP
              (NP (JJ various) (VBG signaling) (NNS pathways))
              (CC and)
              (NP (JJ transcription) (NNS factors)))))))
    (. .)))

det(differentiation-2, The-1)
nsubj(myotubes-9, differentiation-2)
case(cells-6, of-3)
compound(cells-6, muscle-4)
compound(cells-6, precursor-5)
nmod:of(differentiation-2, cells-6)
case(mature-8, into-7)
nmod:into(cells-6, mature-8)
root(ROOT-0, myotubes-9)
amod(process-12, is_a-10)
amod(process-12, complex-11)
dobj(myotubes-9, process-12)
acl(process-12, regulated-13)
case(pathways-17, by-14)
amod(pathways-17, various-15)
amod(pathways-17, signaling-16)
nmod:by(regulated-13, pathways-17)
cc(pathways-17, and-18)
amod(factors-20, transcription-19)
nmod:by(regulated-13, factors-20)
conj:and(pathways-17, factors-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN listeriolysin_O/NN on/IN TNFRSF14/NNP protein/NN levels/NNS during/IN the/DT differentiation/NN of/IN C2C12/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN listeriolysin_O))))
      (PP (IN on)
        (NP (NNP TNFRSF14) (NN protein) (NNS levels)))
      (PP (IN during)
        (NP
          (NP (DT the) (NN differentiation))
          (PP (IN of)
            (NP (CD C2C12) (NNS cells))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(listeriolysin_O-10, of-9)
nmod:of(effect-8, listeriolysin_O-10)
case(levels-14, on-11)
compound(levels-14, TNFRSF14-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
case(differentiation-17, during-15)
det(differentiation-17, the-16)
nmod:during(investigated-6, differentiation-17)
case(cells-20, of-18)
nummod(cells-20, C2C12-19)
nmod:of(differentiation-17, cells-20)

When/WRB cultured/VBD in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, C2C12/NNP cells/NNS showed/VBD increased/VBN expression/NN of/IN TNFRSF14/CD protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN upon/IN treatment/NN with/IN listeriolysin/NN

(ROOT
  (SBARQ
    (WHADVP (WRB When))
    (SQ (VBD cultured)
      (NP
        (NP (NN in_a) (NN medium))
        (PP (VBG favoring)
          (NP
            (NP (NN differentiation))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Dulbecco))
                (VP (VBN modified)
                  (NP (NNP Eagle) (NN medium))
                  (S
                    (VP (VBG containing)
                      (NP
                        (ADJP (CD 2) (NN %))
                        (NN horse) (NN serum))))))
              (-RRB- -RRB-))
            (, ,)
            (SBAR
              (S
                (NP (NNP C2C12) (NNS cells))
                (VP (VBD showed)
                  (VP (VBN increased)
                    (NP
                      (NP (NN expression))
                      (PP (IN of)
                        (NP
                          (NP (CD TNFRSF14) (NN protein) (NNS levels))
                          (NP (NN in_a) (JJ time-dependent) (NN manner)))))
                    (PP (IN upon)
                      (NP (NN treatment)))
                    (PP (IN with)
                      (NP (NN listeriolysin)))))))))))))

advmod(cultured-2, When-1)
root(ROOT-0, cultured-2)
compound(medium-4, in_a-3)
nsubj(cultured-2, medium-4)
case(differentiation-6, favoring-5)
nmod:favoring(medium-4, differentiation-6)
dep(differentiation-6, Dulbecco-8)
acl(Dulbecco-8, modified-9)
compound(medium-11, Eagle-10)
dobj(modified-9, medium-11)
xcomp(modified-9, containing-12)
compound(%-14, 2-13)
amod(serum-16, %-14)
compound(serum-16, horse-15)
dobj(containing-12, serum-16)
compound(cells-20, C2C12-19)
nsubj(showed-21, cells-20)
acl:relcl(differentiation-6, showed-21)
dep(showed-21, increased-22)
dobj(increased-22, expression-23)
case(levels-27, of-24)
nummod(levels-27, TNFRSF14-25)
compound(levels-27, protein-26)
nmod:of(expression-23, levels-27)
compound(manner-30, in_a-28)
amod(manner-30, time-dependent-29)
dep(levels-27, manner-30)
case(treatment-32, upon-31)
nmod:upon(increased-22, treatment-32)
case(listeriolysin-34, with-33)
nmod:with(increased-22, listeriolysin-34)

O./NNP Furthermore/RB ,/, we/PRP found/VBD that/IN listeriolysin_O/NN prolonged/VBN the/DT half-life/NN of/IN TNFRSF14/NNP protein/NN from/IN 10/CD to/TO 18/CD hours/NNS ,/, suggesting/VBG that/IN this/DT bacterial/JJ toxin/NN may/MD play/VB a/DT role/NN in/IN promoting/VBG skeletal_muscle/JJ differentiation/NN by/IN modulating/VBG TNFRSF14/NNP signaling/VBG ./.

(ROOT
  (S
    (ADVP (NNP O.))
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NN listeriolysin_O))
          (VP (VBN prolonged)
            (NP
              (NP (DT the) (NN half-life))
              (PP (IN of)
                (NP (NNP TNFRSF14) (NN protein))))
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))
            (, ,)
            (S
              (VP (VBG suggesting)
                (SBAR (IN that)
                  (S
                    (NP (DT this) (JJ bacterial) (NN toxin))
                    (VP (MD may)
                      (VP (VB play)
                        (NP (DT a) (NN role))
                        (PP (IN in)
                          (S
                            (VP (VBG promoting)
                              (NP (JJ skeletal_muscle) (NN differentiation))
                              (PP (IN by)
                                (S
                                  (VP (VBG modulating)
                                    (NP (NNP TNFRSF14))
                                    (S
                                      (VP (VBG signaling)))))))))))))))))))
    (. .)))

advmod(found-5, O.-1)
advmod(found-5, Furthermore-2)
nsubj(found-5, we-4)
root(ROOT-0, found-5)
mark(prolonged-8, that-6)
nsubj(prolonged-8, listeriolysin_O-7)
ccomp(found-5, prolonged-8)
det(half-life-10, the-9)
dobj(prolonged-8, half-life-10)
case(protein-13, of-11)
compound(protein-13, TNFRSF14-12)
nmod:of(half-life-10, protein-13)
case(hours-18, from-14)
compound(18-17, 10-15)
dep(18-17, to-16)
nummod(hours-18, 18-17)
nmod:from(prolonged-8, hours-18)
advcl(prolonged-8, suggesting-20)
mark(play-26, that-21)
det(toxin-24, this-22)
amod(toxin-24, bacterial-23)
nsubj(play-26, toxin-24)
aux(play-26, may-25)
ccomp(suggesting-20, play-26)
det(role-28, a-27)
dobj(play-26, role-28)
mark(promoting-30, in-29)
advcl(play-26, promoting-30)
amod(differentiation-32, skeletal_muscle-31)
dobj(promoting-30, differentiation-32)
mark(modulating-34, by-33)
advcl(promoting-30, modulating-34)
dobj(modulating-34, TNFRSF14-35)
advcl(modulating-34, signaling-36)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT mechanisms/NNS underlying/VBG skeletal_muscle/JJ development/NN and/CC may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NNS mechanisms))
              (VP (VBG underlying)
                (NP (JJ skeletal_muscle) (NN development)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN treatment))
                (PP (IN of)
                  (NP (NNS muscle-related_disorders)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-14, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-8, into-6)
det(mechanisms-8, the-7)
nmod:into(insights-5, mechanisms-8)
acl(mechanisms-8, underlying-9)
amod(development-11, skeletal_muscle-10)
dobj(underlying-9, development-11)
cc(provide-3, and-12)
aux(have-14, may-13)
conj:and(provide-3, have-14)
dobj(have-14, implications-15)
case(treatment-18, for-16)
det(treatment-18, the-17)
nmod:for(implications-15, treatment-18)
case(muscle-related_disorders-20, of-19)
nmod:of(treatment-18, muscle-related_disorders-20)

Methsuximide/JJ is_a/NNS widely/RB used/VBN antiepileptic/JJ drug/NN that/WDT has_been/VBP shown/VBN to_be/VBP effective/JJ in/IN the/DT treatment/NN of/IN various/JJ types/NNS of/IN epilepsy/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Methsuximide) (NNS is_a))
      (VP
        (ADVP (RB widely))
        (VBN used)
        (NP
          (NP (JJ antiepileptic) (NN drug))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP has_been)
                (VP (VBN shown))))))))
    (VP (VBP to_be)
      (ADJP (JJ effective)
        (PP (IN in)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP
                (NP (JJ various) (NNS types))
                (PP (IN of)
                  (NP (NN epilepsy)))))))))
    (. .)))

amod(is_a-2, Methsuximide-1)
nsubj(to_be-10, is_a-2)
advmod(used-4, widely-3)
acl(is_a-2, used-4)
amod(drug-6, antiepileptic-5)
dobj(used-4, drug-6)
nsubj(has_been-8, drug-6)
ref(drug-6, that-7)
acl:relcl(drug-6, has_been-8)
dep(has_been-8, shown-9)
root(ROOT-0, to_be-10)
xcomp(to_be-10, effective-11)
case(treatment-14, in-12)
det(treatment-14, the-13)
nmod:in(effective-11, treatment-14)
case(types-17, of-15)
amod(types-17, various-16)
nmod:of(treatment-14, types-17)
case(epilepsy-19, of-18)
nmod:of(types-17, epilepsy-19)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN Methsuximide/NNP on/IN juvenile_myoclonic_epilepsy/NN was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Methsuximide)))
      (PP (IN on)
        (NP (NN juvenile_myoclonic_epilepsy))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-12, study-3)
det(effect-6, the-5)
nsubjpass(investigated-12, effect-6)
case(Methsuximide-8, of-7)
nmod:of(effect-6, Methsuximide-8)
case(juvenile_myoclonic_epilepsy-10, on-9)
nmod:on(effect-6, juvenile_myoclonic_epilepsy-10)
auxpass(investigated-12, was-11)
root(ROOT-0, investigated-12)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, Methsuximide/NNP reduced/VBD the/DT risk/NN of/IN juvenile_myoclonic_epilepsy/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Methsuximide))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN juvenile_myoclonic_epilepsy))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, Methsuximide-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(juvenile_myoclonic_epilepsy-11, of-10)
nmod:of(risk-9, juvenile_myoclonic_epilepsy-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT results/NNS suggest/VBP that/IN Methsuximide/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS with/IN juvenile_myoclonic_epilepsy/JJ and/CC associated/VBN photophobia/NN and/CC phonophobia/NN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Methsuximide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP
                  (ADJP (JJ juvenile_myoclonic_epilepsy)
                    (CC and)
                    (VBN associated))
                  (NX
                    (NX (NN photophobia))
                    (CC and)
                    (NX (NN phonophobia) (NNS symptoms))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Methsuximide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(photophobia-18, with-14)
amod(photophobia-18, juvenile_myoclonic_epilepsy-15)
cc(juvenile_myoclonic_epilepsy-15, and-16)
conj:and(juvenile_myoclonic_epilepsy-15, associated-17)
amod(photophobia-18, associated-17)
nmod:with(option-11, photophobia-18)
cc(photophobia-18, and-19)
compound(symptoms-21, phonophobia-20)
nmod:with(option-11, symptoms-21)
conj:and(photophobia-18, symptoms-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN this/DT drug/NN in/IN this/DT patient/JJ population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS findings))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                (PP (IN for)
                  (NP
                    (NP (DT this) (NN drug))
                    (PP (IN in)
                      (NP (DT this) (JJ patient) (NN population)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(drug-18, for-16)
det(drug-18, this-17)
nmod:for(determine-11, drug-18)
case(population-22, in-19)
det(population-22, this-20)
amod(population-22, patient-21)
nmod:in(drug-18, population-22)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, various-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

In/IN particular/JJ ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN fenprostalene/JJ levels/NNS in/IN hyperfenprostalenemic/JJ patients/NNS and/CC a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (JJ fenprostalene) (NNS levels))
              (PP (IN in)
                (NP
                  (NP (JJ hyperfenprostalenemic) (NNS patients))
                  (CC and)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(particular-2, In-1)
advcl(associated-9, particular-2)
det(omega-3_fatty_acids-6, these-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(associated-9, omega-3_fatty_acids-6)
aux(associated-9, have-7)
auxpass(associated-9, been-8)
root(ROOT-0, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, fenprostalene-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperfenprostalenemic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
det(risk-20, a-18)
amod(risk-20, decreased-19)
nmod:in(levels-13, risk-20)
conj:and(patients-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ;/: however/RB ,/, it/PRP is/VBZ believed/VBN that/IN the/DT anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (: ;)
    (S
      (ADVP (RB however))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ anti-inflammatory)
                  (CC and)
                  (JJ anti-thrombotic) (NNS properties))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (VP (MD may)
                (VP (VB contribute)
                  (PP (TO to)
                    (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
advmod(believed-16, however-12)
nsubjpass(believed-16, it-14)
auxpass(believed-16, is-15)
parataxis(understood-10, believed-16)
mark(contribute-28, that-17)
det(properties-22, the-18)
amod(properties-22, anti-inflammatory-19)
cc(anti-inflammatory-19, and-20)
conj:and(anti-inflammatory-19, anti-thrombotic-21)
amod(properties-22, anti-thrombotic-21)
nsubj(contribute-28, properties-22)
case(EPA-24, of-23)
nmod:of(properties-22, EPA-24)
cc(EPA-24, and-25)
nmod:of(properties-22, DHA-26)
conj:and(EPA-24, DHA-26)
aux(contribute-28, may-27)
ccomp(believed-16, contribute-28)
case(effects-32, to-29)
nmod:poss(effects-32, their-30)
amod(effects-32, cardioprotective-31)
nmod:to(contribute-28, effects-32)

Additionally/RB ,/, these/DT fatty_acids/NNS may/MD also/RB modulate/VBP lipid/NN metabolism/NN ,/, improve/VB endothelial/JJ function/NN ,/, and/CC reduce/VB oxidative_stress/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (MD may)
      (ADVP (RB also))
      (VP (VBP modulate)
        (NP (NN lipid) (NN metabolism))
        (, ,)
        (S
          (VP
            (VP (VB improve)
              (NP (JJ endothelial) (NN function)))
            (, ,)
            (CC and)
            (VP (VB reduce)
              (NP (NNS oxidative_stress)))))))
    (. .)))

advmod(modulate-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubj(modulate-7, fatty_acids-4)
aux(modulate-7, may-5)
advmod(modulate-7, also-6)
root(ROOT-0, modulate-7)
compound(metabolism-9, lipid-8)
dobj(modulate-7, metabolism-9)
dep(modulate-7, improve-11)
amod(function-13, endothelial-12)
dobj(improve-11, function-13)
cc(improve-11, and-15)
dep(modulate-7, reduce-16)
conj:and(improve-11, reduce-16)
dobj(reduce-16, oxidative_stress-17)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS involved/VBN in/IN the/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP risk/NN reduction/NN and/CC fenprostalene/JJ levels/NNS in/IN hyperfenprostalenemic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (JJ beneficial) (NNS effects))
                      (PP (IN of)
                        (NP (NNP EPA)
                          (CC and)
                          (NNP DHA)))))
                  (PP (IN on)
                    (NP
                      (NP (NNP CHD)
                        (NX
                          (NX (NN risk) (NN reduction))
                          (CC and)
                          (NX (JJ fenprostalene) (NNS levels))))
                      (PP (IN in)
                        (NP (JJ hyperfenprostalenemic) (NNS patients))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, involved-10)
case(effects-14, in-11)
det(effects-14, the-12)
amod(effects-14, beneficial-13)
nmod:in(involved-10, effects-14)
case(EPA-16, of-15)
nmod:of(effects-14, EPA-16)
cc(EPA-16, and-17)
nmod:of(effects-14, DHA-18)
conj:and(EPA-16, DHA-18)
case(reduction-22, on-19)
dep(reduction-22, CHD-20)
compound(reduction-22, risk-21)
nmod:on(involved-10, reduction-22)
cc(reduction-22, and-23)
amod(levels-25, fenprostalene-24)
nmod:on(involved-10, levels-25)
conj:and(reduction-22, levels-25)
case(patients-28, in-26)
amod(patients-28, hyperfenprostalenemic-27)
nmod:in(reduction-22, patients-28)

Nonetheless/RB ,/, current/JJ evidence/NN suggests/VBZ that/IN increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN improving/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP (JJ current) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP (JJ dietary) (NN intake)
                (CC or)
                (NN supplementation))
              (PP (IN with)
                (NP (JJ long-chain) (NN omega-3_fatty_acids)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG improving)
                      (NP (NN cardiovascular_health)))))))))))
    (. .)))

advmod(suggests-5, Nonetheless-1)
amod(evidence-4, current-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
mark(strategy-19, that-6)
csubj(strategy-19, increasing-7)
amod(intake-9, dietary-8)
dobj(increasing-7, intake-9)
cc(intake-9, or-10)
dobj(increasing-7, supplementation-11)
conj:or(intake-9, supplementation-11)
case(omega-3_fatty_acids-14, with-12)
amod(omega-3_fatty_acids-14, long-chain-13)
nmod:with(increasing-7, omega-3_fatty_acids-14)
aux(strategy-19, may-15)
cop(strategy-19, be-16)
det(strategy-19, a-17)
amod(strategy-19, promising-18)
ccomp(suggests-5, strategy-19)
mark(improving-21, for-20)
acl(strategy-19, improving-21)
dobj(improving-21, cardiovascular_health-22)

Obesity/RB is_a/VBD major/JJ public_health/NN concern/NN due/JJ to/TO its/PRP$ association/NN with/IN the/DT development/NN of/IN various/JJ metabolic_disorders/NNS ./.

(ROOT
  (SQ
    (ADVP (RB Obesity))
    (VBD is_a)
    (NP (JJ major) (NN public_health) (NN concern))
    (ADJP (JJ due)
      (PP (TO to)
        (NP
          (NP (PRP$ its) (NN association))
          (PP (IN with)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (JJ various) (NNS metabolic_disorders))))))))
    (. .)))

advmod(due-6, Obesity-1)
aux(due-6, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
nsubj(due-6, concern-5)
root(ROOT-0, due-6)
case(association-9, to-7)
nmod:poss(association-9, its-8)
nmod:to(due-6, association-9)
case(development-12, with-10)
det(development-12, the-11)
nmod:with(association-9, development-12)
case(metabolic_disorders-15, of-13)
amod(metabolic_disorders-15, various-14)
nmod:of(development-12, metabolic_disorders-15)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN glucose_homeostasis/JJ and_insulin/NN secretion/NN ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP (JJ glucose_homeostasis) (NN and_insulin) (NN secretion)))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(secretion-10, in-7)
amod(secretion-10, glucose_homeostasis-8)
compound(secretion-10, and_insulin-9)
nmod:in(role-6, secretion-10)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN xenobiotic/JJ receptors/NNS ,/, which/WDT are/VBP involved/VBN in/IN the/DT detoxification/NN of/IN foreign/JJ substances/NNS ,/, may/MD also/RB play/VB a/DT role/NN in/IN glucose_metabolism/NN and_insulin/NN secretion/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ xenobiotic) (NNS receptors))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBP are)
                    (VP (VBN involved)
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN detoxification))
                          (PP (IN of)
                            (NP (JJ foreign) (NNS substances)))))))))
              (, ,))
            (VP (MD may) (RB also)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP (NN glucose_metabolism) (NN and_insulin) (NN secretion))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-21, that-5)
amod(receptors-7, xenobiotic-6)
nsubjpass(involved-11, receptors-7)
nsubj(play-21, receptors-7)
ref(receptors-7, which-9)
auxpass(involved-11, are-10)
acl:relcl(receptors-7, involved-11)
case(detoxification-14, in-12)
det(detoxification-14, the-13)
nmod:in(involved-11, detoxification-14)
case(substances-17, of-15)
amod(substances-17, foreign-16)
nmod:of(detoxification-14, substances-17)
aux(play-21, may-19)
advmod(play-21, also-20)
ccomp(suggested-4, play-21)
det(role-23, a-22)
dobj(play-21, role-23)
case(secretion-27, in-24)
compound(secretion-27, glucose_metabolism-25)
compound(secretion-27, and_insulin-26)
nmod:in(role-23, secretion-27)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT relationship/NN between/IN obesity/JJ and/CC xenobiotic_receptor/JJ hypersecretion/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (ADJP (JJ obesity)
                    (CC and)
                    (JJ xenobiotic_receptor))
                  (NN hypersecretion))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(relationship-10, the-9)
dobj(investigate-8, relationship-10)
case(hypersecretion-15, between-11)
amod(hypersecretion-15, obesity-12)
cc(obesity-12, and-13)
conj:and(obesity-12, xenobiotic_receptor-14)
amod(hypersecretion-15, xenobiotic_receptor-14)
nmod:between(relationship-10, hypersecretion-15)
case(pancreas-18, by-16)
det(pancreas-18, the-17)
nmod:by(investigate-8, pancreas-18)

We/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Propiconazole/NNP on/IN the/DT secretion/NN of/IN xenobiotic_receptor/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Propiconazole)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN xenobiotic_receptor) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

nsubj(examined-2, We-1)
root(ROOT-0, examined-2)
det(effects-4, the-3)
dobj(examined-2, effects-4)
case(glucose-8, of-5)
nummod(glucose-8, 16.7-6)
amod(glucose-8, mmol/L-7)
nmod:of(effects-4, glucose-8)
cc(glucose-8, and-9)
nummod(Propiconazole-12, 10-10)
compound(Propiconazole-12, mmol/L-11)
nmod:of(effects-4, Propiconazole-12)
conj:and(glucose-8, Propiconazole-12)
case(secretion-15, on-13)
det(secretion-15, the-14)
nmod:on(examined-2, secretion-15)
case(and_insulin-18, of-16)
compound(and_insulin-18, xenobiotic_receptor-17)
nmod:of(secretion-15, and_insulin-18)
case(pancreata-22, by-19)
amod(pancreata-22, isolated-20)
amod(pancreata-22, perfused-21)
nmod:by(examined-2, pancreata-22)
case(genetically_obese-24, from-23)
nmod:from(pancreata-22, genetically_obese-24)
appos(genetically_obese-24, fa/fa-26)
cc(genetically_obese-24, and-28)
amod(rats-35, lean-29)
dep(lean-29, Fa-31)
nmod:from(pancreata-22, rats-35)
conj:and(genetically_obese-24, rats-35)

Our/PRP$ results/NNS showed/VBD that/IN xenobiotic_receptor/NN secretion/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT glucose/NN and/CC Propiconazole/JJ stimulation/NN conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN xenobiotic_receptor) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP
                        (NP (DT both) (NN glucose))
                        (CC and)
                        (NP (JJ Propiconazole) (NN stimulation) (NNS conditions))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-13, that-4)
compound(secretion-6, xenobiotic_receptor-5)
nsubjpass(compared-13, secretion-6)
nsubj:xsubj(lean-15, secretion-6)
auxpass(compared-13, was-7)
advmod(higher-9, significantly-8)
advmod(compared-13, higher-9)
case(rats-12, in-10)
amod(rats-12, obese-11)
nmod:in(higher-9, rats-12)
ccomp(showed-3, compared-13)
mark(lean-15, to-14)
xcomp(compared-13, lean-15)
dobj(lean-15, rats-16)
case(glucose-19, under-17)
det(glucose-19, both-18)
nmod:under(lean-15, glucose-19)
cc(glucose-19, and-20)
amod(conditions-23, Propiconazole-21)
compound(conditions-23, stimulation-22)
nmod:under(lean-15, conditions-23)
conj:and(glucose-19, conditions-23)

Additionally/RB ,/, there/EX was/VBD a/DT significant/JJ increase/NN in/IN insulin_secretion/NN in/IN response/NN to/TO Propiconazole/NNP stimulation/NN in/IN both/DT lean/JJ and/CC obese/JJ rats/NNS ,/, but/CC not/RB with/IN glucose/NN stimulation/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NNP Propiconazole) (NN stimulation)))))
      (PP (IN in)
        (NP (DT both)
          (ADJP (JJ lean)
            (CC and)
            (JJ obese))
          (NNS rats)))
      (, ,)
      (CC but)
      (ADVP (RB not))
      (PP (IN with)
        (NP (NN glucose) (NN stimulation))))
    (. .)))

advmod(was-4, Additionally-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
det(increase-7, a-5)
amod(increase-7, significant-6)
nsubj(was-4, increase-7)
case(insulin_secretion-9, in-8)
nmod:in(increase-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(was-4, response-11)
case(stimulation-14, to-12)
compound(stimulation-14, Propiconazole-13)
nmod:to(response-11, stimulation-14)
case(rats-20, in-15)
det(rats-20, both-16)
amod(rats-20, lean-17)
cc(lean-17, and-18)
conj:and(lean-17, obese-19)
amod(rats-20, obese-19)
nmod:in(was-4, rats-20)
cc(was-4, but-22)
advmod(stimulation-26, not-23)
case(stimulation-26, with-24)
compound(stimulation-26, glucose-25)
conj:but(was-4, stimulation-26)

These/DT findings/NNS suggest/VBP that/IN xenobiotic_receptor/NN hypersecretion/NN may/MD be/VB associated/VBN with/IN the/DT development/NN of/IN obesity/NN and/CC could/MD potentially/RB be/VB a/DT target/NN for/IN therapeutic/JJ interventions/NNS aimed/VBN at/IN preventing/VBG or/CC treating/VBG obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN xenobiotic_receptor) (NN hypersecretion))
          (VP
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB be)
                (NP
                  (NP (DT a) (NN target))
                  (PP (IN for)
                    (NP
                      (NP (JJ therapeutic) (NNS interventions))
                      (VP (VBN aimed)
                        (PP (IN at)
                          (S
                            (VP
                              (VP (VBG preventing))
                              (CC or)
                              (VP (VBG treating)
                                (NP (JJ obesity-related) (NNS metabolic_disorders))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(associated-9, that-4)
compound(hypersecretion-6, xenobiotic_receptor-5)
nsubjpass(associated-9, hypersecretion-6)
aux(associated-9, may-7)
auxpass(associated-9, be-8)
ccomp(suggest-3, associated-9)
case(development-12, with-10)
det(development-12, the-11)
nmod:with(associated-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
cc(associated-9, and-15)
aux(target-20, could-16)
advmod(target-20, potentially-17)
cop(target-20, be-18)
det(target-20, a-19)
ccomp(suggest-3, target-20)
conj:and(associated-9, target-20)
case(interventions-23, for-21)
amod(interventions-23, therapeutic-22)
nmod:for(target-20, interventions-23)
acl(interventions-23, aimed-24)
mark(preventing-26, at-25)
advcl(aimed-24, preventing-26)
cc(preventing-26, or-27)
advcl(aimed-24, treating-28)
conj:or(preventing-26, treating-28)
amod(metabolic_disorders-30, obesity-related-29)
dobj(treating-28, metabolic_disorders-30)

The/DT regulation/NN of/IN adipocyte/JJ differentiation/NN is_a/VBD complex/JJ process/NN that/WDT involves/VBZ numerous/JJ transcription/JJ factors/NNS and/CC signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (JJ adipocyte) (NN differentiation))))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (JJ numerous) (JJ transcription) (NNS factors))
                (CC and)
                (NP (VBG signaling) (NNS pathways))))))))
    (. .)))

det(regulation-2, The-1)
nsubj(is_a-6, regulation-2)
case(differentiation-5, of-3)
amod(differentiation-5, adipocyte-4)
nmod:of(regulation-2, differentiation-5)
root(ROOT-0, is_a-6)
amod(process-8, complex-7)
dobj(is_a-6, process-8)
nsubj(involves-10, process-8)
ref(process-8, that-9)
acl:relcl(process-8, involves-10)
amod(factors-13, numerous-11)
amod(factors-13, transcription-12)
dobj(involves-10, factors-13)
cc(factors-13, and-14)
amod(pathways-16, signaling-15)
dobj(involves-10, pathways-16)
conj:and(factors-13, pathways-16)

In/IN recent/JJ years/NNS ,/, there/EX has_been/VBP growing/VBG interest/NN in/IN the/DT development/NN of/IN small/JJ molecules/NNS that/WDT can/MD modulate/VBP adipocyte/JJ differentiation/NN as/IN potential/JJ therapeutic/JJ agents/NNS for/IN obesity/JJ and/CC related/VBN metabolic_disorders/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ recent) (NNS years)))
    (, ,)
    (NP (EX there))
    (VP (VBP has_been)
      (VP (VBG growing)
        (NP (NN interest))
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (JJ small) (NNS molecules))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD can)
                      (VP (VBP modulate)
                        (NP (JJ adipocyte) (NN differentiation))
                        (PP (IN as)
                          (NP
                            (NP (JJ potential) (JJ therapeutic) (NNS agents))
                            (PP (IN for)
                              (NP
                                (ADJP (JJ obesity)
                                  (CC and)
                                  (VBN related))
                                (NNS metabolic_disorders)))))))))))))))
    (. .)))

case(years-3, In-1)
amod(years-3, recent-2)
nmod:in(has_been-6, years-3)
expl(has_been-6, there-5)
root(ROOT-0, has_been-6)
xcomp(has_been-6, growing-7)
nsubj(has_been-6, interest-8)
case(development-11, in-9)
det(development-11, the-10)
nmod:in(growing-7, development-11)
case(molecules-14, of-12)
amod(molecules-14, small-13)
nmod:of(development-11, molecules-14)
nsubj(modulate-17, molecules-14)
ref(molecules-14, that-15)
aux(modulate-17, can-16)
acl:relcl(molecules-14, modulate-17)
amod(differentiation-19, adipocyte-18)
dobj(modulate-17, differentiation-19)
case(agents-23, as-20)
amod(agents-23, potential-21)
amod(agents-23, therapeutic-22)
nmod:as(modulate-17, agents-23)
case(metabolic_disorders-28, for-24)
amod(metabolic_disorders-28, obesity-25)
cc(obesity-25, and-26)
conj:and(obesity-25, related-27)
amod(metabolic_disorders-28, related-27)
nmod:for(agents-23, metabolic_disorders-28)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN AZD1208/NNP on/IN adipocyte/JJ differentiation/NN in/IN 3T3-L1/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP AZD1208))))
      (PP (IN on)
        (NP (JJ adipocyte) (NN differentiation)))
      (PP (IN in)
        (NP (CD 3T3-L1) (NNS cells))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(AZD1208-10, of-9)
nmod:of(effects-8, AZD1208-10)
case(differentiation-13, on-11)
amod(differentiation-13, adipocyte-12)
nmod:on(investigated-6, differentiation-13)
case(cells-16, in-14)
nummod(cells-16, 3T3-L1-15)
nmod:in(investigated-6, cells-16)

Our/PRP$ results/NNS showed/VBD that/IN AZD1208/NNP reduced/VBD the/DT expression/NN of/IN key/JJ transcription/JJ factors/NNS involved/VBN in/IN adipogenesis/NNS ,/, including/VBG C/EBP-a/NNP and/CC PPAR-y/NNP ,/, as/RB well/RB as/IN the/DT expression/NN of/IN GPR-32/NNP ,/, ACC/NNP ,/, and/CC perilipin_A/NN ./. Furthermore/RB ,/, AZD1208/NNP also/RB inhibited/VBD the/DT phosphorylation/NN of/IN STAT-3/NN during/IN adipocyte/JJ differentiation/NN ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (NNP AZD1208))
            (VP (VBD reduced)
              (NP
                (NP (DT the) (NN expression))
                (PP (IN of)
                  (NP
                    (NP (JJ key) (JJ transcription) (NNS factors))
                    (VP (VBN involved)
                      (PP (IN in)
                        (NP
                          (NP (NNS adipogenesis))
                          (, ,)
                          (PP (VBG including)
                            (NP (NNP C/EBP-a)
                              (CC and)
                              (NNP PPAR-y)))
                          (, ,)
                          (ADVP (RB as) (RB well)
                            (PP (IN as)
                              (NP
                                (NP (DT the) (NN expression))
                                (PP (IN of)
                                  (NP
                                    (NP (NNP GPR-32))
                                    (, ,)
                                    (NP (NNP ACC))
                                    (, ,)
                                    (CC and)
                                    (NP (NN perilipin_A)))))))))))))))))
      (. .))
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NNP AZD1208))
      (ADVP (RB also))
      (VP (VBD inhibited)
        (NP
          (NP (DT the) (NN phosphorylation))
          (PP (IN of)
            (NP (NN STAT-3))))
        (PP (IN during)
          (NP (JJ adipocyte) (NN differentiation)))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, AZD1208-5)
ccomp(showed-3, reduced-6)
det(expression-8, the-7)
dobj(reduced-6, expression-8)
case(factors-12, of-9)
amod(factors-12, key-10)
amod(factors-12, transcription-11)
nmod:of(expression-8, factors-12)
acl(factors-12, involved-13)
case(adipogenesis-15, in-14)
nmod:in(involved-13, adipogenesis-15)
case(C/EBP-a-18, including-17)
nmod:including(adipogenesis-15, C/EBP-a-18)
cc(C/EBP-a-18, and-19)
nmod:including(adipogenesis-15, PPAR-y-20)
conj:and(C/EBP-a-18, PPAR-y-20)
advmod(well-23, as-22)
advmod(adipogenesis-15, well-23)
case(expression-26, as-24)
det(expression-26, the-25)
nmod:as(well-23, expression-26)
case(GPR-32-28, of-27)
nmod:of(expression-26, GPR-32-28)
nmod:of(expression-26, ACC-30)
conj:and(GPR-32-28, ACC-30)
cc(GPR-32-28, and-32)
nmod:of(expression-26, perilipin_A-33)
conj:and(GPR-32-28, perilipin_A-33)
advmod(inhibited-39, Furthermore-35)
nsubj(inhibited-39, AZD1208-37)
advmod(inhibited-39, also-38)
parataxis(showed-3, inhibited-39)
det(phosphorylation-41, the-40)
dobj(inhibited-39, phosphorylation-41)
case(STAT-3-43, of-42)
nmod:of(phosphorylation-41, STAT-3-43)
case(differentiation-46, during-44)
amod(differentiation-46, adipocyte-45)
nmod:during(inhibited-39, differentiation-46)

These/DT findings/NNS suggest/VBP that/IN AZD1208/NNP may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN obesity/JJ and/CC related/VBN metabolic_disorders/NNS by/IN modulating/VBG key/JJ signaling/VBG pathways/NNS involved/VBN in/IN adipogenesis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP AZD1208))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (ADJP (JJ obesity)
                        (CC and)
                        (VBN related))
                      (NNS metabolic_disorders)))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (JJ key) (VBG signaling) (NNS pathways))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NNS adipogenesis)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, AZD1208-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(have-7, agent-12)
case(metabolic_disorders-17, for-13)
amod(metabolic_disorders-17, obesity-14)
cc(obesity-14, and-15)
conj:and(obesity-14, related-16)
amod(metabolic_disorders-17, related-16)
nmod:for(agent-12, metabolic_disorders-17)
mark(modulating-19, by-18)
advcl(have-7, modulating-19)
amod(pathways-22, key-20)
amod(pathways-22, signaling-21)
dobj(modulating-19, pathways-22)
acl(pathways-22, involved-23)
case(adipogenesis-25, in-24)
nmod:in(involved-23, adipogenesis-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanism/NN of/IN action/NN of/IN AZD1208/NN and/CC its/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NN mechanism))
                (PP (IN of)
                  (NP
                    (NP (NN action))
                    (PP (IN of)
                      (NP
                        (NP (NN AZD1208))
                        (CC and)
                        (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS applications))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanism-9, the-8)
dobj(elucidate-7, mechanism-9)
case(action-11, of-10)
nmod:of(mechanism-9, action-11)
case(AZD1208-13, of-12)
nmod:of(action-11, AZD1208-13)
cc(AZD1208-13, and-14)
nmod:poss(applications-18, its-15)
amod(applications-18, potential-16)
amod(applications-18, clinical-17)
nmod:of(action-11, applications-18)
conj:and(AZD1208-13, applications-18)

Obesity/JJ is_a/NN major/JJ health/NN concern/NN worldwide/RB and/CC its/PRP$ prevalence/JJ has_been/NN increasing/VBG over/IN the/DT past/JJ few/JJ decades/NNS ./.

(ROOT
  (S
    (NP (JJ Obesity) (NN is_a))
    (VP
      (VP
        (NP (JJ major) (NN health) (NN concern))
        (ADVP (RB worldwide)))
      (CC and)
      (VP
        (NP (PRP$ its) (JJ prevalence) (NN has_been))
        (PP (VBG increasing)
          (PP (IN over)
            (NP (DT the) (JJ past) (JJ few) (NNS decades))))))
    (. .)))

amod(is_a-2, Obesity-1)
nsubj(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
root(ROOT-0, concern-5)
advmod(concern-5, worldwide-6)
cc(concern-5, and-7)
nmod:poss(has_been-10, its-8)
amod(has_been-10, prevalence-9)
conj:and(concern-5, has_been-10)
case(decades-16, increasing-11)
case(decades-16, over-12)
det(decades-16, the-13)
amod(decades-16, past-14)
amod(decades-16, few-15)
advcl(has_been-10, decades-16)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN heat_shock_proteins/NNS -LRB-/-LRB- HSPs/NNP -RRB-/-RRB- may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS heat_shock_proteins))
              (PRN (-LRB- -LRB-)
                (NP (NNP HSPs))
                (-RRB- -RRB-)))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-11, that-5)
nsubj(play-11, heat_shock_proteins-6)
appos(heat_shock_proteins-6, HSPs-8)
aux(play-11, may-10)
ccomp(suggested-4, play-11)
det(role-13, a-12)
dobj(play-11, role-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(role-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)

In/IN particular/JJ ,/, Hsp110/NNS ,/, a/DT member/NN of/IN the/DT HSP70/NNP family/NN ,/, has_been/VBP shown/VBN to_be/NN hypersecreted/VBN by/IN the/DT pancreas/NN in/IN obese/JJ individuals/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP
      (NP (NNS Hsp110))
      (, ,)
      (NP
        (NP (DT a) (NN member))
        (PP (IN of)
          (NP (DT the) (NNP HSP70) (NN family))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (NP
          (NP (NN to_be))
          (VP (VBN hypersecreted)
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))
        (PP (IN in)
          (NP (JJ obese) (NNS individuals)))))
    (. .)))

case(particular-2, In-1)
advcl(has_been-13, particular-2)
nsubj(has_been-13, Hsp110-4)
det(member-7, a-6)
appos(Hsp110-4, member-7)
case(family-11, of-8)
det(family-11, the-9)
compound(family-11, HSP70-10)
nmod:of(member-7, family-11)
root(ROOT-0, has_been-13)
dep(has_been-13, shown-14)
dobj(shown-14, to_be-15)
acl(to_be-15, hypersecreted-16)
case(pancreas-19, by-17)
det(pancreas-19, the-18)
nmod:by(hypersecreted-16, pancreas-19)
case(individuals-22, in-20)
amod(individuals-22, obese-21)
nmod:in(shown-14, individuals-22)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Hsp110/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS Hsp110)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(Hsp110-20, of-19)
nmod:of(hypersecretion-18, Hsp110-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Cerulenin/NNP on/IN the/DT secretion/NN of/IN Hsp110/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- individuals/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Cerulenin)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ Hsp110) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS individuals)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(Cerulenin-16, 10-14)
compound(Cerulenin-16, mmol/L-15)
nmod:of(effects-8, Cerulenin-16)
conj:and(glucose-12, Cerulenin-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, Hsp110-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(individuals-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, individuals-39)
conj:and(genetically_obese-28, individuals-39)

Our/PRP$ results/NNS showed/VBD that/IN Hsp110/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN perfused/JJ pancreata/NN from/IN genetically_obese/JJ individuals/NNS compared/VBN to/TO lean/VB individuals/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC Cerulenin/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ Hsp110) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS individuals))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS individuals))
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP
                            (NP (DT both) (NN glucose))
                            (CC and)
                            (NP (JJ Cerulenin) (NN stimulation))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-16, that-4)
amod(secretion-6, Hsp110-5)
nsubjpass(compared-16, secretion-6)
nsubj:xsubj(lean-18, secretion-6)
auxpass(compared-16, was-7)
advmod(higher-9, significantly-8)
advmod(compared-16, higher-9)
case(pancreata-12, in-10)
amod(pancreata-12, perfused-11)
nmod:in(higher-9, pancreata-12)
case(individuals-15, from-13)
amod(individuals-15, genetically_obese-14)
nmod:from(pancreata-12, individuals-15)
ccomp(showed-3, compared-16)
mark(lean-18, to-17)
xcomp(compared-16, lean-18)
dobj(lean-18, individuals-19)
case(response-21, in-20)
nmod:in(lean-18, response-21)
case(glucose-24, to-22)
det(glucose-24, both-23)
nmod:to(response-21, glucose-24)
cc(glucose-24, and-25)
amod(stimulation-27, Cerulenin-26)
nmod:to(response-21, stimulation-27)
conj:and(glucose-24, stimulation-27)

Furthermore/RB ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO Cerulenin/NNP stimulation/NN in/IN both/DT groups/NNS ,/, but/CC no/DT significant/JJ difference/NN was/VBD observed/VBN between/IN genetically_obese/JJ and/CC lean/JJ individuals/NNS ./.

(ROOT
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (PRP we))
      (VP (VBD observed)
        (NP
          (NP (DT a) (JJ significant) (NN decrease))
          (PP (IN in)
            (NP (NN insulin_secretion))))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP (NNP Cerulenin) (NN stimulation)))))
        (PP (IN in)
          (NP (DT both) (NNS groups)))))
    (, ,)
    (CC but)
    (S
      (NP (DT no) (JJ significant) (NN difference))
      (VP (VBD was)
        (VP (VBN observed)
          (PP (IN between)
            (NP (JJ genetically_obese)
              (CC and)
              (JJ lean) (NNS individuals))))))
    (. .)))

advmod(observed-4, Furthermore-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(observed-4, decrease-7)
case(insulin_secretion-9, in-8)
nmod:in(decrease-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(stimulation-14, to-12)
compound(stimulation-14, Cerulenin-13)
nmod:to(response-11, stimulation-14)
case(groups-17, in-15)
det(groups-17, both-16)
nmod:in(observed-4, groups-17)
cc(observed-4, but-19)
neg(difference-22, no-20)
amod(difference-22, significant-21)
nsubjpass(observed-24, difference-22)
auxpass(observed-24, was-23)
conj:but(observed-4, observed-24)
case(individuals-29, between-25)
amod(individuals-29, genetically_obese-26)
cc(genetically_obese-26, and-27)
conj:and(genetically_obese-26, lean-28)
amod(individuals-29, lean-28)
nmod:between(observed-24, individuals-29)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN Hsp110/NNS by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN and/CC provide/VB new/JJ insights/NNS into/IN potential/JJ therapeutic/JJ targets/NNS for/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS Hsp110))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))
            (CC and)
            (VP (VB provide)
              (NP (JJ new) (NNS insights))
              (PP (IN into)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
nsubj(provide-20, hypersecretion-5)
case(Hsp110-7, of-6)
nmod:of(hypersecretion-5, Hsp110-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(Hsp110-7, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
cc(involved-13, and-19)
ccomp(suggest-3, provide-20)
conj:and(involved-13, provide-20)
amod(insights-22, new-21)
dobj(provide-20, insights-22)
case(targets-26, into-23)
amod(targets-26, potential-24)
amod(targets-26, therapeutic-25)
nmod:into(provide-20, targets-26)
case(condition-29, for-27)
det(condition-29, this-28)
nmod:for(targets-26, condition-29)

The/DT immune/JJ system/NN is_a/VBZ complex/JJ network/NN of/IN cells/NNS and/CC molecules/NNS that/IN work/VB together/RB to/TO protect/VB the/DT body/NN from/IN infection/NN and_disease/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ immune) (NN system))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN network))
        (PP (IN of)
          (NP (NNS cells)
            (CC and)
            (NNS molecules)))
        (SBAR
          (WHNP (IN that))
          (S
            (VP (VB work)
              (ADVP (RB together))
              (S
                (VP (TO to)
                  (VP (VB protect)
                    (NP (DT the) (NN body))
                    (PP (IN from)
                      (NP (NN infection) (NN and_disease)))))))))))
    (. .)))

det(system-3, The-1)
amod(system-3, immune-2)
nsubj(is_a-4, system-3)
root(ROOT-0, is_a-4)
amod(network-6, complex-5)
dobj(is_a-4, network-6)
nsubj(work-12, network-6)
nsubj:xsubj(protect-15, network-6)
case(cells-8, of-7)
nmod:of(network-6, cells-8)
cc(cells-8, and-9)
nmod:of(network-6, molecules-10)
conj:and(cells-8, molecules-10)
ref(network-6, that-11)
acl:relcl(network-6, work-12)
advmod(work-12, together-13)
mark(protect-15, to-14)
xcomp(work-12, protect-15)
det(body-17, the-16)
dobj(protect-15, body-17)
case(and_disease-20, from-18)
compound(and_disease-20, infection-19)
nmod:from(protect-15, and_disease-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT relationship/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, thymulin/NN ,/, and/CC CD4/CD levels/NNS in_a/JJ cohort/NN of/IN patients/NNS with/IN HIV/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN relationship))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NN alkaline_phosphatase))
                (, ,)
                (NP (NN thymulin))
                (, ,)
                (CC and)
                (NP
                  (NP
                    (ADJP
                      (NP (CD CD4) (NNS levels))
                      (JJ in_a))
                    (NN cohort))
                  (PP (IN of)
                    (NP (NNS patients)))))))))
      (PP (IN with)
        (NP (NNP HIV))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(relationship-8, the-7)
dobj(investigated-6, relationship-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(relationship-8, levels-11)
case(alkaline_phosphatase-13, of-12)
nmod:of(levels-11, alkaline_phosphatase-13)
nmod:of(levels-11, thymulin-15)
conj:and(alkaline_phosphatase-13, thymulin-15)
cc(alkaline_phosphatase-13, and-17)
nummod(levels-19, CD4-18)
nmod:npmod(in_a-20, levels-19)
amod(cohort-21, in_a-20)
nmod:of(levels-11, cohort-21)
conj:and(alkaline_phosphatase-13, cohort-21)
case(patients-23, of-22)
nmod:of(cohort-21, patients-23)
case(HIV-25, with-24)
nmod:with(investigated-6, HIV-25)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, thymulin/NN -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/VBP less/JJR than/IN 0.01/CD -RRB-/-RRB- and/CC serum/NN CD4/CD levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP
            (VP (VBD was)
              (NP
                (NP (DT a) (JJ significant) (NN correlation))
                (PP (IN between)
                  (NP
                    (NP (NN serum) (NNS levels))
                    (PP (IN of)
                      (NP (NN alkaline_phosphatase)))))))
            (PRN (-LRB- -LRB-)
              (SBAR
                (X
                  (X (SYM r))
                  (NP (SYM =)))
                (S
                  (NP
                    (NP (CD 0.3))
                    (PRN (, ,)
                      (ADVP (RB p))
                      (NP
                        (QP (JJR less) (IN than) (CD 0.01)))
                      (-RRB- -RRB-))
                    (, ,)
                    (NP
                      (NP (NN thymulin))
                      (-LRB- -LRB-)
                      (NP
                        (FRAG
                          (X
                            (X (SYM r))
                            (NP (SYM =)))
                          (NP (CD 0.42)))))
                    (, ,))
                  (VP (VBP p)
                    (NP
                      (QP (JJR less) (IN than) (CD 0.01))))))
              (-RRB- -RRB-))
            (CC and)
            (VP (NN serum)
              (NP (CD CD4) (NNS levels)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(correlation-9, that-4)
expl(correlation-9, there-5)
cop(correlation-9, was-6)
det(correlation-9, a-7)
amod(correlation-9, significant-8)
ccomp(showed-3, correlation-9)
case(levels-12, between-10)
compound(levels-12, serum-11)
nmod:between(correlation-9, levels-12)
case(alkaline_phosphatase-14, of-13)
nmod:of(levels-12, alkaline_phosphatase-14)
dep(=-17, r-16)
dep(p-32, =-17)
nsubj(p-32, 0.3-18)
dep(0.01-23, p-20)
advmod(0.01-23, less-21)
mwe(less-21, than-22)
dep(0.3-18, 0.01-23)
appos(0.3-18, thymulin-26)
dep(=-29, r-28)
dep(0.42-30, =-29)
dep(thymulin-26, 0.42-30)
parataxis(correlation-9, p-32)
advmod(0.01-35, less-33)
mwe(less-33, than-34)
dobj(p-32, 0.01-35)
cc(correlation-9, and-37)
ccomp(showed-3, serum-38)
conj:and(correlation-9, serum-38)
nummod(levels-40, CD4-39)
nsubj(correlation-9, levels-40)

These/DT findings/NNS suggest/VBP that/IN alkaline_phosphatase/NN and/CC thymulin/NN may/MD play/VB important/JJ roles/NNS in/IN the/DT regulation/NN of/IN immune/JJ function/NN in/IN patients/NNS with/IN HIV/NNP ,/, and/CC could/MD potentially/RB serve/VB as/IN biomarkers/NNS for/IN disease/NN progression/NN or/CC treatment/NN response/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN alkaline_phosphatase)
            (CC and)
            (NN thymulin))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP (JJ important) (NNS roles))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (JJ immune) (NN function))
                        (PP (IN in)
                          (NP (NNS patients)))))))
                (PP (IN with)
                  (NP (NNP HIV)))))
            (, ,)
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB serve)
                (PP (IN as)
                  (NP
                    (NP (NNS biomarkers))
                    (PP (IN for)
                      (NP
                        (NP (NN disease) (NN progression))
                        (CC or)
                        (NP (NN treatment) (NN response))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, alkaline_phosphatase-5)
nsubj(serve-26, alkaline_phosphatase-5)
cc(alkaline_phosphatase-5, and-6)
conj:and(alkaline_phosphatase-5, thymulin-7)
nsubj(play-9, thymulin-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
amod(roles-11, important-10)
dobj(play-9, roles-11)
case(regulation-14, in-12)
det(regulation-14, the-13)
nmod:in(play-9, regulation-14)
case(function-17, of-15)
amod(function-17, immune-16)
nmod:of(regulation-14, function-17)
case(patients-19, in-18)
nmod:in(function-17, patients-19)
case(HIV-21, with-20)
nmod:with(play-9, HIV-21)
cc(play-9, and-23)
aux(serve-26, could-24)
advmod(serve-26, potentially-25)
ccomp(suggest-3, serve-26)
conj:and(play-9, serve-26)
case(biomarkers-28, as-27)
nmod:as(serve-26, biomarkers-28)
case(progression-31, for-29)
compound(progression-31, disease-30)
nmod:for(biomarkers-28, progression-31)
cc(progression-31, or-32)
compound(response-34, treatment-33)
nmod:for(biomarkers-28, response-34)
conj:or(progression-31, response-34)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO explore/VB their/PRP$ clinical/JJ implications/NNS for/IN the/DT management/NN of/IN HIV_infection/NNP ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (PRP$ their) (JJ clinical) (NNS implications))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN management))
                      (PP (IN of)
                        (NP (NNP HIV_infection))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
ccomp(warranted-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(associations-11, these-10)
dobj(underlying-9, associations-11)
cc(elucidate-6, and-12)
mark(explore-14, to-13)
ccomp(warranted-4, explore-14)
conj:and(elucidate-6, explore-14)
nmod:poss(implications-17, their-15)
amod(implications-17, clinical-16)
dobj(explore-14, implications-17)
case(management-20, for-18)
det(management-20, the-19)
nmod:for(implications-17, management-20)
case(HIV_infection-22, of-21)
nmod:of(management-20, HIV_infection-22)

The/DT enzymes/NNS acyl-CoA_cholesterol_acyl_transferase/JJ -LRB-/-LRB- EC/NNP 4.1.3.7/CD -RRB-/-RRB- ,/, acetyl-CoA_carboxylase/JJ -LRB-/-LRB- EC/NNP 6.4.1.2/CD -RRB-/-RRB- ,/, and/CC fatty_acid_synthetase/JJ play/VBP crucial/JJ roles/NNS in/IN lipid/NN metabolism/NN ,/, particularly/RB in/IN the/DT brain/NN where/WRB they/PRP are/VBP involved/VBN in/IN myelin/NN synthesis/NN and/CC maintenance/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS enzymes))
      (ADJP
        (ADJP (JJ acyl-CoA_cholesterol_acyl_transferase))
        (PRN (-LRB- -LRB-)
          (NAC (NNP EC) (CD 4.1.3.7))
          (-RRB- -RRB-))
        (, ,)
        (ADJP
          (ADJP (JJ acetyl-CoA_carboxylase))
          (PRN (-LRB- -LRB-)
            (NAC (NNP EC) (CD 6.4.1.2))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (ADJP (JJ fatty_acid_synthetase))))
    (VP (VBP play)
      (NP
        (NP
          (NP (JJ crucial) (NNS roles))
          (PP (IN in)
            (NP (NN lipid) (NN metabolism))))
        (, ,)
        (CONJP (RB particularly) (IN in))
        (NP
          (NP (DT the) (NN brain))
          (SBAR
            (WHADVP (WRB where))
            (S
              (NP (PRP they))
              (VP (VBP are)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP (NN myelin) (NN synthesis)
                      (CC and)
                      (NN maintenance))))))))))
    (. .)))

det(enzymes-2, The-1)
nsubj(play-17, enzymes-2)
amod(enzymes-2, acyl-CoA_cholesterol_acyl_transferase-3)
dep(acyl-CoA_cholesterol_acyl_transferase-3, EC-5)
dep(EC-5, 4.1.3.7-6)
amod(enzymes-2, acetyl-CoA_carboxylase-9)
conj:and(acyl-CoA_cholesterol_acyl_transferase-3, acetyl-CoA_carboxylase-9)
dep(acetyl-CoA_carboxylase-9, EC-11)
dep(EC-11, 6.4.1.2-12)
cc(acyl-CoA_cholesterol_acyl_transferase-3, and-15)
amod(enzymes-2, fatty_acid_synthetase-16)
conj:and(acyl-CoA_cholesterol_acyl_transferase-3, fatty_acid_synthetase-16)
root(ROOT-0, play-17)
amod(roles-19, crucial-18)
dobj(play-17, roles-19)
case(metabolism-22, in-20)
compound(metabolism-22, lipid-21)
nmod:in(roles-19, metabolism-22)
cc(roles-19, particularly-24)
dep(particularly-24, in-25)
det(brain-27, the-26)
dobj(play-17, brain-27)
conj:particularly(roles-19, brain-27)
advmod(involved-31, where-28)
nsubjpass(involved-31, they-29)
auxpass(involved-31, are-30)
acl:relcl(brain-27, involved-31)
case(synthesis-34, in-32)
compound(synthesis-34, myelin-33)
nmod:in(involved-31, synthesis-34)
cc(synthesis-34, and-35)
nmod:in(involved-31, maintenance-36)
conj:and(synthesis-34, maintenance-36)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT activities/NNS of/IN these/DT enzymes/NNS in/IN the/DT brains/NNS of/IN 14-day-old/JJ and/CC adult/JJ rats/NNS ,/, as/RB well/RB as/IN the/DT effects/NNS of/IN TS-962/NN on/IN their/PRP$ activities/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS activities))
        (PP (IN of)
          (NP
            (NP (DT these) (NNS enzymes))
            (PP (IN in)
              (NP
                (NP (DT the) (NNS brains))
                (PP (IN of)
                  (NP
                    (NP
                      (ADJP (JJ 14-day-old)
                        (CC and)
                        (JJ adult))
                      (NNS rats))
                    (, ,)
                    (CONJP (RB as) (RB well) (IN as))
                    (NP
                      (NP (DT the) (NNS effects))
                      (PP (IN of)
                        (NP (NN TS-962)))
                      (PP (IN on)
                        (NP (PRP$ their) (NNS activities))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(activities-8, the-7)
dobj(investigated-6, activities-8)
case(enzymes-11, of-9)
det(enzymes-11, these-10)
nmod:of(activities-8, enzymes-11)
case(brains-14, in-12)
det(brains-14, the-13)
nmod:in(enzymes-11, brains-14)
case(rats-19, of-15)
amod(rats-19, 14-day-old-16)
cc(14-day-old-16, and-17)
conj:and(14-day-old-16, adult-18)
amod(rats-19, adult-18)
nmod:of(brains-14, rats-19)
cc(rats-19, as-21)
mwe(as-21, well-22)
mwe(as-21, as-23)
det(effects-25, the-24)
nmod:of(brains-14, effects-25)
conj:and(rats-19, effects-25)
case(TS-962-27, of-26)
nmod:of(effects-25, TS-962-27)
case(activities-30, on-28)
nmod:poss(activities-30, their-29)
nmod:on(effects-25, activities-30)

Our/PRP$ results/NNS showed/VBD that/IN the/DT activities/NNS of/IN these/DT enzymes/NNS were/VBD higher/JJR in/IN adult/JJ rat/NN brains/NNS compared/VBN to/TO those/DT of/IN 14-day-old/JJ rats/NNS ,/, indicating/VBG a/DT developmental/JJ regulation/NN of/IN lipid/NN metabolism/NN in/IN the/DT brain/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NNS activities))
            (PP (IN of)
              (NP (DT these) (NNS enzymes))))
          (VP (VBD were)
            (NP (JJR higher))
            (PP (IN in)
              (NP (JJ adult) (NN rat) (NNS brains)))
            (PP (VBN compared)
              (PP (TO to)
                (NP
                  (NP (DT those))
                  (PP (IN of)
                    (NP
                      (NP (JJ 14-day-old) (NNS rats))
                      (, ,)
                      (VP (VBG indicating)
                        (NP
                          (NP (DT a) (JJ developmental) (NN regulation))
                          (PP (IN of)
                            (NP
                              (NP (NN lipid) (NN metabolism))
                              (PP (IN in)
                                (NP (DT the) (NN brain))))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(higher-11, that-4)
det(activities-6, the-5)
nsubj(higher-11, activities-6)
case(enzymes-9, of-7)
det(enzymes-9, these-8)
nmod:of(activities-6, enzymes-9)
cop(higher-11, were-10)
ccomp(showed-3, higher-11)
case(brains-15, in-12)
amod(brains-15, adult-13)
compound(brains-15, rat-14)
nmod:in(higher-11, brains-15)
case(those-18, compared-16)
mwe(compared-16, to-17)
advcl(higher-11, those-18)
case(rats-21, of-19)
amod(rats-21, 14-day-old-20)
nmod:of(those-18, rats-21)
acl(rats-21, indicating-23)
det(regulation-26, a-24)
amod(regulation-26, developmental-25)
dobj(indicating-23, regulation-26)
case(metabolism-29, of-27)
compound(metabolism-29, lipid-28)
nmod:of(regulation-26, metabolism-29)
case(brain-32, in-30)
det(brain-32, the-31)
nmod:in(metabolism-29, brain-32)

Furthermore/RB ,/, treatment/NN with/IN TS-962/NNP resulted/VBD in_a/JJ significant/JJ inhibition/NN of/IN acyl-CoA_cholesterol_acyl_transferase/JJ activity/NN and/CC a/DT modest/JJ inhibition/NN of/IN acetyl-CoA_carboxylase/JJ activity/NN ,/, while/IN fatty_acid_synthetase/JJ activity/NN was/VBD not/RB affected/VBN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP TS-962))))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN inhibition))
        (PP (IN of)
          (NP
            (NP (JJ acyl-CoA_cholesterol_acyl_transferase) (NN activity))
            (CC and)
            (NP
              (NP (DT a) (JJ modest) (NN inhibition))
              (PP (IN of)
                (NP (JJ acetyl-CoA_carboxylase) (NN activity)))))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (JJ fatty_acid_synthetase) (NN activity))
          (VP (VBD was) (RB not)
            (VP (VBN affected))))))
    (. .)))

advmod(resulted-6, Furthermore-1)
nsubj(resulted-6, treatment-3)
case(TS-962-5, with-4)
nmod:with(treatment-3, TS-962-5)
root(ROOT-0, resulted-6)
amod(inhibition-9, in_a-7)
amod(inhibition-9, significant-8)
dobj(resulted-6, inhibition-9)
case(activity-12, of-10)
amod(activity-12, acyl-CoA_cholesterol_acyl_transferase-11)
nmod:of(inhibition-9, activity-12)
cc(activity-12, and-13)
det(inhibition-16, a-14)
amod(inhibition-16, modest-15)
nmod:of(inhibition-9, inhibition-16)
conj:and(activity-12, inhibition-16)
case(activity-19, of-17)
amod(activity-19, acetyl-CoA_carboxylase-18)
nmod:of(inhibition-16, activity-19)
mark(affected-26, while-21)
amod(activity-23, fatty_acid_synthetase-22)
nsubjpass(affected-26, activity-23)
auxpass(affected-26, was-24)
neg(affected-26, not-25)
advcl(resulted-6, affected-26)

These/DT findings/NNS suggest/VBP that/IN TS-962/NNP may/MD have/VB potential/JJ therapeutic/JJ applications/NNS for/IN disorders/NNS related/VBN to/TO abnormal/JJ lipid/NN metabolism/NN in/IN the/DT brain/NN ,/, such/JJ as/IN demyelinating_diseases/NNS or/CC neurodegenerative_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP TS-962))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN for)
                  (NP
                    (NP (NNS disorders))
                    (VP (VBN related)
                      (PP (TO to)
                        (NP
                          (NP (JJ abnormal) (NN lipid) (NN metabolism))
                          (PP (IN in)
                            (NP (DT the) (NN brain))))))))
                (, ,)
                (PP (JJ such) (IN as)
                  (NP (NNS demyelinating_diseases)
                    (CC or)
                    (NNS neurodegenerative_disorders)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, TS-962-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(disorders-12, for-11)
nmod:for(applications-10, disorders-12)
acl(disorders-12, related-13)
case(metabolism-17, to-14)
amod(metabolism-17, abnormal-15)
compound(metabolism-17, lipid-16)
nmod:to(related-13, metabolism-17)
case(brain-20, in-18)
det(brain-20, the-19)
nmod:in(metabolism-17, brain-20)
case(demyelinating_diseases-24, such-22)
mwe(such-22, as-23)
nmod:such_as(applications-10, demyelinating_diseases-24)
cc(demyelinating_diseases-24, or-25)
nmod:such_as(applications-10, neurodegenerative_disorders-26)
conj:or(demyelinating_diseases-24, neurodegenerative_disorders-26)

The/DT use/NN of/IN natural/JJ products/NNS in/IN medical/JJ treatments/NNS has_been/VBP increasing/VBG due/JJ to/TO their/PRP$ potential/JJ therapeutic/JJ properties/NNS and/CC minimal/JJ side/NN effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP
          (NP (JJ natural) (NNS products))
          (PP (IN in)
            (NP (JJ medical) (NNS treatments))))))
    (VP (VBP has_been)
      (VP (VBG increasing)
        (ADJP (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (JJ potential)
              (NX
                (NX (JJ therapeutic) (NNS properties))
                (CC and)
                (NX (JJ minimal) (NN side) (NNS effects))))))))
    (. .)))

det(use-2, The-1)
nsubj(has_been-9, use-2)
case(products-5, of-3)
amod(products-5, natural-4)
nmod:of(use-2, products-5)
case(treatments-8, in-6)
amod(treatments-8, medical-7)
nmod:in(products-5, treatments-8)
root(ROOT-0, has_been-9)
xcomp(has_been-9, increasing-10)
xcomp(increasing-10, due-11)
case(properties-16, to-12)
nmod:poss(properties-16, their-13)
amod(properties-16, potential-14)
amod(properties-16, therapeutic-15)
nmod:to(due-11, properties-16)
cc(properties-16, and-17)
amod(effects-20, minimal-18)
compound(effects-20, side-19)
nmod:to(due-11, effects-20)
conj:and(properties-16, effects-20)

One/CD such/JJ product/NN is/VBZ cordycepin/NN ,/, which/WDT has_been/NN found/VBD to/TO possess/VB anti-inflammatory/JJ and/CC analgesic/JJ properties/NNS ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN product))
    (VP (VBZ is)
      (NP
        (NP (NN cordycepin))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (NP (NN has_been))
            (VP (VBD found)
              (S
                (VP (TO to)
                  (VP (VB possess)
                    (NP (JJ anti-inflammatory)
                      (CC and)
                      (JJ analgesic) (NNS properties))))))))))
    (. .)))

nummod(product-3, One-1)
amod(product-3, such-2)
nsubj(cordycepin-5, product-3)
cop(cordycepin-5, is-4)
root(ROOT-0, cordycepin-5)
dobj(found-9, cordycepin-5)
nsubj:xsubj(possess-11, cordycepin-5)
ref(cordycepin-5, which-7)
nsubj(found-9, has_been-8)
acl:relcl(cordycepin-5, found-9)
mark(possess-11, to-10)
xcomp(found-9, possess-11)
amod(properties-15, anti-inflammatory-12)
cc(anti-inflammatory-12, and-13)
conj:and(anti-inflammatory-12, analgesic-14)
amod(properties-15, analgesic-14)
dobj(possess-11, properties-15)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN cordycepin/NN on/IN cervical_lordosis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN cordycepin))
          (PP (IN on)
            (NP
              (NP (NNS cervical_lordosis))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effects-6, the-5)
nsubjpass(investigated-17, effects-6)
case(cordycepin-8, of-7)
nmod:of(effects-6, cordycepin-8)
case(cervical_lordosis-10, on-9)
nmod:on(cordycepin-8, cervical_lordosis-10)
nmod:on(cordycepin-8, photophobia-12)
conj:and(cervical_lordosis-10, photophobia-12)
cc(cervical_lordosis-10, and-14)
nmod:on(cordycepin-8, phonophobia-15)
conj:and(cervical_lordosis-10, phonophobia-15)
auxpass(investigated-17, were-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, cordycepin/NN reduced/VBD the/DT risk/NN of/IN cervical_lordosis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN cordycepin))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS cervical_lordosis))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-12, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-12, cordycepin-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(cervical_lordosis-16, of-15)
nmod:of(risk-14, cervical_lordosis-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN cordycepin/NN may/MD have/VB potential/JJ as/IN a/DT natural/JJ alternative/NN for/IN the/DT treatment/NN of/IN pain-related_disorders/NNS such/JJ as/IN migraines/NNS and/CC tension/NN headaches/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cordycepin))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ natural) (NN alternative))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP
                          (NP (NNS pain-related_disorders))
                          (PP (JJ such) (IN as)
                            (NP
                              (NP (NNS migraines))
                              (CC and)
                              (NP (NN tension) (NNS headaches)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, cordycepin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(alternative-12, as-9)
det(alternative-12, a-10)
amod(alternative-12, natural-11)
nmod:as(have-7, alternative-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(alternative-12, treatment-15)
case(pain-related_disorders-17, of-16)
nmod:of(treatment-15, pain-related_disorders-17)
case(migraines-20, such-18)
mwe(such-18, as-19)
nmod:such_as(pain-related_disorders-17, migraines-20)
cc(migraines-20, and-21)
compound(headaches-23, tension-22)
nmod:such_as(pain-related_disorders-17, headaches-23)
conj:and(migraines-20, headaches-23)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN treatment/NN with/IN cordycepin/NN for/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ optimal) (NN dosage)
                  (CC and)
                  (NN duration))
                (PP (IN of)
                  (NP (NN treatment))))
              (PP (IN with)
                (NP
                  (NP (NN cordycepin))
                  (PP (IN for)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(determine-6, to-5)
xcomp(warranted-4, determine-6)
det(dosage-9, the-7)
amod(dosage-9, optimal-8)
dobj(determine-6, dosage-9)
cc(dosage-9, and-10)
dobj(determine-6, duration-11)
conj:and(dosage-9, duration-11)
case(treatment-13, of-12)
nmod:of(dosage-9, treatment-13)
case(cordycepin-15, with-14)
nmod:with(determine-6, cordycepin-15)
case(conditions-18, for-16)
det(conditions-18, these-17)
nmod:for(cordycepin-15, conditions-18)

Obesity/RB is_a/JJ global/JJ public_health/JJ problem/NN that/WDT affects/VBZ millions/NNS of/IN people/NNS worldwide/RB and/CC is/VBZ associated/VBN with/IN several/JJ comorbidities/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (ADJP (RB Obesity) (JJ is_a))
        (JJ global) (JJ public_health) (NN problem))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ affects)
            (NP
              (NP (NNS millions))
              (PP (IN of)
                (NP (NNS people))))))))
    (ADVP (RB worldwide)
      (CC and))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ several) (NNS comorbidities))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(problem-5, is_a-2)
amod(problem-5, global-3)
amod(problem-5, public_health-4)
nsubj(affects-7, problem-5)
nsubjpass(associated-14, problem-5)
ref(problem-5, that-6)
acl:relcl(problem-5, affects-7)
dobj(affects-7, millions-8)
case(people-10, of-9)
nmod:of(millions-8, people-10)
advmod(associated-14, worldwide-11)
cc(worldwide-11, and-12)
auxpass(associated-14, is-13)
root(ROOT-0, associated-14)
case(comorbidities-17, with-15)
amod(comorbidities-17, several-16)
nmod:with(associated-14, comorbidities-17)
acl(comorbidities-17, including-19)
dobj(including-19, type_2_diabetes-20)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN glucose_homeostasis/NNS by/IN secreting/VBG insulin/NN ,/, which/WDT regulates/VBZ glucose_uptake/NN and/CC utilization/NN by/IN peripheral/JJ tissues/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP (NNS glucose_homeostasis))))
      (PP (IN by)
        (S
          (VP (VBG secreting)
            (NP
              (NP (NN insulin))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ regulates)
                    (NP (NN glucose_uptake)
                      (CC and)
                      (NN utilization))))))
            (PP (IN by)
              (NP (JJ peripheral) (NNS tissues)))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(glucose_homeostasis-8, in-7)
nmod:in(role-6, glucose_homeostasis-8)
mark(secreting-10, by-9)
advcl(plays-3, secreting-10)
dobj(secreting-10, insulin-11)
nsubj(regulates-14, insulin-11)
ref(insulin-11, which-13)
acl:relcl(insulin-11, regulates-14)
dobj(regulates-14, glucose_uptake-15)
cc(glucose_uptake-15, and-16)
dobj(regulates-14, utilization-17)
conj:and(glucose_uptake-15, utilization-17)
case(tissues-20, by-18)
amod(tissues-20, peripheral-19)
nmod:by(secreting-10, tissues-20)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN CDC25A/NNP ,/, a/DT protein/NN phosphatase/NN involved/VBN in/IN cell/NN cycle/NN regulation/NN ,/, may/MD contribute/VB to/TO the/DT development/NN of/IN insulin_resistance/NN and/CC obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NNP CDC25A))
                  (, ,)
                  (NP
                    (NP (DT a) (NN protein) (NN phosphatase))
                    (VP (VBN involved)
                      (PP (IN in)
                        (NP (NN cell) (NN cycle) (NN regulation)))))
                  (, ,))))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN insulin_resistance)
                        (CC and)
                        (NN obesity)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(contribute-21, that-5)
det(hypersecretion-7, the-6)
nsubj(contribute-21, hypersecretion-7)
case(CDC25A-9, of-8)
nmod:of(hypersecretion-7, CDC25A-9)
det(phosphatase-13, a-11)
compound(phosphatase-13, protein-12)
appos(CDC25A-9, phosphatase-13)
acl(phosphatase-13, involved-14)
case(regulation-18, in-15)
compound(regulation-18, cell-16)
compound(regulation-18, cycle-17)
nmod:in(involved-14, regulation-18)
aux(contribute-21, may-20)
ccomp(suggested-4, contribute-21)
case(development-24, to-22)
det(development-24, the-23)
nmod:to(contribute-21, development-24)
case(insulin_resistance-26, of-25)
nmod:of(development-24, insulin_resistance-26)
cc(insulin_resistance-26, and-27)
nmod:of(development-24, obesity-28)
conj:and(insulin_resistance-26, obesity-28)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN CDC25A/NNP by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Benzamide_riboside/NNP on/IN the/DT secretion/NN of/IN CDC25A/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (NNP CDC25A)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Benzamide_riboside)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP CDC25A) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(CDC25A-14, of-13)
nmod:of(hypersecretion-12, CDC25A-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(Benzamide_riboside-30, 10-28)
compound(Benzamide_riboside-30, mmol/L-29)
nmod:of(effects-22, Benzamide_riboside-30)
conj:and(glucose-26, Benzamide_riboside-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
compound(and_insulin-36, CDC25A-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
appos(genetically_obese-42, fa/fa-44)
cc(genetically_obese-42, and-46)
amod(rats-53, lean-47)
dep(lean-47, Fa-49)
nmod:from(pancreata-40, rats-53)
conj:and(genetically_obese-42, rats-53)

Our/PRP$ results/NNS showed/VBD that/IN perfused/JJ pancreata/NN from/IN obese/JJ rats/NNS secreted/VBD significantly/RB higher/JJR levels/NNS of/IN CDC25A/NNP compared/VBN to/TO lean/JJ rats/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC Benzamide_riboside/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ perfused) (NN pancreata))
            (PP (IN from)
              (NP (JJ obese) (NNS rats))))
          (VP (VBD secreted)
            (NP
              (NP
                (ADJP (RB significantly) (JJR higher))
                (NNS levels))
              (PP (IN of)
                (NP (NNP CDC25A))))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (DT both) (NN glucose))
                    (CC and)
                    (NP (JJ Benzamide_riboside) (NN stimulation))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(secreted-10, that-4)
amod(pancreata-6, perfused-5)
nsubj(secreted-10, pancreata-6)
case(rats-9, from-7)
amod(rats-9, obese-8)
nmod:from(pancreata-6, rats-9)
ccomp(showed-3, secreted-10)
advmod(higher-12, significantly-11)
amod(levels-13, higher-12)
dobj(secreted-10, levels-13)
case(CDC25A-15, of-14)
nmod:of(levels-13, CDC25A-15)
case(rats-19, compared-16)
mwe(compared-16, to-17)
amod(rats-19, lean-18)
advcl(secreted-10, rats-19)
case(response-21, in-20)
nmod:in(secreted-10, response-21)
case(glucose-24, to-22)
det(glucose-24, both-23)
nmod:to(response-21, glucose-24)
cc(glucose-24, and-25)
amod(stimulation-27, Benzamide_riboside-26)
nmod:to(response-21, stimulation-27)
conj:and(glucose-24, stimulation-27)

However/RB ,/, no/DT significant/JJ differences/NNS were/VBD observed/VBN in/IN insulin_secretion/NN between/IN obese/JJ and/CC lean/JJ rats/NNS under/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT no) (JJ significant) (NNS differences))
    (VP (VBD were)
      (VP (VBN observed)
        (PP (IN in)
          (NP
            (NP (NN insulin_secretion))
            (PP (IN between)
              (NP (JJ obese)
                (CC and)
                (JJ lean) (NNS rats)))))
        (PP (IN under)
          (NP (DT these) (NNS conditions)))))
    (. .)))

advmod(observed-7, However-1)
neg(differences-5, no-3)
amod(differences-5, significant-4)
nsubjpass(observed-7, differences-5)
auxpass(observed-7, were-6)
root(ROOT-0, observed-7)
case(insulin_secretion-9, in-8)
nmod:in(observed-7, insulin_secretion-9)
case(rats-14, between-10)
amod(rats-14, obese-11)
cc(obese-11, and-12)
conj:and(obese-11, lean-13)
amod(rats-14, lean-13)
nmod:between(insulin_secretion-9, rats-14)
case(conditions-17, under-15)
det(conditions-17, these-16)
nmod:under(observed-7, conditions-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN CDC25A/NNP may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN but/CC not/RB necessarily/RB linked/VBN to/TO impaired_insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NNP CDC25A))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NNS pathogenesis))
                      (PP (IN of)
                        (NP (NN obesity)))))))))))
      (CC but)
      (ADVP (RB not) (RB necessarily))
      (VP (VBN linked)
        (PP (TO to)
          (NP (NN impaired_insulin_secretion)))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
nsubj(linked-19, findings-2)
root(ROOT-0, suggest-3)
mark(involved-10, that-4)
nsubjpass(involved-10, hypersecretion-5)
case(CDC25A-7, of-6)
nmod:of(hypersecretion-5, CDC25A-7)
aux(involved-10, may-8)
auxpass(involved-10, be-9)
ccomp(suggest-3, involved-10)
case(pathogenesis-13, in-11)
det(pathogenesis-13, the-12)
nmod:in(involved-10, pathogenesis-13)
case(obesity-15, of-14)
nmod:of(pathogenesis-13, obesity-15)
cc(suggest-3, but-16)
dep(necessarily-18, not-17)
advmod(suggest-3, necessarily-18)
conj:but(suggest-3, linked-19)
case(impaired_insulin_secretion-21, to-20)
nmod:to(linked-19, impaired_insulin_secretion-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (NNS obesity-related_disorders))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(obesity-related_disorders-15, for-14)
nmod:for(targets-13, obesity-related_disorders-15)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN the/DT human/JJ diet/NN and/CC have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (NP
          (NP (JJ essential) (NNS components))
          (PP (IN of)
            (NP (DT the) (JJ human) (NN diet)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ various) (NN health) (NNS benefits)))))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
nsubjpass(associated-24, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, the-18)
amod(diet-20, human-19)
nmod:of(components-16, diet-20)
cc(components-16, and-21)
aux(associated-24, have-22)
auxpass(associated-24, been-23)
conj:and(components-16, associated-24)
case(benefits-28, with-25)
amod(benefits-28, various-26)
compound(benefits-28, health-27)
nmod:with(associated-24, benefits-28)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN cerium_nitrate/JJ levels/NNS in/IN hypercerium/JJ nitratemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ cerium_nitrate) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hypercerium) (JJ nitratemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-14, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-14, omega-3_fatty_acids-7)
appos(omega-3_fatty_acids-7, EPA-9)
cc(EPA-9, and-10)
appos(omega-3_fatty_acids-7, DHA-11)
conj:and(EPA-9, DHA-11)
auxpass(associated-14, are-13)
ccomp(shown-4, associated-14)
case(levels-18, with-15)
amod(levels-18, decreased-16)
amod(levels-18, cerium_nitrate-17)
nmod:with(associated-14, levels-18)
case(patients-22, in-19)
amod(patients-22, hypercerium-20)
amod(patients-22, nitratemic-21)
nmod:in(levels-18, patients-22)

Furthermore/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(found-7, Furthermore-1)
det(fatty_acids-4, these-3)
nsubjpass(found-7, fatty_acids-4)
nsubj:xsubj(decrease-9, fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(decrease-9, to-8)
xcomp(found-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD reduce/VB inflammation/NN ,/, improve/VB lipid/NN profiles/NNS ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP
                  (VP (VB reduce)
                    (NP (NN inflammation)))
                  (, ,)
                  (VP (VB improve)
                    (NP (NN lipid) (NNS profiles)))
                  (, ,)
                  (CC and)
                  (VP (VB enhance)
                    (NP (JJ endothelial) (NN function))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
nsubjpass(believed-14, it-12)
auxpass(believed-14, is-13)
conj:but(understood-9, believed-14)
mark(reduce-20, that-15)
nsubj(reduce-20, EPA-16)
nsubj(improve-23, EPA-16)
nsubj(enhance-28, EPA-16)
cc(EPA-16, and-17)
conj:and(EPA-16, DHA-18)
nsubj(reduce-20, DHA-18)
aux(reduce-20, may-19)
ccomp(believed-14, reduce-20)
dobj(reduce-20, inflammation-21)
ccomp(believed-14, improve-23)
conj:and(reduce-20, improve-23)
compound(profiles-25, lipid-24)
dobj(improve-23, profiles-25)
cc(reduce-20, and-27)
ccomp(believed-14, enhance-28)
conj:and(reduce-20, enhance-28)
amod(function-30, endothelial-29)
dobj(enhance-28, function-30)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ approach/NN for/IN preventing/VBG or/CC managing/VBG hypercerium/NN nitratemia/NN and/CC CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (NN approach))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (CC or)
                    (VBG managing)
                    (NP
                      (NP (NN hypercerium) (NN nitratemia))
                      (CC and)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(approach-15, that-4)
csubj(approach-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(approach-15, may-11)
cop(approach-15, be-12)
det(approach-15, a-13)
amod(approach-15, promising-14)
ccomp(suggest-3, approach-15)
mark(preventing-17, for-16)
advcl(approach-15, preventing-17)
cc(preventing-17, or-18)
advcl(approach-15, managing-19)
conj:or(preventing-17, managing-19)
compound(nitratemia-21, hypercerium-20)
dobj(preventing-17, nitratemia-21)
cc(nitratemia-21, and-22)
dobj(preventing-17, CHD-23)
conj:and(nitratemia-21, CHD-23)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT exact/JJ mechanisms/NNS of/IN action/NN and/CC optimal/JJ dosages/NNS for/IN these/DT beneficial/JJ effects/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ exact) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (NN action))
                    (CC and)
                    (NP (JJ optimal) (NNS dosages)))))
              (PP (IN for)
                (NP (DT these) (JJ beneficial) (NNS effects))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, exact-8)
dobj(elucidate-6, mechanisms-9)
case(action-11, of-10)
nmod:of(mechanisms-9, action-11)
cc(action-11, and-12)
amod(dosages-14, optimal-13)
nmod:of(mechanisms-9, dosages-14)
conj:and(action-11, dosages-14)
case(effects-18, for-15)
det(effects-18, these-16)
amod(effects-18, beneficial-17)
nmod:for(elucidate-6, effects-18)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN and/CC coordination/NN of/IN various/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN programs/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation)
                  (CC and)
                  (NN coordination))
                (PP (IN of)
                  (NP
                    (NP (JJ various) (VBG signaling) (NNS pathways))
                    (CC and)
                    (NP (NN gene) (NN expression) (NNS programs))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
cc(activation-10, and-11)
dobj(involves-8, coordination-12)
conj:and(activation-10, coordination-12)
case(pathways-16, of-13)
amod(pathways-16, various-14)
amod(pathways-16, signaling-15)
nmod:of(activation-10, pathways-16)
cc(pathways-16, and-17)
compound(programs-20, gene-18)
compound(programs-20, expression-19)
nmod:of(activation-10, programs-20)
conj:and(pathways-16, programs-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN glutaric_anhydride/NN on/IN the/DT expression/NN and/CC stability/NN of/IN mT-2/JJ protein/NN in/IN C2C12/CD cells/NNS cultured/VBN under/IN differentiation-favoring/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN glutaric_anhydride))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (CC and)
          (NP
            (NP (NN stability))
            (PP (IN of)
              (NP (JJ mT-2) (NN protein))))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (PP (IN under)
              (NP (JJ differentiation-favoring) (NNS conditions)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(glutaric_anhydride-10, of-9)
nmod:of(effect-8, glutaric_anhydride-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(investigated-6, expression-13)
cc(expression-13, and-14)
nmod:on(investigated-6, stability-15)
conj:and(expression-13, stability-15)
case(protein-18, of-16)
amod(protein-18, mT-2-17)
nmod:of(stability-15, protein-18)
case(cells-21, in-19)
nummod(cells-21, C2C12-20)
nmod:in(investigated-6, cells-21)
acl(cells-21, cultured-22)
case(conditions-25, under-23)
amod(conditions-25, differentiation-favoring-24)
nmod:under(cultured-22, conditions-25)

Our/PRP$ results/NNS showed/VBD that/IN glutaric_anhydride/JJ treatment/NN up-regulated/VBD mT-2/JJ protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN ,/, with/IN a/DT significant/JJ increase/NN observed/VBN after/IN 24/CD hours/NNS of/IN treatment/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ glutaric_anhydride) (NN treatment))
          (VP (VBD up-regulated)
            (NP (JJ mT-2) (NN protein) (NNS levels))
            (NP (JJ in_a) (JJ time-dependent) (NN manner))
            (, ,)
            (PP (IN with)
              (NP
                (NP (DT a) (JJ significant) (NN increase))
                (VP (VBN observed)
                  (PP (IN after)
                    (NP
                      (NP (CD 24) (NNS hours))
                      (PP (IN of)
                        (NP (NN treatment))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(up-regulated-7, that-4)
amod(treatment-6, glutaric_anhydride-5)
nsubj(up-regulated-7, treatment-6)
ccomp(showed-3, up-regulated-7)
amod(levels-10, mT-2-8)
compound(levels-10, protein-9)
iobj(up-regulated-7, levels-10)
amod(manner-13, in_a-11)
amod(manner-13, time-dependent-12)
dobj(up-regulated-7, manner-13)
case(increase-18, with-15)
det(increase-18, a-16)
amod(increase-18, significant-17)
nmod:with(up-regulated-7, increase-18)
acl(increase-18, observed-19)
case(hours-22, after-20)
nummod(hours-22, 24-21)
nmod:after(observed-19, hours-22)
case(treatment-24, of-23)
nmod:of(hours-22, treatment-24)

Moreover/RB ,/, glutaric_anhydride/JJ treatment/NN significantly/RB prolonged/VBN mT-2/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ,/, suggesting/VBG that/IN it/PRP may/MD enhance/VB the/DT stability/NN of/IN mT-2/JJ protein/NN during/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (JJ glutaric_anhydride) (NN treatment))
    (ADVP (RB significantly))
    (VP (VBN prolonged)
      (NP (JJ mT-2) (NN protein) (NN half-life))
      (PP (IN from)
        (NP (CD 10)))
      (PP (TO to)
        (NP (CD 18) (NNS hours)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (MD may)
                (VP (VB enhance)
                  (NP
                    (NP (DT the) (NN stability))
                    (PP (IN of)
                      (NP (JJ mT-2) (NN protein))))
                  (PP (IN during)
                    (NP (JJ skeletal_muscle) (NN differentiation))))))))))
    (. .)))

advmod(prolonged-6, Moreover-1)
amod(treatment-4, glutaric_anhydride-3)
nsubj(prolonged-6, treatment-4)
advmod(prolonged-6, significantly-5)
root(ROOT-0, prolonged-6)
amod(half-life-9, mT-2-7)
compound(half-life-9, protein-8)
dobj(prolonged-6, half-life-9)
case(10-11, from-10)
nmod:from(prolonged-6, 10-11)
case(hours-14, to-12)
nummod(hours-14, 18-13)
nmod:to(prolonged-6, hours-14)
advcl(prolonged-6, suggesting-16)
mark(enhance-20, that-17)
nsubj(enhance-20, it-18)
aux(enhance-20, may-19)
ccomp(suggesting-16, enhance-20)
det(stability-22, the-21)
dobj(enhance-20, stability-22)
case(protein-25, of-23)
amod(protein-25, mT-2-24)
nmod:of(stability-22, protein-25)
case(differentiation-28, during-26)
amod(differentiation-28, skeletal_muscle-27)
nmod:during(enhance-20, differentiation-28)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG skeletal_muscle/JJ differentiation_and/NN suggest/VBP that/IN glutaric_anhydride/NN may/MD have/VB therapeutic/JJ potential/NN for/IN treating/VBG muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP provide)
      (SBAR
        (S
          (NP
            (NP (JJ new) (NNS insights))
            (PP (IN into)
              (NP
                (NP (DT the) (JJ molecular) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP (JJ skeletal_muscle) (NN differentiation_and))))))
          (VP (VBP suggest)
            (SBAR (IN that)
              (S
                (NP (NN glutaric_anhydride))
                (VP (MD may)
                  (VP (VB have)
                    (NP
                      (NP (JJ therapeutic) (NN potential))
                      (PP (IN for)
                        (S
                          (VP (VBG treating)
                            (NP (NNS muscle-related_disorders))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
nsubj(suggest-13, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(insights-5, mechanisms-9)
acl(mechanisms-9, underlying-10)
amod(differentiation_and-12, skeletal_muscle-11)
dobj(underlying-10, differentiation_and-12)
ccomp(provide-3, suggest-13)
mark(have-17, that-14)
nsubj(have-17, glutaric_anhydride-15)
aux(have-17, may-16)
ccomp(suggest-13, have-17)
amod(potential-19, therapeutic-18)
dobj(have-17, potential-19)
mark(treating-21, for-20)
acl(potential-19, treating-21)
dobj(treating-21, muscle-related_disorders-22)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ,/, including/VBG a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits)))))
          (, ,)
          (S
            (VP (VBG including)
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (VBG developing) (NN coronary_heart_disease))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
nsubj:xsubj(have-26, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(have-26, to-25)
xcomp(shown-24, have-26)
amod(benefits-29, numerous-27)
compound(benefits-29, health-28)
dobj(have-26, benefits-29)
xcomp(shown-24, including-31)
det(risk-34, a-32)
amod(risk-34, decreased-33)
dobj(including-31, risk-34)
case(coronary_heart_disease-37, of-35)
amod(coronary_heart_disease-37, developing-36)
nmod:of(risk-34, coronary_heart_disease-37)
appos(coronary_heart_disease-37, CHD-39)

Recent/JJ studies/NNS have/VBP also/RB demonstrated/VBN a/DT correlation/NN between/IN long-chain/JJ omega-3_fatty_acids/JJ and/CC decreased/VBN gentisic_acid/JJ levels/NNS in/IN hypergentisic/JJ acidmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN demonstrated)
        (NP
          (NP (DT a) (NN correlation))
          (PP (IN between)
            (NP
              (NP (JJ long-chain)
                (ADJP (JJ omega-3_fatty_acids)
                  (CC and)
                  (VBN decreased))
                (JJ gentisic_acid) (NNS levels))
              (PP (IN in)
                (NP (JJ hypergentisic) (JJ acidmic) (NNS patients))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-5, studies-2)
aux(demonstrated-5, have-3)
advmod(demonstrated-5, also-4)
root(ROOT-0, demonstrated-5)
det(correlation-7, a-6)
dobj(demonstrated-5, correlation-7)
case(levels-14, between-8)
amod(levels-14, long-chain-9)
amod(levels-14, omega-3_fatty_acids-10)
cc(omega-3_fatty_acids-10, and-11)
conj:and(omega-3_fatty_acids-10, decreased-12)
amod(levels-14, decreased-12)
amod(levels-14, gentisic_acid-13)
nmod:between(correlation-7, levels-14)
case(patients-18, in-15)
amod(patients-18, hypergentisic-16)
amod(patients-18, acidmic-17)
nmod:in(levels-14, patients-18)

Gentisic/JJ acid/JJ is_a/NN metabolite/VBD that/IN has_been/VBP linked/VBN to/TO inflammation/NNS and/CC oxidative_stress/NNS ,/, both/DT of/IN which/WDT are/VBP known/VBN to/TO play/VB a/DT role/NN in/IN the/DT development/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (JJ Gentisic) (JJ acid) (NN is_a))
    (VP (VBD metabolite)
      (SBAR (IN that)
        (S
          (VP (VBP has_been)
            (VP (VBN linked)
              (PP (TO to)
                (NP
                  (NP (NNS inflammation)
                    (CC and)
                    (NNS oxidative_stress))
                  (, ,)
                  (SBAR
                    (WHNP (DT both)
                      (WHPP (IN of)
                        (WHNP (WDT which))))
                    (S
                      (VP (VBP are)
                        (VP (VBN known)
                          (S
                            (VP (TO to)
                              (VP (VB play)
                                (NP
                                  (NP (DT a) (NN role))
                                  (PP (IN in)
                                    (NP
                                      (NP (DT the) (NN development))
                                      (PP (IN of)
                                        (NP (NNP CHD))))))))))))))))))))
    (. .)))

amod(is_a-3, Gentisic-1)
amod(is_a-3, acid-2)
nsubj(metabolite-4, is_a-3)
root(ROOT-0, metabolite-4)
mark(has_been-6, that-5)
ccomp(metabolite-4, has_been-6)
dep(has_been-6, linked-7)
case(inflammation-9, to-8)
nmod:to(linked-7, inflammation-9)
nsubjpass(known-17, inflammation-9)
nsubj:xsubj(play-19, inflammation-9)
cc(inflammation-9, and-10)
nmod:to(linked-7, oxidative_stress-11)
conj:and(inflammation-9, oxidative_stress-11)
nsubjpass(known-17, oxidative_stress-11)
nsubj:xsubj(play-19, oxidative_stress-11)
dep(which-15, both-13)
case(which-15, of-14)
ref(inflammation-9, which-15)
auxpass(known-17, are-16)
acl:relcl(inflammation-9, known-17)
mark(play-19, to-18)
xcomp(known-17, play-19)
det(role-21, a-20)
dobj(play-19, role-21)
case(development-24, in-22)
det(development-24, the-23)
nmod:in(role-21, development-24)
case(CHD-26, of-25)
nmod:of(development-24, CHD-26)

By/IN decreasing/VBG gentisic_acid/JJ levels/NNS ,/, long-chain/JJ omega-3_fatty_acids/NN may/MD help/VB reduce/VB the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN By)
      (S
        (VP (VBG decreasing)
          (NP (JJ gentisic_acid) (NNS levels)))))
    (, ,)
    (NP (JJ long-chain) (NN omega-3_fatty_acids))
    (VP (MD may)
      (VP (VB help)
        (VP (VB reduce)
          (NP
            (NP (DT the) (NN risk))
            (PP (IN of)
              (NP (NNP CHD)))))))
    (. .)))

mark(decreasing-2, By-1)
advcl(help-9, decreasing-2)
amod(levels-4, gentisic_acid-3)
dobj(decreasing-2, levels-4)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(help-9, omega-3_fatty_acids-7)
aux(help-9, may-8)
root(ROOT-0, help-9)
xcomp(help-9, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
case(CHD-14, of-13)
nmod:of(risk-12, CHD-14)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN preventing/VBG and/CC managing/VBG CHD/NNP ,/, particularly/RB in/IN individuals/NNS who/WP are/VBP at/IN increased/VBN risk/NN due/JJ to/TO elevated/JJ gentisic_acid/JJ levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG preventing))
                      (CC and)
                      (VP (VBG managing)
                        (NP (NNP CHD))
                        (, ,)
                        (ADVP (RB particularly))
                        (PP (IN in)
                          (NP
                            (NP (NNS individuals))
                            (SBAR
                              (WHNP (WP who))
                              (S
                                (VP (VBP are)
                                  (PP (IN at)
                                    (NP
                                      (NP (VBN increased) (NN risk))
                                      (ADJP (JJ due)
                                        (PP (TO to)
                                          (NP (JJ elevated) (JJ gentisic_acid) (NNS levels)))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(preventing-17, for-16)
acl(strategy-15, preventing-17)
cc(preventing-17, and-18)
acl(strategy-15, managing-19)
conj:and(preventing-17, managing-19)
dobj(managing-19, CHD-20)
advmod(individuals-24, particularly-22)
case(individuals-24, in-23)
nmod:in(managing-19, individuals-24)
nsubj(risk-29, individuals-24)
ref(individuals-24, who-25)
cop(risk-29, are-26)
case(risk-29, at-27)
amod(risk-29, increased-28)
acl:relcl(individuals-24, risk-29)
amod(risk-29, due-30)
case(levels-34, to-31)
amod(levels-34, elevated-32)
amod(levels-34, gentisic_acid-33)
nmod:to(due-30, levels-34)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(populations-21, for-18)
amod(populations-21, different-19)
amod(populations-21, patient-20)
nmod:for(dosages-17, populations-21)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN multiple/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN programs/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ multiple) (VBG signaling) (NNS pathways))
                    (CC and)
                    (NP (NN gene) (NN expression) (NNS programs))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, multiple-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)
cc(pathways-14, and-15)
compound(programs-18, gene-16)
compound(programs-18, expression-17)
nmod:of(activation-10, programs-18)
conj:and(pathways-14, programs-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN M50354/NNP ,/, a/DT novel/JJ small/JJ molecule/NN compound/NN ,/, on/IN the/DT expression/NN of/IN TH_1/NNP protein/NN in/IN C2C12/CD cells/NNS cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/JJ -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP M50354))
            (, ,)
            (NP (DT a) (JJ novel) (JJ small) (NN molecule) (NN compound))
            (, ,))))
      (PP (IN on)
        (NP
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (NNP TH_1))))
          (NP
            (NP (NN protein))
            (PP (IN in)
              (NP (CD C2C12) (NNS cells))))
          (NP
            (NP (VBN cultured) (NN in_a) (NN medium))
            (PP (VBG favoring)
              (NP
                (NP (JJ differentiation) (-LRB- -LRB-) (NNP Dulbecco) (VBN modified) (NNP Eagle) (NN medium))
                (VP (VBG containing)
                  (NP
                    (ADJP (CD 2) (NN %))
                    (NN horse) (NN serum))))))
          (-RRB- -RRB-))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(M50354-10, of-9)
nmod:of(effect-8, M50354-10)
det(compound-16, a-12)
amod(compound-16, novel-13)
amod(compound-16, small-14)
compound(compound-16, molecule-15)
appos(M50354-10, compound-16)
case(expression-20, on-18)
det(expression-20, the-19)
nmod:on(investigated-6, expression-20)
case(TH_1-22, of-21)
nmod:of(expression-20, TH_1-22)
dep(expression-20, protein-23)
case(cells-26, in-24)
nummod(cells-26, C2C12-25)
nmod:in(protein-23, cells-26)
amod(medium-29, cultured-27)
compound(medium-29, in_a-28)
dep(expression-20, medium-29)
case(medium-36, favoring-30)
amod(medium-36, differentiation-31)
compound(medium-36, Dulbecco-33)
amod(medium-36, modified-34)
compound(medium-36, Eagle-35)
nmod:favoring(medium-29, medium-36)
acl(medium-36, containing-37)
compound(%-39, 2-38)
amod(serum-41, %-39)
compound(serum-41, horse-40)
dobj(containing-37, serum-41)

Our/PRP$ results/NNS demonstrate/VBP that/IN M50354/CD up-regulated/JJ TH_1/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ TH_1/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP (CD M50354) (JJ up-regulated) (NNP TH_1) (NN protein) (NNS levels))
          (VP (NN in_a)
            (NP
              (NP (JJ time-dependent) (NN manner)
                (CC and)
                (JJ prolonged) (NNP TH_1) (NN protein) (NN half-life))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(in_a-10, that-4)
nummod(levels-9, M50354-5)
amod(levels-9, up-regulated-6)
compound(levels-9, TH_1-7)
compound(levels-9, protein-8)
nsubj(in_a-10, levels-9)
ccomp(demonstrate-3, in_a-10)
amod(manner-12, time-dependent-11)
dobj(in_a-10, manner-12)
cc(manner-12, and-13)
amod(half-life-17, prolonged-14)
compound(half-life-17, TH_1-15)
compound(half-life-17, protein-16)
dobj(in_a-10, half-life-17)
conj:and(manner-12, half-life-17)
case(hours-22, from-18)
compound(18-21, 10-19)
dep(18-21, to-20)
nummod(hours-22, 18-21)
nmod:from(manner-12, hours-22)

These/DT findings/NNS suggest/VBP that/IN M50354/NNP may/MD play/VB an/DT important/JJ role/NN in/IN regulating/VBG skeletal_muscle/JJ differentiation_and/NN could/MD be/VB a/DT potential/JJ therapeutic/JJ agent/NN for/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP M50354))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (SBAR
                        (S
                          (NP (JJ skeletal_muscle) (NN differentiation_and))
                          (VP (MD could)
                            (VP (VB be)
                              (NP
                                (NP (DT a) (JJ potential) (JJ therapeutic) (NN agent))
                                (PP (IN for)
                                  (NP (NNS muscle-related_disorders)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, M50354-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, an-8)
amod(role-10, important-9)
dobj(play-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
amod(differentiation_and-14, skeletal_muscle-13)
nsubj(agent-20, differentiation_and-14)
aux(agent-20, could-15)
cop(agent-20, be-16)
det(agent-20, a-17)
amod(agent-20, potential-18)
amod(agent-20, therapeutic-19)
ccomp(regulating-12, agent-20)
case(muscle-related_disorders-22, for-21)
nmod:for(agent-20, muscle-related_disorders-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/JJ molecular/JJ mechanisms/NNS by/IN which/WDT M50354/NNP modulates/VBZ TH_1/NNP protein/NN expression/NN and/CC stability/NN ,/, and/CC to/TO evaluate/VB its/PRP$ efficacy/NN and/CC safety/NN in/IN vivo/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (JJ underlying) (JJ molecular) (NNS mechanisms))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (NNP M50354))
                      (VP (VBZ modulates)
                        (NP
                          (NP (NNP TH_1) (NN protein) (NN expression))
                          (CC and)
                          (NP (NN stability)))))))))
            (, ,)
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP (PRP$ its) (NN efficacy)
                  (CC and)
                  (NN safety))
                (PP (IN in)
                  (NP (NN vivo)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-10, the-7)
amod(mechanisms-10, underlying-8)
amod(mechanisms-10, molecular-9)
dobj(elucidate-6, mechanisms-10)
mark(modulates-14, by-11)
dobj(modulates-14, which-12)
nsubj(modulates-14, M50354-13)
advcl(elucidate-6, modulates-14)
compound(expression-17, TH_1-15)
compound(expression-17, protein-16)
dobj(modulates-14, expression-17)
cc(expression-17, and-18)
dobj(modulates-14, stability-19)
conj:and(expression-17, stability-19)
cc(elucidate-6, and-21)
mark(evaluate-23, to-22)
ccomp(needed-4, evaluate-23)
conj:and(elucidate-6, evaluate-23)
nmod:poss(efficacy-25, its-24)
dobj(evaluate-23, efficacy-25)
cc(efficacy-25, and-26)
dobj(evaluate-23, safety-27)
conj:and(efficacy-25, safety-27)
case(vivo-29, in-28)
nmod:in(evaluate-23, vivo-29)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN and/CC have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (NP
          (NP (JJ essential) (NNS components))
          (PP (IN of)
            (NP (DT a) (JJ healthy) (NN diet)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP (JJ numerous) (NN health) (NNS benefits)))))))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
nsubjpass(shown-24, Omega-3_fatty_acids-1)
nsubj:xsubj(have-26, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)
cc(components-16, and-21)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
conj:and(components-16, shown-24)
mark(have-26, to-25)
xcomp(shown-24, have-26)
amod(benefits-29, numerous-27)
compound(benefits-29, health-28)
dobj(have-26, benefits-29)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB associated/VBN with/IN decreased/VBN clofibrate/JJ levels/NNS in/IN hyperclofibratemic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ clofibrate) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hyperclofibratemic) (NNS patients)))))
                  (, ,)
                  (ADVP
                    (ADVP (RB as) (RB well))
                    (PP (IN as)
                      (NP
                        (NP
                          (NP (DT a) (VBN decreased) (NN risk))
                          (PP (IN of)
                            (S
                              (VP (VBG developing)
                                (NP (NN coronary_heart_disease))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(associated-10, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-10, omega-3_fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(suggested-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, clofibrate-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperclofibratemic-16)
nmod:in(levels-14, patients-17)
advmod(associated-10, as-19)
mwe(as-19, well-20)
case(risk-24, as-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:as(as-19, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

Clofibrate/NNP is_a/VBZ lipid-lowering/JJ medication/NN that/WDT has_been/VBP used/VBN to/TO treat/VB hyperlipidemia/NN ,/, a/DT condition/NN characterized/VBN by/IN high/JJ levels/NNS of/IN cholesterol/NN and/CC triglycerides/NNPS in/IN the/DT blood/NN ./.

(ROOT
  (S
    (NP (NNP Clofibrate))
    (VP (VBZ is_a)
      (NP
        (NP (JJ lipid-lowering) (NN medication))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN used)
                (S
                  (VP (TO to)
                    (VP (VB treat)
                      (NP
                        (NP (NN hyperlipidemia))
                        (, ,)
                        (NP
                          (NP (DT a) (NN condition))
                          (VP (VBN characterized)
                            (PP (IN by)
                              (NP
                                (NP (JJ high) (NNS levels))
                                (PP (IN of)
                                  (NP
                                    (NP (NN cholesterol))
                                    (CC and)
                                    (NP (NNPS triglycerides))))
                                (PP (IN in)
                                  (NP (DT the) (NN blood)))))))))))))))))
    (. .)))

nsubj(is_a-2, Clofibrate-1)
root(ROOT-0, is_a-2)
amod(medication-4, lipid-lowering-3)
dobj(is_a-2, medication-4)
nsubj(has_been-6, medication-4)
ref(medication-4, that-5)
acl:relcl(medication-4, has_been-6)
dep(has_been-6, used-7)
mark(treat-9, to-8)
xcomp(used-7, treat-9)
dobj(treat-9, hyperlipidemia-10)
det(condition-13, a-12)
appos(hyperlipidemia-10, condition-13)
acl(condition-13, characterized-14)
case(levels-17, by-15)
amod(levels-17, high-16)
nmod:by(characterized-14, levels-17)
case(cholesterol-19, of-18)
nmod:of(levels-17, cholesterol-19)
cc(cholesterol-19, and-20)
nmod:of(levels-17, triglycerides-21)
conj:and(cholesterol-19, triglycerides-21)
case(blood-24, in-22)
det(blood-24, the-23)
nmod:in(levels-17, blood-24)

The/DT association/NN between/IN omega-3_fatty_acids/JJ and/CC decreased/VBN clofibrate/JJ levels/NNS suggests/VBZ that/IN these/DT fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN regulating/VBG lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN association))
      (PP (IN between)
        (NP
          (ADJP (JJ omega-3_fatty_acids)
            (CC and)
            (VBN decreased))
          (JJ clofibrate) (NNS levels))))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NN lipid) (NN metabolism)))))))))))
    (. .)))

det(association-2, The-1)
nsubj(suggests-9, association-2)
case(levels-8, between-3)
amod(levels-8, omega-3_fatty_acids-4)
cc(omega-3_fatty_acids-4, and-5)
conj:and(omega-3_fatty_acids-4, decreased-6)
amod(levels-8, decreased-6)
amod(levels-8, clofibrate-7)
nmod:between(association-2, levels-8)
root(ROOT-0, suggests-9)
mark(play-14, that-10)
det(fatty_acids-12, these-11)
nsubj(play-14, fatty_acids-12)
aux(play-14, may-13)
ccomp(suggests-9, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
mark(regulating-18, in-17)
acl(role-16, regulating-18)
compound(metabolism-20, lipid-19)
dobj(regulating-18, metabolism-20)

In/IN addition/NN ,/, the/DT protective/JJ effect/NN of/IN omega-3_fatty_acids/NN against/IN CHD/NNP may/MD be/VB related/VBN to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB endothelial/JJ function/NN ,/, and/CC lower/VB blood_pressure/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (JJ protective) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN omega-3_fatty_acids))
          (PP (IN against)
            (NP (NNP CHD))))))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN related)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VB improve)
                      (NP (JJ endothelial) (NN function)))
                    (, ,)
                    (CC and)
                    (VP (VB lower)
                      (NP (NN blood_pressure)))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(related-13, addition-2)
det(effect-6, the-4)
amod(effect-6, protective-5)
nsubjpass(related-13, effect-6)
case(omega-3_fatty_acids-8, of-7)
nmod:of(effect-6, omega-3_fatty_acids-8)
case(CHD-10, against-9)
nmod:against(omega-3_fatty_acids-8, CHD-10)
aux(related-13, may-11)
auxpass(related-13, be-12)
root(ROOT-0, related-13)
case(ability-16, to-14)
nmod:poss(ability-16, their-15)
nmod:to(related-13, ability-16)
mark(reduce-18, to-17)
acl(ability-16, reduce-18)
dobj(reduce-18, inflammation-19)
acl(ability-16, improve-21)
conj:and(reduce-18, improve-21)
amod(function-23, endothelial-22)
dobj(improve-21, function-23)
cc(reduce-18, and-25)
acl(ability-16, lower-26)
conj:and(reduce-18, lower-26)
dobj(lower-26, blood_pressure-27)

These/DT findings/NNS highlight/VB the/DT potential/JJ health/NN benefits/NNS of/IN consuming/VBG a/DT diet/NN rich/JJ in/IN long-chain/JJ omega-3_fatty_acids/NN ,/, and/CC suggest/VBP that/IN these/DT nutrients/NNS may/MD be/VB useful/JJ in/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VB highlight)
        (NP
          (NP (DT the) (JJ potential) (NN health) (NNS benefits))
          (PP (IN of)
            (S
              (VP (VBG consuming)
                (NP
                  (NP (DT a) (NN diet))
                  (PP (JJ rich) (IN in)
                    (NP (JJ long-chain) (NN omega-3_fatty_acids))))))))))
    (, ,)
    (NP (CC and))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS nutrients))
          (VP (MD may)
            (VP (VB be)
              (ADJP (JJ useful)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
ccomp(suggest-18, highlight-3)
det(benefits-7, the-4)
amod(benefits-7, potential-5)
compound(benefits-7, health-6)
dobj(highlight-3, benefits-7)
mark(consuming-9, of-8)
acl(benefits-7, consuming-9)
det(diet-11, a-10)
dobj(consuming-9, diet-11)
case(omega-3_fatty_acids-15, rich-12)
case(omega-3_fatty_acids-15, in-13)
amod(omega-3_fatty_acids-15, long-chain-14)
nmod:in(diet-11, omega-3_fatty_acids-15)
nsubj(suggest-18, and-17)
root(ROOT-0, suggest-18)
mark(useful-24, that-19)
det(nutrients-21, these-20)
nsubj(useful-24, nutrients-21)
aux(useful-24, may-22)
cop(useful-24, be-23)
ccomp(suggest-18, useful-24)
case(prevention-27, in-25)
det(prevention-27, the-26)
nmod:in(useful-24, prevention-27)
cc(prevention-27, and-28)
nmod:in(useful-24, treatment-29)
conj:and(prevention-27, treatment-29)
case(cardiovascular_disease-31, of-30)
nmod:of(prevention-27, cardiovascular_disease-31)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN found/VBN to/TO have/VB a/DT wide/JJ range/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN found)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP
                          (NP (DT a) (JJ wide) (NN range))
                          (PP (IN of)
                            (NP (NN health) (NNS benefits))))))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(found-8, polyunsaturated_fatty_acids-4)
nsubj:xsubj(have-10, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
acl:relcl(polyunsaturated_fatty_acids-4, found-8)
mark(have-10, to-9)
xcomp(found-8, have-10)
det(range-13, a-11)
amod(range-13, wide-12)
dobj(have-10, range-13)
case(benefits-16, of-14)
compound(benefits-16, health-15)
nmod:of(range-13, benefits-16)

Among/IN them/PRP ,/, long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/VB associated/VBN with/IN decreased/VBN DPCP/NNP levels/NNS in/IN hyperDPCPmic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (PRP them)))
    (, ,)
    (NP
      (NP (JJ long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (VB to_be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (VBN decreased) (NNP DPCP) (NNS levels)))
                  (PP (IN in)
                    (NP (JJ hyperDPCPmic) (NNS patients)))))))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(them-2, Among-1)
nmod:among(shown-27, them-2)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(shown-27, omega-3_fatty_acids-5)
nsubjpass(decreased-38, omega-3_fatty_acids-5)
dep(omega-3_fatty_acids-5, eicosapentaenoic_acid-7)
dobj(eicosapentaenoic_acid-7, EPA-9)
compound(n-3-13, 20:5-12)
dep(EPA-9, n-3-13)
cc(eicosapentaenoic_acid-7, and-15)
dep(omega-3_fatty_acids-5, docosahexaenoic_acid-16)
conj:and(eicosapentaenoic_acid-7, docosahexaenoic_acid-16)
dobj(docosahexaenoic_acid-16, DHA-18)
compound(n-3-22, 22:6-21)
dep(DHA-18, n-3-22)
aux(shown-27, have-25)
auxpass(shown-27, been-26)
root(ROOT-0, shown-27)
ccomp(shown-27, to_be-28)
dep(to_be-28, associated-29)
case(levels-33, with-30)
amod(levels-33, decreased-31)
compound(levels-33, DPCP-32)
nmod:with(associated-29, levels-33)
case(patients-36, in-34)
amod(patients-36, hyperDPCPmic-35)
nmod:in(associated-29, patients-36)
cc(shown-27, and-37)
conj:and(shown-27, decreased-38)
dobj(decreased-38, risk-39)
case(coronary_heart_disease-42, of-40)
amod(coronary_heart_disease-42, developing-41)
nmod:of(risk-39, coronary_heart_disease-42)
appos(coronary_heart_disease-42, CHD-44)

Several/JJ studies/NNS have/VBP reported/VBN that/IN these/DT omega-3_fatty_acids/NNS play/VBP a/DT crucial/JJ role/NN in/IN maintaining/VBG cardiovascular_health/NN by/IN reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC decreasing/VBG blood_pressure/NN ./.

(ROOT
  (S
    (NP (JJ Several) (NNS studies))
    (VP (VBP have)
      (VP (VBN reported)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS omega-3_fatty_acids))
            (VP (VBP play)
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG maintaining)
                    (NP (NN cardiovascular_health))
                    (PP (IN by)
                      (S
                        (VP
                          (VP (VBG reducing)
                            (NP (NN inflammation)))
                          (, ,)
                          (VP (VBG improving)
                            (NP (NN lipid) (NNS profiles)))
                          (, ,)
                          (CC and)
                          (VP (VBG decreasing)
                            (NP (NN blood_pressure))))))))))))))
    (. .)))

amod(studies-2, Several-1)
nsubj(reported-4, studies-2)
aux(reported-4, have-3)
root(ROOT-0, reported-4)
mark(play-8, that-5)
det(omega-3_fatty_acids-7, these-6)
nsubj(play-8, omega-3_fatty_acids-7)
ccomp(reported-4, play-8)
det(role-11, a-9)
amod(role-11, crucial-10)
dobj(play-8, role-11)
mark(maintaining-13, in-12)
advcl(play-8, maintaining-13)
dobj(maintaining-13, cardiovascular_health-14)
mark(reducing-16, by-15)
advcl(maintaining-13, reducing-16)
dobj(reducing-16, inflammation-17)
advcl(maintaining-13, improving-19)
conj:and(reducing-16, improving-19)
compound(profiles-21, lipid-20)
dobj(improving-19, profiles-21)
cc(reducing-16, and-23)
advcl(maintaining-13, decreasing-24)
conj:and(reducing-16, decreasing-24)
dobj(decreasing-24, blood_pressure-25)

Furthermore/RB ,/, they/PRP have/VBP been/VBN suggested/VBN to/TO enhance/VB insulin_sensitivity/NN and/CC reduce/VB the/DT risk/NN of/IN type_2_diabetes/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN suggested)
          (S
            (VP (TO to)
              (VP
                (VP (VB enhance)
                  (NP (NN insulin_sensitivity)))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS type_2_diabetes)))))))))))
    (. .)))

advmod(suggested-6, Furthermore-1)
nsubjpass(suggested-6, they-3)
nsubj:xsubj(enhance-8, they-3)
nsubj:xsubj(reduce-11, they-3)
aux(suggested-6, have-4)
auxpass(suggested-6, been-5)
root(ROOT-0, suggested-6)
mark(enhance-8, to-7)
xcomp(suggested-6, enhance-8)
dobj(enhance-8, insulin_sensitivity-9)
cc(enhance-8, and-10)
xcomp(suggested-6, reduce-11)
conj:and(enhance-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(type_2_diabetes-15, of-14)
nmod:of(risk-13, type_2_diabetes-15)

The/DT beneficial/JJ effects/NNS of/IN long-chain/JJ omega-3_fatty_acids/NN on/IN human/JJ health/NN are/VBP supported/VBN by/IN numerous/JJ epidemiological/JJ and/CC clinical/JJ studies/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ beneficial) (NNS effects))
      (PP (IN of)
        (NP
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (PP (IN on)
            (NP (JJ human) (NN health))))))
    (VP (VBP are)
      (VP (VBN supported)
        (PP (IN by)
          (NP (JJ numerous)
            (ADJP (JJ epidemiological)
              (CC and)
              (JJ clinical))
            (NNS studies)))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, beneficial-2)
nsubjpass(supported-11, effects-3)
case(omega-3_fatty_acids-6, of-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nmod:of(effects-3, omega-3_fatty_acids-6)
case(health-9, on-7)
amod(health-9, human-8)
nmod:on(omega-3_fatty_acids-6, health-9)
auxpass(supported-11, are-10)
root(ROOT-0, supported-11)
case(studies-17, by-12)
amod(studies-17, numerous-13)
amod(studies-17, epidemiological-14)
cc(epidemiological-14, and-15)
conj:and(epidemiological-14, clinical-16)
amod(studies-17, clinical-16)
nmod:by(supported-11, studies-17)

Therefore/RB ,/, the/DT consumption/NN of/IN foods/NNS rich/JJ in/IN these/DT fatty_acids/NNS or/CC supplementation/NN with/IN omega-3/JJ supplements/NNS may/MD be/VB an/DT effective/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC improving/VBG overall/JJ health/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP
          (NP (NNS foods))
          (ADJP (JJ rich)
            (PP (IN in)
              (NP
                (NP (DT these) (NNS fatty_acids))
                (CC or)
                (NP
                  (NP (NN supplementation))
                  (PP (IN with)
                    (NP (JJ omega-3) (NNS supplements))))))))))
    (VP (MD may)
      (VP (VB be)
        (NP (DT an) (JJ effective) (NN strategy))
        (PP (IN for)
          (S
            (VP
              (VP (VBG preventing)
                (NP (NNP CHD)))
              (CC and)
              (VP (VBG improving)
                (NP (JJ overall) (NN health))))))))
    (. .)))

advmod(strategy-20, Therefore-1)
det(consumption-4, the-3)
nsubj(strategy-20, consumption-4)
case(foods-6, of-5)
nmod:of(consumption-4, foods-6)
amod(foods-6, rich-7)
case(fatty_acids-10, in-8)
det(fatty_acids-10, these-9)
nmod:in(rich-7, fatty_acids-10)
cc(fatty_acids-10, or-11)
nmod:in(rich-7, supplementation-12)
conj:or(fatty_acids-10, supplementation-12)
case(supplements-15, with-13)
amod(supplements-15, omega-3-14)
nmod:with(supplementation-12, supplements-15)
aux(strategy-20, may-16)
cop(strategy-20, be-17)
det(strategy-20, an-18)
amod(strategy-20, effective-19)
root(ROOT-0, strategy-20)
mark(preventing-22, for-21)
advcl(strategy-20, preventing-22)
dobj(preventing-22, CHD-23)
cc(preventing-22, and-24)
advcl(strategy-20, improving-25)
conj:and(preventing-22, improving-25)
amod(health-27, overall-26)
dobj(improving-25, health-27)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (ADJP (JJ essential)
        (PP (IN for)
          (NP (JJ human) (NN health)))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, for-16)
amod(health-18, human-17)
nmod:for(essential-15, health-18)

These/DT long-chain_fatty_acids/NNS are/VBP known/VBN to/TO have/VB various/JJ beneficial/JJ effects/NNS on/IN the/DT body/NN ,/, including/VBG a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS long-chain_fatty_acids))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ various) (JJ beneficial) (NNS effects))
                (PP (IN on)
                  (NP (DT the) (NN body)))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(long-chain_fatty_acids-2, These-1)
nsubjpass(known-4, long-chain_fatty_acids-2)
nsubj:xsubj(have-6, long-chain_fatty_acids-2)
auxpass(known-4, are-3)
root(ROOT-0, known-4)
mark(have-6, to-5)
xcomp(known-4, have-6)
amod(effects-9, various-7)
amod(effects-9, beneficial-8)
dobj(have-6, effects-9)
case(body-12, on-10)
det(body-12, the-11)
nmod:on(effects-9, body-12)
acl(effects-9, including-14)
det(risk-17, a-15)
amod(risk-17, decreased-16)
dobj(including-14, risk-17)
mark(developing-19, of-18)
acl(risk-17, developing-19)
dobj(developing-19, coronary_heart_disease-20)
appos(risk-17, CHD-22)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN EPA/NNP and/CC DHA/NNP are/VBP associated/VBN with/IN decreased/VBN humisol/JJ levels/NNS in/IN hyperhumisolmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ humisol) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperhumisolmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(associated-11, that-6)
nsubjpass(associated-11, EPA-7)
cc(EPA-7, and-8)
conj:and(EPA-7, DHA-9)
nsubjpass(associated-11, DHA-9)
auxpass(associated-11, are-10)
ccomp(shown-5, associated-11)
case(levels-15, with-12)
amod(levels-15, decreased-13)
amod(levels-15, humisol-14)
nmod:with(associated-11, levels-15)
case(patients-18, in-16)
amod(patients-18, hyperhumisolmic-17)
nmod:in(levels-15, patients-18)

Humisol/JJ is_a/NN marker/NN of/IN inflammation/NN ,/, and/CC its/PRP$ reduction/NN is/VBZ considered/VBN a/DT key/JJ factor/NN in/IN preventing/VBG cardiovascular_diseases/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Humisol) (NN is_a) (NN marker))
      (PP (IN of)
        (NP
          (NP (NN inflammation))
          (, ,)
          (CC and)
          (NP (PRP$ its) (NN reduction)))))
    (VP (VBZ is)
      (VP (VBN considered)
        (NP (DT a) (JJ key) (NN factor))
        (PP (IN in)
          (S
            (VP (VBG preventing)
              (NP (NNS cardiovascular_diseases)))))))
    (. .)))

amod(marker-3, Humisol-1)
compound(marker-3, is_a-2)
nsubjpass(considered-11, marker-3)
case(inflammation-5, of-4)
nmod:of(marker-3, inflammation-5)
cc(inflammation-5, and-7)
nmod:poss(reduction-9, its-8)
nmod:of(marker-3, reduction-9)
conj:and(inflammation-5, reduction-9)
auxpass(considered-11, is-10)
root(ROOT-0, considered-11)
det(factor-14, a-12)
amod(factor-14, key-13)
dobj(considered-11, factor-14)
mark(preventing-16, in-15)
advcl(considered-11, preventing-16)
dobj(preventing-16, cardiovascular_diseases-17)

Furthermore/RB ,/, the/DT consumption/NN of/IN omega-3_fatty_acids/JJ has_been/NN linked/VBN to/TO improved/JJ lipid/NN profiles/NNS ,/, reduced/VBD blood_pressure/NN ,/, and/CC decreased/VBD risk/NN of/IN arrhythmias/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP
          (NP (JJ omega-3_fatty_acids) (NN has_been))
          (VP (VBN linked)
            (PP (TO to)
              (NP (JJ improved) (NN lipid) (NNS profiles))))))
      (, ,))
    (VP
      (VP (VBD reduced)
        (NP (NN blood_pressure)))
      (, ,)
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP (NNS arrhythmias))))))
    (. .)))

advmod(reduced-14, Furthermore-1)
det(consumption-4, the-3)
nsubj(reduced-14, consumption-4)
nsubj(decreased-18, consumption-4)
case(has_been-7, of-5)
amod(has_been-7, omega-3_fatty_acids-6)
nmod:of(consumption-4, has_been-7)
acl(has_been-7, linked-8)
case(profiles-12, to-9)
amod(profiles-12, improved-10)
compound(profiles-12, lipid-11)
nmod:to(linked-8, profiles-12)
root(ROOT-0, reduced-14)
dobj(reduced-14, blood_pressure-15)
cc(reduced-14, and-17)
conj:and(reduced-14, decreased-18)
dobj(decreased-18, risk-19)
case(arrhythmias-21, of-20)
nmod:of(risk-19, arrhythmias-21)

Therefore/RB ,/, it/PRP is/VBZ recommended/VBN that/IN individuals/NNS consume/VBP an/DT adequate/JJ amount/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS to/TO maintain/VB overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP (VBN recommended)
        (SBAR (IN that)
          (S
            (NP (NNS individuals))
            (VP (VBP consume)
              (NP
                (NP (DT an) (JJ adequate) (NN amount))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NNS supplements)))))))
      (S
        (VP (TO to)
          (VP (VB maintain)
            (NP (JJ overall) (NN cardiovascular_health))))))
    (. .)))

advmod(recommended-5, Therefore-1)
nsubjpass(recommended-5, it-3)
nsubj:xsubj(maintain-22, it-3)
auxpass(recommended-5, is-4)
root(ROOT-0, recommended-5)
mark(consume-8, that-6)
nsubj(consume-8, individuals-7)
ccomp(recommended-5, consume-8)
det(amount-11, an-9)
amod(amount-11, adequate-10)
dobj(consume-8, amount-11)
case(EPA-13, of-12)
nmod:of(amount-11, EPA-13)
cc(EPA-13, and-14)
nmod:of(amount-11, DHA-15)
conj:and(EPA-13, DHA-15)
case(sources-18, through-16)
amod(sources-18, dietary-17)
nmod:through(consume-8, sources-18)
cc(sources-18, or-19)
nmod:through(consume-8, supplements-20)
conj:or(sources-18, supplements-20)
mark(maintain-22, to-21)
xcomp(recommended-5, maintain-22)
amod(cardiovascular_health-24, overall-23)
dobj(maintain-22, cardiovascular_health-24)

Obesity/NNP is_a/VBD major/JJ public_health/NN concern/NN worldwide/RB ,/, and/CC is/VBZ associated/VBN with/IN an/DT increased/VBN risk/NN of/IN metabolic_disorders/NNS such/JJ as/IN diabetes/NN and_cardiovascular/NN diseases/NNS ./.

(ROOT
  (S
    (NP (NNP Obesity))
    (VP
      (VP (VBD is_a)
        (NP (JJ major) (NN public_health) (NN concern))
        (ADVP (RB worldwide)))
      (, ,)
      (CC and)
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT an) (VBN increased) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNS metabolic_disorders))
                  (PP (JJ such) (IN as)
                    (NP (NN diabetes) (NN and_cardiovascular) (NNS diseases))))))))))
    (. .)))

nsubj(is_a-2, Obesity-1)
nsubjpass(associated-10, Obesity-1)
root(ROOT-0, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
dobj(is_a-2, concern-5)
advmod(is_a-2, worldwide-6)
cc(is_a-2, and-8)
auxpass(associated-10, is-9)
conj:and(is_a-2, associated-10)
case(risk-14, with-11)
det(risk-14, an-12)
amod(risk-14, increased-13)
nmod:with(associated-10, risk-14)
case(metabolic_disorders-16, of-15)
nmod:of(risk-14, metabolic_disorders-16)
case(diseases-21, such-17)
mwe(such-17, as-18)
compound(diseases-21, diabetes-19)
compound(diseases-21, and_cardiovascular-20)
nmod:such_as(metabolic_disorders-16, diseases-21)

Dysregulation/NN of/IN lipid/NN metabolism/NN plays/VBZ a/DT key/JJ role/NN in/IN the/DT development/NN of/IN obesity/NN and/CC its/PRP$ related_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (NN Dysregulation))
      (PP (IN of)
        (NP (NN lipid) (NN metabolism))))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ key) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NN obesity))
                (CC and)
                (NP (PRP$ its) (NNS related_disorders))))))))
    (. .)))

nsubj(plays-5, Dysregulation-1)
case(metabolism-4, of-2)
compound(metabolism-4, lipid-3)
nmod:of(Dysregulation-1, metabolism-4)
root(ROOT-0, plays-5)
det(role-8, a-6)
amod(role-8, key-7)
dobj(plays-5, role-8)
case(development-11, in-9)
det(development-11, the-10)
nmod:in(role-8, development-11)
case(obesity-13, of-12)
nmod:of(development-11, obesity-13)
cc(obesity-13, and-14)
nmod:poss(related_disorders-16, its-15)
nmod:of(development-11, related_disorders-16)
conj:and(obesity-13, related_disorders-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT expression/NN levels/NNS of/IN several/JJ lipid/NN metabolism-related/JJ genes/NNS in/IN adipose_tissue/JJ samples/NNS from/IN obese/JJ individuals/NNS using/VBG real-time/JJ RT-PCR/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN expression) (NNS levels))
        (PP (IN of)
          (NP
            (NP (JJ several) (NN lipid) (JJ metabolism-related) (NNS genes))
            (PP (IN in)
              (NP (JJ adipose_tissue) (NNS samples))))))
      (PP (IN from)
        (NP
          (NP (JJ obese) (NNS individuals))
          (VP (VBG using)
            (NP (JJ real-time) (NN RT-PCR))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(levels-9, the-7)
compound(levels-9, expression-8)
dobj(investigated-6, levels-9)
case(genes-14, of-10)
amod(genes-14, several-11)
compound(genes-14, lipid-12)
amod(genes-14, metabolism-related-13)
nmod:of(levels-9, genes-14)
case(samples-17, in-15)
amod(samples-17, adipose_tissue-16)
nmod:in(genes-14, samples-17)
case(individuals-20, from-18)
amod(individuals-20, obese-19)
nmod:from(investigated-6, individuals-20)
acl(individuals-20, using-21)
amod(RT-PCR-23, real-time-22)
dobj(using-21, RT-PCR-23)

Our/PRP$ results/NNS showed/VBD that/IN the/DT expression/NN levels/NNS of/IN acetyl_CoA/NN carboxylase/NN -LRB-/-LRB- ACC/NNP -RRB-/-RRB- ,/, MMS/NNP synthase/NN -LRB-/-LRB- HR_1/CD .18/CD -RRB-/-RRB- ,/, malic_enzyme/NN -LRB-/-LRB- ME/NNP -RRB-/-RRB- ,/, apolipoprotein_B100/NNS -LRB-/-LRB- apoB100/JJ -RRB-/-RRB- ,/, sterol/JJ regulating/VBG element/NN binding_protein/NN -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- ,/, carnitine_palmitoyltransferase/NN -LRB-/-LRB- CPT-1/NNP -RRB-/-RRB- and/CC peroxisome_proliferators-activated_receptor/JJ -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- genes/NNS were/VBD significantly/RB altered/VBN in/IN obese/JJ individuals/NNS compared/VBN to/TO non-obese/JJ controls/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN expression) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP
                    (NP (NN acetyl_CoA) (NN carboxylase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP ACC))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NNP MMS) (NN synthase))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD HR_1) (CD .18)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN malic_enzyme))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP ME))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NNS apolipoprotein_B100))
                    (PRN (-LRB- -LRB-) (JJ apoB100) (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ sterol) (VBG regulating) (NN element) (NN binding_protein))
                    (-LRB- -LRB-)
                    (NP (NNS SREBP-1c))
                    (-RRB- -RRB-))
                  (, ,)
                  (NP
                    (NP (NN carnitine_palmitoyltransferase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CPT-1))
                      (-RRB- -RRB-))))
                (CC and)
                (NP
                  (ADJP
                    (ADJP (JJ peroxisome_proliferators-activated_receptor))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PPARa))
                      (-RRB- -RRB-)))
                  (NNS genes)))))
          (VP (VBD were) (RB significantly)
            (VP (VBN altered)
              (PP (IN in)
                (NP
                  (NP (JJ obese) (NNS individuals))
                  (VP (VBN compared)
                    (PP (TO to)
                      (NP (JJ non-obese) (NNS controls)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(altered-52, that-4)
det(levels-7, the-5)
compound(levels-7, expression-6)
nsubjpass(altered-52, levels-7)
case(carboxylase-10, of-8)
compound(carboxylase-10, acetyl_CoA-9)
nmod:of(levels-7, carboxylase-10)
appos(carboxylase-10, ACC-12)
compound(synthase-16, MMS-15)
appos(carboxylase-10, synthase-16)
compound(.18-19, HR_1-18)
dep(synthase-16, .18-19)
appos(carboxylase-10, malic_enzyme-22)
appos(malic_enzyme-22, ME-24)
appos(carboxylase-10, apolipoprotein_B100-27)
dep(apolipoprotein_B100-27, apoB100-29)
amod(binding_protein-35, sterol-32)
amod(binding_protein-35, regulating-33)
compound(binding_protein-35, element-34)
appos(carboxylase-10, binding_protein-35)
dep(binding_protein-35, SREBP-1c-37)
appos(carboxylase-10, carnitine_palmitoyltransferase-40)
appos(carnitine_palmitoyltransferase-40, CPT-1-42)
cc(carboxylase-10, and-44)
amod(genes-49, peroxisome_proliferators-activated_receptor-45)
dep(peroxisome_proliferators-activated_receptor-45, PPARa-47)
nmod:of(levels-7, genes-49)
conj:and(carboxylase-10, genes-49)
auxpass(altered-52, were-50)
advmod(altered-52, significantly-51)
ccomp(showed-3, altered-52)
case(individuals-55, in-53)
amod(individuals-55, obese-54)
nmod:in(altered-52, individuals-55)
acl(individuals-55, compared-56)
case(controls-59, to-57)
amod(controls-59, non-obese-58)
nmod:to(compared-56, controls-59)

These/DT findings/NNS provide/VBP further/JJ insight/NN into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG dysregulated/JJ lipid/NN metabolism/NN in/IN obesity/NN ,/, and/CC highlight/VB potential/JJ targets/NNS for/IN therapeutic/JJ intervention/NN to/TO prevent/VB or/CC treat/VB obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ further) (NN insight))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP
                (NP (JJ dysregulated) (NN lipid) (NN metabolism))
                (PP (IN in)
                  (NP (NN obesity))))))))
      (, ,)
      (CC and)
      (VP (VB highlight)
        (NP
          (NP (JJ potential) (NNS targets))
          (PP (IN for)
            (NP (JJ therapeutic) (NN intervention))))
        (S
          (VP (TO to)
            (VP
              (VP (VB prevent))
              (CC or)
              (VP (VB treat)
                (NP (JJ obesity-related) (NNS metabolic_disorders))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(highlight-18, findings-2)
root(ROOT-0, provide-3)
amod(insight-5, further-4)
dobj(provide-3, insight-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(provide-3, mechanisms-9)
acl(mechanisms-9, underlying-10)
amod(metabolism-13, dysregulated-11)
compound(metabolism-13, lipid-12)
dobj(underlying-10, metabolism-13)
case(obesity-15, in-14)
nmod:in(metabolism-13, obesity-15)
cc(provide-3, and-17)
conj:and(provide-3, highlight-18)
amod(targets-20, potential-19)
dobj(highlight-18, targets-20)
case(intervention-23, for-21)
amod(intervention-23, therapeutic-22)
nmod:for(targets-20, intervention-23)
mark(prevent-25, to-24)
advcl(highlight-18, prevent-25)
cc(prevent-25, or-26)
advcl(highlight-18, treat-27)
conj:or(prevent-25, treat-27)
amod(metabolic_disorders-29, obesity-related-28)
dobj(treat-27, metabolic_disorders-29)

The/DT use/NN of/IN histamine_hydrochloride/JJ has_been/NN investigated/VBD as/IN a/DT potential/JJ treatment/NN for/IN various/JJ symptoms/NNS ,/, including/VBG bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (JJ histamine_hydrochloride) (NN has_been))))
    (VP (VBD investigated)
      (PP (IN as)
        (NP
          (NP (DT a) (JJ potential) (NN treatment))
          (PP (IN for)
            (NP (JJ various) (NNS symptoms)))))
      (, ,)
      (S
        (VP (VBG including)
          (NP
            (NP (NNS bronchospasms))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP (NN phonophobia))))))
    (. .)))

det(use-2, The-1)
nsubj(investigated-6, use-2)
case(has_been-5, of-3)
amod(has_been-5, histamine_hydrochloride-4)
nmod:of(use-2, has_been-5)
root(ROOT-0, investigated-6)
case(treatment-10, as-7)
det(treatment-10, a-8)
amod(treatment-10, potential-9)
nmod:as(investigated-6, treatment-10)
case(symptoms-13, for-11)
amod(symptoms-13, various-12)
nmod:for(treatment-10, symptoms-13)
xcomp(investigated-6, including-15)
dobj(including-15, bronchospasms-16)
dobj(including-15, photophobia-18)
conj:and(bronchospasms-16, photophobia-18)
cc(bronchospasms-16, and-20)
dobj(including-15, phonophobia-21)
conj:and(bronchospasms-16, phonophobia-21)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN histamine_hydrochloride/NN were/VBD evaluated/VBN at/IN 2/CD hours/NNS after/IN dosing/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NN histamine_hydrochloride))))
    (VP (VBD were)
      (VP (VBN evaluated)
        (PP (IN at)
          (NP
            (NP (CD 2) (NNS hours))
            (PP (IN after)
              (NP (NN dosing)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(effects-6, the-5)
nsubjpass(evaluated-10, effects-6)
case(histamine_hydrochloride-8, of-7)
nmod:of(effects-6, histamine_hydrochloride-8)
auxpass(evaluated-10, were-9)
root(ROOT-0, evaluated-10)
case(hours-13, at-11)
nummod(hours-13, 2-12)
nmod:at(evaluated-10, hours-13)
case(dosing-15, after-14)
nmod:after(hours-13, dosing-15)

The/DT results/NNS showed/VBD that/IN histamine_hydrochloride/NN reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN histamine_hydrochloride))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, histamine_hydrochloride-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(bronchospasms-10, of-9)
nmod:of(risk-8, bronchospasms-10)
case(%-13, by-11)
nummod(%-13, 14-12)
nmod:by(reduced-6, %-13)
nummod(%-16, 95-15)
dep(%-13, %-16)
acl:relcl(%-16, CI-17)
nummod(%-19, 6-20-18)
dobj(CI-17, %-19)
appos(%-19, P-21)
dep(0.0005-23, =-22)
dep(%-19, 0.0005-23)
xcomp(reduced-6, photophobia-26)
case(%-29, by-27)
nummod(%-29, 17-28)
nmod:by(photophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(photophobia-26, and-42)
xcomp(reduced-6, phonophobia-43)
conj:and(photophobia-26, phonophobia-43)
case(%-46, by-44)
nummod(%-46, 14-45)
nmod:by(phonophobia-43, %-46)
nummod(%-49, 95-48)
appos(%-46, %-49)
dep(%-52, CI-50)
nummod(%-52, 17-20-51)
nmod(%-49, %-52)
dep(%-49, P-54)
compound(0.0001-56, <-55)
nummod(P-54, 0.0001-56)

These/DT findings/NNS suggest/VBP that/IN histamine_hydrochloride/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN the/DT treatment/NN of/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN histamine_hydrochloride))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, histamine_hydrochloride-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(treatment-14, for-12)
det(treatment-14, the-13)
nmod:for(option-11, treatment-14)
case(symptoms-17, of-15)
det(symptoms-17, these-16)
nmod:of(treatment-14, symptoms-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN histamine_hydrochloride/NN in/IN these/DT populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP
                      (NP (NN histamine_hydrochloride))
                      (PP (IN in)
                        (NP (DT these) (NNS populations))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(explore-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(explore-6, profile-12)
conj:and(effects-9, profile-12)
case(histamine_hydrochloride-14, of-13)
nmod:of(profile-12, histamine_hydrochloride-14)
case(populations-17, in-15)
det(populations-17, these-16)
nmod:in(histamine_hydrochloride-14, populations-17)

The/DT incidence/NN of/IN oral_moniliasis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN are/VBP common/JJ symptoms/NNS in/IN patients/NNS with/IN migraine_headaches/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN incidence))
      (PP (IN of)
        (NP
          (NP (NNS oral_moniliasis))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBP are)
      (NP
        (NP (JJ common) (NNS symptoms))
        (PP (IN in)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (NNS migraine_headaches)))))))
    (. .)))

det(incidence-2, The-1)
nsubj(symptoms-12, incidence-2)
case(oral_moniliasis-4, of-3)
nmod:of(incidence-2, oral_moniliasis-4)
nmod:of(incidence-2, photophobia-6)
conj:and(oral_moniliasis-4, photophobia-6)
cc(oral_moniliasis-4, and-8)
nmod:of(incidence-2, phonophobia-9)
conj:and(oral_moniliasis-4, phonophobia-9)
cop(symptoms-12, are-10)
amod(symptoms-12, common-11)
root(ROOT-0, symptoms-12)
case(patients-14, in-13)
nmod:in(symptoms-12, patients-14)
case(migraine_headaches-16, with-15)
nmod:with(patients-14, migraine_headaches-16)

The/DT use/NN of/IN Hydroxystilbamidine/NNP has_been/NN investigated/VBD to/TO determine/VB its/PRP$ efficacy/NN in/IN reducing/VBG the/DT occurrence/NN of/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (NNP Hydroxystilbamidine) (NN has_been))))
    (VP (VBD investigated)
      (S
        (VP (TO to)
          (VP (VB determine)
            (NP (PRP$ its) (NN efficacy))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN occurrence))
                    (PP (IN of)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(use-2, The-1)
nsubj(investigated-6, use-2)
nsubj:xsubj(determine-8, use-2)
case(has_been-5, of-3)
compound(has_been-5, Hydroxystilbamidine-4)
nmod:of(use-2, has_been-5)
root(ROOT-0, investigated-6)
mark(determine-8, to-7)
xcomp(investigated-6, determine-8)
nmod:poss(efficacy-10, its-9)
dobj(determine-8, efficacy-10)
mark(reducing-12, in-11)
advcl(determine-8, reducing-12)
det(occurrence-14, the-13)
dobj(reducing-12, occurrence-14)
case(symptoms-17, of-15)
det(symptoms-17, these-16)
nmod:of(occurrence-14, symptoms-17)

In/IN a/DT randomized_controlled_trial/NN ,/, patients/NNS were/VBD administered/VBN Hydroxystilbamidine/JJ and/CC assessed/VBN for/IN the/DT presence/NN of/IN oral_moniliasis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN at/IN 2/CD hours/NNS post-dosing/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (NN randomized_controlled_trial)))
    (, ,)
    (NP (NNS patients))
    (VP (VBD were)
      (VP (VBN administered)
        (NP
          (UCP
            (ADJP (JJ Hydroxystilbamidine))
            (CC and)
            (VP (VBN assessed)
              (PP (IN for)
                (NP
                  (NP (DT the) (NN presence))
                  (PP (IN of)
                    (NP
                      (NP (NNS oral_moniliasis))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia))))))
              (PP (IN at)
                (NP (CD 2) (NNS hours)))))
          (NN post-dosing))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, a-2)
nmod:in(administered-7, randomized_controlled_trial-3)
nsubjpass(administered-7, patients-5)
auxpass(administered-7, were-6)
root(ROOT-0, administered-7)
amod(post-dosing-24, Hydroxystilbamidine-8)
cc(Hydroxystilbamidine-8, and-9)
conj:and(Hydroxystilbamidine-8, assessed-10)
amod(post-dosing-24, assessed-10)
case(presence-13, for-11)
det(presence-13, the-12)
nmod:for(assessed-10, presence-13)
case(oral_moniliasis-15, of-14)
nmod:of(presence-13, oral_moniliasis-15)
nmod:of(presence-13, photophobia-17)
conj:and(oral_moniliasis-15, photophobia-17)
cc(oral_moniliasis-15, and-19)
nmod:of(presence-13, phonophobia-20)
conj:and(oral_moniliasis-15, phonophobia-20)
case(hours-23, at-21)
nummod(hours-23, 2-22)
nmod:at(assessed-10, hours-23)
dobj(administered-7, post-dosing-24)

Results/NNS showed/VBD that/IN Hydroxystilbamidine/NNP reduced/VBD the/DT risk/NN of/IN oral_moniliasis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP Hydroxystilbamidine))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS oral_moniliasis))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(reduced-5, that-3)
nsubj(reduced-5, Hydroxystilbamidine-4)
ccomp(showed-2, reduced-5)
det(risk-7, the-6)
dobj(reduced-5, risk-7)
case(oral_moniliasis-9, of-8)
nmod:of(risk-7, oral_moniliasis-9)
case(%-12, by-10)
nummod(%-12, 14-11)
nmod:by(reduced-5, %-12)
nummod(%-15, 95-14)
dep(%-12, %-15)
acl:relcl(%-15, CI-16)
nummod(%-18, 6-20-17)
dobj(CI-16, %-18)
appos(%-18, P-20)
dep(0.0005-22, =-21)
dep(%-18, 0.0005-22)
xcomp(reduced-5, photophobia-25)
case(%-28, by-26)
nummod(%-28, 17-27)
nmod:by(photophobia-25, %-28)
nummod(%-31, 95-30)
appos(%-28, %-31)
dep(%-34, CI-32)
nummod(%-34, 12-22-33)
nmod(%-31, %-34)
dep(%-31, P-36)
compound(0.0001-38, <-37)
nummod(P-36, 0.0001-38)
cc(photophobia-25, and-41)
xcomp(reduced-5, phonophobia-42)
conj:and(photophobia-25, phonophobia-42)
case(%-45, by-43)
nummod(%-45, 14-44)
nmod:by(phonophobia-42, %-45)
nummod(%-48, 95-47)
appos(%-45, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

These/DT findings/NNS suggest/VBP that/IN Hydroxystilbamidine/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN reducing/VBG the/DT incidence/NN of/IN these/DT symptoms/NNS in/IN patients/NNS with/IN migraine_headaches/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Hydroxystilbamidine))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN incidence))
                        (PP (IN of)
                          (NP
                            (NP (DT these) (NNS symptoms))
                            (PP (IN in)
                              (NP (NNS patients))))))
                      (PP (IN with)
                        (NP (NNS migraine_headaches))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Hydroxystilbamidine-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(incidence-15, the-14)
dobj(reducing-13, incidence-15)
case(symptoms-18, of-16)
det(symptoms-18, these-17)
nmod:of(incidence-15, symptoms-18)
case(patients-20, in-19)
nmod:in(symptoms-18, patients-20)
case(migraine_headaches-22, with-21)
nmod:with(reducing-13, migraine_headaches-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC evaluate/VB the/DT safety/NN and/CC long-term/JJ efficacy/NN of/IN this/DT treatment/NN approach/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (NN safety))
                  (CC and)
                  (NP
                    (NP (JJ long-term) (NN efficacy))
                    (PP (IN of)
                      (NP (DT this) (NN treatment) (NN approach)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(evaluate-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, evaluate-10)
conj:and(confirm-6, evaluate-10)
det(safety-12, the-11)
dobj(evaluate-10, safety-12)
cc(safety-12, and-13)
amod(efficacy-15, long-term-14)
dobj(evaluate-10, efficacy-15)
conj:and(safety-12, efficacy-15)
case(approach-19, of-16)
det(approach-19, this-17)
compound(approach-19, treatment-18)
nmod:of(efficacy-15, approach-19)

Brugada_Syndrome/JJ -LRB-/-LRB- BrS/NNP -RRB-/-RRB- is_a/NNS rare_genetic_disorder/VBP that/IN can/MD cause/VB sudden_cardiac_death/NN in/IN patients/NNS with/IN heart_failure/NN -LRB-/-LRB- HF/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Brugada_Syndrome)
      (PRN (-LRB- -LRB-)
        (NP (NNP BrS))
        (-RRB- -RRB-))
      (NNS is_a))
    (VP (VBP rare_genetic_disorder)
      (SBAR (IN that)
        (S
          (VP (MD can)
            (VP (VB cause)
              (NP
                (NP
                  (NP (NN sudden_cardiac_death))
                  (PP (IN in)
                    (NP
                      (NP (NNS patients))
                      (PP (IN with)
                        (NP (NN heart_failure))))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP HF))
                  (-RRB- -RRB-))))))))
    (. .)))

amod(is_a-5, Brugada_Syndrome-1)
appos(is_a-5, BrS-3)
nsubj(rare_genetic_disorder-6, is_a-5)
root(ROOT-0, rare_genetic_disorder-6)
mark(cause-9, that-7)
aux(cause-9, can-8)
ccomp(rare_genetic_disorder-6, cause-9)
dobj(cause-9, sudden_cardiac_death-10)
case(patients-12, in-11)
nmod:in(sudden_cardiac_death-10, patients-12)
case(heart_failure-14, with-13)
nmod:with(patients-12, heart_failure-14)
appos(sudden_cardiac_death-10, HF-16)

Dronedarone/NNP ,/, an/DT antiarrhythmic/JJ medication/NN ,/, has_been/VBP shown/VBN to/TO reduce/VB the/DT risk/NN of/IN BrS/NNP in/IN HF/NNP patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Dronedarone))
      (, ,)
      (NP (DT an) (JJ antiarrhythmic) (NN medication))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNP BrS))))
              (PP (IN in)
                (NP (NNP HF) (NNS patients))))))))
    (. .)))

nsubj(has_been-7, Dronedarone-1)
det(medication-5, an-3)
amod(medication-5, antiarrhythmic-4)
appos(Dronedarone-1, medication-5)
root(ROOT-0, has_been-7)
dep(has_been-7, shown-8)
mark(reduce-10, to-9)
xcomp(shown-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
case(BrS-14, of-13)
nmod:of(risk-12, BrS-14)
case(patients-17, in-15)
compound(patients-17, HF-16)
nmod:in(reduce-10, patients-17)

In/IN this/DT study/NN ,/, the/DT relative/JJ risk/NN -LRB-/-LRB- RR/NNP -RRB-/-RRB- of/IN BrS/NNP was/VBD found/VBN to_be/NN 0.79/CD -LRB-/-LRB- 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- with/IN a/DT 21/CD %/NN reduction/NN in/IN risk/NN in/IN patients/NNS treated/VBN with/IN dronedarone/NN compared/VBN to/TO those/DT who/WP were/VBD not/RB ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP
        (NP (DT the) (JJ relative) (NN risk))
        (PRN (-LRB- -LRB-)
          (NP (NNP RR))
          (-RRB- -RRB-)))
      (PP (IN of)
        (NP (NNP BrS))))
    (VP (VBD was)
      (VP (VBN found)
        (NP
          (NP (NN to_be) (CD 0.79))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
              (: :)
              (NP
                (QP (CD 0.67-0) (CD .93))))
            (-RRB- -RRB-)))
        (PP (IN with)
          (NP
            (NP (DT a)
              (ADJP (CD 21) (NN %))
              (NN reduction))
            (PP (IN in)
              (NP (NN risk)))))
        (PP (IN in)
          (NP
            (NP (NNS patients))
            (VP (VBN treated)
              (PP (IN with)
                (NP
                  (NP (NN dronedarone))
                  (VP (VBN compared)
                    (PP (TO to)
                      (NP
                        (NP (DT those))
                        (SBAR
                          (WHNP (WP who))
                          (S
                            (VP (VBD were)
                              (ADVP (RB not)))))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(found-14, study-3)
det(risk-7, the-5)
amod(risk-7, relative-6)
nsubjpass(found-14, risk-7)
appos(risk-7, RR-9)
case(BrS-12, of-11)
nmod:of(risk-7, BrS-12)
auxpass(found-14, was-13)
root(ROOT-0, found-14)
dobj(found-14, to_be-15)
nummod(to_be-15, 0.79-16)
nummod(-RSB--24, 95-18)
compound(-RSB--24, %-19)
compound(-RSB--24, confidence-20)
amod(-RSB--24, interval-21)
amod(-RSB--24, -LSB--22)
compound(-RSB--24, CI-23)
dep(to_be-15, -RSB--24)
compound(.93-27, 0.67-0-26)
dep(-RSB--24, .93-27)
case(reduction-33, with-29)
det(reduction-33, a-30)
compound(%-32, 21-31)
amod(reduction-33, %-32)
nmod:with(found-14, reduction-33)
case(risk-35, in-34)
nmod:in(reduction-33, risk-35)
case(patients-37, in-36)
nmod:in(found-14, patients-37)
acl(patients-37, treated-38)
case(dronedarone-40, with-39)
nmod:with(treated-38, dronedarone-40)
acl(dronedarone-40, compared-41)
case(those-43, to-42)
nmod:to(compared-41, those-43)
nsubj(were-45, those-43)
ref(those-43, who-44)
acl:relcl(those-43, were-45)
neg(were-45, not-46)

These/DT findings/NNS suggest/VBP that/IN dronedarone/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN reducing/VBG the/DT risk/NN of/IN BrS/NNP in/IN HF/NNP patients/NNS and/CC could/MD potentially/RB improve/VB their/PRP$ overall/JJ prognosis/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN dronedarone))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                  (PP (IN for)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP BrS)))
                          (PP (IN in)
                            (NP (NNP HF) (NNS patients))))))))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB improve)
                (NP (PRP$ their) (JJ overall) (NN prognosis))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, dronedarone-5)
nsubj(improve-24, dronedarone-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(BrS-17, of-16)
nmod:of(risk-15, BrS-17)
case(patients-20, in-18)
compound(patients-20, HF-19)
nmod:in(risk-15, patients-20)
cc(option-11, and-21)
aux(improve-24, could-22)
advmod(improve-24, potentially-23)
ccomp(suggest-3, improve-24)
conj:and(option-11, improve-24)
nmod:poss(prognosis-27, their-25)
amod(prognosis-27, overall-26)
dobj(improve-24, prognosis-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC assess/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN dronedarone/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB assess)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP
                      (NP (NN dronedarone))
                      (PP (IN in)
                        (NP (DT this) (NN population))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(assess-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, assess-10)
conj:and(confirm-6, assess-10)
det(safety-13, the-11)
amod(safety-13, long-term-12)
dobj(assess-10, safety-13)
cc(safety-13, and-14)
dobj(assess-10, efficacy-15)
conj:and(safety-13, efficacy-15)
case(dronedarone-17, of-16)
nmod:of(safety-13, dronedarone-17)
case(population-20, in-18)
det(population-20, this-19)
nmod:in(dronedarone-17, population-20)

The/DT solute_carrier_family_1/JJ -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- is_a/NN group/NN of/IN transporters/NNS that/WDT play/VBP a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN neurotransmitter/NN glutamate/VBD levels/NNS in/IN the/DT brain/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ solute_carrier_family_1)
        (PRN (-LRB- -LRB-)
          (NP (NNP SLC1))
          (-RRB- -RRB-))
        (NN is_a) (NN group))
      (PP (IN of)
        (NP
          (NP (NNS transporters))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP play)
                (NP
                  (NP (DT a) (JJ crucial) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN regulation))
                      (PP (IN of)
                        (NP (NN neurotransmitter))))))))))))
    (VP (VBD glutamate)
      (NP
        (NP (NNS levels))
        (PP (IN in)
          (NP (DT the) (NN brain)))))
    (. .)))

det(group-7, The-1)
amod(group-7, solute_carrier_family_1-2)
appos(group-7, SLC1-4)
compound(group-7, is_a-6)
nsubj(glutamate-20, group-7)
case(transporters-9, of-8)
nmod:of(group-7, transporters-9)
nsubj(play-11, transporters-9)
ref(transporters-9, that-10)
acl:relcl(transporters-9, play-11)
det(role-14, a-12)
amod(role-14, crucial-13)
dobj(play-11, role-14)
case(regulation-17, in-15)
det(regulation-17, the-16)
nmod:in(role-14, regulation-17)
case(neurotransmitter-19, of-18)
nmod:of(regulation-17, neurotransmitter-19)
root(ROOT-0, glutamate-20)
dobj(glutamate-20, levels-21)
case(brain-24, in-22)
det(brain-24, the-23)
nmod:in(levels-21, brain-24)

This/DT family/NN consists/VBZ of/IN five/CD high-affinity/JJ glutamate_transporters/NNS ,/, including/VBG EAAC1/NNP ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP ,/, and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/NNP ,/, SLC1A2/NNP ,/, SLC1A3/NNP ,/, SLC1A6/NNP ,/, and/CC SLC1A7/NNP respectively/RB -RRB-/-RRB- ,/, which/WDT are/VBP responsible/JJ for/IN the/DT uptake/NN of/IN glutamate/NN from/IN the/DT synaptic/JJ cleft/NN ./.

(ROOT
  (S
    (NP (DT This) (NN family))
    (VP (VBZ consists)
      (PP (IN of)
        (NP
          (NP (CD five) (JJ high-affinity) (NNS glutamate_transporters))
          (, ,)
          (VP (VBG including)
            (NP
              (NP (NNP EAAC1))
              (, ,)
              (NP (NNP GLT-1))
              (, ,)
              (NP (NNP GLAST))
              (, ,)
              (NP
                (NP (NNP EAAT4))
                (, ,)
                (CC and)
                (NP
                  (NP
                    (NP (NNP EAAT5) (-LRB- -LRB-) (NNP SLC1A1))
                    (, ,)
                    (NP (NNP SLC1A2))
                    (, ,)
                    (NP (NNP SLC1A3))
                    (, ,)
                    (NP (NNP SLC1A6))
                    (, ,)
                    (CC and)
                    (NP (NNP SLC1A7)))
                  (ADVP (RB respectively)))
                (-RRB- -RRB-))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBP are)
                    (ADJP (JJ responsible)
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN uptake))
                          (PP (IN of)
                            (NP
                              (NP (NN glutamate))
                              (PP (IN from)
                                (NP (DT the) (JJ synaptic) (NN cleft))))))))))))))))
    (. .)))

det(family-2, This-1)
nsubj(consists-3, family-2)
root(ROOT-0, consists-3)
case(glutamate_transporters-7, of-4)
nummod(glutamate_transporters-7, five-5)
amod(glutamate_transporters-7, high-affinity-6)
nmod:of(consists-3, glutamate_transporters-7)
acl(glutamate_transporters-7, including-9)
dobj(including-9, EAAC1-10)
nsubj(responsible-36, EAAC1-10)
appos(EAAC1-10, GLT-1-12)
appos(EAAC1-10, GLAST-14)
appos(EAAC1-10, EAAT4-16)
cc(EAAT4-16, and-18)
compound(SLC1A1-21, EAAT5-19)
appos(EAAC1-10, SLC1A1-21)
conj:and(EAAT4-16, SLC1A1-21)
conj:and(EAAT4-16, SLC1A2-23)
conj:and(SLC1A1-21, SLC1A2-23)
conj:and(EAAT4-16, SLC1A3-25)
conj:and(SLC1A1-21, SLC1A3-25)
conj:and(EAAT4-16, SLC1A6-27)
conj:and(SLC1A1-21, SLC1A6-27)
cc(SLC1A1-21, and-29)
conj:and(EAAT4-16, SLC1A7-30)
conj:and(SLC1A1-21, SLC1A7-30)
advmod(SLC1A1-21, respectively-31)
ref(EAAC1-10, which-34)
cop(responsible-36, are-35)
acl:relcl(EAAC1-10, responsible-36)
case(uptake-39, for-37)
det(uptake-39, the-38)
nmod:for(responsible-36, uptake-39)
case(glutamate-41, of-40)
nmod:of(uptake-39, glutamate-41)
case(cleft-45, from-42)
det(cleft-45, the-43)
amod(cleft-45, synaptic-44)
nmod:from(glutamate-41, cleft-45)

In/IN addition/NN to/TO these/DT high-affinity/JJ glutamate_transporters/NNS ,/, SLC1/NNP also/RB includes/VBZ two/CD neutral/JJ transporters/NNS :/: histamine_2_receptor/NNP and/CC ASCT2/NNP -LRB-/-LRB- SLC1A4/NNP and/CC ALC1A5/NNP respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (DT these) (JJ high-affinity) (NNS glutamate_transporters)))))
    (, ,)
    (NP (NNP SLC1))
    (ADVP (RB also))
    (VP (VBZ includes)
      (NP
        (NP (CD two) (JJ neutral) (NNS transporters))
        (: :)
        (NP
          (NP (NNP histamine_2_receptor)
            (CC and)
            (NNP ASCT2))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP SLC1A4)
                (CC and)
                (NNP ALC1A5))
              (ADJP (RB respectively)))
            (-RRB- -RRB-)))))
    (. .)))

case(glutamate_transporters-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
det(glutamate_transporters-6, these-4)
amod(glutamate_transporters-6, high-affinity-5)
nmod:in_addition_to(includes-10, glutamate_transporters-6)
nsubj(includes-10, SLC1-8)
advmod(includes-10, also-9)
root(ROOT-0, includes-10)
nummod(transporters-13, two-11)
amod(transporters-13, neutral-12)
dobj(includes-10, transporters-13)
dep(transporters-13, histamine_2_receptor-15)
cc(histamine_2_receptor-15, and-16)
dep(transporters-13, ASCT2-17)
conj:and(histamine_2_receptor-15, ASCT2-17)
dep(histamine_2_receptor-15, SLC1A4-19)
cc(SLC1A4-19, and-20)
dep(histamine_2_receptor-15, ALC1A5-21)
conj:and(SLC1A4-19, ALC1A5-21)
amod(SLC1A4-19, respectively-22)

The/DT neutral/JJ transporters/NNS have/VBP been/VBN associated/VBN with/IN the/DT uptake/NN of/IN other/JJ amino_acids/NNS such/JJ as/IN histamine/NN and/CC alanine/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ neutral) (NNS transporters))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT the) (NN uptake))
              (PP (IN of)
                (NP
                  (NP (JJ other) (NNS amino_acids))
                  (PP (JJ such) (IN as)
                    (NP (NN histamine)
                      (CC and)
                      (NN alanine))))))))))
    (. .)))

det(transporters-3, The-1)
amod(transporters-3, neutral-2)
nsubjpass(associated-6, transporters-3)
aux(associated-6, have-4)
auxpass(associated-6, been-5)
root(ROOT-0, associated-6)
case(uptake-9, with-7)
det(uptake-9, the-8)
nmod:with(associated-6, uptake-9)
case(amino_acids-12, of-10)
amod(amino_acids-12, other-11)
nmod:of(uptake-9, amino_acids-12)
case(histamine-15, such-13)
mwe(such-13, as-14)
nmod:such_as(amino_acids-12, histamine-15)
cc(histamine-15, and-16)
nmod:such_as(amino_acids-12, alanine-17)
conj:and(histamine-15, alanine-17)

The/DT expression/NN and/CC function/NN of/IN these/DT transporters/NNS are/VBP critical/JJ for/IN maintaining/VBG proper/JJ neurotransmission/NN and/CC dysfunction/NN in/IN their/PRP$ activity/NN has_been/NN implicated/VBN in/IN neurological_disorders/NNS such/JJ as/IN epilepsy/NN and/CC schizophrenia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN expression))
      (CC and)
      (NP
        (NP (NN function))
        (PP (IN of)
          (NP (DT these) (NNS transporters)))))
    (VP (VBP are)
      (ADJP (JJ critical)
        (PP (IN for)
          (S
            (VP (VBG maintaining)
              (NP (JJ proper) (NN neurotransmission)
                (CC and)
                (NN dysfunction))
              (PP (IN in)
                (NP
                  (NP (PRP$ their) (NN activity) (NN has_been))
                  (VP (VBN implicated)
                    (PP (IN in)
                      (NP
                        (NP (NNS neurological_disorders))
                        (PP (JJ such) (IN as)
                          (NP (NN epilepsy)
                            (CC and)
                            (NN schizophrenia)))))))))))))
    (. .)))

det(expression-2, The-1)
nsubj(critical-9, expression-2)
cc(expression-2, and-3)
conj:and(expression-2, function-4)
nsubj(critical-9, function-4)
case(transporters-7, of-5)
det(transporters-7, these-6)
nmod:of(function-4, transporters-7)
cop(critical-9, are-8)
root(ROOT-0, critical-9)
mark(maintaining-11, for-10)
advcl(critical-9, maintaining-11)
amod(neurotransmission-13, proper-12)
dobj(maintaining-11, neurotransmission-13)
cc(neurotransmission-13, and-14)
dobj(maintaining-11, dysfunction-15)
conj:and(neurotransmission-13, dysfunction-15)
case(has_been-19, in-16)
nmod:poss(has_been-19, their-17)
compound(has_been-19, activity-18)
nmod:in(maintaining-11, has_been-19)
acl(has_been-19, implicated-20)
case(neurological_disorders-22, in-21)
nmod:in(implicated-20, neurological_disorders-22)
case(epilepsy-25, such-23)
mwe(such-23, as-24)
nmod:such_as(neurological_disorders-22, epilepsy-25)
cc(epilepsy-25, and-26)
nmod:such_as(neurological_disorders-22, schizophrenia-27)
conj:and(epilepsy-25, schizophrenia-27)

Thus/RB ,/, understanding/VBG the/DT structure/NN and/CC function/NN of/IN these/DT transporters/NNS is/VBZ crucial/JJ for/IN developing/VBG therapies/NNS to/TO treat/VB these/DT disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (S
      (VP (VBG understanding)
        (NP
          (NP (DT the) (NN structure)
            (CC and)
            (NN function))
          (PP (IN of)
            (NP (DT these) (NNS transporters))))))
    (VP (VBZ is)
      (ADJP (JJ crucial)
        (PP (IN for)
          (S
            (VP (VBG developing)
              (NP (NNS therapies))
              (S
                (VP (TO to)
                  (VP (VB treat)
                    (NP (DT these) (NNS disorders))))))))))
    (. .)))

advmod(crucial-12, Thus-1)
csubj(crucial-12, understanding-3)
det(structure-5, the-4)
dobj(understanding-3, structure-5)
cc(structure-5, and-6)
dobj(understanding-3, function-7)
conj:and(structure-5, function-7)
case(transporters-10, of-8)
det(transporters-10, these-9)
nmod:of(structure-5, transporters-10)
cop(crucial-12, is-11)
root(ROOT-0, crucial-12)
mark(developing-14, for-13)
advcl(crucial-12, developing-14)
dobj(developing-14, therapies-15)
mark(treat-17, to-16)
advcl(developing-14, treat-17)
det(disorders-19, these-18)
dobj(treat-17, disorders-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(associated-20, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, numerous-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN coumestrol/JJ levels/NNS in/IN hypercoumestrolmic/JJ patients/NNS ,/, thereby/RB reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ coumestrol) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hypercoumestrolmic) (NNS patients)))))
                (, ,)
                (S
                  (ADVP (RB thereby))
                  (VP (VBG reducing)
                    (NP
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, coumestrol-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hypercoumestrolmic-16)
nmod:in(levels-14, patients-17)
advmod(reducing-20, thereby-19)
xcomp(associated-10, reducing-20)
det(risk-22, the-21)
dobj(reducing-20, risk-22)
mark(developing-24, of-23)
acl(risk-22, developing-24)
dobj(developing-24, coronary_heart_disease-25)
appos(risk-22, CHD-27)

The/DT reduction/NN in/IN coumestrol/JJ levels/NNS is/VBZ thought/VBN to_be/JJ due/JJ to/TO the/DT anti-inflammatory/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN reduction))
      (PP (IN in)
        (NP (JJ coumestrol) (NNS levels))))
    (VP (VBZ is)
      (VP (VBN thought)
        (ADVP (JJ to_be))
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (JJ anti-inflammatory) (NNS properties))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))))))
    (. .)))

det(reduction-2, The-1)
nsubjpass(thought-7, reduction-2)
case(levels-5, in-3)
amod(levels-5, coumestrol-4)
nmod:in(reduction-2, levels-5)
auxpass(thought-7, is-6)
root(ROOT-0, thought-7)
advmod(thought-7, to_be-8)
xcomp(thought-7, due-9)
case(properties-13, to-10)
det(properties-13, the-11)
amod(properties-13, anti-inflammatory-12)
nmod:to(due-9, properties-13)
case(EPA-15, of-14)
nmod:of(properties-13, EPA-15)
cc(EPA-15, and-16)
nmod:of(properties-13, DHA-17)
conj:and(EPA-15, DHA-17)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN metabolism/NN ,/, decrease_blood_pressure/NN ,/, and/CC reduce/VB the/DT risk/NN of/IN arrhythmias/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP
                    (NP (NN lipid) (NN metabolism))
                    (, ,)
                    (NP (NN decrease_blood_pressure))
                    (, ,)))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS arrhythmias)))))))))))
    (. .)))

advmod(shown-8, Additionally-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(improve-10, EPA-3)
nsubj:xsubj(reduce-17, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(improve-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(improve-10, to-9)
xcomp(shown-8, improve-10)
compound(metabolism-12, lipid-11)
dobj(improve-10, metabolism-12)
appos(metabolism-12, decrease_blood_pressure-14)
cc(improve-10, and-16)
xcomp(shown-8, reduce-17)
conj:and(improve-10, reduce-17)
det(risk-19, the-18)
dobj(reduce-17, risk-19)
case(arrhythmias-21, of-20)
nmod:of(risk-19, arrhythmias-21)

Therefore/RB ,/, incorporating/VBG EPA/NNP and/CC DHA/NNP into/IN the/DT diet/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG CHD/NNP risk/NN and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG incorporating)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))
        (PP (IN into)
          (NP (DT the) (NN diet)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP (NNP CHD) (NN risk)))
                (CC and)
                (VP (VBG improving)
                  (NP (JJ overall) (NN cardiovascular_health)))))))))
    (. .)))

advmod(strategy-14, Therefore-1)
csubj(strategy-14, incorporating-3)
dobj(incorporating-3, EPA-4)
cc(EPA-4, and-5)
dobj(incorporating-3, DHA-6)
conj:and(EPA-4, DHA-6)
case(diet-9, into-7)
det(diet-9, the-8)
nmod:into(incorporating-3, diet-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, an-12)
amod(strategy-14, effective-13)
root(ROOT-0, strategy-14)
mark(reducing-16, for-15)
acl(strategy-14, reducing-16)
compound(risk-18, CHD-17)
dobj(reducing-16, risk-18)
cc(reducing-16, and-19)
acl(strategy-14, improving-20)
conj:and(reducing-16, improving-20)
amod(cardiovascular_health-22, overall-21)
dobj(improving-20, cardiovascular_health-22)

Enzymes/NNS play/VBP a/DT crucial/JJ role/NN in/IN various/JJ metabolic/JJ pathways/NNS ,/, and/CC their/PRP$ identification/NN and/CC characterization/NN are/VBP important/JJ for/IN understanding/VBG cellular/JJ processes/NNS ./.

(ROOT
  (S
    (S
      (NP (NNS Enzymes))
      (VP (VBP play)
        (NP
          (NP (DT a) (JJ crucial) (NN role))
          (PP (IN in)
            (NP (JJ various) (JJ metabolic) (NNS pathways))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP$ their) (NN identification)
        (CC and)
        (NN characterization))
      (VP (VBP are)
        (ADJP (JJ important)
          (PP (IN for)
            (S
              (VP (VBG understanding)
                (NP (JJ cellular) (NNS processes))))))))
    (. .)))

nsubj(play-2, Enzymes-1)
root(ROOT-0, play-2)
det(role-5, a-3)
amod(role-5, crucial-4)
dobj(play-2, role-5)
case(pathways-9, in-6)
amod(pathways-9, various-7)
amod(pathways-9, metabolic-8)
nmod:in(role-5, pathways-9)
cc(play-2, and-11)
nmod:poss(identification-13, their-12)
nsubj(important-17, identification-13)
cc(identification-13, and-14)
conj:and(identification-13, characterization-15)
nsubj(important-17, characterization-15)
cop(important-17, are-16)
conj:and(play-2, important-17)
mark(understanding-19, for-18)
advcl(important-17, understanding-19)
amod(processes-21, cellular-20)
dobj(understanding-19, processes-21)

In/IN this/DT study/NN ,/, we/PRP identified/VBD several/JJ enzymes/NNS from/IN a/DT plant/NN extract/VB using/VBG biochemical/JJ assays/NNS and/CC mass_spectrometry/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD identified)
      (NP (JJ several) (NNS enzymes))
      (PP (IN from)
        (NP (DT a) (NN plant)))
      (S
        (VP (VB extract)
          (S
            (VP (VBG using)
              (NP (JJ biochemical) (NNS assays)
                (CC and)
                (NN mass_spectrometry)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(identified-6, study-3)
nsubj(identified-6, we-5)
root(ROOT-0, identified-6)
amod(enzymes-8, several-7)
dobj(identified-6, enzymes-8)
case(plant-11, from-9)
det(plant-11, a-10)
nmod:from(identified-6, plant-11)
dep(identified-6, extract-12)
xcomp(extract-12, using-13)
amod(assays-15, biochemical-14)
dobj(using-13, assays-15)
cc(assays-15, and-16)
dobj(using-13, mass_spectrometry-17)
conj:and(assays-15, mass_spectrometry-17)

These/DT enzymes/NNS included/VBD sinapine/JJ dehydrogenase/JJ -LRB-/-LRB- ADH/NNP -RRB-/-RRB- ,/, alpha-glycerol-3-phosphate_dehydrogenase/JJ -LRB-/-LRB- alpha/NN GPDH/NNS -RRB-/-RRB- ,/, malate_dehydrogenase/JJ -LRB-/-LRB- MDH/NNP -RRB-/-RRB- ,/, isocitrate_dehydrogenase/JJ -LRB-/-LRB- IDH/NNP -RRB-/-RRB- ,/, glucose-6-phosphate_dehydrogenase/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- ,/, transpeptidase/JJ -LRB-/-LRB- 6PGD/CD -RRB-/-RRB- and_alpha-amylase/JJ -LRB-/-LRB- AMY/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS enzymes))
    (VP (VBD included)
      (ADJP
        (ADJP (JJ sinapine) (JJ dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP ADH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ alpha-glycerol-3-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NN alpha) (NNS GPDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ malate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP MDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ isocitrate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP IDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ glucose-6-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP G6PD))
          (-RRB- -RRB-))
        (, ,)
        (ADJP
          (ADJP
            (ADJP (JJ transpeptidase))
            (PRN (-LRB- -LRB-)
              (NP (CD 6PGD))
              (-RRB- -RRB-)))
          (ADJP (JJ and_alpha-amylase)))
        (PRN (-LRB- -LRB-)
          (NP (NNP AMY))
          (-RRB- -RRB-))))
    (. .)))

det(enzymes-2, These-1)
nsubj(included-3, enzymes-2)
root(ROOT-0, included-3)
amod(dehydrogenase-5, sinapine-4)
xcomp(included-3, dehydrogenase-5)
dep(dehydrogenase-5, ADH-7)
dep(dehydrogenase-5, alpha-glycerol-3-phosphate_dehydrogenase-10)
compound(GPDH-13, alpha-12)
dep(dehydrogenase-5, GPDH-13)
dep(dehydrogenase-5, malate_dehydrogenase-16)
dep(dehydrogenase-5, MDH-18)
dep(dehydrogenase-5, isocitrate_dehydrogenase-21)
dep(dehydrogenase-5, IDH-23)
dep(dehydrogenase-5, glucose-6-phosphate_dehydrogenase-26)
dep(dehydrogenase-5, G6PD-28)
dep(dehydrogenase-5, transpeptidase-31)
dep(transpeptidase-31, 6PGD-33)
dep(transpeptidase-31, and_alpha-amylase-35)
dep(dehydrogenase-5, AMY-37)

Further/JJ analysis/NN of/IN these/DT enzymes/NNS may/MD provide/VB insights/NNS into/IN their/PRP$ physiological/JJ roles/NNS and/CC potential/JJ applications/NNS in/IN biotechnology/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Further) (NN analysis))
      (PP (IN of)
        (NP (DT these) (NNS enzymes))))
    (VP (MD may)
      (VP (VB provide)
        (NP
          (NP (NNS insights))
          (PP (IN into)
            (NP (PRP$ their)
              (NX
                (NX (JJ physiological) (NNS roles))
                (CC and)
                (NX (JJ potential) (NNS applications))))))
        (PP (IN in)
          (NP (NN biotechnology)))))
    (. .)))

amod(analysis-2, Further-1)
nsubj(provide-7, analysis-2)
case(enzymes-5, of-3)
det(enzymes-5, these-4)
nmod:of(analysis-2, enzymes-5)
aux(provide-7, may-6)
root(ROOT-0, provide-7)
dobj(provide-7, insights-8)
case(roles-12, into-9)
nmod:poss(roles-12, their-10)
amod(roles-12, physiological-11)
nmod:into(insights-8, roles-12)
cc(roles-12, and-13)
amod(applications-15, potential-14)
nmod:into(insights-8, applications-15)
conj:and(roles-12, applications-15)
case(biotechnology-17, in-16)
nmod:in(provide-7, biotechnology-17)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP (JJ numerous) (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(shown-20, polyunsaturated_fatty_acids-16)
nsubj:xsubj(have-22, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(shown-20, have-18)
auxpass(shown-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, shown-20)
mark(have-22, to-21)
xcomp(shown-20, have-22)
amod(benefits-25, numerous-23)
compound(benefits-25, health-24)
dobj(have-22, benefits-25)

Recent/JJ studies/NNS have/VBP revealed/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Lamivudine/JJ levels/NNS in/IN hyperLamivudinemic/JJ patients/NNS ,/, which/WDT may/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN viral_infections/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN revealed)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Lamivudine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperLamivudinemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB have)
                                (NP
                                  (NP (NNS implications))
                                  (PP (IN for)
                                    (NP
                                      (NP (DT the) (NN treatment))
                                      (PP (IN of)
                                        (NP (NNS viral_infections))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(revealed-4, studies-2)
aux(revealed-4, have-3)
root(ROOT-0, revealed-4)
mark(associated-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-9, omega-3_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(revealed-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, Lamivudine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperLamivudinemic-15)
nmod:in(levels-13, patients-16)
nsubj(have-20, patients-16)
ref(patients-16, which-18)
aux(have-20, may-19)
acl:relcl(patients-16, have-20)
dobj(have-20, implications-21)
case(treatment-24, for-22)
det(treatment-24, the-23)
nmod:for(implications-21, treatment-24)
case(viral_infections-26, of-25)
nmod:of(treatment-24, viral_infections-26)

Moreover/RB ,/, these/DT fatty_acids/NNS have/VBP also/RB been/VBN found/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(found-8, Moreover-1)
det(fatty_acids-4, these-3)
nsubjpass(found-8, fatty_acids-4)
nsubj:xsubj(reduce-10, fatty_acids-4)
aux(found-8, have-5)
advmod(found-8, also-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(reduce-10, to-9)
xcomp(found-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN but/CC may/MD include/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (CC but)
      (VP (MD may)
        (VP (VB include)
          (NP (JJ anti-inflammatory)
            (CC and)
            (JJ anti-thrombotic) (NNS properties)))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
nsubj(include-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
auxpass(understood-10, are-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-11)
aux(include-13, may-12)
conj:but(understood-10, include-13)
amod(properties-17, anti-inflammatory-14)
cc(anti-inflammatory-14, and-15)
conj:and(anti-inflammatory-14, anti-thrombotic-16)
amod(properties-17, anti-thrombotic-16)
dobj(include-13, properties-17)

Given/VBN their/PRP$ potential/JJ health/NN benefits/NNS ,/, increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG and/CC treating/VBG various_diseases/NNS ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
    (, ,)
    (NP
      (NP (VBG increasing) (JJ dietary) (NN intake))
      (PP (IN of)
        (NP (JJ long-chain) (NN omega-3_fatty_acids))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT a) (JJ promising) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG preventing))
                (CC and)
                (VP (VBG treating)
                  (NP (NNS various_diseases)))))))))
    (. .)))

case(benefits-5, Given-1)
nmod:poss(benefits-5, their-2)
amod(benefits-5, potential-3)
compound(benefits-5, health-4)
nmod:given(strategy-17, benefits-5)
amod(intake-9, increasing-7)
amod(intake-9, dietary-8)
nsubj(strategy-17, intake-9)
case(omega-3_fatty_acids-12, of-10)
amod(omega-3_fatty_acids-12, long-chain-11)
nmod:of(intake-9, omega-3_fatty_acids-12)
aux(strategy-17, may-13)
cop(strategy-17, be-14)
det(strategy-17, a-15)
amod(strategy-17, promising-16)
root(ROOT-0, strategy-17)
mark(preventing-19, for-18)
acl(strategy-17, preventing-19)
cc(preventing-19, and-20)
acl(strategy-17, treating-21)
conj:and(preventing-19, treating-21)
dobj(treating-21, various_diseases-22)

Obesity/RB is_a/JJ major/JJ public_health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN several/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes_mellitus/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN public_health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ several) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes_mellitus)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(metabolic_disorders-12, with-10)
amod(metabolic_disorders-12, several-11)
nmod:with(associated-9, metabolic_disorders-12)
acl(metabolic_disorders-12, including-14)
dobj(including-14, type_2_diabetes_mellitus-15)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN oxidative_stress/NN plays/VBZ a/DT critical/JJ role/NN in/IN the/DT development/NN of/IN obesity/NN and/CC its/PRP$ related/JJ complications/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NN oxidative_stress))
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ critical) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (NN obesity))
                        (CC and)
                        (NP (PRP$ its) (JJ related) (NNS complications))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(plays-7, that-5)
nsubj(plays-7, oxidative_stress-6)
ccomp(suggested-4, plays-7)
det(role-10, a-8)
amod(role-10, critical-9)
dobj(plays-7, role-10)
case(development-13, in-11)
det(development-13, the-12)
nmod:in(role-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(obesity-15, and-16)
nmod:poss(complications-19, its-17)
amod(complications-19, related-18)
nmod:of(development-13, complications-19)
conj:and(obesity-15, complications-19)

One/CD of/IN the/DT key/JJ enzymes/NNS involved/VBN in/IN the/DT regulation/NN of/IN oxidative_stress/NNS is/VBZ 1-cysPrx/JJ ,/, which/WDT is/VBZ secreted/VBN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ key) (NNS enzymes))
          (VP (VBN involved)
            (PP (IN in)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP (NNS oxidative_stress)))))))))
    (VP (VBZ is)
      (ADJP (JJ 1-cysPrx))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ is)
            (VP (VBN secreted)
              (PP (IN by)
                (NP (DT the) (NN pancreas))))))))
    (. .)))

nsubj(1-cysPrx-13, One-1)
case(enzymes-5, of-2)
det(enzymes-5, the-3)
amod(enzymes-5, key-4)
nmod:of(One-1, enzymes-5)
acl(enzymes-5, involved-6)
case(regulation-9, in-7)
det(regulation-9, the-8)
nmod:in(involved-6, regulation-9)
case(oxidative_stress-11, of-10)
nmod:of(regulation-9, oxidative_stress-11)
cop(1-cysPrx-13, is-12)
root(ROOT-0, 1-cysPrx-13)
nsubjpass(secreted-17, which-15)
auxpass(secreted-17, is-16)
ccomp(1-cysPrx-13, secreted-17)
case(pancreas-20, by-18)
det(pancreas-20, the-19)
nmod:by(secreted-17, pancreas-20)

However/RB ,/, the/DT relationship/NN between/IN 1-cysPrx/JJ secretion/NN and/CC the/DT development/NN of/IN obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN relationship))
      (PP (IN between)
        (NP
          (NP (JJ 1-cysPrx) (NN secretion))
          (CC and)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity)))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remains-13, However-1)
det(relationship-4, the-3)
nsubj(remains-13, relationship-4)
case(secretion-7, between-5)
amod(secretion-7, 1-cysPrx-6)
nmod:between(relationship-4, secretion-7)
cc(secretion-7, and-8)
det(development-10, the-9)
nmod:between(relationship-4, development-10)
conj:and(secretion-7, development-10)
case(obesity-12, of-11)
nmod:of(development-10, obesity-12)
root(ROOT-0, remains-13)
xcomp(remains-13, unclear-14)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB this/DT relationship/NN by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ palmitoyl_trifluoromethyl_ketone/NN on/IN the/DT secretion/JJ of_1-cysPrx/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB-

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP (DT this) (NN relationship))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (JJ mmol/L) (NN palmitoyl_trifluoromethyl_ketone)))))
                  (PP (IN on)
                    (NP (DT the) (JJ secretion) (JJ of_1-cysPrx) (NN and_insulin)))
                  (PP (IN by)
                    (NP
                      (NP (VBN isolated)
                        (NX
                          (NX
                            (NX
                              (NX (JJ perfused) (NN pancreata))
                              (PP (IN from)
                                (NP (NN genetically_obese))))
                            (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
                          (CC and)
                          (NX (JJ lean))))
                      (-LRB- -LRB-)
                      (NP (NNP Fa))
                      (: /))))))))))
    (. ?) (-RRB- -RRB-)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, this-9)
dobj(evaluate-8, relationship-10)
mark(examining-12, by-11)
advcl(evaluate-8, examining-12)
det(effects-14, the-13)
dobj(examining-12, effects-14)
case(glucose-18, of-15)
nummod(glucose-18, 16.7-16)
amod(glucose-18, mmol/L-17)
nmod:of(effects-14, glucose-18)
cc(glucose-18, and-19)
nummod(palmitoyl_trifluoromethyl_ketone-22, 10-20)
amod(palmitoyl_trifluoromethyl_ketone-22, mmol/L-21)
nmod:of(effects-14, palmitoyl_trifluoromethyl_ketone-22)
conj:and(glucose-18, palmitoyl_trifluoromethyl_ketone-22)
case(and_insulin-27, on-23)
det(and_insulin-27, the-24)
amod(and_insulin-27, secretion-25)
amod(and_insulin-27, of_1-cysPrx-26)
nmod:on(examining-12, and_insulin-27)
case(pancreata-31, by-28)
amod(pancreata-31, isolated-29)
amod(pancreata-31, perfused-30)
nmod:by(examining-12, pancreata-31)
case(genetically_obese-33, from-32)
nmod:from(pancreata-31, genetically_obese-33)
dep(pancreata-31, fa/fa-35)
cc(pancreata-31, and-37)
nmod:by(examining-12, lean-38)
conj:and(pancreata-31, lean-38)
dep(pancreata-31, Fa-40)

rats/NNS ./.

(ROOT
  (NP (NNS rats) (. .)))

root(ROOT-0, rats-1)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN 1-cysPrx/JJ secretion/NN in/IN response/NN to/TO both/DT glucose/NN and/CC palmitoyl_trifluoromethyl_ketone/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ 1-cysPrx) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (DT both) (NN glucose)
                    (CC and)
                    (NN palmitoyl_trifluoromethyl_ketone)))))
            (PP (IN in)
              (NP (JJ obese) (NNS rats)))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, 1-cysPrx-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(glucose-17, to-15)
cc:preconj(glucose-17, both-16)
nmod:to(response-14, glucose-17)
cc(glucose-17, and-18)
nmod:to(response-14, palmitoyl_trifluoromethyl_ketone-19)
conj:and(glucose-17, palmitoyl_trifluoromethyl_ketone-19)
case(rats-22, in-20)
amod(rats-22, obese-21)
nmod:in(was-6, rats-22)
case(rats-26, compared-23)
mwe(compared-23, to-24)
amod(rats-26, lean-25)
advcl(was-6, rats-26)

Furthermore/RB ,/, there/EX was/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN body/NN weight/NN and_1-cysPrx/JJ secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP
          (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
          (PP (IN between)
            (NP (NN body) (NN weight))))
        (NP (JJ and_1-cysPrx) (NN secretion)))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NN glucose) (NN stimulation))))))
    (. .)))

advmod(was-4, Furthermore-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
det(correlation-8, a-5)
amod(correlation-8, significant-6)
amod(correlation-8, positive-7)
iobj(was-4, correlation-8)
case(weight-11, between-9)
compound(weight-11, body-10)
nmod:between(correlation-8, weight-11)
amod(secretion-13, and_1-cysPrx-12)
dep(correlation-8, secretion-13)
case(response-15, in-14)
nmod:in(was-4, response-15)
case(stimulation-18, to-16)
compound(stimulation-18, glucose-17)
nmod:to(response-15, stimulation-18)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of_1-cysPrx/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN and/CC its/PRP$ related/JJ complications/NNS ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN oxidative_stress/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN hypersecretion) (NN of_1-cysPrx))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (NN obesity))
                        (CC and)
                        (NP
                          (NP (PRP$ its) (JJ related) (NNS complications))
                          (, ,)
                          (ADVP (RB possibly))))))))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NNS oxidative_stress))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
compound(of_1-cysPrx-6, hypersecretion-5)
nsubj(play-8, of_1-cysPrx-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-10, a-9)
dobj(play-8, role-10)
case(development-13, in-11)
det(development-13, the-12)
nmod:in(role-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(obesity-15, and-16)
nmod:poss(complications-19, its-17)
amod(complications-19, related-18)
nmod:of(development-13, complications-19)
conj:and(obesity-15, complications-19)
advmod(complications-19, possibly-21)
case(effects-24, through-22)
nmod:poss(effects-24, its-23)
nmod:through(play-8, effects-24)
case(oxidative_stress-26, on-25)
nmod:on(effects-24, oxidative_stress-26)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS implications))
                  (PP (IN of)
                    (NP (DT these) (NNS findings))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-13, potential-11)
amod(implications-13, therapeutic-12)
dobj(elucidate-6, implications-13)
conj:and(mechanisms-9, implications-13)
case(findings-16, of-14)
det(findings-16, these-15)
nmod:of(implications-13, findings-16)

The/DT role/NN of/IN long-chain/NN omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, in/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/JJ has_been/NN extensively/RB studied/VBN ./.

(ROOT
  (NP
    (NP
      (NP (DT The) (NN role))
      (PP (IN of)
        (NP (NN long-chain))))
    (ADJP (JJ omega-3_fatty_acids))
    (, ,)
    (VP
      (VP (VBN eicosapentaenoic_acid)
        (NP
          (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD 20:5) (CD n-3)))
            (-RRB- -RRB-))))
      (CC and)
      (VP (VBN docosahexaenoic_acid)
        (NP
          (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD 22:6) (CD n-3)))
            (-RRB- -RRB-)))))
    (, ,)
    (PP (IN in)
      (NP
        (NP (DT the) (NN prevention)
          (CC and)
          (NN treatment))
        (PP (IN of)
          (NP
            (NP (JJ cardiovascular_disease) (NN has_been))
            (ADJP (RB extensively) (VBN studied))))))
    (. .)))

det(role-2, The-1)
root(ROOT-0, role-2)
case(long-chain-4, of-3)
nmod:of(role-2, long-chain-4)
amod(role-2, omega-3_fatty_acids-5)
dep(role-2, eicosapentaenoic_acid-7)
dobj(eicosapentaenoic_acid-7, EPA-9)
compound(n-3-13, 20:5-12)
dep(EPA-9, n-3-13)
cc(eicosapentaenoic_acid-7, and-15)
dep(role-2, docosahexaenoic_acid-16)
conj:and(eicosapentaenoic_acid-7, docosahexaenoic_acid-16)
dobj(docosahexaenoic_acid-16, DHA-18)
compound(n-3-22, 22:6-21)
dep(DHA-18, n-3-22)
case(prevention-27, in-25)
det(prevention-27, the-26)
nmod:in(role-2, prevention-27)
cc(prevention-27, and-28)
nmod:in(role-2, treatment-29)
conj:and(prevention-27, treatment-29)
case(has_been-32, of-30)
amod(has_been-32, cardiovascular_disease-31)
nmod:of(prevention-27, has_been-32)
advmod(studied-34, extensively-33)
amod(has_been-32, studied-34)

Recent/JJ evidence/NN suggests/VBZ that/IN these/DT fatty_acids/NNS may/MD have/VB beneficial/JJ effects/NNS on/IN the/DT lipid/NN profile/NN of/IN hyperanthracitemic/JJ patients/NNS ,/, leading/VBG to/TO decreased/VBN anthracite/JJ levels/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ beneficial) (NNS effects))
                (PP (IN on)
                  (NP
                    (NP (DT the) (NN lipid) (NN profile))
                    (PP (IN of)
                      (NP (JJ hyperanthracitemic) (NNS patients)))
                    (, ,)
                    (VP (VBG leading)
                      (PP (TO to)
                        (NP (VBN decreased) (JJ anthracite) (NNS levels))))))))))))
    (. .)))

amod(evidence-2, Recent-1)
nsubj(suggests-3, evidence-2)
root(ROOT-0, suggests-3)
mark(have-8, that-4)
det(fatty_acids-6, these-5)
nsubj(have-8, fatty_acids-6)
aux(have-8, may-7)
ccomp(suggests-3, have-8)
amod(effects-10, beneficial-9)
dobj(have-8, effects-10)
case(profile-14, on-11)
det(profile-14, the-12)
compound(profile-14, lipid-13)
nmod:on(effects-10, profile-14)
case(patients-17, of-15)
amod(patients-17, hyperanthracitemic-16)
nmod:of(profile-14, patients-17)
acl(profile-14, leading-19)
case(levels-23, to-20)
amod(levels-23, decreased-21)
amod(levels-23, anthracite-22)
nmod:to(leading-19, levels-23)

Moreover/RB ,/, epidemiological/JJ studies/NNS have/VBP shown/VBN that/IN higher/JJR intake/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJR higher) (NN intake))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(shown-6, Moreover-1)
amod(studies-4, epidemiological-3)
nsubj(shown-6, studies-4)
aux(shown-6, have-5)
root(ROOT-0, shown-6)
mark(associated-15, that-7)
amod(intake-9, higher-8)
nsubjpass(associated-15, intake-9)
case(EPA-11, of-10)
nmod:of(intake-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(intake-9, DHA-13)
conj:and(EPA-11, DHA-13)
auxpass(associated-15, is-14)
ccomp(shown-6, associated-15)
case(risk-19, with-16)
det(risk-19, a-17)
amod(risk-19, decreased-18)
nmod:with(associated-15, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, oxidative_stress/NNS ,/, and/CC endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NNS oxidative_stress))
                (, ,)
                (CC and)
                (NP (JJ endothelial) (NN function))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
dobj(involve-13, modulation-14)
case(inflammation-16, of-15)
nmod:of(modulation-14, inflammation-16)
nmod:of(modulation-14, oxidative_stress-18)
conj:and(inflammation-16, oxidative_stress-18)
cc(inflammation-16, and-20)
amod(function-22, endothelial-21)
nmod:of(modulation-14, function-22)
conj:and(inflammation-16, function-22)

These/DT findings/NNS highlight/VB the/DT potential/JJ importance/NN of/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN as/IN part/NN of/IN a/DT healthy/JJ diet/NN for/IN the/DT prevention/NN and/CC management/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (JJ potential) (NN importance))
        (PP (IN of)
          (S
            (VP (VBG increasing)
              (NP
                (NP (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))
              (PP (IN as)
                (NP
                  (NP (NN part))
                  (PP (IN of)
                    (NP
                      (NP (DT a) (JJ healthy) (NN diet))
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN prevention)
                            (CC and)
                            (NN management))
                          (PP (IN of)
                            (NP (NN cardiovascular_disease))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
root(ROOT-0, highlight-3)
det(importance-6, the-4)
amod(importance-6, potential-5)
dobj(highlight-3, importance-6)
mark(increasing-8, of-7)
acl(importance-6, increasing-8)
dobj(increasing-8, intake-9)
case(omega-3_fatty_acids-12, of-10)
amod(omega-3_fatty_acids-12, long-chain-11)
nmod:of(intake-9, omega-3_fatty_acids-12)
case(part-14, as-13)
nmod:as(increasing-8, part-14)
case(diet-18, of-15)
det(diet-18, a-16)
amod(diet-18, healthy-17)
nmod:of(part-14, diet-18)
case(prevention-21, for-19)
det(prevention-21, the-20)
nmod:for(diet-18, prevention-21)
cc(prevention-21, and-22)
nmod:for(diet-18, management-23)
conj:and(prevention-21, management-23)
case(cardiovascular_disease-25, of-24)
nmod:of(prevention-21, cardiovascular_disease-25)

Obesity/RB is_a/JJ major/JJ health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN numerous/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ numerous) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(metabolic_disorders-12, with-10)
amod(metabolic_disorders-12, numerous-11)
nmod:with(associated-9, metabolic_disorders-12)
acl(metabolic_disorders-12, including-14)
dobj(including-14, type_2_diabetes-15)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN glucose_homeostasis/NNS by/IN secreting/VBG insulin/NN and/CC other/JJ hormones/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP (NNS glucose_homeostasis))))
      (PP (IN by)
        (S
          (VP (VBG secreting)
            (NP
              (NP (NN insulin))
              (CC and)
              (NP (JJ other) (NNS hormones)))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(glucose_homeostasis-8, in-7)
nmod:in(role-6, glucose_homeostasis-8)
mark(secreting-10, by-9)
advcl(plays-3, secreting-10)
dobj(secreting-10, insulin-11)
cc(insulin-11, and-12)
amod(hormones-14, other-13)
dobj(secreting-10, hormones-14)
conj:and(insulin-11, hormones-14)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN SLC16A2/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN SLC16A2))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(involved-15, that-5)
det(hypersecretion-7, the-6)
nsubjpass(involved-15, hypersecretion-7)
case(SLC16A2-9, of-8)
nmod:of(hypersecretion-7, SLC16A2-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(SLC16A2-9, pancreas-12)
aux(involved-15, may-13)
auxpass(involved-15, be-14)
ccomp(suggested-4, involved-15)
case(development-18, in-16)
det(development-18, the-17)
nmod:in(involved-15, development-18)
case(obesity-20, of-19)
nmod:of(development-18, obesity-20)

However/RB ,/, the/DT relationship/NN between/IN SLC16A2/NN secretion/NN and/CC obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN relationship))
      (PP (IN between)
        (NP (NN SLC16A2) (NN secretion)
          (CC and)
          (NN obesity))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

advmod(remains-10, However-1)
det(relationship-4, the-3)
nsubj(remains-10, relationship-4)
case(secretion-7, between-5)
compound(secretion-7, SLC16A2-6)
nmod:between(relationship-4, secretion-7)
cc(secretion-7, and-8)
nmod:between(relationship-4, obesity-9)
conj:and(secretion-7, obesity-9)
root(ROOT-0, remains-10)
xcomp(remains-10, unclear-11)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB this/DT relationship/NN by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Silychristin/NNP on/IN the/DT secretion/NN of/IN SLC16A2/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP (DT this) (NN relationship))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (NN mmol/L) (NNP Silychristin)))))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN secretion))
                      (PP (IN of)
                        (NP (NNP SLC16A2) (NN and_insulin)))))))))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, this-9)
dobj(evaluate-8, relationship-10)
mark(examining-12, by-11)
advcl(evaluate-8, examining-12)
det(effects-14, the-13)
dobj(examining-12, effects-14)
case(glucose-18, of-15)
nummod(glucose-18, 16.7-16)
amod(glucose-18, mmol/L-17)
nmod:of(effects-14, glucose-18)
cc(glucose-18, and-19)
nummod(Silychristin-22, 10-20)
compound(Silychristin-22, mmol/L-21)
nmod:of(effects-14, Silychristin-22)
conj:and(glucose-18, Silychristin-22)
case(secretion-25, on-23)
det(secretion-25, the-24)
nmod:on(examining-12, secretion-25)
case(and_insulin-28, of-26)
compound(and_insulin-28, SLC16A2-27)
nmod:of(secretion-25, and_insulin-28)
case(pancreata-32, by-29)
amod(pancreata-32, isolated-30)
amod(pancreata-32, perfused-31)
nmod:by(aimed-6, pancreata-32)
case(genetically_obese-34, from-33)
nmod:from(pancreata-32, genetically_obese-34)
appos(genetically_obese-34, fa/fa-36)
cc(genetically_obese-34, and-38)
amod(rats-45, lean-39)
dep(lean-39, Fa-41)
nmod:from(pancreata-32, rats-45)
conj:and(genetically_obese-34, rats-45)

Our/PRP$ results/NNS showed/VBD that/IN the/DT hypersecretion/NN of/IN SLC16A2/NNP was/VBD significantly/RB higher/JJR in/IN the/DT pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT high/JJ glucose/NN and/CC Silychristin/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN hypersecretion))
            (PP (IN of)
              (NP (NNP SLC16A2))))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP
                        (NP (DT both) (JJ high) (NN glucose))
                        (CC and)
                        (NP (JJ Silychristin) (NN stimulation))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-18, that-4)
det(hypersecretion-6, the-5)
nsubjpass(compared-18, hypersecretion-6)
nsubj:xsubj(lean-20, hypersecretion-6)
case(SLC16A2-8, of-7)
nmod:of(hypersecretion-6, SLC16A2-8)
auxpass(compared-18, was-9)
advmod(higher-11, significantly-10)
advmod(compared-18, higher-11)
case(pancreata-14, in-12)
det(pancreata-14, the-13)
nmod:in(higher-11, pancreata-14)
case(rats-17, from-15)
amod(rats-17, genetically_obese-16)
nmod:from(pancreata-14, rats-17)
ccomp(showed-3, compared-18)
mark(lean-20, to-19)
xcomp(compared-18, lean-20)
dobj(lean-20, rats-21)
case(glucose-25, under-22)
det(glucose-25, both-23)
amod(glucose-25, high-24)
nmod:under(lean-20, glucose-25)
cc(glucose-25, and-26)
amod(stimulation-28, Silychristin-27)
nmod:under(lean-20, stimulation-28)
conj:and(glucose-25, stimulation-28)

Moreover/RB ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO high/JJ glucose/NN stimulation/NN in/IN both/DT groups/NNS ,/, but/CC no/DT significant/JJ effect/NN was/VBD observed/VBN with/IN Silychristin/NNP stimulation/NN ./.

(ROOT
  (S
    (S
      (ADVP (RB Moreover))
      (, ,)
      (NP (PRP we))
      (VP (VBD observed)
        (NP
          (NP (DT a) (JJ significant) (NN decrease))
          (PP (IN in)
            (NP (NN insulin_secretion))))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP
                (NP (JJ high) (NN glucose) (NN stimulation))
                (PP (IN in)
                  (NP (DT both) (NNS groups)))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT no) (JJ significant) (NN effect))
      (VP (VBD was)
        (VP (VBN observed)
          (PP (IN with)
            (NP (NNP Silychristin) (NN stimulation))))))
    (. .)))

advmod(observed-4, Moreover-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(observed-4, decrease-7)
case(insulin_secretion-9, in-8)
nmod:in(decrease-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(stimulation-15, to-12)
amod(stimulation-15, high-13)
compound(stimulation-15, glucose-14)
nmod:to(response-11, stimulation-15)
case(groups-18, in-16)
det(groups-18, both-17)
nmod:in(stimulation-15, groups-18)
cc(observed-4, but-20)
neg(effect-23, no-21)
amod(effect-23, significant-22)
nsubjpass(observed-25, effect-23)
auxpass(observed-25, was-24)
conj:but(observed-4, observed-25)
case(stimulation-28, with-26)
compound(stimulation-28, Silychristin-27)
nmod:with(observed-25, stimulation-28)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN SLC16A2/NNP by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, which/WDT could/MD provide/VB insights/NNS into/IN potential/JJ therapeutic/JJ targets/NNS for/IN obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP SLC16A2)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (NN obesity))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD could)
                              (VP (VB provide)
                                (NP (NNS insights))
                                (PP (IN into)
                                  (NP
                                    (NP (JJ potential) (JJ therapeutic) (NNS targets))
                                    (PP (IN for)
                                      (NP (JJ obesity-related) (NNS metabolic_disorders)))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(SLC16A2-7, of-6)
nmod:of(hypersecretion-5, SLC16A2-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
nsubj(provide-22, obesity-18)
ref(obesity-18, which-20)
aux(provide-22, could-21)
acl:relcl(obesity-18, provide-22)
dobj(provide-22, insights-23)
case(targets-27, into-24)
amod(targets-27, potential-25)
amod(targets-27, therapeutic-26)
nmod:into(provide-22, targets-27)
case(metabolic_disorders-30, for-28)
amod(metabolic_disorders-30, obesity-related-29)
nmod:for(targets-27, metabolic_disorders-30)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ research/NN has/VBZ shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Ryanodine/JJ levels/NNS in/IN hyperRyanodinemic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Ryanodine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperRyanodinemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-9, omega-3_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, Ryanodine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperRyanodinemic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
amod(risk-19, decreased-18)
nmod:in(levels-13, risk-19)
conj:and(patients-16, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

Ryanodine/NNP is_a/VBD calcium/NN channel/NN receptor/NN that/WDT plays/VBZ a/DT crucial/JJ role/NN in/IN regulating/VBG muscle_contraction/NN ./.

(ROOT
  (S
    (NP (NNP Ryanodine))
    (VP (VBD is_a)
      (NP
        (NP (NN calcium) (NN channel) (NN receptor))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NN muscle_contraction)))))))))))
    (. .)))

nsubj(is_a-2, Ryanodine-1)
root(ROOT-0, is_a-2)
compound(receptor-5, calcium-3)
compound(receptor-5, channel-4)
dobj(is_a-2, receptor-5)
nsubj(plays-7, receptor-5)
ref(receptor-5, that-6)
acl:relcl(receptor-5, plays-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(plays-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
dobj(regulating-12, muscle_contraction-13)

HyperRyanodinemia/NNP is_a/NN condition/NN characterized/VBD by/IN the/DT excessive/JJ release/NN of/IN calcium/NN ions/NNS from/IN the/DT sarcoplasmic/JJ reticulum/NN ,/, leading/VBG to/TO abnormal/JJ muscle_contraction/NN ./.

(ROOT
  (S
    (NP (NNP HyperRyanodinemia) (NN is_a) (NN condition))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (DT the) (JJ excessive) (NN release))
          (PP (IN of)
            (NP (NN calcium) (NNS ions)))))
      (PP (IN from)
        (NP (DT the) (JJ sarcoplasmic) (NN reticulum)))
      (, ,)
      (PP (VBG leading)
        (PP (TO to)
          (NP (JJ abnormal) (NN muscle_contraction)))))
    (. .)))

compound(condition-3, HyperRyanodinemia-1)
compound(condition-3, is_a-2)
nsubj(characterized-4, condition-3)
root(ROOT-0, characterized-4)
case(release-8, by-5)
det(release-8, the-6)
amod(release-8, excessive-7)
nmod:by(characterized-4, release-8)
case(ions-11, of-9)
compound(ions-11, calcium-10)
nmod:of(release-8, ions-11)
case(reticulum-15, from-12)
det(reticulum-15, the-13)
amod(reticulum-15, sarcoplasmic-14)
nmod:from(characterized-4, reticulum-15)
case(muscle_contraction-20, leading-17)
case(muscle_contraction-20, to-18)
amod(muscle_contraction-20, abnormal-19)
advcl(characterized-4, muscle_contraction-20)

The/DT association/NN between/IN omega-3_fatty_acids/JJ and/CC decreased/VBN Ryanodine/JJ levels/NNS suggest/VBP that/IN these/DT nutrients/NNS may/MD play/VB a/DT role/NN in/IN regulating/VBG calcium/NN signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN association))
      (PP (IN between)
        (NP
          (ADJP (JJ omega-3_fatty_acids)
            (CC and)
            (VBN decreased))
          (JJ Ryanodine) (NNS levels))))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS nutrients))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NN calcium))))))
              (S
                (VP (VBG signaling)
                  (NP (NNS pathways)))))))))
    (. .)))

det(association-2, The-1)
nsubj(suggest-9, association-2)
case(levels-8, between-3)
amod(levels-8, omega-3_fatty_acids-4)
cc(omega-3_fatty_acids-4, and-5)
conj:and(omega-3_fatty_acids-4, decreased-6)
amod(levels-8, decreased-6)
amod(levels-8, Ryanodine-7)
nmod:between(association-2, levels-8)
root(ROOT-0, suggest-9)
mark(play-14, that-10)
det(nutrients-12, these-11)
nsubj(play-14, nutrients-12)
aux(play-14, may-13)
ccomp(suggest-9, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
mark(regulating-18, in-17)
acl(role-16, regulating-18)
dobj(regulating-18, calcium-19)
xcomp(play-14, signaling-20)
dobj(signaling-20, pathways-21)

In/IN addition/NN ,/, the/DT protective/JJ effect/NN of/IN omega-3_fatty_acids/JJ against/IN CHD/NNP has_been/NN attributed/VBD to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC prevent/VB arrhythmias/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (JJ protective) (NN effect))
      (PP (IN of)
        (NP
          (ADJP (JJ omega-3_fatty_acids)
            (PP (IN against)
              (NP (NNP CHD))))
          (NN has_been))))
    (VP (VBD attributed)
      (PP (TO to)
        (NP (PRP$ their) (NN ability)
          (S
            (VP (TO to)
              (VP
                (VP (VB reduce)
                  (NP
                    (NP (NN inflammation))
                    (, ,)
                    (NP (JJR lower) (NN blood_pressure))
                    (, ,)))
                (CC and)
                (VP (VB prevent)
                  (NP (NNS arrhythmias)))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(attributed-12, addition-2)
det(effect-6, the-4)
amod(effect-6, protective-5)
nsubj(attributed-12, effect-6)
case(has_been-11, of-7)
amod(has_been-11, omega-3_fatty_acids-8)
case(CHD-10, against-9)
nmod:against(omega-3_fatty_acids-8, CHD-10)
nmod:of(effect-6, has_been-11)
root(ROOT-0, attributed-12)
case(ability-15, to-13)
nmod:poss(ability-15, their-14)
nmod:to(attributed-12, ability-15)
mark(reduce-17, to-16)
acl(ability-15, reduce-17)
dobj(reduce-17, inflammation-18)
amod(blood_pressure-21, lower-20)
appos(inflammation-18, blood_pressure-21)
cc(reduce-17, and-23)
acl(ability-15, prevent-24)
conj:and(reduce-17, prevent-24)
dobj(prevent-24, arrhythmias-25)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD have/VB important/JJ implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ important) (NNS implications))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-13, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(have-13, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(have-13, may-12)
ccomp(suggest-3, have-13)
amod(implications-15, important-14)
dobj(have-13, implications-15)
case(prevention-18, for-16)
det(prevention-18, the-17)
nmod:for(implications-15, prevention-18)
cc(prevention-18, and-19)
nmod:for(implications-15, treatment-20)
conj:and(prevention-18, treatment-20)
case(cardiovascular_disease-22, of-21)
nmod:of(prevention-18, cardiovascular_disease-22)

The/DT ABCB1a/JJ protein/NN ,/, also/RB known/VBN as/IN P-glycoprotein/NNP ,/, plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT efflux/NN of/IN xenobiotics/NNS and/CC drugs/NNS out/IN of/IN cells/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ ABCB1a) (NN protein))
      (, ,)
      (VP
        (ADVP (RB also))
        (VBN known)
        (PP (IN as)
          (NP (NNP P-glycoprotein))))
      (, ,))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN efflux))
            (PP (IN of)
              (NP (NNS xenobiotics)
                (CC and)
                (NNS drugs))))))
      (PP (IN out)
        (PP (IN of)
          (NP (NNS cells)))))
    (. .)))

det(protein-3, The-1)
amod(protein-3, ABCB1a-2)
nsubj(plays-10, protein-3)
advmod(known-6, also-5)
acl(protein-3, known-6)
case(P-glycoprotein-8, as-7)
nmod:as(known-6, P-glycoprotein-8)
root(ROOT-0, plays-10)
det(role-13, a-11)
amod(role-13, crucial-12)
dobj(plays-10, role-13)
case(efflux-16, in-14)
det(efflux-16, the-15)
nmod:in(role-13, efflux-16)
case(xenobiotics-18, of-17)
nmod:of(efflux-16, xenobiotics-18)
cc(xenobiotics-18, and-19)
nmod:of(efflux-16, drugs-20)
conj:and(xenobiotics-18, drugs-20)
case(cells-23, out-21)
mwe(out-21, of-22)
nmod:out_of(plays-10, cells-23)

Therefore/RB ,/, understanding/VBG the/DT regulation/NN of/IN ABCB1a/JJ expression/NN and/CC function/NN is/VBZ important/JJ for/IN drug/NN development/NN and/CC cancer/NN treatment/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG understanding)
        (NP
          (NP (DT the) (NN regulation))
          (PP (IN of)
            (NP (JJ ABCB1a) (NN expression)
              (CC and)
              (NN function))))))
    (VP (VBZ is)
      (ADJP (JJ important)
        (PP (IN for)
          (NP
            (NP (NN drug) (NN development))
            (CC and)
            (NP (NN cancer) (NN treatment))))))
    (. .)))

advmod(important-12, Therefore-1)
csubj(important-12, understanding-3)
det(regulation-5, the-4)
dobj(understanding-3, regulation-5)
case(expression-8, of-6)
amod(expression-8, ABCB1a-7)
nmod:of(regulation-5, expression-8)
cc(expression-8, and-9)
nmod:of(regulation-5, function-10)
conj:and(expression-8, function-10)
cop(important-12, is-11)
root(ROOT-0, important-12)
case(development-15, for-13)
compound(development-15, drug-14)
nmod:for(important-12, development-15)
cc(development-15, and-16)
compound(treatment-18, cancer-17)
nmod:for(important-12, treatment-18)
conj:and(development-15, treatment-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN tesetaxel/JJ on/IN ABCB1a/JJ protein/NN levels/NNS and/CC stability/NN in/IN C2C12/CD cells/NNS cultured/VBN under/IN differentiation-promoting/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (ADJP (JJ tesetaxel)
              (PP (IN on)
                (NP (JJ ABCB1a) (NN protein))))
            (NNS levels)
            (CC and)
            (NN stability))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (PP (IN under)
              (NP (JJ differentiation-promoting) (NNS conditions)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(levels-14, of-9)
amod(levels-14, tesetaxel-10)
case(protein-13, on-11)
amod(protein-13, ABCB1a-12)
nmod:on(tesetaxel-10, protein-13)
nmod:of(effect-8, levels-14)
cc(levels-14, and-15)
nmod:of(effect-8, stability-16)
conj:and(levels-14, stability-16)
case(cells-19, in-17)
nummod(cells-19, C2C12-18)
nmod:in(investigated-6, cells-19)
acl(cells-19, cultured-20)
case(conditions-23, under-21)
amod(conditions-23, differentiation-promoting-22)
nmod:under(cultured-20, conditions-23)

Our/PRP$ results/NNS showed/VBD that/IN tesetaxel/JJ up-regulated/JJ ABCB1a/JJ protein/NN levels/NNS in_a/VBD time-dependent/JJ manner/NN and/CC prolonged/VBN its/PRP$ half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ tesetaxel) (JJ up-regulated) (JJ ABCB1a) (NN protein) (NNS levels))
          (VP
            (VP (VBD in_a)
              (NP (JJ time-dependent) (NN manner)))
            (CC and)
            (VP (VBN prolonged)
              (NP (PRP$ its) (NN half-life))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(in_a-10, that-4)
amod(levels-9, tesetaxel-5)
amod(levels-9, up-regulated-6)
amod(levels-9, ABCB1a-7)
compound(levels-9, protein-8)
nsubj(in_a-10, levels-9)
nsubj(prolonged-14, levels-9)
ccomp(showed-3, in_a-10)
amod(manner-12, time-dependent-11)
dobj(in_a-10, manner-12)
cc(in_a-10, and-13)
ccomp(showed-3, prolonged-14)
conj:and(in_a-10, prolonged-14)
nmod:poss(half-life-16, its-15)
dobj(prolonged-14, half-life-16)
case(hours-21, from-17)
compound(18-20, 10-18)
dep(18-20, to-19)
nummod(hours-21, 18-20)
nmod:from(prolonged-14, hours-21)

These/DT findings/NNS suggest/VBP that/IN tesetaxel/NN may/MD have/VB potential/JJ as/IN a/DT modulator/NN of/IN ABCB1a/NNS expression/NN and/CC function/NN ,/, which/WDT could/MD be/VB useful/JJ for/IN enhancing/VBG the/DT efficacy/NN of/IN chemotherapy/JJ drugs/NNS that/WDT are/VBP substrates/NNS for/IN this/DT transporter/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN tesetaxel))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP
                  (ADJP (JJ potential)
                    (PP (IN as)
                      (NP
                        (NP (DT a) (NN modulator))
                        (PP (IN of)
                          (NP (NNS ABCB1a))))))
                  (NN expression))
                (CC and)
                (NP
                  (NP (NN function))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD could)
                        (VP (VB be)
                          (ADJP (JJ useful)
                            (PP (IN for)
                              (S
                                (VP (VBG enhancing)
                                  (NP
                                    (NP (DT the) (NN efficacy))
                                    (PP (IN of)
                                      (NP
                                        (NP (JJ chemotherapy) (NNS drugs))
                                        (SBAR
                                          (WHNP (WDT that))
                                          (S
                                            (VP (VBP are)
                                              (NP
                                                (NP (NNS substrates))
                                                (PP (IN for)
                                                  (NP (DT this) (NN transporter)))))))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, tesetaxel-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(expression-14, potential-8)
case(modulator-11, as-9)
det(modulator-11, a-10)
nmod:as(potential-8, modulator-11)
case(ABCB1a-13, of-12)
nmod:of(modulator-11, ABCB1a-13)
dobj(have-7, expression-14)
cc(expression-14, and-15)
dobj(have-7, function-16)
conj:and(expression-14, function-16)
nsubj(useful-21, function-16)
ref(function-16, which-18)
aux(useful-21, could-19)
cop(useful-21, be-20)
acl:relcl(function-16, useful-21)
mark(enhancing-23, for-22)
advcl(useful-21, enhancing-23)
det(efficacy-25, the-24)
dobj(enhancing-23, efficacy-25)
case(drugs-28, of-26)
amod(drugs-28, chemotherapy-27)
nmod:of(efficacy-25, drugs-28)
nsubj(substrates-31, drugs-28)
ref(drugs-28, that-29)
cop(substrates-31, are-30)
acl:relcl(drugs-28, substrates-31)
case(transporter-34, for-32)
det(transporter-34, this-33)
nmod:for(substrates-31, transporter-34)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO evaluate/VB their/PRP$ clinical/JJ relevance/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP (PRP$ their) (JJ clinical) (NN relevance))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-6, and-13)
mark(evaluate-15, to-14)
ccomp(needed-4, evaluate-15)
conj:and(elucidate-6, evaluate-15)
nmod:poss(relevance-18, their-16)
amod(relevance-18, clinical-17)
dobj(evaluate-15, relevance-18)

The/DT identification/NN of/IN biomarkers/NNS for/IN disease/NN diagnosis/NN and/CC prognosis/NN is/VBZ of/IN great/JJ significance/NN in/IN the/DT field/NN of/IN medicine/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN identification))
      (PP (IN of)
        (NP
          (NP (NNS biomarkers))
          (PP (IN for)
            (NP (NN disease) (NN diagnosis)
              (CC and)
              (NN prognosis))))))
    (VP (VBZ is)
      (PP (IN of)
        (NP
          (NP (JJ great) (NN significance))
          (PP (IN in)
            (NP
              (NP (DT the) (NN field))
              (PP (IN of)
                (NP (NN medicine))))))))
    (. .)))

det(identification-2, The-1)
nsubj(significance-13, identification-2)
case(biomarkers-4, of-3)
nmod:of(identification-2, biomarkers-4)
case(diagnosis-7, for-5)
compound(diagnosis-7, disease-6)
nmod:for(biomarkers-4, diagnosis-7)
cc(diagnosis-7, and-8)
nmod:for(biomarkers-4, prognosis-9)
conj:and(diagnosis-7, prognosis-9)
cop(significance-13, is-10)
case(significance-13, of-11)
amod(significance-13, great-12)
root(ROOT-0, significance-13)
case(field-16, in-14)
det(field-16, the-15)
nmod:in(significance-13, field-16)
case(medicine-18, of-17)
nmod:of(field-16, medicine-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN and/CC Azosemide/NNP with/IN serum/JJ Slc12a2/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NN alkaline_phosphatase))
                (CC and)
                (NP (NNP Azosemide)))))))
      (PP (IN with)
        (NP (JJ serum) (JJ Slc12a2) (NNS levels))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(correlation-8, the-7)
dobj(investigated-6, correlation-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(correlation-8, levels-11)
case(alkaline_phosphatase-13, of-12)
nmod:of(levels-11, alkaline_phosphatase-13)
cc(alkaline_phosphatase-13, and-14)
nmod:of(levels-11, Azosemide-15)
conj:and(alkaline_phosphatase-13, Azosemide-15)
case(levels-19, with-16)
amod(levels-19, serum-17)
amod(levels-19, Slc12a2-18)
nmod:with(investigated-6, levels-19)

Our/PRP$ results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC Azosemide/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- with/IN serum/NN Slc12a2/NNS levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NNP Azosemide))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-))))))))
      (PP (IN with)
        (NP (NN serum) (NNS Slc12a2) (NNS levels))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(alkaline_phosphatase-12, of-11)
nmod:of(levels-10, alkaline_phosphatase-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(alkaline_phosphatase-12, <-19)
dobj(<-19, 0.01-20)
cc(alkaline_phosphatase-12, and-22)
nmod:of(levels-10, Azosemide-23)
conj:and(alkaline_phosphatase-12, Azosemide-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(Azosemide-23, <-30)
dobj(<-30, 0.01-31)
case(levels-36, with-33)
compound(levels-36, serum-34)
compound(levels-36, Slc12a2-35)
nmod:with(showed-3, levels-36)

These/DT findings/NNS suggest/VBP that/IN these/DT biomarkers/NNS may/MD have/VB potential/JJ as/IN diagnostic/JJ or/CC prognostic/JJ indicators/NNS for/IN certain/JJ diseases/NNS associated/VBN with/IN altered/VBN Slc12a2/NNS expression/NN ,/, such/JJ as/IN renal_tubular_disorders/NN or/CC hypertension/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS biomarkers))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP
                  (ADJP (JJ potential)
                    (PP (IN as)
                      (NP
                        (NP (JJ diagnostic)
                          (CC or)
                          (JJ prognostic) (NNS indicators))
                        (PP (IN for)
                          (NP
                            (NP (JJ certain) (NNS diseases))
                            (VP (VBN associated)
                              (PP (IN with)
                                (NP (VBN altered) (NNS Slc12a2)))))))))
                  (NN expression))
                (, ,)
                (PP (JJ such) (IN as)
                  (NP (NN renal_tubular_disorders)
                    (CC or)
                    (NN hypertension)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-8, that-4)
det(biomarkers-6, these-5)
nsubj(have-8, biomarkers-6)
aux(have-8, may-7)
ccomp(suggest-3, have-8)
amod(expression-22, potential-9)
case(indicators-14, as-10)
amod(indicators-14, diagnostic-11)
cc(diagnostic-11, or-12)
conj:or(diagnostic-11, prognostic-13)
amod(indicators-14, prognostic-13)
nmod:as(potential-9, indicators-14)
case(diseases-17, for-15)
amod(diseases-17, certain-16)
nmod:for(indicators-14, diseases-17)
acl(diseases-17, associated-18)
case(Slc12a2-21, with-19)
amod(Slc12a2-21, altered-20)
nmod:with(associated-18, Slc12a2-21)
dobj(have-8, expression-22)
case(renal_tubular_disorders-26, such-24)
mwe(such-24, as-25)
nmod:such_as(expression-22, renal_tubular_disorders-26)
cc(renal_tubular_disorders-26, or-27)
nmod:such_as(expression-22, hypertension-28)
conj:or(renal_tubular_disorders-26, hypertension-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO validate/VB these/DT findings/NNS and/CC to/TO explore/VB the/DT underlying/VBG mechanisms/NNS linking/VBG these/DT biomarkers/NNS to/TO Slc12a2/JJ expression/NN in/IN disease/NN states/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB validate)
                (NP (DT these) (NNS findings))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBG linking)
                    (NP (DT these) (NNS biomarkers))
                    (PP (TO to)
                      (NP
                        (NP (JJ Slc12a2) (NN expression))
                        (PP (IN in)
                          (NP (NN disease) (NNS states)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(validate-6, to-5)
ccomp(needed-4, validate-6)
det(findings-8, these-7)
dobj(validate-6, findings-8)
cc(validate-6, and-9)
mark(explore-11, to-10)
ccomp(needed-4, explore-11)
conj:and(validate-6, explore-11)
det(mechanisms-14, the-12)
amod(mechanisms-14, underlying-13)
dobj(explore-11, mechanisms-14)
acl(mechanisms-14, linking-15)
det(biomarkers-17, these-16)
dobj(linking-15, biomarkers-17)
case(expression-20, to-18)
amod(expression-20, Slc12a2-19)
nmod:to(linking-15, expression-20)
case(states-23, in-21)
compound(states-23, disease-22)
nmod:in(expression-20, states-23)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN linked/VBN to/TO several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP (JJ several) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(linked-20, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(linked-20, have-18)
auxpass(linked-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, linked-20)
case(benefits-24, to-21)
amod(benefits-24, several-22)
compound(benefits-24, health-23)
nmod:to(linked-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD decrease/VB N-tritylmorpholine/JJ levels/NNS in/IN hyperN-tritylmorpholinemic/JJ patients/NNS ,/, which/WDT could/MD potentially/RB reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB decrease)
                (NP
                  (NP (JJ N-tritylmorpholine) (NNS levels))
                  (PP (IN in)
                    (NP
                      (NP (JJ hyperN-tritylmorpholinemic) (NNS patients))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD could) (RB potentially)
                            (VP (VB reduce)
                              (NP
                                (NP
                                  (NP (DT the) (NN risk))
                                  (PP (IN of)
                                    (S
                                      (VP (VBG developing)
                                        (NP (NN coronary_heart_disease))))))
                                (PRN (-LRB- -LRB-)
                                  (NP (NNP CHD))
                                  (-RRB- -RRB-))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(decrease-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubj(decrease-10, omega-3_fatty_acids-8)
aux(decrease-10, may-9)
ccomp(shown-4, decrease-10)
amod(levels-12, N-tritylmorpholine-11)
dobj(decrease-10, levels-12)
case(patients-15, in-13)
amod(patients-15, hyperN-tritylmorpholinemic-14)
nmod:in(levels-12, patients-15)
nsubj(reduce-20, patients-15)
ref(patients-15, which-17)
aux(reduce-20, could-18)
advmod(reduce-20, potentially-19)
acl:relcl(patients-15, reduce-20)
det(risk-22, the-21)
dobj(reduce-20, risk-22)
mark(developing-24, of-23)
acl(risk-22, developing-24)
dobj(developing-24, coronary_heart_disease-25)
appos(risk-22, CHD-27)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ properties/NNS ,/, which/WDT could/MD explain/VB their/PRP$ role/NN in/IN reducing/VBG N-tritylmorpholine/JJ levels/NNS and/CC protecting/VBG against/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ anti-inflammatory) (NNS properties))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD could)
                      (VP (VB explain)
                        (NP
                          (NP (PRP$ their) (NN role))
                          (PP (IN in)
                            (S
                              (VP
                                (VP (VBG reducing)
                                  (NP (JJ N-tritylmorpholine) (NNS levels)))
                                (CC and)
                                (VP (VBG protecting)
                                  (PP (IN against)
                                    (NP (NNP CHD))))))))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(have-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(have-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(have-7, to-6)
xcomp(known-5, have-7)
amod(properties-9, anti-inflammatory-8)
dobj(have-7, properties-9)
nsubj(explain-13, properties-9)
ref(properties-9, which-11)
aux(explain-13, could-12)
acl:relcl(properties-9, explain-13)
nmod:poss(role-15, their-14)
dobj(explain-13, role-15)
mark(reducing-17, in-16)
acl(role-15, reducing-17)
amod(levels-19, N-tritylmorpholine-18)
dobj(reducing-17, levels-19)
cc(reducing-17, and-20)
acl(role-15, protecting-21)
conj:and(reducing-17, protecting-21)
case(CHD-23, against-22)
nmod:against(protecting-21, CHD-23)

Furthermore/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS ,/, reduce/VB blood_pressure/NN ,/, and/CC prevent/VB arrhythmias/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP (NN blood_pressure)))
                (, ,)
                (CC and)
                (VP (VB prevent)
                  (NP (NNS arrhythmias)))))))))
    (. .)))

advmod(shown-7, Furthermore-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(improve-9, fatty_acids-4)
nsubj:xsubj(reduce-13, fatty_acids-4)
nsubj:xsubj(prevent-17, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
xcomp(shown-7, reduce-13)
conj:and(improve-9, reduce-13)
dobj(reduce-13, blood_pressure-14)
cc(improve-9, and-16)
xcomp(shown-7, prevent-17)
conj:and(improve-9, prevent-17)
dobj(prevent-17, arrhythmias-18)

Overall/RB ,/, increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ approach/NN for/IN preventing/VBG CHD/NNP and/CC improving/VBG cardiovascular_health/NN in/IN high-risk/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
    (VP (MD may)
      (VP (VB be)
        (NP (DT a) (JJ promising) (NN approach))
        (PP (IN for)
          (S
            (VP
              (VP (VBG preventing)
                (NP (NNP CHD)))
              (CC and)
              (VP (VBG improving)
                (NP
                  (NP (NN cardiovascular_health))
                  (PP (IN in)
                    (NP (JJ high-risk) (NNS patients))))))))))
    (. .)))

advmod(approach-13, Overall-1)
csubj(approach-13, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(omega-3_fatty_acids-8, of-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nmod:of(intake-5, omega-3_fatty_acids-8)
aux(approach-13, may-9)
cop(approach-13, be-10)
det(approach-13, a-11)
amod(approach-13, promising-12)
root(ROOT-0, approach-13)
mark(preventing-15, for-14)
advcl(approach-13, preventing-15)
dobj(preventing-15, CHD-16)
cc(preventing-15, and-17)
advcl(approach-13, improving-18)
conj:and(preventing-15, improving-18)
dobj(improving-18, cardiovascular_health-19)
case(patients-22, in-20)
amod(patients-22, high-risk-21)
nmod:in(cardiovascular_health-19, patients-22)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO investigate/VB the/DT potential/JJ involvement/NN of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/JJ '/: ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN SC-56631/NN ,/, on/IN the/DT early/JJ effect/NN of/IN S_protein/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- in/IN regulating/VBG lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (JJ potential) (NN involvement))
              (PP (IN of)
                (NP
                  (NP (NNS adenosine_3) (POS '))
                  (CD ,5))))
            ('' ') (: -)
            (NP
              (NP
                (NP
                  (NP (NN cyclic_monophosphate))
                  (PRN (-LRB- -LRB-)
                    (NP (NN cAMP))
                    (-RRB- -RRB-)))
                (CC and)
                (NP (JJ guanosine_3)
                  (PRN (: ')
                    (NP (CD ,5))
                    ('' ') (: -))
                  (NN cyclic_monophosphate)))
              (PRN (-LRB- -LRB-)
                (NP (NN cGMP))
                (-RRB- -RRB-))
              (, ,)
              (ADVP (RB as) (RB well)
                (PP (IN as)
                  (NP (NN SC-56631))))
              (, ,)
              (PP (IN on)
                (NP
                  (NP
                    (NP (DT the) (JJ early) (NN effect))
                    (PP (IN of)
                      (NP (NNP S_protein))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP PRL))
                    (-RRB- -RRB-))))))))
      (PP (IN in)
        (S
          (VP (VBG regulating)
            (NP (JJ lactose) (NNS biosynthesis))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(involvement-11, the-9)
amod(involvement-11, potential-10)
dobj(investigate-8, involvement-11)
case(adenosine_3-13, of-12)
nmod:'(involvement-11, adenosine_3-13)
case(adenosine_3-13, '-14)
nummod(adenosine_3-13, ,5-15)
parataxis(investigate-8, cyclic_monophosphate-18)
appos(cyclic_monophosphate-18, cAMP-20)
cc(cyclic_monophosphate-18, and-22)
amod(cyclic_monophosphate-28, guanosine_3-23)
dep(cyclic_monophosphate-28, ,5-25)
parataxis(investigate-8, cyclic_monophosphate-28)
conj:and(cyclic_monophosphate-18, cyclic_monophosphate-28)
appos(cyclic_monophosphate-18, cGMP-30)
advmod(well-34, as-33)
advmod(cyclic_monophosphate-18, well-34)
case(SC-56631-36, as-35)
nmod:as(well-34, SC-56631-36)
case(effect-41, on-38)
det(effect-41, the-39)
amod(effect-41, early-40)
nmod:on(cyclic_monophosphate-18, effect-41)
case(S_protein-43, of-42)
nmod:of(effect-41, S_protein-43)
appos(effect-41, PRL-45)
mark(regulating-48, in-47)
advcl(aimed-6, regulating-48)
amod(biosynthesis-50, lactose-49)
dobj(regulating-48, biosynthesis-50)

To/TO achieve/VB this/DT ,/, we/PRP utilized/VBD cultured/VBN mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD utilized)
      (VP (VBN cultured)
        (S
          (NP
            (NP (JJ mammary_gland) (NNS explants))
            (VP (VBN derived)
              (PP (IN from)
                (NP (NNS mice)))
              (NP-TMP (CD 12-14) (NNS days))))
          (ADJP (JJ pregnant)))))
    (. .)))

mark(achieve-2, To-1)
advcl(utilized-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(utilized-6, we-5)
root(ROOT-0, utilized-6)
dep(utilized-6, cultured-7)
amod(explants-9, mammary_gland-8)
nsubj(pregnant-15, explants-9)
acl(explants-9, derived-10)
case(mice-12, from-11)
nmod:from(derived-10, mice-12)
nummod(days-14, 12-14-13)
nmod:tmod(derived-10, days-14)
xcomp(cultured-7, pregnant-15)

Our/PRP$ results/NNS demonstrate/VBP that/IN cAMP/NN and/CC cGMP/NN may/MD play/VB significant/JJ roles/NNS in/IN the/DT early/JJ effects/NNS of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS in/IN mammary_glands/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (MD may)
            (VP (VB play)
              (NP (JJ significant) (NNS roles))
              (PP (IN in)
                (NP
                  (NP (DT the) (JJ early) (NNS effects))
                  (PP (IN of)
                    (NP (NNP PRL)))))
              (PP (IN on)
                (NP
                  (NP (JJ lactose) (NNS biosynthesis))
                  (PP (IN in)
                    (NP (NNS mammary_glands))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(play-9, that-4)
nsubj(play-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubj(play-9, cGMP-7)
aux(play-9, may-8)
ccomp(demonstrate-3, play-9)
amod(roles-11, significant-10)
dobj(play-9, roles-11)
case(effects-15, in-12)
det(effects-15, the-13)
amod(effects-15, early-14)
nmod:in(play-9, effects-15)
case(PRL-17, of-16)
nmod:of(effects-15, PRL-17)
case(biosynthesis-20, on-18)
amod(biosynthesis-20, lactose-19)
nmod:on(play-9, biosynthesis-20)
case(mammary_glands-22, in-21)
nmod:in(biosynthesis-20, mammary_glands-22)

Furthermore/RB ,/, our/PRP$ findings/NNS suggest/VBP that/IN SC-56631/NNP ,/, a/DT selective/JJ PRL_receptor/NNP antagonist/NN ,/, may/MD inhibit/VB the/DT effects/NNS of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS through/IN modulation/NN of/IN cAMP/NN and/CC cGMP/NN signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP$ our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP SC-56631))
            (, ,)
            (NP (DT a) (JJ selective) (NNP PRL_receptor) (NN antagonist))
            (, ,))
          (VP (MD may)
            (VP (VB inhibit)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (NNP PRL))))
              (PP (IN on)
                (NP (JJ lactose) (NNS biosynthesis)))
              (PP (IN through)
                (NP
                  (NP (NN modulation))
                  (PP (IN of)
                    (NP (NN cAMP)
                      (CC and)
                      (NN cGMP)))))
              (S
                (VP (VBG signaling)
                  (NP (NNS pathways)))))))))
    (. .)))

advmod(suggest-5, Furthermore-1)
nmod:poss(findings-4, our-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(inhibit-15, that-6)
nsubj(inhibit-15, SC-56631-7)
det(antagonist-12, a-9)
amod(antagonist-12, selective-10)
compound(antagonist-12, PRL_receptor-11)
appos(SC-56631-7, antagonist-12)
aux(inhibit-15, may-14)
ccomp(suggest-5, inhibit-15)
det(effects-17, the-16)
dobj(inhibit-15, effects-17)
case(PRL-19, of-18)
nmod:of(effects-17, PRL-19)
case(biosynthesis-22, on-20)
amod(biosynthesis-22, lactose-21)
nmod:on(inhibit-15, biosynthesis-22)
case(modulation-24, through-23)
nmod:through(inhibit-15, modulation-24)
case(cAMP-26, of-25)
nmod:of(modulation-24, cAMP-26)
cc(cAMP-26, and-27)
nmod:of(modulation-24, cGMP-28)
conj:and(cAMP-26, cGMP-28)
xcomp(inhibit-15, signaling-29)
dobj(signaling-29, pathways-30)

These/DT results/NNS provide/VBP insight/NN into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG lactation/JJ regulation/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/NN therapies/NNS for/IN lactation/NN disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP
      (VP (VBP provide)
        (NP (NN insight))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP (JJ lactation) (NN regulation))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (NN novel) (NNS therapies))
                    (PP (IN for)
                      (NP (NN lactation) (NNS disorders)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(provide-3, results-2)
nsubj(have-14, results-2)
root(ROOT-0, provide-3)
dobj(provide-3, insight-4)
case(mechanisms-8, into-5)
det(mechanisms-8, the-6)
amod(mechanisms-8, molecular-7)
nmod:into(provide-3, mechanisms-8)
acl(mechanisms-8, underlying-9)
amod(regulation-11, lactation-10)
dobj(underlying-9, regulation-11)
cc(provide-3, and-12)
aux(have-14, may-13)
conj:and(provide-3, have-14)
dobj(have-14, implications-15)
case(development-18, for-16)
det(development-18, the-17)
nmod:for(implications-15, development-18)
case(therapies-21, of-19)
compound(therapies-21, novel-20)
nmod:of(development-18, therapies-21)
case(disorders-24, for-22)
compound(disorders-24, lactation-23)
nmod:for(therapies-21, disorders-24)

Gnetin/NNP C/NNP is_a/NNP flavonoid/VBD that/IN has_been/VBP shown/VBN to/TO exhibit/VB potent/JJ anti-tumor/JJ activities/NNS ./.

(ROOT
  (S
    (NP (NNP Gnetin) (NNP C) (NNP is_a))
    (VP (VBD flavonoid)
      (SBAR (IN that)
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB exhibit)
                    (NP (JJ potent) (JJ anti-tumor) (NNS activities))))))))))
    (. .)))

compound(is_a-3, Gnetin-1)
compound(is_a-3, C-2)
nsubj(flavonoid-4, is_a-3)
root(ROOT-0, flavonoid-4)
mark(has_been-6, that-5)
ccomp(flavonoid-4, has_been-6)
dep(has_been-6, shown-7)
mark(exhibit-9, to-8)
xcomp(shown-7, exhibit-9)
amod(activities-12, potent-10)
amod(activities-12, anti-tumor-11)
dobj(exhibit-9, activities-12)

Previous/JJ studies/NNS have/VBP suggested/VBN that/IN gnetin_C/NN induces/VBZ apoptosis/NNS in/IN melanoma/NN cells/NNS by/IN activating/VBG the/DT VIP/NNP signaling/VBG pathway/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NN gnetin_C))
            (VP (VBZ induces)
              (NP
                (NP (NNS apoptosis))
                (PP (IN in)
                  (NP (NN melanoma) (NNS cells))))
              (PP (IN by)
                (S
                  (VP (VBG activating)
                    (NP (DT the) (NNP VIP) (VBG signaling) (NN pathway))))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(induces-7, that-5)
nsubj(induces-7, gnetin_C-6)
ccomp(suggested-4, induces-7)
dobj(induces-7, apoptosis-8)
case(cells-11, in-9)
compound(cells-11, melanoma-10)
nmod:in(apoptosis-8, cells-11)
mark(activating-13, by-12)
advcl(induces-7, activating-13)
det(pathway-17, the-14)
compound(pathway-17, VIP-15)
amod(pathway-17, signaling-16)
dobj(activating-13, pathway-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN VIP/NNP antagonist/NN -LSB-/NNS 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP and/CC peptide/JJ Tyrosinase/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ Tyrosinase/NNP antagonist/NN ,/, on/IN the/DT gnetin_C/JJ response/NN to/TO either/DT Tyrosinase/NNP or/CC VIP/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP
              (NP (NNP VIP)
                (NX
                  (NX
                    (NX (NN antagonist) (NNS -LSB-))
                    (ADJP (JJ 4Cl-D-Phe6)))
                  (, ,)
                  (NX (NNP Leu17) (NNP -RSB-) (NNP VIP))
                  (CC and)
                  (NX (JJ peptide) (NNP Tyrosinase))))
              (PRN (-LRB- -LRB-)
                (NP (CD 6-38))
                (-RRB- -RRB-)))
            (, ,)
            (NP (DT a) (JJ putative) (NNP Tyrosinase) (NN antagonist))
            (, ,))))
      (PP (IN on)
        (NP (DT the) (JJ gnetin_C) (NN response)))
      (PP (TO to)
        (NP (DT either) (NNP Tyrosinase)
          (CC or)
          (NNP VIP))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(-LSB--12, of-9)
dep(-LSB--12, VIP-10)
compound(-LSB--12, antagonist-11)
nmod:of(effects-8, -LSB--12)
amod(-LSB--12, 4Cl-D-Phe6-13)
compound(VIP-17, Leu17-15)
compound(VIP-17, -RSB--16)
nmod:of(effects-8, VIP-17)
conj:and(-LSB--12, VIP-17)
cc(-LSB--12, and-18)
amod(Tyrosinase-20, peptide-19)
nmod:of(effects-8, Tyrosinase-20)
conj:and(-LSB--12, Tyrosinase-20)
appos(-LSB--12, 6-38-22)
det(antagonist-28, a-25)
amod(antagonist-28, putative-26)
compound(antagonist-28, Tyrosinase-27)
appos(-LSB--12, antagonist-28)
case(response-33, on-30)
det(response-33, the-31)
amod(response-33, gnetin_C-32)
nmod:on(investigated-6, response-33)
case(Tyrosinase-36, to-34)
cc:preconj(Tyrosinase-36, either-35)
nmod:to(investigated-6, Tyrosinase-36)
cc(Tyrosinase-36, or-37)
nmod:to(investigated-6, VIP-38)
conj:or(Tyrosinase-36, VIP-38)

Our/PRP$ results/NNS showed/VBD that/IN the/DT VIP/NNP antagonist/NN had/VBD no/DT effect/NN on/IN the/DT gnetin_C/JJ response/NN to/TO either/DT Tyrosinase/NNP or/CC VIP/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT the) (NNP VIP) (NN antagonist))
          (VP (VBD had)
            (NP
              (NP (DT no) (NN effect))
              (PP (IN on)
                (NP
                  (NP (DT the) (JJ gnetin_C) (NN response))
                  (PP (TO to)
                    (NP (DT either) (NNP Tyrosinase)
                      (CC or)
                      (NNP VIP))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-8, that-4)
det(antagonist-7, the-5)
compound(antagonist-7, VIP-6)
nsubj(had-8, antagonist-7)
ccomp(showed-3, had-8)
neg(effect-10, no-9)
dobj(had-8, effect-10)
case(response-14, on-11)
det(response-14, the-12)
amod(response-14, gnetin_C-13)
nmod:on(effect-10, response-14)
case(Tyrosinase-17, to-15)
cc:preconj(Tyrosinase-17, either-16)
nmod:to(response-14, Tyrosinase-17)
cc(Tyrosinase-17, or-18)
nmod:to(response-14, VIP-19)
conj:or(Tyrosinase-17, VIP-19)

However/RB ,/, the/DT peptide/JJ Tyrosinase/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- blocked/VBD the/DT gnetin_C/JJ response/NN to/TO Tyrosinase/NNP ,/, suggesting/VBG that/IN Tyrosinase/NNP may/MD play/VB a/DT role/NN in/IN gnetin_C-induced/JJ apoptosis/NNS in/IN melanoma/NN cells/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (JJ peptide) (NN Tyrosinase))
      (PRN (-LRB- -LRB-)
        (NP (CD 6-38))
        (-RRB- -RRB-)))
    (VP (VBD blocked)
      (NP
        (NP (DT the) (JJ gnetin_C) (NN response))
        (PP (TO to)
          (NP (NNP Tyrosinase))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (NNP Tyrosinase))
              (VP (MD may)
                (VP (VB play)
                  (NP
                    (NP (DT a) (NN role))
                    (PP (IN in)
                      (NP (JJ gnetin_C-induced) (NNS apoptosis))))
                  (PP (IN in)
                    (NP (NN melanoma) (NNS cells))))))))))
    (. .)))

advmod(blocked-9, However-1)
det(Tyrosinase-5, the-3)
amod(Tyrosinase-5, peptide-4)
nsubj(blocked-9, Tyrosinase-5)
appos(Tyrosinase-5, 6-38-7)
root(ROOT-0, blocked-9)
det(response-12, the-10)
amod(response-12, gnetin_C-11)
dobj(blocked-9, response-12)
case(Tyrosinase-14, to-13)
nmod:to(response-12, Tyrosinase-14)
advcl(blocked-9, suggesting-16)
mark(play-20, that-17)
nsubj(play-20, Tyrosinase-18)
aux(play-20, may-19)
ccomp(suggesting-16, play-20)
det(role-22, a-21)
dobj(play-20, role-22)
case(apoptosis-25, in-23)
amod(apoptosis-25, gnetin_C-induced-24)
nmod:in(role-22, apoptosis-25)
case(cells-28, in-26)
compound(cells-28, melanoma-27)
nmod:in(play-20, cells-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT interaction/NN and/CC its/PRP$ potential/JJ therapeutic/JJ implications/NNS for/IN melanoma/JJ treatment/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ molecular) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT this) (NN interaction))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS implications))
                      (PP (IN for)
                        (NP (JJ melanoma) (NN treatment))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
case(interaction-12, underlying-10)
det(interaction-12, this-11)
nmod:underlying(mechanisms-9, interaction-12)
cc(interaction-12, and-13)
nmod:poss(implications-17, its-14)
amod(implications-17, potential-15)
amod(implications-17, therapeutic-16)
nmod:underlying(mechanisms-9, implications-17)
conj:and(interaction-12, implications-17)
case(treatment-20, for-18)
amod(treatment-20, melanoma-19)
nmod:for(implications-17, treatment-20)

This/DT study/NN aimed/VBD to/TO investigate/VB the/DT effects/NNS of/IN ammonium_hydroxide/NN on/IN the/DT incidence/NN of/IN adverse_reactions/NNS ,/, including/VBG bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NN ammonium_hydroxide)))
              (PP (IN on)
                (NP
                  (NP (DT the) (NN incidence))
                  (PP (IN of)
                    (NP
                      (NP (NNS adverse_reactions))
                      (, ,)
                      (VP (VBG including)
                        (NP
                          (NP (NNS bronchospasms))
                          (, ,)
                          (NP (NN photophobia))
                          (, ,)
                          (CC and)
                          (NP (NN phonophobia)))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effects-7, the-6)
dobj(investigate-5, effects-7)
case(ammonium_hydroxide-9, of-8)
nmod:of(effects-7, ammonium_hydroxide-9)
case(incidence-12, on-10)
det(incidence-12, the-11)
nmod:on(effects-7, incidence-12)
case(adverse_reactions-14, of-13)
nmod:of(incidence-12, adverse_reactions-14)
acl(adverse_reactions-14, including-16)
dobj(including-16, bronchospasms-17)
dobj(including-16, photophobia-19)
conj:and(bronchospasms-17, photophobia-19)
cc(bronchospasms-17, and-21)
dobj(including-16, phonophobia-22)
conj:and(bronchospasms-17, phonophobia-22)

A/DT total/NN of/IN 200/CD participants/NNS were/VBD enrolled/VBN in/IN the/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (NN total))
      (PP (IN of)
        (NP (CD 200) (NNS participants))))
    (VP (VBD were)
      (VP (VBN enrolled)
        (PP (IN in)
          (NP (DT the)
            (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
            (NN trial)))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
case(participants-5, of-3)
nummod(participants-5, 200-4)
nmod:of(total-2, participants-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(trial-15, in-8)
det(trial-15, the-9)
amod(placebo-controlled-14, randomized-10)
amod(placebo-controlled-14, double-blind-12)
amod(trial-15, placebo-controlled-14)
nmod:in(enrolled-7, trial-15)

The/DT results/NNS showed/VBD that/WDT at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, ammonium_hydroxide/VBP significantly/RB reduced/VBN the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (WDT that)
          (NX
            (NX
              (NX
                (NP (IN at) (CD 2) (NNS hours))
                (SBAR (IN after)
                  (S
                    (S
                      (VP (VBG dosing)))
                    (, ,)
                    (VP (VBP ammonium_hydroxide)
                      (ADVP (RB significantly))
                      (VP (VBN reduced)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNS bronchospasms))))
                        (PP (IN by)
                          (NP (CD 14) (NN %))))))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))
                (-RRB- -RRB-)))
            (, ,)
            (NX
              (NX
                (NX (NN photophobia))
                (PP (IN by)
                  (NP (CD 17) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 12-22) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NX
              (NX (NN phonophobia))
              (PP (IN by)
                (NP (CD 14) (NN %))))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 95) (NN %))
            (PP (NNP CI)
              (NP (CD 17-20) (NN %))))
          (, ,)
          (NP (NNP P)
            (QP (CD <) (CD 0.0001)))
          (-RRB- -RRB-))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
dep(hours-7, that-4)
amod(hours-7, at-5)
nummod(hours-7, 2-6)
dobj(showed-3, hours-7)
mark(ammonium_hydroxide-11, after-8)
dep(ammonium_hydroxide-11, dosing-9)
dep(hours-7, ammonium_hydroxide-11)
advmod(ammonium_hydroxide-11, significantly-12)
dep(ammonium_hydroxide-11, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(bronchospasms-17, of-16)
nmod:of(risk-15, bronchospasms-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
nsubj(CI-24, %-23)
dep(hours-7, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
dobj(showed-3, photophobia-33)
conj:and(hours-7, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
nsubj(CI-40, %-39)
dep(photophobia-33, CI-40)
nummod(%-42, 12-22-41)
dobj(CI-40, %-42)
nsubj(<-45, P-44)
dep(CI-40, <-45)
dobj(<-45, 0.0001-46)
cc(hours-7, and-49)
dobj(showed-3, phonophobia-50)
conj:and(hours-7, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(hours-7, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN ammonium_hydroxide/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ option/NN for/IN reducing/VBG the/DT incidence/NN of/IN adverse_reactions/NNS associated/VBN with/IN certain/JJ medical/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN ammonium_hydroxide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN incidence))
                        (PP (IN of)
                          (NP
                            (NP (NNS adverse_reactions))
                            (VP (VBN associated)
                              (PP (IN with)
                                (NP (JJ certain) (JJ medical) (NNS conditions))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, ammonium_hydroxide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(incidence-15, the-14)
dobj(reducing-13, incidence-15)
case(adverse_reactions-17, of-16)
nmod:of(incidence-15, adverse_reactions-17)
acl(adverse_reactions-17, associated-18)
case(conditions-22, with-19)
amod(conditions-22, certain-20)
amod(conditions-22, medical-21)
nmod:with(associated-18, conditions-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(elucidate-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, elucidate-10)
conj:and(confirm-6, elucidate-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(elucidate-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, such/PDT as/RB eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/JJ -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/JJ -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (ADJP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (NP (PDT such)
      (NP
        (NP (RB as) (JJ eicosapentaenoic_acid))
        (-LRB- -LRB-)
        (NP (NNP EPA))
        (-RRB- -RRB-) (-LRB- -LRB-)
        (ADJP (CD 20:5) (JJ n-3))
        (-RRB- -RRB-))
      (CC and)
      (NP
        (NP (JJ docosahexaenoic_acid))
        (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-) (-LRB- -LRB-)
        (ADJP (CD 22:6) (JJ n-3))
        (-RRB- -RRB-))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
dep(shown-26, omega-3_fatty_acids-2)
dep(eicosapentaenoic_acid-6, such-4)
advmod(eicosapentaenoic_acid-6, as-5)
nsubjpass(shown-26, eicosapentaenoic_acid-6)
nsubj:xsubj(have-28, eicosapentaenoic_acid-6)
dep(eicosapentaenoic_acid-6, EPA-8)
compound(n-3-12, 20:5-11)
amod(eicosapentaenoic_acid-6, n-3-12)
cc(eicosapentaenoic_acid-6, and-14)
conj:and(eicosapentaenoic_acid-6, docosahexaenoic_acid-15)
nsubjpass(shown-26, docosahexaenoic_acid-15)
nsubj:xsubj(have-28, docosahexaenoic_acid-15)
dep(docosahexaenoic_acid-15, DHA-17)
compound(n-3-21, 22:6-20)
amod(docosahexaenoic_acid-15, n-3-21)
aux(shown-26, have-24)
auxpass(shown-26, been-25)
root(ROOT-0, shown-26)
mark(have-28, to-27)
xcomp(shown-26, have-28)
amod(benefits-31, numerous-29)
compound(benefits-31, health-30)
dobj(have-28, benefits-31)

One/CD of/IN these/DT benefits/NNS is/VBZ their/PRP$ association/NN with/IN decreased/VBN Chloral/JJ levels/NNS in/IN hyperChloralmic/JJ patients/NNS ,/, which/WDT has_been/NN demonstrated/VBD in/IN several/JJ studies/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP (DT these) (NNS benefits))))
    (VP (VBZ is)
      (NP
        (NP (PRP$ their) (NN association))
        (PP (IN with)
          (NP
            (NP (VBN decreased) (JJ Chloral) (NNS levels))
            (PP (IN in)
              (NP
                (NP (JJ hyperChloralmic) (NNS patients))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NN has_been))
                    (VP (VBD demonstrated)
                      (PP (IN in)
                        (NP (JJ several) (NNS studies))))))))))))
    (. .)))

nsubj(association-7, One-1)
case(benefits-4, of-2)
det(benefits-4, these-3)
nmod:of(One-1, benefits-4)
cop(association-7, is-5)
nmod:poss(association-7, their-6)
root(ROOT-0, association-7)
case(levels-11, with-8)
amod(levels-11, decreased-9)
amod(levels-11, Chloral-10)
nmod:with(association-7, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperChloralmic-13)
nmod:in(levels-11, patients-14)
dobj(demonstrated-18, patients-14)
ref(patients-14, which-16)
nsubj(demonstrated-18, has_been-17)
acl:relcl(patients-14, demonstrated-18)
case(studies-21, in-19)
amod(studies-21, several-20)
nmod:in(demonstrated-18, studies-21)

In/IN addition/NN ,/, these/DT fatty_acids/NNS have/VBP also/RB been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, one/CD of/IN the/DT leading/VBG causes/NNS of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (VP (VB coronary_heart_disease)
                      (NP
                        (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                        (, ,)
                        (NP
                          (NP (CD one))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (VBG leading) (NNS causes))
                              (PP (IN of)
                                (NP (NN death)))))))
                      (ADVP (RB worldwide)))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(linked-9, addition-2)
det(fatty_acids-5, these-4)
nsubjpass(linked-9, fatty_acids-5)
aux(linked-9, have-6)
advmod(linked-9, also-7)
auxpass(linked-9, been-8)
root(ROOT-0, linked-9)
case(risk-13, to-10)
det(risk-13, a-11)
amod(risk-13, decreased-12)
nmod:to(linked-9, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
xcomp(developing-15, coronary_heart_disease-16)
dobj(coronary_heart_disease-16, CHD-18)
appos(CHD-18, one-21)
case(causes-25, of-22)
det(causes-25, the-23)
amod(causes-25, leading-24)
nmod:of(one-21, causes-25)
case(death-27, of-26)
nmod:of(causes-25, death-27)
advmod(coronary_heart_disease-16, worldwide-28)

The/DT mechanisms/NNS behind/IN these/DT effects/NNS are/VBP still/RB being/VBG investigated/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD help/VB to/TO reduce/VB inflammation/NN and/CC improve/VB lipid/NN metabolism/NN ,/, among/IN other/JJ potential/JJ mechanisms/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (PP (IN behind)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB still)
        (VP (VBG being)
          (VP (VBN investigated)))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP (VB help)
                  (S
                    (VP (TO to)
                      (VP
                        (VP (VB reduce)
                          (NP (NN inflammation)))
                        (CC and)
                        (VP (VB improve)
                          (NP
                            (NP (NN lipid) (NN metabolism))
                            (, ,)
                            (PP (IN among)
                              (NP (JJ other) (JJ potential) (NNS mechanisms)))))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(investigated-9, mechanisms-2)
case(effects-5, behind-3)
det(effects-5, these-4)
nmod:behind(mechanisms-2, effects-5)
aux(investigated-9, are-6)
advmod(investigated-9, still-7)
auxpass(investigated-9, being-8)
root(ROOT-0, investigated-9)
cc(investigated-9, but-11)
nsubjpass(believed-14, it-12)
auxpass(believed-14, is-13)
conj:but(investigated-9, believed-14)
mark(help-20, that-15)
nsubj(help-20, EPA-16)
nsubj:xsubj(reduce-22, EPA-16)
nsubj:xsubj(improve-25, EPA-16)
cc(EPA-16, and-17)
conj:and(EPA-16, DHA-18)
nsubj(help-20, DHA-18)
nsubj:xsubj(reduce-22, DHA-18)
aux(help-20, may-19)
ccomp(believed-14, help-20)
mark(reduce-22, to-21)
xcomp(help-20, reduce-22)
dobj(reduce-22, inflammation-23)
cc(reduce-22, and-24)
xcomp(help-20, improve-25)
conj:and(reduce-22, improve-25)
compound(metabolism-27, lipid-26)
dobj(improve-25, metabolism-27)
case(mechanisms-32, among-29)
amod(mechanisms-32, other-30)
amod(mechanisms-32, potential-31)
nmod:among(metabolism-27, mechanisms-32)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT simple/JJ and/CC effective/JJ way/NN to/TO improve/VB cardiovascular_health/NN and/CC reduce/VB the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a)
                (ADJP (JJ simple)
                  (CC and)
                  (JJ effective))
                (NN way)
                (S
                  (VP (TO to)
                    (VP
                      (VP (VB improve)
                        (NP (NN cardiovascular_health)))
                      (CC and)
                      (VP (VB reduce)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD))))
                        (PP (IN in)
                          (NP (JJ high-risk) (NNS individuals)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(way-16, that-4)
amod(intake-6, increasing-5)
nsubj(way-16, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(way-16, may-10)
cop(way-16, be-11)
det(way-16, a-12)
amod(way-16, simple-13)
cc(simple-13, and-14)
conj:and(simple-13, effective-15)
amod(way-16, effective-15)
ccomp(suggest-3, way-16)
mark(improve-18, to-17)
acl(way-16, improve-18)
dobj(improve-18, cardiovascular_health-19)
cc(improve-18, and-20)
acl(way-16, reduce-21)
conj:and(improve-18, reduce-21)
det(risk-23, the-22)
dobj(reduce-21, risk-23)
case(CHD-25, of-24)
nmod:of(risk-23, CHD-25)
case(individuals-28, in-26)
amod(individuals-28, high-risk-27)
nmod:in(reduce-21, individuals-28)

The/DT regulation/NN of/IN lactose/NN biosynthesis/VBZ in/IN mammary_glands/NNS during/IN pregnancy/NN is_a/JJ complex/JJ process/NN that/WDT involves/VBZ various/JJ signaling/VBG molecules/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN lactose))))
    (VP (VBZ biosynthesis)
      (PP (IN in)
        (NP (NNS mammary_glands)))
      (PP (IN during)
        (NP (NN pregnancy)))
      (NP-TMP
        (NP (JJ is_a) (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP (JJ various) (VBG signaling) (NNS molecules)))))))
    (. .)))

det(regulation-2, The-1)
nsubj(biosynthesis-5, regulation-2)
case(lactose-4, of-3)
nmod:of(regulation-2, lactose-4)
root(ROOT-0, biosynthesis-5)
case(mammary_glands-7, in-6)
nmod:in(biosynthesis-5, mammary_glands-7)
case(pregnancy-9, during-8)
nmod:during(biosynthesis-5, pregnancy-9)
amod(process-12, is_a-10)
amod(process-12, complex-11)
nmod:tmod(biosynthesis-5, process-12)
nsubj(involves-14, process-12)
ref(process-12, that-13)
acl:relcl(process-12, involves-14)
amod(molecules-17, various-15)
amod(molecules-17, signaling-16)
dobj(involves-14, molecules-17)

Adenosine_3/NNP '/POS ,5/CD '/'' -/: cyclic_monophosphate/VB -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- are/VBP two/CD important/JJ second/JJ messengers/NNS that/WDT play/VBP a/DT crucial/JJ role/NN in/IN lactation/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Adenosine_3) (POS '))
        (ADJP (CD ,5))
        ('' ')
        (PRN (: -)
          (S
            (VP (VB cyclic_monophosphate)
              (NP
                (NP (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-))
                (CC and)
                (NP
                  (NP (NNS guanosine_3) (POS '))
                  (NX (CD ,5)))
                ('' '))))
          (: -))
        (NN cyclic_monophosphate))
      (PRN (-LRB- -LRB-)
        (NP (NN cGMP))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (CD two) (JJ important) (JJ second) (NNS messengers))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP (NN lactation)))))))))
    (. .)))

nmod:poss(cyclic_monophosphate-16, Adenosine_3-1)
case(Adenosine_3-1, '-2)
amod(cyclic_monophosphate-16, ,5-3)
dep(cyclic_monophosphate-16, cyclic_monophosphate-6)
dobj(cyclic_monophosphate-6, cAMP-8)
cc(cAMP-8, and-10)
nmod:poss(,5-13, guanosine_3-11)
case(guanosine_3-11, '-12)
dobj(cyclic_monophosphate-6, ,5-13)
conj:and(cAMP-8, ,5-13)
nsubj(messengers-24, cyclic_monophosphate-16)
appos(cyclic_monophosphate-16, cGMP-18)
cop(messengers-24, are-20)
nummod(messengers-24, two-21)
amod(messengers-24, important-22)
amod(messengers-24, second-23)
root(ROOT-0, messengers-24)
nsubj(play-26, messengers-24)
ref(messengers-24, that-25)
acl:relcl(messengers-24, play-26)
det(role-29, a-27)
amod(role-29, crucial-28)
dobj(play-26, role-29)
case(lactation-31, in-30)
nmod:in(role-29, lactation-31)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT possible/JJ roles/NNS of/IN cAMP/NN and/CC cGMP/NN ,/, as/RB well/RB as/IN the/DT effect/NN of/IN TG4010/NNP ,/, on/IN the/DT early/JJ stages/NNS of/IN arm_1p/NNS -LRB-/-LRB- PRL/NNP -RRB-/-RRB- -/: induced/VBN lactose/JJ biosynthesis/NNS in/IN cultured/JJ mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS at/IN 12-14/CD days/NNS of/IN pregnancy/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ possible) (NNS roles))
        (PP (IN of)
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))))
      (, ,)
      (ADVP
        (ADVP (RB as) (RB well))
        (PP (IN as)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP (NNP TG4010))))))
      (, ,)
      (PP (IN on)
        (NP
          (NP (DT the) (JJ early) (NNS stages))
          (PP (IN of)
            (NP
              (NP
                (NP (NNS arm_1p))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PRL))
                  (-RRB- -RRB-)))
              (: -)
              (NP
                (NP (VBN induced) (JJ lactose) (NNS biosynthesis))
                (PP (IN in)
                  (NP
                    (NP (JJ cultured) (JJ mammary_gland) (NNS explants))
                    (VP (VBN derived)
                      (PP (IN from)
                        (NP (NNS mice)))
                      (PP (IN at)
                        (NP
                          (NP (CD 12-14) (NNS days))
                          (PP (IN of)
                            (NP (NN pregnancy))))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(roles-9, the-7)
amod(roles-9, possible-8)
dobj(investigated-6, roles-9)
case(cAMP-11, of-10)
nmod:of(roles-9, cAMP-11)
cc(cAMP-11, and-12)
nmod:of(roles-9, cGMP-13)
conj:and(cAMP-11, cGMP-13)
advmod(investigated-6, as-15)
mwe(as-15, well-16)
case(effect-19, as-17)
det(effect-19, the-18)
nmod:as(as-15, effect-19)
case(TG4010-21, of-20)
nmod:of(effect-19, TG4010-21)
case(stages-26, on-23)
det(stages-26, the-24)
amod(stages-26, early-25)
nmod:on(investigated-6, stages-26)
case(arm_1p-28, of-27)
nmod:of(stages-26, arm_1p-28)
appos(arm_1p-28, PRL-30)
amod(biosynthesis-35, induced-33)
amod(biosynthesis-35, lactose-34)
dep(arm_1p-28, biosynthesis-35)
case(explants-39, in-36)
amod(explants-39, cultured-37)
amod(explants-39, mammary_gland-38)
nmod:in(biosynthesis-35, explants-39)
acl(explants-39, derived-40)
case(mice-42, from-41)
nmod:from(derived-40, mice-42)
case(days-45, at-43)
nummod(days-45, 12-14-44)
nmod:at(derived-40, days-45)
case(pregnancy-47, of-46)
nmod:of(days-45, pregnancy-47)

Our/PRP$ results/NNS showed/VBD that/IN both/DT cAMP/NN and/CC cGMP/NN were/VBD involved/VBN in/IN the/DT regulation/NN of/IN lactose/JJ biosynthesis/NNS ,/, with/IN cAMP/NN playing/VBG a/DT more/RBR dominant/JJ role/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT both) (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (VBD were)
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (JJ lactose) (NNS biosynthesis)))))
              (, ,)
              (PP (IN with)
                (NP
                  (NP (NN cAMP))
                  (VP (VBG playing)
                    (NP (DT a)
                      (ADJP (RBR more) (JJ dominant))
                      (NN role))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(involved-10, that-4)
cc:preconj(cAMP-6, both-5)
nsubjpass(involved-10, cAMP-6)
cc(cAMP-6, and-7)
conj:and(cAMP-6, cGMP-8)
nsubjpass(involved-10, cGMP-8)
auxpass(involved-10, were-9)
ccomp(showed-3, involved-10)
case(regulation-13, in-11)
det(regulation-13, the-12)
nmod:in(involved-10, regulation-13)
case(biosynthesis-16, of-14)
amod(biosynthesis-16, lactose-15)
nmod:of(regulation-13, biosynthesis-16)
case(cAMP-19, with-18)
nmod:with(involved-10, cAMP-19)
acl(cAMP-19, playing-20)
det(role-24, a-21)
advmod(dominant-23, more-22)
amod(role-24, dominant-23)
dobj(playing-20, role-24)

Additionally/RB ,/, treatment/NN with/IN TG4010/NNP enhanced/VBD the/DT effect/NN of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS ,/, suggesting/VBG its/PRP$ potential/JJ use/NN as/IN a/DT therapeutic/JJ agent/NN for/IN lactation-related_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP TG4010))))
    (VP (VBD enhanced)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP PRL))))
      (PP (IN on)
        (NP (JJ lactose) (NNS biosynthesis)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (NP (PRP$ its) (JJ potential) (NN use))
          (PP (IN as)
            (NP
              (NP (DT a) (JJ therapeutic) (NN agent))
              (PP (IN for)
                (NP (NNS lactation-related_disorders))))))))
    (. .)))

advmod(enhanced-6, Additionally-1)
nsubj(enhanced-6, treatment-3)
case(TG4010-5, with-4)
nmod:with(treatment-3, TG4010-5)
root(ROOT-0, enhanced-6)
det(effect-8, the-7)
dobj(enhanced-6, effect-8)
case(PRL-10, of-9)
nmod:of(effect-8, PRL-10)
case(biosynthesis-13, on-11)
amod(biosynthesis-13, lactose-12)
nmod:on(enhanced-6, biosynthesis-13)
advcl(enhanced-6, suggesting-15)
nmod:poss(use-18, its-16)
amod(use-18, potential-17)
dobj(suggesting-15, use-18)
case(agent-22, as-19)
det(agent-22, a-20)
amod(agent-22, therapeutic-21)
nmod:as(suggesting-15, agent-22)
case(lactation-related_disorders-24, for-23)
nmod:for(agent-22, lactation-related_disorders-24)

Overall/RB ,/, our/PRP$ findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG lactose/JJ biosynthesis/NNS during/IN pregnancy/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/NN treatments/NNS for/IN lactation-related_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (PRP$ our) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (JJ molecular) (NNS mechanisms))
              (VP (VBG underlying)
                (NP (JJ lactose) (NNS biosynthesis))
                (PP (IN during)
                  (NP (NN pregnancy))))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (NN novel) (NNS treatments))
                    (PP (IN for)
                      (NP (NNS lactation-related_disorders)))))))))))
    (. .)))

advmod(provide-5, Overall-1)
nmod:poss(findings-4, our-3)
nsubj(provide-5, findings-4)
nsubj(have-19, findings-4)
root(ROOT-0, provide-5)
amod(insights-7, new-6)
dobj(provide-5, insights-7)
case(mechanisms-11, into-8)
det(mechanisms-11, the-9)
amod(mechanisms-11, molecular-10)
nmod:into(insights-7, mechanisms-11)
acl(mechanisms-11, underlying-12)
amod(biosynthesis-14, lactose-13)
dobj(underlying-12, biosynthesis-14)
case(pregnancy-16, during-15)
nmod:during(underlying-12, pregnancy-16)
cc(provide-5, and-17)
aux(have-19, may-18)
conj:and(provide-5, have-19)
dobj(have-19, implications-20)
case(development-23, for-21)
det(development-23, the-22)
nmod:for(implications-20, development-23)
case(treatments-26, of-24)
compound(treatments-26, novel-25)
nmod:of(development-23, treatments-26)
case(lactation-related_disorders-28, for-27)
nmod:for(treatments-26, lactation-related_disorders-28)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ properties/NNS and/CC are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN ABT-431/NN in/IN hyperABT-431mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN known)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ anti-inflammatory) (NNS properties)))))))
      (CC and)
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN ABT-431))
                  (PP (IN in)
                    (NP (JJ hyperABT-431mic) (NNS patients))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-15, omega-3_fatty_acids-2)
nsubj:xsubj(have-17, omega-3_fatty_acids-2)
nsubjpass(associated-22, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(have-17, to-16)
xcomp(known-15, have-17)
amod(properties-19, anti-inflammatory-18)
dobj(have-17, properties-19)
cc(known-15, and-20)
auxpass(associated-22, are-21)
conj:and(known-15, associated-22)
case(levels-25, with-23)
amod(levels-25, decreased-24)
nmod:with(associated-22, levels-25)
case(ABT-431-27, of-26)
nmod:of(levels-25, ABT-431-27)
case(patients-30, in-28)
amod(patients-30, hyperABT-431mic-29)
nmod:in(ABT-431-27, patients-30)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN these/DT fatty_acids/NNS are/VBP linked/VBN with/IN a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN linked)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN reduced) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(linked-10, that-6)
det(fatty_acids-8, these-7)
nsubjpass(linked-10, fatty_acids-8)
auxpass(linked-10, are-9)
ccomp(shown-5, linked-10)
case(risk-14, with-11)
det(risk-14, a-12)
amod(risk-14, reduced-13)
nmod:with(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS remain/VBP unclear/JJ ,/, but/CC may/MD involve/VB the/DT modulation/NN of/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP remain)
        (ADJP (JJ unclear)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (DT the) (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (NP (NN inflammation))
                (, ,)
                (CC and)
                (NP (NNS oxidative_stress))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(remain-7, mechanisms-2)
nsubj(involve-12, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
root(ROOT-0, remain-7)
xcomp(remain-7, unclear-8)
cc(remain-7, but-10)
aux(involve-12, may-11)
conj:but(remain-7, involve-12)
det(modulation-14, the-13)
dobj(involve-12, modulation-14)
case(metabolism-17, of-15)
compound(metabolism-17, lipid-16)
nmod:of(modulation-14, metabolism-17)
nmod:of(modulation-14, inflammation-19)
conj:and(metabolism-17, inflammation-19)
cc(metabolism-17, and-21)
nmod:of(modulation-14, oxidative_stress-22)
conj:and(metabolism-17, oxidative_stress-22)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ or/CC supplementation/JJ strategies/NNS may/MD be/VB a/DT promising/JJ approach/NN for/IN preventing/VBG CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary)
                  (CC or)
                  (JJ supplementation) (NNS strategies)))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (NN approach))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (NP (NNP CHD))
                    (PP (IN in)
                      (NP (JJ high-risk) (NNS individuals)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(approach-21, that-4)
csubj(approach-21, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(strategies-16, through-12)
amod(strategies-16, dietary-13)
cc(dietary-13, or-14)
conj:or(dietary-13, supplementation-15)
amod(strategies-16, supplementation-15)
nmod:through(increasing-5, strategies-16)
aux(approach-21, may-17)
cop(approach-21, be-18)
det(approach-21, a-19)
amod(approach-21, promising-20)
ccomp(suggest-3, approach-21)
mark(preventing-23, for-22)
advcl(approach-21, preventing-23)
dobj(preventing-23, CHD-24)
case(individuals-27, in-25)
amod(individuals-27, high-risk-26)
nmod:in(preventing-23, individuals-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS involved/VBN and/CC to/TO optimize/VB the/DT use/NN of/IN omega-3_fatty_acids/JJ for/IN cardiovascular_disease/JJ prevention/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ precise) (NNS mechanisms))
                  (VP (VBN involved)))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP
                  (NP (DT the) (NN use))
                  (PP (IN of)
                    (NP (JJ omega-3_fatty_acids)))
                  (PP (IN for)
                    (NP (JJ cardiovascular_disease) (NN prevention))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
cc(elucidate-6, and-11)
mark(optimize-13, to-12)
ccomp(needed-4, optimize-13)
conj:and(elucidate-6, optimize-13)
det(use-15, the-14)
dobj(optimize-13, use-15)
case(omega-3_fatty_acids-17, of-16)
nmod:of(use-15, omega-3_fatty_acids-17)
case(prevention-20, for-18)
amod(prevention-20, cardiovascular_disease-19)
nmod:for(use-15, prevention-20)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN for/IN their/PRP$ anti-inflammatory/JJ properties/NNS and/CC have/VBP been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN glatiramer_acetate/NN in/IN patients/NNS with/IN hyperglatiramer/NN acetatemia/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN known)
          (PP (IN for)
            (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (VBN decreased) (NNS levels))
                (PP (IN of)
                  (NP
                    (NP (NN glatiramer_acetate))
                    (PP (IN in)
                      (NP (NNS patients)))))))
            (PP (IN with)
              (NP (NN hyperglatiramer) (NN acetatemia)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-15, omega-3_fatty_acids-2)
nsubjpass(associated-23, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
case(properties-19, for-16)
nmod:poss(properties-19, their-17)
amod(properties-19, anti-inflammatory-18)
nmod:for(known-15, properties-19)
cc(known-15, and-20)
aux(associated-23, have-21)
auxpass(associated-23, been-22)
conj:and(known-15, associated-23)
case(levels-26, with-24)
amod(levels-26, decreased-25)
nmod:with(associated-23, levels-26)
case(glatiramer_acetate-28, of-27)
nmod:of(levels-26, glatiramer_acetate-28)
case(patients-30, in-29)
nmod:in(glatiramer_acetate-28, patients-30)
case(acetatemia-33, with-31)
compound(acetatemia-33, hyperglatiramer-32)
nmod:with(associated-23, acetatemia-33)

Furthermore/RB ,/, studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS may/MD also/RB reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may) (RB also)
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(shown-5, Furthermore-1)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
mark(reduce-11, that-6)
det(fatty_acids-8, these-7)
nsubj(reduce-11, fatty_acids-8)
aux(reduce-11, may-9)
advmod(reduce-11, also-10)
ccomp(shown-5, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
dobj(developing-15, coronary_heart_disease-16)
appos(risk-13, CHD-18)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD modulate/VBP immune/JJ responses/NNS and/CC improve/VB lipid/NN profiles/NNS ,/, leading/VBG to/TO a/DT reduction/NN in/IN inflammation/NN and/CC a/DT decrease/NN in/IN the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP
                (VP (MD may)
                  (VP (VBP modulate)
                    (NP (JJ immune) (NNS responses))))
                (CC and)
                (VP (VB improve)
                  (NP
                    (NP (NN lipid) (NNS profiles))
                    (, ,)
                    (VP (VBG leading)
                      (PP (TO to)
                        (NP
                          (NP (DT a) (NN reduction))
                          (PP (IN in)
                            (NP
                              (NP (NN inflammation))
                              (CC and)
                              (NP
                                (NP (DT a) (NN decrease))
                                (PP (IN in)
                                  (NP
                                    (NP (DT the) (NN risk))
                                    (PP (IN of)
                                      (NP (NNP CHD)))))))))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(modulate-21, that-16)
nsubj(modulate-21, EPA-17)
nsubj(improve-25, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
nsubj(modulate-21, DHA-19)
aux(modulate-21, may-20)
ccomp(believed-15, modulate-21)
amod(responses-23, immune-22)
dobj(modulate-21, responses-23)
cc(modulate-21, and-24)
ccomp(believed-15, improve-25)
conj:and(modulate-21, improve-25)
compound(profiles-27, lipid-26)
dobj(improve-25, profiles-27)
acl(profiles-27, leading-29)
case(reduction-32, to-30)
det(reduction-32, a-31)
nmod:to(leading-29, reduction-32)
case(inflammation-34, in-33)
nmod:in(reduction-32, inflammation-34)
cc(inflammation-34, and-35)
det(decrease-37, a-36)
nmod:in(reduction-32, decrease-37)
conj:and(inflammation-34, decrease-37)
case(risk-40, in-38)
det(risk-40, the-39)
nmod:in(decrease-37, risk-40)
case(CHD-42, of-41)
nmod:of(risk-40, CHD-42)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT potential/JJ benefits/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT prevention/NN and/CC treatment/NN of/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (JJ potential) (NNS benefits))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN treatment))
                  (PP (IN of)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(benefits-10, the-8)
amod(benefits-10, potential-9)
dobj(elucidate-7, benefits-10)
case(EPA-12, of-11)
nmod:of(benefits-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(benefits-10, DHA-14)
conj:and(EPA-12, DHA-14)
case(prevention-17, in-15)
det(prevention-17, the-16)
nmod:in(elucidate-7, prevention-17)
cc(prevention-17, and-18)
nmod:in(elucidate-7, treatment-19)
conj:and(prevention-17, treatment-19)
case(conditions-22, of-20)
det(conditions-22, these-21)
nmod:of(prevention-17, conditions-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN associated/VBN with/IN a/DT variety/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (DT a) (NN variety))
                      (PP (IN of)
                        (NP (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(associated-20, nutrients-16)
ref(nutrients-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(nutrients-16, associated-20)
case(variety-23, with-21)
det(variety-23, a-22)
nmod:with(associated-20, variety-23)
case(benefits-26, of-24)
compound(benefits-26, health-25)
nmod:of(variety-23, benefits-26)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB effective/JJ in/IN reducing/VBG isoflupredone_acetate/JJ levels/NNS in/IN hyperisoflupredone/JJ acetatemic/JJ patients/NNS ,/, as/RB well/RB as/IN decreasing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ effective)
                  (PP (IN in)
                    (S
                      (VP
                        (VP (VBG reducing)
                          (NP
                            (NP (JJ isoflupredone_acetate) (NNS levels))
                            (PP (IN in)
                              (NP (JJ hyperisoflupredone) (JJ acetatemic) (NNS patients)))))
                        (, ,)
                        (CONJP (RB as) (RB well) (IN as))
                        (VP (VBG decreasing)
                          (NP
                            (NP
                              (NP (DT the) (NN risk))
                              (PP (IN of)
                                (S
                                  (VP (VBG developing)
                                    (NP (NN coronary_heart_disease))))))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(effective-11, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubj(effective-11, omega-3_fatty_acids-8)
aux(effective-11, may-9)
cop(effective-11, be-10)
ccomp(shown-4, effective-11)
mark(reducing-13, in-12)
advcl(effective-11, reducing-13)
amod(levels-15, isoflupredone_acetate-14)
dobj(reducing-13, levels-15)
case(patients-19, in-16)
amod(patients-19, hyperisoflupredone-17)
amod(patients-19, acetatemic-18)
nmod:in(levels-15, patients-19)
cc(reducing-13, as-21)
mwe(as-21, well-22)
mwe(as-21, as-23)
advcl(effective-11, decreasing-24)
conj:and(reducing-13, decreasing-24)
det(risk-26, the-25)
dobj(decreasing-24, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, coronary_heart_disease-29)
appos(risk-26, CHD-31)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO possess/VB anti-inflammatory/JJ properties/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ beneficial/JJ effects/NNS on/IN isoflupredone_acetate/JJ levels/NNS and/CC CHD/NNP risk/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB possess)
              (NP
                (NP (JJ anti-inflammatory) (NNS properties))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB contribute)
                        (PP (TO to)
                          (NP
                            (NP (PRP$ their) (JJ beneficial) (NNS effects))
                            (PP (IN on)
                              (NP
                                (NP (JJ isoflupredone_acetate) (NNS levels))
                                (CC and)
                                (NP (NNP CHD) (NN risk))))))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(possess-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(possess-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(possess-7, to-6)
xcomp(known-5, possess-7)
amod(properties-9, anti-inflammatory-8)
dobj(possess-7, properties-9)
nsubj(contribute-13, properties-9)
ref(properties-9, which-11)
aux(contribute-13, may-12)
acl:relcl(properties-9, contribute-13)
case(effects-17, to-14)
nmod:poss(effects-17, their-15)
amod(effects-17, beneficial-16)
nmod:to(contribute-13, effects-17)
case(levels-20, on-18)
amod(levels-20, isoflupredone_acetate-19)
nmod:on(effects-17, levels-20)
cc(levels-20, and-21)
compound(risk-23, CHD-22)
nmod:on(effects-17, risk-23)
conj:and(levels-20, risk-23)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS ,/, reduce/VB blood_pressure/NN ,/, and/CC decrease/VB the/DT risk/NN of/IN arrhythmias/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP (NN blood_pressure)))
                (, ,)
                (CC and)
                (VP (VB decrease)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS arrhythmias)))))))))))
    (. .)))

advmod(shown-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(improve-9, fatty_acids-4)
nsubj:xsubj(reduce-13, fatty_acids-4)
nsubj:xsubj(decrease-17, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
xcomp(shown-7, reduce-13)
conj:and(improve-9, reduce-13)
dobj(reduce-13, blood_pressure-14)
cc(improve-9, and-16)
xcomp(shown-7, decrease-17)
conj:and(improve-9, decrease-17)
det(risk-19, the-18)
dobj(decrease-17, risk-19)
case(arrhythmias-21, of-20)
nmod:of(risk-19, arrhythmias-21)

Given/VBN their/PRP$ potential/JJ therapeutic/JJ benefits/NNS ,/, further/JJ research/NN should/MD be/VB conducted/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG their/PRP$ cardioprotective/JJ effects/NNS and/CC their/PRP$ potential/JJ use/NN in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP (PRP$ their) (JJ potential) (JJ therapeutic) (NNS benefits)))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (MD should)
      (VP (VB be)
        (VP (VBN conducted)
          (S
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (PP (VBG underlying)
                    (NP
                      (NP (PRP$ their) (JJ cardioprotective) (NNS effects))
                      (CC and)
                      (NP
                        (NP (PRP$ their) (JJ potential) (NN use))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN prevention)
                              (CC and)
                              (NN treatment))
                            (PP (IN of)
                              (NP (NNP CHD)))))))))))))))
    (. .)))

case(benefits-5, Given-1)
nmod:poss(benefits-5, their-2)
amod(benefits-5, potential-3)
amod(benefits-5, therapeutic-4)
nmod:given(conducted-11, benefits-5)
amod(research-8, further-7)
nsubjpass(conducted-11, research-8)
nsubj:xsubj(explore-13, research-8)
aux(conducted-11, should-9)
auxpass(conducted-11, be-10)
root(ROOT-0, conducted-11)
mark(explore-13, to-12)
xcomp(conducted-11, explore-13)
det(mechanisms-15, the-14)
dobj(explore-13, mechanisms-15)
case(effects-19, underlying-16)
nmod:poss(effects-19, their-17)
amod(effects-19, cardioprotective-18)
nmod:underlying(mechanisms-15, effects-19)
cc(effects-19, and-20)
nmod:poss(use-23, their-21)
amod(use-23, potential-22)
nmod:underlying(mechanisms-15, use-23)
conj:and(effects-19, use-23)
case(prevention-26, in-24)
det(prevention-26, the-25)
nmod:in(use-23, prevention-26)
cc(prevention-26, and-27)
nmod:in(use-23, treatment-28)
conj:and(prevention-26, treatment-28)
case(CHD-30, of-29)
nmod:of(prevention-26, CHD-30)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT are/VBP known/VBN to/TO have/VB a/DT range/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP are)
              (VP (VBN known)
                (S
                  (VP (TO to)
                    (VP (VB have)
                      (NP
                        (NP (DT a) (NN range))
                        (PP (IN of)
                          (NP (NN health) (NNS benefits)))))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(known-7, polyunsaturated_fatty_acids-4)
nsubj:xsubj(have-9, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
auxpass(known-7, are-6)
acl:relcl(polyunsaturated_fatty_acids-4, known-7)
mark(have-9, to-8)
xcomp(known-7, have-9)
det(range-11, a-10)
dobj(have-9, range-11)
case(benefits-14, of-12)
compound(benefits-14, health-13)
nmod:of(range-11, benefits-14)

Among/IN these/DT benefits/NNS ,/, recent/JJ studies/NNS suggest/VBP that/IN long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, may/MD be/VB associated/VBN with/IN decreased/VBN i-BET151/JJ levels/NNS in/IN hyperi-BET151mic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these) (NNS benefits)))
    (, ,)
    (NP (JJ recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ long-chain) (JJ omega-3_fatty_acids))
            (, ,)
            (VP
              (VP (VBN eicosapentaenoic_acid)
                (NP
                  (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 20:5) (CD n-3)))
                    (-RRB- -RRB-))))
              (CC and)
              (VP (VBN docosahexaenoic_acid)
                (NP
                  (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 22:6) (CD n-3)))
                    (-RRB- -RRB-)))))
            (, ,))
          (VP
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ i-BET151) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hyperi-BET151mic) (NNS patients))))))))
            (CC and)
            (VP (VBD decreased)
              (NP
                (NP (NN risk))
                (PP (IN of)
                  (NP
                    (NP (VBG developing) (NN coronary_heart_disease))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(benefits-3, Among-1)
det(benefits-3, these-2)
nmod:among(suggest-7, benefits-3)
amod(studies-6, recent-5)
nsubj(suggest-7, studies-6)
root(ROOT-0, suggest-7)
mark(associated-32, that-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nsubjpass(associated-32, omega-3_fatty_acids-10)
nsubjpass(decreased-41, omega-3_fatty_acids-10)
dep(omega-3_fatty_acids-10, eicosapentaenoic_acid-12)
dobj(eicosapentaenoic_acid-12, EPA-14)
compound(n-3-18, 20:5-17)
dep(EPA-14, n-3-18)
cc(eicosapentaenoic_acid-12, and-20)
dep(omega-3_fatty_acids-10, docosahexaenoic_acid-21)
conj:and(eicosapentaenoic_acid-12, docosahexaenoic_acid-21)
dobj(docosahexaenoic_acid-21, DHA-23)
compound(n-3-27, 22:6-26)
dep(DHA-23, n-3-27)
aux(associated-32, may-30)
auxpass(associated-32, be-31)
ccomp(suggest-7, associated-32)
case(levels-36, with-33)
amod(levels-36, decreased-34)
amod(levels-36, i-BET151-35)
nmod:with(associated-32, levels-36)
case(patients-39, in-37)
amod(patients-39, hyperi-BET151mic-38)
nmod:in(levels-36, patients-39)
cc(associated-32, and-40)
ccomp(suggest-7, decreased-41)
conj:and(associated-32, decreased-41)
dobj(decreased-41, risk-42)
case(coronary_heart_disease-45, of-43)
amod(coronary_heart_disease-45, developing-44)
nmod:of(risk-42, coronary_heart_disease-45)
appos(coronary_heart_disease-45, CHD-47)

In/IN this/DT review/NN ,/, we/PRP summarize/VB the/DT current/JJ evidence/NN on/IN the/DT potential/JJ mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP may/MD exert/VB their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review)))
    (, ,)
    (NP (PRP we))
    (VP (VB summarize)
      (NP
        (NP (DT the) (JJ current) (NN evidence))
        (PP (IN on)
          (NP (DT the) (JJ potential) (NNS mechanisms))))
      (PP (IN by)
        (SBAR
          (WHNP (WDT which))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may)
              (VP (VB exert)
                (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))
    (. .)))

case(review-3, In-1)
det(review-3, this-2)
nmod:in(summarize-6, review-3)
nsubj(summarize-6, we-5)
root(ROOT-0, summarize-6)
det(evidence-9, the-7)
amod(evidence-9, current-8)
dobj(summarize-6, evidence-9)
case(mechanisms-13, on-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, potential-12)
nmod:on(evidence-9, mechanisms-13)
mark(exert-20, by-14)
dobj(exert-20, which-15)
nsubj(exert-20, EPA-16)
cc(EPA-16, and-17)
conj:and(EPA-16, DHA-18)
nsubj(exert-20, DHA-18)
aux(exert-20, may-19)
advcl(summarize-6, exert-20)
nmod:poss(effects-23, their-21)
amod(effects-23, cardioprotective-22)
dobj(exert-20, effects-23)

These/DT mechanisms/NNS include/VBP reducing/VBG inflammation/NN ,/, improving/VBG endothelial/JJ function/NN ,/, decreasing/VBG triglyceride_levels/NNS ,/, and/CC reducing/VBG platelet_aggregation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS mechanisms))
    (VP (VBP include)
      (S
        (VP
          (VP (VBG reducing)
            (NP (NN inflammation)))
          (, ,)
          (VP (VBG improving)
            (NP (JJ endothelial) (NN function)))
          (, ,)
          (VP (VBG decreasing)
            (NP (NNS triglyceride_levels)))
          (, ,)
          (CC and)
          (VP (VBG reducing)
            (NP (NN platelet_aggregation))))))
    (. .)))

det(mechanisms-2, These-1)
nsubj(include-3, mechanisms-2)
root(ROOT-0, include-3)
ccomp(include-3, reducing-4)
dobj(reducing-4, inflammation-5)
ccomp(include-3, improving-7)
conj:and(reducing-4, improving-7)
amod(function-9, endothelial-8)
dobj(improving-7, function-9)
ccomp(include-3, decreasing-11)
conj:and(reducing-4, decreasing-11)
dobj(decreasing-11, triglyceride_levels-12)
cc(reducing-4, and-14)
ccomp(include-3, reducing-15)
conj:and(reducing-4, reducing-15)
dobj(reducing-15, platelet_aggregation-16)

In/IN addition/NN to/TO their/PRP$ potential/JJ cardiovascular_benefits/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN shown/VBN to/TO have/VB other/JJ health/NN benefits/NNS such/JJ as/IN improving/VBG cognitive/JJ function/NN and/CC reducing/VBG the/DT risk/NN of/IN certain/JJ cancers/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (JJ potential) (NNS cardiovascular_benefits)))))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ other) (NN health) (NNS benefits))
                  (PP (JJ such) (IN as)
                    (S
                      (VP
                        (VP (VBG improving)
                          (NP (JJ cognitive) (NN function)))
                        (CC and)
                        (VP (VBG reducing)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP (JJ certain) (NNS cancers)))))))))))))))
    (. .)))

case(cardiovascular_benefits-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(cardiovascular_benefits-6, their-4)
amod(cardiovascular_benefits-6, potential-5)
nmod:in_addition_to(shown-14, cardiovascular_benefits-6)
nsubjpass(shown-14, EPA-8)
nsubj:xsubj(have-16, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubjpass(shown-14, DHA-10)
nsubj:xsubj(have-16, DHA-10)
aux(shown-14, have-11)
advmod(shown-14, also-12)
auxpass(shown-14, been-13)
root(ROOT-0, shown-14)
mark(have-16, to-15)
xcomp(shown-14, have-16)
amod(benefits-19, other-17)
compound(benefits-19, health-18)
dobj(have-16, benefits-19)
mark(improving-22, such-20)
mwe(such-20, as-21)
acl(benefits-19, improving-22)
amod(function-24, cognitive-23)
dobj(improving-22, function-24)
cc(improving-22, and-25)
acl(benefits-19, reducing-26)
conj:and(improving-22, reducing-26)
det(risk-28, the-27)
dobj(reducing-26, risk-28)
case(cancers-31, of-29)
amod(cancers-31, certain-30)
nmod:of(risk-28, cancers-31)

The/DT current/JJ evidence/NN suggests/VBZ that/IN increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT safe/JJ and/CC effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ health/NN outcomes/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ current) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP (JJ dietary) (NN intake)
                (CC or)
                (NN supplementation))
              (PP (IN with)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a)
                  (ADJP (JJ safe)
                    (CC and)
                    (JJ effective))
                  (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN health) (NNS outcomes))))))))))))
    (. .)))

det(evidence-3, The-1)
amod(evidence-3, current-2)
nsubj(suggests-4, evidence-3)
root(ROOT-0, suggests-4)
mark(strategy-21, that-5)
csubj(strategy-21, increasing-6)
amod(intake-8, dietary-7)
dobj(increasing-6, intake-8)
cc(intake-8, or-9)
dobj(increasing-6, supplementation-10)
conj:or(intake-8, supplementation-10)
case(EPA-12, with-11)
nmod:with(increasing-6, EPA-12)
cc(EPA-12, and-13)
nmod:with(increasing-6, DHA-14)
conj:and(EPA-12, DHA-14)
aux(strategy-21, may-15)
cop(strategy-21, be-16)
det(strategy-21, a-17)
amod(strategy-21, safe-18)
cc(safe-18, and-19)
conj:and(safe-18, effective-20)
amod(strategy-21, effective-20)
ccomp(suggests-4, strategy-21)
mark(reducing-23, for-22)
acl(strategy-21, reducing-23)
det(risk-25, the-24)
dobj(reducing-23, risk-25)
case(CHD-27, of-26)
nmod:of(risk-25, CHD-27)
cc(reducing-23, and-28)
acl(strategy-21, improving-29)
conj:and(reducing-23, improving-29)
amod(outcomes-32, overall-30)
compound(outcomes-32, health-31)
dobj(improving-29, outcomes-32)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN SCH_23390/NNP on/IN Agaricus-induced/JJ catalepsy/NN ,/, photophobia/NN and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP SCH_23390)))
      (PP (IN on)
        (NP
          (NP (JJ Agaricus-induced) (NN catalepsy))
          (, ,)
          (NP (NN photophobia)
            (CC and)
            (NN phonophobia)))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effects-6, the-5)
nsubjpass(investigated-17, effects-6)
case(SCH_23390-8, of-7)
nmod:of(effects-6, SCH_23390-8)
case(catalepsy-11, on-9)
amod(catalepsy-11, Agaricus-induced-10)
nmod:on(effects-6, catalepsy-11)
appos(catalepsy-11, photophobia-13)
cc(photophobia-13, and-14)
appos(catalepsy-11, phonophobia-15)
conj:and(photophobia-13, phonophobia-15)
auxpass(investigated-17, were-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, SCH_23390/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN Agaricus_catalepsy/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP SCH_23390))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNP Agaricus_catalepsy))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, SCH_23390-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(Agaricus_catalepsy-17, of-16)
nmod:of(risk-15, Agaricus_catalepsy-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN SCH_23390/NNP may/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT treatment/NN of/IN disorders/NNS associated/VBN with/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP SCH_23390))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (NNS disorders))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (DT these) (NNS symptoms))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, SCH_23390-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(treatment-13, in-11)
det(treatment-13, the-12)
nmod:in(applications-10, treatment-13)
case(disorders-15, of-14)
nmod:of(treatment-13, disorders-15)
acl(disorders-15, associated-16)
case(symptoms-19, with-17)
det(symptoms-19, these-18)
nmod:with(associated-16, symptoms-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT underlying/VBG mechanisms/NNS of/IN these/DT effects/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN treatment/NN with/IN SCH_23390/NNP for/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (NN treatment))
                      (PP (IN with)
                        (NP (NNP SCH_23390))))))
                (PP (IN for)
                  (NP (DT these) (NNS conditions)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(explore-6, mechanisms-9)
case(effects-12, of-10)
det(effects-12, these-11)
nmod:of(mechanisms-9, effects-12)
cc(explore-6, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(explore-6, determine-15)
det(dosage-18, the-16)
amod(dosage-18, optimal-17)
dobj(determine-15, dosage-18)
cc(dosage-18, and-19)
dobj(determine-15, duration-20)
conj:and(dosage-18, duration-20)
case(treatment-22, of-21)
nmod:of(dosage-18, treatment-22)
case(SCH_23390-24, with-23)
nmod:with(treatment-22, SCH_23390-24)
case(conditions-27, for-25)
det(conditions-27, these-26)
nmod:for(determine-15, conditions-27)

Dysmenorrhea/NNP is_a/NNP common/JJ and/CC painful_condition/JJ experienced/VBD by/IN many/JJ women/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Dysmenorrhea) (NNP is_a))
      (ADJP (JJ common)
        (CC and)
        (JJ painful_condition)))
    (VP (VBD experienced)
      (PP (IN by)
        (NP (JJ many) (NNS women))))
    (. .)))

compound(is_a-2, Dysmenorrhea-1)
nsubj(experienced-6, is_a-2)
amod(is_a-2, common-3)
cc(common-3, and-4)
amod(is_a-2, painful_condition-5)
conj:and(common-3, painful_condition-5)
root(ROOT-0, experienced-6)
case(women-9, by-7)
amod(women-9, many-8)
nmod:by(experienced-6, women-9)

Flufenamic_acid/NNP ,/, a/DT nonsteroidal/JJ anti-inflammatory/JJ drug/NN ,/, has_been/VBP shown/VBN to/TO effectively/RB alleviate/VB the/DT symptoms/NNS of/IN dysmenorrhea/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Flufenamic_acid))
      (, ,)
      (NP (DT a) (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB effectively))
              (VB alleviate)
              (NP
                (NP (DT the) (NNS symptoms))
                (PP (IN of)
                  (NP (NN dysmenorrhea)))))))))
    (. .)))

nsubj(has_been-8, Flufenamic_acid-1)
det(drug-6, a-3)
amod(drug-6, nonsteroidal-4)
amod(drug-6, anti-inflammatory-5)
appos(Flufenamic_acid-1, drug-6)
root(ROOT-0, has_been-8)
dep(has_been-8, shown-9)
mark(alleviate-12, to-10)
advmod(alleviate-12, effectively-11)
xcomp(shown-9, alleviate-12)
det(symptoms-14, the-13)
dobj(alleviate-12, symptoms-14)
case(dysmenorrhea-16, of-15)
nmod:of(symptoms-14, dysmenorrhea-16)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN Flufenamic_acid/NNP on/IN dysmenorrhea/NN and/CC associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Flufenamic_acid)))
      (PP (IN on)
        (NP
          (NP (NN dysmenorrhea))
          (CC and)
          (NP
            (NP (VBN associated) (NNS symptoms))
            (PP (JJ such) (IN as)
              (NP (NN photophobia)
                (CC and)
                (NN phonophobia)))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-20, study-3)
det(effect-6, the-5)
nsubjpass(investigated-20, effect-6)
case(Flufenamic_acid-8, of-7)
nmod:of(effect-6, Flufenamic_acid-8)
case(dysmenorrhea-10, on-9)
nmod:on(effect-6, dysmenorrhea-10)
cc(dysmenorrhea-10, and-11)
amod(symptoms-13, associated-12)
nmod:on(effect-6, symptoms-13)
conj:and(dysmenorrhea-10, symptoms-13)
case(photophobia-16, such-14)
mwe(such-14, as-15)
nmod:such_as(symptoms-13, photophobia-16)
cc(photophobia-16, and-17)
nmod:such_as(symptoms-13, phonophobia-18)
conj:and(photophobia-16, phonophobia-18)
auxpass(investigated-20, were-19)
root(ROOT-0, investigated-20)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, Flufenamic_acid/NNP reduced/VBD the/DT risk/NN of/IN spasmodic_dysmenorrhoea/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NNP Flufenamic_acid))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN spasmodic_dysmenorrhoea))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-12, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-12, Flufenamic_acid-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(spasmodic_dysmenorrhoea-16, of-15)
nmod:of(risk-14, spasmodic_dysmenorrhoea-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN Flufenamic_acid/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN women/NNS suffering/VBG from/IN dysmenorrhea/NN and/CC associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Flufenamic_acid))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS women))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP
                          (NP (NN dysmenorrhea))
                          (CC and)
                          (NP (VBN associated) (NNS symptoms)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Flufenamic_acid-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(women-13, for-12)
nmod:for(option-11, women-13)
acl(women-13, suffering-14)
case(dysmenorrhea-16, from-15)
nmod:from(suffering-14, dysmenorrhea-16)
cc(dysmenorrhea-16, and-17)
amod(symptoms-19, associated-18)
nmod:from(suffering-14, symptoms-19)
conj:and(dysmenorrhea-16, symptoms-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN treatment/NN with/IN Flufenamic_acid/NNP for/IN maximum/JJ efficacy/NN and/CC safety/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (NN treatment))
                      (PP (IN with)
                        (NP (NNP Flufenamic_acid))))))
                (PP (IN for)
                  (NP
                    (NP (JJ maximum) (NN efficacy)
                      (CC and)
                      (NN safety))
                    (PP (IN in)
                      (NP (DT this) (NN population)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(dosage-13, the-11)
amod(dosage-13, optimal-12)
dobj(determine-10, dosage-13)
cc(dosage-13, and-14)
dobj(determine-10, duration-15)
conj:and(dosage-13, duration-15)
case(treatment-17, of-16)
nmod:of(dosage-13, treatment-17)
case(Flufenamic_acid-19, with-18)
nmod:with(treatment-17, Flufenamic_acid-19)
case(efficacy-22, for-20)
amod(efficacy-22, maximum-21)
nmod:for(determine-10, efficacy-22)
cc(efficacy-22, and-23)
nmod:for(determine-10, safety-24)
conj:and(efficacy-22, safety-24)
case(population-27, in-25)
det(population-27, this-26)
nmod:in(efficacy-22, population-27)

Cholesterol/JJ esterification/NN is_a/VBD crucial/JJ process/NN in/IN the/DT regulation/NN of/IN cellular/JJ cholesterol/NN homeostasis/NNS ./.

(ROOT
  (S
    (NP (JJ Cholesterol) (NN esterification))
    (VP (VBD is_a)
      (NP (JJ crucial) (NN process))
      (PP (IN in)
        (NP
          (NP (DT the) (NN regulation))
          (PP (IN of)
            (NP (JJ cellular) (NN cholesterol) (NNS homeostasis))))))
    (. .)))

amod(esterification-2, Cholesterol-1)
nsubj(is_a-3, esterification-2)
root(ROOT-0, is_a-3)
amod(process-5, crucial-4)
dobj(is_a-3, process-5)
case(regulation-8, in-6)
det(regulation-8, the-7)
nmod:in(is_a-3, regulation-8)
case(homeostasis-12, of-9)
amod(homeostasis-12, cellular-10)
compound(homeostasis-12, cholesterol-11)
nmod:of(regulation-8, homeostasis-12)

Acyl-CoA/JJ cholesterol_acyltransferase/NN -LRB-/-LRB- ACAT/NNP -RRB-/-RRB- is/VBZ the/DT enzyme/NN responsible/JJ for/IN this/DT process/NN ,/, and/CC it/PRP has_been/VBP suggested/VBN that/IN ACAT/JJ inhibitors/NNS may/MD be/VB useful/JJ for/IN the/DT treatment/NN of/IN atherosclerosis/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (JJ Acyl-CoA) (NN cholesterol_acyltransferase))
        (PRN (-LRB- -LRB-)
          (NP (NNP ACAT))
          (-RRB- -RRB-)))
      (VP (VBZ is)
        (S
          (NP (DT the) (NN enzyme))
          (ADJP (JJ responsible)
            (PP (IN for)
              (NP (DT this) (NN process)))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP (JJ ACAT) (NNS inhibitors))
              (VP (MD may)
                (VP (VB be)
                  (ADJP (JJ useful))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NNS atherosclerosis))))))))))))
    (. .)))

amod(cholesterol_acyltransferase-2, Acyl-CoA-1)
nsubj(is-6, cholesterol_acyltransferase-2)
appos(cholesterol_acyltransferase-2, ACAT-4)
root(ROOT-0, is-6)
det(enzyme-8, the-7)
nsubj(responsible-9, enzyme-8)
xcomp(is-6, responsible-9)
case(process-12, for-10)
det(process-12, this-11)
nmod:for(responsible-9, process-12)
cc(is-6, and-14)
nsubj(has_been-16, it-15)
conj:and(is-6, has_been-16)
dep(has_been-16, suggested-17)
mark(useful-23, that-18)
amod(inhibitors-20, ACAT-19)
nsubj(useful-23, inhibitors-20)
aux(useful-23, may-21)
cop(useful-23, be-22)
ccomp(suggested-17, useful-23)
case(treatment-26, for-24)
det(treatment-26, the-25)
nmod:for(useful-23, treatment-26)
case(atherosclerosis-28, of-27)
nmod:of(treatment-26, atherosclerosis-28)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN SMP-500/NNP ,/, a/DT potential/JJ ACAT/JJ inhibitor/NN ,/, on/IN ACAT/JJ levels/NNS in/IN vitro/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP SMP-500))
            (, ,)
            (NP (DT a) (JJ potential) (JJ ACAT) (NN inhibitor))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (JJ ACAT) (NNS levels))
          (PP (IN in)
            (NP (NN vitro))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(SMP-500-10, of-9)
nmod:of(effect-8, SMP-500-10)
det(inhibitor-15, a-12)
amod(inhibitor-15, potential-13)
amod(inhibitor-15, ACAT-14)
appos(SMP-500-10, inhibitor-15)
case(levels-19, on-17)
amod(levels-19, ACAT-18)
nmod:on(investigated-6, levels-19)
case(vitro-21, in-20)
nmod:in(levels-19, vitro-21)

We/PRP found/VBD that/IN the/DT non-transfected/JJ SMP-500/NN group/NN had/VBD significantly/RB lower/JJR ACAT/NNP levels/NNS than/IN the/DT non-transfected/JJ non-SMP-500/JJ group/NN -LRB-/-LRB- 352/CD ±/VBP 26/CD vs/NN 765/CD ±/VBP 22/CD ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (DT the) (JJ non-transfected) (NN SMP-500) (NN group))
          (VP (VBD had)
            (NP
              (ADJP (RB significantly) (JJR lower))
              (NNP ACAT) (NNS levels))
            (PP (IN than)
              (NP
                (NP (DT the) (JJ non-transfected) (JJ non-SMP-500) (NN group))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (CD 352))
                    (VP (VBP ±)
                      (NP
                        (NP (CD 26) (NN vs))
                        (SBAR
                          (S
                            (NP (CD 765))
                            (VP (VBP ±)
                              (ADJP
                                (NP (CD 22))
                                (JJ ng/L))
                              (, ,)
                              (SBAR
                                (S
                                  (NP (NNP P))
                                  (VP (VBP <)
                                    (NP (CD 0.001)))))))))))
                  (-RRB- -RRB-))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(had-8, that-3)
det(group-7, the-4)
amod(group-7, non-transfected-5)
compound(group-7, SMP-500-6)
nsubj(had-8, group-7)
ccomp(found-2, had-8)
advmod(lower-10, significantly-9)
amod(levels-12, lower-10)
compound(levels-12, ACAT-11)
dobj(had-8, levels-12)
case(group-17, than-13)
det(group-17, the-14)
amod(group-17, non-transfected-15)
amod(group-17, non-SMP-500-16)
nmod:than(had-8, group-17)
nsubj(±-20, 352-19)
dep(group-17, ±-20)
nummod(vs-22, 26-21)
dobj(±-20, vs-22)
nsubj(±-24, 765-23)
acl:relcl(vs-22, ±-24)
nmod:npmod(ng/L-26, 22-25)
xcomp(±-24, ng/L-26)
nsubj(<-29, P-28)
ccomp(±-24, <-29)
dobj(<-29, 0.001-30)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN ACAT/JJ levels/NNS between/IN the/DT transfected/JJ SMP-500/NN and/CC transfected/JJ non-SMP-500/JJ groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (JJ ACAT) (NNS levels)))
        (PP (IN between)
          (NP
            (NP (DT the) (JJ transfected) (NN SMP-500))
            (CC and)
            (NP (JJ transfected) (JJ non-SMP-500) (NNS groups))))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(levels-10, in-8)
amod(levels-10, ACAT-9)
nmod:in(difference-7, levels-10)
case(SMP-500-14, between-11)
det(SMP-500-14, the-12)
amod(SMP-500-14, transfected-13)
nmod:between(difference-7, SMP-500-14)
cc(SMP-500-14, and-15)
amod(groups-18, transfected-16)
amod(groups-18, non-SMP-500-17)
nmod:between(difference-7, groups-18)
conj:and(SMP-500-14, groups-18)

These/DT results/NNS suggest/VBP that/IN SMP-500/NNP may/MD be/VB an/DT effective/JJ inhibitor/NN of/IN ACAT/JJ activity/NN and/CC could/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT treatment/NN of/IN atherosclerosis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP SMP-500))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT an) (JJ effective) (NN inhibitor))
                  (PP (IN of)
                    (NP (JJ ACAT) (NN activity))))))
            (CC and)
            (VP (MD could)
              (VP (VB have)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NNS atherosclerosis))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(inhibitor-10, that-4)
nsubj(inhibitor-10, SMP-500-5)
nsubj(have-16, SMP-500-5)
aux(inhibitor-10, may-6)
cop(inhibitor-10, be-7)
det(inhibitor-10, an-8)
amod(inhibitor-10, effective-9)
ccomp(suggest-3, inhibitor-10)
case(activity-13, of-11)
amod(activity-13, ACAT-12)
nmod:of(inhibitor-10, activity-13)
cc(inhibitor-10, and-14)
aux(have-16, could-15)
ccomp(suggest-3, have-16)
conj:and(inhibitor-10, have-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
dobj(have-16, applications-19)
case(treatment-22, in-20)
det(treatment-22, the-21)
nmod:in(applications-19, treatment-22)
case(atherosclerosis-24, of-23)
nmod:of(treatment-22, atherosclerosis-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC to/TO investigate/VB the/DT mechanism/NN by/IN which/WDT SMP-500/NNP inhibits/VBZ ACAT/JJ activity/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS findings))))
            (CC and)
            (VP (TO to)
              (VP (VB investigate)
                (NP (DT the) (NN mechanism))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (NNP SMP-500))
                      (VP (VBZ inhibits)
                        (NP (JJ ACAT) (NN activity))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
mark(investigate-11, to-10)
ccomp(needed-4, investigate-11)
conj:and(confirm-6, investigate-11)
det(mechanism-13, the-12)
dobj(investigate-11, mechanism-13)
mark(inhibits-17, by-14)
dobj(inhibits-17, which-15)
nsubj(inhibits-17, SMP-500-16)
advcl(investigate-11, inhibits-17)
amod(activity-19, ACAT-18)
dobj(inhibits-17, activity-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT a) (JJ healthy) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN FG-4497/NN in/IN hyperFG-4497mic/JJ patients/NNS ,/, which/WDT in/IN turn/NN reduces/VBZ the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN FG-4497))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperFG-4497mic) (NNS patients))
                              (, ,)
                              (SBAR
                                (WHNP (WDT which))
                                (S
                                  (PP (IN in)
                                    (NP (NN turn)))
                                  (VP (VBZ reduces)
                                    (NP
                                      (NP (DT the) (NN risk))
                                      (PP (IN of)
                                        (S
                                          (VP (VBG developing)
                                            (NP (NN coronary_heart_disease))))))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(FG-4497-15, of-14)
nmod:of(levels-13, FG-4497-15)
case(patients-18, in-16)
amod(patients-18, hyperFG-4497mic-17)
nmod:in(FG-4497-15, patients-18)
nsubj(reduces-23, patients-18)
ref(patients-18, which-20)
case(turn-22, in-21)
nmod:in(reduces-23, turn-22)
acl:relcl(patients-18, reduces-23)
det(risk-25, the-24)
dobj(reduces-23, risk-25)
mark(developing-27, of-26)
acl(risk-25, developing-27)
dobj(developing-27, coronary_heart_disease-28)
appos(FG-4497-15, CHD-30)

The/DT cardioprotective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP have/VBP been/VBN attributed/VBN to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ cardioprotective) (NNS effects))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN attributed)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP
                        (NP (NN inflammation))
                        (, ,)
                        (NP (JJR lower) (NN blood_pressure))
                        (, ,)))
                    (CC and)
                    (VP (VB improve)
                      (NP (NN lipid) (NN metabolism)))))))))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, cardioprotective-2)
nsubjpass(attributed-10, effects-3)
case(EPA-5, of-4)
nmod:of(effects-3, EPA-5)
cc(EPA-5, and-6)
nmod:of(effects-3, DHA-7)
conj:and(EPA-5, DHA-7)
aux(attributed-10, have-8)
auxpass(attributed-10, been-9)
root(ROOT-0, attributed-10)
case(ability-13, to-11)
nmod:poss(ability-13, their-12)
nmod:to(attributed-10, ability-13)
mark(reduce-15, to-14)
acl(ability-13, reduce-15)
dobj(reduce-15, inflammation-16)
amod(blood_pressure-19, lower-18)
appos(inflammation-16, blood_pressure-19)
cc(reduce-15, and-21)
acl(ability-13, improve-22)
conj:and(reduce-15, improve-22)
compound(metabolism-24, lipid-23)
dobj(improve-22, metabolism-24)

Furthermore/RB ,/, it/PRP has_been/NN observed/VBD that/IN dietary/JJ supplementation/NN with/IN these/DT fatty_acids/NNS can/MD improve/VB cardiovascular/JJ outcomes/NNS in/IN high-risk/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP it))
    (VP (NN has_been)
      (VP (VBD observed)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ dietary) (NN supplementation))
              (PP (IN with)
                (NP (DT these) (NNS fatty_acids))))
            (VP (MD can)
              (VP (VB improve)
                (NP (JJ cardiovascular) (NNS outcomes))
                (PP (IN in)
                  (NP (JJ high-risk) (NNS populations)))))))))
    (. .)))

advmod(observed-5, Furthermore-1)
nsubj(observed-5, it-3)
dep(observed-5, has_been-4)
root(ROOT-0, observed-5)
mark(improve-13, that-6)
amod(supplementation-8, dietary-7)
nsubj(improve-13, supplementation-8)
case(fatty_acids-11, with-9)
det(fatty_acids-11, these-10)
nmod:with(supplementation-8, fatty_acids-11)
aux(improve-13, can-12)
ccomp(observed-5, improve-13)
amod(outcomes-15, cardiovascular-14)
dobj(improve-13, outcomes-15)
case(populations-18, in-16)
amod(populations-18, high-risk-17)
nmod:in(improve-13, populations-18)

These/DT findings/NNS suggest/VBP that/IN incorporating/VBG EPA/NNP and/CC DHA/NNP into/IN the/DT diet/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG incorporating)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (PP (IN into)
                (NP (DT the) (NN diet)))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT an) (JJ effective) (NN strategy))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG preventing)
                      (NP (NNP CHD)))
                    (CC and)
                    (VP (VBG improving)
                      (NP (JJ overall) (NN cardiovascular_health)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, incorporating-5)
dobj(incorporating-5, EPA-6)
cc(EPA-6, and-7)
dobj(incorporating-5, DHA-8)
conj:and(EPA-6, DHA-8)
case(diet-11, into-9)
det(diet-11, the-10)
nmod:into(incorporating-5, diet-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(preventing-18, for-17)
advcl(strategy-16, preventing-18)
dobj(preventing-18, CHD-19)
cc(preventing-18, and-20)
advcl(strategy-16, improving-21)
conj:and(preventing-18, improving-21)
amod(cardiovascular_health-23, overall-22)
dobj(improving-21, cardiovascular_health-23)

The/DT adenosine_A3_receptor/NNS has_been/VBP implicated/VBN in/IN various/JJ physiological/JJ and/CC pathological/JJ conditions/NNS ,/, including/VBG cancer/NN ,/, inflammation/NN ,/, and_cardiovascular/NN diseases/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS adenosine_A3_receptor))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (JJ various)
              (ADJP (JJ physiological)
                (CC and)
                (JJ pathological))
              (NNS conditions))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (NN cancer))
                (, ,)
                (NP (NN inflammation))
                (, ,)
                (NP (NN and_cardiovascular) (NNS diseases))))))))
    (. .)))

det(adenosine_A3_receptor-2, The-1)
nsubj(has_been-3, adenosine_A3_receptor-2)
root(ROOT-0, has_been-3)
dep(has_been-3, implicated-4)
case(conditions-10, in-5)
amod(conditions-10, various-6)
amod(conditions-10, physiological-7)
cc(physiological-7, and-8)
conj:and(physiological-7, pathological-9)
amod(conditions-10, pathological-9)
nmod:in(implicated-4, conditions-10)
acl(conditions-10, including-12)
dobj(including-12, cancer-13)
appos(cancer-13, inflammation-15)
compound(diseases-18, and_cardiovascular-17)
appos(cancer-13, diseases-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN and/CC LJ-1888/NN with/IN serum/JJ adenosine_A3_receptor/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP (NN alkaline_phosphatase)
                (CC and)
                (NN LJ-1888))))))
      (PP (IN with)
        (NP (JJ serum) (JJ adenosine_A3_receptor) (NNS levels))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(correlation-8, the-7)
dobj(investigated-6, correlation-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(correlation-8, levels-11)
case(alkaline_phosphatase-13, of-12)
nmod:of(levels-11, alkaline_phosphatase-13)
cc(alkaline_phosphatase-13, and-14)
nmod:of(levels-11, LJ-1888-15)
conj:and(alkaline_phosphatase-13, LJ-1888-15)
case(levels-19, with-16)
amod(levels-19, serum-17)
amod(levels-19, adenosine_A3_receptor-18)
nmod:with(investigated-6, levels-19)

Our/PRP$ results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, LJ-1888/NN -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC serum/NN adenosine_A3_receptor/JJ levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN LJ-1888))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NN serum))
                  (NP (JJ adenosine_A3_receptor) (NNS levels)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(alkaline_phosphatase-12, of-11)
nmod:of(levels-10, alkaline_phosphatase-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(alkaline_phosphatase-12, <-19)
dobj(<-19, 0.01-20)
nmod:of(levels-10, LJ-1888-23)
conj:and(alkaline_phosphatase-12, LJ-1888-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(LJ-1888-23, <-30)
dobj(<-30, 0.01-31)
cc(alkaline_phosphatase-12, and-33)
nmod:of(levels-10, serum-34)
conj:and(alkaline_phosphatase-12, serum-34)
amod(levels-36, adenosine_A3_receptor-35)
dep(serum-34, levels-36)

These/DT findings/NNS suggest/VBP that/IN alkaline_phosphatase/NN and/CC LJ-1888/NN may/MD be/VB potential/JJ biomarkers/NNS for/IN adenosine_A3_receptor-related_diseases/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN alkaline_phosphatase)
            (CC and)
            (NN LJ-1888))
          (VP (MD may)
            (VP (VB be)
              (NP (JJ potential) (NNS biomarkers))
              (PP (IN for)
                (NP (NN adenosine_A3_receptor-related_diseases))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(biomarkers-11, that-4)
nsubj(biomarkers-11, alkaline_phosphatase-5)
cc(alkaline_phosphatase-5, and-6)
conj:and(alkaline_phosphatase-5, LJ-1888-7)
nsubj(biomarkers-11, LJ-1888-7)
aux(biomarkers-11, may-8)
cop(biomarkers-11, be-9)
amod(biomarkers-11, potential-10)
ccomp(suggest-3, biomarkers-11)
case(adenosine_A3_receptor-related_diseases-13, for-12)
nmod:for(biomarkers-11, adenosine_A3_receptor-related_diseases-13)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN this/DT correlation/NN and/CC to/TO explore/VB the/DT clinical/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT this) (NN correlation))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP (DT these) (NNS findings))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(correlation-12, of-10)
det(correlation-12, this-11)
nmod:of(mechanisms-9, correlation-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
det(implications-18, the-16)
amod(implications-18, clinical-17)
dobj(explore-15, implications-18)
case(findings-21, of-19)
det(findings-21, these-20)
nmod:of(implications-18, findings-21)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(associated-20, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, associated-20)
case(risk-24, with-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:with(associated-20, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

Recent/JJ studies/NNS have/VBP also/RB indicated/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB associated/VBN with/IN decreased/VBN Saccharin/JJ levels/NNS in/IN hyperSaccharinmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP
        (ADVP (RB also))
        (VBN indicated)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (JJ Saccharin) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hyperSaccharinmic) (NNS patients))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(indicated-5, studies-2)
aux(indicated-5, have-3)
advmod(indicated-5, also-4)
root(ROOT-0, indicated-5)
mark(associated-12, that-6)
det(omega-3_fatty_acids-9, these-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nsubjpass(associated-12, omega-3_fatty_acids-9)
aux(associated-12, may-10)
auxpass(associated-12, be-11)
ccomp(indicated-5, associated-12)
case(levels-16, with-13)
amod(levels-16, decreased-14)
amod(levels-16, Saccharin-15)
nmod:with(associated-12, levels-16)
case(patients-19, in-17)
amod(patients-19, hyperSaccharinmic-18)
nmod:in(levels-16, patients-19)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP has_been/VBP suggested/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD modulate/VBP lipid/NN metabolism/NN ,/, reduce/VB inflammation/NN ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP (NN lipid) (NN metabolism))
                  (, ,)
                  (S
                    (VP
                      (VP (VB reduce)
                        (NP (NN inflammation)))
                      (, ,)
                      (CC and)
                      (VP (VB improve)
                        (NP (JJ endothelial) (NN function))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubj(has_been-14, it-13)
conj:but(understood-10, has_been-14)
dep(has_been-14, suggested-15)
mark(modulate-21, that-16)
nsubj(modulate-21, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
nsubj(modulate-21, DHA-19)
aux(modulate-21, may-20)
ccomp(suggested-15, modulate-21)
compound(metabolism-23, lipid-22)
dobj(modulate-21, metabolism-23)
dep(modulate-21, reduce-25)
dobj(reduce-25, inflammation-26)
cc(reduce-25, and-28)
dep(modulate-21, improve-29)
conj:and(reduce-25, improve-29)
amod(function-31, endothelial-30)
dobj(improve-29, function-31)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS ,/, as/RB well/RB as/IN the/DT potential/JJ implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and/CC other/JJ related/JJ conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ precise) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))
                    (VP (VBD exert)
                      (NP (PRP$ their) (JJ cardioprotective) (NNS effects))
                      (, ,)
                      (ADVP
                        (ADVP (RB as) (RB well))
                        (PP (IN as)
                          (NP
                            (NP
                              (NP (DT the) (JJ potential) (NNS implications))
                              (PP (IN for)
                                (NP
                                  (NP (DT the) (NN prevention)
                                    (CC and)
                                    (NN treatment))
                                  (PP (IN of)
                                    (NP (NNP CHD))))))
                            (CC and)
                            (NP (JJ other) (JJ related) (NNS conditions))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
mark(exert-15, by-10)
dobj(exert-15, which-11)
nsubj(exert-15, EPA-12)
cc(EPA-12, and-13)
conj:and(EPA-12, DHA-14)
nsubj(exert-15, DHA-14)
advcl(elucidate-6, exert-15)
nmod:poss(effects-18, their-16)
amod(effects-18, cardioprotective-17)
dobj(exert-15, effects-18)
advmod(exert-15, as-20)
mwe(as-20, well-21)
case(implications-25, as-22)
det(implications-25, the-23)
amod(implications-25, potential-24)
nmod:as(as-20, implications-25)
case(prevention-28, for-26)
det(prevention-28, the-27)
nmod:for(implications-25, prevention-28)
cc(prevention-28, and-29)
nmod:for(implications-25, treatment-30)
conj:and(prevention-28, treatment-30)
case(CHD-32, of-31)
nmod:of(prevention-28, CHD-32)
cc(implications-25, and-33)
amod(conditions-36, other-34)
amod(conditions-36, related-35)
nmod:as(as-20, conditions-36)
conj:and(implications-25, conditions-36)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN various/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN programs/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ various) (VBG signaling) (NNS pathways))
                    (CC and)
                    (NP (NN gene) (NN expression) (NNS programs))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, various-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)
cc(pathways-14, and-15)
compound(programs-18, gene-16)
compound(programs-18, expression-17)
nmod:of(activation-10, programs-18)
conj:and(pathways-14, programs-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN MC1626/NNP on/IN the/DT regulation/NN of/IN Gcn5l2/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS cultured/VBN under/IN differentiation-favoring/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP MC1626))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN regulation))
          (PP (IN of)
            (NP (JJ Gcn5l2) (NN protein) (NNS levels)))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (PP (IN under)
              (NP (JJ differentiation-favoring) (NNS conditions)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(MC1626-10, of-9)
nmod:of(effect-8, MC1626-10)
case(regulation-13, on-11)
det(regulation-13, the-12)
nmod:on(investigated-6, regulation-13)
case(levels-17, of-14)
amod(levels-17, Gcn5l2-15)
compound(levels-17, protein-16)
nmod:of(regulation-13, levels-17)
case(cells-20, in-18)
nummod(cells-20, C2C12-19)
nmod:in(investigated-6, cells-20)
acl(cells-20, cultured-21)
case(conditions-24, under-22)
amod(conditions-24, differentiation-favoring-23)
nmod:under(cultured-21, conditions-24)

Our/PRP$ results/NNS demonstrate/VBP that/IN MC1626/NNP treatment/NN up-regulated/VBD Gcn5l2/JJ protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/VBN its/PRP$ half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP (NNP MC1626) (NN treatment))
          (VP
            (VP (VBD up-regulated)
              (NP (JJ Gcn5l2) (NN protein) (NNS levels))
              (NP (JJ in_a) (JJ time-dependent) (NN manner)))
            (CC and)
            (VP (VBN prolonged)
              (NP (PRP$ its) (NN half-life))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(up-regulated-7, that-4)
compound(treatment-6, MC1626-5)
nsubj(up-regulated-7, treatment-6)
nsubj(prolonged-15, treatment-6)
ccomp(demonstrate-3, up-regulated-7)
amod(levels-10, Gcn5l2-8)
compound(levels-10, protein-9)
iobj(up-regulated-7, levels-10)
amod(manner-13, in_a-11)
amod(manner-13, time-dependent-12)
dobj(up-regulated-7, manner-13)
cc(up-regulated-7, and-14)
ccomp(demonstrate-3, prolonged-15)
conj:and(up-regulated-7, prolonged-15)
nmod:poss(half-life-17, its-16)
dobj(prolonged-15, half-life-17)
case(hours-22, from-18)
compound(18-21, 10-19)
dep(18-21, to-20)
nummod(hours-22, 18-21)
nmod:from(prolonged-15, hours-22)

Gcn5l2/NNP is/VBZ known/VBN to/TO play/VB a/DT crucial/JJ role/NN in/IN skeletal_muscle/JJ differentiation/NN by/IN regulating/VBG myogenic/JJ gene/NN expression/NN programs/NNS ./.

(ROOT
  (S
    (NP (NNP Gcn5l2))
    (VP (VBZ is)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP (JJ skeletal_muscle) (NN differentiation))))
              (PP (IN by)
                (S
                  (VP (VBG regulating)
                    (NP (JJ myogenic) (NN gene) (NN expression) (NNS programs))))))))))
    (. .)))

nsubjpass(known-3, Gcn5l2-1)
nsubj:xsubj(play-5, Gcn5l2-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
mark(play-5, to-4)
xcomp(known-3, play-5)
det(role-8, a-6)
amod(role-8, crucial-7)
dobj(play-5, role-8)
case(differentiation-11, in-9)
amod(differentiation-11, skeletal_muscle-10)
nmod:in(role-8, differentiation-11)
mark(regulating-13, by-12)
advcl(play-5, regulating-13)
amod(programs-17, myogenic-14)
compound(programs-17, gene-15)
compound(programs-17, expression-16)
dobj(regulating-13, programs-17)

Therefore/RB ,/, our/PRP$ findings/NNS suggest/VBP that/IN MC1626/NNP may/MD enhance/VB skeletal_muscle/JJ differentiation/NN by/IN modulating/VBG Gcn5l2/JJ protein/NN levels/NNS and/CC function/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP (PRP$ our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP MC1626))
          (VP (MD may)
            (VP (VB enhance)
              (NP (JJ skeletal_muscle) (NN differentiation))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP (JJ Gcn5l2) (NN protein) (NNS levels)
                      (CC and)
                      (NN function))))))))))
    (. .)))

advmod(suggest-5, Therefore-1)
nmod:poss(findings-4, our-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(enhance-9, that-6)
nsubj(enhance-9, MC1626-7)
aux(enhance-9, may-8)
ccomp(suggest-5, enhance-9)
amod(differentiation-11, skeletal_muscle-10)
dobj(enhance-9, differentiation-11)
mark(modulating-13, by-12)
advcl(enhance-9, modulating-13)
amod(levels-16, Gcn5l2-14)
compound(levels-16, protein-15)
dobj(modulating-13, levels-16)
cc(levels-16, and-17)
dobj(modulating-13, function-18)
conj:and(levels-16, function-18)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/JJ molecular/JJ mechanisms/NNS involved/VBN in/IN this/DT process/NN and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN MC1626/NNP for/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ underlying) (JJ molecular) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN process)))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP MC1626))))
                (PP (IN for)
                  (NP (JJ skeletal_muscle) (NNS disorders)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-10, the-7)
amod(mechanisms-10, underlying-8)
amod(mechanisms-10, molecular-9)
dobj(elucidate-6, mechanisms-10)
acl(mechanisms-10, involved-11)
case(process-14, in-12)
det(process-14, this-13)
nmod:in(involved-11, process-14)
cc(elucidate-6, and-15)
mark(explore-17, to-16)
ccomp(needed-4, explore-17)
conj:and(elucidate-6, explore-17)
det(applications-21, the-18)
amod(applications-21, potential-19)
amod(applications-21, therapeutic-20)
dobj(explore-17, applications-21)
case(MC1626-23, of-22)
nmod:of(applications-21, MC1626-23)
case(disorders-26, for-24)
amod(disorders-26, skeletal_muscle-25)
nmod:for(explore-17, disorders-26)

The/DT prevalence/NN of/IN obesity/NN has/VBZ continued/VBN to/TO rise/VB ,/, and/CC it/PRP is/VBZ now/RB considered/VBN a/DT global/JJ epidemic/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN prevalence))
        (PP (IN of)
          (NP (NN obesity))))
      (VP (VBZ has)
        (VP (VBN continued)
          (S
            (VP (TO to)
              (VP (VB rise)))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBZ is) (RB now)
        (VP (VBN considered)
          (NP (DT a) (JJ global) (NN epidemic)))))
    (. .)))

det(prevalence-2, The-1)
nsubj(continued-6, prevalence-2)
nsubj:xsubj(rise-8, prevalence-2)
case(obesity-4, of-3)
nmod:of(prevalence-2, obesity-4)
aux(continued-6, has-5)
root(ROOT-0, continued-6)
mark(rise-8, to-7)
xcomp(continued-6, rise-8)
cc(continued-6, and-10)
nsubjpass(considered-14, it-11)
auxpass(considered-14, is-12)
advmod(considered-14, now-13)
conj:and(continued-6, considered-14)
det(epidemic-17, a-15)
amod(epidemic-17, global-16)
dobj(considered-14, epidemic-17)

The/DT pathogenesis/NN of/IN obesity/NN is/VBZ complex/JJ and/CC multifactorial/JJ ,/, but/CC it/PRP has_been/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN certain/JJ hormones/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN pathogenesis))
        (PP (IN of)
          (NP (NN obesity))))
      (VP (VBZ is)
        (ADJP (JJ complex)
          (CC and)
          (JJ multifactorial))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN hypersecretion))
                (PP (IN of)
                  (NP
                    (NP (JJ certain) (NNS hormones))
                    (PP (IN by)
                      (NP (DT the) (NN pancreas))))))
              (VP (MD may)
                (VP (VB play)
                  (NP (DT a) (NN role)))))))))
    (. .)))

det(pathogenesis-2, The-1)
nsubj(complex-6, pathogenesis-2)
nsubj(multifactorial-8, pathogenesis-2)
case(obesity-4, of-3)
nmod:of(pathogenesis-2, obesity-4)
cop(complex-6, is-5)
root(ROOT-0, complex-6)
cc(complex-6, and-7)
conj:and(complex-6, multifactorial-8)
cc(complex-6, but-10)
nsubj(has_been-12, it-11)
conj:but(complex-6, has_been-12)
dep(has_been-12, suggested-13)
mark(play-24, that-14)
det(hypersecretion-16, the-15)
nsubj(play-24, hypersecretion-16)
case(hormones-19, of-17)
amod(hormones-19, certain-18)
nmod:of(hypersecretion-16, hormones-19)
case(pancreas-22, by-20)
det(pancreas-22, the-21)
nmod:by(hormones-19, pancreas-22)
aux(play-24, may-23)
ccomp(suggested-13, play-24)
det(role-26, a-25)
dobj(play-24, role-26)

One/CD such/JJ hormone/NN is/VBZ arm_1p/NN ,/, which/WDT has_been/VBP shown/VBN to/TO have/VB both/DT metabolic/JJ and/CC anti-inflammatory/JJ effects/NNS ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN hormone))
    (VP (VBZ is)
      (NP
        (NP (NN arm_1p))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB have)
                      (NP (DT both)
                        (ADJP (JJ metabolic)
                          (CC and)
                          (JJ anti-inflammatory))
                        (NNS effects)))))))))))
    (. .)))

nummod(hormone-3, One-1)
amod(hormone-3, such-2)
nsubj(arm_1p-5, hormone-3)
cop(arm_1p-5, is-4)
root(ROOT-0, arm_1p-5)
nsubj(has_been-8, arm_1p-5)
ref(arm_1p-5, which-7)
acl:relcl(arm_1p-5, has_been-8)
dep(has_been-8, shown-9)
mark(have-11, to-10)
xcomp(shown-9, have-11)
det(effects-16, both-12)
amod(effects-16, metabolic-13)
cc(metabolic-13, and-14)
conj:and(metabolic-13, anti-inflammatory-15)
amod(effects-16, anti-inflammatory-15)
dobj(have-11, effects-16)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN arm_1p/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS arm_1p)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(arm_1p-20, of-19)
nmod:of(hypersecretion-18, arm_1p-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO do/VB so/RB ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ PLX3397/NN on/IN the/DT secretion/NN of/IN arm_1p/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- individuals/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB do)
          (ADVP (RB so)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN PLX3397)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ arm_1p) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS individuals)))))))
    (. .)))

mark(do-2, To-1)
advcl(examined-6, do-2)
advmod(do-2, so-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(PLX3397-16, 10-14)
amod(PLX3397-16, mmol/L-15)
nmod:of(effects-8, PLX3397-16)
conj:and(glucose-12, PLX3397-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, arm_1p-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(individuals-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, individuals-39)
conj:and(genetically_obese-28, individuals-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN arm_1p/JJ secretion/NN in/IN response/NN to/TO both/DT glucose/NN and/CC PLX3397/NNP in/IN obese/JJ individuals/NNS compared/VBN to/TO lean/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ arm_1p) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (DT both) (NN glucose))
                    (CC and)
                    (NP (NNP PLX3397))))))
            (PP (IN in)
              (NP
                (NP (JJ obese) (NNS individuals))
                (VP (VBN compared)
                  (PP (TO to)
                    (NP (JJ lean) (NNS individuals))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, arm_1p-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(glucose-17, to-15)
det(glucose-17, both-16)
nmod:to(response-14, glucose-17)
cc(glucose-17, and-18)
nmod:to(response-14, PLX3397-19)
conj:and(glucose-17, PLX3397-19)
case(individuals-22, in-20)
amod(individuals-22, obese-21)
nmod:in(was-6, individuals-22)
acl(individuals-22, compared-23)
case(individuals-26, to-24)
amod(individuals-26, lean-25)
nmod:to(compared-23, individuals-26)

Additionally/RB ,/, insulin_secretion/NN was/VBD also/RB significantly/RB increased/VBN in/IN obese/JJ individuals/NNS in/IN response/NN to/TO glucose/NN but/CC not/RB PLX3397/NNP ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was) (RB also)
      (ADVP (RB significantly))
      (VP (VBN increased)
        (PP (IN in)
          (NP (JJ obese) (NNS individuals)))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP
                (NP (NN glucose))
                (CC but)
                (RB not)
                (NP (NNP PLX3397))))))))
    (. .)))

advmod(increased-7, Additionally-1)
nsubjpass(increased-7, insulin_secretion-3)
auxpass(increased-7, was-4)
advmod(increased-7, also-5)
advmod(increased-7, significantly-6)
root(ROOT-0, increased-7)
case(individuals-10, in-8)
amod(individuals-10, obese-9)
nmod:in(increased-7, individuals-10)
case(response-12, in-11)
nmod:in(increased-7, response-12)
case(glucose-14, to-13)
nmod:to(response-12, glucose-14)
cc(glucose-14, but-15)
neg(PLX3397-17, not-16)
nmod:to(response-12, PLX3397-17)
conj:but(glucose-14, PLX3397-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN arm_1p/NNS may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ,/, potentially/RB through/IN its/PRP$ metabolic/JJ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNS arm_1p))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (ADVP (RB potentially))
                (PP (IN through)
                  (NP
                    (NP (PRP$ its) (JJ metabolic) (NNS effects))
                    (PP (IN on)
                      (NP (NN insulin_secretion)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-10, that-4)
nsubjpass(involved-10, hypersecretion-5)
case(arm_1p-7, of-6)
nmod:of(hypersecretion-5, arm_1p-7)
aux(involved-10, may-8)
auxpass(involved-10, be-9)
ccomp(suggest-3, involved-10)
case(pathogenesis-13, in-11)
det(pathogenesis-13, the-12)
nmod:in(involved-10, pathogenesis-13)
case(obesity-15, of-14)
nmod:of(pathogenesis-13, obesity-15)
advmod(effects-21, potentially-17)
case(effects-21, through-18)
nmod:poss(effects-21, its-19)
amod(effects-21, metabolic-20)
nmod:through(involved-10, effects-21)
case(insulin_secretion-23, on-22)
nmod:on(effects-21, insulin_secretion-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB this/DT relationship/NN and/CC its/PRP$ potential/JJ therapeutic/JJ implications/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT this) (NN relationship))
                (CC and)
                (NP
                  (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS implications))
                  (PP (IN for)
                    (NP (JJ obesity) (NN management))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(relationship-9, this-8)
dobj(elucidate-7, relationship-9)
cc(relationship-9, and-10)
nmod:poss(implications-14, its-11)
amod(implications-14, potential-12)
amod(implications-14, therapeutic-13)
dobj(elucidate-7, implications-14)
conj:and(relationship-9, implications-14)
case(management-17, for-15)
amod(management-17, obesity-16)
nmod:for(implications-14, management-17)

In/IN this/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ study/NN ,/, the/DT effect/NN of/IN OC000459/NNP on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD evaluated/VBN in/IN patients/NNS with/IN migraine/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP OC000459)))
      (PP (IN on)
        (NP
          (NP (NNS bronchospasms))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (NP (NNS patients)))
        (PP (IN with)
          (NP (NN migraine)))))
    (. .)))

case(study-8, In-1)
det(study-8, this-2)
amod(study-8, randomized-3)
amod(study-8, double-blind-5)
amod(study-8, placebo-controlled-7)
nmod:in(evaluated-22, study-8)
det(effect-11, the-10)
nsubjpass(evaluated-22, effect-11)
case(OC000459-13, of-12)
nmod:of(effect-11, OC000459-13)
case(bronchospasms-15, on-14)
nmod:on(effect-11, bronchospasms-15)
nmod:on(effect-11, photophobia-17)
conj:and(bronchospasms-15, photophobia-17)
cc(bronchospasms-15, and-19)
nmod:on(effect-11, phonophobia-20)
conj:and(bronchospasms-15, phonophobia-20)
auxpass(evaluated-22, was-21)
root(ROOT-0, evaluated-22)
case(patients-24, in-23)
nmod:in(evaluated-22, patients-24)
case(migraine-26, with-25)
nmod:with(evaluated-22, migraine-26)

The/DT study/NN included/VBD a/DT total/NN of/IN 500/CD patients/NNS who/WP were/VBD randomized/VBN to/TO receive/VB either/DT OC000459/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD included)
      (NP
        (NP (DT a) (NN total))
        (PP (IN of)
          (NP
            (NP (CD 500) (NNS patients))
            (SBAR
              (WHNP (WP who))
              (S
                (VP (VBD were)
                  (VP (VBN randomized)
                    (S
                      (VP (TO to)
                        (VP (VB receive)
                          (NP (DT either) (NN OC000459)
                            (CC or)
                            (NN placebo)))))))))))))
    (. .)))

det(study-2, The-1)
nsubj(included-3, study-2)
root(ROOT-0, included-3)
det(total-5, a-4)
dobj(included-3, total-5)
case(patients-8, of-6)
nummod(patients-8, 500-7)
nmod:of(total-5, patients-8)
nsubjpass(randomized-11, patients-8)
nsubj:xsubj(receive-13, patients-8)
ref(patients-8, who-9)
auxpass(randomized-11, were-10)
acl:relcl(patients-8, randomized-11)
mark(receive-13, to-12)
xcomp(randomized-11, receive-13)
cc:preconj(OC000459-15, either-14)
dobj(receive-13, OC000459-15)
cc(OC000459-15, or-16)
dobj(receive-13, placebo-17)
conj:or(OC000459-15, placebo-17)

At_2/CD hours/NNS after/IN dosing/VBG ,/, the/DT risk/NN of/IN bronchospasms/NNS was/VBD significantly/RB reduced/VBN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/RB =/SYM 0.0005/CD -RRB-/-RRB- in/IN the/DT OC000459/NNP group/NN compared/VBN to/TO the/DT placebo/NN group/NN ./.

(ROOT
  (S
    (PP
      (NP (CD At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP
      (NP (DT the) (NN risk))
      (PP (IN of)
        (NP (NNS bronchospasms))))
    (VP (VBD was)
      (VP
        (VP
          (ADVP (RB significantly))
          (VBN reduced)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (ADVP (RB P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (PP (IN in)
          (NP
            (NP (DT the) (NNP OC000459) (NN group))
            (VP (VBN compared)
              (PP (TO to)
                (NP (DT the) (NN placebo) (NN group))))))))
    (. .)))

nummod(hours-2, At_2-1)
dep(reduced-12, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
det(risk-7, the-6)
nsubj(reduced-12, risk-7)
case(bronchospasms-9, of-8)
nmod:of(risk-7, bronchospasms-9)
aux(reduced-12, was-10)
advmod(reduced-12, significantly-11)
root(ROOT-0, reduced-12)
case(%-15, by-13)
nummod(%-15, 14-14)
nmod:by(reduced-12, %-15)
nummod(%-18, 95-17)
nsubj(CI-19, %-18)
parataxis(reduced-12, CI-19)
nummod(%-21, 6-20-20)
dobj(CI-19, %-21)
advmod(%-21, P-23)
dep(0.0005-25, =-24)
dep(%-21, 0.0005-25)
case(group-30, in-27)
det(group-30, the-28)
compound(group-30, OC000459-29)
nmod:in(reduced-12, group-30)
acl(group-30, compared-31)
case(group-35, to-32)
det(group-35, the-33)
compound(group-35, placebo-34)
nmod:to(compared-31, group-35)

Similarly/RB ,/, photophobia/NN was/VBD reduced/VBN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- in/IN the/DT OC000459/NNP group/NN compared/VBN to/TO the/DT placebo/NN group/NN ./.

(ROOT
  (S
    (ADVP (RB Similarly))
    (, ,)
    (NP (NN photophobia))
    (VP (VBD was)
      (VP
        (VP (VBN reduced)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (CC and)
        (VP (NN phonophobia)
          (NP (IN by) (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (S
              (NP (CD 95) (NN %))
              (VP (VBP CI)
                (NP (CD 17-20) (NN %))
                (, ,)
                (SBAR
                  (S
                    (NP (NNP P))
                    (VP (VBP <)
                      (NP (CD 0.0001)))))))
            (-RRB- -RRB-))
          (PP (IN in)
            (NP
              (NP (DT the) (NNP OC000459) (NN group))
              (VP (VBN compared)
                (PP (TO to)
                  (NP (DT the) (NN placebo) (NN group)))))))))
    (. .)))

advmod(reduced-5, Similarly-1)
nsubjpass(reduced-5, photophobia-3)
auxpass(reduced-5, was-4)
root(ROOT-0, reduced-5)
case(%-8, by-6)
nummod(%-8, 17-7)
nmod:by(reduced-5, %-8)
nummod(%-11, 95-10)
nsubj(CI-12, %-11)
parataxis(reduced-5, CI-12)
nummod(%-14, 12-22-13)
dobj(CI-12, %-14)
nsubj(<-17, P-16)
dep(CI-12, <-17)
dobj(<-17, 0.0001-18)
cc(reduced-5, and-20)
conj:and(reduced-5, phonophobia-21)
amod(%-24, by-22)
nummod(%-24, 14-23)
dobj(phonophobia-21, %-24)
nummod(%-27, 95-26)
nsubj(CI-28, %-27)
parataxis(phonophobia-21, CI-28)
nummod(%-30, 17-20-29)
dobj(CI-28, %-30)
nsubj(<-33, P-32)
dep(CI-28, <-33)
dobj(<-33, 0.0001-34)
case(group-39, in-36)
det(group-39, the-37)
compound(group-39, OC000459-38)
nmod:in(phonophobia-21, group-39)
acl(group-39, compared-40)
case(group-44, to-41)
det(group-44, the-42)
compound(group-44, placebo-43)
nmod:to(compared-40, group-44)

These/DT results/NNS suggest/VBP that/IN OC000459/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN migraine/JJ patients/NNS experiencing/VBG bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP OC000459))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (JJ migraine) (NNS patients))
                    (VP (VBG experiencing)
                      (NP
                        (NP (NNS bronchospasms))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, OC000459-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-14, for-12)
amod(patients-14, migraine-13)
nmod:for(option-11, patients-14)
acl(patients-14, experiencing-15)
dobj(experiencing-15, bronchospasms-16)
dobj(experiencing-15, photophobia-18)
conj:and(bronchospasms-16, photophobia-18)
cc(bronchospasms-16, and-20)
dobj(experiencing-15, phonophobia-21)
conj:and(bronchospasms-16, phonophobia-21)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT findings/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN of/IN OC000459/NN in/IN migraine/JJ treatment/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP
                      (NP (NN action))
                      (PP (IN of)
                        (NP
                          (NP (NN OC000459))
                          (PP (IN in)
                            (NP (JJ migraine) (NN treatment))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
xcomp(warranted-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(warranted-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)
case(OC000459-17, of-16)
nmod:of(action-15, OC000459-17)
case(treatment-20, in-18)
amod(treatment-20, migraine-19)
nmod:in(OC000459-17, treatment-20)

In/IN the/DT field/NN of/IN biochemistry/NN ,/, enzymes/NNS play/VBP a/DT crucial/JJ role/NN in/IN catalyzing/JJ various/JJ biological/JJ reactions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN field))
        (PP (IN of)
          (NP (NN biochemistry)))))
    (, ,)
    (NP (NNS enzymes))
    (VP (VBP play)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP (JJ catalyzing) (JJ various) (JJ biological) (NNS reactions)))))
    (. .)))

case(field-3, In-1)
det(field-3, the-2)
nmod:in(play-8, field-3)
case(biochemistry-5, of-4)
nmod:of(field-3, biochemistry-5)
nsubj(play-8, enzymes-7)
root(ROOT-0, play-8)
det(role-11, a-9)
amod(role-11, crucial-10)
dobj(play-8, role-11)
case(reactions-16, in-12)
amod(reactions-16, catalyzing-13)
amod(reactions-16, various-14)
amod(reactions-16, biological-15)
nmod:in(role-11, reactions-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT expression/NN and/CC activity/NN levels/NNS of/IN seven/CD key/JJ enzymes/NNS ,/, including/VBG Oleic_acid/NNP dehydrogenase/NN -LRB-/-LRB- ADH/NNP -RRB-/-RRB- ,/, alpha-glycerol-3-phosphate_dehydrogenase/JJ -LRB-/-LRB- alpha/NN GPDH/NNS -RRB-/-RRB- ,/, malate_dehydrogenase/NN -LRB-/-LRB- MDH/NNP -RRB-/-RRB- ,/, isocitrate_dehydrogenase/NN -LRB-/-LRB- IDH/NNP -RRB-/-RRB- ,/, glucose-6-phosphate_dehydrogenase/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- ,/, lipoxygenase-3/JJ -LRB-/-LRB- 6PGD/CD -RRB-/-RRB- and_alpha-amylase/NN -LRB-/-LRB- AMY/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP
            (NP (DT the) (NN expression)
              (CC and)
              (NN activity) (NNS levels))
            (PP (IN of)
              (NP (CD seven) (JJ key) (NNS enzymes))))
          (, ,)
          (NP
            (NP (VBG including) (NNP Oleic_acid) (NN dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP ADH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ alpha-glycerol-3-phosphate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NN alpha) (NNS GPDH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN malate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP MDH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN isocitrate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP IDH))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ glucose-6-phosphate_dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP G6PD))
              (-RRB- -RRB-)))
          (, ,)
          (NP (JJ lipoxygenase-3)
            (PRN (-LRB- -LRB-)
              (NP (CD 6PGD))
              (-RRB- -RRB-))
            (NN and_alpha-amylase)))
        (PRN (-LRB- -LRB-)
          (NP (NNP AMY))
          (-RRB- -RRB-))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(levels-11, the-7)
compound(levels-11, expression-8)
cc(expression-8, and-9)
conj:and(expression-8, activity-10)
compound(levels-11, activity-10)
dobj(investigated-6, levels-11)
case(enzymes-15, of-12)
nummod(enzymes-15, seven-13)
amod(enzymes-15, key-14)
nmod:of(levels-11, enzymes-15)
amod(dehydrogenase-19, including-17)
compound(dehydrogenase-19, Oleic_acid-18)
appos(levels-11, dehydrogenase-19)
appos(dehydrogenase-19, ADH-21)
appos(levels-11, alpha-glycerol-3-phosphate_dehydrogenase-24)
compound(GPDH-27, alpha-26)
appos(alpha-glycerol-3-phosphate_dehydrogenase-24, GPDH-27)
appos(levels-11, malate_dehydrogenase-30)
appos(malate_dehydrogenase-30, MDH-32)
appos(levels-11, isocitrate_dehydrogenase-35)
appos(isocitrate_dehydrogenase-35, IDH-37)
appos(levels-11, glucose-6-phosphate_dehydrogenase-40)
appos(glucose-6-phosphate_dehydrogenase-40, G6PD-42)
amod(and_alpha-amylase-49, lipoxygenase-3-45)
appos(and_alpha-amylase-49, 6PGD-47)
appos(levels-11, and_alpha-amylase-49)
appos(levels-11, AMY-51)

We/PRP used/VBD a/DT combination/NN of/IN biochemical/JJ assays/NNS and/CC gene/NN expression/NN analysis/NN to/TO determine/VB their/PRP$ respective/JJ roles/NNS in/IN cellular/JJ metabolism/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD used)
      (NP
        (NP (DT a) (NN combination))
        (PP (IN of)
          (NP
            (NP (JJ biochemical) (NNS assays))
            (CC and)
            (NP (NN gene) (NN expression) (NN analysis)))))
      (S
        (VP (TO to)
          (VP (VB determine)
            (NP
              (NP (PRP$ their) (JJ respective) (NNS roles))
              (PP (IN in)
                (NP (JJ cellular) (NN metabolism))))))))
    (. .)))

nsubj(used-2, We-1)
root(ROOT-0, used-2)
det(combination-4, a-3)
dobj(used-2, combination-4)
case(assays-7, of-5)
amod(assays-7, biochemical-6)
nmod:of(combination-4, assays-7)
cc(assays-7, and-8)
compound(analysis-11, gene-9)
compound(analysis-11, expression-10)
nmod:of(combination-4, analysis-11)
conj:and(assays-7, analysis-11)
mark(determine-13, to-12)
advcl(used-2, determine-13)
nmod:poss(roles-16, their-14)
amod(roles-16, respective-15)
dobj(determine-13, roles-16)
case(metabolism-19, in-17)
amod(metabolism-19, cellular-18)
nmod:in(roles-16, metabolism-19)

Our/PRP$ results/NNS showed/VBD that/IN each/DT enzyme/NN exhibited/VBD distinct/JJ patterns/NNS of/IN expression/NN and/CC activity/NN levels/NNS ,/, suggesting/VBG their/PRP$ involvement/NN in/IN different/JJ metabolic/JJ pathways/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT each) (NN enzyme))
          (VP (VBD exhibited)
            (NP
              (NP (JJ distinct) (NNS patterns))
              (PP (IN of)
                (NP
                  (NP (NN expression))
                  (CC and)
                  (NP (NN activity) (NNS levels)))))
            (, ,)
            (S
              (VP (VBG suggesting)
                (NP
                  (NP (PRP$ their) (NN involvement))
                  (PP (IN in)
                    (NP (JJ different) (JJ metabolic) (NNS pathways))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(exhibited-7, that-4)
det(enzyme-6, each-5)
nsubj(exhibited-7, enzyme-6)
ccomp(showed-3, exhibited-7)
amod(patterns-9, distinct-8)
dobj(exhibited-7, patterns-9)
case(expression-11, of-10)
nmod:of(patterns-9, expression-11)
cc(expression-11, and-12)
compound(levels-14, activity-13)
nmod:of(patterns-9, levels-14)
conj:and(expression-11, levels-14)
advcl(exhibited-7, suggesting-16)
nmod:poss(involvement-18, their-17)
dobj(suggesting-16, involvement-18)
case(pathways-22, in-19)
amod(pathways-22, different-20)
amod(pathways-22, metabolic-21)
nmod:in(involvement-18, pathways-22)

These/DT findings/NNS provide/VBP important/JJ insights/NNS into/IN the/DT regulation/NN of/IN cellular/JJ metabolism/NN and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS targeting/VBG these/DT enzymes/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ important) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN regulation))
              (PP (IN of)
                (NP (JJ cellular) (NN metabolism)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (VP (VBG targeting)
                      (NP (DT these) (NNS enzymes)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-14, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, important-4)
dobj(provide-3, insights-5)
case(regulation-8, into-6)
det(regulation-8, the-7)
nmod:into(insights-5, regulation-8)
case(metabolism-11, of-9)
amod(metabolism-11, cellular-10)
nmod:of(regulation-8, metabolism-11)
cc(provide-3, and-12)
aux(have-14, may-13)
conj:and(provide-3, have-14)
dobj(have-14, implications-15)
case(development-18, for-16)
det(development-18, the-17)
nmod:for(implications-15, development-18)
case(strategies-22, of-19)
amod(strategies-22, novel-20)
amod(strategies-22, therapeutic-21)
nmod:of(development-18, strategies-22)
acl(strategies-22, targeting-23)
det(enzymes-25, these-24)
dobj(targeting-23, enzymes-25)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN pelrinone/NN on/IN the/DT risk/NN of/IN coronary_artery_thrombosis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN pelrinone))
          (PP (IN on)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNS coronary_artery_thrombosis))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP (NN phonophobia)))))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-20, study-3)
det(effects-6, the-5)
nsubjpass(investigated-20, effects-6)
case(pelrinone-8, of-7)
nmod:of(effects-6, pelrinone-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(pelrinone-8, risk-11)
case(coronary_artery_thrombosis-13, of-12)
nmod:of(risk-11, coronary_artery_thrombosis-13)
nmod:of(risk-11, photophobia-15)
conj:and(coronary_artery_thrombosis-13, photophobia-15)
cc(coronary_artery_thrombosis-13, and-17)
nmod:of(risk-11, phonophobia-18)
conj:and(coronary_artery_thrombosis-13, phonophobia-18)
auxpass(investigated-20, were-19)
root(ROOT-0, investigated-20)

Pelrinone/NNP was/VBD administered/VBN and/CC the/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, it/PRP significantly/RB reduced/VBD the/DT risk/NN of/IN coronary_artery_thrombosis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (NNP Pelrinone))
      (VP (VBD was)
        (VP (VBN administered))))
    (CC and)
    (S
      (NP (DT the) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (PP
              (PP (IN at)
                (NP (CD 2) (NN h)))
              (PP (IN after)
                (S
                  (VP (VBG dosing)))))
            (, ,)
            (NP (PRP it))
            (ADVP (RB significantly))
            (VP (VBD reduced)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNS coronary_artery_thrombosis))))
              (PP (IN by)
                (NP
                  (NP (CD 14) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 95) (NN %))
                      (SBAR
                        (S
                          (VP (VBP CI)
                            (NP
                              (NP
                                (NP (CD 6-20) (NN %))
                                (, ,)
                                (NP (NNP P)))
                              (X
                                (X (SYM =))
                                (NP (CD 0.0005))))))))
                    (-RRB- -RRB-))))
              (, ,)
              (UCP
                (ADJP (JJ photophobia)
                  (PP (IN by)
                    (NP
                      (NP (CD 17) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 95) (NN %))
                          (PP (NNP CI)
                            (NP (CD 12-22) (NN %))))
                        (, ,)
                        (NP (NNP P)
                          (QP (CD <) (CD 0.0001)))
                        (-RRB- -RRB-)))))
                (, ,)
                (CC and)
                (VP (NN phonophobia)
                  (PP (IN by)
                    (NP
                      (NP (CD 14) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 95) (NN %))
                          (PP (NNP CI)
                            (NP (CD 17-20) (NN %))))
                        (, ,)
                        (NP (NNP P)
                          (QP (CD <) (CD 0.0001)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubjpass(administered-3, Pelrinone-1)
auxpass(administered-3, was-2)
root(ROOT-0, administered-3)
cc(administered-3, and-4)
det(results-6, the-5)
nsubj(showed-7, results-6)
conj:and(administered-3, showed-7)
mark(reduced-17, that-8)
case(h-11, at-9)
nummod(h-11, 2-10)
nmod:at(reduced-17, h-11)
mark(dosing-13, after-12)
nmod(h-11, dosing-13)
nsubj(reduced-17, it-15)
advmod(reduced-17, significantly-16)
ccomp(showed-7, reduced-17)
det(risk-19, the-18)
dobj(reduced-17, risk-19)
case(coronary_artery_thrombosis-21, of-20)
nmod:of(risk-19, coronary_artery_thrombosis-21)
case(%-24, by-22)
nummod(%-24, 14-23)
nmod:by(reduced-17, %-24)
nummod(%-27, 95-26)
dep(%-24, %-27)
acl:relcl(%-27, CI-28)
nummod(%-30, 6-20-29)
dobj(CI-28, %-30)
appos(%-30, P-32)
dep(0.0005-34, =-33)
dep(%-30, 0.0005-34)
xcomp(reduced-17, photophobia-37)
case(%-40, by-38)
nummod(%-40, 17-39)
nmod:by(photophobia-37, %-40)
nummod(%-43, 95-42)
appos(%-40, %-43)
dep(%-46, CI-44)
nummod(%-46, 12-22-45)
nmod(%-43, %-46)
dep(%-43, P-48)
compound(0.0001-50, <-49)
nummod(P-48, 0.0001-50)
cc(photophobia-37, and-53)
xcomp(reduced-17, phonophobia-54)
conj:and(photophobia-37, phonophobia-54)
case(%-57, by-55)
nummod(%-57, 14-56)
nmod:by(phonophobia-54, %-57)
nummod(%-60, 95-59)
appos(%-57, %-60)
dep(%-63, CI-61)
nummod(%-63, 17-20-62)
nmod(%-60, %-63)
dep(%-60, P-65)
compound(0.0001-67, <-66)
nummod(P-65, 0.0001-67)

These/DT findings/NNS suggest/VBP that/IN pelrinone/NN may/MD have/VB potential/JJ therapeutic/JJ benefits/NNS in/IN reducing/VBG the/DT risk/NN of/IN coronary_artery_thrombosis/NNS and/CC alleviating/VBG photophobia/NN and/CC phonophobia/NN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN pelrinone))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ potential) (JJ therapeutic) (NNS benefits))
              (PP (IN in)
                (S
                  (VP
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNS coronary_artery_thrombosis)))))
                    (CC and)
                    (VP (VBG alleviating)
                      (NP
                        (NP (NN photophobia))
                        (CC and)
                        (NP (NN phonophobia) (NNS symptoms))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, pelrinone-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(benefits-10, potential-8)
amod(benefits-10, therapeutic-9)
dobj(have-7, benefits-10)
mark(reducing-12, in-11)
advcl(have-7, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(coronary_artery_thrombosis-16, of-15)
nmod:of(risk-14, coronary_artery_thrombosis-16)
cc(reducing-12, and-17)
advcl(have-7, alleviating-18)
conj:and(reducing-12, alleviating-18)
dobj(alleviating-18, photophobia-19)
cc(photophobia-19, and-20)
compound(symptoms-22, phonophobia-21)
dobj(alleviating-18, symptoms-22)
conj:and(photophobia-19, symptoms-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(mechanisms-8, the-7)
dobj(explore-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(explore-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(explore-6, determine-14)
amod(dosages-16, optimal-15)
dobj(determine-14, dosages-16)
case(use-19, for-17)
amod(use-19, clinical-18)
nmod:for(determine-14, use-19)

Obesity/JJ is_a/NN complex_disorder/VBP that/IN is/VBZ influenced/VBN by/IN both/DT genetic/JJ and/CC environmental/JJ factors/NNS ./.

(ROOT
  (S
    (NP (JJ Obesity) (NN is_a))
    (VP (VBP complex_disorder)
      (SBAR (IN that)
        (S
          (VP (VBZ is)
            (VP (VBN influenced)
              (PP (IN by)
                (NP (DT both)
                  (ADJP (JJ genetic)
                    (CC and)
                    (JJ environmental))
                  (NNS factors))))))))
    (. .)))

amod(is_a-2, Obesity-1)
nsubj(complex_disorder-3, is_a-2)
root(ROOT-0, complex_disorder-3)
mark(influenced-6, that-4)
auxpass(influenced-6, is-5)
ccomp(complex_disorder-3, influenced-6)
case(factors-12, by-7)
det(factors-12, both-8)
amod(factors-12, genetic-9)
cc(genetic-9, and-10)
conj:and(genetic-9, environmental-11)
amod(factors-12, environmental-11)
nmod:by(influenced-6, factors-12)

The/DT role/NN of/IN pancreatic/JJ PGH_synthase_1/NNS -LRB-/-LRB- PGHS-1/NNP -RRB-/-RRB- hypersecretion/VBN in/IN the/DT development/NN of/IN obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The) (NN role))
          (PP (IN of)
            (NP (JJ pancreatic) (NNS PGH_synthase_1))))
        (PRN (-LRB- -LRB-)
          (NP (NNP PGHS-1))
          (-RRB- -RRB-)))
      (VP (VBN hypersecretion)
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (NN obesity)))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

det(role-2, The-1)
nsubj(remains-15, role-2)
case(PGH_synthase_1-5, of-3)
amod(PGH_synthase_1-5, pancreatic-4)
nmod:of(role-2, PGH_synthase_1-5)
appos(role-2, PGHS-1-7)
acl(role-2, hypersecretion-9)
case(development-12, in-10)
det(development-12, the-11)
nmod:in(hypersecretion-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
root(ROOT-0, remains-15)
xcomp(remains-15, unclear-16)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN PGH_synthase_1/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS PGH_synthase_1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(PGH_synthase_1-20, of-19)
nmod:of(hypersecretion-18, PGH_synthase_1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN MF-tricyclic/NNP on/IN the/DT secretion/NN of/IN PGH_synthase_1/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP MF-tricyclic)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ PGH_synthase_1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(MF-tricyclic-16, 10-14)
compound(MF-tricyclic-16, mmol/L-15)
nmod:of(effects-8, MF-tricyclic-16)
conj:and(glucose-12, MF-tricyclic-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, PGH_synthase_1-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN PGHS-1/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC MF-tricyclic/JJ stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ PGHS-1) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (VBN isolated) (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP
                            (NP (DT both) (NN glucose))
                            (CC and)
                            (NP (JJ MF-tricyclic) (NN stimulation))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-17, that-4)
amod(secretion-6, PGHS-1-5)
nsubjpass(compared-17, secretion-6)
nsubj:xsubj(lean-19, secretion-6)
auxpass(compared-17, was-7)
advmod(higher-9, significantly-8)
advmod(compared-17, higher-9)
case(pancreata-13, in-10)
amod(pancreata-13, isolated-11)
amod(pancreata-13, perfused-12)
nmod:in(higher-9, pancreata-13)
case(rats-16, from-14)
amod(rats-16, genetically_obese-15)
nmod:from(pancreata-13, rats-16)
ccomp(showed-3, compared-17)
mark(lean-19, to-18)
xcomp(compared-17, lean-19)
dobj(lean-19, rats-20)
case(response-22, in-21)
nmod:in(lean-19, response-22)
case(glucose-25, to-23)
det(glucose-25, both-24)
nmod:to(response-22, glucose-25)
cc(glucose-25, and-26)
amod(stimulation-28, MF-tricyclic-27)
nmod:to(response-22, stimulation-28)
conj:and(glucose-25, stimulation-28)

Additionally/RB ,/, insulin_secretion/NN was/VBD significantly/RB lower/JJR in/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC MF-tricyclic/JJ stimulation/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (ADVP
        (ADVP (RB significantly) (JJR lower))
        (PP (IN in)
          (NP
            (NP (VBN isolated) (JJ perfused) (NN pancreata))
            (PP (IN from)
              (NP (JJ genetically_obese) (NNS rats))))))
      (VP (VBN compared)
        (S
          (VP (TO to)
            (VP (VB lean)
              (NP (NNS rats))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP
                      (NP (DT both) (NN glucose))
                      (CC and)
                      (NP (JJ MF-tricyclic) (NN stimulation)))))))))))
    (. .)))

advmod(compared-14, Additionally-1)
nsubjpass(compared-14, insulin_secretion-3)
nsubj:xsubj(lean-16, insulin_secretion-3)
auxpass(compared-14, was-4)
advmod(lower-6, significantly-5)
advmod(compared-14, lower-6)
case(pancreata-10, in-7)
amod(pancreata-10, isolated-8)
amod(pancreata-10, perfused-9)
nmod:in(lower-6, pancreata-10)
case(rats-13, from-11)
amod(rats-13, genetically_obese-12)
nmod:from(pancreata-10, rats-13)
root(ROOT-0, compared-14)
mark(lean-16, to-15)
xcomp(compared-14, lean-16)
dobj(lean-16, rats-17)
case(response-19, in-18)
nmod:in(lean-16, response-19)
case(glucose-22, to-20)
det(glucose-22, both-21)
nmod:to(response-19, glucose-22)
cc(glucose-22, and-23)
amod(stimulation-25, MF-tricyclic-24)
nmod:to(response-19, stimulation-25)
conj:and(glucose-22, stimulation-25)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN PGH_synthase_1/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, potentially/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS PGH_synthase_1))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB play)
              (NP (DT a) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (, ,)
              (ADVP (RB potentially))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(PGH_synthase_1-7, of-6)
nmod:of(hypersecretion-5, PGH_synthase_1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(PGH_synthase_1-7, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(play-12, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
advmod(effects-24, potentially-21)
case(effects-24, through-22)
nmod:poss(effects-24, its-23)
nmod:through(play-12, effects-24)
case(insulin_secretion-26, on-25)
nmod:on(effects-24, insulin_secretion-26)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT relationship/NN ,/, which/WDT may/MD provide/VB new/JJ insights/NNS into/IN potential/JJ therapeutic/JJ targets/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT this) (NN relationship))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD may)
                            (VP (VB provide)
                              (NP
                                (NP (JJ new) (NNS insights))
                                (PP (IN into)
                                  (NP
                                    (NP (JJ potential) (JJ therapeutic) (NNS targets))
                                    (PP (IN for)
                                      (NP (JJ obesity) (NN management)))))))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(relationship-13, in-11)
det(relationship-13, this-12)
nmod:in(involved-10, relationship-13)
nsubj(provide-17, relationship-13)
ref(relationship-13, which-15)
aux(provide-17, may-16)
acl:relcl(relationship-13, provide-17)
amod(insights-19, new-18)
dobj(provide-17, insights-19)
case(targets-23, into-20)
amod(targets-23, potential-21)
amod(targets-23, therapeutic-22)
nmod:into(insights-19, targets-23)
case(management-26, for-24)
amod(management-26, obesity-25)
nmod:for(targets-23, management-26)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-17, omega-3_fatty_acids-2)
nsubj:xsubj(have-19, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
mark(have-19, to-18)
xcomp(shown-17, have-19)
amod(benefits-22, various-20)
compound(benefits-22, health-21)
dobj(have-19, benefits-22)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN Zol/NNP in/IN hyperZolmic/JJ patients/NNS and/CC a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NNP Zol))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperZolmic) (NNS patients))
                              (CC and)
                              (NP
                                (NP (DT a) (VBN reduced) (NN risk))
                                (PP (IN of)
                                  (S
                                    (VP (VBG developing)
                                      (NP (NN coronary_heart_disease)))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(Zol-14, of-13)
nmod:of(levels-12, Zol-14)
case(patients-17, in-15)
amod(patients-17, hyperZolmic-16)
nmod:in(Zol-14, patients-17)
cc(patients-17, and-18)
det(risk-21, a-19)
amod(risk-21, reduced-20)
nmod:in(Zol-14, risk-21)
conj:and(patients-17, risk-21)
mark(developing-23, of-22)
acl(risk-21, developing-23)
dobj(developing-23, coronary_heart_disease-24)
appos(Zol-14, CHD-26)

EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ effects/NNS through/IN several/JJ mechanisms/NNS ,/, such/JJ as/IN reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC enhancing/VBG endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBD exert)
      (NP (PRP$ their) (NNS effects))
      (PP (IN through)
        (NP
          (NP (JJ several) (NNS mechanisms))
          (, ,)
          (PP (JJ such) (IN as)
            (S
              (VP
                (VP (VBG reducing)
                  (NP (NN inflammation)))
                (, ,)
                (VP (VBG improving)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (CC and)
                (VP (VBG enhancing)
                  (NP (JJ endothelial) (NN function)))))))))
    (. .)))

nsubj(exert-4, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubj(exert-4, DHA-3)
root(ROOT-0, exert-4)
nmod:poss(effects-6, their-5)
dobj(exert-4, effects-6)
case(mechanisms-9, through-7)
amod(mechanisms-9, several-8)
nmod:through(exert-4, mechanisms-9)
mark(reducing-13, such-11)
mwe(such-11, as-12)
acl(mechanisms-9, reducing-13)
dobj(reducing-13, inflammation-14)
acl(mechanisms-9, improving-16)
conj:and(reducing-13, improving-16)
compound(profiles-18, lipid-17)
dobj(improving-16, profiles-18)
cc(reducing-13, and-20)
acl(mechanisms-9, enhancing-21)
conj:and(reducing-13, enhancing-21)
amod(function-23, endothelial-22)
dobj(enhancing-21, function-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG and/CC managing/VBG CHD/NNP and/CC hyperZolmia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (CC and)
                    (VBG managing)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (NN hyperZolmia)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, promising-14)
ccomp(suggest-3, strategy-15)
mark(preventing-17, for-16)
advcl(strategy-15, preventing-17)
cc(preventing-17, and-18)
advcl(strategy-15, managing-19)
conj:and(preventing-17, managing-19)
dobj(preventing-17, CHD-20)
cc(CHD-20, and-21)
dobj(preventing-17, hyperZolmia-22)
conj:and(CHD-20, hyperZolmia-22)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT exact/JJ mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN these/DT fatty_acids/NNS on/IN Zol/JJ levels/NNS and/CC CHD/NNP risk/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ exact) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT the) (JJ beneficial) (NNS effects))
                    (PP (IN of)
                      (NP (DT these) (NNS fatty_acids))))))
              (PP (IN on)
                (NP
                  (NP (JJ Zol) (NNS levels))
                  (CC and)
                  (NP (NNP CHD) (NN risk)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, exact-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-13, the-11)
amod(effects-13, beneficial-12)
dobj(underlying-10, effects-13)
case(fatty_acids-16, of-14)
det(fatty_acids-16, these-15)
nmod:of(effects-13, fatty_acids-16)
case(levels-19, on-17)
amod(levels-19, Zol-18)
nmod:on(elucidate-6, levels-19)
cc(levels-19, and-20)
compound(risk-22, CHD-21)
nmod:on(elucidate-6, risk-22)
conj:and(levels-19, risk-22)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/NN associated/VBN with/IN decreased/VBN oxypeucedanin/NN levels/NNS in/IN hyperoxypeucedaninmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NN oxypeucedanin) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperoxypeucedaninmic) (NNS patients))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-18, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
aux(shown-18, have-16)
auxpass(shown-18, been-17)
root(ROOT-0, shown-18)
dobj(shown-18, to_be-19)
acl(to_be-19, associated-20)
case(levels-24, with-21)
amod(levels-24, decreased-22)
compound(levels-24, oxypeucedanin-23)
nmod:with(associated-20, levels-24)
case(patients-27, in-25)
amod(patients-27, hyperoxypeucedaninmic-26)
nmod:in(levels-24, patients-27)

Additionally/RB ,/, numerous/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ numerous) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(demonstrated-6, Additionally-1)
amod(studies-4, numerous-3)
nsubj(demonstrated-6, studies-4)
aux(demonstrated-6, have-5)
root(ROOT-0, demonstrated-6)
mark(associated-11, that-7)
det(fatty_acids-9, these-8)
nsubjpass(associated-11, fatty_acids-9)
auxpass(associated-11, are-10)
ccomp(demonstrated-6, associated-11)
case(risk-15, with-12)
det(risk-15, a-13)
amod(risk-15, decreased-14)
nmod:with(associated-11, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS mechanisms))
    (VP
      (VP
        (PP (IN by)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (VBD exert)
                (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))
        (VBP are)
        (ADVP (RB not))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP (JJ anti-inflammatory)
            (CC and)
            (JJ anti-thrombotic) (NNS properties)))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-15, mechanisms-2)
nsubj(involve-19, mechanisms-2)
mark(exert-8, by-3)
dobj(exert-8, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
advcl(understood-15, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, cardioprotective-10)
dobj(exert-8, effects-11)
auxpass(understood-15, are-12)
neg(understood-15, not-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-17)
aux(involve-19, may-18)
conj:but(understood-15, involve-19)
amod(properties-23, anti-inflammatory-20)
cc(anti-inflammatory-20, and-21)
conj:and(anti-inflammatory-20, anti-thrombotic-22)
amod(properties-23, anti-thrombotic-22)
dobj(involve-19, properties-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT simple/JJ and/CC effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a)
                  (ADJP (JJ simple)
                    (CC and)
                    (JJ effective))
                  (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ high-risk) (NNS individuals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-16, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(strategy-16, may-10)
cop(strategy-16, be-11)
det(strategy-16, a-12)
amod(strategy-16, simple-13)
cc(simple-13, and-14)
conj:and(simple-13, effective-15)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
case(individuals-25, in-23)
amod(individuals-25, high-risk-24)
nmod:in(reducing-18, individuals-25)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT a) (JJ healthy) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- by/IN decreasing/VBG phosphorus-32/JJ levels/NNS in/IN hyperphosphorus-32mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP
                  (NP (DT a) (JJ protective) (NN effect))
                  (PP (IN against)
                    (NP (NN coronary_heart_disease))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP CHD))
                  (-RRB- -RRB-)))
              (PP (IN by)
                (S
                  (VP (VBG decreasing)
                    (NP
                      (NP (JJ phosphorus-32) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hyperphosphorus-32mic) (NNS patients))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(have-9, that-4)
det(omega-3_fatty_acids-7, these-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(have-9, omega-3_fatty_acids-7)
aux(have-9, may-8)
ccomp(suggest-3, have-9)
det(effect-12, a-10)
amod(effect-12, protective-11)
dobj(have-9, effect-12)
case(coronary_heart_disease-14, against-13)
nmod:against(effect-12, coronary_heart_disease-14)
appos(effect-12, CHD-16)
mark(decreasing-19, by-18)
advcl(have-9, decreasing-19)
amod(levels-21, phosphorus-32-20)
dobj(decreasing-19, levels-21)
case(patients-24, in-22)
amod(patients-24, hyperphosphorus-32mic-23)
nmod:in(levels-21, patients-24)

The/DT mechanism/NN behind/IN this/DT effect/NN is/VBZ thought/VBN to_be/NN related/VBN to/TO the/DT ability/NN of/IN EPA/NNP and/CC DHA/NNP to/TO inhibit/VB the/DT production/NN of/IN pro-inflammatory/JJ cytokines/NNS ,/, which/WDT are/VBP known/VBN to/TO contribute/VB to/TO the/DT development/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN mechanism))
      (PP (IN behind)
        (NP (DT this) (NN effect))))
    (VP (VBZ is)
      (VP (VBN thought)
        (S
          (NP
            (NP (NN to_be))
            (VP (VBN related)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN ability))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA)))))))
          (VP (TO to)
            (VP (VB inhibit)
              (NP
                (NP (DT the) (NN production))
                (PP (IN of)
                  (NP
                    (NP (JJ pro-inflammatory) (NNS cytokines))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP are)
                          (VP (VBN known)
                            (S
                              (VP (TO to)
                                (VP (VB contribute)
                                  (PP (TO to)
                                    (NP
                                      (NP (DT the) (NN development))
                                      (PP (IN of)
                                        (NP (NNP CHD))))))))))))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(thought-7, mechanism-2)
case(effect-5, behind-3)
det(effect-5, this-4)
nmod:behind(mechanism-2, effect-5)
auxpass(thought-7, is-6)
root(ROOT-0, thought-7)
dobj(thought-7, to_be-8)
nsubj:xsubj(inhibit-18, to_be-8)
acl(to_be-8, related-9)
case(ability-12, to-10)
det(ability-12, the-11)
nmod:to(related-9, ability-12)
case(EPA-14, of-13)
nmod:of(ability-12, EPA-14)
cc(EPA-14, and-15)
nmod:of(ability-12, DHA-16)
conj:and(EPA-14, DHA-16)
mark(inhibit-18, to-17)
xcomp(thought-7, inhibit-18)
det(production-20, the-19)
dobj(inhibit-18, production-20)
case(cytokines-23, of-21)
amod(cytokines-23, pro-inflammatory-22)
nmod:of(production-20, cytokines-23)
nsubjpass(known-27, cytokines-23)
nsubj:xsubj(contribute-29, cytokines-23)
ref(cytokines-23, which-25)
auxpass(known-27, are-26)
acl:relcl(cytokines-23, known-27)
mark(contribute-29, to-28)
xcomp(known-27, contribute-29)
case(development-32, to-30)
det(development-32, the-31)
nmod:to(contribute-29, development-32)
case(CHD-34, of-33)
nmod:of(development-32, CHD-34)

This/DT finding/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN developing/VBG CHD/NNP ,/, particularly/RB in/IN individuals/NNS with/IN high/JJ levels/NNS of/IN phosphorus-32/JJ ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NNP CHD))
                              (, ,)
                              (PP
                                (ADVP (RB particularly))
                                (IN in)
                                (NP
                                  (NP (NNS individuals))
                                  (PP (IN with)
                                    (NP
                                      (NP (JJ high) (NNS levels))
                                      (PP (IN of)
                                        (NP (JJ phosphorus-32))))))))))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(strategy-15, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-15, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggests-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, CHD-22)
advmod(individuals-26, particularly-24)
case(individuals-26, in-25)
nmod:in(developing-21, individuals-26)
case(levels-29, with-27)
amod(levels-29, high-28)
nmod:with(individuals-26, levels-29)
case(phosphorus-32-31, of-30)
nmod:of(levels-29, phosphorus-32-31)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT potential/JJ benefits/NNS of/IN omega-3_fatty_acids/JJ in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (JJ potential) (NNS benefits))
                (PP (IN of)
                  (NP (JJ omega-3_fatty_acids))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN treatment))
                  (PP (IN of)
                    (NP (NNP CHD))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(benefits-10, the-8)
amod(benefits-10, potential-9)
dobj(understand-7, benefits-10)
case(omega-3_fatty_acids-12, of-11)
nmod:of(benefits-10, omega-3_fatty_acids-12)
case(prevention-15, in-13)
det(prevention-15, the-14)
nmod:in(understand-7, prevention-15)
cc(prevention-15, and-16)
nmod:in(understand-7, treatment-17)
conj:and(prevention-15, treatment-17)
case(CHD-19, of-18)
nmod:of(prevention-15, CHD-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN linked/VBN to/TO numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(linked-20, nutrients-16)
ref(nutrients-16, that-17)
aux(linked-20, have-18)
auxpass(linked-20, been-19)
acl:relcl(nutrients-16, linked-20)
case(benefits-24, to-21)
amod(benefits-24, numerous-22)
compound(benefits-24, health-23)
nmod:to(linked-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN polyketide/JJ levels/NNS in/IN hyperpolyketidemic/JJ patients/NNS and/CC a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ polyketide) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperpolyketidemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (DT a) (VBN reduced) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, polyketide-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperpolyketidemic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
det(risk-20, a-18)
amod(risk-20, reduced-19)
nmod:in(levels-13, risk-20)
conj:and(patients-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

Polyketides/NNS are/VBP a/DT class/NN of/IN natural/JJ products/NNS that/WDT are/VBP synthesized/VBN by/IN bacteria/NNS ,/, fungi/NNS ,/, and/CC plants/NNS ./.

(ROOT
  (S
    (NP (NNS Polyketides))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN class))
        (PP (IN of)
          (NP (JJ natural) (NNS products)))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP are)
              (VP (VBN synthesized)
                (PP (IN by)
                  (NP
                    (NP (NNS bacteria))
                    (, ,)
                    (NP (NNS fungi))
                    (, ,)
                    (CC and)
                    (NP (NNS plants))))))))))
    (. .)))

nsubj(class-4, Polyketides-1)
cop(class-4, are-2)
det(class-4, a-3)
root(ROOT-0, class-4)
nsubjpass(synthesized-10, class-4)
case(products-7, of-5)
amod(products-7, natural-6)
nmod:of(class-4, products-7)
ref(class-4, that-8)
auxpass(synthesized-10, are-9)
acl:relcl(class-4, synthesized-10)
case(bacteria-12, by-11)
nmod:by(synthesized-10, bacteria-12)
nmod:by(synthesized-10, fungi-14)
conj:and(bacteria-12, fungi-14)
cc(bacteria-12, and-16)
nmod:by(synthesized-10, plants-17)
conj:and(bacteria-12, plants-17)

Elevated/JJ polyketide/JJ levels/NNS have/VBP been/VBN linked/VBN to/TO an/DT increased/VBN risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (JJ Elevated) (JJ polyketide) (NNS levels))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT an) (VBN increased) (NN risk))
              (PP (IN of)
                (NP (NNP CHD))))))))
    (. .)))

amod(levels-3, Elevated-1)
amod(levels-3, polyketide-2)
nsubjpass(linked-6, levels-3)
aux(linked-6, have-4)
auxpass(linked-6, been-5)
root(ROOT-0, linked-6)
case(risk-10, to-7)
det(risk-10, an-8)
amod(risk-10, increased-9)
nmod:to(linked-6, risk-10)
case(CHD-12, of-11)
nmod:of(risk-10, CHD-12)

EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO lower/JJR polyketide/JJ levels/NNS through/IN their/PRP$ anti-inflammatory/JJ effects/NNS and/CC ability/NN to/TO modulate/VBP lipid/NN metabolism/NN ./.

(ROOT
  (S
    (S
      (NP (NNP EPA)
        (CC and)
        (NNP DHA))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (PP (TO to)
              (NP (JJR lower) (JJ polyketide) (NNS levels)))
            (PP (IN through)
              (NP (PRP$ their) (JJ anti-inflammatory) (NNS effects)))))))
    (CC and)
    (S
      (NP (NN ability)
        (S
          (VP (TO to))))
      (VP (VBP modulate)
        (NP (NN lipid) (NN metabolism))))
    (. .)))

nsubjpass(shown-6, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(shown-6, DHA-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
case(levels-10, to-7)
amod(levels-10, lower-8)
amod(levels-10, polyketide-9)
nmod:to(shown-6, levels-10)
case(effects-14, through-11)
nmod:poss(effects-14, their-12)
amod(effects-14, anti-inflammatory-13)
nmod:through(shown-6, effects-14)
cc(shown-6, and-15)
nsubj(modulate-18, ability-16)
acl(ability-16, to-17)
conj:and(shown-6, modulate-18)
compound(metabolism-20, lipid-19)
dobj(modulate-18, metabolism-20)

In/IN addition/NN to/TO their/PRP$ cardioprotective/JJ effects/NNS ,/, omega-3_fatty_acids/JJ have/VBP also/RB been/VBN linked/VBN to/TO improved/VBN cognitive/JJ function/NN ,/, reduced/VBN inflammation/NN ,/, and/CC a/DT lower/JJR risk/NN of/IN certain/JJ cancers/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (VBN improved) (JJ cognitive) (NN function))
              (, ,)
              (NP (VBN reduced) (NN inflammation))
              (, ,)
              (CC and)
              (NP
                (NP (DT a) (JJR lower) (NN risk))
                (PP (IN of)
                  (NP (JJ certain) (NNS cancers)))))))))
    (. .)))

case(effects-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(effects-6, their-4)
amod(effects-6, cardioprotective-5)
nmod:in_addition_to(linked-12, effects-6)
nsubjpass(linked-12, omega-3_fatty_acids-8)
aux(linked-12, have-9)
advmod(linked-12, also-10)
auxpass(linked-12, been-11)
root(ROOT-0, linked-12)
case(function-16, to-13)
amod(function-16, improved-14)
amod(function-16, cognitive-15)
nmod:to(linked-12, function-16)
amod(inflammation-19, reduced-18)
nmod:to(linked-12, inflammation-19)
conj:and(function-16, inflammation-19)
cc(function-16, and-21)
det(risk-24, a-22)
amod(risk-24, lower-23)
nmod:to(linked-12, risk-24)
conj:and(function-16, risk-24)
case(cancers-27, of-25)
amod(cancers-27, certain-26)
nmod:of(risk-24, cancers-27)

These/DT findings/NNS underscore/VBP the/DT importance/NN of/IN including/VBG adequate/JJ amounts/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT diet/NN for/IN overall/JJ health/NN and_disease/NN prevention/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP underscore)
      (NP
        (NP (DT the) (NN importance))
        (PP (IN of)
          (S
            (VP (VBG including)
              (NP
                (NP (JJ adequate) (NNS amounts))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA)))))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN diet))
            (PP (IN for)
              (NP (JJ overall) (NN health) (NN and_disease) (NN prevention)))))))
    (. .)))

det(findings-2, These-1)
nsubj(underscore-3, findings-2)
root(ROOT-0, underscore-3)
det(importance-5, the-4)
dobj(underscore-3, importance-5)
mark(including-7, of-6)
acl(importance-5, including-7)
amod(amounts-9, adequate-8)
dobj(including-7, amounts-9)
case(EPA-11, of-10)
nmod:of(amounts-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(amounts-9, DHA-13)
conj:and(EPA-11, DHA-13)
case(diet-16, in-14)
det(diet-16, the-15)
nmod:in(importance-5, diet-16)
case(prevention-21, for-17)
amod(prevention-21, overall-18)
compound(prevention-21, health-19)
compound(prevention-21, and_disease-20)
nmod:for(diet-16, prevention-21)

Enzymes/NNS play/VBP a/DT critical/JJ role/NN in/IN the/DT regulation/NN of/IN metabolic/JJ processes/NNS in/IN living/NN organisms/NNS ./.

(ROOT
  (S
    (NP (NNS Enzymes))
    (VP (VBP play)
      (NP
        (NP (DT a) (JJ critical) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (JJ metabolic) (NNS processes))
                (PP (IN in)
                  (NP (NN living) (NNS organisms)))))))))
    (. .)))

nsubj(play-2, Enzymes-1)
root(ROOT-0, play-2)
det(role-5, a-3)
amod(role-5, critical-4)
dobj(play-2, role-5)
case(regulation-8, in-6)
det(regulation-8, the-7)
nmod:in(role-5, regulation-8)
case(processes-11, of-9)
amod(processes-11, metabolic-10)
nmod:of(regulation-8, processes-11)
case(organisms-14, in-12)
compound(organisms-14, living-13)
nmod:in(processes-11, organisms-14)

In/IN this/DT study/NN ,/, we/PRP identified/VBD several/JJ key/JJ enzymes/NNS involved/VBN in/IN various/JJ metabolic/JJ pathways/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD identified)
      (NP
        (NP (JJ several) (JJ key) (NNS enzymes))
        (VP (VBN involved)
          (PP (IN in)
            (NP (JJ various) (JJ metabolic) (NNS pathways))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(identified-6, study-3)
nsubj(identified-6, we-5)
root(ROOT-0, identified-6)
amod(enzymes-9, several-7)
amod(enzymes-9, key-8)
dobj(identified-6, enzymes-9)
acl(enzymes-9, involved-10)
case(pathways-14, in-11)
amod(pathways-14, various-12)
amod(pathways-14, metabolic-13)
nmod:in(involved-10, pathways-14)

These/DT enzymes/NNS included/VBD 4-hydroxybiphenyl/JJ dehydrogenase/JJ -LRB-/-LRB- ADH/NNP -RRB-/-RRB- ,/, alpha-glycerol-3-phosphate_dehydrogenase/JJ -LRB-/-LRB- alpha/NN GPDH/NNS -RRB-/-RRB- ,/, malate_dehydrogenase/JJ -LRB-/-LRB- MDH/NNP -RRB-/-RRB- ,/, isocitrate_dehydrogenase/JJ -LRB-/-LRB- IDH/NNP -RRB-/-RRB- ,/, glucose-6-phosphate_dehydrogenase/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- ,/, GlcAT-D/JJ -LRB-/-LRB- 6PGD/CD -RRB-/-RRB- and_alpha-amylase/JJ -LRB-/-LRB- AMY/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS enzymes))
    (VP (VBD included)
      (ADJP
        (ADJP (JJ 4-hydroxybiphenyl) (JJ dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP ADH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ alpha-glycerol-3-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NN alpha) (NNS GPDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ malate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP MDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ isocitrate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP IDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ glucose-6-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP G6PD))
          (-RRB- -RRB-))
        (, ,)
        (ADJP
          (ADJP
            (ADJP (JJ GlcAT-D))
            (PRN (-LRB- -LRB-)
              (NP (CD 6PGD))
              (-RRB- -RRB-)))
          (ADJP (JJ and_alpha-amylase)))
        (PRN (-LRB- -LRB-)
          (NP (NNP AMY))
          (-RRB- -RRB-))))
    (. .)))

det(enzymes-2, These-1)
nsubj(included-3, enzymes-2)
root(ROOT-0, included-3)
amod(dehydrogenase-5, 4-hydroxybiphenyl-4)
xcomp(included-3, dehydrogenase-5)
dep(dehydrogenase-5, ADH-7)
dep(dehydrogenase-5, alpha-glycerol-3-phosphate_dehydrogenase-10)
compound(GPDH-13, alpha-12)
dep(dehydrogenase-5, GPDH-13)
dep(dehydrogenase-5, malate_dehydrogenase-16)
dep(dehydrogenase-5, MDH-18)
dep(dehydrogenase-5, isocitrate_dehydrogenase-21)
dep(dehydrogenase-5, IDH-23)
dep(dehydrogenase-5, glucose-6-phosphate_dehydrogenase-26)
dep(dehydrogenase-5, G6PD-28)
dep(dehydrogenase-5, GlcAT-D-31)
dep(GlcAT-D-31, 6PGD-33)
dep(GlcAT-D-31, and_alpha-amylase-35)
dep(dehydrogenase-5, AMY-37)

The/DT activity/NN of/IN these/DT enzymes/NNS was/VBD analyzed/VBN using/VBG various/JJ biochemical/JJ assays/NNS ,/, and/CC their/PRP$ potential/JJ roles/NNS in/IN cellular/JJ metabolism/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN activity))
        (PP (IN of)
          (NP (DT these) (NNS enzymes))))
      (VP (VBD was)
        (VP (VBN analyzed)
          (S
            (VP (VBG using)
              (NP (JJ various) (JJ biochemical) (NNS assays)))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (PRP$ their) (JJ potential) (NNS roles))
        (PP (IN in)
          (NP (JJ cellular) (NN metabolism))))
      (VP (VBD were)
        (VP (VBN investigated))))
    (. .)))

det(activity-2, The-1)
nsubjpass(analyzed-7, activity-2)
case(enzymes-5, of-3)
det(enzymes-5, these-4)
nmod:of(activity-2, enzymes-5)
auxpass(analyzed-7, was-6)
root(ROOT-0, analyzed-7)
xcomp(analyzed-7, using-8)
amod(assays-11, various-9)
amod(assays-11, biochemical-10)
dobj(using-8, assays-11)
cc(analyzed-7, and-13)
nmod:poss(roles-16, their-14)
amod(roles-16, potential-15)
nsubjpass(investigated-21, roles-16)
case(metabolism-19, in-17)
amod(metabolism-19, cellular-18)
nmod:in(roles-16, metabolism-19)
auxpass(investigated-21, were-20)
conj:and(analyzed-7, investigated-21)

Our/PRP$ findings/NNS suggest/VBP that/IN these/DT enzymes/NNS are/VBP involved/VBN in_a/JJ wide/JJ range/NN of/IN metabolic/JJ pathways/NNS ,/, including/VBG carbohydrate/JJ metabolism/NN ,/, energy/NN production/NN ,/, and/CC amino_acid/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS enzymes))
          (VP (VBP are)
            (VP (VBN involved)
              (NP
                (NP (JJ in_a) (JJ wide) (NN range))
                (PP (IN of)
                  (NP (JJ metabolic) (NNS pathways)))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (JJ carbohydrate) (NN metabolism))
                    (, ,)
                    (NP (NN energy) (NN production))
                    (, ,)
                    (CC and)
                    (NP (JJ amino_acid) (NNS biosynthesis))))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-8, that-4)
det(enzymes-6, these-5)
nsubjpass(involved-8, enzymes-6)
auxpass(involved-8, are-7)
ccomp(suggest-3, involved-8)
amod(range-11, in_a-9)
amod(range-11, wide-10)
dobj(involved-8, range-11)
case(pathways-14, of-12)
amod(pathways-14, metabolic-13)
nmod:of(range-11, pathways-14)
acl(range-11, including-16)
amod(metabolism-18, carbohydrate-17)
dobj(including-16, metabolism-18)
compound(production-21, energy-20)
dobj(including-16, production-21)
conj:and(metabolism-18, production-21)
cc(metabolism-18, and-23)
amod(biosynthesis-25, amino_acid-24)
dobj(including-16, biosynthesis-25)
conj:and(metabolism-18, biosynthesis-25)

Further/JJ studies/NNS on/IN the/DT regulation/NN and/CC function/NN of/IN these/DT enzymes/NNS could/MD provide/VB valuable/JJ insights/NNS into/IN the/DT mechanisms/NNS underlying/VBG cellular/JJ metabolism/NN and/CC may/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Further) (NNS studies))
      (PP (IN on)
        (NP
          (NP (DT the) (NN regulation))
          (CC and)
          (NP
            (NP (NN function))
            (PP (IN of)
              (NP (DT these) (NNS enzymes)))))))
    (VP
      (VP (MD could)
        (VP (VB provide)
          (NP (JJ valuable) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NNS mechanisms))
              (VP (VBG underlying)
                (NP (JJ cellular) (NN metabolism)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (JJ important) (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP (NNS metabolic_disorders)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubj(provide-12, studies-2)
nsubj(have-23, studies-2)
case(regulation-5, on-3)
det(regulation-5, the-4)
nmod:on(studies-2, regulation-5)
cc(regulation-5, and-6)
nmod:on(studies-2, function-7)
conj:and(regulation-5, function-7)
case(enzymes-10, of-8)
det(enzymes-10, these-9)
nmod:of(function-7, enzymes-10)
aux(provide-12, could-11)
root(ROOT-0, provide-12)
amod(insights-14, valuable-13)
dobj(provide-12, insights-14)
case(mechanisms-17, into-15)
det(mechanisms-17, the-16)
nmod:into(provide-12, mechanisms-17)
acl(mechanisms-17, underlying-18)
amod(metabolism-20, cellular-19)
dobj(underlying-18, metabolism-20)
cc(provide-12, and-21)
aux(have-23, may-22)
conj:and(provide-12, have-23)
amod(implications-25, important-24)
dobj(have-23, implications-25)
case(development-28, for-26)
det(development-28, the-27)
nmod:for(implications-25, development-28)
case(strategies-32, of-29)
amod(strategies-32, novel-30)
amod(strategies-32, therapeutic-31)
nmod:of(development-28, strategies-32)
case(metabolic_disorders-34, for-33)
nmod:for(strategies-32, metabolic_disorders-34)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

In/IN particular/JJ ,/, long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/JJ -RRB-/-RRB- ,/, have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ,/, including/VBG a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (IN In)
      (ADJP (JJ particular) (, ,) (JJ long-chain) (JJ omega-3_fatty_acids)))
    (, ,)
    (PP (VBN eicosapentaenoic_acid)
      (NP
        (NP
          (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD 20:5) (CD n-3)))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP (JJ docosahexaenoic_acid))
          (-LRB- -LRB-)
          (NP (NNP DHA))
          (-RRB- -RRB-) (-LRB- -LRB-)
          (ADJP (CD 22:6) (JJ n-3))
          (-RRB- -RRB-))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP (JJ numerous) (NN health) (NNS benefits)))
          (, ,)
          (S
            (VP (VBG including)
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (VBG developing) (NN coronary_heart_disease))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(omega-3_fatty_acids-5, In-1)
amod(omega-3_fatty_acids-5, particular-2)
amod(omega-3_fatty_acids-5, long-chain-4)
advmod(associated-27, omega-3_fatty_acids-5)
case(EPA-9, eicosapentaenoic_acid-7)
nmod:eicosapentaenoic_acid(associated-27, EPA-9)
compound(n-3-13, 20:5-12)
dep(EPA-9, n-3-13)
cc(EPA-9, and-15)
conj:and(EPA-9, docosahexaenoic_acid-16)
nmod:eicosapentaenoic_acid(associated-27, docosahexaenoic_acid-16)
dep(docosahexaenoic_acid-16, DHA-18)
compound(n-3-22, 22:6-21)
amod(docosahexaenoic_acid-16, n-3-22)
aux(associated-27, have-25)
auxpass(associated-27, been-26)
root(ROOT-0, associated-27)
case(benefits-31, with-28)
amod(benefits-31, numerous-29)
compound(benefits-31, health-30)
nmod:with(associated-27, benefits-31)
xcomp(associated-27, including-33)
det(risk-36, a-34)
amod(risk-36, decreased-35)
dobj(including-33, risk-36)
case(coronary_heart_disease-39, of-37)
amod(coronary_heart_disease-39, developing-38)
nmod:of(risk-36, coronary_heart_disease-39)
appos(coronary_heart_disease-39, CHD-41)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN strontium/NN levels/NNS in/IN hyperstrontiummic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN strontium) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperstrontiummic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(associated-10, that-6)
det(fatty_acids-8, these-7)
nsubjpass(associated-10, fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-5, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, strontium-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperstrontiummic-16)
nmod:in(levels-14, patients-17)

This/DT finding/NN is/VBZ particularly/RB significant/JJ given/VBN the/DT potential/JJ detrimental/JJ effects/NNS of/IN high/JJ strontium/NN levels/NNS on/IN bone/NN health/NN and/CC the/DT increasing/VBG prevalence/NN of/IN hyperstrontiummia/NN worldwide/RB ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ is)
      (ADVP (RB particularly) (JJ significant))
      (VP (VBN given)
        (NP
          (NP (DT the) (JJ potential) (JJ detrimental) (NNS effects))
          (PP (IN of)
            (NP (JJ high) (NN strontium) (NNS levels)))
          (PP (IN on)
            (NP
              (NP (NN bone) (NN health))
              (CC and)
              (NP
                (NP (DT the) (VBG increasing) (NN prevalence))
                (PP (IN of)
                  (NP (NN hyperstrontiummia)))))))
        (ADVP (RB worldwide))))
    (. .)))

det(finding-2, This-1)
nsubjpass(given-6, finding-2)
auxpass(given-6, is-3)
advmod(significant-5, particularly-4)
advmod(given-6, significant-5)
root(ROOT-0, given-6)
det(effects-10, the-7)
amod(effects-10, potential-8)
amod(effects-10, detrimental-9)
dobj(given-6, effects-10)
case(levels-14, of-11)
amod(levels-14, high-12)
compound(levels-14, strontium-13)
nmod:of(effects-10, levels-14)
case(health-17, on-15)
compound(health-17, bone-16)
nmod:on(effects-10, health-17)
cc(health-17, and-18)
det(prevalence-21, the-19)
amod(prevalence-21, increasing-20)
nmod:on(effects-10, prevalence-21)
conj:and(health-17, prevalence-21)
case(hyperstrontiummia-23, of-22)
nmod:of(prevalence-21, hyperstrontiummia-23)
advmod(given-6, worldwide-24)

While/IN the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG bone/NN health/NN ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (NNS mechanisms))
          (VP (VBG underlying)
            (NP (DT these) (NNS associations))))
        (VP (VBP are) (RB not)
          (ADVP (RB yet))
          (VP
            (ADVP (RB fully))
            (VBN understood)))))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (NN bone) (NN health))))))))))))
    (. .)))

mark(understood-11, While-1)
det(mechanisms-3, the-2)
nsubjpass(understood-11, mechanisms-3)
acl(mechanisms-3, underlying-4)
det(associations-6, these-5)
dobj(underlying-4, associations-6)
auxpass(understood-11, are-7)
neg(understood-11, not-8)
advmod(understood-11, yet-9)
advmod(understood-11, fully-10)
advcl(suggest-15, understood-11)
det(findings-14, these-13)
nsubj(suggest-15, findings-14)
root(ROOT-0, suggest-15)
mark(strategy-27, that-16)
amod(intake-18, increasing-17)
nsubj(strategy-27, intake-18)
case(EPA-20, of-19)
nmod:of(intake-18, EPA-20)
cc(EPA-20, and-21)
nmod:of(intake-18, DHA-22)
conj:and(EPA-20, DHA-22)
aux(strategy-27, may-23)
cop(strategy-27, be-24)
det(strategy-27, an-25)
amod(strategy-27, effective-26)
ccomp(suggest-15, strategy-27)
mark(reducing-29, for-28)
acl(strategy-27, reducing-29)
det(risk-31, the-30)
dobj(reducing-29, risk-31)
case(CHD-33, of-32)
nmod:of(risk-31, CHD-33)
cc(reducing-29, and-34)
acl(strategy-27, improving-35)
conj:and(reducing-29, improving-35)
compound(health-37, bone-36)
dobj(improving-35, health-37)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT potential/JJ benefits/NNS of/IN omega-3_fatty_acids/JJ in/IN these/DT contexts/NNS and/CC to/TO identify/VB optimal/JJ intake/NN levels/NNS for/IN different/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS benefits))
                  (PP (IN of)
                    (NP (JJ omega-3_fatty_acids))))
                (PP (IN in)
                  (NP (DT these) (NNS contexts)))))
            (CC and)
            (VP (TO to)
              (VP (VB identify)
                (NP
                  (NP (JJ optimal) (NN intake) (NNS levels))
                  (PP (IN for)
                    (NP (JJ different) (NNS populations))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(benefits-9, the-7)
amod(benefits-9, potential-8)
dobj(explore-6, benefits-9)
case(omega-3_fatty_acids-11, of-10)
nmod:of(benefits-9, omega-3_fatty_acids-11)
case(contexts-14, in-12)
det(contexts-14, these-13)
nmod:in(explore-6, contexts-14)
cc(explore-6, and-15)
mark(identify-17, to-16)
ccomp(needed-4, identify-17)
conj:and(explore-6, identify-17)
amod(levels-20, optimal-18)
compound(levels-20, intake-19)
dobj(identify-17, levels-20)
case(populations-23, for-21)
amod(populations-23, different-22)
nmod:for(levels-20, populations-23)

The/DT present/JJ study/NN investigated/VBD the/DT effect/NN of/IN U18666a/NNS on/IN the/DT incidence/NN of/IN holoprosencephaly/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNS U18666a))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN incidence))
          (PP (IN of)
            (NP
              (NP (NN holoprosencephaly))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(investigated-4, study-3)
root(ROOT-0, investigated-4)
det(effect-6, the-5)
dobj(investigated-4, effect-6)
case(U18666a-8, of-7)
nmod:of(effect-6, U18666a-8)
case(incidence-11, on-9)
det(incidence-11, the-10)
nmod:on(investigated-4, incidence-11)
case(holoprosencephaly-13, of-12)
nmod:of(incidence-11, holoprosencephaly-13)
nmod:of(incidence-11, photophobia-15)
conj:and(holoprosencephaly-13, photophobia-15)
cc(holoprosencephaly-13, and-17)
nmod:of(incidence-11, phonophobia-18)
conj:and(holoprosencephaly-13, phonophobia-18)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, U18666a/NNS significantly/RB reduced/VBD the/DT risk/NN of/IN holoprosencephaly/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNS U18666a))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN holoprosencephaly))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, U18666a-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(holoprosencephaly-17, of-16)
nmod:of(risk-15, holoprosencephaly-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN U18666a/NNS may/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT prevention/NN and/CC treatment/NN of/IN these/DT neurological_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNS U18666a))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (DT these) (NNS neurological_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, U18666a-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(prevention-13, in-11)
det(prevention-13, the-12)
nmod:in(applications-10, prevention-13)
cc(prevention-13, and-14)
nmod:in(applications-10, treatment-15)
conj:and(prevention-13, treatment-15)
case(neurological_disorders-18, of-16)
det(neurological_disorders-18, these-17)
nmod:of(prevention-13, neurological_disorders-18)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN and/CC to/TO determine/VB optimal/JJ dosing/JJ regimens/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (JJ dosing) (NNS regimens))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
ccomp(needed-4, investigate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(investigate-6, mechanisms-9)
case(action-11, of-10)
nmod:of(mechanisms-9, action-11)
cc(investigate-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(investigate-6, determine-14)
amod(regimens-17, optimal-15)
amod(regimens-17, dosing-16)
dobj(determine-14, regimens-17)
case(use-20, for-18)
amod(use-20, clinical-19)
nmod:for(determine-14, use-20)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP gained/VBN significant/JJ attention/NN due/JJ to/TO their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN gained)
        (NP
          (NP (JJ significant) (NN attention))
          (ADJP (JJ due)
            (PP (TO to)
              (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))))))
    (. .)))

nsubj(gained-15, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(gained-15, have-14)
root(ROOT-0, gained-15)
amod(attention-17, significant-16)
dobj(gained-15, attention-17)
amod(attention-17, due-18)
case(benefits-23, to-19)
nmod:poss(benefits-23, their-20)
amod(benefits-23, potential-21)
compound(benefits-23, health-22)
nmod:to(due-18, benefits-23)

In/IN particular/JJ ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN linked/VBN to/TO a/DT decrease/NN in/IN Kojic_Acid/NNP levels/NNS in/IN hyperKojic/NN

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (NN decrease))
              (PP (IN in)
                (NP (NNP Kojic_Acid) (NNS levels)))))
          (PP (IN in)
            (NP (NN hyperKojic))))))))

case(particular-2, In-1)
advcl(linked-9, particular-2)
nsubjpass(linked-9, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(linked-9, DHA-6)
aux(linked-9, have-7)
auxpass(linked-9, been-8)
root(ROOT-0, linked-9)
case(decrease-12, to-10)
det(decrease-12, a-11)
nmod:to(linked-9, decrease-12)
case(levels-15, in-13)
compound(levels-15, Kojic_Acid-14)
nmod:in(decrease-12, levels-15)
case(hyperKojic-17, in-16)
nmod:in(linked-9, hyperKojic-17)

Acidmic/JJ patients/NNS ,/, which/WDT may/MD be/VB beneficial/JJ for/IN individuals/NNS at/IN risk/NN of/IN developing/VBG coronary_heart_disease/VBP -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Acidmic) (NNS patients))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (MD may)
            (VP (VB be)
              (ADJP (JJ beneficial)
                (PP (IN for)
                  (NP (NNS individuals))))
              (PP (IN at)
                (NP
                  (NP (NN risk))
                  (PP (IN of)
                    (NP (VBG developing))))))))))
    (VP (VBP coronary_heart_disease)
      (PRN (-LRB- -LRB-)
        (NP (NNP CHD))
        (-RRB- -RRB-)))
    (. .)))

amod(patients-2, Acidmic-1)
nsubj(beneficial-7, patients-2)
nsubj(coronary_heart_disease-14, patients-2)
ref(patients-2, which-4)
aux(beneficial-7, may-5)
cop(beneficial-7, be-6)
acl:relcl(patients-2, beneficial-7)
case(individuals-9, for-8)
nmod:for(beneficial-7, individuals-9)
case(risk-11, at-10)
nmod:at(beneficial-7, risk-11)
case(developing-13, of-12)
nmod:of(risk-11, developing-13)
root(ROOT-0, coronary_heart_disease-14)
dep(coronary_heart_disease-14, CHD-16)

This/DT association/NN has_been/NN attributed/VBN to/TO the/DT ability/NN of/IN these/DT long-chain/JJ omega-3_fatty_acids/NN to/TO modulate/VBP various/JJ metabolic/JJ pathways/NNS involved/VBN in/IN lipid/NN metabolism/NN and/CC inflammation/NN ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN association) (NN has_been))
      (VP (VBN attributed)
        (PP (TO to)
          (NP
            (NP (DT the) (NN ability))
            (PP (IN of)
              (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids)))))
        (PP (TO to))))
    (VP (VBP modulate)
      (NP
        (NP (JJ various) (JJ metabolic) (NNS pathways))
        (VP (VBN involved)
          (PP (IN in)
            (NP (NN lipid) (NN metabolism)
              (CC and)
              (NN inflammation))))))
    (. .)))

det(has_been-3, This-1)
compound(has_been-3, association-2)
nsubj(modulate-13, has_been-3)
acl(has_been-3, attributed-4)
case(ability-7, to-5)
det(ability-7, the-6)
nmod:to(attributed-4, ability-7)
case(omega-3_fatty_acids-11, of-8)
det(omega-3_fatty_acids-11, these-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(ability-7, omega-3_fatty_acids-11)
case(ability-7, to-12)
root(ROOT-0, modulate-13)
amod(pathways-16, various-14)
amod(pathways-16, metabolic-15)
dobj(modulate-13, pathways-16)
acl(pathways-16, involved-17)
case(metabolism-20, in-18)
compound(metabolism-20, lipid-19)
nmod:in(involved-17, metabolism-20)
cc(metabolism-20, and-21)
nmod:in(involved-17, inflammation-22)
conj:and(metabolism-20, inflammation-22)

Additionally/RB ,/, studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP supplementation/NN can/MD improve/VB several/JJ cardiovascular_risk/NN factors/NNS ,/, such/JJ as/IN blood_pressure/NN ,/, triglyceride_levels/NNS ,/, and/CC endothelial/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (ADJP (NNP EPA)
                (CC and)
                (NNP DHA))
              (NN supplementation))
            (VP (MD can)
              (VP (VB improve)
                (NP
                  (NP (JJ several) (NN cardiovascular_risk) (NNS factors))
                  (, ,)
                  (PP (JJ such) (IN as)
                    (NP
                      (NP (NN blood_pressure))
                      (, ,)
                      (NP (NNS triglyceride_levels))
                      (, ,)
                      (CC and)
                      (NP (JJ endothelial) (NN function)))))))))))
    (. .)))

advmod(shown-5, Additionally-1)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
mark(improve-12, that-6)
amod(supplementation-10, EPA-7)
cc(EPA-7, and-8)
conj:and(EPA-7, DHA-9)
amod(supplementation-10, DHA-9)
nsubj(improve-12, supplementation-10)
aux(improve-12, can-11)
ccomp(shown-5, improve-12)
amod(factors-15, several-13)
compound(factors-15, cardiovascular_risk-14)
dobj(improve-12, factors-15)
case(blood_pressure-19, such-17)
mwe(such-17, as-18)
nmod:such_as(factors-15, blood_pressure-19)
nmod:such_as(factors-15, triglyceride_levels-21)
conj:and(blood_pressure-19, triglyceride_levels-21)
cc(blood_pressure-19, and-23)
amod(function-25, endothelial-24)
nmod:such_as(factors-15, function-25)
conj:and(blood_pressure-19, function-25)

Therefore/RB ,/, increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC other/JJ related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NNS supplements)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT a) (JJ promising) (NN strategy))
          (PP (IN for)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ other) (JJ related) (NNS metabolic_disorders)))))))))))
    (. .)))

advmod(strategy-19, Therefore-1)
csubj(strategy-19, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(EPA-7, of-6)
nmod:of(intake-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(intake-5, DHA-9)
conj:and(EPA-7, DHA-9)
case(sources-12, through-10)
amod(sources-12, dietary-11)
nmod:through(increasing-3, sources-12)
cc(sources-12, or-13)
nmod:through(increasing-3, supplements-14)
conj:or(sources-12, supplements-14)
aux(strategy-19, may-15)
cop(strategy-19, be-16)
det(strategy-19, a-17)
amod(strategy-19, promising-18)
root(ROOT-0, strategy-19)
mark(reducing-21, for-20)
acl(strategy-19, reducing-21)
det(risk-23, the-22)
dobj(reducing-21, risk-23)
case(CHD-25, of-24)
nmod:of(risk-23, CHD-25)
cc(CHD-25, and-26)
amod(metabolic_disorders-29, other-27)
amod(metabolic_disorders-29, related-28)
nmod:of(risk-23, metabolic_disorders-29)
conj:and(CHD-25, metabolic_disorders-29)

Vasoactive_intestinal_peptide/JJ -LRB-/-LRB- VIP/NNP -RRB-/-RRB- is_a/NNS neuropeptide/VBD that/IN plays/VBZ a/DT role/NN in/IN various/JJ physiological/JJ processes/NNS ,/, including/VBG smooth/JJ muscle_relaxation/NN ,/, immune/JJ regulation/NN ,/, and/CC neurotransmission/NN ./.

(ROOT
  (S
    (NP (JJ Vasoactive_intestinal_peptide)
      (PRN (-LRB- -LRB-)
        (NP (NNP VIP))
        (-RRB- -RRB-))
      (NNS is_a))
    (VP (VBD neuropeptide)
      (SBAR (IN that)
        (S
          (VP (VBZ plays)
            (NP
              (NP (DT a) (NN role))
              (PP (IN in)
                (NP
                  (NP (JJ various) (JJ physiological) (NNS processes))
                  (, ,)
                  (VP (VBG including)
                    (NP
                      (NP (JJ smooth) (NN muscle_relaxation))
                      (, ,)
                      (NP (JJ immune) (NN regulation))
                      (, ,)
                      (CC and)
                      (NP (NN neurotransmission)))))))))))
    (. .)))

amod(is_a-5, Vasoactive_intestinal_peptide-1)
appos(is_a-5, VIP-3)
nsubj(neuropeptide-6, is_a-5)
root(ROOT-0, neuropeptide-6)
mark(plays-8, that-7)
ccomp(neuropeptide-6, plays-8)
det(role-10, a-9)
dobj(plays-8, role-10)
case(processes-14, in-11)
amod(processes-14, various-12)
amod(processes-14, physiological-13)
nmod:in(role-10, processes-14)
acl(processes-14, including-16)
amod(muscle_relaxation-18, smooth-17)
dobj(including-16, muscle_relaxation-18)
amod(regulation-21, immune-20)
dobj(including-16, regulation-21)
conj:and(muscle_relaxation-18, regulation-21)
cc(muscle_relaxation-18, and-23)
dobj(including-16, neurotransmission-24)
conj:and(muscle_relaxation-18, neurotransmission-24)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN VIP/NNP antagonist/NNP -LSB-/NNP 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP and/CC peptide/JJ beta-lg/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- on/IN the/DT response/NN of/IN DTAB/NNP was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNP VIP) (NNP antagonist) (NNP -LSB-)
            (NX
              (NX (JJ 4Cl-D-Phe6))
              (, ,)
              (NX (NNP Leu17) (NNP -RSB-) (NNP VIP))
              (CC and)
              (NX (JJ peptide) (NN beta-lg))))
          (PRN (-LRB- -LRB-)
            (NP (CD 6-38))
            (-RRB- -RRB-))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN response))
          (PP (IN of)
            (NP (NNP DTAB))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-28, study-3)
det(effect-6, the-5)
nsubjpass(investigated-28, effect-6)
case(4Cl-D-Phe6-11, of-7)
compound(4Cl-D-Phe6-11, VIP-8)
compound(4Cl-D-Phe6-11, antagonist-9)
dep(4Cl-D-Phe6-11, -LSB--10)
nmod:of(effect-6, 4Cl-D-Phe6-11)
compound(VIP-15, Leu17-13)
compound(VIP-15, -RSB--14)
nmod:of(effect-6, VIP-15)
conj:and(4Cl-D-Phe6-11, VIP-15)
cc(4Cl-D-Phe6-11, and-16)
amod(beta-lg-18, peptide-17)
nmod:of(effect-6, beta-lg-18)
conj:and(4Cl-D-Phe6-11, beta-lg-18)
appos(4Cl-D-Phe6-11, 6-38-20)
case(response-24, on-22)
det(response-24, the-23)
nmod:on(effect-6, response-24)
case(DTAB-26, of-25)
nmod:of(response-24, DTAB-26)
auxpass(investigated-28, was-27)
root(ROOT-0, investigated-28)

The/DT results/NNS showed/VBD that/IN -LSB-/NNP 4Cl-D-Phe6/CD ,/, Leu17/NNP -RSB-/NNP VIP/NNP had/VBD no/DT effect/NN on/IN the/DT DTAB/NNP response/NN to/TO either/DT beta-lg/NN or/CC VIP/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP -LSB-) (CD 4Cl-D-Phe6))
            (, ,)
            (NP (NNP Leu17) (NNP -RSB-) (NNP VIP)))
          (VP (VBD had)
            (NP
              (NP (DT no) (NN effect))
              (PP (IN on)
                (NP
                  (NP (DT the) (NNP DTAB) (NN response))
                  (PP (TO to)
                    (NP
                      (NP (DT either) (NN beta-lg))
                      (CC or)
                      (NP (NNP VIP)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-11, that-4)
nsubj(had-11, -LSB--5)
nummod(-LSB--5, 4Cl-D-Phe6-6)
compound(VIP-10, Leu17-8)
compound(VIP-10, -RSB--9)
appos(-LSB--5, VIP-10)
ccomp(showed-3, had-11)
neg(effect-13, no-12)
dobj(had-11, effect-13)
case(response-17, on-14)
det(response-17, the-15)
compound(response-17, DTAB-16)
nmod:on(effect-13, response-17)
case(beta-lg-20, to-18)
det(beta-lg-20, either-19)
nmod:to(response-17, beta-lg-20)
cc(beta-lg-20, or-21)
nmod:to(response-17, VIP-22)
conj:or(beta-lg-20, VIP-22)

However/RB ,/, beta-lg/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ beta-lg/JJ antagonist/NN ,/, blocked/VBD the/DT DTAB/NNP response/NN to/TO beta-lg/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP
        (NP (NN beta-lg))
        (PRN (-LRB- -LRB-)
          (NP (CD 6-38))
          (-RRB- -RRB-)))
      (, ,)
      (NP (DT a) (JJ putative) (JJ beta-lg) (NN antagonist))
      (, ,))
    (VP (VBD blocked)
      (NP
        (NP (DT the) (NNP DTAB) (NN response))
        (PP (TO to)
          (NP (NN beta-lg)))))
    (. .)))

advmod(blocked-13, However-1)
nsubj(blocked-13, beta-lg-3)
appos(beta-lg-3, 6-38-5)
det(antagonist-11, a-8)
amod(antagonist-11, putative-9)
amod(antagonist-11, beta-lg-10)
appos(beta-lg-3, antagonist-11)
root(ROOT-0, blocked-13)
det(response-16, the-14)
compound(response-16, DTAB-15)
dobj(blocked-13, response-16)
case(beta-lg-18, to-17)
nmod:to(response-16, beta-lg-18)

These/DT findings/NNS suggest/VBP that/IN beta-lg/NN may/MD be/VB involved/VBN in/IN the/DT regulation/NN of/IN DTAB/NNP response/NN and/CC that/IN beta-lg/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- may/MD have/VB potential/JJ therapeutic/JJ applications/NNS for/IN conditions/NNS where/WRB excessive/JJ DTAB/JJ activity/NN is/VBZ present/JJ ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NN beta-lg))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN regulation))
                      (PP (IN of)
                        (NP (NNP DTAB) (NN response))))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN beta-lg))
              (PRN (-LRB- -LRB-)
                (NP (CD 6-38))
                (-RRB- -RRB-)))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN for)
                    (NP (NNS conditions))))
                (SBAR
                  (WHADVP (WRB where))
                  (S
                    (NP (JJ excessive) (JJ DTAB) (NN activity))
                    (VP (VBZ is)
                      (ADJP (JJ present)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-8, that-4)
nsubjpass(involved-8, beta-lg-5)
aux(involved-8, may-6)
auxpass(involved-8, be-7)
ccomp(suggest-3, involved-8)
case(regulation-11, in-9)
det(regulation-11, the-10)
nmod:in(involved-8, regulation-11)
case(response-14, of-12)
compound(response-14, DTAB-13)
nmod:of(regulation-11, response-14)
cc(involved-8, and-15)
mark(have-22, that-16)
nsubj(have-22, beta-lg-17)
appos(beta-lg-17, 6-38-19)
aux(have-22, may-21)
ccomp(suggest-3, have-22)
conj:and(involved-8, have-22)
amod(applications-25, potential-23)
amod(applications-25, therapeutic-24)
dobj(have-22, applications-25)
case(conditions-27, for-26)
nmod:for(applications-25, conditions-27)
advmod(present-33, where-28)
amod(activity-31, excessive-29)
amod(activity-31, DTAB-30)
nsubj(present-33, activity-31)
cop(present-33, is-32)
advcl(have-22, present-33)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanism/NN of/IN action/NN of/IN these/DT peptides/NNS and/CC their/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NN mechanism))
                (PP (IN of)
                  (NP
                    (NP (NN action))
                    (PP (IN of)
                      (NP
                        (NP (DT these) (NNS peptides))
                        (CC and)
                        (NP (PRP$ their) (JJ potential) (JJ clinical) (NNS applications))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanism-8, the-7)
dobj(elucidate-6, mechanism-8)
case(action-10, of-9)
nmod:of(mechanism-8, action-10)
case(peptides-13, of-11)
det(peptides-13, these-12)
nmod:of(action-10, peptides-13)
cc(peptides-13, and-14)
nmod:poss(applications-18, their-15)
amod(applications-18, potential-16)
amod(applications-18, clinical-17)
nmod:of(action-10, applications-18)
conj:and(peptides-13, applications-18)

Omega-3_fatty_acids/NNP have/VBP been/VBN investigated/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ,/, particularly/RB in/IN relation/NN to/TO cardiovascular_disease/VB ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN investigated)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN in)
            (NP (NN relation)
              (S
                (VP (TO to)
                  (VP (VB cardiovascular_disease)))))))))
    (. .)))

nsubjpass(investigated-4, Omega-3_fatty_acids-1)
aux(investigated-4, have-2)
auxpass(investigated-4, been-3)
root(ROOT-0, investigated-4)
case(benefits-9, for-5)
nmod:poss(benefits-9, their-6)
amod(benefits-9, potential-7)
compound(benefits-9, health-8)
nmod:for(investigated-4, benefits-9)
advmod(relation-13, particularly-11)
case(relation-13, in-12)
nmod:in(investigated-4, relation-13)
mark(cardiovascular_disease-15, to-14)
acl(relation-13, cardiovascular_disease-15)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP of/IN particular/JJ interest/NN due/JJ to/TO their/PRP$ association/NN with/IN decreased/VBN Carglumic_Acid/NNP levels/NNS in/IN hyperCarglumic/JJ Acidmic/NNP patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (PP (IN of)
          (NP
            (NP (JJ particular) (NN interest))
            (ADJP (JJ due)
              (PP (TO to)
                (NP (PRP$ their) (NN association))))))
        (PP (IN with)
          (NP (VBN decreased) (NNP Carglumic_Acid) (NNS levels)))
        (PP (IN in)
          (NP (JJ hyperCarglumic) (NNP Acidmic) (NNS patients))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(interest-17, omega-3_fatty_acids-2)
nsubj(decreased-31, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
cop(interest-17, are-14)
case(interest-17, of-15)
amod(interest-17, particular-16)
root(ROOT-0, interest-17)
amod(interest-17, due-18)
case(association-21, to-19)
nmod:poss(association-21, their-20)
nmod:to(due-18, association-21)
case(levels-25, with-22)
amod(levels-25, decreased-23)
compound(levels-25, Carglumic_Acid-24)
nmod:with(interest-17, levels-25)
case(patients-29, in-26)
amod(patients-29, hyperCarglumic-27)
compound(patients-29, Acidmic-28)
nmod:in(interest-17, patients-29)
cc(interest-17, and-30)
conj:and(interest-17, decreased-31)
dobj(decreased-31, risk-32)
case(coronary_heart_disease-35, of-33)
amod(coronary_heart_disease-35, developing-34)
nmod:of(risk-32, coronary_heart_disease-35)
appos(coronary_heart_disease-35, CHD-37)

Several/JJ studies/NNS have/VBP demonstrated/VBN that/IN EPA/NNP and/CC DHA/NNP supplementation/NN can/MD improve/VB lipid/NN profiles/NNS ,/, reduce/VB inflammation/NN ,/, and/CC decrease_blood_pressure/VB ./.

(ROOT
  (S
    (NP (JJ Several) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (ADJP (NNP EPA)
                (CC and)
                (NNP DHA))
              (NN supplementation))
            (VP (MD can)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP (NN inflammation)))
                (, ,)
                (CC and)
                (VP (VB decrease_blood_pressure))))))))
    (. .)))

amod(studies-2, Several-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(improve-11, that-5)
amod(supplementation-9, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
amod(supplementation-9, DHA-8)
nsubj(improve-11, supplementation-9)
nsubj(reduce-15, supplementation-9)
nsubj(decrease_blood_pressure-19, supplementation-9)
aux(improve-11, can-10)
ccomp(demonstrated-4, improve-11)
compound(profiles-13, lipid-12)
dobj(improve-11, profiles-13)
ccomp(demonstrated-4, reduce-15)
conj:and(improve-11, reduce-15)
dobj(reduce-15, inflammation-16)
cc(improve-11, and-18)
ccomp(demonstrated-4, decrease_blood_pressure-19)
conj:and(improve-11, decrease_blood_pressure-19)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN gene/NN expression/NN or/CC changes/NNS in/IN membrane/NN fluidity/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN gene) (NN expression))
                (CC or)
                (NP
                  (NP (NNS changes))
                  (PP (IN in)
                    (NP (NN membrane) (NN fluidity))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
dobj(involve-13, modulation-14)
case(expression-17, of-15)
compound(expression-17, gene-16)
nmod:of(modulation-14, expression-17)
cc(expression-17, or-18)
nmod:of(modulation-14, changes-19)
conj:or(expression-17, changes-19)
case(fluidity-22, in-20)
compound(fluidity-22, membrane-21)
nmod:in(changes-19, fluidity-22)

Despite/IN promising/JJ results/NNS from/IN observational/JJ and/CC clinical/JJ studies/NNS ,/, further/JJ research/NN is/VBZ needed/VBN to/TO determine/VB optimal/JJ dosages/NNS and/CC the/DT long-term/JJ effects/NNS of/IN omega-3/JJ supplementation/NN on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (PP (IN Despite)
      (NP
        (NP (JJ promising) (NNS results))
        (PP (IN from)
          (NP
            (ADJP (JJ observational)
              (CC and)
              (JJ clinical))
            (NNS studies)))))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (JJ optimal) (NNS dosages))
                (CC and)
                (NP
                  (NP (DT the) (JJ long-term) (NNS effects))
                  (PP (IN of)
                    (NP (JJ omega-3) (NN supplementation)))
                  (PP (IN on)
                    (NP (NN cardiovascular_health))))))))))
    (. .)))

case(results-3, Despite-1)
amod(results-3, promising-2)
nmod:despite(needed-13, results-3)
case(studies-8, from-4)
amod(studies-8, observational-5)
cc(observational-5, and-6)
conj:and(observational-5, clinical-7)
amod(studies-8, clinical-7)
nmod:from(results-3, studies-8)
amod(research-11, further-10)
nsubjpass(needed-13, research-11)
nsubj:xsubj(determine-15, research-11)
auxpass(needed-13, is-12)
root(ROOT-0, needed-13)
mark(determine-15, to-14)
xcomp(needed-13, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
cc(dosages-17, and-18)
det(effects-21, the-19)
amod(effects-21, long-term-20)
dobj(determine-15, effects-21)
conj:and(dosages-17, effects-21)
case(supplementation-24, of-22)
amod(supplementation-24, omega-3-23)
nmod:of(effects-21, supplementation-24)
case(cardiovascular_health-26, on-25)
nmod:on(effects-21, cardiovascular_health-26)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-9, for-6)
nmod:poss(benefits-9, their-7)
compound(benefits-9, health-8)
nmod:for(studied-5, benefits-9)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP known/VBN to_be/VB associated/VBN with/IN decreased/VBN furamidine/NN levels/NNS in/IN hyperfuramidinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (VB to_be)
            (VP (VBN associated)
              (PP (IN with)
                (NP (VBN decreased) (NN furamidine) (NNS levels)))
              (PP (IN in)
                (NP (JJ hyperfuramidinemic) (NNS patients))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-23, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
auxpass(known-23, are-22)
root(ROOT-0, known-23)
ccomp(known-23, to_be-24)
dep(to_be-24, associated-25)
case(levels-29, with-26)
amod(levels-29, decreased-27)
compound(levels-29, furamidine-28)
nmod:with(associated-25, levels-29)
case(patients-32, in-30)
amod(patients-32, hyperfuramidinemic-31)
nmod:in(associated-25, patients-32)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN found/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(found-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(found-7, fatty_acids-4)
nsubj:xsubj(reduce-9, fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(reduce-9, to-8)
xcomp(found-7, reduce-9)
det(risk-11, the-10)
dobj(reduce-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

The/DT mechanism/NN behind/IN this/DT protective/JJ effect/NN is/VBZ thought/VBN to_be/NN related/VBN to/TO the/DT ability/NN of/IN EPA/NNP and/CC DHA/NNP to/TO reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN mechanism))
      (PP (IN behind)
        (NP (DT this) (JJ protective) (NN effect))))
    (VP (VBZ is)
      (VP (VBN thought)
        (S
          (NP
            (NP (NN to_be))
            (VP (VBN related)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN ability))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA)))))))
          (VP (TO to)
            (VP
              (VP (VB reduce)
                (NP
                  (NP (NN inflammation))
                  (, ,)
                  (NP (JJR lower) (NN blood_pressure))
                  (, ,)))
              (CC and)
              (VP (VB improve)
                (NP (NN lipid) (NN metabolism))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(thought-8, mechanism-2)
case(effect-6, behind-3)
det(effect-6, this-4)
amod(effect-6, protective-5)
nmod:behind(mechanism-2, effect-6)
auxpass(thought-8, is-7)
root(ROOT-0, thought-8)
dobj(thought-8, to_be-9)
nsubj:xsubj(reduce-19, to_be-9)
nsubj:xsubj(improve-26, to_be-9)
acl(to_be-9, related-10)
case(ability-13, to-11)
det(ability-13, the-12)
nmod:to(related-10, ability-13)
case(EPA-15, of-14)
nmod:of(ability-13, EPA-15)
cc(EPA-15, and-16)
nmod:of(ability-13, DHA-17)
conj:and(EPA-15, DHA-17)
mark(reduce-19, to-18)
xcomp(thought-8, reduce-19)
dobj(reduce-19, inflammation-20)
amod(blood_pressure-23, lower-22)
appos(inflammation-20, blood_pressure-23)
cc(reduce-19, and-25)
xcomp(thought-8, improve-26)
conj:and(reduce-19, improve-26)
compound(metabolism-28, lipid-27)
dobj(improve-26, metabolism-28)

Several/JJ studies/NNS have/VBP demonstrated/VBN that/IN supplementation/NN with/IN EPA/NNP and/CC DHA/NNP can/MD lead/VB to/TO significant/JJ reductions/NNS in/IN cardiovascular_events/NNS ,/, including/VBG myocardial_infarction/NN and_stroke/NN ./.

(ROOT
  (S
    (NP (JJ Several) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN supplementation))
              (PP (IN with)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (MD can)
              (VP (VB lead)
                (PP (TO to)
                  (NP
                    (NP (JJ significant) (NNS reductions))
                    (PP (IN in)
                      (NP
                        (NP (NNS cardiovascular_events))
                        (, ,)
                        (VP (VBG including)
                          (NP (NN myocardial_infarction) (NN and_stroke)))))))))))))
    (. .)))

amod(studies-2, Several-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(lead-12, that-5)
nsubj(lead-12, supplementation-6)
case(EPA-8, with-7)
nmod:with(supplementation-6, EPA-8)
cc(EPA-8, and-9)
nmod:with(supplementation-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(lead-12, can-11)
ccomp(demonstrated-4, lead-12)
case(reductions-15, to-13)
amod(reductions-15, significant-14)
nmod:to(lead-12, reductions-15)
case(cardiovascular_events-17, in-16)
nmod:in(reductions-15, cardiovascular_events-17)
acl(cardiovascular_events-17, including-19)
compound(and_stroke-21, myocardial_infarction-20)
dobj(including-19, and_stroke-21)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN through/IN diet/NN or/CC supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))
              (PP (IN through)
                (NP (NN diet)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ high-risk) (NNS individuals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-18, that-4)
csubj(strategy-18, increasing-5)
dobj(increasing-5, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
case(diet-11, through-10)
nmod:through(increasing-5, diet-11)
cc(diet-11, or-12)
nmod:through(increasing-5, supplementation-13)
conj:or(diet-11, supplementation-13)
aux(strategy-18, may-14)
cop(strategy-18, be-15)
det(strategy-18, an-16)
amod(strategy-18, effective-17)
ccomp(suggest-3, strategy-18)
mark(reducing-20, for-19)
acl(strategy-18, reducing-20)
det(risk-22, the-21)
dobj(reducing-20, risk-22)
case(CHD-24, of-23)
nmod:of(risk-22, CHD-24)
case(individuals-27, in-25)
amod(individuals-27, high-risk-26)
nmod:in(reducing-20, individuals-27)

Omega-3_fatty_acids/NNS have/VBP been/VBN the/DT subject/NN of/IN numerous/JJ studies/NNS due/JJ to/TO their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (NP
          (NP (DT the) (NN subject))
          (PP (IN of)
            (NP
              (NP (JJ numerous) (NNS studies))
              (ADJP (JJ due)
                (PP (TO to)
                  (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))))))))
    (. .)))

nsubj(subject-5, Omega-3_fatty_acids-1)
aux(subject-5, have-2)
cop(subject-5, been-3)
det(subject-5, the-4)
root(ROOT-0, subject-5)
case(studies-8, of-6)
amod(studies-8, numerous-7)
nmod:of(subject-5, studies-8)
amod(studies-8, due-9)
case(benefits-14, to-10)
nmod:poss(benefits-14, their-11)
amod(benefits-14, potential-12)
compound(benefits-14, health-13)
nmod:to(due-9, benefits-14)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/NN associated/VBN with/IN decreased/VBN calcium_acetate/JJ levels/NNS in/IN hypercalcium/JJ acetatemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (JJ calcium_acetate) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hypercalcium) (JJ acetatemic) (NNS patients))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-17, omega-3_fatty_acids-2)
advmod(eicosapentaenoic_acid-5, specifically-4)
acl(omega-3_fatty_acids-2, eicosapentaenoic_acid-5)
dobj(eicosapentaenoic_acid-5, EPA-7)
cc(EPA-7, and-9)
dobj(eicosapentaenoic_acid-5, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
dobj(shown-17, to_be-18)
acl(to_be-18, associated-19)
case(levels-23, with-20)
amod(levels-23, decreased-21)
amod(levels-23, calcium_acetate-22)
nmod:with(associated-19, levels-23)
case(patients-27, in-24)
amod(patients-27, hypercalcium-25)
amod(patients-27, acetatemic-26)
nmod:in(levels-23, patients-27)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))
                        (NP
                          (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(found-7, fatty_acids-4)
nsubj:xsubj(decrease-9, fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(decrease-9, to-8)
xcomp(found-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
iobj(developing-13, coronary_heart_disease-14)
dobj(developing-13, CHD-16)
det(cause-21, a-19)
amod(cause-21, leading-20)
appos(CHD-16, cause-21)
case(morbidity-23, of-22)
nmod:of(cause-21, morbidity-23)
cc(morbidity-23, and-24)
nmod:of(cause-21, mortality-25)
conj:and(morbidity-23, mortality-25)
advmod(decrease-9, worldwide-26)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, lipid/NN metabolism/NN ,/, and/CC vascular_function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN inflammation))
                (, ,)
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (CC and)
                (NP (NN vascular_function))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
nsubj(involve-14, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
aux(involve-14, may-13)
conj:but(understood-10, involve-14)
dobj(involve-14, modulation-15)
case(inflammation-17, of-16)
nmod:of(modulation-15, inflammation-17)
compound(metabolism-20, lipid-19)
nmod:of(modulation-15, metabolism-20)
conj:and(inflammation-17, metabolism-20)
cc(inflammation-17, and-22)
nmod:of(modulation-15, vascular_function-23)
conj:and(inflammation-17, vascular_function-23)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and/CC other/JJ related/JJ conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN treatment))
                  (PP (IN of)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ other) (JJ related) (NNS conditions)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(applications-11, the-8)
amod(applications-11, potential-9)
amod(applications-11, therapeutic-10)
dobj(elucidate-7, applications-11)
case(EPA-13, of-12)
nmod:of(applications-11, EPA-13)
cc(EPA-13, and-14)
nmod:of(applications-11, DHA-15)
conj:and(EPA-13, DHA-15)
case(prevention-18, in-16)
det(prevention-18, the-17)
nmod:in(elucidate-7, prevention-18)
cc(prevention-18, and-19)
nmod:in(elucidate-7, treatment-20)
conj:and(prevention-18, treatment-20)
case(CHD-22, of-21)
nmod:of(prevention-18, CHD-22)
cc(CHD-22, and-23)
amod(conditions-26, other-24)
amod(conditions-26, related-25)
nmod:of(prevention-18, conditions-26)
conj:and(CHD-22, conditions-26)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN phosphoramidon/NN was/VBD evaluated/VBN on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NN phosphoramidon))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN on)
          (NP
            (NP (NNS bronchospasms))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP (NN phonophobia))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(effect-6, the-5)
nsubjpass(evaluated-10, effect-6)
case(phosphoramidon-8, of-7)
nmod:of(effect-6, phosphoramidon-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
case(bronchospasms-12, on-11)
nmod:on(evaluated-10, bronchospasms-12)
nmod:on(evaluated-10, photophobia-14)
conj:and(bronchospasms-12, photophobia-14)
cc(bronchospasms-12, and-16)
nmod:on(evaluated-10, phonophobia-17)
conj:and(bronchospasms-12, phonophobia-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, phosphoramidon/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NN phosphoramidon))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, phosphoramidon-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(bronchospasms-17, of-16)
nmod:of(risk-15, bronchospasms-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN phosphoramidon/NN may/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT treatment/NN of/IN conditions/NNS associated/VBN with/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN phosphoramidon))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (NNS conditions))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (NNS bronchospasms))
                              (, ,)
                              (NP (NN photophobia))
                              (, ,)
                              (CC and)
                              (NP (NN phonophobia)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, phosphoramidon-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(treatment-13, in-11)
det(treatment-13, the-12)
nmod:in(applications-10, treatment-13)
case(conditions-15, of-14)
nmod:of(treatment-13, conditions-15)
acl(conditions-15, associated-16)
case(bronchospasms-18, with-17)
nmod:with(associated-16, bronchospasms-18)
nmod:with(associated-16, photophobia-20)
conj:and(bronchospasms-18, photophobia-20)
cc(bronchospasms-18, and-22)
nmod:with(associated-16, phonophobia-23)
conj:and(bronchospasms-18, phonophobia-23)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO investigate/VB the/DT underlying/VBG mechanisms/NNS of/IN these/DT effects/NNS and/CC to/TO evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN phosphoramidon/NN in/IN clinical/JJ settings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NN phosphoramidon))))
                (PP (IN in)
                  (NP (JJ clinical) (NNS settings)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(investigate-6, to-5)
ccomp(warranted-4, investigate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(investigate-6, mechanisms-9)
case(effects-12, of-10)
det(effects-12, these-11)
nmod:of(mechanisms-9, effects-12)
cc(investigate-6, and-13)
mark(evaluate-15, to-14)
ccomp(warranted-4, evaluate-15)
conj:and(investigate-6, evaluate-15)
det(safety-18, the-16)
amod(safety-18, long-term-17)
dobj(evaluate-15, safety-18)
cc(safety-18, and-19)
dobj(evaluate-15, efficacy-20)
conj:and(safety-18, efficacy-20)
case(phosphoramidon-22, of-21)
nmod:of(safety-18, phosphoramidon-22)
case(settings-25, in-23)
amod(settings-25, clinical-24)
nmod:in(evaluate-15, settings-25)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO possess/VB several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB possess)
              (NP (JJ several) (NN health) (NNS benefits)))))))
    (. .)))

nsubjpass(known-15, Omega-3_fatty_acids-1)
nsubj:xsubj(possess-17, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(possess-17, to-16)
xcomp(known-15, possess-17)
amod(benefits-20, several-18)
compound(benefits-20, health-19)
dobj(possess-17, benefits-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN beta-Escin/JJ levels/NNS in/IN hyperbeta-Escinmic/JJ patients/NNS ,/, which/WDT is_a/NN precursor/NN for/IN the/DT development/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ beta-Escin) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperbeta-Escinmic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP
                              (NP
                                (NP (NN is_a) (NN precursor))
                                (PP (IN for)
                                  (NP
                                    (NP (DT the) (NN development))
                                    (PP (IN of)
                                      (NP (NN coronary_heart_disease))))))
                              (PRN (-LRB- -LRB-)
                                (NP (NNP CHD))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, beta-Escin-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperbeta-Escinmic-16)
nmod:in(levels-14, patients-17)
nsubj(precursor-21, patients-17)
ref(patients-17, which-19)
compound(precursor-21, is_a-20)
acl:relcl(patients-17, precursor-21)
case(development-24, for-22)
det(development-24, the-23)
nmod:for(precursor-21, development-24)
case(coronary_heart_disease-26, of-25)
nmod:of(development-24, coronary_heart_disease-26)
dep(precursor-21, CHD-28)

EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO inhibit/VB the/DT production/NN of/IN pro-inflammatory/JJ cytokines/NNS and/CC reduce/VB oxidative_stress/NNS ,/, which/WDT play/VBP a/DT crucial/JJ role/NN in/IN the/DT pathogenesis/NNS of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP
                (VP (VB inhibit)
                  (NP
                    (NP (DT the) (NN production))
                    (PP (IN of)
                      (NP (JJ pro-inflammatory) (NNS cytokines)))))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP (NNS oxidative_stress))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP play)
                          (NP
                            (NP (DT a) (JJ crucial) (NN role))
                            (PP (IN in)
                              (NP
                                (NP (DT the) (NNS pathogenesis))
                                (PP (IN of)
                                  (NP (NNP CHD)))))))))))))))))
    (. .)))

nsubjpass(found-6, EPA-1)
nsubj:xsubj(inhibit-8, EPA-1)
nsubj:xsubj(reduce-15, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(found-6, DHA-3)
nsubj:xsubj(inhibit-8, DHA-3)
aux(found-6, have-4)
auxpass(found-6, been-5)
root(ROOT-0, found-6)
mark(inhibit-8, to-7)
xcomp(found-6, inhibit-8)
det(production-10, the-9)
dobj(inhibit-8, production-10)
case(cytokines-13, of-11)
amod(cytokines-13, pro-inflammatory-12)
nmod:of(production-10, cytokines-13)
cc(inhibit-8, and-14)
xcomp(found-6, reduce-15)
conj:and(inhibit-8, reduce-15)
dobj(reduce-15, oxidative_stress-16)
nsubj(play-19, oxidative_stress-16)
ref(oxidative_stress-16, which-18)
acl:relcl(oxidative_stress-16, play-19)
det(role-22, a-20)
amod(role-22, crucial-21)
dobj(play-19, role-22)
case(pathogenesis-25, in-23)
det(pathogenesis-25, the-24)
nmod:in(role-22, pathogenesis-25)
case(CHD-27, of-26)
nmod:of(pathogenesis-25, CHD-27)

Additionally/RB ,/, these/DT fatty_acids/NNS enhance/VB endothelial/JJ function/NN ,/, modulate/VBP lipid/NN metabolism/NN ,/, and/CC improve/VB insulin_sensitivity/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP
      (VP
        (S
          (VP (VB enhance)
            (NP (JJ endothelial) (NN function))))
        (, ,)
        (VP (VBP modulate)
          (NP (NN lipid) (NN metabolism))))
      (, ,)
      (CC and)
      (VP (VB improve)
        (ADVP (RB insulin_sensitivity))))
    (. .)))

advmod(modulate-9, Additionally-1)
det(fatty_acids-4, these-3)
nsubj(modulate-9, fatty_acids-4)
nsubj(improve-14, fatty_acids-4)
ccomp(modulate-9, enhance-5)
amod(function-7, endothelial-6)
dobj(enhance-5, function-7)
root(ROOT-0, modulate-9)
compound(metabolism-11, lipid-10)
dobj(modulate-9, metabolism-11)
cc(modulate-9, and-13)
conj:and(modulate-9, improve-14)
advmod(improve-14, insulin_sensitivity-15)

The/DT consumption/NN of/IN omega-3_fatty_acids/JJ has_been/NN recommended/VBD as/IN a/DT preventive/JJ measure/NN for/IN CHD/NNP due/JJ to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN consumption))
      (PP (IN of)
        (NP (JJ omega-3_fatty_acids) (NN has_been))))
    (VP (VBD recommended)
      (PP (IN as)
        (NP
          (NP
            (NP (DT a) (JJ preventive) (NN measure))
            (PP (IN for)
              (NP (NNP CHD))))
          (ADJP (JJ due)
            (PP (TO to)
              (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))
    (. .)))

det(consumption-2, The-1)
nsubj(recommended-6, consumption-2)
case(has_been-5, of-3)
amod(has_been-5, omega-3_fatty_acids-4)
nmod:of(consumption-2, has_been-5)
root(ROOT-0, recommended-6)
case(measure-10, as-7)
det(measure-10, a-8)
amod(measure-10, preventive-9)
nmod:as(recommended-6, measure-10)
case(CHD-12, for-11)
nmod:for(measure-10, CHD-12)
amod(measure-10, due-13)
case(effects-17, to-14)
nmod:poss(effects-17, their-15)
amod(effects-17, cardioprotective-16)
nmod:to(due-13, effects-17)

Therefore/RB ,/, dietary/JJ supplementation/NN with/IN EPA/NNP and/CC DHA/NNP may/MD reduce/VB the/DT risk/NN of/IN developing/VBG CHD/NNP by/IN lowering/VBG beta-Escin/JJ levels/NNS in/IN hyperbeta-Escinmic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (JJ dietary) (NN supplementation))
      (PP (IN with)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (MD may)
      (VP (VB reduce)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (S
              (VP (VBG developing)
                (NP (NNP CHD))
                (PP (IN by)
                  (S
                    (VP (VBG lowering)
                      (NP
                        (NP (JJ beta-Escin) (NNS levels))
                        (PP (IN in)
                          (NP (JJ hyperbeta-Escinmic) (NNS patients)))))))))))))
    (. .)))

advmod(reduce-10, Therefore-1)
amod(supplementation-4, dietary-3)
nsubj(reduce-10, supplementation-4)
case(EPA-6, with-5)
nmod:with(supplementation-4, EPA-6)
cc(EPA-6, and-7)
nmod:with(supplementation-4, DHA-8)
conj:and(EPA-6, DHA-8)
aux(reduce-10, may-9)
root(ROOT-0, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, CHD-15)
mark(lowering-17, by-16)
advcl(developing-14, lowering-17)
amod(levels-19, beta-Escin-18)
dobj(lowering-17, levels-19)
case(patients-22, in-20)
amod(patients-22, hyperbeta-Escinmic-21)
nmod:in(levels-19, patients-22)

Melatonin/NNP ,/, a/DT hormone/NN secreted/VBN by/IN the/DT pineal/JJ gland/NN ,/, has_been/VBP shown/VBN to/TO have/VB numerous/JJ physiological/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Melatonin))
      (, ,)
      (NP
        (NP (DT a) (NN hormone))
        (VP (VBN secreted)
          (PP (IN by)
            (NP (DT the) (JJ pineal) (NN gland)))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP (JJ numerous) (JJ physiological) (NNS effects)))))))
    (. .)))

nsubj(has_been-11, Melatonin-1)
det(hormone-4, a-3)
appos(Melatonin-1, hormone-4)
acl(hormone-4, secreted-5)
case(gland-9, by-6)
det(gland-9, the-7)
amod(gland-9, pineal-8)
nmod:by(secreted-5, gland-9)
root(ROOT-0, has_been-11)
dep(has_been-11, shown-12)
mark(have-14, to-13)
xcomp(shown-12, have-14)
amod(effects-17, numerous-15)
amod(effects-17, physiological-16)
dobj(have-14, effects-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT impact/NN of/IN melatonin/NN on/IN the/DT expression/NN levels/NNS of/IN key/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN impact))
        (PP (IN of)
          (NP (NN melatonin)))
        (PP (IN on)
          (NP
            (NP (DT the) (NN expression) (NNS levels))
            (PP (IN of)
              (NP
                (NP (JJ key) (NNS genes))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP (NN lipid) (NN metabolism))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(impact-8, the-7)
dobj(investigated-6, impact-8)
case(melatonin-10, of-9)
nmod:of(impact-8, melatonin-10)
case(levels-14, on-11)
det(levels-14, the-12)
compound(levels-14, expression-13)
nmod:on(impact-8, levels-14)
case(genes-17, of-15)
amod(genes-17, key-16)
nmod:of(levels-14, genes-17)
acl(genes-17, involved-18)
case(metabolism-21, in-19)
compound(metabolism-21, lipid-20)
nmod:in(involved-18, metabolism-21)

Our/PRP$ results/NNS showed/VBD that/IN melatonin/NN upregulated/VBD the/DT expression/NN levels/NNS of/IN peroxisome_proliferator-activated_receptor-a/JJ -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- and/CC its/PRP$ target/NN gene/NN carnitine_palmitoyl-CoA/JJ transferase/NN 1/CD -LRB-/-LRB- CPT1/NNP -RRB-/-RRB- ,/, which/WDT are/VBP associated/VBN with/IN lipolysis/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN melatonin))
          (VP (VBD upregulated)
            (NP
              (NP (DT the) (NN expression) (NNS levels))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (ADVP (JJ peroxisome_proliferator-activated_receptor-a))
                      (NP (-LRB- -LRB-) (NNP PPARa) (-RRB- -RRB-))
                      (CC and)
                      (NP (PRP$ its) (NN target) (NN gene)))
                    (NP (JJ carnitine_palmitoyl-CoA) (NN transferase) (CD 1)))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CPT1))
                    (-RRB- -RRB-))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBP are)
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (NNS lipolysis))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(upregulated-6, that-4)
nsubj(upregulated-6, melatonin-5)
ccomp(showed-3, upregulated-6)
det(levels-9, the-7)
compound(levels-9, expression-8)
dobj(upregulated-6, levels-9)
case(PPARa-13, of-10)
advmod(PPARa-13, peroxisome_proliferator-activated_receptor-a-11)
nmod:of(levels-9, PPARa-13)
nsubjpass(associated-28, PPARa-13)
cc(PPARa-13, and-15)
nmod:poss(gene-18, its-16)
compound(gene-18, target-17)
nmod:of(levels-9, gene-18)
conj:and(PPARa-13, gene-18)
nsubjpass(associated-28, gene-18)
amod(transferase-20, carnitine_palmitoyl-CoA-19)
dep(PPARa-13, transferase-20)
nummod(transferase-20, 1-21)
appos(PPARa-13, CPT1-23)
ref(PPARa-13, which-26)
auxpass(associated-28, are-27)
acl:relcl(PPARa-13, associated-28)
case(lipolysis-30, with-29)
nmod:with(associated-28, lipolysis-30)

Conversely/RB ,/, melatonin/NN downregulated/VBD the/DT expression/NN levels/NNS of/IN sterol_regulatory_element_binding_protein-1c/JJ -LRB-/-LRB- SREBP-1c/NNS -RRB-/-RRB- ,/, Pirfenidone/NNP synthase/JJ -LRB-/-LRB- Smad2_and_4/NNS -RRB-/-RRB- ,/, and/CC stearoyl-CoA_desaturase-1/JJ -LRB-/-LRB- SCD1/NNP -RRB-/-RRB- ,/, which/WDT are/VBP associated/VBN with/IN lipogenesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Conversely))
    (, ,)
    (NP (NN melatonin))
    (VP (VBD downregulated)
      (NP
        (NP (DT the) (NN expression) (NNS levels))
        (PP (IN of)
          (NP
            (NP
              (NP (JJ sterol_regulatory_element_binding_protein-1c) (-LRB- -LRB-) (NNS SREBP-1c) (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NNP Pirfenidone))
                (NP (JJ synthase) (-LRB- -LRB-) (NNS Smad2_and_4) (-RRB- -RRB-))))
            (, ,)
            (CC and)
            (NP
              (NP (JJ stearoyl-CoA_desaturase-1))
              (PRN (-LRB- -LRB-)
                (NP (NNP SCD1))
                (-RRB- -RRB-)))
            (, ,)))
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (NNS lipogenesis)))))))))
    (. .)))

advmod(downregulated-4, Conversely-1)
nsubj(downregulated-4, melatonin-3)
root(ROOT-0, downregulated-4)
det(levels-7, the-5)
compound(levels-7, expression-6)
dobj(downregulated-4, levels-7)
nsubjpass(associated-28, levels-7)
case(SREBP-1c-11, of-8)
amod(SREBP-1c-11, sterol_regulatory_element_binding_protein-1c-9)
nmod:of(levels-7, SREBP-1c-11)
appos(SREBP-1c-11, Pirfenidone-14)
amod(Smad2_and_4-17, synthase-15)
dep(Pirfenidone-14, Smad2_and_4-17)
cc(SREBP-1c-11, and-20)
nmod:of(levels-7, stearoyl-CoA_desaturase-1-21)
conj:and(SREBP-1c-11, stearoyl-CoA_desaturase-1-21)
appos(stearoyl-CoA_desaturase-1-21, SCD1-23)
ref(levels-7, which-26)
auxpass(associated-28, are-27)
acl:relcl(levels-7, associated-28)
case(lipogenesis-30, with-29)
nmod:with(associated-28, lipogenesis-30)

These/DT findings/NNS suggest/VBP that/IN melatonin/NN may/MD play/VB a/DT role/NN in/IN regulating/VBG lipid/NN metabolism/NN by/IN promoting/VBG lipolysis/NNS while/IN inhibiting/VBG lipogenesis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN melatonin))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NN lipid) (NN metabolism))
                      (PP (IN by)
                        (S
                          (VP (VBG promoting)
                            (NP (NNS lipolysis))
                            (SBAR (IN while)
                              (S
                                (VP (VBG inhibiting)
                                  (NP (NNS lipogenesis)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, melatonin-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
compound(metabolism-13, lipid-12)
dobj(regulating-11, metabolism-13)
mark(promoting-15, by-14)
advcl(regulating-11, promoting-15)
dobj(promoting-15, lipolysis-16)
mark(inhibiting-18, while-17)
advcl(promoting-15, inhibiting-18)
dobj(inhibiting-18, lipogenesis-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT potential/JJ therapeutic/JJ implications/NNS of/IN these/DT findings/NNS for/IN metabolic_disorders/NNS such/JJ as/IN obesity/NN and/CC diabetes/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS implications))
                (PP (IN of)
                  (NP
                    (NP (DT these) (NNS findings))
                    (PP (IN for)
                      (NP
                        (NP (NNS metabolic_disorders))
                        (PP (JJ such) (IN as)
                          (NP (NN obesity)
                            (CC and)
                            (NN diabetes)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(implications-10, the-7)
amod(implications-10, potential-8)
amod(implications-10, therapeutic-9)
dobj(determine-6, implications-10)
case(findings-13, of-11)
det(findings-13, these-12)
nmod:of(implications-10, findings-13)
case(metabolic_disorders-15, for-14)
nmod:for(findings-13, metabolic_disorders-15)
case(obesity-18, such-16)
mwe(such-16, as-17)
nmod:such_as(metabolic_disorders-15, obesity-18)
cc(obesity-18, and-19)
nmod:such_as(metabolic_disorders-15, diabetes-20)
conj:and(obesity-18, diabetes-20)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO possess/VB a/DT range/NN of/IN beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB possess)
                (NP
                  (NP (DT a) (NN range))
                  (PP (IN of)
                    (NP
                      (NP (JJ beneficial) (NNS effects))
                      (PP (IN on)
                        (NP (JJ human) (NN health))))))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(possess-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(possess-18, to-17)
xcomp(shown-16, possess-18)
det(range-20, a-19)
dobj(possess-18, range-20)
case(effects-23, of-21)
amod(effects-23, beneficial-22)
nmod:of(range-20, effects-23)
case(health-26, on-24)
amod(health-26, human-25)
nmod:on(effects-23, health-26)

One/CD of/IN these/DT effects/NNS is/VBZ the/DT ability/NN to/TO decrease/VB nifuratel/JJ levels/NNS in/IN hypernifuratelmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP (DT these) (NNS effects))))
    (VP (VBZ is)
      (NP (DT the) (NN ability)
        (S
          (VP (TO to)
            (VP (VB decrease)
              (NP
                (NP (JJ nifuratel) (NNS levels))
                (PP (IN in)
                  (NP (JJ hypernifuratelmic) (NNS patients)))))))))
    (. .)))

nsubj(ability-7, One-1)
case(effects-4, of-2)
det(effects-4, these-3)
nmod:of(One-1, effects-4)
cop(ability-7, is-5)
det(ability-7, the-6)
root(ROOT-0, ability-7)
mark(decrease-9, to-8)
acl(ability-7, decrease-9)
amod(levels-11, nifuratel-10)
dobj(decrease-9, levels-11)
case(patients-14, in-12)
amod(patients-14, hypernifuratelmic-13)
nmod:in(levels-11, patients-14)

Nifuratel/NNP is_a/VBZ compound/NN that/WDT has_been/VBP implicated/VBN in/IN the/DT development/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Nifuratel))
    (VP (VBZ is_a)
      (NP
        (NP (NN compound))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN implicated)
                (PP (IN in)
                  (NP
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN coronary_heart_disease))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(is_a-2, Nifuratel-1)
root(ROOT-0, is_a-2)
dobj(is_a-2, compound-3)
nsubj(has_been-5, compound-3)
ref(compound-3, that-4)
acl:relcl(compound-3, has_been-5)
dep(has_been-5, implicated-6)
case(development-9, in-7)
det(development-9, the-8)
nmod:in(implicated-6, development-9)
case(coronary_heart_disease-11, of-10)
nmod:of(development-9, coronary_heart_disease-11)
appos(development-9, CHD-13)

In/IN addition/NN to/TO reducing/VBG nifuratel/JJ levels/NNS ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP also/RB been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (S
            (VP (VBG reducing)
              (NP (JJ nifuratel) (NNS levels)))))))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NNP CHD))))))))))
    (. .)))

mark(reducing-4, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
acl(associated-13, reducing-4)
amod(levels-6, nifuratel-5)
dobj(reducing-4, levels-6)
amod(omega-3_fatty_acids-9, long-chain-8)
nsubjpass(associated-13, omega-3_fatty_acids-9)
aux(associated-13, have-10)
advmod(associated-13, also-11)
auxpass(associated-13, been-12)
root(ROOT-0, associated-13)
case(risk-17, with-14)
det(risk-17, a-15)
amod(risk-17, decreased-16)
nmod:with(associated-13, risk-17)
mark(developing-19, of-18)
acl(risk-17, developing-19)
dobj(developing-19, CHD-20)

This/DT protective/JJ effect/NN may/MD be/VB due/JJ to/TO the/DT ability/NN of/IN omega-3_fatty_acids/JJ to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (NN ability))
              (PP (IN of)
                (NP (JJ omega-3_fatty_acids)))
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VB improve)
                      (NP (NN lipid) (NN metabolism)))
                    (, ,)
                    (CC and)
                    (VP (VB enhance)
                      (NP (JJ endothelial) (NN function)))))))))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubj(due-6, effect-3)
aux(due-6, may-4)
cop(due-6, be-5)
root(ROOT-0, due-6)
case(ability-9, to-7)
det(ability-9, the-8)
nmod:to(due-6, ability-9)
case(omega-3_fatty_acids-11, of-10)
nmod:of(ability-9, omega-3_fatty_acids-11)
mark(reduce-13, to-12)
acl(ability-9, reduce-13)
dobj(reduce-13, inflammation-14)
acl(ability-9, improve-16)
conj:and(reduce-13, improve-16)
compound(metabolism-18, lipid-17)
dobj(improve-16, metabolism-18)
cc(reduce-13, and-20)
acl(ability-9, enhance-21)
conj:and(reduce-13, enhance-21)
amod(function-23, endothelial-22)
dobj(enhance-21, function-23)

Given/VBN these/DT findings/NNS ,/, increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT viable/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ populations/NNS ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP (DT these) (NNS findings)))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP (JJ dietary) (NN intake)
          (CC or)
          (NN supplementation))
        (PP (IN with)
          (NP (NNP EPA)
            (CC and)
            (NNP DHA)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT a) (JJ viable) (NN strategy))
          (PP (IN for)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNP CHD))))
                (PP (IN in)
                  (NP (JJ high-risk) (NNS populations)))))))))
    (. .)))

case(findings-3, Given-1)
det(findings-3, these-2)
nmod:given(strategy-18, findings-3)
csubj(strategy-18, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
cc(intake-7, or-8)
dobj(increasing-5, supplementation-9)
conj:or(intake-7, supplementation-9)
case(EPA-11, with-10)
nmod:with(increasing-5, EPA-11)
cc(EPA-11, and-12)
nmod:with(increasing-5, DHA-13)
conj:and(EPA-11, DHA-13)
aux(strategy-18, may-14)
cop(strategy-18, be-15)
det(strategy-18, a-16)
amod(strategy-18, viable-17)
root(ROOT-0, strategy-18)
mark(reducing-20, for-19)
acl(strategy-18, reducing-20)
det(risk-22, the-21)
dobj(reducing-20, risk-22)
case(CHD-24, of-23)
nmod:of(risk-22, CHD-24)
case(populations-27, in-25)
amod(populations-27, high-risk-26)
nmod:in(reducing-20, populations-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC determine/VB optimal/JJ dosing/JJ strategies/NNS for/IN achieving/VBG maximal/JJ benefits/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (RB fully)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects)))))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (JJ dosing) (NNS strategies))
                  (PP (IN for)
                    (S
                      (VP (VBG achieving)
                        (NP (JJ maximal) (NNS benefits))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
nsubj:xsubj(determine-14, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
xcomp(needed-4, determine-14)
conj:and(elucidate-7, determine-14)
amod(strategies-17, optimal-15)
amod(strategies-17, dosing-16)
dobj(determine-14, strategies-17)
mark(achieving-19, for-18)
acl(strategies-17, achieving-19)
amod(benefits-21, maximal-20)
dobj(achieving-19, benefits-21)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN the/DT human/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT the) (JJ human) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, the-18)
amod(diet-20, human-19)
nmod:of(components-16, diet-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN a/DT decrease/NN in/IN thioacetazon/NN levels/NNS in/IN hyperthioacetazonmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT a) (NN decrease))
                    (PP (IN in)
                      (NP
                        (NP (NN thioacetazon) (NNS levels))
                        (PP (IN in)
                          (NP (JJ hyperthioacetazonmic) (NNS patients)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(decrease-13, with-11)
det(decrease-13, a-12)
nmod:with(associated-10, decrease-13)
case(levels-16, in-14)
compound(levels-16, thioacetazon-15)
nmod:in(decrease-13, levels-16)
case(patients-19, in-17)
amod(patients-19, hyperthioacetazonmic-18)
nmod:in(levels-16, patients-19)

Furthermore/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(has_been-9, Furthermore-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, decreased-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

This/DT reduction/NN in/IN CHD/NNP risk/NN may/MD be/VB due/JJ to/TO the/DT anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN these/DT fatty_acids/NNS ,/, as/RB well/RB as/IN their/PRP$ ability/NN to/TO lower/VB triglyceride_levels/NNS and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN reduction))
      (PP (IN in)
        (NP (NNP CHD) (NN risk))))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (JJ anti-inflammatory)
                (CC and)
                (JJ anti-thrombotic) (NNS properties))
              (PP (IN of)
                (NP
                  (NP (DT these) (NNS fatty_acids))
                  (, ,)
                  (ADVP (RB as) (RB well)
                    (PP (IN as)
                      (NP (PRP$ their) (NN ability)
                        (S
                          (VP (TO to)
                            (VP
                              (VP (VB lower)
                                (NP (NNS triglyceride_levels)))
                              (CC and)
                              (VP (VB improve)
                                (NP (JJ endothelial) (NN function))))))))))))))))
    (. .)))

det(reduction-2, This-1)
nsubj(due-8, reduction-2)
case(risk-5, in-3)
compound(risk-5, CHD-4)
nmod:in(reduction-2, risk-5)
aux(due-8, may-6)
cop(due-8, be-7)
root(ROOT-0, due-8)
case(properties-14, to-9)
det(properties-14, the-10)
amod(properties-14, anti-inflammatory-11)
cc(anti-inflammatory-11, and-12)
conj:and(anti-inflammatory-11, anti-thrombotic-13)
amod(properties-14, anti-thrombotic-13)
nmod:to(due-8, properties-14)
case(fatty_acids-17, of-15)
det(fatty_acids-17, these-16)
nmod:of(properties-14, fatty_acids-17)
advmod(well-20, as-19)
advmod(fatty_acids-17, well-20)
case(ability-23, as-21)
nmod:poss(ability-23, their-22)
nmod:as(well-20, ability-23)
mark(lower-25, to-24)
acl(ability-23, lower-25)
dobj(lower-25, triglyceride_levels-26)
cc(lower-25, and-27)
acl(ability-23, improve-28)
conj:and(lower-25, improve-28)
amod(function-30, endothelial-29)
dobj(improve-28, function-30)

Therefore/RB ,/, increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT incidence/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (VBG increasing) (JJ dietary) (NN intake))
      (PP (IN of)
        (NP (JJ long-chain) (NN omega-3_fatty_acids))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN incidence))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (CC and)
                (VP (VBG improving)
                  (NP (JJ overall) (NN cardiovascular_health)))))))))
    (. .)))

advmod(strategy-13, Therefore-1)
amod(intake-5, increasing-3)
amod(intake-5, dietary-4)
nsubj(strategy-13, intake-5)
case(omega-3_fatty_acids-8, of-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nmod:of(intake-5, omega-3_fatty_acids-8)
aux(strategy-13, may-9)
cop(strategy-13, be-10)
det(strategy-13, an-11)
amod(strategy-13, effective-12)
root(ROOT-0, strategy-13)
mark(reducing-15, for-14)
acl(strategy-13, reducing-15)
det(incidence-17, the-16)
dobj(reducing-15, incidence-17)
case(CHD-19, of-18)
nmod:of(incidence-17, CHD-19)
cc(reducing-15, and-20)
acl(strategy-13, improving-21)
conj:and(reducing-15, improving-21)
amod(cardiovascular_health-23, overall-22)
dobj(improving-21, cardiovascular_health-23)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT relationship/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, p-hydroxybenzoic_acid/JJ ,/, and/CC serum/NN dromyosuppressin/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (NN serum) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (NN alkaline_phosphatase))
                      (, ,)
                      (NP (JJ p-hydroxybenzoic_acid))
                      (, ,)
                      (CC and)
                      (NP (NN serum) (NN dromyosuppressin) (NNS levels)))))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(relationship-8, the-7)
dobj(investigate-6, relationship-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(relationship-8, levels-11)
case(alkaline_phosphatase-13, of-12)
nmod:of(levels-11, alkaline_phosphatase-13)
nmod:of(levels-11, p-hydroxybenzoic_acid-15)
conj:and(alkaline_phosphatase-13, p-hydroxybenzoic_acid-15)
cc(alkaline_phosphatase-13, and-17)
compound(levels-20, serum-18)
compound(levels-20, dromyosuppressin-19)
nmod:of(levels-11, levels-20)
conj:and(alkaline_phosphatase-13, levels-20)

A/DT total/NN of/IN 100/CD participants/NNS were/VBD enrolled/VBN in/IN the/DT study/NN and/CC their/PRP$ serum/NN samples/NNS were/VBD collected/VBN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 100) (NNS participants))))
      (VP (VBD were)
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study))))))
    (CC and)
    (S
      (NP (PRP$ their) (NN serum) (NNS samples))
      (VP (VBD were)
        (VP (VBN collected))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
case(participants-5, of-3)
nummod(participants-5, 100-4)
nmod:of(total-2, participants-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(study-10, in-8)
det(study-10, the-9)
nmod:in(enrolled-7, study-10)
cc(enrolled-7, and-11)
nmod:poss(samples-14, their-12)
compound(samples-14, serum-13)
nsubjpass(collected-16, samples-14)
auxpass(collected-16, were-15)
conj:and(enrolled-7, collected-16)

The/DT results/NNS revealed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, p-hydroxybenzoic_acid/JJ -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC serum/NN dromyosuppressin/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD revealed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (JJ p-hydroxybenzoic_acid))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP (NN serum) (NN dromyosuppressin) (NNS levels))))))))
    (. .)))

det(results-2, The-1)
nsubj(revealed-3, results-2)
root(ROOT-0, revealed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(revealed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(alkaline_phosphatase-12, of-11)
nmod:of(levels-10, alkaline_phosphatase-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(alkaline_phosphatase-12, <-19)
dobj(<-19, 0.01-20)
nmod:of(levels-10, p-hydroxybenzoic_acid-23)
conj:and(alkaline_phosphatase-12, p-hydroxybenzoic_acid-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(p-hydroxybenzoic_acid-23, <-30)
dobj(<-30, 0.01-31)
cc(alkaline_phosphatase-12, and-33)
compound(levels-36, serum-34)
compound(levels-36, dromyosuppressin-35)
nmod:of(levels-10, levels-36)
conj:and(alkaline_phosphatase-12, levels-36)

These/DT findings/NNS suggest/VBP that/IN alkaline_phosphatase/NN and/CC p-hydroxybenzoic_acid/JJ may/MD play/VB a/DT role/NN in/IN the/DT regulation/NN of/IN dromyosuppressin/NN levels/NNS in/IN the/DT body/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (UCP (NN alkaline_phosphatase)
              (CC and)
              (JJ p-hydroxybenzoic_acid)))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (NN dromyosuppressin) (NNS levels))
                        (PP (IN in)
                          (NP (DT the) (NN body)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
csubj(play-9, alkaline_phosphatase-5)
cc(alkaline_phosphatase-5, and-6)
conj:and(alkaline_phosphatase-5, p-hydroxybenzoic_acid-7)
csubj(play-9, p-hydroxybenzoic_acid-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(regulation-14, in-12)
det(regulation-14, the-13)
nmod:in(role-11, regulation-14)
case(levels-17, of-15)
compound(levels-17, dromyosuppressin-16)
nmod:of(regulation-14, levels-17)
case(body-20, in-18)
det(body-20, the-19)
nmod:in(levels-17, body-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC clinical/JJ implications/NNS of/IN these/DT correlations/NNS in/IN various_disease/JJ conditions/NNS associated/VBN with/IN altered/JJ levels/NNS of/IN these/DT biomarkers/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS correlations))
                      (PP (IN in)
                        (NP
                          (NP (JJ various_disease) (NNS conditions))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP
                                (NP (JJ altered) (NNS levels))
                                (PP (IN of)
                                  (NP (DT these) (NNS biomarkers)))))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-12, clinical-11)
dobj(elucidate-6, implications-12)
conj:and(mechanisms-9, implications-12)
case(correlations-15, of-13)
det(correlations-15, these-14)
nmod:of(implications-12, correlations-15)
case(conditions-18, in-16)
amod(conditions-18, various_disease-17)
nmod:in(correlations-15, conditions-18)
acl(conditions-18, associated-19)
case(levels-22, with-20)
amod(levels-22, altered-21)
nmod:with(associated-19, levels-22)
case(biomarkers-25, of-23)
det(biomarkers-25, these-24)
nmod:of(levels-22, biomarkers-25)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ research/NN suggests/VBZ that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB associated/VBN with/IN decreased/VBN chromium/NN levels/NNS in/IN hyperchromiummic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN chromium) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperchromiummic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(suggests-3, research-2)
root(ROOT-0, suggests-3)
mark(associated-9, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(associated-9, omega-3_fatty_acids-6)
aux(associated-9, may-7)
auxpass(associated-9, be-8)
ccomp(suggests-3, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, chromium-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperchromiummic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
amod(risk-19, decreased-18)
nmod:in(levels-13, risk-19)
conj:and(patients-16, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

This/DT finding/NN is/VBZ particularly/RB significant/JJ given/VBN the/DT high/JJ prevalence/NN of/IN CHD/NNP and/CC the/DT need/NN for/IN effective/JJ preventative/JJ measures/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ is)
      (ADVP (RB particularly) (JJ significant))
      (VP (VBN given)
        (NP
          (NP
            (NP (DT the) (JJ high) (NN prevalence))
            (PP (IN of)
              (NP (NNP CHD))))
          (CC and)
          (NP
            (NP (DT the) (NN need))
            (PP (IN for)
              (NP (JJ effective) (JJ preventative) (NNS measures)))))))
    (. .)))

det(finding-2, This-1)
nsubjpass(given-6, finding-2)
auxpass(given-6, is-3)
advmod(significant-5, particularly-4)
advmod(given-6, significant-5)
root(ROOT-0, given-6)
det(prevalence-9, the-7)
amod(prevalence-9, high-8)
dobj(given-6, prevalence-9)
case(CHD-11, of-10)
nmod:of(prevalence-9, CHD-11)
cc(prevalence-9, and-12)
det(need-14, the-13)
dobj(given-6, need-14)
conj:and(prevalence-9, need-14)
case(measures-18, for-15)
amod(measures-18, effective-16)
amod(measures-18, preventative-17)
nmod:for(need-14, measures-18)

The/DT mechanism/NN underlying/VBG this/DT association/NN is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN to/TO involve/VB the/DT anti-inflammatory/JJ and/CC antioxidant/JJ properties/NNS of/IN omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (VP (VBG underlying)
          (NP (DT this) (NN association))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB involve)
                (NP
                  (NP (DT the) (JJ anti-inflammatory)
                    (CC and)
                    (JJ antioxidant) (NNS properties))
                  (PP (IN of)
                    (NP (JJ omega-3_fatty_acids))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(understood-10, mechanism-2)
acl(mechanism-2, underlying-3)
det(association-5, this-4)
dobj(underlying-3, association-5)
auxpass(understood-10, is-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(thought-15, it-13)
nsubj:xsubj(involve-17, it-13)
auxpass(thought-15, is-14)
conj:but(understood-10, thought-15)
mark(involve-17, to-16)
xcomp(thought-15, involve-17)
det(properties-22, the-18)
amod(properties-22, anti-inflammatory-19)
cc(anti-inflammatory-19, and-20)
conj:and(anti-inflammatory-19, antioxidant-21)
amod(properties-22, antioxidant-21)
dobj(involve-17, properties-22)
case(omega-3_fatty_acids-24, of-23)
nmod:of(properties-22, omega-3_fatty_acids-24)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS by/IN which/WDT these/DT compounds/NNS exert/VBP their/PRP$ beneficial/JJ effects/NNS on/IN chromium/NN levels/NNS and_cardiovascular/NN health/NN ,/, as/RB well/RB as/IN to/TO explore/VB potential/JJ therapeutic/JJ applications/NNS for/IN these/DT compounds/NNS in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ precise) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (DT these) (NNS compounds))
                    (VP (VBP exert)
                      (NP
                        (NP (PRP$ their) (JJ beneficial) (NNS effects))
                        (PP (IN on)
                          (NP
                            (NP
                              (NP (NN chromium) (NNS levels))
                              (NP (NN and_cardiovascular) (NN health)))
                            (, ,)
                            (CONJP (RB as) (RB well) (IN as))
                            (S
                              (VP (TO to)
                                (VP (VB explore)
                                  (NP
                                    (NP (JJ potential) (JJ therapeutic) (NNS applications))
                                    (PP (IN for)
                                      (NP
                                        (NP (DT these) (NNS compounds))
                                        (PP (IN in)
                                          (NP
                                            (NP (DT the) (NN prevention)
                                              (CC and)
                                              (NN treatment))
                                            (PP (IN of)
                                              (NP (NNP CHD)))))))))))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
mark(exert-14, by-10)
dobj(exert-14, which-11)
det(compounds-13, these-12)
nsubj(exert-14, compounds-13)
advcl(elucidate-6, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, beneficial-16)
dobj(exert-14, effects-17)
case(levels-20, on-18)
compound(levels-20, chromium-19)
nmod:on(effects-17, levels-20)
compound(health-22, and_cardiovascular-21)
dep(levels-20, health-22)
cc(levels-20, as-24)
mwe(as-24, well-25)
mwe(as-24, as-26)
mark(explore-28, to-27)
acl(levels-20, explore-28)
amod(applications-31, potential-29)
amod(applications-31, therapeutic-30)
dobj(explore-28, applications-31)
case(compounds-34, for-32)
det(compounds-34, these-33)
nmod:for(applications-31, compounds-34)
case(prevention-37, in-35)
det(prevention-37, the-36)
nmod:in(compounds-34, prevention-37)
cc(prevention-37, and-38)
nmod:in(compounds-34, treatment-39)
conj:and(prevention-37, treatment-39)
case(CHD-41, of-40)
nmod:of(prevention-37, CHD-41)

Omega-3_fatty_acids/NNP have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN human/JJ health/NN ,/, particularly/RB in/IN relation/NN to/TO cardiovascular_disease/VB ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (JJ human) (NN health)))))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN in)
            (NP (NN relation)
              (S
                (VP (TO to)
                  (VP (VB cardiovascular_disease)))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(effects-9, for-6)
nmod:poss(effects-9, their-7)
amod(effects-9, beneficial-8)
nmod:for(studied-5, effects-9)
case(health-12, on-10)
amod(health-12, human-11)
nmod:on(effects-9, health-12)
advmod(relation-16, particularly-14)
case(relation-16, in-15)
nmod:in(studied-5, relation-16)
mark(cardiovascular_disease-18, to-17)
acl(relation-16, cardiovascular_disease-18)

Among/IN these/DT ,/, long-chain/NN omega-3_fatty_acids/JJ such/JJ as/IN eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN shown/VBN to_be/VB associated/VBN with/IN decreased/VBN GW501516/NNP levels/NNS in/IN hyperGW501516mic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these)))
    (, ,)
    (NP
      (NP (NN long-chain))
      (RRC
        (ADJP (JJ omega-3_fatty_acids) (JJ such))
        (SBAR (IN as)
          (S
            (VP
              (VP (VBN eicosapentaenoic_acid)
                (PRN (-LRB- -LRB-)
                  (NP (NNP EPA))
                  (-RRB- -RRB-)))
              (CC and)
              (VP (VBN docosahexaenoic_acid))))))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (VB to_be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (VBN decreased) (NNP GW501516) (NNS levels)))
                  (PP (IN in)
                    (NP (JJ hyperGW501516mic) (NNS patients)))))))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(these-2, Among-1)
nmod:among(shown-19, these-2)
nsubjpass(shown-19, long-chain-4)
nsubjpass(decreased-30, long-chain-4)
amod(such-6, omega-3_fatty_acids-5)
acl:relcl(long-chain-4, such-6)
mark(eicosapentaenoic_acid-8, as-7)
dep(such-6, eicosapentaenoic_acid-8)
dep(eicosapentaenoic_acid-8, EPA-10)
cc(eicosapentaenoic_acid-8, and-12)
dep(such-6, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-8, docosahexaenoic_acid-13)
appos(long-chain-4, DHA-15)
aux(shown-19, have-17)
auxpass(shown-19, been-18)
root(ROOT-0, shown-19)
ccomp(shown-19, to_be-20)
dep(to_be-20, associated-21)
case(levels-25, with-22)
amod(levels-25, decreased-23)
compound(levels-25, GW501516-24)
nmod:with(associated-21, levels-25)
case(patients-28, in-26)
amod(patients-28, hyperGW501516mic-27)
nmod:in(associated-21, patients-28)
cc(shown-19, and-29)
conj:and(shown-19, decreased-30)
dobj(decreased-30, risk-31)
case(coronary_heart_disease-34, of-32)
amod(coronary_heart_disease-34, developing-33)
nmod:of(risk-31, coronary_heart_disease-34)
appos(coronary_heart_disease-34, CHD-36)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP thought/VBN to/TO involve/VB a/DT range/NN of/IN physiological/JJ processes/NNS ,/, including/VBG regulation/NN of/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP (VBP are)
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP (VB involve)
              (NP
                (NP (DT a) (NN range))
                (PP (IN of)
                  (NP (JJ physiological) (NNS processes)))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (NN lipid) (NN metabolism))
                        (, ,)
                        (NP (NN inflammation))
                        (, ,)
                        (CC and)
                        (NP (NNS oxidative_stress))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(thought-7, mechanisms-2)
nsubj:xsubj(involve-9, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(thought-7, are-6)
root(ROOT-0, thought-7)
mark(involve-9, to-8)
xcomp(thought-7, involve-9)
det(range-11, a-10)
dobj(involve-9, range-11)
case(processes-14, of-12)
amod(processes-14, physiological-13)
nmod:of(range-11, processes-14)
acl(range-11, including-16)
dobj(including-16, regulation-17)
case(metabolism-20, of-18)
compound(metabolism-20, lipid-19)
nmod:of(regulation-17, metabolism-20)
nmod:of(regulation-17, inflammation-22)
conj:and(metabolism-20, inflammation-22)
cc(metabolism-20, and-24)
nmod:of(regulation-17, oxidative_stress-25)
conj:and(metabolism-20, oxidative_stress-25)

Studies/NNPS have/VBP also/RB suggested/VBN that/IN the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD have/VB additional/JJ benefits/NNS beyond/IN cardiovascular_health/NN ,/, such/JJ as/IN improving/VBG cognitive/JJ function/NN and/CC reducing/VBG the/DT risk/NN of/IN certain/JJ types/NNS of/IN cancer/NN ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP
        (ADVP (RB also))
        (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN intake))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (MD may)
              (VP (VB have)
                (NP (JJ additional) (NNS benefits))
                (PP (IN beyond)
                  (NP
                    (NP (NN cardiovascular_health))
                    (, ,)
                    (PP (JJ such) (IN as)
                      (S
                        (VP
                          (VP (VBG improving)
                            (NP (JJ cognitive) (NN function)))
                          (CC and)
                          (VP (VBG reducing)
                            (NP
                              (NP (DT the) (NN risk))
                              (PP (IN of)
                                (NP
                                  (NP (JJ certain) (NNS types))
                                  (PP (IN of)
                                    (NP (NN cancer))))))))))))))))))
    (. .)))

nsubj(suggested-4, Studies-1)
aux(suggested-4, have-2)
advmod(suggested-4, also-3)
root(ROOT-0, suggested-4)
mark(have-13, that-5)
det(intake-7, the-6)
nsubj(have-13, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(have-13, may-12)
ccomp(suggested-4, have-13)
amod(benefits-15, additional-14)
dobj(have-13, benefits-15)
case(cardiovascular_health-17, beyond-16)
nmod:beyond(have-13, cardiovascular_health-17)
mark(improving-21, such-19)
mwe(such-19, as-20)
acl(cardiovascular_health-17, improving-21)
amod(function-23, cognitive-22)
dobj(improving-21, function-23)
cc(improving-21, and-24)
acl(cardiovascular_health-17, reducing-25)
conj:and(improving-21, reducing-25)
det(risk-27, the-26)
dobj(reducing-25, risk-27)
case(types-30, of-28)
amod(types-30, certain-29)
nmod:of(risk-27, types-30)
case(cancer-32, of-31)
nmod:of(types-30, cancer-32)

As/IN a/DT result/NN ,/, there/EX has_been/VBP considerable/JJ interest/NN in/IN the/DT potential/JJ therapeutic/JJ applications/NNS of/IN these/DT fatty_acids/NNS ,/, both/DT as/IN dietary/JJ supplements/NNS and/CC as/IN components/NNS of/IN functional/JJ foods/NNS ./.

(ROOT
  (S
    (PP (IN As)
      (NP (DT a) (NN result)))
    (, ,)
    (NP (EX there))
    (VP (VBP has_been)
      (NP
        (NP (JJ considerable) (NN interest))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
            (PP (IN of)
              (NP (DT these) (NNS fatty_acids))))))
      (, ,)
      (PP (DT both)
        (PP (IN as)
          (NP (JJ dietary) (NNS supplements)))
        (CC and)
        (PP (IN as)
          (NP
            (NP (NNS components))
            (PP (IN of)
              (NP (JJ functional) (NNS foods)))))))
    (. .)))

case(result-3, As-1)
det(result-3, a-2)
nmod:as(has_been-6, result-3)
expl(has_been-6, there-5)
root(ROOT-0, has_been-6)
conj:and(has_been-6, has_been-6')
amod(interest-8, considerable-7)
dobj(has_been-6, interest-8)
case(applications-13, in-9)
det(applications-13, the-10)
amod(applications-13, potential-11)
amod(applications-13, therapeutic-12)
nmod:in(interest-8, applications-13)
case(fatty_acids-16, of-14)
det(fatty_acids-16, these-15)
nmod:of(applications-13, fatty_acids-16)
cc:preconj(supplements-21, both-18)
case(supplements-21, as-19)
amod(supplements-21, dietary-20)
nmod:as(has_been-6, supplements-21)
cc(has_been-6, and-22)
case(components-24, as-23)
nmod:as(has_been-6', components-24)
case(foods-27, of-25)
amod(foods-27, functional-26)
nmod:of(components-24, foods-27)

However/RB ,/, further/JJ research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB their/PRP$ mechanisms/NNS of/IN action/NN and/CC to/TO establish/VB optimal/JJ dosages/NNS for/IN specific/JJ health/NN outcomes/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (PRP$ their) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))
            (CC and)
            (VP (TO to)
              (VP (VB establish)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ specific) (NN health) (NNS outcomes)))))))))
    (. .)))

advmod(needed-6, However-1)
amod(research-4, further-3)
nsubjpass(needed-6, research-4)
auxpass(needed-6, is-5)
root(ROOT-0, needed-6)
mark(elucidate-9, to-7)
advmod(elucidate-9, fully-8)
ccomp(needed-6, elucidate-9)
nmod:poss(mechanisms-11, their-10)
dobj(elucidate-9, mechanisms-11)
case(action-13, of-12)
nmod:of(mechanisms-11, action-13)
cc(elucidate-9, and-14)
mark(establish-16, to-15)
ccomp(needed-6, establish-16)
conj:and(elucidate-9, establish-16)
amod(dosages-18, optimal-17)
dobj(establish-16, dosages-18)
case(outcomes-22, for-19)
amod(outcomes-22, specific-20)
compound(outcomes-22, health-21)
nmod:for(establish-16, outcomes-22)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (NN cardiovascular_health))))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, widely-16)
root(ROOT-0, studied-17)
case(effects-21, for-18)
nmod:poss(effects-21, their-19)
amod(effects-21, beneficial-20)
nmod:for(studied-17, effects-21)
case(cardiovascular_health-23, on-22)
nmod:on(effects-21, cardiovascular_health-23)

Recent/JJ evidence/NN suggests/VBZ that/IN EPA/NNP and/CC DHA/NNP may/MD be/VB associated/VBN with/IN decreased/VBN remacemide/JJ levels/NNS in/IN hyperremacemidemic/JJ patients/NNS ,/, which/WDT could/MD potentially/RB contribute/VB to/TO the/DT reduction/NN of/IN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ remacemide) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperremacemidemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD could) (RB potentially)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP
                                      (NP (DT the) (NN reduction))
                                      (PP (IN of)
                                        (NP
                                          (NP (NN risk))
                                          (PP (IN of)
                                            (S
                                              (VP (VBG developing)
                                                (NP (NN coronary_heart_disease))))))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(evidence-2, Recent-1)
nsubj(suggests-3, evidence-2)
root(ROOT-0, suggests-3)
mark(associated-10, that-4)
nsubjpass(associated-10, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubjpass(associated-10, DHA-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(suggests-3, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, remacemide-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperremacemidemic-16)
nmod:in(levels-14, patients-17)
nsubj(contribute-22, patients-17)
ref(patients-17, which-19)
aux(contribute-22, could-20)
advmod(contribute-22, potentially-21)
acl:relcl(patients-17, contribute-22)
case(reduction-25, to-23)
det(reduction-25, the-24)
nmod:to(contribute-22, reduction-25)
case(risk-27, of-26)
nmod:of(reduction-25, risk-27)
mark(developing-29, of-28)
acl(risk-27, developing-29)
dobj(developing-29, coronary_heart_disease-30)
appos(reduction-25, CHD-32)

This/DT association/NN has_been/NN attributed/VBN to/TO the/DT ability/NN of/IN omega-3_fatty_acids/JJ to/TO modulate/VBP lipid/NN metabolism/NN and/CC reduce/VB inflammation/NN ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN association) (NN has_been))
      (VP (VBN attributed)
        (PP (TO to)
          (NP
            (NP (DT the) (NN ability))
            (PP (IN of)
              (NP
                (QP (JJ omega-3_fatty_acids) (TO to))))))))
    (VP
      (VP (VBP modulate)
        (NP (NN lipid) (NN metabolism)))
      (CC and)
      (VP (VB reduce)
        (NP (NN inflammation))))
    (. .)))

det(has_been-3, This-1)
compound(has_been-3, association-2)
nsubj(modulate-11, has_been-3)
nsubj(reduce-15, has_been-3)
acl(has_been-3, attributed-4)
case(ability-7, to-5)
det(ability-7, the-6)
nmod:to(attributed-4, ability-7)
case(omega-3_fatty_acids-9, of-8)
nmod:of(ability-7, omega-3_fatty_acids-9)
dep(omega-3_fatty_acids-9, to-10)
root(ROOT-0, modulate-11)
compound(metabolism-13, lipid-12)
dobj(modulate-11, metabolism-13)
cc(modulate-11, and-14)
conj:and(modulate-11, reduce-15)
dobj(reduce-15, inflammation-16)

Several/JJ mechanisms/NNS have/VBP been/VBN proposed/VBN to/TO explain/VB these/DT effects/NNS ,/, including/VBG the/DT inhibition/NN of/IN hepatic/JJ triglyceride_synthesis/NNS and/CC secretion/NN ,/, activation/NN of/IN peroxisome_proliferator-activated_receptors/NNS ,/, and/CC modulation/NN of/IN cytokine/JJ production/NN ./.

(ROOT
  (S
    (NP (JJ Several) (NNS mechanisms))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN proposed)
          (S
            (VP (TO to)
              (VP (VB explain)
                (NP
                  (NP (DT these) (NNS effects))
                  (, ,)
                  (VP (VBG including)
                    (NP
                      (NP
                        (NP (DT the) (NN inhibition))
                        (PP (IN of)
                          (NP (JJ hepatic) (NNS triglyceride_synthesis)
                            (CC and)
                            (NN secretion))))
                      (, ,)
                      (NP
                        (NP (NN activation))
                        (PP (IN of)
                          (NP (NNS peroxisome_proliferator-activated_receptors))))
                      (, ,)
                      (CC and)
                      (NP
                        (NP (NN modulation))
                        (PP (IN of)
                          (NP (JJ cytokine) (NN production)))))))))))))
    (. .)))

amod(mechanisms-2, Several-1)
nsubjpass(proposed-5, mechanisms-2)
nsubj:xsubj(explain-7, mechanisms-2)
aux(proposed-5, have-3)
auxpass(proposed-5, been-4)
root(ROOT-0, proposed-5)
mark(explain-7, to-6)
xcomp(proposed-5, explain-7)
det(effects-9, these-8)
dobj(explain-7, effects-9)
acl(effects-9, including-11)
det(inhibition-13, the-12)
dobj(including-11, inhibition-13)
case(triglyceride_synthesis-16, of-14)
amod(triglyceride_synthesis-16, hepatic-15)
nmod:of(inhibition-13, triglyceride_synthesis-16)
cc(triglyceride_synthesis-16, and-17)
nmod:of(inhibition-13, secretion-18)
conj:and(triglyceride_synthesis-16, secretion-18)
dobj(including-11, activation-20)
conj:and(inhibition-13, activation-20)
case(peroxisome_proliferator-activated_receptors-22, of-21)
nmod:of(activation-20, peroxisome_proliferator-activated_receptors-22)
cc(inhibition-13, and-24)
dobj(including-11, modulation-25)
conj:and(inhibition-13, modulation-25)
case(production-28, of-26)
amod(production-28, cytokine-27)
nmod:of(modulation-25, production-28)

In/IN addition/NN ,/, omega-3_fatty_acids/JJ have/VBP been/VBN shown/VBN to/TO improve/VB endothelial/JJ function/NN ,/, reduce/VB platelet_aggregation/NN ,/, and/CC lower/JJR blood_pressure/NN ,/, all/DT of/IN which/WDT are/VBP important/JJ factors/NNS in/IN the/DT prevention/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (JJ endothelial) (NN function)))
                (, ,)
                (VP (VB reduce)
                  (NP
                    (NP (NN platelet_aggregation))
                    (, ,)
                    (CC and)
                    (NP (JJR lower) (NN blood_pressure))
                    (, ,))
                  (SBAR
                    (WHNP (DT all)
                      (WHPP (IN of)
                        (WHNP (WDT which))))
                    (S
                      (VP (VBP are)
                        (NP
                          (NP (JJ important) (NNS factors))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN prevention))
                              (PP (IN of)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-7, addition-2)
nsubjpass(shown-7, omega-3_fatty_acids-4)
nsubj:xsubj(improve-9, omega-3_fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
amod(function-11, endothelial-10)
dobj(improve-9, function-11)
dep(improve-9, reduce-13)
dobj(reduce-13, platelet_aggregation-14)
cc(platelet_aggregation-14, and-16)
amod(blood_pressure-18, lower-17)
dobj(reduce-13, blood_pressure-18)
conj:and(platelet_aggregation-14, blood_pressure-18)
dep(which-22, all-20)
case(which-22, of-21)
nsubj(factors-25, which-22)
cop(factors-25, are-23)
amod(factors-25, important-24)
dep(reduce-13, factors-25)
case(prevention-28, in-26)
det(prevention-28, the-27)
nmod:in(factors-25, prevention-28)
case(CHD-30, of-29)
nmod:of(prevention-28, CHD-30)

Overall/RB ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN hyperremacemidemic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP (JJ dietary) (NN intake)
                (CC or)
                (NN supplementation))
              (PP (IN with)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ hyperremacemidemic) (NNS patients))))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(strategy-20, that-6)
csubj(strategy-20, increasing-7)
amod(intake-9, dietary-8)
dobj(increasing-7, intake-9)
cc(intake-9, or-10)
dobj(increasing-7, supplementation-11)
conj:or(intake-9, supplementation-11)
case(EPA-13, with-12)
nmod:with(increasing-7, EPA-13)
cc(EPA-13, and-14)
nmod:with(increasing-7, DHA-15)
conj:and(EPA-13, DHA-15)
aux(strategy-20, may-16)
cop(strategy-20, be-17)
det(strategy-20, a-18)
amod(strategy-20, promising-19)
ccomp(suggest-5, strategy-20)
mark(reducing-22, for-21)
acl(strategy-20, reducing-22)
det(risk-24, the-23)
dobj(reducing-22, risk-24)
case(CHD-26, of-25)
nmod:of(risk-24, CHD-26)
case(patients-29, in-27)
amod(patients-29, hyperremacemidemic-28)
nmod:in(reducing-22, patients-29)

Sizofiran/NNP ,/, a/DT β-glucan/NN derived/VBN from/IN the/DT cell/NN wall/NN of/IN Schizophyllum_commune/NNP ,/, has_been/VBP shown/VBN to/TO possess/VB immunomodulatory/JJ and/CC anti-tumor/JJ properties/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Sizofiran))
      (, ,)
      (NP
        (NP (DT a) (NN β-glucan))
        (VP (VBN derived)
          (PP (IN from)
            (NP
              (NP (DT the) (NN cell) (NN wall))
              (PP (IN of)
                (NP (NNP Schizophyllum_commune)))))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB possess)
              (NP (JJ immunomodulatory)
                (CC and)
                (JJ anti-tumor) (NNS properties)))))))
    (. .)))

nsubj(has_been-13, Sizofiran-1)
det(β-glucan-4, a-3)
appos(Sizofiran-1, β-glucan-4)
acl(β-glucan-4, derived-5)
case(wall-9, from-6)
det(wall-9, the-7)
compound(wall-9, cell-8)
nmod:from(derived-5, wall-9)
case(Schizophyllum_commune-11, of-10)
nmod:of(wall-9, Schizophyllum_commune-11)
root(ROOT-0, has_been-13)
dep(has_been-13, shown-14)
mark(possess-16, to-15)
xcomp(shown-14, possess-16)
amod(properties-20, immunomodulatory-17)
cc(immunomodulatory-17, and-18)
conj:and(immunomodulatory-17, anti-tumor-19)
amod(properties-20, anti-tumor-19)
dobj(possess-16, properties-20)

In/IN this/DT study/NN ,/, the/DT potential/JJ protective/JJ effects/NNS of/IN sizofiran/NN against/IN DNA_damage/NNP and/CC photophobia/phonophobia/NNP were/VBD investigated/VBN in_a/JJ randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (JJ potential) (JJ protective) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN sizofiran))
          (PP (IN against)
            (NP (NNP DNA_damage)
              (CC and)
              (NNP photophobia/phonophobia))))))
    (VP (VBD were)
      (VP (VBN investigated)
        (NP (JJ in_a)
          (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
          (NN trial))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-16, study-3)
det(effects-8, the-5)
amod(effects-8, potential-6)
amod(effects-8, protective-7)
nsubjpass(investigated-16, effects-8)
case(sizofiran-10, of-9)
nmod:of(effects-8, sizofiran-10)
case(DNA_damage-12, against-11)
nmod:against(sizofiran-10, DNA_damage-12)
cc(DNA_damage-12, and-13)
nmod:against(sizofiran-10, photophobia/phonophobia-14)
conj:and(DNA_damage-12, photophobia/phonophobia-14)
auxpass(investigated-16, were-15)
root(ROOT-0, investigated-16)
amod(trial-23, in_a-17)
amod(placebo-controlled-22, randomized-18)
amod(placebo-controlled-22, double-blind-20)
amod(trial-23, placebo-controlled-22)
dobj(investigated-16, trial-23)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, sizofiran/NN was/VBD found/VBD to/TO significantly/RB reduce/VB the/DT risk/NN of/IN sister-chromatid_exchange/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN sizofiran))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (JJ sister-chromatid_exchange))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(hours-2, At_2-1)
dep(found-8, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubjpass(found-8, sizofiran-6)
nsubj:xsubj(reduce-11, sizofiran-6)
nsubj(photophobia-31, sizofiran-6)
nsubj(phonophobia-48, sizofiran-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(sister-chromatid_exchange-15, of-14)
nmod:of(risk-13, sister-chromatid_exchange-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-8, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-8, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-8, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-8, and-47)
conj:and(found-8, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-8, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT findings/NNS suggest/VBP that/IN sizofiran/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN DNA_damage/NNP and/CC light/sound/JJ sensitivity/NN in/IN humans/NNS ,/, potentially/RB making/VBG it/PRP a/DT promising/JJ therapeutic/JJ agent/NN for/IN conditions/NNS associated/VBN with/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN sizofiran))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP
                    (NP (NNP DNA_damage))
                    (CC and)
                    (NP
                      (NP (JJ light/sound) (NN sensitivity))
                      (PP (IN in)
                        (NP
                          (NP (NNS humans))
                          (, ,)
                          (SBAR
                            (S
                              (ADVP (RB potentially))
                              (VP (VBG making)
                                (NP (PRP it))
                                (NP
                                  (NP (DT a) (JJ promising) (JJ therapeutic) (NN agent))
                                  (PP (IN for)
                                    (NP
                                      (NP (NNS conditions))
                                      (VP (VBN associated)
                                        (PP (IN with)
                                          (NP (DT these) (NNS symptoms)))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, sizofiran-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, protective-9)
dobj(have-7, effect-10)
case(DNA_damage-12, against-11)
nmod:against(effect-10, DNA_damage-12)
cc(DNA_damage-12, and-13)
amod(sensitivity-15, light/sound-14)
nmod:against(effect-10, sensitivity-15)
conj:and(DNA_damage-12, sensitivity-15)
case(humans-17, in-16)
nmod:in(sensitivity-15, humans-17)
advmod(making-20, potentially-19)
acl:relcl(humans-17, making-20)
iobj(making-20, it-21)
det(agent-25, a-22)
amod(agent-25, promising-23)
amod(agent-25, therapeutic-24)
dobj(making-20, agent-25)
case(conditions-27, for-26)
nmod:for(agent-25, conditions-27)
acl(conditions-27, associated-28)
case(symptoms-31, with-29)
det(symptoms-31, these-30)
nmod:with(associated-28, symptoms-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)

In/IN recent/JJ years/NNS ,/, there/EX has_been/VBP a/DT growing/VBG interest/NN in/IN the/DT development/NN of/IN drugs/NNS that/WDT can/MD prevent/VB or/CC reduce/VB the/DT risk/NN of/IN phototoxic_reactions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ recent) (NNS years)))
    (, ,)
    (NP (EX there))
    (VP (VBP has_been)
      (NP
        (NP (DT a) (VBG growing) (NN interest))
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NNS drugs))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD can)
                      (VP
                        (VP (VB prevent))
                        (CC or)
                        (VP (VB reduce)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP (NNS phototoxic_reactions)))))))))))))))
    (. .)))

case(years-3, In-1)
amod(years-3, recent-2)
nmod:in(has_been-6, years-3)
expl(has_been-6, there-5)
root(ROOT-0, has_been-6)
det(interest-9, a-7)
amod(interest-9, growing-8)
dobj(has_been-6, interest-9)
case(development-12, in-10)
det(development-12, the-11)
nmod:in(interest-9, development-12)
case(drugs-14, of-13)
nmod:of(development-12, drugs-14)
nsubj(prevent-17, drugs-14)
nsubj(reduce-19, drugs-14)
ref(drugs-14, that-15)
aux(prevent-17, can-16)
acl:relcl(drugs-14, prevent-17)
cc(prevent-17, or-18)
acl:relcl(drugs-14, reduce-19)
conj:or(prevent-17, reduce-19)
det(risk-21, the-20)
dobj(reduce-19, risk-21)
case(phototoxic_reactions-23, of-22)
nmod:of(risk-21, phototoxic_reactions-23)

One/CD such/JJ drug/NN is/VBZ PHA-665752/NN ,/, which/WDT has_been/VBP shown/VBN to_be/NN effective/JJ in/IN reducing/VBG the/DT risk/NN of/IN phototoxic_reactions/NNS ,/, photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN drug))
    (VP (VBZ is)
      (NP
        (NP (NN PHA-665752))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (NP (NN to_be))
                (S
                  (ADJP (JJ effective)
                    (PP (IN in)
                      (S
                        (VP (VBG reducing)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP
                                (NP (NNS phototoxic_reactions))
                                (, ,)
                                (NP (NN photophobia)
                                  (CC and)
                                  (NN phonophobia))))))))))))))))
    (. .)))

nummod(drug-3, One-1)
amod(drug-3, such-2)
nsubj(PHA-665752-5, drug-3)
cop(PHA-665752-5, is-4)
root(ROOT-0, PHA-665752-5)
nsubj(has_been-8, PHA-665752-5)
ref(PHA-665752-5, which-7)
acl:relcl(PHA-665752-5, has_been-8)
dep(has_been-8, shown-9)
dobj(shown-9, to_be-10)
xcomp(shown-9, effective-11)
mark(reducing-13, in-12)
advcl(effective-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(phototoxic_reactions-17, of-16)
nmod:of(risk-15, phototoxic_reactions-17)
appos(phototoxic_reactions-17, photophobia-19)
cc(photophobia-19, and-20)
appos(phototoxic_reactions-17, phonophobia-21)
conj:and(photophobia-19, phonophobia-21)

In/IN a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN involving/VBG a/DT large/JJ cohort/NN of/IN patients/NNS ,/, PHA-665752/NNP was/VBD administered/VBN at/IN 2/CD hours/NNS after/IN dosing/VBG ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial))
        (VP (VBG involving)
          (NP
            (NP (DT a) (JJ large) (NN cohort))
            (PP (IN of)
              (NP (NNS patients)))))))
    (, ,)
    (NP (NNP PHA-665752))
    (VP (VBD was)
      (VP (VBN administered)
        (PP (IN at)
          (NP (CD 2) (NNS hours)))
        (PP (IN after)
          (S
            (VP (VBG dosing))))))
    (. .)))

case(trial-8, In-1)
det(trial-8, a-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(administered-18, trial-8)
acl(trial-8, involving-9)
det(cohort-12, a-10)
amod(cohort-12, large-11)
dobj(involving-9, cohort-12)
case(patients-14, of-13)
nmod:of(cohort-12, patients-14)
nsubjpass(administered-18, PHA-665752-16)
auxpass(administered-18, was-17)
root(ROOT-0, administered-18)
case(hours-21, at-19)
nummod(hours-21, 2-20)
nmod:at(administered-18, hours-21)
mark(dosing-23, after-22)
advcl(administered-18, dosing-23)

The/DT results/NNS showed/VBD that/IN PHA-665752/NNP reduced/VBD the/DT risk/NN of/IN phototoxic_reactions/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP PHA-665752))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS phototoxic_reactions))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, PHA-665752-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(phototoxic_reactions-10, of-9)
nmod:of(risk-8, phototoxic_reactions-10)
case(%-13, by-11)
nummod(%-13, 14-12)
nmod:by(reduced-6, %-13)
nummod(%-16, 95-15)
dep(%-13, %-16)
acl:relcl(%-16, CI-17)
nummod(%-19, 6-20-18)
dobj(CI-17, %-19)
appos(%-19, P-21)
dep(0.0005-23, =-22)
dep(%-19, 0.0005-23)
xcomp(reduced-6, photophobia-26)
case(%-29, by-27)
nummod(%-29, 17-28)
nmod:by(photophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(photophobia-26, and-42)
xcomp(reduced-6, phonophobia-43)
conj:and(photophobia-26, phonophobia-43)
case(%-46, by-44)
nummod(%-46, 14-45)
nmod:by(phonophobia-43, %-46)
nummod(%-49, 95-48)
appos(%-46, %-49)
dep(%-52, CI-50)
nummod(%-52, 17-20-51)
nmod(%-49, %-52)
dep(%-49, P-54)
compound(0.0001-56, <-55)
nummod(P-54, 0.0001-56)

These/DT findings/NNS suggest/VBP that/IN PHA-665752/NNP may/MD be/VB a/DT promising/JJ drug/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN phototoxic_reactions/NNS ,/, photophobia/NN and/CC phonophobia/NN in/IN patients/NNS who/WP are/VBP at/IN risk/NN for/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP PHA-665752))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN drug))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (NNS phototoxic_reactions))
                        (, ,)
                        (NP
                          (NP (NN photophobia)
                            (CC and)
                            (NN phonophobia))
                          (PP (IN in)
                            (NP
                              (NP (NNS patients))
                              (SBAR
                                (WHNP (WP who))
                                (S
                                  (VP (VBP are)
                                    (PP (IN at)
                                      (NP
                                        (NP (NN risk))
                                        (PP (IN for)
                                          (NP (DT these) (NNS conditions)))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(drug-10, that-4)
nsubj(drug-10, PHA-665752-5)
aux(drug-10, may-6)
cop(drug-10, be-7)
det(drug-10, a-8)
amod(drug-10, promising-9)
ccomp(suggest-3, drug-10)
case(prevention-13, for-11)
det(prevention-13, the-12)
nmod:for(drug-10, prevention-13)
cc(prevention-13, and-14)
nmod:for(drug-10, treatment-15)
conj:and(prevention-13, treatment-15)
case(phototoxic_reactions-17, of-16)
nmod:of(prevention-13, phototoxic_reactions-17)
appos(phototoxic_reactions-17, photophobia-19)
cc(photophobia-19, and-20)
appos(phototoxic_reactions-17, phonophobia-21)
conj:and(photophobia-19, phonophobia-21)
case(patients-23, in-22)
nmod:in(photophobia-19, patients-23)
nsubj(risk-27, patients-23)
ref(patients-23, who-24)
cop(risk-27, are-25)
case(risk-27, at-26)
acl:relcl(patients-23, risk-27)
case(conditions-30, for-28)
det(conditions-30, these-29)
nmod:for(risk-27, conditions-30)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN treatment/NN with/IN PHA-665752/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dose)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP (NN treatment))))
                (PP (IN with)
                  (NP (NN PHA-665752)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(dose-14, the-12)
amod(dose-14, optimal-13)
dobj(determine-11, dose-14)
cc(dose-14, and-15)
dobj(determine-11, duration-16)
conj:and(dose-14, duration-16)
case(treatment-18, of-17)
nmod:of(dose-14, treatment-18)
case(PHA-665752-20, with-19)
nmod:with(determine-11, PHA-665752-20)

The/DT regulation/NN of/IN lactose/NN biosynthesis/VBZ in/IN the/DT mammary_gland/JJ during/IN pregnancy/NN is_a/NN complex/JJ process/NN that/WDT involves/VBZ multiple/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN lactose))))
    (VP (VBZ biosynthesis)
      (PP (IN in)
        (NP
          (NP (DT the)
            (ADJP (JJ mammary_gland)
              (PP (IN during)
                (NP (NN pregnancy) (NN is_a))))
            (JJ complex) (NN process))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ involves)
                (NP (JJ multiple) (VBG signaling) (NNS pathways))))))))
    (. .)))

det(regulation-2, The-1)
nsubj(biosynthesis-5, regulation-2)
case(lactose-4, of-3)
nmod:of(regulation-2, lactose-4)
root(ROOT-0, biosynthesis-5)
case(process-13, in-6)
det(process-13, the-7)
amod(process-13, mammary_gland-8)
case(is_a-11, during-9)
compound(is_a-11, pregnancy-10)
nmod:during(mammary_gland-8, is_a-11)
amod(process-13, complex-12)
nmod:in(biosynthesis-5, process-13)
nsubj(involves-15, process-13)
ref(process-13, that-14)
acl:relcl(process-13, involves-15)
amod(pathways-18, multiple-16)
amod(pathways-18, signaling-17)
dobj(involves-15, pathways-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT potential/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/VB -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN the/DT natural/JJ compound/NN pannarin/NN ,/, on/IN the/DT early/JJ effects/NNS of/IN acid_1/NNS -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ potential) (NNS roles))
        (PP (IN of)
          (NP
            (NP
              (NP (NNS adenosine_3) (POS '))
              (ADJP (CD ,5))
              ('' ')
              (PRN (: -)
                (S
                  (VP (VB cyclic_monophosphate)
                    (NP
                      (NP (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-))
                      (CC and)
                      (NP
                        (NP (NNS guanosine_3) (POS '))
                        (NX (CD ,5)))
                      ('' '))))
                (: -))
              (NN cyclic_monophosphate))
            (PRN (-LRB- -LRB-)
              (NP (NN cGMP))
              (-RRB- -RRB-)))))
      (, ,)
      (ADVP
        (ADVP (RB as) (RB well))
        (PP (IN as)
          (NP (DT the) (JJ natural) (NN compound) (NN pannarin))))
      (, ,)
      (PP (IN on)
        (NP
          (NP (DT the) (JJ early) (NNS effects))
          (PP (IN of)
            (NP
              (NP (NNS acid_1))
              (PRN (-LRB- -LRB-)
                (NP (NNP PRL))
                (-RRB- -RRB-))))))
      (PP (IN on)
        (NP (JJ lactose) (NNS biosynthesis))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(roles-9, the-7)
amod(roles-9, potential-8)
dobj(investigated-6, roles-9)
case(cyclic_monophosphate-26, of-10)
nmod:poss(cyclic_monophosphate-26, adenosine_3-11)
case(adenosine_3-11, '-12)
amod(cyclic_monophosphate-26, ,5-13)
dep(cyclic_monophosphate-26, cyclic_monophosphate-16)
dobj(cyclic_monophosphate-16, cAMP-18)
cc(cAMP-18, and-20)
nmod:poss(,5-23, guanosine_3-21)
case(guanosine_3-21, '-22)
dobj(cyclic_monophosphate-16, ,5-23)
conj:and(cAMP-18, ,5-23)
nmod:of(roles-9, cyclic_monophosphate-26)
appos(cyclic_monophosphate-26, cGMP-28)
advmod(investigated-6, as-31)
mwe(as-31, well-32)
case(pannarin-37, as-33)
det(pannarin-37, the-34)
amod(pannarin-37, natural-35)
compound(pannarin-37, compound-36)
nmod:as(as-31, pannarin-37)
case(effects-42, on-39)
det(effects-42, the-40)
amod(effects-42, early-41)
nmod:on(investigated-6, effects-42)
case(acid_1-44, of-43)
nmod:of(effects-42, acid_1-44)
appos(acid_1-44, PRL-46)
case(biosynthesis-50, on-48)
amod(biosynthesis-50, lactose-49)
nmod:on(investigated-6, biosynthesis-50)

Cultured/JJ mammary_gland/JJ explants/NNS were/VBD derived/VBN from/IN mice/NNS at/IN 12-14/CD days/NNS of/IN pregnancy/NN and/CC treated/VBN with/IN PRL/NNP in/IN combination/NN with/IN cAMP/NN ,/, cGMP/NN ,/, or/CC pannarin/NN ./.

(ROOT
  (S
    (NP (JJ Cultured) (JJ mammary_gland) (NNS explants))
    (VP (VBD were)
      (VP
        (VP (VBN derived)
          (PP (IN from)
            (NP (NNS mice)))
          (PP (IN at)
            (NP
              (NP (CD 12-14) (NNS days))
              (PP (IN of)
                (NP (NN pregnancy))))))
        (CC and)
        (VP (VBN treated)
          (PP (IN with)
            (NP (NNP PRL)))
          (PP (IN in)
            (NP
              (NP (NN combination))
              (PP (IN with)
                (NP
                  (NP (NN cAMP))
                  (, ,)
                  (NP (NN cGMP))
                  (, ,)
                  (CC or)
                  (NP (NN pannarin)))))))))
    (. .)))

amod(explants-3, Cultured-1)
amod(explants-3, mammary_gland-2)
nsubjpass(derived-5, explants-3)
nsubjpass(treated-14, explants-3)
auxpass(derived-5, were-4)
root(ROOT-0, derived-5)
case(mice-7, from-6)
nmod:from(derived-5, mice-7)
case(days-10, at-8)
nummod(days-10, 12-14-9)
nmod:at(derived-5, days-10)
case(pregnancy-12, of-11)
nmod:of(days-10, pregnancy-12)
cc(derived-5, and-13)
conj:and(derived-5, treated-14)
case(PRL-16, with-15)
nmod:with(treated-14, PRL-16)
case(combination-18, in-17)
nmod:in(treated-14, combination-18)
case(cAMP-20, with-19)
nmod:with(combination-18, cAMP-20)
nmod:with(combination-18, cGMP-22)
conj:or(cAMP-20, cGMP-22)
cc(cAMP-20, or-24)
nmod:with(combination-18, pannarin-25)
conj:or(cAMP-20, pannarin-25)

Our/PRP$ results/NNS indicate/VBP that/IN cAMP/NN and/CC cGMP/NN may/MD play/VB a/DT role/NN in/IN mediating/VBG the/DT early/JJ effects/NNS of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS ,/, as/IN treatment/NN with/IN these/DT cyclic_nucleotides/NNS enhanced/VBN lactose/JJ production/NN in/IN response/NN to/TO PRL/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG mediating)
                      (NP
                        (NP (DT the) (JJ early) (NNS effects))
                        (PP (IN of)
                          (NP (NNP PRL))))
                      (PP (IN on)
                        (NP (JJ lactose) (NNS biosynthesis)))
                      (, ,)
                      (PP (IN as)
                        (NP
                          (NP (NN treatment))
                          (PP (IN with)
                            (NP
                              (NP (DT these) (NNS cyclic_nucleotides))
                              (VP (VBN enhanced)
                                (NP (JJ lactose) (NN production))
                                (PP (IN in)
                                  (NP
                                    (NP (NN response))
                                    (PP (TO to)
                                      (NP (NNP PRL)))))))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(indicate-3, results-2)
root(ROOT-0, indicate-3)
mark(play-9, that-4)
nsubj(play-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubj(play-9, cGMP-7)
aux(play-9, may-8)
ccomp(indicate-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(mediating-13, in-12)
acl(role-11, mediating-13)
det(effects-16, the-14)
amod(effects-16, early-15)
dobj(mediating-13, effects-16)
case(PRL-18, of-17)
nmod:of(effects-16, PRL-18)
case(biosynthesis-21, on-19)
amod(biosynthesis-21, lactose-20)
nmod:on(mediating-13, biosynthesis-21)
case(treatment-24, as-23)
nmod:as(mediating-13, treatment-24)
case(cyclic_nucleotides-27, with-25)
det(cyclic_nucleotides-27, these-26)
nmod:with(treatment-24, cyclic_nucleotides-27)
acl(cyclic_nucleotides-27, enhanced-28)
amod(production-30, lactose-29)
dobj(enhanced-28, production-30)
case(response-32, in-31)
nmod:in(enhanced-28, response-32)
case(PRL-34, to-33)
nmod:to(response-32, PRL-34)

Additionally/RB ,/, treatment/NN with/IN pannarin/NN also/RB increased/VBD lactose/JJ biosynthesis/NNS in/IN response/NN to/TO PRL/NNP ,/, suggesting/VBG that/IN this/DT natural/JJ compound/NN may/MD be/VB a/DT useful/JJ tool/NN for/IN enhancing/VBG milk/NN production/NN in/IN lactating/VBG animals/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NN pannarin))))
    (ADVP (RB also))
    (VP (VBD increased)
      (NP (JJ lactose) (NNS biosynthesis))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NNP PRL)))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (DT this) (JJ natural) (NN compound))
              (VP (MD may)
                (VP (VB be)
                  (NP
                    (NP (DT a) (JJ useful) (NN tool))
                    (PP (IN for)
                      (S
                        (VP (VBG enhancing)
                          (NP (NN milk) (NN production))
                          (PP (IN in)
                            (S
                              (VP (VBG lactating)
                                (NP (NNS animals))))))))))))))))
    (. .)))

advmod(increased-7, Additionally-1)
nsubj(increased-7, treatment-3)
case(pannarin-5, with-4)
nmod:with(treatment-3, pannarin-5)
advmod(increased-7, also-6)
root(ROOT-0, increased-7)
amod(biosynthesis-9, lactose-8)
dobj(increased-7, biosynthesis-9)
case(response-11, in-10)
nmod:in(increased-7, response-11)
case(PRL-13, to-12)
nmod:to(response-11, PRL-13)
advcl(increased-7, suggesting-15)
mark(tool-24, that-16)
det(compound-19, this-17)
amod(compound-19, natural-18)
nsubj(tool-24, compound-19)
aux(tool-24, may-20)
cop(tool-24, be-21)
det(tool-24, a-22)
amod(tool-24, useful-23)
ccomp(suggesting-15, tool-24)
mark(enhancing-26, for-25)
acl(tool-24, enhancing-26)
compound(production-28, milk-27)
dobj(enhancing-26, production-28)
mark(lactating-30, in-29)
advcl(enhancing-26, lactating-30)
dobj(lactating-30, animals-31)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT mechanisms/NNS underlying/VBG the/DT regulation/NN of/IN lactose/JJ biosynthesis/NNS during/IN pregnancy/NN and/CC suggest/VBP potential/JJ therapeutic/JJ targets/NNS for/IN improving/VBG milk/NN production/NN in/IN dairy/NN animals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NNS mechanisms))
            (VP (VBG underlying)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP (JJ lactose) (NNS biosynthesis))))
              (PP (IN during)
                (NP (NN pregnancy)))))))
      (CC and)
      (VP (VBP suggest)
        (NP
          (NP (JJ potential) (JJ therapeutic) (NNS targets))
          (PP (IN for)
            (S
              (VP (VBG improving)
                (NP (NN milk) (NN production))
                (PP (IN in)
                  (NP (NN dairy) (NNS animals)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(suggest-18, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-8, into-6)
det(mechanisms-8, the-7)
nmod:into(provide-3, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(regulation-11, the-10)
dobj(underlying-9, regulation-11)
case(biosynthesis-14, of-12)
amod(biosynthesis-14, lactose-13)
nmod:of(regulation-11, biosynthesis-14)
case(pregnancy-16, during-15)
nmod:during(underlying-9, pregnancy-16)
cc(provide-3, and-17)
conj:and(provide-3, suggest-18)
amod(targets-21, potential-19)
amod(targets-21, therapeutic-20)
dobj(suggest-18, targets-21)
mark(improving-23, for-22)
acl(targets-21, improving-23)
compound(production-25, milk-24)
dobj(improving-23, production-25)
case(animals-28, in-26)
compound(animals-28, dairy-27)
nmod:in(improving-23, animals-28)

Obesity/RB is_a/JJ major/JJ public_health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN various/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN public_health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(metabolic_disorders-12, with-10)
amod(metabolic_disorders-12, various-11)
nmod:with(associated-9, metabolic_disorders-12)
acl(metabolic_disorders-12, including-14)
dobj(including-14, type_2_diabetes-15)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT development/NN of/IN obesity/JJ by/IN secreting/VBG various/JJ factors/NNS that/WDT regulate/VB insulin_secretion/NN and_glucose/JJ metabolism/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN pancreas))
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (ADJP (JJ obesity)
                          (PP (IN by)
                            (S
                              (VP (VBG secreting)
                                (NP
                                  (NP (JJ various) (NNS factors))
                                  (SBAR
                                    (WHNP (WDT that))
                                    (S
                                      (VP (VB regulate)
                                        (NP (NN insulin_secretion))))))))))
                        (JJ and_glucose) (NN metabolism)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(plays-8, that-5)
det(pancreas-7, the-6)
nsubj(plays-8, pancreas-7)
ccomp(suggested-4, plays-8)
det(role-11, a-9)
amod(role-11, crucial-10)
dobj(plays-8, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(metabolism-25, of-15)
amod(metabolism-25, obesity-16)
mark(secreting-18, by-17)
advcl(obesity-16, secreting-18)
amod(factors-20, various-19)
dobj(secreting-18, factors-20)
nsubj(regulate-22, factors-20)
ref(factors-20, that-21)
acl:relcl(factors-20, regulate-22)
dobj(regulate-22, insulin_secretion-23)
amod(metabolism-25, and_glucose-24)
nmod:of(development-14, metabolism-25)

One/CD such/JJ factor/NN is/VBZ mTREM-1/JJ ,/, which/WDT has_been/VBP shown/VBN to_be/NN hypersecreted/VBN in/IN obese/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN factor))
    (VP (VBZ is)
      (ADJP (JJ mTREM-1))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (NP
                (NP (NN to_be))
                (VP (VBN hypersecreted)
                  (PP (IN in)
                    (NP (JJ obese) (NNS individuals))))))))))
    (. .)))

nummod(factor-3, One-1)
amod(factor-3, such-2)
nsubj(mTREM-1-5, factor-3)
cop(mTREM-1-5, is-4)
root(ROOT-0, mTREM-1-5)
nsubj(has_been-8, which-7)
ccomp(mTREM-1-5, has_been-8)
dep(has_been-8, shown-9)
dobj(shown-9, to_be-10)
acl(to_be-10, hypersecreted-11)
case(individuals-14, in-12)
amod(individuals-14, obese-13)
nmod:in(hypersecreted-11, individuals-14)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN mTREM-1/JJ by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ LR12/NN on/IN the/DT secretion/NN of/IN mTREM-1/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))
                (CC and)
                (NP
                  (NP (DT the) (NN hypersecretion))
                  (PP (IN of)
                    (NP (JJ mTREM-1)))))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN LR12)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ mTREM-1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-20, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(development-7, and-10)
det(hypersecretion-12, the-11)
nmod:between(relationship-4, hypersecretion-12)
conj:and(development-7, hypersecretion-12)
case(mTREM-1-14, of-13)
nmod:of(hypersecretion-12, mTREM-1-14)
case(pancreas-17, by-15)
det(pancreas-17, the-16)
nmod:by(evaluate-2, pancreas-17)
nsubj(examined-20, we-19)
root(ROOT-0, examined-20)
det(effects-22, the-21)
dobj(examined-20, effects-22)
case(glucose-26, of-23)
nummod(glucose-26, 16.7-24)
amod(glucose-26, mmol/L-25)
nmod:of(effects-22, glucose-26)
cc(glucose-26, and-27)
nummod(LR12-30, 10-28)
amod(LR12-30, mmol/L-29)
nmod:of(effects-22, LR12-30)
conj:and(glucose-26, LR12-30)
case(secretion-33, on-31)
det(secretion-33, the-32)
nmod:on(examined-20, secretion-33)
case(and_insulin-36, of-34)
amod(and_insulin-36, mTREM-1-35)
nmod:of(secretion-33, and_insulin-36)
case(pancreata-40, by-37)
amod(pancreata-40, isolated-38)
amod(pancreata-40, perfused-39)
nmod:by(examined-20, pancreata-40)
case(genetically_obese-42, from-41)
nmod:from(pancreata-40, genetically_obese-42)
appos(genetically_obese-42, fa/fa-44)
cc(genetically_obese-42, and-46)
amod(rats-53, lean-47)
dep(lean-47, Fa-49)
nmod:from(pancreata-40, rats-53)
conj:and(genetically_obese-42, rats-53)

Our/PRP$ results/NNS showed/VBD that/IN mTREM-1/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT conditions/NNS ,/, suggesting/VBG a/DT potential/JJ role/NN for/IN mTREM-1/JJ in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ mTREM-1) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP (DT both) (NNS conditions)))
                    (, ,)
                    (S
                      (VP (VBG suggesting)
                        (NP
                          (NP (DT a) (JJ potential) (NN role))
                          (PP (IN for)
                            (NP (JJ mTREM-1))))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN development))
                            (PP (IN of)
                              (NP (NN obesity)))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-13, that-4)
amod(secretion-6, mTREM-1-5)
nsubjpass(compared-13, secretion-6)
nsubj:xsubj(lean-15, secretion-6)
auxpass(compared-13, was-7)
advmod(higher-9, significantly-8)
advmod(compared-13, higher-9)
case(rats-12, in-10)
amod(rats-12, obese-11)
nmod:in(higher-9, rats-12)
ccomp(showed-3, compared-13)
mark(lean-15, to-14)
xcomp(compared-13, lean-15)
dobj(lean-15, rats-16)
case(conditions-19, under-17)
det(conditions-19, both-18)
nmod:under(lean-15, conditions-19)
advcl(lean-15, suggesting-21)
det(role-24, a-22)
amod(role-24, potential-23)
dobj(suggesting-21, role-24)
case(mTREM-1-26, for-25)
nmod:for(role-24, mTREM-1-26)
case(development-29, in-27)
det(development-29, the-28)
nmod:in(suggesting-21, development-29)
case(obesity-31, of-30)
nmod:of(development-29, obesity-31)

Additionally/RB ,/, insulin_secretion/NN was/VBD impaired/VBN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN high/JJ glucose/NN conditions/NNS ,/, indicating/VBG a/DT possible/JJ link/NN between/IN mTREM-1/JJ hypersecretion/NN and_insulin/NN resistance/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (VP (VBN impaired)
        (PP (IN in)
          (NP
            (NP (JJ obese) (NNS rats))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP
                        (NP (JJ high) (NN glucose) (NNS conditions))
                        (, ,)
                        (VP (VBG indicating)
                          (NP
                            (NP (DT a) (JJ possible) (NN link))
                            (PP (IN between)
                              (NP (JJ mTREM-1) (NN hypersecretion) (NN and_insulin) (NN resistance)))))))))))))))
    (. .)))

advmod(impaired-5, Additionally-1)
nsubjpass(impaired-5, insulin_secretion-3)
auxpass(impaired-5, was-4)
root(ROOT-0, impaired-5)
case(rats-8, in-6)
amod(rats-8, obese-7)
nmod:in(impaired-5, rats-8)
acl(rats-8, compared-9)
mark(lean-11, to-10)
xcomp(compared-9, lean-11)
dobj(lean-11, rats-12)
case(conditions-16, under-13)
amod(conditions-16, high-14)
compound(conditions-16, glucose-15)
nmod:under(lean-11, conditions-16)
acl(conditions-16, indicating-18)
det(link-21, a-19)
amod(link-21, possible-20)
dobj(indicating-18, link-21)
case(resistance-26, between-22)
amod(resistance-26, mTREM-1-23)
compound(resistance-26, hypersecretion-24)
compound(resistance-26, and_insulin-25)
nmod:between(link-21, resistance-26)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT pathogenesis/NNS of/IN obesity/NN and/CC may/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP (NN obesity)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (JJ important) (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP (DT this) (NN condition)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-13, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(pathogenesis-8, into-6)
det(pathogenesis-8, the-7)
nmod:into(insights-5, pathogenesis-8)
case(obesity-10, of-9)
nmod:of(pathogenesis-8, obesity-10)
cc(provide-3, and-11)
aux(have-13, may-12)
conj:and(provide-3, have-13)
amod(implications-15, important-14)
dobj(have-13, implications-15)
case(development-18, for-16)
det(development-18, the-17)
nmod:for(implications-15, development-18)
case(strategies-22, of-19)
amod(strategies-22, novel-20)
amod(strategies-22, therapeutic-21)
nmod:of(development-18, strategies-22)
case(condition-25, for-23)
det(condition-25, this-24)
nmod:for(strategies-22, condition-25)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS known/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (VP (VBN known)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (NN cardiovascular_health))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
acl(nutrients-16, known-17)
case(effects-21, for-18)
nmod:poss(effects-21, their-19)
amod(effects-21, beneficial-20)
nmod:for(known-17, effects-21)
case(cardiovascular_health-23, on-22)
nmod:on(effects-21, cardiovascular_health-23)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN TEI-5624/NN in/IN hyperTEI-5624mic/JJ patients/NNS ,/, indicating/VBG their/PRP$ potential/JJ role/NN in/IN preventing/VBG and/CC managing/VBG TEI-5624-associated_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN TEI-5624))
                        (PP (IN in)
                          (NP (JJ hyperTEI-5624mic) (NNS patients)))))))
                (, ,)
                (S
                  (VP (VBG indicating)
                    (NP (PRP$ their) (JJ potential) (NN role))
                    (PP (IN in)
                      (S
                        (VP (VBG preventing)
                          (CC and)
                          (VBG managing)
                          (NP (NNS TEI-5624-associated_disorders)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(TEI-5624-14, of-13)
nmod:of(levels-12, TEI-5624-14)
case(patients-17, in-15)
amod(patients-17, hyperTEI-5624mic-16)
nmod:in(TEI-5624-14, patients-17)
xcomp(associated-9, indicating-19)
nmod:poss(role-22, their-20)
amod(role-22, potential-21)
dobj(indicating-19, role-22)
mark(preventing-24, in-23)
advcl(indicating-19, preventing-24)
cc(preventing-24, and-25)
advcl(indicating-19, managing-26)
conj:and(preventing-24, managing-26)
dobj(preventing-24, TEI-5624-associated_disorders-27)

Moreover/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP (DT a) (VBN reduced) (NN risk))
            (PP (IN of)
              (S
                (VP (VBG developing)
                  (VP (VB coronary_heart_disease)
                    (NP
                      (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                      (, ,)
                      (NP
                        (NP (DT a) (VBG leading) (NN cause))
                        (PP (IN of)
                          (NP (NN mortality)))))
                    (ADVP (RB worldwide))))))))))
    (. .)))

advmod(has_been-9, Moreover-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, reduced-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
xcomp(developing-16, coronary_heart_disease-17)
dobj(coronary_heart_disease-17, CHD-19)
det(cause-24, a-22)
amod(cause-24, leading-23)
appos(CHD-19, cause-24)
case(mortality-26, of-25)
nmod:of(cause-24, mortality-26)
advmod(coronary_heart_disease-17, worldwide-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN omega-3_fatty_acids/JJ through/IN dietary/NN sources/NNS or/CC supplements/NNS may/MD have/VB important/JJ implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and/CC other/JJ related_diseases/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP
                    (ADJP (JJ omega-3_fatty_acids)
                      (PP (IN through)
                        (NP (NN dietary))))
                    (NNS sources)
                    (CC or)
                    (NNS supplements))))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ important) (NNS implications))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)
                        (CC and)
                        (JJ other) (NNS related_diseases)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-16, that-4)
csubj(have-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(sources-12, of-8)
amod(sources-12, omega-3_fatty_acids-9)
case(dietary-11, through-10)
nmod:through(omega-3_fatty_acids-9, dietary-11)
nmod:of(intake-7, sources-12)
cc(sources-12, or-13)
nmod:of(intake-7, supplements-14)
conj:or(sources-12, supplements-14)
aux(have-16, may-15)
ccomp(suggest-3, have-16)
amod(implications-18, important-17)
dobj(have-16, implications-18)
case(prevention-21, for-19)
det(prevention-21, the-20)
nmod:for(implications-18, prevention-21)
cc(prevention-21, and-22)
nmod:for(implications-18, treatment-23)
conj:and(prevention-21, treatment-23)
case(related_diseases-28, of-24)
compound(related_diseases-28, CHD-25)
cc(CHD-25, and-26)
conj:and(CHD-25, other-27)
compound(related_diseases-28, other-27)
nmod:of(prevention-21, related_diseases-28)

Further/RB research/NN is/VBZ warranted/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN different/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ different) (NNS populations))))))))))
    (. .)))

advmod(warranted-4, Further-1)
nsubjpass(warranted-4, research-2)
auxpass(warranted-4, is-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
ccomp(warranted-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(elucidate-6, and-12)
mark(determine-14, to-13)
ccomp(warranted-4, determine-14)
conj:and(elucidate-6, determine-14)
amod(dosages-16, optimal-15)
dobj(determine-14, dosages-16)
case(populations-19, for-17)
amod(populations-19, different-18)
nmod:for(dosages-16, populations-19)

The/DT regulation/NN of/IN lipid/NN metabolism/NN is/VBZ critical/JJ for/IN maintaining/VBG cellular/JJ homeostasis/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN lipid) (NN metabolism))))
    (VP (VBZ is)
      (ADJP (JJ critical)
        (PP (IN for)
          (S
            (VP (VBG maintaining)
              (NP (JJ cellular) (NNS homeostasis)))))))
    (. .)))

det(regulation-2, The-1)
nsubj(critical-7, regulation-2)
case(metabolism-5, of-3)
compound(metabolism-5, lipid-4)
nmod:of(regulation-2, metabolism-5)
cop(critical-7, is-6)
root(ROOT-0, critical-7)
mark(maintaining-9, for-8)
advcl(critical-7, maintaining-9)
amod(homeostasis-11, cellular-10)
dobj(maintaining-9, homeostasis-11)

Intracellular/JJ lipid_droplets/NNS are/VBP important/JJ organelles/NNS involved/VBN in/IN lipid/NN storage/NN and/CC metabolism/NN ./.

(ROOT
  (S
    (NP (JJ Intracellular) (NNS lipid_droplets))
    (VP (VBP are)
      (NP
        (NP (JJ important) (NNS organelles))
        (VP (VBN involved)
          (PP (IN in)
            (NP (NN lipid) (NN storage)
              (CC and)
              (NN metabolism))))))
    (. .)))

amod(lipid_droplets-2, Intracellular-1)
nsubj(organelles-5, lipid_droplets-2)
cop(organelles-5, are-3)
amod(organelles-5, important-4)
root(ROOT-0, organelles-5)
acl(organelles-5, involved-6)
case(storage-9, in-7)
compound(storage-9, lipid-8)
nmod:in(involved-6, storage-9)
cc(storage-9, and-10)
nmod:in(involved-6, metabolism-11)
conj:and(storage-9, metabolism-11)

In/IN this/DT study/NN ,/, Oil-Red-O/JJ staining/NN was/VBD used/VBN to/TO detect/VB the/DT presence/NN of/IN intracellular/NN lipid_droplets/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (JJ Oil-Red-O) (NN staining))
    (VP (VBD was)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB detect)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP (NN intracellular) (NNS lipid_droplets)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(used-8, study-3)
amod(staining-6, Oil-Red-O-5)
nsubjpass(used-8, staining-6)
nsubj:xsubj(detect-10, staining-6)
auxpass(used-8, was-7)
root(ROOT-0, used-8)
mark(detect-10, to-9)
xcomp(used-8, detect-10)
det(presence-12, the-11)
dobj(detect-10, presence-12)
case(lipid_droplets-15, of-13)
compound(lipid_droplets-15, intracellular-14)
nmod:of(presence-12, lipid_droplets-15)

The/DT expression/NN of/IN key/JJ regulatory/JJ genes/NNS involved/VBN in/IN lipid/NN metabolism/NN ,/, including/VBG sterol_regulatory_element-binding_protein_1/JJ -LRB-/-LRB- SREBP-1/NNP -RRB-/-RRB- ,/, 5,6-Dihydro-5-azacytidine/JJ synthase/JJ -LRB-/-LRB- AtRbcS1A/JJ -RRB-/-RRB- ,/, Acetyl-CoA_carboxylase_1/JJ and_2/JJ -LRB-/-LRB- ACC1/NNP and/CC ACC2/NNP -RRB-/-RRB- ,/, Peroxisome_proliferator_activated_receptor-a/JJ -LRB-/-LRB- PPARa/NNP -RRB-/-RRB- ,/, and/CC carnitine_palmitoyl_transferase_1/JJ -LRB-/-LRB- CPT-1/NNP -RRB-/-RRB- ,/, was/VBD analyzed/VBN by/IN real/JJ time/NN reverse/JJ transcription-Polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- qRT-PCR/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN expression))
      (PP (IN of)
        (NP
          (NP (JJ key) (JJ regulatory) (NNS genes))
          (VP (VBN involved)
            (PP (IN in)
              (NP (NN lipid) (NN metabolism)))))))
    (, ,)
    (S
      (VP (VBG including)
        (ADJP
          (ADJP (JJ sterol_regulatory_element-binding_protein_1))
          (PRN (-LRB- -LRB-)
            (NP (NNP SREBP-1))
            (-RRB- -RRB-))
          (, ,)
          (ADJP (JJ 5,6-Dihydro-5-azacytidine) (JJ synthase))
          (PRN (-LRB- -LRB-)
            (ADJP (JJ AtRbcS1A))
            (-RRB- -RRB-))
          (, ,)
          (ADJP (JJ Acetyl-CoA_carboxylase_1) (JJ and_2))
          (PRN (-LRB- -LRB-)
            (NP (NNP ACC1)
              (CC and)
              (NNP ACC2))
            (-RRB- -RRB-))
          (, ,)
          (ADJP (JJ Peroxisome_proliferator_activated_receptor-a))
          (PRN (-LRB- -LRB-)
            (NP (NNP PPARa))
            (-RRB- -RRB-))
          (, ,)
          (CC and)
          (ADJP (JJ carnitine_palmitoyl_transferase_1))
          (PRN (-LRB- -LRB-)
            (NP (NNP CPT-1))
            (-RRB- -RRB-)))))
    (, ,)
    (VP (VBD was)
      (VP (VBN analyzed)
        (PP (IN by)
          (NP
            (NP
              (ADJP (JJ real)
                (NP-TMP (NN time)))
              (JJ reverse) (JJ transcription-Polymerase) (NN chain) (NN reaction))
            (PRN (-LRB- -LRB-) (JJ qRT-PCR) (-RRB- -RRB-))))))
    (. .)))

det(expression-2, The-1)
nsubjpass(analyzed-44, expression-2)
case(genes-6, of-3)
amod(genes-6, key-4)
amod(genes-6, regulatory-5)
nmod:of(expression-2, genes-6)
acl(genes-6, involved-7)
case(metabolism-10, in-8)
compound(metabolism-10, lipid-9)
nmod:in(involved-7, metabolism-10)
advcl(analyzed-44, including-12)
xcomp(including-12, sterol_regulatory_element-binding_protein_1-13)
dep(sterol_regulatory_element-binding_protein_1-13, SREBP-1-15)
amod(synthase-19, 5,6-Dihydro-5-azacytidine-18)
xcomp(including-12, synthase-19)
conj:and(sterol_regulatory_element-binding_protein_1-13, synthase-19)
dep(sterol_regulatory_element-binding_protein_1-13, AtRbcS1A-21)
amod(and_2-25, Acetyl-CoA_carboxylase_1-24)
xcomp(including-12, and_2-25)
conj:and(sterol_regulatory_element-binding_protein_1-13, and_2-25)
dep(sterol_regulatory_element-binding_protein_1-13, ACC1-27)
cc(ACC1-27, and-28)
dep(sterol_regulatory_element-binding_protein_1-13, ACC2-29)
conj:and(ACC1-27, ACC2-29)
xcomp(including-12, Peroxisome_proliferator_activated_receptor-a-32)
conj:and(sterol_regulatory_element-binding_protein_1-13, Peroxisome_proliferator_activated_receptor-a-32)
dep(sterol_regulatory_element-binding_protein_1-13, PPARa-34)
cc(sterol_regulatory_element-binding_protein_1-13, and-37)
xcomp(including-12, carnitine_palmitoyl_transferase_1-38)
conj:and(sterol_regulatory_element-binding_protein_1-13, carnitine_palmitoyl_transferase_1-38)
dep(sterol_regulatory_element-binding_protein_1-13, CPT-1-40)
auxpass(analyzed-44, was-43)
root(ROOT-0, analyzed-44)
case(reaction-51, by-45)
amod(reaction-51, real-46)
nmod:tmod(real-46, time-47)
amod(reaction-51, reverse-48)
amod(reaction-51, transcription-Polymerase-49)
compound(reaction-51, chain-50)
nmod:by(analyzed-44, reaction-51)
dep(reaction-51, qRT-PCR-53)

Our/PRP$ results/NNS suggest/VBP that/IN these/DT genes/NNS play/VB important/JJ roles/NNS in/IN regulating/VBG intracellular/JJ lipid/NN metabolism/NN and/CC may/MD be/VB potential/JJ targets/NNS for/IN therapeutic/JJ intervention/NN in/IN metabolic_disorders/NNS such/JJ as/IN obesity/NN and/CC diabetes/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS genes))
            (VP (VB play)
              (NP
                (NP (JJ important) (NNS roles))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ intracellular) (NN lipid) (NN metabolism))))))))))
      (CC and)
      (VP (MD may)
        (VP (VB be)
          (NP
            (NP (JJ potential) (NNS targets))
            (PP (IN for)
              (NP (JJ therapeutic) (NN intervention))))
          (PP (IN in)
            (NP
              (NP (NNS metabolic_disorders))
              (PP (JJ such) (IN as)
                (NP (NN obesity)
                  (CC and)
                  (NN diabetes))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
det(genes-6, these-5)
nsubj(play-7, genes-6)
ccomp(suggest-3, play-7)
amod(roles-9, important-8)
dobj(play-7, roles-9)
mark(regulating-11, in-10)
acl(roles-9, regulating-11)
amod(metabolism-14, intracellular-12)
compound(metabolism-14, lipid-13)
dobj(regulating-11, metabolism-14)
cc(suggest-3, and-15)
aux(targets-19, may-16)
cop(targets-19, be-17)
amod(targets-19, potential-18)
conj:and(suggest-3, targets-19)
case(intervention-22, for-20)
amod(intervention-22, therapeutic-21)
nmod:for(targets-19, intervention-22)
case(metabolic_disorders-24, in-23)
nmod:in(targets-19, metabolic_disorders-24)
case(obesity-27, such-25)
mwe(such-25, as-26)
nmod:such_as(metabolic_disorders-24, obesity-27)
cc(obesity-27, and-28)
nmod:such_as(metabolic_disorders-24, diabetes-29)
conj:and(obesity-27, diabetes-29)

Omega-3_fatty_acids/NNP have/VBP been/VBN widely/RB studied/VBN due/JJ to/TO their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (S
            (ADJP (JJ due)
              (PP (TO to)
                (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, widely-4)
root(ROOT-0, studied-5)
xcomp(studied-5, due-6)
case(benefits-11, to-7)
nmod:poss(benefits-11, their-8)
amod(benefits-11, potential-9)
compound(benefits-11, health-10)
nmod:to(due-6, benefits-11)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP particularly/RB important/JJ for/IN maintaining/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (ADJP (RB particularly) (JJ important)
        (PP (IN for)
          (S
            (VP (VBG maintaining)
              (NP (NN cardiovascular_health)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(important-16, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
cop(important-16, are-14)
advmod(important-16, particularly-15)
root(ROOT-0, important-16)
mark(maintaining-18, for-17)
advcl(important-16, maintaining-18)
dobj(maintaining-18, cardiovascular_health-19)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN 2-bromopropane/JJ levels/NNS in/IN hyper2-bromopropanemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ 2-bromopropane) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyper2-bromopropanemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, 2-bromopropane-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyper2-bromopropanemic-15)
nmod:in(levels-13, patients-16)

This/DT finding/NN suggests/VBZ that/IN omega-3/JJ supplementation/NN may/MD be/VB an/DT effective/JJ treatment/NN for/IN reducing/VBG the/DT toxic/JJ effects/NNS of/IN 2-bromopropane/JJ exposure/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (JJ omega-3) (NN supplementation))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (JJ toxic) (NNS effects))
                        (PP (IN of)
                          (NP (JJ 2-bromopropane) (NN exposure)))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(treatment-11, that-4)
amod(supplementation-6, omega-3-5)
nsubj(treatment-11, supplementation-6)
aux(treatment-11, may-7)
cop(treatment-11, be-8)
det(treatment-11, an-9)
amod(treatment-11, effective-10)
ccomp(suggests-3, treatment-11)
mark(reducing-13, for-12)
acl(treatment-11, reducing-13)
det(effects-16, the-14)
amod(effects-16, toxic-15)
dobj(reducing-13, effects-16)
case(exposure-19, of-17)
amod(exposure-19, 2-bromopropane-18)
nmod:of(effects-16, exposure-19)

Additionally/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(linked-7, Additionally-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(linked-7, omega-3_fatty_acids-4)
aux(linked-7, have-5)
auxpass(linked-7, been-6)
root(ROOT-0, linked-7)
case(risk-11, to-8)
det(risk-11, a-9)
amod(risk-11, decreased-10)
nmod:to(linked-7, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

Mechanisms/NNPS underlying/VBG the/DT cardioprotective/JJ effects/NNS of/IN these/DT fatty_acids/NNS include/VBP reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC decreasing/VBG blood_pressure/NN ./.

(ROOT
  (S
    (NP
      (NP (NNPS Mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ cardioprotective) (NNS effects))
          (PP (IN of)
            (NP (DT these) (NNS fatty_acids))))))
    (VP (VBP include)
      (VP
        (VP (VBG reducing)
          (NP (NN inflammation)))
        (, ,)
        (VP (VBG improving)
          (NP (NN lipid) (NNS profiles)))
        (, ,)
        (CC and)
        (VP (VBG decreasing)
          (NP (NN blood_pressure)))))
    (. .)))

nsubj(include-9, Mechanisms-1)
acl(Mechanisms-1, underlying-2)
det(effects-5, the-3)
amod(effects-5, cardioprotective-4)
dobj(underlying-2, effects-5)
case(fatty_acids-8, of-6)
det(fatty_acids-8, these-7)
nmod:of(effects-5, fatty_acids-8)
root(ROOT-0, include-9)
dep(include-9, reducing-10)
dobj(reducing-10, inflammation-11)
dep(include-9, improving-13)
conj:and(reducing-10, improving-13)
compound(profiles-15, lipid-14)
dobj(improving-13, profiles-15)
cc(reducing-10, and-17)
dep(include-9, decreasing-18)
conj:and(reducing-10, decreasing-18)
dobj(decreasing-18, blood_pressure-19)

Overall/RB ,/, increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD have/VB significant/JJ health/NN benefits/NNS in/IN both/DT hyper2-bromopropanemic/JJ patients/NNS and/CC individuals/NNS at/IN risk/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NN supplementation)))))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ significant) (NN health) (NNS benefits))
          (PP (IN in)
            (NP (DT both) (JJ hyper2-bromopropanemic) (NNS patients)
              (CC and)
              (NNS individuals))))
        (PP (IN at)
          (NP
            (NP (NN risk))
            (PP (IN for)
              (NP (NNP CHD)))))))
    (. .)))

advmod(have-15, Overall-1)
csubj(have-15, increasing-3)
dobj(increasing-3, intake-4)
case(EPA-6, of-5)
nmod:of(intake-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(intake-4, DHA-8)
conj:and(EPA-6, DHA-8)
case(sources-11, through-9)
amod(sources-11, dietary-10)
nmod:through(increasing-3, sources-11)
cc(sources-11, or-12)
nmod:through(increasing-3, supplementation-13)
conj:or(sources-11, supplementation-13)
aux(have-15, may-14)
root(ROOT-0, have-15)
amod(benefits-18, significant-16)
compound(benefits-18, health-17)
dobj(have-15, benefits-18)
case(patients-22, in-19)
cc:preconj(patients-22, both-20)
amod(patients-22, hyper2-bromopropanemic-21)
nmod:in(benefits-18, patients-22)
cc(patients-22, and-23)
nmod:in(benefits-18, individuals-24)
conj:and(patients-22, individuals-24)
case(risk-26, at-25)
nmod:at(have-15, risk-26)
case(CHD-28, for-27)
nmod:for(risk-26, CHD-28)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN associated/VBN with/IN several/JJ health/NN benefits/NNS ,/, including/VBG decreased/VBN risk/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (JJ several) (NN health) (NNS benefits))
                      (, ,)
                      (VP (VBG including)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (NP (NN coronary_heart_disease))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(associated-20, nutrients-16)
ref(nutrients-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(nutrients-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, several-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)
acl(benefits-24, including-26)
amod(risk-28, decreased-27)
dobj(including-26, risk-28)
case(coronary_heart_disease-30, of-29)
nmod:of(risk-28, coronary_heart_disease-30)
appos(risk-28, CHD-32)

In/IN hyperLacidipinemic/JJ patients/NNS ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO decrease/VB Lacidipine/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ hyperLacidipinemic) (NNS patients)))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP (JJ Lacidipine) (NNS levels))))))))
    (. .)))

case(patients-3, In-1)
amod(patients-3, hyperLacidipinemic-2)
nmod:in(shown-10, patients-3)
det(omega-3_fatty_acids-7, these-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(shown-10, omega-3_fatty_acids-7)
nsubj:xsubj(decrease-12, omega-3_fatty_acids-7)
aux(shown-10, have-8)
auxpass(shown-10, been-9)
root(ROOT-0, shown-10)
mark(decrease-12, to-11)
xcomp(shown-10, decrease-12)
amod(levels-14, Lacidipine-13)
dobj(decrease-12, levels-14)

The/DT mechanisms/NNS underlying/VBG this/DT effect/NN are/VBP not/RB yet/RB fully/RB understood/VBN ,/, although/IN it/PRP is/VBZ thought/VBN that/IN the/DT anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN omega-3s/JJ may/MD play/VB a/DT role/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT this) (NN effect))))
    (VP (VBP are) (RB not)
      (ADVP (RB yet))
      (VP
        (ADVP (RB fully))
        (VBN understood) (, ,)
        (SBAR (IN although)
          (S
            (NP (PRP it))
            (VP (VBZ is)
              (VP (VBN thought)
                (SBAR (IN that)
                  (S
                    (NP
                      (NP (DT the) (JJ anti-inflammatory)
                        (CC and)
                        (JJ anti-thrombotic) (NNS properties))
                      (PP (IN of)
                        (NP (JJ omega-3s))))
                    (VP (MD may)
                      (VP (VB play)
                        (NP (DT a) (NN role))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effect-5, this-4)
dobj(underlying-3, effect-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
mark(thought-15, although-12)
nsubjpass(thought-15, it-13)
auxpass(thought-15, is-14)
advcl(understood-10, thought-15)
mark(play-25, that-16)
det(properties-21, the-17)
amod(properties-21, anti-inflammatory-18)
cc(anti-inflammatory-18, and-19)
conj:and(anti-inflammatory-18, anti-thrombotic-20)
amod(properties-21, anti-thrombotic-20)
nsubj(play-25, properties-21)
case(omega-3s-23, of-22)
nmod:of(properties-21, omega-3s-23)
aux(play-25, may-24)
ccomp(thought-15, play-25)
det(role-27, a-26)
dobj(play-25, role-27)

Several/JJ epidemiological/JJ studies/NNS have/VBP linked/VBN higher/JJR intake/NN of/IN EPA/NNP and/CC DHA/NNP with/IN lower/JJR incidence/NN of/IN CHD/NNP ,/, suggesting/VBG that/IN these/DT fatty_acids/NNS may/MD be/VB important/JJ in/IN the/DT prevention/NN and/CC management/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (JJ Several) (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN linked)
        (NP
          (NP (JJR higher) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN with)
          (NP
            (NP (JJR lower) (NN incidence))
            (PP (IN of)
              (NP (NNP CHD)))
            (, ,)
            (VP (VBG suggesting)
              (SBAR (IN that)
                (S
                  (NP (DT these) (NNS fatty_acids))
                  (VP (MD may)
                    (VP (VB be)
                      (ADJP (JJ important))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN prevention)
                            (CC and)
                            (NN management))
                          (PP (IN of)
                            (NP (NN cardiovascular_disease))))))))))))))
    (. .)))

amod(studies-3, Several-1)
amod(studies-3, epidemiological-2)
nsubj(linked-5, studies-3)
aux(linked-5, have-4)
root(ROOT-0, linked-5)
amod(intake-7, higher-6)
dobj(linked-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(incidence-14, with-12)
amod(incidence-14, lower-13)
nmod:with(linked-5, incidence-14)
case(CHD-16, of-15)
nmod:of(incidence-14, CHD-16)
acl(incidence-14, suggesting-18)
mark(important-24, that-19)
det(fatty_acids-21, these-20)
nsubj(important-24, fatty_acids-21)
aux(important-24, may-22)
cop(important-24, be-23)
ccomp(suggesting-18, important-24)
case(prevention-27, in-25)
det(prevention-27, the-26)
nmod:in(important-24, prevention-27)
cc(prevention-27, and-28)
nmod:in(important-24, management-29)
conj:and(prevention-27, management-29)
case(cardiovascular_disease-31, of-30)
nmod:of(prevention-27, cardiovascular_disease-31)

Further/RB research/NN is/VBZ needed/VBN to/TO better/RBR understand/VB the/DT relationship/NN between/IN omega-3_fatty_acids/JJ ,/, Lacidipine/JJ levels/NNS ,/, and/CC CHD/NNP risk/NN ,/, but/CC current/JJ evidence/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ approach/NN for/IN reducing/VBG cardiovascular_risk/NN in/IN hyperLacidipinemic/JJ patients/NNS ./.

(ROOT
  (S
    (S
      (ADVP (RB Further))
      (NP (NN research))
      (VP (VBZ is)
        (VP (VBN needed)
          (S
            (VP (TO to)
              (VP
                (ADVP (RBR better))
                (VB understand)
                (NP
                  (NP (DT the) (NN relationship))
                  (PP (IN between)
                    (NP
                      (NP (JJ omega-3_fatty_acids) (, ,) (JJ Lacidipine) (NNS levels))
                      (, ,)
                      (CC and)
                      (NP (NNP CHD) (NN risk)))))))))))
    (, ,)
    (CC but)
    (S
      (NP (JJ current) (NN evidence))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP
              (NP (VBG increasing) (NN intake))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ promising) (JJ therapeutic) (NN approach))
                  (PP (IN for)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP (NN cardiovascular_risk))
                          (PP (IN in)
                            (NP (JJ hyperLacidipinemic) (NNS patients))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, better-6)
xcomp(needed-4, understand-7)
det(relationship-9, the-8)
dobj(understand-7, relationship-9)
case(levels-14, between-10)
amod(levels-14, omega-3_fatty_acids-11)
amod(levels-14, Lacidipine-13)
nmod:between(relationship-9, levels-14)
cc(levels-14, and-16)
compound(risk-18, CHD-17)
nmod:between(relationship-9, risk-18)
conj:and(levels-14, risk-18)
cc(needed-4, but-20)
amod(evidence-22, current-21)
nsubj(suggests-23, evidence-22)
conj:but(needed-4, suggests-23)
mark(approach-36, that-24)
amod(intake-26, increasing-25)
nsubj(approach-36, intake-26)
case(EPA-28, of-27)
nmod:of(intake-26, EPA-28)
cc(EPA-28, and-29)
nmod:of(intake-26, DHA-30)
conj:and(EPA-28, DHA-30)
aux(approach-36, may-31)
cop(approach-36, be-32)
det(approach-36, a-33)
amod(approach-36, promising-34)
amod(approach-36, therapeutic-35)
ccomp(suggests-23, approach-36)
mark(reducing-38, for-37)
acl(approach-36, reducing-38)
dobj(reducing-38, cardiovascular_risk-39)
case(patients-42, in-40)
amod(patients-42, hyperLacidipinemic-41)
nmod:in(cardiovascular_risk-39, patients-42)

Glaucoma/NNP is_a/JJ common/JJ cause/NN of/IN blindness/NN worldwide/RB and/CC is/VBZ characterized/VBN by/IN progressive/JJ optic_nerve_damage/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Glaucoma) (JJ is_a) (JJ common) (NN cause))
      (PP (IN of)
        (NP (NN blindness))))
    (ADVP (RB worldwide)
      (CC and))
    (VP (VBZ is)
      (VP (VBN characterized)
        (PP (IN by)
          (NP (JJ progressive) (NN optic_nerve_damage)))))
    (. .)))

compound(cause-4, Glaucoma-1)
amod(cause-4, is_a-2)
amod(cause-4, common-3)
nsubjpass(characterized-10, cause-4)
case(blindness-6, of-5)
nmod:of(cause-4, blindness-6)
advmod(characterized-10, worldwide-7)
cc(worldwide-7, and-8)
auxpass(characterized-10, is-9)
root(ROOT-0, characterized-10)
case(optic_nerve_damage-13, by-11)
amod(optic_nerve_damage-13, progressive-12)
nmod:by(characterized-10, optic_nerve_damage-13)

Current/JJ treatments/NNS for/IN glaucoma/NN aim/VBP to/TO lower/JJR intraocular/JJ pressure/NN ,/, but/CC these/DT treatments/NNS are/VBP not/RB always/RB effective/JJ and/CC can/MD have/VB undesirable/JJ side/NN effects/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (JJ Current) (NNS treatments))
        (PP (IN for)
          (NP (NN glaucoma))))
      (VP (VBP aim)
        (PP (TO to)
          (NP (JJR lower) (JJ intraocular) (NN pressure)))))
    (, ,)
    (CC but)
    (S
      (NP (DT these) (NNS treatments))
      (VP
        (VP (VBP are)
          (ADJP (RB not) (RB always) (JJ effective)))
        (CC and)
        (VP (MD can)
          (VP (VB have)
            (NP (JJ undesirable) (NN side) (NNS effects))))))
    (. .)))

amod(treatments-2, Current-1)
nsubj(aim-5, treatments-2)
case(glaucoma-4, for-3)
nmod:for(treatments-2, glaucoma-4)
root(ROOT-0, aim-5)
case(pressure-9, to-6)
amod(pressure-9, lower-7)
amod(pressure-9, intraocular-8)
nmod:to(aim-5, pressure-9)
cc(aim-5, but-11)
det(treatments-13, these-12)
nsubj(effective-17, treatments-13)
nsubj(have-20, treatments-13)
cop(effective-17, are-14)
neg(effective-17, not-15)
advmod(effective-17, always-16)
conj:but(aim-5, effective-17)
cc(effective-17, and-18)
aux(have-20, can-19)
conj:but(aim-5, have-20)
conj:and(effective-17, have-20)
amod(effects-23, undesirable-21)
compound(effects-23, side-22)
dobj(have-20, effects-23)

Ripasudil/NNP is_a/VBD novel/NN drug/NN that/WDT has_been/VBP shown/VBN to/TO reduce/VB intraocular/JJ pressure/NN by/IN inhibiting/VBG Rho_kinase/NNP ,/, an/DT enzyme/NN involved/VBN in/IN the/DT regulation/NN of/IN cell/NN shape/NN and/CC movement/NN ./.

(ROOT
  (S
    (NP (NNP Ripasudil))
    (VP (VBD is_a)
      (NP
        (NP (NN novel) (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB reduce)
                      (NP (JJ intraocular) (NN pressure))
                      (PP (IN by)
                        (S
                          (VP (VBG inhibiting)
                            (NP
                              (NP (NNP Rho_kinase))
                              (, ,)
                              (NP
                                (NP (DT an) (NN enzyme))
                                (VP (VBN involved)
                                  (PP (IN in)
                                    (NP
                                      (NP (DT the) (NN regulation))
                                      (PP (IN of)
                                        (NP (NN cell) (NN shape)
                                          (CC and)
                                          (NN movement))))))))))))))))))))
    (. .)))

nsubj(is_a-2, Ripasudil-1)
root(ROOT-0, is_a-2)
compound(drug-4, novel-3)
dobj(is_a-2, drug-4)
nsubj(has_been-6, drug-4)
ref(drug-4, that-5)
acl:relcl(drug-4, has_been-6)
dep(has_been-6, shown-7)
mark(reduce-9, to-8)
xcomp(shown-7, reduce-9)
amod(pressure-11, intraocular-10)
dobj(reduce-9, pressure-11)
mark(inhibiting-13, by-12)
advcl(reduce-9, inhibiting-13)
dobj(inhibiting-13, Rho_kinase-14)
det(enzyme-17, an-16)
appos(Rho_kinase-14, enzyme-17)
acl(enzyme-17, involved-18)
case(regulation-21, in-19)
det(regulation-21, the-20)
nmod:in(involved-18, regulation-21)
case(shape-24, of-22)
compound(shape-24, cell-23)
nmod:of(regulation-21, shape-24)
cc(shape-24, and-25)
nmod:of(regulation-21, movement-26)
conj:and(shape-24, movement-26)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN Ripasudil/NNP was/VBD evaluated/VBN in/IN patients/NNS with/IN primary_open_angle_glaucoma/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NNP Ripasudil))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (NP (NNS patients)))
        (PP (IN with)
          (NP (NN primary_open_angle_glaucoma)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(Ripasudil-8, of-7)
nmod:of(efficacy-6, Ripasudil-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
case(patients-12, in-11)
nmod:in(evaluated-10, patients-12)
case(primary_open_angle_glaucoma-14, with-13)
nmod:with(evaluated-10, primary_open_angle_glaucoma-14)

At_2/JJ h/NN after/IN dosing/VBG ,/, Ripasudil/NNP reduced/VBD the/DT risk/NN of/IN primary_open_angle_glaucoma/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Ripasudil))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN primary_open_angle_glaucoma))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, Ripasudil-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(primary_open_angle_glaucoma-11, of-10)
nmod:of(risk-9, primary_open_angle_glaucoma-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT results/NNS suggest/VBP that/IN Ripasudil/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN patients/NNS with/IN primary_open_angle_glaucoma/NN and/CC associated/VBN symptoms/NNS of/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Ripasudil))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP
                  (NP (NN primary_open_angle_glaucoma))
                  (CC and)
                  (NP
                    (NP (VBN associated) (NNS symptoms))
                    (PP (IN of)
                      (NP (NN photophobia)
                        (CC and)
                        (NN phonophobia)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Ripasudil-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(primary_open_angle_glaucoma-15, with-14)
nmod:with(option-11, primary_open_angle_glaucoma-15)
cc(primary_open_angle_glaucoma-15, and-16)
amod(symptoms-18, associated-17)
nmod:with(option-11, symptoms-18)
conj:and(primary_open_angle_glaucoma-15, symptoms-18)
case(photophobia-20, of-19)
nmod:of(symptoms-18, photophobia-20)
cc(photophobia-20, and-21)
nmod:of(symptoms-18, phonophobia-22)
conj:and(photophobia-20, phonophobia-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC determine/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN Ripasudil/NNP in/IN the/DT treatment/NN of/IN glaucoma/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NNP Ripasudil))))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NN glaucoma)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(safety-13, the-11)
amod(safety-13, long-term-12)
dobj(determine-10, safety-13)
cc(safety-13, and-14)
dobj(determine-10, efficacy-15)
conj:and(safety-13, efficacy-15)
case(Ripasudil-17, of-16)
nmod:of(safety-13, Ripasudil-17)
case(treatment-20, in-18)
det(treatment-20, the-19)
nmod:in(determine-10, treatment-20)
case(glaucoma-22, of-21)
nmod:of(treatment-20, glaucoma-22)

Omega-3_fatty_acids/NNS are/VBP a/DT class/NN of/IN essential/JJ fatty_acids/NNS that/WDT have/VBP been/VBN linked/VBN to/TO several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN class))
        (PP (IN of)
          (NP (JJ essential) (NNS fatty_acids)))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP (JJ several) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(class-4, Omega-3_fatty_acids-1)
cop(class-4, are-2)
det(class-4, a-3)
root(ROOT-0, class-4)
nsubjpass(linked-11, class-4)
case(fatty_acids-7, of-5)
amod(fatty_acids-7, essential-6)
nmod:of(class-4, fatty_acids-7)
ref(class-4, that-8)
aux(linked-11, have-9)
auxpass(linked-11, been-10)
acl:relcl(class-4, linked-11)
case(benefits-15, to-12)
amod(benefits-15, several-13)
compound(benefits-15, health-14)
nmod:to(linked-11, benefits-15)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, including/VBG eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to_be/VB associated/VBN with/IN decreased/VBN levels/NNS of/IN nerobolil/NN in/IN hypernerobolilmic/JJ patients/NNS and/CC reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (VP
          (VP (VBN eicosapentaenoic_acid))
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-))
          (CC and)
          (VP (VBN docosahexaenoic_acid)
            (PRN (-LRB- -LRB-)
              (NP (NNP DHA))
              (-RRB- -RRB-))))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (VB to_be)
              (VP
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (NNS levels))
                      (PP (IN of)
                        (NP (NN nerobolil)))))
                  (PP (IN in)
                    (NP (JJ hypernerobolilmic) (NNS patients))))
                (CC and)
                (VP (VBN reduced)
                  (NP
                    (NP (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (VBG developing) (NN coronary_heart_disease))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(found-17, omega-3_fatty_acids-2)
advcl(found-17, including-4)
dep(including-4, eicosapentaenoic_acid-5)
dep(eicosapentaenoic_acid-5, EPA-7)
cc(eicosapentaenoic_acid-5, and-9)
dep(including-4, docosahexaenoic_acid-10)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-10)
dep(docosahexaenoic_acid-10, DHA-12)
aux(found-17, have-15)
auxpass(found-17, been-16)
root(ROOT-0, found-17)
ccomp(found-17, to_be-18)
dep(to_be-18, associated-19)
case(levels-22, with-20)
amod(levels-22, decreased-21)
nmod:with(associated-19, levels-22)
case(nerobolil-24, of-23)
nmod:of(levels-22, nerobolil-24)
case(patients-27, in-25)
amod(patients-27, hypernerobolilmic-26)
nmod:in(associated-19, patients-27)
cc(associated-19, and-28)
dep(to_be-18, reduced-29)
conj:and(associated-19, reduced-29)
dobj(reduced-29, risk-30)
case(coronary_heart_disease-33, of-31)
amod(coronary_heart_disease-33, developing-32)
nmod:of(risk-30, coronary_heart_disease-33)
appos(coronary_heart_disease-33, CHD-35)

The/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP are/VBP thought/VBN to_be/JJ due/JJ to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB endothelial/JJ function/NN ,/, and/CC reduce/VB triglyceride_levels/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ beneficial) (NNS effects))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA)))
      (PP (IN on)
        (NP (NNP CHD))))
    (VP (VBP are)
      (VP (VBN thought)
        (ADVP (JJ to_be))
        (ADJP (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VB improve)
                      (NP (JJ endothelial) (NN function)))
                    (, ,)
                    (CC and)
                    (VP (VB reduce)
                      (NP (NNS triglyceride_levels)))))))))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, beneficial-2)
nsubjpass(thought-11, effects-3)
case(EPA-5, of-4)
nmod:of(effects-3, EPA-5)
cc(EPA-5, and-6)
nmod:of(effects-3, DHA-7)
conj:and(EPA-5, DHA-7)
case(CHD-9, on-8)
nmod:on(effects-3, CHD-9)
auxpass(thought-11, are-10)
root(ROOT-0, thought-11)
advmod(thought-11, to_be-12)
xcomp(thought-11, due-13)
case(ability-16, to-14)
nmod:poss(ability-16, their-15)
nmod:to(due-13, ability-16)
mark(reduce-18, to-17)
acl(ability-16, reduce-18)
dobj(reduce-18, inflammation-19)
acl(ability-16, improve-21)
conj:and(reduce-18, improve-21)
amod(function-23, endothelial-22)
dobj(improve-21, function-23)
cc(reduce-18, and-25)
acl(ability-16, reduce-26)
conj:and(reduce-18, reduce-26)
dobj(reduce-26, triglyceride_levels-27)

Several/JJ studies/NNS have/VBP shown/VBN that/IN supplementation/NN with/IN omega-3_fatty_acids/NN can/MD lower/VB serum/NN triglyceride_levels/NNS ,/, decrease_blood_pressure/NN ,/, and/CC improve/VB lipid/NN profiles/NNS ./.

(ROOT
  (S
    (NP (JJ Several) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN supplementation))
              (PP (IN with)
                (NP (NN omega-3_fatty_acids))))
            (VP (MD can)
              (VP
                (VP (VB lower)
                  (NP
                    (NP (NN serum) (NNS triglyceride_levels))
                    (, ,)
                    (NP (NN decrease_blood_pressure))
                    (, ,)))
                (CC and)
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))))))))
    (. .)))

amod(studies-2, Several-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(lower-10, that-5)
nsubj(lower-10, supplementation-6)
nsubj(improve-17, supplementation-6)
case(omega-3_fatty_acids-8, with-7)
nmod:with(supplementation-6, omega-3_fatty_acids-8)
aux(lower-10, can-9)
ccomp(shown-4, lower-10)
compound(triglyceride_levels-12, serum-11)
dobj(lower-10, triglyceride_levels-12)
appos(triglyceride_levels-12, decrease_blood_pressure-14)
cc(lower-10, and-16)
ccomp(shown-4, improve-17)
conj:and(lower-10, improve-17)
compound(profiles-19, lipid-18)
dobj(improve-17, profiles-19)

In/IN addition/NN ,/, omega-3_fatty_acids/JJ have/VBP been/VBN shown/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS and/CC may/MD play/VB a/DT role/NN in/IN the/DT prevention/NN of/IN other/JJ chronic_diseases/NNS such/JJ as/IN cancer/NN and/CC rheumatoid_arthritis/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP (JJ anti-inflammatory) (NNS effects))))))))
      (CC and)
      (VP (MD may)
        (VP (VB play)
          (NP
            (NP (DT a) (NN role))
            (PP (IN in)
              (NP
                (NP (DT the) (NN prevention))
                (PP (IN of)
                  (NP
                    (NP (JJ other) (NNS chronic_diseases))
                    (PP (JJ such) (IN as)
                      (NP (NN cancer)
                        (CC and)
                        (NNS rheumatoid_arthritis)))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-7, addition-2)
nsubjpass(shown-7, omega-3_fatty_acids-4)
nsubj:xsubj(have-9, omega-3_fatty_acids-4)
nsubj(play-14, omega-3_fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(have-9, to-8)
xcomp(shown-7, have-9)
amod(effects-11, anti-inflammatory-10)
dobj(have-9, effects-11)
cc(shown-7, and-12)
aux(play-14, may-13)
conj:and(shown-7, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
case(prevention-19, in-17)
det(prevention-19, the-18)
nmod:in(role-16, prevention-19)
case(chronic_diseases-22, of-20)
amod(chronic_diseases-22, other-21)
nmod:of(prevention-19, chronic_diseases-22)
case(cancer-25, such-23)
mwe(such-23, as-24)
nmod:such_as(chronic_diseases-22, cancer-25)
cc(cancer-25, and-26)
nmod:such_as(chronic_diseases-22, rheumatoid_arthritis-27)
conj:and(cancer-25, rheumatoid_arthritis-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC other/JJ chronic_diseases/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD)
                            (CC and)
                            (JJ other) (NNS chronic_diseases)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-14, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-14, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, an-12)
amod(strategy-14, effective-13)
ccomp(suggest-3, strategy-14)
mark(reducing-16, for-15)
acl(strategy-14, reducing-16)
det(risk-18, the-17)
dobj(reducing-16, risk-18)
case(chronic_diseases-23, of-19)
compound(chronic_diseases-23, CHD-20)
cc(CHD-20, and-21)
conj:and(CHD-20, other-22)
compound(chronic_diseases-23, other-22)
nmod:of(risk-18, chronic_diseases-23)

Efflux/NNP transporters/NNS such/JJ as/IN ABCB1a/NNS play/VBP a/DT critical/JJ role/NN in/IN the/DT disposition/NN of/IN many/JJ drugs/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Efflux) (NNS transporters))
      (PP (JJ such) (IN as)
        (NP (NNS ABCB1a))))
    (VP (VBP play)
      (NP
        (NP (DT a) (JJ critical) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN disposition))
            (PP (IN of)
              (NP (JJ many) (NNS drugs)))))))
    (. .)))

compound(transporters-2, Efflux-1)
nsubj(play-6, transporters-2)
case(ABCB1a-5, such-3)
mwe(such-3, as-4)
nmod:such_as(transporters-2, ABCB1a-5)
root(ROOT-0, play-6)
det(role-9, a-7)
amod(role-9, critical-8)
dobj(play-6, role-9)
case(disposition-12, in-10)
det(disposition-12, the-11)
nmod:in(role-9, disposition-12)
case(drugs-15, of-13)
amod(drugs-15, many-14)
nmod:of(disposition-12, drugs-15)

In/IN vitro/NN studies/NNS were/VBD conducted/VBN to/TO investigate/VB the/DT effect/NN of/IN SC-52151/NN on/IN ABCB1a/JJ expression/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN vitro)))
    (NP (NNS studies))
    (VP (VBD were)
      (VP (VBN conducted)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN effect))
                (PP (IN of)
                  (NP (NN SC-52151))))
              (PP (IN on)
                (NP (JJ ABCB1a) (NN expression))))))))
    (. .)))

case(vitro-2, In-1)
nmod:in(conducted-5, vitro-2)
nsubjpass(conducted-5, studies-3)
nsubj:xsubj(investigate-7, studies-3)
auxpass(conducted-5, were-4)
root(ROOT-0, conducted-5)
mark(investigate-7, to-6)
xcomp(conducted-5, investigate-7)
det(effect-9, the-8)
dobj(investigate-7, effect-9)
case(SC-52151-11, of-10)
nmod:of(effect-9, SC-52151-11)
case(expression-14, on-12)
amod(expression-14, ABCB1a-13)
nmod:on(investigate-7, expression-14)

The/DT results/NNS showed/VBD that/IN the/DT non-transfected/JJ SC-52151/NN group/NN had/VBD significantly/RB lower/JJR levels/NNS of/IN ABCB1a/NNS compared/VBN to/TO the/DT non-transfected/JJ non-SC-52151/JJ group/NN -LRB-/-LRB- 352/CD ±/VBP 26/CD ng/L/JJ vs/NN 765/CD ±/VBP 22/CD ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT the) (JJ non-transfected) (NN SC-52151) (NN group))
          (VP (VBD had)
            (NP
              (NP
                (ADJP (RB significantly) (JJR lower))
                (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NNS ABCB1a))
                  (VP (VBN compared)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (JJ non-transfected) (JJ non-SC-52151) (NN group))
                        (PRN (-LRB- -LRB-)
                          (S
                            (NP (CD 352))
                            (VP (VBP ±)
                              (NP
                                (NP (CD 26) (JJ ng/L) (NN vs))
                                (SBAR
                                  (S
                                    (NP (CD 765))
                                    (VP (VBP ±)
                                      (ADJP
                                        (NP (CD 22))
                                        (JJ ng/L))
                                      (, ,)
                                      (SBAR
                                        (S
                                          (NP (NNP P))
                                          (VP (VBP <)
                                            (NP (CD 0.001)))))))))))
                          (-RRB- -RRB-))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-9, that-4)
det(group-8, the-5)
amod(group-8, non-transfected-6)
compound(group-8, SC-52151-7)
nsubj(had-9, group-8)
ccomp(showed-3, had-9)
advmod(lower-11, significantly-10)
amod(levels-12, lower-11)
dobj(had-9, levels-12)
case(ABCB1a-14, of-13)
nmod:of(levels-12, ABCB1a-14)
acl(ABCB1a-14, compared-15)
case(group-20, to-16)
det(group-20, the-17)
amod(group-20, non-transfected-18)
amod(group-20, non-SC-52151-19)
nmod:to(compared-15, group-20)
nsubj(±-23, 352-22)
dep(group-20, ±-23)
nummod(vs-26, 26-24)
amod(vs-26, ng/L-25)
dobj(±-23, vs-26)
nsubj(±-28, 765-27)
acl:relcl(vs-26, ±-28)
nmod:npmod(ng/L-30, 22-29)
xcomp(±-28, ng/L-30)
nsubj(<-33, P-32)
ccomp(±-28, <-33)
dobj(<-33, 0.001-34)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN ABCB1a/JJ levels/NNS between/IN the/DT transfected/JJ SC-52151/NN and/CC transfected/JJ non-SC-52151/JJ groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (JJ ABCB1a) (NNS levels)))
        (PP (IN between)
          (NP
            (NP (DT the) (JJ transfected) (NN SC-52151))
            (CC and)
            (NP (JJ transfected) (JJ non-SC-52151) (NNS groups))))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(levels-10, in-8)
amod(levels-10, ABCB1a-9)
nmod:in(difference-7, levels-10)
case(SC-52151-14, between-11)
det(SC-52151-14, the-12)
amod(SC-52151-14, transfected-13)
nmod:between(difference-7, SC-52151-14)
cc(SC-52151-14, and-15)
amod(groups-18, transfected-16)
amod(groups-18, non-SC-52151-17)
nmod:between(difference-7, groups-18)
conj:and(SC-52151-14, groups-18)

These/DT findings/NNS suggest/VBP that/IN SC-52151/NNP may/MD have/VB a/DT potential/JJ role/NN in/IN modulating/VBG ABCB1a/JJ expression/NN and/CC may/MD be/VB useful/JJ in/IN improving/VBG drug/NN efficacy/NN and/CC reducing/VBG drug/NN resistance/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP SC-52151))
          (VP
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ potential) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG modulating)
                        (NP (JJ ABCB1a) (NN expression))))))))
            (CC and)
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ useful)
                  (PP (IN in)
                    (S
                      (VP
                        (VP (VBG improving)
                          (NP (NN drug) (NN efficacy)))
                        (CC and)
                        (VP (VBG reducing)
                          (NP (NN drug) (NN resistance)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, SC-52151-5)
nsubj(useful-18, SC-52151-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(role-10, a-8)
amod(role-10, potential-9)
dobj(have-7, role-10)
mark(modulating-12, in-11)
acl(role-10, modulating-12)
amod(expression-14, ABCB1a-13)
dobj(modulating-12, expression-14)
cc(have-7, and-15)
aux(useful-18, may-16)
cop(useful-18, be-17)
ccomp(suggest-3, useful-18)
conj:and(have-7, useful-18)
mark(improving-20, in-19)
advcl(useful-18, improving-20)
compound(efficacy-22, drug-21)
dobj(improving-20, efficacy-22)
cc(improving-20, and-23)
advcl(useful-18, reducing-24)
conj:and(improving-20, reducing-24)
compound(resistance-26, drug-25)
dobj(reducing-24, resistance-26)

Further/JJ studies/NNS are/VBP required/VBN to/TO explore/VB these/DT possibilities/NNS and/CC determine/VB the/DT clinical/JJ relevance/NN of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN required)
        (S
          (VP (TO to)
            (VP
              (VP (VB explore)
                (NP (DT these) (NNS possibilities)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ clinical) (NN relevance))
                  (PP (IN of)
                    (NP (DT these) (NNS findings))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(required-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(required-4, are-3)
root(ROOT-0, required-4)
mark(explore-6, to-5)
xcomp(required-4, explore-6)
det(possibilities-8, these-7)
dobj(explore-6, possibilities-8)
cc(explore-6, and-9)
xcomp(required-4, determine-10)
conj:and(explore-6, determine-10)
det(relevance-13, the-11)
amod(relevance-13, clinical-12)
dobj(determine-10, relevance-13)
case(findings-16, of-14)
det(findings-16, these-15)
nmod:of(relevance-13, findings-16)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT a) (JJ healthy) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)

These/DT long-chain_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ,/, including/VBG decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS long-chain_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (JJ numerous) (NN health) (NNS benefits))
              (, ,)
              (VP (VBG including)
                (NP
                  (NP
                    (NP (VBN decreased) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

det(long-chain_fatty_acids-2, These-1)
nsubjpass(associated-5, long-chain_fatty_acids-2)
aux(associated-5, have-3)
auxpass(associated-5, been-4)
root(ROOT-0, associated-5)
case(benefits-9, with-6)
amod(benefits-9, numerous-7)
compound(benefits-9, health-8)
nmod:with(associated-5, benefits-9)
acl(benefits-9, including-11)
amod(risk-13, decreased-12)
dobj(including-11, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
dobj(developing-15, coronary_heart_disease-16)
appos(risk-13, CHD-18)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN hypercarnosinemic/JJ patients/NNS have/VBP decreased/VBN levels/NNS of/IN carnosine/NN when/WRB consuming/VBG omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ hypercarnosinemic) (NNS patients))
            (VP (VBP have)
              (VP (VBN decreased)
                (NP
                  (NP (NNS levels))
                  (PP (IN of)
                    (NP (NN carnosine))))
                (SBAR
                  (WHADVP (WRB when))
                  (S
                    (VP (VBG consuming)
                      (ADJP (JJ omega-3_fatty_acids)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(decreased-10, that-6)
amod(patients-8, hypercarnosinemic-7)
nsubj(decreased-10, patients-8)
aux(decreased-10, have-9)
ccomp(shown-5, decreased-10)
dobj(decreased-10, levels-11)
case(carnosine-13, of-12)
nmod:of(levels-11, carnosine-13)
advmod(consuming-15, when-14)
advcl(decreased-10, consuming-15)
xcomp(consuming-15, omega-3_fatty_acids-16)

Carnosine/JJ is_a/NN dipeptide/VBD that/IN is/VBZ found/VBN in/IN high/JJ concentrations/NNS in/IN muscle/NN tissue/NN and/CC has_been/NN implicated/VBN in/IN the/DT development/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (JJ Carnosine) (NN is_a))
    (VP (VBD dipeptide)
      (SBAR (IN that)
        (S
          (VP (VBZ is)
            (VP (VBN found)
              (PP (IN in)
                (NP
                  (NP (JJ high) (NNS concentrations))
                  (PP (IN in)
                    (NP (NN muscle) (NN tissue)
                      (CC and)
                      (NN has_been)))
                  (VP (VBN implicated)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (NNP CHD)))))))))))))
    (. .)))

amod(is_a-2, Carnosine-1)
nsubj(dipeptide-3, is_a-2)
root(ROOT-0, dipeptide-3)
mark(found-6, that-4)
auxpass(found-6, is-5)
ccomp(dipeptide-3, found-6)
case(concentrations-9, in-7)
amod(concentrations-9, high-8)
nmod:in(found-6, concentrations-9)
case(tissue-12, in-10)
compound(tissue-12, muscle-11)
nmod:in(concentrations-9, tissue-12)
cc(tissue-12, and-13)
nmod:in(concentrations-9, has_been-14)
conj:and(tissue-12, has_been-14)
acl(concentrations-9, implicated-15)
case(development-18, in-16)
det(development-18, the-17)
nmod:in(implicated-15, development-18)
case(CHD-20, of-19)
nmod:of(development-18, CHD-20)

The/DT mechanism/NN by/IN which/WDT omega-3_fatty_acids/JJ decrease/NN carnosine/NN levels/NNS is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN they/PRP may/MD interfere/VB with/IN the/DT synthesis/NN or/CC metabolism/NN of/IN carnosine/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (JJ omega-3_fatty_acids) (NN decrease) (NN carnosine))
            (VP (NNS levels)))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (MD may)
                (VP (VB interfere)
                  (PP (IN with)
                    (NP
                      (NP (DT the) (NN synthesis)
                        (CC or)
                        (NN metabolism))
                      (PP (IN of)
                        (NP (NN carnosine))))))))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(levels-8, mechanism-2)
nsubjpass(understood-13, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
amod(carnosine-7, omega-3_fatty_acids-5)
compound(carnosine-7, decrease-6)
nsubj(levels-8, carnosine-7)
acl:relcl(mechanism-2, levels-8)
auxpass(understood-13, is-9)
neg(understood-13, not-10)
advmod(understood-13, yet-11)
advmod(understood-13, fully-12)
root(ROOT-0, understood-13)
cc(understood-13, but-15)
nsubjpass(believed-18, it-16)
auxpass(believed-18, is-17)
conj:but(understood-13, believed-18)
mark(interfere-22, that-19)
nsubj(interfere-22, they-20)
aux(interfere-22, may-21)
ccomp(believed-18, interfere-22)
case(synthesis-25, with-23)
det(synthesis-25, the-24)
nmod:with(interfere-22, synthesis-25)
cc(synthesis-25, or-26)
nmod:with(interfere-22, metabolism-27)
conj:or(synthesis-25, metabolism-27)
case(carnosine-29, of-28)
nmod:of(synthesis-25, carnosine-29)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT relationship/NN between/IN omega-3_fatty_acids/JJ ,/, carnosine/JJ levels/NNS ,/, and/CC CHD/NNP risk/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NN relationship))
                (PP (IN between)
                  (NP
                    (NP (JJ omega-3_fatty_acids) (, ,) (JJ carnosine) (NNS levels))
                    (, ,)
                    (CC and)
                    (NP (NNP CHD) (NN risk))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(relationship-9, the-8)
dobj(elucidate-7, relationship-9)
case(levels-14, between-10)
amod(levels-14, omega-3_fatty_acids-11)
amod(levels-14, carnosine-13)
nmod:between(relationship-9, levels-14)
cc(levels-14, and-16)
compound(risk-18, CHD-17)
nmod:between(relationship-9, risk-18)
conj:and(levels-14, risk-18)

Nonetheless/RB ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN hypercarnosinemic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NNS supplements)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ hypercarnosinemic) (NNS patients))))))))))))
    (. .)))

advmod(suggest-5, Nonetheless-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(strategy-22, that-6)
csubj(strategy-22, increasing-7)
dobj(increasing-7, intake-8)
case(EPA-10, of-9)
nmod:of(intake-8, EPA-10)
cc(EPA-10, and-11)
nmod:of(intake-8, DHA-12)
conj:and(EPA-10, DHA-12)
case(sources-15, through-13)
amod(sources-15, dietary-14)
nmod:through(increasing-7, sources-15)
cc(sources-15, or-16)
nmod:through(increasing-7, supplements-17)
conj:or(sources-15, supplements-17)
aux(strategy-22, may-18)
cop(strategy-22, be-19)
det(strategy-22, an-20)
amod(strategy-22, effective-21)
ccomp(suggest-5, strategy-22)
mark(reducing-24, for-23)
acl(strategy-22, reducing-24)
det(risk-26, the-25)
dobj(reducing-24, risk-26)
case(CHD-28, of-27)
nmod:of(risk-26, CHD-28)
case(patients-31, in-29)
amod(patients-31, hypercarnosinemic-30)
nmod:in(reducing-24, patients-31)

The/DT objective/NN of/IN this/DT study/NN was/VBD to/TO investigate/VB the/DT effects/NNS of/IN benzyl_alcohol/NN on/IN the/DT risk/NN of/IN osseous_demineralization/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN objective))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NN benzyl_alcohol)))
              (PP (IN on)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (NN osseous_demineralization))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (. .)))

det(objective-2, The-1)
nsubj(was-6, objective-2)
nsubj:xsubj(investigate-8, objective-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(objective-2, study-5)
root(ROOT-0, was-6)
mark(investigate-8, to-7)
xcomp(was-6, investigate-8)
det(effects-10, the-9)
dobj(investigate-8, effects-10)
case(benzyl_alcohol-12, of-11)
nmod:of(effects-10, benzyl_alcohol-12)
case(risk-15, on-13)
det(risk-15, the-14)
nmod:on(effects-10, risk-15)
case(osseous_demineralization-17, of-16)
nmod:of(risk-15, osseous_demineralization-17)
nmod:of(risk-15, photophobia-19)
conj:and(osseous_demineralization-17, photophobia-19)
cc(osseous_demineralization-17, and-21)
nmod:of(risk-15, phonophobia-22)
conj:and(osseous_demineralization-17, phonophobia-22)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN with/IN a/DT total/NN of/IN 100/CD participants/NNS who/WP were/VBD administered/VBN benzyl_alcohol/JJ ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN with)
          (NP
            (NP (DT a) (NN total))
            (PP (IN of)
              (NP
                (NP (CD 100) (NNS participants))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD were)
                      (VP (VBN administered)
                        (ADJP (JJ benzyl_alcohol))))))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(total-7, with-5)
det(total-7, a-6)
nmod:with(conducted-4, total-7)
case(participants-10, of-8)
nummod(participants-10, 100-9)
nmod:of(total-7, participants-10)
nsubjpass(administered-13, participants-10)
ref(participants-10, who-11)
auxpass(administered-13, were-12)
acl:relcl(participants-10, administered-13)
xcomp(administered-13, benzyl_alcohol-14)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, benzyl_alcohol/NN significantly/RB reduced/VBD the/DT risk/NN of/IN osseous_demineralization/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN benzyl_alcohol))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN osseous_demineralization))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, benzyl_alcohol-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(osseous_demineralization-17, of-16)
nmod:of(risk-15, osseous_demineralization-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN benzyl_alcohol/NN may/MD have/VB potential/JJ therapeutic/JJ benefits/NNS in/IN preventing/VBG osseous_demineralization/NN and/CC reducing/VBG the/DT severity/NN of/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN benzyl_alcohol))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ potential) (JJ therapeutic) (NNS benefits))
              (PP (IN in)
                (S
                  (VP
                    (VP (VBG preventing)
                      (NP (NN osseous_demineralization)))
                    (CC and)
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN severity))
                        (PP (IN of)
                          (NP (NN photophobia)
                            (CC and)
                            (NN phonophobia)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, benzyl_alcohol-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(benefits-10, potential-8)
amod(benefits-10, therapeutic-9)
dobj(have-7, benefits-10)
mark(preventing-12, in-11)
advcl(have-7, preventing-12)
dobj(preventing-12, osseous_demineralization-13)
cc(preventing-12, and-14)
advcl(have-7, reducing-15)
conj:and(preventing-12, reducing-15)
det(severity-17, the-16)
dobj(reducing-15, severity-17)
case(photophobia-19, of-18)
nmod:of(severity-17, photophobia-19)
cc(photophobia-19, and-20)
nmod:of(severity-17, phonophobia-21)
conj:and(photophobia-19, phonophobia-21)

Further/RB research/NN is/VBZ needed/VBN to/TO confirm/VB these/DT results/NNS and/CC determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN treatment/NN with/IN benzyl_alcohol/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP (NN treatment))))
                (PP (IN with)
                  (NP (NN benzyl_alcohol)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(confirm-6, research-2)
nsubj:xsubj(determine-10, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(dosage-13, the-11)
amod(dosage-13, optimal-12)
dobj(determine-10, dosage-13)
cc(dosage-13, and-14)
dobj(determine-10, duration-15)
conj:and(dosage-13, duration-15)
case(treatment-17, of-16)
nmod:of(dosage-13, treatment-17)
case(benzyl_alcohol-19, with-18)
nmod:with(determine-10, benzyl_alcohol-19)

Omega-3_fatty_acids/NNS have/VBP gained/VBN attention/NN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ,/, particularly/RB in/IN the/DT context/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN gained)
        (NP (NN attention))
        (PP (IN for)
          (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
        (, ,)
        (PP
          (ADVP (RB particularly))
          (IN in)
          (NP
            (NP (DT the) (NN context))
            (PP (IN of)
              (NP (NN cardiovascular_disease)))))))
    (. .)))

nsubj(gained-3, Omega-3_fatty_acids-1)
aux(gained-3, have-2)
root(ROOT-0, gained-3)
dobj(gained-3, attention-4)
case(benefits-9, for-5)
nmod:poss(benefits-9, their-6)
amod(benefits-9, potential-7)
compound(benefits-9, health-8)
nmod:for(gained-3, benefits-9)
advmod(context-14, particularly-11)
case(context-14, in-12)
det(context-14, the-13)
nmod:in(gained-3, context-14)
case(cardiovascular_disease-16, of-15)
nmod:of(context-14, cardiovascular_disease-16)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to_be/VB associated/VBN with/IN decreased/VBN levels/NNS of/IN glaucarubin/NN in/IN hyperglaucarubinmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (VB to_be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP (NN glaucarubin)))))
                (PP (IN in)
                  (NP (JJ hyperglaucarubinmic) (NNS patients)))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(found-24, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(found-24, have-22)
auxpass(found-24, been-23)
root(ROOT-0, found-24)
ccomp(found-24, to_be-25)
dep(to_be-25, associated-26)
case(levels-29, with-27)
amod(levels-29, decreased-28)
nmod:with(associated-26, levels-29)
case(glaucarubin-31, of-30)
nmod:of(levels-29, glaucarubin-31)
case(patients-34, in-32)
amod(patients-34, hyperglaucarubinmic-33)
nmod:in(associated-26, patients-34)

Furthermore/RB ,/, studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP also/RB associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (ADVP (RB also))
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(shown-5, Furthermore-1)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
mark(associated-11, that-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-11, omega-3_fatty_acids-8)
auxpass(associated-11, are-9)
advmod(associated-11, also-10)
ccomp(shown-5, associated-11)
case(risk-15, with-12)
det(risk-15, a-13)
amod(risk-15, decreased-14)
nmod:with(associated-11, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ actions/NNS ,/, as/RB well/RB as/IN modulation/NN of/IN lipid/NN metabolism/NN and/CC vascular_function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP
              (ADJP (JJ anti-inflammatory)
                (CC and)
                (JJ anti-thrombotic))
              (NNS actions))
            (, ,)
            (ADVP (RB as) (RB well)
              (PP (IN as)
                (NP
                  (NP (NN modulation))
                  (PP (IN of)
                    (NP (NN lipid) (NN metabolism)
                      (CC and)
                      (NN vascular_function))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
amod(actions-17, anti-inflammatory-14)
cc(anti-inflammatory-14, and-15)
conj:and(anti-inflammatory-14, anti-thrombotic-16)
amod(actions-17, anti-thrombotic-16)
dobj(involve-13, actions-17)
advmod(well-20, as-19)
advmod(actions-17, well-20)
case(modulation-22, as-21)
nmod:as(well-20, modulation-22)
case(metabolism-25, of-23)
compound(metabolism-25, lipid-24)
nmod:of(modulation-22, metabolism-25)
cc(metabolism-25, and-26)
nmod:of(modulation-22, vascular_function-27)
conj:and(metabolism-25, vascular_function-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN cardiovascular_health))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-14, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-14, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, a-12)
amod(strategy-14, promising-13)
ccomp(suggest-3, strategy-14)
mark(reducing-16, for-15)
acl(strategy-14, reducing-16)
det(risk-18, the-17)
dobj(reducing-16, risk-18)
case(CHD-20, of-19)
nmod:of(risk-18, CHD-20)
cc(reducing-16, and-21)
acl(strategy-14, improving-22)
conj:and(reducing-16, improving-22)
amod(cardiovascular_health-24, overall-23)
dobj(improving-22, cardiovascular_health-24)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(associated-8, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
acl:relcl(polyunsaturated_fatty_acids-4, associated-8)
case(benefits-12, with-9)
amod(benefits-12, numerous-10)
compound(benefits-12, health-11)
nmod:with(associated-8, benefits-12)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP particularly/RB important/JJ for/IN their/PRP$ role/NN in/IN reducing/VBG inflammation/NN and/CC protecting/VBG against/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (ADJP (RB particularly) (JJ important)
        (PP (IN for)
          (NP
            (NP (PRP$ their) (NN role))
            (PP (IN in)
              (S
                (VP
                  (VP (VBG reducing)
                    (NP (NN inflammation)))
                  (CC and)
                  (VP (VBG protecting)
                    (PP (IN against)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(important-17, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
cop(important-17, are-15)
advmod(important-17, particularly-16)
root(ROOT-0, important-17)
case(role-20, for-18)
nmod:poss(role-20, their-19)
nmod:for(important-17, role-20)
mark(reducing-22, in-21)
acl(role-20, reducing-22)
dobj(reducing-22, inflammation-23)
cc(reducing-22, and-24)
acl(role-20, protecting-25)
conj:and(reducing-22, protecting-25)
case(cardiovascular_disease-27, against-26)
nmod:against(protecting-25, cardiovascular_disease-27)

In/IN this/DT study/NN ,/, the/DT association/NN between/IN long-chain/JJ omega-3_fatty_acids/JJ and/CC flumethasone/JJ levels/NNS in/IN hyperflumethasonemic/JJ patients/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN association))
      (PP (IN between)
        (NP
          (NP (JJ long-chain)
            (ADJP (JJ omega-3_fatty_acids)
              (CC and)
              (JJ flumethasone))
            (NNS levels))
          (PP (IN in)
            (NP (JJ hyperflumethasonemic) (NNS patients))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(association-6, the-5)
nsubjpass(investigated-17, association-6)
case(levels-12, between-7)
amod(levels-12, long-chain-8)
amod(levels-12, omega-3_fatty_acids-9)
cc(omega-3_fatty_acids-9, and-10)
conj:and(omega-3_fatty_acids-9, flumethasone-11)
amod(levels-12, flumethasone-11)
nmod:between(association-6, levels-12)
case(patients-15, in-13)
amod(patients-15, hyperflumethasonemic-14)
nmod:in(levels-12, patients-15)
auxpass(investigated-17, was-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, EPA/NNP -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC DHA/NNP -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, were/VBD associated/VBN with/IN decreased/VBN flumethasone/JJ levels/NNS in/IN hyperflumethasonemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (, ,)
            (NP
              (NP
                (NP (NNP EPA))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD 20:5) (CD n-3)))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (NNP DHA))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD 22:6) (CD n-3)))
                  (-RRB- -RRB-))))
            (, ,))
          (VP (VBD were)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (JJ flumethasone) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperflumethasonemic) (NNS patients))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(associated-21, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(associated-21, omega-3_fatty_acids-6)
appos(omega-3_fatty_acids-6, EPA-8)
compound(n-3-11, 20:5-10)
dep(EPA-8, n-3-11)
cc(EPA-8, and-13)
appos(omega-3_fatty_acids-6, DHA-14)
conj:and(EPA-8, DHA-14)
compound(n-3-17, 22:6-16)
dep(DHA-14, n-3-17)
auxpass(associated-21, were-20)
ccomp(showed-3, associated-21)
case(levels-25, with-22)
amod(levels-25, decreased-23)
amod(levels-25, flumethasone-24)
nmod:with(associated-21, levels-25)
case(patients-28, in-26)
amod(patients-28, hyperflumethasonemic-27)
nmod:in(levels-25, patients-28)

Additionally/RB ,/, these/DT fatty_acids/NNS were/VBD found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBD were)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB decrease)
              (NP
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP CHD))
                  (-RRB- -RRB-))))))))
    (. .)))

advmod(found-6, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(found-6, fatty_acids-4)
nsubj:xsubj(decrease-8, fatty_acids-4)
auxpass(found-6, were-5)
root(ROOT-0, found-6)
mark(decrease-8, to-7)
xcomp(found-6, decrease-8)
det(risk-10, the-9)
dobj(decrease-8, risk-10)
mark(developing-12, of-11)
acl(risk-10, developing-12)
dobj(developing-12, coronary_heart_disease-13)
appos(risk-10, CHD-15)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS may/MD be/VB related/VBN to/TO the/DT ability/NN of/IN omega-3_fatty_acids/JJ to/TO modulate/VBP lipid/NN metabolism/NN ,/, reduce/VB oxidative_stress/NNS ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (SBAR
          (S
            (NP (DT these) (NNS effects))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN related)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN ability))
                      (PP (IN of)
                        (NP
                          (QP (JJ omega-3_fatty_acids) (TO to)))))))))))))
    (VP (VBP modulate)
      (NP (NN lipid) (NN metabolism))
      (, ,)
      (S
        (VP
          (VP (VB reduce)
            (NP (NNS oxidative_stress)))
          (, ,)
          (CC and)
          (VP (VB improve)
            (NP (JJ endothelial) (NN function))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(modulate-15, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
nsubjpass(related-8, effects-5)
aux(related-8, may-6)
auxpass(related-8, be-7)
ccomp(underlying-3, related-8)
case(ability-11, to-9)
det(ability-11, the-10)
nmod:to(related-8, ability-11)
case(omega-3_fatty_acids-13, of-12)
nmod:of(ability-11, omega-3_fatty_acids-13)
dep(omega-3_fatty_acids-13, to-14)
root(ROOT-0, modulate-15)
compound(metabolism-17, lipid-16)
dobj(modulate-15, metabolism-17)
dep(modulate-15, reduce-19)
dobj(reduce-19, oxidative_stress-20)
cc(reduce-19, and-22)
dep(modulate-15, improve-23)
conj:and(reduce-19, improve-23)
amod(function-25, endothelial-24)
dobj(improve-23, function-25)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ health/NN outcomes/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN health) (NNS outcomes))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-14, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-14, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, a-12)
amod(strategy-14, promising-13)
ccomp(suggest-3, strategy-14)
mark(reducing-16, for-15)
acl(strategy-14, reducing-16)
det(risk-18, the-17)
dobj(reducing-16, risk-18)
case(CHD-20, of-19)
nmod:of(risk-18, CHD-20)
cc(reducing-16, and-21)
acl(strategy-14, improving-22)
conj:and(reducing-16, improving-22)
amod(outcomes-25, overall-23)
compound(outcomes-25, health-24)
dobj(improving-22, outcomes-25)

Darifenacin/NNP is_a/NNP selective/JJ muscarinic_receptor/NN antagonist/VBP used/VBN for/IN the/DT treatment/NN of/IN overactive_bladder/NN ./.

(ROOT
  (S
    (NP (NNP Darifenacin) (NNP is_a) (JJ selective) (NN muscarinic_receptor))
    (VP (VBP antagonist)
      (VP (VBN used)
        (PP (IN for)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP (NN overactive_bladder)))))))
    (. .)))

compound(muscarinic_receptor-4, Darifenacin-1)
compound(muscarinic_receptor-4, is_a-2)
amod(muscarinic_receptor-4, selective-3)
nsubj(antagonist-5, muscarinic_receptor-4)
root(ROOT-0, antagonist-5)
dep(antagonist-5, used-6)
case(treatment-9, for-7)
det(treatment-9, the-8)
nmod:for(used-6, treatment-9)
case(overactive_bladder-11, of-10)
nmod:of(treatment-9, overactive_bladder-11)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN darifenacin/NN on/IN faecal_incontinence/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN darifenacin))
          (PP (IN on)
            (NP
              (NP (NN faecal_incontinence))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effect-6, the-5)
nsubjpass(investigated-17, effect-6)
case(darifenacin-8, of-7)
nmod:of(effect-6, darifenacin-8)
case(faecal_incontinence-10, on-9)
nmod:on(darifenacin-8, faecal_incontinence-10)
nmod:on(darifenacin-8, photophobia-12)
conj:and(faecal_incontinence-10, photophobia-12)
cc(faecal_incontinence-10, and-14)
nmod:on(darifenacin-8, phonophobia-15)
conj:and(faecal_incontinence-10, phonophobia-15)
auxpass(investigated-17, was-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, darifenacin/NN significantly/RB reduced/VBD the/DT risk/NN of/IN faecal_incontinence/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN darifenacin))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN faecal_incontinence))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, darifenacin-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(faecal_incontinence-17, of-16)
nmod:of(risk-15, faecal_incontinence-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN darifenacin/NN may/MD be/VB a/DT useful/JJ treatment/NN option/NN for/IN patients/NNS with/IN overactive_bladder/NN who/WP experience/VBP associated/VBN symptoms/NNS such/JJ as/IN faecal_incontinence/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN darifenacin))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ useful) (NN treatment) (NN option))
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP
                  (NP (NN overactive_bladder))
                  (SBAR
                    (WHNP (WP who))
                    (S
                      (VP (VBP experience)
                        (VP (VBN associated)
                          (NP
                            (NP (NNS symptoms))
                            (PP (JJ such) (IN as)
                              (NP
                                (NP (NN faecal_incontinence))
                                (, ,)
                                (NP (NN photophobia))
                                (, ,)
                                (CC and)
                                (NP (NN phonophobia))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, darifenacin-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, useful-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(overactive_bladder-15, with-14)
nmod:with(option-11, overactive_bladder-15)
nsubj(experience-17, overactive_bladder-15)
ref(overactive_bladder-15, who-16)
acl:relcl(overactive_bladder-15, experience-17)
dep(experience-17, associated-18)
dobj(associated-18, symptoms-19)
case(faecal_incontinence-22, such-20)
mwe(such-20, as-21)
nmod:such_as(symptoms-19, faecal_incontinence-22)
nmod:such_as(symptoms-19, photophobia-24)
conj:and(faecal_incontinence-22, photophobia-24)
cc(faecal_incontinence-22, and-26)
nmod:such_as(symptoms-19, phonophobia-27)
conj:and(faecal_incontinence-22, phonophobia-27)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN darifenacin/NN in/IN this/DT patient/JJ population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (NN darifenacin))
                      (PP (IN in)
                        (NP (DT this) (JJ patient) (NN population))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
ccomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(warranted-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(darifenacin-17, for-16)
nmod:for(regimen-15, darifenacin-17)
case(population-21, in-18)
det(population-21, this-19)
amod(population-21, patient-20)
nmod:in(darifenacin-17, population-21)

The/DT liver/NN is_a/VBZ central/JJ organ/NN in/IN regulating/VBG lipid/NN metabolism/NN and/CC maintaining/VBG systemic/JJ energy_homeostasis/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN liver))
    (VP (VBZ is_a)
      (NP
        (NP (JJ central) (NN organ))
        (PP (IN in)
          (S
            (VP
              (VP (VBG regulating)
                (NP (NN lipid) (NN metabolism)))
              (CC and)
              (VP (VBG maintaining)
                (NP (JJ systemic) (NNS energy_homeostasis))))))))
    (. .)))

det(liver-2, The-1)
nsubj(is_a-3, liver-2)
root(ROOT-0, is_a-3)
amod(organ-5, central-4)
dobj(is_a-3, organ-5)
mark(regulating-7, in-6)
acl(organ-5, regulating-7)
compound(metabolism-9, lipid-8)
dobj(regulating-7, metabolism-9)
cc(regulating-7, and-10)
acl(organ-5, maintaining-11)
conj:and(regulating-7, maintaining-11)
amod(energy_homeostasis-13, systemic-12)
dobj(maintaining-11, energy_homeostasis-13)

Dysregulation/NN of/IN hepatic/JJ lipid/NN metabolism/NN is/VBZ associated/VBN with/IN the/DT development/NN of/IN hepatic_steatosis/NNS ,/, which/WDT is_a/NN hallmark/NN of/IN nonalcoholic_fatty_liver_disease/NN -LRB-/-LRB- NAFLD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NN Dysregulation))
      (PP (IN of)
        (NP (JJ hepatic) (NN lipid) (NN metabolism))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NNS hepatic_steatosis))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP
                      (NP
                        (NP (NN is_a) (NN hallmark))
                        (PP (IN of)
                          (NP (NN nonalcoholic_fatty_liver_disease))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP NAFLD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubjpass(associated-7, Dysregulation-1)
case(metabolism-5, of-2)
amod(metabolism-5, hepatic-3)
compound(metabolism-5, lipid-4)
nmod:of(Dysregulation-1, metabolism-5)
auxpass(associated-7, is-6)
root(ROOT-0, associated-7)
case(development-10, with-8)
det(development-10, the-9)
nmod:with(associated-7, development-10)
case(hepatic_steatosis-12, of-11)
nmod:of(development-10, hepatic_steatosis-12)
nsubj(hallmark-16, hepatic_steatosis-12)
ref(hepatic_steatosis-12, which-14)
compound(hallmark-16, is_a-15)
acl:relcl(hepatic_steatosis-12, hallmark-16)
case(nonalcoholic_fatty_liver_disease-18, of-17)
nmod:of(hallmark-16, nonalcoholic_fatty_liver_disease-18)
dep(hallmark-16, NAFLD-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN CH5036249/NNP ,/, a/DT synthetic/JJ LXR/NNP agonist/NN ,/, on/IN hepatic/JJ lipid/NN metabolism/NN in/IN C57BL/6J/CD mice/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP CH5036249))
            (, ,)
            (NP (DT a) (JJ synthetic) (NNP LXR) (NN agonist))
            (, ,))))
      (PP (IN on)
        (NP (JJ hepatic) (NN lipid) (NN metabolism)))
      (PP (IN in)
        (NP (CD C57BL/6J) (NNS mice))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(CH5036249-10, of-9)
nmod:of(effect-8, CH5036249-10)
det(agonist-15, a-12)
amod(agonist-15, synthetic-13)
compound(agonist-15, LXR-14)
appos(CH5036249-10, agonist-15)
case(metabolism-20, on-17)
amod(metabolism-20, hepatic-18)
compound(metabolism-20, lipid-19)
nmod:on(investigated-6, metabolism-20)
case(mice-23, in-21)
nummod(mice-23, C57BL/6J-22)
nmod:in(investigated-6, mice-23)

Our/PRP$ results/NNS demonstrate/VBP that/IN administration/NN of/IN CH5036249/NNP leads/VBZ to/TO induction/NN of/IN the/DT lipogenic/JJ genes/NNS Srebp-1c/NN ,/, Fas/NNP ,/, and/CC Vitamin_D_receptor/NNP in/IN the/DT liver/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN administration))
            (PP (IN of)
              (NP (NNP CH5036249))))
          (VP (VBZ leads)
            (PP (TO to)
              (NP
                (NP (NN induction))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ lipogenic) (NNS genes) (NN Srebp-1c))
                    (, ,)
                    (NP (NNP Fas))
                    (, ,)
                    (CC and)
                    (NP (NNP Vitamin_D_receptor))))))
            (PP (IN in)
              (NP (DT the) (NN liver)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(leads-8, that-4)
nsubj(leads-8, administration-5)
case(CH5036249-7, of-6)
nmod:of(administration-5, CH5036249-7)
ccomp(demonstrate-3, leads-8)
case(induction-10, to-9)
nmod:to(leads-8, induction-10)
case(Srebp-1c-15, of-11)
det(Srebp-1c-15, the-12)
amod(Srebp-1c-15, lipogenic-13)
compound(Srebp-1c-15, genes-14)
nmod:of(induction-10, Srebp-1c-15)
nmod:of(induction-10, Fas-17)
conj:and(Srebp-1c-15, Fas-17)
cc(Srebp-1c-15, and-19)
nmod:of(induction-10, Vitamin_D_receptor-20)
conj:and(Srebp-1c-15, Vitamin_D_receptor-20)
case(liver-23, in-21)
det(liver-23, the-22)
nmod:in(leads-8, liver-23)

This/DT induction/NN is/VBZ associated/VBN with/IN massive/JJ hepatic_steatosis/NNS along/IN the/DT entire/JJ liver/NN lobule/NN and/CC a/DT 2.5-fold/JJ increase/NN in/IN very_low_density_lipoprotein-triglyceride/JJ -LRB-/-LRB- VLDL-TG/NNP -RRB-/-RRB- secretion/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN induction))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ massive) (NNS hepatic_steatosis))
            (PP (IN along)
              (NP
                (NP (DT the) (JJ entire) (NN liver) (NN lobule))
                (CC and)
                (NP
                  (NP (DT a) (JJ 2.5-fold) (NN increase))
                  (PP (IN in)
                    (NP (JJ very_low_density_lipoprotein-triglyceride)
                      (PRN (-LRB- -LRB-)
                        (NP (NNP VLDL-TG))
                        (-RRB- -RRB-))
                      (NNS secretion))))))))))
    (. .)))

det(induction-2, This-1)
nsubjpass(associated-4, induction-2)
auxpass(associated-4, is-3)
root(ROOT-0, associated-4)
case(hepatic_steatosis-7, with-5)
amod(hepatic_steatosis-7, massive-6)
nmod:with(associated-4, hepatic_steatosis-7)
case(lobule-12, along-8)
det(lobule-12, the-9)
amod(lobule-12, entire-10)
compound(lobule-12, liver-11)
nmod:along(hepatic_steatosis-7, lobule-12)
cc(lobule-12, and-13)
det(increase-16, a-14)
amod(increase-16, 2.5-fold-15)
nmod:along(hepatic_steatosis-7, increase-16)
conj:and(lobule-12, increase-16)
case(secretion-22, in-17)
amod(secretion-22, very_low_density_lipoprotein-triglyceride-18)
appos(secretion-22, VLDL-TG-20)
nmod:in(increase-16, secretion-22)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG hepatic/JJ lipid/NN metabolism/NN and/CC suggest/VBP that/IN targeting/VBG LXR/NNP signaling/VBG may/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN NAFLD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP (JJ hepatic) (NN lipid) (NN metabolism))))))
      (CC and)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (S
              (VP (VBG targeting)
                (NP (NNP LXR))
                (S
                  (VP (VBG signaling)))))
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
                  (PP (IN for)
                    (NP (NNP NAFLD))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(suggest-15, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(provide-3, mechanisms-9)
acl(mechanisms-9, underlying-10)
amod(metabolism-13, hepatic-11)
compound(metabolism-13, lipid-12)
dobj(underlying-10, metabolism-13)
cc(provide-3, and-14)
conj:and(provide-3, suggest-15)
mark(strategy-25, that-16)
csubj(strategy-25, targeting-17)
dobj(targeting-17, LXR-18)
advcl(targeting-17, signaling-19)
aux(strategy-25, may-20)
cop(strategy-25, be-21)
det(strategy-25, a-22)
amod(strategy-25, potential-23)
amod(strategy-25, therapeutic-24)
ccomp(suggest-15, strategy-25)
case(NAFLD-27, for-26)
nmod:for(strategy-25, NAFLD-27)

Omega-3_fatty_acids/NNP have/VBP been/VBN widely/RB studied/VBN due/JJ to/TO their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (S
            (ADJP (JJ due)
              (PP (TO to)
                (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, widely-4)
root(ROOT-0, studied-5)
xcomp(studied-5, due-6)
case(benefits-11, to-7)
nmod:poss(benefits-11, their-8)
amod(benefits-11, potential-9)
compound(benefits-11, health-10)
nmod:to(due-6, benefits-11)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP associated/VBN with/IN decreased/VBN potassium_thiocyanate/NN levels/NNS in/IN hyperpotassium/NN thiocyanatemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NN potassium_thiocyanate) (NNS levels)))
          (PP (IN in)
            (NP (NN hyperpotassium) (JJ thiocyanatemic) (NNS patients)))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(associated-15, omega-3_fatty_acids-2)
nsubjpass(decreased-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(associated-15, are-14)
root(ROOT-0, associated-15)
case(levels-19, with-16)
amod(levels-19, decreased-17)
compound(levels-19, potassium_thiocyanate-18)
nmod:with(associated-15, levels-19)
case(patients-23, in-20)
compound(patients-23, hyperpotassium-21)
amod(patients-23, thiocyanatemic-22)
nmod:in(associated-15, patients-23)
cc(associated-15, and-24)
conj:and(associated-15, decreased-25)
dobj(decreased-25, risk-26)
case(coronary_heart_disease-29, of-27)
amod(coronary_heart_disease-29, developing-28)
nmod:of(risk-26, coronary_heart_disease-29)
appos(coronary_heart_disease-29, CHD-31)

These/DT findings/NNS suggest/VBP that/IN the/DT consumption/NN of/IN foods/NNS rich/JJ in/IN EPA/NNP and/CC DHA/NNP ,/, such/JJ as/IN fatty/JJ fish/NN ,/, may/MD have/VB a/DT protective/JJ effect/NN against/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN consumption))
            (PP (IN of)
              (NP
                (NP (NNS foods))
                (ADJP (JJ rich)
                  (PP (IN in)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))))
                (, ,)
                (PP (JJ such) (IN as)
                  (NP (JJ fatty) (NN fish)))
                (, ,))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP (NNP CHD)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-21, that-4)
det(consumption-6, the-5)
nsubj(have-21, consumption-6)
case(foods-8, of-7)
nmod:of(consumption-6, foods-8)
amod(foods-8, rich-9)
case(EPA-11, in-10)
nmod:in(rich-9, EPA-11)
cc(EPA-11, and-12)
nmod:in(rich-9, DHA-13)
conj:and(EPA-11, DHA-13)
case(fish-18, such-15)
mwe(such-15, as-16)
amod(fish-18, fatty-17)
nmod:such_as(foods-8, fish-18)
aux(have-21, may-20)
ccomp(suggest-3, have-21)
det(effect-24, a-22)
amod(effect-24, protective-23)
dobj(have-21, effect-24)
case(CHD-26, against-25)
nmod:against(effect-24, CHD-26)

However/RB ,/, the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP still/RB under/IN investigation/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP (VBP are)
      (ADVP (RB still))
      (PP (IN under)
        (NP (NN investigation))))
    (. .)))

advmod(investigation-11, However-1)
det(mechanisms-4, the-3)
nsubj(investigation-11, mechanisms-4)
acl(mechanisms-4, underlying-5)
det(effects-7, these-6)
dobj(underlying-5, effects-7)
cop(investigation-11, are-8)
advmod(investigation-11, still-9)
case(investigation-11, under-10)
root(ROOT-0, investigation-11)

Further/RB research/NN is/VBZ needed/VBN to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN treatment))
                  (PP (IN of)
                    (NP (NN cardiovascular_disease))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(explore-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(applications-10, the-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(explore-6, applications-10)
case(EPA-12, of-11)
nmod:of(applications-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(applications-10, DHA-14)
conj:and(EPA-12, DHA-14)
case(prevention-17, in-15)
det(prevention-17, the-16)
nmod:in(explore-6, prevention-17)
cc(prevention-17, and-18)
nmod:in(explore-6, treatment-19)
conj:and(prevention-17, treatment-19)
case(cardiovascular_disease-21, of-20)
nmod:of(prevention-17, cardiovascular_disease-21)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN various/JJ physiological/JJ and/CC pathological/JJ conditions/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder)
      (SBAR
        (WHNP (WDT that))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP (JJ various)
            (ADJP (JJ physiological)
              (CC and)
              (JJ pathological))
            (NNS conditions)))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
nsubjpass(associated-7, metabolic_disorder-4)
ccomp(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
root(ROOT-0, associated-7)
case(conditions-13, with-8)
amod(conditions-13, various-9)
amod(conditions-13, physiological-10)
cc(physiological-10, and-11)
conj:and(physiological-10, pathological-12)
amod(conditions-13, pathological-12)
nmod:with(associated-7, conditions-13)

The/DT development/NN of/IN obesity/NN involves/VBZ the/DT interplay/NN of/IN genetic/JJ ,/, environmental/JJ ,/, and/CC lifestyle/NN factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN development))
      (PP (IN of)
        (NP (NN obesity))))
    (VP (VBZ involves)
      (NP
        (NP (DT the) (NN interplay))
        (PP (IN of)
          (NP
            (UCP
              (ADJP (JJ genetic))
              (, ,)
              (ADJP (JJ environmental))
              (, ,)
              (CC and)
              (NP (NN lifestyle)))
            (NNS factors)))))
    (. .)))

det(development-2, The-1)
nsubj(involves-5, development-2)
case(obesity-4, of-3)
nmod:of(development-2, obesity-4)
root(ROOT-0, involves-5)
det(interplay-7, the-6)
dobj(involves-5, interplay-7)
case(factors-15, of-8)
amod(factors-15, genetic-9)
conj:and(genetic-9, environmental-11)
amod(factors-15, environmental-11)
cc(genetic-9, and-13)
conj:and(genetic-9, lifestyle-14)
amod(factors-15, lifestyle-14)
nmod:of(interplay-7, factors-15)

The/DT neuropeptide/JJ receptor/NN Ntsr-1/VBZ has_been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN feeding/VBG behavior/NN and/CC energy_homeostasis/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ neuropeptide) (NN receptor))
    (VP (VBZ Ntsr-1)
      (VP (VBN has_been)
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NN regulation))
              (PP (IN of)
                (NP
                  (NP (VBG feeding) (NN behavior))
                  (CC and)
                  (NP (NNS energy_homeostasis)))))))))
    (. .)))

det(receptor-3, The-1)
amod(receptor-3, neuropeptide-2)
nsubj(Ntsr-1-4, receptor-3)
root(ROOT-0, Ntsr-1-4)
dep(Ntsr-1-4, has_been-5)
dep(has_been-5, implicated-6)
case(regulation-9, in-7)
det(regulation-9, the-8)
nmod:in(implicated-6, regulation-9)
case(behavior-12, of-10)
amod(behavior-12, feeding-11)
nmod:of(regulation-9, behavior-12)
cc(behavior-12, and-13)
nmod:of(regulation-9, energy_homeostasis-14)
conj:and(behavior-12, energy_homeostasis-14)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN Ntsr-1/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS Ntsr-1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(Ntsr-1-20, of-19)
nmod:of(hypersecretion-18, Ntsr-1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ enterogastrone/NN on/IN the/DT secretion/NN of/IN Ntsr-1/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN enterogastrone)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ Ntsr-1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(enterogastrone-17, 10-15)
amod(enterogastrone-17, mmol/L-16)
nmod:of(effects-9, enterogastrone-17)
conj:and(glucose-13, enterogastrone-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, Ntsr-1-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN obese/JJ rats/NNS had/VBD significantly/RB higher/JJR levels/NNS of/IN Ntsr-1/JJ secretion/NN compared/VBN to/TO lean/JJ rats/NNS under/IN both/DT basal/JJ and/CC stimulated/VBN conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ obese) (NNS rats))
          (VP (VBD had)
            (NP
              (NP
                (ADJP (RB significantly) (JJR higher))
                (NNS levels))
              (PP (IN of)
                (NP (JJ Ntsr-1) (NN secretion))))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))
            (PP (IN under)
              (NP (DT both)
                (ADJP (JJ basal)
                  (CC and)
                  (VBN stimulated))
                (NNS conditions)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-7, that-4)
amod(rats-6, obese-5)
nsubj(had-7, rats-6)
ccomp(showed-3, had-7)
advmod(higher-9, significantly-8)
amod(levels-10, higher-9)
dobj(had-7, levels-10)
case(secretion-13, of-11)
amod(secretion-13, Ntsr-1-12)
nmod:of(levels-10, secretion-13)
case(rats-17, compared-14)
mwe(compared-14, to-15)
amod(rats-17, lean-16)
advcl(had-7, rats-17)
case(conditions-23, under-18)
det(conditions-23, both-19)
amod(conditions-23, basal-20)
cc(basal-20, and-21)
conj:and(basal-20, stimulated-22)
amod(conditions-23, stimulated-22)
nmod:under(had-7, conditions-23)

Furthermore/RB ,/, we/PRP found/VBD that/IN enterogastrone/VBP stimulated/VBN Ntsr-1/JJ secretion/NN in/IN both/DT lean/JJ and/CC obese/JJ rats/NNS ,/, but/CC had/VBD no/DT effect/NN on/IN insulin_secretion/NN in/IN either/DT group/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (VP
            (VP (VBP enterogastrone)
              (VP (VBN stimulated)
                (NP (JJ Ntsr-1) (NN secretion))
                (PP (IN in)
                  (NP (DT both)
                    (ADJP (JJ lean)
                      (CC and)
                      (JJ obese))
                    (NNS rats)))))
            (, ,)
            (CC but)
            (VP (VBD had)
              (NP
                (NP (DT no) (NN effect))
                (PP (IN on)
                  (NP
                    (NP (NN insulin_secretion))
                    (PP (IN in)
                      (NP (DT either) (NN group)))))))))))
    (. .)))

advmod(found-4, Furthermore-1)
nsubj(found-4, we-3)
root(ROOT-0, found-4)
mark(enterogastrone-6, that-5)
ccomp(found-4, enterogastrone-6)
dep(enterogastrone-6, stimulated-7)
amod(secretion-9, Ntsr-1-8)
dobj(stimulated-7, secretion-9)
case(rats-15, in-10)
det(rats-15, both-11)
amod(rats-15, lean-12)
cc(lean-12, and-13)
conj:and(lean-12, obese-14)
amod(rats-15, obese-14)
nmod:in(stimulated-7, rats-15)
cc(enterogastrone-6, but-17)
ccomp(found-4, had-18)
conj:but(enterogastrone-6, had-18)
neg(effect-20, no-19)
dobj(had-18, effect-20)
case(insulin_secretion-22, on-21)
nmod:on(effect-20, insulin_secretion-22)
case(group-25, in-23)
det(group-25, either-24)
nmod:in(insulin_secretion-22, group-25)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN Ntsr-1/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN feeding/NN behavior/NN or/CC energy_expenditure/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NNS Ntsr-1))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB possibly))
                (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN feeding) (NN behavior)
                      (CC or)
                      (NN energy_expenditure))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(Ntsr-1-7, of-6)
nmod:of(hypersecretion-5, Ntsr-1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(Ntsr-1-7, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
advmod(effects-24, possibly-21)
case(effects-24, through-22)
nmod:poss(effects-24, its-23)
nmod:through(play-12, effects-24)
case(behavior-27, on-25)
compound(behavior-27, feeding-26)
nmod:on(effects-24, behavior-27)
cc(behavior-27, or-28)
nmod:on(effects-24, energy_expenditure-29)
conj:or(behavior-27, energy_expenditure-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG this/DT relationship/NN and/CC to/TO explore/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN relationship))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (JJ obesity) (NN management))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(relationship-11, this-10)
dobj(underlying-9, relationship-11)
cc(elucidate-6, and-12)
mark(explore-14, to-13)
ccomp(needed-4, explore-14)
conj:and(elucidate-6, explore-14)
amod(targets-17, potential-15)
amod(targets-17, therapeutic-16)
dobj(explore-14, targets-17)
case(management-20, for-18)
amod(management-20, obesity-19)
nmod:for(targets-17, management-20)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN studied/VBN in/IN relation/NN to/TO their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN studied)
          (PP (IN in)
            (NP
              (NP (NN relation))
              (PP (TO to)
                (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(studied-24, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
dep(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(Omega-3_fatty_acids-1, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(studied-24, have-22)
auxpass(studied-24, been-23)
root(ROOT-0, studied-24)
case(relation-26, in-25)
nmod:in(studied-24, relation-26)
case(benefits-31, to-27)
nmod:poss(benefits-31, their-28)
amod(benefits-31, potential-29)
compound(benefits-31, health-30)
nmod:to(relation-26, benefits-31)

Recent/JJ research/NN has/VBZ shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN azaserine/JJ levels/NNS in/IN hyperazaserinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ azaserine) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperazaserinemic) (NNS patients)))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-9, omega-3_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, azaserine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperazaserinemic-15)
nmod:in(levels-13, patients-16)

Azaserine/VB is_a/NN carcinogen/NN that/WDT has_been/VBP linked/VBN to/TO the/DT development/NN of/IN pancreatic_cancer/NN ./.

(ROOT
  (S
    (VP (VB Azaserine)
      (NP
        (NP (NN is_a) (NN carcinogen))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN pancreatic_cancer)))))))))))
    (. .)))

root(ROOT-0, Azaserine-1)
compound(carcinogen-3, is_a-2)
dobj(Azaserine-1, carcinogen-3)
nsubj(has_been-5, carcinogen-3)
ref(carcinogen-3, that-4)
acl:relcl(carcinogen-3, has_been-5)
dep(has_been-5, linked-6)
case(development-9, to-7)
det(development-9, the-8)
nmod:to(linked-6, development-9)
case(pancreatic_cancer-11, of-10)
nmod:of(development-9, pancreatic_cancer-11)

In/IN addition/NN ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-8, addition-2)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(found-8, omega-3_fatty_acids-5)
nsubj:xsubj(decrease-10, omega-3_fatty_acids-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(decrease-10, to-9)
xcomp(found-8, decrease-10)
det(risk-12, the-11)
dobj(decrease-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

This/DT protective/JJ effect/NN may/MD be/VB due/JJ to/TO the/DT ability/NN of/IN omega-3_fatty_acids/JJ to/TO reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB lipid/NN profiles/NNS ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (NN ability))
              (PP (IN of)
                (NP
                  (ADJP (JJ omega-3_fatty_acids)
                    (S
                      (VP (TO to)
                        (VP
                          (VP (VB reduce)
                            (NP
                              (NP (NN inflammation))
                              (, ,)
                              (NP (JJR lower) (NN blood_pressure))
                              (, ,)))
                          (CC and)
                          (VP (VB improve)
                            (NP (NN lipid)))))))
                  (NNS profiles))))))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubj(due-6, effect-3)
aux(due-6, may-4)
cop(due-6, be-5)
root(ROOT-0, due-6)
case(ability-9, to-7)
det(ability-9, the-8)
nmod:to(due-6, ability-9)
case(profiles-22, of-10)
amod(profiles-22, omega-3_fatty_acids-11)
mark(reduce-13, to-12)
xcomp(omega-3_fatty_acids-11, reduce-13)
dobj(reduce-13, inflammation-14)
amod(blood_pressure-17, lower-16)
appos(inflammation-14, blood_pressure-17)
cc(reduce-13, and-19)
xcomp(omega-3_fatty_acids-11, improve-20)
conj:and(reduce-13, improve-20)
dobj(improve-20, lipid-21)
nmod:of(ability-9, profiles-22)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD have/VB important/JJ health/NN benefits/NNS and/CC could/MD be/VB a/DT valuable/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN chronic_diseases/NNS such/JJ as/IN CHD/NNP and/CC cancer/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP
            (VP (MD may)
              (VP (VB have)
                (NP (JJ important) (NN health) (NNS benefits))))
            (CC and)
            (VP (MD could)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ valuable) (NN strategy))
                  (PP (IN for)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP
                              (NP (NNS chronic_diseases))
                              (PP (JJ such) (IN as)
                                (NP
                                  (NP (NNP CHD))
                                  (CC and)
                                  (NP (NN cancer)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-12, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(have-12, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(have-12, may-11)
ccomp(suggest-3, have-12)
amod(benefits-15, important-13)
compound(benefits-15, health-14)
dobj(have-12, benefits-15)
cc(have-12, and-16)
aux(strategy-21, could-17)
cop(strategy-21, be-18)
det(strategy-21, a-19)
amod(strategy-21, valuable-20)
ccomp(suggest-3, strategy-21)
conj:and(have-12, strategy-21)
mark(reducing-23, for-22)
acl(strategy-21, reducing-23)
det(risk-25, the-24)
dobj(reducing-23, risk-25)
case(chronic_diseases-27, of-26)
nmod:of(risk-25, chronic_diseases-27)
case(CHD-30, such-28)
mwe(such-28, as-29)
nmod:such_as(chronic_diseases-27, CHD-30)
cc(CHD-30, and-31)
nmod:such_as(chronic_diseases-27, cancer-32)
conj:and(CHD-30, cancer-32)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ various) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(associated-20, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, various-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP can/MD decrease/VB the/DT levels/NNS of/IN butaprost/NN in/IN hyperbutaprostmic/JJ patients/NNS ,/, which/WDT is_a/VBZ significant/JJ risk/NN factor/NN for/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD can)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NN butaprost))
                        (PP (IN in)
                          (NP
                            (NP (JJ hyperbutaprostmic) (NNS patients))
                            (, ,)
                            (SBAR
                              (WHNP (WDT which))
                              (S
                                (VP (VBZ is_a)
                                  (NP
                                    (NP (JJ significant) (NN risk) (NN factor))
                                    (PP (IN for)
                                      (S
                                        (VP (VBG developing)
                                          (NP (NN coronary_heart_disease))))))))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(decrease-10, that-5)
nsubj(decrease-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(decrease-10, DHA-8)
aux(decrease-10, can-9)
ccomp(shown-4, decrease-10)
det(levels-12, the-11)
dobj(decrease-10, levels-12)
case(butaprost-14, of-13)
nmod:of(levels-12, butaprost-14)
case(patients-17, in-15)
amod(patients-17, hyperbutaprostmic-16)
nmod:in(butaprost-14, patients-17)
nsubj(is_a-20, patients-17)
ref(patients-17, which-19)
acl:relcl(patients-17, is_a-20)
amod(factor-23, significant-21)
compound(factor-23, risk-22)
dobj(is_a-20, factor-23)
mark(developing-25, for-24)
acl(factor-23, developing-25)
dobj(developing-25, coronary_heart_disease-26)
appos(butaprost-14, CHD-28)

Butaprost/NNP is/VBZ known/VBN to/TO contribute/VB to/TO CHD/NNP by/IN promoting/VBG platelet_aggregation/NN and/CC vasoconstriction/NN ./.

(ROOT
  (S
    (NP (NNP Butaprost))
    (VP (VBZ is)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB contribute)
              (PP (TO to)
                (NP (NNP CHD)))
              (PP (IN by)
                (S
                  (VP (VBG promoting)
                    (NP (NN platelet_aggregation)
                      (CC and)
                      (NN vasoconstriction))))))))))
    (. .)))

nsubjpass(known-3, Butaprost-1)
nsubj:xsubj(contribute-5, Butaprost-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
mark(contribute-5, to-4)
xcomp(known-3, contribute-5)
case(CHD-7, to-6)
nmod:to(contribute-5, CHD-7)
mark(promoting-9, by-8)
advcl(contribute-5, promoting-9)
dobj(promoting-9, platelet_aggregation-10)
cc(platelet_aggregation-10, and-11)
dobj(promoting-9, vasoconstriction-12)
conj:and(platelet_aggregation-10, vasoconstriction-12)

The/DT mechanism/NN of/IN action/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP reduce/VB butaprost/JJ levels/NNS is/VBZ not/RB fully/RB understood/VBN ,/, but/CC it/PRP may/MD involve/VB the/DT inhibition/NN of/IN cyclooxygenase-2/JJ -LRB-/-LRB- COX-2/NNP -RRB-/-RRB- activity/NN or/CC the/DT modulation/NN of/IN gene/NN expression/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (PP (IN of)
          (NP
            (NP (NN action))
            (PP (IN by)
              (SBAR
                (WHNP (WDT which))
                (S
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))
                  (VP (VB reduce)
                    (NP (JJ butaprost) (NNS levels)))))))))
      (VP (VBZ is)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (DT the) (NN inhibition))
            (PP (IN of)
              (NP
                (NP (JJ cyclooxygenase-2)
                  (PRN (-LRB- -LRB-)
                    (NP (NNP COX-2))
                    (-RRB- -RRB-))
                  (NN activity))
                (CC or)
                (NP
                  (NP (DT the) (NN modulation))
                  (PP (IN of)
                    (NP (NN gene) (NN expression))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(understood-16, mechanism-2)
case(action-4, of-3)
nmod:of(mechanism-2, action-4)
mark(reduce-10, by-5)
dobj(reduce-10, which-6)
nsubj(reduce-10, EPA-7)
cc(EPA-7, and-8)
conj:and(EPA-7, DHA-9)
nsubj(reduce-10, DHA-9)
acl(action-4, reduce-10)
amod(levels-12, butaprost-11)
dobj(reduce-10, levels-12)
auxpass(understood-16, is-13)
neg(understood-16, not-14)
advmod(understood-16, fully-15)
root(ROOT-0, understood-16)
cc(understood-16, but-18)
nsubj(involve-21, it-19)
aux(involve-21, may-20)
conj:but(understood-16, involve-21)
det(inhibition-23, the-22)
dobj(involve-21, inhibition-23)
case(activity-29, of-24)
amod(activity-29, cyclooxygenase-2-25)
appos(activity-29, COX-2-27)
nmod:of(inhibition-23, activity-29)
cc(activity-29, or-30)
det(modulation-32, the-31)
nmod:of(inhibition-23, modulation-32)
conj:or(activity-29, modulation-32)
case(expression-35, of-33)
compound(expression-35, gene-34)
nmod:of(modulation-32, expression-35)

In/IN addition/NN to/TO reducing/VBG butaprost/JJ levels/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN shown/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC reduce/VB blood_pressure/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (S
            (VP (VBG reducing)
              (NP (JJ butaprost) (NNS levels)))))))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB have)
                  (NP (JJ anti-inflammatory) (NNS effects)))
                (, ,)
                (VP
                  (VP (VB improve)
                    (NP (NN lipid) (NN metabolism)))
                  (, ,)
                  (CC and)
                  (VP (VB reduce)
                    (NP (NN blood_pressure))))))))))
    (. .)))

mark(reducing-4, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
acl(shown-14, reducing-4)
amod(levels-6, butaprost-5)
dobj(reducing-4, levels-6)
nsubjpass(shown-14, EPA-8)
nsubj:xsubj(have-16, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubjpass(shown-14, DHA-10)
nsubj:xsubj(have-16, DHA-10)
aux(shown-14, have-11)
advmod(shown-14, also-12)
auxpass(shown-14, been-13)
root(ROOT-0, shown-14)
mark(have-16, to-15)
xcomp(shown-14, have-16)
amod(effects-18, anti-inflammatory-17)
dobj(have-16, effects-18)
dep(have-16, improve-20)
compound(metabolism-22, lipid-21)
dobj(improve-20, metabolism-22)
cc(improve-20, and-24)
dep(have-16, reduce-25)
conj:and(improve-20, reduce-25)
dobj(reduce-25, blood_pressure-26)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN could/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD could)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-15, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, could-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
case(CHD-21, of-20)
nmod:of(risk-19, CHD-21)

The/DT health/NN benefits/NNS of/IN omega-3_fatty_acids/JJ ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN health) (NNS benefits))
      (PP (IN of)
        (NP (JJ omega-3_fatty_acids)))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied))))
    (. .)))

det(benefits-3, The-1)
compound(benefits-3, health-2)
nsubjpass(studied-21, benefits-3)
case(omega-3_fatty_acids-5, of-4)
nmod:of(benefits-3, omega-3_fatty_acids-5)
advmod(eicosapentaenoic_acid-8, specifically-7)
acl(benefits-3, eicosapentaenoic_acid-8)
dobj(eicosapentaenoic_acid-8, EPA-10)
cc(EPA-10, and-12)
dobj(eicosapentaenoic_acid-8, docosahexaenoic_acid-13)
conj:and(EPA-10, docosahexaenoic_acid-13)
appos(EPA-10, DHA-15)
aux(studied-21, have-18)
auxpass(studied-21, been-19)
advmod(studied-21, widely-20)
root(ROOT-0, studied-21)

These/DT long-chain_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN dextran_phosphate/JJ levels/NNS in/IN hyperdextran/JJ phosphatemic/JJ patients/NNS ,/, indicating/VBG a/DT potential/JJ role/NN in/IN preventing/VBG cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS long-chain_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (JJ dextran_phosphate) (NNS levels))
              (PP (IN in)
                (NP (JJ hyperdextran) (JJ phosphatemic) (NNS patients)))))
          (, ,)
          (S
            (VP (VBG indicating)
              (NP (DT a) (JJ potential) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG preventing)
                    (NP (NN cardiovascular_disease))))))))))
    (. .)))

det(long-chain_fatty_acids-2, These-1)
nsubjpass(associated-5, long-chain_fatty_acids-2)
aux(associated-5, have-3)
auxpass(associated-5, been-4)
root(ROOT-0, associated-5)
case(levels-9, with-6)
amod(levels-9, decreased-7)
amod(levels-9, dextran_phosphate-8)
nmod:with(associated-5, levels-9)
case(patients-13, in-10)
amod(patients-13, hyperdextran-11)
amod(patients-13, phosphatemic-12)
nmod:in(levels-9, patients-13)
xcomp(associated-5, indicating-15)
det(role-18, a-16)
amod(role-18, potential-17)
dobj(indicating-15, role-18)
mark(preventing-20, in-19)
advcl(indicating-15, preventing-20)
dobj(preventing-20, cardiovascular_disease-21)

Studies/NNPS have/VBP also/RB shown/VBN that/IN consumption/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN consumption))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(shown-4, Studies-1)
aux(shown-4, have-2)
advmod(shown-4, also-3)
root(ROOT-0, shown-4)
mark(associated-12, that-5)
nsubjpass(associated-12, consumption-6)
case(EPA-8, of-7)
nmod:of(consumption-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(consumption-6, DHA-10)
conj:and(EPA-8, DHA-10)
auxpass(associated-12, is-11)
ccomp(shown-4, associated-12)
case(risk-16, with-13)
det(risk-16, a-14)
amod(risk-16, decreased-15)
nmod:with(associated-12, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, coronary_heart_disease-19)
appos(risk-16, CHD-21)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (JJ anti-inflammatory)
              (CC and)
              (JJ anti-thrombotic) (NNS properties))
            (PP (IN of)
              (NP (JJ omega-3_fatty_acids)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
nsubj(involve-14, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
auxpass(understood-10, are-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
aux(involve-14, may-13)
conj:but(understood-10, involve-14)
amod(properties-18, anti-inflammatory-15)
cc(anti-inflammatory-15, and-16)
conj:and(anti-inflammatory-15, anti-thrombotic-17)
amod(properties-18, anti-thrombotic-17)
dobj(involve-14, properties-18)
case(omega-3_fatty_acids-20, of-19)
nmod:of(properties-18, omega-3_fatty_acids-20)

Given/VBN the/DT high/JJ prevalence/NN of/IN CHD/NNP worldwide/RB ,/, further/JJ research/NN into/IN the/DT potential/JJ therapeutic/JJ benefits/NNS of/IN EPA/NNP and/CC DHA/NNP is/VBZ warranted/VBN ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP
        (NP (DT the) (JJ high) (NN prevalence))
        (PP (IN of)
          (NP (NNP CHD)))))
    (ADVP (RB worldwide))
    (, ,)
    (NP
      (NP (JJ further) (NN research))
      (PP (IN into)
        (NP
          (NP (DT the) (JJ potential) (JJ therapeutic) (NNS benefits))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))))
    (VP (VBZ is)
      (VP (VBN warranted)))
    (. .)))

case(prevalence-4, Given-1)
det(prevalence-4, the-2)
amod(prevalence-4, high-3)
nmod:given(warranted-21, prevalence-4)
case(CHD-6, of-5)
nmod:of(prevalence-4, CHD-6)
advmod(warranted-21, worldwide-7)
amod(research-10, further-9)
nsubjpass(warranted-21, research-10)
case(benefits-15, into-11)
det(benefits-15, the-12)
amod(benefits-15, potential-13)
amod(benefits-15, therapeutic-14)
nmod:into(research-10, benefits-15)
case(EPA-17, of-16)
nmod:of(benefits-15, EPA-17)
cc(EPA-17, and-18)
nmod:of(benefits-15, DHA-19)
conj:and(EPA-17, DHA-19)
auxpass(warranted-21, is-20)
root(ROOT-0, warranted-21)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ several) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(fatty_acids-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(fatty_acids-16, are-14)
amod(fatty_acids-16, essential-15)
root(ROOT-0, fatty_acids-16)
nsubjpass(associated-20, fatty_acids-16)
ref(fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(fatty_acids-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, several-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NN ,/, EPA/NNP and/CC DHA/NNP ,/, may/MD reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- by/IN decreasing/VBG bucillamine/JJ levels/NNS in/IN hyperbucillaminemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NN omega-3_fatty_acids))
              (, ,)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (MD may)
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))
                (PP (IN by)
                  (S
                    (VP (VBG decreasing)
                      (NP
                        (NP (JJ bucillamine) (NNS levels))
                        (PP (IN in)
                          (NP (JJ hyperbucillaminemic) (NNS patients)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(reduce-14, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(reduce-14, omega-3_fatty_acids-7)
appos(omega-3_fatty_acids-7, EPA-9)
cc(EPA-9, and-10)
appos(omega-3_fatty_acids-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(reduce-14, may-13)
ccomp(shown-4, reduce-14)
det(risk-16, the-15)
dobj(reduce-14, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, coronary_heart_disease-19)
appos(risk-16, CHD-21)
mark(decreasing-24, by-23)
advcl(reduce-14, decreasing-24)
amod(levels-26, bucillamine-25)
dobj(decreasing-24, levels-26)
case(patients-29, in-27)
amod(patients-29, hyperbucillaminemic-28)
nmod:in(levels-26, patients-29)

Hyperbucillaminemia/NNP is_a/NN condition/NN characterized/VBD by/IN high/JJ levels/NNS of/IN bucillamine/NN ,/, which/WDT has_been/VBP linked/VBN to/TO increased/VBN risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNP Hyperbucillaminemia) (NN is_a) (NN condition))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ high) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NN bucillamine))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBP has_been)
                    (VP (VBN linked)
                      (PP (TO to)
                        (NP
                          (NP (VBN increased) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD))))))))))))))
    (. .)))

compound(condition-3, Hyperbucillaminemia-1)
compound(condition-3, is_a-2)
nsubj(characterized-4, condition-3)
root(ROOT-0, characterized-4)
case(levels-7, by-5)
amod(levels-7, high-6)
nmod:by(characterized-4, levels-7)
case(bucillamine-9, of-8)
nmod:of(levels-7, bucillamine-9)
nsubj(has_been-12, bucillamine-9)
ref(bucillamine-9, which-11)
acl:relcl(bucillamine-9, has_been-12)
dep(has_been-12, linked-13)
case(risk-16, to-14)
amod(risk-16, increased-15)
nmod:to(linked-13, risk-16)
case(CHD-18, of-17)
nmod:of(risk-16, CHD-18)

The/DT exact/JJ mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP lower/JJR bucillamine/JJ levels/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN that/IN they/PRP may/MD act/VB through/IN various/JJ pathways/NNS involved/VBN in/IN lipid/NN metabolism/NN and/CC inflammation/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ exact) (NNS mechanisms))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (NP (JJR lower) (JJ bucillamine) (NNS levels)))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (MD may)
                (VP (VB act)
                  (PP (IN through)
                    (NP
                      (NP (JJ various) (NNS pathways))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NN lipid) (NN metabolism)
                            (CC and)
                            (NN inflammation)))))))))))))
    (. .)))

det(mechanisms-3, The-1)
amod(mechanisms-3, exact-2)
nmod:by(levels-11, mechanisms-3)
nsubjpass(understood-16, mechanisms-3)
case(which-5, by-4)
ref(mechanisms-3, which-5)
dep(levels-11, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
dep(levels-11, DHA-8)
amod(levels-11, lower-9)
amod(levels-11, bucillamine-10)
acl:relcl(mechanisms-3, levels-11)
auxpass(understood-16, are-12)
neg(understood-16, not-13)
advmod(understood-16, yet-14)
advmod(understood-16, fully-15)
root(ROOT-0, understood-16)
cc(understood-16, but-18)
nsubjpass(thought-21, it-19)
auxpass(thought-21, is-20)
conj:but(understood-16, thought-21)
mark(act-25, that-22)
nsubj(act-25, they-23)
aux(act-25, may-24)
ccomp(thought-21, act-25)
case(pathways-28, through-26)
amod(pathways-28, various-27)
nmod:through(act-25, pathways-28)
acl(pathways-28, involved-29)
case(metabolism-32, in-30)
compound(metabolism-32, lipid-31)
nmod:in(involved-29, metabolism-32)
cc(metabolism-32, and-33)
nmod:in(involved-29, inflammation-34)
conj:and(metabolism-32, inflammation-34)

These/DT findings/NNS highlight/VB the/DT potential/JJ therapeutic/JJ benefits/NNS of/IN omega-3_fatty_acids/JJ in/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP ,/, as/RB well/RB as/IN other/JJ related/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (JJ potential) (JJ therapeutic) (NNS benefits))
        (PP (IN of)
          (NP
            (ADJP (JJ omega-3_fatty_acids)
              (PP (IN in)
                (NP
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN management))
                    (PP (IN of)
                      (NP (NNP CHD))))
                  (, ,)
                  (ADVP (RB as) (RB well)
                    (PP (IN as)
                      (ADJP (JJ other)))))))
            (JJ related) (NNS conditions)))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
root(ROOT-0, highlight-3)
det(benefits-7, the-4)
amod(benefits-7, potential-5)
amod(benefits-7, therapeutic-6)
dobj(highlight-3, benefits-7)
case(conditions-23, of-8)
amod(conditions-23, omega-3_fatty_acids-9)
case(prevention-12, in-10)
det(prevention-12, the-11)
nmod:in(omega-3_fatty_acids-9, prevention-12)
cc(prevention-12, and-13)
nmod:in(omega-3_fatty_acids-9, management-14)
conj:and(prevention-12, management-14)
case(CHD-16, of-15)
nmod:of(prevention-12, CHD-16)
advmod(well-19, as-18)
advmod(prevention-12, well-19)
case(other-21, as-20)
advcl(well-19, other-21)
amod(conditions-23, related-22)
nmod:of(benefits-7, conditions-23)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ doses/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS doses))
                  (PP (IN for)
                    (NP (JJ clinical) (NN use))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(doses-17, optimal-16)
dobj(determine-15, doses-17)
case(use-20, for-18)
amod(use-20, clinical-19)
nmod:for(doses-17, use-20)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN studied/VBN extensively/RB for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN studied)
          (ADVP (RB extensively))
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-16, have-14)
auxpass(studied-16, been-15)
root(ROOT-0, studied-16)
advmod(studied-16, extensively-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-16, benefits-22)

Recent/JJ research/NN has/VBZ suggested/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD play/VB a/DT role/NN in/IN the/DT regulation/NN of/IN temsirolimus/JJ levels/NNS in/IN hypertemsirolimusmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN regulation))
                      (PP (IN of)
                        (NP
                          (NP (JJ temsirolimus) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hypertemsirolimusmic) (NNS patients))))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(suggested-4, research-2)
aux(suggested-4, has-3)
root(ROOT-0, suggested-4)
mark(play-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubj(play-10, omega-3_fatty_acids-8)
aux(play-10, may-9)
ccomp(suggested-4, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
case(regulation-15, in-13)
det(regulation-15, the-14)
nmod:in(role-12, regulation-15)
case(levels-18, of-16)
amod(levels-18, temsirolimus-17)
nmod:of(regulation-15, levels-18)
case(patients-21, in-19)
amod(patients-21, hypertemsirolimusmic-20)
nmod:in(levels-18, patients-21)

Furthermore/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(has_been-9, Furthermore-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, associated-10)
case(risk-14, with-11)
det(risk-14, a-12)
amod(risk-14, decreased-13)
nmod:with(associated-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (JJ anti-inflammatory)
              (CC and)
              (JJ anti-thrombotic) (NNS properties))
            (PP (IN of)
              (NP (JJ omega-3_fatty_acids)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
amod(properties-17, anti-inflammatory-14)
cc(anti-inflammatory-14, and-15)
conj:and(anti-inflammatory-14, anti-thrombotic-16)
amod(properties-17, anti-thrombotic-16)
dobj(involve-13, properties-17)
case(omega-3_fatty_acids-19, of-18)
nmod:of(properties-17, omega-3_fatty_acids-19)

Future/JJ studies/NNS are/VBP needed/VBN to/TO further/RBR explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (JJ Future) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RBR further))
              (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN treatment))
                  (PP (IN of)
                    (NP (NN cardiovascular_disease))))))))))
    (. .)))

amod(studies-2, Future-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-7, to-5)
advmod(explore-7, further-6)
xcomp(needed-4, explore-7)
det(applications-11, the-8)
amod(applications-11, potential-9)
amod(applications-11, therapeutic-10)
dobj(explore-7, applications-11)
case(EPA-13, of-12)
nmod:of(applications-11, EPA-13)
cc(EPA-13, and-14)
nmod:of(applications-11, DHA-15)
conj:and(EPA-13, DHA-15)
case(prevention-18, in-16)
det(prevention-18, the-17)
nmod:in(explore-7, prevention-18)
cc(prevention-18, and-19)
nmod:in(explore-7, treatment-20)
conj:and(prevention-18, treatment-20)
case(cardiovascular_disease-22, of-21)
nmod:of(prevention-18, cardiovascular_disease-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN linked/VBN to/TO a/DT variety/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (NN variety))
              (PP (IN of)
                (NP (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(linked-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(linked-16, have-14)
auxpass(linked-16, been-15)
root(ROOT-0, linked-16)
case(variety-19, to-17)
det(variety-19, a-18)
nmod:to(linked-16, variety-19)
case(benefits-22, of-20)
compound(benefits-22, health-21)
nmod:of(variety-19, benefits-22)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN canthaxanthin/NN levels/NNS in/IN hypercanthaxanthinmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN canthaxanthin) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hypercanthaxanthinmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, canthaxanthin-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hypercanthaxanthinmic-16)
nmod:in(levels-14, patients-17)

Additionally/RB ,/, individuals/NNS who/WP consume/VBP foods/NNS rich/JJ in/IN EPA/NNP and/CC DHA/NNP have/VBP a/DT lower/JJR risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NNS individuals))
      (SBAR
        (WHNP (WP who))
        (S
          (VP (VBP consume)
            (S
              (NP (NNS foods))
              (ADJP (JJ rich)
                (PP (IN in)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA)))))))))
    (VP (VBP have)
      (NP
        (NP
          (NP (DT a) (JJR lower) (NN risk))
          (PP (IN of)
            (S
              (VP (VBG developing)
                (NP (NN coronary_heart_disease))))))
        (PRN (-LRB- -LRB-)
          (NP (NNP CHD))
          (-RRB- -RRB-))))
    (. .)))

advmod(have-12, Additionally-1)
nsubj(consume-5, individuals-3)
nsubj(have-12, individuals-3)
ref(individuals-3, who-4)
acl:relcl(individuals-3, consume-5)
nsubj(rich-7, foods-6)
xcomp(consume-5, rich-7)
case(EPA-9, in-8)
nmod:in(rich-7, EPA-9)
cc(EPA-9, and-10)
nmod:in(rich-7, DHA-11)
conj:and(EPA-9, DHA-11)
root(ROOT-0, have-12)
det(risk-15, a-13)
amod(risk-15, lower-14)
dobj(have-12, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

The/DT mechanisms/NNS behind/IN these/DT effects/NNS are/VBP still/RB being/VBG investigated/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN the/DT anti-inflammatory/JJ properties/NNS of/IN omega-3_fatty_acids/JJ may/MD play/VB a/DT role/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (PP (IN behind)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB still)
        (VP (VBG being)
          (VP (VBN investigated)))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ anti-inflammatory) (NNS properties))
                (PP (IN of)
                  (NP (JJ omega-3_fatty_acids))))
              (VP (MD may)
                (VP (VB play)
                  (NP (DT a) (NN role)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(investigated-9, mechanisms-2)
case(effects-5, behind-3)
det(effects-5, these-4)
nmod:behind(mechanisms-2, effects-5)
aux(investigated-9, are-6)
advmod(investigated-9, still-7)
auxpass(investigated-9, being-8)
root(ROOT-0, investigated-9)
cc(investigated-9, but-11)
nsubjpass(believed-14, it-12)
auxpass(believed-14, is-13)
conj:but(investigated-9, believed-14)
mark(play-22, that-15)
det(properties-18, the-16)
amod(properties-18, anti-inflammatory-17)
nsubj(play-22, properties-18)
case(omega-3_fatty_acids-20, of-19)
nmod:of(properties-18, omega-3_fatty_acids-20)
aux(play-22, may-21)
ccomp(believed-14, play-22)
det(role-24, a-23)
dobj(play-22, role-24)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN diet/NN or/CC supplementation/NN may/MD have/VB potential/JJ health/NN benefits/NNS for/IN those/DT at/IN risk/NN for/IN CHD/NNP or/CC with/IN high/JJ canthaxanthin/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (NN diet)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ potential) (NN health) (NNS benefits))
              (PP (IN for)
                (NP (DT those)))
              (PP
                (PP (IN at)
                  (NP
                    (NP (NN risk))
                    (PP (IN for)
                      (NP (NNP CHD)))))
                (CC or)
                (PP (IN with)
                  (NP (JJ high) (NN canthaxanthin) (NNS levels)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-17, that-4)
csubj(have-17, increasing-5)
csubj(have-17', increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(diet-13, through-12)
nmod:through(increasing-5, diet-13)
cc(diet-13, or-14)
nmod:through(increasing-5, supplementation-15)
conj:or(diet-13, supplementation-15)
aux(have-17, may-16)
ccomp(suggest-3, have-17)
ccomp(suggest-3, have-17')
conj:or(have-17, have-17')
amod(benefits-20, potential-18)
compound(benefits-20, health-19)
dobj(have-17, benefits-20)
case(those-22, for-21)
nmod:for(have-17, those-22)
case(risk-24, at-23)
nmod:at(have-17, risk-24)
case(CHD-26, for-25)
nmod:for(risk-24, CHD-26)
cc(have-17, or-27)
case(levels-31, with-28)
amod(levels-31, high-29)
compound(levels-31, canthaxanthin-30)
nmod:with(have-17', levels-31)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT relationship/NN between/IN omega-3_fatty_acids/JJ and/CC these/DT health/NN outcomes/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NN relationship))
                (PP (IN between)
                  (NP
                    (ADJP (JJ omega-3_fatty_acids)
                      (CC and)
                      (DT these))
                    (NN health) (NNS outcomes)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(relationship-9, the-8)
dobj(understand-7, relationship-9)
case(outcomes-15, between-10)
amod(outcomes-15, omega-3_fatty_acids-11)
cc(omega-3_fatty_acids-11, and-12)
conj:and(omega-3_fatty_acids-11, these-13)
amod(outcomes-15, these-13)
compound(outcomes-15, health-14)
nmod:between(relationship-9, outcomes-15)

Omega-3_fatty_acids/NNP ,/, including/VBG eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to_be/VB associated/VBN with/IN a/DT reduction/NN in/IN PF-03814735/NN levels/NNS in/IN hyperPF-03814735mic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (VP
          (VP (VBN eicosapentaenoic_acid))
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-))
          (CC and)
          (VP (VBN docosahexaenoic_acid)
            (PRN (-LRB- -LRB-)
              (NP (NNP DHA))
              (-RRB- -RRB-))))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (VB to_be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT a) (NN reduction))
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (NN PF-03814735) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hyperPF-03814735mic) (NNS patients))))
                        (, ,)
                        (CONJP (RB as) (RB well) (IN as))
                        (NP
                          (NP (DT a) (VBN decreased) (NN risk))
                          (PP (IN of)
                            (NP
                              (NP (VBG developing) (NN coronary_heart_disease))
                              (PRN (-LRB- -LRB-)
                                (NP (NNP CHD))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

nsubjpass(found-16, Omega-3_fatty_acids-1)
advcl(found-16, including-3)
dep(including-3, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(including-3, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
ccomp(found-16, to_be-17)
dep(to_be-17, associated-18)
case(reduction-21, with-19)
det(reduction-21, a-20)
nmod:with(associated-18, reduction-21)
case(levels-24, in-22)
compound(levels-24, PF-03814735-23)
nmod:in(reduction-21, levels-24)
case(patients-27, in-25)
amod(patients-27, hyperPF-03814735mic-26)
nmod:in(levels-24, patients-27)
cc(levels-24, as-29)
mwe(as-29, well-30)
mwe(as-29, as-31)
det(risk-34, a-32)
amod(risk-34, decreased-33)
nmod:in(reduction-21, risk-34)
conj:and(levels-24, risk-34)
case(coronary_heart_disease-37, of-35)
amod(coronary_heart_disease-37, developing-36)
nmod:of(risk-34, coronary_heart_disease-37)
appos(coronary_heart_disease-37, CHD-39)

These/DT findings/NNS suggest/VBP that/IN the/DT consumption/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN consumption))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-14, that-4)
det(consumption-6, the-5)
nsubj(strategy-14, consumption-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(consumption-6, omega-3_fatty_acids-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, a-12)
amod(strategy-14, promising-13)
ccomp(suggest-3, strategy-14)
case(prevention-17, for-15)
det(prevention-17, the-16)
nmod:for(strategy-14, prevention-17)
cc(prevention-17, and-18)
nmod:for(strategy-14, treatment-19)
conj:and(prevention-17, treatment-19)
case(CHD-21, of-20)
nmod:of(prevention-17, CHD-21)

Further/RB research/NN is/VBZ warranted/VBN to/TO elucidate/VB the/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (NNS mechanisms))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA))
                      (VP (VBD exert)
                        (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(warranted-4, Further-1)
nsubjpass(warranted-4, research-2)
auxpass(warranted-4, is-3)
root(ROOT-0, warranted-4)
mark(elucidate-6, to-5)
ccomp(warranted-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
mark(exert-14, by-9)
dobj(exert-14, which-10)
nsubj(exert-14, EPA-11)
cc(EPA-11, and-12)
conj:and(EPA-11, DHA-13)
nsubj(exert-14, DHA-13)
advcl(elucidate-6, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, cardioprotective-16)
dobj(exert-14, effects-17)
cc(elucidate-6, and-18)
mark(determine-20, to-19)
ccomp(warranted-4, determine-20)
conj:and(elucidate-6, determine-20)
amod(dosages-22, optimal-21)
dobj(determine-20, dosages-22)
case(populations-26, for-23)
amod(populations-26, different-24)
amod(populations-26, patient-25)
nmod:for(dosages-22, populations-26)

Additionally/RB ,/, studies/NNS investigating/VBG the/DT potential/JJ synergistic/JJ effects/NNS of/IN omega-3_fatty_acids/JJ with/IN other/JJ dietary/NN or/CC pharmacological/NN interventions/NNS may/MD provide/VB valuable/JJ insights/NNS into/IN the/DT development/NN of/IN effective/JJ CHD/NNP prevention/NN strategies/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NNS studies))
      (VP (VBG investigating)
        (NP
          (NP (DT the) (JJ potential) (JJ synergistic) (NNS effects))
          (PP (IN of)
            (NP
              (ADJP (JJ omega-3_fatty_acids)
                (PP (IN with)
                  (NP (JJ other) (NN dietary)
                    (CC or)
                    (NN pharmacological))))
              (NNS interventions))))))
    (VP (MD may)
      (VP (VB provide)
        (NP (JJ valuable) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP (JJ effective) (NNP CHD) (NN prevention) (NNS strategies)))))))
    (. .)))

advmod(provide-18, Additionally-1)
nsubj(provide-18, studies-3)
acl(studies-3, investigating-4)
det(effects-8, the-5)
amod(effects-8, potential-6)
amod(effects-8, synergistic-7)
dobj(investigating-4, effects-8)
case(interventions-16, of-9)
amod(interventions-16, omega-3_fatty_acids-10)
case(dietary-13, with-11)
amod(dietary-13, other-12)
nmod:with(omega-3_fatty_acids-10, dietary-13)
cc(dietary-13, or-14)
nmod:with(omega-3_fatty_acids-10, pharmacological-15)
conj:or(dietary-13, pharmacological-15)
nmod:of(effects-8, interventions-16)
aux(provide-18, may-17)
root(ROOT-0, provide-18)
amod(insights-20, valuable-19)
dobj(provide-18, insights-20)
case(development-23, into-21)
det(development-23, the-22)
nmod:into(provide-18, development-23)
case(strategies-28, of-24)
amod(strategies-28, effective-25)
compound(strategies-28, CHD-26)
compound(strategies-28, prevention-27)
nmod:of(development-23, strategies-28)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(associated-20, nutrients-16)
ref(nutrients-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(nutrients-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, numerous-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS may/MD also/RB play/VB a/DT role/NN in/IN decreasing/VBG polychlorinated_biphenyl/JJ -LRB-/-LRB- PCB/NNP -RRB-/-RRB- levels/NNS in/IN hyperPCBmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (MD may) (RB also)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG decreasing)
                        (NP (JJ polychlorinated_biphenyl)
                          (PRN (-LRB- -LRB-)
                            (NP (NNP PCB))
                            (-RRB- -RRB-))
                          (NNS levels))))))
                (PP (IN in)
                  (NP (JJ hyperPCBmic) (NNS patients)))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(play-10, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubj(play-10, long-chain_fatty_acids-7)
aux(play-10, may-8)
advmod(play-10, also-9)
ccomp(shown-4, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
mark(decreasing-14, in-13)
acl(role-12, decreasing-14)
amod(levels-19, polychlorinated_biphenyl-15)
appos(levels-19, PCB-17)
dobj(decreasing-14, levels-19)
case(patients-22, in-20)
amod(patients-22, hyperPCBmic-21)
nmod:in(play-10, patients-22)

PCBs/NNS are/VBP persistent/JJ organic/JJ pollutants/NNS that/WDT have/VBP been/VBN linked/VBN to/TO numerous/JJ adverse/JJ health/NN effects/NNS ,/, including/VBG an/DT increased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS PCBs))
    (VP (VBP are)
      (NP
        (NP
          (NP (JJ persistent) (JJ organic) (NNS pollutants))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP have)
                (VP (VBN been)
                  (VP (VBN linked)
                    (PP (TO to)
                      (NP
                        (NP (JJ numerous) (JJ adverse) (NN health) (NNS effects))
                        (, ,)
                        (VP (VBG including)
                          (NP
                            (NP (DT an) (VBN increased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease)))))))))))))))
        (PRN (-LRB- -LRB-)
          (NP (NNP CHD))
          (-RRB- -RRB-))))
    (. .)))

nsubj(pollutants-5, PCBs-1)
cop(pollutants-5, are-2)
amod(pollutants-5, persistent-3)
amod(pollutants-5, organic-4)
root(ROOT-0, pollutants-5)
nsubjpass(linked-9, pollutants-5)
ref(pollutants-5, that-6)
aux(linked-9, have-7)
auxpass(linked-9, been-8)
acl:relcl(pollutants-5, linked-9)
case(effects-14, to-10)
amod(effects-14, numerous-11)
amod(effects-14, adverse-12)
compound(effects-14, health-13)
nmod:to(linked-9, effects-14)
acl(effects-14, including-16)
det(risk-19, an-17)
amod(risk-19, increased-18)
dobj(including-16, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(pollutants-5, CHD-24)

In/IN addition/NN to/TO reducing/VBG PCB/NNP levels/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN shown/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG CHD/NNP through/IN their/PRP$ anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (S
            (VP (VBG reducing)
              (NP (NNP PCB) (NNS levels)))))))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NNP CHD))
                        (PP (IN through)
                          (NP (PRP$ their)
                            (ADJP (JJ anti-inflammatory)
                              (CC and)
                              (JJ anti-thrombotic))
                            (NNS properties)))))))))))))
    (. .)))

mark(reducing-4, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
acl(shown-14, reducing-4)
compound(levels-6, PCB-5)
dobj(reducing-4, levels-6)
nsubjpass(shown-14, EPA-8)
nsubj:xsubj(decrease-16, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubjpass(shown-14, DHA-10)
nsubj:xsubj(decrease-16, DHA-10)
aux(shown-14, have-11)
advmod(shown-14, also-12)
auxpass(shown-14, been-13)
root(ROOT-0, shown-14)
mark(decrease-16, to-15)
xcomp(shown-14, decrease-16)
det(risk-18, the-17)
dobj(decrease-16, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, CHD-21)
case(properties-27, through-22)
nmod:poss(properties-27, their-23)
amod(properties-27, anti-inflammatory-24)
cc(anti-inflammatory-24, and-25)
conj:and(anti-inflammatory-24, anti-thrombotic-26)
amod(properties-27, anti-thrombotic-26)
nmod:through(developing-20, properties-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG both/DT PCB/NNP levels/NNS and/CC the/DT risk/NN of/IN CHD/NNP in/IN susceptible/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT both) (NNP PCB) (NNS levels))
                        (CC and)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (PP (IN in)
                        (NP (JJ susceptible) (NNS individuals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-16, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(levels-21, both-19)
compound(levels-21, PCB-20)
dobj(reducing-18, levels-21)
cc(levels-21, and-22)
det(risk-24, the-23)
dobj(reducing-18, risk-24)
conj:and(levels-21, risk-24)
case(CHD-26, of-25)
nmod:of(risk-24, CHD-26)
case(individuals-29, in-27)
amod(individuals-29, susceptible-28)
nmod:in(reducing-18, individuals-29)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN specific/JJ transcription/JJ factors/NNS and/CC regulatory/JJ proteins/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ specific) (JJ transcription) (NNS factors))
                    (CC and)
                    (NP (JJ regulatory) (NNS proteins))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(factors-14, of-11)
amod(factors-14, specific-12)
amod(factors-14, transcription-13)
nmod:of(activation-10, factors-14)
cc(factors-14, and-15)
amod(proteins-17, regulatory-16)
nmod:of(activation-10, proteins-17)
conj:and(factors-14, proteins-17)

Among/IN these/DT ,/, the/DT v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog/JJ protein/NN -LRB-/-LRB- MYC/NNP -RRB-/-RRB- has_been/VBP shown/VBN to/TO play/VB a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN muscle/NN development/NN and/CC regeneration/NN ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these)))
    (, ,)
    (NP
      (NP (DT the) (JJ v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog) (NN protein))
      (PRN (-LRB- -LRB-)
        (NP (NNP MYC))
        (-RRB- -RRB-)))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NN muscle) (NN development)
                        (CC and)
                        (NN regeneration)))))))))))
    (. .)))

case(these-2, Among-1)
nmod:among(has_been-10, these-2)
det(protein-6, the-4)
amod(protein-6, v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog-5)
nsubj(has_been-10, protein-6)
appos(protein-6, MYC-8)
root(ROOT-0, has_been-10)
dep(has_been-10, shown-11)
mark(play-13, to-12)
xcomp(shown-11, play-13)
det(role-16, a-14)
amod(role-16, crucial-15)
dobj(play-13, role-16)
case(regulation-19, in-17)
det(regulation-19, the-18)
nmod:in(role-16, regulation-19)
case(development-22, of-20)
compound(development-22, muscle-21)
nmod:of(regulation-19, development-22)
cc(development-22, and-23)
nmod:of(regulation-19, regeneration-24)
conj:and(development-22, regeneration-24)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN didymin/JJ on/IN MYC/NNP expression/NN and/CC stability/NN in/IN C2C12/CD cells/NNS cultured/VBN in/IN differentiation-promoting/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (ADJP (JJ didymin)
              (PP (IN on)
                (NP (NNP MYC))))
            (NN expression)
            (CC and)
            (NN stability))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (PP (IN in)
              (NP (JJ differentiation-promoting) (NNS conditions)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(expression-13, of-9)
amod(expression-13, didymin-10)
case(MYC-12, on-11)
nmod:on(didymin-10, MYC-12)
nmod:of(effects-8, expression-13)
cc(expression-13, and-14)
nmod:of(effects-8, stability-15)
conj:and(expression-13, stability-15)
case(cells-18, in-16)
nummod(cells-18, C2C12-17)
nmod:in(investigated-6, cells-18)
acl(cells-18, cultured-19)
case(conditions-22, in-20)
amod(conditions-22, differentiation-promoting-21)
nmod:in(cultured-19, conditions-22)

Our/PRP$ results/NNS showed/VBD that/IN didymin/JJ treatment/NN up-regulated/VBD MYC/NNP protein/NN levels/NNS in_a/JJ time-dependent/JJ manner/NN ,/, with/IN a/DT significant/JJ increase/NN observed/VBN after/IN 48/CD hours/NNS of/IN treatment/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ didymin) (NN treatment))
          (VP (VBD up-regulated)
            (NP (NNP MYC) (NN protein) (NNS levels))
            (NP (JJ in_a) (JJ time-dependent) (NN manner))
            (, ,)
            (PP (IN with)
              (NP
                (NP (DT a) (JJ significant) (NN increase))
                (VP (VBN observed)
                  (PP (IN after)
                    (NP
                      (NP (CD 48) (NNS hours))
                      (PP (IN of)
                        (NP (NN treatment))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(up-regulated-7, that-4)
amod(treatment-6, didymin-5)
nsubj(up-regulated-7, treatment-6)
ccomp(showed-3, up-regulated-7)
compound(levels-10, MYC-8)
compound(levels-10, protein-9)
iobj(up-regulated-7, levels-10)
amod(manner-13, in_a-11)
amod(manner-13, time-dependent-12)
dobj(up-regulated-7, manner-13)
case(increase-18, with-15)
det(increase-18, a-16)
amod(increase-18, significant-17)
nmod:with(up-regulated-7, increase-18)
acl(increase-18, observed-19)
case(hours-22, after-20)
nummod(hours-22, 48-21)
nmod:after(observed-19, hours-22)
case(treatment-24, of-23)
nmod:of(hours-22, treatment-24)

Furthermore/RB ,/, didymin/JJ treatment/NN prolonged/VBN MYC/VBD half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ,/, suggesting/VBG that/IN it/PRP may/MD act/VB by/IN stabilizing/VBG MYC/NNP protein/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (JJ didymin) (NN treatment))
      (VP (VBN prolonged)))
    (VP (VBD MYC)
      (NP (NN half-life))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (MD may)
                (VP (VB act)
                  (PP (IN by)
                    (S
                      (VP (VBG stabilizing)
                        (NP (NNP MYC) (NN protein))))))))))))
    (. .)))

advmod(MYC-6, Furthermore-1)
amod(treatment-4, didymin-3)
nsubj(MYC-6, treatment-4)
acl(treatment-4, prolonged-5)
root(ROOT-0, MYC-6)
dobj(MYC-6, half-life-7)
case(hours-12, from-8)
compound(18-11, 10-9)
dep(18-11, to-10)
nummod(hours-12, 18-11)
nmod:from(MYC-6, hours-12)
advcl(MYC-6, suggesting-14)
mark(act-18, that-15)
nsubj(act-18, it-16)
aux(act-18, may-17)
ccomp(suggesting-14, act-18)
mark(stabilizing-20, by-19)
advcl(act-18, stabilizing-20)
compound(protein-22, MYC-21)
dobj(stabilizing-20, protein-22)

These/DT findings/NNS suggest/VBP that/IN didymin/NN may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN promoting/VBG skeletal_muscle/JJ differentiation_and/JJ regeneration/NN by/IN modulating/VBG MYC/NNP expression/NN and/CC stability/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN didymin))
          (VP (MD may)
            (VP (VB have)
              (NP
                (ADJP (JJ potential)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN agent))
                      (PP (IN for)
                        (S
                          (VP (VBG promoting)
                            (NP (JJ skeletal_muscle) (JJ differentiation_and) (NN regeneration))
                            (PP (IN by)
                              (S
                                (VP (VBG modulating)
                                  (NP (NNP MYC)))))))))))
                (NN expression)
                (CC and)
                (NN stability)))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, didymin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(expression-21, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(potential-8, agent-12)
mark(promoting-14, for-13)
acl(agent-12, promoting-14)
amod(regeneration-17, skeletal_muscle-15)
amod(regeneration-17, differentiation_and-16)
dobj(promoting-14, regeneration-17)
mark(modulating-19, by-18)
advcl(promoting-14, modulating-19)
dobj(modulating-19, MYC-20)
dobj(have-7, expression-21)
cc(expression-21, and-22)
dobj(have-7, stability-23)
conj:and(expression-21, stability-23)

The/DT use/NN of/IN penthiobarbital/JJ has_been/NN investigated/VBD for/IN the/DT treatment/NN of/IN various/JJ medical/JJ conditions/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (JJ penthiobarbital) (NN has_been))))
    (VP (VBD investigated)
      (PP (IN for)
        (NP
          (NP (DT the) (NN treatment))
          (PP (IN of)
            (NP (JJ various) (JJ medical) (NNS conditions))))))
    (. .)))

det(use-2, The-1)
nsubj(investigated-6, use-2)
case(has_been-5, of-3)
amod(has_been-5, penthiobarbital-4)
nmod:of(use-2, has_been-5)
root(ROOT-0, investigated-6)
case(treatment-9, for-7)
det(treatment-9, the-8)
nmod:for(investigated-6, treatment-9)
case(conditions-13, of-10)
amod(conditions-13, various-11)
amod(conditions-13, medical-12)
nmod:of(treatment-9, conditions-13)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN penthiobarbital/NN on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN penthiobarbital))
          (PP (IN on)
            (NP
              (NP (NNS bronchospasms))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD were)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-17, study-3)
det(effects-6, the-5)
nsubjpass(evaluated-17, effects-6)
case(penthiobarbital-8, of-7)
nmod:of(effects-6, penthiobarbital-8)
case(bronchospasms-10, on-9)
nmod:on(penthiobarbital-8, bronchospasms-10)
nmod:on(penthiobarbital-8, photophobia-12)
conj:and(bronchospasms-10, photophobia-12)
cc(bronchospasms-10, and-14)
nmod:on(penthiobarbital-8, phonophobia-15)
conj:and(bronchospasms-10, phonophobia-15)
auxpass(evaluated-17, were-16)
root(ROOT-0, evaluated-17)

Results/NNS showed/VBD that/IN at/IN 2/CD h/VBP after/IN dosing/VBG ,/, penthiobarbital/JJ significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (QP (IN at) (CD 2)))
          (VP (VBP h)
            (ADJP
              (ADJP
                (ADJP
                  (PP (IN after)
                    (S
                      (VP (VBG dosing))))
                  (, ,) (JJ penthiobarbital))
                (SBAR
                  (S
                    (ADVP (RB significantly))
                    (VP (VBD reduced)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNS bronchospasms))))
                      (PP (IN by)
                        (NP (CD 14) (NN %)))))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))
                (-RRB- -RRB-))
              (, ,)
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP (CD 17) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 12-22) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-))
              (, ,)
              (CC and)
              (ADJP (JJ phonophobia)
                (PP (IN by)
                  (NP (CD 14) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 17-20) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-)))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(h-6, that-3)
advmod(2-5, at-4)
nsubj(h-6, 2-5)
ccomp(showed-2, h-6)
mark(dosing-8, after-7)
advcl(penthiobarbital-10, dosing-8)
xcomp(h-6, penthiobarbital-10)
advmod(reduced-12, significantly-11)
ccomp(penthiobarbital-10, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(bronchospasms-16, of-15)
nmod:of(risk-14, bronchospasms-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
nsubj(CI-23, %-22)
dep(penthiobarbital-10, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(h-6, photophobia-32)
conj:and(penthiobarbital-10, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
nsubj(CI-39, %-38)
dep(penthiobarbital-10, CI-39)
nummod(%-41, 12-22-40)
dobj(CI-39, %-41)
nsubj(<-44, P-43)
dep(CI-39, <-44)
dobj(<-44, 0.0001-45)
cc(penthiobarbital-10, and-48)
xcomp(h-6, phonophobia-49)
conj:and(penthiobarbital-10, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
nsubj(CI-56, %-55)
dep(penthiobarbital-10, CI-56)
nummod(%-58, 17-20-57)
dobj(CI-56, %-58)
nsubj(<-61, P-60)
dep(CI-56, <-61)
dobj(<-61, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN penthiobarbital/NN may/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT management/NN of/IN respiratory/NN and/CC sensory_disorders/NNS associated/VBN with/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN penthiobarbital))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP
                      (NP (DT the) (NN management))
                      (PP (IN of)
                        (NP (NN respiratory))))
                    (CC and)
                    (NP
                      (NP (NNS sensory_disorders))
                      (VP (VBN associated)
                        (PP (IN with)
                          (NP
                            (NP (NNS bronchospasms))
                            (, ,)
                            (NP (NN photophobia))
                            (, ,)
                            (CC and)
                            (NP (NN phonophobia))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, penthiobarbital-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(management-13, in-11)
det(management-13, the-12)
nmod:in(applications-10, management-13)
case(respiratory-15, of-14)
nmod:of(management-13, respiratory-15)
cc(management-13, and-16)
nmod:in(applications-10, sensory_disorders-17)
conj:and(management-13, sensory_disorders-17)
acl(sensory_disorders-17, associated-18)
case(bronchospasms-20, with-19)
nmod:with(associated-18, bronchospasms-20)
nmod:with(associated-18, photophobia-22)
conj:and(bronchospasms-20, photophobia-22)
cc(bronchospasms-20, and-24)
nmod:with(associated-18, phonophobia-25)
conj:and(bronchospasms-20, phonophobia-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN penthiobarbital/NN in/IN these/DT patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP
                      (NP (NN penthiobarbital))
                      (PP (IN in)
                        (NP (DT these) (JJ patient) (NNS populations))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(investigate-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(investigate-6, profile-12)
conj:and(effects-9, profile-12)
case(penthiobarbital-14, of-13)
nmod:of(profile-12, penthiobarbital-14)
case(populations-18, in-15)
det(populations-18, these-16)
amod(populations-18, patient-17)
nmod:in(penthiobarbital-14, populations-18)

The/DT development/NN of/IN acute_monocytic_leukemia/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN are/VBP serious/JJ medical/JJ conditions/NNS that/WDT require/VBP effective/JJ treatments/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN development))
      (PP (IN of)
        (NP
          (NP (NNP acute_monocytic_leukemia))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBP are)
      (NP
        (NP (JJ serious) (JJ medical) (NNS conditions))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP require)
              (NP (JJ effective) (NNS treatments)))))))
    (. .)))

det(development-2, The-1)
nsubj(conditions-13, development-2)
case(acute_monocytic_leukemia-4, of-3)
nmod:of(development-2, acute_monocytic_leukemia-4)
nmod:of(development-2, photophobia-6)
conj:and(acute_monocytic_leukemia-4, photophobia-6)
cc(acute_monocytic_leukemia-4, and-8)
nmod:of(development-2, phonophobia-9)
conj:and(acute_monocytic_leukemia-4, phonophobia-9)
cop(conditions-13, are-10)
amod(conditions-13, serious-11)
amod(conditions-13, medical-12)
root(ROOT-0, conditions-13)
nsubj(require-15, conditions-13)
ref(conditions-13, that-14)
acl:relcl(conditions-13, require-15)
amod(treatments-17, effective-16)
dobj(require-15, treatments-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT efficacy/NN of/IN NMS-P937/NN in/IN reducing/VBG the/DT risk/NN of/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN efficacy))
        (PP (IN of)
          (NP (NN NMS-P937))))
      (PP (IN in)
        (S
          (VP (VBG reducing)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (DT these) (NNS conditions))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(efficacy-8, the-7)
dobj(investigated-6, efficacy-8)
case(NMS-P937-10, of-9)
nmod:of(efficacy-8, NMS-P937-10)
mark(reducing-12, in-11)
advcl(investigated-6, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(conditions-17, of-15)
det(conditions-17, these-16)
nmod:of(risk-14, conditions-17)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, NMS-P937/NNP was/VBD found/VBD to/TO significantly/RB reduce/VB the/DT risk/NN of/IN acute_monocytic_leukemia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP NMS-P937))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NN acute_monocytic_leukemia))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(hours-2, At_2-1)
dep(found-8, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubjpass(found-8, NMS-P937-6)
nsubj:xsubj(reduce-11, NMS-P937-6)
nsubj(photophobia-31, NMS-P937-6)
nsubj(phonophobia-48, NMS-P937-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(acute_monocytic_leukemia-15, of-14)
nmod:of(risk-13, acute_monocytic_leukemia-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-8, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-8, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-8, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-8, and-47)
conj:and(found-8, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-8, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT results/NNS suggest/VBP that/IN NMS-P937/NNP has/VBZ potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN these/DT conditions/NNS and/CC warrants/NNS further/JJ investigation/NN in/IN clinical/JJ trials/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP NMS-P937))
          (VP (VBZ has)
            (NP
              (NP
                (ADJP (JJ potential)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN agent))
                      (PP (IN for)
                        (NP (DT these) (NNS conditions)
                          (CC and)
                          (NNS warrants))))))
                (JJ further) (NN investigation))
              (PP (IN in)
                (NP (JJ clinical) (NNS trials))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(has-6, that-4)
nsubj(has-6, NMS-P937-5)
ccomp(suggest-3, has-6)
amod(investigation-18, potential-7)
case(agent-11, as-8)
det(agent-11, a-9)
amod(agent-11, therapeutic-10)
nmod:as(potential-7, agent-11)
case(conditions-14, for-12)
det(conditions-14, these-13)
nmod:for(agent-11, conditions-14)
cc(conditions-14, and-15)
nmod:for(agent-11, warrants-16)
conj:and(conditions-14, warrants-16)
amod(investigation-18, further-17)
dobj(has-6, investigation-18)
case(trials-21, in-19)
amod(trials-21, clinical-20)
nmod:in(investigation-18, trials-21)

The/DT findings/NNS may/MD have/VB important/JJ implications/NNS for/IN the/DT management/NN and/CC treatment/NN of/IN patients/NNS with/IN acute_monocytic_leukemia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS findings))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN management)
                (CC and)
                (NN treatment))
              (PP (IN of)
                (NP (NNS patients))))))
        (PP (IN with)
          (NP
            (NP (NN acute_monocytic_leukemia))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP (NN phonophobia))))))
    (. .)))

det(findings-2, The-1)
nsubj(have-4, findings-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
amod(implications-6, important-5)
dobj(have-4, implications-6)
case(management-9, for-7)
det(management-9, the-8)
nmod:for(implications-6, management-9)
cc(management-9, and-10)
nmod:for(implications-6, treatment-11)
conj:and(management-9, treatment-11)
case(patients-13, of-12)
nmod:of(management-9, patients-13)
case(acute_monocytic_leukemia-15, with-14)
nmod:with(have-4, acute_monocytic_leukemia-15)
nmod:with(have-4, photophobia-17)
conj:and(acute_monocytic_leukemia-15, photophobia-17)
cc(acute_monocytic_leukemia-15, and-19)
nmod:with(have-4, phonophobia-20)
conj:and(acute_monocytic_leukemia-15, phonophobia-20)

The/DT serotonin/NN 2B/CD receptor/NN -LRB-/-LRB- 5-HT2B/CD -RRB-/-RRB- is/VBZ known/VBN to/TO play/VB a/DT role/NN in/IN the/DT regulation/NN of/IN intestinal/JJ absorption/NN of/IN orally/RB administered/VBN drugs/NNS ,/, including/VBG metformin/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN serotonin) (CD 2B) (NN receptor))
      (PRN (-LRB- -LRB-)
        (NP (CD 5-HT2B))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP (JJ intestinal) (NN absorption))
                        (PP (IN of)
                          (NP
                            (NP
                              (ADJP (RB orally) (VBN administered))
                              (NNS drugs))
                            (, ,)
                            (VP (VBG including)
                              (NP (NN metformin)))))))))))))))
    (. .)))

det(receptor-4, The-1)
compound(receptor-4, serotonin-2)
nummod(receptor-4, 2B-3)
nsubjpass(known-9, receptor-4)
nsubj:xsubj(play-11, receptor-4)
appos(receptor-4, 5-HT2B-6)
auxpass(known-9, is-8)
root(ROOT-0, known-9)
mark(play-11, to-10)
xcomp(known-9, play-11)
det(role-13, a-12)
dobj(play-11, role-13)
case(regulation-16, in-14)
det(regulation-16, the-15)
nmod:in(role-13, regulation-16)
case(absorption-19, of-17)
amod(absorption-19, intestinal-18)
nmod:of(regulation-16, absorption-19)
case(drugs-23, of-20)
advmod(administered-22, orally-21)
amod(drugs-23, administered-22)
nmod:of(absorption-19, drugs-23)
acl(drugs-23, including-25)
dobj(including-25, metformin-26)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN SB_200646/NNP ,/, a/DT selective/JJ 5-HT2B/JJ antagonist/NN ,/, on/IN the/DT transport/NN of/IN metformin/NN across/IN Caco-2/JJ cell/NN monolayers/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NNP SB_200646))
          (, ,)
          (NP (DT a) (JJ selective) (JJ 5-HT2B) (NN antagonist))
          (, ,)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN transport))
          (PP (IN of)
            (NP
              (NP (NN metformin))
              (PP (IN across)
                (NP (JJ Caco-2) (NN cell) (NNS monolayers))))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-25, study-3)
det(effect-6, the-5)
nsubjpass(investigated-25, effect-6)
case(SB_200646-8, of-7)
nmod:of(effect-6, SB_200646-8)
det(antagonist-13, a-10)
amod(antagonist-13, selective-11)
amod(antagonist-13, 5-HT2B-12)
appos(SB_200646-8, antagonist-13)
case(transport-17, on-15)
det(transport-17, the-16)
nmod:on(effect-6, transport-17)
case(metformin-19, of-18)
nmod:of(transport-17, metformin-19)
case(monolayers-23, across-20)
amod(monolayers-23, Caco-2-21)
compound(monolayers-23, cell-22)
nmod:across(metformin-19, monolayers-23)
auxpass(investigated-25, was-24)
root(ROOT-0, investigated-25)

Results/NNS showed/VBD that/IN at_a/NN concentration/NN of_1/VBD microM/NN ,/, SB_200646/NNP moderately/RB decreased/VBD the/DT basolateral-to-apical/JJ transport/NN of/IN -LSB-/NNP -LRB-/-LRB- 14/CD -RRB-/-RRB- C/$ -RSB-/CD metformin/CD and/CC significantly/RB increased/VBD its/PRP$ intracellular/NN accumulation/NN from/IN the/DT basolateral/JJ side/NN ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (NN at_a) (NN concentration))
            (VP (VBD of_1)
              (NP (NN microM))
              (, ,)
              (SBAR
                (S
                  (NP (NNP SB_200646))
                  (ADVP (RB moderately))
                  (VP (VBD decreased)
                    (NP
                      (NP (DT the) (JJ basolateral-to-apical) (NN transport))
                      (PP (IN of)
                        (NP
                          (NP (NNP -LSB-))
                          (-LRB- -LRB-)
                          (NP (CD 14))
                          (-RRB- -RRB-)
                          (ADJP
                            (QP ($ C) (CD -RSB-) (CD metformin)))))))))))))
      (CC and)
      (VP
        (ADVP (RB significantly))
        (VBD increased)
        (NP (PRP$ its) (NN intracellular) (NN accumulation))
        (PP (IN from)
          (NP (DT the) (JJ basolateral) (NN side)))))
    (. .)))

nsubj(showed-2, Results-1)
nsubj(increased-25, Results-1)
root(ROOT-0, showed-2)
mark(of_1-6, that-3)
compound(concentration-5, at_a-4)
nsubj(of_1-6, concentration-5)
ccomp(showed-2, of_1-6)
dobj(of_1-6, microM-7)
nsubj(decreased-11, SB_200646-9)
advmod(decreased-11, moderately-10)
dep(of_1-6, decreased-11)
det(transport-14, the-12)
amod(transport-14, basolateral-to-apical-13)
dobj(decreased-11, transport-14)
case(-LSB--16, of-15)
nmod:of(transport-14, -LSB--16)
dep(-LSB--16, 14-18)
amod(-LSB--16, C-20)
compound(metformin-22, -RSB--21)
nummod(C-20, metformin-22)
cc(showed-2, and-23)
advmod(increased-25, significantly-24)
conj:and(showed-2, increased-25)
nmod:poss(accumulation-28, its-26)
compound(accumulation-28, intracellular-27)
dobj(increased-25, accumulation-28)
case(side-32, from-29)
det(side-32, the-30)
amod(side-32, basolateral-31)
nmod:from(increased-25, side-32)

These/DT findings/NNS suggest/VBP that/IN SB_200646/NN at/IN low/JJ concentrations/NNS inhibits/VBZ apical/JJ 5-HT2B/CD rather/RB than/IN basolateral/JJ hOCT2/NNS ,/, which/WDT may/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN drugs/NNS targeting/VBG intestinal/JJ drug/NN absorption/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN SB_200646))
            (PP (IN at)
              (NP (JJ low) (NNS concentrations))))
          (VP (VBZ inhibits)
            (ADJP (JJ apical)
              (NP-TMP (CD 5-HT2B))
              (PP (RB rather) (IN than)
                (NP
                  (NP (JJ basolateral) (NNS hOCT2))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB have)
                          (NP
                            (NP (JJ important) (NNS implications))
                            (PP (IN for)
                              (NP
                                (NP (DT the) (NN development))
                                (PP (IN of)
                                  (NP (NNS drugs)))))
                            (VP (VBG targeting)
                              (NP (JJ intestinal) (NN drug) (NN absorption)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(inhibits-9, that-4)
nsubj(inhibits-9, SB_200646-5)
case(concentrations-8, at-6)
amod(concentrations-8, low-7)
nmod:at(SB_200646-5, concentrations-8)
ccomp(suggest-3, inhibits-9)
xcomp(inhibits-9, apical-10)
nmod:tmod(apical-10, 5-HT2B-11)
case(hOCT2-15, rather-12)
mwe(rather-12, than-13)
amod(hOCT2-15, basolateral-14)
nmod:rather_than(apical-10, hOCT2-15)
nsubj(have-19, hOCT2-15)
ref(hOCT2-15, which-17)
aux(have-19, may-18)
acl:relcl(hOCT2-15, have-19)
amod(implications-21, important-20)
dobj(have-19, implications-21)
case(development-24, for-22)
det(development-24, the-23)
nmod:for(implications-21, development-24)
case(drugs-26, of-25)
nmod:of(development-24, drugs-26)
acl(implications-21, targeting-27)
amod(absorption-30, intestinal-28)
compound(absorption-30, drug-29)
dobj(targeting-27, absorption-30)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanism/NN by/IN which/WDT SB_200646/NNP affects/VBZ metformin/NN transport/NN and/CC to/TO determine/VB its/PRP$ potential/NN as/IN a/DT therapeutic/JJ agent/NN for/IN improving/VBG drug/NN delivery/NN via/IN oral/JJ administration/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP (DT the) (NN mechanism))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (NNP SB_200646))
                      (VP (VBZ affects)
                        (NP (NN metformin) (NN transport))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (PRP$ its) (NN potential))
                (PP (IN as)
                  (NP
                    (NP (DT a) (JJ therapeutic) (NN agent))
                    (PP (IN for)
                      (S
                        (VP (VBG improving)
                          (NP
                            (NP (NN drug) (NN delivery))
                            (PP (IN via)
                              (NP (JJ oral) (NN administration)))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanism-9, the-8)
dobj(elucidate-7, mechanism-9)
mark(affects-13, by-10)
dobj(affects-13, which-11)
nsubj(affects-13, SB_200646-12)
advcl(elucidate-7, affects-13)
compound(transport-15, metformin-14)
dobj(affects-13, transport-15)
cc(elucidate-7, and-16)
mark(determine-18, to-17)
ccomp(needed-4, determine-18)
conj:and(elucidate-7, determine-18)
nmod:poss(potential-20, its-19)
dobj(determine-18, potential-20)
case(agent-24, as-21)
det(agent-24, a-22)
amod(agent-24, therapeutic-23)
nmod:as(determine-18, agent-24)
mark(improving-26, for-25)
acl(agent-24, improving-26)
compound(delivery-28, drug-27)
dobj(improving-26, delivery-28)
case(administration-31, via-29)
amod(administration-31, oral-30)
nmod:via(delivery-28, administration-31)

Abstract/NNP :/: Peptidylglycine_alpha-amidating_monooxygenase/JJ -LRB-/-LRB- PAM/NNP -RRB-/-RRB- is_a/NN multifunctional/NN enzyme/VBD that/IN catalyzes/VBZ the/DT final/JJ step/NN in/IN the/DT biosynthesis/NNS of/IN amidated/JJ peptides/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Abstract))
      (: :)
      (NP (JJ Peptidylglycine_alpha-amidating_monooxygenase)
        (PRN (-LRB- -LRB-)
          (NP (NNP PAM))
          (-RRB- -RRB-))
        (NN is_a) (NN multifunctional)))
    (VP (VBD enzyme)
      (SBAR (IN that)
        (S
          (VP (VBZ catalyzes)
            (NP
              (NP (DT the) (JJ final) (NN step))
              (PP (IN in)
                (NP
                  (NP (DT the) (NNS biosynthesis))
                  (PP (IN of)
                    (NP (JJ amidated) (NNS peptides))))))))))
    (. .)))

nsubj(enzyme-9, Abstract-1)
amod(multifunctional-8, Peptidylglycine_alpha-amidating_monooxygenase-3)
appos(multifunctional-8, PAM-5)
compound(multifunctional-8, is_a-7)
dep(Abstract-1, multifunctional-8)
root(ROOT-0, enzyme-9)
mark(catalyzes-11, that-10)
ccomp(enzyme-9, catalyzes-11)
det(step-14, the-12)
amod(step-14, final-13)
dobj(catalyzes-11, step-14)
case(biosynthesis-17, in-15)
det(biosynthesis-17, the-16)
nmod:in(step-14, biosynthesis-17)
case(peptides-20, of-18)
amod(peptides-20, amidated-19)
nmod:of(biosynthesis-17, peptides-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN PAM/NNP exists/VBZ in/IN two/CD forms/NNS ,/, PAM/NNP and/CC PAM-G/NNP ,/, which/WDT differ/VBP in/IN their/PRP$ molecular/JJ weight/NN and/CC immunoreactivity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP PAM))
            (VP (VBZ exists)
              (PP (IN in)
                (NP
                  (NP (CD two) (NNS forms))
                  (, ,)
                  (NP
                    (NP (NNP PAM)
                      (CC and)
                      (NNP PAM-G))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP differ)
                          (PP (IN in)
                            (NP (PRP$ their) (JJ molecular) (NN weight)
                              (CC and)
                              (NN immunoreactivity))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(exists-7, that-5)
nsubj(exists-7, PAM-6)
ccomp(shown-4, exists-7)
case(forms-10, in-8)
nummod(forms-10, two-9)
nmod:in(exists-7, forms-10)
appos(forms-10, PAM-12)
nsubj(differ-17, PAM-12)
cc(PAM-12, and-13)
appos(forms-10, PAM-G-14)
conj:and(PAM-12, PAM-G-14)
nsubj(differ-17, PAM-G-14)
ref(PAM-12, which-16)
acl:relcl(PAM-12, differ-17)
case(weight-21, in-18)
nmod:poss(weight-21, their-19)
amod(weight-21, molecular-20)
nmod:in(differ-17, weight-21)
cc(weight-21, and-22)
nmod:in(differ-17, immunoreactivity-23)
conj:and(weight-21, immunoreactivity-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT regulation/NN of/IN PAM/NNP and/CC PAM-G/NNP secretion/VBN by/IN carbachol/JJ and_4-phenyl-3-butenoic/JJ acid/NN -LRB-/-LRB- PBA/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP (DT the) (NN regulation))
          (PP (IN of)
            (NP (NNP PAM)
              (CC and)
              (NNP PAM-G))))
        (VP (VBN secretion)
          (PP (IN by)
            (NP (JJ carbachol) (JJ and_4-phenyl-3-butenoic) (NN acid))))
        (PRN (-LRB- -LRB-)
          (NP (NNP PBA))
          (-RRB- -RRB-))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(regulation-8, the-7)
dobj(investigated-6, regulation-8)
case(PAM-10, of-9)
nmod:of(regulation-8, PAM-10)
cc(PAM-10, and-11)
nmod:of(regulation-8, PAM-G-12)
conj:and(PAM-10, PAM-G-12)
acl(regulation-8, secretion-13)
case(acid-17, by-14)
amod(acid-17, carbachol-15)
amod(acid-17, and_4-phenyl-3-butenoic-16)
nmod:by(secretion-13, acid-17)
appos(regulation-8, PBA-19)

Our/PRP$ results/NNS demonstrate/VBP that/IN PAM-G/NNP is/VBZ cosecreted/VBN with/IN PAM/NNP in/IN response/NN to/TO carbachol/NNP and/CC PBA/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP (NNP PAM-G))
          (VP (VBZ is)
            (VP (VBN cosecreted)
              (PP (IN with)
                (NP (NNP PAM)))
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (NNP carbachol)
                      (CC and)
                      (NNP PBA))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(cosecreted-7, that-4)
nsubjpass(cosecreted-7, PAM-G-5)
auxpass(cosecreted-7, is-6)
ccomp(demonstrate-3, cosecreted-7)
case(PAM-9, with-8)
nmod:with(cosecreted-7, PAM-9)
case(response-11, in-10)
nmod:in(cosecreted-7, response-11)
case(carbachol-13, to-12)
nmod:to(response-11, carbachol-13)
cc(carbachol-13, and-14)
nmod:to(response-11, PBA-15)
conj:and(carbachol-13, PBA-15)

Furthermore/RB ,/, the/DT stimulation/NN of/IN PAM/NNP and/CC PAM-G/NNP secretion/VBN by/IN PBA/NNP does/VBZ not/RB involve/VB cholinergic/JJ neural/JJ pathways/NNS ,/, suggesting/VBG a/DT direct/JJ action/NN on/IN PAM/NNP cells/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN stimulation))
      (PP (IN of)
        (NP (NNP PAM)
          (CC and)
          (NNP PAM-G)))
      (VP (VBN secretion)
        (PP (IN by)
          (NP (NNP PBA)))))
    (VP (VBZ does) (RB not)
      (VP (VB involve)
        (NP (JJ cholinergic) (JJ neural) (NNS pathways))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (DT a) (JJ direct) (NN action))
              (PP (IN on)
                (NP (NNP PAM) (NNS cells))))))))
    (. .)))

advmod(involve-14, Furthermore-1)
det(stimulation-4, the-3)
nsubj(involve-14, stimulation-4)
case(PAM-6, of-5)
nmod:of(stimulation-4, PAM-6)
cc(PAM-6, and-7)
nmod:of(stimulation-4, PAM-G-8)
conj:and(PAM-6, PAM-G-8)
acl(stimulation-4, secretion-9)
case(PBA-11, by-10)
nmod:by(secretion-9, PBA-11)
aux(involve-14, does-12)
neg(involve-14, not-13)
root(ROOT-0, involve-14)
amod(pathways-17, cholinergic-15)
amod(pathways-17, neural-16)
dobj(involve-14, pathways-17)
advcl(involve-14, suggesting-19)
det(action-22, a-20)
amod(action-22, direct-21)
dobj(suggesting-19, action-22)
case(cells-25, on-23)
compound(cells-25, PAM-24)
nmod:on(action-22, cells-25)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT regulation/NN of/IN amidated/JJ peptide/JJ biosynthesis/NNS and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/NN therapeutics/NNS targeting/VBG this/DT pathway/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN regulation))
              (PP (IN of)
                (NP (JJ amidated) (JJ peptide) (NNS biosynthesis)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (NN novel) (NNS therapeutics)))))
            (VP (VBG targeting)
              (NP (DT this) (NN pathway)))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-15, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(regulation-8, into-6)
det(regulation-8, the-7)
nmod:into(insights-5, regulation-8)
case(biosynthesis-12, of-9)
amod(biosynthesis-12, amidated-10)
amod(biosynthesis-12, peptide-11)
nmod:of(regulation-8, biosynthesis-12)
cc(provide-3, and-13)
aux(have-15, may-14)
conj:and(provide-3, have-15)
dobj(have-15, implications-16)
case(development-19, for-17)
det(development-19, the-18)
nmod:for(implications-16, development-19)
case(therapeutics-22, of-20)
compound(therapeutics-22, novel-21)
nmod:of(development-19, therapeutics-22)
acl(implications-16, targeting-23)
det(pathway-25, this-24)
dobj(targeting-23, pathway-25)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN several/JJ comorbidities/NNS ,/, including/VBG type_2_diabetes_mellitus/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder)
      (SBAR
        (WHNP (WDT that))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ several) (NNS comorbidities))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes_mellitus)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
nsubjpass(associated-7, metabolic_disorder-4)
ccomp(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
root(ROOT-0, associated-7)
case(comorbidities-10, with-8)
amod(comorbidities-10, several-9)
nmod:with(associated-7, comorbidities-10)
acl(comorbidities-10, including-12)
dobj(including-12, type_2_diabetes_mellitus-13)

The/DT pathogenesis/NNS of/IN obesity/NN and/CC its/PRP$ relationship/NN with/IN various/JJ metabolic/JJ hormones/NNS ,/, such/JJ as/IN thyroid_hormones/NNS -LRB-/-LRB- TH/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NNS pathogenesis))
        (PP (IN of)
          (NP (NN obesity))))
      (CC and)
      (NP
        (NP (PRP$ its) (NN relationship))
        (PP (IN with)
          (NP
            (NP (JJ various) (JJ metabolic) (NNS hormones))
            (, ,)
            (PP (JJ such) (IN as)
              (NP
                (NP (NNS thyroid_hormones))
                (PRN (-LRB- -LRB-)
                  (NP (NNP TH))
                  (-RRB- -RRB-))))
            (, ,)))))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied))))
    (. .)))

det(pathogenesis-2, The-1)
nsubjpass(studied-23, pathogenesis-2)
case(obesity-4, of-3)
nmod:of(pathogenesis-2, obesity-4)
cc(pathogenesis-2, and-5)
nmod:poss(relationship-7, its-6)
conj:and(pathogenesis-2, relationship-7)
nsubjpass(studied-23, relationship-7)
case(hormones-11, with-8)
amod(hormones-11, various-9)
amod(hormones-11, metabolic-10)
nmod:with(relationship-7, hormones-11)
case(thyroid_hormones-15, such-13)
mwe(such-13, as-14)
nmod:such_as(hormones-11, thyroid_hormones-15)
appos(thyroid_hormones-15, TH-17)
aux(studied-23, have-20)
auxpass(studied-23, been-21)
advmod(studied-23, extensively-22)
root(ROOT-0, studied-23)

It/PRP has_been/VBP suggested/VBN that/IN hypersecretion/NN of/IN TH_1/NNP by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (PRP It))
    (VP (VBP has_been)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NNP TH_1)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

nsubj(has_been-2, It-1)
root(ROOT-0, has_been-2)
dep(has_been-2, suggested-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(TH_1-7, of-6)
nmod:of(hypersecretion-5, TH_1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggested-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN TH_1/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP TH_1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(TH_1-20, of-19)
nmod:of(hypersecretion-18, TH_1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ CORM-A1/NN on/IN the/DT secretion/NN of/IN TH_1/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN CORM-A1)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP TH_1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(CORM-A1-16, 10-14)
amod(CORM-A1-16, mmol/L-15)
nmod:of(effects-8, CORM-A1-16)
conj:and(glucose-12, CORM-A1-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, TH_1-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN the/DT secretion/NN of/IN TH_1/NNP was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT basal/JJ and/CC stimulated/VBN conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (NNP TH_1))))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP (DT both)
                        (ADJP (JJ basal)
                          (CC and)
                          (VBN stimulated))
                        (NNS conditions)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-15, that-4)
det(secretion-6, the-5)
nsubjpass(compared-15, secretion-6)
nsubj:xsubj(lean-17, secretion-6)
case(TH_1-8, of-7)
nmod:of(secretion-6, TH_1-8)
auxpass(compared-15, was-9)
advmod(higher-11, significantly-10)
advmod(compared-15, higher-11)
case(rats-14, in-12)
amod(rats-14, obese-13)
nmod:in(higher-11, rats-14)
ccomp(showed-3, compared-15)
mark(lean-17, to-16)
xcomp(compared-15, lean-17)
dobj(lean-17, rats-18)
case(conditions-24, under-19)
det(conditions-24, both-20)
amod(conditions-24, basal-21)
cc(basal-21, and-22)
conj:and(basal-21, stimulated-23)
amod(conditions-24, stimulated-23)
nmod:under(lean-17, conditions-24)

Furthermore/RB ,/, treatment/NN with/IN CORM-A1/NNP resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN TH_1/NNP secretion/NN in/IN both/DT lean/JJ and/CC obese/JJ rats/NNS ,/, whereas/IN insulin_secretion/NN was/VBD not/RB affected/VBN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN treatment))
      (PP (IN with)
        (NP (NNP CORM-A1))))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NNP TH_1) (NN secretion))))
      (PP (IN in)
        (NP (DT both)
          (ADJP (JJ lean)
            (CC and)
            (JJ obese))
          (NNS rats)))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP (NN insulin_secretion))
          (VP (VBD was) (RB not)
            (VP (VBN affected))))))
    (. .)))

advmod(resulted-6, Furthermore-1)
nsubj(resulted-6, treatment-3)
case(CORM-A1-5, with-4)
nmod:with(treatment-3, CORM-A1-5)
root(ROOT-0, resulted-6)
amod(decrease-9, in_a-7)
amod(decrease-9, significant-8)
dobj(resulted-6, decrease-9)
case(secretion-12, in-10)
compound(secretion-12, TH_1-11)
nmod:in(decrease-9, secretion-12)
case(rats-18, in-13)
det(rats-18, both-14)
amod(rats-18, lean-15)
cc(lean-15, and-16)
conj:and(lean-15, obese-17)
amod(rats-18, obese-17)
nmod:in(resulted-6, rats-18)
mark(affected-24, whereas-20)
nsubjpass(affected-24, insulin_secretion-21)
auxpass(affected-24, was-22)
neg(affected-24, not-23)
advcl(resulted-6, affected-24)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN TH_1/NNP by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN and/CC that/IN CORM-A1/NNP may/MD have/VB therapeutic/JJ potential/NN for/IN treating/VBG this/DT condition/NN through/IN its/PRP$ ability/NN to/TO modulate/VBP TH_1/CD secretion/NN ./.

(ROOT
  (SINV
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP suggest)
        (SBAR
          (SBAR (IN that)
            (S
              (NP
                (NP (NN hypersecretion))
                (PP (IN of)
                  (NP (NNP TH_1)))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))
              (VP (MD may)
                (VP (VB be)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (NN obesity))))))))))
          (CC and)
          (SBAR (IN that)
            (S
              (NP (NNP CORM-A1))
              (VP (MD may)
                (VP (VB have)
                  (NP
                    (NP (JJ therapeutic) (NN potential))
                    (PP (IN for)
                      (S
                        (VP (VBG treating)
                          (NP (DT this) (NN condition))
                          (PP (IN through)
                            (NP (PRP$ its) (NN ability)
                              (S
                                (VP (TO to))))))))))))))))
    (VP (VBP modulate))
    (NP (CD TH_1) (NN secretion))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
dep(modulate-34, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(TH_1-7, of-6)
nmod:of(hypersecretion-5, TH_1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
cc(involved-13, and-19)
mark(have-23, that-20)
nsubj(have-23, CORM-A1-21)
aux(have-23, may-22)
ccomp(suggest-3, have-23)
conj:and(involved-13, have-23)
amod(potential-25, therapeutic-24)
dobj(have-23, potential-25)
mark(treating-27, for-26)
acl(potential-25, treating-27)
det(condition-29, this-28)
dobj(treating-27, condition-29)
case(ability-32, through-30)
nmod:poss(ability-32, its-31)
nmod:through(treating-27, ability-32)
acl(ability-32, to-33)
root(ROOT-0, modulate-34)
nummod(secretion-36, TH_1-35)
nsubj(modulate-34, secretion-36)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (ADJP (JJ essential)
        (PP (IN for)
          (NP (JJ human) (NN health)))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, for-16)
amod(health-18, human-17)
nmod:for(essential-15, health-18)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NN can/MD decrease/VB esculin/NN levels/NNS in/IN hyperesculinmic/JJ patients/NNS and/CC reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD can)
              (VP
                (VP (VB decrease)
                  (NP
                    (NP (NN esculin) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperesculinmic) (NNS patients)))))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(decrease-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(decrease-9, omega-3_fatty_acids-7)
nsubj(reduce-16, omega-3_fatty_acids-7)
aux(decrease-9, can-8)
ccomp(shown-4, decrease-9)
compound(levels-11, esculin-10)
dobj(decrease-9, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperesculinmic-13)
nmod:in(levels-11, patients-14)
cc(decrease-9, and-15)
ccomp(shown-4, reduce-16)
conj:and(decrease-9, reduce-16)
det(risk-18, the-17)
dobj(reduce-16, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, coronary_heart_disease-21)
appos(risk-18, CHD-23)

These/DT findings/NNS suggest/VBP that/IN EPA/NNP and/CC DHA/NNP may/MD have/VB therapeutic/JJ potential/NN in/IN preventing/VBG and/CC treating/VBG CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ therapeutic) (NN potential))
              (PP (IN in)
                (S
                  (VP
                    (VP (VBG preventing))
                    (CC and)
                    (VP (VBG treating)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-9, that-4)
nsubj(have-9, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(have-9, DHA-7)
aux(have-9, may-8)
ccomp(suggest-3, have-9)
amod(potential-11, therapeutic-10)
dobj(have-9, potential-11)
mark(preventing-13, in-12)
advcl(have-9, preventing-13)
cc(preventing-13, and-14)
advcl(have-9, treating-15)
conj:and(preventing-13, treating-15)
dobj(treating-15, CHD-16)

Furthermore/RB ,/, the/DT mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS exert/VBP their/PRP$ beneficial/JJ effects/NNS on/IN cardiovascular_health/NN are/VBP being/VBG actively/RB investigated/VBN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NNS mechanisms))
      (SBAR
        (WHPP (IN by)
          (WHNP (WDT which)))
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (VBP exert)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (NN cardiovascular_health))))))))
    (VP (VBP are)
      (VP (VBG being)
        (VP
          (ADVP (RB actively))
          (VBN investigated))))
    (. .)))

advmod(investigated-18, Furthermore-1)
det(mechanisms-4, the-3)
nmod:by(exert-9, mechanisms-4)
nsubjpass(investigated-18, mechanisms-4)
case(which-6, by-5)
ref(mechanisms-4, which-6)
det(fatty_acids-8, these-7)
nsubj(exert-9, fatty_acids-8)
acl:relcl(mechanisms-4, exert-9)
nmod:poss(effects-12, their-10)
amod(effects-12, beneficial-11)
dobj(exert-9, effects-12)
case(cardiovascular_health-14, on-13)
nmod:on(effects-12, cardiovascular_health-14)
aux(investigated-18, are-15)
auxpass(investigated-18, being-16)
advmod(investigated-18, actively-17)
root(ROOT-0, investigated-18)

Overall/RB ,/, these/DT results/VBZ highlight/VB the/DT importance/NN of/IN omega-3_fatty_acids/JJ in/IN maintaining/VBG human/JJ health/NN and/CC preventing/VBG chronic_diseases/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these))
    (VP (VBZ results)
      (VP (VB highlight)
        (NP
          (NP (DT the) (NN importance))
          (PP (IN of)
            (NP
              (ADJP (JJ omega-3_fatty_acids)
                (PP (IN in)
                  (S
                    (VP
                      (VP (VBG maintaining)
                        (NP (JJ human) (NN health)))
                      (CC and)
                      (VP (VBG preventing))))))
              (NNS chronic_diseases))))))
    (. .)))

advmod(results-4, Overall-1)
nsubj(results-4, these-3)
root(ROOT-0, results-4)
xcomp(results-4, highlight-5)
det(importance-7, the-6)
dobj(highlight-5, importance-7)
case(chronic_diseases-16, of-8)
amod(chronic_diseases-16, omega-3_fatty_acids-9)
mark(maintaining-11, in-10)
advcl(omega-3_fatty_acids-9, maintaining-11)
amod(health-13, human-12)
dobj(maintaining-11, health-13)
cc(maintaining-11, and-14)
advcl(omega-3_fatty_acids-9, preventing-15)
conj:and(maintaining-11, preventing-15)
nmod:of(importance-7, chronic_diseases-16)

Obesity/RB is_a/JJ complex/JJ disease/NN that/WDT is/VBZ influenced/VBN by/IN genetic/JJ ,/, environmental/JJ ,/, and/CC lifestyle/NN factors/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN disease)
      (SBAR
        (WHNP (WDT that))))
    (VP (VBZ is)
      (VP (VBN influenced)
        (PP (IN by)
          (NP
            (UCP
              (ADJP (JJ genetic))
              (, ,)
              (ADJP (JJ environmental))
              (, ,)
              (CC and)
              (NP (NN lifestyle)))
            (NNS factors)))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(disease-4, is_a-2)
amod(disease-4, complex-3)
nsubjpass(influenced-7, disease-4)
ccomp(disease-4, that-5)
auxpass(influenced-7, is-6)
root(ROOT-0, influenced-7)
case(factors-15, by-8)
amod(factors-15, genetic-9)
conj:and(genetic-9, environmental-11)
amod(factors-15, environmental-11)
cc(genetic-9, and-13)
conj:and(genetic-9, lifestyle-14)
amod(factors-15, lifestyle-14)
nmod:by(influenced-7, factors-15)

One/CD of/IN the/DT potential/JJ contributors/NNS to/TO the/DT development/NN of/IN obesity/NN is/VBZ the/DT hypersecretion/NN of/IN alpha-PAK/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ potential) (NNS contributors))
          (PP (TO to)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (NN obesity))))))))
    (VP (VBZ is)
      (NP
        (NP (DT the) (NN hypersecretion))
        (PP (IN of)
          (NP (NN alpha-PAK))))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (. .)))

nsubj(hypersecretion-13, One-1)
case(contributors-5, of-2)
det(contributors-5, the-3)
amod(contributors-5, potential-4)
nmod:of(One-1, contributors-5)
case(development-8, to-6)
det(development-8, the-7)
nmod:to(contributors-5, development-8)
case(obesity-10, of-9)
nmod:of(development-8, obesity-10)
cop(hypersecretion-13, is-11)
det(hypersecretion-13, the-12)
root(ROOT-0, hypersecretion-13)
case(alpha-PAK-15, of-14)
nmod:of(hypersecretion-13, alpha-PAK-15)
case(pancreas-18, by-16)
det(pancreas-18, the-17)
nmod:by(hypersecretion-13, pancreas-18)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/JJ and_alpha-PAK/JJ hypersecretion/NN by/IN examining/VBG the/DT effects/NNS of/IN glucose/NN and/CC FRAX597/NN on/IN alpha-PAK/JJ and_insulin/NN secretion/NN in/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- individuals/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (JJ obesity) (JJ and_alpha-PAK) (NN hypersecretion))))))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP (NN glucose)
                        (CC and)
                        (NN FRAX597)))))))
            (PP (IN on)
              (NP
                (NP (JJ alpha-PAK) (NN and_insulin) (NN secretion))
                (PP (IN in)
                  (NP (VBN isolated) (JJ perfused) (NN pancreata))))))))
      (PP (IN from)
        (NP
          (NP
            (NP (NN genetically_obese))
            (PRN (-LRB- -LRB-)
              (NP (NN fa/fa))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS individuals)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(hypersecretion-17, of-14)
amod(hypersecretion-17, obesity-15)
amod(hypersecretion-17, and_alpha-PAK-16)
nmod:of(development-13, hypersecretion-17)
mark(examining-19, by-18)
advcl(evaluate-8, examining-19)
det(effects-21, the-20)
dobj(examining-19, effects-21)
case(glucose-23, of-22)
nmod:of(effects-21, glucose-23)
cc(glucose-23, and-24)
nmod:of(effects-21, FRAX597-25)
conj:and(glucose-23, FRAX597-25)
case(secretion-29, on-26)
amod(secretion-29, alpha-PAK-27)
compound(secretion-29, and_insulin-28)
nmod:on(evaluate-8, secretion-29)
case(pancreata-33, in-30)
amod(pancreata-33, isolated-31)
amod(pancreata-33, perfused-32)
nmod:in(secretion-29, pancreata-33)
case(genetically_obese-35, from-34)
nmod:from(aimed-6, genetically_obese-35)
appos(genetically_obese-35, fa/fa-37)
cc(genetically_obese-35, and-39)
amod(individuals-46, lean-40)
dep(lean-40, Fa-42)
nmod:from(aimed-6, individuals-46)
conj:and(genetically_obese-35, individuals-46)

Our/PRP$ results/NNS showed/VBD that/IN 16.7/CD mmol/L/JJ glucose/NN significantly/RB increased/VBD alpha-PAK/JJ secretion/NN in/IN both/DT lean/JJ and/CC obese/JJ pancreata/NN ,/, while/IN 10/CD mmol/L/JJ FRAX597/NN inhibited/VBD alpha-PAK/JJ secretion/NN in/IN both/DT groups/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (CD 16.7) (JJ mmol/L) (NN glucose))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP (JJ alpha-PAK) (NN secretion))
            (PP (IN in)
              (NP (DT both)
                (ADJP (JJ lean)
                  (CC and)
                  (JJ obese))
                (NN pancreata)))
            (, ,)
            (SBAR (IN while)
              (S
                (NP (CD 10) (JJ mmol/L) (NN FRAX597))
                (VP (VBD inhibited)
                  (NP
                    (NP (JJ alpha-PAK) (NN secretion))
                    (PP (IN in)
                      (NP (DT both) (NNS groups)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-9, that-4)
nummod(glucose-7, 16.7-5)
amod(glucose-7, mmol/L-6)
nsubj(increased-9, glucose-7)
advmod(increased-9, significantly-8)
ccomp(showed-3, increased-9)
amod(secretion-11, alpha-PAK-10)
dobj(increased-9, secretion-11)
case(pancreata-17, in-12)
det(pancreata-17, both-13)
amod(pancreata-17, lean-14)
cc(lean-14, and-15)
conj:and(lean-14, obese-16)
amod(pancreata-17, obese-16)
nmod:in(increased-9, pancreata-17)
mark(inhibited-23, while-19)
nummod(FRAX597-22, 10-20)
amod(FRAX597-22, mmol/L-21)
nsubj(inhibited-23, FRAX597-22)
advcl(increased-9, inhibited-23)
amod(secretion-25, alpha-PAK-24)
dobj(inhibited-23, secretion-25)
case(groups-28, in-26)
det(groups-28, both-27)
nmod:in(secretion-25, groups-28)

Interestingly/RB ,/, obese/JJ pancreata/NN exhibited/VBD higher/JJR basal/JJ levels/NNS of/IN alpha-PAK/JJ secretion/NN compared/VBN to/TO lean/JJ pancreata/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (JJ obese) (NN pancreata))
    (VP (VBD exhibited)
      (NP
        (NP (JJR higher) (JJ basal) (NNS levels))
        (PP (IN of)
          (NP (JJ alpha-PAK) (NN secretion))))
      (PP (VBN compared)
        (PP (TO to)
          (NP (JJ lean) (NN pancreata)))))
    (. .)))

advmod(exhibited-5, Interestingly-1)
amod(pancreata-4, obese-3)
nsubj(exhibited-5, pancreata-4)
root(ROOT-0, exhibited-5)
amod(levels-8, higher-6)
amod(levels-8, basal-7)
dobj(exhibited-5, levels-8)
case(secretion-11, of-9)
amod(secretion-11, alpha-PAK-10)
nmod:of(levels-8, secretion-11)
case(pancreata-15, compared-12)
mwe(compared-12, to-13)
amod(pancreata-15, lean-14)
advcl(exhibited-5, pancreata-15)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN alpha-PAK/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ,/, and/CC targeting/VBG this/DT pathway/NN may/MD have/VB therapeutic/JJ potential/NN for/IN treating/VBG obesity-associated/JJ complications/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NN alpha-PAK))))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))))
          (, ,)
          (CC and)
          (S
            (S
              (VP (VBG targeting)
                (NP (DT this) (NN pathway))))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ therapeutic) (NN potential))
                  (PP (IN for)
                    (S
                      (VP (VBG treating)
                        (NP (JJ obesity-associated) (NNS complications))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-9, that-4)
nsubj(contribute-9, hypersecretion-5)
case(alpha-PAK-7, of-6)
nmod:of(hypersecretion-5, alpha-PAK-7)
aux(contribute-9, may-8)
ccomp(suggest-3, contribute-9)
case(development-12, to-10)
det(development-12, the-11)
nmod:to(contribute-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
cc(contribute-9, and-16)
csubj(have-21, targeting-17)
det(pathway-19, this-18)
dobj(targeting-17, pathway-19)
aux(have-21, may-20)
ccomp(suggest-3, have-21)
conj:and(contribute-9, have-21)
amod(potential-23, therapeutic-22)
dobj(have-21, potential-23)
mark(treating-25, for-24)
acl(potential-23, treating-25)
amod(complications-27, obesity-associated-26)
dobj(treating-25, complications-27)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO evaluate/VB the/DT effect/NN of/IN bosentan/NN on/IN the/DT incidence/NN of/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN bosentan))))
            (PP (IN on)
              (NP
                (NP
                  (NP (DT the) (NN incidence))
                  (PP (IN of)
                    (NP (NNS bronchospasms))))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(evaluate-8, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(evaluate-8, to-7)
xcomp(was-6, evaluate-8)
det(effect-10, the-9)
dobj(evaluate-8, effect-10)
case(bosentan-12, of-11)
nmod:of(effect-10, bosentan-12)
case(incidence-15, on-13)
det(incidence-15, the-14)
nmod:on(evaluate-8, incidence-15)
case(bronchospasms-17, of-16)
nmod:of(incidence-15, bronchospasms-17)
nmod:on(evaluate-8, photophobia-19)
conj:and(incidence-15, photophobia-19)
cc(incidence-15, and-21)
nmod:on(evaluate-8, phonophobia-22)
conj:and(incidence-15, phonophobia-22)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN in/IN patients/NNS with/IN a/DT history/NN of/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (NP (NNS patients)))
        (PP (IN with)
          (NP
            (NP (DT a) (NN history))
            (PP (IN of)
              (NP (DT these) (NNS symptoms)))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(patients-11, in-10)
nmod:in(conducted-9, patients-11)
case(history-14, with-12)
det(history-14, a-13)
nmod:with(conducted-9, history-14)
case(symptoms-17, of-15)
det(symptoms-17, these-16)
nmod:of(history-14, symptoms-17)

At_2/JJ h/NN after/IN dosing/VBG ,/, bosentan/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN bosentan))
    (ADVP (RB significantly))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS bronchospasms))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-8, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-8, bosentan-6)
advmod(reduced-8, significantly-7)
root(ROOT-0, reduced-8)
det(risk-10, the-9)
dobj(reduced-8, risk-10)
case(bronchospasms-12, of-11)
nmod:of(risk-10, bronchospasms-12)
case(%-15, by-13)
nummod(%-15, 14-14)
nmod:by(reduced-8, %-15)
nummod(%-18, 95-17)
dep(%-15, %-18)
acl:relcl(%-18, CI-19)
nummod(%-21, 6-20-20)
dobj(CI-19, %-21)
appos(%-21, P-23)
dep(0.0005-25, =-24)
dep(%-21, 0.0005-25)
xcomp(reduced-8, photophobia-28)
case(%-31, by-29)
nummod(%-31, 17-30)
nmod:by(photophobia-28, %-31)
nummod(%-34, 95-33)
appos(%-31, %-34)
dep(%-37, CI-35)
nummod(%-37, 12-22-36)
nmod(%-34, %-37)
dep(%-34, P-39)
compound(0.0001-41, <-40)
nummod(P-39, 0.0001-41)
cc(photophobia-28, and-44)
xcomp(reduced-8, phonophobia-45)
conj:and(photophobia-28, phonophobia-45)
case(%-48, by-46)
nummod(%-48, 14-47)
nmod:by(phonophobia-45, %-48)
nummod(%-51, 95-50)
appos(%-48, %-51)
dep(%-54, CI-52)
nummod(%-54, 17-20-53)
nmod(%-51, %-54)
dep(%-51, P-56)
compound(0.0001-58, <-57)
nummod(P-56, 0.0001-58)

These/DT findings/NNS suggest/VBP that/IN bosentan/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN patients/NNS with/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN bosentan))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, bosentan-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(symptoms-16, with-14)
det(symptoms-16, these-15)
nmod:with(patients-13, symptoms-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN treatment/NN with/IN bosentan/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP (NN treatment))))
                (PP (IN with)
                  (NP (NN bosentan)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(dosage-13, the-11)
amod(dosage-13, optimal-12)
dobj(determine-10, dosage-13)
cc(dosage-13, and-14)
dobj(determine-10, duration-15)
conj:and(dosage-13, duration-15)
case(treatment-17, of-16)
nmod:of(dosage-13, treatment-17)
case(bosentan-19, with-18)
nmod:with(determine-10, bosentan-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated/JJ fats/NNS that/WDT have/VBP been/VBN shown/VBN to/TO have/VB a/DT variety/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (JJ polyunsaturated) (NNS fats))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP
                          (NP (DT a) (NN variety))
                          (PP (IN of)
                            (NP (NN health) (NNS benefits))))))))))))))
    (. .)))

nsubj(fats-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(fats-17, are-14)
amod(fats-17, essential-15)
amod(fats-17, polyunsaturated-16)
root(ROOT-0, fats-17)
nsubjpass(shown-21, fats-17)
nsubj:xsubj(have-23, fats-17)
ref(fats-17, that-18)
aux(shown-21, have-19)
auxpass(shown-21, been-20)
acl:relcl(fats-17, shown-21)
mark(have-23, to-22)
xcomp(shown-21, have-23)
det(variety-25, a-24)
dobj(have-23, variety-25)
case(benefits-28, of-26)
compound(benefits-28, health-27)
nmod:of(variety-25, benefits-28)

Recent/JJ studies/NNS have/VBP linked/VBN these/DT long-chain/JJ omega-3_fatty_acids/JJ with/IN decreased/VBN Muscimol/NN levels/NNS in/IN hyperMuscimolmic/JJ patients/NNS ,/, suggesting/VBG a/DT potential/JJ therapeutic/JJ role/NN in/IN the/DT treatment/NN of/IN Muscimol-related_disorders/NNP ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN linked)
        (NP
          (NP (DT these) (JJ long-chain)
            (ADJP (JJ omega-3_fatty_acids)
              (PP (IN with)
                (NP (VBN decreased) (NN Muscimol))))
            (NNS levels))
          (PP (IN in)
            (NP (JJ hyperMuscimolmic) (NNS patients))))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (DT a) (JJ potential) (JJ therapeutic) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN treatment))
                  (PP (IN of)
                    (NP (NNP Muscimol-related_disorders))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(linked-4, studies-2)
aux(linked-4, have-3)
root(ROOT-0, linked-4)
det(levels-11, these-5)
amod(levels-11, long-chain-6)
amod(levels-11, omega-3_fatty_acids-7)
case(Muscimol-10, with-8)
amod(Muscimol-10, decreased-9)
nmod:with(omega-3_fatty_acids-7, Muscimol-10)
dobj(linked-4, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperMuscimolmic-13)
nmod:in(levels-11, patients-14)
advcl(linked-4, suggesting-16)
det(role-20, a-17)
amod(role-20, potential-18)
amod(role-20, therapeutic-19)
dobj(suggesting-16, role-20)
case(treatment-23, in-21)
det(treatment-23, the-22)
nmod:in(role-20, treatment-23)
case(Muscimol-related_disorders-25, of-24)
nmod:of(treatment-23, Muscimol-related_disorders-25)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, which/WDT is_a/NN leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP
                      (NP
                        (NP (NN coronary_heart_disease))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-)))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (NP
                            (NP (NN is_a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality))))
                          (ADVP (RB worldwide)))))))))))))
    (. .)))

advmod(associated-8, Additionally-1)
nsubjpass(associated-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(associated-8, DHA-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(risk-12, with-9)
det(risk-12, a-10)
amod(risk-12, decreased-11)
nmod:with(associated-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
dep(cause-23, coronary_heart_disease-15)
appos(coronary_heart_disease-15, CHD-17)
ref(coronary_heart_disease-15, which-20)
compound(cause-23, is_a-21)
amod(cause-23, leading-22)
acl:relcl(coronary_heart_disease-15, cause-23)
case(morbidity-25, of-24)
nmod:of(cause-23, morbidity-25)
cc(morbidity-25, and-26)
nmod:of(cause-23, mortality-27)
conj:and(morbidity-25, mortality-27)
advmod(cause-23, worldwide-28)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP complex/JJ and/CC multifactorial/JJ ,/, but/CC may/MD involve/VB anti-inflammatory/JJ ,/, anti-thrombotic/JJ ,/, and/CC lipid-modifying/JJ properties/NNS of/IN omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (JJ complex)
          (CC and)
          (JJ multifactorial)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (JJ anti-inflammatory) (, ,)
              (ADJP (JJ anti-thrombotic))
              (, ,)
              (CC and)
              (JJ lipid-modifying) (NNS properties))
            (PP (IN of)
              (NP (JJ omega-3_fatty_acids)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(complex-8, mechanisms-2)
nsubj(multifactorial-10, mechanisms-2)
nsubj(involve-14, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
cop(complex-8, are-7)
root(ROOT-0, complex-8)
cc(complex-8, and-9)
conj:and(complex-8, multifactorial-10)
cc(complex-8, but-12)
aux(involve-14, may-13)
conj:but(complex-8, involve-14)
amod(anti-thrombotic-17, anti-inflammatory-15)
dobj(involve-14, anti-thrombotic-17)
cc(anti-thrombotic-17, and-19)
amod(properties-21, lipid-modifying-20)
dobj(involve-14, properties-21)
conj:and(anti-thrombotic-17, properties-21)
case(omega-3_fatty_acids-23, of-22)
nmod:of(anti-thrombotic-17, omega-3_fatty_acids-23)

Overall/RB ,/, these/DT findings/NNS highlight/VB the/DT importance/NN of/IN incorporating/VBG omega-3_fatty_acids/JJ into/IN our/PRP$ diets/NNS as/IN a/DT means/NN of/IN promoting/VBG cardiovascular_health/NN and/CC reducing/VBG the/DT burden/NN of/IN Muscimol-related_diseases/NNP ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (NN importance))
        (PP (IN of)
          (S
            (VP (VBG incorporating)
              (ADJP (JJ omega-3_fatty_acids))
              (PP (IN into)
                (NP
                  (NP (PRP$ our) (NNS diets))
                  (PP (IN as)
                    (NP
                      (NP (DT a) (NN means))
                      (PP (IN of)
                        (S
                          (VP
                            (VP (VBG promoting)
                              (NP (NN cardiovascular_health)))
                            (CC and)
                            (VP (VBG reducing)
                              (NP
                                (NP (DT the) (NN burden))
                                (PP (IN of)
                                  (NP (NNP Muscimol-related_diseases)))))))))))))))))
    (. .)))

advmod(highlight-5, Overall-1)
det(findings-4, these-3)
nsubj(highlight-5, findings-4)
root(ROOT-0, highlight-5)
det(importance-7, the-6)
dobj(highlight-5, importance-7)
mark(incorporating-9, of-8)
acl(importance-7, incorporating-9)
xcomp(incorporating-9, omega-3_fatty_acids-10)
case(diets-13, into-11)
nmod:poss(diets-13, our-12)
nmod:into(incorporating-9, diets-13)
case(means-16, as-14)
det(means-16, a-15)
nmod:as(diets-13, means-16)
mark(promoting-18, of-17)
acl(means-16, promoting-18)
dobj(promoting-18, cardiovascular_health-19)
cc(promoting-18, and-20)
acl(means-16, reducing-21)
conj:and(promoting-18, reducing-21)
det(burden-23, the-22)
dobj(reducing-21, burden-23)
case(Muscimol-related_diseases-25, of-24)
nmod:of(burden-23, Muscimol-related_diseases-25)

In/IN vitro/NN studies/NNS have/VBP been/VBN conducted/VBN to/TO evaluate/VB the/DT effect/NN of/IN piritrexim/NN on/IN CH-DHFR/JJ levels/NNS in/IN non-transfected/JJ and/CC transfected/JJ groups/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN vitro)))
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN conducted)
          (S
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (NN effect))
                  (PP (IN of)
                    (NP (NN piritrexim))))
                (PP (IN on)
                  (NP
                    (NP (JJ CH-DHFR) (NNS levels))
                    (PP (IN in)
                      (NP (JJ non-transfected)
                        (CC and)
                        (JJ transfected) (NNS groups)))))))))))
    (. .)))

case(vitro-2, In-1)
nmod:in(conducted-6, vitro-2)
nsubjpass(conducted-6, studies-3)
nsubj:xsubj(evaluate-8, studies-3)
aux(conducted-6, have-4)
auxpass(conducted-6, been-5)
root(ROOT-0, conducted-6)
mark(evaluate-8, to-7)
xcomp(conducted-6, evaluate-8)
det(effect-10, the-9)
dobj(evaluate-8, effect-10)
case(piritrexim-12, of-11)
nmod:of(effect-10, piritrexim-12)
case(levels-15, on-13)
amod(levels-15, CH-DHFR-14)
nmod:on(evaluate-8, levels-15)
case(groups-20, in-16)
amod(groups-20, non-transfected-17)
cc(non-transfected-17, and-18)
conj:and(non-transfected-17, transfected-19)
amod(groups-20, transfected-19)
nmod:in(levels-15, groups-20)

The/DT results/NNS showed/VBD that/IN the/DT CH-DHFR/NN level/NN of/IN the/DT non-transfected/JJ piritrexim/NN group/NN was/VBD significantly/RB lower/JJR than/IN the/DT non-transfected/JJ non-piritrexim/JJ group/NN -LRB-/-LRB- 352/CD ±/VBP 26/CD ng/L/JJ vs/NN 765/CD ±/VBP 22/CD ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RRB-/-RRB- ,/, indicating/VBG that/IN piritrexim/NN has/VBZ an/DT inhibitory/JJ effect/NN on/IN CH-DHFR/NN expression/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN CH-DHFR) (NN level))
            (PP (IN of)
              (NP (DT the) (JJ non-transfected) (NN piritrexim) (NN group))))
          (VP (VBD was)
            (ADJP (RB significantly) (JJR lower))
            (PP (IN than)
              (NP
                (NP (DT the) (JJ non-transfected) (JJ non-piritrexim) (NN group))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (CD 352))
                    (VP (VBP ±)
                      (NP
                        (NP (CD 26) (JJ ng/L) (NN vs))
                        (SBAR
                          (S
                            (NP (CD 765))
                            (VP (VBP ±)
                              (ADJP
                                (NP (CD 22))
                                (JJ ng/L))
                              (, ,)
                              (SBAR
                                (S
                                  (NP (NNP P))
                                  (VP (VBP <)
                                    (NP (CD 0.001)))))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (S
              (VP (VBG indicating)
                (SBAR (IN that)
                  (S
                    (NP (NN piritrexim))
                    (VP (VBZ has)
                      (NP
                        (NP (DT an) (JJ inhibitory) (NN effect))
                        (PP (IN on)
                          (NP (NN CH-DHFR) (NN expression)))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(lower-15, that-4)
det(level-7, the-5)
compound(level-7, CH-DHFR-6)
nsubj(lower-15, level-7)
case(group-12, of-8)
det(group-12, the-9)
amod(group-12, non-transfected-10)
compound(group-12, piritrexim-11)
nmod:of(level-7, group-12)
cop(lower-15, was-13)
advmod(lower-15, significantly-14)
ccomp(showed-3, lower-15)
case(group-20, than-16)
det(group-20, the-17)
amod(group-20, non-transfected-18)
amod(group-20, non-piritrexim-19)
nmod:than(lower-15, group-20)
nsubj(±-23, 352-22)
dep(group-20, ±-23)
nummod(vs-26, 26-24)
amod(vs-26, ng/L-25)
dobj(±-23, vs-26)
nsubj(±-28, 765-27)
acl:relcl(vs-26, ±-28)
nmod:npmod(ng/L-30, 22-29)
xcomp(±-28, ng/L-30)
nsubj(<-33, P-32)
ccomp(±-28, <-33)
dobj(<-33, 0.001-34)
xcomp(lower-15, indicating-37)
mark(has-40, that-38)
nsubj(has-40, piritrexim-39)
ccomp(indicating-37, has-40)
det(effect-43, an-41)
amod(effect-43, inhibitory-42)
dobj(has-40, effect-43)
case(expression-46, on-44)
compound(expression-46, CH-DHFR-45)
nmod:on(effect-43, expression-46)

However/RB ,/, no/DT significant/JJ difference/NN was/VBD observed/VBN in/IN CH-DHFR/NN levels/NNS between/IN the/DT transfected/JJ piritrexim/NN and/CC transfected/VBN non-piritrexim/JJ groups/NNS ,/, suggesting/VBG that/IN transfection/NN may/MD not/RB affect/VB the/DT response/NN to/TO piritrexim/VB treatment/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT no) (JJ significant) (NN difference))
    (VP (VBD was)
      (VP
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP (NN CH-DHFR) (NNS levels))
              (PP (IN between)
                (NP (DT the) (JJ transfected) (NN piritrexim))))))
        (CC and)
        (VP (VBN transfected)
          (NP (JJ non-piritrexim) (NNS groups))
          (, ,)
          (S
            (VP (VBG suggesting)
              (SBAR (IN that)
                (S
                  (NP (NN transfection))
                  (VP (MD may) (RB not)
                    (VP (VB affect)
                      (NP (DT the) (NN response)
                        (S
                          (VP (TO to)
                            (VP (VB piritrexim)
                              (NP (NN treatment)))))))))))))))
    (. .)))

advmod(observed-7, However-1)
neg(difference-5, no-3)
amod(difference-5, significant-4)
nsubjpass(observed-7, difference-5)
nsubjpass(transfected-16, difference-5)
auxpass(observed-7, was-6)
root(ROOT-0, observed-7)
case(levels-10, in-8)
compound(levels-10, CH-DHFR-9)
nmod:in(observed-7, levels-10)
case(piritrexim-14, between-11)
det(piritrexim-14, the-12)
amod(piritrexim-14, transfected-13)
nmod:between(levels-10, piritrexim-14)
cc(observed-7, and-15)
conj:and(observed-7, transfected-16)
amod(groups-18, non-piritrexim-17)
dobj(transfected-16, groups-18)
advcl(transfected-16, suggesting-20)
mark(affect-25, that-21)
nsubj(affect-25, transfection-22)
aux(affect-25, may-23)
neg(affect-25, not-24)
ccomp(suggesting-20, affect-25)
det(response-27, the-26)
dobj(affect-25, response-27)
mark(piritrexim-29, to-28)
acl(response-27, piritrexim-29)
dobj(piritrexim-29, treatment-30)

These/DT findings/NNS may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS targeting/VBG DHFR/NN in/IN cancer/NN treatment/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP
                  (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                  (VP (VBG targeting)
                    (NP
                      (NP (NN DHFR))
                      (PP (IN in)
                        (NP (NN cancer) (NN treatment))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(have-4, findings-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
dobj(have-4, implications-5)
case(development-8, for-6)
det(development-8, the-7)
nmod:for(implications-5, development-8)
case(strategies-12, of-9)
amod(strategies-12, novel-10)
amod(strategies-12, therapeutic-11)
nmod:of(development-8, strategies-12)
acl(strategies-12, targeting-13)
dobj(targeting-13, DHFR-14)
case(treatment-17, in-15)
compound(treatment-17, cancer-16)
nmod:in(DHFR-14, treatment-17)

Tabimorelin/NNP is_a/VBD synthetic/JJ peptide/NN with/IN growth_hormone-releasing/JJ activity/NN that/WDT has_been/VBP shown/VBN to/TO have/VB potential/JJ therapeutic/JJ effects/NNS in/IN various_disorders/NNS ./.

(ROOT
  (S
    (NP (NNP Tabimorelin))
    (VP (VBD is_a)
      (NP (JJ synthetic) (NN peptide))
      (PP (IN with)
        (NP
          (NP (JJ growth_hormone-releasing) (NN activity))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP has_been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP
                          (NP (JJ potential) (JJ therapeutic) (NNS effects))
                          (PP (IN in)
                            (NP (NNS various_disorders))))))))))))))
    (. .)))

nsubj(is_a-2, Tabimorelin-1)
root(ROOT-0, is_a-2)
amod(peptide-4, synthetic-3)
dobj(is_a-2, peptide-4)
case(activity-7, with-5)
amod(activity-7, growth_hormone-releasing-6)
nmod:with(is_a-2, activity-7)
nsubj(has_been-9, activity-7)
ref(activity-7, that-8)
acl:relcl(activity-7, has_been-9)
dep(has_been-9, shown-10)
mark(have-12, to-11)
xcomp(shown-10, have-12)
amod(effects-15, potential-13)
amod(effects-15, therapeutic-14)
dobj(have-12, effects-15)
case(various_disorders-17, in-16)
nmod:in(effects-15, various_disorders-17)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN Tabimorelin/NNP on/IN overeating/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP Tabimorelin)))
      (PP (IN on)
        (NP
          (NP (NN overeating))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effects-6, the-5)
nsubjpass(investigated-17, effects-6)
case(Tabimorelin-8, of-7)
nmod:of(effects-6, Tabimorelin-8)
case(overeating-10, on-9)
nmod:on(effects-6, overeating-10)
nmod:on(effects-6, photophobia-12)
conj:and(overeating-10, photophobia-12)
cc(overeating-10, and-14)
nmod:on(effects-6, phonophobia-15)
conj:and(overeating-10, phonophobia-15)
auxpass(investigated-17, were-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, Tabimorelin/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN overeating/VBG by/IN 14/CD %/NN with/IN a/DT 95/CD %/NN confidence/NN interval/NN of/IN 6-20/CD %/NN and/CC P/NNP value/NN of/IN 0.0005/CD ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (ADVP (IN at)
              (NP (CD 2) (NNS hours)))
            (IN after)
            (S
              (VP (VBG dosing))))
          (, ,)
          (NP (NNP Tabimorelin))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG overeating)
                    (PP (IN by)
                      (NP (CD 14) (NN %)))
                    (PP (IN with)
                      (NP
                        (NP
                          (NP (DT a)
                            (ADJP (CD 95) (NN %))
                            (NN confidence) (NN interval))
                          (PP (IN of)
                            (NP (CD 6-20) (NN %))))
                        (CC and)
                        (NP
                          (NP (NNP P) (NN value))
                          (PP (IN of)
                            (NP (CD 0.0005))))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
advmod(dosing-9, hours-7)
mark(dosing-9, after-8)
advcl(reduced-13, dosing-9)
nsubj(reduced-13, Tabimorelin-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
mark(overeating-17, of-16)
acl(risk-15, overeating-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(overeating-17, %-20)
case(interval-26, with-21)
det(interval-26, a-22)
compound(%-24, 95-23)
amod(interval-26, %-24)
compound(interval-26, confidence-25)
nmod:with(overeating-17, interval-26)
case(%-29, of-27)
nummod(%-29, 6-20-28)
nmod:of(interval-26, %-29)
cc(interval-26, and-30)
compound(value-32, P-31)
nmod:with(overeating-17, value-32)
conj:and(interval-26, value-32)
case(0.0005-34, of-33)
nmod:of(value-32, 0.0005-34)

Additionally/RB ,/, it/PRP also/RB demonstrated/VBD a/DT significant/JJ reduction/NN in/IN photophobia/NN by/IN 17/CD %/NN with/IN a/DT 95/CD %/NN confidence/NN interval/NN of/IN 12-22/CD %/NN ,/, and/CC P/NNP value/NN less/JJR than/IN 0.0001/CD ,/, as/RB well/RB as/IN a/DT significant/JJ decrease/NN in/IN phonophobia/NN by/IN 14/CD %/NN with/IN a/DT 95/CD %/NN confidence/NN interval/NN of/IN 17-20/CD %/NN ,/, and/CC P/NNP value/NN less/JJR than/IN 0.0001/CD ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (S
      (NP (PRP it))
      (ADVP (RB also))
      (VP (VBD demonstrated)
        (NP
          (NP (DT a) (JJ significant) (NN reduction))
          (PP (IN in)
            (NP (NN photophobia))))
        (PP (IN by)
          (NP (CD 17) (NN %)))
        (PP (IN with)
          (NP
            (NP (DT a)
              (ADJP (CD 95) (NN %))
              (NN confidence) (NN interval))
            (PP (IN of)
              (NP (CD 12-22) (NN %)))))))
    (, ,)
    (CC and)
    (S
      (NP (NNP P))
      (VP (NN value)
        (NP
          (NP
            (QP (JJR less) (IN than) (CD 0.0001)))
          (, ,)
          (CONJP (RB as) (RB well) (IN as))
          (NP
            (NP (DT a) (JJ significant) (NN decrease))
            (PP (IN in)
              (NP (NN phonophobia)))))
        (PP (IN by)
          (NP (CD 14) (NN %)))
        (PP (IN with)
          (NP
            (NP
              (NP (DT a)
                (ADJP (CD 95) (NN %))
                (NN confidence) (NN interval))
              (PP (IN of)
                (NP (CD 17-20) (NN %))))
            (, ,)
            (CC and)
            (NP
              (NP (NNP P) (NN value))
              (NP
                (QP (JJR less) (IN than) (CD 0.0001))))))))
    (. .)))

advmod(demonstrated-5, Additionally-1)
nsubj(demonstrated-5, it-3)
advmod(demonstrated-5, also-4)
root(ROOT-0, demonstrated-5)
det(reduction-8, a-6)
amod(reduction-8, significant-7)
dobj(demonstrated-5, reduction-8)
case(photophobia-10, in-9)
nmod:in(reduction-8, photophobia-10)
case(%-13, by-11)
nummod(%-13, 17-12)
nmod:by(demonstrated-5, %-13)
case(interval-19, with-14)
det(interval-19, a-15)
compound(%-17, 95-16)
amod(interval-19, %-17)
compound(interval-19, confidence-18)
nmod:with(demonstrated-5, interval-19)
case(%-22, of-20)
nummod(%-22, 12-22-21)
nmod:of(interval-19, %-22)
cc(demonstrated-5, and-24)
nsubj(value-26, P-25)
conj:and(demonstrated-5, value-26)
advmod(0.0001-29, less-27)
mwe(less-27, than-28)
dobj(value-26, 0.0001-29)
cc(0.0001-29, as-31)
mwe(as-31, well-32)
mwe(as-31, as-33)
det(decrease-36, a-34)
amod(decrease-36, significant-35)
dobj(value-26, decrease-36)
conj:and(0.0001-29, decrease-36)
case(phonophobia-38, in-37)
nmod:in(decrease-36, phonophobia-38)
case(%-41, by-39)
nummod(%-41, 14-40)
nmod:by(value-26, %-41)
case(interval-47, with-42)
det(interval-47, a-43)
compound(%-45, 95-44)
amod(interval-47, %-45)
compound(interval-47, confidence-46)
nmod:with(value-26, interval-47)
case(%-50, of-48)
nummod(%-50, 17-20-49)
nmod:of(interval-47, %-50)
cc(interval-47, and-52)
compound(value-54, P-53)
nmod:with(value-26, value-54)
conj:and(interval-47, value-54)
advmod(0.0001-57, less-55)
mwe(less-55, than-56)
dep(value-54, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN Tabimorelin/NNP may/MD be/VB a/DT potential/JJ therapeutic/JJ option/NN for/IN individuals/NNS suffering/VBG from/IN overeating/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Tabimorelin))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP
                          (NP (NN overeating))
                          (, ,)
                          (NP (NN photophobia))
                          (, ,)
                          (CC and)
                          (NP (NN phonophobia)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Tabimorelin-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(overeating-16, from-15)
nmod:from(suffering-14, overeating-16)
nmod:from(suffering-14, photophobia-18)
conj:and(overeating-16, photophobia-18)
cc(overeating-16, and-20)
nmod:from(suffering-14, phonophobia-21)
conj:and(overeating-16, phonophobia-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ efficacy/NN and/CC safety/NN of/IN Tabimorelin/NNP in/IN these/DT populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NN efficacy)
                  (CC and)
                  (NN safety))
                (PP (IN of)
                  (NP (NNP Tabimorelin))))
              (PP (IN in)
                (NP (DT these) (NNS populations))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(efficacy-9, the-7)
amod(efficacy-9, long-term-8)
dobj(investigate-6, efficacy-9)
cc(efficacy-9, and-10)
dobj(investigate-6, safety-11)
conj:and(efficacy-9, safety-11)
case(Tabimorelin-13, of-12)
nmod:of(efficacy-9, Tabimorelin-13)
case(populations-16, in-14)
det(populations-16, these-15)
nmod:in(investigate-6, populations-16)

The/DT pathogenesis/NN of/IN Lupus_Nephritis/NNP -LRB-/-LRB- LN/NNP -RRB-/-RRB- is/VBZ complex/JJ and/CC involves/VBZ multiple/JJ factors/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN pathogenesis))
        (PP (IN of)
          (NP (NNP Lupus_Nephritis))))
      (PRN (-LRB- -LRB-)
        (NP (NNP LN))
        (-RRB- -RRB-)))
    (VP
      (VP (VBZ is)
        (ADJP (JJ complex)))
      (CC and)
      (VP (VBZ involves)
        (NP (JJ multiple) (NNS factors))))
    (. .)))

det(pathogenesis-2, The-1)
nsubj(complex-9, pathogenesis-2)
nsubj(involves-11, pathogenesis-2)
case(Lupus_Nephritis-4, of-3)
nmod:of(pathogenesis-2, Lupus_Nephritis-4)
appos(pathogenesis-2, LN-6)
cop(complex-9, is-8)
root(ROOT-0, complex-9)
cc(complex-9, and-10)
conj:and(complex-9, involves-11)
amod(factors-13, multiple-12)
dobj(involves-11, factors-13)

Hippuric_acid/NNP -LRB-/-LRB- HA/NNP -RRB-/-RRB- is_a/VBD natural/JJ compound/NN produced/VBN by/IN the/DT liver/NN from/IN benzoic_acid/NN ,/, which/WDT has_been/VBP shown/VBN to/TO have/VB anti-inflammatory/JJ and/CC antioxidant/JJ properties/NNS ./.

(ROOT
  (S
    (NP (NNP Hippuric_acid) (-LRB- -LRB-)
      (NP (NNP HA))
      (-RRB- -RRB-))
    (VP (VBD is_a)
      (NP (JJ natural) (NN compound))
      (PP (VBN produced)
        (PP (IN by)
          (NP (DT the) (NN liver))))
      (PP (IN from)
        (NP
          (NP (NN benzoic_acid))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBP has_been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP (JJ anti-inflammatory)
                          (CC and)
                          (JJ antioxidant) (NNS properties))))))))))))
    (. .)))

nsubj(is_a-5, Hippuric_acid-1)
dep(Hippuric_acid-1, HA-3)
root(ROOT-0, is_a-5)
amod(compound-7, natural-6)
dobj(is_a-5, compound-7)
case(liver-11, produced-8)
case(liver-11, by-9)
det(liver-11, the-10)
advcl(is_a-5, liver-11)
case(benzoic_acid-13, from-12)
nmod:from(is_a-5, benzoic_acid-13)
nsubj(has_been-16, benzoic_acid-13)
ref(benzoic_acid-13, which-15)
acl:relcl(benzoic_acid-13, has_been-16)
dep(has_been-16, shown-17)
mark(have-19, to-18)
xcomp(shown-17, have-19)
amod(properties-23, anti-inflammatory-20)
cc(anti-inflammatory-20, and-21)
conj:and(anti-inflammatory-20, antioxidant-22)
amod(properties-23, antioxidant-22)
dobj(have-19, properties-23)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN HA/NNP on/IN LN/NNP and/CC associated/VBN symptoms/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP HA)))
      (PP (IN on)
        (NP
          (NP (NNP LN))
          (CC and)
          (NP (VBN associated) (NNS symptoms)))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-15, study-3)
det(effect-6, the-5)
nsubjpass(investigated-15, effect-6)
case(HA-8, of-7)
nmod:of(effect-6, HA-8)
case(LN-10, on-9)
nmod:on(effect-6, LN-10)
cc(LN-10, and-11)
amod(symptoms-13, associated-12)
nmod:on(effect-6, symptoms-13)
conj:and(LN-10, symptoms-13)
auxpass(investigated-15, was-14)
root(ROOT-0, investigated-15)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN in/IN patients/NNS with/IN LN/NNP ,/, who/WP were/VBD administered/VBN HA/NNP at_a/NN dose/NN of/IN 500/CD mg/NN twice/RB daily/RB for/IN 4/CD weeks/NNS ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (NP (NNS patients)))
        (PP (IN with)
          (NP
            (NP (NNP LN))
            (, ,)
            (SBAR
              (WHNP (WP who))
              (S
                (VP (VBD were)
                  (VP (VBN administered)
                    (NP
                      (NP (NNP HA) (NN at_a) (NN dose))
                      (PP (IN of)
                        (NP (CD 500) (NN mg))))
                    (ADVP (RB twice) (RB daily))
                    (PP (IN for)
                      (NP (CD 4) (NNS weeks)))))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(patients-6, in-5)
nmod:in(conducted-4, patients-6)
case(LN-8, with-7)
nmod:with(conducted-4, LN-8)
nsubjpass(administered-12, LN-8)
ref(LN-8, who-10)
auxpass(administered-12, were-11)
acl:relcl(LN-8, administered-12)
compound(dose-15, HA-13)
compound(dose-15, at_a-14)
dobj(administered-12, dose-15)
case(mg-18, of-16)
nummod(mg-18, 500-17)
nmod:of(dose-15, mg-18)
advmod(daily-20, twice-19)
advmod(administered-12, daily-20)
case(weeks-23, for-21)
nummod(weeks-23, 4-22)
nmod:for(administered-12, weeks-23)

At_2/JJ h/NN after/IN dosing/VBG ,/, HA/NNP reduced/VBD the/DT risk/NN of/IN Lupus_Nephritis/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP HA))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNPS Lupus_Nephritis))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, HA-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Lupus_Nephritis-11, of-10)
nmod:of(risk-9, Lupus_Nephritis-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN HA/NNP has/VBZ potential/JJ as/IN an/DT adjunct/JJ therapy/NN for/IN LN/NNP and/CC its/PRP$ associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP HA))
          (VP (VBZ has)
            (ADJP (JJ potential)
              (PP (IN as)
                (NP
                  (NP
                    (NP (DT an) (JJ adjunct) (NN therapy))
                    (PP (IN for)
                      (NP (NNP LN))))
                  (CC and)
                  (NP (PRP$ its) (VBN associated) (NNS symptoms)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(has-6, that-4)
nsubj(has-6, HA-5)
ccomp(suggest-3, has-6)
xcomp(has-6, potential-7)
case(therapy-11, as-8)
det(therapy-11, an-9)
amod(therapy-11, adjunct-10)
nmod:as(potential-7, therapy-11)
case(LN-13, for-12)
nmod:for(therapy-11, LN-13)
cc(therapy-11, and-14)
nmod:poss(symptoms-17, its-15)
amod(symptoms-17, associated-16)
nmod:as(potential-7, symptoms-17)
conj:and(therapy-11, symptoms-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN of/IN HA/NNP in/IN LN/NNP ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP
                      (NP (NN action))
                      (PP (IN of)
                        (NP (NNP HA)))))
                  (PP (IN in)
                    (NP (NNP LN))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
case(action-15, of-14)
nmod:of(mechanisms-13, action-15)
case(HA-17, of-16)
nmod:of(action-15, HA-17)
case(LN-19, in-18)
nmod:in(mechanisms-13, LN-19)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-26, omega-3_fatty_acids-2)
advmod(eicosapentaenoic_acid-5, specifically-4)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-5)
dobj(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
dep(EPA-7, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dobj(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
dep(DHA-16, n-3-20)
aux(studied-26, have-23)
auxpass(studied-26, been-24)
advmod(studied-26, extensively-25)
root(ROOT-0, studied-26)
case(benefits-31, for-27)
nmod:poss(benefits-31, their-28)
amod(benefits-31, potential-29)
compound(benefits-31, health-30)
nmod:for(studied-26, benefits-31)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN the/DT prevention/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP
                      (NP (DT the) (NN prevention))
                      (PP (IN of)
                        (NP (NN coronary_heart_disease))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
det(fatty_acids-6, these-5)
nsubj(play-8, fatty_acids-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-10, a-9)
dobj(play-8, role-10)
case(prevention-13, in-11)
det(prevention-13, the-12)
nmod:in(role-10, prevention-13)
case(coronary_heart_disease-15, of-14)
nmod:of(prevention-13, coronary_heart_disease-15)
appos(prevention-13, CHD-17)

In/IN addition/NN ,/, they/PRP have/VBP been/VBN found/VBN to_be/NN associated/VBN with/IN decreased/VBN Tazarotene/JJ levels/NNS in/IN hyperTazarotenemic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (JJ Tazarotene) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperTazarotenemic) (NNS patients))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-7, addition-2)
nsubjpass(found-7, they-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
dobj(found-7, to_be-8)
acl(to_be-8, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, Tazarotene-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperTazarotenemic-15)
nmod:in(levels-13, patients-16)

This/DT finding/NN may/MD have/VB important/JJ implications/NNS for/IN the/DT treatment/NN of/IN hyperTazarotenemia/NN ,/, which/WDT is_a/JJ condition/NN characterized/VBN by/IN high/JJ levels/NNS of/IN Tazarotene/NNP in/IN the/DT blood/NN and/CC is/VBZ associated/VBN with/IN an/DT increased/VBN risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP
                  (NP (NN hyperTazarotenemia))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP
                        (NP (JJ is_a) (NN condition))
                        (VP (VBN characterized)
                          (PP (IN by)
                            (NP
                              (NP (JJ high) (NNS levels))
                              (PP (IN of)
                                (NP (NNP Tazarotene)))
                              (PP (IN in)
                                (NP (DT the) (NN blood)))))
                          (ADVP (CC and))))
                      (VP (VBZ is)
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (DT an) (VBN increased) (NN risk))
                              (PP (IN of)
                                (S
                                  (VP (VBG developing)
                                    (NP (NNP CHD))))))))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(have-4, finding-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
amod(implications-6, important-5)
dobj(have-4, implications-6)
case(treatment-9, for-7)
det(treatment-9, the-8)
nmod:for(implications-6, treatment-9)
case(hyperTazarotenemia-11, of-10)
nmod:of(treatment-9, hyperTazarotenemia-11)
dobj(associated-27, hyperTazarotenemia-11)
ref(hyperTazarotenemia-11, which-13)
amod(condition-15, is_a-14)
nsubjpass(associated-27, condition-15)
acl(condition-15, characterized-16)
case(levels-19, by-17)
amod(levels-19, high-18)
nmod:by(characterized-16, levels-19)
case(Tazarotene-21, of-20)
nmod:of(levels-19, Tazarotene-21)
case(blood-24, in-22)
det(blood-24, the-23)
nmod:in(levels-19, blood-24)
advmod(characterized-16, and-25)
auxpass(associated-27, is-26)
acl:relcl(hyperTazarotenemia-11, associated-27)
case(risk-31, with-28)
det(risk-31, an-29)
amod(risk-31, increased-30)
nmod:with(associated-27, risk-31)
mark(developing-33, of-32)
acl(risk-31, developing-33)
dobj(developing-33, CHD-34)

The/DT mechanisms/NNS underlying/VBG the/DT effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN Tazarotene/JJ levels/NNS and/CC CHD/NNP risk/NN are/VBP not/RB fully/RB understood/VBN but/CC may/MD involve/VB changes/NNS in/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA)))
          (PP (IN on)
            (NP
              (NP (JJ Tazarotene) (NNS levels))
              (CC and)
              (NP (NNP CHD) (NN risk)))))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NNS changes))
            (PP (IN in)
              (NP
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (NP (NN inflammation))
                (, ,)
                (CC and)
                (NP (NNS oxidative_stress))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-19, mechanisms-2)
nsubj(involve-22, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, the-4)
dobj(underlying-3, effects-5)
case(EPA-7, of-6)
nmod:of(effects-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(effects-5, DHA-9)
conj:and(EPA-7, DHA-9)
case(levels-12, on-10)
amod(levels-12, Tazarotene-11)
nmod:on(effects-5, levels-12)
cc(levels-12, and-13)
compound(risk-15, CHD-14)
nmod:on(effects-5, risk-15)
conj:and(levels-12, risk-15)
auxpass(understood-19, are-16)
neg(understood-19, not-17)
advmod(understood-19, fully-18)
root(ROOT-0, understood-19)
cc(understood-19, but-20)
aux(involve-22, may-21)
conj:but(understood-19, involve-22)
dobj(involve-22, changes-23)
case(metabolism-26, in-24)
compound(metabolism-26, lipid-25)
nmod:in(changes-23, metabolism-26)
nmod:in(changes-23, inflammation-28)
conj:and(metabolism-26, inflammation-28)
cc(metabolism-26, and-30)
nmod:in(changes-23, oxidative_stress-31)
conj:and(metabolism-26, oxidative_stress-31)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB these/DT mechanisms/NNS and/CC to/TO determine/VB the/DT optimal/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and/CC hyperTazarotenemia/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT these) (NNS mechanisms))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN intake))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA)))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN prevention)
                        (CC and)
                        (NN treatment))
                      (PP (IN of)
                        (NP (NNP CHD)
                          (CC and)
                          (NNP hyperTazarotenemia))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, these-7)
dobj(elucidate-6, mechanisms-8)
cc(elucidate-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(elucidate-6, determine-11)
det(intake-14, the-12)
amod(intake-14, optimal-13)
dobj(determine-11, intake-14)
case(EPA-16, of-15)
nmod:of(intake-14, EPA-16)
cc(EPA-16, and-17)
nmod:of(intake-14, DHA-18)
conj:and(EPA-16, DHA-18)
case(prevention-21, for-19)
det(prevention-21, the-20)
nmod:for(intake-14, prevention-21)
cc(prevention-21, and-22)
nmod:for(intake-14, treatment-23)
conj:and(prevention-21, treatment-23)
case(CHD-25, of-24)
nmod:of(prevention-21, CHD-25)
cc(CHD-25, and-26)
nmod:of(prevention-21, hyperTazarotenemia-27)
conj:and(CHD-25, hyperTazarotenemia-27)

Migraine/VB is_a/JJ common/JJ neurological_disorder/NN that/WDT affects/VBZ millions/NNS of/IN people/NNS worldwide/RB ./.

(ROOT
  (S
    (VP (VB Migraine)
      (NP
        (NP (JJ is_a) (JJ common) (NN neurological_disorder))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP
                (NP (NNS millions))
                (PP (IN of)
                  (NP (NNS people))))))))
      (ADVP (RB worldwide)))
    (. .)))

root(ROOT-0, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
dobj(Migraine-1, neurological_disorder-4)
nsubj(affects-6, neurological_disorder-4)
ref(neurological_disorder-4, that-5)
acl:relcl(neurological_disorder-4, affects-6)
dobj(affects-6, millions-7)
case(people-9, of-8)
nmod:of(millions-7, people-9)
advmod(Migraine-1, worldwide-10)

It/PRP is/VBZ characterized/VBN by/IN recurrent/JJ headaches/NNS ,/, photophobia/NN ,/, phonophobia/NN ,/, and/CC nausea/NN ./.

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (VP (VBN characterized)
        (PP (IN by)
          (NP
            (NP (JJ recurrent) (NNS headaches))
            (, ,)
            (NP
              (NP (NN photophobia))
              (, ,)
              (NP (NN phonophobia))
              (, ,)
              (CC and)
              (NP (NN nausea)))))))
    (. .)))

nsubjpass(characterized-3, It-1)
auxpass(characterized-3, is-2)
root(ROOT-0, characterized-3)
case(headaches-6, by-4)
amod(headaches-6, recurrent-5)
nmod:by(characterized-3, headaches-6)
appos(headaches-6, photophobia-8)
appos(headaches-6, phonophobia-10)
conj:and(photophobia-8, phonophobia-10)
cc(photophobia-8, and-12)
appos(headaches-6, nausea-13)
conj:and(photophobia-8, nausea-13)

BMS-180194/NNP is_a/VBD novel/NN drug/NN that/WDT has_been/VBP developed/VBN for/IN the/DT treatment/NN of/IN migraine/NN ./.

(ROOT
  (S
    (NP (NNP BMS-180194))
    (VP (VBD is_a)
      (NP
        (NP (NN novel) (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN developed)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NN migraine)))))))))))
    (. .)))

nsubj(is_a-2, BMS-180194-1)
root(ROOT-0, is_a-2)
compound(drug-4, novel-3)
dobj(is_a-2, drug-4)
nsubj(has_been-6, drug-4)
ref(drug-4, that-5)
acl:relcl(drug-4, has_been-6)
dep(has_been-6, developed-7)
case(treatment-10, for-8)
det(treatment-10, the-9)
nmod:for(developed-7, treatment-10)
case(migraine-12, of-11)
nmod:of(treatment-10, migraine-12)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN BMS-180194/NN was/VBD evaluated/VBN in/IN reducing/VBG the/DT risk/NN of/IN leukocytopenia/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN patients/NNS with/IN migraine/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NN BMS-180194))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (NNP leukocytopenia))
                    (, ,)
                    (NP (NN photophobia))
                    (, ,)
                    (CC and)
                    (NP
                      (NP (NN phonophobia))
                      (PP (IN in)
                        (NP (NNS patients)))))))
              (PP (IN with)
                (NP (NN migraine))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(BMS-180194-8, of-7)
nmod:of(efficacy-6, BMS-180194-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
mark(reducing-12, in-11)
advcl(evaluated-10, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(leukocytopenia-16, of-15)
nmod:of(risk-14, leukocytopenia-16)
nmod:of(risk-14, photophobia-18)
conj:and(leukocytopenia-16, photophobia-18)
cc(leukocytopenia-16, and-20)
nmod:of(risk-14, phonophobia-21)
conj:and(leukocytopenia-16, phonophobia-21)
case(patients-23, in-22)
nmod:in(phonophobia-21, patients-23)
case(migraine-25, with-24)
nmod:with(reducing-12, migraine-25)

The/DT study/NN showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, BMS-180194/NNP reduced/VBD the/DT risk/NN of/IN leukocytopenia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP BMS-180194))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN leukocytopenia))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(study-2, The-1)
nsubj(showed-3, study-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-12, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-12, BMS-180194-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(leukocytopenia-16, of-15)
nmod:of(risk-14, leukocytopenia-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT results/NNS suggest/VBP that/IN BMS-180194/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS with/IN migraine/NN who/WP experience/VBP these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP BMS-180194))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP
                  (NP (NN migraine))
                  (SBAR
                    (WHNP (WP who))
                    (S
                      (VP (VBP experience)
                        (NP (DT these) (NNS symptoms))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, BMS-180194-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(migraine-15, with-14)
nmod:with(option-11, migraine-15)
nsubj(experience-17, migraine-15)
ref(migraine-15, who-16)
acl:relcl(migraine-15, experience-17)
det(symptoms-19, these-18)
dobj(experience-17, symptoms-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC to/TO evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN BMS-180194/NN in/IN treating/VBG migraine/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS findings))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NN BMS-180194))))
                (PP (IN in)
                  (S
                    (VP (VBG treating)
                      (NP (NN migraine)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
mark(evaluate-11, to-10)
ccomp(needed-4, evaluate-11)
conj:and(confirm-6, evaluate-11)
det(safety-14, the-12)
amod(safety-14, long-term-13)
dobj(evaluate-11, safety-14)
cc(safety-14, and-15)
dobj(evaluate-11, efficacy-16)
conj:and(safety-14, efficacy-16)
case(BMS-180194-18, of-17)
nmod:of(safety-14, BMS-180194-18)
mark(treating-20, in-19)
advcl(evaluate-11, treating-20)
dobj(treating-20, migraine-21)

This/DT study/NN aimed/VBD to/TO evaluate/VB the/DT effect/NN of/IN propentofylline/NN on/IN the/DT incidence/NN of/IN migraine_symptoms/NNS ,/, including/VBG bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN propentofylline))))
            (PP (IN on)
              (NP
                (NP (DT the) (NN incidence))
                (PP (IN of)
                  (NP
                    (NP (NNS migraine_symptoms))
                    (, ,)
                    (VP (VBG including)
                      (NP
                        (NP (NNS bronchospasms))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(evaluate-5, study-2)
root(ROOT-0, aimed-3)
mark(evaluate-5, to-4)
xcomp(aimed-3, evaluate-5)
det(effect-7, the-6)
dobj(evaluate-5, effect-7)
case(propentofylline-9, of-8)
nmod:of(effect-7, propentofylline-9)
case(incidence-12, on-10)
det(incidence-12, the-11)
nmod:on(evaluate-5, incidence-12)
case(migraine_symptoms-14, of-13)
nmod:of(incidence-12, migraine_symptoms-14)
acl(migraine_symptoms-14, including-16)
dobj(including-16, bronchospasms-17)
dobj(including-16, photophobia-19)
conj:and(bronchospasms-17, photophobia-19)
cc(bronchospasms-17, and-21)
dobj(including-16, phonophobia-22)
conj:and(bronchospasms-17, phonophobia-22)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN in/IN which/WDT participants/NNS received/VBD a/DT single/JJ dose/NN of/IN propentofylline/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNS participants))
              (VP (VBD received)
                (NP
                  (NP (DT a) (JJ single) (NN dose))
                  (PP (IN of)
                    (NP (NN propentofylline)
                      (CC or)
                      (NN placebo))))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
mark(received-13, in-10)
dobj(received-13, which-11)
nsubj(received-13, participants-12)
advcl(conducted-9, received-13)
det(dose-16, a-14)
amod(dose-16, single-15)
dobj(received-13, dose-16)
case(propentofylline-18, of-17)
nmod:of(dose-16, propentofylline-18)
cc(propentofylline-18, or-19)
nmod:of(dose-16, placebo-20)
conj:or(propentofylline-18, placebo-20)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, propentofylline/NN was/VBD found/VBD to/TO significantly/RB reduce/VB the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN propentofylline))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNS bronchospasms))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(hours-2, At_2-1)
dep(found-8, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubjpass(found-8, propentofylline-6)
nsubj:xsubj(reduce-11, propentofylline-6)
nsubj(photophobia-31, propentofylline-6)
nsubj(phonophobia-48, propentofylline-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(bronchospasms-15, of-14)
nmod:of(risk-13, bronchospasms-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-8, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-8, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-8, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-8, and-47)
conj:and(found-8, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-8, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT results/NNS suggest/VBP that/IN propentofylline/NN may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN patients/NNS with/IN migraine/NN who/WP experience/VBP these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN propentofylline))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP
                  (NP (NN migraine))
                  (SBAR
                    (WHNP (WP who))
                    (S
                      (VP (VBP experience)
                        (NP (DT these) (NNS symptoms))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, propentofylline-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(migraine-15, with-14)
nmod:with(option-11, migraine-15)
nsubj(experience-17, migraine-15)
ref(migraine-15, who-16)
acl:relcl(migraine-15, experience-17)
det(symptoms-19, these-18)
dobj(experience-17, symptoms-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN propentofylline/NN in/IN this/DT patient/JJ population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (NN propentofylline))
                      (PP (IN in)
                        (NP (DT this) (JJ patient) (NN population))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(regimen-14, the-11)
amod(regimen-14, optimal-12)
amod(regimen-14, dosing-13)
dobj(determine-10, regimen-14)
case(propentofylline-16, for-15)
nmod:for(regimen-14, propentofylline-16)
case(population-20, in-17)
det(population-20, this-18)
amod(population-20, patient-19)
nmod:in(propentofylline-16, population-20)

Neurotransmitters/NNS play/VBP a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN physiological/JJ and/CC behavioral/JJ processes/NNS ./.

(ROOT
  (S
    (NP (NNS Neurotransmitters))
    (VP (VBP play)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (ADJP (JJ physiological)
                  (CC and)
                  (JJ behavioral))
                (NNS processes)))))))
    (. .)))

nsubj(play-2, Neurotransmitters-1)
root(ROOT-0, play-2)
det(role-5, a-3)
amod(role-5, crucial-4)
dobj(play-2, role-5)
case(regulation-8, in-6)
det(regulation-8, the-7)
nmod:in(role-5, regulation-8)
case(processes-13, of-9)
amod(processes-13, physiological-10)
cc(physiological-10, and-11)
conj:and(physiological-10, behavioral-12)
amod(processes-13, behavioral-12)
nmod:of(regulation-8, processes-13)

To/TO investigate/VB the/DT presence/NN and/CC distribution/NN of/IN neurotransmitters/NNS in/IN the/DT nervous/JJ system/NN ,/, antibodies/NNS against/IN specific/JJ transporters/NNS and/CC enzymes/NNS have/VBP been/VBN developed/VBN ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB investigate)
          (NP
            (NP (DT the) (NN presence)
              (CC and)
              (NN distribution))
            (PP (IN of)
              (NP
                (NP (NNS neurotransmitters))
                (PP (IN in)
                  (NP (DT the) (JJ nervous) (NN system)))))))))
    (, ,)
    (NP
      (NP (NNS antibodies))
      (PP (IN against)
        (NP (JJ specific) (NNS transporters)
          (CC and)
          (NNS enzymes))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN developed))))
    (. .)))

mark(investigate-2, To-1)
advcl(developed-22, investigate-2)
det(presence-4, the-3)
dobj(investigate-2, presence-4)
cc(presence-4, and-5)
dobj(investigate-2, distribution-6)
conj:and(presence-4, distribution-6)
case(neurotransmitters-8, of-7)
nmod:of(presence-4, neurotransmitters-8)
case(system-12, in-9)
det(system-12, the-10)
amod(system-12, nervous-11)
nmod:in(neurotransmitters-8, system-12)
nsubjpass(developed-22, antibodies-14)
case(transporters-17, against-15)
amod(transporters-17, specific-16)
nmod:against(antibodies-14, transporters-17)
cc(transporters-17, and-18)
nmod:against(antibodies-14, enzymes-19)
conj:and(transporters-17, enzymes-19)
aux(developed-22, have-20)
auxpass(developed-22, been-21)
root(ROOT-0, developed-22)

In/IN this/DT study/NN ,/, antibodies/NNS against/IN vesicular/NN BI-L-239/NN transporters/NNS -LRB-/-LRB- Alox-5/NNS -RRB-/-RRB- ,/, vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- ,/, tyrosine_hydroxylase/NN -LRB-/-LRB- TH/NNP -RRB-/-RRB- ,/, dopamine_beta-hydroxylase/JJ -LRB-/-LRB- DBH/NNP -RRB-/-RRB- ,/, serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- ,/, vasoactive_intestinal_peptide/NN -LRB-/-LRB- VIP/NNP -RRB-/-RRB- ,/, and/CC protein_gene_product_9/CD .5/CD -LRB-/-LRB- PGP_9/CD .5/CD -RRB-/-RRB- were/VBD used/VBN to/TO identify/VB the/DT distribution/NN of/IN these/DT neurotransmitters/NNS in/IN different/JJ regions/NNS of/IN the/DT nervous/JJ system/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (NNS antibodies))
      (PP (IN against)
        (NP
          (NP
            (NP
              (NP (NN vesicular) (NN BI-L-239) (NNS transporters))
              (-LRB- -LRB-)
              (NP (NNS Alox-5))
              (-RRB- -RRB-))
            (, ,)
            (NP
              (NP (NN vesicular_acetylcholine_transporter))
              (PRN (-LRB- -LRB-)
                (NP (NNP VAChT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN tyrosine_hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP TH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ dopamine_beta-hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP DBH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN vasoactive_intestinal_peptide))
              (PRN (-LRB- -LRB-)
                (NP (NNP VIP))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (QP (CD protein_gene_product_9) (CD .5))))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD PGP_9) (CD .5)))
            (-RRB- -RRB-)))))
    (VP (VBD were)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB identify)
              (NP
                (NP (DT the) (NN distribution))
                (PP (IN of)
                  (NP (DT these) (NNS neurotransmitters))))
              (PP (IN in)
                (NP
                  (NP (JJ different) (NNS regions))
                  (PP (IN of)
                    (NP (DT the) (JJ nervous) (NN system))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(used-47, study-3)
nsubjpass(used-47, antibodies-5)
nsubj:xsubj(identify-49, antibodies-5)
case(transporters-9, against-6)
compound(transporters-9, vesicular-7)
compound(transporters-9, BI-L-239-8)
nmod:against(antibodies-5, transporters-9)
dep(transporters-9, Alox-5-11)
nmod:against(antibodies-5, vesicular_acetylcholine_transporter-14)
conj:and(transporters-9, vesicular_acetylcholine_transporter-14)
appos(vesicular_acetylcholine_transporter-14, VAChT-16)
nmod:against(antibodies-5, tyrosine_hydroxylase-19)
conj:and(transporters-9, tyrosine_hydroxylase-19)
appos(tyrosine_hydroxylase-19, TH-21)
nmod:against(antibodies-5, dopamine_beta-hydroxylase-24)
conj:and(transporters-9, dopamine_beta-hydroxylase-24)
appos(dopamine_beta-hydroxylase-24, DBH-26)
nmod:against(antibodies-5, serotonin-29)
conj:and(transporters-9, serotonin-29)
appos(serotonin-29, 5-HT-31)
nmod:against(antibodies-5, vasoactive_intestinal_peptide-34)
conj:and(transporters-9, vasoactive_intestinal_peptide-34)
appos(vasoactive_intestinal_peptide-34, VIP-36)
cc(transporters-9, and-39)
compound(.5-41, protein_gene_product_9-40)
nmod:against(antibodies-5, .5-41)
conj:and(transporters-9, .5-41)
compound(.5-44, PGP_9-43)
dep(transporters-9, .5-44)
auxpass(used-47, were-46)
root(ROOT-0, used-47)
mark(identify-49, to-48)
xcomp(used-47, identify-49)
det(distribution-51, the-50)
dobj(identify-49, distribution-51)
case(neurotransmitters-54, of-52)
det(neurotransmitters-54, these-53)
nmod:of(distribution-51, neurotransmitters-54)
case(regions-57, in-55)
amod(regions-57, different-56)
nmod:in(identify-49, regions-57)
case(system-61, of-58)
det(system-61, the-59)
amod(system-61, nervous-60)
nmod:of(regions-57, system-61)

These/DT antibodies/NNS were/VBD found/VBN to_be/JJ effective/JJ in/IN labeling/VBG specific/JJ neuronal_populations/NNS ,/, allowing/VBG for/IN detailed/JJ analysis/NN of/IN their/PRP$ function/NN and/CC connectivity/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS antibodies))
    (VP (VBD were)
      (VP (VBN found)
        (ADJP (JJ to_be))
        (S
          (ADJP (JJ effective)
            (PP (IN in)
              (S
                (VP (VBG labeling)
                  (NP (JJ specific) (NNS neuronal_populations)))))))
        (, ,)
        (S
          (VP (VBG allowing)
            (PP (IN for)
              (NP
                (NP (JJ detailed) (NN analysis))
                (PP (IN of)
                  (NP (PRP$ their) (NN function)
                    (CC and)
                    (NN connectivity)))))))))
    (. .)))

det(antibodies-2, These-1)
nsubjpass(found-4, antibodies-2)
auxpass(found-4, were-3)
root(ROOT-0, found-4)
xcomp(found-4, to_be-5)
xcomp(found-4, effective-6)
mark(labeling-8, in-7)
advcl(effective-6, labeling-8)
amod(neuronal_populations-10, specific-9)
dobj(labeling-8, neuronal_populations-10)
xcomp(found-4, allowing-12)
case(analysis-15, for-13)
amod(analysis-15, detailed-14)
nmod:for(allowing-12, analysis-15)
case(function-18, of-16)
nmod:poss(function-18, their-17)
nmod:of(analysis-15, function-18)
cc(function-18, and-19)
nmod:of(analysis-15, connectivity-20)
conj:and(function-18, connectivity-20)

The/DT results/NNS of/IN this/DT study/NN provide/VBP valuable/JJ insights/NNS into/IN the/DT role/NN of/IN these/DT neurotransmitters/NNS in/IN normal/JJ and/CC pathological/JJ conditions/NNS ,/, which/WDT could/MD lead/VB to/TO the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN neurological_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS results))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBP provide)
      (NP
        (NP (JJ valuable) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NN role))
            (PP (IN of)
              (NP
                (NP (DT these) (NNS neurotransmitters))
                (PP (IN in)
                  (NP
                    (NP
                      (ADJP (JJ normal)
                        (CC and)
                        (JJ pathological))
                      (NNS conditions))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (MD could)
                          (VP (VB lead)
                            (PP (TO to)
                              (NP
                                (NP (DT the) (NN development))
                                (PP (IN of)
                                  (NP
                                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                                    (PP (IN for)
                                      (NP (NNS neurological_disorders)))))))))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(provide-6, results-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(results-2, study-5)
root(ROOT-0, provide-6)
amod(insights-8, valuable-7)
dobj(provide-6, insights-8)
case(role-11, into-9)
det(role-11, the-10)
nmod:into(insights-8, role-11)
case(neurotransmitters-14, of-12)
det(neurotransmitters-14, these-13)
nmod:of(role-11, neurotransmitters-14)
case(conditions-19, in-15)
amod(conditions-19, normal-16)
cc(normal-16, and-17)
conj:and(normal-16, pathological-18)
amod(conditions-19, pathological-18)
nmod:in(neurotransmitters-14, conditions-19)
nsubj(lead-23, conditions-19)
ref(conditions-19, which-21)
aux(lead-23, could-22)
acl:relcl(conditions-19, lead-23)
case(development-26, to-24)
det(development-26, the-25)
nmod:to(lead-23, development-26)
case(strategies-30, of-27)
amod(strategies-30, novel-28)
amod(strategies-30, therapeutic-29)
nmod:of(development-26, strategies-30)
case(neurological_disorders-32, for-31)
nmod:for(strategies-30, neurological_disorders-32)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN the/DT human/JJ diet/NN that/WDT have/VBP been/VBN shown/VBN to/TO play/VB a/DT key/JJ role/NN in/IN maintaining/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ human) (NN diet))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP have)
                  (VP (VBN been)
                    (VP (VBN shown)
                      (S
                        (VP (TO to)
                          (VP (VB play)
                            (NP (DT a) (JJ key) (NN role))
                            (PP (IN in)
                              (S
                                (VP (VBG maintaining)
                                  (NP (NN cardiovascular_health)))))))))))))))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, the-18)
amod(diet-20, human-19)
nmod:of(components-16, diet-20)
nsubjpass(shown-24, diet-20)
nsubj:xsubj(play-26, diet-20)
ref(diet-20, that-21)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
acl:relcl(diet-20, shown-24)
mark(play-26, to-25)
xcomp(shown-24, play-26)
det(role-29, a-27)
amod(role-29, key-28)
dobj(play-26, role-29)
mark(maintaining-31, in-30)
advcl(play-26, maintaining-31)
dobj(maintaining-31, cardiovascular_health-32)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN DNP/NNP levels/NNS in/IN hyperDNPmic/JJ patients/NNS ,/, which/WDT is_a/JJ significant/JJ risk/NN factor/NN for/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,)
              (PP (JJ such) (IN as)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (VBN decreased) (NNP DNP) (NNS levels)))
                (PP (IN in)
                  (NP
                    (NP (JJ hyperDNPmic) (NNS patients))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP
                          (NP
                            (NP (JJ is_a) (JJ significant) (NN risk) (NN factor))
                            (PP (IN for)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-16, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-16, omega-3_fatty_acids-7)
case(EPA-11, such-9)
mwe(such-9, as-10)
nmod:such_as(omega-3_fatty_acids-7, EPA-11)
cc(EPA-11, and-12)
nmod:such_as(omega-3_fatty_acids-7, DHA-13)
conj:and(EPA-11, DHA-13)
auxpass(associated-16, are-15)
ccomp(demonstrated-4, associated-16)
case(levels-20, with-17)
amod(levels-20, decreased-18)
compound(levels-20, DNP-19)
nmod:with(associated-16, levels-20)
case(patients-23, in-21)
amod(patients-23, hyperDNPmic-22)
nmod:in(associated-16, patients-23)
nsubj(factor-29, patients-23)
ref(patients-23, which-25)
amod(factor-29, is_a-26)
amod(factor-29, significant-27)
compound(factor-29, risk-28)
acl:relcl(patients-23, factor-29)
mark(developing-31, for-30)
acl(factor-29, developing-31)
dobj(developing-31, coronary_heart_disease-32)
dep(factor-29, CHD-34)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (JJ dietary) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN cardiovascular_health))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
cc(reducing-18, and-23)
acl(strategy-16, improving-24)
conj:and(reducing-18, improving-24)
amod(cardiovascular_health-26, overall-25)
dobj(improving-24, cardiovascular_health-26)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosages/NNS of/IN EPA/NNP and/CC DHA/NNP for/IN achieving/VBG these/DT beneficial/JJ effects/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NNS dosages))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))))
                (PP (IN for)
                  (S
                    (VP (VBG achieving)
                      (NP (DT these) (JJ beneficial) (NNS effects)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
det(dosages-18, the-16)
amod(dosages-18, optimal-17)
dobj(determine-15, dosages-18)
case(EPA-20, of-19)
nmod:of(dosages-18, EPA-20)
cc(EPA-20, and-21)
nmod:of(dosages-18, DHA-22)
conj:and(EPA-20, DHA-22)
mark(achieving-24, for-23)
advcl(determine-15, achieving-24)
det(effects-27, these-25)
amod(effects-27, beneficial-26)
dobj(achieving-24, effects-27)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT expression/NN and/CC activity/NN of/IN several/JJ key/JJ enzymes/NNS in/IN various/JJ metabolic/JJ pathways/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN expression)
          (CC and)
          (NN activity))
        (PP (IN of)
          (NP
            (NP (JJ several) (JJ key) (NNS enzymes))
            (PP (IN in)
              (NP (JJ various) (JJ metabolic) (NNS pathways)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(expression-8, the-7)
dobj(investigated-6, expression-8)
cc(expression-8, and-9)
dobj(investigated-6, activity-10)
conj:and(expression-8, activity-10)
case(enzymes-14, of-11)
amod(enzymes-14, several-12)
amod(enzymes-14, key-13)
nmod:of(expression-8, enzymes-14)
case(pathways-18, in-15)
amod(pathways-18, various-16)
amod(pathways-18, metabolic-17)
nmod:in(enzymes-14, pathways-18)

These/DT enzymes/NNS included/VBD HET0016/CD dehydrogenase/NN -LRB-/-LRB- ADH/NNP -RRB-/-RRB- ,/, alpha-glycerol-3-phosphate_dehydrogenase/JJ -LRB-/-LRB- alpha/NN GPDH/NNS -RRB-/-RRB- ,/, malate_dehydrogenase/JJ -LRB-/-LRB- MDH/NNP -RRB-/-RRB- ,/, isocitrate_dehydrogenase/JJ -LRB-/-LRB- IDH/NNP -RRB-/-RRB- ,/, glucose-6-phosphate_dehydrogenase/JJ -LRB-/-LRB- G6PD/NNP -RRB-/-RRB- ,/, anthocyanidin_reductase/JJ -LRB-/-LRB- 6PGD/CD -RRB-/-RRB- and_alpha-amylase/JJ -LRB-/-LRB- AMY/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS enzymes))
    (VP (VBD included)
      (ADJP
        (ADJP (CD HET0016) (NN dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP ADH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ alpha-glycerol-3-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NN alpha) (NNS GPDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ malate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP MDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ isocitrate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP IDH))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ glucose-6-phosphate_dehydrogenase))
        (PRN (-LRB- -LRB-)
          (NP (NNP G6PD))
          (-RRB- -RRB-))
        (, ,)
        (ADJP
          (ADJP
            (ADJP (JJ anthocyanidin_reductase))
            (PRN (-LRB- -LRB-)
              (NP (CD 6PGD))
              (-RRB- -RRB-)))
          (ADJP (JJ and_alpha-amylase)))
        (PRN (-LRB- -LRB-)
          (NP (NNP AMY))
          (-RRB- -RRB-))))
    (. .)))

det(enzymes-2, These-1)
nsubj(included-3, enzymes-2)
root(ROOT-0, included-3)
compound(dehydrogenase-5, HET0016-4)
xcomp(included-3, dehydrogenase-5)
dep(dehydrogenase-5, ADH-7)
dep(dehydrogenase-5, alpha-glycerol-3-phosphate_dehydrogenase-10)
compound(GPDH-13, alpha-12)
dep(dehydrogenase-5, GPDH-13)
dep(dehydrogenase-5, malate_dehydrogenase-16)
dep(dehydrogenase-5, MDH-18)
dep(dehydrogenase-5, isocitrate_dehydrogenase-21)
dep(dehydrogenase-5, IDH-23)
dep(dehydrogenase-5, glucose-6-phosphate_dehydrogenase-26)
dep(dehydrogenase-5, G6PD-28)
dep(dehydrogenase-5, anthocyanidin_reductase-31)
dep(anthocyanidin_reductase-31, 6PGD-33)
dep(anthocyanidin_reductase-31, and_alpha-amylase-35)
dep(dehydrogenase-5, AMY-37)

The/DT activity/NN of/IN these/DT enzymes/NNS was/VBD measured/VBN in/IN different/JJ tissues/NNS and/CC under/IN various/JJ conditions/NNS to/TO gain/VB insight/NN into/IN their/PRP$ roles/NNS in/IN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN activity))
      (PP (IN of)
        (NP (DT these) (NNS enzymes))))
    (VP (VBD was)
      (VP (VBN measured)
        (PP (IN in)
          (NP (JJ different) (NNS tissues))))
      (CC and)
      (PP (IN under)
        (NP (JJ various) (NNS conditions)))
      (S
        (VP (TO to)
          (VP (VB gain)
            (NP (NN insight))
            (PP (IN into)
              (NP
                (NP (PRP$ their) (NNS roles))
                (PP (IN in)
                  (NP (NN metabolism)))))))))
    (. .)))

det(activity-2, The-1)
nsubjpass(measured-7, activity-2)
nsubj:xsubj(gain-16, activity-2)
case(enzymes-5, of-3)
det(enzymes-5, these-4)
nmod:of(activity-2, enzymes-5)
auxpass(measured-7, was-6)
root(ROOT-0, measured-7)
case(tissues-10, in-8)
amod(tissues-10, different-9)
nmod:in(measured-7, tissues-10)
cc(measured-7, and-11)
case(conditions-14, under-12)
amod(conditions-14, various-13)
conj:and(measured-7, conditions-14)
mark(gain-16, to-15)
xcomp(measured-7, gain-16)
dobj(gain-16, insight-17)
case(roles-20, into-18)
nmod:poss(roles-20, their-19)
nmod:into(gain-16, roles-20)
case(metabolism-22, in-21)
nmod:in(roles-20, metabolism-22)

Our/PRP$ findings/NNS suggest/VBP that/IN these/DT enzymes/NNS play/VB critical/JJ roles/NNS in_a/NN range/NN of/IN metabolic/JJ processes/NNS ,/, including/VBG energy/NN production/NN ,/, glycolysis/NNS ,/, and/CC carbohydrate/JJ metabolism/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS enzymes))
          (VP (VB play)
            (NP (JJ critical) (NNS roles))
            (NP
              (NP (NN in_a) (NN range))
              (PP (IN of)
                (NP (JJ metabolic) (NNS processes)))
              (, ,)
              (VP (VBG including)
                (NP
                  (NP (NN energy) (NN production))
                  (, ,)
                  (NP (NNS glycolysis))
                  (, ,)
                  (CC and)
                  (NP (JJ carbohydrate) (NN metabolism)))))))))
    (. .)))

nmod:poss(findings-2, Our-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
det(enzymes-6, these-5)
nsubj(play-7, enzymes-6)
ccomp(suggest-3, play-7)
amod(roles-9, critical-8)
iobj(play-7, roles-9)
compound(range-11, in_a-10)
dobj(play-7, range-11)
case(processes-14, of-12)
amod(processes-14, metabolic-13)
nmod:of(range-11, processes-14)
acl(range-11, including-16)
compound(production-18, energy-17)
dobj(including-16, production-18)
dobj(including-16, glycolysis-20)
conj:and(production-18, glycolysis-20)
cc(production-18, and-22)
amod(metabolism-24, carbohydrate-23)
dobj(including-16, metabolism-24)
conj:and(production-18, metabolism-24)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT complex/JJ interplay/NN between/IN these/DT enzymes/NNS and/CC their/PRP$ impact/NN on/IN overall/JJ metabolic/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (JJ complex) (NN interplay))
                (PP (IN between)
                  (NP
                    (NP (DT these) (NNS enzymes))
                    (CC and)
                    (NP
                      (NP (PRP$ their) (NN impact))
                      (PP (IN on)
                        (NP (JJ overall) (JJ metabolic) (NN function))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(interplay-10, the-8)
amod(interplay-10, complex-9)
dobj(understand-7, interplay-10)
case(enzymes-13, between-11)
det(enzymes-13, these-12)
nmod:between(interplay-10, enzymes-13)
cc(enzymes-13, and-14)
nmod:poss(impact-16, their-15)
nmod:between(interplay-10, impact-16)
conj:and(enzymes-13, impact-16)
case(function-20, on-17)
amod(function-20, overall-18)
amod(function-20, metabolic-19)
nmod:on(impact-16, function-20)

The/DT use/NN of/IN photosensitizing/VBG agents/NNS in/IN the/DT treatment/NN of/IN various_diseases/NNS has_been/VBP associated/VBN with/IN the/DT risk/NN of/IN phototoxic_reactions/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP
          (NP (VBG photosensitizing) (NNS agents))
          (PP (IN in)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP (NNS various_diseases))))))))
    (VP (VBP has_been)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT the) (NN risk))
            (PP (IN of)
              (NP
                (NP (NNS phototoxic_reactions))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

det(use-2, The-1)
nsubj(has_been-11, use-2)
case(agents-5, of-3)
amod(agents-5, photosensitizing-4)
nmod:of(use-2, agents-5)
case(treatment-8, in-6)
det(treatment-8, the-7)
nmod:in(agents-5, treatment-8)
case(various_diseases-10, of-9)
nmod:of(treatment-8, various_diseases-10)
root(ROOT-0, has_been-11)
dep(has_been-11, associated-12)
case(risk-15, with-13)
det(risk-15, the-14)
nmod:with(associated-12, risk-15)
case(phototoxic_reactions-17, of-16)
nmod:of(risk-15, phototoxic_reactions-17)
nmod:of(risk-15, photophobia-19)
conj:and(phototoxic_reactions-17, photophobia-19)
cc(phototoxic_reactions-17, and-21)
nmod:of(risk-15, phonophobia-22)
conj:and(phototoxic_reactions-17, phonophobia-22)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN Butibufen/NNP on/IN reducing/VBG these/DT adverse_reactions/NNS was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Butibufen)))
      (PP (IN on)
        (S
          (VP (VBG reducing)
            (NP (DT these) (NNS adverse_reactions))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-14, study-3)
det(effect-6, the-5)
nsubjpass(investigated-14, effect-6)
case(Butibufen-8, of-7)
nmod:of(effect-6, Butibufen-8)
mark(reducing-10, on-9)
acl(effect-6, reducing-10)
det(adverse_reactions-12, these-11)
dobj(reducing-10, adverse_reactions-12)
auxpass(investigated-14, was-13)
root(ROOT-0, investigated-14)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, Butibufen/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN phototoxic_reactions/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP Butibufen))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS phototoxic_reactions))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, Butibufen-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(phototoxic_reactions-17, of-16)
nmod:of(risk-15, phototoxic_reactions-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN Butibufen/NNP may/MD be/VB a/DT promising/JJ agent/NN for/IN the/DT management/NN of/IN photosensitivity-related/JJ adverse_reactions/NNS and/CC warrants/NNS further/JJ investigation/NN in/IN clinical/JJ trials/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Butibufen))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN agent))
                (PP (IN for)
                  (NP
                    (NP (DT the)
                      (NAC (NN management)
                        (PP (IN of)
                          (NP (JJ photosensitivity-related) (NNS adverse_reactions)
                            (CC and)
                            (NNS warrants))))
                      (JJ further) (NN investigation))
                    (PP (IN in)
                      (NP (JJ clinical) (NNS trials)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(agent-10, that-4)
nsubj(agent-10, Butibufen-5)
aux(agent-10, may-6)
cop(agent-10, be-7)
det(agent-10, a-8)
amod(agent-10, promising-9)
ccomp(suggest-3, agent-10)
case(investigation-20, for-11)
det(investigation-20, the-12)
dep(investigation-20, management-13)
case(adverse_reactions-16, of-14)
amod(adverse_reactions-16, photosensitivity-related-15)
nmod:of(management-13, adverse_reactions-16)
cc(adverse_reactions-16, and-17)
nmod:of(management-13, warrants-18)
conj:and(adverse_reactions-16, warrants-18)
amod(investigation-20, further-19)
nmod:for(agent-10, investigation-20)
case(trials-23, in-21)
amod(trials-23, clinical-22)
nmod:in(investigation-20, trials-23)

Omega-3_polyunsaturated_fatty_acids/NNP -LRB-/-LRB- PUFAs/NNP -RRB-/-RRB- have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNP Omega-3_polyunsaturated_fatty_acids) (-LRB- -LRB-)
      (NP (NNP PUFAs))
      (-RRB- -RRB-))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-8, Omega-3_polyunsaturated_fatty_acids-1)
dep(Omega-3_polyunsaturated_fatty_acids-1, PUFAs-3)
aux(studied-8, have-5)
auxpass(studied-8, been-6)
advmod(studied-8, extensively-7)
root(ROOT-0, studied-8)
case(benefits-13, for-9)
nmod:poss(benefits-13, their-10)
amod(benefits-13, potential-11)
compound(benefits-13, health-12)
nmod:for(studied-8, benefits-13)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ and/CC cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (ADJP (JJ anti-inflammatory)
                  (CC and)
                  (JJ cardioprotective))
                (NNS effects)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-15, omega-3_fatty_acids-2)
nsubj:xsubj(have-17, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(have-17, to-16)
xcomp(known-15, have-17)
amod(effects-21, anti-inflammatory-18)
cc(anti-inflammatory-18, and-19)
conj:and(anti-inflammatory-18, cardioprotective-20)
amod(effects-21, cardioprotective-20)
dobj(have-17, effects-21)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS may/MD also/RB play/VB a/DT role/NN in/IN regulating/VBG zinc/NN metabolism/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may) (RB also)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (NN zinc) (NN metabolism))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(play-10, that-5)
det(fatty_acids-7, these-6)
nsubj(play-10, fatty_acids-7)
aux(play-10, may-8)
advmod(play-10, also-9)
ccomp(shown-4, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
mark(regulating-14, in-13)
acl(role-12, regulating-14)
compound(metabolism-16, zinc-15)
dobj(regulating-14, metabolism-16)

In/IN hyperZnOmic/JJ patients/NNS ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN ZnO/NNP levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ hyperZnOmic) (NNS patients)))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP (VBN decreased) (NNP ZnO) (NNS levels))))))
    (. .)))

case(patients-3, In-1)
amod(patients-3, hyperZnOmic-2)
nmod:in(associated-9, patients-3)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(associated-9, omega-3_fatty_acids-6)
aux(associated-9, have-7)
auxpass(associated-9, been-8)
root(ROOT-0, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, ZnO-12)
nmod:with(associated-9, levels-13)

Furthermore/RB ,/, epidemiological/JJ studies/NNS have/VBP demonstrated/VBN that/IN a/DT diet/NN rich/JJ in/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT a) (NN diet))
              (PP (JJ rich) (IN in)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(demonstrated-6, Furthermore-1)
amod(studies-4, epidemiological-3)
nsubj(demonstrated-6, studies-4)
aux(demonstrated-6, have-5)
root(ROOT-0, demonstrated-6)
mark(associated-16, that-7)
det(diet-9, a-8)
nsubjpass(associated-16, diet-9)
case(EPA-12, rich-10)
case(EPA-12, in-11)
nmod:in(diet-9, EPA-12)
cc(EPA-12, and-13)
nmod:in(diet-9, DHA-14)
conj:and(EPA-12, DHA-14)
auxpass(associated-16, is-15)
ccomp(demonstrated-6, associated-16)
case(risk-20, with-17)
det(risk-20, a-18)
amod(risk-20, decreased-19)
nmod:with(associated-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

These/DT findings/NNS suggest/VBP that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT important/JJ dietary/JJ component/NN for/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP and/CC zinc-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ important) (JJ dietary) (NN component))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN management))
                    (PP (IN of)
                      (NP
                        (NP (NNP CHD))
                        (CC and)
                        (NP (NNS zinc-related_disorders))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(component-12, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubj(component-12, omega-3_fatty_acids-6)
aux(component-12, may-7)
cop(component-12, be-8)
det(component-12, an-9)
amod(component-12, important-10)
amod(component-12, dietary-11)
ccomp(suggest-3, component-12)
case(prevention-15, for-13)
det(prevention-15, the-14)
nmod:for(component-12, prevention-15)
cc(prevention-15, and-16)
nmod:for(component-12, management-17)
conj:and(prevention-15, management-17)
case(CHD-19, of-18)
nmod:of(prevention-15, CHD-19)
cc(CHD-19, and-20)
nmod:of(prevention-15, zinc-related_disorders-21)
conj:and(CHD-19, zinc-related_disorders-21)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB optimal/JJ doses/NNS for/IN therapeutic/JJ interventions/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS doses))
                  (PP (IN for)
                    (NP (JJ therapeutic) (NNS interventions))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(associations-11, these-10)
dobj(underlying-9, associations-11)
cc(elucidate-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(elucidate-6, determine-14)
amod(doses-16, optimal-15)
dobj(determine-14, doses-16)
case(interventions-19, for-17)
amod(interventions-19, therapeutic-18)
nmod:for(doses-16, interventions-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN EPA/NNP and/CC DHA/NNP are/VBP associated/VBN with/IN decreased/VBN allylglycine/JJ levels/NNS in/IN hyperallylglycinemic/JJ patients/NNS ,/, which/WDT suggests/VBZ a/DT potential/JJ therapeutic/JJ role/NN for/IN these/DT fatty_acids/NNS in/IN the/DT management/NN of/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ allylglycine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperallylglycinemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (VBZ suggests)
                              (NP
                                (NP (DT a) (JJ potential) (JJ therapeutic) (NN role))
                                (PP (IN for)
                                  (NP
                                    (NP (DT these) (NNS fatty_acids))
                                    (PP (IN in)
                                      (NP
                                        (NP (DT the) (NN management))
                                        (PP (IN of)
                                          (NP (DT this) (NN condition)))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-10, that-5)
nsubjpass(associated-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubjpass(associated-10, DHA-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, allylglycine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperallylglycinemic-16)
nmod:in(levels-14, patients-17)
nsubj(suggests-20, patients-17)
ref(patients-17, which-19)
acl:relcl(patients-17, suggests-20)
det(role-24, a-21)
amod(role-24, potential-22)
amod(role-24, therapeutic-23)
dobj(suggests-20, role-24)
case(fatty_acids-27, for-25)
det(fatty_acids-27, these-26)
nmod:for(role-24, fatty_acids-27)
case(management-30, in-28)
det(management-30, the-29)
nmod:in(fatty_acids-27, management-30)
case(condition-33, of-31)
det(condition-33, this-32)
nmod:of(management-30, condition-33)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (VBN reduced) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (VP (VB coronary_heart_disease)
                      (NP
                        (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                        (, ,)
                        (NP
                          (NP (DT a) (VBG leading) (NN cause))
                          (PP (IN of)
                            (NP (NN morbidity)
                              (CC and)
                              (NN mortality)))))
                      (ADVP (RB worldwide)))))))))))
    (. .)))

advmod(linked-8, Additionally-1)
nsubjpass(linked-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(linked-8, DHA-5)
aux(linked-8, have-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, reduced-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
xcomp(developing-14, coronary_heart_disease-15)
dobj(coronary_heart_disease-15, CHD-17)
det(cause-22, a-20)
amod(cause-22, leading-21)
appos(CHD-17, cause-22)
case(morbidity-24, of-23)
nmod:of(cause-22, morbidity-24)
cc(morbidity-24, and-25)
nmod:of(cause-22, mortality-26)
conj:and(morbidity-24, mortality-26)
advmod(coronary_heart_disease-15, worldwide-27)

This/DT protective/JJ effect/NN may/MD be/VB due/JJ to/TO their/PRP$ ability/NN to/TO lower/JJR triglyceride_levels/NNS ,/, reduce/VB inflammation/NN ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (PRP$ their) (NN ability))
              (PP (TO to)
                (NP (JJR lower) (NNS triglyceride_levels)))))))
      (, ,)
      (VP
        (VP (VB reduce)
          (NP (NN inflammation)))
        (, ,)
        (CC and)
        (VP (VB improve)
          (NP (JJ endothelial) (NN function)))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubj(due-6, effect-3)
aux(due-6, may-4)
cop(due-6, be-5)
root(ROOT-0, due-6)
case(ability-9, to-7)
nmod:poss(ability-9, their-8)
nmod:to(due-6, ability-9)
case(triglyceride_levels-12, to-10)
amod(triglyceride_levels-12, lower-11)
nmod:to(ability-9, triglyceride_levels-12)
dep(due-6, reduce-14)
dobj(reduce-14, inflammation-15)
cc(reduce-14, and-17)
dep(due-6, improve-18)
conj:and(reduce-14, improve-18)
amod(function-20, endothelial-19)
dobj(improve-18, function-20)

Given/VBN the/DT growing/VBG body/NN of/IN evidence/NN supporting/VBG the/DT health/NN benefits/NNS of/IN omega-3_fatty_acids/JJ ,/, further/JJ research/NN is/VBZ warranted/VBN to/TO fully/RB elucidate/VB their/PRP$ mechanisms/NNS of/IN action/NN and/CC potential/JJ clinical/JJ applications/NNS in/IN the/DT prevention/NN and/CC treatment/NN of/IN various_diseases/NNS ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP
        (NP (DT the) (VBG growing) (NN body))
        (PP (IN of)
          (NP
            (NP (NN evidence))
            (VP (VBG supporting)
              (NP
                (NP (DT the) (NN health) (NNS benefits))
                (PP (IN of)
                  (NP (JJ omega-3_fatty_acids)))))))))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP
                  (NP (PRP$ their) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ clinical) (NNS applications))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN prevention)
                        (CC and)
                        (NN treatment))
                      (PP (IN of)
                        (NP (NNS various_diseases))))))))))))
    (. .)))

case(body-4, Given-1)
det(body-4, the-2)
amod(body-4, growing-3)
nmod:given(warranted-17, body-4)
case(evidence-6, of-5)
nmod:of(body-4, evidence-6)
acl(evidence-6, supporting-7)
det(benefits-10, the-8)
compound(benefits-10, health-9)
dobj(supporting-7, benefits-10)
case(omega-3_fatty_acids-12, of-11)
nmod:of(benefits-10, omega-3_fatty_acids-12)
amod(research-15, further-14)
nsubjpass(warranted-17, research-15)
nsubj:xsubj(elucidate-20, research-15)
auxpass(warranted-17, is-16)
root(ROOT-0, warranted-17)
mark(elucidate-20, to-18)
advmod(elucidate-20, fully-19)
xcomp(warranted-17, elucidate-20)
nmod:poss(mechanisms-22, their-21)
dobj(elucidate-20, mechanisms-22)
case(action-24, of-23)
nmod:of(mechanisms-22, action-24)
cc(mechanisms-22, and-25)
amod(applications-28, potential-26)
amod(applications-28, clinical-27)
dobj(elucidate-20, applications-28)
conj:and(mechanisms-22, applications-28)
case(prevention-31, in-29)
det(prevention-31, the-30)
nmod:in(applications-28, prevention-31)
cc(prevention-31, and-32)
nmod:in(applications-28, treatment-33)
conj:and(prevention-31, treatment-33)
case(various_diseases-35, of-34)
nmod:of(prevention-31, various_diseases-35)

Eicosapentaenoic_acid/NNP -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- are/VBP long-chain/JJ omega-3_fatty_acids/NNS that/WDT have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP Eicosapentaenoic_acid))
          (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (JJ long-chain) (NNS omega-3_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP (JJ numerous) (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(omega-3_fatty_acids-12, Eicosapentaenoic_acid-1)
dep(Eicosapentaenoic_acid-1, EPA-3)
cc(Eicosapentaenoic_acid-1, and-5)
conj:and(Eicosapentaenoic_acid-1, docosahexaenoic_acid-6)
nsubj(omega-3_fatty_acids-12, docosahexaenoic_acid-6)
appos(Eicosapentaenoic_acid-1, DHA-8)
cop(omega-3_fatty_acids-12, are-10)
amod(omega-3_fatty_acids-12, long-chain-11)
root(ROOT-0, omega-3_fatty_acids-12)
nsubjpass(shown-16, omega-3_fatty_acids-12)
nsubj:xsubj(have-18, omega-3_fatty_acids-12)
ref(omega-3_fatty_acids-12, that-13)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
acl:relcl(omega-3_fatty_acids-12, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (S
                              (VP (VBG developing)
                                (NP (NN coronary_heart_disease))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
det(fatty_acids-6, these-5)
nsubj(play-8, fatty_acids-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-10, a-9)
dobj(play-8, role-10)
mark(reducing-12, in-11)
acl(role-10, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

In/IN addition/NN ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN esorubicin/NN in/IN hyperesorubicinmic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN esorubicin))
                  (PP (IN in)
                    (NP (JJ hyperesorubicinmic) (NNS patients))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(associated-9, addition-2)
nsubjpass(associated-9, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(associated-9, DHA-6)
aux(associated-9, have-7)
auxpass(associated-9, been-8)
root(ROOT-0, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(esorubicin-14, of-13)
nmod:of(levels-12, esorubicin-14)
case(patients-17, in-15)
amod(patients-17, hyperesorubicinmic-16)
nmod:in(esorubicin-14, patients-17)

Esorubicin/NNP is_a/VBZ chemotherapy/JJ drug/NN used/VBN to/TO treat/VB various/JJ types/NNS of/IN cancer/NN ,/, but/CC it/PRP can/MD cause/VB cardiotoxicity/RB as/IN a/DT side/NN effect/NN ./.

(ROOT
  (S
    (S
      (NP (NNP Esorubicin))
      (VP (VBZ is_a)
        (NP
          (NP (JJ chemotherapy) (NN drug))
          (VP (VBN used)
            (S
              (VP (TO to)
                (VP (VB treat)
                  (NP
                    (NP (JJ various) (NNS types))
                    (PP (IN of)
                      (NP (NN cancer)))))))))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (MD can)
        (VP (VB cause)
          (ADVP (RB cardiotoxicity))
          (PP (IN as)
            (NP (DT a) (NN side) (NN effect))))))
    (. .)))

nsubj(is_a-2, Esorubicin-1)
root(ROOT-0, is_a-2)
amod(drug-4, chemotherapy-3)
dobj(is_a-2, drug-4)
acl(drug-4, used-5)
mark(treat-7, to-6)
xcomp(used-5, treat-7)
amod(types-9, various-8)
dobj(treat-7, types-9)
case(cancer-11, of-10)
nmod:of(types-9, cancer-11)
cc(is_a-2, but-13)
nsubj(cause-16, it-14)
aux(cause-16, can-15)
conj:but(is_a-2, cause-16)
advmod(cause-16, cardiotoxicity-17)
case(effect-21, as-18)
det(effect-21, a-19)
compound(effect-21, side-20)
nmod:as(cause-16, effect-21)

The/DT mechanisms/NNS underlying/VBG the/DT protective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP and/CC esorubicin-induced/JJ cardiotoxicity/NN are/VBP not/RB fully/RB understood/VBN ,/, but/CC they/PRP may/MD involve/VB anti-inflammatory/JJ and/CC anti-arrhythmic/JJ properties/NNS of/IN these/DT fatty_acids/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP
            (NP (DT the) (JJ protective) (NNS effects))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA)))
            (PP (IN on)
              (NP
                (NP (NNP CHD))
                (CC and)
                (NP (JJ esorubicin-induced) (NN cardiotoxicity)))))))
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP they))
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (JJ anti-inflammatory)
              (CC and)
              (JJ anti-arrhythmic) (NNS properties))
            (PP (IN of)
              (NP (DT these) (NNS fatty_acids)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-19, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(CHD-12, on-11)
nmod:on(effects-6, CHD-12)
cc(CHD-12, and-13)
amod(cardiotoxicity-15, esorubicin-induced-14)
nmod:on(effects-6, cardiotoxicity-15)
conj:and(CHD-12, cardiotoxicity-15)
auxpass(understood-19, are-16)
neg(understood-19, not-17)
advmod(understood-19, fully-18)
root(ROOT-0, understood-19)
cc(understood-19, but-21)
nsubj(involve-24, they-22)
aux(involve-24, may-23)
conj:but(understood-19, involve-24)
amod(properties-28, anti-inflammatory-25)
cc(anti-inflammatory-25, and-26)
conj:and(anti-inflammatory-25, anti-arrhythmic-27)
amod(properties-28, anti-arrhythmic-27)
dobj(involve-24, properties-28)
case(fatty_acids-31, of-29)
det(fatty_acids-31, these-30)
nmod:of(properties-28, fatty_acids-31)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ beneficial/JJ effects/NNS on/IN cardiovascular_health/JJ and/CC cancer/NN treatment/NN outcomes/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ molecular) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))
                    (VP (VBD exert)
                      (NP
                        (NP (PRP$ their) (JJ beneficial) (NNS effects))
                        (PP (IN on)
                          (NP
                            (UCP (JJ cardiovascular_health)
                              (CC and)
                              (NN cancer) (NN treatment))
                            (NNS outcomes)))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
mark(exert-15, by-10)
dobj(exert-15, which-11)
nsubj(exert-15, EPA-12)
cc(EPA-12, and-13)
conj:and(EPA-12, DHA-14)
nsubj(exert-15, DHA-14)
advcl(elucidate-6, exert-15)
nmod:poss(effects-18, their-16)
amod(effects-18, beneficial-17)
dobj(exert-15, effects-18)
case(outcomes-24, on-19)
dep(treatment-23, cardiovascular_health-20)
cc(treatment-23, and-21)
conj:and(treatment-23, cancer-22)
amod(outcomes-24, cancer-22)
amod(outcomes-24, treatment-23)
nmod:on(effects-18, outcomes-24)

Safinamide/JJ is_a/NN monoamine_oxidase_B/NN inhibitor/VBP that/IN has_been/VBP shown/VBN to/TO have/VB neuroprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (JJ Safinamide) (NN is_a) (NN monoamine_oxidase_B))
    (VP (VBP inhibitor)
      (SBAR (IN that)
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB have)
                    (NP (JJ neuroprotective) (NNS effects))))))))))
    (. .)))

amod(monoamine_oxidase_B-3, Safinamide-1)
compound(monoamine_oxidase_B-3, is_a-2)
nsubj(inhibitor-4, monoamine_oxidase_B-3)
root(ROOT-0, inhibitor-4)
mark(has_been-6, that-5)
ccomp(inhibitor-4, has_been-6)
dep(has_been-6, shown-7)
mark(have-9, to-8)
xcomp(shown-7, have-9)
amod(effects-11, neuroprotective-10)
dobj(have-9, effects-11)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN Safinamide/NNP was/VBD evaluated/VBN in/IN patients/NNS with/IN Encephalomyelitis/NNP ,/, photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NNP Safinamide))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP
                (NP (NNP Encephalomyelitis))
                (, ,)
                (NP (NN photophobia)
                  (CC and)
                  (NN phonophobia))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(Safinamide-8, of-7)
nmod:of(efficacy-6, Safinamide-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
case(patients-12, in-11)
nmod:in(evaluated-10, patients-12)
case(Encephalomyelitis-14, with-13)
nmod:with(patients-12, Encephalomyelitis-14)
appos(Encephalomyelitis-14, photophobia-16)
cc(photophobia-16, and-17)
appos(Encephalomyelitis-14, phonophobia-18)
conj:and(photophobia-16, phonophobia-18)

At_2/JJ h/NN after/IN dosing/VBG ,/, Safinamide/NNP reduced/VBD the/DT risk/NN of/IN Encephalomyelitis/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Safinamide))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNPS Encephalomyelitis))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, Safinamide-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Encephalomyelitis-11, of-10)
nmod:of(risk-9, Encephalomyelitis-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN Safinamide/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS with/IN Encephalomyelitis/NNP ,/, photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Safinamide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP
                        (NP (NNP Encephalomyelitis))
                        (, ,)
                        (NP (NN photophobia)
                          (CC and)
                          (NN phonophobia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Safinamide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(Encephalomyelitis-15, with-14)
nmod:with(patients-13, Encephalomyelitis-15)
appos(Encephalomyelitis-15, photophobia-17)
cc(photophobia-17, and-18)
appos(Encephalomyelitis-15, phonophobia-19)
conj:and(photophobia-17, phonophobia-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN this/DT medication/NN in/IN these/DT patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (DT this) (NN medication))
                      (PP (IN in)
                        (NP (DT these) (JJ patient) (NNS populations))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(medication-18, for-16)
det(medication-18, this-17)
nmod:for(regimen-15, medication-18)
case(populations-22, in-19)
det(populations-22, these-20)
amod(populations-22, patient-21)
nmod:in(medication-18, populations-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, widely-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN taeniacides/JJ levels/NNS in/IN hypertaeniacidesmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ taeniacides) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hypertaeniacidesmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, taeniacides-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hypertaeniacidesmic-16)
nmod:in(levels-14, patients-17)

Additionally/RB ,/, consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(has_been-8, Additionally-1)
nsubj(has_been-8, consumption-3)
case(EPA-5, of-4)
nmod:of(consumption-3, EPA-5)
cc(EPA-5, and-6)
nmod:of(consumption-3, DHA-7)
conj:and(EPA-5, DHA-7)
root(ROOT-0, has_been-8)
dep(has_been-8, linked-9)
case(risk-13, to-10)
det(risk-13, a-11)
amod(risk-13, decreased-12)
nmod:to(linked-9, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
dobj(developing-15, coronary_heart_disease-16)
appos(risk-13, CHD-18)

This/DT protective/JJ effect/NN is/VBZ thought/VBN to_be/JJ due/JJ to/TO the/DT ability/NN of/IN omega-3_fatty_acids/JJ to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN profiles/NNS ,/, and/CC decrease_blood_pressure/VB ./.

(ROOT
  (S
    (NP (DT This) (JJ protective) (NN effect))
    (VP (VBZ is)
      (VP (VBN thought)
        (ADVP (JJ to_be))
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (NN ability))
              (PP (IN of)
                (NP (JJ omega-3_fatty_acids)))
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VB improve)
                      (NP (NN lipid) (NNS profiles)))
                    (, ,)
                    (CC and)
                    (VP (VB decrease_blood_pressure))))))))))
    (. .)))

det(effect-3, This-1)
amod(effect-3, protective-2)
nsubjpass(thought-5, effect-3)
auxpass(thought-5, is-4)
root(ROOT-0, thought-5)
advmod(thought-5, to_be-6)
xcomp(thought-5, due-7)
case(ability-10, to-8)
det(ability-10, the-9)
nmod:to(due-7, ability-10)
case(omega-3_fatty_acids-12, of-11)
nmod:of(ability-10, omega-3_fatty_acids-12)
mark(reduce-14, to-13)
acl(ability-10, reduce-14)
dobj(reduce-14, inflammation-15)
acl(ability-10, improve-17)
conj:and(reduce-14, improve-17)
compound(profiles-19, lipid-18)
dobj(improve-17, profiles-19)
cc(reduce-14, and-21)
acl(ability-10, decrease_blood_pressure-22)
conj:and(reduce-14, decrease_blood_pressure-22)

While/IN the/DT exact/JJ mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS are/VBP still/RB being/VBG investigated/VBN ,/, increasing/VBG evidence/NN suggests/VBZ that/IN they/PRP may/MD be/VB a/DT promising/JJ dietary/JJ intervention/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (JJ exact) (NNS mechanisms))
          (SBAR
            (WHPP (IN by)
              (WHNP (WDT which)))
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (VBD exert)
                (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))
        (VP (VBP are) (RB still)
          (VP (VBG being)
            (VP (VBN investigated))))))
    (, ,)
    (NP (VBG increasing) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ dietary) (NN intervention))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

mark(investigated-17, While-1)
det(mechanisms-4, the-2)
amod(mechanisms-4, exact-3)
nmod:by(exert-10, mechanisms-4)
nsubjpass(investigated-17, mechanisms-4)
case(which-6, by-5)
ref(mechanisms-4, which-6)
nsubj(exert-10, EPA-7)
cc(EPA-7, and-8)
conj:and(EPA-7, DHA-9)
nsubj(exert-10, DHA-9)
acl:relcl(mechanisms-4, exert-10)
nmod:poss(effects-13, their-11)
amod(effects-13, cardioprotective-12)
dobj(exert-10, effects-13)
aux(investigated-17, are-14)
advmod(investigated-17, still-15)
auxpass(investigated-17, being-16)
advcl(suggests-21, investigated-17)
amod(evidence-20, increasing-19)
nsubj(suggests-21, evidence-20)
root(ROOT-0, suggests-21)
mark(intervention-29, that-22)
nsubj(intervention-29, they-23)
aux(intervention-29, may-24)
cop(intervention-29, be-25)
det(intervention-29, a-26)
amod(intervention-29, promising-27)
amod(intervention-29, dietary-28)
ccomp(suggests-21, intervention-29)
case(prevention-32, for-30)
det(prevention-32, the-31)
nmod:for(intervention-29, prevention-32)
cc(prevention-32, and-33)
nmod:for(intervention-29, treatment-34)
conj:and(prevention-32, treatment-34)
case(CHD-36, of-35)
nmod:of(prevention-32, CHD-36)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN pirmenol/NN on/IN abnormal_automaticity/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN pirmenol))
          (PP (IN on)
            (NP
              (NP (NN abnormal_automaticity))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effects-6, the-5)
nsubjpass(investigated-17, effects-6)
case(pirmenol-8, of-7)
nmod:of(effects-6, pirmenol-8)
case(abnormal_automaticity-10, on-9)
nmod:on(pirmenol-8, abnormal_automaticity-10)
nmod:on(pirmenol-8, photophobia-12)
conj:and(abnormal_automaticity-10, photophobia-12)
cc(abnormal_automaticity-10, and-14)
nmod:on(pirmenol-8, phonophobia-15)
conj:and(abnormal_automaticity-10, phonophobia-15)
auxpass(investigated-17, were-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, pirmenol/NN significantly/RB reduced/VBD the/DT risk/NN of/IN abnormal_automaticity/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN pirmenol))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN abnormal_automaticity))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, pirmenol-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(abnormal_automaticity-17, of-16)
nmod:of(risk-15, abnormal_automaticity-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN pirmenol/NN may/MD be/VB a/DT potential/JJ therapeutic/JJ option/NN for/IN patients/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN pirmenol))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, pirmenol-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, experiencing-14)
det(symptoms-16, these-15)
dobj(experiencing-14, symptoms-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN pirmenol/NN in/IN treating/VBG abnormal_automaticity/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (NN pirmenol)))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP
                      (NP (NN abnormal_automaticity))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(investigate-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(investigate-6, profile-12)
conj:and(effects-9, profile-12)
case(pirmenol-14, of-13)
nmod:of(profile-12, pirmenol-14)
mark(treating-16, in-15)
advcl(investigate-6, treating-16)
dobj(treating-16, abnormal_automaticity-17)
dobj(treating-16, photophobia-19)
conj:and(abnormal_automaticity-17, photophobia-19)
cc(abnormal_automaticity-17, and-21)
dobj(treating-16, phonophobia-22)
conj:and(abnormal_automaticity-17, phonophobia-22)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(studied-25, have-22)
auxpass(studied-25, been-23)
advmod(studied-25, extensively-24)
root(ROOT-0, studied-25)
case(benefits-30, for-26)
nmod:poss(benefits-30, their-27)
amod(benefits-30, potential-28)
compound(benefits-30, health-29)
nmod:for(studied-25, benefits-30)

In/IN particular/JJ ,/, these/DT fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN sulphathiazole/NN in/IN hypersulphathiazolemic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN sulphathiazole))
                  (PP (IN in)
                    (NP (JJ hypersulphathiazolemic) (NNS patients))))))))))
    (. .)))

case(particular-2, In-1)
advcl(associated-8, particular-2)
det(fatty_acids-5, these-4)
nsubjpass(associated-8, fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-11, with-9)
amod(levels-11, decreased-10)
nmod:with(associated-8, levels-11)
case(sulphathiazole-13, of-12)
nmod:of(levels-11, sulphathiazole-13)
case(patients-16, in-14)
amod(patients-16, hypersulphathiazolemic-15)
nmod:in(sulphathiazole-13, patients-16)

Furthermore/RB ,/, epidemiological/JJ studies/NNS have/VBP shown/VBN that/IN increased/VBN consumption/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (VBN increased) (NN consumption))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(shown-6, Furthermore-1)
amod(studies-4, epidemiological-3)
nsubj(shown-6, studies-4)
aux(shown-6, have-5)
root(ROOT-0, shown-6)
mark(associated-15, that-7)
amod(consumption-9, increased-8)
nsubjpass(associated-15, consumption-9)
case(EPA-11, of-10)
nmod:of(consumption-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(consumption-9, DHA-13)
conj:and(EPA-11, DHA-13)
auxpass(associated-15, is-14)
ccomp(shown-6, associated-15)
case(risk-19, with-16)
det(risk-19, a-17)
amod(risk-19, decreased-18)
nmod:with(associated-15, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

Several/JJ mechanisms/NNS have/VBP been/VBN proposed/VBN to/TO explain/VB the/DT cardioprotective/JJ effects/NNS of/IN these/DT fatty_acids/NNS ,/, including/VBG their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, lower/JJR triglyceride_levels/NNS ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (JJ Several) (NNS mechanisms))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN proposed)
          (S
            (VP (TO to)
              (VP (VB explain)
                (NP
                  (NP (DT the) (JJ cardioprotective) (NNS effects))
                  (PP (IN of)
                    (NP (DT these) (NNS fatty_acids)))
                  (, ,)
                  (VP (VBG including)
                    (NP (PRP$ their) (NN ability)
                      (S
                        (VP (TO to)
                          (VP
                            (VP (VB reduce)
                              (NP
                                (NP (NN inflammation))
                                (, ,)
                                (NP (JJR lower) (NNS triglyceride_levels))
                                (, ,)))
                            (CC and)
                            (VP (VB improve)
                              (NP-TMP (JJ endothelial) (NN function)))))))))))))))
    (. .)))

amod(mechanisms-2, Several-1)
nsubjpass(proposed-5, mechanisms-2)
nsubj:xsubj(explain-7, mechanisms-2)
aux(proposed-5, have-3)
auxpass(proposed-5, been-4)
root(ROOT-0, proposed-5)
mark(explain-7, to-6)
xcomp(proposed-5, explain-7)
det(effects-10, the-8)
amod(effects-10, cardioprotective-9)
dobj(explain-7, effects-10)
case(fatty_acids-13, of-11)
det(fatty_acids-13, these-12)
nmod:of(effects-10, fatty_acids-13)
acl(effects-10, including-15)
nmod:poss(ability-17, their-16)
dobj(including-15, ability-17)
mark(reduce-19, to-18)
acl(ability-17, reduce-19)
dobj(reduce-19, inflammation-20)
amod(triglyceride_levels-23, lower-22)
appos(inflammation-20, triglyceride_levels-23)
cc(reduce-19, and-25)
acl(ability-17, improve-26)
conj:and(reduce-19, improve-26)
amod(function-28, endothelial-27)
nmod:tmod(improve-26, function-28)

These/DT findings/NNS suggest/VBP that/IN EPA/NNP and/CC DHA/NNP may/MD be/VB important/JJ dietary/JJ components/NNS for/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (JJ important) (JJ dietary) (NNS components))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN management))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(components-12, that-4)
nsubj(components-12, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(components-12, DHA-7)
aux(components-12, may-8)
cop(components-12, be-9)
amod(components-12, important-10)
amod(components-12, dietary-11)
ccomp(suggest-3, components-12)
case(prevention-15, for-13)
det(prevention-15, the-14)
nmod:for(components-12, prevention-15)
cc(prevention-15, and-16)
nmod:for(components-12, management-17)
conj:and(prevention-15, management-17)
case(CHD-19, of-18)
nmod:of(prevention-15, CHD-19)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG their/PRP$ beneficial/JJ effects/NNS and/CC to/TO determine/VB optimal/JJ intake/NN levels/NNS for/IN different/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (PRP$ their) (JJ beneficial) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NN intake) (NNS levels))
                  (PP (IN for)
                    (NP (JJ different) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
nmod:poss(effects-13, their-11)
amod(effects-13, beneficial-12)
dobj(underlying-10, effects-13)
cc(understand-7, and-14)
mark(determine-16, to-15)
ccomp(needed-4, determine-16)
conj:and(understand-7, determine-16)
amod(levels-19, optimal-17)
compound(levels-19, intake-18)
dobj(determine-16, levels-19)
case(populations-22, for-20)
amod(populations-22, different-21)
nmod:for(levels-19, populations-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP long-chain_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (NNS long-chain_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ various) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(long-chain_fatty_acids-15, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(long-chain_fatty_acids-15, are-14)
root(ROOT-0, long-chain_fatty_acids-15)
nsubjpass(associated-19, long-chain_fatty_acids-15)
ref(long-chain_fatty_acids-15, that-16)
aux(associated-19, have-17)
auxpass(associated-19, been-18)
acl:relcl(long-chain_fatty_acids-15, associated-19)
case(benefits-23, with-20)
amod(benefits-23, various-21)
compound(benefits-23, health-22)
nmod:with(associated-19, benefits-23)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD decrease/VB suriclone/JJ levels/NNS in/IN hypersuriclonemic/JJ patients/NNS ,/, which/WDT is_a/JJ risk/NN factor/NN for/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may)
              (VP (VB decrease)
                (NP
                  (NP (JJ suriclone) (NNS levels))
                  (PP (IN in)
                    (NP
                      (NP (JJ hypersuriclonemic) (NNS patients))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP
                            (NP
                              (NP (JJ is_a) (NN risk) (NN factor))
                              (PP (IN for)
                                (S
                                  (VP (VBG developing)
                                    (NP (NN coronary_heart_disease))))))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(decrease-10, that-5)
nsubj(decrease-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(decrease-10, DHA-8)
aux(decrease-10, may-9)
ccomp(suggested-4, decrease-10)
amod(levels-12, suriclone-11)
dobj(decrease-10, levels-12)
case(patients-15, in-13)
amod(patients-15, hypersuriclonemic-14)
nmod:in(levels-12, patients-15)
nsubj(factor-20, patients-15)
ref(patients-15, which-17)
amod(factor-20, is_a-18)
compound(factor-20, risk-19)
acl:relcl(patients-15, factor-20)
mark(developing-22, for-21)
acl(factor-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
dep(factor-20, CHD-25)

Furthermore/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG CHD/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN CHD))))))))))))
    (. .)))

advmod(shown-7, Furthermore-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(reduce-9, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(reduce-9, to-8)
xcomp(shown-7, reduce-9)
det(risk-11, the-10)
dobj(reduce-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, CHD-14)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS are/VBP multifactorial/JJ and/CC may/MD involve/VB modulation/NN of/IN inflammation/NN ,/, blood/NN lipid/NN levels/NNS ,/, endothelial/JJ function/NN ,/, and/CC cardiac_arrhythmias/NNS ./.

(ROOT
  (S
    (NP (DT The)
      (NX
        (NX
          (NX (NNS mechanisms))
          (PP (IN by)
            (SBAR
              (WHNP (WDT which))
              (S
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))
                (VP (VBD exert)
                  (SBAR
                    (S
                      (NP (PRP$ their) (JJ cardioprotective) (NNS effects))
                      (VP (VBP are)
                        (ADJP (JJ multifactorial))))))))))
        (CC and)))
    (VP (MD may)
      (VP (VB involve)
        (NP
          (NP (NN modulation))
          (PP (IN of)
            (NP
              (NP (NN inflammation))
              (, ,)
              (NP (NN blood) (NN lipid) (NNS levels))
              (, ,)
              (NP (JJ endothelial) (NN function))
              (, ,)
              (CC and)
              (NP (NNS cardiac_arrhythmias)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(involve-16, mechanisms-2)
mark(exert-8, by-3)
dobj(exert-8, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
acl(mechanisms-2, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, cardioprotective-10)
nsubj(multifactorial-13, effects-11)
cop(multifactorial-13, are-12)
ccomp(exert-8, multifactorial-13)
cc(mechanisms-2, and-14)
aux(involve-16, may-15)
root(ROOT-0, involve-16)
dobj(involve-16, modulation-17)
case(inflammation-19, of-18)
nmod:of(modulation-17, inflammation-19)
compound(levels-23, blood-21)
compound(levels-23, lipid-22)
nmod:of(modulation-17, levels-23)
conj:and(inflammation-19, levels-23)
amod(function-26, endothelial-25)
nmod:of(modulation-17, function-26)
conj:and(inflammation-19, function-26)
cc(inflammation-19, and-28)
nmod:of(modulation-17, cardiac_arrhythmias-29)
conj:and(inflammation-19, cardiac_arrhythmias-29)

Therefore/RB ,/, increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS may/MD be/VB a/DT promising/JJ approach/NN for/IN reducing/VBG the/DT incidence/NN of/IN CHD/NNP in/IN at-risk/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NNS supplements)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT a) (JJ promising) (NN approach))
          (PP (IN for)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN incidence))
                  (PP (IN of)
                    (NP (NNP CHD))))
                (PP (IN in)
                  (NP (JJ at-risk) (NNS populations)))))))))
    (. .)))

advmod(approach-19, Therefore-1)
csubj(approach-19, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(EPA-7, of-6)
nmod:of(intake-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(intake-5, DHA-9)
conj:and(EPA-7, DHA-9)
case(sources-12, through-10)
amod(sources-12, dietary-11)
nmod:through(increasing-3, sources-12)
cc(sources-12, or-13)
nmod:through(increasing-3, supplements-14)
conj:or(sources-12, supplements-14)
aux(approach-19, may-15)
cop(approach-19, be-16)
det(approach-19, a-17)
amod(approach-19, promising-18)
root(ROOT-0, approach-19)
mark(reducing-21, for-20)
acl(approach-19, reducing-21)
det(incidence-23, the-22)
dobj(reducing-21, incidence-23)
case(CHD-25, of-24)
nmod:of(incidence-23, CHD-25)
case(populations-28, in-26)
amod(populations-28, at-risk-27)
nmod:in(reducing-21, populations-28)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN linked/VBN to/TO a/DT wide/JJ range/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP
                      (NP (DT a) (JJ wide) (NN range))
                      (PP (IN of)
                        (NP (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(linked-20, nutrients-16)
ref(nutrients-16, that-17)
aux(linked-20, have-18)
auxpass(linked-20, been-19)
acl:relcl(nutrients-16, linked-20)
case(range-24, to-21)
det(range-24, a-22)
amod(range-24, wide-23)
nmod:to(linked-20, range-24)
case(benefits-27, of-25)
compound(benefits-27, health-26)
nmod:of(range-24, benefits-27)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- by/IN decreasing/VBG VPC12249/CD levels/NNS in/IN hyperVPC12249mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))
                        (PP (IN by)
                          (S
                            (VP (VBG decreasing)
                              (NP
                                (NP (CD VPC12249) (NNS levels))
                                (PP (IN in)
                                  (NP (JJ hyperVPC12249mic) (NNS patients)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(play-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubj(play-9, long-chain_fatty_acids-7)
aux(play-9, may-8)
ccomp(shown-4, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(reducing-13, in-12)
acl(role-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)
mark(decreasing-23, by-22)
advcl(reducing-13, decreasing-23)
nummod(levels-25, VPC12249-24)
dobj(decreasing-23, levels-25)
case(patients-28, in-26)
amod(patients-28, hyperVPC12249mic-27)
nmod:in(levels-25, patients-28)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ properties/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ anti-inflammatory) (NNS effects))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD may)
                      (VP (VB contribute)
                        (PP (TO to)
                          (NP (PRP$ their) (JJ cardioprotective) (NNS properties)))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(have-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(have-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(have-7, to-6)
xcomp(known-5, have-7)
amod(effects-9, anti-inflammatory-8)
dobj(have-7, effects-9)
nsubj(contribute-13, effects-9)
ref(effects-9, which-11)
aux(contribute-13, may-12)
acl:relcl(effects-9, contribute-13)
case(properties-17, to-14)
nmod:poss(properties-17, their-15)
amod(properties-17, cardioprotective-16)
nmod:to(contribute-13, properties-17)

In/IN addition/NN ,/, they/PRP have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS and/CC reduce/VB blood_pressure/NN ,/, both/DT of/IN which/WDT are/VBP important/JJ risk/NN factors/NNS for/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP (NN blood_pressure))
                    (, ,)
                    (SBAR
                      (WHNP (DT both)
                        (WHPP (IN of)
                          (WHNP (WDT which))))
                      (S
                        (VP (VBP are)
                          (NP
                            (NP (JJ important) (NN risk) (NNS factors))
                            (PP (IN for)
                              (NP (NNP CHD)))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-7, addition-2)
nsubjpass(shown-7, they-4)
nsubj:xsubj(improve-9, they-4)
nsubj:xsubj(reduce-13, they-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
cc(improve-9, and-12)
xcomp(shown-7, reduce-13)
conj:and(improve-9, reduce-13)
dobj(reduce-13, blood_pressure-14)
nsubj(factors-22, blood_pressure-14)
dep(which-18, both-16)
case(which-18, of-17)
ref(blood_pressure-14, which-18)
cop(factors-22, are-19)
amod(factors-22, important-20)
compound(factors-22, risk-21)
acl:relcl(blood_pressure-14, factors-22)
case(CHD-24, for-23)
nmod:for(factors-22, CHD-24)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN omega-3_fatty_acids/JJ through/IN dietary/NN sources/NNS or/CC supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP
                (ADJP (JJ omega-3_fatty_acids)
                  (PP (IN through)
                    (NP (NN dietary))))
                (NNS sources)
                (CC or)
                (NN supplementation))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ high-risk) (NNS individuals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-18, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-18, intake-6)
case(sources-11, of-7)
amod(sources-11, omega-3_fatty_acids-8)
case(dietary-10, through-9)
nmod:through(omega-3_fatty_acids-8, dietary-10)
nmod:of(intake-6, sources-11)
cc(sources-11, or-12)
nmod:of(intake-6, supplementation-13)
conj:or(sources-11, supplementation-13)
aux(strategy-18, may-14)
cop(strategy-18, be-15)
det(strategy-18, an-16)
amod(strategy-18, effective-17)
ccomp(suggest-3, strategy-18)
mark(reducing-20, for-19)
acl(strategy-18, reducing-20)
det(risk-22, the-21)
dobj(reducing-20, risk-22)
case(CHD-24, of-23)
nmod:of(risk-22, CHD-24)
case(individuals-27, in-25)
amod(individuals-27, high-risk-26)
nmod:in(reducing-20, individuals-27)

Obesity/JJ is_a/NN complex/NN multifactorial_disease/VBD that/IN is/VBZ influenced/VBN by/IN genetic/JJ ,/, environmental/JJ ,/, and/CC behavioral/JJ factors/NNS ./.

(ROOT
  (S
    (NP (JJ Obesity) (NN is_a) (NN complex))
    (VP (VBD multifactorial_disease)
      (SBAR (IN that)
        (S
          (VP (VBZ is)
            (VP (VBN influenced)
              (PP (IN by)
                (NP
                  (ADJP
                    (ADJP (JJ genetic))
                    (, ,)
                    (ADJP (JJ environmental))
                    (, ,)
                    (CC and)
                    (ADJP (JJ behavioral)))
                  (NNS factors))))))))
    (. .)))

amod(complex-3, Obesity-1)
compound(complex-3, is_a-2)
nsubj(multifactorial_disease-4, complex-3)
root(ROOT-0, multifactorial_disease-4)
mark(influenced-7, that-5)
auxpass(influenced-7, is-6)
ccomp(multifactorial_disease-4, influenced-7)
case(factors-15, by-8)
amod(factors-15, genetic-9)
conj:and(genetic-9, environmental-11)
amod(factors-15, environmental-11)
cc(genetic-9, and-13)
conj:and(genetic-9, behavioral-14)
amod(factors-15, behavioral-14)
nmod:by(influenced-7, factors-15)

The/DT role/NN of/IN pancreatic_dysfunction/NN in/IN the/DT development/NN of/IN obesity/JJ has_been/NN studied/VBD extensively/RB ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN role))
      (PP (IN of)
        (NP
          (NP (NN pancreatic_dysfunction))
          (PP (IN in)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (JJ obesity) (NN has_been))))))))
    (VP (VBD studied)
      (ADVP (RB extensively)))
    (. .)))

det(role-2, The-1)
nsubj(studied-11, role-2)
case(pancreatic_dysfunction-4, of-3)
nmod:of(role-2, pancreatic_dysfunction-4)
case(development-7, in-5)
det(development-7, the-6)
nmod:in(pancreatic_dysfunction-4, development-7)
case(has_been-10, of-8)
amod(has_been-10, obesity-9)
nmod:of(development-7, has_been-10)
root(ROOT-0, studied-11)
advmod(studied-11, extensively-12)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN cdk7/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS cdk7)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(cdk7-20, of-19)
nmod:of(hypersecretion-18, cdk7-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT objective/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ Tp40/NNS on/IN the/DT secretion/NN of/IN cdk7/JJ and_insulin/NN by/IN isolated/JJ perfused/JJ pancreata/NN from/IN genetically_obese/JJ -LRB-/-LRB- fa/fa/NNS -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN objective)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NNS Tp40))))
        (PP (IN on)
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (JJ cdk7) (NN and_insulin))))))
      (PP (IN by)
        (NP (JJ isolated) (JJ perfused) (NN pancreata)))
      (PP (IN from)
        (NP
          (NP (JJ genetically_obese) (-LRB- -LRB-) (NNS fa/fa) (-RRB- -RRB-))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS rats)))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(objective-4, this-3)
dobj(achieve-2, objective-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(Tp40-17, 10-15)
amod(Tp40-17, mmol/L-16)
nmod:of(effects-9, Tp40-17)
conj:and(glucose-13, Tp40-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(effects-9, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, cdk7-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(fa/fa-31, from-28)
amod(fa/fa-31, genetically_obese-29)
nmod:from(examined-7, fa/fa-31)
cc(fa/fa-31, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(examined-7, rats-40)
conj:and(fa/fa-31, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN perfusion/NN with/IN high/JJ glucose/NN concentration/NN significantly/RB increased/VBD cdk7/JJ secretion/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN perfusion))
            (PP (IN with)
              (NP (JJ high) (NN glucose) (NN concentration))))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP (JJ cdk7) (NN secretion))
            (PP (IN in)
              (NP (DT both) (JJ obese)
                (CC and)
                (JJ lean) (NNS rats)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-11, that-4)
nsubj(increased-11, perfusion-5)
case(concentration-9, with-6)
amod(concentration-9, high-7)
compound(concentration-9, glucose-8)
nmod:with(perfusion-5, concentration-9)
advmod(increased-11, significantly-10)
ccomp(showed-3, increased-11)
amod(secretion-13, cdk7-12)
dobj(increased-11, secretion-13)
case(rats-19, in-14)
det(rats-19, both-15)
amod(rats-19, obese-16)
cc(obese-16, and-17)
conj:and(obese-16, lean-18)
amod(rats-19, lean-18)
nmod:in(increased-11, rats-19)

However/RB ,/, Tp40/JJ treatment/NN resulted/VBD in_a/JJ significant/JJ increase/NN in/IN cdk7/JJ secretion/NN only/RB in/IN obese/JJ rats/NNS but/CC not/RB in/IN lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ Tp40) (NN treatment))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (JJ cdk7) (NN secretion))))
      (PP (RB only)
        (PP (IN in)
          (NP (JJ obese) (NNS rats)))
        (CC but)
        (ADVP (RB not))
        (PP (IN in)
          (NP (JJ lean) (NNS rats)))))
    (. .)))

advmod(resulted-5, However-1)
amod(treatment-4, Tp40-3)
nsubj(resulted-5, treatment-4)
nsubj(resulted-5', treatment-4)
root(ROOT-0, resulted-5)
conj:but(resulted-5, resulted-5')
amod(increase-8, in_a-6)
amod(increase-8, significant-7)
dobj(resulted-5, increase-8)
case(secretion-11, in-9)
amod(secretion-11, cdk7-10)
nmod:in(increase-8, secretion-11)
advmod(rats-15, only-12)
case(rats-15, in-13)
amod(rats-15, obese-14)
nmod:in(resulted-5, rats-15)
cc(resulted-5, but-16)
advmod(rats-20, not-17)
case(rats-20, in-18)
amod(rats-20, lean-19)
nmod:in(resulted-5', rats-20)

Additionally/RB ,/, we/PRP observed/VBD a/DT significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN response/NN to/TO high/JJ glucose/NN concentration/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (JJ high) (NN glucose) (NN concentration)))))
      (PP (IN in)
        (NP
          (NP (JJ obese) (NNS rats))
          (VP (VBN compared)
            (PP (TO to)
              (NP (JJ lean) (NNS rats)))))))
    (. .)))

advmod(observed-4, Additionally-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(observed-4, decrease-7)
case(insulin_secretion-9, in-8)
nmod:in(decrease-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(concentration-15, to-12)
amod(concentration-15, high-13)
compound(concentration-15, glucose-14)
nmod:to(response-11, concentration-15)
case(rats-18, in-16)
amod(rats-18, obese-17)
nmod:in(observed-4, rats-18)
acl(rats-18, compared-19)
case(rats-22, to-20)
amod(rats-22, lean-21)
nmod:to(compared-19, rats-22)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN cdk7/NNS by/IN the/DT pancreas/NN may/MD play/VB a/DT critical/JJ role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, and/CC targeting/VBG cdk7/JJ signaling/VBG pathways/NNS may/MD represent/VB a/DT novel/JJ therapeutic/JJ approach/NN for/IN treating/VBG obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NNS cdk7))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (JJ critical) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity)))))))))
          (, ,)
          (CC and)
          (S
            (S
              (VP (VBG targeting)
                (NP (JJ cdk7) (VBG signaling) (NNS pathways))))
            (VP (MD may)
              (VP (VB represent)
                (NP (DT a) (JJ novel) (JJ therapeutic) (NN approach))
                (PP (IN for)
                  (S
                    (VP (VBG treating)
                      (NP (JJ obesity-related) (NNS metabolic_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(cdk7-7, of-6)
nmod:of(hypersecretion-5, cdk7-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(cdk7-7, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-15, a-13)
amod(role-15, critical-14)
dobj(play-12, role-15)
case(development-18, in-16)
det(development-18, the-17)
nmod:in(role-15, development-18)
case(obesity-20, of-19)
nmod:of(development-18, obesity-20)
cc(play-12, and-22)
csubj(represent-28, targeting-23)
amod(pathways-26, cdk7-24)
amod(pathways-26, signaling-25)
dobj(targeting-23, pathways-26)
aux(represent-28, may-27)
ccomp(suggest-3, represent-28)
conj:and(play-12, represent-28)
det(approach-32, a-29)
amod(approach-32, novel-30)
amod(approach-32, therapeutic-31)
dobj(represent-28, approach-32)
mark(treating-34, for-33)
advcl(represent-28, treating-34)
amod(metabolic_disorders-36, obesity-related-35)
dobj(treating-34, metabolic_disorders-36)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Among/IN them/PRP ,/, long-chain/JJ omega-3_fatty_acids/NNS such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN shown/VBN to/TO have/VB a/DT protective/JJ effect/NN against/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (PRP them)))
    (, ,)
    (NP
      (NP (JJ long-chain) (NNS omega-3_fatty_acids))
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-)))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP
                    (NP (DT a) (JJ protective) (NN effect))
                    (PP (IN against)
                      (NP (NN coronary_heart_disease))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

case(them-2, Among-1)
nmod:among(shown-19, them-2)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(shown-19, omega-3_fatty_acids-5)
nsubj:xsubj(have-21, omega-3_fatty_acids-5)
case(EPA-10, such-6)
mwe(such-6, as-7)
advmod(EPA-10, eicosapentaenoic_acid-8)
nmod:such_as(omega-3_fatty_acids-5, EPA-10)
cc(EPA-10, and-12)
nmod:such_as(omega-3_fatty_acids-5, docosahexaenoic_acid-13)
conj:and(EPA-10, docosahexaenoic_acid-13)
appos(EPA-10, DHA-15)
aux(shown-19, have-17)
auxpass(shown-19, been-18)
root(ROOT-0, shown-19)
mark(have-21, to-20)
xcomp(shown-19, have-21)
det(effect-24, a-22)
amod(effect-24, protective-23)
dobj(have-21, effect-24)
case(coronary_heart_disease-26, against-25)
nmod:against(effect-24, coronary_heart_disease-26)
appos(effect-24, CHD-28)

Recent/JJ studies/NNS have/VBP also/RB demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN B-cell_maturation_antigen/NNP -LRB-/-LRB- BCMA/NNP -RRB-/-RRB- in/IN hyperBCMAmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (VBN decreased) (NNS levels))
                      (PP (IN of)
                        (NP (NNP B-cell_maturation_antigen))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP BCMA))
                      (-RRB- -RRB-))
                    (PP (IN in)
                      (NP (JJ hyperBCMAmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-5, studies-2)
aux(demonstrated-5, have-3)
advmod(demonstrated-5, also-4)
root(ROOT-0, demonstrated-5)
mark(associated-10, that-6)
det(fatty_acids-8, these-7)
nsubjpass(associated-10, fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-5, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(B-cell_maturation_antigen-15, of-14)
nmod:of(levels-13, B-cell_maturation_antigen-15)
appos(levels-13, BCMA-17)
case(patients-21, in-19)
amod(patients-21, hyperBCMAmic-20)
nmod:in(levels-13, patients-21)

BCMA/NNP is_a/NN member/NN of/IN the/DT tumor_necrosis_factor_receptor_superfamily/NN and/CC has_been/NN implicated/VBN in/IN the/DT development/NN and/CC progression/NN of/IN multiple_myeloma/NN ./.

(ROOT
  (NP
    (NP (NNP BCMA) (NN is_a) (NN member))
    (PP (IN of)
      (NP
        (NP (DT the) (NN tumor_necrosis_factor_receptor_superfamily)
          (CC and)
          (NN has_been))
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NN development)
                (CC and)
                (NN progression))
              (PP (IN of)
                (NP (NN multiple_myeloma))))))))
    (. .)))

compound(member-3, BCMA-1)
compound(member-3, is_a-2)
root(ROOT-0, member-3)
case(tumor_necrosis_factor_receptor_superfamily-6, of-4)
det(tumor_necrosis_factor_receptor_superfamily-6, the-5)
nmod:of(member-3, tumor_necrosis_factor_receptor_superfamily-6)
cc(tumor_necrosis_factor_receptor_superfamily-6, and-7)
nmod:of(member-3, has_been-8)
conj:and(tumor_necrosis_factor_receptor_superfamily-6, has_been-8)
acl(tumor_necrosis_factor_receptor_superfamily-6, implicated-9)
case(development-12, in-10)
det(development-12, the-11)
nmod:in(implicated-9, development-12)
cc(development-12, and-13)
nmod:in(implicated-9, progression-14)
conj:and(development-12, progression-14)
case(multiple_myeloma-16, of-15)
nmod:of(development-12, multiple_myeloma-16)

The/DT mechanism/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP decrease/VB BCMA/NNP levels/NNS is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP may/MD involve/VB modulation/NN of/IN inflammatory/JJ pathways/NNS or/CC interference/NN with/IN BCMA/NNP signaling/VBG ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VB decrease)
              (NP (NNP BCMA) (NNS levels))))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP (JJ inflammatory) (NNS pathways)
                (CC or)
                (NN interference))))
          (PP (IN with)
            (NP (NNP BCMA)))
          (S
            (VP (VBG signaling))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(decrease-8, mechanism-2)
nsubjpass(understood-15, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(decrease-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(decrease-8, DHA-7)
acl:relcl(mechanism-2, decrease-8)
compound(levels-10, BCMA-9)
dobj(decrease-8, levels-10)
auxpass(understood-15, is-11)
neg(understood-15, not-12)
advmod(understood-15, yet-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-17)
nsubj(involve-20, it-18)
aux(involve-20, may-19)
conj:but(understood-15, involve-20)
dobj(involve-20, modulation-21)
case(pathways-24, of-22)
amod(pathways-24, inflammatory-23)
nmod:of(modulation-21, pathways-24)
cc(pathways-24, or-25)
nmod:of(modulation-21, interference-26)
conj:or(pathways-24, interference-26)
case(BCMA-28, with-27)
nmod:with(involve-20, BCMA-28)
xcomp(involve-20, signaling-29)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/JJ may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and/CC other/JJ BCMA-related_diseases/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)
                        (CC and)
                        (JJ other) (NNS BCMA-related_diseases)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, omega-3_fatty_acids-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(prevention-14, for-12)
det(prevention-14, the-13)
nmod:for(option-11, prevention-14)
cc(prevention-14, and-15)
nmod:for(option-11, treatment-16)
conj:and(prevention-14, treatment-16)
case(BCMA-related_diseases-21, of-17)
compound(BCMA-related_diseases-21, CHD-18)
cc(CHD-18, and-19)
conj:and(CHD-18, other-20)
compound(BCMA-related_diseases-21, other-20)
nmod:of(prevention-14, BCMA-related_diseases-21)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC to/TO determine/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN omega-3/JJ supplementation/NN for/IN maximum/JJ benefit/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (VBG underlying) (NNS mechanisms))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dose)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP (JJ omega-3) (NN supplementation))))
                (PP (IN for)
                  (NP (JJ maximum) (NN benefit)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(elucidate-6, and-10)
mark(determine-12, to-11)
ccomp(needed-4, determine-12)
conj:and(elucidate-6, determine-12)
det(dose-15, the-13)
amod(dose-15, optimal-14)
dobj(determine-12, dose-15)
cc(dose-15, and-16)
dobj(determine-12, duration-17)
conj:and(dose-15, duration-17)
case(supplementation-20, of-18)
amod(supplementation-20, omega-3-19)
nmod:of(dose-15, supplementation-20)
case(benefit-23, for-21)
amod(benefit-23, maximum-22)
nmod:for(determine-12, benefit-23)

Obesity/RB is_a/JJ complex/JJ medical/JJ condition/NN that/WDT has_been/VBP linked/VBN to/TO numerous/JJ health/NN issues/NNS ,/, including/VBG diabetes/NN and_cardiovascular/NN disease/NN ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (JJ medical) (NN condition))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBP has_been)
          (VP (VBN linked)
            (PP (TO to)
              (NP
                (NP (JJ numerous) (NN health) (NNS issues))
                (, ,)
                (VP (VBG including)
                  (NP (NN diabetes) (NN and_cardiovascular) (NN disease)))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(condition-5, is_a-2)
amod(condition-5, complex-3)
amod(condition-5, medical-4)
root(ROOT-0, condition-5)
nsubj(has_been-7, condition-5)
ref(condition-5, that-6)
acl:relcl(condition-5, has_been-7)
dep(has_been-7, linked-8)
case(issues-12, to-9)
amod(issues-12, numerous-10)
compound(issues-12, health-11)
nmod:to(linked-8, issues-12)
acl(issues-12, including-14)
compound(disease-17, diabetes-15)
compound(disease-17, and_cardiovascular-16)
dobj(including-14, disease-17)

The/DT pathogenesis/NN of/IN obesity/NN is/VBZ not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ known/VBN that/IN the/DT secretion/NN of/IN various/JJ hormones/NNS by/IN adipose_tissue/NN plays/VBZ a/DT significant/JJ role/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN pathogenesis))
        (PP (IN of)
          (NP (NN obesity))))
      (VP (VBZ is)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN known)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN secretion))
                (PP (IN of)
                  (NP
                    (NP (JJ various) (NNS hormones))
                    (PP (IN by)
                      (NP (NN adipose_tissue))))))
              (VP (VBZ plays)
                (NP (DT a) (JJ significant) (NN role))))))))
    (. .)))

det(pathogenesis-2, The-1)
nsubjpass(understood-8, pathogenesis-2)
case(obesity-4, of-3)
nmod:of(pathogenesis-2, obesity-4)
auxpass(understood-8, is-5)
neg(understood-8, not-6)
advmod(understood-8, fully-7)
root(ROOT-0, understood-8)
cc(understood-8, but-10)
nsubjpass(known-13, it-11)
auxpass(known-13, is-12)
conj:but(understood-8, known-13)
mark(plays-22, that-14)
det(secretion-16, the-15)
nsubj(plays-22, secretion-16)
case(hormones-19, of-17)
amod(hormones-19, various-18)
nmod:of(secretion-16, hormones-19)
case(adipose_tissue-21, by-20)
nmod:by(hormones-19, adipose_tissue-21)
ccomp(known-13, plays-22)
det(role-25, a-23)
amod(role-25, significant-24)
dobj(plays-22, role-25)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT pancreas/NN may/MD also/RB contribute/VB to/TO the/DT development/NN of/IN obesity/NN through/IN the/DT hypersecretion/NN of/IN TH_1/NNP ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN pancreas))
            (VP (MD may) (RB also)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (PP (IN through)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP TH_1)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(contribute-10, that-5)
det(pancreas-7, the-6)
nsubj(contribute-10, pancreas-7)
aux(contribute-10, may-8)
advmod(contribute-10, also-9)
ccomp(suggested-4, contribute-10)
case(development-13, to-11)
det(development-13, the-12)
nmod:to(contribute-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
case(hypersecretion-18, through-16)
det(hypersecretion-18, the-17)
nmod:through(contribute-10, hypersecretion-18)
case(TH_1-20, of-19)
nmod:of(hypersecretion-18, TH_1-20)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN TH_1/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP TH_1)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(TH_1-20, of-19)
nmod:of(hypersecretion-18, TH_1-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ methyl_gallate/NN on/IN the/DT secretion/NN of/IN TH_1/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB-

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN methyl_gallate)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP TH_1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated)
            (NX
              (NX
                (NX
                  (NX (JJ perfused) (NN pancreata))
                  (PP (IN from)
                    (NP (NN genetically_obese))))
                (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
              (CC and)
              (NX (JJ lean))))
          (-LRB- -LRB-)
          (NP (NNP Fa))
          (: /))))
    (. ?) (-RRB- -RRB-)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(methyl_gallate-17, 10-15)
amod(methyl_gallate-17, mmol/L-16)
nmod:of(effects-9, methyl_gallate-17)
conj:and(glucose-13, methyl_gallate-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
compound(and_insulin-23, TH_1-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
dep(pancreata-27, fa/fa-31)
cc(pancreata-27, and-33)
nmod:by(examined-7, lean-34)
conj:and(pancreata-27, lean-34)
dep(pancreata-27, Fa-36)

rats/NNS ./.

(ROOT
  (NP (NNS rats) (. .)))

root(ROOT-0, rats-1)

Our/PRP$ results/NNS showed/VBD that/IN isolated/VBN perfused/JJ pancreata/NN from/IN obese/JJ rats/NNS exhibited/VBD significantly/RB higher/JJR levels/NNS of/IN TH_1/NNP secretion/NN in/IN response/NN to/TO glucose/NN and/CC methyl_gallate/JJ stimulation/NN compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBN isolated) (JJ perfused) (NN pancreata))
            (PP (IN from)
              (NP (JJ obese) (NNS rats))))
          (VP (VBD exhibited)
            (NP
              (NP
                (ADJP (RB significantly) (JJR higher))
                (NNS levels))
              (PP (IN of)
                (NP (NNP TH_1) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (NN glucose))
                    (CC and)
                    (NP (JJ methyl_gallate) (NN stimulation))))))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS rats))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(exhibited-11, that-4)
amod(pancreata-7, isolated-5)
amod(pancreata-7, perfused-6)
nsubj(exhibited-11, pancreata-7)
case(rats-10, from-8)
amod(rats-10, obese-9)
nmod:from(pancreata-7, rats-10)
ccomp(showed-3, exhibited-11)
advmod(higher-13, significantly-12)
amod(levels-14, higher-13)
dobj(exhibited-11, levels-14)
case(secretion-17, of-15)
compound(secretion-17, TH_1-16)
nmod:of(levels-14, secretion-17)
case(response-19, in-18)
nmod:in(exhibited-11, response-19)
case(glucose-21, to-20)
nmod:to(response-19, glucose-21)
cc(glucose-21, and-22)
amod(stimulation-24, methyl_gallate-23)
nmod:to(response-19, stimulation-24)
conj:and(glucose-21, stimulation-24)
case(rats-28, compared-25)
mwe(compared-25, to-26)
amod(rats-28, lean-27)
advcl(exhibited-11, rats-28)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN TH_1/NN by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN in/IN genetically/RB susceptible/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NN TH_1))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (PP (IN in)
                (NP
                  (ADJP (RB genetically) (JJ susceptible))
                  (NNS individuals))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-12, that-4)
nsubj(contribute-12, hypersecretion-5)
case(TH_1-7, of-6)
nmod:of(hypersecretion-5, TH_1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(TH_1-7, pancreas-10)
aux(contribute-12, may-11)
ccomp(suggest-3, contribute-12)
case(development-15, to-13)
det(development-15, the-14)
nmod:to(contribute-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
case(individuals-21, in-18)
advmod(susceptible-20, genetically-19)
amod(individuals-21, susceptible-20)
nmod:in(contribute-12, individuals-21)

Further/JJ investigation/NN into/IN this/DT mechanism/NN could/MD lead/VB to/TO new/JJ therapeutic/JJ approaches/NNS for/IN treating/VBG obesity-related_diseases/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Further) (NN investigation))
      (PP (IN into)
        (NP (DT this) (NN mechanism))))
    (VP (MD could)
      (VP (VB lead)
        (PP (TO to)
          (NP
            (NP (JJ new) (JJ therapeutic) (NNS approaches))
            (PP (IN for)
              (S
                (VP (VBG treating)
                  (NP (NNS obesity-related_diseases)))))))))
    (. .)))

amod(investigation-2, Further-1)
nsubj(lead-7, investigation-2)
case(mechanism-5, into-3)
det(mechanism-5, this-4)
nmod:into(investigation-2, mechanism-5)
aux(lead-7, could-6)
root(ROOT-0, lead-7)
case(approaches-11, to-8)
amod(approaches-11, new-9)
amod(approaches-11, therapeutic-10)
nmod:to(lead-7, approaches-11)
mark(treating-13, for-12)
acl(approaches-11, treating-13)
dobj(treating-13, obesity-related_diseases-14)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN Pristane/JJ levels/NNS in/IN hyperPristanemic/JJ patients/NNS and/CC a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Pristane) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperPristanemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (DT a) (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, Pristane-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperPristanemic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
det(risk-20, a-18)
amod(risk-20, decreased-19)
nmod:in(levels-13, risk-20)
conj:and(patients-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

The/DT mechanisms/NNS behind/IN this/DT effect/NN are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD reduce/VB inflammation/NN and/CC oxidative_stress/NNS ,/, leading/VBG to/TO improved/VBN cardiovascular_health/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (PP (IN behind)
          (NP (DT this) (NN effect))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP (VB reduce)
                  (NP (NN inflammation)
                    (CC and)
                    (NNS oxidative_stress))))))
          (, ,)
          (PP (VBG leading)
            (PP (TO to)
              (NP (VBN improved) (NN cardiovascular_health)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
case(effect-5, behind-3)
det(effect-5, this-4)
nmod:behind(mechanisms-2, effect-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(reduce-21, that-16)
nsubj(reduce-21, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
nsubj(reduce-21, DHA-19)
aux(reduce-21, may-20)
ccomp(believed-15, reduce-21)
dobj(reduce-21, inflammation-22)
cc(inflammation-22, and-23)
dobj(reduce-21, oxidative_stress-24)
conj:and(inflammation-22, oxidative_stress-24)
case(cardiovascular_health-29, leading-26)
case(cardiovascular_health-29, to-27)
amod(cardiovascular_health-29, improved-28)
advcl(believed-15, cardiovascular_health-29)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN omega-3_fatty_acids/JJ may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG and/CC managing/VBG CHD/NNP and/CC related/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (CC and)
                    (VBG managing)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ related) (NNS conditions)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-13, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-13, intake-6)
case(omega-3_fatty_acids-8, of-7)
nmod:of(intake-6, omega-3_fatty_acids-8)
aux(strategy-13, may-9)
cop(strategy-13, be-10)
det(strategy-13, a-11)
amod(strategy-13, promising-12)
ccomp(suggest-3, strategy-13)
mark(preventing-15, for-14)
advcl(strategy-13, preventing-15)
cc(preventing-15, and-16)
advcl(strategy-13, managing-17)
conj:and(preventing-15, managing-17)
dobj(preventing-15, CHD-18)
cc(CHD-18, and-19)
amod(conditions-21, related-20)
dobj(preventing-15, conditions-21)
conj:and(CHD-18, conditions-21)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))))
                (PP (IN in)
                  (NP (NN cardiovascular_disease)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-7, explore-15)
det(applications-19, the-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
dobj(explore-15, applications-19)
case(EPA-21, of-20)
nmod:of(applications-19, EPA-21)
cc(EPA-21, and-22)
nmod:of(applications-19, DHA-23)
conj:and(EPA-21, DHA-23)
case(cardiovascular_disease-25, in-24)
nmod:in(explore-15, cardiovascular_disease-25)

The/DT solute_carrier_family_1/JJ -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- is_a/NN group/NN of/IN membrane/NN transport/NN proteins/VBZ that/IN are/VBP involved/VBN in/IN the/DT uptake/NN of/IN glutamate/JJ and/CC other/JJ neutral/JJ amino_acids/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ solute_carrier_family_1)
        (PRN (-LRB- -LRB-)
          (NP (NNP SLC1))
          (-RRB- -RRB-))
        (NN is_a) (NN group))
      (PP (IN of)
        (NP (NN membrane) (NN transport))))
    (VP (VBZ proteins)
      (SBAR (IN that)
        (S
          (VP (VBP are)
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN uptake))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ glutamate)
                        (CC and)
                        (JJ other))
                      (JJ neutral) (NNS amino_acids))))))))))
    (. .)))

det(group-7, The-1)
amod(group-7, solute_carrier_family_1-2)
appos(group-7, SLC1-4)
compound(group-7, is_a-6)
nsubj(proteins-11, group-7)
case(transport-10, of-8)
compound(transport-10, membrane-9)
nmod:of(group-7, transport-10)
root(ROOT-0, proteins-11)
mark(involved-14, that-12)
auxpass(involved-14, are-13)
ccomp(proteins-11, involved-14)
case(uptake-17, in-15)
det(uptake-17, the-16)
nmod:in(involved-14, uptake-17)
case(amino_acids-23, of-18)
amod(amino_acids-23, glutamate-19)
cc(glutamate-19, and-20)
conj:and(glutamate-19, other-21)
amod(amino_acids-23, other-21)
amod(amino_acids-23, neutral-22)
nmod:of(uptake-17, amino_acids-23)

This/DT protein/NN family/NN includes/VBZ five/CD high-affinity/JJ glutamate_transporters/NNS ,/, namely/RB EAAC1/CD ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/CD ,/, SLC1A2/CD ,/, SLC1A3/CD ,/, SLC1A6/CD ,/, and/CC SLC1A7/CD respectively/RB -RRB-/-RRB- ,/, which/WDT play/VB a/DT crucial/JJ role/NN in/IN regulating/VBG extracellular/NN levels/NNS of/IN glutamate/NN in/IN the/DT central/JJ nervous/JJ system/NN ./.

(ROOT
  (S
    (NP (DT This) (NN protein) (NN family))
    (VP (VBZ includes)
      (NP
        (NP (CD five) (JJ high-affinity) (NNS glutamate_transporters))
        (, ,)
        (NP
          (QP (RB namely) (CD EAAC1)))
        (, ,)
        (NP
          (NP (NNP GLT-1) (, ,) (NNP GLAST) (, ,) (NNP EAAT4)
            (CC and)
            (NNP EAAT5))
          (-LRB- -LRB-)
          (NP
            (NP (CD SLC1A1) (, ,) (CD SLC1A2) (, ,) (CD SLC1A3) (, ,) (CD SLC1A6) (, ,)
              (CC and)
              (CD SLC1A7))
            (ADVP (RB respectively)))
          (-RRB- -RRB-))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VB play)
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG regulating)
                    (NP
                      (NP (NN extracellular) (NNS levels))
                      (PP (IN of)
                        (NP (NN glutamate))))
                    (PP (IN in)
                      (NP (DT the) (JJ central) (JJ nervous) (NN system)))))))))))
    (. .)))

det(family-3, This-1)
compound(family-3, protein-2)
nsubj(includes-4, family-3)
root(ROOT-0, includes-4)
nummod(glutamate_transporters-7, five-5)
amod(glutamate_transporters-7, high-affinity-6)
dobj(includes-4, glutamate_transporters-7)
nsubj(play-34, glutamate_transporters-7)
advmod(EAAC1-10, namely-9)
appos(glutamate_transporters-7, EAAC1-10)
appos(glutamate_transporters-7, GLT-1-12)
appos(glutamate_transporters-7, GLAST-14)
conj:and(GLT-1-12, GLAST-14)
appos(glutamate_transporters-7, EAAT4-16)
conj:and(GLT-1-12, EAAT4-16)
cc(GLT-1-12, and-17)
appos(glutamate_transporters-7, EAAT5-18)
conj:and(GLT-1-12, EAAT5-18)
dep(GLT-1-12, SLC1A1-20)
nummod(SLC1A1-20, SLC1A2-22)
nummod(SLC1A1-20, SLC1A3-24)
nummod(SLC1A1-20, SLC1A6-26)
cc(SLC1A1-20, and-28)
dep(GLT-1-12, SLC1A7-29)
conj:and(SLC1A1-20, SLC1A7-29)
advmod(SLC1A1-20, respectively-30)
ref(glutamate_transporters-7, which-33)
acl:relcl(glutamate_transporters-7, play-34)
det(role-37, a-35)
amod(role-37, crucial-36)
dobj(play-34, role-37)
mark(regulating-39, in-38)
advcl(play-34, regulating-39)
compound(levels-41, extracellular-40)
dobj(regulating-39, levels-41)
case(glutamate-43, of-42)
nmod:of(levels-41, glutamate-43)
case(system-48, in-44)
det(system-48, the-45)
amod(system-48, central-46)
amod(system-48, nervous-47)
nmod:in(regulating-39, system-48)

In/IN addition/NN to/TO these/DT glutamate_transporters/NNS ,/, the/DT SLC1/NNP family/NN also/RB includes/VBZ two/CD neutral/JJ CP-10/NN transporters/NNS -/: S100a1/NNP and/CC ASCT2/NNP -LRB-/-LRB- SLC1A4/NNP and/CC ALC1A5/NNP respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (DT these) (NNS glutamate_transporters)))))
    (, ,)
    (NP (DT the) (NNP SLC1) (NN family))
    (ADVP (RB also))
    (VP (VBZ includes)
      (NP
        (NP (CD two) (JJ neutral) (NN CP-10) (NNS transporters))
        (: -)
        (NP
          (NP (NNP S100a1)
            (CC and)
            (NNP ASCT2))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP SLC1A4)
                (CC and)
                (NNP ALC1A5))
              (ADJP (RB respectively)))
            (-RRB- -RRB-)))))
    (. .)))

case(glutamate_transporters-5, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
det(glutamate_transporters-5, these-4)
nmod:in_addition_to(includes-11, glutamate_transporters-5)
det(family-9, the-7)
compound(family-9, SLC1-8)
nsubj(includes-11, family-9)
advmod(includes-11, also-10)
root(ROOT-0, includes-11)
nummod(transporters-15, two-12)
amod(transporters-15, neutral-13)
compound(transporters-15, CP-10-14)
dobj(includes-11, transporters-15)
dep(transporters-15, S100a1-17)
cc(S100a1-17, and-18)
dep(transporters-15, ASCT2-19)
conj:and(S100a1-17, ASCT2-19)
dep(S100a1-17, SLC1A4-21)
cc(SLC1A4-21, and-22)
dep(S100a1-17, ALC1A5-23)
conj:and(SLC1A4-21, ALC1A5-23)
amod(SLC1A4-21, respectively-24)

These/DT transporters/NNS are/VBP involved/VBN in/IN the/DT uptake/NN of/IN neutral/JJ amino_acids/NNS such/JJ as/IN alanine/NN and/CC serine/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS transporters))
    (VP (VBP are)
      (VP (VBN involved)
        (PP (IN in)
          (NP
            (NP (DT the) (NN uptake))
            (PP (IN of)
              (NP
                (NP (JJ neutral) (NNS amino_acids))
                (PP (JJ such) (IN as)
                  (NP (NN alanine)
                    (CC and)
                    (NN serine)))))))))
    (. .)))

det(transporters-2, These-1)
nsubjpass(involved-4, transporters-2)
auxpass(involved-4, are-3)
root(ROOT-0, involved-4)
case(uptake-7, in-5)
det(uptake-7, the-6)
nmod:in(involved-4, uptake-7)
case(amino_acids-10, of-8)
amod(amino_acids-10, neutral-9)
nmod:of(uptake-7, amino_acids-10)
case(alanine-13, such-11)
mwe(such-11, as-12)
nmod:such_as(amino_acids-10, alanine-13)
cc(alanine-13, and-14)
nmod:such_as(amino_acids-10, serine-15)
conj:and(alanine-13, serine-15)

Dysregulation/NN of/IN these/DT transporters/NNS has_been/VBP implicated/VBN in_a/JJ variety/NN of/IN neurological_disorders/NNS such/JJ as/IN epilepsy/NN ,/, Alzheimer/NNP 's/POS _/JJ disease/NN and/CC schizophrenia/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Dysregulation))
      (PP (IN of)
        (NP (DT these) (NNS transporters))))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (NP
          (NP (JJ in_a) (NN variety))
          (PP (IN of)
            (NP
              (NP (NNS neurological_disorders))
              (PP (JJ such) (IN as)
                (NP
                  (NP (NN epilepsy))
                  (, ,)
                  (NP
                    (NP (NNP Alzheimer) (POS 's))
                    (JJ _) (NN disease)
                    (CC and)
                    (NN schizophrenia)))))))))
    (. .)))

nsubj(has_been-5, Dysregulation-1)
case(transporters-4, of-2)
det(transporters-4, these-3)
nmod:of(Dysregulation-1, transporters-4)
root(ROOT-0, has_been-5)
dep(has_been-5, implicated-6)
amod(variety-8, in_a-7)
dobj(implicated-6, variety-8)
case(neurological_disorders-10, of-9)
nmod:of(variety-8, neurological_disorders-10)
case(epilepsy-13, such-11)
mwe(such-11, as-12)
nmod:such_as(neurological_disorders-10, epilepsy-13)
nmod:poss(disease-18, Alzheimer-15)
case(Alzheimer-15, 's-16)
amod(disease-18, _-17)
appos(epilepsy-13, disease-18)
cc(disease-18, and-19)
appos(epilepsy-13, schizophrenia-20)
conj:and(disease-18, schizophrenia-20)

Understanding/VBG the/DT function/NN and/CC regulation/NN of/IN these/DT transporters/NNS may/MD provide/VB new/JJ insights/NNS into/IN the/DT pathophysiology/NN of/IN these/DT diseases/NNS and/CC may/MD lead/VB to/TO the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS ./.

(ROOT
  (S
    (S
      (VP (VBG Understanding)
        (NP
          (NP (DT the) (NN function))
          (CC and)
          (NP
            (NP (NN regulation))
            (PP (IN of)
              (NP (DT these) (NNS transporters)))))))
    (VP
      (VP (MD may)
        (VP (VB provide)
          (NP (JJ new) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (NN pathophysiology))
              (PP (IN of)
                (NP (DT these) (NNS diseases)))))))
      (CC and)
      (VP (MD may)
        (VP (VB lead)
          (PP (TO to)
            (NP
              (NP (DT the) (NN development))
              (PP (IN of)
                (NP (JJ novel) (JJ therapeutic) (NNS strategies))))))))
    (. .)))

csubj(provide-10, Understanding-1)
csubj(lead-21, Understanding-1)
det(function-3, the-2)
dobj(Understanding-1, function-3)
cc(function-3, and-4)
dobj(Understanding-1, regulation-5)
conj:and(function-3, regulation-5)
case(transporters-8, of-6)
det(transporters-8, these-7)
nmod:of(regulation-5, transporters-8)
aux(provide-10, may-9)
root(ROOT-0, provide-10)
amod(insights-12, new-11)
dobj(provide-10, insights-12)
case(pathophysiology-15, into-13)
det(pathophysiology-15, the-14)
nmod:into(provide-10, pathophysiology-15)
case(diseases-18, of-16)
det(diseases-18, these-17)
nmod:of(pathophysiology-15, diseases-18)
cc(provide-10, and-19)
aux(lead-21, may-20)
conj:and(provide-10, lead-21)
case(development-24, to-22)
det(development-24, the-23)
nmod:to(lead-21, development-24)
case(strategies-28, of-25)
amod(strategies-28, novel-26)
amod(strategies-28, therapeutic-27)
nmod:of(development-24, strategies-28)

The/DT health/NN benefits/NNS of/IN omega-3_fatty_acids/NN have/VBP been/VBN extensively/RB studied/VBN in/IN the/DT context/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN health) (NNS benefits))
      (PP (IN of)
        (NP (NN omega-3_fatty_acids))))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN in)
            (NP
              (NP (DT the) (NN context))
              (PP (IN of)
                (NP (NN cardiovascular_disease))))))))
    (. .)))

det(benefits-3, The-1)
compound(benefits-3, health-2)
nsubjpass(studied-9, benefits-3)
case(omega-3_fatty_acids-5, of-4)
nmod:of(benefits-3, omega-3_fatty_acids-5)
aux(studied-9, have-6)
auxpass(studied-9, been-7)
advmod(studied-9, extensively-8)
root(ROOT-0, studied-9)
case(context-12, in-10)
det(context-12, the-11)
nmod:in(studied-9, context-12)
case(cardiovascular_disease-14, of-13)
nmod:of(context-12, cardiovascular_disease-14)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/VB associated/VBN with/IN decreased/VBN sulfochloranthine/NN levels/NNS in/IN hypersulfochloranthinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (VB to_be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (VBN decreased) (NN sulfochloranthine) (NNS levels)))
                (PP (IN in)
                  (NP (JJ hypersulfochloranthinemic) (NNS patients)))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
ccomp(shown-24, to_be-25)
dep(to_be-25, associated-26)
case(levels-30, with-27)
amod(levels-30, decreased-28)
compound(levels-30, sulfochloranthine-29)
nmod:with(associated-26, levels-30)
case(patients-33, in-31)
amod(patients-33, hypersulfochloranthinemic-32)
nmod:in(associated-26, patients-33)

Furthermore/RB ,/, these/DT fatty_acids/NNS are/VBP also/RB associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP are)
      (ADVP (RB also))
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(associated-7, Furthermore-1)
det(fatty_acids-4, these-3)
nsubjpass(associated-7, fatty_acids-4)
auxpass(associated-7, are-5)
advmod(associated-7, also-6)
root(ROOT-0, associated-7)
case(risk-11, with-8)
det(risk-11, a-9)
amod(risk-11, decreased-10)
nmod:with(associated-7, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

The/DT exact/JJ mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB improvements/NNS in/IN lipid/NN metabolism/NN ,/, anti-inflammatory/JJ effects/NNS ,/, and/CC modulation/NN of/IN cardiac/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ exact) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NNS improvements))
            (PP (IN in)
              (NP
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (NP (JJ anti-inflammatory) (NNS effects))
                (, ,)
                (CC and)
                (NP
                  (NP (NN modulation))
                  (PP (IN of)
                    (NP (JJ cardiac) (NN function))))))))))
    (. .)))

det(mechanisms-3, The-1)
amod(mechanisms-3, exact-2)
nsubjpass(understood-12, mechanisms-3)
nsubj(involve-16, mechanisms-3)
acl(mechanisms-3, underlying-4)
det(effects-7, these-5)
amod(effects-7, protective-6)
dobj(underlying-4, effects-7)
auxpass(understood-12, are-8)
neg(understood-12, not-9)
advmod(understood-12, yet-10)
advmod(understood-12, fully-11)
root(ROOT-0, understood-12)
cc(understood-12, but-14)
aux(involve-16, may-15)
conj:but(understood-12, involve-16)
dobj(involve-16, improvements-17)
case(metabolism-20, in-18)
compound(metabolism-20, lipid-19)
nmod:in(improvements-17, metabolism-20)
amod(effects-23, anti-inflammatory-22)
nmod:in(improvements-17, effects-23)
conj:and(metabolism-20, effects-23)
cc(metabolism-20, and-25)
nmod:in(improvements-17, modulation-26)
conj:and(metabolism-20, modulation-26)
case(function-29, of-27)
amod(function-29, cardiac-28)
nmod:of(modulation-26, function-29)

These/DT findings/NNS suggest/VBP that/IN dietary/JJ supplementation/NN with/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ dietary) (NN supplementation))
            (PP (IN with)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-14, that-4)
amod(supplementation-6, dietary-5)
nsubj(strategy-14, supplementation-6)
case(omega-3_fatty_acids-9, with-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:with(supplementation-6, omega-3_fatty_acids-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, a-12)
amod(strategy-14, promising-13)
ccomp(suggest-3, strategy-14)
case(prevention-17, for-15)
det(prevention-17, the-16)
nmod:for(strategy-14, prevention-17)
cc(prevention-17, and-18)
nmod:for(strategy-14, treatment-19)
conj:and(prevention-17, treatment-19)
case(CHD-21, of-20)
nmod:of(prevention-17, CHD-21)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (JJ human) (NN health))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(effects-9, for-6)
nmod:poss(effects-9, their-7)
amod(effects-9, beneficial-8)
nmod:for(studied-5, effects-9)
case(health-12, on-10)
amod(health-12, human-11)
nmod:on(effects-9, health-12)

Among/IN the/DT various/JJ types/NNS of/IN omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN found/VBN to_be/VBP particularly/RB effective/JJ in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN Among)
      (NP
        (NP (DT the) (JJ various) (NNS types))
        (PP (IN of)
          (NP (JJ omega-3_fatty_acids)))))
    (, ,)
    (S
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (SBAR
            (S (-LRB- -LRB-)
              (NP (NNP DHA))
              (-RRB- -RRB-)
              (VP (VBP have)
                (VP (VBN been)
                  (VP (VBN found)))))))))
    (VP (VBP to_be)
      (ADJP (RB particularly) (JJ effective)
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (VBG developing) (NN coronary_heart_disease))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(types-4, Among-1)
det(types-4, the-2)
amod(types-4, various-3)
nmod:among(to_be-20, types-4)
case(omega-3_fatty_acids-6, of-5)
nmod:of(types-4, omega-3_fatty_acids-6)
csubj(to_be-20, eicosapentaenoic_acid-8)
dep(eicosapentaenoic_acid-8, EPA-10)
cc(eicosapentaenoic_acid-8, and-12)
conj:and(eicosapentaenoic_acid-8, docosahexaenoic_acid-13)
csubj(to_be-20, docosahexaenoic_acid-13)
nsubjpass(found-19, DHA-15)
aux(found-19, have-17)
auxpass(found-19, been-18)
ccomp(docosahexaenoic_acid-13, found-19)
root(ROOT-0, to_be-20)
advmod(effective-22, particularly-21)
xcomp(to_be-20, effective-22)
mark(reducing-24, in-23)
advcl(effective-22, reducing-24)
det(risk-26, the-25)
dobj(reducing-24, risk-26)
case(coronary_heart_disease-29, of-27)
amod(coronary_heart_disease-29, developing-28)
nmod:of(risk-26, coronary_heart_disease-29)
appos(coronary_heart_disease-29, CHD-31)

Recent/JJ studies/NNS have/VBP also/RB shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN L-lysine/JJ levels/NNS in/IN hyperL-lysinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ L-lysine) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperL-lysinemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-5, studies-2)
aux(shown-5, have-3)
advmod(shown-5, also-4)
root(ROOT-0, shown-5)
mark(associated-11, that-6)
det(omega-3_fatty_acids-9, these-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nsubjpass(associated-11, omega-3_fatty_acids-9)
auxpass(associated-11, are-10)
ccomp(shown-5, associated-11)
case(levels-15, with-12)
amod(levels-15, decreased-13)
amod(levels-15, L-lysine-14)
nmod:with(associated-11, levels-15)
case(patients-18, in-16)
amod(patients-18, hyperL-lysinemic-17)
nmod:in(levels-15, patients-18)

This/DT finding/NN suggests/VBZ that/IN EPA/NNP and/CC DHA/NNP may/MD play/VB a/DT role/NN in/IN regulating/VBG L-lysine/JJ metabolism/NN ,/, which/WDT could/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP
                        (NP (JJ L-lysine) (NN metabolism))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD could)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(play-9, that-4)
nsubj(play-9, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(play-9, DHA-7)
aux(play-9, may-8)
ccomp(suggests-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(regulating-13, in-12)
acl(role-11, regulating-13)
amod(metabolism-15, L-lysine-14)
dobj(regulating-13, metabolism-15)
nsubj(contribute-19, metabolism-15)
ref(metabolism-15, which-17)
aux(contribute-19, could-18)
acl:relcl(metabolism-15, contribute-19)
case(effects-23, to-20)
nmod:poss(effects-23, their-21)
amod(effects-23, cardioprotective-22)
nmod:to(contribute-19, effects-23)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG this/DT association/NN and/CC to/TO determine/VB the/DT optimal/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP for/IN maintaining/VBG healthy/JJ L-lysine/JJ levels/NNS and/CC reducing/VBG the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN association))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN intake))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG maintaining)
                        (NP (JJ healthy) (JJ L-lysine) (NNS levels)))
                      (CC and)
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(association-11, this-10)
dobj(underlying-9, association-11)
cc(elucidate-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(elucidate-6, determine-14)
det(intake-17, the-15)
amod(intake-17, optimal-16)
dobj(determine-14, intake-17)
case(EPA-19, of-18)
nmod:of(intake-17, EPA-19)
cc(EPA-19, and-20)
nmod:of(intake-17, DHA-21)
conj:and(EPA-19, DHA-21)
mark(maintaining-23, for-22)
advcl(determine-14, maintaining-23)
amod(levels-26, healthy-24)
amod(levels-26, L-lysine-25)
dobj(maintaining-23, levels-26)
cc(maintaining-23, and-27)
advcl(determine-14, reducing-28)
conj:and(maintaining-23, reducing-28)
det(risk-30, the-29)
dobj(reducing-28, risk-30)
case(CHD-32, of-31)
nmod:of(risk-30, CHD-32)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (PP (IN for)
          (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))))
    (. .)))

nsubjpass(known-15, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
case(benefits-20, for-16)
nmod:poss(benefits-20, their-17)
amod(benefits-20, potential-18)
compound(benefits-20, health-19)
nmod:for(known-15, benefits-20)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(play-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(play-9, omega-3_fatty_acids-7)
aux(play-9, may-8)
ccomp(demonstrated-4, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(reducing-13, in-12)
acl(role-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

In/IN addition/NN to/TO their/PRP$ cardioprotective/JJ effects/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN sotrastaurin/NN in/IN hypersotrastaurinmic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN sotrastaurin))
                  (PP (IN in)
                    (NP (JJ hypersotrastaurinmic) (NNS patients))))))))))
    (. .)))

case(effects-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(effects-6, their-4)
amod(effects-6, cardioprotective-5)
nmod:in_addition_to(associated-13, effects-6)
nsubjpass(associated-13, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubjpass(associated-13, DHA-10)
aux(associated-13, have-11)
auxpass(associated-13, been-12)
root(ROOT-0, associated-13)
case(levels-16, with-14)
amod(levels-16, decreased-15)
nmod:with(associated-13, levels-16)
case(sotrastaurin-18, of-17)
nmod:of(levels-16, sotrastaurin-18)
case(patients-21, in-19)
amod(patients-21, hypersotrastaurinmic-20)
nmod:in(sotrastaurin-18, patients-21)

Sotrastaurin/NNP is_a/NNP protein_kinase_C_inhibitor/VBP that/DT has_been/NN implicated/VBN in/IN the/DT pathogenesis/NNS of/IN various_diseases/NNS ,/, including/VBG autoimmune_disorders/NNS and/CC cancer/NN ./.

(ROOT
  (S
    (NP (NNP Sotrastaurin) (NNP is_a))
    (VP (VBP protein_kinase_C_inhibitor)
      (NP
        (NP (DT that) (NN has_been))
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP
                  (NP (NNS various_diseases))
                  (, ,)
                  (VP (VBG including)
                    (NP (NNS autoimmune_disorders)
                      (CC and)
                      (NN cancer))))))))))
    (. .)))

compound(is_a-2, Sotrastaurin-1)
nsubj(protein_kinase_C_inhibitor-3, is_a-2)
root(ROOT-0, protein_kinase_C_inhibitor-3)
det(has_been-5, that-4)
dobj(protein_kinase_C_inhibitor-3, has_been-5)
acl(has_been-5, implicated-6)
case(pathogenesis-9, in-7)
det(pathogenesis-9, the-8)
nmod:in(implicated-6, pathogenesis-9)
case(various_diseases-11, of-10)
nmod:of(pathogenesis-9, various_diseases-11)
acl(various_diseases-11, including-13)
dobj(including-13, autoimmune_disorders-14)
cc(autoimmune_disorders-14, and-15)
dobj(including-13, cancer-16)
conj:and(autoimmune_disorders-14, cancer-16)

The/DT mechanism/NN by/IN which/WDT omega-3_fatty_acids/JJ modulate/VBP sotrastaurin/NN levels/NNS remains/VBZ unclear/JJ ,/, but/CC it/PRP is/VBZ thought/VBN to/TO involve/VB the/DT regulation/NN of/IN gene/NN expression/NN and/CC signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (JJ omega-3_fatty_acids))
            (VP (VBP modulate)
              (NP (NN sotrastaurin) (NNS levels))))))
      (VP (VBZ remains)
        (ADJP (JJ unclear))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB involve)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP
                      (NP (NN gene) (NN expression))
                      (CC and)
                      (NP (VBG signaling) (NNS pathways)))))))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(modulate-6, mechanism-2)
nsubj(remains-9, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(modulate-6, omega-3_fatty_acids-5)
acl:relcl(mechanism-2, modulate-6)
compound(levels-8, sotrastaurin-7)
dobj(modulate-6, levels-8)
root(ROOT-0, remains-9)
xcomp(remains-9, unclear-10)
cc(remains-9, but-12)
nsubjpass(thought-15, it-13)
nsubj:xsubj(involve-17, it-13)
auxpass(thought-15, is-14)
conj:but(remains-9, thought-15)
mark(involve-17, to-16)
xcomp(thought-15, involve-17)
det(regulation-19, the-18)
dobj(involve-17, regulation-19)
case(expression-22, of-20)
compound(expression-22, gene-21)
nmod:of(regulation-19, expression-22)
cc(expression-22, and-23)
amod(pathways-25, signaling-24)
nmod:of(regulation-19, pathways-25)
conj:and(expression-22, pathways-25)

These/DT findings/NNS suggest/VBP that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD have/VB therapeutic/JJ potential/NN in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and/CC other/JJ diseases/NNS associated/VBN with/IN sotrastaurin/NN dysregulation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ therapeutic) (NN potential))
              (PP (IN in)
                (NP
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD))))
                  (CC and)
                  (NP
                    (NP (JJ other) (NNS diseases))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP (NN sotrastaurin) (NN dysregulation))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-8, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubj(have-8, omega-3_fatty_acids-6)
aux(have-8, may-7)
ccomp(suggest-3, have-8)
amod(potential-10, therapeutic-9)
dobj(have-8, potential-10)
case(prevention-13, in-11)
det(prevention-13, the-12)
nmod:in(have-8, prevention-13)
cc(prevention-13, and-14)
nmod:in(have-8, treatment-15)
conj:and(prevention-13, treatment-15)
case(CHD-17, of-16)
nmod:of(prevention-13, CHD-17)
cc(prevention-13, and-18)
amod(diseases-20, other-19)
nmod:in(have-8, diseases-20)
conj:and(prevention-13, diseases-20)
acl(diseases-20, associated-21)
case(dysregulation-24, with-22)
compound(dysregulation-24, sotrastaurin-23)
nmod:with(associated-21, dysregulation-24)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO possess/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB possess)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(possess-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(possess-18, to-17)
xcomp(shown-16, possess-18)
amod(benefits-21, various-19)
compound(benefits-21, health-20)
dobj(possess-18, benefits-21)

In/IN particular/JJ ,/, studies/NNS have/VBP suggested/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD decrease/VB levels/NNS of/IN NAN-190/NN in/IN hyperNAN-190mic/JJ patients/NNS and/CC reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD may)
              (VP
                (VP (VB decrease)
                  (NP
                    (NP (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN NAN-190))
                        (PP (IN in)
                          (NP (JJ hyperNAN-190mic) (NNS patients)))))))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(particular-2, In-1)
advcl(suggested-6, particular-2)
nsubj(suggested-6, studies-4)
aux(suggested-6, have-5)
root(ROOT-0, suggested-6)
mark(decrease-12, that-7)
det(omega-3_fatty_acids-10, these-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nsubj(decrease-12, omega-3_fatty_acids-10)
nsubj(reduce-20, omega-3_fatty_acids-10)
aux(decrease-12, may-11)
ccomp(suggested-6, decrease-12)
dobj(decrease-12, levels-13)
case(NAN-190-15, of-14)
nmod:of(levels-13, NAN-190-15)
case(patients-18, in-16)
amod(patients-18, hyperNAN-190mic-17)
nmod:in(NAN-190-15, patients-18)
cc(decrease-12, and-19)
ccomp(suggested-6, reduce-20)
conj:and(decrease-12, reduce-20)
det(risk-22, the-21)
dobj(reduce-20, risk-22)
mark(developing-24, of-23)
acl(risk-22, developing-24)
dobj(developing-24, coronary_heart_disease-25)
appos(risk-22, CHD-27)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN the/DT anti-inflammatory/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP play/VBP a/DT key/JJ role/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ anti-inflammatory) (NNS properties))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (VP (VBP play)
                (NP (DT a) (JJ key) (NN role))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(play-24, that-16)
det(properties-19, the-17)
amod(properties-19, anti-inflammatory-18)
nsubj(play-24, properties-19)
case(EPA-21, of-20)
nmod:of(properties-19, EPA-21)
cc(EPA-21, and-22)
nmod:of(properties-19, DHA-23)
conj:and(EPA-21, DHA-23)
ccomp(believed-15, play-24)
det(role-27, a-25)
amod(role-27, key-26)
dobj(play-24, role-27)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS ,/, reduce/VB blood_pressure/NN ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP
                  (VP (VB reduce)
                    (NP (NN blood_pressure)))
                  (, ,)
                  (CC and)
                  (VP (VB improve)
                    (NP (JJ endothelial) (NN function))))))))))
    (. .)))

advmod(shown-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(improve-9, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(improve-9, to-8)
xcomp(shown-7, improve-9)
compound(profiles-11, lipid-10)
dobj(improve-9, profiles-11)
dep(improve-9, reduce-13)
dobj(reduce-13, blood_pressure-14)
cc(reduce-13, and-16)
dep(improve-9, improve-17)
conj:and(reduce-13, improve-17)
amod(function-19, endothelial-18)
dobj(improve-17, function-19)

Given/VBN the/DT potential/JJ health/NN benefits/NNS associated/VBN with/IN omega-3_fatty_acids/JJ ,/, further/JJ research/NN is/VBZ warranted/VBN to/TO better/RBR understand/VB their/PRP$ therapeutic/JJ potential/NN in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP
        (NP (DT the) (JJ potential) (NN health) (NNS benefits))
        (VP (VBN associated)
          (PP (IN with)
            (ADJP (JJ omega-3_fatty_acids))))))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (ADVP (RBR better))
              (VB understand)
              (NP
                (NP (PRP$ their) (JJ therapeutic) (NN potential))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

case(benefits-5, Given-1)
det(benefits-5, the-2)
amod(benefits-5, potential-3)
compound(benefits-5, health-4)
nmod:given(warranted-13, benefits-5)
acl(benefits-5, associated-6)
case(omega-3_fatty_acids-8, with-7)
advcl(associated-6, omega-3_fatty_acids-8)
amod(research-11, further-10)
nsubjpass(warranted-13, research-11)
nsubj:xsubj(understand-16, research-11)
auxpass(warranted-13, is-12)
root(ROOT-0, warranted-13)
mark(understand-16, to-14)
advmod(understand-16, better-15)
xcomp(warranted-13, understand-16)
nmod:poss(potential-19, their-17)
amod(potential-19, therapeutic-18)
dobj(understand-16, potential-19)
case(prevention-22, in-20)
det(prevention-22, the-21)
nmod:in(potential-19, prevention-22)
cc(prevention-22, and-23)
nmod:in(potential-19, treatment-24)
conj:and(prevention-22, treatment-24)
case(CHD-26, of-25)
nmod:of(prevention-22, CHD-26)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN Dixyrazine/JJ levels/NNS in/IN hyperDixyrazinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Dixyrazine) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperDixyrazinemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-14, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-14, omega-3_fatty_acids-7)
appos(omega-3_fatty_acids-7, EPA-9)
cc(EPA-9, and-10)
appos(omega-3_fatty_acids-7, DHA-11)
conj:and(EPA-9, DHA-11)
auxpass(associated-14, are-13)
ccomp(shown-4, associated-14)
case(levels-18, with-15)
amod(levels-18, decreased-16)
amod(levels-18, Dixyrazine-17)
nmod:with(associated-14, levels-18)
case(patients-21, in-19)
amod(patients-21, hyperDixyrazinemic-20)
nmod:in(levels-18, patients-21)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(shown-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(shown-7, fatty_acids-4)
nsubj:xsubj(decrease-9, fatty_acids-4)
aux(shown-7, have-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
mark(decrease-9, to-8)
xcomp(shown-7, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

The/DT mechanism/NN behind/IN this/DT effect/NN is/VBZ believed/VBN to_be/JJ related/VBN to/TO the/DT anti-inflammatory/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP ,/, which/WDT may/MD reduce/VB the/DT risk/NN of/IN atherosclerosis/NNS and/CC other/JJ cardiovascular_diseases/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN mechanism))
      (PP (IN behind)
        (NP (DT this) (NN effect))))
    (VP (VBZ is)
      (VP (VBN believed)
        (ADJP (JJ to_be))
        (PP (VBN related)
          (PP (TO to)
            (NP
              (NP (DT the) (JJ anti-inflammatory) (NNS properties))
              (PP (IN of)
                (NP
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB reduce)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP
                                (NP (NNS atherosclerosis))
                                (CC and)
                                (NP (JJ other) (NNS cardiovascular_diseases))))))))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(believed-7, mechanism-2)
case(effect-5, behind-3)
det(effect-5, this-4)
nmod:behind(mechanism-2, effect-5)
auxpass(believed-7, is-6)
root(ROOT-0, believed-7)
xcomp(believed-7, to_be-8)
case(properties-13, related-9)
case(properties-13, to-10)
det(properties-13, the-11)
amod(properties-13, anti-inflammatory-12)
advcl(believed-7, properties-13)
case(EPA-15, of-14)
nmod:of(properties-13, EPA-15)
nsubj(reduce-21, EPA-15)
cc(EPA-15, and-16)
nmod:of(properties-13, DHA-17)
conj:and(EPA-15, DHA-17)
nsubj(reduce-21, DHA-17)
ref(EPA-15, which-19)
aux(reduce-21, may-20)
acl:relcl(EPA-15, reduce-21)
det(risk-23, the-22)
dobj(reduce-21, risk-23)
case(atherosclerosis-25, of-24)
nmod:of(risk-23, atherosclerosis-25)
cc(atherosclerosis-25, and-26)
amod(cardiovascular_diseases-28, other-27)
nmod:of(risk-23, cardiovascular_diseases-28)
conj:and(atherosclerosis-25, cardiovascular_diseases-28)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG Dixyrazine/JJ levels/NNS in/IN hyperDixyrazinemic/JJ patients/NNS and/CC preventing/VBG CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (JJ Dixyrazine) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hyperDixyrazinemic) (NNS patients)))))
                      (CC and)
                      (VP (VBG preventing)
                        (NP (NNP CHD))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
amod(levels-19, Dixyrazine-18)
dobj(reducing-17, levels-19)
case(patients-22, in-20)
amod(patients-22, hyperDixyrazinemic-21)
nmod:in(levels-19, patients-22)
cc(reducing-17, and-23)
acl(strategy-15, preventing-24)
conj:and(reducing-17, preventing-24)
dobj(preventing-24, CHD-25)

However/RB ,/, further/JJ research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-6, However-1)
amod(research-4, further-3)
nsubjpass(needed-6, research-4)
auxpass(needed-6, is-5)
root(ROOT-0, needed-6)
mark(understand-9, to-7)
advmod(understand-9, fully-8)
ccomp(needed-6, understand-9)
det(mechanisms-11, the-10)
dobj(understand-9, mechanisms-11)
acl(mechanisms-11, underlying-12)
det(effects-14, these-13)
dobj(underlying-12, effects-14)
cc(understand-9, and-15)
mark(determine-17, to-16)
ccomp(needed-6, determine-17)
conj:and(understand-9, determine-17)
amod(dosages-19, optimal-18)
dobj(determine-17, dosages-19)
case(populations-23, for-20)
amod(populations-23, different-21)
amod(populations-23, patient-22)
nmod:for(dosages-19, populations-23)

Omega-3_fatty_acids/NNS have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, widely-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, such/PDT as/RB eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ cardiovascular_benefits/NNS ,/, including/VBG reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADJP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (NP (PDT such)
      (NP (RB as) (JJ eicosapentaenoic_acid)
        (PRN (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-)))
      (CC and)
      (NP
        (NP (JJ docosahexaenoic_acid))
        (PRN (-LRB- -LRB-)
          (NP (NNP DHA))
          (-RRB- -RRB-)))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NNS cardiovascular_benefits)))))
          (, ,)
          (S
            (VP (VBG including)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (VBG developing) (NN coronary_heart_disease))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
dep(shown-18, omega-3_fatty_acids-2)
dep(eicosapentaenoic_acid-6, such-4)
advmod(eicosapentaenoic_acid-6, as-5)
nsubjpass(shown-18, eicosapentaenoic_acid-6)
nsubj:xsubj(have-20, eicosapentaenoic_acid-6)
appos(eicosapentaenoic_acid-6, EPA-8)
cc(eicosapentaenoic_acid-6, and-10)
conj:and(eicosapentaenoic_acid-6, docosahexaenoic_acid-11)
nsubjpass(shown-18, docosahexaenoic_acid-11)
nsubj:xsubj(have-20, docosahexaenoic_acid-11)
appos(docosahexaenoic_acid-11, DHA-13)
aux(shown-18, have-16)
auxpass(shown-18, been-17)
root(ROOT-0, shown-18)
mark(have-20, to-19)
xcomp(shown-18, have-20)
amod(cardiovascular_benefits-22, numerous-21)
dobj(have-20, cardiovascular_benefits-22)
xcomp(shown-18, including-24)
advcl(including-24, reducing-25)
det(risk-27, the-26)
dobj(reducing-25, risk-27)
case(coronary_heart_disease-30, of-28)
amod(coronary_heart_disease-30, developing-29)
nmod:of(risk-27, coronary_heart_disease-30)
appos(coronary_heart_disease-30, CHD-32)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT fatty_acids/NNS may/MD also/RB be/VB associated/VBN with/IN decreased/VBN oleuropein/NN levels/NNS in/IN hyperoleuropeinmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS fatty_acids))
          (VP (MD may) (RB also)
            (VP (VB be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN oleuropein) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperoleuropeinmic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(associated-10, that-4)
det(fatty_acids-6, these-5)
nsubjpass(associated-10, fatty_acids-6)
aux(associated-10, may-7)
advmod(associated-10, also-8)
auxpass(associated-10, be-9)
ccomp(suggest-3, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, oleuropein-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperoleuropeinmic-16)
nmod:in(levels-14, patients-17)

Oleuropein/NNP is_a/NNP bioactive/VBD compound/NN found/VBN in/IN olives/NNS and/CC olive/JJ oil/NN that/WDT has_been/VBP linked/VBN to/TO increased/VBN oxidative_stress/NNS and/CC inflammation/NN ,/, both/DT of/IN which/WDT are/VBP risk/NN factors/NNS for/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNP Oleuropein) (NNP is_a))
    (VP (VBD bioactive)
      (NP
        (NP (NN compound))
        (VP (VBN found)
          (PP (IN in)
            (NP
              (NP (NNS olives))
              (CC and)
              (NP (JJ olive) (NN oil)))))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP (VBN increased) (NNS oxidative_stress)
                      (CC and)
                      (NN inflammation))
                    (, ,)
                    (SBAR
                      (WHNP (DT both)
                        (WHPP (IN of)
                          (WHNP (WDT which))))
                      (S
                        (VP (VBP are)
                          (NP
                            (NP (NN risk) (NNS factors))
                            (PP (IN for)
                              (NP (NNP CHD)))))))))))))))
    (. .)))

compound(is_a-2, Oleuropein-1)
nsubj(bioactive-3, is_a-2)
root(ROOT-0, bioactive-3)
dobj(bioactive-3, compound-4)
nsubj(has_been-12, compound-4)
acl(compound-4, found-5)
case(olives-7, in-6)
nmod:in(found-5, olives-7)
cc(olives-7, and-8)
amod(oil-10, olive-9)
nmod:in(found-5, oil-10)
conj:and(olives-7, oil-10)
ref(compound-4, that-11)
acl:relcl(compound-4, has_been-12)
dep(has_been-12, linked-13)
case(oxidative_stress-16, to-14)
amod(oxidative_stress-16, increased-15)
nmod:to(linked-13, oxidative_stress-16)
nsubj(factors-25, oxidative_stress-16)
cc(oxidative_stress-16, and-17)
nmod:to(linked-13, inflammation-18)
conj:and(oxidative_stress-16, inflammation-18)
nsubj(factors-25, inflammation-18)
dep(which-22, both-20)
case(which-22, of-21)
ref(oxidative_stress-16, which-22)
cop(factors-25, are-23)
compound(factors-25, risk-24)
acl:relcl(oxidative_stress-16, factors-25)
case(CHD-27, for-26)
nmod:for(factors-25, CHD-27)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP reduce/VB oleuropein/NN levels/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB modulation/NN of/IN lipid/NN metabolism/NN and/CC antioxidant/NN pathways/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS mechanisms))
    (VP
      (VP
        (PP (IN by)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (VB reduce)
                (NP (NN oleuropein) (NNS levels))))))
        (VBP are)
        (ADVP (RB not))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP (NN lipid) (NN metabolism)
                (CC and)
                (NN antioxidant) (NNS pathways)))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-14, mechanisms-2)
nsubj(involve-18, mechanisms-2)
mark(reduce-8, by-3)
dobj(reduce-8, which-4)
nsubj(reduce-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(reduce-8, DHA-7)
advcl(understood-14, reduce-8)
compound(levels-10, oleuropein-9)
dobj(reduce-8, levels-10)
auxpass(understood-14, are-11)
neg(understood-14, not-12)
advmod(understood-14, fully-13)
root(ROOT-0, understood-14)
cc(understood-14, but-16)
aux(involve-18, may-17)
conj:but(understood-14, involve-18)
dobj(involve-18, modulation-19)
case(metabolism-22, of-20)
compound(metabolism-22, lipid-21)
nmod:of(modulation-19, metabolism-22)
cc(metabolism-22, and-23)
compound(pathways-25, antioxidant-24)
nmod:of(modulation-19, pathways-25)
conj:and(metabolism-22, pathways-25)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/JJ may/MD be/VB a/DT promising/JJ dietary/JJ intervention/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP through/IN modulation/NN of/IN oleuropein/NN levels/NNS and/CC associated/VBN pathways/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ dietary) (NN intervention))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN through)
                        (NP
                          (NP (NN modulation))
                          (PP (IN of)
                            (NP
                              (NP (NN oleuropein) (NNS levels))
                              (CC and)
                              (NP (VBN associated) (NNS pathways)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(intervention-11, that-4)
nsubj(intervention-11, omega-3_fatty_acids-5)
aux(intervention-11, may-6)
cop(intervention-11, be-7)
det(intervention-11, a-8)
amod(intervention-11, promising-9)
amod(intervention-11, dietary-10)
ccomp(suggest-3, intervention-11)
mark(reducing-13, for-12)
acl(intervention-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(CHD-17, of-16)
nmod:of(risk-15, CHD-17)
case(modulation-19, through-18)
nmod:through(reducing-13, modulation-19)
case(levels-22, of-20)
compound(levels-22, oleuropein-21)
nmod:of(modulation-19, levels-22)
cc(levels-22, and-23)
amod(pathways-25, associated-24)
nmod:of(modulation-19, pathways-25)
conj:and(levels-22, pathways-25)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS and/CC timing/NN of/IN supplementation/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (VBG underlying) (NNS mechanisms))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (CC and)
                  (NP
                    (NP (NN timing))
                    (PP (IN of)
                      (NP (NN supplementation)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(elucidate-6, and-10)
mark(determine-12, to-11)
ccomp(needed-4, determine-12)
conj:and(elucidate-6, determine-12)
amod(dosages-14, optimal-13)
dobj(determine-12, dosages-14)
cc(dosages-14, and-15)
dobj(determine-12, timing-16)
conj:and(dosages-14, timing-16)
case(supplementation-18, of-17)
nmod:of(timing-16, supplementation-18)

Omega-3_fatty_acids/NNS are/VBP essential/JJ nutrients/NNS that/WDT are/VBP not/RB synthesized/VBN by/IN the/DT human/JJ body/NN and/CC must/MD be/VB obtained/VBN through/IN dietary/JJ sources/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP
      (VP (VBP are)
        (NP
          (NP (JJ essential) (NNS nutrients))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP are)
                (ADVP (RB not))
                (VP (VBN synthesized)
                  (PP (IN by)
                    (NP (DT the) (JJ human) (NN body)))))))))
      (CC and)
      (VP (MD must)
        (VP (VB be)
          (VP (VBN obtained)
            (PP (IN through)
              (NP (JJ dietary) (NNS sources)))))))
    (. .)))

nsubj(nutrients-4, Omega-3_fatty_acids-1)
nsubjpass(obtained-16, Omega-3_fatty_acids-1)
cop(nutrients-4, are-2)
amod(nutrients-4, essential-3)
root(ROOT-0, nutrients-4)
nsubjpass(synthesized-8, nutrients-4)
ref(nutrients-4, that-5)
auxpass(synthesized-8, are-6)
neg(synthesized-8, not-7)
acl:relcl(nutrients-4, synthesized-8)
case(body-12, by-9)
det(body-12, the-10)
amod(body-12, human-11)
nmod:by(synthesized-8, body-12)
cc(nutrients-4, and-13)
aux(obtained-16, must-14)
auxpass(obtained-16, be-15)
conj:and(nutrients-4, obtained-16)
nsubjpass(synthesized-8, obtained-16)
case(sources-19, through-17)
amod(sources-19, dietary-18)
nmod:through(obtained-16, sources-19)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO provide/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB provide)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
nsubj:xsubj(provide-26, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(provide-26, to-25)
xcomp(shown-24, provide-26)
amod(benefits-29, numerous-27)
compound(benefits-29, health-28)
dobj(provide-26, benefits-29)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN EPA/NNP and/CC DHA/NNP might/MD be/VB associated/VBN with/IN decreased/VBN levels/NNS of/IN bitopertin/NN in/IN hyperbitopertinmic/JJ patients/NNS ,/, a/DT condition/NN characterized/VBN by/IN elevated/JJ levels/NNS of/IN bitopertin/NN in/IN the/DT blood/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD might)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (NNS levels))
                      (PP (IN of)
                        (NP
                          (NP
                            (NP (NN bitopertin))
                            (PP (IN in)
                              (NP (JJ hyperbitopertinmic) (NNS patients))))
                          (, ,)
                          (NP
                            (NP (DT a) (NN condition))
                            (VP (VBN characterized)
                              (PP (IN by)
                                (NP
                                  (NP (JJ elevated) (NNS levels))
                                  (PP (IN of)
                                    (NP
                                      (NP (NN bitopertin))
                                      (PP (IN in)
                                        (NP (DT the) (NN blood))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(associated-11, that-5)
nsubjpass(associated-11, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubjpass(associated-11, DHA-8)
aux(associated-11, might-9)
auxpass(associated-11, be-10)
ccomp(suggested-4, associated-11)
case(levels-14, with-12)
amod(levels-14, decreased-13)
nmod:with(associated-11, levels-14)
case(bitopertin-16, of-15)
nmod:of(levels-14, bitopertin-16)
case(patients-19, in-17)
amod(patients-19, hyperbitopertinmic-18)
nmod:in(bitopertin-16, patients-19)
det(condition-22, a-21)
appos(bitopertin-16, condition-22)
acl(condition-22, characterized-23)
case(levels-26, by-24)
amod(levels-26, elevated-25)
nmod:by(characterized-23, levels-26)
case(bitopertin-28, of-27)
nmod:of(levels-26, bitopertin-28)
case(blood-31, in-29)
det(blood-31, the-30)
nmod:in(bitopertin-28, blood-31)

Bitopertin/NNP is_a/NNP biomarker/VBP for/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Bitopertin) (NNP is_a))
    (VP (VBP biomarker)
      (PP (IN for)
        (NP
          (NP
            (NP (NN coronary_heart_disease))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (DT a) (VBG leading) (NN cause))
            (PP (IN of)
              (NP (NN death))))))
      (ADVP (RB worldwide)))
    (. .)))

compound(is_a-2, Bitopertin-1)
nsubj(biomarker-3, is_a-2)
root(ROOT-0, biomarker-3)
case(coronary_heart_disease-5, for-4)
nmod:for(biomarker-3, coronary_heart_disease-5)
appos(coronary_heart_disease-5, CHD-7)
det(cause-12, a-10)
amod(cause-12, leading-11)
appos(coronary_heart_disease-5, cause-12)
case(death-14, of-13)
nmod:of(cause-12, death-14)
advmod(biomarker-3, worldwide-15)

In/IN addition/NN to/TO lowering/VBG bitopertin/NN levels/NNS ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP also/RB been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (VBG lowering) (NN bitopertin) (NNS levels)))))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT a) (VBN decreased) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NNP CHD))))))))))
    (. .)))

case(levels-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
amod(levels-6, lowering-4)
compound(levels-6, bitopertin-5)
nmod:in_addition_to(associated-13, levels-6)
amod(omega-3_fatty_acids-9, long-chain-8)
nsubjpass(associated-13, omega-3_fatty_acids-9)
aux(associated-13, have-10)
advmod(associated-13, also-11)
auxpass(associated-13, been-12)
root(ROOT-0, associated-13)
case(risk-17, with-14)
det(risk-17, a-15)
amod(risk-17, decreased-16)
nmod:with(associated-13, risk-17)
mark(developing-19, of-18)
acl(risk-17, developing-19)
dobj(developing-19, CHD-20)

The/DT mechanisms/NNS underlying/VBG these/DT associations/NNS are/VBP still/RB not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ thought/VBN that/IN the/DT anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP may/MD play/VB a/DT role/NN in/IN their/PRP$ protective/JJ effects/NNS against/IN CHD/NNP ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS associations))))
      (VP (VBP are) (RB still)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN thought)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ anti-inflammatory)
                  (CC and)
                  (JJ anti-thrombotic) (NNS properties))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (VP (MD may)
                (VP (VB play)
                  (NP
                    (NP (DT a) (NN role))
                    (PP (IN in)
                      (NP
                        (NP (PRP$ their) (JJ protective) (NNS effects))
                        (PP (IN against)
                          (NP (NNP CHD)))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(associations-5, these-4)
dobj(underlying-3, associations-5)
auxpass(understood-10, are-6)
advmod(understood-10, still-7)
neg(understood-10, not-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(thought-15, it-13)
auxpass(thought-15, is-14)
conj:but(understood-10, thought-15)
mark(play-27, that-16)
det(properties-21, the-17)
amod(properties-21, anti-inflammatory-18)
cc(anti-inflammatory-18, and-19)
conj:and(anti-inflammatory-18, anti-thrombotic-20)
amod(properties-21, anti-thrombotic-20)
nsubj(play-27, properties-21)
case(EPA-23, of-22)
nmod:of(properties-21, EPA-23)
cc(EPA-23, and-24)
nmod:of(properties-21, DHA-25)
conj:and(EPA-23, DHA-25)
aux(play-27, may-26)
ccomp(thought-15, play-27)
det(role-29, a-28)
dobj(play-27, role-29)
case(effects-33, in-30)
nmod:poss(effects-33, their-31)
amod(effects-33, protective-32)
nmod:in(role-29, effects-33)
case(CHD-35, against-34)
nmod:against(effects-33, CHD-35)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ high-risk) (NNS individuals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-15, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
case(CHD-21, of-20)
nmod:of(risk-19, CHD-21)
case(individuals-24, in-22)
amod(individuals-24, high-risk-23)
nmod:in(reducing-17, individuals-24)

The/DT lactation/JJ process/NN in/IN mammals/NNS is/VBZ regulated/VBN by/IN various/JJ biochemical/JJ pathways/NNS ,/, including/VBG the/DT STAT_1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- signaling/VBG pathway/RB ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ lactation) (NN process))
      (PP (IN in)
        (NP (NNS mammals))))
    (VP (VBZ is)
      (VP (VBN regulated)
        (PP (IN by)
          (NP
            (NP (JJ various) (JJ biochemical) (NNS pathways))
            (, ,)
            (VP (VBG including)
              (S
                (NP (DT the) (NNP STAT_1) (-LRB- -LRB-) (NNP PRL) (-RRB- -RRB-))
                (VP (VBG signaling)
                  (ADVP (RB pathway)))))))))
    (. .)))

det(process-3, The-1)
amod(process-3, lactation-2)
nsubjpass(regulated-7, process-3)
case(mammals-5, in-4)
nmod:in(process-3, mammals-5)
auxpass(regulated-7, is-6)
root(ROOT-0, regulated-7)
case(pathways-11, by-8)
amod(pathways-11, various-9)
amod(pathways-11, biochemical-10)
nmod:by(regulated-7, pathways-11)
acl(pathways-11, including-13)
det(PRL-17, the-14)
compound(PRL-17, STAT_1-15)
nsubj(signaling-19, PRL-17)
advcl(including-13, signaling-19)
advmod(signaling-19, pathway-20)

In/IN this/DT study/NN ,/, we/PRP have/VBP investigated/VBN the/DT potential/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cAMP/NN -RRB-/-RRB- ,/, guanosine_3/JJ '/: ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, and/CC Procyanidin/NNP on/IN the/DT early/JJ effect/NN of/IN STAT_1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBP have)
      (VP (VBN investigated)
        (NP
          (NP
            (NP (DT the) (JJ potential) (NNS roles))
            (PP (IN of)
              (NP
                (NP (NNS adenosine_3) (POS '))
                (CD ,5)))
            ('' '))
          (: -)
          (NP
            (NP (NN cyclic_monophosphate))
            (PRN (-LRB- -LRB-)
              (NP (NN cAMP))
              (-RRB- -RRB-)))
          (, ,)
          (NP (JJ guanosine_3)
            (PRN (: ')
              (NP (CD ,5))
              ('' ') (: -))
            (NN cyclic_monophosphate))
          (PRN (-LRB- -LRB-)
            (NP (NN cGMP))
            (-RRB- -RRB-))
          (, ,)
          (CC and)
          (NP
            (NP (NNP Procyanidin))
            (PP (IN on)
              (NP
                (NP
                  (NP (DT the) (JJ early) (NN effect))
                  (PP (IN of)
                    (NP (NNP STAT_1))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PRL))
                  (-RRB- -RRB-))))))
        (PP (IN on)
          (NP (JJ lactose) (NNS biosynthesis)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-7, study-3)
nsubj(investigated-7, we-5)
aux(investigated-7, have-6)
root(ROOT-0, investigated-7)
det(roles-10, the-8)
amod(roles-10, potential-9)
dobj(investigated-7, roles-10)
case(adenosine_3-12, of-11)
nmod:'(roles-10, adenosine_3-12)
case(adenosine_3-12, '-13)
nummod(adenosine_3-12, ,5-14)
dobj(investigated-7, cyclic_monophosphate-17)
conj:and(roles-10, cyclic_monophosphate-17)
appos(cyclic_monophosphate-17, cAMP-19)
amod(cyclic_monophosphate-27, guanosine_3-22)
dep(cyclic_monophosphate-27, ,5-24)
dobj(investigated-7, cyclic_monophosphate-27)
conj:and(roles-10, cyclic_monophosphate-27)
appos(roles-10, cGMP-29)
cc(roles-10, and-32)
dobj(investigated-7, Procyanidin-33)
conj:and(roles-10, Procyanidin-33)
case(effect-37, on-34)
det(effect-37, the-35)
amod(effect-37, early-36)
nmod:on(Procyanidin-33, effect-37)
case(STAT_1-39, of-38)
nmod:of(effect-37, STAT_1-39)
appos(effect-37, PRL-41)
case(biosynthesis-45, on-43)
amod(biosynthesis-45, lactose-44)
nmod:on(investigated-7, biosynthesis-45)

To/TO achieve/VB this/DT ,/, we/PRP used/VBD cultured/VBN mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD used)
      (VP (VBN cultured)
        (S
          (NP
            (NP (JJ mammary_gland) (NNS explants))
            (VP (VBN derived)
              (PP (IN from)
                (NP (NNS mice)))
              (NP-TMP (CD 12-14) (NNS days))))
          (ADJP (JJ pregnant)))))
    (. .)))

mark(achieve-2, To-1)
advcl(used-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(used-6, we-5)
root(ROOT-0, used-6)
dep(used-6, cultured-7)
amod(explants-9, mammary_gland-8)
nsubj(pregnant-15, explants-9)
acl(explants-9, derived-10)
case(mice-12, from-11)
nmod:from(derived-10, mice-12)
nummod(days-14, 12-14-13)
nmod:tmod(derived-10, days-14)
xcomp(cultured-7, pregnant-15)

Our/PRP$ results/NNS show/VBP that/IN cAMP/NN and/CC cGMP/NN may/MD play/VB important/JJ roles/NNS in/IN regulating/VBG lactose/JJ biosynthesis/NNS in/IN response/NN to/TO STAT_1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- signaling/VBG ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (JJ important) (NNS roles))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ lactose) (NNS biosynthesis))
                      (PP (IN in)
                        (NP
                          (NP
                            (NP (NN response))
                            (PP (TO to)
                              (NP (NNP STAT_1))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP PRL))
                            (-RRB- -RRB-))))))))
              (S
                (VP (VBG signaling))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(play-9, that-4)
nsubj(play-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubj(play-9, cGMP-7)
aux(play-9, may-8)
ccomp(show-3, play-9)
amod(roles-11, important-10)
dobj(play-9, roles-11)
mark(regulating-13, in-12)
acl(roles-11, regulating-13)
amod(biosynthesis-15, lactose-14)
dobj(regulating-13, biosynthesis-15)
case(response-17, in-16)
nmod:in(regulating-13, response-17)
case(STAT_1-19, to-18)
nmod:to(response-17, STAT_1-19)
appos(response-17, PRL-21)
xcomp(play-9, signaling-23)

Additionally/RB ,/, we/PRP found/VBD that/IN Procyanidin/NNP ,/, a/DT natural/JJ compound/NN with/IN antioxidant/JJ properties/NNS ,/, can/MD modulate/VBP the/DT early/JJ effects/NNS of/IN STAT_1/NNP -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP Procyanidin))
            (, ,)
            (NP
              (NP (DT a) (JJ natural) (NN compound))
              (PP (IN with)
                (NP (JJ antioxidant) (NNS properties))))
            (, ,))
          (VP (MD can)
            (VP (VBP modulate)
              (NP
                (NP
                  (NP (DT the) (JJ early) (NNS effects))
                  (PP (IN of)
                    (NP (NNP STAT_1))))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PRL))
                  (-RRB- -RRB-))
                (PP (IN on)
                  (NP (JJ lactose) (NNS biosynthesis)))))))))
    (. .)))

advmod(found-4, Additionally-1)
nsubj(found-4, we-3)
root(ROOT-0, found-4)
mark(modulate-16, that-5)
nsubj(modulate-16, Procyanidin-6)
det(compound-10, a-8)
amod(compound-10, natural-9)
appos(Procyanidin-6, compound-10)
case(properties-13, with-11)
amod(properties-13, antioxidant-12)
nmod:with(compound-10, properties-13)
aux(modulate-16, can-15)
ccomp(found-4, modulate-16)
det(effects-19, the-17)
amod(effects-19, early-18)
dobj(modulate-16, effects-19)
case(STAT_1-21, of-20)
nmod:of(effects-19, STAT_1-21)
appos(effects-19, PRL-23)
case(biosynthesis-27, on-25)
amod(biosynthesis-27, lactose-26)
nmod:on(effects-19, biosynthesis-27)

These/DT findings/NNS suggest/VBP that/IN cAMP/NN ,/, cGMP/NN ,/, and/CC Procyanidin/NNP may/MD have/VB therapeutic/JJ potential/NN for/IN enhancing/VBG lactation/NN in/IN mammals/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN cAMP))
            (, ,)
            (NP (NN cGMP))
            (, ,)
            (CC and)
            (NP (NNP Procyanidin)))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ therapeutic) (NN potential))
                (PP (IN for)
                  (S
                    (VP (VBG enhancing)
                      (NP (NN lactation))
                      (PP (IN in)
                        (NP (NNS mammals))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-12, that-4)
nsubj(have-12, cAMP-5)
conj:and(cAMP-5, cGMP-7)
nsubj(have-12, cGMP-7)
cc(cAMP-5, and-9)
conj:and(cAMP-5, Procyanidin-10)
nsubj(have-12, Procyanidin-10)
aux(have-12, may-11)
ccomp(suggest-3, have-12)
amod(potential-14, therapeutic-13)
dobj(have-12, potential-14)
mark(enhancing-16, for-15)
acl(potential-14, enhancing-16)
dobj(enhancing-16, lactation-17)
case(mammals-19, in-18)
nmod:in(enhancing-16, mammals-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB their/PRP$ clinical/JJ relevance/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (PRP$ their) (JJ clinical) (NN relevance))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
nmod:poss(relevance-18, their-16)
amod(relevance-18, clinical-17)
dobj(determine-15, relevance-18)

The/DT health/NN benefits/NNS of/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN health) (NNS benefits))
      (PP (IN of)
        (NP
          (NP (JJ long-chain) (NNS omega-3_fatty_acids))
          (, ,)
          (PP (JJ such) (IN as)
            (NP
              (NP
                (ADVP (JJ eicosapentaenoic_acid))
                (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
                (CC and)
                (NP (NN docosahexaenoic_acid)))
              (PRN (-LRB- -LRB-)
                (NP (NNP DHA))
                (-RRB- -RRB-))))
          (, ,))))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied))))
    (. .)))

det(benefits-3, The-1)
compound(benefits-3, health-2)
nsubjpass(studied-23, benefits-3)
case(omega-3_fatty_acids-6, of-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nmod:of(benefits-3, omega-3_fatty_acids-6)
case(EPA-12, such-8)
mwe(such-8, as-9)
advmod(EPA-12, eicosapentaenoic_acid-10)
nmod:such_as(omega-3_fatty_acids-6, EPA-12)
cc(EPA-12, and-14)
nmod:such_as(omega-3_fatty_acids-6, docosahexaenoic_acid-15)
conj:and(EPA-12, docosahexaenoic_acid-15)
appos(EPA-12, DHA-17)
aux(studied-23, have-20)
auxpass(studied-23, been-21)
advmod(studied-23, extensively-22)
root(ROOT-0, studied-23)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN terconazole/JJ levels/NNS in/IN hyperterconazolemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ terconazole) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperterconazolemic) (NNS patients)))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, terconazole-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperterconazolemic-15)
nmod:in(levels-13, patients-16)

Additionally/RB ,/, studies/NNS have/VBP shown/VBN that/IN consumption/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN consumption))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(shown-5, Additionally-1)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
mark(associated-13, that-6)
nsubjpass(associated-13, consumption-7)
case(EPA-9, of-8)
nmod:of(consumption-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(consumption-7, DHA-11)
conj:and(EPA-9, DHA-11)
auxpass(associated-13, is-12)
ccomp(shown-5, associated-13)
case(risk-17, with-14)
det(risk-17, a-15)
amod(risk-17, decreased-16)
nmod:with(associated-13, risk-17)
mark(developing-19, of-18)
acl(risk-17, developing-19)
dobj(developing-19, coronary_heart_disease-20)
appos(risk-17, CHD-22)

The/DT mechanisms/NNS underlying/VBG the/DT protective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP against/IN CHD/NNP are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC modulate/VBP vascular_function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ protective) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN against)
          (NP (NNP CHD)))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP (PRP$ their) (NN ability)
            (S
              (VP (TO to)
                (VP
                  (VP (VB reduce)
                    (NP (NN inflammation)))
                  (, ,)
                  (VP (VB improve)
                    (NP (NN lipid) (NN metabolism)))))))))
      (, ,)
      (CC and)
      (VP (VBP modulate)
        (NP (NN vascular_function))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-16, mechanisms-2)
nsubj(involve-20, mechanisms-2)
nsubj(modulate-32, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(CHD-12, against-11)
nmod:against(underlying-3, CHD-12)
auxpass(understood-16, are-13)
neg(understood-16, not-14)
advmod(understood-16, fully-15)
root(ROOT-0, understood-16)
cc(understood-16, but-18)
aux(involve-20, may-19)
conj:but(understood-16, involve-20)
nmod:poss(ability-22, their-21)
dobj(involve-20, ability-22)
mark(reduce-24, to-23)
acl(ability-22, reduce-24)
dobj(reduce-24, inflammation-25)
dep(reduce-24, improve-27)
compound(metabolism-29, lipid-28)
dobj(improve-27, metabolism-29)
cc(understood-16, and-31)
conj:and(understood-16, modulate-32)
dobj(modulate-32, vascular_function-33)

Therefore/RB ,/, the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (DT the) (NN intake))
      (PP (IN of)
        (NP (JJ long-chain) (NN omega-3_fatty_acids))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (CC and)
                (VP (VBG improving)
                  (NP (JJ overall) (NN cardiovascular_health)))))))))
    (. .)))

advmod(strategy-12, Therefore-1)
det(intake-4, the-3)
nsubj(strategy-12, intake-4)
case(omega-3_fatty_acids-7, of-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nmod:of(intake-4, omega-3_fatty_acids-7)
aux(strategy-12, may-8)
cop(strategy-12, be-9)
det(strategy-12, an-10)
amod(strategy-12, effective-11)
root(ROOT-0, strategy-12)
mark(reducing-14, for-13)
acl(strategy-12, reducing-14)
det(risk-16, the-15)
dobj(reducing-14, risk-16)
case(CHD-18, of-17)
nmod:of(risk-16, CHD-18)
cc(reducing-14, and-19)
acl(strategy-12, improving-20)
conj:and(reducing-14, improving-20)
amod(cardiovascular_health-22, overall-21)
dobj(improving-20, cardiovascular_health-22)

This/DT study/VBP evaluated/VBN the/DT effect/NN of/IN eslicarbazepine/NN on/IN the/DT incidence/NN of/IN common/JJ migraine_symptoms/NNS ,/, including/VBG bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBP study)
      (VP (VBN evaluated)
        (NP
          (NP (DT the) (NN effect))
          (PP (IN of)
            (NP (NN eslicarbazepine))))
        (PP (IN on)
          (NP
            (NP (DT the) (NN incidence))
            (PP (IN of)
              (NP
                (NP (JJ common) (NNS migraine_symptoms))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (NNS bronchospasms))
                    (, ,)
                    (NP (NN photophobia))
                    (, ,)
                    (CC and)
                    (NP (NN phonophobia))))))))))
    (. .)))

nsubj(study-2, This-1)
root(ROOT-0, study-2)
dep(study-2, evaluated-3)
det(effect-5, the-4)
dobj(evaluated-3, effect-5)
case(eslicarbazepine-7, of-6)
nmod:of(effect-5, eslicarbazepine-7)
case(incidence-10, on-8)
det(incidence-10, the-9)
nmod:on(evaluated-3, incidence-10)
case(migraine_symptoms-13, of-11)
amod(migraine_symptoms-13, common-12)
nmod:of(incidence-10, migraine_symptoms-13)
acl(migraine_symptoms-13, including-15)
dobj(including-15, bronchospasms-16)
dobj(including-15, photophobia-18)
conj:and(bronchospasms-16, photophobia-18)
cc(bronchospasms-16, and-20)
dobj(including-15, phonophobia-21)
conj:and(bronchospasms-16, phonophobia-21)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, eslicarbazepine/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN eslicarbazepine))
    (ADVP (RB significantly))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS bronchospasms))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-8, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-8, eslicarbazepine-6)
advmod(reduced-8, significantly-7)
root(ROOT-0, reduced-8)
det(risk-10, the-9)
dobj(reduced-8, risk-10)
case(bronchospasms-12, of-11)
nmod:of(risk-10, bronchospasms-12)
case(%-15, by-13)
nummod(%-15, 14-14)
nmod:by(reduced-8, %-15)
nummod(%-18, 95-17)
dep(%-15, %-18)
acl:relcl(%-18, CI-19)
nummod(%-21, 6-20-20)
dobj(CI-19, %-21)
appos(%-21, P-23)
dep(0.0005-25, =-24)
dep(%-21, 0.0005-25)
xcomp(reduced-8, photophobia-28)
case(%-31, by-29)
nummod(%-31, 17-30)
nmod:by(photophobia-28, %-31)
nummod(%-34, 95-33)
appos(%-31, %-34)
dep(%-37, CI-35)
nummod(%-37, 12-22-36)
nmod(%-34, %-37)
dep(%-34, P-39)
compound(0.0001-41, <-40)
nummod(P-39, 0.0001-41)
cc(photophobia-28, and-44)
xcomp(reduced-8, phonophobia-45)
conj:and(photophobia-28, phonophobia-45)
case(%-48, by-46)
nummod(%-48, 14-47)
nmod:by(phonophobia-45, %-48)
nummod(%-51, 95-50)
appos(%-48, %-51)
dep(%-54, CI-52)
nummod(%-54, 17-20-53)
nmod(%-51, %-54)
dep(%-51, P-56)
compound(0.0001-58, <-57)
nummod(P-56, 0.0001-58)

These/DT findings/NNS suggest/VBP that/IN eslicarbazepine/NN may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN individuals/NNS suffering/VBG from/IN migraines/NNS with/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN eslicarbazepine))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP
                          (NP (NNS migraines))
                          (PP (IN with)
                            (NP (DT these) (NNS symptoms))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, eslicarbazepine-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(migraines-16, from-15)
nmod:from(suffering-14, migraines-16)
case(symptoms-19, with-17)
det(symptoms-19, these-18)
nmod:with(migraines-16, symptoms-19)

Further/RB research/NN is/VBZ warranted/VBN to/TO explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO assess/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN eslicarbazepine/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB assess)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP
                      (NP (NN eslicarbazepine))
                      (PP (IN in)
                        (NP (DT this) (NN population))))))))))))
    (. .)))

advmod(warranted-4, Further-1)
nsubjpass(warranted-4, research-2)
auxpass(warranted-4, is-3)
root(ROOT-0, warranted-4)
mark(explore-6, to-5)
ccomp(warranted-4, explore-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, potential-8)
dobj(explore-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(explore-6, and-13)
mark(assess-15, to-14)
ccomp(warranted-4, assess-15)
conj:and(explore-6, assess-15)
det(safety-18, the-16)
amod(safety-18, long-term-17)
dobj(assess-15, safety-18)
cc(safety-18, and-19)
dobj(assess-15, efficacy-20)
conj:and(safety-18, efficacy-20)
case(eslicarbazepine-22, of-21)
nmod:of(safety-18, eslicarbazepine-22)
case(population-25, in-23)
det(population-25, this-24)
nmod:in(eslicarbazepine-22, population-25)

Vasoactive_intestinal_peptide/NNP -LRB-/-LRB- VIP/NNP -RRB-/-RRB- and/CC JTK-14/NNP are/VBP neuropeptides/NNS that/WDT play/VBP a/DT role/NN in/IN regulating/VBG immune/JJ responses/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Vasoactive_intestinal_peptide))
        (-LRB- -LRB-)
        (NP (NNP VIP))
        (-RRB- -RRB-))
      (CC and)
      (NP (NNP JTK-14)))
    (VP (VBP are)
      (NP
        (NP (NNS neuropeptides))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ immune) (NNS responses)))))))))))
    (. .)))

nsubj(neuropeptides-8, Vasoactive_intestinal_peptide-1)
dep(Vasoactive_intestinal_peptide-1, VIP-3)
cc(Vasoactive_intestinal_peptide-1, and-5)
conj:and(Vasoactive_intestinal_peptide-1, JTK-14-6)
nsubj(neuropeptides-8, JTK-14-6)
cop(neuropeptides-8, are-7)
root(ROOT-0, neuropeptides-8)
nsubj(play-10, neuropeptides-8)
ref(neuropeptides-8, that-9)
acl:relcl(neuropeptides-8, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
mark(regulating-14, in-13)
acl(role-12, regulating-14)
amod(responses-16, immune-15)
dobj(regulating-14, responses-16)

The/DT VIP/NNP antagonist/NN -LSB-/VBZ 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP has_been/VBP shown/VBN to/TO have/VB no/DT effect/NN on/IN the/DT TAPI-2/JJ response/NN to/TO either/DT JTK-14/NN or/CC VIP/NNP ,/, indicating/VBG that/IN the/DT inhibition/NN of/IN TAPI-2/NN is/VBZ not/RB mediated/VBN through/IN VIP/NNP receptors/NNS ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNP VIP) (NN antagonist))
      (VP (VBZ -LSB-)
        (ADJP (JJ 4Cl-D-Phe6))))
    (, ,)
    (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (DT no) (NN effect))
                (PP (IN on)
                  (NP
                    (NP (DT the) (JJ TAPI-2) (NN response))
                    (PP (TO to)
                      (NP
                        (NP (DT either) (NN JTK-14))
                        (CC or)
                        (NP (NNP VIP))))))))))
        (, ,)
        (S
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP
                  (NP (DT the) (NN inhibition))
                  (PP (IN of)
                    (NP (NN TAPI-2))))
                (VP (VBZ is) (RB not)
                  (VP (VBN mediated)
                    (PP (IN through)
                      (NP (NNP VIP) (NNS receptors)))))))))))
    (. .)))

det(antagonist-3, The-1)
compound(antagonist-3, VIP-2)
nsubj(-LSB--4, antagonist-3)
ccomp(has_been-10, -LSB--4)
xcomp(-LSB--4, 4Cl-D-Phe6-5)
compound(VIP-9, Leu17-7)
compound(VIP-9, -RSB--8)
nsubj(has_been-10, VIP-9)
root(ROOT-0, has_been-10)
dep(has_been-10, shown-11)
mark(have-13, to-12)
xcomp(shown-11, have-13)
neg(effect-15, no-14)
dobj(have-13, effect-15)
case(response-19, on-16)
det(response-19, the-17)
amod(response-19, TAPI-2-18)
nmod:on(effect-15, response-19)
case(JTK-14-22, to-20)
det(JTK-14-22, either-21)
nmod:to(response-19, JTK-14-22)
cc(JTK-14-22, or-23)
nmod:to(response-19, VIP-24)
conj:or(JTK-14-22, VIP-24)
xcomp(shown-11, indicating-26)
mark(mediated-34, that-27)
det(inhibition-29, the-28)
nsubjpass(mediated-34, inhibition-29)
case(TAPI-2-31, of-30)
nmod:of(inhibition-29, TAPI-2-31)
auxpass(mediated-34, is-32)
neg(mediated-34, not-33)
ccomp(indicating-26, mediated-34)
case(receptors-37, through-35)
compound(receptors-37, VIP-36)
nmod:through(mediated-34, receptors-37)

On/IN the/DT other/JJ hand/NN ,/, the/DT peptide/JJ JTK-14/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, which/WDT is_a/RB putative/VBP JTK-14/JJ antagonist/NN ,/, was/VBD found/VBN to/TO block/VB the/DT TAPI-2/JJ response/NN to/TO JTK-14/NN ./.

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (JJ other) (NN hand)))
    (, ,)
    (NP
      (NP (DT the) (JJ peptide) (NN JTK-14))
      (PRN (-LRB- -LRB-)
        (NP (CD 6-38))
        (-RRB- -RRB-))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (ADVP (RB is_a))
          (VP (VBP putative)
            (NP (JJ JTK-14) (NN antagonist)))))
      (, ,))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB block)
              (NP
                (NP (DT the) (JJ TAPI-2) (NN response))
                (PP (TO to)
                  (NP (NN JTK-14)))))))))
    (. .)))

case(hand-4, On-1)
det(hand-4, the-2)
amod(hand-4, other-3)
nmod:on(found-20, hand-4)
det(JTK-14-8, the-6)
amod(JTK-14-8, peptide-7)
nsubj(putative-15, JTK-14-8)
nsubjpass(found-20, JTK-14-8)
nsubj:xsubj(block-22, JTK-14-8)
appos(JTK-14-8, 6-38-10)
ref(JTK-14-8, which-13)
advmod(putative-15, is_a-14)
acl:relcl(JTK-14-8, putative-15)
amod(antagonist-17, JTK-14-16)
dobj(putative-15, antagonist-17)
auxpass(found-20, was-19)
root(ROOT-0, found-20)
mark(block-22, to-21)
xcomp(found-20, block-22)
det(response-25, the-23)
amod(response-25, TAPI-2-24)
dobj(block-22, response-25)
case(JTK-14-27, to-26)
nmod:to(response-25, JTK-14-27)

These/DT findings/NNS suggest/VBP that/IN JTK-14/NNP may/MD be/VB involved/VBN in/IN regulating/VBG TAPI-2/NN activity/NN and/CC that/IN further/JJ investigation/NN into/IN its/PRP$ mechanism/NN of/IN action/NN may/MD provide/VB insight/NN into/IN potential/JJ therapeutic/JJ targets/NNS for/IN immune-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP JTK-14))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (NN TAPI-2) (NN activity))))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ further) (NN investigation))
              (PP (IN into)
                (NP
                  (NP (PRP$ its) (NN mechanism))
                  (PP (IN of)
                    (NP (NN action))))))
            (VP (MD may)
              (VP (VB provide)
                (NP (NN insight))
                (PP (IN into)
                  (NP
                    (NP (JJ potential) (JJ therapeutic) (NNS targets))
                    (PP (IN for)
                      (NP (NNS immune-related_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-8, that-4)
nsubjpass(involved-8, JTK-14-5)
aux(involved-8, may-6)
auxpass(involved-8, be-7)
ccomp(suggest-3, involved-8)
mark(regulating-10, in-9)
advcl(involved-8, regulating-10)
compound(activity-12, TAPI-2-11)
dobj(regulating-10, activity-12)
cc(involved-8, and-13)
mark(provide-23, that-14)
amod(investigation-16, further-15)
nsubj(provide-23, investigation-16)
case(mechanism-19, into-17)
nmod:poss(mechanism-19, its-18)
nmod:into(investigation-16, mechanism-19)
case(action-21, of-20)
nmod:of(mechanism-19, action-21)
aux(provide-23, may-22)
ccomp(suggest-3, provide-23)
conj:and(involved-8, provide-23)
dobj(provide-23, insight-24)
case(targets-28, into-25)
amod(targets-28, potential-26)
amod(targets-28, therapeutic-27)
nmod:into(provide-23, targets-28)
case(immune-related_disorders-30, for-29)
nmod:for(targets-28, immune-related_disorders-30)

Obesity/RB is_a/VBZ complex/JJ and/CC multifactorial/JJ disorder/NN that/WDT is/VBZ influenced/VBN by/IN genetic/JJ and/CC environmental/JJ factors/NNS ./.

(ROOT
  (SINV
    (ADVP (RB Obesity))
    (VP (VBZ is_a))
    (NP
      (NP
        (ADJP (JJ complex)
          (CC and)
          (JJ multifactorial))
        (NN disorder))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ is)
            (VP (VBN influenced)
              (PP (IN by)
                (NP
                  (ADJP (JJ genetic)
                    (CC and)
                    (JJ environmental))
                  (NNS factors))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
amod(disorder-6, complex-3)
cc(complex-3, and-4)
conj:and(complex-3, multifactorial-5)
amod(disorder-6, multifactorial-5)
nsubj(is_a-2, disorder-6)
nsubjpass(influenced-9, disorder-6)
ref(disorder-6, that-7)
auxpass(influenced-9, is-8)
acl:relcl(disorder-6, influenced-9)
case(factors-14, by-10)
amod(factors-14, genetic-11)
cc(genetic-11, and-12)
conj:and(genetic-11, environmental-13)
amod(factors-14, environmental-13)
nmod:by(influenced-9, factors-14)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN link_protein/NN by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN link_protein))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-14, that-5)
det(hypersecretion-7, the-6)
nsubj(play-14, hypersecretion-7)
case(link_protein-9, of-8)
nmod:of(hypersecretion-7, link_protein-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(link_protein-9, pancreas-12)
aux(play-14, may-13)
ccomp(suggested-4, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
case(development-19, in-17)
det(development-19, the-18)
nmod:in(role-16, development-19)
case(obesity-21, of-20)
nmod:of(development-19, obesity-21)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN link_protein/NN by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ SRT3025/NN on/IN the/DT secretion/NN of/IN link_protein/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN link_protein)))))))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (JJ mmol/L) (NN SRT3025)))))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN secretion))
                      (PP (IN of)
                        (NP (NN link_protein) (NN and_insulin))))))))
            (PP (IN by)
              (NP (VBN isolated) (JJ perfused) (NN pancreata))))))
      (PP (IN from)
        (NP
          (NP
            (NP (NN genetically_obese))
            (PRN (-LRB- -LRB-)
              (NP (NN fa/fa))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS rats)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(link_protein-20, of-19)
nmod:of(hypersecretion-18, link_protein-20)
mark(examining-22, by-21)
advcl(evaluate-8, examining-22)
det(effects-24, the-23)
dobj(examining-22, effects-24)
case(glucose-28, of-25)
nummod(glucose-28, 16.7-26)
amod(glucose-28, mmol/L-27)
nmod:of(effects-24, glucose-28)
cc(glucose-28, and-29)
nummod(SRT3025-32, 10-30)
amod(SRT3025-32, mmol/L-31)
nmod:of(effects-24, SRT3025-32)
conj:and(glucose-28, SRT3025-32)
case(secretion-35, on-33)
det(secretion-35, the-34)
nmod:on(examining-22, secretion-35)
case(and_insulin-38, of-36)
compound(and_insulin-38, link_protein-37)
nmod:of(secretion-35, and_insulin-38)
case(pancreata-42, by-39)
amod(pancreata-42, isolated-40)
amod(pancreata-42, perfused-41)
nmod:by(evaluate-8, pancreata-42)
case(genetically_obese-44, from-43)
nmod:from(aimed-6, genetically_obese-44)
appos(genetically_obese-44, fa/fa-46)
cc(genetically_obese-44, and-48)
amod(rats-55, lean-49)
dep(lean-49, Fa-51)
nmod:from(aimed-6, rats-55)
conj:and(genetically_obese-44, rats-55)

Our/PRP$ results/NNS showed/VBD that/IN both/DT glucose/NN and/CC SRT3025/NNP significantly/RB increased/VBD link_protein/NN secretion/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ,/, but/CC to/TO a/DT greater/JJR extent/NN in/IN obese/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT both) (NN glucose))
            (CC and)
            (NP (NNP SRT3025)))
          (ADVP (RB significantly))
          (VP
            (VP (VBD increased)
              (NP (NN link_protein) (NN secretion))
              (PP (IN in)
                (NP (DT both) (JJ obese)
                  (CC and)
                  (JJ lean) (NNS rats))))
            (, ,)
            (CC but)
            (PP (TO to)
              (NP (DT a) (JJR greater) (NN extent)))
            (PP (IN in)
              (NP (JJ obese) (NNS rats)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-10, that-4)
det(glucose-6, both-5)
nsubj(increased-10, glucose-6)
cc(glucose-6, and-7)
conj:and(glucose-6, SRT3025-8)
nsubj(increased-10, SRT3025-8)
advmod(increased-10, significantly-9)
ccomp(showed-3, increased-10)
compound(secretion-12, link_protein-11)
dobj(increased-10, secretion-12)
case(rats-18, in-13)
det(rats-18, both-14)
amod(rats-18, obese-15)
cc(obese-15, and-16)
conj:and(obese-15, lean-17)
amod(rats-18, lean-17)
nmod:in(increased-10, rats-18)
cc(increased-10, but-20)
case(extent-24, to-21)
det(extent-24, a-22)
amod(extent-24, greater-23)
ccomp(showed-3, extent-24)
conj:but(increased-10, extent-24)
case(rats-27, in-25)
amod(rats-27, obese-26)
nmod:in(increased-10, rats-27)

Interestingly/RB ,/, insulin_secretion/NN was/VBD also/RB elevated/JJ in/IN response/NN to/TO glucose/NN and/CC SRT3025/NN ,/, but/CC only/RB in/IN lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (ADJP (RB also) (JJ elevated))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NN glucose)
              (CC and)
              (NN SRT3025)))))
      (, ,)
      (CC but)
      (ADVP (RB only))
      (PP (IN in)
        (NP (JJ lean) (NNS rats))))
    (. .)))

advmod(elevated-6, Interestingly-1)
nsubj(elevated-6, insulin_secretion-3)
cop(elevated-6, was-4)
advmod(elevated-6, also-5)
root(ROOT-0, elevated-6)
case(response-8, in-7)
nmod:in(elevated-6, response-8)
case(glucose-10, to-9)
nmod:to(response-8, glucose-10)
cc(glucose-10, and-11)
nmod:to(response-8, SRT3025-12)
conj:and(glucose-10, SRT3025-12)
cc(elevated-6, but-14)
advmod(rats-18, only-15)
case(rats-18, in-16)
amod(rats-18, lean-17)
conj:but(elevated-6, rats-18)

These/DT findings/NNS suggest/VBP that/IN link_protein/NN may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN link_protein))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (PP
                  (ADVP (RB possibly))
                  (IN through)
                  (NP
                    (NP (PRP$ its) (NNS effects))
                    (PP (IN on)
                      (NP (NN insulin_secretion)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-8, that-4)
nsubjpass(involved-8, link_protein-5)
aux(involved-8, may-6)
auxpass(involved-8, be-7)
ccomp(suggest-3, involved-8)
case(pathogenesis-11, in-9)
det(pathogenesis-11, the-10)
nmod:in(involved-8, pathogenesis-11)
case(obesity-13, of-12)
nmod:of(pathogenesis-11, obesity-13)
advmod(effects-18, possibly-15)
case(effects-18, through-16)
nmod:poss(effects-18, its-17)
nmod:through(involved-8, effects-18)
case(insulin_secretion-20, on-19)
nmod:on(effects-18, insulin_secretion-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB this/DT relationship/NN and/CC its/PRP$ potential/JJ therapeutic/JJ implications/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT this) (NN relationship))
                (CC and)
                (NP
                  (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS implications))
                  (PP (IN for)
                    (NP (JJ obesity) (NN management))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(relationship-8, this-7)
dobj(elucidate-6, relationship-8)
cc(relationship-8, and-9)
nmod:poss(implications-13, its-10)
amod(implications-13, potential-11)
amod(implications-13, therapeutic-12)
dobj(elucidate-6, implications-13)
conj:and(relationship-8, implications-13)
case(management-16, for-14)
amod(management-16, obesity-15)
nmod:for(implications-13, management-16)

Eicosapentaenoic_acid/NNP -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- are/VBP long-chain/JJ omega-3_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP Eicosapentaenoic_acid))
          (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (JJ long-chain) (NNS omega-3_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubj(omega-3_fatty_acids-12, Eicosapentaenoic_acid-1)
dep(Eicosapentaenoic_acid-1, EPA-3)
cc(Eicosapentaenoic_acid-1, and-5)
conj:and(Eicosapentaenoic_acid-1, docosahexaenoic_acid-6)
nsubj(omega-3_fatty_acids-12, docosahexaenoic_acid-6)
appos(Eicosapentaenoic_acid-1, DHA-8)
cop(omega-3_fatty_acids-12, are-10)
amod(omega-3_fatty_acids-12, long-chain-11)
root(ROOT-0, omega-3_fatty_acids-12)
nsubjpass(associated-16, omega-3_fatty_acids-12)
ref(omega-3_fatty_acids-12, that-13)
aux(associated-16, have-14)
auxpass(associated-16, been-15)
acl:relcl(omega-3_fatty_acids-12, associated-16)
case(risk-20, with-17)
det(risk-20, a-18)
amod(risk-20, decreased-19)
nmod:with(associated-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP also/RB associated/VBN with/IN decreased/VBN levels/NNS of/IN ED-110/NN in/IN hyperED-110mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (ADVP (RB also))
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN ED-110))
                        (PP (IN in)
                          (NP (JJ hyperED-110mic) (NNS patients)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
auxpass(associated-10, are-8)
advmod(associated-10, also-9)
ccomp(shown-4, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(ED-110-15, of-14)
nmod:of(levels-13, ED-110-15)
case(patients-18, in-16)
amod(patients-18, hyperED-110mic-17)
nmod:in(ED-110-15, patients-18)

ED-110/JJ is_a/NN protein/NN that/WDT has_been/VBP implicated/VBN in/IN the/DT development/NN of/IN atherosclerosis/NNS and/CC CHD/NNP ./.

(ROOT
  (NP
    (NP (JJ ED-110) (NN is_a) (NN protein))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBP has_been)
          (VP (VBN implicated)
            (PP (IN in)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (NNS atherosclerosis))
                    (CC and)
                    (NP (NNP CHD))))))))))
    (. .)))

amod(protein-3, ED-110-1)
compound(protein-3, is_a-2)
root(ROOT-0, protein-3)
nsubj(has_been-5, protein-3)
ref(protein-3, that-4)
acl:relcl(protein-3, has_been-5)
dep(has_been-5, implicated-6)
case(development-9, in-7)
det(development-9, the-8)
nmod:in(implicated-6, development-9)
case(atherosclerosis-11, of-10)
nmod:of(development-9, atherosclerosis-11)
cc(atherosclerosis-11, and-12)
nmod:of(development-9, CHD-13)
conj:and(atherosclerosis-11, CHD-13)

The/DT mechanisms/NNS underlying/VBG the/DT protective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB their/PRP$ anti-inflammatory/JJ properties/NNS and/CC effects/NNS on/IN lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ protective) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties)
            (CC and)
            (NNS effects))
          (PP (IN on)
            (NP (NN lipid) (NN metabolism))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-14, mechanisms-2)
nsubj(involve-18, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
auxpass(understood-14, are-11)
neg(understood-14, not-12)
advmod(understood-14, fully-13)
root(ROOT-0, understood-14)
cc(understood-14, but-16)
aux(involve-18, may-17)
conj:but(understood-14, involve-18)
nmod:poss(properties-21, their-19)
amod(properties-21, anti-inflammatory-20)
dobj(involve-18, properties-21)
cc(properties-21, and-22)
dobj(involve-18, effects-23)
conj:and(properties-21, effects-23)
case(metabolism-26, on-24)
compound(metabolism-26, lipid-25)
nmod:on(involve-18, metabolism-26)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT promising/JJ strategy/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-15, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, promising-14)
ccomp(suggest-3, strategy-15)
case(prevention-18, for-16)
det(prevention-18, the-17)
nmod:for(strategy-15, prevention-18)
cc(prevention-18, and-19)
nmod:for(strategy-15, treatment-20)
conj:and(prevention-18, treatment-20)
case(CHD-22, of-21)
nmod:of(prevention-18, CHD-22)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT exact/JJ mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS exert/VBP their/PRP$ beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ exact) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (DT these) (NNS fatty_acids))
                    (VP (VBP exert)
                      (NP
                        (NP (PRP$ their) (JJ beneficial) (NNS effects))
                        (PP (IN on)
                          (NP (NN cardiovascular_health)))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, exact-8)
dobj(elucidate-6, mechanisms-9)
mark(exert-14, by-10)
dobj(exert-14, which-11)
det(fatty_acids-13, these-12)
nsubj(exert-14, fatty_acids-13)
advcl(elucidate-6, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, beneficial-16)
dobj(exert-14, effects-17)
case(cardiovascular_health-19, on-18)
nmod:on(effects-17, cardiovascular_health-19)

Ranirestat/NNP is_a/VBZ promising/VBG therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN Methemoglobinemias/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (NNP Ranirestat))
    (VP (VBZ is_a)
      (VP (VBG promising)
        (NP
          (NP (JJ therapeutic) (NN agent))
          (PP (IN for)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP
                  (NP (NNP Methemoglobinemias))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP (NN phonophobia)))))))))
    (. .)))

nsubj(is_a-2, Ranirestat-1)
root(ROOT-0, is_a-2)
xcomp(is_a-2, promising-3)
amod(agent-5, therapeutic-4)
dobj(promising-3, agent-5)
case(treatment-8, for-6)
det(treatment-8, the-7)
nmod:for(agent-5, treatment-8)
case(Methemoglobinemias-10, of-9)
nmod:of(treatment-8, Methemoglobinemias-10)
nmod:of(treatment-8, photophobia-12)
conj:and(Methemoglobinemias-10, photophobia-12)
cc(Methemoglobinemias-10, and-14)
nmod:of(treatment-8, phonophobia-15)
conj:and(Methemoglobinemias-10, phonophobia-15)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN Ranirestat/NNP were/VBD evaluated/VBN at/IN 2/CD h/NN after/IN dosing/VBG ,/, and/CC it/PRP was/VBD found/VBN that/IN it/PRP reduced/VBD the/DT risk/NN of/IN Methemoglobinemias/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (S
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP Ranirestat))))
      (VP (VBD were)
        (VP (VBN evaluated)
          (PP (IN at)
            (NP (CD 2) (NN h)))
          (PP (IN after)
            (S
              (VP (VBG dosing)))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBD was)
        (VP
          (VP (VBN found)
            (SBAR (IN that)
              (S
                (NP (PRP it))
                (VP (VBD reduced)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNPS Methemoglobinemias))))
                  (PP (IN by)
                    (NP
                      (NP (CD 14) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 95) (NN %))
                          (SBAR
                            (S
                              (VP (VBP CI)
                                (NP
                                  (NP
                                    (NP (CD 6-20) (NN %))
                                    (, ,)
                                    (NP (NNP P)))
                                  (X
                                    (X (SYM =))
                                    (NP (CD 0.0005))))))))
                        (-RRB- -RRB-))))
                  (, ,)
                  (PP
                    (NP (NN photophobia))
                    (PP (IN by)
                      (NP (CD 17) (NN %)))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (CD 95) (NN %))
                        (VP (VBP CI)
                          (NP (CD 12-22) (NN %))
                          (, ,)
                          (SBAR
                            (S
                              (NP (NNP P))
                              (VP (VBP <)
                                (NP (CD 0.0001)))))))
                      (-RRB- -RRB-)))))))
          (, ,)
          (CC and)
          (VP (NN phonophobia)
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (PP (NNP CI)
                      (NP (CD 17-20) (NN %))))
                  (, ,)
                  (NP (NNP P)
                    (QP (CD <) (CD 0.0001)))
                  (-RRB- -RRB-))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(effects-6, the-5)
nsubjpass(evaluated-10, effects-6)
case(Ranirestat-8, of-7)
nmod:of(effects-6, Ranirestat-8)
auxpass(evaluated-10, were-9)
root(ROOT-0, evaluated-10)
case(h-13, at-11)
nummod(h-13, 2-12)
nmod:at(evaluated-10, h-13)
mark(dosing-15, after-14)
advcl(evaluated-10, dosing-15)
cc(evaluated-10, and-17)
nsubjpass(found-20, it-18)
auxpass(found-20, was-19)
conj:and(evaluated-10, found-20)
mark(reduced-23, that-21)
nsubj(reduced-23, it-22)
ccomp(found-20, reduced-23)
det(risk-25, the-24)
dobj(reduced-23, risk-25)
case(Methemoglobinemias-27, of-26)
nmod:of(risk-25, Methemoglobinemias-27)
case(%-30, by-28)
nummod(%-30, 14-29)
nmod:by(reduced-23, %-30)
nummod(%-33, 95-32)
dep(%-30, %-33)
acl:relcl(%-33, CI-34)
nummod(%-36, 6-20-35)
dobj(CI-34, %-36)
appos(%-36, P-38)
dep(0.0005-40, =-39)
dep(%-36, 0.0005-40)
nmod(reduced-23, photophobia-43)
case(%-46, by-44)
nummod(%-46, 17-45)
nmod:by(photophobia-43, %-46)
nummod(%-49, 95-48)
nsubj(CI-50, %-49)
dep(photophobia-43, CI-50)
nummod(%-52, 12-22-51)
dobj(CI-50, %-52)
nsubj(<-55, P-54)
dep(CI-50, <-55)
dobj(<-55, 0.0001-56)
cc(found-20, and-59)
conj:and(evaluated-10, phonophobia-60)
conj:and(found-20, phonophobia-60)
case(%-63, by-61)
nummod(%-63, 14-62)
nmod:by(phonophobia-60, %-63)
nummod(%-66, 95-65)
appos(%-63, %-66)
dep(%-69, CI-67)
nummod(%-69, 17-20-68)
nmod(%-66, %-69)
dep(%-66, P-71)
compound(0.0001-73, <-72)
nummod(P-71, 0.0001-73)

These/DT results/NNS suggest/VBP that/IN Ranirestat/NNP could/MD be/VB an/DT effective/JJ therapeutic/JJ option/NN for/IN patients/NNS suffering/VBG from/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Ranirestat))
          (VP (MD could)
            (VP (VB be)
              (NP (DT an) (JJ effective) (JJ therapeutic) (NN option))
              (PP (IN for)
                (NP
                  (NP (NNS patients))
                  (VP (VBG suffering)
                    (PP (IN from)
                      (NP (DT these) (NNS conditions)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Ranirestat-5)
aux(option-11, could-6)
cop(option-11, be-7)
det(option-11, an-8)
amod(option-11, effective-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, suffering-14)
case(conditions-17, from-15)
det(conditions-17, these-16)
nmod:from(suffering-14, conditions-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN treatment/NN with/IN Ranirestat/NNP to/TO maximize/VB its/PRP$ therapeutic/JJ benefits/NNS while/IN minimizing/VBG potential/JJ side/NN effects/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ optimal) (NN dose)
                  (CC and)
                  (NN duration))
                (PP (IN of)
                  (NP
                    (NP (NN treatment))
                    (PP (IN with)
                      (NP (NNP Ranirestat))))))
              (S
                (VP (TO to)
                  (VP (VB maximize)
                    (NP (PRP$ its) (JJ therapeutic) (NNS benefits))
                    (SBAR (IN while)
                      (S
                        (VP (VBG minimizing)
                          (NP (JJ potential) (NN side) (NNS effects)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(dose-9, the-7)
amod(dose-9, optimal-8)
dobj(determine-6, dose-9)
cc(dose-9, and-10)
dobj(determine-6, duration-11)
conj:and(dose-9, duration-11)
case(treatment-13, of-12)
nmod:of(dose-9, treatment-13)
case(Ranirestat-15, with-14)
nmod:with(treatment-13, Ranirestat-15)
mark(maximize-17, to-16)
advcl(determine-6, maximize-17)
nmod:poss(benefits-20, its-18)
amod(benefits-20, therapeutic-19)
dobj(maximize-17, benefits-20)
mark(minimizing-22, while-21)
advcl(maximize-17, minimizing-22)
amod(effects-25, potential-23)
compound(effects-25, side-24)
dobj(minimizing-22, effects-25)

Omega-3_fatty_acids/NNS have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ,/, particularly/RB in/IN the/DT context/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN in)
            (NP
              (NP (DT the) (NN context))
              (PP (IN of)
                (NP (NN cardiovascular_disease))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, widely-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)
advmod(context-15, particularly-12)
case(context-15, in-13)
det(context-15, the-14)
nmod:in(studied-5, context-15)
case(cardiovascular_disease-17, of-16)
nmod:of(context-15, cardiovascular_disease-17)

Among/IN these/DT fatty_acids/NNS ,/, eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN found/VBN to_be/NN associated/VBN with/IN decreased/VBN levels/NNS of/IN S-amlodipine/NNP in/IN hyperS-amlodipinemic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these) (NNS fatty_acids)))
    (, ,)
    (NP
      (NP
        (ADVP (JJ eicosapentaenoic_acid))
        (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NNS levels))
                  (PP (IN of)
                    (NP (NNP S-amlodipine)))))))
          (PP (IN in)
            (NP (JJ hyperS-amlodipinemic) (NNS patients))))))
    (. .)))

case(fatty_acids-3, Among-1)
det(fatty_acids-3, these-2)
nmod:among(found-16, fatty_acids-3)
advmod(EPA-7, eicosapentaenoic_acid-5)
nsubjpass(found-16, EPA-7)
cc(EPA-7, and-9)
conj:and(EPA-7, docosahexaenoic_acid-10)
nsubjpass(found-16, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
dobj(found-16, to_be-17)
acl(to_be-17, associated-18)
case(levels-21, with-19)
amod(levels-21, decreased-20)
nmod:with(associated-18, levels-21)
case(S-amlodipine-23, of-22)
nmod:of(levels-21, S-amlodipine-23)
case(patients-26, in-24)
amod(patients-26, hyperS-amlodipinemic-25)
nmod:in(found-16, patients-26)

In/IN addition/NN ,/, EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(linked-10, addition-2)
nsubjpass(linked-10, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(linked-10, DHA-6)
aux(linked-10, have-7)
advmod(linked-10, also-8)
auxpass(linked-10, been-9)
root(ROOT-0, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, decreased-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/JJ may/MD have/VB a/DT protective/JJ effect/NN on/IN cardiovascular_health/NN through/IN their/PRP$ ability/NN to/TO modulate/VBP blood_pressure/JJ and/CC reduce/VB the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN on)
                  (NP (NN cardiovascular_health))))
              (PP (IN through)
                (NP
                  (NP (PRP$ their) (NN ability))
                  (X (TO to))
                  (SBAR
                    (S
                      (VP
                        (VP (VBP modulate)
                          (ADJP (JJ blood_pressure)))
                        (CC and)
                        (VP (VB reduce)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP (NNP CHD)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, omega-3_fatty_acids-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, protective-9)
dobj(have-7, effect-10)
case(cardiovascular_health-12, on-11)
nmod:on(effect-10, cardiovascular_health-12)
case(ability-15, through-13)
nmod:poss(ability-15, their-14)
nmod:through(have-7, ability-15)
dep(ability-15, to-16)
acl:relcl(ability-15, modulate-17)
xcomp(modulate-17, blood_pressure-18)
cc(modulate-17, and-19)
acl:relcl(ability-15, reduce-20)
conj:and(modulate-17, reduce-20)
det(risk-22, the-21)
dobj(reduce-20, risk-22)
case(CHD-24, of-23)
nmod:of(risk-22, CHD-24)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS and/CC formulations/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages)
                  (CC and)
                  (NNS formulations))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
cc(dosages-17, and-18)
dobj(determine-15, formulations-19)
conj:and(dosages-17, formulations-19)
case(use-22, for-20)
amod(use-22, clinical-21)
nmod:for(determine-15, use-22)

Neocarzinostatin/NNP is_a/VBZ potent/JJ antitumor/NN antibiotic/JJ that/WDT has_been/VBP shown/VBN to/TO have/VB therapeutic/JJ effects/NNS against/IN various_cancers/NNS ./.

(ROOT
  (S
    (NP (NNP Neocarzinostatin))
    (VP (VBZ is_a)
      (NP
        (NP (JJ potent) (NN antitumor) (JJ antibiotic))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB have)
                      (NP
                        (NP (JJ therapeutic) (NNS effects))
                        (PP (IN against)
                          (NP (NNS various_cancers)))))))))))))
    (. .)))

nsubj(is_a-2, Neocarzinostatin-1)
root(ROOT-0, is_a-2)
amod(antitumor-4, potent-3)
dobj(is_a-2, antitumor-4)
nsubj(has_been-7, antitumor-4)
amod(antitumor-4, antibiotic-5)
ref(antitumor-4, that-6)
acl:relcl(antitumor-4, has_been-7)
dep(has_been-7, shown-8)
mark(have-10, to-9)
xcomp(shown-8, have-10)
amod(effects-12, therapeutic-11)
dobj(have-10, effects-12)
case(various_cancers-14, against-13)
nmod:against(effects-12, various_cancers-14)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN Neocarzinostatin/NNP was/VBD evaluated/VBN in/IN reducing/VBG the/DT risk/NN of/IN sarcoma-180/JJ ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NNP Neocarzinostatin))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (JJ sarcoma-180))))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(Neocarzinostatin-8, of-7)
nmod:of(efficacy-6, Neocarzinostatin-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
mark(reducing-12, in-11)
advcl(evaluated-10, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(sarcoma-180-16, of-15)
nmod:of(risk-14, sarcoma-180-16)
dobj(reducing-12, photophobia-18)
conj:and(risk-14, photophobia-18)
cc(risk-14, and-20)
dobj(reducing-12, phonophobia-21)
conj:and(risk-14, phonophobia-21)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, Neocarzinostatin/NNP reduced/VBD the/DT risk/NN of/IN sarcoma-180/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP Neocarzinostatin))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (ADJP
                  (ADJP
                    (ADJP (JJ sarcoma-180)
                      (PP (IN by)
                        (NP (CD 14) (NN %))))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (CD 95) (NN %))
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (ADJP
                    (ADJP (JJ photophobia)
                      (PP (IN by)
                        (NP (CD 17) (NN %))))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (CD 95) (NN %))
                        (VP (VBP CI)
                          (NP (CD 12-22) (NN %))
                          (, ,)
                          (SBAR
                            (S
                              (NP (NNP P))
                              (VP (VBP <)
                                (NP (CD 0.0001)))))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (CC and)
                  (ADJP
                    (ADJP (JJ phonophobia)
                      (PP (IN by)
                        (NP (CD 14) (NN %))))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (CD 95) (NN %))
                        (VP (VBP CI)
                          (NP (CD 17-20) (NN %))
                          (, ,)
                          (SBAR
                            (S
                              (NP (NNP P))
                              (VP (VBP <)
                                (NP (CD 0.0001)))))))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-12, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-12, Neocarzinostatin-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(sarcoma-180-16, of-15)
acl(risk-14, sarcoma-180-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(sarcoma-180-16, %-19)
nummod(%-22, 95-21)
nsubj(CI-23, %-22)
dep(sarcoma-180-16, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
acl(risk-14, photophobia-32)
conj:and(sarcoma-180-16, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
nsubj(CI-39, %-38)
dep(photophobia-32, CI-39)
nummod(%-41, 12-22-40)
dobj(CI-39, %-41)
nsubj(<-44, P-43)
dep(CI-39, <-44)
dobj(<-44, 0.0001-45)
cc(sarcoma-180-16, and-48)
acl(risk-14, phonophobia-49)
conj:and(sarcoma-180-16, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
nsubj(CI-56, %-55)
dep(phonophobia-49, CI-56)
nummod(%-58, 17-20-57)
dobj(CI-56, %-58)
nsubj(<-61, P-60)
dep(CI-56, <-61)
dobj(<-61, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN Neocarzinostatin/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Neocarzinostatin))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN agent))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (DT these) (NNS conditions)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(agent-11, that-4)
nsubj(agent-11, Neocarzinostatin-5)
aux(agent-11, may-6)
cop(agent-11, be-7)
det(agent-11, a-8)
amod(agent-11, promising-9)
amod(agent-11, therapeutic-10)
ccomp(suggest-3, agent-11)
case(treatment-14, for-12)
det(treatment-14, the-13)
nmod:for(agent-11, treatment-14)
case(conditions-17, of-15)
det(conditions-17, these-16)
nmod:of(treatment-14, conditions-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/NN and/CC duration/NN of/IN treatment/NN with/IN Neocarzinostatin/NNP for/IN maximum/JJ efficacy/NN and/CC minimal/JJ adverse/JJ effects/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosing)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (NN treatment))
                      (PP (IN with)
                        (NP (NNP Neocarzinostatin))))))
                (PP (IN for)
                  (NP
                    (NP (JJ maximum) (NN efficacy))
                    (CC and)
                    (NP (JJ minimal) (JJ adverse) (NNS effects))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(dosing-14, the-12)
amod(dosing-14, optimal-13)
dobj(determine-11, dosing-14)
cc(dosing-14, and-15)
dobj(determine-11, duration-16)
conj:and(dosing-14, duration-16)
case(treatment-18, of-17)
nmod:of(dosing-14, treatment-18)
case(Neocarzinostatin-20, with-19)
nmod:with(treatment-18, Neocarzinostatin-20)
case(efficacy-23, for-21)
amod(efficacy-23, maximum-22)
nmod:for(determine-11, efficacy-23)
cc(efficacy-23, and-24)
amod(effects-27, minimal-25)
amod(effects-27, adverse-26)
nmod:for(determine-11, effects-27)
conj:and(efficacy-23, effects-27)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN involving/VBG various/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (PP (VBG involving)
          (NP
            (NP (JJ various) (VBG signaling) (NNS pathways))
            (CC and)
            (NP (NN gene) (NN expression))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
case(pathways-10, involving-7)
amod(pathways-10, various-8)
amod(pathways-10, signaling-9)
nmod:involving(process-6, pathways-10)
cc(pathways-10, and-11)
compound(expression-13, gene-12)
nmod:involving(process-6, expression-13)
conj:and(pathways-10, expression-13)

Cinnoline/NNP ,/, a/DT heterocyclic/JJ compound/NN ,/, has_been/NN shown/VBN to/TO modulate/VBP cellular/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN in/IN various/JJ cell/NN types/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Cinnoline))
      (, ,)
      (NP (DT a) (JJ heterocyclic) (NN compound))
      (, ,)
      (NP
        (NP (NN has_been))
        (VP (VBN shown)
          (PP (TO to)))))
    (VP (VBP modulate)
      (NP
        (NP (JJ cellular) (VBG signaling) (NNS pathways))
        (CC and)
        (NP
          (NP (NN gene) (NN expression))
          (PP (IN in)
            (NP (JJ various) (NN cell) (NNS types))))))
    (. .)))

nsubj(modulate-10, Cinnoline-1)
det(compound-5, a-3)
amod(compound-5, heterocyclic-4)
appos(Cinnoline-1, compound-5)
appos(Cinnoline-1, has_been-7)
acl(has_been-7, shown-8)
nmod(shown-8, to-9)
root(ROOT-0, modulate-10)
amod(pathways-13, cellular-11)
amod(pathways-13, signaling-12)
dobj(modulate-10, pathways-13)
cc(pathways-13, and-14)
compound(expression-16, gene-15)
dobj(modulate-10, expression-16)
conj:and(pathways-13, expression-16)
case(types-20, in-17)
amod(types-20, various-18)
compound(types-20, cell-19)
nmod:in(expression-16, types-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN cinnoline/NN on/IN the/DT expression/NN and/CC stability/NN of/IN phophodiesterase_10A/JJ -LRB-/-LRB- PDE10A/NNP -RRB-/-RRB- protein/NN during/IN myoblast/JJ differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN cinnoline))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (CC and)
          (NP
            (NP (NN stability))
            (PP (IN of)
              (NP
                (NP (JJ phophodiesterase_10A)
                  (PRN (-LRB- -LRB-)
                    (NP (NNP PDE10A))
                    (-RRB- -RRB-))
                  (NN protein))
                (PP (IN during)
                  (NP (JJ myoblast) (NN differentiation)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(cinnoline-10, of-9)
nmod:of(effect-8, cinnoline-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(investigated-6, expression-13)
cc(expression-13, and-14)
nmod:on(investigated-6, stability-15)
conj:and(expression-13, stability-15)
case(protein-21, of-16)
amod(protein-21, phophodiesterase_10A-17)
appos(protein-21, PDE10A-19)
nmod:of(stability-15, protein-21)
case(differentiation-24, during-22)
amod(differentiation-24, myoblast-23)
nmod:during(protein-21, differentiation-24)

We/PRP cultured/VBD C2C12/CD cells/NNS in_a/JJ medium/NN favoring/VBG differentiation_and/VBN treated/VBN them/PRP with/IN cinnoline/JJ at/IN different/JJ time/NN points/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD cultured)
      (NP
        (ADJP
          (NP (CD C2C12) (NNS cells))
          (JJ in_a))
        (NN medium))
      (S
        (VP (VBG favoring)
          (VP (VBN differentiation_and)
            (VP (VBN treated)
              (NP (PRP them))
              (PP (IN with)
                (NP
                  (ADJP (JJ cinnoline)
                    (PP (IN at)
                      (NP (JJ different) (NN time))))
                  (NNS points))))))))
    (. .)))

nsubj(cultured-2, We-1)
root(ROOT-0, cultured-2)
nummod(cells-4, C2C12-3)
nmod:npmod(in_a-5, cells-4)
amod(medium-6, in_a-5)
dobj(cultured-2, medium-6)
xcomp(cultured-2, favoring-7)
dep(favoring-7, differentiation_and-8)
dep(differentiation_and-8, treated-9)
dobj(treated-9, them-10)
case(points-16, with-11)
amod(points-16, cinnoline-12)
case(time-15, at-13)
amod(time-15, different-14)
nmod:at(cinnoline-12, time-15)
nmod:with(treated-9, points-16)

We/PRP found/VBD that/IN cinnoline/JJ up-regulated/JJ PDE10A/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ PDE10A/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (JJ cinnoline)
            (NX
              (NX
                (NX (JJ up-regulated) (NNP PDE10A) (NN protein) (NNS levels) (NN in_a))
                (NP (JJ time-dependent) (NN manner)))
              (CC and)
              (NX (JJ prolonged) (NNP PDE10A) (NN protein))))
          (VP (NN half-life)
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(half-life-16, that-3)
amod(in_a-9, cinnoline-4)
amod(in_a-9, up-regulated-5)
compound(in_a-9, PDE10A-6)
compound(in_a-9, protein-7)
compound(in_a-9, levels-8)
nsubj(half-life-16, in_a-9)
amod(manner-11, time-dependent-10)
dep(in_a-9, manner-11)
cc(in_a-9, and-12)
amod(protein-15, prolonged-13)
compound(protein-15, PDE10A-14)
conj:and(in_a-9, protein-15)
nsubj(half-life-16, protein-15)
ccomp(found-2, half-life-16)
case(hours-21, from-17)
compound(18-20, 10-18)
dep(18-20, to-19)
nummod(hours-21, 18-20)
nmod:from(half-life-16, hours-21)

These/DT findings/NNS suggest/VBP that/IN cinnoline/NN may/MD play/VB a/DT role/NN in/IN regulating/VBG skeletal_muscle/JJ differentiation/NN by/IN modulating/VBG PDE10A/NN levels/NNS and/CC stability/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cinnoline))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ skeletal_muscle) (NN differentiation))
                      (PP (IN by)
                        (S
                          (VP (VBG modulating)
                            (NP
                              (NP (NN PDE10A) (NNS levels))
                              (CC and)
                              (NP (NN stability)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, cinnoline-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
amod(differentiation-13, skeletal_muscle-12)
dobj(regulating-11, differentiation-13)
mark(modulating-15, by-14)
advcl(regulating-11, modulating-15)
compound(levels-17, PDE10A-16)
dobj(modulating-15, levels-17)
cc(levels-17, and-18)
dobj(modulating-15, stability-19)
conj:and(levels-17, stability-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ applications/NNS of/IN cinnoline/NN in/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP
                      (NP (NN cinnoline))
                      (PP (IN in)
                        (NP (NNS muscle-related_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(applications-13, potential-11)
amod(applications-13, therapeutic-12)
dobj(elucidate-6, applications-13)
conj:and(mechanisms-9, applications-13)
case(cinnoline-15, of-14)
nmod:of(applications-13, cinnoline-15)
case(muscle-related_disorders-17, in-16)
nmod:in(cinnoline-15, muscle-related_disorders-17)

Obesity/JJ is_a/NN growing/VBG health/NN concern/NN worldwide/JJ and/CC has_been/JJ associated/VBN with/IN various/JJ metabolic_disorders/NNS ./.

(ROOT
  (NP
    (NP
      (NP (JJ Obesity) (NN is_a))
      (VP (VBG growing)
        (NP (NN health) (NN concern))))
    (ADJP (JJ worldwide)
      (CC and)
      (JJ has_been))
    (VP (VBN associated)
      (PP (IN with)
        (NP (JJ various) (NNS metabolic_disorders))))
    (. .)))

amod(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
acl(is_a-2, growing-3)
compound(concern-5, health-4)
dobj(growing-3, concern-5)
amod(is_a-2, worldwide-6)
cc(worldwide-6, and-7)
amod(is_a-2, has_been-8)
conj:and(worldwide-6, has_been-8)
acl(is_a-2, associated-9)
case(metabolic_disorders-12, with-10)
amod(metabolic_disorders-12, various-11)
nmod:with(associated-9, metabolic_disorders-12)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN glucose/NN and/CC lipid/NN metabolism/NN through/IN the/DT secretion/NN of/IN insulin/NN and/CC lipase/NN ,/, respectively/RB ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (NN glucose))
                (CC and)
                (NP (NN lipid) (NN metabolism)))))))
      (PP (IN through)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN insulin)
              (CC and)
              (NN lipase)))))
      (, ,)
      (ADVP (RB respectively)))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(regulation-9, in-7)
det(regulation-9, the-8)
nmod:in(role-6, regulation-9)
case(glucose-11, of-10)
nmod:of(regulation-9, glucose-11)
cc(glucose-11, and-12)
compound(metabolism-14, lipid-13)
nmod:of(regulation-9, metabolism-14)
conj:and(glucose-11, metabolism-14)
case(secretion-17, through-15)
det(secretion-17, the-16)
nmod:through(plays-3, secretion-17)
case(insulin-19, of-18)
nmod:of(secretion-17, insulin-19)
cc(insulin-19, and-20)
nmod:of(secretion-17, lipase-21)
conj:and(insulin-19, lipase-21)
advmod(plays-3, respectively-23)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC hypersecretion/NN of/IN lipase/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)
                      (CC and)
                      (NN hypersecretion)))
                  (PP (IN of)
                    (NP (NN lipase))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(obesity-15, and-16)
nmod:of(development-13, hypersecretion-17)
conj:and(obesity-15, hypersecretion-17)
case(lipase-19, of-18)
nmod:of(development-13, lipase-19)
case(pancreas-22, by-20)
det(pancreas-22, the-21)
nmod:by(evaluate-8, pancreas-22)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ erucic_acids/NNS on/IN the/DT secretion/NN of/IN lipase/JJ and_insulin/NN by/IN isolated/JJ perfused/JJ pancreata/NN from/IN genetically_obese/JJ -LRB-/-LRB- fa/fa/NNS -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NNS erucic_acids))))
        (PP (IN on)
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (JJ lipase) (NN and_insulin))))))
      (PP (IN by)
        (NP (JJ isolated) (JJ perfused) (NN pancreata)))
      (PP (IN from)
        (NP
          (NP (JJ genetically_obese) (-LRB- -LRB-) (NNS fa/fa) (-RRB- -RRB-))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS rats)))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(erucic_acids-16, 10-14)
amod(erucic_acids-16, mmol/L-15)
nmod:of(effects-8, erucic_acids-16)
conj:and(glucose-12, erucic_acids-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(effects-8, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, lipase-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(fa/fa-30, from-27)
amod(fa/fa-30, genetically_obese-28)
nmod:from(examined-6, fa/fa-30)
cc(fa/fa-30, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(examined-6, rats-39)
conj:and(fa/fa-30, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN there/EX was/VBD a/DT significant/JJ increase/NN in/IN lipase/JJ secretion/NN in/IN response/NN to/TO both/DT glucose/NN and/CC erucic_acids/NNS in/IN the/DT obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (VBD was)
            (NP
              (NP (DT a) (JJ significant) (NN increase))
              (PP (IN in)
                (NP (JJ lipase) (NN secretion))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP (DT both) (NN glucose))
                    (CC and)
                    (NP (NNS erucic_acids))))))
            (PP (IN in)
              (NP
                (NP (DT the) (JJ obese) (NNS rats))
                (VP (VBN compared)
                  (PP (TO to)
                    (NP (JJ lean) (NNS rats))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(was-6, that-4)
expl(was-6, there-5)
ccomp(showed-3, was-6)
det(increase-9, a-7)
amod(increase-9, significant-8)
nsubj(was-6, increase-9)
case(secretion-12, in-10)
amod(secretion-12, lipase-11)
nmod:in(increase-9, secretion-12)
case(response-14, in-13)
nmod:in(was-6, response-14)
case(glucose-17, to-15)
det(glucose-17, both-16)
nmod:to(response-14, glucose-17)
cc(glucose-17, and-18)
nmod:to(response-14, erucic_acids-19)
conj:and(glucose-17, erucic_acids-19)
case(rats-23, in-20)
det(rats-23, the-21)
amod(rats-23, obese-22)
nmod:in(was-6, rats-23)
acl(rats-23, compared-24)
case(rats-27, to-25)
amod(rats-27, lean-26)
nmod:to(compared-24, rats-27)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN insulin_secretion/NN between/IN the/DT two/CD groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (NN insulin_secretion)))
        (PP (IN between)
          (NP (DT the) (CD two) (NNS groups)))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(insulin_secretion-9, in-8)
nmod:in(difference-7, insulin_secretion-9)
case(groups-13, between-10)
det(groups-13, the-11)
nummod(groups-13, two-12)
nmod:between(difference-7, groups-13)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN lipase/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, highlighting/VBG a/DT potential/JJ target/NN for/IN therapeutic/JJ interventions/NNS aimed/VBN at/IN preventing/VBG or/CC treating/VBG obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NN lipase))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (S
                  (VP (VBG highlighting)
                    (NP
                      (NP (DT a) (JJ potential) (NN target))
                      (PP (IN for)
                        (NP
                          (NP (JJ therapeutic) (NNS interventions))
                          (VP (VBN aimed)
                            (PP (IN at)
                              (S
                                (VP
                                  (VP (VBG preventing))
                                  (CC or)
                                  (VP (VBG treating)
                                    (NP (JJ obesity-related) (NNS metabolic_disorders))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(lipase-7, of-6)
nmod:of(hypersecretion-5, lipase-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(lipase-7, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
xcomp(involved-13, highlighting-20)
det(target-23, a-21)
amod(target-23, potential-22)
dobj(highlighting-20, target-23)
case(interventions-26, for-24)
amod(interventions-26, therapeutic-25)
nmod:for(target-23, interventions-26)
acl(interventions-26, aimed-27)
mark(preventing-29, at-28)
advcl(aimed-27, preventing-29)
cc(preventing-29, or-30)
advcl(aimed-27, treating-31)
conj:or(preventing-29, treating-31)
amod(metabolic_disorders-33, obesity-related-32)
dobj(treating-31, metabolic_disorders-33)

Cardiovascular_disease/NNP is/VBZ often/RB accompanied/VBN by/IN albuminuria/NN ,/, a/DT condition/NN in/IN which/WDT the/DT protein/NN albumin/VBP leaks/NNS into/IN the/DT urine/NN ./.

(ROOT
  (S
    (NP (NNP Cardiovascular_disease))
    (VP (VBZ is) (RB often)
      (VP (VBN accompanied)
        (PP (IN by)
          (NP
            (NP (NN albuminuria))
            (, ,)
            (NP (DT a) (NN condition))))
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (DT the) (NN protein))
              (VP (VBP albumin)
                (NP (NNS leaks))
                (PP (IN into)
                  (NP (DT the) (NN urine)))))))))
    (. .)))

nsubjpass(accompanied-4, Cardiovascular_disease-1)
auxpass(accompanied-4, is-2)
advmod(accompanied-4, often-3)
root(ROOT-0, accompanied-4)
case(albuminuria-6, by-5)
nmod:by(accompanied-4, albuminuria-6)
det(condition-9, a-8)
appos(albuminuria-6, condition-9)
mark(albumin-14, in-10)
dobj(albumin-14, which-11)
det(protein-13, the-12)
nsubj(albumin-14, protein-13)
advcl(accompanied-4, albumin-14)
dobj(albumin-14, leaks-15)
case(urine-18, into-16)
det(urine-18, the-17)
nmod:into(albumin-14, urine-18)

Pitavastatin/NNP is_a/VBD lipid-lowering/JJ drug/NN that/WDT has_been/VBP shown/VBN to/TO have/VB beneficial/JJ effects/NNS on/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (NNP Pitavastatin))
    (VP (VBD is_a)
      (NP
        (NP (JJ lipid-lowering) (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB have)
                      (NP
                        (NP (JJ beneficial) (NNS effects))
                        (PP (IN on)
                          (NP (NN cardiovascular_disease)))))))))))))
    (. .)))

nsubj(is_a-2, Pitavastatin-1)
root(ROOT-0, is_a-2)
amod(drug-4, lipid-lowering-3)
dobj(is_a-2, drug-4)
nsubj(has_been-6, drug-4)
ref(drug-4, that-5)
acl:relcl(drug-4, has_been-6)
dep(has_been-6, shown-7)
mark(have-9, to-8)
xcomp(shown-7, have-9)
amod(effects-11, beneficial-10)
dobj(have-9, effects-11)
case(cardiovascular_disease-13, on-12)
nmod:on(effects-11, cardiovascular_disease-13)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB whether/IN pitavastatin/NN could/MD reduce/VB the/DT risk/NN of/IN albuminuria/NN in/IN patients/NNS with/IN heart_failure/NN -LRB-/-LRB- HF/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (SBAR (IN whether)
              (S
                (NP (NN pitavastatin))
                (VP (MD could)
                  (VP (VB reduce)
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (NP
                          (NP
                            (NP (NN albuminuria))
                            (PP (IN in)
                              (NP
                                (NP (NNS patients))
                                (PP (IN with)
                                  (NP (NN heart_failure))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP HF))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
mark(reduce-10, whether-7)
nsubj(reduce-10, pitavastatin-8)
aux(reduce-10, could-9)
ccomp(investigate-6, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
case(albuminuria-14, of-13)
nmod:of(risk-12, albuminuria-14)
case(patients-16, in-15)
nmod:in(albuminuria-14, patients-16)
case(heart_failure-18, with-17)
nmod:with(patients-16, heart_failure-18)
appos(albuminuria-14, HF-20)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN ,/, and/CC the/DT results/NNS showed/VBD that/IN pitavastatin/NN reduced/VBD the/DT risk/NN of/IN albuminuria/NN in/IN patients/NNS with/IN HF/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (DT A) (NN randomized_controlled_trial))
      (VP (VBD was)
        (VP (VBN conducted))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (NN pitavastatin))
            (VP (VBD reduced)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NN albuminuria))))
              (PP (IN in)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (NNP HF)))))
              (PP (IN by)
                (NP
                  (NP (CD 21) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                      (: :)
                      (NP
                        (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                        (: :)
                        (NP
                          (QP (CD 0.67-0) (CD .93)))))
                    (-RRB- -RRB-)))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
cc(conducted-4, and-6)
det(results-8, the-7)
nsubj(showed-9, results-8)
conj:and(conducted-4, showed-9)
mark(reduced-12, that-10)
nsubj(reduced-12, pitavastatin-11)
ccomp(showed-9, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(albuminuria-16, of-15)
nmod:of(risk-14, albuminuria-16)
case(patients-18, in-17)
nmod:in(reduced-12, patients-18)
case(HF-20, with-19)
nmod:with(patients-18, HF-20)
case(%-23, by-21)
nummod(%-23, 21-22)
nmod:by(reduced-12, %-23)
amod(-RSB--29, relative-25)
compound(-RSB--29, risk-26)
compound(-RSB--29, -LSB--27)
compound(-RSB--29, RR-28)
dep(%-23, -RSB--29)
nummod(-RSB--39, 0.79-31)
nummod(-RSB--39, 95-33)
compound(-RSB--39, %-34)
compound(-RSB--39, confidence-35)
amod(-RSB--39, interval-36)
amod(-RSB--39, -LSB--37)
compound(-RSB--39, CI-38)
dep(-RSB--29, -RSB--39)
compound(.93-42, 0.67-0-41)
dep(-RSB--39, .93-42)

These/DT findings/NNS suggest/VBP that/IN pitavastatin/NN may/MD have/VB a/DT protective/JJ effect/NN on/IN renal_function/NN in/IN patients/NNS with/IN HF/NNP and/CC could/MD be/VB considered/VBN as/IN a/DT therapeutic/JJ option/NN for/IN reducing/VBG the/DT risk/NN of/IN albuminuria/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN pitavastatin))
          (VP
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ protective) (NN effect))
                  (PP (IN on)
                    (NP
                      (NP (NN renal_function))
                      (PP (IN in)
                        (NP
                          (NP (NNS patients))
                          (PP (IN with)
                            (NP (NNP HF))))))))))
            (CC and)
            (VP (MD could)
              (VP (VB be)
                (VP (VBN considered)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN option))
                      (PP (IN for)
                        (S
                          (VP (VBG reducing)
                            (NP
                              (NP (DT the) (NN risk))
                              (PP (IN of)
                                (NP
                                  (NP (NN albuminuria))
                                  (PP (IN in)
                                    (NP (DT this) (NN population))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, pitavastatin-5)
nsubjpass(considered-20, pitavastatin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, protective-9)
dobj(have-7, effect-10)
case(renal_function-12, on-11)
nmod:on(effect-10, renal_function-12)
case(patients-14, in-13)
nmod:in(renal_function-12, patients-14)
case(HF-16, with-15)
nmod:with(patients-14, HF-16)
cc(have-7, and-17)
aux(considered-20, could-18)
auxpass(considered-20, be-19)
ccomp(suggest-3, considered-20)
conj:and(have-7, considered-20)
case(option-24, as-21)
det(option-24, a-22)
amod(option-24, therapeutic-23)
nmod:as(considered-20, option-24)
mark(reducing-26, for-25)
acl(option-24, reducing-26)
det(risk-28, the-27)
dobj(reducing-26, risk-28)
case(albuminuria-30, of-29)
nmod:of(risk-28, albuminuria-30)
case(population-33, in-31)
det(population-33, this-32)
nmod:in(albuminuria-30, population-33)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT underlying/VBG mechanisms/NNS of/IN this/DT effect/NN and/CC to/TO explore/VB its/PRP$ potential/JJ clinical/JJ implications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT this) (NN effect))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS implications))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
ccomp(needed-4, determine-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(determine-6, mechanisms-9)
case(effect-12, of-10)
det(effect-12, this-11)
nmod:of(mechanisms-9, effect-12)
cc(determine-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(determine-6, explore-15)
nmod:poss(implications-19, its-16)
amod(implications-19, potential-17)
amod(implications-19, clinical-18)
dobj(explore-15, implications-19)

Azimilide/NNP is/VBZ an/DT antiarrhythmic/JJ drug/NN that/WDT has/VBZ shown/VBN promising/JJ results/NNS in/IN clinical/JJ trials/NNS ./.

(ROOT
  (S
    (NP (NNP Azimilide))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ antiarrhythmic) (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ has)
              (VP (VBN shown)
                (NP (JJ promising) (NNS results))
                (PP (IN in)
                  (NP (JJ clinical) (NNS trials)))))))))
    (. .)))

nsubj(drug-5, Azimilide-1)
cop(drug-5, is-2)
det(drug-5, an-3)
amod(drug-5, antiarrhythmic-4)
root(ROOT-0, drug-5)
nsubj(shown-8, drug-5)
ref(drug-5, that-6)
aux(shown-8, has-7)
acl:relcl(drug-5, shown-8)
amod(results-10, promising-9)
dobj(shown-8, results-10)
case(trials-13, in-11)
amod(trials-13, clinical-12)
nmod:in(shown-8, trials-13)

In/IN patients/NNS with/IN heart_failure/NN -LRB-/-LRB- HF/NNP -RRB-/-RRB- ,/, arrhythmias/NNS are/VBP a/DT major/JJ concern/NN due/JJ to/TO the/DT increased/VBN risk/NN of/IN sudden_cardiac_death/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP
          (NP (NNS patients))
          (PP (IN with)
            (NP (NN heart_failure))))
        (PRN (-LRB- -LRB-)
          (NP (NNP HF))
          (-RRB- -RRB-))))
    (, ,)
    (NP (NNS arrhythmias))
    (VP (VBP are)
      (NP
        (NP (DT a) (JJ major) (NN concern))
        (ADJP (JJ due)
          (PP (TO to)
            (NP
              (NP (DT the) (VBN increased) (NN risk))
              (PP (IN of)
                (NP (NN sudden_cardiac_death))))))))
    (. .)))

case(patients-2, In-1)
nmod:in(concern-13, patients-2)
case(heart_failure-4, with-3)
nmod:with(patients-2, heart_failure-4)
appos(patients-2, HF-6)
nsubj(concern-13, arrhythmias-9)
cop(concern-13, are-10)
det(concern-13, a-11)
amod(concern-13, major-12)
root(ROOT-0, concern-13)
amod(concern-13, due-14)
case(risk-18, to-15)
det(risk-18, the-16)
amod(risk-18, increased-17)
nmod:to(due-14, risk-18)
case(sudden_cardiac_death-20, of-19)
nmod:of(risk-18, sudden_cardiac_death-20)

Azimilide/JJ has_been/NN found/VBD to/TO reduce/VB the/DT risk/NN of/IN action/NN potential/JJ duration/NN -LRB-/-LRB- APD/NNP -RRB-/-RRB- prolongation/VBN in/IN patients/NNS with/IN HF/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/NNS CI/NNP -RSB-/NNP :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Azimilide) (NN has_been))
    (VP (VBD found)
      (S
        (VP (TO to)
          (VP (VB reduce)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (NP (NN action) (JJ potential) (NN duration))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP APD))
                        (-RRB- -RRB-)))
                    (VP (VBN prolongation)
                      (PP (IN in)
                        (NP (NNS patients)))
                      (PP (IN with)
                        (NP (NNP HF)))
                      (PP (IN by)
                        (NP (CD 21) (NN %)))))
                  (-LRB- -LRB-)
                  (NP
                    (NP
                      (NP (JJ relative) (NN risk))
                      (NP (NNP -LSB-) (NNP RR) (NNP -RSB-)))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (NNS -LSB-))
                      (NP (NNP CI) (NNP -RSB-)))
                    (: :)
                    (NP
                      (QP (CD 0.67-0) (CD .93))))
                  (-RRB- -RRB-))))))))
    (. .)))

amod(has_been-2, Azimilide-1)
nsubj(found-3, has_been-2)
nsubj:xsubj(reduce-5, has_been-2)
root(ROOT-0, found-3)
mark(reduce-5, to-4)
xcomp(found-3, reduce-5)
det(risk-7, the-6)
dobj(reduce-5, risk-7)
case(duration-11, of-8)
compound(duration-11, action-9)
amod(duration-11, potential-10)
nmod:of(risk-7, duration-11)
appos(duration-11, APD-13)
acl(duration-11, prolongation-15)
case(patients-17, in-16)
nmod:in(prolongation-15, patients-17)
case(HF-19, with-18)
nmod:with(prolongation-15, HF-19)
case(%-22, by-20)
nummod(%-22, 21-21)
nmod:by(prolongation-15, %-22)
amod(risk-25, relative-24)
dep(duration-11, risk-25)
compound(-RSB--28, -LSB--26)
compound(-RSB--28, RR-27)
dep(risk-25, -RSB--28)
nummod(-LSB--36, 0.79-30)
nummod(-LSB--36, 95-32)
compound(-LSB--36, %-33)
compound(-LSB--36, confidence-34)
amod(-LSB--36, interval-35)
dep(risk-25, -LSB--36)
compound(-RSB--38, CI-37)
dep(-LSB--36, -RSB--38)
compound(.93-41, 0.67-0-40)
dep(risk-25, .93-41)

This/DT reduction/NN in/IN APD_prolongation/NNP is/VBZ significant/JJ as/IN it/PRP indicates/VBZ a/DT lower/JJR risk/NN of/IN arrhythmias/NNS and/CC sudden_cardiac_death/NN in/IN these/DT patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT This) (NN reduction))
      (PP (IN in)
        (NP (NNP APD_prolongation))))
    (VP (VBZ is)
      (ADJP (JJ significant))
      (SBAR (IN as)
        (S
          (NP (PRP it))
          (VP (VBZ indicates)
            (NP
              (NP (DT a) (JJR lower) (NN risk))
              (PP (IN of)
                (NP (NNS arrhythmias)
                  (CC and)
                  (NN sudden_cardiac_death)))
              (PP (IN in)
                (NP (DT these) (NNS patients))))))))
    (. .)))

det(reduction-2, This-1)
nsubj(significant-6, reduction-2)
case(APD_prolongation-4, in-3)
nmod:in(reduction-2, APD_prolongation-4)
cop(significant-6, is-5)
root(ROOT-0, significant-6)
mark(indicates-9, as-7)
nsubj(indicates-9, it-8)
advcl(significant-6, indicates-9)
det(risk-12, a-10)
amod(risk-12, lower-11)
dobj(indicates-9, risk-12)
case(arrhythmias-14, of-13)
nmod:of(risk-12, arrhythmias-14)
cc(arrhythmias-14, and-15)
nmod:of(risk-12, sudden_cardiac_death-16)
conj:and(arrhythmias-14, sudden_cardiac_death-16)
case(patients-19, in-17)
det(patients-19, these-18)
nmod:in(risk-12, patients-19)

These/DT findings/NNS suggest/VBP that/IN azimilide/NN may/MD be/VB a/DT valuable/JJ treatment/NN option/NN for/IN patients/NNS with/IN HF/NNP who/WP are/VBP at/IN high/JJ risk/NN for/IN arrhythmias/NNS and/CC sudden_cardiac_death/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN azimilide))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ valuable) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP (NNP HF)))
                    (SBAR
                      (WHNP (WP who))
                      (S
                        (VP (VBP are)
                          (PP (IN at)
                            (NP
                              (NP (JJ high) (NN risk))
                              (PP (IN for)
                                (NP (NNS arrhythmias)
                                  (CC and)
                                  (NN sudden_cardiac_death))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, azimilide-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, valuable-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
nsubj(risk-20, patients-13)
case(HF-15, with-14)
nmod:with(patients-13, HF-15)
ref(patients-13, who-16)
cop(risk-20, are-17)
case(risk-20, at-18)
amod(risk-20, high-19)
acl:relcl(patients-13, risk-20)
case(arrhythmias-22, for-21)
nmod:for(risk-20, arrhythmias-22)
cc(arrhythmias-22, and-23)
nmod:for(risk-20, sudden_cardiac_death-24)
conj:and(arrhythmias-22, sudden_cardiac_death-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/NN and/CC duration/NN of/IN treatment/NN with/IN azimilide/NN in/IN this/DT patient/JJ population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosing)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP (NN treatment))))
                (PP (IN with)
                  (NP
                    (NP (NN azimilide))
                    (PP (IN in)
                      (NP (DT this) (JJ patient) (NN population)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(dosing-14, the-12)
amod(dosing-14, optimal-13)
dobj(determine-11, dosing-14)
cc(dosing-14, and-15)
dobj(determine-11, duration-16)
conj:and(dosing-14, duration-16)
case(treatment-18, of-17)
nmod:of(dosing-14, treatment-18)
case(azimilide-20, with-19)
nmod:with(determine-11, azimilide-20)
case(population-24, in-21)
det(population-24, this-22)
amod(population-24, patient-23)
nmod:in(azimilide-20, population-24)

The/DT present/JJ study/NN aimed/VBN to/TO investigate/VB the/DT relationship/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/JJ ,/, mitiglinide/JJ and/CC serum/JJ insulin/NN levels/NNS in_a/VBD cohort/NN of/IN patients/NNS with/IN type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ present) (NN study))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN relationship))
                (PP (IN between)
                  (NP
                    (NP (NN serum) (NNS levels))
                    (PP (IN of)
                      (NP
                        (ADJP (JJ alkaline_phosphatase) (, ,) (JJ mitiglinide)
                          (CC and)
                          (JJ serum))
                        (NN insulin) (NNS levels)))))))))))
    (VP (VBD in_a)
      (NP
        (NP (NN cohort))
        (PP (IN of)
          (NP (NNS patients))))
      (PP (IN with)
        (NP (NNS type_2_diabetes))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(in_a-20, study-3)
acl(study-3, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(relationship-8, the-7)
dobj(investigate-6, relationship-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(relationship-8, levels-11)
case(levels-19, of-12)
amod(levels-19, alkaline_phosphatase-13)
conj:and(alkaline_phosphatase-13, mitiglinide-15)
amod(levels-19, mitiglinide-15)
cc(alkaline_phosphatase-13, and-16)
conj:and(alkaline_phosphatase-13, serum-17)
amod(levels-19, serum-17)
compound(levels-19, insulin-18)
nmod:of(levels-11, levels-19)
root(ROOT-0, in_a-20)
dobj(in_a-20, cohort-21)
case(patients-23, of-22)
nmod:of(cohort-21, patients-23)
case(type_2_diabetes-25, with-24)
nmod:with(in_a-20, type_2_diabetes-25)

A/DT total/NN of/IN 100/CD patients/NNS were/VBD enrolled/VBN in/IN the/DT study/NN and/CC their/PRP$ clinical/JJ and/CC laboratory/NN data/NNS were/VBD collected/VBN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 100) (NNS patients))))
      (VP (VBD were)
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study))))))
    (CC and)
    (S
      (NP (PRP$ their) (JJ clinical)
        (CC and)
        (NN laboratory) (NNS data))
      (VP (VBD were)
        (VP (VBN collected))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
case(patients-5, of-3)
nummod(patients-5, 100-4)
nmod:of(total-2, patients-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(study-10, in-8)
det(study-10, the-9)
nmod:in(enrolled-7, study-10)
cc(enrolled-7, and-11)
nmod:poss(clinical-13, their-12)
nsubjpass(collected-18, clinical-13)
cc(clinical-13, and-14)
compound(data-16, laboratory-15)
conj:and(clinical-13, data-16)
nsubjpass(collected-18, data-16)
auxpass(collected-18, were-17)
conj:and(enrolled-7, collected-18)

The/DT results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC mitiglinide/NN -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- with/IN serum/NN insulin/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NN mitiglinide))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-))))))))
      (PP (IN with)
        (NP (NN serum) (NN insulin) (NNS levels))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(alkaline_phosphatase-12, of-11)
nmod:of(levels-10, alkaline_phosphatase-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(alkaline_phosphatase-12, <-19)
dobj(<-19, 0.01-20)
cc(alkaline_phosphatase-12, and-22)
nmod:of(levels-10, mitiglinide-23)
conj:and(alkaline_phosphatase-12, mitiglinide-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(mitiglinide-23, <-30)
dobj(<-30, 0.01-31)
case(levels-36, with-33)
compound(levels-36, serum-34)
compound(levels-36, insulin-35)
nmod:with(showed-3, levels-36)

This/DT suggests/VBZ that/IN higher/JJR levels/NNS of/IN alkaline_phosphatase/NN and/CC mitiglinide/NN are/VBP associated/VBN with/IN increased_insulin_secretion/NN in/IN patients/NNS with/IN type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJR higher) (NNS levels))
            (PP (IN of)
              (NP (NN alkaline_phosphatase)
                (CC and)
                (NN mitiglinide))))
          (VP (VBP are)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (NN increased_insulin_secretion))
                  (PP (IN in)
                    (NP (NNS patients)))))
              (PP (IN with)
                (NP (NNS type_2_diabetes))))))))
    (. .)))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
mark(associated-11, that-3)
amod(levels-5, higher-4)
nsubjpass(associated-11, levels-5)
case(alkaline_phosphatase-7, of-6)
nmod:of(levels-5, alkaline_phosphatase-7)
cc(alkaline_phosphatase-7, and-8)
nmod:of(levels-5, mitiglinide-9)
conj:and(alkaline_phosphatase-7, mitiglinide-9)
auxpass(associated-11, are-10)
ccomp(suggests-2, associated-11)
case(increased_insulin_secretion-13, with-12)
nmod:with(associated-11, increased_insulin_secretion-13)
case(patients-15, in-14)
nmod:in(increased_insulin_secretion-13, patients-15)
case(type_2_diabetes-17, with-16)
nmod:with(associated-11, type_2_diabetes-17)

These/DT findings/NNS may/MD have/VB important/JJ implications/NNS for/IN the/DT management/NN of/IN diabetes/NN ,/, as/IN targeting/VBG alkaline_phosphatase/NN and/CC mitiglinide/NN could/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN improving/VBG insulin_secretion/NN in/IN these/DT patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN management))
              (PP (IN of)
                (NP (NN diabetes))))))
        (, ,)
        (SBAR (IN as)
          (S
            (S
              (VP (VBG targeting)
                (NP (NN alkaline_phosphatase)
                  (CC and)
                  (NN mitiglinide))))
            (VP (MD could)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
                  (PP (IN for)
                    (S
                      (VP (VBG improving)
                        (NP
                          (NP (NN insulin_secretion))
                          (PP (IN in)
                            (NP (DT these) (NNS patients))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(have-4, findings-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
amod(implications-6, important-5)
dobj(have-4, implications-6)
case(management-9, for-7)
det(management-9, the-8)
nmod:for(implications-6, management-9)
case(diabetes-11, of-10)
nmod:of(management-9, diabetes-11)
mark(strategy-23, as-13)
csubj(strategy-23, targeting-14)
dobj(targeting-14, alkaline_phosphatase-15)
cc(alkaline_phosphatase-15, and-16)
dobj(targeting-14, mitiglinide-17)
conj:and(alkaline_phosphatase-15, mitiglinide-17)
aux(strategy-23, could-18)
cop(strategy-23, be-19)
det(strategy-23, a-20)
amod(strategy-23, potential-21)
amod(strategy-23, therapeutic-22)
advcl(have-4, strategy-23)
mark(improving-25, for-24)
acl(strategy-23, improving-25)
dobj(improving-25, insulin_secretion-26)
case(patients-29, in-27)
det(patients-29, these-28)
nmod:in(insulin_secretion-26, patients-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC explore/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT association/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS findings)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN association)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(explore-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-13, the-11)
amod(mechanisms-13, underlying-12)
dobj(explore-10, mechanisms-13)
acl(mechanisms-13, involved-14)
case(association-17, in-15)
det(association-17, this-16)
nmod:in(involved-14, association-17)

Migraine/JJ is_a/JJ common/JJ neurological_disorder/NN characterized/VBD by/IN recurrent/JJ attacks/NNS of/IN severe/JJ headache/NN ,/, often/RB accompanied/VBN by/IN photophobia/NN ,/, phonophobia/NN ,/, and/CC other/JJ symptoms/NNS ./.

(ROOT
  (S
    (NP (JJ Migraine) (JJ is_a) (JJ common) (NN neurological_disorder))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ recurrent) (NNS attacks))
          (PP (IN of)
            (NP
              (NP (JJ severe) (NN headache))
              (, ,)
              (VP
                (ADVP (RB often))
                (VBN accompanied)
                (PP (IN by)
                  (NP
                    (NP (NN photophobia))
                    (, ,)
                    (NP (NN phonophobia))
                    (, ,)
                    (CC and)
                    (NP (JJ other) (NNS symptoms))))))))))
    (. .)))

amod(neurological_disorder-4, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
nsubj(characterized-5, neurological_disorder-4)
root(ROOT-0, characterized-5)
case(attacks-8, by-6)
amod(attacks-8, recurrent-7)
nmod:by(characterized-5, attacks-8)
case(headache-11, of-9)
amod(headache-11, severe-10)
nmod:of(attacks-8, headache-11)
advmod(accompanied-14, often-13)
acl(headache-11, accompanied-14)
case(photophobia-16, by-15)
nmod:by(accompanied-14, photophobia-16)
nmod:by(accompanied-14, phonophobia-18)
conj:and(photophobia-16, phonophobia-18)
cc(photophobia-16, and-20)
amod(symptoms-22, other-21)
nmod:by(accompanied-14, symptoms-22)
conj:and(photophobia-16, symptoms-22)

Lergotrile/VB is_a/JJ medication/NN that/WDT has_been/VBP used/VBN for/IN the/DT treatment/NN of/IN migraine/NN ./.

(ROOT
  (S
    (VP (VB Lergotrile)
      (NP
        (NP (JJ is_a) (NN medication))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN used)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NN migraine)))))))))))
    (. .)))

root(ROOT-0, Lergotrile-1)
amod(medication-3, is_a-2)
dobj(Lergotrile-1, medication-3)
nsubj(has_been-5, medication-3)
ref(medication-3, that-4)
acl:relcl(medication-3, has_been-5)
dep(has_been-5, used-6)
case(treatment-9, for-7)
det(treatment-9, the-8)
nmod:for(used-6, treatment-9)
case(migraine-11, of-10)
nmod:of(treatment-9, migraine-11)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN Lergotrile/NNP on/IN the/DT risk/NN of/IN Mydriasis/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Lergotrile)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP
              (NP (NNP Mydriasis))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD was)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-20, study-3)
det(effect-6, the-5)
nsubjpass(investigated-20, effect-6)
case(Lergotrile-8, of-7)
nmod:of(effect-6, Lergotrile-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(effect-6, risk-11)
case(Mydriasis-13, of-12)
nmod:of(risk-11, Mydriasis-13)
nmod:of(risk-11, photophobia-15)
conj:and(Mydriasis-13, photophobia-15)
cc(Mydriasis-13, and-17)
nmod:of(risk-11, phonophobia-18)
conj:and(Mydriasis-13, phonophobia-18)
auxpass(investigated-20, was-19)
root(ROOT-0, investigated-20)

The/DT study/NN involved/VBD a/DT randomized_controlled_trial/NN with/IN a/DT total/NN of/IN 500/CD participants/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD involved)
      (NP (DT a) (NN randomized_controlled_trial))
      (PP (IN with)
        (NP
          (NP (DT a) (NN total))
          (PP (IN of)
            (NP (CD 500) (NNS participants))))))
    (. .)))

det(study-2, The-1)
nsubj(involved-3, study-2)
root(ROOT-0, involved-3)
det(randomized_controlled_trial-5, a-4)
dobj(involved-3, randomized_controlled_trial-5)
case(total-8, with-6)
det(total-8, a-7)
nmod:with(involved-3, total-8)
case(participants-11, of-9)
nummod(participants-11, 500-10)
nmod:of(total-8, participants-11)

At_2/JJ h/NN after/IN dosing/VBG ,/, Lergotrile/NNP reduced/VBD the/DT risk/NN of/IN Mydriasis/NNPS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Lergotrile))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNPS Mydriasis))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, Lergotrile-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(Mydriasis-11, of-10)
nmod:of(risk-9, Mydriasis-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN Lergotrile/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN reducing/VBG the/DT risk/NN of/IN these/DT common/JJ symptoms/NNS associated/VBN with/IN migraine/JJ attacks/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Lergotrile))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (DT these) (JJ common) (NNS symptoms))
                            (VP (VBN associated)
                              (PP (IN with)
                                (NP (JJ migraine) (NNS attacks))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Lergotrile-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(symptoms-19, of-16)
det(symptoms-19, these-17)
amod(symptoms-19, common-18)
nmod:of(risk-15, symptoms-19)
acl(symptoms-19, associated-20)
case(attacks-23, with-21)
amod(attacks-23, migraine-22)
nmod:with(associated-20, attacks-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO investigate/VB the/DT long-term/JJ effects/NNS of/IN Lergotrile/NNP on/IN migraine/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (JJ long-term) (NNS effects))
                  (PP (IN of)
                    (NP (NNP Lergotrile))))
                (PP (IN on)
                  (NP (JJ migraine) (NN management)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(investigate-11, to-10)
ccomp(needed-4, investigate-11)
conj:and(confirm-6, investigate-11)
det(effects-14, the-12)
amod(effects-14, long-term-13)
dobj(investigate-11, effects-14)
case(Lergotrile-16, of-15)
nmod:of(effects-14, Lergotrile-16)
case(management-19, on-17)
amod(management-19, migraine-18)
nmod:on(investigate-11, management-19)

Neurotransmitters/NNS play/VBP a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN various/JJ physiological/JJ processes/NNS in/IN the/DT human/JJ body/NN ./.

(ROOT
  (S
    (NP (NNS Neurotransmitters))
    (VP (VBP play)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (JJ various) (JJ physiological) (NNS processes))
                (PP (IN in)
                  (NP (DT the) (JJ human) (NN body)))))))))
    (. .)))

nsubj(play-2, Neurotransmitters-1)
root(ROOT-0, play-2)
det(role-5, a-3)
amod(role-5, crucial-4)
dobj(play-2, role-5)
case(regulation-8, in-6)
det(regulation-8, the-7)
nmod:in(role-5, regulation-8)
case(processes-12, of-9)
amod(processes-12, various-10)
amod(processes-12, physiological-11)
nmod:of(regulation-8, processes-12)
case(body-16, in-13)
det(body-16, the-14)
amod(body-16, human-15)
nmod:in(processes-12, body-16)

In/IN order/NN to/TO study/VB the/DT expression/NN and/CC localization/NN of/IN different/JJ neurotransmitters/NNS ,/, several/JJ antibodies/NNS against/IN key/JJ transporters/NNS and/CC enzymes/NNS were/VBD utilized/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN order)
        (S
          (VP (TO to)
            (VP (VB study)
              (NP
                (NP (DT the) (NN expression)
                  (CC and)
                  (NN localization))
                (PP (IN of)
                  (NP (JJ different) (NNS neurotransmitters)))))))))
    (, ,)
    (NP
      (NP (JJ several) (NNS antibodies))
      (PP (IN against)
        (NP (JJ key) (NNS transporters)
          (CC and)
          (NNS enzymes))))
    (VP (VBD were)
      (VP (VBN utilized)))
    (. .)))

case(order-2, In-1)
nmod:in(utilized-21, order-2)
mark(study-4, to-3)
acl(order-2, study-4)
det(expression-6, the-5)
dobj(study-4, expression-6)
cc(expression-6, and-7)
dobj(study-4, localization-8)
conj:and(expression-6, localization-8)
case(neurotransmitters-11, of-9)
amod(neurotransmitters-11, different-10)
nmod:of(expression-6, neurotransmitters-11)
amod(antibodies-14, several-13)
nsubjpass(utilized-21, antibodies-14)
case(transporters-17, against-15)
amod(transporters-17, key-16)
nmod:against(antibodies-14, transporters-17)
cc(transporters-17, and-18)
nmod:against(antibodies-14, enzymes-19)
conj:and(transporters-17, enzymes-19)
auxpass(utilized-21, were-20)
root(ROOT-0, utilized-21)

These/DT included/VBD antibodies/NNS against/IN vesicular/NN tetrahydropterin/NN transporters/NNS -LRB-/-LRB- p-aminohippuric_acid/JJ -RRB-/-RRB- ,/, vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- ,/, tyrosine_hydroxylase/NN -LRB-/-LRB- TH/NNP -RRB-/-RRB- ,/, dopamine_beta-hydroxylase/JJ -LRB-/-LRB- DBH/NNP -RRB-/-RRB- ,/, serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- ,/, vasoactive_intestinal_peptide/NN -LRB-/-LRB- VIP/NNP -RRB-/-RRB- ,/, and/CC protein_gene_product_9/CD .5/CD -LRB-/-LRB- PGP_9/CD .5/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These))
    (VP (VBD included)
      (NP (NNS antibodies))
      (PP (IN against)
        (NP
          (NP
            (NP
              (NP (NN vesicular) (NN tetrahydropterin) (NNS transporters))
              (PRN (-LRB- -LRB-) (JJ p-aminohippuric_acid) (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN vesicular_acetylcholine_transporter))
              (PRN (-LRB- -LRB-)
                (NP (NNP VAChT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN tyrosine_hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP TH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (JJ dopamine_beta-hydroxylase))
              (PRN (-LRB- -LRB-)
                (NP (NNP DBH))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN vasoactive_intestinal_peptide))
              (PRN (-LRB- -LRB-)
                (NP (NNP VIP))
                (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (QP (CD protein_gene_product_9) (CD .5))))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD PGP_9) (CD .5)))
            (-RRB- -RRB-)))))
    (. .)))

nsubj(included-2, These-1)
root(ROOT-0, included-2)
dobj(included-2, antibodies-3)
case(transporters-7, against-4)
compound(transporters-7, vesicular-5)
compound(transporters-7, tetrahydropterin-6)
nmod:against(included-2, transporters-7)
dep(transporters-7, p-aminohippuric_acid-9)
nmod:against(included-2, vesicular_acetylcholine_transporter-12)
conj:and(transporters-7, vesicular_acetylcholine_transporter-12)
appos(vesicular_acetylcholine_transporter-12, VAChT-14)
nmod:against(included-2, tyrosine_hydroxylase-17)
conj:and(transporters-7, tyrosine_hydroxylase-17)
appos(tyrosine_hydroxylase-17, TH-19)
nmod:against(included-2, dopamine_beta-hydroxylase-22)
conj:and(transporters-7, dopamine_beta-hydroxylase-22)
appos(dopamine_beta-hydroxylase-22, DBH-24)
nmod:against(included-2, serotonin-27)
conj:and(transporters-7, serotonin-27)
appos(serotonin-27, 5-HT-29)
nmod:against(included-2, vasoactive_intestinal_peptide-32)
conj:and(transporters-7, vasoactive_intestinal_peptide-32)
appos(vasoactive_intestinal_peptide-32, VIP-34)
cc(transporters-7, and-37)
compound(.5-39, protein_gene_product_9-38)
nmod:against(included-2, .5-39)
conj:and(transporters-7, .5-39)
compound(.5-42, PGP_9-41)
dep(transporters-7, .5-42)

Immunohistochemical/JJ techniques/NNS were/VBD employed/VBN to/TO visualize/VB the/DT distribution/NN of/IN these/DT markers/NNS in/IN various/JJ tissues/NNS and/CC organs/NNS ,/, including/VBG the/DT nervous/JJ system/NN ,/, endocrine/JJ glands/NNS ,/, and_gastrointestinal/JJ tract/NN ./.

(ROOT
  (S
    (NP (JJ Immunohistochemical) (NNS techniques))
    (VP (VBD were)
      (VP (VBN employed)
        (S
          (VP (TO to)
            (VP (VB visualize)
              (NP
                (NP (DT the) (NN distribution))
                (PP (IN of)
                  (NP
                    (NP (DT these) (NNS markers))
                    (PP (IN in)
                      (NP (JJ various) (NNS tissues)
                        (CC and)
                        (NNS organs)))
                    (, ,)
                    (VP (VBG including)
                      (NP
                        (NP (DT the) (JJ nervous) (NN system))
                        (, ,)
                        (NP (JJ endocrine) (NNS glands))
                        (, ,)
                        (NP (JJ and_gastrointestinal) (NN tract))))))))))))
    (. .)))

amod(techniques-2, Immunohistochemical-1)
nsubjpass(employed-4, techniques-2)
nsubj:xsubj(visualize-6, techniques-2)
auxpass(employed-4, were-3)
root(ROOT-0, employed-4)
mark(visualize-6, to-5)
xcomp(employed-4, visualize-6)
det(distribution-8, the-7)
dobj(visualize-6, distribution-8)
case(markers-11, of-9)
det(markers-11, these-10)
nmod:of(distribution-8, markers-11)
case(tissues-14, in-12)
amod(tissues-14, various-13)
nmod:in(markers-11, tissues-14)
cc(tissues-14, and-15)
nmod:in(markers-11, organs-16)
conj:and(tissues-14, organs-16)
acl(markers-11, including-18)
det(system-21, the-19)
amod(system-21, nervous-20)
dobj(including-18, system-21)
amod(glands-24, endocrine-23)
appos(system-21, glands-24)
amod(tract-27, and_gastrointestinal-26)
appos(system-21, tract-27)

The/DT results/NNS obtained/VBN from/IN these/DT studies/NNS provide/VBP valuable/JJ insights/NNS into/IN the/DT role/NN of/IN these/DT neurotransmitters/NNS in/IN different/JJ physiological/JJ processes/NNS and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN neurological_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS results))
      (VP (VBN obtained)
        (PP (IN from)
          (NP (DT these) (NNS studies)))))
    (VP
      (VP (VBP provide)
        (NP (JJ valuable) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NN role))
            (PP (IN of)
              (NP
                (NP (DT these) (NNS neurotransmitters))
                (PP (IN in)
                  (NP (JJ different) (JJ physiological) (NNS processes))))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP (NNS neurological_disorders)))))))))))
    (. .)))

det(results-2, The-1)
nsubj(provide-7, results-2)
nsubj(have-22, results-2)
acl(results-2, obtained-3)
case(studies-6, from-4)
det(studies-6, these-5)
nmod:from(obtained-3, studies-6)
root(ROOT-0, provide-7)
amod(insights-9, valuable-8)
dobj(provide-7, insights-9)
case(role-12, into-10)
det(role-12, the-11)
nmod:into(provide-7, role-12)
case(neurotransmitters-15, of-13)
det(neurotransmitters-15, these-14)
nmod:of(role-12, neurotransmitters-15)
case(processes-19, in-16)
amod(processes-19, different-17)
amod(processes-19, physiological-18)
nmod:in(neurotransmitters-15, processes-19)
cc(provide-7, and-20)
aux(have-22, may-21)
conj:and(provide-7, have-22)
dobj(have-22, implications-23)
case(development-26, for-24)
det(development-26, the-25)
nmod:for(implications-23, development-26)
case(strategies-30, of-27)
amod(strategies-30, novel-28)
amod(strategies-30, therapeutic-29)
nmod:of(development-26, strategies-30)
case(neurological_disorders-32, for-31)
nmod:for(strategies-30, neurological_disorders-32)

Gastrointestinal/JJ disorders/NNS are/VBP common/JJ in/IN heart_failure/JJ -LRB-/-LRB- HF/NNP -RRB-/-RRB- patients/NNS ,/, and/CC colonic_inertia/NN is/VBZ one/CD of/IN the/DT most/RBS frequent/JJ complications/NNS ./.

(ROOT
  (S
    (S
      (NP (JJ Gastrointestinal) (NNS disorders))
      (VP (VBP are)
        (ADJP (JJ common))
        (PP (IN in)
          (NP (JJ heart_failure)
            (PRN (-LRB- -LRB-)
              (NP (NNP HF))
              (-RRB- -RRB-))
            (NNS patients)))))
    (, ,)
    (CC and)
    (S
      (NP (NN colonic_inertia))
      (VP (VBZ is)
        (NP
          (NP (CD one))
          (PP (IN of)
            (NP (DT the)
              (ADJP (RBS most) (JJ frequent))
              (NNS complications))))))
    (. .)))

amod(disorders-2, Gastrointestinal-1)
nsubj(common-4, disorders-2)
cop(common-4, are-3)
root(ROOT-0, common-4)
case(patients-10, in-5)
amod(patients-10, heart_failure-6)
appos(patients-10, HF-8)
nmod:in(common-4, patients-10)
cc(common-4, and-12)
nsubj(one-15, colonic_inertia-13)
cop(one-15, is-14)
conj:and(common-4, one-15)
case(complications-20, of-16)
det(complications-20, the-17)
advmod(frequent-19, most-18)
amod(complications-20, frequent-19)
nmod:of(one-15, complications-20)

Cilansetron/NNP ,/, a/DT selective/JJ 5-hydroxytryptamine/JJ 3/CD -LRB-/-LRB- 5-HT3/CD -RRB-/-RRB- receptor_antagonist/NN ,/, has_been/VBP shown/VBN to_be/NN effective/JJ in/IN treating/VBG irritable_bowel_syndrome/NN with/IN constipation/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Cilansetron))
      (, ,)
      (NP (DT a) (JJ selective)
        (ADJP (JJ 5-hydroxytryptamine)
          (NP-TMP (CD 3)))
        (PRN (-LRB- -LRB-)
          (NP (CD 5-HT3))
          (-RRB- -RRB-))
        (NN receptor_antagonist))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (NP (NN to_be))
        (S
          (ADJP (JJ effective)
            (PP (IN in)
              (S
                (VP (VBG treating)
                  (NP (NN irritable_bowel_syndrome))
                  (PP (IN with)
                    (NP (NN constipation))))))))))
    (. .)))

nsubj(has_been-12, Cilansetron-1)
det(receptor_antagonist-10, a-3)
amod(receptor_antagonist-10, selective-4)
amod(receptor_antagonist-10, 5-hydroxytryptamine-5)
nmod:tmod(5-hydroxytryptamine-5, 3-6)
appos(receptor_antagonist-10, 5-HT3-8)
appos(Cilansetron-1, receptor_antagonist-10)
root(ROOT-0, has_been-12)
dep(has_been-12, shown-13)
dobj(shown-13, to_be-14)
xcomp(shown-13, effective-15)
mark(treating-17, in-16)
advcl(effective-15, treating-17)
dobj(treating-17, irritable_bowel_syndrome-18)
case(constipation-20, with-19)
nmod:with(treating-17, constipation-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN cilansetron/NN on/IN colonic_inertia/NN in/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN cilansetron))))
      (PP (IN on)
        (NP
          (NP (NN colonic_inertia))
          (PP (IN in)
            (NP (NNS patients)))))
      (PP (IN with)
        (NP (NNP HF))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(cilansetron-10, of-9)
nmod:of(effect-8, cilansetron-10)
case(colonic_inertia-12, on-11)
nmod:on(investigated-6, colonic_inertia-12)
case(patients-14, in-13)
nmod:in(colonic_inertia-12, patients-14)
case(HF-16, with-15)
nmod:with(investigated-6, HF-16)

A/DT systematic/JJ review/NN and/CC meta-analysis/NNS of/IN randomized_controlled_trials/NNS were/VBD conducted/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (JJ systematic) (NN review))
      (CC and)
      (NP
        (NP (NNS meta-analysis))
        (PP (IN of)
          (NP (NNS randomized_controlled_trials)))))
    (VP (VBD were)
      (VP (VBN conducted)))
    (. .)))

det(review-3, A-1)
amod(review-3, systematic-2)
nsubjpass(conducted-9, review-3)
cc(review-3, and-4)
conj:and(review-3, meta-analysis-5)
nsubjpass(conducted-9, meta-analysis-5)
case(randomized_controlled_trials-7, of-6)
nmod:of(meta-analysis-5, randomized_controlled_trials-7)
auxpass(conducted-9, were-8)
root(ROOT-0, conducted-9)

We/PRP found/VBD that/IN cilansetron/NN reduced/VBD the/DT risk/NN of/IN colonic_inertia/NN in/IN patients/NNS with/IN HF/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NN cilansetron))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN colonic_inertia))))
            (PP (IN in)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (NNP HF)))))
            (PP (IN by)
              (NP
                (NP (CD 21) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                      (: :)
                      (NP
                        (QP (CD 0.67-0) (CD .93)))))
                  (-RRB- -RRB-))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(reduced-5, that-3)
nsubj(reduced-5, cilansetron-4)
ccomp(found-2, reduced-5)
det(risk-7, the-6)
dobj(reduced-5, risk-7)
case(colonic_inertia-9, of-8)
nmod:of(risk-7, colonic_inertia-9)
case(patients-11, in-10)
nmod:in(reduced-5, patients-11)
case(HF-13, with-12)
nmod:with(patients-11, HF-13)
case(%-16, by-14)
nummod(%-16, 21-15)
nmod:by(reduced-5, %-16)
amod(-RSB--22, relative-18)
compound(-RSB--22, risk-19)
compound(-RSB--22, -LSB--20)
compound(-RSB--22, RR-21)
dep(%-16, -RSB--22)
nummod(-RSB--32, 0.79-24)
nummod(-RSB--32, 95-26)
compound(-RSB--32, %-27)
compound(-RSB--32, confidence-28)
amod(-RSB--32, interval-29)
amod(-RSB--32, -LSB--30)
compound(-RSB--32, CI-31)
dep(-RSB--22, -RSB--32)
compound(.93-35, 0.67-0-34)
dep(-RSB--32, .93-35)

These/DT results/NNS suggest/VBP that/IN cilansetron/NN may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN colonic_inertia/NN in/IN HF/NNP patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cilansetron))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NN colonic_inertia))
                    (PP (IN in)
                      (NP (NNP HF) (NNS patients)))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, cilansetron-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(colonic_inertia-13, for-12)
nmod:for(option-11, colonic_inertia-13)
case(patients-16, in-14)
compound(patients-16, HF-15)
nmod:in(colonic_inertia-13, patients-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC to/TO explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN cilansetron/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS findings))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ beneficial) (NNS effects))
                      (PP (IN of)
                        (NP
                          (NP (NN cilansetron))
                          (PP (IN in)
                            (NP (DT this) (NN population))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
mark(explore-11, to-10)
ccomp(needed-4, explore-11)
conj:and(confirm-6, explore-11)
det(mechanisms-14, the-12)
amod(mechanisms-14, potential-13)
dobj(explore-11, mechanisms-14)
acl(mechanisms-14, underlying-15)
det(effects-18, the-16)
amod(effects-18, beneficial-17)
dobj(underlying-15, effects-18)
case(cilansetron-20, of-19)
nmod:of(effects-18, cilansetron-20)
case(population-23, in-21)
det(population-23, this-22)
nmod:in(cilansetron-20, population-23)

The/DT organochlorine/JJ pesticide/NN DDT/NN and/CC its/PRP$ metabolites/NNS ,/, including/VBG DDE/NNP ,/, have/VBP been/VBN shown/VBN to/TO cause/VB a/DT wide/JJ range/NN of/IN toxic/JJ effects/NNS in/IN both/DT animals/NNS and/CC humans/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (JJ organochlorine) (NN pesticide) (NN DDT))
        (CC and)
        (NP (PRP$ its) (NNS metabolites)))
      (, ,)
      (VP (VBG including)
        (NP (NNP DDE)))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB cause)
                (NP
                  (NP (DT a) (JJ wide) (NN range))
                  (PP (IN of)
                    (NP
                      (NP (JJ toxic) (NNS effects))
                      (PP (IN in)
                        (NP (DT both) (NNS animals)
                          (CC and)
                          (NNS humans))))))))))))
    (. .)))

det(DDT-4, The-1)
amod(DDT-4, organochlorine-2)
compound(DDT-4, pesticide-3)
nsubjpass(shown-14, DDT-4)
nsubj:xsubj(cause-16, DDT-4)
cc(DDT-4, and-5)
nmod:poss(metabolites-7, its-6)
conj:and(DDT-4, metabolites-7)
nsubjpass(shown-14, metabolites-7)
nsubj:xsubj(cause-16, metabolites-7)
acl(DDT-4, including-9)
dobj(including-9, DDE-10)
aux(shown-14, have-12)
auxpass(shown-14, been-13)
root(ROOT-0, shown-14)
mark(cause-16, to-15)
xcomp(shown-14, cause-16)
det(range-19, a-17)
amod(range-19, wide-18)
dobj(cause-16, range-19)
case(effects-22, of-20)
amod(effects-22, toxic-21)
nmod:of(range-19, effects-22)
case(animals-25, in-23)
cc:preconj(animals-25, both-24)
nmod:in(effects-22, animals-25)
cc(animals-25, and-26)
nmod:in(effects-22, humans-27)
conj:and(animals-25, humans-27)

Among/IN these/DT metabolites/NNS ,/, 3-methylsulfonyl-DDE/JJ has_been/NN identified/VBD as/IN a/DT major/JJ component/NN of/IN human/JJ serum/NN and/CC adipose_tissue/NN ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these) (NNS metabolites)))
    (, ,)
    (NP (JJ 3-methylsulfonyl-DDE) (NN has_been))
    (VP (VBD identified)
      (PP (IN as)
        (NP
          (NP (DT a) (JJ major) (NN component))
          (PP (IN of)
            (NP (JJ human) (NN serum)
              (CC and)
              (NN adipose_tissue))))))
    (. .)))

case(metabolites-3, Among-1)
det(metabolites-3, these-2)
nmod:among(identified-7, metabolites-3)
amod(has_been-6, 3-methylsulfonyl-DDE-5)
nsubj(identified-7, has_been-6)
root(ROOT-0, identified-7)
case(component-11, as-8)
det(component-11, a-9)
amod(component-11, major-10)
nmod:as(identified-7, component-11)
case(serum-14, of-12)
amod(serum-14, human-13)
nmod:of(component-11, serum-14)
cc(serum-14, and-15)
nmod:of(component-11, adipose_tissue-16)
conj:and(serum-14, adipose_tissue-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN 3-methylsulfonyl-DDE/JJ on/IN body/NN weight/NN ,/, villus/JJ height/NN ,/, villus/JJ surface/NN area/NN ,/, plasma/NN concentration/NN of/IN 3-methylsulfonyl-DDE/JJ ,/, and/CC expression/NN of/IN CYP11B1/2/NNP in/IN rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP
              (ADJP (JJ 3-methylsulfonyl-DDE)
                (PP (IN on)
                  (NP (NN body))))
              (NN weight))
            (, ,)
            (NP
              (NP (JJ villus) (NN height))
              (, ,)
              (NP (JJ villus) (NN surface) (NN area)))
            (, ,)
            (NP
              (NP (NN plasma) (NN concentration))
              (PP (IN of)
                (NP (JJ 3-methylsulfonyl-DDE))))
            (, ,)
            (CC and)
            (NP
              (NP (NN expression))
              (PP (IN of)
                (NP (NNP CYP11B1/2)))))))
      (PP (IN in)
        (NP (NNS rats))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(weight-13, of-9)
amod(weight-13, 3-methylsulfonyl-DDE-10)
case(body-12, on-11)
nmod:on(3-methylsulfonyl-DDE-10, body-12)
nmod:of(effects-8, weight-13)
amod(height-16, villus-15)
nmod:of(effects-8, height-16)
conj:and(weight-13, height-16)
amod(area-20, villus-18)
compound(area-20, surface-19)
appos(height-16, area-20)
compound(concentration-23, plasma-22)
nmod:of(effects-8, concentration-23)
conj:and(weight-13, concentration-23)
case(3-methylsulfonyl-DDE-25, of-24)
nmod:of(concentration-23, 3-methylsulfonyl-DDE-25)
cc(weight-13, and-27)
nmod:of(effects-8, expression-28)
conj:and(weight-13, expression-28)
case(CYP11B1/2-30, of-29)
nmod:of(expression-28, CYP11B1/2-30)
case(rats-32, in-31)
nmod:in(investigated-6, rats-32)

Our/PRP$ results/NNS showed/VBD that/IN the/DT intervention/NN with/IN 3-methylsulfonyl-DDE/JJ led/VBN to/TO a/DT significant/JJ decrease/NN in/IN body/NN weight/NN ,/, villus/VBZ height/NN ,/, and/CC villus/VBZ surface/NN area/NN compared/VBN to/TO the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN intervention))
            (PP (IN with)
              (NP (JJ 3-methylsulfonyl-DDE)
                (ADJP (VBN led)
                  (PP (TO to)
                    (NP
                      (NP (DT a) (JJ significant) (NN decrease))
                      (PP (IN in)
                        (NP (NN body))))))
                (NN weight)))
            (, ,))
          (VP
            (VP (VBZ villus)
              (NP (NN height)))
            (, ,)
            (CC and)
            (VP (VBZ villus)
              (NP (NN surface) (NN area))
              (PP (VBN compared)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN control) (NN group))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.01)))
                      (-RRB- -RRB-))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(villus-18, that-4)
det(intervention-6, the-5)
nsubj(villus-18, intervention-6)
nsubj(villus-22, intervention-6)
case(weight-16, with-7)
amod(weight-16, 3-methylsulfonyl-DDE-8)
amod(weight-16, led-9)
case(decrease-13, to-10)
det(decrease-13, a-11)
amod(decrease-13, significant-12)
nmod:to(led-9, decrease-13)
case(body-15, in-14)
nmod:in(decrease-13, body-15)
nmod:with(intervention-6, weight-16)
ccomp(showed-3, villus-18)
dobj(villus-18, height-19)
cc(villus-18, and-21)
ccomp(showed-3, villus-22)
conj:and(villus-18, villus-22)
compound(area-24, surface-23)
dobj(villus-22, area-24)
case(group-29, compared-25)
mwe(compared-25, to-26)
det(group-29, the-27)
compound(group-29, control-28)
advcl(villus-22, group-29)
appos(group-29, P-31)
compound(0.01-33, <-32)
nummod(P-31, 0.01-33)

However/RB ,/, the/DT plasma/NN concentration/NN of/IN 3-methylsulfonyl-DDE/JJ and/CC expression/NN of/IN CYP11B1/2/NNP in/IN the/DT intervened/VBN group/NN had/VBD recovered/VBN to/TO normal/JJ levels/NNS -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP
        (NP (DT the) (NN plasma) (NN concentration))
        (PP (IN of)
          (NP (JJ 3-methylsulfonyl-DDE))))
      (CC and)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP (NNP CYP11B1/2)))
        (PP (IN in)
          (NP (DT the) (VBN intervened) (NN group)))))
    (VP (VBD had)
      (VP (VBN recovered)
        (PP (TO to)
          (NP
            (NP (JJ normal) (NNS levels))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD >) (CD 0.05)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(recovered-17, However-1)
det(concentration-5, the-3)
compound(concentration-5, plasma-4)
nsubj(recovered-17, concentration-5)
case(3-methylsulfonyl-DDE-7, of-6)
nmod:of(concentration-5, 3-methylsulfonyl-DDE-7)
cc(concentration-5, and-8)
conj:and(concentration-5, expression-9)
nsubj(recovered-17, expression-9)
case(CYP11B1/2-11, of-10)
nmod:of(expression-9, CYP11B1/2-11)
case(group-15, in-12)
det(group-15, the-13)
amod(group-15, intervened-14)
nmod:in(expression-9, group-15)
aux(recovered-17, had-16)
root(ROOT-0, recovered-17)
case(levels-20, to-18)
amod(levels-20, normal-19)
nmod:to(recovered-17, levels-20)
appos(levels-20, P-22)
compound(0.05-24, >-23)
nummod(P-22, 0.05-24)

These/DT findings/NNS suggest/VBP that/IN exposure/NN to/TO 3-methylsulfonyl-DDE/JJ may/MD cause/VB adverse/JJ effects/NNS on/IN intestinal/JJ morphology/NN and/CC body/NN weight/NN in/IN rats/NNS but/CC may/MD not/RB lead/VB to/TO long-lasting/JJ changes/NNS in/IN plasma/NN concentration/NN or/CC gene/NN expression/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN exposure))
            (PP (TO to)
              (NP (JJ 3-methylsulfonyl-DDE))))
          (VP
            (VP (MD may)
              (VP (VB cause)
                (NP
                  (NP (JJ adverse) (NNS effects))
                  (PP (IN on)
                    (NP
                      (NP (JJ intestinal) (NN morphology))
                      (CC and)
                      (NP (NN body) (NN weight)))))
                (PP (IN in)
                  (NP (NNS rats)))))
            (CC but)
            (VP (MD may) (RB not)
              (VP (VB lead)
                (PP (TO to)
                  (NP
                    (NP (JJ long-lasting) (NNS changes))
                    (PP (IN in)
                      (NP
                        (NP (NN plasma) (NN concentration))
                        (CC or)
                        (NP (NN gene) (NN expression))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(cause-9, that-4)
nsubj(cause-9, exposure-5)
nsubj(lead-23, exposure-5)
case(3-methylsulfonyl-DDE-7, to-6)
nmod:to(exposure-5, 3-methylsulfonyl-DDE-7)
aux(cause-9, may-8)
ccomp(suggest-3, cause-9)
amod(effects-11, adverse-10)
dobj(cause-9, effects-11)
case(morphology-14, on-12)
amod(morphology-14, intestinal-13)
nmod:on(effects-11, morphology-14)
cc(morphology-14, and-15)
compound(weight-17, body-16)
nmod:on(effects-11, weight-17)
conj:and(morphology-14, weight-17)
case(rats-19, in-18)
nmod:in(cause-9, rats-19)
cc(cause-9, but-20)
aux(lead-23, may-21)
neg(lead-23, not-22)
ccomp(suggest-3, lead-23)
conj:but(cause-9, lead-23)
case(changes-26, to-24)
amod(changes-26, long-lasting-25)
nmod:to(lead-23, changes-26)
case(concentration-29, in-27)
compound(concentration-29, plasma-28)
nmod:in(changes-26, concentration-29)
cc(concentration-29, or-30)
compound(expression-32, gene-31)
nmod:in(changes-26, expression-32)
conj:or(concentration-29, expression-32)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT potential/JJ health/NN risks/NNS associated/VBN with/IN exposure/NN to/TO this/DT compound/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ potential) (NN health) (NNS risks))
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (NN exposure))
                      (PP (TO to)
                        (NP (DT this) (NN compound))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(risks-10, the-7)
amod(risks-10, potential-8)
compound(risks-10, health-9)
dobj(determine-6, risks-10)
acl(risks-10, associated-11)
case(exposure-13, with-12)
nmod:with(associated-11, exposure-13)
case(compound-16, to-14)
det(compound-16, this-15)
nmod:to(exposure-13, compound-16)

Dendritic/JJ cells/NNS -LRB-/-LRB- DCs/NNP -RRB-/-RRB- are/VBP a/DT type/NN of/IN immune/JJ cell/NN that/WDT play/VBP a/DT crucial/JJ role/NN in/IN the/DT initiation/NN and/CC regulation/NN of/IN immune/JJ responses/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Dendritic) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP (NNP DCs))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN type))
        (PP (IN of)
          (NP (JJ immune) (NN cell)))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN initiation))
                    (CC and)
                    (NP
                      (NP (NN regulation))
                      (PP (IN of)
                        (NP (JJ immune) (NNS responses))))))))))))
    (. .)))

amod(cells-2, Dendritic-1)
nsubj(type-8, cells-2)
appos(cells-2, DCs-4)
cop(type-8, are-6)
det(type-8, a-7)
root(ROOT-0, type-8)
nsubj(play-13, type-8)
case(cell-11, of-9)
amod(cell-11, immune-10)
nmod:of(type-8, cell-11)
ref(type-8, that-12)
acl:relcl(type-8, play-13)
det(role-16, a-14)
amod(role-16, crucial-15)
dobj(play-13, role-16)
case(initiation-19, in-17)
det(initiation-19, the-18)
nmod:in(role-16, initiation-19)
cc(initiation-19, and-20)
nmod:in(role-16, regulation-21)
conj:and(initiation-19, regulation-21)
case(responses-24, of-22)
amod(responses-24, immune-23)
nmod:of(regulation-21, responses-24)

Among/IN DC/NNP subsets/NNS ,/, conventional/JJ type_2/JJ dendritic/JJ cells/NNS -LRB-/-LRB- cDC2s/JJ -RRB-/-RRB- are/VBP known/VBN to_be/RB important/JJ for/IN the/DT activation/NN of/IN T_cells/NNP ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (NNP DC) (NNS subsets)))
    (, ,)
    (NP
      (NP (JJ conventional) (JJ type_2) (JJ dendritic) (NNS cells))
      (PRN (-LRB- -LRB-) (JJ cDC2s) (-RRB- -RRB-)))
    (VP (VBP are)
      (VP (VBN known)
        (ADJP (RB to_be) (JJ important))
        (PP (IN for)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (NNP T_cells)))))))
    (. .)))

case(subsets-3, Among-1)
compound(subsets-3, DC-2)
nmod:among(known-13, subsets-3)
amod(cells-8, conventional-5)
amod(cells-8, type_2-6)
amod(cells-8, dendritic-7)
nsubjpass(known-13, cells-8)
dep(cells-8, cDC2s-10)
auxpass(known-13, are-12)
root(ROOT-0, known-13)
advmod(important-15, to_be-14)
xcomp(known-13, important-15)
case(activation-18, for-16)
det(activation-18, the-17)
nmod:for(known-13, activation-18)
case(T_cells-20, of-19)
nmod:of(activation-18, T_cells-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN AG-024322/NNP ,/, a/DT novel/NN compound/NN with/IN potential/JJ immunomodulatory/JJ activity/NN ,/, on/IN cDC2/JJ levels/NNS in/IN vitro/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP AG-024322))
            (, ,)
            (NP (DT a) (NN novel) (NN compound)))))
      (PP (IN with)
        (NP (JJ potential) (JJ immunomodulatory) (NN activity)))
      (, ,)
      (PP (IN on)
        (NP
          (NP (JJ cDC2) (NNS levels))
          (PP (IN in)
            (NP (NN vitro))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(AG-024322-10, of-9)
nmod:of(effect-8, AG-024322-10)
det(compound-14, a-12)
compound(compound-14, novel-13)
appos(AG-024322-10, compound-14)
case(activity-18, with-15)
amod(activity-18, potential-16)
amod(activity-18, immunomodulatory-17)
nmod:with(investigated-6, activity-18)
case(levels-22, on-20)
amod(levels-22, cDC2-21)
nmod:on(investigated-6, levels-22)
case(vitro-24, in-23)
nmod:in(levels-22, vitro-24)

Our/PRP$ results/NNS showed/VBD that/IN the/DT cDC2/JJ level/NN of/IN the/DT non-transfected/JJ AG-024322/NN group/NN was/VBD significantly/RB lower/JJR than/IN the/DT non-transfected/JJ non-AG-024322/JJ group/NN

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (JJ cDC2) (NN level))
            (PP (IN of)
              (NP (DT the) (JJ non-transfected) (NN AG-024322) (NN group))))
          (VP (VBD was)
            (ADJP
              (ADJP (RB significantly) (JJR lower))
              (PP (IN than)
                (NP (DT the) (JJ non-transfected) (JJ non-AG-024322) (NN group))))))))))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(lower-15, that-4)
det(level-7, the-5)
amod(level-7, cDC2-6)
nsubj(lower-15, level-7)
case(group-12, of-8)
det(group-12, the-9)
amod(group-12, non-transfected-10)
compound(group-12, AG-024322-11)
nmod:of(level-7, group-12)
cop(lower-15, was-13)
advmod(lower-15, significantly-14)
ccomp(showed-3, lower-15)
case(group-20, than-16)
det(group-20, the-17)
amod(group-20, non-transfected-18)
amod(group-20, non-AG-024322-19)
nmod:than(lower-15, group-20)

-LSB-/NNP -LRB-/-LRB- 352/CD ±/NNP 26/CD -RRB-/-RRB- vs/VBP -LRB-/-LRB- 765/CD ±/VBP 22/CD -RRB-/-RRB- ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RSB-/CD ,/, indicating/VBG a/DT potential/JJ inhibitory/JJ effect/NN of/IN AG-024322/NN on/IN cDC2/JJ differentiation/NN or/CC survival/NN ./.

(ROOT
  (S
    (NP (NNP -LSB-) (-LRB- -LRB-)
      (NP (CD 352) (NNP ±) (CD 26))
      (-RRB- -RRB-))
    (VP (VBP vs)
      (ADJP
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 765))
            (VP (VBP ±)
              (NP (CD 22))))
          (-RRB- -RRB-))
        (JJ ng/L))
      (PRN (, ,)
        (S
          (NP (NNP P))
          (VP (VBP <)
            (NP
              (QP (CD 0.001) (CD -RSB-)))))
        (, ,))
      (S
        (VP (VBG indicating)
          (NP
            (NP (DT a) (JJ potential) (JJ inhibitory) (NN effect))
            (PP (IN of)
              (NP (NN AG-024322))))
          (PP (IN on)
            (NP (JJ cDC2) (NN differentiation)
              (CC or)
              (NN survival))))))
    (. .)))

nsubj(vs-7, -LSB--1)
nummod(±-4, 352-3)
dep(-LSB--1, ±-4)
nummod(±-4, 26-5)
root(ROOT-0, vs-7)
nsubj(±-10, 765-9)
dep(ng/L-13, ±-10)
dobj(±-10, 22-11)
xcomp(vs-7, ng/L-13)
nsubj(<-16, P-15)
parataxis(vs-7, <-16)
compound(-RSB--18, 0.001-17)
dobj(<-16, -RSB--18)
xcomp(vs-7, indicating-20)
det(effect-24, a-21)
amod(effect-24, potential-22)
amod(effect-24, inhibitory-23)
dobj(indicating-20, effect-24)
case(AG-024322-26, of-25)
nmod:of(effect-24, AG-024322-26)
case(differentiation-29, on-27)
amod(differentiation-29, cDC2-28)
nmod:on(indicating-20, differentiation-29)
cc(differentiation-29, or-30)
nmod:on(indicating-20, survival-31)
conj:or(differentiation-29, survival-31)

However/RB ,/, we/PRP found/VBD no/DT significant/JJ difference/NN in/IN cDC2/JJ levels/NNS between/IN transfected/JJ AG-024322/NN and/CC transfected/JJ non-AG-024322/JJ groups/NNS ,/, suggesting/VBG that/IN AG-024322/NNP may/MD not/RB affect/VB cDC2/JJ function/NN once/IN they/PRP are/VBP fully/RB differentiated/VBN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (JJ cDC2) (NNS levels)))
        (PP (IN between)
          (NP
            (NP (JJ transfected) (NN AG-024322))
            (CC and)
            (NP (JJ transfected) (JJ non-AG-024322) (NNS groups)))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (NNP AG-024322))
              (VP (MD may) (RB not)
                (VP (VB affect)
                  (NP (JJ cDC2) (NN function))
                  (SBAR (IN once)
                    (S
                      (NP (PRP they))
                      (VP (VBP are)
                        (VP
                          (ADVP (RB fully))
                          (VBN differentiated))))))))))))
    (. .)))

advmod(found-4, However-1)
nsubj(found-4, we-3)
root(ROOT-0, found-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
dobj(found-4, difference-7)
case(levels-10, in-8)
amod(levels-10, cDC2-9)
nmod:in(difference-7, levels-10)
case(AG-024322-13, between-11)
amod(AG-024322-13, transfected-12)
nmod:between(difference-7, AG-024322-13)
cc(AG-024322-13, and-14)
amod(groups-17, transfected-15)
amod(groups-17, non-AG-024322-16)
nmod:between(difference-7, groups-17)
conj:and(AG-024322-13, groups-17)
advcl(found-4, suggesting-19)
mark(affect-24, that-20)
nsubj(affect-24, AG-024322-21)
aux(affect-24, may-22)
neg(affect-24, not-23)
ccomp(suggesting-19, affect-24)
amod(function-26, cDC2-25)
dobj(affect-24, function-26)
mark(differentiated-31, once-27)
nsubjpass(differentiated-31, they-28)
auxpass(differentiated-31, are-29)
advmod(differentiated-31, fully-30)
advcl(affect-24, differentiated-31)

These/DT findings/NNS provide/VBP insights/NNS into/IN the/DT potential/JJ immunomodulatory/JJ properties/NNS of/IN AG-024322/NN and/CC warrant/VBP further/JJ investigation/NN into/IN its/PRP$ mechanism/NN of/IN action/NN and/CC therapeutic/JJ potential/NN for/IN immune-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ potential) (JJ immunomodulatory) (NNS properties))
            (PP (IN of)
              (NP (NN AG-024322))))))
      (CC and)
      (VP (VBP warrant)
        (NP
          (NP (JJ further) (NN investigation))
          (PP (IN into)
            (NP
              (NP
                (NP (PRP$ its) (NN mechanism))
                (PP (IN of)
                  (NP (NN action))))
              (CC and)
              (NP
                (NP (JJ therapeutic) (NN potential))
                (PP (IN for)
                  (NP (NNS immune-related_disorders)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(warrant-13, findings-2)
root(ROOT-0, provide-3)
dobj(provide-3, insights-4)
case(properties-9, into-5)
det(properties-9, the-6)
amod(properties-9, potential-7)
amod(properties-9, immunomodulatory-8)
nmod:into(provide-3, properties-9)
case(AG-024322-11, of-10)
nmod:of(properties-9, AG-024322-11)
cc(provide-3, and-12)
conj:and(provide-3, warrant-13)
amod(investigation-15, further-14)
dobj(warrant-13, investigation-15)
case(mechanism-18, into-16)
nmod:poss(mechanism-18, its-17)
nmod:into(investigation-15, mechanism-18)
case(action-20, of-19)
nmod:of(mechanism-18, action-20)
cc(mechanism-18, and-21)
amod(potential-23, therapeutic-22)
nmod:into(investigation-15, potential-23)
conj:and(mechanism-18, potential-23)
case(immune-related_disorders-25, for-24)
nmod:for(potential-23, immune-related_disorders-25)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN linked/VBN to/TO various/JJ health/NN benefits/NNS ,/, including/VBG reduced/VBN risk/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN linked)
                  (PP (TO to)
                    (NP
                      (NP (JJ various) (NN health) (NNS benefits))
                      (, ,)
                      (VP (VBG including)
                        (NP
                          (NP (VBN reduced) (NN risk))
                          (PP (IN of)
                            (NP (NN cardiovascular_disease))))))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(linked-8, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
aux(linked-8, have-6)
auxpass(linked-8, been-7)
acl:relcl(polyunsaturated_fatty_acids-4, linked-8)
case(benefits-12, to-9)
amod(benefits-12, various-10)
compound(benefits-12, health-11)
nmod:to(linked-8, benefits-12)
acl(benefits-12, including-14)
amod(risk-16, reduced-15)
dobj(including-14, risk-16)
case(cardiovascular_disease-18, of-17)
nmod:of(risk-16, cardiovascular_disease-18)

Eicosapentaenoic_acid/NNP -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- are/VBP long-chain/JJ omega-3_fatty_acids/NNS that/WDT have/VBP been/VBN shown/VBN to/TO decrease/VB 5,7-Dihydroxytryptamine/JJ levels/NNS in/IN hyper5,7-Dihydroxytryptaminemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP Eicosapentaenoic_acid))
          (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (JJ long-chain) (NNS omega-3_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB decrease)
                        (NP
                          (NP (JJ 5,7-Dihydroxytryptamine) (NNS levels))
                          (PP (IN in)
                            (NP (JJ hyper5,7-Dihydroxytryptaminemic) (NNS patients))))))))))))))
    (. .)))

nsubj(omega-3_fatty_acids-12, Eicosapentaenoic_acid-1)
dep(Eicosapentaenoic_acid-1, EPA-3)
cc(Eicosapentaenoic_acid-1, and-5)
conj:and(Eicosapentaenoic_acid-1, docosahexaenoic_acid-6)
nsubj(omega-3_fatty_acids-12, docosahexaenoic_acid-6)
appos(Eicosapentaenoic_acid-1, DHA-8)
cop(omega-3_fatty_acids-12, are-10)
amod(omega-3_fatty_acids-12, long-chain-11)
root(ROOT-0, omega-3_fatty_acids-12)
nsubjpass(shown-16, omega-3_fatty_acids-12)
nsubj:xsubj(decrease-18, omega-3_fatty_acids-12)
ref(omega-3_fatty_acids-12, that-13)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
acl:relcl(omega-3_fatty_acids-12, shown-16)
mark(decrease-18, to-17)
xcomp(shown-16, decrease-18)
amod(levels-20, 5,7-Dihydroxytryptamine-19)
dobj(decrease-18, levels-20)
case(patients-23, in-21)
amod(patients-23, hyper5,7-Dihydroxytryptaminemic-22)
nmod:in(levels-20, patients-23)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(associated-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(associated-7, fatty_acids-4)
aux(associated-7, have-5)
auxpass(associated-7, been-6)
root(ROOT-0, associated-7)
case(risk-11, with-8)
det(risk-11, a-9)
amod(risk-11, decreased-10)
nmod:with(associated-7, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

Several/JJ mechanisms/NNS have/VBP been/VBN proposed/VBN to/TO explain/VB the/DT cardioprotective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP ,/, including/VBG their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC modulate/VBP autonomic/JJ function/NN ./.

(ROOT
  (S
    (NP (JJ Several) (NNS mechanisms))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN proposed)
            (S
              (VP (TO to)
                (VP (VB explain)
                  (NP
                    (NP (DT the) (JJ cardioprotective) (NNS effects))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA)))
                    (, ,)
                    (VP (VBG including)
                      (NP (PRP$ their) (NN ability)
                        (S
                          (VP (TO to)
                            (VP
                              (VP (VB reduce)
                                (NP (NN inflammation)))
                              (, ,)
                              (VP (VB improve)
                                (NP (NN lipid) (NN metabolism)))))))))))))))
      (, ,)
      (CC and)
      (VP (VBP modulate)
        (NP (JJ autonomic) (NN function))))
    (. .)))

amod(mechanisms-2, Several-1)
nsubjpass(proposed-5, mechanisms-2)
nsubj:xsubj(explain-7, mechanisms-2)
nsubj(modulate-28, mechanisms-2)
aux(proposed-5, have-3)
auxpass(proposed-5, been-4)
root(ROOT-0, proposed-5)
mark(explain-7, to-6)
xcomp(proposed-5, explain-7)
det(effects-10, the-8)
amod(effects-10, cardioprotective-9)
dobj(explain-7, effects-10)
case(EPA-12, of-11)
nmod:of(effects-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(effects-10, DHA-14)
conj:and(EPA-12, DHA-14)
acl(effects-10, including-16)
nmod:poss(ability-18, their-17)
dobj(including-16, ability-18)
mark(reduce-20, to-19)
acl(ability-18, reduce-20)
dobj(reduce-20, inflammation-21)
dep(reduce-20, improve-23)
compound(metabolism-25, lipid-24)
dobj(improve-23, metabolism-25)
cc(proposed-5, and-27)
conj:and(proposed-5, modulate-28)
amod(function-30, autonomic-29)
dobj(modulate-28, function-30)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC other/JJ related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (JJ other) (NNS related_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, a-14)
amod(strategy-16, promising-15)
ccomp(suggest-3, strategy-16)
mark(preventing-18, for-17)
advcl(strategy-16, preventing-18)
dobj(preventing-18, CHD-19)
cc(CHD-19, and-20)
amod(related_disorders-22, other-21)
dobj(preventing-18, related_disorders-22)
conj:and(CHD-19, related_disorders-22)

Obesity/RB is_a/VBZ complex/JJ and/CC multifactorial/JJ disorder/NN that/WDT is/VBZ associated/VBN with/IN an/DT increased/VBN risk/NN of/IN various/JJ health/NN problems/NNS ./.

(ROOT
  (SINV
    (ADVP (RB Obesity))
    (VP (VBZ is_a))
    (NP
      (NP
        (ADJP (JJ complex)
          (CC and)
          (JJ multifactorial))
        (NN disorder))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ is)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (DT an) (VBN increased) (NN risk))
                  (PP (IN of)
                    (NP (JJ various) (NN health) (NNS problems))))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
amod(disorder-6, complex-3)
cc(complex-3, and-4)
conj:and(complex-3, multifactorial-5)
amod(disorder-6, multifactorial-5)
nsubj(is_a-2, disorder-6)
nsubjpass(associated-9, disorder-6)
ref(disorder-6, that-7)
auxpass(associated-9, is-8)
acl:relcl(disorder-6, associated-9)
case(risk-13, with-10)
det(risk-13, an-11)
amod(risk-13, increased-12)
nmod:with(associated-9, risk-13)
case(problems-17, of-14)
amod(problems-17, various-15)
compound(problems-17, health-16)
nmod:of(risk-13, problems-17)

The/DT hypersecretion/NN of/IN paternally_expressed_gene_3/NNS -LRB-/-LRB- PEG3/NNP -RRB-/-RRB- by/IN the/DT pancreas/NN has_been/NN suggested/VBD to/TO play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The) (NN hypersecretion))
          (PP (IN of)
            (NP (NNS paternally_expressed_gene_3))))
        (PRN (-LRB- -LRB-)
          (NP (NNP PEG3))
          (-RRB- -RRB-)))
      (PP (IN by)
        (NP (DT the) (NN pancreas) (NN has_been))))
    (VP (VBD suggested)
      (S
        (VP (TO to)
          (VP (VB play)
            (NP
              (NP (DT a) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity))))))))))
    (. .)))

det(hypersecretion-2, The-1)
nsubj(suggested-12, hypersecretion-2)
nsubj:xsubj(play-14, hypersecretion-2)
case(paternally_expressed_gene_3-4, of-3)
nmod:of(hypersecretion-2, paternally_expressed_gene_3-4)
appos(hypersecretion-2, PEG3-6)
case(has_been-11, by-8)
det(has_been-11, the-9)
compound(has_been-11, pancreas-10)
nmod:by(hypersecretion-2, has_been-11)
root(ROOT-0, suggested-12)
mark(play-14, to-13)
xcomp(suggested-12, play-14)
det(role-16, a-15)
dobj(play-14, role-16)
case(development-19, in-17)
det(development-19, the-18)
nmod:in(role-16, development-19)
case(obesity-21, of-20)
nmod:of(development-19, obesity-21)

To/TO evaluate/VB this/DT relationship/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ butantrone/NN on/IN the/DT secretion/NN of/IN PEG3/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP (DT this) (NN relationship)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN butantrone)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP PEG3) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-7, evaluate-2)
det(relationship-4, this-3)
dobj(evaluate-2, relationship-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(butantrone-17, 10-15)
amod(butantrone-17, mmol/L-16)
nmod:of(effects-9, butantrone-17)
conj:and(glucose-13, butantrone-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
compound(and_insulin-23, PEG3-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN PEG3/NNP secretion/NN was/VBD significantly/RB higher/JJR in/IN the/DT pancreata/NN from/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT glucose-stimulated/JJ and/CC non-stimulated/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP PEG3) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP (DT both)
                        (ADJP (JJ glucose-stimulated)
                          (CC and)
                          (JJ non-stimulated))
                        (NNS conditions)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-16, that-4)
compound(secretion-6, PEG3-5)
nsubjpass(compared-16, secretion-6)
nsubj:xsubj(lean-18, secretion-6)
auxpass(compared-16, was-7)
advmod(higher-9, significantly-8)
advmod(compared-16, higher-9)
case(pancreata-12, in-10)
det(pancreata-12, the-11)
nmod:in(higher-9, pancreata-12)
case(rats-15, from-13)
amod(rats-15, obese-14)
nmod:from(pancreata-12, rats-15)
ccomp(showed-3, compared-16)
mark(lean-18, to-17)
xcomp(compared-16, lean-18)
dobj(lean-18, rats-19)
case(conditions-25, under-20)
det(conditions-25, both-21)
amod(conditions-25, glucose-stimulated-22)
cc(glucose-stimulated-22, and-23)
conj:and(glucose-stimulated-22, non-stimulated-24)
amod(conditions-25, non-stimulated-24)
nmod:under(lean-18, conditions-25)

In/IN contrast/NN ,/, insulin_secretion/NN was/VBD significantly/RB lower/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN glucose-stimulated/JJ conditions/NNS but/CC not/RB under/IN non-stimulated/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was)
      (ADVP
        (ADVP (RB significantly) (JJR lower))
        (PP (IN in)
          (NP (JJ obese) (NNS rats))))
      (VP (VBN compared)
        (S
          (VP (TO to)
            (VP (VB lean)
              (NP (NNS rats))
              (PP (IN under)
                (NP (JJ glucose-stimulated) (NNS conditions)))
              (PRN (CC but)
                (ADVP (RB not))
                (PP (IN under)
                  (NP (JJ non-stimulated) (NNS conditions)))))))))
    (. .)))

case(contrast-2, In-1)
nmod:in(compared-11, contrast-2)
nsubjpass(compared-11, insulin_secretion-4)
nsubj:xsubj(lean-13, insulin_secretion-4)
auxpass(compared-11, was-5)
advmod(lower-7, significantly-6)
advmod(compared-11, lower-7)
case(rats-10, in-8)
amod(rats-10, obese-9)
nmod:in(lower-7, rats-10)
root(ROOT-0, compared-11)
mark(lean-13, to-12)
xcomp(compared-11, lean-13)
dobj(lean-13, rats-14)
case(conditions-17, under-15)
amod(conditions-17, glucose-stimulated-16)
nmod:under(lean-13, conditions-17)
cc(conditions-22, but-18)
dep(conditions-22, not-19)
case(conditions-22, under-20)
amod(conditions-22, non-stimulated-21)
dep(lean-13, conditions-22)

Treatment/NNP with/IN butantrone/NN ,/, an/DT inhibitor/NN of/IN PEG3/NNP secretion/NN ,/, significantly/RB reduced/VBD PEG3/NNP secretion/NN in/IN both/DT lean/JJ and/CC obese/JJ rats/NNS but/CC had/VBD no/DT effect/NN on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Treatment))
        (PP (IN with)
          (NP (NN butantrone))))
      (, ,)
      (NP
        (NP (DT an) (NN inhibitor))
        (PP (IN of)
          (NP (NNP PEG3) (NN secretion))))
      (, ,))
    (ADVP (RB significantly))
    (VP
      (VP (VBD reduced)
        (NP (NNP PEG3) (NN secretion))
        (PP (IN in)
          (NP (DT both)
            (ADJP (JJ lean)
              (CC and)
              (JJ obese))
            (NNS rats))))
      (CC but)
      (VP (VBD had)
        (NP
          (NP (DT no) (NN effect))
          (PP (IN on)
            (NP (NN insulin_secretion))))))
    (. .)))

nsubj(reduced-12, Treatment-1)
nsubj(had-22, Treatment-1)
case(butantrone-3, with-2)
nmod:with(Treatment-1, butantrone-3)
det(inhibitor-6, an-5)
appos(Treatment-1, inhibitor-6)
case(secretion-9, of-7)
compound(secretion-9, PEG3-8)
nmod:of(inhibitor-6, secretion-9)
advmod(reduced-12, significantly-11)
root(ROOT-0, reduced-12)
compound(secretion-14, PEG3-13)
dobj(reduced-12, secretion-14)
case(rats-20, in-15)
det(rats-20, both-16)
amod(rats-20, lean-17)
cc(lean-17, and-18)
conj:and(lean-17, obese-19)
amod(rats-20, obese-19)
nmod:in(reduced-12, rats-20)
cc(reduced-12, but-21)
conj:but(reduced-12, had-22)
neg(effect-24, no-23)
dobj(had-22, effect-24)
case(insulin_secretion-26, on-25)
nmod:on(effect-24, insulin_secretion-26)

These/DT findings/NNS suggest/VBP that/IN the/DT hypersecretion/NN of/IN PEG3/NNP by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN hypersecretion))
            (PP (IN of)
              (NP (NNP PEG3)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NN obesity)))))
              (, ,)
              (ADVP (RB possibly))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-13, that-4)
det(hypersecretion-6, the-5)
nsubj(contribute-13, hypersecretion-6)
case(PEG3-8, of-7)
nmod:of(hypersecretion-6, PEG3-8)
case(pancreas-11, by-9)
det(pancreas-11, the-10)
nmod:by(hypersecretion-6, pancreas-11)
aux(contribute-13, may-12)
ccomp(suggest-3, contribute-13)
case(development-16, to-14)
det(development-16, the-15)
nmod:to(contribute-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
advmod(effects-23, possibly-20)
case(effects-23, through-21)
nmod:poss(effects-23, its-22)
nmod:through(contribute-13, effects-23)
case(insulin_secretion-25, on-24)
nmod:on(effects-23, insulin_secretion-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ strategies/NNS for/IN targeting/VBG PEG3/NN in/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS strategies))
                  (PP (IN for)
                    (S
                      (VP (VBG targeting)
                        (NP (NN PEG3))
                        (PP (IN in)
                          (NP (JJ obesity) (NN management)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(strategies-13, potential-11)
amod(strategies-13, therapeutic-12)
dobj(elucidate-6, strategies-13)
conj:and(mechanisms-9, strategies-13)
mark(targeting-15, for-14)
acl(strategies-13, targeting-15)
dobj(targeting-15, PEG3-16)
case(management-19, in-17)
amod(management-19, obesity-18)
nmod:in(targeting-15, management-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to/TO have/VB beneficial/JJ effects/NNS in/IN hyperZD1611mic/JJ patients/NNS and/CC in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (VP (VBN found)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP
                    (NP (JJ beneficial) (NNS effects))
                    (PP (IN in)
                      (NP (JJ hyperZD1611mic) (NNS patients))))))))
          (CC and)
          (VP (IN in)
            (S
              (VP (VBG reducing)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

nsubjpass(found-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
mark(have-18, to-17)
xcomp(found-16, have-18)
amod(effects-20, beneficial-19)
dobj(have-18, effects-20)
case(patients-23, in-21)
amod(patients-23, hyperZD1611mic-22)
nmod:in(effects-20, patients-23)
cc(found-16, and-24)
conj:and(found-16, in-25)
xcomp(in-25, reducing-26)
det(risk-28, the-27)
dobj(reducing-26, risk-28)
mark(developing-30, of-29)
acl(risk-28, developing-30)
dobj(developing-30, coronary_heart_disease-31)
appos(risk-28, CHD-33)

In/IN particular/JJ ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN ZD1611/NN levels/NNS in/IN hyperZD1611mic/JJ patients/NNS ,/, providing/VBG a/DT potential/JJ therapeutic/JJ avenue/NN for/IN this/DT condition/NN ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NN ZD1611) (NNS levels))
              (PP (IN in)
                (NP (JJ hyperZD1611mic) (NNS patients)))))
          (, ,)
          (S
            (VP (VBG providing)
              (NP (DT a) (JJ potential) (JJ therapeutic) (NN avenue))
              (PP (IN for)
                (NP (DT this) (NN condition))))))))
    (. .)))

case(particular-2, In-1)
advcl(associated-8, particular-2)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(associated-8, omega-3_fatty_acids-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-12, with-9)
amod(levels-12, decreased-10)
compound(levels-12, ZD1611-11)
nmod:with(associated-8, levels-12)
case(patients-15, in-13)
amod(patients-15, hyperZD1611mic-14)
nmod:in(levels-12, patients-15)
xcomp(associated-8, providing-17)
det(avenue-21, a-18)
amod(avenue-21, potential-19)
amod(avenue-21, therapeutic-20)
dobj(providing-17, avenue-21)
case(condition-24, for-22)
det(condition-24, this-23)
nmod:for(providing-17, condition-24)

Additionally/RB ,/, research/NN has/VBZ shown/VBN that/IN EPA/NNP and/CC DHA/NNP intake/NN is/VBZ associated/VBN with/IN a/DT lower/JJR risk/NN of/IN CHD/NNP through/IN various/JJ mechanisms/NNS ,/, including/VBG reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC enhancing/VBG endothelial/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (ADJP (NNP EPA)
                (CC and)
                (NNP DHA))
              (NN intake))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT a) (JJR lower) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (PP (IN through)
                  (NP
                    (NP (JJ various) (NNS mechanisms))
                    (, ,)
                    (VP (VBG including)
                      (S
                        (VP
                          (VP (VBG reducing)
                            (NP (NN inflammation)))
                          (, ,)
                          (VP (VBG improving)
                            (NP (NN lipid) (NNS profiles)))
                          (, ,)
                          (CC and)
                          (VP (VBG enhancing)
                            (NP (JJ endothelial) (NN function))))))))))))))
    (. .)))

advmod(shown-5, Additionally-1)
nsubj(shown-5, research-3)
aux(shown-5, has-4)
root(ROOT-0, shown-5)
mark(associated-12, that-6)
amod(intake-10, EPA-7)
cc(EPA-7, and-8)
conj:and(EPA-7, DHA-9)
amod(intake-10, DHA-9)
nsubjpass(associated-12, intake-10)
auxpass(associated-12, is-11)
ccomp(shown-5, associated-12)
case(risk-16, with-13)
det(risk-16, a-14)
amod(risk-16, lower-15)
nmod:with(associated-12, risk-16)
case(CHD-18, of-17)
nmod:of(risk-16, CHD-18)
case(mechanisms-21, through-19)
amod(mechanisms-21, various-20)
nmod:through(associated-12, mechanisms-21)
acl(mechanisms-21, including-23)
ccomp(including-23, reducing-24)
dobj(reducing-24, inflammation-25)
ccomp(including-23, improving-27)
conj:and(reducing-24, improving-27)
compound(profiles-29, lipid-28)
dobj(improving-27, profiles-29)
cc(reducing-24, and-31)
ccomp(including-23, enhancing-32)
conj:and(reducing-24, enhancing-32)
amod(function-34, endothelial-33)
dobj(enhancing-32, function-34)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/NN intake/NN or/CC supplementation/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG and/CC managing/VBG cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN dietary) (NN intake)
              (CC or)
              (NN supplementation))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG preventing)
                      (CC and)
                      (VBG managing)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-17, that-4)
amod(intake-7, increasing-5)
compound(intake-7, dietary-6)
nsubj(strategy-17, intake-7)
cc(intake-7, or-8)
conj:or(intake-7, supplementation-9)
nsubj(strategy-17, supplementation-9)
case(omega-3_fatty_acids-12, of-10)
amod(omega-3_fatty_acids-12, long-chain-11)
nmod:of(intake-7, omega-3_fatty_acids-12)
aux(strategy-17, may-13)
cop(strategy-17, be-14)
det(strategy-17, a-15)
amod(strategy-17, promising-16)
ccomp(suggest-3, strategy-17)
mark(preventing-19, for-18)
acl(strategy-17, preventing-19)
cc(preventing-19, and-20)
acl(strategy-17, managing-21)
conj:and(preventing-19, managing-21)
dobj(preventing-19, cardiovascular_disease-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to/TO have/VB several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ several) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(found-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
mark(have-18, to-17)
xcomp(found-16, have-18)
amod(benefits-21, several-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN bis-benzimidazole/JJ levels/NNS in/IN hyperbis-benzimidazolemic/JJ patients/NNS ,/, which/WDT is/VBZ indicative/JJ of/IN a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ bis-benzimidazole) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperbis-benzimidazolemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (VBZ is)
                              (NP
                                (NP (JJ indicative))
                                (PP (IN of)
                                  (NP
                                    (NP
                                      (NP (DT a) (VBN reduced) (NN risk))
                                      (PP (IN of)
                                        (S
                                          (VP (VBG developing)
                                            (NP (NN coronary_heart_disease))))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, bis-benzimidazole-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperbis-benzimidazolemic-16)
nmod:in(levels-14, patients-17)
nsubj(indicative-21, patients-17)
ref(patients-17, which-19)
cop(indicative-21, is-20)
acl:relcl(patients-17, indicative-21)
case(risk-25, of-22)
det(risk-25, a-23)
amod(risk-25, reduced-24)
nmod:of(indicative-21, risk-25)
mark(developing-27, of-26)
acl(risk-25, developing-27)
dobj(developing-27, coronary_heart_disease-28)
appos(risk-25, CHD-30)

EPA/NNP and/CC DHA/NNP are/VBP essential/JJ fatty_acids/NNS that/WDT can/MD not/RB be/VB synthesized/VBN by/IN the/DT human/JJ body/NN and/CC must/MD be/VB obtained/VBN through/IN diet/NN or/CC supplementation/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP
      (VP (VBP are)
        (NP
          (NP (JJ essential) (NNS fatty_acids))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (MD can) (RB not)
                (VP (VB be)
                  (VP (VBN synthesized)
                    (PP (IN by)
                      (NP (DT the) (JJ human) (NN body))))))))))
      (CC and)
      (VP (MD must)
        (VP (VB be)
          (VP (VBN obtained)
            (PP (IN through)
              (NP (NN diet)
                (CC or)
                (NN supplementation)))))))
    (. .)))

nsubj(fatty_acids-6, EPA-1)
nsubjpass(obtained-19, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubj(fatty_acids-6, DHA-3)
cop(fatty_acids-6, are-4)
amod(fatty_acids-6, essential-5)
root(ROOT-0, fatty_acids-6)
nsubjpass(synthesized-11, fatty_acids-6)
ref(fatty_acids-6, that-7)
aux(synthesized-11, can-8)
neg(synthesized-11, not-9)
auxpass(synthesized-11, be-10)
acl:relcl(fatty_acids-6, synthesized-11)
case(body-15, by-12)
det(body-15, the-13)
amod(body-15, human-14)
nmod:by(synthesized-11, body-15)
cc(fatty_acids-6, and-16)
aux(obtained-19, must-17)
auxpass(obtained-19, be-18)
conj:and(fatty_acids-6, obtained-19)
nsubjpass(synthesized-11, obtained-19)
case(diet-21, through-20)
nmod:through(obtained-19, diet-21)
cc(diet-21, or-22)
nmod:through(obtained-19, supplementation-23)
conj:or(diet-21, supplementation-23)

The/DT anti-inflammatory/JJ properties/NNS of/IN these/DT fatty_acids/NNS may/MD contribute/VB to/TO their/PRP$ protective/JJ effects/NNS against/IN CHD/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ anti-inflammatory) (NNS properties))
      (PP (IN of)
        (NP (DT these) (NNS fatty_acids))))
    (VP (MD may)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (PRP$ their) (JJ protective) (NNS effects))
            (PP (IN against)
              (NP (NNP CHD)))))))
    (. .)))

det(properties-3, The-1)
amod(properties-3, anti-inflammatory-2)
nsubj(contribute-8, properties-3)
case(fatty_acids-6, of-4)
det(fatty_acids-6, these-5)
nmod:of(properties-3, fatty_acids-6)
aux(contribute-8, may-7)
root(ROOT-0, contribute-8)
case(effects-12, to-9)
nmod:poss(effects-12, their-10)
amod(effects-12, protective-11)
nmod:to(contribute-8, effects-12)
case(CHD-14, against-13)
nmod:against(effects-12, CHD-14)

Furthermore/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO decrease/VB triglyceride_levels/NNS ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB decrease)
                  (NP
                    (NP (NNS triglyceride_levels))
                    (, ,)
                    (NP (JJR lower) (NN blood_pressure))
                    (, ,)))
                (CC and)
                (VP (VB improve)
                  (NP-TMP (JJ endothelial) (NN function)))))))))
    (. .)))

advmod(shown-8, Furthermore-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(decrease-10, EPA-3)
nsubj:xsubj(improve-17, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(decrease-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(decrease-10, to-9)
xcomp(shown-8, decrease-10)
dobj(decrease-10, triglyceride_levels-11)
amod(blood_pressure-14, lower-13)
appos(triglyceride_levels-11, blood_pressure-14)
cc(decrease-10, and-16)
xcomp(shown-8, improve-17)
conj:and(decrease-10, improve-17)
amod(function-19, endothelial-18)
nmod:tmod(improve-17, function-19)

These/DT findings/NNS suggest/VBP that/IN incorporating/VBG foods/NNS rich/JJ in/IN omega-3_fatty_acids/JJ or/CC taking/VBG supplements/NNS may/MD be/VB a/DT viable/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN susceptible/JJ populations/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG incorporating) (NNS foods))
            (ADJP (JJ rich)
              (PP (IN in)
                (NP
                  (UCP (JJ omega-3_fatty_acids)
                    (CC or)
                    (VBG taking))
                  (NNS supplements)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ viable) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNP CHD))))
                      (PP (IN in)
                        (NP (JJ susceptible) (NNS populations))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-17, that-4)
amod(foods-6, incorporating-5)
nsubj(strategy-17, foods-6)
amod(foods-6, rich-7)
case(supplements-12, in-8)
amod(supplements-12, omega-3_fatty_acids-9)
cc(omega-3_fatty_acids-9, or-10)
conj:or(omega-3_fatty_acids-9, taking-11)
amod(supplements-12, taking-11)
nmod:in(rich-7, supplements-12)
aux(strategy-17, may-13)
cop(strategy-17, be-14)
det(strategy-17, a-15)
amod(strategy-17, viable-16)
ccomp(suggest-3, strategy-17)
mark(reducing-19, for-18)
acl(strategy-17, reducing-19)
det(risk-21, the-20)
dobj(reducing-19, risk-21)
case(CHD-23, of-22)
nmod:of(risk-21, CHD-23)
case(populations-26, in-24)
amod(populations-26, susceptible-25)
nmod:in(reducing-19, populations-26)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN human/JJ nutrition/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (JJ human) (NN nutrition)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(nutrition-19, of-17)
amod(nutrition-19, human-18)
nmod:of(components-16, nutrition-19)

These/DT long-chain_fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO have/VB a/DT positive/JJ impact/NN on/IN human/JJ health/NN ,/, including/VBG a/DT decrease/NN in/IN fluroxene/JJ levels/NNS in/IN hyperfluroxenemic/JJ patients/NNS and/CC a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS long-chain_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ positive) (NN impact))
                  (PP (IN on)
                    (NP (JJ human) (NN health)))
                  (, ,)
                  (VP (VBG including)
                    (NP
                      (NP (DT a) (NN decrease))
                      (PP (IN in)
                        (NP
                          (NP (JJ fluroxene) (NNS levels))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperfluroxenemic) (NNS patients))
                              (CC and)
                              (NP
                                (NP
                                  (NP (DT a) (VBN decreased) (NN risk))
                                  (PP (IN of)
                                    (S
                                      (VP (VBG developing)
                                        (NP (NN coronary_heart_disease))))))
                                (PRN (-LRB- -LRB-)
                                  (NP (NNP CHD))
                                  (-RRB- -RRB-))))))))))))))))
    (. .)))

det(long-chain_fatty_acids-2, These-1)
nsubjpass(shown-5, long-chain_fatty_acids-2)
nsubj:xsubj(have-7, long-chain_fatty_acids-2)
aux(shown-5, have-3)
auxpass(shown-5, been-4)
root(ROOT-0, shown-5)
mark(have-7, to-6)
xcomp(shown-5, have-7)
det(impact-10, a-8)
amod(impact-10, positive-9)
dobj(have-7, impact-10)
case(health-13, on-11)
amod(health-13, human-12)
nmod:on(impact-10, health-13)
acl(impact-10, including-15)
det(decrease-17, a-16)
dobj(including-15, decrease-17)
case(levels-20, in-18)
amod(levels-20, fluroxene-19)
nmod:in(decrease-17, levels-20)
case(patients-23, in-21)
amod(patients-23, hyperfluroxenemic-22)
nmod:in(levels-20, patients-23)
cc(patients-23, and-24)
det(risk-27, a-25)
amod(risk-27, decreased-26)
nmod:in(levels-20, risk-27)
conj:and(patients-23, risk-27)
mark(developing-29, of-28)
acl(risk-27, developing-29)
dobj(developing-29, coronary_heart_disease-30)
appos(risk-27, CHD-32)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO reduce/VB inflammation/NN ,/, improve/VB lipid/NN profiles/NNS ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP
              (VP (VB reduce)
                (NP (NN inflammation)))
              (, ,)
              (VP (VB improve)
                (NP (NN lipid) (NNS profiles)))
              (, ,)
              (CC and)
              (VP (VB enhance)
                (NP-TMP (JJ endothelial) (NN function))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(reduce-7, EPA-1)
nsubj:xsubj(improve-10, EPA-1)
nsubj:xsubj(enhance-15, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(reduce-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(reduce-7, to-6)
xcomp(known-5, reduce-7)
dobj(reduce-7, inflammation-8)
xcomp(known-5, improve-10)
conj:and(reduce-7, improve-10)
compound(profiles-12, lipid-11)
dobj(improve-10, profiles-12)
cc(reduce-7, and-14)
xcomp(known-5, enhance-15)
conj:and(reduce-7, enhance-15)
amod(function-17, endothelial-16)
nmod:tmod(enhance-15, function-17)

The/DT mechanisms/NNS underlying/VBG the/DT cardioprotective/JJ effects/NNS of/IN these/DT fatty_acids/NNS are/VBP complex/JJ and/CC involve/VBP multiple/JJ pathways/NNS ,/, including/VBG modulation/NN of/IN gene/NN expression/NN ,/, regulation/NN of/IN ion/NN channels/NNS ,/, and/CC activation/NN of/IN signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ cardioprotective) (NNS effects))
          (PP (IN of)
            (NP (DT these) (NNS fatty_acids))))))
    (VP
      (VP (VBP are)
        (ADJP (JJ complex)))
      (CC and)
      (VP (VBP involve)
        (NP
          (NP (JJ multiple) (NNS pathways))
          (, ,)
          (VP (VBG including)
            (NP
              (NP
                (NP (NN modulation))
                (PP (IN of)
                  (NP (NN gene) (NN expression))))
              (, ,)
              (NP
                (NP (NN regulation))
                (PP (IN of)
                  (NP (NN ion) (NNS channels))))
              (, ,)
              (CC and)
              (NP
                (NP (NN activation))
                (PP (IN of)
                  (NP (VBG signaling) (NNS pathways)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(complex-11, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, cardioprotective-5)
dobj(underlying-3, effects-6)
case(fatty_acids-9, of-7)
det(fatty_acids-9, these-8)
nmod:of(effects-6, fatty_acids-9)
cop(complex-11, are-10)
root(ROOT-0, complex-11)
cc(complex-11, and-12)
conj:and(complex-11, involve-13)
amod(pathways-15, multiple-14)
dobj(involve-13, pathways-15)
acl(pathways-15, including-17)
dobj(including-17, modulation-18)
case(expression-21, of-19)
compound(expression-21, gene-20)
nmod:of(modulation-18, expression-21)
dobj(including-17, regulation-23)
conj:and(modulation-18, regulation-23)
case(channels-26, of-24)
compound(channels-26, ion-25)
nmod:of(regulation-23, channels-26)
cc(modulation-18, and-28)
dobj(including-17, activation-29)
conj:and(modulation-18, activation-29)
case(pathways-32, of-30)
amod(pathways-32, signaling-31)
nmod:of(activation-29, pathways-32)

Several/JJ clinical/JJ trials/NNS have/VBP demonstrated/VBN the/DT beneficial/JJ effects/NNS of/IN omega-3_fatty_acids/JJ on/IN cardiovascular_health/NN ,/, including/VBG reductions/NNS in/IN cardiovascular_mortality/NN and/CC morbidity/NN ./.

(ROOT
  (S
    (NP (JJ Several) (JJ clinical) (NNS trials))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (NP
          (NP
            (NP (DT the) (JJ beneficial) (NNS effects))
            (PP (IN of)
              (NP (JJ omega-3_fatty_acids))))
          (PP (IN on)
            (NP (NN cardiovascular_health)))
          (, ,)
          (VP (VBG including)
            (NP
              (NP (NNS reductions))
              (PP (IN in)
                (NP (NN cardiovascular_mortality)
                  (CC and)
                  (NN morbidity))))))))
    (. .)))

amod(trials-3, Several-1)
amod(trials-3, clinical-2)
nsubj(demonstrated-5, trials-3)
aux(demonstrated-5, have-4)
root(ROOT-0, demonstrated-5)
det(effects-8, the-6)
amod(effects-8, beneficial-7)
dobj(demonstrated-5, effects-8)
case(omega-3_fatty_acids-10, of-9)
nmod:of(effects-8, omega-3_fatty_acids-10)
case(cardiovascular_health-12, on-11)
nmod:on(effects-8, cardiovascular_health-12)
acl(effects-8, including-14)
dobj(including-14, reductions-15)
case(cardiovascular_mortality-17, in-16)
nmod:in(reductions-15, cardiovascular_mortality-17)
cc(cardiovascular_mortality-17, and-18)
nmod:in(reductions-15, morbidity-19)
conj:and(cardiovascular_mortality-17, morbidity-19)

Therefore/RB ,/, the/DT inclusion/NN of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT diet/NN or/CC through/IN supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (DT the) (NN inclusion))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA)))
      (PP
        (PP (IN in)
          (NP (DT the) (NN diet)))
        (CC or)
        (PP (IN through)
          (NP (NN supplementation)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNP CHD))))))))))
    (. .)))

advmod(strategy-19, Therefore-1)
det(inclusion-4, the-3)
conj:or(inclusion-4, inclusion-4')
nsubj(strategy-19, inclusion-4)
nsubj(strategy-19, inclusion-4')
case(EPA-6, of-5)
nmod:of(inclusion-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(inclusion-4, DHA-8)
conj:and(EPA-6, DHA-8)
case(diet-11, in-9)
det(diet-11, the-10)
nmod:in(inclusion-4, diet-11)
cc(inclusion-4, or-12)
case(supplementation-14, through-13)
nmod:through(inclusion-4', supplementation-14)
aux(strategy-19, may-15)
cop(strategy-19, be-16)
det(strategy-19, an-17)
amod(strategy-19, effective-18)
root(ROOT-0, strategy-19)
mark(reducing-21, for-20)
acl(strategy-19, reducing-21)
det(risk-23, the-22)
dobj(reducing-21, risk-23)
case(CHD-25, of-24)
nmod:of(risk-23, CHD-25)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, lysergol/NN ,/, and/CC serum_albumin/NN levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN correlation))
              (PP (IN between)
                (NP
                  (NP (NN serum) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (NN alkaline_phosphatase))
                      (, ,)
                      (NP (NN lysergol))
                      (, ,)
                      (CC and)
                      (NP (NN serum_albumin) (NNS levels)))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(correlation-10, the-9)
dobj(investigate-8, correlation-10)
case(levels-13, between-11)
compound(levels-13, serum-12)
nmod:between(correlation-10, levels-13)
case(alkaline_phosphatase-15, of-14)
nmod:of(levels-13, alkaline_phosphatase-15)
nmod:of(levels-13, lysergol-17)
conj:and(alkaline_phosphatase-15, lysergol-17)
cc(alkaline_phosphatase-15, and-19)
compound(levels-21, serum_albumin-20)
nmod:of(levels-13, levels-21)
conj:and(alkaline_phosphatase-15, levels-21)

A/DT total/NN of/IN 200/CD participants/NNS were/VBD enrolled/VBN in/IN this/DT cross-sectional/JJ study/NN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (NN total))
      (PP (IN of)
        (NP (CD 200) (NNS participants))))
    (VP (VBD were)
      (VP (VBN enrolled)
        (PP (IN in)
          (NP (DT this) (JJ cross-sectional) (NN study)))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
case(participants-5, of-3)
nummod(participants-5, 200-4)
nmod:of(total-2, participants-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(study-11, in-8)
det(study-11, this-9)
amod(study-11, cross-sectional-10)
nmod:in(enrolled-7, study-11)

Serum/JJ levels/NNS of/IN alkaline_phosphatase/NN and/CC lysergol/NN were/VBD measured/VBN using/VBG standard/JJ laboratory/NN techniques/NNS ,/, while/IN serum_albumin/NN levels/NNS were/VBD determined/VBN by/IN the/DT bromocresol_green/NN method/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Serum) (NNS levels))
      (PP (IN of)
        (NP (NN alkaline_phosphatase)
          (CC and)
          (NN lysergol))))
    (VP (VBD were)
      (VP (VBN measured)
        (S
          (VP (VBG using)
            (NP (JJ standard) (NN laboratory) (NNS techniques))))
        (, ,)
        (SBAR (IN while)
          (S
            (NP (NN serum_albumin) (NNS levels))
            (VP (VBD were)
              (VP (VBN determined)
                (PP (IN by)
                  (NP (DT the) (NN bromocresol_green) (NN method)))))))))
    (. .)))

amod(levels-2, Serum-1)
nsubjpass(measured-8, levels-2)
case(alkaline_phosphatase-4, of-3)
nmod:of(levels-2, alkaline_phosphatase-4)
cc(alkaline_phosphatase-4, and-5)
nmod:of(levels-2, lysergol-6)
conj:and(alkaline_phosphatase-4, lysergol-6)
auxpass(measured-8, were-7)
root(ROOT-0, measured-8)
xcomp(measured-8, using-9)
amod(techniques-12, standard-10)
compound(techniques-12, laboratory-11)
dobj(using-9, techniques-12)
mark(determined-18, while-14)
compound(levels-16, serum_albumin-15)
nsubjpass(determined-18, levels-16)
auxpass(determined-18, were-17)
advcl(measured-8, determined-18)
case(method-22, by-19)
det(method-22, the-20)
compound(method-22, bromocresol_green-21)
nmod:by(determined-18, method-22)

The/DT results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ,/, lysergol/NN -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC serum_albumin/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN alkaline_phosphatase))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN lysergol))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP (NN serum_albumin) (NNS levels))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(alkaline_phosphatase-12, of-11)
nmod:of(levels-10, alkaline_phosphatase-12)
dep(<-19, r-14)
dep(0.3-16, =-15)
dep(<-19, 0.3-16)
nsubj(<-19, p-18)
dep(alkaline_phosphatase-12, <-19)
dobj(<-19, 0.01-20)
nmod:of(levels-10, lysergol-23)
conj:and(alkaline_phosphatase-12, lysergol-23)
dep(<-30, r-25)
dep(0.42-27, =-26)
dep(<-30, 0.42-27)
nsubj(<-30, p-29)
dep(lysergol-23, <-30)
dobj(<-30, 0.01-31)
cc(alkaline_phosphatase-12, and-33)
compound(levels-35, serum_albumin-34)
nmod:of(levels-10, levels-35)
conj:and(alkaline_phosphatase-12, levels-35)

These/DT findings/NNS suggest/VBP that/IN elevated/JJ levels/NNS of/IN alkaline_phosphatase/NN and/CC lysergol/NN may/MD be/VB associated/VBN with/IN decreased/VBN serum_albumin/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ elevated) (NNS levels))
            (PP (IN of)
              (NP (NN alkaline_phosphatase)
                (CC and)
                (NN lysergol))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (VBN decreased) (NN serum_albumin) (NNS levels)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(associated-13, that-4)
amod(levels-6, elevated-5)
nsubjpass(associated-13, levels-6)
case(alkaline_phosphatase-8, of-7)
nmod:of(levels-6, alkaline_phosphatase-8)
cc(alkaline_phosphatase-8, and-9)
nmod:of(levels-6, lysergol-10)
conj:and(alkaline_phosphatase-8, lysergol-10)
aux(associated-13, may-11)
auxpass(associated-13, be-12)
ccomp(suggest-3, associated-13)
case(levels-17, with-14)
amod(levels-17, decreased-15)
compound(levels-17, serum_albumin-16)
nmod:with(associated-13, levels-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT underlying/VBG mechanisms/NNS and/CC clinical/JJ implications/NNS of/IN these/DT correlations/NNS in/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS correlations))
                      (PP (IN in)
                        (NP (JJ different) (JJ patient) (NNS populations))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(explore-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(implications-12, clinical-11)
dobj(explore-6, implications-12)
conj:and(mechanisms-9, implications-12)
case(correlations-15, of-13)
det(correlations-15, these-14)
nmod:of(implications-12, correlations-15)
case(populations-19, in-16)
amod(populations-19, different-17)
amod(populations-19, patient-18)
nmod:in(correlations-15, populations-19)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(studied-25, have-22)
auxpass(studied-25, been-23)
advmod(studied-25, extensively-24)
root(ROOT-0, studied-25)
case(benefits-29, for-26)
nmod:poss(benefits-29, their-27)
compound(benefits-29, health-28)
nmod:for(studied-25, benefits-29)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN amygdalin/NN levels/NNS in/IN hyperamygdalinmic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN amygdalin) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperamygdalinmic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, amygdalin-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperamygdalinmic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
amod(risk-19, decreased-18)
nmod:in(levels-13, risk-19)
conj:and(patients-16, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, and/CC improve/VB lipid/NN profile/NN ,/, which/WDT are/VBP all/DT risk/NN factors/NNS for/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB reduce)
                  (NP
                    (NP (NN inflammation))
                    (, ,)
                    (NP (JJR lower) (NN blood_pressure))
                    (, ,)))
                (CC and)
                (VP (VB improve)
                  (NP
                    (NP (NN lipid) (NN profile))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP are)
                          (NP
                            (NP (DT all) (NN risk) (NNS factors))
                            (PP (IN for)
                              (NP (NNP CHD)))))))))))))))
    (. .)))

nsubjpass(shown-6, EPA-1)
nsubj:xsubj(reduce-8, EPA-1)
nsubj:xsubj(improve-15, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(shown-6, DHA-3)
nsubj:xsubj(reduce-8, DHA-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
mark(reduce-8, to-7)
xcomp(shown-6, reduce-8)
dobj(reduce-8, inflammation-9)
amod(blood_pressure-12, lower-11)
appos(inflammation-9, blood_pressure-12)
cc(reduce-8, and-14)
xcomp(shown-6, improve-15)
conj:and(reduce-8, improve-15)
compound(profile-17, lipid-16)
dobj(improve-15, profile-17)
nsubj(factors-23, profile-17)
ref(profile-17, which-19)
cop(factors-23, are-20)
det(factors-23, all-21)
compound(factors-23, risk-22)
acl:relcl(profile-17, factors-23)
case(CHD-25, for-24)
nmod:for(factors-23, CHD-25)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO modulate/VBP the/DT expression/NN of/IN genes/NNS involved/VBN in/IN lipid/NN metabolism/NN and/CC inflammation/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (PP (TO to))
          (SBAR
            (S
              (VP (VBP modulate)
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP
                      (NP (NNS genes))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NN lipid) (NN metabolism)
                            (CC and)
                            (NN inflammation)))))))))))))
    (. .)))

advmod(shown-8, Additionally-1)
nsubjpass(shown-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
nmod(shown-8, to-9)
ccomp(shown-8, modulate-10)
det(expression-12, the-11)
dobj(modulate-10, expression-12)
case(genes-14, of-13)
nmod:of(expression-12, genes-14)
acl(genes-14, involved-15)
case(metabolism-18, in-16)
compound(metabolism-18, lipid-17)
nmod:in(involved-15, metabolism-18)
cc(metabolism-18, and-19)
nmod:in(involved-15, inflammation-20)
conj:and(metabolism-18, inflammation-20)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP reduce/VB amygdalin/NN levels/NNS are/VBP not/RB fully/RB understood/VBN but/CC may/MD involve/VB their/PRP$ ability/NN to/TO modulate/VBP the/DT expression/NN of/IN genes/NNS involved/VBN in/IN amygdalin/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (SBAR
        (S
          (VP
            (VP
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))
                    (VP (VB reduce)
                      (NP (NN amygdalin) (NNS levels))))))
              (VBP are)
              (ADVP (RB not))
              (VP
                (ADVP (RB fully))
                (VBN understood)))
            (CC but)
            (VP (MD may)
              (VP (VB involve)
                (NP (PRP$ their) (NN ability)
                  (S
                    (VP (TO to))))))))))
    (VP (VBP modulate)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP
            (NP (NNS genes))
            (VP (VBN involved)
              (PP (IN in)
                (NP (NN amygdalin) (NN metabolism))))))))
    (. .)))

det(mechanisms-2, The-1)
dobj(reduce-8, mechanisms-2)
nsubj(modulate-21, mechanisms-2)
mark(reduce-8, by-3)
ref(mechanisms-2, which-4)
nsubj(reduce-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(reduce-8, DHA-7)
advcl(understood-14, reduce-8)
compound(levels-10, amygdalin-9)
dobj(reduce-8, levels-10)
auxpass(understood-14, are-11)
neg(understood-14, not-12)
advmod(understood-14, fully-13)
acl:relcl(mechanisms-2, understood-14)
cc(understood-14, but-15)
aux(involve-17, may-16)
acl:relcl(mechanisms-2, involve-17)
conj:but(understood-14, involve-17)
nmod:poss(ability-19, their-18)
dobj(involve-17, ability-19)
acl(ability-19, to-20)
root(ROOT-0, modulate-21)
det(expression-23, the-22)
dobj(modulate-21, expression-23)
case(genes-25, of-24)
nmod:of(expression-23, genes-25)
acl(genes-25, involved-26)
case(metabolism-29, in-27)
compound(metabolism-29, amygdalin-28)
nmod:in(involved-26, metabolism-29)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN developing/VBG CHD/NNP and/CC managing/VBG hyperamygdalinmia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (S
                            (VP
                              (VP (VBG developing)
                                (NP (NNP CHD)))
                              (CC and)
                              (VP (VBG managing)
                                (NP (NN hyperamygdalinmia))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, promising-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, CHD-22)
cc(developing-21, and-23)
acl(risk-19, managing-24)
conj:and(developing-21, managing-24)
dobj(managing-24, hyperamygdalinmia-25)

Migraine/JJ is_a/NN neurological_disorder/VBP that/IN affects/VBZ millions/NNS of/IN people/NNS worldwide/RB ./.

(ROOT
  (S
    (NP (JJ Migraine) (NN is_a))
    (VP (VBP neurological_disorder)
      (SBAR (IN that)
        (S
          (VP (VBZ affects)
            (NP
              (NP (NNS millions))
              (PP (IN of)
                (NP (NNS people))))
            (ADVP (RB worldwide))))))
    (. .)))

amod(is_a-2, Migraine-1)
nsubj(neurological_disorder-3, is_a-2)
root(ROOT-0, neurological_disorder-3)
mark(affects-5, that-4)
ccomp(neurological_disorder-3, affects-5)
dobj(affects-5, millions-6)
case(people-8, of-7)
nmod:of(millions-6, people-8)
advmod(affects-5, worldwide-9)

The/DT symptoms/NNS of/IN migraine/NN include/VBP nausea/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ,/, which/WDT can/MD significantly/RB reduce/VB the/DT quality_of_life/NN for/IN those/DT affected/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS symptoms))
      (PP (IN of)
        (NP (NN migraine))))
    (VP (VBP include)
      (NP
        (NP (NN nausea))
        (, ,)
        (NP (NN photophobia))
        (, ,)
        (CC and)
        (NP
          (NP (NN phonophobia))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (MD can) (RB significantly)
                (VP (VB reduce)
                  (NP (DT the) (NN quality_of_life))
                  (PP (IN for)
                    (NP (DT those) (VBN affected))))))))))
    (. .)))

det(symptoms-2, The-1)
nsubj(include-5, symptoms-2)
case(migraine-4, of-3)
nmod:of(symptoms-2, migraine-4)
root(ROOT-0, include-5)
dobj(include-5, nausea-6)
dobj(include-5, photophobia-8)
conj:and(nausea-6, photophobia-8)
cc(nausea-6, and-10)
dobj(include-5, phonophobia-11)
conj:and(nausea-6, phonophobia-11)
nsubj(reduce-16, phonophobia-11)
ref(phonophobia-11, which-13)
aux(reduce-16, can-14)
advmod(reduce-16, significantly-15)
acl:relcl(phonophobia-11, reduce-16)
det(quality_of_life-18, the-17)
dobj(reduce-16, quality_of_life-18)
case(those-20, for-19)
nmod:for(reduce-16, those-20)
amod(those-20, affected-21)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN RC-3095/NNP ,/, a/DT selective/JJ antagonist/NN for/IN the/DT neuropeptide_Y_Y1_receptor/NNS ,/, can/MD reduce/VB the/DT frequency/NN and/CC severity/NN of/IN migraine/JJ attacks/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNP RC-3095))
              (, ,)
              (NP
                (NP (DT a) (JJ selective) (NN antagonist))
                (PP (IN for)
                  (NP (DT the) (NNS neuropeptide_Y_Y1_receptor))))
              (, ,))
            (VP (MD can)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN frequency)
                    (CC and)
                    (NN severity))
                  (PP (IN of)
                    (NP (JJ migraine) (NN attacks))))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(reduce-16, that-5)
nsubj(reduce-16, RC-3095-6)
det(antagonist-10, a-8)
amod(antagonist-10, selective-9)
appos(RC-3095-6, antagonist-10)
case(neuropeptide_Y_Y1_receptor-13, for-11)
det(neuropeptide_Y_Y1_receptor-13, the-12)
nmod:for(antagonist-10, neuropeptide_Y_Y1_receptor-13)
aux(reduce-16, can-15)
ccomp(shown-4, reduce-16)
det(frequency-18, the-17)
dobj(reduce-16, frequency-18)
cc(frequency-18, and-19)
dobj(reduce-16, severity-20)
conj:and(frequency-18, severity-20)
case(attacks-23, of-21)
amod(attacks-23, migraine-22)
nmod:of(frequency-18, attacks-23)

In/IN this/DT randomized_controlled_trial/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN RC-3095/NN on/IN the/DT risk/NN of/IN nausea_reduction/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN patients/NNS with/IN migraine/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN randomized_controlled_trial)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN RC-3095))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP
              (NP (NN nausea_reduction))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP
                (NP (NN phonophobia))
                (PP (IN in)
                  (NP (NNS patients))))))))
      (PP (IN with)
        (NP (NN migraine))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, this-2)
nmod:in(investigated-6, randomized_controlled_trial-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(RC-3095-10, of-9)
nmod:of(effect-8, RC-3095-10)
case(risk-13, on-11)
det(risk-13, the-12)
nmod:on(investigated-6, risk-13)
case(nausea_reduction-15, of-14)
nmod:of(risk-13, nausea_reduction-15)
nmod:of(risk-13, photophobia-17)
conj:and(nausea_reduction-15, photophobia-17)
cc(nausea_reduction-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(nausea_reduction-15, phonophobia-20)
case(patients-22, in-21)
nmod:in(phonophobia-20, patients-22)
case(migraine-24, with-23)
nmod:with(investigated-6, migraine-24)

Patients/NNPS were/VBD given/VBN a/DT single/JJ dose/NN of/IN RC-3095/NN or/CC placebo/NN and/CC monitored/VBN for/IN 2/CD hours/NNS after/IN dosing/VBG ./.

(ROOT
  (S
    (NP (NNPS Patients))
    (VP
      (VP (VBD were)
        (VP (VBN given)
          (NP
            (NP (DT a) (JJ single) (NN dose))
            (PP (IN of)
              (NP (NN RC-3095)
                (CC or)
                (NN placebo))))))
      (CC and)
      (VP (VBN monitored)
        (PP (IN for)
          (NP (CD 2) (NNS hours)))
        (PP (IN after)
          (S
            (VP (VBG dosing))))))
    (. .)))

nsubjpass(given-3, Patients-1)
nsubjpass(monitored-12, Patients-1)
auxpass(given-3, were-2)
root(ROOT-0, given-3)
det(dose-6, a-4)
amod(dose-6, single-5)
dobj(given-3, dose-6)
case(RC-3095-8, of-7)
nmod:of(dose-6, RC-3095-8)
cc(RC-3095-8, or-9)
nmod:of(dose-6, placebo-10)
conj:or(RC-3095-8, placebo-10)
cc(given-3, and-11)
conj:and(given-3, monitored-12)
case(hours-15, for-13)
nummod(hours-15, 2-14)
nmod:for(monitored-12, hours-15)
mark(dosing-17, after-16)
advcl(monitored-12, dosing-17)

At_2/JJ h/NN after/IN dosing/VBG ,/, RC-3095/NNP reduced/VBD the/DT risk/NN of/IN nausea_reduction/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- compared/VBN to/TO placebo/NN ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP RC-3095))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN nausea_reduction))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-))
              (VP (VBN compared)
                (PP (TO to)
                  (NP (NN placebo)))))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, RC-3095-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(nausea_reduction-11, of-10)
nmod:of(risk-9, nausea_reduction-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)
acl(%-47, compared-59)
case(placebo-61, to-60)
nmod:to(compared-59, placebo-61)

These/DT results/NNS suggest/VBP that/IN RC-3095/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN reducing/VBG the/DT symptoms/NNS associated/VBN with/IN migraine/JJ attacks/NNS and/CC improving/VBG the/DT quality_of_life/NN for/IN those/DT affected/VBN by/IN this/DT debilitating/JJ condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP RC-3095))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NNS symptoms))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP (JJ migraine) (NNS attacks))))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (DT the) (NN quality_of_life))
                        (PP (IN for)
                          (NP
                            (NP (DT those))
                            (VP (VBN affected)
                              (PP (IN by)
                                (NP (DT this) (JJ debilitating) (NN condition))))))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, RC-3095-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
mark(reducing-13, for-12)
acl(option-11, reducing-13)
det(symptoms-15, the-14)
dobj(reducing-13, symptoms-15)
acl(symptoms-15, associated-16)
case(attacks-19, with-17)
amod(attacks-19, migraine-18)
nmod:with(associated-16, attacks-19)
cc(reducing-13, and-20)
acl(option-11, improving-21)
conj:and(reducing-13, improving-21)
det(quality_of_life-23, the-22)
dobj(improving-21, quality_of_life-23)
case(those-25, for-24)
nmod:for(improving-21, those-25)
acl(those-25, affected-26)
case(condition-30, by-27)
det(condition-30, this-28)
amod(condition-30, debilitating-29)
nmod:by(affected-26, condition-30)

The/DT vasoactive_intestinal_peptide/JJ -LRB-/-LRB- VIP/NNP -RRB-/-RRB- is_a/NN neuropeptide/VBD that/IN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN various/JJ physiological/JJ processes/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ vasoactive_intestinal_peptide) (-LRB- -LRB-) (NNP VIP) (-RRB- -RRB-) (NN is_a))
    (VP (VBD neuropeptide)
      (SBAR (IN that)
        (S
          (VP (VBZ plays)
            (NP
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (JJ various) (JJ physiological) (NNS processes))))))))))
    (. .)))

det(is_a-6, The-1)
amod(is_a-6, vasoactive_intestinal_peptide-2)
compound(is_a-6, VIP-4)
nsubj(neuropeptide-7, is_a-6)
root(ROOT-0, neuropeptide-7)
mark(plays-9, that-8)
ccomp(neuropeptide-7, plays-9)
det(role-12, a-10)
amod(role-12, crucial-11)
dobj(plays-9, role-12)
case(regulation-15, in-13)
det(regulation-15, the-14)
nmod:in(role-12, regulation-15)
case(processes-19, of-16)
amod(processes-19, various-17)
amod(processes-19, physiological-18)
nmod:of(regulation-15, processes-19)

The/DT present/JJ study/NN aimed/VBN to/TO investigate/VB the/DT effects/NNS of/IN VIP/NNP antagonist/NN -LSB-/VBD 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP and/CC RhoB-GG/NNP antagonist/NN peptide/NN RhoB-GG/NNP -LRB-/-LRB- 6-38/CD -RRB-/-RRB- on/IN FTI-277/NN response/NN to/TO either/DT RhoB-GG/NNP or/CC VIP/NNP ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ present) (NN study))
      (VP (VBN aimed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (NNP VIP) (NN antagonist)))))))))
    (VP (VBD -LSB-)
      (NP
        (NP
          (NP (JJ 4Cl-D-Phe6))
          (, ,)
          (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
          (CC and)
          (NP (NNP RhoB-GG) (NN antagonist) (NN peptide) (NNP RhoB-GG)))
        (PRN (-LRB- -LRB-)
          (NP (CD 6-38))
          (-RRB- -RRB-)))
      (PP (IN on)
        (NP (NN FTI-277) (NN response)))
      (PP (TO to)
        (NP (DT either) (NNP RhoB-GG)
          (CC or)
          (NNP VIP))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(-LSB--12, study-3)
acl(study-3, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(effects-8, the-7)
dobj(investigate-6, effects-8)
case(antagonist-11, of-9)
compound(antagonist-11, VIP-10)
nmod:of(effects-8, antagonist-11)
root(ROOT-0, -LSB--12)
dobj(-LSB--12, 4Cl-D-Phe6-13)
compound(VIP-17, Leu17-15)
compound(VIP-17, -RSB--16)
dobj(-LSB--12, VIP-17)
conj:and(4Cl-D-Phe6-13, VIP-17)
cc(4Cl-D-Phe6-13, and-18)
compound(RhoB-GG-22, RhoB-GG-19)
compound(RhoB-GG-22, antagonist-20)
compound(RhoB-GG-22, peptide-21)
dobj(-LSB--12, RhoB-GG-22)
conj:and(4Cl-D-Phe6-13, RhoB-GG-22)
appos(4Cl-D-Phe6-13, 6-38-24)
case(response-28, on-26)
compound(response-28, FTI-277-27)
nmod:on(-LSB--12, response-28)
case(RhoB-GG-31, to-29)
cc:preconj(RhoB-GG-31, either-30)
nmod:to(-LSB--12, RhoB-GG-31)
cc(RhoB-GG-31, or-32)
nmod:to(-LSB--12, VIP-33)
conj:or(RhoB-GG-31, VIP-33)

Our/PRP$ results/NNS showed/VBD that/IN the/DT VIP/NNP antagonist/NN -LSB-/VBZ 4Cl-D-Phe6/JJ ,/, Leu17/NNP -RSB-/NNP VIP/NNP had/VBD no/DT effect/NN on/IN the/DT FTI-277/JJ response/NN to/TO either/DT RhoB-GG/NNP or/CC VIP/NNP ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (DT the) (NNP VIP) (NN antagonist))
            (VP (VBZ -LSB-)
              (ADJP (JJ 4Cl-D-Phe6)))))))
    (, ,)
    (NP (NNP Leu17) (NNP -RSB-) (NNP VIP))
    (VP (VBD had)
      (NP
        (NP (DT no) (NN effect))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ FTI-277) (NN response))
            (PP (TO to)
              (NP (DT either) (NNP RhoB-GG)
                (CC or)
                (NNP VIP)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
ccomp(had-14, showed-3)
mark(-LSB--8, that-4)
det(antagonist-7, the-5)
compound(antagonist-7, VIP-6)
nsubj(-LSB--8, antagonist-7)
ccomp(showed-3, -LSB--8)
xcomp(-LSB--8, 4Cl-D-Phe6-9)
compound(VIP-13, Leu17-11)
compound(VIP-13, -RSB--12)
nsubj(had-14, VIP-13)
root(ROOT-0, had-14)
neg(effect-16, no-15)
dobj(had-14, effect-16)
case(response-20, on-17)
det(response-20, the-18)
amod(response-20, FTI-277-19)
nmod:on(effect-16, response-20)
case(RhoB-GG-23, to-21)
cc:preconj(RhoB-GG-23, either-22)
nmod:to(response-20, RhoB-GG-23)
cc(RhoB-GG-23, or-24)
nmod:to(response-20, VIP-25)
conj:or(RhoB-GG-23, VIP-25)

However/RB ,/, the/DT peptide/JJ RhoB-GG/NN -LRB-/-LRB- 6-38/CD -RRB-/-RRB- ,/, a/DT putative/JJ RhoB-GG/JJ antagonist/NN ,/, blocked/VBD the/DT FTI-277/JJ response/NN to/TO RhoB-GG/NNP ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP
        (NP (DT the) (JJ peptide) (NN RhoB-GG))
        (PRN (-LRB- -LRB-)
          (NP (CD 6-38))
          (-RRB- -RRB-)))
      (, ,)
      (NP (DT a) (JJ putative) (JJ RhoB-GG) (NN antagonist))
      (, ,))
    (VP (VBD blocked)
      (NP
        (NP (DT the) (JJ FTI-277) (NN response))
        (PP (TO to)
          (NP (NNP RhoB-GG)))))
    (. .)))

advmod(blocked-15, However-1)
det(RhoB-GG-5, the-3)
amod(RhoB-GG-5, peptide-4)
nsubj(blocked-15, RhoB-GG-5)
appos(RhoB-GG-5, 6-38-7)
det(antagonist-13, a-10)
amod(antagonist-13, putative-11)
amod(antagonist-13, RhoB-GG-12)
appos(RhoB-GG-5, antagonist-13)
root(ROOT-0, blocked-15)
det(response-18, the-16)
amod(response-18, FTI-277-17)
dobj(blocked-15, response-18)
case(RhoB-GG-20, to-19)
nmod:to(response-18, RhoB-GG-20)

These/DT findings/NNS suggest/VBP that/IN RhoB-GG/NNP may/MD play/VB a/DT crucial/JJ role/NN in/IN mediating/VBG FTI-277/JJ response/NN and/CC that/IN its/PRP$ antagonism/NN could/MD be/VB a/DT potential/JJ therapeutic/JJ target/NN for/IN diseases/NNS involving/VBG aberrant/JJ RhoB/NNP signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP RhoB-GG))
            (VP (MD may)
              (VP (VB play)
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG mediating)
                      (NP (JJ FTI-277) (NN response)))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP (PRP$ its) (NN antagonism))
            (VP (MD could)
              (VP (VB be)
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN target))
                (PP (IN for)
                  (NP
                    (NP (NNS diseases))
                    (PP (VBG involving)
                      (NP (JJ aberrant) (NNP RhoB) (VBG signaling) (NNS pathways)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, RhoB-GG-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(play-7, role-10)
mark(mediating-12, in-11)
advcl(play-7, mediating-12)
amod(response-14, FTI-277-13)
dobj(mediating-12, response-14)
cc(play-7, and-15)
mark(target-24, that-16)
nmod:poss(antagonism-18, its-17)
nsubj(target-24, antagonism-18)
aux(target-24, could-19)
cop(target-24, be-20)
det(target-24, a-21)
amod(target-24, potential-22)
amod(target-24, therapeutic-23)
ccomp(suggest-3, target-24)
conj:and(play-7, target-24)
case(diseases-26, for-25)
nmod:for(target-24, diseases-26)
case(pathways-31, involving-27)
amod(pathways-31, aberrant-28)
compound(pathways-31, RhoB-29)
amod(pathways-31, signaling-30)
nmod:involving(diseases-26, pathways-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanism/NN of/IN action/NN of/IN these/DT peptides/NNS and/CC their/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NN mechanism))
                (PP (IN of)
                  (NP
                    (NP (NN action))
                    (PP (IN of)
                      (NP
                        (NP (DT these) (NNS peptides))
                        (CC and)
                        (NP (PRP$ their) (JJ potential) (JJ clinical) (NNS applications))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanism-8, the-7)
dobj(elucidate-6, mechanism-8)
case(action-10, of-9)
nmod:of(mechanism-8, action-10)
case(peptides-13, of-11)
det(peptides-13, these-12)
nmod:of(action-10, peptides-13)
cc(peptides-13, and-14)
nmod:poss(applications-18, their-15)
amod(applications-18, potential-16)
amod(applications-18, clinical-17)
nmod:of(action-10, applications-18)
conj:and(peptides-13, applications-18)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN maintaining/VBG optimal/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (ADJP (JJ essential)
        (PP (IN for)
          (S
            (VP (VBG maintaining)
              (NP (JJ optimal) (NN health)))))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
mark(maintaining-17, for-16)
advcl(essential-15, maintaining-17)
amod(health-19, optimal-18)
dobj(maintaining-17, health-19)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS can/MD have/VB a/DT significant/JJ impact/NN on/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (MD can)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ significant) (NN impact))
                  (PP (IN on)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(have-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubj(have-9, long-chain_fatty_acids-7)
aux(have-9, can-8)
ccomp(shown-4, have-9)
det(impact-12, a-10)
amod(impact-12, significant-11)
dobj(have-9, impact-12)
mark(reducing-14, on-13)
acl(impact-12, reducing-14)
det(risk-16, the-15)
dobj(reducing-14, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, coronary_heart_disease-19)
appos(risk-16, CHD-21)

In/IN hypercyacrinmic/JJ patients/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO decrease/VB cyacrin/NN levels/NNS ,/, which/WDT is_a/RB known/VBN risk/NN factor/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ hypercyacrinmic) (NNS patients)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (NN cyacrin) (NNS levels))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (ADVP (RB is_a))
                      (VP (VBN known)
                        (NP
                          (NP (NN risk) (NN factor))
                          (PP (IN for)
                            (NP (NNP CHD))))))))))))))
    (. .)))

case(patients-3, In-1)
amod(patients-3, hypercyacrinmic-2)
nmod:in(found-10, patients-3)
nsubjpass(found-10, EPA-5)
nsubj:xsubj(decrease-12, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubjpass(found-10, DHA-7)
nsubj:xsubj(decrease-12, DHA-7)
aux(found-10, have-8)
auxpass(found-10, been-9)
root(ROOT-0, found-10)
mark(decrease-12, to-11)
xcomp(found-10, decrease-12)
compound(levels-14, cyacrin-13)
dobj(decrease-12, levels-14)
nsubj(known-18, levels-14)
ref(levels-14, which-16)
advmod(known-18, is_a-17)
acl:relcl(levels-14, known-18)
compound(factor-20, risk-19)
dobj(known-18, factor-20)
case(CHD-22, for-21)
nmod:for(factor-20, CHD-22)

These/DT findings/NNS suggest/VBP that/IN EPA/NNP and/CC DHA/NNP may/MD be/VB important/JJ dietary/JJ factors/NNS in/IN the/DT prevention/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (JJ important) (JJ dietary) (NNS factors))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN prevention))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(factors-12, that-4)
nsubj(factors-12, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(factors-12, DHA-7)
aux(factors-12, may-8)
cop(factors-12, be-9)
amod(factors-12, important-10)
amod(factors-12, dietary-11)
ccomp(suggest-3, factors-12)
case(prevention-15, in-13)
det(prevention-15, the-14)
nmod:in(factors-12, prevention-15)
case(CHD-17, of-16)
nmod:of(prevention-15, CHD-17)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS exert/VBP their/PRP$ beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP (DT the) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (DT these) (NNS fatty_acids))
                    (VP (VBP exert)
                      (NP
                        (NP (PRP$ their) (JJ beneficial) (NNS effects))
                        (PP (IN on)
                          (NP (NN cardiovascular_health)))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
mark(exert-14, by-10)
dobj(exert-14, which-11)
det(fatty_acids-13, these-12)
nsubj(exert-14, fatty_acids-13)
advcl(understand-7, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, beneficial-16)
dobj(exert-14, effects-17)
case(cardiovascular_health-19, on-18)
nmod:on(effects-17, cardiovascular_health-19)

Nonetheless/RB ,/, these/DT results/NNS provide/VBP compelling/JJ evidence/NN for/IN the/DT inclusion/NN of/IN omega-3_fatty_acids/JJ in_a/JJ heart-healthy/JJ diet/NN ./.

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP (DT these) (NNS results))
    (VP (VBP provide)
      (NP
        (NP (JJ compelling) (NN evidence))
        (PP (IN for)
          (NP
            (NP (DT the) (NN inclusion))
            (PP (IN of)
              (NP (JJ omega-3_fatty_acids) (JJ in_a) (JJ heart-healthy) (NN diet)))))))
    (. .)))

advmod(provide-5, Nonetheless-1)
det(results-4, these-3)
nsubj(provide-5, results-4)
root(ROOT-0, provide-5)
amod(evidence-7, compelling-6)
dobj(provide-5, evidence-7)
case(inclusion-10, for-8)
det(inclusion-10, the-9)
nmod:for(evidence-7, inclusion-10)
case(diet-15, of-11)
amod(diet-15, omega-3_fatty_acids-12)
amod(diet-15, in_a-13)
amod(diet-15, heart-healthy-14)
nmod:of(inclusion-10, diet-15)

Tetrachlorodecaoxygen/NNP -LRB-/-LRB- TCDO/NNP -RRB-/-RRB- is_a/VBD novel/NN compound/NN that/WDT has/VBZ shown/VBN potential/JJ in/IN reducing/VBG the/DT risk/NN of/IN acute_radiation_syndrome/NN -LRB-/-LRB- ARS/NNP -RRB-/-RRB- in/IN preclinical/JJ studies/NNS ./.

(ROOT
  (S
    (NP (NNP Tetrachlorodecaoxygen) (-LRB- -LRB-)
      (NP (NNP TCDO))
      (-RRB- -RRB-))
    (VP (VBD is_a)
      (NP
        (NP
          (NP (NN novel) (NN compound))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ has)
                (VP (VBN shown)
                  (ADJP (JJ potential))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NN acute_radiation_syndrome))))))))))))
        (PRN (-LRB- -LRB-)
          (NP (NNP ARS))
          (-RRB- -RRB-)))
      (PP (IN in)
        (NP (JJ preclinical) (NNS studies))))
    (. .)))

nsubj(is_a-5, Tetrachlorodecaoxygen-1)
dep(Tetrachlorodecaoxygen-1, TCDO-3)
root(ROOT-0, is_a-5)
compound(compound-7, novel-6)
dobj(is_a-5, compound-7)
nsubj(shown-10, compound-7)
ref(compound-7, that-8)
aux(shown-10, has-9)
acl:relcl(compound-7, shown-10)
xcomp(shown-10, potential-11)
mark(reducing-13, in-12)
advcl(shown-10, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(acute_radiation_syndrome-17, of-16)
nmod:of(risk-15, acute_radiation_syndrome-17)
appos(compound-7, ARS-19)
case(studies-23, in-21)
amod(studies-23, preclinical-22)
nmod:in(is_a-5, studies-23)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT effectiveness/NN of/IN TCDO/NNP in/IN reducing/VBG the/DT risk/NN of/IN ARS/NNP and/CC associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN effectiveness))
              (PP (IN of)
                (NP (NNP TCDO))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (NP (NNP ARS))))
                    (CC and)
                    (NP
                      (NP (VBN associated) (NNS symptoms))
                      (PP (JJ such) (IN as)
                        (NP (NN photophobia)
                          (CC and)
                          (NN phonophobia))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(effectiveness-10, the-9)
dobj(investigate-8, effectiveness-10)
case(TCDO-12, of-11)
nmod:of(effectiveness-10, TCDO-12)
mark(reducing-14, in-13)
advcl(investigate-8, reducing-14)
det(risk-16, the-15)
dobj(reducing-14, risk-16)
case(ARS-18, of-17)
nmod:of(risk-16, ARS-18)
cc(risk-16, and-19)
amod(symptoms-21, associated-20)
dobj(reducing-14, symptoms-21)
conj:and(risk-16, symptoms-21)
case(photophobia-24, such-22)
mwe(such-22, as-23)
nmod:such_as(symptoms-21, photophobia-24)
cc(photophobia-24, and-25)
nmod:such_as(symptoms-21, phonophobia-26)
conj:and(photophobia-24, phonophobia-26)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT cohort/NN of/IN individuals/NNS exposed/VBN to/TO radiation/NN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN cohort))
            (PP (IN of)
              (NP
                (NP (NNS individuals))
                (VP (VBN exposed)
                  (PP (TO to)
                    (NP (NN radiation))))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(cohort-12, on-10)
det(cohort-12, a-11)
nmod:on(conducted-9, cohort-12)
case(individuals-14, of-13)
nmod:of(cohort-12, individuals-14)
acl(individuals-14, exposed-15)
case(radiation-17, to-16)
nmod:to(exposed-15, radiation-17)

At_2/JJ h/NN after/IN dosing/VBG ,/, TCDO/NNP reduced/VBD the/DT risk/NN of/IN ARS/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP TCDO))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNP ARS))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, TCDO-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(ARS-11, of-10)
nmod:of(risk-9, ARS-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN TCDO/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ agent/NN for/IN mitigating/VBG the/DT effects/NNS of/IN radiation/NN exposure/NN and/CC improving/VBG quality_of_life/NN for/IN individuals/NNS at/IN risk/NN of/IN developing/VBG ARS/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP TCDO))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN agent))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG mitigating)
                        (NP
                          (NP (DT the) (NNS effects))
                          (PP (IN of)
                            (NP (NN radiation) (NN exposure)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP
                          (NP (NN quality_of_life))
                          (PP (IN for)
                            (NP (NNS individuals))))
                        (PP (IN at)
                          (NP
                            (NP (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NNP ARS)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(agent-11, that-4)
nsubj(agent-11, TCDO-5)
aux(agent-11, may-6)
cop(agent-11, be-7)
det(agent-11, a-8)
amod(agent-11, promising-9)
amod(agent-11, therapeutic-10)
ccomp(suggest-3, agent-11)
mark(mitigating-13, for-12)
acl(agent-11, mitigating-13)
det(effects-15, the-14)
dobj(mitigating-13, effects-15)
case(exposure-18, of-16)
compound(exposure-18, radiation-17)
nmod:of(effects-15, exposure-18)
cc(mitigating-13, and-19)
acl(agent-11, improving-20)
conj:and(mitigating-13, improving-20)
dobj(improving-20, quality_of_life-21)
case(individuals-23, for-22)
nmod:for(quality_of_life-21, individuals-23)
case(risk-25, at-24)
nmod:at(improving-20, risk-25)
mark(developing-27, of-26)
acl(risk-25, developing-27)
dobj(developing-27, ARS-28)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO investigate/VB its/PRP$ safety/NN and/CC efficacy/NN in/IN larger/JJR populations/NNS and/CC under/IN different/JJ exposure/NN scenarios/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP (PRP$ its) (NN safety)
                (CC and)
                (NN efficacy))
              (PP
                (PP (IN in)
                  (NP (JJR larger) (NNS populations)))
                (CC and)
                (PP (IN under)
                  (NP (JJ different) (NN exposure) (NNS scenarios)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
nsubj:xsubj(investigate-6', studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(investigate-6, to-5)
xcomp(warranted-4, investigate-6)
xcomp(warranted-4, investigate-6')
conj:and(investigate-6, investigate-6')
nmod:poss(safety-8, its-7)
dobj(investigate-6, safety-8)
cc(safety-8, and-9)
dobj(investigate-6, efficacy-10)
conj:and(safety-8, efficacy-10)
case(populations-13, in-11)
amod(populations-13, larger-12)
nmod:in(investigate-6, populations-13)
cc(investigate-6, and-14)
case(scenarios-18, under-15)
amod(scenarios-18, different-16)
compound(scenarios-18, exposure-17)
nmod:under(investigate-6', scenarios-18)

The/DT thyroid/NN gland/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT regulation/NN of/IN metabolism/NN ,/, growth/NN ,/, and/CC development/NN ./.

(ROOT
  (S
    (NP (DT The) (NN thyroid) (NN gland))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP
                (NP (NN metabolism))
                (, ,)
                (NP (NN growth))
                (, ,)
                (CC and)
                (NP (NN development))))))))
    (. .)))

det(gland-3, The-1)
compound(gland-3, thyroid-2)
nsubj(plays-4, gland-3)
root(ROOT-0, plays-4)
det(role-7, a-5)
amod(role-7, crucial-6)
dobj(plays-4, role-7)
case(regulation-10, in-8)
det(regulation-10, the-9)
nmod:in(role-7, regulation-10)
case(metabolism-12, of-11)
nmod:of(regulation-10, metabolism-12)
nmod:of(regulation-10, growth-14)
conj:and(metabolism-12, growth-14)
cc(metabolism-12, and-16)
nmod:of(regulation-10, development-17)
conj:and(metabolism-12, development-17)

Exposure/NNS to/TO environmental/JJ chemicals/NNS has_been/VBP shown/VBN to/TO disrupt/VB thyroid_hormone/JJ homeostasis/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Exposure))
      (PP (TO to)
        (NP (JJ environmental) (NNS chemicals))))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB disrupt)
              (NP (JJ thyroid_hormone) (NNS homeostasis)))))))
    (. .)))

nsubj(has_been-5, Exposure-1)
case(chemicals-4, to-2)
amod(chemicals-4, environmental-3)
nmod:to(Exposure-1, chemicals-4)
root(ROOT-0, has_been-5)
dep(has_been-5, shown-6)
mark(disrupt-8, to-7)
xcomp(shown-6, disrupt-8)
amod(homeostasis-10, thyroid_hormone-9)
dobj(disrupt-8, homeostasis-10)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN four/CD common/JJ environmental/JJ chemicals/NNS ,/, valienol/NN ,/, triclocarban/NN ,/, 2,2/CD '/POS ,4,4/CD '/'' -/: tetrabromodiphenyl_ether/NN -LRB-/-LRB- BDE-47/NNP -RRB-/-RRB- ,/, and/CC bisphenol_A/NN -LRB-/-LRB- BPA/NNP -RRB-/-RRB- ,/, on/IN iodide/JJ uptake/NN ,/, alpha-glucosidase/JJ activity/NN ,/, and/CC gene/NN expression/NN involved/VBN in/IN thyroid_hormone/JJ synthesis/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (CD four) (JJ common) (JJ environmental) (NNS chemicals))
          (, ,)
          (NP (NN valienol))
          (, ,)
          (NP (NN triclocarban))
          (, ,)
          (NP
            (NP (CD 2,2) (POS '))
            (ADJP (CD ,4,4))
            ('' ')
            (PRN (: -)
              (NP
                (NP
                  (NP
                    (NP (NN tetrabromodiphenyl_ether))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP BDE-47))
                      (-RRB- -RRB-)))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (NN bisphenol_A))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP BPA))
                      (-RRB- -RRB-)))
                  (, ,))
                (PP (IN on)
                  (NP (JJ iodide) (NN uptake))))
              (, ,)
              (ADJP (JJ alpha-glucosidase)))
            (NN activity))
          (, ,)
          (CC and)
          (NP
            (NP (NN gene) (NN expression))
            (VP (VBN involved)
              (PP (IN in)
                (NP (JJ thyroid_hormone) (NN synthesis))))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-48, study-3)
det(effects-6, the-5)
nsubjpass(investigated-48, effects-6)
case(chemicals-11, of-7)
nummod(chemicals-11, four-8)
amod(chemicals-11, common-9)
amod(chemicals-11, environmental-10)
nmod:of(effects-6, chemicals-11)
nmod:of(effects-6, valienol-13)
conj:and(chemicals-11, valienol-13)
nmod:of(effects-6, triclocarban-15)
conj:and(chemicals-11, triclocarban-15)
nmod:poss(activity-38, 2,2-17)
case(2,2-17, '-18)
amod(activity-38, ,4,4-19)
dep(activity-38, tetrabromodiphenyl_ether-22)
appos(tetrabromodiphenyl_ether-22, BDE-47-24)
cc(tetrabromodiphenyl_ether-22, and-27)
conj:and(tetrabromodiphenyl_ether-22, bisphenol_A-28)
dep(activity-38, bisphenol_A-28)
appos(bisphenol_A-28, BPA-30)
case(uptake-35, on-33)
amod(uptake-35, iodide-34)
nmod:on(tetrabromodiphenyl_ether-22, uptake-35)
dep(tetrabromodiphenyl_ether-22, alpha-glucosidase-37)
nmod:of(effects-6, activity-38)
conj:and(chemicals-11, activity-38)
cc(chemicals-11, and-40)
compound(expression-42, gene-41)
nmod:of(effects-6, expression-42)
conj:and(chemicals-11, expression-42)
acl(expression-42, involved-43)
case(synthesis-46, in-44)
amod(synthesis-46, thyroid_hormone-45)
nmod:in(involved-43, synthesis-46)
auxpass(investigated-48, were-47)
root(ROOT-0, investigated-48)

The/DT results/NNS showed/VBD that/IN valienol/NN significantly/RB decreased/VBD iodide/JJ uptake/JJ and_alpha-glucosidase/JJ activity/NN while/IN also/RB downregulating/VBG the/DT expression/NN of/IN genes/NNS involved/VBN in/IN thyroid_hormone/JJ synthesis/NN including/VBG thyroglobulin/NN -LRB-/-LRB- Tg/NNP -RRB-/-RRB- ,/, sodium-iodide_symporter/NN -LRB-/-LRB- Nis/NNP -RRB-/-RRB- ,/, thyroid_peroxidase/NN -LRB-/-LRB- Tpo/NNP -RRB-/-RRB- ,/, and/CC thyrotropin_receptor/NN -LRB-/-LRB- Tshr/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN valienol))
          (ADVP (RB significantly))
          (VP (VBD decreased)
            (NP
              (NP (JJ iodide) (JJ uptake) (JJ and_alpha-glucosidase) (NN activity))
              (SBAR
                (WHNP (IN while))
                (S
                  (ADVP (RB also))
                  (VP (VBG downregulating)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP
                          (NP (NNS genes))
                          (VP (VBN involved)
                            (PP (IN in)
                              (NP
                                (NP
                                  (NP (JJ thyroid_hormone) (NN synthesis) (VBG including) (NN thyroglobulin))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP Tg))
                                    (-RRB- -RRB-)))
                                (, ,)
                                (NP
                                  (NP (NN sodium-iodide_symporter))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP Nis))
                                    (-RRB- -RRB-)))
                                (, ,)
                                (NP
                                  (NP (NN thyroid_peroxidase))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP Tpo))
                                    (-RRB- -RRB-)))
                                (, ,)
                                (CC and)
                                (NP
                                  (NP (NN thyrotropin_receptor))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP Tshr))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(decreased-7, that-4)
nsubj(decreased-7, valienol-5)
advmod(decreased-7, significantly-6)
ccomp(showed-3, decreased-7)
amod(activity-11, iodide-8)
amod(activity-11, uptake-9)
amod(activity-11, and_alpha-glucosidase-10)
dobj(decreased-7, activity-11)
nsubj(downregulating-14, while-12)
advmod(downregulating-14, also-13)
acl:relcl(activity-11, downregulating-14)
det(expression-16, the-15)
dobj(downregulating-14, expression-16)
case(genes-18, of-17)
nmod:of(expression-16, genes-18)
acl(genes-18, involved-19)
case(thyroglobulin-24, in-20)
amod(thyroglobulin-24, thyroid_hormone-21)
compound(thyroglobulin-24, synthesis-22)
amod(thyroglobulin-24, including-23)
nmod:in(involved-19, thyroglobulin-24)
appos(thyroglobulin-24, Tg-26)
nmod:in(involved-19, sodium-iodide_symporter-29)
conj:and(thyroglobulin-24, sodium-iodide_symporter-29)
appos(sodium-iodide_symporter-29, Nis-31)
nmod:in(involved-19, thyroid_peroxidase-34)
conj:and(thyroglobulin-24, thyroid_peroxidase-34)
appos(thyroid_peroxidase-34, Tpo-36)
cc(thyroglobulin-24, and-39)
nmod:in(involved-19, thyrotropin_receptor-40)
conj:and(thyroglobulin-24, thyrotropin_receptor-40)
appos(thyrotropin_receptor-40, Tshr-42)

Triclocarban/JJ exposure/NN resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN Tg/NNP expression/NN and_alpha-glucosidase/JJ activity/NN ./.

(ROOT
  (S
    (NP (JJ Triclocarban) (NN exposure))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NNP Tg) (NN expression) (JJ and_alpha-glucosidase) (NN activity)))))
    (. .)))

amod(exposure-2, Triclocarban-1)
nsubj(resulted-3, exposure-2)
root(ROOT-0, resulted-3)
amod(decrease-6, in_a-4)
amod(decrease-6, significant-5)
dobj(resulted-3, decrease-6)
case(activity-11, in-7)
compound(activity-11, Tg-8)
compound(activity-11, expression-9)
amod(activity-11, and_alpha-glucosidase-10)
nmod:in(decrease-6, activity-11)

BDE-47/JJ exposure/NN led/VBD to/TO a/DT significant/JJ decrease/NN in/IN Nis/NNP expression/NN while/IN BPA/NNP exposure/NN resulted/VBD in_a/JJ significant/JJ downregulation/NN of/IN Tpo/NNP expression/NN ./.

(ROOT
  (S
    (NP (JJ BDE-47) (NN exposure))
    (VP (VBD led)
      (PP (TO to)
        (NP
          (NP (DT a) (JJ significant) (NN decrease))
          (PP (IN in)
            (NP (NNP Nis) (NN expression)))))
      (SBAR (IN while)
        (S
          (NP (NNP BPA) (NN exposure))
          (VP (VBD resulted)
            (NP
              (NP (JJ in_a) (JJ significant) (NN downregulation))
              (PP (IN of)
                (NP (NNP Tpo) (NN expression))))))))
    (. .)))

amod(exposure-2, BDE-47-1)
nsubj(led-3, exposure-2)
root(ROOT-0, led-3)
case(decrease-7, to-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
nmod:to(led-3, decrease-7)
case(expression-10, in-8)
compound(expression-10, Nis-9)
nmod:in(decrease-7, expression-10)
mark(resulted-14, while-11)
compound(exposure-13, BPA-12)
nsubj(resulted-14, exposure-13)
advcl(led-3, resulted-14)
amod(downregulation-17, in_a-15)
amod(downregulation-17, significant-16)
dobj(resulted-14, downregulation-17)
case(expression-20, of-18)
compound(expression-20, Tpo-19)
nmod:of(downregulation-17, expression-20)

These/DT findings/NNS suggest/VBP that/IN environmental/JJ chemicals/NNS can/MD interfere/VB with/IN iodide/JJ uptake/JJ and_alpha-glucosidase/JJ activity/NN as/RB well/RB as/IN disrupt/VB gene/NN expression/NN involved/VBN in/IN thyroid_hormone/JJ synthesis/NN which/WDT may/MD lead/VB to/TO adverse/JJ health/NN effects/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ environmental) (NNS chemicals))
          (VP (MD can)
            (VP
              (VP (VB interfere)
                (PP (IN with)
                  (NP (JJ iodide) (JJ uptake) (JJ and_alpha-glucosidase) (NN activity))))
              (CONJP (RB as) (RB well) (IN as))
              (VP (VB disrupt)
                (NP
                  (NP (NN gene) (NN expression))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (JJ thyroid_hormone) (NN synthesis))))
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB lead)
                          (PP (TO to)
                            (NP (JJ adverse) (NN health) (NNS effects))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(interfere-8, that-4)
amod(chemicals-6, environmental-5)
nsubj(interfere-8, chemicals-6)
nsubj(disrupt-17, chemicals-6)
aux(interfere-8, can-7)
ccomp(suggest-3, interfere-8)
case(activity-13, with-9)
amod(activity-13, iodide-10)
amod(activity-13, uptake-11)
amod(activity-13, and_alpha-glucosidase-12)
nmod:with(interfere-8, activity-13)
cc(interfere-8, as-14)
mwe(as-14, well-15)
mwe(as-14, as-16)
ccomp(suggest-3, disrupt-17)
conj:and(interfere-8, disrupt-17)
compound(expression-19, gene-18)
dobj(disrupt-17, expression-19)
nsubj(lead-26, expression-19)
acl(expression-19, involved-20)
case(synthesis-23, in-21)
amod(synthesis-23, thyroid_hormone-22)
nmod:in(involved-20, synthesis-23)
ref(expression-19, which-24)
aux(lead-26, may-25)
acl:relcl(expression-19, lead-26)
case(effects-30, to-27)
amod(effects-30, adverse-28)
compound(effects-30, health-29)
nmod:to(lead-26, effects-30)

Skeletal/JJ muscle/NN differentiation/NN is_a/NN highly/RB regulated/VBN process/NN that/WDT involves/VBZ the/DT activation/NN of/IN specific/JJ signaling/VBG pathways/NNS ,/, including/VBG the/DT inhibitor/NN of/IN apoptosis/NNS -LRB-/-LRB- IAP/NNP -RRB-/-RRB- pathway/RB ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NN differentiation) (NN is_a))
    (ADVP (RB highly))
    (VP (VBN regulated)
      (NP
        (NP (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP (JJ specific) (VBG signaling) (NNS pathways))))))))
      (, ,)
      (S
        (VP (VBG including)
          (NP
            (NP (DT the) (NN inhibitor))
            (PP (IN of)
              (NP
                (NP (NNS apoptosis))
                (PRN (-LRB- -LRB-)
                  (NP (NNP IAP))
                  (-RRB- -RRB-)))))
          (ADVP (RB pathway)))))
    (. .)))

amod(is_a-4, Skeletal-1)
compound(is_a-4, muscle-2)
compound(is_a-4, differentiation-3)
nsubj(regulated-6, is_a-4)
advmod(regulated-6, highly-5)
root(ROOT-0, regulated-6)
dobj(regulated-6, process-7)
nsubj(involves-9, process-7)
ref(process-7, that-8)
acl:relcl(process-7, involves-9)
det(activation-11, the-10)
dobj(involves-9, activation-11)
case(pathways-15, of-12)
amod(pathways-15, specific-13)
amod(pathways-15, signaling-14)
nmod:of(activation-11, pathways-15)
advcl(regulated-6, including-17)
det(inhibitor-19, the-18)
dobj(including-17, inhibitor-19)
case(apoptosis-21, of-20)
nmod:of(inhibitor-19, apoptosis-21)
appos(apoptosis-21, IAP-23)
advmod(including-17, pathway-25)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN LCL161/NNP on/IN IAP-SPECT/JJ protein/NN levels/NNS and/CC half-life/NN during/IN skeletal_muscle/JJ differentiation/NN using/VBG C2C12/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP LCL161))))
      (PP (IN on)
        (NP
          (NP (JJ IAP-SPECT) (NN protein) (NNS levels))
          (CC and)
          (NP (NN half-life))))
      (PP (IN during)
        (NP
          (NP (JJ skeletal_muscle) (NN differentiation))
          (VP (VBG using)
            (NP (CD C2C12) (NNS cells))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(LCL161-10, of-9)
nmod:of(effect-8, LCL161-10)
case(levels-14, on-11)
amod(levels-14, IAP-SPECT-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
cc(levels-14, and-15)
nmod:on(investigated-6, half-life-16)
conj:and(levels-14, half-life-16)
case(differentiation-19, during-17)
amod(differentiation-19, skeletal_muscle-18)
nmod:during(investigated-6, differentiation-19)
acl(differentiation-19, using-20)
nummod(cells-22, C2C12-21)
dobj(using-20, cells-22)

Our/PRP$ results/NNS showed/VBD that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, LCL161/CD up-regulated/JJ IAP-SPECT/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ IAP-SPECT/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-))
                    (, ,)
                    (NP
                      (NP (CD LCL161) (JJ up-regulated) (JJ IAP-SPECT) (NN protein) (NNS levels))
                      (NP (NN in_a) (JJ time-dependent) (NN manner))))
                  (CC and)
                  (NX (JJ prolonged) (JJ IAP-SPECT) (NN protein)))
                (NX (NN half-life)))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(cultured-9, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
ccomp(showed-3, cultured-9)
dep(half-life-38, in_a-10)
compound(differentiation-13, medium-11)
amod(differentiation-13, favoring-12)
dep(half-life-38, differentiation-13)
dep(differentiation-13, Dulbecco-15)
case(medium-18, modified-16)
compound(medium-18, Eagle-17)
nmod:modified(Dulbecco-15, medium-18)
acl(medium-18, containing-19)
compound(%-21, 2-20)
amod(serum-23, %-21)
compound(serum-23, horse-22)
dobj(containing-19, serum-23)
nummod(levels-30, LCL161-26)
amod(levels-30, up-regulated-27)
amod(levels-30, IAP-SPECT-28)
compound(levels-30, protein-29)
dep(differentiation-13, levels-30)
compound(manner-33, in_a-31)
amod(manner-33, time-dependent-32)
dep(levels-30, manner-33)
cc(differentiation-13, and-34)
amod(protein-37, prolonged-35)
amod(protein-37, IAP-SPECT-36)
conj:and(differentiation-13, protein-37)
dep(half-life-38, protein-37)
dobj(cultured-9, half-life-38)
case(hours-43, from-39)
compound(18-42, 10-40)
dep(18-42, to-41)
nummod(hours-43, 18-42)
nmod:from(cultured-9, hours-43)

These/DT findings/NNS suggest/VBP that/IN LCL161/NNP may/MD play/VB a/DT role/NN in/IN promoting/VBG skeletal_muscle/JJ differentiation/NN through/IN its/PRP$ regulation/NN of/IN the/DT IAP/NNP pathway/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP LCL161))
          (VP (MD may)
            (VP (VB play)
              (NP (DT a) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG promoting)
                    (NP (JJ skeletal_muscle) (NN differentiation))
                    (PP (IN through)
                      (NP
                        (NP (PRP$ its) (NN regulation))
                        (PP (IN of)
                          (NP (DT the) (NNP IAP) (NN pathway)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, LCL161-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(promoting-11, in-10)
advcl(play-7, promoting-11)
amod(differentiation-13, skeletal_muscle-12)
dobj(promoting-11, differentiation-13)
case(regulation-16, through-14)
nmod:poss(regulation-16, its-15)
nmod:through(promoting-11, regulation-16)
case(pathway-20, of-17)
det(pathway-20, the-18)
compound(pathway-20, IAP-19)
nmod:of(regulation-16, pathway-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT effect/NN and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN LCL161/NNP in/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN effect))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP LCL161))))
                (PP (IN in)
                  (NP (JJ skeletal_muscle) (NNS disorders)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effect-12, this-11)
dobj(underlying-10, effect-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
det(applications-19, the-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
dobj(explore-15, applications-19)
case(LCL161-21, of-20)
nmod:of(applications-19, LCL161-21)
case(disorders-24, in-22)
amod(disorders-24, skeletal_muscle-23)
nmod:in(explore-15, disorders-24)

The/DT solute_carrier_family_1/NNP -LRB-/-LRB- SLC1/NNP -RRB-/-RRB- is/VBZ comprised/VBN of/IN a/DT group/NN of/IN proteins/NNS that/WDT function/VBP as/IN high-affinity/JJ glutamate_transporters/NNS ,/, including/VBG EAAC1/NNP ,/, GLT-1/NNP ,/, GLAST/NNP ,/, EAAT4/NNP and/CC EAAT5/NNP -LRB-/-LRB- SLC1A1/NNP ,/, SLC1A2/NNP ,/, SLC1A3/NNP ,/, SLC1A6/NNP and/CC SLC1A7/NNP respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNP solute_carrier_family_1) (-LRB- -LRB-) (NNP SLC1) (-RRB- -RRB-))
    (VP (VBZ is)
      (VP (VBN comprised)
        (PP (IN of)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP
                (NP (NNS proteins))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBP function)
                      (PP (IN as)
                        (NP (JJ high-affinity) (NNS glutamate_transporters))))))))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (NNP EAAC1) (, ,) (NNP GLT-1) (, ,) (NNP GLAST) (, ,) (NNP EAAT4)
                  (CC and)
                  (NNP EAAT5))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP SLC1A1))
                    (, ,)
                    (NP
                      (NP (NNP SLC1A2) (, ,) (NNP SLC1A3) (, ,) (NNP SLC1A6)
                        (CC and)
                        (NNP SLC1A7))
                      (ADVP (RB respectively))))
                  (-RRB- -RRB-))))))))
    (. .)))

det(SLC1-4, The-1)
compound(SLC1-4, solute_carrier_family_1-2)
nsubjpass(comprised-7, SLC1-4)
auxpass(comprised-7, is-6)
root(ROOT-0, comprised-7)
case(group-10, of-8)
det(group-10, a-9)
nmod:of(comprised-7, group-10)
case(proteins-12, of-11)
nmod:of(group-10, proteins-12)
nsubj(function-14, proteins-12)
ref(proteins-12, that-13)
acl:relcl(proteins-12, function-14)
case(glutamate_transporters-17, as-15)
amod(glutamate_transporters-17, high-affinity-16)
nmod:as(function-14, glutamate_transporters-17)
acl(group-10, including-19)
dobj(including-19, EAAC1-20)
dobj(including-19, GLT-1-22)
conj:and(EAAC1-20, GLT-1-22)
dobj(including-19, GLAST-24)
conj:and(EAAC1-20, GLAST-24)
dobj(including-19, EAAT4-26)
conj:and(EAAC1-20, EAAT4-26)
cc(EAAC1-20, and-27)
dobj(including-19, EAAT5-28)
conj:and(EAAC1-20, EAAT5-28)
dep(EAAC1-20, SLC1A1-30)
appos(SLC1A1-30, SLC1A2-32)
appos(SLC1A1-30, SLC1A3-34)
conj:and(SLC1A2-32, SLC1A3-34)
appos(SLC1A1-30, SLC1A6-36)
conj:and(SLC1A2-32, SLC1A6-36)
cc(SLC1A2-32, and-37)
appos(SLC1A1-30, SLC1A7-38)
conj:and(SLC1A2-32, SLC1A7-38)
advmod(SLC1A2-32, respectively-39)

Additionally/RB ,/, this/DT family/NN also/RB includes/VBZ two/CD neutral/JJ iodoantipyrine/JJ transporters/NNS ,/, C-11/NNP and/CC ASCT2/NNP -LRB-/-LRB- SLC1A4/NNP and/CC ALC1A5/NNP respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT this) (NN family))
    (ADVP (RB also))
    (VP (VBZ includes)
      (NP
        (NP (CD two) (JJ neutral) (JJ iodoantipyrine) (NNS transporters))
        (, ,)
        (NP
          (NP (NNP C-11)
            (CC and)
            (NNP ASCT2))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP SLC1A4)
                (CC and)
                (NNP ALC1A5))
              (ADJP (RB respectively)))
            (-RRB- -RRB-)))))
    (. .)))

advmod(includes-6, Additionally-1)
det(family-4, this-3)
nsubj(includes-6, family-4)
advmod(includes-6, also-5)
root(ROOT-0, includes-6)
nummod(transporters-10, two-7)
amod(transporters-10, neutral-8)
amod(transporters-10, iodoantipyrine-9)
dobj(includes-6, transporters-10)
appos(transporters-10, C-11-12)
cc(C-11-12, and-13)
appos(transporters-10, ASCT2-14)
conj:and(C-11-12, ASCT2-14)
dep(C-11-12, SLC1A4-16)
cc(SLC1A4-16, and-17)
dep(C-11-12, ALC1A5-18)
conj:and(SLC1A4-16, ALC1A5-18)
amod(SLC1A4-16, respectively-19)

These/DT transporters/NNS are/VBP responsible/JJ for/IN the/DT uptake/NN of/IN glutamate/JJ and/CC other/JJ amino_acids/NNS into/IN cells/NNS and/CC play/VB a/DT crucial/JJ role/NN in/IN regulating/VBG neurotransmitter/NN levels/NNS in/IN the/DT brain/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS transporters))
    (VP
      (VP (VBP are)
        (ADJP (JJ responsible)
          (PP (IN for)
            (NP
              (NP (DT the) (NN uptake))
              (PP (IN of)
                (NP (JJ glutamate)
                  (CC and)
                  (JJ other) (NNS amino_acids))))))
        (PP (IN into)
          (NP (NNS cells))))
      (CC and)
      (VP (VB play)
        (NP
          (NP (DT a) (JJ crucial) (NN role))
          (PP (IN in)
            (S
              (VP (VBG regulating)
                (NP (NN neurotransmitter) (NNS levels))
                (PP (IN in)
                  (NP (DT the) (NN brain)))))))))
    (. .)))

det(transporters-2, These-1)
nsubj(responsible-4, transporters-2)
nsubj(play-16, transporters-2)
cop(responsible-4, are-3)
root(ROOT-0, responsible-4)
case(uptake-7, for-5)
det(uptake-7, the-6)
nmod:for(responsible-4, uptake-7)
case(amino_acids-12, of-8)
amod(amino_acids-12, glutamate-9)
cc(glutamate-9, and-10)
conj:and(glutamate-9, other-11)
amod(amino_acids-12, other-11)
nmod:of(uptake-7, amino_acids-12)
case(cells-14, into-13)
nmod:into(responsible-4, cells-14)
cc(responsible-4, and-15)
conj:and(responsible-4, play-16)
det(role-19, a-17)
amod(role-19, crucial-18)
dobj(play-16, role-19)
mark(regulating-21, in-20)
acl(role-19, regulating-21)
compound(levels-23, neurotransmitter-22)
dobj(regulating-21, levels-23)
case(brain-26, in-24)
det(brain-26, the-25)
nmod:in(regulating-21, brain-26)

Dysregulation/NN of/IN these/DT transporters/NNS has_been/VBP implicated/VBN in_a/JJ number/NN of/IN neurological_disorders/NNS such/JJ as/IN epilepsy/NN ,/, schizophrenia/NN ,/, and/CC Alzheimer/NNP 's/POS _/JJ disease/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Dysregulation))
      (PP (IN of)
        (NP (DT these) (NNS transporters))))
    (VP (VBP has_been)
      (VP (VBN implicated)
        (NP
          (NP (JJ in_a) (NN number))
          (PP (IN of)
            (NP
              (NP (NNS neurological_disorders))
              (PP (JJ such) (IN as)
                (NP
                  (NP (NN epilepsy))
                  (, ,)
                  (NP (NN schizophrenia))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (NNP Alzheimer) (POS 's))
                    (JJ _) (NN disease)))))))))
    (. .)))

nsubj(has_been-5, Dysregulation-1)
case(transporters-4, of-2)
det(transporters-4, these-3)
nmod:of(Dysregulation-1, transporters-4)
root(ROOT-0, has_been-5)
dep(has_been-5, implicated-6)
amod(number-8, in_a-7)
dobj(implicated-6, number-8)
case(neurological_disorders-10, of-9)
nmod:of(number-8, neurological_disorders-10)
case(epilepsy-13, such-11)
mwe(such-11, as-12)
nmod:such_as(neurological_disorders-10, epilepsy-13)
nmod:such_as(neurological_disorders-10, schizophrenia-15)
conj:and(epilepsy-13, schizophrenia-15)
cc(epilepsy-13, and-17)
nmod:poss(disease-21, Alzheimer-18)
case(Alzheimer-18, 's-19)
amod(disease-21, _-20)
nmod:such_as(neurological_disorders-10, disease-21)
conj:and(epilepsy-13, disease-21)

Understanding/VBG the/DT function/NN of/IN these/DT transporters/NNS is/VBZ therefore/RB essential/JJ for/IN developing/VBG new/JJ therapies/NNS to/TO treat/VB these/DT conditions/NNS ./.

(ROOT
  (S
    (S
      (VP (VBG Understanding)
        (NP
          (NP (DT the) (NN function))
          (PP (IN of)
            (NP (DT these) (NNS transporters))))))
    (VP (VBZ is)
      (ADJP (RB therefore) (JJ essential)
        (PP (IN for)
          (S
            (VP (VBG developing)
              (NP (JJ new) (NNS therapies))
              (S
                (VP (TO to)
                  (VP (VB treat)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

csubj(essential-9, Understanding-1)
det(function-3, the-2)
dobj(Understanding-1, function-3)
case(transporters-6, of-4)
det(transporters-6, these-5)
nmod:of(function-3, transporters-6)
cop(essential-9, is-7)
advmod(essential-9, therefore-8)
root(ROOT-0, essential-9)
mark(developing-11, for-10)
advcl(essential-9, developing-11)
amod(therapies-13, new-12)
dobj(developing-11, therapies-13)
mark(treat-15, to-14)
advcl(developing-11, treat-15)
det(conditions-17, these-16)
dobj(treat-15, conditions-17)

In/IN this/DT review/NN article/NN ,/, we/PRP discuss/VB the/DT current/JJ knowledge/NN on/IN the/DT structure/NN and/CC function/NN of/IN the/DT SLC1/NNP family/NN transporters/NNS and/CC their/PRP$ potential/JJ as/IN targets/NNS for/IN drug/NN development/NN in/IN neurological_disorders/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review) (NN article)))
    (, ,)
    (NP (PRP we))
    (VP (VB discuss)
      (NP (DT the) (JJ current) (NN knowledge))
      (PP (IN on)
        (NP
          (NP
            (NP (DT the) (NN structure)
              (CC and)
              (NN function))
            (PP (IN of)
              (NP (DT the) (NNP SLC1) (NN family) (NNS transporters))))
          (CC and)
          (NP (PRP$ their)
            (ADJP (JJ potential)
              (PP (IN as)
                (NP
                  (NP (NNS targets))
                  (PP (IN for)
                    (NP (NN drug))))))
            (NN development))))
      (PP (IN in)
        (NP (NNS neurological_disorders))))
    (. .)))

case(article-4, In-1)
det(article-4, this-2)
compound(article-4, review-3)
nmod:in(discuss-7, article-4)
nsubj(discuss-7, we-6)
root(ROOT-0, discuss-7)
det(knowledge-10, the-8)
amod(knowledge-10, current-9)
dobj(discuss-7, knowledge-10)
case(structure-13, on-11)
det(structure-13, the-12)
nmod:on(discuss-7, structure-13)
cc(structure-13, and-14)
nmod:on(discuss-7, function-15)
conj:and(structure-13, function-15)
case(transporters-20, of-16)
det(transporters-20, the-17)
compound(transporters-20, SLC1-18)
compound(transporters-20, family-19)
nmod:of(structure-13, transporters-20)
cc(structure-13, and-21)
nmod:poss(development-28, their-22)
amod(development-28, potential-23)
case(targets-25, as-24)
nmod:as(potential-23, targets-25)
case(drug-27, for-26)
nmod:for(targets-25, drug-27)
nmod:on(discuss-7, development-28)
conj:and(structure-13, development-28)
case(neurological_disorders-30, in-29)
nmod:in(discuss-7, neurological_disorders-30)

7-t-butyldimethylsilyl-10-hydroxycamptothecin/JJ -LRB-/-LRB- BS-10HCT/NNP -RRB-/-RRB- is_a/VBZ potent/JJ antitumor/NN agent/NN that/WDT has/VBZ shown/VBN promising/JJ results/NNS in/IN preclinical/JJ studies/NNS ./.

(ROOT
  (SINV
    (ADJP (JJ 7-t-butyldimethylsilyl-10-hydroxycamptothecin))
    (PRN (-LRB- -LRB-)
      (NP (NNP BS-10HCT))
      (-RRB- -RRB-))
    (VP (VBZ is_a))
    (NP
      (NP (JJ potent) (NN antitumor) (NN agent))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ has)
            (VP (VBN shown)
              (NP (JJ promising) (NNS results))
              (PP (IN in)
                (NP (JJ preclinical) (NNS studies))))))))
    (. .)))

dep(is_a-5, 7-t-butyldimethylsilyl-10-hydroxycamptothecin-1)
dep(is_a-5, BS-10HCT-3)
root(ROOT-0, is_a-5)
amod(agent-8, potent-6)
compound(agent-8, antitumor-7)
nsubj(is_a-5, agent-8)
nsubj(shown-11, agent-8)
ref(agent-8, that-9)
aux(shown-11, has-10)
acl:relcl(agent-8, shown-11)
amod(results-13, promising-12)
dobj(shown-11, results-13)
case(studies-16, in-14)
amod(studies-16, preclinical-15)
nmod:in(shown-11, studies-16)

However/RB ,/, the/DT clinical/JJ use/NN of/IN BS-10HCT/NN is/VBZ limited/VBN by/IN its/PRP$ toxicity/NN and/CC narrow/JJ therapeutic/JJ window/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (JJ clinical) (NN use))
      (PP (IN of)
        (NP (NN BS-10HCT))))
    (VP (VBZ is)
      (VP (VBN limited)
        (PP (IN by)
          (NP
            (NP (PRP$ its) (NN toxicity))
            (CC and)
            (NP (JJ narrow) (JJ therapeutic) (NN window))))))
    (. .)))

advmod(limited-9, However-1)
det(use-5, the-3)
amod(use-5, clinical-4)
nsubjpass(limited-9, use-5)
case(BS-10HCT-7, of-6)
nmod:of(use-5, BS-10HCT-7)
auxpass(limited-9, is-8)
root(ROOT-0, limited-9)
case(toxicity-12, by-10)
nmod:poss(toxicity-12, its-11)
nmod:by(limited-9, toxicity-12)
cc(toxicity-12, and-13)
amod(window-16, narrow-14)
amod(window-16, therapeutic-15)
nmod:by(limited-9, window-16)
conj:and(toxicity-12, window-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT potential/NN of/IN urinary/JJ excretion/NN of/IN 3-hydroxyisovaleric_acid/JJ -LRB-/-LRB- 3-HIA/CD -RRB-/-RRB- and/CC 7-t-butyldimethylsilyl-10-hydroxycamptothecin/JJ -LRB-/-LRB- BS-10HCT/NNP -RRB-/-RRB- as/IN early/JJ indicators/NNS of/IN decreased/VBN BS-10HCT/NN status/NN in/IN experimental/JJ BS-10HCT/NN deficiency/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN potential))
        (PP (IN of)
          (NP
            (NP (JJ urinary) (NN excretion))
            (PP (IN of)
              (NP
                (NP
                  (NP (JJ 3-hydroxyisovaleric_acid))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 3-HIA))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (JJ 7-t-butyldimethylsilyl-10-hydroxycamptothecin))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP BS-10HCT))
                    (-RRB- -RRB-))))))))
      (PP (IN as)
        (NP
          (NP (JJ early) (NNS indicators))
          (PP (IN of)
            (NP
              (NP (VBN decreased) (NN BS-10HCT) (NN status))
              (PP (IN in)
                (NP (JJ experimental) (NN BS-10HCT) (NN deficiency))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(potential-8, the-7)
dobj(investigated-6, potential-8)
case(excretion-11, of-9)
amod(excretion-11, urinary-10)
nmod:of(potential-8, excretion-11)
case(3-hydroxyisovaleric_acid-13, of-12)
nmod:of(excretion-11, 3-hydroxyisovaleric_acid-13)
appos(3-hydroxyisovaleric_acid-13, 3-HIA-15)
cc(3-hydroxyisovaleric_acid-13, and-17)
nmod:of(excretion-11, 7-t-butyldimethylsilyl-10-hydroxycamptothecin-18)
conj:and(3-hydroxyisovaleric_acid-13, 7-t-butyldimethylsilyl-10-hydroxycamptothecin-18)
appos(7-t-butyldimethylsilyl-10-hydroxycamptothecin-18, BS-10HCT-20)
case(indicators-24, as-22)
amod(indicators-24, early-23)
nmod:as(investigated-6, indicators-24)
case(status-28, of-25)
amod(status-28, decreased-26)
compound(status-28, BS-10HCT-27)
nmod:of(indicators-24, status-28)
case(deficiency-32, in-29)
amod(deficiency-32, experimental-30)
compound(deficiency-32, BS-10HCT-31)
nmod:in(status-28, deficiency-32)

Our/PRP$ results/NNS showed/VBD that/IN increased/VBN urinary/JJ excretion/NN of/IN 3-HIA/CD and/CC decreased/VBN urinary/JJ excretion/NN of/IN BS-10HCT/NN were/VBD highly/RB sensitive/JJ early/JJ indicators/NNS of/IN decreased/VBN BS-10HCT/NN status/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP
              (NP (VBN increased) (JJ urinary) (NN excretion))
              (PP (IN of)
                (NP (CD 3-HIA))))
            (CC and)
            (NP
              (NP (VBN decreased) (JJ urinary) (NN excretion))
              (PP (IN of)
                (NP (NN BS-10HCT)))))
          (VP (VBD were)
            (NP
              (NP
                (ADJP (RB highly) (JJ sensitive))
                (JJ early) (NNS indicators))
              (PP (IN of)
                (NP (VBN decreased) (NN BS-10HCT) (NN status))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(indicators-20, that-4)
amod(excretion-7, increased-5)
amod(excretion-7, urinary-6)
nsubj(indicators-20, excretion-7)
case(3-HIA-9, of-8)
nmod:of(excretion-7, 3-HIA-9)
cc(excretion-7, and-10)
amod(excretion-13, decreased-11)
amod(excretion-13, urinary-12)
conj:and(excretion-7, excretion-13)
nsubj(indicators-20, excretion-13)
case(BS-10HCT-15, of-14)
nmod:of(excretion-13, BS-10HCT-15)
cop(indicators-20, were-16)
advmod(sensitive-18, highly-17)
amod(indicators-20, sensitive-18)
amod(indicators-20, early-19)
ccomp(showed-3, indicators-20)
case(status-24, of-21)
amod(status-24, decreased-22)
compound(status-24, BS-10HCT-23)
nmod:of(indicators-20, status-24)

These/DT findings/NNS suggest/VBP that/IN monitoring/VBG urinary/JJ excretion/NN of/IN 3-HIA/NNP and/CC BS-10HCT/NNP could/MD be/VB a/DT useful/JJ tool/NN for/IN assessing/VBG the/DT efficacy/NN and/CC toxicity/NN of/IN BS-10HCT/NN in/IN clinical/JJ trials/NNS ,/, and/CC may/MD help/VB to/TO optimize/VB its/PRP$ dosing/JJ regimen/NN to/TO improve/VB patient/JJ outcomes/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG monitoring)
              (NP
                (NP (JJ urinary) (NN excretion))
                (PP (IN of)
                  (NP (NNP 3-HIA)
                    (CC and)
                    (NNP BS-10HCT))))))
          (VP
            (VP (MD could)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ useful) (NN tool))
                  (PP (IN for)
                    (S
                      (VP (VBG assessing)
                        (NP
                          (NP (DT the) (NN efficacy)
                            (CC and)
                            (NN toxicity))
                          (PP (IN of)
                            (NP
                              (NP (NN BS-10HCT))
                              (PP (IN in)
                                (NP (JJ clinical) (NNS trials))))))))))))
            (, ,)
            (CC and)
            (VP (MD may)
              (VP (VB help)
                (S
                  (VP (TO to)
                    (VP (VB optimize)
                      (NP (PRP$ its) (JJ dosing) (NN regimen))
                      (S
                        (VP (TO to)
                          (VP (VB improve)
                            (NP (JJ patient) (NNS outcomes))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(tool-16, that-4)
csubj(tool-16, monitoring-5)
csubj(help-31, monitoring-5)
amod(excretion-7, urinary-6)
dobj(monitoring-5, excretion-7)
case(3-HIA-9, of-8)
nmod:of(excretion-7, 3-HIA-9)
cc(3-HIA-9, and-10)
nmod:of(excretion-7, BS-10HCT-11)
conj:and(3-HIA-9, BS-10HCT-11)
aux(tool-16, could-12)
cop(tool-16, be-13)
det(tool-16, a-14)
amod(tool-16, useful-15)
ccomp(suggest-3, tool-16)
mark(assessing-18, for-17)
acl(tool-16, assessing-18)
det(efficacy-20, the-19)
dobj(assessing-18, efficacy-20)
cc(efficacy-20, and-21)
dobj(assessing-18, toxicity-22)
conj:and(efficacy-20, toxicity-22)
case(BS-10HCT-24, of-23)
nmod:of(efficacy-20, BS-10HCT-24)
case(trials-27, in-25)
amod(trials-27, clinical-26)
nmod:in(BS-10HCT-24, trials-27)
cc(tool-16, and-29)
aux(help-31, may-30)
ccomp(suggest-3, help-31)
conj:and(tool-16, help-31)
mark(optimize-33, to-32)
xcomp(help-31, optimize-33)
nmod:poss(regimen-36, its-34)
amod(regimen-36, dosing-35)
dobj(optimize-33, regimen-36)
mark(improve-38, to-37)
advcl(optimize-33, improve-38)
amod(outcomes-40, patient-39)
dobj(improve-38, outcomes-40)

Methyl/NNP 2,5-dihydroxycinnamate/CD -LRB-/-LRB- MDHC/NNP -RRB-/-RRB- is_a/VBZ known/VBN compound/NN with/IN potential/JJ therapeutic/JJ properties/NNS for/IN the/DT treatment/NN of/IN migraines/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Methyl) (CD 2,5-dihydroxycinnamate))
      (PRN (-LRB- -LRB-)
        (NP (NNP MDHC))
        (-RRB- -RRB-)))
    (VP (VBZ is_a)
      (VP (VBN known)
        (NP (NN compound))
        (PP (IN with)
          (NP
            (NP (JJ potential) (JJ therapeutic) (NNS properties))
            (PP (IN for)
              (NP
                (NP (DT the) (NN treatment))
                (PP (IN of)
                  (NP (NNS migraines)))))))))
    (. .)))

nsubj(is_a-6, Methyl-1)
nummod(Methyl-1, 2,5-dihydroxycinnamate-2)
appos(Methyl-1, MDHC-4)
root(ROOT-0, is_a-6)
dep(is_a-6, known-7)
dobj(known-7, compound-8)
case(properties-12, with-9)
amod(properties-12, potential-10)
amod(properties-12, therapeutic-11)
nmod:with(known-7, properties-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(properties-12, treatment-15)
case(migraines-17, of-16)
nmod:of(treatment-15, migraines-17)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN MDHC/NNP on/IN migraine_symptoms/NNS were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP MDHC)))
      (PP (IN on)
        (NP (NNS migraine_symptoms))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-12, study-3)
det(effects-6, the-5)
nsubjpass(investigated-12, effects-6)
case(MDHC-8, of-7)
nmod:of(effects-6, MDHC-8)
case(migraine_symptoms-10, on-9)
nmod:on(effects-6, migraine_symptoms-10)
auxpass(investigated-12, were-11)
root(ROOT-0, investigated-12)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS with/IN diagnosed/VBN migraines/NNS ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP (NNS patients)))))
        (PP (IN with)
          (NP (VBN diagnosed) (NNS migraines)))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(group-12, on-10)
det(group-12, a-11)
nmod:on(conducted-9, group-12)
case(patients-14, of-13)
nmod:of(group-12, patients-14)
case(migraines-17, with-15)
amod(migraines-17, diagnosed-16)
nmod:with(conducted-9, migraines-17)

The/DT patients/NNS were/VBD administered/VBN MDHC/NNP or_a/NN placebo/NN and/CC their/PRP$ symptoms/NNS were/VBD monitored/VBN for/IN 2/CD hours/NNS after/IN dosing/VBG ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNS patients))
      (VP (VBD were)
        (VP (VBN administered)
          (NP (NNP MDHC) (NN or_a) (NN placebo)))))
    (CC and)
    (S
      (NP (PRP$ their) (NNS symptoms))
      (VP (VBD were)
        (VP (VBN monitored)
          (PP (IN for)
            (NP (CD 2) (NNS hours)))
          (PP (IN after)
            (S
              (VP (VBG dosing)))))))
    (. .)))

det(patients-2, The-1)
nsubjpass(administered-4, patients-2)
auxpass(administered-4, were-3)
root(ROOT-0, administered-4)
compound(placebo-7, MDHC-5)
compound(placebo-7, or_a-6)
dobj(administered-4, placebo-7)
cc(administered-4, and-8)
nmod:poss(symptoms-10, their-9)
nsubjpass(monitored-12, symptoms-10)
auxpass(monitored-12, were-11)
conj:and(administered-4, monitored-12)
case(hours-15, for-13)
nummod(hours-15, 2-14)
nmod:for(monitored-12, hours-15)
mark(dosing-17, after-16)
advcl(monitored-12, dosing-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, MDHC/NNP reduced/VBD the/DT risk/NN of/IN hypersegmentation/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP MDHC))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN hypersegmentation))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-12, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-12, MDHC-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(hypersegmentation-16, of-15)
nmod:of(risk-14, hypersegmentation-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN MDHC/NNP has/VBZ potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN migraines/NNS and/CC may/MD be/VB useful/JJ in/IN reducing/VBG migraine-associated_symptoms/NNS such/JJ as/IN hypersegmentation/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP MDHC))
          (VP
            (VP (VBZ has)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NNS migraines))))))))
            (CC and)
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ useful)
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP (NNS migraine-associated_symptoms))
                          (PP (JJ such) (IN as)
                            (NP
                              (NP (NN hypersegmentation))
                              (, ,)
                              (NP (NN photophobia))
                              (, ,)
                              (CC and)
                              (NP (NN phonophobia)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(has-6, that-4)
nsubj(has-6, MDHC-5)
nsubj(useful-20, MDHC-5)
ccomp(suggest-3, has-6)
xcomp(has-6, potential-7)
case(agent-11, as-8)
det(agent-11, a-9)
amod(agent-11, therapeutic-10)
nmod:as(has-6, agent-11)
case(treatment-14, for-12)
det(treatment-14, the-13)
nmod:for(agent-11, treatment-14)
case(migraines-16, of-15)
nmod:of(treatment-14, migraines-16)
cc(has-6, and-17)
aux(useful-20, may-18)
cop(useful-20, be-19)
ccomp(suggest-3, useful-20)
conj:and(has-6, useful-20)
mark(reducing-22, in-21)
advcl(useful-20, reducing-22)
dobj(reducing-22, migraine-associated_symptoms-23)
case(hypersegmentation-26, such-24)
mwe(such-24, as-25)
nmod:such_as(migraine-associated_symptoms-23, hypersegmentation-26)
nmod:such_as(migraine-associated_symptoms-23, photophobia-28)
conj:and(hypersegmentation-26, photophobia-28)
cc(hypersegmentation-26, and-30)
nmod:such_as(migraine-associated_symptoms-23, phonophobia-31)
conj:and(hypersegmentation-26, phonophobia-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN treatment/NN with/IN MDHC/NNP ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (NN treatment))
                      (PP (IN with)
                        (NP (NNP MDHC))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
det(dosage-18, the-16)
amod(dosage-18, optimal-17)
dobj(determine-15, dosage-18)
cc(dosage-18, and-19)
dobj(determine-15, duration-20)
conj:and(dosage-18, duration-20)
case(treatment-22, of-21)
nmod:of(dosage-18, treatment-22)
case(MDHC-24, with-23)
nmod:with(treatment-22, MDHC-24)

Histamine/JJ 2/CD receptors/NNS -LRB-/-LRB- H2R/NNP -RRB-/-RRB- are/VBP G_protein-coupled_receptors/NNS that/WDT play/VBP an/DT important/JJ role/NN in/IN regulating/VBG vascular/NN tone/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Histamine) (CD 2) (NNS receptors))
      (PRN (-LRB- -LRB-)
        (NP (NNP H2R))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (NNS G_protein-coupled_receptors))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NN vascular) (NN tone)))))))))))
    (. .)))

amod(receptors-3, Histamine-1)
nummod(receptors-3, 2-2)
nsubj(G_protein-coupled_receptors-8, receptors-3)
appos(receptors-3, H2R-5)
cop(G_protein-coupled_receptors-8, are-7)
root(ROOT-0, G_protein-coupled_receptors-8)
nsubj(play-10, G_protein-coupled_receptors-8)
ref(G_protein-coupled_receptors-8, that-9)
acl:relcl(G_protein-coupled_receptors-8, play-10)
det(role-13, an-11)
amod(role-13, important-12)
dobj(play-10, role-13)
mark(regulating-15, in-14)
acl(role-13, regulating-15)
compound(tone-17, vascular-16)
dobj(regulating-15, tone-17)

Activation/NN of/IN H2R/NNP has_been/VBP shown/VBN to/TO stimulate/VB meciadanol/JJ metabolism/NN in/IN the/DT endothelium/NN of/IN the/DT bovine/JJ pulmonary_artery/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Activation))
      (PP (IN of)
        (NP (NNP H2R))))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB stimulate)
              (NP (JJ meciadanol) (NN metabolism))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN endothelium))
                  (PP (IN of)
                    (NP (DT the) (JJ bovine) (NN pulmonary_artery))))))))))
    (. .)))

nsubj(has_been-4, Activation-1)
case(H2R-3, of-2)
nmod:of(Activation-1, H2R-3)
root(ROOT-0, has_been-4)
dep(has_been-4, shown-5)
mark(stimulate-7, to-6)
xcomp(shown-5, stimulate-7)
amod(metabolism-9, meciadanol-8)
dobj(stimulate-7, metabolism-9)
case(endothelium-12, in-10)
det(endothelium-12, the-11)
nmod:in(stimulate-7, endothelium-12)
case(pulmonary_artery-16, of-13)
det(pulmonary_artery-16, the-14)
amod(pulmonary_artery-16, bovine-15)
nmod:of(endothelium-12, pulmonary_artery-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT signaling/VBG pathways/NNS involved/VBN in/IN this/DT process/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (VBG signaling) (NNS pathways))
        (VP (VBN involved)
          (PP (IN in)
            (NP (DT this) (NN process))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(pathways-9, the-7)
amod(pathways-9, signaling-8)
dobj(investigated-6, pathways-9)
acl(pathways-9, involved-10)
case(process-13, in-11)
det(process-13, this-12)
nmod:in(involved-10, process-13)

We/PRP found/VBD that/IN activation/NN of/IN meciadanol/JJ metabolism/NN by/IN H2R/NNP was/VBD not/RB blocked/VBN by/IN pertussis/NN toxin/NN ,/, which/WDT ADP-ribosylates/VBZ a/DT membrane_protein/NN of/IN molecular/JJ mass/NN 40/CD kDa/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP
                (NP (JJ meciadanol) (NN metabolism))
                (PP (IN by)
                  (NP (NNP H2R))))))
          (VP (VBD was) (RB not)
            (VP (VBN blocked)
              (PP (IN by)
                (NP
                  (NP (NN pertussis) (NN toxin))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBZ ADP-ribosylates)
                        (NP
                          (NP (DT a) (NN membrane_protein))
                          (PP (IN of)
                            (NP (JJ molecular) (NN mass) (CD 40) (NN kDa))))))))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(blocked-12, that-3)
nsubjpass(blocked-12, activation-4)
case(metabolism-7, of-5)
amod(metabolism-7, meciadanol-6)
nmod:of(activation-4, metabolism-7)
case(H2R-9, by-8)
nmod:by(metabolism-7, H2R-9)
auxpass(blocked-12, was-10)
neg(blocked-12, not-11)
ccomp(found-2, blocked-12)
case(toxin-15, by-13)
compound(toxin-15, pertussis-14)
nmod:by(blocked-12, toxin-15)
nsubj(ADP-ribosylates-18, toxin-15)
ref(toxin-15, which-17)
acl:relcl(toxin-15, ADP-ribosylates-18)
det(membrane_protein-20, a-19)
dobj(ADP-ribosylates-18, membrane_protein-20)
case(kDa-25, of-21)
amod(kDa-25, molecular-22)
compound(kDa-25, mass-23)
nummod(kDa-25, 40-24)
nmod:of(membrane_protein-20, kDa-25)

However/RB ,/, botulinum/NN toxin/NN ,/, which/WDT ADP-ribosylates/VBZ a/DT membrane_protein/NN of/IN molecular/JJ mass/NN 24/CD kDa/NN ,/, fully/RB blocked/VBD histamine_2_receptor-stimulated/JJ meciadanol/JJ metabolism/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (NN botulinum) (NN toxin))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ ADP-ribosylates)
            (NP
              (NP (DT a) (NN membrane_protein))
              (PP (IN of)
                (NP (JJ molecular) (NN mass) (CD 24) (NN kDa)))))))
      (, ,))
    (ADVP (RB fully))
    (VP (VBD blocked)
      (NP (JJ histamine_2_receptor-stimulated) (JJ meciadanol) (NN metabolism)))
    (. .)))

advmod(blocked-17, However-1)
compound(toxin-4, botulinum-3)
nsubj(ADP-ribosylates-7, toxin-4)
nsubj(blocked-17, toxin-4)
ref(toxin-4, which-6)
acl:relcl(toxin-4, ADP-ribosylates-7)
det(membrane_protein-9, a-8)
dobj(ADP-ribosylates-7, membrane_protein-9)
case(kDa-14, of-10)
amod(kDa-14, molecular-11)
compound(kDa-14, mass-12)
nummod(kDa-14, 24-13)
nmod:of(membrane_protein-9, kDa-14)
advmod(blocked-17, fully-16)
root(ROOT-0, blocked-17)
amod(metabolism-20, histamine_2_receptor-stimulated-18)
amod(metabolism-20, meciadanol-19)
dobj(blocked-17, metabolism-20)

These/DT results/NNS suggest/VBP that/IN a/DT novel/NN signaling/VBG pathway/RB involving/VBG a/DT membrane_protein/NN with/IN a/DT molecular/JJ mass/NN of/IN 24/CD kDa/NN is/VBZ involved/VBN in/IN H2R-mediated/JJ meciadanol/JJ metabolism/NN in/IN the/DT endothelium/NN of/IN the/DT bovine/JJ pulmonary_artery/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT a) (NN novel))
            (VP (VBG signaling)
              (ADVP (RB pathway))
              (S
                (VP (VBG involving)
                  (NP (DT a) (NN membrane_protein))
                  (PP (IN with)
                    (NP
                      (NP (DT a) (JJ molecular) (NN mass))
                      (PP (IN of)
                        (NP (CD 24) (NN kDa)))))))))
          (VP (VBZ is)
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (JJ H2R-mediated) (JJ meciadanol) (NN metabolism))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN endothelium))
                      (PP (IN of)
                        (NP (DT the) (JJ bovine) (NN pulmonary_artery))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(involved-20, that-4)
det(novel-6, a-5)
nsubjpass(involved-20, novel-6)
acl(novel-6, signaling-7)
advmod(signaling-7, pathway-8)
advcl(signaling-7, involving-9)
det(membrane_protein-11, a-10)
dobj(involving-9, membrane_protein-11)
case(mass-15, with-12)
det(mass-15, a-13)
amod(mass-15, molecular-14)
nmod:with(involving-9, mass-15)
case(kDa-18, of-16)
nummod(kDa-18, 24-17)
nmod:of(mass-15, kDa-18)
auxpass(involved-20, is-19)
ccomp(suggest-3, involved-20)
case(metabolism-24, in-21)
amod(metabolism-24, H2R-mediated-22)
amod(metabolism-24, meciadanol-23)
nmod:in(involved-20, metabolism-24)
case(endothelium-27, in-25)
det(endothelium-27, the-26)
nmod:in(metabolism-24, endothelium-27)
case(pulmonary_artery-31, of-28)
det(pulmonary_artery-31, the-29)
amod(pulmonary_artery-31, bovine-30)
nmod:of(endothelium-27, pulmonary_artery-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT exact/JJ mechanism/NN by/IN which/WDT this/DT pathway/NN regulates/VBZ meciadanol/JJ metabolism/NN and/CC its/PRP$ potential/JJ implications/NNS for/IN cardiovascular_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP (DT the) (JJ exact) (NN mechanism))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (DT this) (NN pathway))
                    (VP (VBZ regulates)
                      (NP
                        (NP (JJ meciadanol) (NN metabolism))
                        (CC and)
                        (NP
                          (NP (PRP$ its) (JJ potential) (NNS implications))
                          (PP (IN for)
                            (NP (NNS cardiovascular_diseases))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(mechanism-9, the-7)
amod(mechanism-9, exact-8)
dobj(determine-6, mechanism-9)
mark(regulates-14, by-10)
dobj(regulates-14, which-11)
det(pathway-13, this-12)
nsubj(regulates-14, pathway-13)
advcl(determine-6, regulates-14)
amod(metabolism-16, meciadanol-15)
dobj(regulates-14, metabolism-16)
cc(metabolism-16, and-17)
nmod:poss(implications-20, its-18)
amod(implications-20, potential-19)
dobj(regulates-14, implications-20)
conj:and(metabolism-16, implications-20)
case(cardiovascular_diseases-22, for-21)
nmod:for(implications-20, cardiovascular_diseases-22)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN the/DT human/JJ diet/NN that/WDT have/VBP been/VBN linked/VBN to/TO various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ human) (NN diet))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP have)
                  (VP (VBN been)
                    (VP (VBN linked)
                      (PP (TO to)
                        (NP (JJ various) (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, the-18)
amod(diet-20, human-19)
nmod:of(components-16, diet-20)
nsubjpass(linked-24, diet-20)
ref(diet-20, that-21)
aux(linked-24, have-22)
auxpass(linked-24, been-23)
acl:relcl(diet-20, linked-24)
case(benefits-28, to-25)
amod(benefits-28, various-26)
compound(benefits-28, health-27)
nmod:to(linked-24, benefits-28)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, specifically/RB EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN beclometasone_dipropionate/NN in/IN hyperbeclometasone/JJ dipropionatemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,) (RB specifically)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN beclometasone_dipropionate))
                        (PP (IN in)
                          (NP (JJ hyperbeclometasone) (JJ dipropionatemic) (NNS patients)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-15, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-15, omega-3_fatty_acids-7)
advmod(omega-3_fatty_acids-7, specifically-9)
dep(omega-3_fatty_acids-7, EPA-10)
cc(EPA-10, and-11)
dep(omega-3_fatty_acids-7, DHA-12)
conj:and(EPA-10, DHA-12)
auxpass(associated-15, are-14)
ccomp(shown-4, associated-15)
case(levels-18, with-16)
amod(levels-18, decreased-17)
nmod:with(associated-15, levels-18)
case(beclometasone_dipropionate-20, of-19)
nmod:of(levels-18, beclometasone_dipropionate-20)
case(patients-24, in-21)
amod(patients-24, hyperbeclometasone-22)
amod(patients-24, dipropionatemic-23)
nmod:in(beclometasone_dipropionate-20, patients-24)

Furthermore/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN found/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(found-7, Furthermore-1)
det(fatty_acids-4, these-3)
nsubjpass(found-7, fatty_acids-4)
nsubj:xsubj(reduce-9, fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(reduce-9, to-8)
xcomp(found-7, reduce-9)
det(risk-11, the-10)
dobj(reduce-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP still/RB being/VBG investigated/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD modulate/VBP immune/JJ responses/NNS and/CC inflammation/NN ,/, which/WDT could/MD explain/VB their/PRP$ ability/NN to/TO reduce/VB beclometasone_dipropionate/JJ levels/NNS and/CC lower/JJR the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB still)
        (VP (VBG being)
          (VP (VBN investigated)))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP
                    (NP (JJ immune) (NNS responses))
                    (CC and)
                    (NP
                      (NP (NN inflammation))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD could)
                            (VP (VB explain)
                              (NP (PRP$ their) (NN ability)
                                (S
                                  (VP (TO to)
                                    (VP (VB reduce)
                                      (NP
                                        (NP (JJ beclometasone_dipropionate) (NNS levels))
                                        (CC and)
                                        (NP
                                          (NP (JJR lower) (DT the) (NN risk))
                                          (PP (IN of)
                                            (NP (NNP CHD))))))))))))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(investigated-9, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
aux(investigated-9, are-6)
advmod(investigated-9, still-7)
auxpass(investigated-9, being-8)
root(ROOT-0, investigated-9)
cc(investigated-9, but-11)
nsubjpass(believed-14, it-12)
auxpass(believed-14, is-13)
conj:but(investigated-9, believed-14)
mark(modulate-20, that-15)
nsubj(modulate-20, EPA-16)
cc(EPA-16, and-17)
conj:and(EPA-16, DHA-18)
nsubj(modulate-20, DHA-18)
aux(modulate-20, may-19)
ccomp(believed-14, modulate-20)
amod(responses-22, immune-21)
dobj(modulate-20, responses-22)
cc(responses-22, and-23)
dobj(modulate-20, inflammation-24)
conj:and(responses-22, inflammation-24)
nsubj(explain-28, inflammation-24)
ref(inflammation-24, which-26)
aux(explain-28, could-27)
acl:relcl(inflammation-24, explain-28)
nmod:poss(ability-30, their-29)
dobj(explain-28, ability-30)
mark(reduce-32, to-31)
acl(ability-30, reduce-32)
amod(levels-34, beclometasone_dipropionate-33)
dobj(reduce-32, levels-34)
cc(levels-34, and-35)
amod(risk-38, lower-36)
det(risk-38, the-37)
dobj(reduce-32, risk-38)
conj:and(levels-34, risk-38)
case(CHD-40, of-39)
nmod:of(risk-38, CHD-40)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN or/CC supplementation/NN with/IN EPA/NNP and/CC DHA/NNP may/MD have/VB therapeutic/JJ potential/NN for/IN individuals/NNS with/IN hyperbeclometasone/JJ dipropionatemia/NN or/CC those/DT at/IN risk/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP (JJ dietary) (NN intake)
                (CC or)
                (NN supplementation))
              (PP (IN with)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA)))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ therapeutic) (NN potential))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP
                        (NP (JJ hyperbeclometasone) (NN dipropionatemia))
                        (CC or)
                        (NP (DT those)))))))
              (PP (IN at)
                (NP
                  (NP (NN risk))
                  (PP (IN for)
                    (NP (NNP CHD))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-15, that-4)
csubj(have-15, increasing-5)
amod(intake-7, dietary-6)
dobj(increasing-5, intake-7)
cc(intake-7, or-8)
dobj(increasing-5, supplementation-9)
conj:or(intake-7, supplementation-9)
case(EPA-11, with-10)
nmod:with(increasing-5, EPA-11)
cc(EPA-11, and-12)
nmod:with(increasing-5, DHA-13)
conj:and(EPA-11, DHA-13)
aux(have-15, may-14)
ccomp(suggest-3, have-15)
amod(potential-17, therapeutic-16)
dobj(have-15, potential-17)
case(individuals-19, for-18)
nmod:for(potential-17, individuals-19)
case(dipropionatemia-22, with-20)
amod(dipropionatemia-22, hyperbeclometasone-21)
nmod:with(individuals-19, dipropionatemia-22)
cc(dipropionatemia-22, or-23)
nmod:with(individuals-19, those-24)
conj:or(dipropionatemia-22, those-24)
case(risk-26, at-25)
nmod:at(have-15, risk-26)
case(CHD-28, for-27)
nmod:for(risk-26, CHD-28)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO investigate/VB the/DT possible/JJ involvement/NN of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/VB -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- ,/, as/RB well/RB as/IN the/DT role/NN of/IN methylation/NN ,/, in/IN the/DT early/JJ effects/NNS of/IN hnRNP_A1/NNS -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP
                (NP (DT the) (JJ possible) (NN involvement))
                (PP (IN of)
                  (NP
                    (NP
                      (NP (NNS adenosine_3) (POS '))
                      (ADJP (CD ,5))
                      ('' ')
                      (PRN (: -)
                        (S
                          (VP (VB cyclic_monophosphate)
                            (NP
                              (NP (-LRB- -LRB-) (NN cAMP) (-RRB- -RRB-))
                              (CC and)
                              (NP
                                (NP (NNS guanosine_3) (POS '))
                                (NX (CD ,5)))
                              ('' '))))
                        (: -))
                      (NN cyclic_monophosphate))
                    (PRN (-LRB- -LRB-)
                      (NP (NN cGMP))
                      (-RRB- -RRB-)))))
              (, ,)
              (CONJP (RB as) (RB well) (IN as))
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP (NN methylation)))))
            (, ,)
            (PP (IN in)
              (NP
                (NP (DT the) (JJ early) (NNS effects))
                (PP (IN of)
                  (NP
                    (NP (NNS hnRNP_A1))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PRL))
                      (-RRB- -RRB-)))))))))
      (PP (IN on)
        (NP (JJ lactose) (NNS biosynthesis))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(involvement-11, the-9)
amod(involvement-11, possible-10)
dobj(investigate-8, involvement-11)
case(cyclic_monophosphate-28, of-12)
nmod:poss(cyclic_monophosphate-28, adenosine_3-13)
case(adenosine_3-13, '-14)
amod(cyclic_monophosphate-28, ,5-15)
dep(cyclic_monophosphate-28, cyclic_monophosphate-18)
dobj(cyclic_monophosphate-18, cAMP-20)
cc(cAMP-20, and-22)
nmod:poss(,5-25, guanosine_3-23)
case(guanosine_3-23, '-24)
dobj(cyclic_monophosphate-18, ,5-25)
conj:and(cAMP-20, ,5-25)
nmod:of(involvement-11, cyclic_monophosphate-28)
appos(cyclic_monophosphate-28, cGMP-30)
cc(involvement-11, as-33)
mwe(as-33, well-34)
mwe(as-33, as-35)
det(role-37, the-36)
dobj(investigate-8, role-37)
conj:and(involvement-11, role-37)
case(methylation-39, of-38)
nmod:of(role-37, methylation-39)
case(effects-44, in-41)
det(effects-44, the-42)
amod(effects-44, early-43)
nmod:in(investigate-8, effects-44)
case(hnRNP_A1-46, of-45)
nmod:of(effects-44, hnRNP_A1-46)
appos(hnRNP_A1-46, PRL-48)
case(biosynthesis-52, on-50)
amod(biosynthesis-52, lactose-51)
nmod:on(aimed-6, biosynthesis-52)

To/TO achieve/VB this/DT ,/, we/PRP utilized/VBD cultured/VBN mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS at/IN 12-14/CD days/NNS of/IN pregnancy/NN ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD utilized)
      (VP (VBN cultured)
        (NP
          (NP (JJ mammary_gland) (NNS explants))
          (VP (VBN derived)
            (PP (IN from)
              (NP (NNS mice)))))
        (PP (IN at)
          (NP
            (NP (CD 12-14) (NNS days))
            (PP (IN of)
              (NP (NN pregnancy)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(utilized-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(utilized-6, we-5)
root(ROOT-0, utilized-6)
dep(utilized-6, cultured-7)
amod(explants-9, mammary_gland-8)
dobj(cultured-7, explants-9)
acl(explants-9, derived-10)
case(mice-12, from-11)
nmod:from(derived-10, mice-12)
case(days-15, at-13)
nummod(days-15, 12-14-14)
nmod:at(cultured-7, days-15)
case(pregnancy-17, of-16)
nmod:of(days-15, pregnancy-17)

Our/PRP$ results/NNS suggest/VBP that/IN cAMP/NN and/CC cGMP/NN may/MD play/VB a/DT crucial/JJ role/NN in/IN regulating/VBG lactose/JJ biosynthesis/NNS downstream/JJ of/IN PRL/NNP signaling/VBG ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cAMP)
            (CC and)
            (NN cGMP))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP
                        (NP (JJ lactose) (NNS biosynthesis))
                        (PP (JJ downstream) (IN of)
                          (NP (NNP PRL))))))))
              (S
                (VP (VBG signaling))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, cAMP-5)
cc(cAMP-5, and-6)
conj:and(cAMP-5, cGMP-7)
nsubj(play-9, cGMP-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-12, a-10)
amod(role-12, crucial-11)
dobj(play-9, role-12)
mark(regulating-14, in-13)
acl(role-12, regulating-14)
amod(biosynthesis-16, lactose-15)
dobj(regulating-14, biosynthesis-16)
case(PRL-19, downstream-17)
case(PRL-19, of-18)
nmod:of(biosynthesis-16, PRL-19)
xcomp(play-9, signaling-20)

Additionally/RB ,/, we/PRP observed/VBD that/IN methylation/NN may/MD also/RB modulate/VBP the/DT effects/NNS of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (SBAR (IN that)
        (S
          (NP (NN methylation))
          (VP (MD may)
            (ADVP (RB also))
            (VP (VBP modulate)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (NNP PRL)))
                (PP (IN on)
                  (NP (JJ lactose) (NNS biosynthesis)))))))))
    (. .)))

advmod(observed-4, Additionally-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
mark(modulate-9, that-5)
nsubj(modulate-9, methylation-6)
aux(modulate-9, may-7)
advmod(modulate-9, also-8)
ccomp(observed-4, modulate-9)
det(effects-11, the-10)
dobj(modulate-9, effects-11)
case(PRL-13, of-12)
nmod:of(effects-11, PRL-13)
case(biosynthesis-16, on-14)
amod(biosynthesis-16, lactose-15)
nmod:on(effects-11, biosynthesis-16)

These/DT findings/NNS provide/VBP valuable/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG lactation/NN and/CC could/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN lactation-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP
          (NP (JJ valuable) (NNS insights))
          (PP (IN into)
            (NP
              (NP (DT the) (JJ molecular) (NNS mechanisms))
              (VP (VBG underlying)
                (NP (NN lactation)))))))
      (CC and)
      (VP (MD could)
        (VP (VB have)
          (NP
            (NP (JJ important) (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP (NNS lactation-related_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-14, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, valuable-4)
dobj(provide-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(insights-5, mechanisms-9)
acl(mechanisms-9, underlying-10)
dobj(underlying-10, lactation-11)
cc(provide-3, and-12)
aux(have-14, could-13)
conj:and(provide-3, have-14)
amod(implications-16, important-15)
dobj(have-14, implications-16)
case(development-19, for-17)
det(development-19, the-18)
nmod:for(implications-16, development-19)
case(strategies-23, of-20)
amod(strategies-23, novel-21)
amod(strategies-23, therapeutic-22)
nmod:of(development-19, strategies-23)
case(lactation-related_disorders-25, for-24)
nmod:for(strategies-23, lactation-related_disorders-25)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB a/DT variety/NN of/IN positive/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (NN variety))
                  (PP (IN of)
                    (NP
                      (NP (JJ positive) (NNS effects))
                      (PP (IN on)
                        (NP (JJ human) (NN health))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-18, omega-3_fatty_acids-2)
nsubj:xsubj(have-20, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
aux(shown-18, have-16)
auxpass(shown-18, been-17)
root(ROOT-0, shown-18)
mark(have-20, to-19)
xcomp(shown-18, have-20)
det(variety-22, a-21)
dobj(have-20, variety-22)
case(effects-25, of-23)
amod(effects-25, positive-24)
nmod:of(variety-22, effects-25)
case(health-28, on-26)
amod(health-28, human-27)
nmod:on(effects-25, health-28)

In/IN particular/JJ ,/, recent/JJ studies/NNS have/VBP found/VBN that/IN EPA/NNP and/CC DHA/NNP are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN CPZ/NNP in/IN hyperCPZmic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (JJ recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN found)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP (NNP CPZ)))
                    (PP (IN in)
                      (NP (JJ hyperCPZmic) (NNS patients)))))))))))
    (. .)))

case(particular-2, In-1)
advcl(found-7, particular-2)
amod(studies-5, recent-4)
nsubj(found-7, studies-5)
aux(found-7, have-6)
root(ROOT-0, found-7)
mark(associated-13, that-8)
nsubjpass(associated-13, EPA-9)
cc(EPA-9, and-10)
conj:and(EPA-9, DHA-11)
nsubjpass(associated-13, DHA-11)
auxpass(associated-13, are-12)
ccomp(found-7, associated-13)
case(levels-16, with-14)
amod(levels-16, decreased-15)
nmod:with(associated-13, levels-16)
case(CPZ-18, of-17)
nmod:of(levels-16, CPZ-18)
case(patients-21, in-19)
amod(patients-21, hyperCPZmic-20)
nmod:in(levels-16, patients-21)

Additionally/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(linked-7, Additionally-1)
det(fatty_acids-4, these-3)
nsubjpass(linked-7, fatty_acids-4)
aux(linked-7, have-5)
auxpass(linked-7, been-6)
root(ROOT-0, linked-7)
case(risk-11, to-8)
det(risk-11, a-9)
amod(risk-11, decreased-10)
nmod:to(linked-7, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC it/PRP has_been/VBP suggested/VBN that/IN they/PRP may/MD be/VB related/VBN to/TO the/DT ability/NN of/IN EPA/NNP and/CC DHA/NNP to/TO modulate/VBP inflammation/NN and/CC lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (SBAR
          (S
            (S
              (NP (DT these) (NNS effects))
              (VP (VBP are)
                (ADJP (RB not) (RB fully) (VBN understood))))
            (, ,)
            (CC but)
            (S
              (NP (PRP it))
              (VP (VBP has_been)
                (VP (VBN suggested)
                  (SBAR (IN that)
                    (S
                      (NP (PRP they))
                      (VP (MD may)
                        (VP (VB be)
                          (VP (VBN related)
                            (PP (TO to)
                              (NP
                                (NP (DT the) (NN ability))
                                (PP (IN of)
                                  (NP (NNP EPA)
                                    (CC and)
                                    (NNP DHA)))))
                            (PP (TO to))))))))))))))
    (VP (VBP modulate)
      (NP
        (NP (NN inflammation))
        (CC and)
        (NP (NN lipid) (NN metabolism))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(modulate-28, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
nsubjpass(understood-9, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
dep(underlying-3, understood-9)
cc(understood-9, but-11)
nsubj(has_been-13, it-12)
dep(underlying-3, has_been-13)
conj:but(understood-9, has_been-13)
dep(has_been-13, suggested-14)
mark(related-19, that-15)
nsubjpass(related-19, they-16)
aux(related-19, may-17)
auxpass(related-19, be-18)
ccomp(suggested-14, related-19)
case(ability-22, to-20)
det(ability-22, the-21)
nmod:to(related-19, ability-22)
case(EPA-24, of-23)
nmod:of(ability-22, EPA-24)
cc(EPA-24, and-25)
nmod:of(ability-22, DHA-26)
conj:and(EPA-24, DHA-26)
case(ability-22, to-27)
root(ROOT-0, modulate-28)
dobj(modulate-28, inflammation-29)
cc(inflammation-29, and-30)
compound(metabolism-32, lipid-31)
dobj(modulate-28, metabolism-32)
conj:and(inflammation-29, metabolism-32)

Given/VBN their/PRP$ potential/JJ health/NN benefits/NNS ,/, there/EX is/VBZ growing/VBG interest/NN in/IN the/DT use/NN of/IN EPA/NNP and/CC DHA/NNP as/IN dietary/JJ supplements/NNS or/CC as/IN components/NNS of/IN functional/JJ foods/NNS ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (VP (VBG growing)
        (NP
          (NP (NN interest))
          (PP (IN in)
            (NP
              (NP (DT the) (NN use))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))))
        (PP
          (PP (IN as)
            (NP (JJ dietary) (NNS supplements)))
          (CC or)
          (PP (IN as)
            (NP
              (NP (NNS components))
              (PP (IN of)
                (NP (JJ functional) (NNS foods))))))))
    (. .)))

case(benefits-5, Given-1)
nmod:poss(benefits-5, their-2)
amod(benefits-5, potential-3)
compound(benefits-5, health-4)
nmod:given(growing-9, benefits-5)
expl(growing-9, there-7)
aux(growing-9, is-8)
root(ROOT-0, growing-9)
conj:or(growing-9, growing-9')
dobj(growing-9, interest-10)
case(use-13, in-11)
det(use-13, the-12)
nmod:in(interest-10, use-13)
case(EPA-15, of-14)
nmod:of(use-13, EPA-15)
cc(EPA-15, and-16)
nmod:of(use-13, DHA-17)
conj:and(EPA-15, DHA-17)
case(supplements-20, as-18)
amod(supplements-20, dietary-19)
nmod:as(growing-9, supplements-20)
cc(growing-9, or-21)
case(components-23, as-22)
nmod:as(growing-9', components-23)
case(foods-26, of-24)
amod(foods-26, functional-25)
nmod:of(components-23, foods-26)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG the/DT effects/NNS of/IN these/DT fatty_acids/NNS on/IN human/JJ health/NN and/CC to/TO determine/VB the/DT optimal/JJ intake/NN levels/NNS for/IN different/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (NNS effects))
                      (PP (IN of)
                        (NP (DT these) (NNS fatty_acids)))
                      (PP (IN on)
                        (NP (JJ human) (NN health))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN intake) (NNS levels))
                  (PP (IN for)
                    (NP (JJ different) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, the-11)
dobj(underlying-10, effects-12)
case(fatty_acids-15, of-13)
det(fatty_acids-15, these-14)
nmod:of(effects-12, fatty_acids-15)
case(health-18, on-16)
amod(health-18, human-17)
nmod:on(effects-12, health-18)
cc(understand-7, and-19)
mark(determine-21, to-20)
ccomp(needed-4, determine-21)
conj:and(understand-7, determine-21)
det(levels-25, the-22)
amod(levels-25, optimal-23)
compound(levels-25, intake-24)
dobj(determine-21, levels-25)
case(populations-28, for-26)
amod(populations-28, different-27)
nmod:for(levels-25, populations-28)

The/DT brain/NN is_a/VBZ complex/JJ network/NN of/IN cells/NNS that/WDT communicate/VB with/IN each/DT other/JJ through/IN various/JJ signaling/VBG molecules/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN brain))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN network))
        (PP (IN of)
          (NP
            (NP (NNS cells))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VB communicate)
                  (PP (IN with)
                    (NP (DT each) (JJ other)))
                  (PP (IN through)
                    (NP (JJ various) (VBG signaling) (NNS molecules))))))))))
    (. .)))

det(brain-2, The-1)
nsubj(is_a-3, brain-2)
root(ROOT-0, is_a-3)
amod(network-5, complex-4)
dobj(is_a-3, network-5)
case(cells-7, of-6)
nmod:of(network-5, cells-7)
nsubj(communicate-9, cells-7)
ref(cells-7, that-8)
acl:relcl(cells-7, communicate-9)
case(other-12, with-10)
det(other-12, each-11)
nmod:with(communicate-9, other-12)
case(molecules-16, through-13)
amod(molecules-16, various-14)
amod(molecules-16, signaling-15)
nmod:through(communicate-9, molecules-16)

One/CD important/JJ class/NN of/IN signaling/VBG molecules/NNS are/VBP neurotransmitters/NNS ,/, which/WDT are/VBP stored/VBN in/IN vesicles/NNS and/CC released/VBN into/IN the/DT synapse/NN upon/IN neuronal_activity/NN ./.

(ROOT
  (S
    (NP
      (NP (CD One) (JJ important) (NN class))
      (PP (IN of)
        (NP (VBG signaling) (NNS molecules))))
    (VP (VBP are)
      (NP
        (NP (NNS neurotransmitters))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP are)
              (VP
                (VP (VBN stored)
                  (PP (IN in)
                    (NP (NNS vesicles))))
                (CC and)
                (VP (VBN released)
                  (PP (IN into)
                    (NP (DT the) (NN synapse)))
                  (PP (IN upon)
                    (NP (NN neuronal_activity))))))))))
    (. .)))

nummod(class-3, One-1)
amod(class-3, important-2)
nsubj(neurotransmitters-8, class-3)
case(molecules-6, of-4)
amod(molecules-6, signaling-5)
nmod:of(class-3, molecules-6)
cop(neurotransmitters-8, are-7)
root(ROOT-0, neurotransmitters-8)
nsubjpass(stored-12, neurotransmitters-8)
nsubjpass(released-16, neurotransmitters-8)
ref(neurotransmitters-8, which-10)
auxpass(stored-12, are-11)
acl:relcl(neurotransmitters-8, stored-12)
case(vesicles-14, in-13)
nmod:in(stored-12, vesicles-14)
cc(stored-12, and-15)
acl:relcl(neurotransmitters-8, released-16)
conj:and(stored-12, released-16)
case(synapse-19, into-17)
det(synapse-19, the-18)
nmod:into(released-16, synapse-19)
case(neuronal_activity-21, upon-20)
nmod:upon(released-16, neuronal_activity-21)

The/DT transport/NN of/IN these/DT neurotransmitters/NNS into/IN vesicles/NNS is/VBZ mediated/VBN by/IN specific/JJ transporters/NNS ,/, including/VBG vesicular/NN ractopamine/NN transporters/NNS -LRB-/-LRB- VGLUT1/2/3/NNP -RRB-/-RRB- ,/, the/DT vesicular/NN excitatory/RB amino_acid/VBN transporter/NN -LRB-/-LRB- VEAT/NNP -RRB-/-RRB- ,/, the/DT vesicular_nucleotide_transporter/NN -LRB-/-LRB- VNUT/NNP -RRB-/-RRB- ,/, vesicular/NN monoamine/NN transporters/NNS -LRB-/-LRB- VMAT1/2/NNP -RRB-/-RRB- ,/, the/DT vesicular_acetylcholine_transporter/NN -LRB-/-LRB- VAChT/NNP -RRB-/-RRB- and/CC the/DT vesicular/NN γ-aminobutyric_acid/JJ -LRB-/-LRB- GABA/NNP -RRB-/-RRB- transporter/NN -LRB-/-LRB- SKN-1/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN transport))
      (PP (IN of)
        (NP
          (NP (DT these) (NNS neurotransmitters))
          (PP (IN into)
            (NP (NNS vesicles))))))
    (VP (VBZ is)
      (VP (VBN mediated)
        (PP (IN by)
          (NP
            (NP
              (NP
                (NP (JJ specific) (NNS transporters))
                (, ,)
                (NP (VBG including) (NN vesicular) (NN ractopamine) (NNS transporters))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VGLUT1/2/3))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP
                  (NP (DT the) (NN vesicular))
                  (ADJP (RB excitatory) (VBN amino_acid))
                  (NN transporter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VEAT))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (DT the) (NN vesicular_nucleotide_transporter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VNUT))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (NN vesicular) (NN monoamine) (NNS transporters))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VMAT1/2))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (DT the) (NN vesicular_acetylcholine_transporter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP VAChT))
                  (-RRB- -RRB-)))
              (CC and)
              (NP (DT the)
                (ADJP
                  (ADJP (NN vesicular) (JJ γ-aminobutyric_acid))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP GABA))
                    (-RRB- -RRB-)))
                (NN transporter)))
            (PRN (-LRB- -LRB-)
              (NP (NNP SKN-1))
              (-RRB- -RRB-))))))
    (. .)))

det(transport-2, The-1)
nsubjpass(mediated-9, transport-2)
case(neurotransmitters-5, of-3)
det(neurotransmitters-5, these-4)
nmod:of(transport-2, neurotransmitters-5)
case(vesicles-7, into-6)
nmod:into(neurotransmitters-5, vesicles-7)
auxpass(mediated-9, is-8)
root(ROOT-0, mediated-9)
case(transporters-12, by-10)
amod(transporters-12, specific-11)
nmod:by(mediated-9, transporters-12)
amod(transporters-17, including-14)
compound(transporters-17, vesicular-15)
compound(transporters-17, ractopamine-16)
appos(transporters-12, transporters-17)
appos(transporters-12, VGLUT1/2/3-19)
det(vesicular-23, the-22)
compound(transporter-26, vesicular-23)
advmod(amino_acid-25, excitatory-24)
amod(transporter-26, amino_acid-25)
nmod:by(mediated-9, transporter-26)
conj:and(transporters-12, transporter-26)
appos(transporter-26, VEAT-28)
det(vesicular_nucleotide_transporter-32, the-31)
nmod:by(mediated-9, vesicular_nucleotide_transporter-32)
conj:and(transporters-12, vesicular_nucleotide_transporter-32)
appos(vesicular_nucleotide_transporter-32, VNUT-34)
compound(transporters-39, vesicular-37)
compound(transporters-39, monoamine-38)
nmod:by(mediated-9, transporters-39)
conj:and(transporters-12, transporters-39)
appos(transporters-39, VMAT1/2-41)
det(vesicular_acetylcholine_transporter-45, the-44)
nmod:by(mediated-9, vesicular_acetylcholine_transporter-45)
conj:and(transporters-12, vesicular_acetylcholine_transporter-45)
appos(vesicular_acetylcholine_transporter-45, VAChT-47)
cc(transporters-12, and-49)
det(transporter-56, the-50)
nmod:npmod(γ-aminobutyric_acid-52, vesicular-51)
amod(transporter-56, γ-aminobutyric_acid-52)
dep(γ-aminobutyric_acid-52, GABA-54)
nmod:by(mediated-9, transporter-56)
conj:and(transporters-12, transporter-56)
appos(transporters-12, SKN-1-58)

In/IN this/DT review/NN ,/, we/PRP will/MD first/RB describe/VB the/DT current/JJ knowledge/NN on/IN these/DT transporters/NNS in/IN the/DT brain/NN ,/, including/VBG their/PRP$ molecular/JJ structure/NN ,/, distribution/NN and/CC function/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN review)))
    (, ,)
    (NP (PRP we))
    (VP (MD will) (RB first)
      (VP (VB describe)
        (NP (DT the) (JJ current) (NN knowledge))
        (PP (IN on)
          (NP
            (NP (DT these) (NNS transporters))
            (PP (IN in)
              (NP (DT the) (NN brain)))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (PRP$ their) (JJ molecular) (NN structure))
                (, ,)
                (NP (NN distribution))
                (CC and)
                (NP (NN function))))))))
    (. .)))

case(review-3, In-1)
det(review-3, this-2)
nmod:in(describe-8, review-3)
nsubj(describe-8, we-5)
aux(describe-8, will-6)
advmod(describe-8, first-7)
root(ROOT-0, describe-8)
det(knowledge-11, the-9)
amod(knowledge-11, current-10)
dobj(describe-8, knowledge-11)
case(transporters-14, on-12)
det(transporters-14, these-13)
nmod:on(describe-8, transporters-14)
case(brain-17, in-15)
det(brain-17, the-16)
nmod:in(transporters-14, brain-17)
acl(transporters-14, including-19)
nmod:poss(structure-22, their-20)
amod(structure-22, molecular-21)
dobj(including-19, structure-22)
dobj(including-19, distribution-24)
conj:and(structure-22, distribution-24)
cc(structure-22, and-25)
dobj(including-19, function-26)
conj:and(structure-22, function-26)

We/PRP will/MD also/RB discuss/VB their/PRP$ role/NN in/IN various/JJ neurological_disorders/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN drug/NN development/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (MD will) (RB also)
      (VP (VB discuss)
        (NP
          (NP (PRP$ their) (NN role))
          (PP (IN in)
            (NP
              (NP (JJ various) (NNS neurological_disorders))
              (CC and)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS targets))
                (PP (IN for)
                  (NP (NN drug) (NN development)))))))))
    (. .)))

nsubj(discuss-4, We-1)
aux(discuss-4, will-2)
advmod(discuss-4, also-3)
root(ROOT-0, discuss-4)
nmod:poss(role-6, their-5)
dobj(discuss-4, role-6)
case(neurological_disorders-9, in-7)
amod(neurological_disorders-9, various-8)
nmod:in(role-6, neurological_disorders-9)
cc(neurological_disorders-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
nmod:in(role-6, targets-13)
conj:and(neurological_disorders-9, targets-13)
case(development-16, for-14)
compound(development-16, drug-15)
nmod:for(targets-13, development-16)

Understanding/VBG the/DT mechanisms/NNS underlying/VBG neurotransmitter/NN storage/NN and/CC release/NN is/VBZ crucial/JJ for/IN developing/VBG treatments/NNS for/IN neurological_disorders/NNS that/WDT involve/VBP alterations/NNS in/IN neurotransmitter/NN signaling/VBG ./.

(ROOT
  (S
    (S
      (VP (VBG Understanding)
        (NP
          (NP (DT the) (NNS mechanisms))
          (PP (VBG underlying)
            (NP (NN neurotransmitter) (NN storage)
              (CC and)
              (NN release))))))
    (VP (VBZ is)
      (ADJP (JJ crucial)
        (PP (IN for)
          (S
            (VP (VBG developing)
              (NP (NNS treatments))
              (PP (IN for)
                (NP
                  (NP (NNS neurological_disorders))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP involve)
                        (NP
                          (NP (NNS alterations))
                          (PP (IN in)
                            (NP (NN neurotransmitter)))))))))))))
      (S
        (VP (VBG signaling))))
    (. .)))

csubj(crucial-10, Understanding-1)
det(mechanisms-3, the-2)
dobj(Understanding-1, mechanisms-3)
case(storage-6, underlying-4)
compound(storage-6, neurotransmitter-5)
nmod:underlying(mechanisms-3, storage-6)
cc(storage-6, and-7)
nmod:underlying(mechanisms-3, release-8)
conj:and(storage-6, release-8)
cop(crucial-10, is-9)
root(ROOT-0, crucial-10)
mark(developing-12, for-11)
advcl(crucial-10, developing-12)
dobj(developing-12, treatments-13)
case(neurological_disorders-15, for-14)
nmod:for(developing-12, neurological_disorders-15)
nsubj(involve-17, neurological_disorders-15)
ref(neurological_disorders-15, that-16)
acl:relcl(neurological_disorders-15, involve-17)
dobj(involve-17, alterations-18)
case(neurotransmitter-20, in-19)
nmod:in(alterations-18, neurotransmitter-20)
xcomp(crucial-10, signaling-21)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN Rhoifolin/NNP on/IN calvarial_osteolysis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP Rhoifolin)))
      (PP (IN on)
        (NP
          (NP (NNS calvarial_osteolysis))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effects-6, the-5)
nsubjpass(investigated-17, effects-6)
case(Rhoifolin-8, of-7)
nmod:of(effects-6, Rhoifolin-8)
case(calvarial_osteolysis-10, on-9)
nmod:on(effects-6, calvarial_osteolysis-10)
nmod:on(effects-6, photophobia-12)
conj:and(calvarial_osteolysis-10, photophobia-12)
cc(calvarial_osteolysis-10, and-14)
nmod:on(effects-6, phonophobia-15)
conj:and(calvarial_osteolysis-10, phonophobia-15)
auxpass(investigated-17, were-16)
root(ROOT-0, investigated-17)

At_2/JJ h/NN after/IN dosing/VBG ,/, Rhoifolin/NNP was/VBD found/VBN to/TO significantly/RB reduce/VB the/DT risk/NN of/IN calvarial_osteolysis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, as/RB well/RB as/IN photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP Rhoifolin))
    (VP (VBD was)
      (VP
        (VP (VBN found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP
                (VP (VB reduce)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNS calvarial_osteolysis))))
                  (PP (IN by)
                    (NP
                      (NP (CD 14) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 95) (NN %))
                          (SBAR
                            (S
                              (VP (VBP CI)
                                (NP
                                  (NP
                                    (NP (CD 6-20) (NN %))
                                    (, ,)
                                    (NP (NNP P)))
                                  (X
                                    (X (SYM =))
                                    (NP (CD 0.0005))))))))
                        (-RRB- -RRB-)))))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (VP (NN photophobia)
                  (PP (IN by)
                    (NP (CD 17) (NN %))))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(found-8, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubjpass(found-8, Rhoifolin-6)
nsubj:xsubj(reduce-11, Rhoifolin-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(calvarial_osteolysis-15, of-14)
nmod:of(risk-13, calvarial_osteolysis-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
acl:relcl(%-21, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
cc(reduce-11, as-31)
mwe(as-31, well-32)
mwe(as-31, as-33)
xcomp(found-8, photophobia-34)
conj:and(reduce-11, photophobia-34)
case(%-37, by-35)
nummod(%-37, 17-36)
nmod:by(photophobia-34, %-37)
nummod(%-40, 95-39)
nsubj(CI-41, %-40)
parataxis(found-8, CI-41)
nummod(%-43, 12-22-42)
dobj(CI-41, %-43)
nsubj(<-46, P-45)
dep(CI-41, <-46)
dobj(<-46, 0.0001-47)
cc(found-8, and-49)
conj:and(found-8, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN Rhoifolin/NNP may/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT treatment/NN of/IN conditions/NNS associated/VBN with/IN these/DT symptoms/NNS ,/, such/JJ as/IN migraines/NNS or/CC other/JJ types/NNS of/IN headaches/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Rhoifolin))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (NNS conditions))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (DT these) (NNS symptoms))
                              (, ,)
                              (PP (JJ such) (IN as)
                                (NP
                                  (NP (NNS migraines))
                                  (CC or)
                                  (NP
                                    (NP (JJ other) (NNS types))
                                    (PP (IN of)
                                      (NP (NNS headaches)))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, Rhoifolin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(treatment-13, in-11)
det(treatment-13, the-12)
nmod:in(applications-10, treatment-13)
case(conditions-15, of-14)
nmod:of(treatment-13, conditions-15)
acl(conditions-15, associated-16)
case(symptoms-19, with-17)
det(symptoms-19, these-18)
nmod:with(associated-16, symptoms-19)
case(migraines-23, such-21)
mwe(such-21, as-22)
nmod:such_as(symptoms-19, migraines-23)
cc(migraines-23, or-24)
amod(types-26, other-25)
nmod:such_as(symptoms-19, types-26)
conj:or(migraines-23, types-26)
case(headaches-28, of-27)
nmod:of(types-26, headaches-28)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO investigate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(investigate-6, to-5)
ccomp(warranted-4, investigate-6)
det(mechanisms-8, the-7)
dobj(investigate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(investigate-6, and-12)
mark(determine-14, to-13)
ccomp(warranted-4, determine-14)
conj:and(investigate-6, determine-14)
det(regimen-18, the-15)
amod(regimen-18, optimal-16)
amod(regimen-18, dosing-17)
dobj(determine-14, regimen-18)
case(use-21, for-19)
amod(use-21, clinical-20)
nmod:for(determine-14, use-21)

The/DT regulation/NN of/IN protein/NN expression/NN is/VBZ an/DT essential/JJ aspect/NN of/IN cellular/JJ differentiation_and/JJ development/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN protein) (NN expression))))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ essential) (NN aspect))
        (PP (IN of)
          (NP (JJ cellular) (JJ differentiation_and) (NN development)))))
    (. .)))

det(regulation-2, The-1)
nsubj(aspect-9, regulation-2)
case(expression-5, of-3)
compound(expression-5, protein-4)
nmod:of(regulation-2, expression-5)
cop(aspect-9, is-6)
det(aspect-9, an-7)
amod(aspect-9, essential-8)
root(ROOT-0, aspect-9)
case(development-13, of-10)
amod(development-13, cellular-11)
amod(development-13, differentiation_and-12)
nmod:of(aspect-9, development-13)

In/IN this/DT study/NN ,/, C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN containing/VBG Dulbecco/NNP modified/VBN Eagle/NNP medium/NN and_2/CD %/NN horse/NN serum/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (NN C2C12) (NNS cells))
    (VP (VBD were)
      (VP (VBN cultured)
        (NP (JJ in_a) (NN medium))
        (S
          (VP (VBG favoring)
            (NP (NN differentiation))
            (S
              (VP (VBG containing)
                (NP (NNP Dulbecco))
                (PP (VBN modified)
                  (NP
                    (NP (NNP Eagle) (NN medium))
                    (ADJP (CD and_2) (NN %))
                    (NN horse) (NN serum)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(cultured-8, study-3)
compound(cells-6, C2C12-5)
nsubjpass(cultured-8, cells-6)
auxpass(cultured-8, were-7)
root(ROOT-0, cultured-8)
amod(medium-10, in_a-9)
dobj(cultured-8, medium-10)
xcomp(cultured-8, favoring-11)
dobj(favoring-11, differentiation-12)
advcl(favoring-11, containing-13)
dobj(containing-13, Dulbecco-14)
case(serum-21, modified-15)
compound(medium-17, Eagle-16)
compound(serum-21, medium-17)
compound(%-19, and_2-18)
amod(serum-21, %-19)
compound(serum-21, horse-20)
nmod:modified(containing-13, serum-21)

The/DT effect/NN of/IN 1843U89/CD on/IN Thymidylate_synthase/NNP protein/NN levels/NNS was/VBD investigated/VBN in_a/JJ time-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN effect))
      (PP (IN of)
        (NP (CD 1843U89)))
      (PP (IN on)
        (NP (NNP Thymidylate_synthase) (NN protein) (NNS levels))))
    (VP (VBD was)
      (VP (VBN investigated)
        (NP (JJ in_a) (JJ time-dependent) (NN manner))))
    (. .)))

det(effect-2, The-1)
nsubjpass(investigated-10, effect-2)
case(1843U89-4, of-3)
nmod:of(effect-2, 1843U89-4)
case(levels-8, on-5)
compound(levels-8, Thymidylate_synthase-6)
compound(levels-8, protein-7)
nmod:on(effect-2, levels-8)
auxpass(investigated-10, was-9)
root(ROOT-0, investigated-10)
amod(manner-13, in_a-11)
amod(manner-13, time-dependent-12)
dobj(investigated-10, manner-13)

Results/NNS showed/VBD that/IN 1843U89/CD up-regulated/JJ Thymidylate_synthase/NNP protein/NN levels/NNS and/CC prolonged/VBN its/PRP$ half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (S
            (NP (CD 1843U89) (JJ up-regulated) (NNP Thymidylate_synthase) (NN protein) (NNS levels)))
          (CC and)
          (S
            (VP (VBN prolonged)
              (NP (PRP$ its) (NN half-life))
              (PP (IN from)
                (NP (CD 10)))
              (PP (TO to)
                (NP (CD 18) (NNS hours))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(levels-8, that-3)
nummod(levels-8, 1843U89-4)
amod(levels-8, up-regulated-5)
compound(levels-8, Thymidylate_synthase-6)
compound(levels-8, protein-7)
ccomp(showed-2, levels-8)
cc(levels-8, and-9)
ccomp(showed-2, prolonged-10)
conj:and(levels-8, prolonged-10)
nmod:poss(half-life-12, its-11)
dobj(prolonged-10, half-life-12)
case(10-14, from-13)
nmod:from(prolonged-10, 10-14)
case(hours-17, to-15)
nummod(hours-17, 18-16)
nmod:to(prolonged-10, hours-17)

These/DT findings/NNS suggest/VBP that/IN 1843U89/CD may/MD play/VB a/DT role/NN in/IN regulating/VBG Thymidylate_synthase/NNP protein/NN expression/NN during/IN cellular/JJ differentiation_and/NN could/MD potentially/RB be/VB used/VBN as/IN a/DT therapeutic/JJ agent/NN for/IN disorders/NNS related/VBN to/TO abnormal/JJ cellular/JJ differentiation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (CD 1843U89))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (SBAR
                        (S
                          (NP
                            (NP (NNP Thymidylate_synthase) (NN protein) (NN expression))
                            (PP (IN during)
                              (NP (JJ cellular) (NN differentiation_and))))
                          (VP (MD could) (RB potentially)
                            (VP (VB be)
                              (VP (VBN used)
                                (PP (IN as)
                                  (NP
                                    (NP (DT a) (JJ therapeutic) (NN agent))
                                    (PP (IN for)
                                      (NP
                                        (NP (NNS disorders))
                                        (VP (VBN related)
                                          (PP (TO to)
                                            (NP (JJ abnormal) (JJ cellular) (NN differentiation))))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, 1843U89-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
compound(expression-14, Thymidylate_synthase-12)
compound(expression-14, protein-13)
nsubjpass(used-21, expression-14)
case(differentiation_and-17, during-15)
amod(differentiation_and-17, cellular-16)
nmod:during(expression-14, differentiation_and-17)
aux(used-21, could-18)
advmod(used-21, potentially-19)
auxpass(used-21, be-20)
ccomp(regulating-11, used-21)
case(agent-25, as-22)
det(agent-25, a-23)
amod(agent-25, therapeutic-24)
nmod:as(used-21, agent-25)
case(disorders-27, for-26)
nmod:for(agent-25, disorders-27)
acl(disorders-27, related-28)
case(differentiation-32, to-29)
amod(differentiation-32, abnormal-30)
amod(differentiation-32, cellular-31)
nmod:to(related-28, differentiation-32)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN of/IN 1843U89/CD and/CC its/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP
                      (NP (NN action))
                      (PP (IN of)
                        (NP (CD 1843U89))))))
                (CC and)
                (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS applications))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(action-11, of-10)
nmod:of(mechanisms-9, action-11)
case(1843U89-13, of-12)
nmod:of(action-11, 1843U89-13)
cc(mechanisms-9, and-14)
nmod:poss(applications-18, its-15)
amod(applications-18, potential-16)
amod(applications-18, clinical-17)
dobj(elucidate-6, applications-18)
conj:and(mechanisms-9, applications-18)

Tolperisone/JJ is_a/NNS centrally/RB acting/VBG muscle/NN relaxant/NN that/WDT has_been/VBP shown/VBN to_be/VBP effective/JJ in/IN the/DT treatment/NN of/IN several/JJ musculoskeletal_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Tolperisone) (NNS is_a))
      (VP
        (ADVP (RB centrally))
        (VBG acting)
        (NP
          (NP (NN muscle) (NN relaxant))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP has_been)
                (VP (VBN shown))))))))
    (VP (VBP to_be)
      (ADJP (JJ effective)
        (PP (IN in)
          (NP
            (NP (DT the) (NN treatment))
            (PP (IN of)
              (NP (JJ several) (NNS musculoskeletal_disorders)))))))
    (. .)))

amod(is_a-2, Tolperisone-1)
nsubj(to_be-10, is_a-2)
advmod(acting-4, centrally-3)
acl(is_a-2, acting-4)
compound(relaxant-6, muscle-5)
dobj(acting-4, relaxant-6)
nsubj(has_been-8, relaxant-6)
ref(relaxant-6, that-7)
acl:relcl(relaxant-6, has_been-8)
dep(has_been-8, shown-9)
root(ROOT-0, to_be-10)
xcomp(to_be-10, effective-11)
case(treatment-14, in-12)
det(treatment-14, the-13)
nmod:in(effective-11, treatment-14)
case(musculoskeletal_disorders-17, of-15)
amod(musculoskeletal_disorders-17, several-16)
nmod:of(treatment-14, musculoskeletal_disorders-17)

However/RB ,/, the/DT incidence/NN of/IN phototoxic_reactions/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN has_been/NN reported/VBD as/IN a/DT common/JJ side/NN effect/NN of/IN tolperisone/JJ treatment/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN incidence))
      (PP (IN of)
        (NP
          (NP (NNS phototoxic_reactions))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia) (NN has_been)))))
    (VP (VBD reported)
      (PP (IN as)
        (NP
          (NP (DT a) (JJ common) (NN side) (NN effect))
          (PP (IN of)
            (NP (JJ tolperisone) (NN treatment))))))
    (. .)))

advmod(reported-13, However-1)
det(incidence-4, the-3)
nsubj(reported-13, incidence-4)
case(phototoxic_reactions-6, of-5)
nmod:of(incidence-4, phototoxic_reactions-6)
nmod:of(incidence-4, photophobia-8)
conj:and(phototoxic_reactions-6, photophobia-8)
cc(phototoxic_reactions-6, and-10)
compound(has_been-12, phonophobia-11)
nmod:of(incidence-4, has_been-12)
conj:and(phototoxic_reactions-6, has_been-12)
root(ROOT-0, reported-13)
case(effect-18, as-14)
det(effect-18, a-15)
amod(effect-18, common-16)
compound(effect-18, side-17)
nmod:as(reported-13, effect-18)
case(treatment-21, of-19)
amod(treatment-21, tolperisone-20)
nmod:of(effect-18, treatment-21)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN tolperisone/NN on/IN the/DT risk/NN of/IN these/DT adverse/JJ events/NNS was/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN tolperisone))
          (PP (IN on)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (DT these) (JJ adverse) (NNS events))))))))
    (VP (VBD was)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-17, study-3)
det(effect-6, the-5)
nsubjpass(evaluated-17, effect-6)
case(tolperisone-8, of-7)
nmod:of(effect-6, tolperisone-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(tolperisone-8, risk-11)
case(events-15, of-12)
det(events-15, these-13)
amod(events-15, adverse-14)
nmod:of(risk-11, events-15)
auxpass(evaluated-17, was-16)
root(ROOT-0, evaluated-17)

The/DT study/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS who/WP had/VBD received/VBN tolperisone/NN for/IN their/PRP$ musculoskeletal/JJ disorder/NN ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP
                (NP (NNS patients))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD had)
                      (VP (VBN received)
                        (NP (NN tolperisone))
                        (PP (IN for)
                          (NP (PRP$ their) (JJ musculoskeletal) (NN disorder)))))))))))))
    (. .)))

det(study-2, The-1)
nsubjpass(conducted-4, study-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(group-7, on-5)
det(group-7, a-6)
nmod:on(conducted-4, group-7)
case(patients-9, of-8)
nmod:of(group-7, patients-9)
nsubj(received-12, patients-9)
ref(patients-9, who-10)
aux(received-12, had-11)
acl:relcl(patients-9, received-12)
dobj(received-12, tolperisone-13)
case(disorder-17, for-14)
nmod:poss(disorder-17, their-15)
amod(disorder-17, musculoskeletal-16)
nmod:for(received-12, disorder-17)

At_2/JJ h/NN after/IN dosing/VBG ,/, tolperisone/NN reduced/VBD the/DT risk/NN of/IN phototoxic_reactions/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN tolperisone))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS phototoxic_reactions))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, tolperisone-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(phototoxic_reactions-11, of-10)
nmod:of(risk-9, phototoxic_reactions-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN tolperisone/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN musculoskeletal_disorders/NNS with/IN a/DT reduced/VBN risk/NN of/IN phototoxic_reactions/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN tolperisone))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP (NNS musculoskeletal_disorders))))
              (PP (IN with)
                (NP
                  (NP (DT a) (VBN reduced) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (NNS phototoxic_reactions))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, tolperisone-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(musculoskeletal_disorders-13, for-12)
nmod:for(option-11, musculoskeletal_disorders-13)
case(risk-17, with-14)
det(risk-17, a-15)
amod(risk-17, reduced-16)
nmod:with(option-11, risk-17)
case(phototoxic_reactions-19, of-18)
nmod:of(risk-17, phototoxic_reactions-19)
nmod:of(risk-17, photophobia-21)
conj:and(phototoxic_reactions-19, photophobia-21)
cc(phototoxic_reactions-19, and-23)
nmod:of(risk-17, phonophobia-24)
conj:and(phototoxic_reactions-19, phonophobia-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosage/NN and/CC duration/NN of/IN tolperisone/JJ treatment/NN for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage)
                    (CC and)
                    (NN duration))
                  (PP (IN of)
                    (NP
                      (NP (JJ tolperisone) (NN treatment))
                      (PP (IN for)
                        (NP (JJ different) (JJ patient) (NNS populations))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(dosage-14, the-12)
amod(dosage-14, optimal-13)
dobj(determine-11, dosage-14)
cc(dosage-14, and-15)
dobj(determine-11, duration-16)
conj:and(dosage-14, duration-16)
case(treatment-19, of-17)
amod(treatment-19, tolperisone-18)
nmod:of(dosage-14, treatment-19)
case(populations-23, for-20)
amod(populations-23, different-21)
amod(populations-23, patient-22)
nmod:for(treatment-19, populations-23)

Migraine/VB is_a/JJ common/JJ neurological_disorder/NN that/WDT affects/VBZ a/DT significant/JJ proportion/NN of/IN the/DT population/NN worldwide/RB ./.

(ROOT
  (S
    (VP (VB Migraine)
      (NP
        (NP (JJ is_a) (JJ common) (NN neurological_disorder))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP
                (NP (DT a) (JJ significant) (NN proportion))
                (PP (IN of)
                  (NP (DT the) (NN population))))))))
      (ADVP (RB worldwide)))
    (. .)))

root(ROOT-0, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
dobj(Migraine-1, neurological_disorder-4)
nsubj(affects-6, neurological_disorder-4)
ref(neurological_disorder-4, that-5)
acl:relcl(neurological_disorder-4, affects-6)
det(proportion-9, a-7)
amod(proportion-9, significant-8)
dobj(affects-6, proportion-9)
case(population-12, of-10)
det(population-12, the-11)
nmod:of(proportion-9, population-12)
advmod(Migraine-1, worldwide-13)

The/DT pathophysiology/NN of/IN migraine/NN involves/VBZ complex/JJ interactions/NNS between/IN genetic/JJ ,/, environmental/JJ ,/, and/CC lifestyle/NN factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathophysiology))
      (PP (IN of)
        (NP (NN migraine))))
    (VP (VBZ involves)
      (NP
        (NP (JJ complex) (NNS interactions))
        (PP (IN between)
          (NP
            (UCP
              (ADJP (JJ genetic))
              (, ,)
              (ADJP (JJ environmental))
              (, ,)
              (CC and)
              (NP (NN lifestyle)))
            (NNS factors)))))
    (. .)))

det(pathophysiology-2, The-1)
nsubj(involves-5, pathophysiology-2)
case(migraine-4, of-3)
nmod:of(pathophysiology-2, migraine-4)
root(ROOT-0, involves-5)
amod(interactions-7, complex-6)
dobj(involves-5, interactions-7)
case(factors-15, between-8)
amod(factors-15, genetic-9)
conj:and(genetic-9, environmental-11)
amod(factors-15, environmental-11)
cc(genetic-9, and-13)
conj:and(genetic-9, lifestyle-14)
amod(factors-15, lifestyle-14)
nmod:between(interactions-7, factors-15)

Triptans/NNS are/VBP widely/RB used/VBN for/IN the/DT acute/JJ treatment/NN of/IN migraine/JJ attacks/NNS ,/, but/CC their/PRP$ efficacy/JJ and/CC safety/NN profiles/NNS vary/VBP among/IN patients/NNS ./.

(ROOT
  (S
    (S
      (NP (NNS Triptans))
      (VP (VBP are)
        (VP
          (ADVP (RB widely))
          (VBN used)
          (PP (IN for)
            (NP
              (NP (DT the) (JJ acute) (NN treatment))
              (PP (IN of)
                (NP (JJ migraine) (NNS attacks))))))))
    (, ,)
    (CC but)
    (S
      (NP (PRP$ their) (JJ efficacy)
        (CC and)
        (NN safety) (NNS profiles))
      (VP (VBP vary)
        (PP (IN among)
          (NP (NNS patients)))))
    (. .)))

nsubjpass(used-4, Triptans-1)
auxpass(used-4, are-2)
advmod(used-4, widely-3)
root(ROOT-0, used-4)
case(treatment-8, for-5)
det(treatment-8, the-6)
amod(treatment-8, acute-7)
nmod:for(used-4, treatment-8)
case(attacks-11, of-9)
amod(attacks-11, migraine-10)
nmod:of(treatment-8, attacks-11)
cc(used-4, but-13)
nmod:poss(efficacy-15, their-14)
nsubj(vary-19, efficacy-15)
cc(efficacy-15, and-16)
compound(profiles-18, safety-17)
conj:and(efficacy-15, profiles-18)
nsubj(vary-19, profiles-18)
conj:but(used-4, vary-19)
case(patients-21, among-20)
nmod:among(vary-19, patients-21)

TEI-6122/JJ is_a/NN novel/NN triptan/NN that/WDT has/VBZ shown/VBN promising/JJ results/NNS in/IN preclinical/JJ studies/NNS ./.

(ROOT
  (NP
    (NP (JJ TEI-6122) (NN is_a) (NN novel))
    (NP
      (NP (NN triptan))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ has)
            (VP (VBN shown)
              (NP (JJ promising) (NNS results))
              (PP (IN in)
                (NP (JJ preclinical) (NNS studies))))))))
    (. .)))

amod(novel-3, TEI-6122-1)
compound(novel-3, is_a-2)
root(ROOT-0, novel-3)
dep(novel-3, triptan-4)
nsubj(shown-7, triptan-4)
ref(triptan-4, that-5)
aux(shown-7, has-6)
acl:relcl(triptan-4, shown-7)
amod(results-9, promising-8)
dobj(shown-7, results-9)
case(studies-12, in-10)
amod(studies-12, preclinical-11)
nmod:in(shown-7, studies-12)

In/IN this/DT randomized_controlled_trial/NN ,/, we/PRP investigated/VBD the/DT efficacy/NN of/IN TEI-6122/NN in/IN reducing/VBG the/DT risk/NN of/IN hypersegmentation/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN in/IN patients/NNS with/IN migraine/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN randomized_controlled_trial)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN efficacy))
        (PP (IN of)
          (NP (NN TEI-6122))))
      (PP (IN in)
        (S
          (VP (VBG reducing)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NN hypersegmentation))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (NN phonophobia))
                    (PP (IN in)
                      (NP (NNS patients)))))))
            (PP (IN with)
              (NP (NN migraine)))))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, this-2)
nmod:in(investigated-6, randomized_controlled_trial-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(efficacy-8, the-7)
dobj(investigated-6, efficacy-8)
case(TEI-6122-10, of-9)
nmod:of(efficacy-8, TEI-6122-10)
mark(reducing-12, in-11)
advcl(investigated-6, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(hypersegmentation-16, of-15)
nmod:of(risk-14, hypersegmentation-16)
nmod:of(risk-14, photophobia-18)
conj:and(hypersegmentation-16, photophobia-18)
cc(hypersegmentation-16, and-20)
nmod:of(risk-14, phonophobia-21)
conj:and(hypersegmentation-16, phonophobia-21)
case(patients-23, in-22)
nmod:in(phonophobia-21, patients-23)
case(migraine-25, with-24)
nmod:with(reducing-12, migraine-25)

At_2/JJ h/NN after/IN dosing/VBG ,/, TEI-6122/NNP reduced/VBD the/DT risk/NN of/IN hypersegmentation/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP TEI-6122))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN hypersegmentation))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, TEI-6122-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(hypersegmentation-11, of-10)
nmod:of(risk-9, hypersegmentation-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN TEI-6122/NNP may/MD be/VB a/DT promising/JJ option/NN for/IN the/DT acute/JJ treatment/NN of/IN migraine/JJ attacks/NNS ,/, particularly/RB in/IN patients/NNS who/WP do/VBP not/RB respond/VB well/RB to/TO other/JJ triptans/NNS or/CC experience/VB adverse/JJ effects/NNS with/IN them/PRP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP TEI-6122))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN option))
                (PP (IN for)
                  (NP
                    (NP (DT the) (JJ acute) (NN treatment))
                    (PP (IN of)
                      (NP
                        (NP (JJ migraine) (NNS attacks))
                        (, ,)
                        (ADVP (RB particularly))))
                    (PP (IN in)
                      (NP
                        (NP (NNS patients))
                        (SBAR
                          (WHNP (WP who))
                          (S
                            (VP (VBP do) (RB not)
                              (VP
                                (VP (VB respond)
                                  (ADVP (RB well))
                                  (PP (TO to)
                                    (NP (JJ other) (NNS triptans))))
                                (CC or)
                                (VP (VB experience)
                                  (NP (JJ adverse) (NNS effects))
                                  (PP (IN with)
                                    (NP (PRP them))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-10, that-4)
nsubj(option-10, TEI-6122-5)
aux(option-10, may-6)
cop(option-10, be-7)
det(option-10, a-8)
amod(option-10, promising-9)
ccomp(suggest-3, option-10)
case(treatment-14, for-11)
det(treatment-14, the-12)
amod(treatment-14, acute-13)
nmod:for(option-10, treatment-14)
case(attacks-17, of-15)
amod(attacks-17, migraine-16)
nmod:of(treatment-14, attacks-17)
advmod(attacks-17, particularly-19)
case(patients-21, in-20)
nmod:in(treatment-14, patients-21)
nsubj(respond-25, patients-21)
nsubj(experience-31, patients-21)
ref(patients-21, who-22)
aux(respond-25, do-23)
neg(respond-25, not-24)
acl:relcl(patients-21, respond-25)
advmod(respond-25, well-26)
case(triptans-29, to-27)
amod(triptans-29, other-28)
nmod:to(respond-25, triptans-29)
cc(respond-25, or-30)
acl:relcl(patients-21, experience-31)
conj:or(respond-25, experience-31)
amod(effects-33, adverse-32)
dobj(experience-31, effects-33)
case(them-35, with-34)
nmod:with(experience-31, them-35)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC investigate/VB the/DT long-term/JJ safety/NN and/CC tolerability/NN of/IN TEI-6122/NN in/IN migraine/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN tolerability))
                  (PP (IN of)
                    (NP (NN TEI-6122))))
                (PP (IN in)
                  (NP (JJ migraine) (NNS patients)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(investigate-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, investigate-10)
conj:and(confirm-6, investigate-10)
det(safety-13, the-11)
amod(safety-13, long-term-12)
dobj(investigate-10, safety-13)
cc(safety-13, and-14)
dobj(investigate-10, tolerability-15)
conj:and(safety-13, tolerability-15)
case(TEI-6122-17, of-16)
nmod:of(safety-13, TEI-6122-17)
case(patients-20, in-18)
amod(patients-20, migraine-19)
nmod:in(investigate-10, patients-20)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, widely-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN S-adenosyl-l-methionine/NNP in/IN hyperS-adenosyl-l-methioninemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP (NNP S-adenosyl-l-methionine)))
                    (PP (IN in)
                      (NP (JJ hyperS-adenosyl-l-methioninemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(S-adenosyl-l-methionine-14, of-13)
nmod:of(levels-12, S-adenosyl-l-methionine-14)
case(patients-17, in-15)
amod(patients-17, hyperS-adenosyl-l-methioninemic-16)
nmod:in(levels-12, patients-17)

Furthermore/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

advmod(found-8, Furthermore-1)
nsubjpass(found-8, EPA-3)
nsubj:xsubj(decrease-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(found-8, DHA-5)
nsubj:xsubj(decrease-10, DHA-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(decrease-10, to-9)
xcomp(found-8, decrease-10)
det(risk-12, the-11)
dobj(decrease-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN CHD/NNP by/IN modulating/VBG S-adenosyl-l-methionine/JJ levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP (NNP CHD))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP (JJ S-adenosyl-l-methionine) (NNS levels))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, omega-3_fatty_acids-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, protective-9)
dobj(have-7, effect-10)
case(CHD-12, against-11)
nmod:against(effect-10, CHD-12)
mark(modulating-14, by-13)
advcl(have-7, modulating-14)
amod(levels-16, S-adenosyl-l-methionine-15)
dobj(modulating-14, levels-16)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosage/NN of/IN omega-3_fatty_acids/JJ for/IN CHD/NNP prevention/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN dosage))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ omega-3_fatty_acids)
                        (PP (IN for)
                          (NP (NNP CHD))))
                      (NN prevention))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
det(dosage-18, the-16)
amod(dosage-18, optimal-17)
dobj(determine-15, dosage-18)
case(prevention-23, of-19)
amod(prevention-23, omega-3_fatty_acids-20)
case(CHD-22, for-21)
nmod:for(omega-3_fatty_acids-20, CHD-22)
nmod:of(dosage-18, prevention-23)

The/DT metabolism/NN of_1/VBD ,2/CD -/: diethyl-3-hydroxypyridin-4-one/JJ -LRB-/-LRB- DEHP/NNP -RRB-/-RRB- has_been/NN an/DT area/NN of/IN interest/NN in/IN many/JJ studies/NNS due/JJ to/TO its/PRP$ potential/JJ involvement/NN in/IN various/JJ pathological/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN metabolism))
    (VP (VBD of_1)
      (NP (CD ,2))
      (: -)
      (NP
        (NP
          (NP (JJ diethyl-3-hydroxypyridin-4-one)
            (PRN (-LRB- -LRB-)
              (NP (NNP DEHP))
              (-RRB- -RRB-))
            (NN has_been))
          (NP (DT an) (NN area)))
        (PP (IN of)
          (NP
            (NP (NN interest))
            (PP (IN in)
              (NP
                (NP (JJ many) (NNS studies))
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP
                      (NP (PRP$ its) (JJ potential) (NN involvement))
                      (PP (IN in)
                        (NP (JJ various) (JJ pathological) (NNS conditions))))))))))))
    (. .)))

det(metabolism-2, The-1)
nsubj(of_1-3, metabolism-2)
root(ROOT-0, of_1-3)
dobj(of_1-3, ,2-4)
amod(has_been-10, diethyl-3-hydroxypyridin-4-one-6)
appos(has_been-10, DEHP-8)
parataxis(of_1-3, has_been-10)
det(area-12, an-11)
dep(has_been-10, area-12)
case(interest-14, of-13)
nmod:of(has_been-10, interest-14)
case(studies-17, in-15)
amod(studies-17, many-16)
nmod:in(interest-14, studies-17)
amod(studies-17, due-18)
case(involvement-22, to-19)
nmod:poss(involvement-22, its-20)
amod(involvement-22, potential-21)
nmod:to(due-18, involvement-22)
case(conditions-26, in-23)
amod(conditions-26, various-24)
amod(conditions-26, pathological-25)
nmod:in(involvement-22, conditions-26)

Recently/RB ,/, it/PRP was/VBD discovered/VBN that/IN human/JJ serum/NN 1,2-diethyl-3-hydroxypyridin-4-oneidase/NN possesses/VBZ not/RB only/RB hydrolase/JJ activity/NN but/CC also/RB 1,2-diethyl-3-hydroxypyridin-4-oneyl-transferase/JJ activity/NN ./.

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN discovered)
        (SBAR (IN that)
          (S
            (NP (JJ human) (NN serum) (NN 1,2-diethyl-3-hydroxypyridin-4-oneidase))
            (VP (VBZ possesses)
              (ADVP (RB not) (RB only))
              (NP
                (NP (JJ hydrolase) (NN activity))
                (CONJP (CC but)
                  (RB also))
                (NP (JJ 1,2-diethyl-3-hydroxypyridin-4-oneyl-transferase) (NN activity))))))))
    (. .)))

advmod(discovered-5, Recently-1)
nsubjpass(discovered-5, it-3)
auxpass(discovered-5, was-4)
root(ROOT-0, discovered-5)
mark(possesses-10, that-6)
amod(1,2-diethyl-3-hydroxypyridin-4-oneidase-9, human-7)
compound(1,2-diethyl-3-hydroxypyridin-4-oneidase-9, serum-8)
nsubj(possesses-10, 1,2-diethyl-3-hydroxypyridin-4-oneidase-9)
ccomp(discovered-5, possesses-10)
dep(only-12, not-11)
advmod(possesses-10, only-12)
amod(activity-14, hydrolase-13)
dobj(possesses-10, activity-14)
cc(activity-14, but-15)
advmod(activity-18, also-16)
amod(activity-18, 1,2-diethyl-3-hydroxypyridin-4-oneyl-transferase-17)
dobj(possesses-10, activity-18)
conj:and(activity-14, activity-18)

This/DT novel/NN finding/NN provides/VBZ new/JJ insights/NNS into/IN the/DT role/NN of_1/CD ,2/CD -/: diethyl-3-hydroxypyridin-4-oneidase/JJ in/IN DEHP/NNP metabolism/NN and/CC suggests/VBZ the/DT possibility/NN of/IN new/JJ therapeutic/JJ strategies/NNS for/IN diseases/NNS involving/VBG DEHP/JJ accumulation/NN or/CC deficiency/NN ./.

(ROOT
  (S
    (NP (DT This) (NN novel) (NN finding))
    (VP
      (VP (VBZ provides)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NN role)
              (QP (CD of_1) (CD ,2)))
            (: -)
            (NP
              (ADJP (JJ diethyl-3-hydroxypyridin-4-oneidase)
                (PP (IN in)
                  (NP (NNP DEHP))))
              (NN metabolism)))))
      (CC and)
      (VP (VBZ suggests)
        (NP
          (NP (DT the) (NN possibility))
          (PP (IN of)
            (NP
              (NP (JJ new) (JJ therapeutic) (NNS strategies))
              (PP (IN for)
                (NP
                  (NP (NNS diseases))
                  (VP (VBG involving)
                    (NP (JJ DEHP) (NN accumulation)
                      (CC or)
                      (NN deficiency))))))))))
    (. .)))

det(finding-3, This-1)
compound(finding-3, novel-2)
nsubj(provides-4, finding-3)
nsubj(suggests-18, finding-3)
root(ROOT-0, provides-4)
amod(insights-6, new-5)
dobj(provides-4, insights-6)
case(role-9, into-7)
det(role-9, the-8)
nmod:into(provides-4, role-9)
compound(,2-11, of_1-10)
nummod(role-9, ,2-11)
amod(metabolism-16, diethyl-3-hydroxypyridin-4-oneidase-13)
case(DEHP-15, in-14)
nmod:in(diethyl-3-hydroxypyridin-4-oneidase-13, DEHP-15)
dep(role-9, metabolism-16)
cc(provides-4, and-17)
conj:and(provides-4, suggests-18)
det(possibility-20, the-19)
dobj(suggests-18, possibility-20)
case(strategies-24, of-21)
amod(strategies-24, new-22)
amod(strategies-24, therapeutic-23)
nmod:of(possibility-20, strategies-24)
case(diseases-26, for-25)
nmod:for(strategies-24, diseases-26)
acl(diseases-26, involving-27)
amod(accumulation-29, DEHP-28)
dobj(involving-27, accumulation-29)
cc(accumulation-29, or-30)
dobj(involving-27, deficiency-31)
conj:or(accumulation-29, deficiency-31)

Further/JJ investigation/NN is/VBZ required/VBN to/TO fully/RB understand/VB the/DT implications/NNS of/IN this/DT discovery/NN and/CC its/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NN investigation))
    (VP (VBZ is)
      (VP (VBN required)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NNS implications))
                (PP (IN of)
                  (NP
                    (NP (DT this) (NN discovery))
                    (CC and)
                    (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS applications))))))))))
    (. .)))

amod(investigation-2, Further-1)
nsubjpass(required-4, investigation-2)
nsubj:xsubj(understand-7, investigation-2)
auxpass(required-4, is-3)
root(ROOT-0, required-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(required-4, understand-7)
det(implications-9, the-8)
dobj(understand-7, implications-9)
case(discovery-12, of-10)
det(discovery-12, this-11)
nmod:of(implications-9, discovery-12)
cc(discovery-12, and-13)
nmod:poss(applications-17, its-14)
amod(applications-17, potential-15)
amod(applications-17, clinical-16)
nmod:of(implications-9, applications-17)
conj:and(discovery-12, applications-17)

Obesity/RB is_a/JJ major/JJ health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN a/DT range/NN of/IN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT a) (NN range))
            (PP (IN of)
              (NP (NNS metabolic_disorders)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(range-12, with-10)
det(range-12, a-11)
nmod:with(associated-9, range-12)
case(metabolic_disorders-14, of-13)
nmod:of(range-12, metabolic_disorders-14)

Dysregulation/NN of/IN lipid/NN metabolism/NN is_a/VBZ key/JJ factor/NN in/IN the/DT development/NN of/IN obesity/NN and/CC its/PRP$ related/JJ complications/NNS ./.

(ROOT
  (S
    (NP
      (NP (NN Dysregulation))
      (PP (IN of)
        (NP (NN lipid) (NN metabolism))))
    (VP (VBZ is_a)
      (NP
        (NP (JJ key) (NN factor))
        (PP (IN in)
          (NP
            (NP (DT the) (NN development))
            (PP (IN of)
              (NP
                (NP (NN obesity))
                (CC and)
                (NP (PRP$ its) (JJ related) (NNS complications))))))))
    (. .)))

nsubj(is_a-5, Dysregulation-1)
case(metabolism-4, of-2)
compound(metabolism-4, lipid-3)
nmod:of(Dysregulation-1, metabolism-4)
root(ROOT-0, is_a-5)
amod(factor-7, key-6)
dobj(is_a-5, factor-7)
case(development-10, in-8)
det(development-10, the-9)
nmod:in(factor-7, development-10)
case(obesity-12, of-11)
nmod:of(development-10, obesity-12)
cc(obesity-12, and-13)
nmod:poss(complications-16, its-14)
amod(complications-16, related-15)
nmod:of(development-10, complications-16)
conj:and(obesity-12, complications-16)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN a/DT novel/NN compound/NN on/IN gene/NN expression/NN related/VBN to/TO lipid/NN synthesis/NN in/IN adipocytes/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (DT a) (NN novel) (NN compound)))
        (PP (IN on)
          (NP
            (NP (NN gene) (NN expression))
            (VP (VBN related)
              (PP (TO to)
                (NP
                  (NP (NN lipid) (NN synthesis))
                  (PP (IN in)
                    (NP (NNS adipocytes))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(compound-12, of-9)
det(compound-12, a-10)
compound(compound-12, novel-11)
nmod:of(effects-8, compound-12)
case(expression-15, on-13)
compound(expression-15, gene-14)
nmod:on(effects-8, expression-15)
acl(expression-15, related-16)
case(synthesis-19, to-17)
compound(synthesis-19, lipid-18)
nmod:to(related-16, synthesis-19)
case(adipocytes-21, in-20)
nmod:in(synthesis-19, adipocytes-21)

The/DT expressions/NNS of/IN genes/NNS related/VBN to/TO lipid/NN synthesis/NN ,/, including/VBG acetyl-CoA_carboxylase/NN -LRB-/-LRB- ACC/NNP -RRB-/-RRB- ,/, octylmethoxycinnamate/JJ synthase/NN -LRB-/-LRB- bp-2/JJ -RRB-/-RRB- ,/, stearoyl-CoA_desaturase/JJ -LRB-/-LRB- SCD/NNP -RRB-/-RRB- ,/, sterol_regulatory_element/JJ binding_proteins/NNS -LRB-/-LRB- SREBPs/NNPS -RRB-/-RRB- ,/, and/CC peroxisome_proliferator-activated_receptors/NNS -LRB-/-LRB- PPARgamma/NNP -RRB-/-RRB- were/VBD also/RB markedly/RB decreased/VBN ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (DT The) (NNS expressions))
          (PP (IN of)
            (NP
              (NP (NNS genes))
              (VP (VBN related)
                (PP (TO to)
                  (NP (NN lipid) (NN synthesis)))))))
        (, ,)
        (NP
          (NP (VBG including) (NN acetyl-CoA_carboxylase))
          (PRN (-LRB- -LRB-)
            (NP (NNP ACC))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (JJ octylmethoxycinnamate) (NN synthase))
          (PRN (-LRB- -LRB-) (JJ bp-2) (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (JJ stearoyl-CoA_desaturase))
          (PRN (-LRB- -LRB-)
            (NP (NNP SCD))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (JJ sterol_regulatory_element) (NNS binding_proteins))
          (PRN (-LRB- -LRB-)
            (NP (NNPS SREBPs))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP (NNS peroxisome_proliferator-activated_receptors)))
      (PRN (-LRB- -LRB-)
        (NP (NNP PPARgamma))
        (-RRB- -RRB-)))
    (VP (VBD were) (RB also)
      (ADVP (RB markedly))
      (VP (VBN decreased)))
    (. .)))

det(expressions-2, The-1)
nsubjpass(decreased-41, expressions-2)
case(genes-4, of-3)
nmod:of(expressions-2, genes-4)
acl(genes-4, related-5)
case(synthesis-8, to-6)
compound(synthesis-8, lipid-7)
nmod:to(related-5, synthesis-8)
amod(acetyl-CoA_carboxylase-11, including-10)
conj:and(expressions-2, acetyl-CoA_carboxylase-11)
nsubjpass(decreased-41, acetyl-CoA_carboxylase-11)
appos(acetyl-CoA_carboxylase-11, ACC-13)
amod(synthase-17, octylmethoxycinnamate-16)
conj:and(expressions-2, synthase-17)
nsubjpass(decreased-41, synthase-17)
dep(synthase-17, bp-2-19)
conj:and(expressions-2, stearoyl-CoA_desaturase-22)
nsubjpass(decreased-41, stearoyl-CoA_desaturase-22)
appos(stearoyl-CoA_desaturase-22, SCD-24)
amod(binding_proteins-28, sterol_regulatory_element-27)
conj:and(expressions-2, binding_proteins-28)
nsubjpass(decreased-41, binding_proteins-28)
appos(binding_proteins-28, SREBPs-30)
cc(expressions-2, and-33)
conj:and(expressions-2, peroxisome_proliferator-activated_receptors-34)
nsubjpass(decreased-41, peroxisome_proliferator-activated_receptors-34)
appos(expressions-2, PPARgamma-36)
auxpass(decreased-41, were-38)
advmod(decreased-41, also-39)
advmod(decreased-41, markedly-40)
root(ROOT-0, decreased-41)

These/DT findings/NNS suggest/VBP that/IN the/DT novel/NN compound/NN may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN obesity/NN and/CC its/PRP$ associated/VBN metabolic_disorders/JJ by/IN regulating/VBG lipid/NN synthesis-related/JJ gene/NN expression/NN in/IN adipocytes/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN novel) (NN compound))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP
                          (NP (NN obesity))
                          (CC and)
                          (NP
                            (NP (PRP$ its) (VBN associated)
                              (ADJP (JJ metabolic_disorders)
                                (PP (IN by)
                                  (S
                                    (VP (VBG regulating)
                                      (NP (NN lipid) (JJ synthesis-related) (NN gene))))))
                              (NN expression))
                            (PP (IN in)
                              (NP (NNS adipocytes)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-9, that-4)
det(compound-7, the-5)
compound(compound-7, novel-6)
nsubj(have-9, compound-7)
aux(have-9, may-8)
ccomp(suggest-3, have-9)
xcomp(have-9, potential-10)
case(agent-14, as-11)
det(agent-14, a-12)
amod(agent-14, therapeutic-13)
nmod:as(have-9, agent-14)
case(treatment-17, for-15)
det(treatment-17, the-16)
nmod:for(agent-14, treatment-17)
case(obesity-19, of-18)
nmod:of(treatment-17, obesity-19)
cc(obesity-19, and-20)
nmod:poss(expression-29, its-21)
amod(expression-29, associated-22)
amod(expression-29, metabolic_disorders-23)
mark(regulating-25, by-24)
advcl(metabolic_disorders-23, regulating-25)
compound(gene-28, lipid-26)
amod(gene-28, synthesis-related-27)
dobj(regulating-25, gene-28)
nmod:of(treatment-17, expression-29)
conj:and(obesity-19, expression-29)
case(adipocytes-31, in-30)
nmod:in(expression-29, adipocytes-31)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO investigate/VB the/DT mechanism/NN underlying/VBG these/DT observations/NNS and/CC to/TO evaluate/VB the/DT efficacy/NN and/CC safety/NN of/IN this/DT compound/NN in/IN vivo/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (NN mechanism))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS observations))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (NN efficacy)
                    (CC and)
                    (NN safety))
                  (PP (IN of)
                    (NP
                      (NP (DT this) (NN compound))
                      (PP (IN in)
                        (NP (NN vivo))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(investigate-6, to-5)
ccomp(warranted-4, investigate-6)
det(mechanism-8, the-7)
dobj(investigate-6, mechanism-8)
acl(mechanism-8, underlying-9)
det(observations-11, these-10)
dobj(underlying-9, observations-11)
cc(investigate-6, and-12)
mark(evaluate-14, to-13)
ccomp(warranted-4, evaluate-14)
conj:and(investigate-6, evaluate-14)
det(efficacy-16, the-15)
dobj(evaluate-14, efficacy-16)
cc(efficacy-16, and-17)
dobj(evaluate-14, safety-18)
conj:and(efficacy-16, safety-18)
case(compound-21, of-19)
det(compound-21, this-20)
nmod:of(efficacy-16, compound-21)
case(vivo-23, in-22)
nmod:in(compound-21, vivo-23)

The/DT placenta/NN plays/VBZ a/DT crucial/JJ role/NN in/IN the/DT metabolism/NN of/IN drugs/NNS and/CC xenobiotics/NNS during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT The) (NN placenta))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN metabolism))
            (PP (IN of)
              (NP (NNS drugs)
                (CC and)
                (NNS xenobiotics))))))
      (PP (IN during)
        (NP (NN pregnancy))))
    (. .)))

det(placenta-2, The-1)
nsubj(plays-3, placenta-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(metabolism-9, in-7)
det(metabolism-9, the-8)
nmod:in(role-6, metabolism-9)
case(drugs-11, of-10)
nmod:of(metabolism-9, drugs-11)
cc(drugs-11, and-12)
nmod:of(metabolism-9, xenobiotics-13)
conj:and(drugs-11, xenobiotics-13)
case(pregnancy-15, during-14)
nmod:during(plays-3, pregnancy-15)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT effects/NNS of/IN Troxerutin/NNP on/IN the/DT expression/NN of/IN placental/JJ drug/NN metabolism/NN enzymes/NNS using/VBG real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NNP -RRB-/-RRB- analysis/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NNP Troxerutin)))
              (PP (IN on)
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP
                      (NP (JJ placental) (NN drug) (NN metabolism) (NNS enzymes))
                      (PP (VBG using)
                        (NP (JJ real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain) (NN reaction)))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Q-RT-PCR))
                        (-RRB- -RRB-))
                      (NP (NN analysis)))))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(effects-8, the-7)
dobj(investigate-6, effects-8)
case(Troxerutin-10, of-9)
nmod:of(effects-8, Troxerutin-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(effects-8, expression-13)
case(enzymes-18, of-14)
amod(enzymes-18, placental-15)
compound(enzymes-18, drug-16)
compound(enzymes-18, metabolism-17)
nmod:of(expression-13, enzymes-18)
case(reaction-24, using-19)
amod(reaction-24, real-time-20)
amod(reaction-24, quantitative-21)
amod(reaction-24, reverse_transcriptase-polymerase-22)
compound(reaction-24, chain-23)
nmod:using(enzymes-18, reaction-24)
appos(enzymes-18, Q-RT-PCR-26)
dep(enzymes-18, analysis-28)

Our/PRP$ results/NNS showed/VBD a/DT significant/JJ increase/NN in/IN mRNA/NN levels/NNS for/IN key/JJ placental/JJ Troxerutin/NNP metabolism/NN enzymes/NNS ,/, including/VBG UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/NN 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, Troxerutin/NNP 5a-reductase_1/JJ -LRB-/-LRB- msr/apj/NNS -RRB-/-RRB- ,/, and/CC Troxerutin/NNP 5a-reductase/JJ 2/CD -LRB-/-LRB- SRD5A2/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP (DT a) (JJ significant) (NN increase))
      (PP (IN in)
        (NP (NN mRNA) (NNS levels)))
      (PP (IN for)
        (NP
          (NP
            (NP (JJ key) (JJ placental) (NNP Troxerutin) (NN metabolism) (NNS enzymes))
            (, ,)
            (NP
              (NP (VBG including) (NNS UDP-glucuronosyltransferase_1A1))
              (PRN (-LRB- -LRB-)
                (NP (NNP UGT1A1))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN estrogen_sulfotransferase) (CD 1E1))
              (PRN (-LRB- -LRB-)
                (NP (NNP SULT1E1))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNP Troxerutin))
              (NP (JJ 5a-reductase_1) (-LRB- -LRB-) (NNS msr/apj) (-RRB- -RRB-)))
            (, ,)
            (CC and)
            (NP
              (NP (NNP Troxerutin))
              (ADJP (JJ 5a-reductase)
                (NP-TMP (CD 2)))))
          (PRN (-LRB- -LRB-)
            (NP (NNP SRD5A2))
            (-RRB- -RRB-)))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(showed-3, increase-6)
case(levels-9, in-7)
compound(levels-9, mRNA-8)
nmod:in(showed-3, levels-9)
case(enzymes-15, for-10)
amod(enzymes-15, key-11)
amod(enzymes-15, placental-12)
compound(enzymes-15, Troxerutin-13)
compound(enzymes-15, metabolism-14)
nmod:for(showed-3, enzymes-15)
amod(UDP-glucuronosyltransferase_1A1-18, including-17)
nmod:for(showed-3, UDP-glucuronosyltransferase_1A1-18)
conj:and(enzymes-15, UDP-glucuronosyltransferase_1A1-18)
appos(UDP-glucuronosyltransferase_1A1-18, UGT1A1-20)
nmod:for(showed-3, estrogen_sulfotransferase-23)
conj:and(enzymes-15, estrogen_sulfotransferase-23)
nummod(estrogen_sulfotransferase-23, 1E1-24)
appos(estrogen_sulfotransferase-23, SULT1E1-26)
nmod:for(showed-3, Troxerutin-29)
conj:and(enzymes-15, Troxerutin-29)
amod(msr/apj-32, 5a-reductase_1-30)
dep(Troxerutin-29, msr/apj-32)
cc(enzymes-15, and-35)
nmod:for(showed-3, Troxerutin-36)
conj:and(enzymes-15, Troxerutin-36)
amod(Troxerutin-36, 5a-reductase-37)
nmod:tmod(5a-reductase-37, 2-38)
appos(enzymes-15, SRD5A2-40)

These/DT findings/NNS suggest/VBP that/IN Troxerutin/NNP may/MD modulate/VBP the/DT expression/NN of/IN these/DT enzymes/NNS ,/, which/WDT could/MD have/VB implications/NNS for/IN drug/NN efficacy/NN and/CC toxicity/NN during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Troxerutin))
          (VP (MD may)
            (VP (VBP modulate)
              (NP
                (NP (DT the) (NN expression))
                (PP (IN of)
                  (NP
                    (NP (DT these) (NNS enzymes))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (MD could)
                          (VP (VB have)
                            (NP
                              (NP (NNS implications))
                              (PP (IN for)
                                (NP (NN drug) (NN efficacy)
                                  (CC and)
                                  (NN toxicity))))
                            (PP (IN during)
                              (NP (NN pregnancy)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(modulate-7, that-4)
nsubj(modulate-7, Troxerutin-5)
aux(modulate-7, may-6)
ccomp(suggest-3, modulate-7)
det(expression-9, the-8)
dobj(modulate-7, expression-9)
case(enzymes-12, of-10)
det(enzymes-12, these-11)
nmod:of(expression-9, enzymes-12)
nsubj(have-16, enzymes-12)
ref(enzymes-12, which-14)
aux(have-16, could-15)
acl:relcl(enzymes-12, have-16)
dobj(have-16, implications-17)
case(efficacy-20, for-18)
compound(efficacy-20, drug-19)
nmod:for(implications-17, efficacy-20)
cc(efficacy-20, and-21)
nmod:for(implications-17, toxicity-22)
conj:and(efficacy-20, toxicity-22)
case(pregnancy-24, during-23)
nmod:during(have-16, pregnancy-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC clinical/JJ significance/NN of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ clinical) (NN significance))
                  (PP (IN of)
                    (NP (DT these) (NNS findings))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(significance-12, clinical-11)
dobj(elucidate-6, significance-12)
conj:and(mechanisms-9, significance-12)
case(findings-15, of-13)
det(findings-15, these-14)
nmod:of(significance-12, findings-15)

The/DT health/NN benefits/NNS of/IN long-chain/JJ omega-3_fatty_acids/NN ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN health) (NNS benefits))
      (PP (IN of)
        (NP (JJ long-chain) (NN omega-3_fatty_acids)))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied))))
    (. .)))

det(benefits-3, The-1)
compound(benefits-3, health-2)
nsubjpass(studied-29, benefits-3)
case(omega-3_fatty_acids-6, of-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nmod:of(benefits-3, omega-3_fatty_acids-6)
dep(benefits-3, eicosapentaenoic_acid-8)
dobj(eicosapentaenoic_acid-8, EPA-10)
compound(n-3-14, 20:5-13)
dep(EPA-10, n-3-14)
cc(eicosapentaenoic_acid-8, and-16)
dep(benefits-3, docosahexaenoic_acid-17)
conj:and(eicosapentaenoic_acid-8, docosahexaenoic_acid-17)
dobj(docosahexaenoic_acid-17, DHA-19)
compound(n-3-23, 22:6-22)
dep(DHA-19, n-3-23)
aux(studied-29, have-26)
auxpass(studied-29, been-27)
advmod(studied-29, extensively-28)
root(ROOT-0, studied-29)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN blood/NN levels/NNS of/IN bile_salt/JJ hydrolase/NN -LRB-/-LRB- BSH/NNP -RRB-/-RRB- in/IN hyperBSHmic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (VBN decreased) (NN blood) (NNS levels))
                      (PP (IN of)
                        (NP (JJ bile_salt) (NN hydrolase))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP BSH))
                      (-RRB- -RRB-))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperBSHmic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP
                                      (NP (DT a) (VBN reduced) (NN risk))
                                      (PP (IN of)
                                        (S
                                          (VP (VBG developing)
                                            (NP (NN coronary_heart_disease))))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, blood-12)
nmod:with(associated-9, levels-13)
case(hydrolase-16, of-14)
amod(hydrolase-16, bile_salt-15)
nmod:of(levels-13, hydrolase-16)
appos(levels-13, BSH-18)
case(patients-22, in-20)
amod(patients-22, hyperBSHmic-21)
nmod:in(levels-13, patients-22)
nsubj(contribute-26, patients-22)
ref(patients-22, which-24)
aux(contribute-26, may-25)
acl:relcl(patients-22, contribute-26)
case(risk-30, to-27)
det(risk-30, a-28)
amod(risk-30, reduced-29)
nmod:to(contribute-26, risk-30)
mark(developing-32, of-31)
acl(risk-30, developing-32)
dobj(developing-32, coronary_heart_disease-33)
appos(risk-30, CHD-35)

BSH/NNP is/VBZ an/DT enzyme/NN involved/VBN in/IN the/DT metabolism/NN of/IN bile_acids/NNS ,/, which/WDT play/VBP a/DT crucial/JJ role/NN in/IN lipid/NN absorption/NN and/CC cholesterol/NN homeostasis/NNS ./.

(ROOT
  (S
    (NP (NNP BSH))
    (VP (VBZ is)
      (NP
        (NP (DT an) (NN enzyme))
        (VP (VBN involved)
          (PP (IN in)
            (NP
              (NP (DT the) (NN metabolism))
              (PP (IN of)
                (NP
                  (NP (NNS bile_acids))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBP play)
                        (NP
                          (NP (DT a) (JJ crucial) (NN role))
                          (PP (IN in)
                            (NP
                              (NP (NN lipid) (NN absorption))
                              (CC and)
                              (NP (NN cholesterol) (NNS homeostasis)))))))))))))))
    (. .)))

nsubj(enzyme-4, BSH-1)
cop(enzyme-4, is-2)
det(enzyme-4, an-3)
root(ROOT-0, enzyme-4)
acl(enzyme-4, involved-5)
case(metabolism-8, in-6)
det(metabolism-8, the-7)
nmod:in(involved-5, metabolism-8)
case(bile_acids-10, of-9)
nmod:of(metabolism-8, bile_acids-10)
nsubj(play-13, bile_acids-10)
ref(bile_acids-10, which-12)
acl:relcl(bile_acids-10, play-13)
det(role-16, a-14)
amod(role-16, crucial-15)
dobj(play-13, role-16)
case(absorption-19, in-17)
compound(absorption-19, lipid-18)
nmod:in(role-16, absorption-19)
cc(absorption-19, and-20)
compound(homeostasis-22, cholesterol-21)
nmod:in(role-16, homeostasis-22)
conj:and(absorption-19, homeostasis-22)

Elevated/JJ BSH/NNP levels/NNS have/VBP been/VBN linked/VBN to/TO dyslipidemia/NN and/CC increased/VBN risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (JJ Elevated) (NNP BSH) (NNS levels))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (VP (VBN linked)
            (PP (TO to)
              (NP (NN dyslipidemia))))
          (CC and)
          (VP (VBN increased)
            (NP
              (NP (NN risk))
              (PP (IN of)
                (NP (NNP CHD))))))))
    (. .)))

amod(levels-3, Elevated-1)
compound(levels-3, BSH-2)
nsubjpass(linked-6, levels-3)
nsubjpass(increased-10, levels-3)
aux(linked-6, have-4)
auxpass(linked-6, been-5)
root(ROOT-0, linked-6)
case(dyslipidemia-8, to-7)
nmod:to(linked-6, dyslipidemia-8)
cc(linked-6, and-9)
conj:and(linked-6, increased-10)
dobj(increased-10, risk-11)
case(CHD-13, of-12)
nmod:of(risk-11, CHD-13)

Long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO modulate/VBP BSH/NNP expression/NN and/CC activity/NN ,/, leading/VBG to/TO decreased/VBN levels/NNS of/IN circulating/VBG bile_acids/NNS ./.

(ROOT
  (SINV
    (S
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (PP (TO to))))))
    (VP (VBP modulate))
    (NP
      (NP (NNP BSH) (NN expression)
        (CC and)
        (NN activity))
      (, ,)
      (VP (VBG leading)
        (PP (TO to)
          (NP
            (NP (VBN decreased) (NNS levels))
            (PP (IN of)
              (NP (VBG circulating) (NNS bile_acids)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-5, omega-3_fatty_acids-2)
aux(shown-5, have-3)
auxpass(shown-5, been-4)
dep(modulate-7, shown-5)
nmod(shown-5, to-6)
root(ROOT-0, modulate-7)
compound(expression-9, BSH-8)
nsubj(modulate-7, expression-9)
cc(expression-9, and-10)
nsubj(modulate-7, activity-11)
conj:and(expression-9, activity-11)
acl(expression-9, leading-13)
case(levels-16, to-14)
amod(levels-16, decreased-15)
nmod:to(leading-13, levels-16)
case(bile_acids-19, of-17)
amod(bile_acids-19, circulating-18)
nmod:of(levels-16, bile_acids-19)

This/DT effect/NN may/MD be/VB mediated/VBN by/IN the/DT anti-inflammatory/JJ and/CC antioxidant/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP ,/, which/WDT can/MD reduce/VB oxidative_stress/NNS and/CC inflammation/NN in/IN the/DT liver/NN and/CC other/JJ tissues/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN effect))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN mediated)
          (PP (IN by)
            (NP
              (NP (DT the) (JJ anti-inflammatory)
                (CC and)
                (JJ antioxidant) (NNS properties))
              (PP (IN of)
                (NP
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD can)
                        (VP (VB reduce)
                          (NP (NNS oxidative_stress)
                            (CC and)
                            (NN inflammation))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN liver))
                              (CC and)
                              (NP (JJ other) (NNS tissues)))))))))))))))
    (. .)))

det(effect-2, This-1)
nsubjpass(mediated-5, effect-2)
aux(mediated-5, may-3)
auxpass(mediated-5, be-4)
root(ROOT-0, mediated-5)
case(properties-11, by-6)
det(properties-11, the-7)
amod(properties-11, anti-inflammatory-8)
cc(anti-inflammatory-8, and-9)
conj:and(anti-inflammatory-8, antioxidant-10)
amod(properties-11, antioxidant-10)
nmod:by(mediated-5, properties-11)
case(EPA-13, of-12)
nmod:of(properties-11, EPA-13)
nsubj(reduce-19, EPA-13)
cc(EPA-13, and-14)
nmod:of(properties-11, DHA-15)
conj:and(EPA-13, DHA-15)
nsubj(reduce-19, DHA-15)
ref(EPA-13, which-17)
aux(reduce-19, can-18)
acl:relcl(EPA-13, reduce-19)
dobj(reduce-19, oxidative_stress-20)
cc(oxidative_stress-20, and-21)
dobj(reduce-19, inflammation-22)
conj:and(oxidative_stress-20, inflammation-22)
case(liver-25, in-23)
det(liver-25, the-24)
nmod:in(reduce-19, liver-25)
cc(liver-25, and-26)
amod(tissues-28, other-27)
nmod:in(reduce-19, tissues-28)
conj:and(liver-25, tissues-28)

In/IN addition/NN ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS ,/, reduce/VB triglyceride_levels/NNS ,/, and/CC lower/JJR blood_pressure/NN ,/, all/DT of/IN which/WDT are/VBP important/JJ risk/NN factors/NNS for/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP
                    (NP (NNS triglyceride_levels))
                    (, ,)
                    (CC and)
                    (NP (JJR lower) (NN blood_pressure))
                    (, ,))
                  (SBAR
                    (WHNP (DT all)
                      (WHPP (IN of)
                        (WHNP (WDT which))))
                    (S
                      (VP (VBP are)
                        (NP
                          (NP (JJ important) (NN risk) (NNS factors))
                          (PP (IN for)
                            (NP (NNP CHD))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-8, addition-2)
det(fatty_acids-5, these-4)
nsubjpass(shown-8, fatty_acids-5)
nsubj:xsubj(improve-10, fatty_acids-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(improve-10, to-9)
xcomp(shown-8, improve-10)
compound(profiles-12, lipid-11)
dobj(improve-10, profiles-12)
dep(improve-10, reduce-14)
dobj(reduce-14, triglyceride_levels-15)
cc(triglyceride_levels-15, and-17)
amod(blood_pressure-19, lower-18)
dobj(reduce-14, blood_pressure-19)
conj:and(triglyceride_levels-15, blood_pressure-19)
dep(which-23, all-21)
case(which-23, of-22)
nsubj(factors-27, which-23)
cop(factors-27, are-24)
amod(factors-27, important-25)
compound(factors-27, risk-26)
dep(reduce-14, factors-27)
case(CHD-29, for-28)
nmod:for(factors-27, CHD-29)

Overall/RB ,/, these/DT findings/NNS suggest/VBP that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ approach/NN for/IN preventing/VBG or/CC managing/VBG CHD/NNP by/IN regulating/VBG BSH/NNP activity/NN and/CC improving/VBG lipid/NN metabolism/NN ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (JJ therapeutic) (NN approach))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG preventing))
                    (CC or)
                    (VP (VBG managing)
                      (NP (NNP CHD))
                      (PP (IN by)
                        (S
                          (VP
                            (VP (VBG regulating)
                              (NP (NNP BSH) (NN activity)))
                            (CC and)
                            (VP (VBG improving)
                              (NP (NN lipid) (NN metabolism)))))))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(approach-14, that-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubj(approach-14, omega-3_fatty_acids-8)
aux(approach-14, may-9)
cop(approach-14, be-10)
det(approach-14, a-11)
amod(approach-14, promising-12)
amod(approach-14, therapeutic-13)
ccomp(suggest-5, approach-14)
mark(preventing-16, for-15)
advcl(approach-14, preventing-16)
cc(preventing-16, or-17)
advcl(approach-14, managing-18)
conj:or(preventing-16, managing-18)
dobj(managing-18, CHD-19)
mark(regulating-21, by-20)
advcl(managing-18, regulating-21)
compound(activity-23, BSH-22)
dobj(regulating-21, activity-23)
cc(regulating-21, and-24)
advcl(managing-18, improving-25)
conj:and(regulating-21, improving-25)
compound(metabolism-27, lipid-26)
dobj(improving-25, metabolism-27)

Obesity/NNP is_a/VBD major/JJ health/NN concern/NN worldwide/RB ,/, and/CC its/PRP$ prevalence/JJ has_been/NN increasing/VBG at/IN an/DT alarming/JJ rate/NN ./.

(ROOT
  (S
    (S
      (NP (NNP Obesity))
      (VP (VBD is_a)
        (NP (JJ major) (NN health) (NN concern))
        (ADVP (RB worldwide))))
    (, ,)
    (CC and)
    (S
      (NP (PRP$ its) (JJ prevalence) (NN has_been))
      (VP (VBG increasing)
        (PP (IN at)
          (NP (DT an) (JJ alarming) (NN rate)))))
    (. .)))

nsubj(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
dobj(is_a-2, concern-5)
advmod(is_a-2, worldwide-6)
cc(is_a-2, and-8)
nmod:poss(has_been-11, its-9)
amod(has_been-11, prevalence-10)
nsubj(increasing-12, has_been-11)
conj:and(is_a-2, increasing-12)
case(rate-16, at-13)
det(rate-16, an-14)
amod(rate-16, alarming-15)
nmod:at(increasing-12, rate-16)

The/DT pathophysiology/NN of/IN obesity/NN is/VBZ complex/JJ and/CC involves/VBZ a/DT variety/NN of/IN genetic/JJ ,/, environmental/JJ ,/, and/CC behavioral/JJ factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathophysiology))
      (PP (IN of)
        (NP (NN obesity))))
    (VP
      (VP (VBZ is)
        (ADJP (JJ complex)))
      (CC and)
      (VP (VBZ involves)
        (NP
          (NP (DT a) (NN variety))
          (PP (IN of)
            (NP
              (ADJP
                (ADJP (JJ genetic))
                (, ,)
                (ADJP (JJ environmental))
                (, ,)
                (CC and)
                (ADJP (JJ behavioral)))
              (NNS factors))))))
    (. .)))

det(pathophysiology-2, The-1)
nsubj(complex-6, pathophysiology-2)
nsubj(involves-8, pathophysiology-2)
case(obesity-4, of-3)
nmod:of(pathophysiology-2, obesity-4)
cop(complex-6, is-5)
root(ROOT-0, complex-6)
cc(complex-6, and-7)
conj:and(complex-6, involves-8)
det(variety-10, a-9)
dobj(involves-8, variety-10)
case(factors-18, of-11)
amod(factors-18, genetic-12)
conj:and(genetic-12, environmental-14)
amod(factors-18, environmental-14)
cc(genetic-12, and-16)
conj:and(genetic-12, behavioral-17)
amod(factors-18, behavioral-17)
nmod:of(variety-10, factors-18)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN SMTNL1/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN SMTNL1))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(involved-15, that-5)
det(hypersecretion-7, the-6)
nsubjpass(involved-15, hypersecretion-7)
case(SMTNL1-9, of-8)
nmod:of(hypersecretion-7, SMTNL1-9)
case(pancreas-12, by-10)
det(pancreas-12, the-11)
nmod:by(SMTNL1-9, pancreas-12)
aux(involved-15, may-13)
auxpass(involved-15, be-14)
ccomp(suggested-4, involved-15)
case(development-18, in-16)
det(development-18, the-17)
nmod:in(involved-15, development-18)
case(obesity-20, of-19)
nmod:of(development-18, obesity-20)

To/TO evaluate/VB this/DT relationship/NN further/RBR ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Tpm/NNP on/IN the/DT secretion/NN of/IN SMTNL1/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP (DT this) (NN relationship))
          (ADVP (RBR further)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Tpm)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP SMTNL1) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-8, evaluate-2)
det(relationship-4, this-3)
dobj(evaluate-2, relationship-4)
advmod(evaluate-2, further-5)
nsubj(examined-8, we-7)
root(ROOT-0, examined-8)
det(effects-10, the-9)
dobj(examined-8, effects-10)
case(glucose-14, of-11)
nummod(glucose-14, 16.7-12)
amod(glucose-14, mmol/L-13)
nmod:of(effects-10, glucose-14)
cc(glucose-14, and-15)
nummod(Tpm-18, 10-16)
compound(Tpm-18, mmol/L-17)
nmod:of(effects-10, Tpm-18)
conj:and(glucose-14, Tpm-18)
case(secretion-21, on-19)
det(secretion-21, the-20)
nmod:on(examined-8, secretion-21)
case(and_insulin-24, of-22)
compound(and_insulin-24, SMTNL1-23)
nmod:of(secretion-21, and_insulin-24)
case(pancreata-28, by-25)
amod(pancreata-28, isolated-26)
amod(pancreata-28, perfused-27)
nmod:by(examined-8, pancreata-28)
case(genetically_obese-30, from-29)
nmod:from(pancreata-28, genetically_obese-30)
appos(genetically_obese-30, fa/fa-32)
cc(genetically_obese-30, and-34)
amod(rats-41, lean-35)
dep(lean-35, Fa-37)
nmod:from(pancreata-28, rats-41)
conj:and(genetically_obese-30, rats-41)

Our/PRP$ results/NNS showed/VBD that/IN the/DT secretion/NN of/IN SMTNL1/NNP was/VBD significantly/RB higher/JJR in/IN the/DT pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC Tpm/NNP stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (NNP SMTNL1))))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN in)
                      (NP
                        (NP (NN response))
                        (PP (TO to)
                          (NP
                            (NP (DT both) (NN glucose))
                            (CC and)
                            (NP (NNP Tpm) (NN stimulation))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-18, that-4)
det(secretion-6, the-5)
nsubjpass(compared-18, secretion-6)
nsubj:xsubj(lean-20, secretion-6)
case(SMTNL1-8, of-7)
nmod:of(secretion-6, SMTNL1-8)
auxpass(compared-18, was-9)
advmod(higher-11, significantly-10)
advmod(compared-18, higher-11)
case(pancreata-14, in-12)
det(pancreata-14, the-13)
nmod:in(higher-11, pancreata-14)
case(rats-17, from-15)
amod(rats-17, genetically_obese-16)
nmod:from(pancreata-14, rats-17)
ccomp(showed-3, compared-18)
mark(lean-20, to-19)
xcomp(compared-18, lean-20)
dobj(lean-20, rats-21)
case(response-23, in-22)
nmod:in(lean-20, response-23)
case(glucose-26, to-24)
det(glucose-26, both-25)
nmod:to(response-23, glucose-26)
cc(glucose-26, and-27)
compound(stimulation-29, Tpm-28)
nmod:to(response-23, stimulation-29)
conj:and(glucose-26, stimulation-29)

Additionally/RB ,/, we/PRP observed/VBD a/DT significant/JJ increase/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN both/DT groups/NNS ,/, but/CC no/DT significant/JJ difference/NN between/IN genetically_obese/JJ and/CC lean/JJ rats/NNS was/VBD observed/VBN ./.

(ROOT
  (S
    (S
      (ADVP (RB Additionally))
      (, ,)
      (NP (PRP we))
      (VP (VBD observed)
        (NP
          (NP (DT a) (JJ significant) (NN increase))
          (PP (IN in)
            (NP (NN insulin_secretion))))
        (PP (IN in)
          (NP
            (NP (NN response))
            (PP (TO to)
              (NP
                (NP (NN glucose) (NN stimulation))
                (PP (IN in)
                  (NP (DT both) (NNS groups)))))))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN between)
          (NP (JJ genetically_obese)
            (CC and)
            (JJ lean) (NNS rats))))
      (VP (VBD was)
        (VP (VBN observed))))
    (. .)))

advmod(observed-4, Additionally-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(increase-7, a-5)
amod(increase-7, significant-6)
dobj(observed-4, increase-7)
case(insulin_secretion-9, in-8)
nmod:in(increase-7, insulin_secretion-9)
case(response-11, in-10)
nmod:in(observed-4, response-11)
case(stimulation-14, to-12)
compound(stimulation-14, glucose-13)
nmod:to(response-11, stimulation-14)
case(groups-17, in-15)
det(groups-17, both-16)
nmod:in(stimulation-14, groups-17)
cc(observed-4, but-19)
neg(difference-22, no-20)
amod(difference-22, significant-21)
nsubjpass(observed-29, difference-22)
case(rats-27, between-23)
amod(rats-27, genetically_obese-24)
cc(genetically_obese-24, and-25)
conj:and(genetically_obese-24, lean-26)
amod(rats-27, lean-26)
nmod:between(difference-22, rats-27)
auxpass(observed-29, was-28)
conj:but(observed-4, observed-29)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN SMTNL1/NNP by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN and/CC could/MD be/VB a/DT potential/JJ target/NN for/IN therapeutic/JJ intervention/NN in/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP SMTNL1)))
            (PP (IN by)
              (NP (DT the) (NN pancreas))))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))
            (CC and)
            (VP (MD could)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ potential) (NN target))
                  (PP (IN for)
                    (NP
                      (NP (JJ therapeutic) (NN intervention))
                      (PP (IN in)
                        (NP (DT this) (NN condition))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-12, that-4)
nsubj(play-12, hypersecretion-5)
case(SMTNL1-7, of-6)
nmod:of(hypersecretion-5, SMTNL1-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(hypersecretion-5, pancreas-10)
aux(play-12, may-11)
ccomp(suggest-3, play-12)
det(role-14, a-13)
dobj(play-12, role-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(role-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)
cc(play-12, and-20)
aux(target-25, could-21)
cop(target-25, be-22)
det(target-25, a-23)
amod(target-25, potential-24)
ccomp(suggest-3, target-25)
conj:and(play-12, target-25)
case(intervention-28, for-26)
amod(intervention-28, therapeutic-27)
nmod:for(target-25, intervention-28)
case(condition-31, in-29)
det(condition-31, this-30)
nmod:in(intervention-28, condition-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT relationship/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP (DT this) (NN relationship))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(relationship-13, in-11)
det(relationship-13, this-12)
nmod:in(involved-10, relationship-13)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ numerous) (JJ beneficial) (NNS effects))
                  (PP (IN on)
                    (NP (JJ human) (NN health))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-17, omega-3_fatty_acids-2)
nsubj:xsubj(have-19, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
mark(have-19, to-18)
xcomp(shown-17, have-19)
amod(effects-22, numerous-20)
amod(effects-22, beneficial-21)
dobj(have-19, effects-22)
case(health-25, on-23)
amod(health-25, human-24)
nmod:on(effects-22, health-25)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN RA-642/NNP in/IN hyperRA-642mic/JJ patients/NNS ,/, which/WDT may/MD reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NNP RA-642))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperRA-642mic) (NNS patients))
                              (, ,)
                              (SBAR
                                (WHNP (WDT which))
                                (S
                                  (VP (MD may)
                                    (VP (VB reduce)
                                      (NP
                                        (NP (DT the) (NN risk))
                                        (PP (IN of)
                                          (S
                                            (VP (VBG developing)
                                              (NP (NN coronary_heart_disease)))))))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(RA-642-14, of-13)
nmod:of(levels-12, RA-642-14)
case(patients-17, in-15)
amod(patients-17, hyperRA-642mic-16)
nmod:in(RA-642-14, patients-17)
nsubj(reduce-21, patients-17)
ref(patients-17, which-19)
aux(reduce-21, may-20)
acl:relcl(patients-17, reduce-21)
det(risk-23, the-22)
dobj(reduce-21, risk-23)
mark(developing-25, of-24)
acl(risk-23, developing-25)
dobj(developing-25, coronary_heart_disease-26)
appos(RA-642-14, CHD-28)

RA-642/JJ is_a/NN known/VBN risk/NN factor/NN for/IN CHD/NNP ,/, and/CC its/PRP$ reduction/NN by/IN EPA/NNP and/CC DHA/NNP suggests/VBZ a/DT potential/JJ mechanism/NN for/IN the/DT cardioprotective/JJ effects/NNS of/IN these/DT fatty_acids/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ RA-642) (NN is_a))
      (VP (VBN known)
        (NP
          (NP
            (NP (NN risk) (NN factor))
            (PP (IN for)
              (NP (NNP CHD))))
          (, ,)
          (CC and)
          (NP
            (NP (PRP$ its) (NN reduction))
            (PP (IN by)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA)))))))
    (VP (VBZ suggests)
      (NP
        (NP (DT a) (JJ potential) (NN mechanism))
        (PP (IN for)
          (NP
            (NP (DT the) (JJ cardioprotective) (NNS effects))
            (PP (IN of)
              (NP (DT these) (NNS fatty_acids)))))))
    (. .)))

amod(is_a-2, RA-642-1)
nsubj(suggests-16, is_a-2)
acl(is_a-2, known-3)
compound(factor-5, risk-4)
dobj(known-3, factor-5)
case(CHD-7, for-6)
nmod:for(factor-5, CHD-7)
cc(factor-5, and-9)
nmod:poss(reduction-11, its-10)
dobj(known-3, reduction-11)
conj:and(factor-5, reduction-11)
case(EPA-13, by-12)
nmod:by(reduction-11, EPA-13)
cc(EPA-13, and-14)
nmod:by(reduction-11, DHA-15)
conj:and(EPA-13, DHA-15)
root(ROOT-0, suggests-16)
det(mechanism-19, a-17)
amod(mechanism-19, potential-18)
dobj(suggests-16, mechanism-19)
case(effects-23, for-20)
det(effects-23, the-21)
amod(effects-23, cardioprotective-22)
nmod:for(mechanism-19, effects-23)
case(fatty_acids-26, of-24)
det(fatty_acids-26, these-25)
nmod:of(effects-23, fatty_acids-26)

Additionally/RB ,/, other/JJ studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP can/MD improve/VB lipid/NN profiles/NNS ,/, reduce/VB inflammation/NN ,/, and/CC lower/JJR blood_pressure/NN ,/, all/DT of/IN which/WDT are/VBP important/JJ factors/NNS in/IN the/DT prevention/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ other) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD can)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (VP (VB reduce)
                  (NP
                    (NP (NN inflammation))
                    (, ,)
                    (CC and)
                    (NP (JJR lower) (NN blood_pressure))
                    (, ,))
                  (SBAR
                    (WHNP (DT all)
                      (WHPP (IN of)
                        (WHNP (WDT which))))
                    (S
                      (VP (VBP are)
                        (NP
                          (NP (JJ important) (NNS factors))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN prevention))
                              (PP (IN of)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

advmod(shown-6, Additionally-1)
amod(studies-4, other-3)
nsubj(shown-6, studies-4)
aux(shown-6, have-5)
root(ROOT-0, shown-6)
mark(improve-12, that-7)
nsubj(improve-12, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubj(improve-12, DHA-10)
aux(improve-12, can-11)
ccomp(shown-6, improve-12)
compound(profiles-14, lipid-13)
dobj(improve-12, profiles-14)
dep(improve-12, reduce-16)
dobj(reduce-16, inflammation-17)
cc(inflammation-17, and-19)
amod(blood_pressure-21, lower-20)
dobj(reduce-16, blood_pressure-21)
conj:and(inflammation-17, blood_pressure-21)
dep(which-25, all-23)
case(which-25, of-24)
nsubj(factors-28, which-25)
cop(factors-28, are-26)
amod(factors-28, important-27)
dep(reduce-16, factors-28)
case(prevention-31, in-29)
det(prevention-31, the-30)
nmod:in(factors-28, prevention-31)
case(CHD-33, of-32)
nmod:of(prevention-31, CHD-33)

Overall/RB ,/, the/DT evidence/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT the) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN cardiovascular_health))))))))))))
    (. .)))

advmod(suggests-5, Overall-1)
det(evidence-4, the-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
mark(strategy-16, that-6)
amod(intake-8, increasing-7)
nsubj(strategy-16, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggests-5, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
cc(reducing-18, and-23)
acl(strategy-16, improving-24)
conj:and(reducing-18, improving-24)
amod(cardiovascular_health-26, overall-25)
dobj(improving-24, cardiovascular_health-26)

Migraine/VB is_a/JJ common/JJ neurological_disorder/NN that/WDT affects/VBZ a/DT significant/JJ proportion/NN of/IN the/DT population/NN worldwide/RB ./.

(ROOT
  (S
    (VP (VB Migraine)
      (NP
        (NP (JJ is_a) (JJ common) (NN neurological_disorder))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP
                (NP (DT a) (JJ significant) (NN proportion))
                (PP (IN of)
                  (NP (DT the) (NN population))))))))
      (ADVP (RB worldwide)))
    (. .)))

root(ROOT-0, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
dobj(Migraine-1, neurological_disorder-4)
nsubj(affects-6, neurological_disorder-4)
ref(neurological_disorder-4, that-5)
acl:relcl(neurological_disorder-4, affects-6)
det(proportion-9, a-7)
amod(proportion-9, significant-8)
dobj(affects-6, proportion-9)
case(population-12, of-10)
det(population-12, the-11)
nmod:of(proportion-9, population-12)
advmod(Migraine-1, worldwide-13)

The/DT pathophysiology/NN of/IN migraine/NN involves/VBZ the/DT activation/NN of/IN trigeminal/JJ vascular/NN system/NN leading/VBG to/TO the/DT release/NN of/IN various/JJ neuropeptides/NNS and/CC inflammatory/JJ mediators/NNS that/WDT cause/VBP pain_and/VBN other/JJ associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathophysiology))
      (PP (IN of)
        (NP (NN migraine))))
    (VP (VBZ involves)
      (NP
        (NP (DT the) (NN activation))
        (PP (IN of)
          (NP (JJ trigeminal) (NN vascular) (NN system))))
      (PP (VBG leading)
        (PP (TO to)
          (NP
            (NP (DT the) (NN release))
            (PP (IN of)
              (NP
                (NP (JJ various) (NNS neuropeptides))
                (CC and)
                (NP
                  (NP (JJ inflammatory) (NNS mediators))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP cause)
                        (VP (VBN pain_and)
                          (NP (JJ other) (VBN associated) (NNS symptoms)))))))))))))
    (. .)))

det(pathophysiology-2, The-1)
nsubj(involves-5, pathophysiology-2)
case(migraine-4, of-3)
nmod:of(pathophysiology-2, migraine-4)
root(ROOT-0, involves-5)
det(activation-7, the-6)
dobj(involves-5, activation-7)
case(system-11, of-8)
amod(system-11, trigeminal-9)
compound(system-11, vascular-10)
nmod:of(activation-7, system-11)
case(release-15, leading-12)
case(release-15, to-13)
det(release-15, the-14)
advcl(involves-5, release-15)
case(neuropeptides-18, of-16)
amod(neuropeptides-18, various-17)
nmod:of(release-15, neuropeptides-18)
cc(neuropeptides-18, and-19)
amod(mediators-21, inflammatory-20)
nmod:of(release-15, mediators-21)
conj:and(neuropeptides-18, mediators-21)
nsubj(cause-23, mediators-21)
ref(mediators-21, that-22)
acl:relcl(mediators-21, cause-23)
dep(cause-23, pain_and-24)
amod(symptoms-27, other-25)
amod(symptoms-27, associated-26)
dobj(pain_and-24, symptoms-27)

A77003/NNP is_a/VBD novel/NN drug/NN that/WDT has_been/VBP developed/VBN for/IN the/DT treatment/NN of/IN migraine/NN ./.

(ROOT
  (S
    (NP (NNP A77003))
    (VP (VBD is_a)
      (NP
        (NP (NN novel) (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN developed)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NN migraine)))))))))))
    (. .)))

nsubj(is_a-2, A77003-1)
root(ROOT-0, is_a-2)
compound(drug-4, novel-3)
dobj(is_a-2, drug-4)
nsubj(has_been-6, drug-4)
ref(drug-4, that-5)
acl:relcl(drug-4, has_been-6)
dep(has_been-6, developed-7)
case(treatment-10, for-8)
det(treatment-10, the-9)
nmod:for(developed-7, treatment-10)
case(migraine-12, of-11)
nmod:of(treatment-10, migraine-12)

In/IN a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ,/, A77003/NNP was/VBD administered/VBN to/TO patients/NNS with/IN acute/JJ migraine/JJ attacks/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)))
    (, ,)
    (NP (NNP A77003))
    (VP (VBD was)
      (VP (VBN administered)
        (PP (TO to)
          (NP (NNS patients)))
        (PP (IN with)
          (NP (JJ acute) (JJ migraine) (NNS attacks)))))
    (. .)))

case(trial-8, In-1)
det(trial-8, a-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(administered-12, trial-8)
nsubjpass(administered-12, A77003-10)
auxpass(administered-12, was-11)
root(ROOT-0, administered-12)
case(patients-14, to-13)
nmod:to(administered-12, patients-14)
case(attacks-18, with-15)
amod(attacks-18, acute-16)
amod(attacks-18, migraine-17)
nmod:with(administered-12, attacks-18)

At_2/JJ h/NN after/IN dosing/VBG ,/, A77003/NNP reduced/VBD the/DT risk/NN of/IN periphlebitis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP A77003))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS periphlebitis))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, A77003-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(periphlebitis-11, of-10)
nmod:of(risk-9, periphlebitis-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN A77003/NNP may/MD be/VB an/DT effective/JJ treatment/NN for/IN migraine-associated_symptoms/NNS and/CC could/MD potentially/RB improve/VB the/DT quality_of_life/NN for/IN patients/NNS suffering/VBG from/IN this/DT debilitating/JJ condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP A77003))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT an) (JJ effective) (NN treatment))
                  (PP (IN for)
                    (NP (NNS migraine-associated_symptoms))))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB improve)
                (NP
                  (NP (DT the) (NN quality_of_life))
                  (PP (IN for)
                    (NP
                      (NP (NNS patients))
                      (VP (VBG suffering)
                        (PP (IN from)
                          (NP (DT this) (JJ debilitating) (NN condition)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(treatment-10, that-4)
nsubj(treatment-10, A77003-5)
nsubj(improve-16, A77003-5)
aux(treatment-10, may-6)
cop(treatment-10, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
ccomp(suggest-3, treatment-10)
case(migraine-associated_symptoms-12, for-11)
nmod:for(treatment-10, migraine-associated_symptoms-12)
cc(treatment-10, and-13)
aux(improve-16, could-14)
advmod(improve-16, potentially-15)
ccomp(suggest-3, improve-16)
conj:and(treatment-10, improve-16)
det(quality_of_life-18, the-17)
dobj(improve-16, quality_of_life-18)
case(patients-20, for-19)
nmod:for(quality_of_life-18, patients-20)
acl(patients-20, suffering-21)
case(condition-25, from-22)
det(condition-25, this-23)
amod(condition-25, debilitating-24)
nmod:from(suffering-21, condition-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO evaluate/VB its/PRP$ long-term/JJ safety/NN and/CC efficacy/NN in/IN larger/JJR patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB evaluate)
              (NP (PRP$ its) (JJ long-term) (NN safety)
                (CC and)
                (NN efficacy))
              (PP (IN in)
                (NP (JJR larger) (JJ patient) (NNS populations))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(evaluate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(evaluate-6, to-5)
xcomp(needed-4, evaluate-6)
nmod:poss(safety-9, its-7)
amod(safety-9, long-term-8)
dobj(evaluate-6, safety-9)
cc(safety-9, and-10)
dobj(evaluate-6, efficacy-11)
conj:and(safety-9, efficacy-11)
case(populations-15, in-12)
amod(populations-15, larger-13)
amod(populations-15, patient-14)
nmod:in(evaluate-6, populations-15)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB associated/VBN with/IN decreased/VBN fencamfamine/JJ levels/NNS in/IN hyperfencamfaminemic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ fencamfamine) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperfencamfaminemic) (NNS patients)))))
                (, ,)
                (ADVP
                  (ADVP (RB as) (RB well))
                  (PP (IN as)
                    (NP
                      (NP
                        (NP (DT a) (VBN reduced) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(associated-10, that-4)
det(omega-3_fatty_acids-7, these-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-10, omega-3_fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(suggest-3, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, fencamfamine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperfencamfaminemic-16)
nmod:in(levels-14, patients-17)
advmod(associated-10, as-19)
mwe(as-19, well-20)
case(risk-24, as-21)
det(risk-24, a-22)
amod(risk-24, reduced-23)
nmod:as(as-19, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

EPA/NNP and/CC DHA/NNP are/VBP thought/VBN to/TO exert/VB their/PRP$ cardioprotective/JJ effects/NNS through/IN various/JJ mechanisms/NNS ,/, including/VBG reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC decreasing/VBG blood_pressure/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN thought)
        (S
          (VP (TO to)
            (VP (VB exert)
              (NP (PRP$ their) (JJ cardioprotective) (NNS effects))
              (PP (IN through)
                (NP
                  (NP (JJ various) (NNS mechanisms))
                  (, ,)
                  (VP (VBG including)
                    (S
                      (VP
                        (VP (VBG reducing)
                          (NP (NN inflammation)))
                        (, ,)
                        (VP (VBG improving)
                          (NP (NN lipid) (NNS profiles)))
                        (, ,)
                        (CC and)
                        (VP (VBG decreasing)
                          (NP (NN blood_pressure)))))))))))))
    (. .)))

nsubjpass(thought-5, EPA-1)
nsubj:xsubj(exert-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(thought-5, DHA-3)
nsubj:xsubj(exert-7, DHA-3)
auxpass(thought-5, are-4)
root(ROOT-0, thought-5)
mark(exert-7, to-6)
xcomp(thought-5, exert-7)
nmod:poss(effects-10, their-8)
amod(effects-10, cardioprotective-9)
dobj(exert-7, effects-10)
case(mechanisms-13, through-11)
amod(mechanisms-13, various-12)
nmod:through(exert-7, mechanisms-13)
acl(mechanisms-13, including-15)
ccomp(including-15, reducing-16)
dobj(reducing-16, inflammation-17)
ccomp(including-15, improving-19)
conj:and(reducing-16, improving-19)
compound(profiles-21, lipid-20)
dobj(improving-19, profiles-21)
cc(reducing-16, and-23)
ccomp(including-15, decreasing-24)
conj:and(reducing-16, decreasing-24)
dobj(decreasing-24, blood_pressure-25)

In/IN addition/NN to/TO their/PRP$ cardiovascular_benefits/NNS ,/, omega-3_fatty_acids/JJ have/VBP also/RB been/VBN shown/VBN to/TO have/VB neuroprotective/JJ effects/NNS and/CC may/MD improve/VB cognitive/JJ function/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (NNS cardiovascular_benefits)))))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP
      (VP (VBP have) (RB also)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP (JJ neuroprotective) (NNS effects))))))))
      (CC and)
      (VP (MD may)
        (VP (VB improve)
          (NP-TMP (JJ cognitive) (NN function)))))
    (. .)))

case(cardiovascular_benefits-5, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(cardiovascular_benefits-5, their-4)
nmod:in_addition_to(shown-11, cardiovascular_benefits-5)
nsubjpass(shown-11, omega-3_fatty_acids-7)
nsubj:xsubj(have-13, omega-3_fatty_acids-7)
nsubj(improve-18, omega-3_fatty_acids-7)
aux(shown-11, have-8)
advmod(shown-11, also-9)
auxpass(shown-11, been-10)
root(ROOT-0, shown-11)
mark(have-13, to-12)
xcomp(shown-11, have-13)
amod(effects-15, neuroprotective-14)
dobj(have-13, effects-15)
cc(shown-11, and-16)
aux(improve-18, may-17)
conj:and(shown-11, improve-18)
amod(function-20, cognitive-19)
nmod:tmod(improve-18, function-20)

Given/VBN their/PRP$ potential/JJ health/NN benefits/NNS ,/, increasing/VBG dietary/JJ intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN consumption/NN of/IN fatty/JJ fish/NN or/CC supplementation/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG CHD/NNP and/CC improving/VBG overall/JJ health/NN ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (JJ dietary) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP
            (NP (NN consumption))
            (PP (IN of)
              (NP (JJ fatty) (NN fish)
                (CC or)
                (NN supplementation)))))))
    (VP (MD may)
      (VP (VB be)
        (NP (DT a) (JJ promising) (NN strategy))
        (PP (IN for)
          (S
            (VP
              (VP (VBG preventing)
                (NP (NNP CHD)))
              (CC and)
              (VP (VBG improving)
                (NP (JJ overall) (NN health))))))))
    (. .)))

case(benefits-5, Given-1)
nmod:poss(benefits-5, their-2)
amod(benefits-5, potential-3)
compound(benefits-5, health-4)
nmod:given(strategy-25, benefits-5)
csubj(strategy-25, increasing-7)
amod(intake-9, dietary-8)
dobj(increasing-7, intake-9)
case(EPA-11, of-10)
nmod:of(intake-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(intake-9, DHA-13)
conj:and(EPA-11, DHA-13)
case(consumption-15, through-14)
nmod:through(increasing-7, consumption-15)
case(fish-18, of-16)
amod(fish-18, fatty-17)
nmod:of(consumption-15, fish-18)
cc(fish-18, or-19)
nmod:of(consumption-15, supplementation-20)
conj:or(fish-18, supplementation-20)
aux(strategy-25, may-21)
cop(strategy-25, be-22)
det(strategy-25, a-23)
amod(strategy-25, promising-24)
root(ROOT-0, strategy-25)
mark(preventing-27, for-26)
advcl(strategy-25, preventing-27)
dobj(preventing-27, CHD-28)
cc(preventing-27, and-29)
advcl(strategy-25, improving-30)
conj:and(preventing-27, improving-30)
amod(health-32, overall-31)
dobj(improving-30, health-32)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/JJ -RRB-/-RRB- and/CC docosahexaenoic_acid/JJ -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/JJ -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
    (, ,)
    (S
      (VP (VBG including)
        (NP
          (NP
            (NP (JJ eicosapentaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 20:5) (JJ n-3))
            (-RRB- -RRB-))
          (CC and)
          (NP
            (NP (JJ docosahexaenoic_acid))
            (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-) (-LRB- -LRB-)
            (ADJP (CD 22:6) (JJ n-3))
            (-RRB- -RRB-)))))
    (, ,)
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-26, omega-3_fatty_acids-2)
advcl(studied-26, including-4)
dobj(including-4, eicosapentaenoic_acid-5)
dep(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
amod(eicosapentaenoic_acid-5, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dobj(including-4, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dep(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
amod(docosahexaenoic_acid-14, n-3-20)
aux(studied-26, have-23)
auxpass(studied-26, been-24)
advmod(studied-26, extensively-25)
root(ROOT-0, studied-26)
case(benefits-31, for-27)
nmod:poss(benefits-31, their-28)
amod(benefits-31, potential-29)
compound(benefits-31, health-30)
nmod:for(studied-26, benefits-31)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT fatty_acids/NNS may/MD be/VB associated/VBN with/IN decreased/VBN somatropin/NN levels/NNS in/IN hypersomatropinmic/JJ patients/NNS ,/, which/WDT could/MD have/VB implications/NNS for/IN the/DT treatment/NN of/IN growth_hormone-related/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (NN somatropin) (NNS levels))
                      (PP (IN in)
                        (NP
                          (NP (JJ hypersomatropinmic) (NNS patients))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (MD could)
                                (VP (VB have)
                                  (NP
                                    (NP (NNS implications))
                                    (PP (IN for)
                                      (NP
                                        (NP (DT the) (NN treatment))
                                        (PP (IN of)
                                          (NP (JJ growth_hormone-related) (NNS disorders)))))))))))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
aux(associated-10, may-8)
auxpass(associated-10, be-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, somatropin-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hypersomatropinmic-16)
nmod:in(levels-14, patients-17)
nsubj(have-21, patients-17)
ref(patients-17, which-19)
aux(have-21, could-20)
acl:relcl(patients-17, have-21)
dobj(have-21, implications-22)
case(treatment-25, for-23)
det(treatment-25, the-24)
nmod:for(implications-22, treatment-25)
case(disorders-28, of-26)
amod(disorders-28, growth_hormone-related-27)
nmod:of(treatment-25, disorders-28)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, a/DT leading/VBG cause/NN of/IN morbidity/NN and/CC mortality/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP
                          (NP
                            (NP (NN coronary_heart_disease))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-)))
                          (, ,)
                          (NP
                            (NP (DT a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN morbidity)
                                (CC and)
                                (NN mortality)))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(shown-8, Additionally-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(decrease-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(decrease-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(decrease-10, to-9)
xcomp(shown-8, decrease-10)
det(risk-12, the-11)
dobj(decrease-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(coronary_heart_disease-15, CHD-17)
det(cause-22, a-20)
amod(cause-22, leading-21)
appos(coronary_heart_disease-15, cause-22)
case(morbidity-24, of-23)
nmod:of(cause-22, morbidity-24)
cc(morbidity-24, and-25)
nmod:of(cause-22, mortality-26)
conj:and(morbidity-24, mortality-26)
advmod(decrease-10, worldwide-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD have/VB important/JJ health/NN benefits/NNS and/CC should/MD be/VB considered/VBN as/IN part/NN of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP
            (VP (MD may)
              (VP (VB have)
                (NP (JJ important) (NN health) (NNS benefits))))
            (CC and)
            (VP (MD should)
              (VP (VB be)
                (VP (VBN considered)
                  (PP (IN as)
                    (NP
                      (NP (NN part))
                      (PP (IN of)
                        (NP (DT a) (JJ healthy) (NN diet))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-11, that-4)
amod(intake-6, increasing-5)
nsubj(have-11, intake-6)
nsubjpass(considered-18, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(have-11, may-10)
ccomp(suggest-3, have-11)
amod(benefits-14, important-12)
compound(benefits-14, health-13)
dobj(have-11, benefits-14)
cc(have-11, and-15)
aux(considered-18, should-16)
auxpass(considered-18, be-17)
ccomp(suggest-3, considered-18)
conj:and(have-11, considered-18)
case(part-20, as-19)
nmod:as(considered-18, part-20)
case(diet-24, of-21)
det(diet-24, a-22)
amod(diet-24, healthy-23)
nmod:of(part-20, diet-24)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO optimize/VB recommendations/NNS for/IN dietary/JJ intake/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP
                  (NP (NNS recommendations))
                  (PP (IN for)
                    (NP (JJ dietary) (NN intake))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(understand-7, and-13)
mark(optimize-15, to-14)
ccomp(needed-4, optimize-15)
conj:and(understand-7, optimize-15)
dobj(optimize-15, recommendations-16)
case(intake-19, for-17)
amod(intake-19, dietary-18)
nmod:for(recommendations-16, intake-19)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBP complex/JJ process/NN regulated/VBN by/IN various/JJ signaling/VBG pathways/NNS and/CC transcription/JJ factors/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBP is_a)
      (NP (JJ complex) (NN process))
      (PP (VBN regulated)
        (PP (IN by)
          (NP
            (NP (JJ various) (VBG signaling) (NNS pathways))
            (CC and)
            (NP (JJ transcription) (NNS factors))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
case(pathways-11, regulated-7)
case(pathways-11, by-8)
amod(pathways-11, various-9)
amod(pathways-11, signaling-10)
advcl(is_a-4, pathways-11)
cc(pathways-11, and-12)
amod(factors-14, transcription-13)
advcl(is_a-4, factors-14)
conj:and(pathways-11, factors-14)

The/DT v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog/JJ protein/NN -LRB-/-LRB- MYC/NNP -RRB-/-RRB- is/VBZ known/VBN to/TO play/VB a/DT crucial/JJ role/NN in/IN the/DT differentiation/JJ of_skeletal_muscle/JJ cells/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog) (NN protein))
      (PRN (-LRB- -LRB-)
        (NP (NNP MYC))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP (DT the) (JJ differentiation) (JJ of_skeletal_muscle) (NNS cells)))))))))
    (. .)))

det(protein-3, The-1)
amod(protein-3, v-myc_avian_myelocytomatosis_viral_oncogene_neuroblastoma-derived_homolog-2)
nsubjpass(known-8, protein-3)
nsubj:xsubj(play-10, protein-3)
appos(protein-3, MYC-5)
auxpass(known-8, is-7)
root(ROOT-0, known-8)
mark(play-10, to-9)
xcomp(known-8, play-10)
det(role-13, a-11)
amod(role-13, crucial-12)
dobj(play-10, role-13)
case(cells-18, in-14)
det(cells-18, the-15)
amod(cells-18, differentiation-16)
amod(cells-18, of_skeletal_muscle-17)
nmod:in(role-13, cells-18)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN CCT137690/NNP ,/, a/DT potent/JJ inhibitor/NN of/IN bromodomain_and_extra-terminal/JJ domain/NN -LRB-/-LRB- BET/NNP -RRB-/-RRB- proteins/NNS ,/, on/IN MYC/NNP expression/NN in/IN C2C12/CD cells/NNS cultured/VBN in/IN differentiation/JJ medium/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP CCT137690))
            (, ,)
            (NP
              (NP (DT a) (JJ potent) (NN inhibitor))
              (PP (IN of)
                (NP
                  (ADJP (JJ bromodomain_and_extra-terminal) (NN domain))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP BET))
                    (-RRB- -RRB-))
                  (NNS proteins))))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (NNP MYC) (NN expression))
          (PP (IN in)
            (NP
              (NP (CD C2C12) (NNS cells))
              (VP (VBN cultured)
                (PP (IN in)
                  (NP (JJ differentiation) (NN medium)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(CCT137690-10, of-9)
nmod:of(effect-8, CCT137690-10)
det(inhibitor-14, a-12)
amod(inhibitor-14, potent-13)
appos(CCT137690-10, inhibitor-14)
case(proteins-21, of-15)
dep(domain-17, bromodomain_and_extra-terminal-16)
amod(proteins-21, domain-17)
appos(proteins-21, BET-19)
nmod:of(inhibitor-14, proteins-21)
case(expression-25, on-23)
compound(expression-25, MYC-24)
nmod:on(investigated-6, expression-25)
case(cells-28, in-26)
nummod(cells-28, C2C12-27)
nmod:in(expression-25, cells-28)
acl(cells-28, cultured-29)
case(medium-32, in-30)
amod(medium-32, differentiation-31)
nmod:in(cultured-29, medium-32)

Our/PRP$ results/NNS showed/VBD that/IN CCT137690/NNP up-regulated/VBD MYC/NNP levels/NNS in_a/JJ time-dependent/JJ manner/NN and/CC prolonged/JJ MYC/NNP half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP CCT137690))
          (VP (VBD up-regulated)
            (NP (NNP MYC) (NNS levels)
              (NX
                (NX (JJ in_a) (JJ time-dependent) (NN manner))
                (CC and)
                (NX (JJ prolonged) (NNP MYC) (NN half-life))))
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(up-regulated-6, that-4)
nsubj(up-regulated-6, CCT137690-5)
ccomp(showed-3, up-regulated-6)
compound(manner-11, MYC-7)
dep(manner-11, levels-8)
amod(manner-11, in_a-9)
amod(manner-11, time-dependent-10)
dobj(up-regulated-6, manner-11)
cc(manner-11, and-12)
amod(half-life-15, prolonged-13)
compound(half-life-15, MYC-14)
dobj(up-regulated-6, half-life-15)
conj:and(manner-11, half-life-15)
case(hours-20, from-16)
compound(18-19, 10-17)
dep(18-19, to-18)
nummod(hours-20, 18-19)
nmod:from(up-regulated-6, hours-20)

These/DT findings/NNS suggest/VBP that/IN BET/NNP proteins/NNS may/MD play/VB a/DT critical/JJ role/NN in/IN regulating/VBG MYC/NNP expression/NN during/IN skeletal_muscle/JJ differentiation/NN ,/, and/CC inhibition/NN of/IN BET/NNP proteins/NNS may/MD have/VB therapeutic/JJ potential/NN for/IN muscle-related_diseases/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (NP (NNP BET) (NNS proteins))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (JJ critical) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (NNP MYC) (NN expression))
                        (PP (IN during)
                          (NP (JJ skeletal_muscle) (NN differentiation))))))))))
          (, ,)
          (CC and)
          (S
            (NP
              (NP (NN inhibition))
              (PP (IN of)
                (NP (NNP BET) (NNS proteins))))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ therapeutic) (NN potential))
                  (PP (IN for)
                    (NP (NNS muscle-related_diseases))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
compound(proteins-6, BET-5)
nsubj(play-8, proteins-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-11, a-9)
amod(role-11, critical-10)
dobj(play-8, role-11)
mark(regulating-13, in-12)
acl(role-11, regulating-13)
compound(expression-15, MYC-14)
dobj(regulating-13, expression-15)
case(differentiation-18, during-16)
amod(differentiation-18, skeletal_muscle-17)
nmod:during(regulating-13, differentiation-18)
cc(play-8, and-20)
nsubj(have-26, inhibition-21)
case(proteins-24, of-22)
compound(proteins-24, BET-23)
nmod:of(inhibition-21, proteins-24)
aux(have-26, may-25)
ccomp(suggest-3, have-26)
conj:and(play-8, have-26)
amod(potential-28, therapeutic-27)
dobj(have-26, potential-28)
case(muscle-related_diseases-30, for-29)
nmod:for(potential-28, muscle-related_diseases-30)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN and/CC have/VBP been/VBN linked/VBN to/TO numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (ADJP (JJ essential)
          (PP (IN for)
            (NP (JJ human) (NN health)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN linked)
            (PP (TO to)
              (NP (JJ numerous) (NN health) (NNS benefits)))))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
nsubjpass(linked-22, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, for-16)
amod(health-18, human-17)
nmod:for(essential-15, health-18)
cc(essential-15, and-19)
aux(linked-22, have-20)
auxpass(linked-22, been-21)
conj:and(essential-15, linked-22)
case(benefits-26, to-23)
amod(benefits-26, numerous-24)
compound(benefits-26, health-25)
nmod:to(linked-22, benefits-26)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN isopropylphenazone/NN in/IN hyperisopropylphenazonemic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN isopropylphenazone))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperisopropylphenazonemic) (NNS patients))
                              (, ,)
                              (ADVP (RB as) (RB well)
                                (PP (IN as)
                                  (NP
                                    (NP (DT a) (VBN decreased) (NN risk))
                                    (PP (IN of)
                                      (S
                                        (VP (VBG developing)
                                          (NP (NN coronary_heart_disease)))))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(isopropylphenazone-15, of-14)
nmod:of(levels-13, isopropylphenazone-15)
case(patients-18, in-16)
amod(patients-18, hyperisopropylphenazonemic-17)
nmod:in(isopropylphenazone-15, patients-18)
advmod(well-21, as-20)
advmod(patients-18, well-21)
case(risk-25, as-22)
det(risk-25, a-23)
amod(risk-25, decreased-24)
nmod:as(well-21, risk-25)
mark(developing-27, of-26)
acl(risk-25, developing-27)
dobj(developing-27, coronary_heart_disease-28)
appos(isopropylphenazone-15, CHD-30)

Isopropylphenazone/NNP is_a/VBD common/JJ drug/NN used/VBN for/IN pain/NN relief/NN ,/, but/CC high/JJ levels/NNS have/VBP been/VBN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (S
      (NP (NNP Isopropylphenazone))
      (VP (VBD is_a)
        (NP
          (NP (JJ common) (NN drug))
          (VP (VBN used)
            (PP (IN for)
              (NP (NN pain) (NN relief)))))))
    (, ,)
    (CC but)
    (S
      (NP (JJ high) (NNS levels))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (DT an) (VBN increased) (NN risk))
                (PP (IN of)
                  (NP (NN cardiovascular_disease)))))))))
    (. .)))

nsubj(is_a-2, Isopropylphenazone-1)
root(ROOT-0, is_a-2)
amod(drug-4, common-3)
dobj(is_a-2, drug-4)
acl(drug-4, used-5)
case(relief-8, for-6)
compound(relief-8, pain-7)
nmod:for(used-5, relief-8)
cc(is_a-2, but-10)
amod(levels-12, high-11)
nsubjpass(associated-15, levels-12)
aux(associated-15, have-13)
auxpass(associated-15, been-14)
conj:but(is_a-2, associated-15)
case(risk-19, with-16)
det(risk-19, an-17)
amod(risk-19, increased-18)
nmod:with(associated-15, risk-19)
case(cardiovascular_disease-21, of-20)
nmod:of(risk-19, cardiovascular_disease-21)

The/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP risk/NN may/MD be/VB due/JJ to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN ,/, lower/JJR triglyceride_levels/NNS ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ beneficial) (NNS effects))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA)))
      (PP (IN on)
        (NP (NNP CHD) (NN risk))))
    (VP (MD may)
      (VP (VB be)
        (ADJP (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP
                        (NP (NN inflammation))
                        (, ,)
                        (NP (JJR lower) (NNS triglyceride_levels))
                        (, ,)))
                    (CC and)
                    (VP (VB improve)
                      (NP (JJ endothelial) (NN function)))))))))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, beneficial-2)
nsubj(due-13, effects-3)
case(EPA-5, of-4)
nmod:of(effects-3, EPA-5)
cc(EPA-5, and-6)
nmod:of(effects-3, DHA-7)
conj:and(EPA-5, DHA-7)
case(risk-10, on-8)
compound(risk-10, CHD-9)
nmod:on(effects-3, risk-10)
aux(due-13, may-11)
cop(due-13, be-12)
root(ROOT-0, due-13)
case(ability-16, to-14)
nmod:poss(ability-16, their-15)
nmod:to(due-13, ability-16)
mark(reduce-18, to-17)
acl(ability-16, reduce-18)
dobj(reduce-18, inflammation-19)
amod(triglyceride_levels-22, lower-21)
appos(inflammation-19, triglyceride_levels-22)
cc(reduce-18, and-24)
acl(ability-16, improve-25)
conj:and(reduce-18, improve-25)
amod(function-27, endothelial-26)
dobj(improve-25, function-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD have/VB important/JJ implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ important) (NNS implications))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN treatment))
                    (PP (IN of)
                      (NP (NN cardiovascular_disease)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-12, that-4)
amod(intake-6, increasing-5)
nsubj(have-12, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(have-12, may-11)
ccomp(suggest-3, have-12)
amod(implications-14, important-13)
dobj(have-12, implications-14)
case(prevention-17, for-15)
det(prevention-17, the-16)
nmod:for(implications-14, prevention-17)
cc(prevention-17, and-18)
nmod:for(implications-14, treatment-19)
conj:and(prevention-17, treatment-19)
case(cardiovascular_disease-21, of-20)
nmod:of(prevention-17, cardiovascular_disease-21)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT effectiveness/NN of/IN U-46619/NN in/IN reducing/VBG the/DT risk/NN of/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN effectiveness))
              (PP (IN of)
                (NP (NN U-46619))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NNS bronchospasms))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(effectiveness-8, the-7)
dobj(investigate-6, effectiveness-8)
case(U-46619-10, of-9)
nmod:of(effectiveness-8, U-46619-10)
mark(reducing-12, in-11)
advcl(investigate-6, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(bronchospasms-16, of-15)
nmod:of(risk-14, bronchospasms-16)
nmod:of(risk-14, photophobia-18)
conj:and(bronchospasms-16, photophobia-18)
cc(bronchospasms-16, and-20)
nmod:of(risk-14, phonophobia-21)
conj:and(bronchospasms-16, phonophobia-21)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS suffering/VBG from/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP
                (NP (NNS patients))
                (VP (VBG suffering)
                  (PP (IN from)
                    (NP (DT these) (NNS symptoms))))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(group-12, on-10)
det(group-12, a-11)
nmod:on(conducted-9, group-12)
case(patients-14, of-13)
nmod:of(group-12, patients-14)
acl(patients-14, suffering-15)
case(symptoms-18, from-16)
det(symptoms-18, these-17)
nmod:from(suffering-15, symptoms-18)

At_2/JJ h/NN after/IN dosing/VBG ,/, U-46619/NNP showed/VBD a/DT significant/JJ reduction/NN in/IN the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP U-46619))
    (VP (VBD showed)
      (NP (DT a) (JJ significant) (NN reduction))
      (PP (IN in)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP (NNS bronchospasms)))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(showed-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(showed-7, U-46619-6)
root(ROOT-0, showed-7)
det(reduction-10, a-8)
amod(reduction-10, significant-9)
dobj(showed-7, reduction-10)
case(risk-13, in-11)
det(risk-13, the-12)
nmod:in(showed-7, risk-13)
case(bronchospasms-15, of-14)
nmod:of(risk-13, bronchospasms-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(showed-7, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
acl:relcl(%-21, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
xcomp(showed-7, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
appos(%-34, %-37)
dep(%-40, CI-38)
nummod(%-40, 12-22-39)
nmod(%-37, %-40)
dep(%-37, P-42)
compound(0.0001-44, <-43)
nummod(P-42, 0.0001-44)
cc(photophobia-31, and-47)
xcomp(showed-7, phonophobia-48)
conj:and(photophobia-31, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
appos(%-51, %-54)
dep(%-57, CI-55)
nummod(%-57, 17-20-56)
nmod(%-54, %-57)
dep(%-54, P-59)
compound(0.0001-61, <-60)
nummod(P-59, 0.0001-61)

These/DT findings/NNS suggest/VBP that/IN U-46619/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS experiencing/VBG these/DT symptoms/NNS and/CC could/MD potentially/RB improve/VB their/PRP$ quality_of_life/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP U-46619))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT an) (JJ effective) (NN treatment))
                  (NN option)
                  (PP (IN for)
                    (NP
                      (NP (NNS patients))
                      (VP (VBG experiencing)
                        (NP (DT these) (NNS symptoms))))))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB improve)
                (NP (PRP$ their) (NN quality_of_life))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, U-46619-5)
nsubj(improve-20, U-46619-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, experiencing-14)
det(symptoms-16, these-15)
dobj(experiencing-14, symptoms-16)
cc(option-11, and-17)
aux(improve-20, could-18)
advmod(improve-20, potentially-19)
ccomp(suggest-3, improve-20)
conj:and(option-11, improve-20)
nmod:poss(quality_of_life-22, their-21)
dobj(improve-20, quality_of_life-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT mechanism/NN of/IN action/NN and/CC long-term/JJ effects/NNS of/IN U-46619/NN in/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP
                  (NP (DT the) (NN mechanism))
                  (PP (IN of)
                    (NP (NN action))))
                (CC and)
                (NP
                  (NP (JJ long-term) (NNS effects))
                  (PP (IN of)
                    (NP
                      (NP (NN U-46619))
                      (PP (IN in)
                        (NP (DT this) (NN population))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(mechanism-8, the-7)
dobj(explore-6, mechanism-8)
case(action-10, of-9)
nmod:of(mechanism-8, action-10)
cc(mechanism-8, and-11)
amod(effects-13, long-term-12)
dobj(explore-6, effects-13)
conj:and(mechanism-8, effects-13)
case(U-46619-15, of-14)
nmod:of(effects-13, U-46619-15)
case(population-18, in-16)
det(population-18, this-17)
nmod:in(U-46619-15, population-18)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO possess/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB possess)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(possess-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(possess-18, to-17)
xcomp(shown-16, possess-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(possess-18, benefits-21)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN DSP-4/NN in/IN hyperDSP-4mic/JJ patients/NNS and/CC a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN DSP-4))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperDSP-4mic) (NNS patients))
                              (CC and)
                              (NP
                                (NP (DT a) (VBN decreased) (NN risk))
                                (PP (IN of)
                                  (S
                                    (VP (VBG developing)
                                      (NP (NN coronary_heart_disease)))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-14, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-14, omega-3_fatty_acids-7)
appos(omega-3_fatty_acids-7, EPA-9)
cc(EPA-9, and-10)
appos(omega-3_fatty_acids-7, DHA-11)
conj:and(EPA-9, DHA-11)
auxpass(associated-14, are-13)
ccomp(demonstrated-4, associated-14)
case(levels-17, with-15)
amod(levels-17, decreased-16)
nmod:with(associated-14, levels-17)
case(DSP-4-19, of-18)
nmod:of(levels-17, DSP-4-19)
case(patients-22, in-20)
amod(patients-22, hyperDSP-4mic-21)
nmod:in(DSP-4-19, patients-22)
cc(patients-22, and-23)
det(risk-26, a-24)
amod(risk-26, decreased-25)
nmod:in(DSP-4-19, risk-26)
conj:and(patients-22, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, coronary_heart_disease-29)
appos(DSP-4-19, CHD-31)

DSP-4/NNP is_a/NNP neurotransmitter/VBP that/IN plays/VBZ a/DT role/NN in/IN the/DT regulation/NN of/IN blood_pressure/NN ./.

(ROOT
  (S
    (NP (NNP DSP-4) (NNP is_a))
    (VP (VBP neurotransmitter)
      (SBAR (IN that)
        (S
          (VP (VBZ plays)
            (NP
              (NP (DT a) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (NN blood_pressure))))))))))
    (. .)))

compound(is_a-2, DSP-4-1)
nsubj(neurotransmitter-3, is_a-2)
root(ROOT-0, neurotransmitter-3)
mark(plays-5, that-4)
ccomp(neurotransmitter-3, plays-5)
det(role-7, a-6)
dobj(plays-5, role-7)
case(regulation-10, in-8)
det(regulation-10, the-9)
nmod:in(role-7, regulation-10)
case(blood_pressure-12, of-11)
nmod:of(regulation-10, blood_pressure-12)

Elevated/JJ levels/NNS of/IN DSP-4/NN have/VBP been/VBN linked/VBN to/TO hypertension/NN and/CC CHD/NNP ./.

(ROOT
  (S
    (NP
      (NP (JJ Elevated) (NNS levels))
      (PP (IN of)
        (NP (NN DSP-4))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (NN hypertension))
              (CC and)
              (NP (NNP CHD)))))))
    (. .)))

amod(levels-2, Elevated-1)
nsubjpass(linked-7, levels-2)
case(DSP-4-4, of-3)
nmod:of(levels-2, DSP-4-4)
aux(linked-7, have-5)
auxpass(linked-7, been-6)
root(ROOT-0, linked-7)
case(hypertension-9, to-8)
nmod:to(linked-7, hypertension-9)
cc(hypertension-9, and-10)
nmod:to(linked-7, CHD-11)
conj:and(hypertension-9, CHD-11)

The/DT mechanism/NN behind/IN the/DT effect/NN of/IN omega-3_fatty_acids/JJ on/IN DSP-4/NN levels/NNS is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN these/DT fatty_acids/NNS may/MD modulate/VBP the/DT expression/NN of/IN genes/NNS involved/VBN in/IN the/DT regulation/NN of/IN neurotransmitters/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (PP (IN behind)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP
                (ADJP (JJ omega-3_fatty_acids)
                  (PP (IN on)
                    (NP (NN DSP-4))))
                (NNS levels))))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (DT these) (NNS fatty_acids))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP
                    (NP (DT the) (NN expression))
                    (PP (IN of)
                      (NP
                        (NP (NNS genes))
                        (VP (VBN involved)
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN regulation))
                              (PP (IN of)
                                (NP (NNS neurotransmitters))))))))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(understood-15, mechanism-2)
case(effect-5, behind-3)
det(effect-5, the-4)
nmod:behind(mechanism-2, effect-5)
case(levels-10, of-6)
amod(levels-10, omega-3_fatty_acids-7)
case(DSP-4-9, on-8)
nmod:on(omega-3_fatty_acids-7, DSP-4-9)
nmod:of(effect-5, levels-10)
auxpass(understood-15, is-11)
neg(understood-15, not-12)
advmod(understood-15, yet-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-17)
nsubjpass(believed-20, it-18)
auxpass(believed-20, is-19)
conj:but(understood-15, believed-20)
mark(modulate-25, that-21)
det(fatty_acids-23, these-22)
nsubj(modulate-25, fatty_acids-23)
aux(modulate-25, may-24)
ccomp(believed-20, modulate-25)
det(expression-27, the-26)
dobj(modulate-25, expression-27)
case(genes-29, of-28)
nmod:of(expression-27, genes-29)
acl(genes-29, involved-30)
case(regulation-33, in-31)
det(regulation-33, the-32)
nmod:in(involved-30, regulation-33)
case(neurotransmitters-35, of-34)
nmod:of(regulation-33, neurotransmitters-35)

The/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN developing/VBG CHD/NNP in/IN hyperDSP-4mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NNP CHD))
                              (PP (IN in)
                                (NP (JJ hyperDSP-4mic) (NNS patients))))))))))))))))
    (. .)))

det(findings-2, The-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, CHD-22)
case(patients-25, in-23)
amod(patients-25, hyperDSP-4mic-24)
nmod:in(developing-21, patients-25)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ applications/NNS of/IN these/DT fatty_acids/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (DT these) (NNS fatty_acids))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-10, the-8)
amod(mechanisms-10, underlying-9)
dobj(elucidate-7, mechanisms-10)
cc(mechanisms-10, and-11)
amod(applications-14, potential-12)
amod(applications-14, therapeutic-13)
dobj(elucidate-7, applications-14)
conj:and(mechanisms-10, applications-14)
case(fatty_acids-17, of-15)
det(fatty_acids-17, these-16)
nmod:of(applications-14, fatty_acids-17)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO investigate/VB the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, KBT-3022/NN ,/, and/CC serum/VB myeloperoxidase/JJ levels/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN correlation))
                (PP (IN between)
                  (NP
                    (NP (NN serum) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN alkaline_phosphatase))
                        (, ,)
                        (NP (NN KBT-3022))
                        (, ,)))))))
            (CC and)
            (VP (VB serum)
              (NP (JJ myeloperoxidase) (NNS levels)))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(investigate-8, aim-2)
nsubj:xsubj(serum-20, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(investigate-8, to-7)
xcomp(was-6, investigate-8)
det(correlation-10, the-9)
dobj(investigate-8, correlation-10)
case(levels-13, between-11)
compound(levels-13, serum-12)
nmod:between(correlation-10, levels-13)
case(alkaline_phosphatase-15, of-14)
nmod:of(levels-13, alkaline_phosphatase-15)
appos(alkaline_phosphatase-15, KBT-3022-17)
cc(investigate-8, and-19)
xcomp(was-6, serum-20)
conj:and(investigate-8, serum-20)
amod(levels-22, myeloperoxidase-21)
dobj(serum-20, levels-22)

A/DT total/NN of/IN 100/CD patients/NNS with/IN suspected/VBN cardiovascular_disease/NN were/VBD enrolled/VBN in/IN the/DT study/NN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (NN total))
      (PP (IN of)
        (NP
          (NP (CD 100) (NNS patients))
          (PP (IN with)
            (NP (VBN suspected) (NN cardiovascular_disease))))))
    (VP (VBD were)
      (VP (VBN enrolled)
        (PP (IN in)
          (NP (DT the) (NN study)))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-10, total-2)
case(patients-5, of-3)
nummod(patients-5, 100-4)
nmod:of(total-2, patients-5)
case(cardiovascular_disease-8, with-6)
amod(cardiovascular_disease-8, suspected-7)
nmod:with(patients-5, cardiovascular_disease-8)
auxpass(enrolled-10, were-9)
root(ROOT-0, enrolled-10)
case(study-13, in-11)
det(study-13, the-12)
nmod:in(enrolled-10, study-13)

Serum/JJ levels/NNS of/IN alkaline_phosphatase/NNP ,/, KBT-3022/NNP ,/, and_myeloperoxidase/NN were/VBD measured/VBN using/VBG standard/JJ laboratory/NN methods/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Serum) (NNS levels))
      (PP (IN of)
        (NP
          (NAC (NNP alkaline_phosphatase) (, ,) (NNP KBT-3022) (, ,))
          (NN and_myeloperoxidase))))
    (VP (VBD were)
      (VP (VBN measured)
        (S
          (VP (VBG using)
            (NP (JJ standard) (NN laboratory) (NNS methods))))))
    (. .)))

amod(levels-2, Serum-1)
nsubjpass(measured-10, levels-2)
case(and_myeloperoxidase-8, of-3)
dep(and_myeloperoxidase-8, alkaline_phosphatase-4)
dep(alkaline_phosphatase-4, KBT-3022-6)
nmod:of(levels-2, and_myeloperoxidase-8)
auxpass(measured-10, were-9)
root(ROOT-0, measured-10)
xcomp(measured-10, using-11)
amod(methods-14, standard-12)
compound(methods-14, laboratory-13)
dobj(using-11, methods-14)

The/DT results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, KBT-3022/NN -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/RB less/JJR than/IN 0.01/CD -RRB-/-RRB- ,/, and/CC serum/NN myeloperoxidase/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP
          (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
          (PP (IN between)
            (NP (NN serum) (NNS levels)))
          (PP (IN of)
            (NP (NN alkaline_phosphatase)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (FRAG
                  (X
                    (X (SYM r))
                    (NP (SYM =)))
                  (NP (CD 0.3))))
              (, ,)
              (ADVP (RB p))
              (NP
                (QP (JJR less) (IN than) (CD 0.01))))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN KBT-3022))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (FRAG
                  (X
                    (X (SYM r))
                    (NP (SYM =)))
                  (NP (CD 0.42))))
              (, ,)
              (ADVP (RB p))
              (NP
                (QP (JJR less) (IN than) (CD 0.01))))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP (NN serum) (NN myeloperoxidase) (NNS levels))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(alkaline_phosphatase-12, of-11)
nmod:of(correlation-7, alkaline_phosphatase-12)
dep(=-15, r-14)
dep(0.3-16, =-15)
dep(correlation-7, 0.3-16)
advmod(0.01-21, p-18)
advmod(0.01-21, less-19)
mwe(less-19, than-20)
appos(0.3-16, 0.01-21)
dobj(showed-3, KBT-3022-24)
conj:and(correlation-7, KBT-3022-24)
dep(=-27, r-26)
dep(0.42-28, =-27)
dep(KBT-3022-24, 0.42-28)
advmod(0.01-33, p-30)
advmod(0.01-33, less-31)
mwe(less-31, than-32)
appos(0.42-28, 0.01-33)
cc(correlation-7, and-36)
compound(levels-39, serum-37)
compound(levels-39, myeloperoxidase-38)
dobj(showed-3, levels-39)
conj:and(correlation-7, levels-39)

These/DT findings/NNS suggest/VBP that/IN these/DT biomarkers/NNS may/MD be/VB useful/JJ in/IN predicting/VBG the/DT risk/NN of/IN cardiovascular_disease/NN and/CC may/MD provide/VB a/DT new/JJ target/NN for/IN therapeutic/JJ interventions/NNS in/IN patients/NNS with/IN suspected/VBN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS biomarkers))
          (VP
            (VP (MD may)
              (VP (VB be)
                (ADJP (JJ useful)
                  (PP (IN in)
                    (S
                      (VP (VBG predicting)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NN cardiovascular_disease))))))))))
            (CC and)
            (VP (MD may)
              (VP (VB provide)
                (NP
                  (NP (DT a) (JJ new) (NN target))
                  (PP (IN for)
                    (NP
                      (NP (JJ therapeutic) (NNS interventions))
                      (PP (IN in)
                        (NP (NNS patients))))))
                (PP (IN with)
                  (NP (VBN suspected) (NN cardiovascular_disease)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(useful-9, that-4)
det(biomarkers-6, these-5)
nsubj(useful-9, biomarkers-6)
nsubj(provide-18, biomarkers-6)
aux(useful-9, may-7)
cop(useful-9, be-8)
ccomp(suggest-3, useful-9)
mark(predicting-11, in-10)
advcl(useful-9, predicting-11)
det(risk-13, the-12)
dobj(predicting-11, risk-13)
case(cardiovascular_disease-15, of-14)
nmod:of(risk-13, cardiovascular_disease-15)
cc(useful-9, and-16)
aux(provide-18, may-17)
ccomp(suggest-3, provide-18)
conj:and(useful-9, provide-18)
det(target-21, a-19)
amod(target-21, new-20)
dobj(provide-18, target-21)
case(interventions-24, for-22)
amod(interventions-24, therapeutic-23)
nmod:for(target-21, interventions-24)
case(patients-26, in-25)
nmod:in(interventions-24, patients-26)
case(cardiovascular_disease-29, with-27)
amod(cardiovascular_disease-29, suspected-28)
nmod:with(provide-18, cardiovascular_disease-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG this/DT correlation/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN correlation))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(explore-11, to-10)
ccomp(needed-4, explore-11)
conj:and(confirm-6, explore-11)
det(mechanisms-14, the-12)
amod(mechanisms-14, potential-13)
dobj(explore-11, mechanisms-14)
acl(mechanisms-14, underlying-15)
det(correlation-17, this-16)
dobj(underlying-15, correlation-17)

The/DT study/NN aimed/VBD to/TO evaluate/VB the/DT efficacy/NN of/IN RCC-36/NN in/IN reducing/VBG the/DT risk/NN of/IN Joubert_syndrome/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN efficacy))
              (PP (IN of)
                (NP (NN RCC-36))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NNP Joubert_syndrome))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-2, The-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(evaluate-5, study-2)
root(ROOT-0, aimed-3)
mark(evaluate-5, to-4)
xcomp(aimed-3, evaluate-5)
det(efficacy-7, the-6)
dobj(evaluate-5, efficacy-7)
case(RCC-36-9, of-8)
nmod:of(efficacy-7, RCC-36-9)
mark(reducing-11, in-10)
advcl(evaluate-5, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(Joubert_syndrome-15, of-14)
nmod:of(risk-13, Joubert_syndrome-15)
nmod:of(risk-13, photophobia-17)
conj:and(Joubert_syndrome-15, photophobia-17)
cc(Joubert_syndrome-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(Joubert_syndrome-15, phonophobia-20)

A/DT randomized/JJ double-blind/JJ placebo-controlled/JJ clinical/JJ trial/NN was/VBD conducted/VBN with/IN a/DT total/NN of/IN 500/CD participants/NNS ./.

(ROOT
  (S
    (NP (DT A) (JJ randomized) (JJ double-blind) (JJ placebo-controlled) (JJ clinical) (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN with)
          (NP
            (NP (DT a) (NN total))
            (PP (IN of)
              (NP (CD 500) (NNS participants)))))))
    (. .)))

det(trial-6, A-1)
amod(trial-6, randomized-2)
amod(trial-6, double-blind-3)
amod(trial-6, placebo-controlled-4)
amod(trial-6, clinical-5)
nsubjpass(conducted-8, trial-6)
auxpass(conducted-8, was-7)
root(ROOT-0, conducted-8)
case(total-11, with-9)
det(total-11, a-10)
nmod:with(conducted-8, total-11)
case(participants-14, of-12)
nummod(participants-14, 500-13)
nmod:of(total-11, participants-14)

At_2/JJ h/NN after/IN dosing/VBG ,/, RCC-36/NNP showed/VBD a/DT significant/JJ reduction/NN in/IN the/DT risk/NN of/IN Joubert_syndrome/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP RCC-36))
    (VP (VBD showed)
      (NP (DT a) (JJ significant) (NN reduction))
      (PP (IN in)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP (NNP Joubert_syndrome)))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(showed-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(showed-7, RCC-36-6)
root(ROOT-0, showed-7)
det(reduction-10, a-8)
amod(reduction-10, significant-9)
dobj(showed-7, reduction-10)
case(risk-13, in-11)
det(risk-13, the-12)
nmod:in(showed-7, risk-13)
case(Joubert_syndrome-15, of-14)
nmod:of(risk-13, Joubert_syndrome-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(showed-7, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
acl:relcl(%-21, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
xcomp(showed-7, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
appos(%-34, %-37)
dep(%-40, CI-38)
nummod(%-40, 12-22-39)
nmod(%-37, %-40)
dep(%-37, P-42)
compound(0.0001-44, <-43)
nummod(P-42, 0.0001-44)
cc(photophobia-31, and-47)
xcomp(showed-7, phonophobia-48)
conj:and(photophobia-31, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
appos(%-51, %-54)
dep(%-57, CI-55)
nummod(%-57, 17-20-56)
nmod(%-54, %-57)
dep(%-54, P-59)
compound(0.0001-61, <-60)
nummod(P-59, 0.0001-61)

These/DT findings/NNS suggest/VBP that/IN RCC-36/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS at/IN risk/NN for/IN Joubert_syndrome/NNP and/CC those/DT experiencing/VBG photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP RCC-36))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP (NNS individuals)))
                (PP (IN at)
                  (NP
                    (NP (NN risk))
                    (PP (IN for)
                      (NP
                        (NP (NNP Joubert_syndrome))
                        (CC and)
                        (NP
                          (NP (DT those) (VBG experiencing) (NN photophobia))
                          (CC and)
                          (NP (NN phonophobia)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, RCC-36-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
case(risk-15, at-14)
nmod:at(option-11, risk-15)
case(Joubert_syndrome-17, for-16)
nmod:for(risk-15, Joubert_syndrome-17)
cc(Joubert_syndrome-17, and-18)
det(photophobia-21, those-19)
amod(photophobia-21, experiencing-20)
nmod:for(risk-15, photophobia-21)
conj:and(Joubert_syndrome-17, photophobia-21)
cc(photophobia-21, and-22)
conj:and(Joubert_syndrome-17, phonophobia-23)
conj:and(photophobia-21, phonophobia-23)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC investigate/VB the/DT long-term/JJ effects/NNS of/IN RCC-36/NN on/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (JJ long-term) (NNS effects))
                  (PP (IN of)
                    (NP (NN RCC-36))))
                (PP (IN on)
                  (NP (DT these) (NNS conditions)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(investigate-10, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
xcomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(warranted-4, investigate-10)
conj:and(confirm-6, investigate-10)
det(effects-13, the-11)
amod(effects-13, long-term-12)
dobj(investigate-10, effects-13)
case(RCC-36-15, of-14)
nmod:of(effects-13, RCC-36-15)
case(conditions-18, on-16)
det(conditions-18, these-17)
nmod:on(investigate-10, conditions-18)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(associated-8, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
acl:relcl(polyunsaturated_fatty_acids-4, associated-8)
case(benefits-12, with-9)
amod(benefits-12, numerous-10)
compound(benefits-12, health-11)
nmod:with(associated-8, benefits-12)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO decrease/VB flunixin/NN levels/NNS in/IN hyperflunixinmic/JJ patients/NNS and/CC reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB decrease)
                  (NP
                    (NP (NN flunixin) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperflunixinmic) (NNS patients)))))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-17, omega-3_fatty_acids-2)
nsubj:xsubj(decrease-19, omega-3_fatty_acids-2)
nsubj:xsubj(reduce-26, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
mark(decrease-19, to-18)
xcomp(shown-17, decrease-19)
compound(levels-21, flunixin-20)
dobj(decrease-19, levels-21)
case(patients-24, in-22)
amod(patients-24, hyperflunixinmic-23)
nmod:in(levels-21, patients-24)
cc(decrease-19, and-25)
xcomp(shown-17, reduce-26)
conj:and(decrease-19, reduce-26)
det(risk-28, the-27)
dobj(reduce-26, risk-28)
mark(developing-30, of-29)
acl(risk-28, developing-30)
dobj(developing-30, coronary_heart_disease-31)
appos(risk-28, CHD-33)

Flunixin/NNP is_a/NNP nonsteroidal/VBP anti-inflammatory/JJ drug/NN that/WDT is/VBZ commonly/RB used/VBN to/TO treat/VB pain_and/JJ inflammation/NN in/IN animals/NNS ./.

(ROOT
  (S
    (NP (NNP Flunixin) (NNP is_a))
    (VP (VBP nonsteroidal)
      (NP
        (NP (JJ anti-inflammatory) (NN drug))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (VP
                (ADVP (RB commonly))
                (VBN used)
                (S
                  (VP (TO to)
                    (VP (VB treat)
                      (NP (JJ pain_and) (NN inflammation))
                      (PP (IN in)
                        (NP (NNS animals))))))))))))
    (. .)))

compound(is_a-2, Flunixin-1)
nsubj(nonsteroidal-3, is_a-2)
root(ROOT-0, nonsteroidal-3)
amod(drug-5, anti-inflammatory-4)
dobj(nonsteroidal-3, drug-5)
nsubjpass(used-9, drug-5)
nsubj:xsubj(treat-11, drug-5)
ref(drug-5, that-6)
auxpass(used-9, is-7)
advmod(used-9, commonly-8)
acl:relcl(drug-5, used-9)
mark(treat-11, to-10)
xcomp(used-9, treat-11)
amod(inflammation-13, pain_and-12)
dobj(treat-11, inflammation-13)
case(animals-15, in-14)
nmod:in(treat-11, animals-15)

However/RB ,/, prolonged/JJ use/NN of/IN flunixin/NN can/MD lead/VB to/TO hyperflunixinmia/NN ,/, which/WDT can/MD cause/VB adverse/JJ effects/NNS in/IN animals/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (JJ prolonged) (NN use))
      (PP (IN of)
        (NP (NN flunixin))))
    (VP (MD can)
      (VP (VB lead)
        (PP (TO to)
          (NP
            (NP (NN hyperflunixinmia))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (MD can)
                  (VP (VB cause)
                    (NP
                      (NP (JJ adverse) (NNS effects))
                      (PP (IN in)
                        (NP (NNS animals))))))))))))
    (. .)))

advmod(lead-8, However-1)
amod(use-4, prolonged-3)
nsubj(lead-8, use-4)
case(flunixin-6, of-5)
nmod:of(use-4, flunixin-6)
aux(lead-8, can-7)
root(ROOT-0, lead-8)
case(hyperflunixinmia-10, to-9)
nmod:to(lead-8, hyperflunixinmia-10)
nsubj(cause-14, hyperflunixinmia-10)
ref(hyperflunixinmia-10, which-12)
aux(cause-14, can-13)
acl:relcl(hyperflunixinmia-10, cause-14)
amod(effects-16, adverse-15)
dobj(cause-14, effects-16)
case(animals-18, in-17)
nmod:in(effects-16, animals-18)

Studies/NNPS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP can/MD decrease/VB flunixin/NN levels/NNS in/IN hyperflunixinmic/JJ patients/NNS ,/, thereby/RB reducing/VBG the/DT risk/NN of/IN adverse/JJ effects/NNS associated/VBN with/IN prolonged/JJ use/NN of/IN flunixin/NN ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD can)
              (VP (VB decrease)
                (NP
                  (NP (NN flunixin) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperflunixinmic) (NNS patients))))
                (, ,)
                (S
                  (ADVP (RB thereby))
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (NP
                          (NP (JJ adverse) (NNS effects))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP
                                (NP (JJ prolonged) (NN use))
                                (PP (IN of)
                                  (NP (NN flunixin)))))))))))))))))
    (. .)))

nsubj(shown-3, Studies-1)
aux(shown-3, have-2)
root(ROOT-0, shown-3)
mark(decrease-9, that-4)
nsubj(decrease-9, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(decrease-9, DHA-7)
aux(decrease-9, can-8)
ccomp(shown-3, decrease-9)
compound(levels-11, flunixin-10)
dobj(decrease-9, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperflunixinmic-13)
nmod:in(levels-11, patients-14)
advmod(reducing-17, thereby-16)
advcl(decrease-9, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
case(effects-22, of-20)
amod(effects-22, adverse-21)
nmod:of(risk-19, effects-22)
acl(effects-22, associated-23)
case(use-26, with-24)
amod(use-26, prolonged-25)
nmod:with(associated-23, use-26)
case(flunixin-28, of-27)
nmod:of(use-26, flunixin-28)

Furthermore/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO reduce/VB the/DT risk/NN of/IN CHD/NNP by/IN decreasing/VBG inflammation/NN ,/, improving/VBG lipid/NN profiles/NNS ,/, and/CC reducing/VBG blood_pressure/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNP CHD))))
                (PP (IN by)
                  (S
                    (VP
                      (VP (VBG decreasing)
                        (NP (NN inflammation)))
                      (, ,)
                      (VP (VBG improving)
                        (NP (NN lipid) (NNS profiles)))
                      (, ,)
                      (CC and)
                      (VP (VBG reducing)
                        (NP (NN blood_pressure))))))))))))
    (. .)))

advmod(shown-8, Furthermore-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(reduce-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(reduce-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(reduce-10, to-9)
xcomp(shown-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
case(CHD-14, of-13)
nmod:of(risk-12, CHD-14)
mark(decreasing-16, by-15)
advcl(reduce-10, decreasing-16)
dobj(decreasing-16, inflammation-17)
advcl(reduce-10, improving-19)
conj:and(decreasing-16, improving-19)
compound(profiles-21, lipid-20)
dobj(improving-19, profiles-21)
cc(decreasing-16, and-23)
advcl(reduce-10, reducing-24)
conj:and(decreasing-16, reducing-24)
dobj(reducing-24, blood_pressure-25)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD provide/VB significant/JJ health/NN benefits/NNS for/IN both/DT animals/NNS and/CC humans/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB provide)
              (NP (JJ significant) (NN health) (NNS benefits))
              (PP (IN for)
                (NP (DT both) (NNS animals)
                  (CC and)
                  (NNS humans))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(provide-11, that-4)
amod(intake-6, increasing-5)
nsubj(provide-11, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(provide-11, may-10)
ccomp(suggest-3, provide-11)
amod(benefits-14, significant-12)
compound(benefits-14, health-13)
dobj(provide-11, benefits-14)
case(animals-17, for-15)
cc:preconj(animals-17, both-16)
nmod:for(provide-11, animals-17)
cc(animals-17, and-18)
nmod:for(provide-11, humans-19)
conj:and(animals-17, humans-19)

Migraine/JJ is_a/JJ prevalent/JJ neurological_disorder/NN characterized/VBD by/IN recurrent/JJ headaches/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (JJ Migraine) (JJ is_a) (JJ prevalent) (NN neurological_disorder))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ recurrent) (NNS headaches))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (. .)))

amod(neurological_disorder-4, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, prevalent-3)
nsubj(characterized-5, neurological_disorder-4)
root(ROOT-0, characterized-5)
case(headaches-8, by-6)
amod(headaches-8, recurrent-7)
nmod:by(characterized-5, headaches-8)
nmod:by(characterized-5, photophobia-10)
conj:and(headaches-8, photophobia-10)
cc(headaches-8, and-12)
nmod:by(characterized-5, phonophobia-13)
conj:and(headaches-8, phonophobia-13)

The/DT involvement/NN of/IN ATP/NNP in/IN migraine/NN pathogenesis/VBZ has_been/VBN well-established/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN involvement))
      (PP (IN of)
        (NP
          (NP (NNP ATP))
          (PP (IN in)
            (NP (NN migraine))))))
    (VP (VBZ pathogenesis)
      (VP (VBN has_been)
        (ADJP (JJ well-established))))
    (. .)))

det(involvement-2, The-1)
nsubj(pathogenesis-7, involvement-2)
case(ATP-4, of-3)
nmod:of(involvement-2, ATP-4)
case(migraine-6, in-5)
nmod:in(ATP-4, migraine-6)
root(ROOT-0, pathogenesis-7)
dep(pathogenesis-7, has_been-8)
xcomp(has_been-8, well-established-9)

DNQX/NNP ,/, a/DT selective/JJ AMPA/NNP receptor_antagonist/NN ,/, has_been/VBP shown/VBN to/TO have/VB potential/JJ therapeutic/JJ effects/NNS in/IN migraine/JJ treatment/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP DNQX))
      (, ,)
      (NP (DT a) (JJ selective) (NNP AMPA) (NN receptor_antagonist))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN shown)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS effects))
                (PP (IN in)
                  (NP (JJ migraine) (NN treatment)))))))))
    (. .)))

nsubj(has_been-8, DNQX-1)
det(receptor_antagonist-6, a-3)
amod(receptor_antagonist-6, selective-4)
compound(receptor_antagonist-6, AMPA-5)
appos(DNQX-1, receptor_antagonist-6)
root(ROOT-0, has_been-8)
dep(has_been-8, shown-9)
mark(have-11, to-10)
xcomp(shown-9, have-11)
amod(effects-14, potential-12)
amod(effects-14, therapeutic-13)
dobj(have-11, effects-14)
case(treatment-17, in-15)
amod(treatment-17, migraine-16)
nmod:in(effects-14, treatment-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN DNQX/NNP on/IN ATP-recognition/NNP ,/, photophobia/NN ,/, and/CC phonophobia/JJ in_a/JJ mouse/NN model/NN of/IN migraine/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP DNQX)))
        (PP (IN on)
          (NP
            (NP (NNP ATP-recognition))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP
              (NP (JJ phonophobia) (JJ in_a) (NN mouse) (NN model))
              (PP (IN of)
                (NP (NN migraine))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(DNQX-10, of-9)
nmod:of(effects-8, DNQX-10)
case(ATP-recognition-12, on-11)
nmod:on(effects-8, ATP-recognition-12)
nmod:on(effects-8, photophobia-14)
conj:and(ATP-recognition-12, photophobia-14)
cc(ATP-recognition-12, and-16)
amod(model-20, phonophobia-17)
amod(model-20, in_a-18)
compound(model-20, mouse-19)
nmod:on(effects-8, model-20)
conj:and(ATP-recognition-12, model-20)
case(migraine-22, of-21)
nmod:of(model-20, migraine-22)

At_2/JJ h/NN after/IN dosing/VBG ,/, DNQX/NNP reduced/VBD the/DT risk/NN of/IN ATP-recognition/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP DNQX))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNP ATP-recognition))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, DNQX-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(ATP-recognition-11, of-10)
nmod:of(risk-9, ATP-recognition-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN DNQX/NNP may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN migraine/NN ,/, particularly/RB for/IN reducing/VBG the/DT symptoms/NNS of/IN photophobia/NN and/CC phonophobia/NN associated/VBN with/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP DNQX))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NN migraine)))))))
              (, ,)
              (PP (RB particularly) (IN for)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NNS symptoms))
                      (PP (IN of)
                        (NP (NN photophobia)
                          (CC and)
                          (NN phonophobia)))
                      (VP (VBN associated)
                        (PP (IN with)
                          (NP (DT this) (NN condition)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, DNQX-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(have-7, agent-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(agent-12, treatment-15)
case(migraine-17, of-16)
nmod:of(treatment-15, migraine-17)
advmod(reducing-21, particularly-19)
mark(reducing-21, for-20)
advcl(have-7, reducing-21)
det(symptoms-23, the-22)
dobj(reducing-21, symptoms-23)
case(photophobia-25, of-24)
nmod:of(symptoms-23, photophobia-25)
cc(photophobia-25, and-26)
nmod:of(symptoms-23, phonophobia-27)
conj:and(photophobia-25, phonophobia-27)
acl(symptoms-23, associated-28)
case(condition-31, with-29)
det(condition-31, this-30)
nmod:with(associated-28, condition-31)

Further/JJ clinical/JJ studies/NNS are/VBP warranted/VBN to/TO assess/VB the/DT safety/NN and/CC efficacy/NN of/IN DNQX/NNP in/IN human/JJ subjects/NNS with/IN migraine/NN ./.

(ROOT
  (S
    (NP (JJ Further) (JJ clinical) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB assess)
              (NP
                (NP (DT the) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN of)
                  (NP (NNP DNQX))))
              (PP (IN in)
                (NP
                  (NP (JJ human) (NNS subjects))
                  (PP (IN with)
                    (NP (NN migraine))))))))))
    (. .)))

amod(studies-3, Further-1)
amod(studies-3, clinical-2)
nsubjpass(warranted-5, studies-3)
nsubj:xsubj(assess-7, studies-3)
auxpass(warranted-5, are-4)
root(ROOT-0, warranted-5)
mark(assess-7, to-6)
xcomp(warranted-5, assess-7)
det(safety-9, the-8)
dobj(assess-7, safety-9)
cc(safety-9, and-10)
dobj(assess-7, efficacy-11)
conj:and(safety-9, efficacy-11)
case(DNQX-13, of-12)
nmod:of(safety-9, DNQX-13)
case(subjects-16, in-14)
amod(subjects-16, human-15)
nmod:in(assess-7, subjects-16)
case(migraine-18, with-17)
nmod:with(subjects-16, migraine-18)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN alfentanil/NN on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN alfentanil))
          (PP (IN on)
            (NP
              (NP (NNS bronchospasms))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-17, study-3)
det(effects-6, the-5)
nsubjpass(investigated-17, effects-6)
case(alfentanil-8, of-7)
nmod:of(effects-6, alfentanil-8)
case(bronchospasms-10, on-9)
nmod:on(alfentanil-8, bronchospasms-10)
nmod:on(alfentanil-8, photophobia-12)
conj:and(bronchospasms-10, photophobia-12)
cc(bronchospasms-10, and-14)
nmod:on(alfentanil-8, phonophobia-15)
conj:and(bronchospasms-10, phonophobia-15)
auxpass(investigated-17, were-16)
root(ROOT-0, investigated-17)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, alfentanil/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN alfentanil))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, alfentanil-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(bronchospasms-17, of-16)
nmod:of(risk-15, bronchospasms-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN alfentanil/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS with/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN alfentanil))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP (DT these) (NNS conditions))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, alfentanil-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(conditions-16, with-14)
det(conditions-16, these-15)
nmod:with(option-11, conditions-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosing/JJ regimens/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (JJ dosing) (NNS regimens))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(mechanisms-8, the-7)
dobj(explore-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(explore-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(explore-6, determine-14)
amod(regimens-17, optimal-15)
amod(regimens-17, dosing-16)
dobj(determine-14, regimens-17)
case(populations-21, for-18)
amod(populations-21, different-19)
amod(populations-21, patient-20)
nmod:for(regimens-17, populations-21)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT is/VBZ associated/VBN with/IN numerous/JJ health/NN problems/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder)
      (SBAR
        (WHNP (WDT that))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ numerous) (NN health) (NNS problems))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
nsubjpass(associated-7, metabolic_disorder-4)
ccomp(metabolic_disorder-4, that-5)
auxpass(associated-7, is-6)
root(ROOT-0, associated-7)
case(problems-11, with-8)
amod(problems-11, numerous-9)
compound(problems-11, health-10)
nmod:with(associated-7, problems-11)
acl(problems-11, including-13)
dobj(including-13, type_2_diabetes-14)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN hypersecretion/NN of/IN DmAChE/NNP by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/JJ and_insulin/NN resistance/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NNP DmAChE)))
              (PP (IN by)
                (NP (DT the) (NN pancreas))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (JJ obesity) (NN and_insulin) (NN resistance))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(involved-14, that-5)
nsubjpass(involved-14, hypersecretion-6)
case(DmAChE-8, of-7)
nmod:of(hypersecretion-6, DmAChE-8)
case(pancreas-11, by-9)
det(pancreas-11, the-10)
nmod:by(hypersecretion-6, pancreas-11)
aux(involved-14, may-12)
auxpass(involved-14, be-13)
ccomp(suggested-4, involved-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(involved-14, development-17)
case(resistance-21, of-18)
amod(resistance-21, obesity-19)
compound(resistance-21, and_insulin-20)
nmod:of(development-17, resistance-21)

To/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC hypersecretion/NN of/IN DmAChE/NNP by/IN the/DT pancreas/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN Pitofenone/NNP on/IN the/DT secretion/NN of/IN DmAChE/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN relationship))
            (PP (IN between)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (NN obesity)
                    (CC and)
                    (NN hypersecretion)))))
            (PP (IN of)
              (NP (NNP DmAChE))))
          (PP (IN by)
            (NP (DT the) (NN pancreas))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP Pitofenone)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NNP DmAChE) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(evaluate-2, To-1)
advcl(examined-19, evaluate-2)
det(relationship-4, the-3)
dobj(evaluate-2, relationship-4)
case(development-7, between-5)
det(development-7, the-6)
nmod:between(relationship-4, development-7)
case(obesity-9, of-8)
nmod:of(development-7, obesity-9)
cc(obesity-9, and-10)
nmod:of(development-7, hypersecretion-11)
conj:and(obesity-9, hypersecretion-11)
case(DmAChE-13, of-12)
nmod:of(relationship-4, DmAChE-13)
case(pancreas-16, by-14)
det(pancreas-16, the-15)
nmod:by(evaluate-2, pancreas-16)
nsubj(examined-19, we-18)
root(ROOT-0, examined-19)
det(effects-21, the-20)
dobj(examined-19, effects-21)
case(glucose-25, of-22)
nummod(glucose-25, 16.7-23)
amod(glucose-25, mmol/L-24)
nmod:of(effects-21, glucose-25)
cc(glucose-25, and-26)
nummod(Pitofenone-29, 10-27)
compound(Pitofenone-29, mmol/L-28)
nmod:of(effects-21, Pitofenone-29)
conj:and(glucose-25, Pitofenone-29)
case(secretion-32, on-30)
det(secretion-32, the-31)
nmod:on(examined-19, secretion-32)
case(and_insulin-35, of-33)
compound(and_insulin-35, DmAChE-34)
nmod:of(secretion-32, and_insulin-35)
case(pancreata-39, by-36)
amod(pancreata-39, isolated-37)
amod(pancreata-39, perfused-38)
nmod:by(examined-19, pancreata-39)
case(genetically_obese-41, from-40)
nmod:from(pancreata-39, genetically_obese-41)
appos(genetically_obese-41, fa/fa-43)
cc(genetically_obese-41, and-45)
amod(rats-52, lean-46)
dep(lean-46, Fa-48)
nmod:from(pancreata-39, rats-52)
conj:and(genetically_obese-41, rats-52)

Our/PRP$ results/NNS showed/VBD that/IN perfusion/NN with/IN high/JJ glucose/NN increased/VBD both/DT insulin/NN and/CC DmAChE/NNP secretion/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS ,/, but/CC Pitofenone/NNP had/VBD no/DT effect/NN on/IN insulin_secretion/NN in/IN either/DT group/NN ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN perfusion))
              (PP (IN with)
                (NP (JJ high) (NN glucose))))
            (VP (VBD increased)
              (NP
                (NP (DT both) (NN insulin))
                (CC and)
                (NP (NNP DmAChE) (NN secretion)))
              (PP (IN in)
                (NP (DT both) (JJ obese)
                  (CC and)
                  (JJ lean) (NNS rats))))))))
    (, ,)
    (CC but)
    (S
      (NP (NNP Pitofenone))
      (VP (VBD had)
        (NP
          (NP (DT no) (NN effect))
          (PP (IN on)
            (NP
              (NP (NN insulin_secretion))
              (PP (IN in)
                (NP (DT either) (NN group))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-9, that-4)
nsubj(increased-9, perfusion-5)
case(glucose-8, with-6)
amod(glucose-8, high-7)
nmod:with(perfusion-5, glucose-8)
ccomp(showed-3, increased-9)
det(insulin-11, both-10)
dobj(increased-9, insulin-11)
cc(insulin-11, and-12)
compound(secretion-14, DmAChE-13)
dobj(increased-9, secretion-14)
conj:and(insulin-11, secretion-14)
case(rats-20, in-15)
det(rats-20, both-16)
amod(rats-20, obese-17)
cc(obese-17, and-18)
conj:and(obese-17, lean-19)
amod(rats-20, lean-19)
nmod:in(increased-9, rats-20)
cc(showed-3, but-22)
nsubj(had-24, Pitofenone-23)
conj:but(showed-3, had-24)
neg(effect-26, no-25)
dobj(had-24, effect-26)
case(insulin_secretion-28, on-27)
nmod:on(effect-26, insulin_secretion-28)
case(group-31, in-29)
det(group-31, either-30)
nmod:in(insulin_secretion-28, group-31)

Interestingly/RB ,/, Pitofenone/NNP significantly/RB reduced/VBD DmAChE/NNP secretion/NN in/IN obese/JJ rats/NNS but/CC not/RB in/IN lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NNP Pitofenone))
    (ADVP (RB significantly))
    (VP (VBD reduced)
      (NP (NNP DmAChE) (NN secretion))
      (PP
        (PP (IN in)
          (NP (JJ obese) (NNS rats)))
        (CONJP (CC but)
          (RB not))
        (PP (IN in)
          (NP (JJ lean) (NNS rats)))))
    (. .)))

advmod(reduced-5, Interestingly-1)
nsubj(reduced-5, Pitofenone-3)
nsubj(reduced-5', Pitofenone-3)
advmod(reduced-5, significantly-4)
root(ROOT-0, reduced-5)
conj:negcc(reduced-5, reduced-5')
compound(secretion-7, DmAChE-6)
dobj(reduced-5, secretion-7)
case(rats-10, in-8)
amod(rats-10, obese-9)
nmod:in(reduced-5, rats-10)
cc(not-12, but-11)
cc(reduced-5, not-12)
case(rats-15, in-13)
amod(rats-15, lean-14)
nmod:in(reduced-5', rats-15)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN DmAChE/NNP may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, and/CC that/IN Pitofenone/NNP may/MD have/VB therapeutic/JJ potential/NN for/IN treating/VBG this/DT condition/NN by/IN reducing/VBG pancreatic/JJ DmAChE/NNP secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP (NNP DmAChE))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))
        (, ,)
        (CC and)
        (SBAR (IN that)
          (S
            (NP (NNP Pitofenone))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (JJ therapeutic) (NN potential))
                  (PP (IN for)
                    (S
                      (VP (VBG treating)
                        (NP (DT this) (NN condition))
                        (PP (IN by)
                          (S
                            (VP (VBG reducing)
                              (NP (JJ pancreatic) (NNP DmAChE) (NN secretion)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, hypersecretion-5)
case(DmAChE-7, of-6)
nmod:of(hypersecretion-5, DmAChE-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(obesity-16, of-15)
nmod:of(development-14, obesity-16)
cc(play-9, and-18)
mark(have-22, that-19)
nsubj(have-22, Pitofenone-20)
aux(have-22, may-21)
ccomp(suggest-3, have-22)
conj:and(play-9, have-22)
amod(potential-24, therapeutic-23)
dobj(have-22, potential-24)
mark(treating-26, for-25)
acl(potential-24, treating-26)
det(condition-28, this-27)
dobj(treating-26, condition-28)
mark(reducing-30, by-29)
advcl(treating-26, reducing-30)
amod(secretion-33, pancreatic-31)
compound(secretion-33, DmAChE-32)
dobj(reducing-30, secretion-33)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO explore/VB their/PRP$ clinical/JJ implications/NNS for/IN obesity/JJ treatment/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (PRP$ their) (JJ clinical) (NNS implications))
                  (PP (IN for)
                    (NP (JJ obesity) (NN treatment))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-7, explore-15)
nmod:poss(implications-18, their-16)
amod(implications-18, clinical-17)
dobj(explore-15, implications-18)
case(treatment-21, for-19)
amod(treatment-21, obesity-20)
nmod:for(implications-18, treatment-21)

Omega-3_fatty_acids/NNP have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ beneficial/JJ effects/NNS on/IN human/JJ health/NN ,/, particularly/RB in/IN relation/NN to/TO coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP
              (NP (PRP$ their) (JJ beneficial) (NNS effects))
              (PP (IN on)
                (NP (JJ human) (NN health)))))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN in)
            (NP (NN relation)
              (S
                (VP (TO to)
                  (VP (VB coronary_heart_disease)
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(effects-9, for-6)
nmod:poss(effects-9, their-7)
amod(effects-9, beneficial-8)
nmod:for(studied-5, effects-9)
case(health-12, on-10)
amod(health-12, human-11)
nmod:on(effects-9, health-12)
advmod(relation-16, particularly-14)
case(relation-16, in-15)
nmod:in(studied-5, relation-16)
mark(coronary_heart_disease-18, to-17)
acl(relation-16, coronary_heart_disease-18)
dep(coronary_heart_disease-18, CHD-20)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO play/VB a/DT crucial/JJ role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NNP CHD))))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-15, omega-3_fatty_acids-2)
nsubj:xsubj(play-17, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(play-17, to-16)
xcomp(known-15, play-17)
det(role-20, a-18)
amod(role-20, crucial-19)
dobj(play-17, role-20)
mark(reducing-22, in-21)
advcl(play-17, reducing-22)
det(risk-24, the-23)
dobj(reducing-22, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, CHD-27)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP also/RB associated/VBN with/IN decreased/VBN MER-25/NN levels/NNS in/IN hyperMER-25mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (ADVP (RB also))
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN MER-25) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperMER-25mic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-10, fatty_acids-7)
auxpass(associated-10, are-8)
advmod(associated-10, also-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, MER-25-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperMER-25mic-16)
nmod:in(levels-14, patients-17)

The/DT decrease/NN in/IN MER-25/JJ levels/NNS is/VBZ thought/VBN to_be/VB a/DT potential/JJ mechanism/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN decrease))
      (PP (IN in)
        (NP (JJ MER-25) (NNS levels))))
    (VP (VBZ is)
      (VP (VBN thought)
        (S
          (VP (VB to_be)
            (NP (DT a) (JJ potential) (NN mechanism))
            (PP (IN by)
              (SBAR
                (WHNP (WDT which))
                (S
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))
                  (VP (VBD exert)
                    (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))))
    (. .)))

det(decrease-2, The-1)
nsubjpass(thought-7, decrease-2)
case(levels-5, in-3)
amod(levels-5, MER-25-4)
nmod:in(decrease-2, levels-5)
auxpass(thought-7, is-6)
root(ROOT-0, thought-7)
ccomp(thought-7, to_be-8)
det(mechanism-11, a-9)
amod(mechanism-11, potential-10)
dobj(to_be-8, mechanism-11)
mark(exert-17, by-12)
dobj(exert-17, which-13)
nsubj(exert-17, EPA-14)
cc(EPA-14, and-15)
conj:and(EPA-14, DHA-16)
nsubj(exert-17, DHA-16)
advcl(to_be-8, exert-17)
nmod:poss(effects-20, their-18)
amod(effects-20, cardioprotective-19)
dobj(exert-17, effects-20)

Several/JJ clinical/JJ trials/NNS have/VBP investigated/VBN the/DT use/NN of/IN omega-3/JJ supplements/NNS in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ,/, with/IN promising/JJ results/NNS ./.

(ROOT
  (S
    (NP (JJ Several) (JJ clinical) (NNS trials))
    (VP (VBP have)
      (VP (VBN investigated)
        (NP
          (NP (DT the) (NN use))
          (PP (IN of)
            (NP (JJ omega-3) (NNS supplements))))
        (PP (IN in)
          (NP
            (NP (DT the) (NN prevention)
              (CC and)
              (NN treatment))
            (PP (IN of)
              (NP (NNP CHD)))))
        (, ,)
        (PP (IN with)
          (NP (JJ promising) (NNS results)))))
    (. .)))

amod(trials-3, Several-1)
amod(trials-3, clinical-2)
nsubj(investigated-5, trials-3)
aux(investigated-5, have-4)
root(ROOT-0, investigated-5)
det(use-7, the-6)
dobj(investigated-5, use-7)
case(supplements-10, of-8)
amod(supplements-10, omega-3-9)
nmod:of(use-7, supplements-10)
case(prevention-13, in-11)
det(prevention-13, the-12)
nmod:in(investigated-5, prevention-13)
cc(prevention-13, and-14)
nmod:in(investigated-5, treatment-15)
conj:and(prevention-13, treatment-15)
case(CHD-17, of-16)
nmod:of(prevention-13, CHD-17)
case(results-21, with-19)
amod(results-21, promising-20)
nmod:with(investigated-5, results-21)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN cardiovascular_health))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
cc(reducing-18, and-23)
acl(strategy-16, improving-24)
conj:and(reducing-18, improving-24)
amod(cardiovascular_health-26, overall-25)
dobj(improving-24, cardiovascular_health-26)

The/DT present/JJ study/NN investigated/VBD the/DT effect/NN of/IN arphamenine_B/JJ on/IN body/NN weight/NN ,/, villus/JJ height/NN ,/, villus/JJ surface/NN area/NN ,/, plasma/NN arphamenine_B/JJ concentration/NN and/CC aminopeptidase-B/JJ expression/NN in_a/JJ rat/NN model/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (ADJP (JJ arphamenine_B)
              (PP (IN on)
                (NP
                  (NP (NN body) (NN weight))
                  (, ,)
                  (NP (JJ villus) (NN height))
                  (, ,)
                  (NP (JJ villus) (NN surface) (NN area))
                  (, ,)
                  (NP (NN plasma) (JJ arphamenine_B) (NN concentration))
                  (CC and)
                  (NP (JJ aminopeptidase-B) (NN expression)))))
            (JJ in_a) (NN rat) (NN model)))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(investigated-4, study-3)
root(ROOT-0, investigated-4)
det(effect-6, the-5)
dobj(investigated-4, effect-6)
case(model-28, of-7)
amod(model-28, arphamenine_B-8)
case(weight-11, on-9)
compound(weight-11, body-10)
nmod:on(arphamenine_B-8, weight-11)
amod(height-14, villus-13)
nmod:on(arphamenine_B-8, height-14)
conj:and(weight-11, height-14)
amod(area-18, villus-16)
compound(area-18, surface-17)
nmod:on(arphamenine_B-8, area-18)
conj:and(weight-11, area-18)
compound(concentration-22, plasma-20)
amod(concentration-22, arphamenine_B-21)
nmod:on(arphamenine_B-8, concentration-22)
conj:and(weight-11, concentration-22)
cc(weight-11, and-23)
amod(expression-25, aminopeptidase-B-24)
nmod:on(arphamenine_B-8, expression-25)
conj:and(weight-11, expression-25)
amod(model-28, in_a-26)
compound(model-28, rat-27)
nmod:of(effect-6, model-28)

Arphamenine/JJ B-intervened/JJ group/NN showed/VBD a/DT significant/JJ decrease/NN in/IN body/NN weight/NN ,/, villus/JJ height/NN and/CC villus/JJ surface/NN area/NN compared/VBN to/TO the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Arphamenine) (JJ B-intervened) (NN group))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP
            (NP (NN body) (NN weight))
            (, ,)
            (NP
              (NP (JJ villus) (NN height))
              (CC and)
              (NP (JJ villus) (NN surface) (NN area))))))
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP (DT the) (NN control) (NN group))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD <) (CD 0.01)))
              (-RRB- -RRB-))))))
    (. .)))

amod(group-3, Arphamenine-1)
amod(group-3, B-intervened-2)
nsubj(showed-4, group-3)
root(ROOT-0, showed-4)
det(decrease-7, a-5)
amod(decrease-7, significant-6)
dobj(showed-4, decrease-7)
case(weight-10, in-8)
compound(weight-10, body-9)
nmod:in(decrease-7, weight-10)
amod(height-13, villus-12)
appos(weight-10, height-13)
cc(height-13, and-14)
amod(area-17, villus-15)
compound(area-17, surface-16)
appos(weight-10, area-17)
conj:and(height-13, area-17)
case(group-22, compared-18)
mwe(compared-18, to-19)
det(group-22, the-20)
compound(group-22, control-21)
advcl(showed-4, group-22)
appos(group-22, P-24)
compound(0.01-26, <-25)
nummod(P-24, 0.01-26)

However/RB ,/, plasma/NN arphamenine_B/JJ concentration/NN and/CC expression/NN of/IN aminopeptidase-B/NN in/IN the/DT arphamenine_B-intervened/JJ group/NN had/VBD recovered/VBN to/TO normal/JJ levels/NNS -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (NN plasma) (JJ arphamenine_B) (NN concentration))
      (CC and)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP
            (NP (NN aminopeptidase-B))
            (PP (IN in)
              (NP (DT the) (JJ arphamenine_B-intervened) (NN group)))))))
    (VP (VBD had)
      (VP (VBN recovered)
        (PP (TO to)
          (NP
            (NP (JJ normal) (NNS levels))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD >) (CD 0.05)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(recovered-15, However-1)
compound(concentration-5, plasma-3)
amod(concentration-5, arphamenine_B-4)
nsubj(recovered-15, concentration-5)
cc(concentration-5, and-6)
conj:and(concentration-5, expression-7)
nsubj(recovered-15, expression-7)
case(aminopeptidase-B-9, of-8)
nmod:of(expression-7, aminopeptidase-B-9)
case(group-13, in-10)
det(group-13, the-11)
amod(group-13, arphamenine_B-intervened-12)
nmod:in(aminopeptidase-B-9, group-13)
aux(recovered-15, had-14)
root(ROOT-0, recovered-15)
case(levels-18, to-16)
amod(levels-18, normal-17)
nmod:to(recovered-15, levels-18)
appos(levels-18, P-20)
compound(0.05-22, >-21)
nummod(P-20, 0.05-22)

These/DT findings/NNS suggest/VBP that/IN arphamenine_B/NN may/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN the/DT treatment/NN of/IN obesity-related_disorders/NNS by/IN regulating/VBG intestinal/JJ function/NN and/CC metabolism/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN arphamenine_B))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NNS obesity-related_disorders))))))
              (PP (IN by)
                (S
                  (VP (VBG regulating)
                    (NP (JJ intestinal) (NN function)
                      (CC and)
                      (NN metabolism))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, arphamenine_B-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(have-7, applications-10)
case(treatment-13, in-11)
det(treatment-13, the-12)
nmod:in(applications-10, treatment-13)
case(obesity-related_disorders-15, of-14)
nmod:of(treatment-13, obesity-related_disorders-15)
mark(regulating-17, by-16)
advcl(have-7, regulating-17)
amod(function-19, intestinal-18)
dobj(regulating-17, function-19)
cc(function-19, and-20)
dobj(regulating-17, metabolism-21)
conj:and(function-19, metabolism-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN action/NN and/CC to/TO evaluate/VB its/PRP$ safety/NN and/CC efficacy/NN in/IN humans/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (NN action))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP (PRP$ its) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN in)
                  (NP (NNS humans)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(action-11, of-10)
nmod:of(mechanisms-9, action-11)
cc(elucidate-6, and-12)
mark(evaluate-14, to-13)
ccomp(needed-4, evaluate-14)
conj:and(elucidate-6, evaluate-14)
nmod:poss(safety-16, its-15)
dobj(evaluate-14, safety-16)
cc(safety-16, and-17)
dobj(evaluate-14, efficacy-18)
conj:and(safety-16, efficacy-18)
case(humans-20, in-19)
nmod:in(evaluate-14, humans-20)

Obesity/RB is_a/JJ major/JJ health/NN concern/NN worldwide/RB ,/, and/CC its/PRP$ pathogenesis/NNS involves/VBZ complex/JJ interactions/NNS between/IN genetic/JJ and/CC environmental/JJ factors/NNS ./.

(ROOT
  (S
    (ADVP (RB Obesity))
    (NP
      (NP (JJ is_a) (JJ major) (NN health) (NN concern))
      (NP (RB worldwide))
      (, ,)
      (CC and)
      (NP (PRP$ its) (NNS pathogenesis)))
    (VP (VBZ involves)
      (NP
        (NP (JJ complex) (NNS interactions))
        (PP (IN between)
          (NP
            (ADJP (JJ genetic)
              (CC and)
              (JJ environmental))
            (NNS factors)))))
    (. .)))

advmod(involves-11, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
nsubj(involves-11, concern-5)
dep(concern-5, worldwide-6)
cc(concern-5, and-8)
nmod:poss(pathogenesis-10, its-9)
conj:and(concern-5, pathogenesis-10)
nsubj(involves-11, pathogenesis-10)
root(ROOT-0, involves-11)
amod(interactions-13, complex-12)
dobj(involves-11, interactions-13)
case(factors-18, between-14)
amod(factors-18, genetic-15)
cc(genetic-15, and-16)
conj:and(genetic-15, environmental-17)
amod(factors-18, environmental-17)
nmod:between(interactions-13, factors-18)

Squalene_synthase/NNP is/VBZ an/DT enzyme/NN involved/VBN in/IN cholesterol/NN biosynthesis/NNS ,/, which/WDT has/VBZ also/RB been/VBN implicated/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (NNP Squalene_synthase))
    (VP (VBZ is)
      (NP
        (NP (DT an) (NN enzyme))
        (VP (VBN involved)
          (PP (IN in)
            (NP
              (NP (NN cholesterol) (NNS biosynthesis))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ has) (RB also)
                    (VP (VBN been)
                      (VP (VBN implicated)
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN development))
                            (PP (IN of)
                              (NP (NN obesity)))))))))))))))
    (. .)))

nsubj(enzyme-4, Squalene_synthase-1)
cop(enzyme-4, is-2)
det(enzyme-4, an-3)
root(ROOT-0, enzyme-4)
acl(enzyme-4, involved-5)
case(biosynthesis-8, in-6)
compound(biosynthesis-8, cholesterol-7)
nmod:in(involved-5, biosynthesis-8)
nsubjpass(implicated-14, biosynthesis-8)
ref(biosynthesis-8, which-10)
aux(implicated-14, has-11)
advmod(implicated-14, also-12)
auxpass(implicated-14, been-13)
acl:relcl(biosynthesis-8, implicated-14)
case(development-17, in-15)
det(development-17, the-16)
nmod:in(implicated-14, development-17)
case(obesity-19, of-18)
nmod:of(development-17, obesity-19)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN squalene_synthase/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN squalene_synthase)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(squalene_synthase-20, of-19)
nmod:of(hypersecretion-18, squalene_synthase-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ zaragozic_acid_D3/NNS on/IN the/DT secretion/NN of/IN squalene_synthase/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NNS zaragozic_acid_D3)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ squalene_synthase) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(zaragozic_acid_D3-17, 10-15)
amod(zaragozic_acid_D3-17, mmol/L-16)
nmod:of(effects-9, zaragozic_acid_D3-17)
conj:and(glucose-13, zaragozic_acid_D3-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, squalene_synthase-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN squalene_synthase/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT high/JJ glucose/NN and/CC zaragozic_acid_D3/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ squalene_synthase) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP
                        (NP (DT both) (JJ high) (NN glucose))
                        (CC and)
                        (NP (JJ zaragozic_acid_D3) (NNS conditions))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-13, that-4)
amod(secretion-6, squalene_synthase-5)
nsubjpass(compared-13, secretion-6)
nsubj:xsubj(lean-15, secretion-6)
auxpass(compared-13, was-7)
advmod(higher-9, significantly-8)
advmod(compared-13, higher-9)
case(rats-12, in-10)
amod(rats-12, obese-11)
nmod:in(higher-9, rats-12)
ccomp(showed-3, compared-13)
mark(lean-15, to-14)
xcomp(compared-13, lean-15)
dobj(lean-15, rats-16)
case(glucose-20, under-17)
det(glucose-20, both-18)
amod(glucose-20, high-19)
nmod:under(lean-15, glucose-20)
cc(glucose-20, and-21)
amod(conditions-23, zaragozic_acid_D3-22)
nmod:under(lean-15, conditions-23)
conj:and(glucose-20, conditions-23)

Additionally/RB ,/, insulin_secretion/NN was/VBD also/RB elevated/VBD in/IN obese/JJ rats/NNS under/IN high/JJ glucose/NN conditions/NNS but/CC not/RB under/IN zaragozic_acid_D3/JJ conditions/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN insulin_secretion))
    (VP (VBD was) (RB also)
      (VP (VBD elevated)
        (PP (IN in)
          (NP (JJ obese) (NNS rats)))
        (PP (IN under)
          (NP (JJ high) (NN glucose) (NNS conditions)))
        (PRN (CC but)
          (ADVP (RB not))
          (PP (IN under)
            (NP (JJ zaragozic_acid_D3) (NNS conditions))))))
    (. .)))

advmod(elevated-6, Additionally-1)
nsubjpass(elevated-6, insulin_secretion-3)
auxpass(elevated-6, was-4)
advmod(elevated-6, also-5)
root(ROOT-0, elevated-6)
case(rats-9, in-7)
amod(rats-9, obese-8)
nmod:in(elevated-6, rats-9)
case(conditions-13, under-10)
amod(conditions-13, high-11)
compound(conditions-13, glucose-12)
nmod:under(elevated-6, conditions-13)
cc(conditions-18, but-14)
dep(conditions-18, not-15)
case(conditions-18, under-16)
amod(conditions-18, zaragozic_acid_D3-17)
dep(elevated-6, conditions-18)

These/DT findings/NNS suggest/VBP that/IN squalene_synthase/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN squalene_synthase))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB possibly))
                (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, squalene_synthase-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
case(development-12, in-10)
det(development-12, the-11)
nmod:in(role-9, development-12)
case(obesity-14, of-13)
nmod:of(development-12, obesity-14)
advmod(effects-19, possibly-16)
case(effects-19, through-17)
nmod:poss(effects-19, its-18)
nmod:through(play-7, effects-19)
case(insulin_secretion-21, on-20)
nmod:on(effects-19, insulin_secretion-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (JJ obesity) (NN management))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(management-16, for-14)
amod(management-16, obesity-15)
nmod:for(targets-13, management-16)

Migraine/JJ is_a/JJ common/JJ neurological_disorder/NN characterized/VBD by/IN recurrent/JJ headaches/NNS and/CC associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN ,/, phonophobia/NN ,/, and/CC bronchospasms/NNS ./.

(ROOT
  (S
    (NP (JJ Migraine) (JJ is_a) (JJ common) (NN neurological_disorder))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ recurrent) (NNS headaches))
          (CC and)
          (NP
            (NP (VBN associated) (NNS symptoms))
            (PP (JJ such) (IN as)
              (NP
                (NP (NN photophobia))
                (, ,)
                (NP (NN phonophobia))
                (, ,)
                (CC and)
                (NP (NNS bronchospasms))))))))
    (. .)))

amod(neurological_disorder-4, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
nsubj(characterized-5, neurological_disorder-4)
root(ROOT-0, characterized-5)
case(headaches-8, by-6)
amod(headaches-8, recurrent-7)
nmod:by(characterized-5, headaches-8)
cc(headaches-8, and-9)
amod(symptoms-11, associated-10)
nmod:by(characterized-5, symptoms-11)
conj:and(headaches-8, symptoms-11)
case(photophobia-14, such-12)
mwe(such-12, as-13)
nmod:such_as(symptoms-11, photophobia-14)
nmod:such_as(symptoms-11, phonophobia-16)
conj:and(photophobia-14, phonophobia-16)
cc(photophobia-14, and-18)
nmod:such_as(symptoms-11, bronchospasms-19)
conj:and(photophobia-14, bronchospasms-19)

Clomacran/NNP is_a/VBZ medication/NN that/WDT has_been/VBP developed/VBN for/IN the/DT treatment/NN of/IN migraine/NN ./.

(ROOT
  (S
    (NP (NNP Clomacran))
    (VP (VBZ is_a)
      (NP
        (NP (NN medication))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN developed)
                (PP (IN for)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NN migraine)))))))))))
    (. .)))

nsubj(is_a-2, Clomacran-1)
root(ROOT-0, is_a-2)
dobj(is_a-2, medication-3)
nsubj(has_been-5, medication-3)
ref(medication-3, that-4)
acl:relcl(medication-3, has_been-5)
dep(has_been-5, developed-6)
case(treatment-9, for-7)
det(treatment-9, the-8)
nmod:for(developed-6, treatment-9)
case(migraine-11, of-10)
nmod:of(treatment-9, migraine-11)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN Clomacran/NNP was/VBD evaluated/VBN in/IN reducing/VBG the/DT risk/NN of/IN migraine-associated_symptoms/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NNP Clomacran))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNS migraine-associated_symptoms)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(Clomacran-8, of-7)
nmod:of(efficacy-6, Clomacran-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
mark(reducing-12, in-11)
advcl(evaluated-10, reducing-12)
det(risk-14, the-13)
dobj(reducing-12, risk-14)
case(migraine-associated_symptoms-16, of-15)
nmod:of(risk-14, migraine-associated_symptoms-16)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, Clomacran/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NNP Clomacran))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, Clomacran-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(bronchospasms-17, of-16)
nmod:of(risk-15, bronchospasms-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN Clomacran/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN individuals/NNS with/IN migraine/NN who/WP experience/VBP these/DT associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Clomacran))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP
                        (NP (NN migraine))
                        (SBAR
                          (WHNP (WP who))
                          (S
                            (VP (VBP experience)
                              (NP (DT these) (VBN associated) (NNS symptoms)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Clomacran-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
case(migraine-15, with-14)
nmod:with(individuals-13, migraine-15)
nsubj(experience-17, migraine-15)
ref(migraine-15, who-16)
acl:relcl(migraine-15, experience-17)
det(symptoms-20, these-18)
amod(symptoms-20, associated-19)
dobj(experience-17, symptoms-20)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO investigate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN Clomacran/NNP in/IN migraine/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NNP Clomacran))))
                (PP (IN in)
                  (NP (JJ migraine) (NN management)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
ccomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(investigate-11, to-10)
ccomp(warranted-4, investigate-11)
conj:and(confirm-6, investigate-11)
det(safety-14, the-12)
amod(safety-14, long-term-13)
dobj(investigate-11, safety-14)
cc(safety-14, and-15)
dobj(investigate-11, efficacy-16)
conj:and(safety-14, efficacy-16)
case(Clomacran-18, of-17)
nmod:of(safety-14, Clomacran-18)
case(management-21, in-19)
amod(management-21, migraine-20)
nmod:in(investigate-11, management-21)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP (JJ various) (NN health) (NNS benefits)))))))
    (. .)))

nsubjpass(known-15, Omega-3_fatty_acids-1)
nsubj:xsubj(have-17, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(have-17, to-16)
xcomp(known-15, have-17)
amod(benefits-20, various-18)
compound(benefits-20, health-19)
dobj(have-17, benefits-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN Taxodione/JJ levels/NNS in/IN hyperTaxodionemic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Taxodione) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperTaxodionemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-14, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-14, omega-3_fatty_acids-7)
appos(omega-3_fatty_acids-7, EPA-9)
cc(EPA-9, and-10)
appos(omega-3_fatty_acids-7, DHA-11)
conj:and(EPA-9, DHA-11)
auxpass(associated-14, are-13)
ccomp(shown-4, associated-14)
case(levels-18, with-15)
amod(levels-18, decreased-16)
amod(levels-18, Taxodione-17)
nmod:with(associated-14, levels-18)
case(patients-21, in-19)
amod(patients-21, hyperTaxodionemic-20)
nmod:in(levels-18, patients-21)
cc(patients-21, and-22)
amod(risk-24, decreased-23)
nmod:in(levels-18, risk-24)
conj:and(patients-21, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

This/DT finding/NN is/VBZ supported/VBN by/IN evidence/NN that/IN EPA/NNP and/CC DHA/NNP can/MD reduce/VB inflammation/NN and/CC improve/VB lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ is)
      (VP (VBN supported)
        (PP (IN by)
          (NP
            (NP (NN evidence))
            (SBAR (IN that)
              (S
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))
                (VP (MD can)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (CC and)
                    (VP (VB improve)
                      (NP (NN lipid) (NN metabolism)))))))))))
    (. .)))

det(finding-2, This-1)
nsubjpass(supported-4, finding-2)
auxpass(supported-4, is-3)
root(ROOT-0, supported-4)
case(evidence-6, by-5)
nmod:by(supported-4, evidence-6)
mark(reduce-12, that-7)
nsubj(reduce-12, EPA-8)
nsubj(improve-15, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubj(reduce-12, DHA-10)
aux(reduce-12, can-11)
dep(evidence-6, reduce-12)
dobj(reduce-12, inflammation-13)
cc(reduce-12, and-14)
dep(evidence-6, improve-15)
conj:and(reduce-12, improve-15)
compound(metabolism-17, lipid-16)
dobj(improve-15, metabolism-17)

Moreover/RB ,/, several/JJ clinical/JJ trials/NNS have/VBP demonstrated/VBN the/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP supplementation/NN on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (JJ several) (JJ clinical) (NNS trials))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (NP
          (NP (DT the) (JJ beneficial) (NNS effects))
          (PP (IN of)
            (NP
              (ADJP (NNP EPA)
                (CC and)
                (NNP DHA))
              (NN supplementation))))
        (PP (IN on)
          (NP (NN cardiovascular_health)))))
    (. .)))

advmod(demonstrated-7, Moreover-1)
amod(trials-5, several-3)
amod(trials-5, clinical-4)
nsubj(demonstrated-7, trials-5)
aux(demonstrated-7, have-6)
root(ROOT-0, demonstrated-7)
det(effects-10, the-8)
amod(effects-10, beneficial-9)
dobj(demonstrated-7, effects-10)
case(supplementation-15, of-11)
amod(supplementation-15, EPA-12)
cc(EPA-12, and-13)
conj:and(EPA-12, DHA-14)
amod(supplementation-15, DHA-14)
nmod:of(effects-10, supplementation-15)
case(cardiovascular_health-17, on-16)
nmod:on(demonstrated-7, cardiovascular_health-17)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT potential/JJ strategy/NN for/IN reducing/VBG CHD/NNP risk/NN in/IN hyperTaxodionemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (NNP CHD) (NN risk))
                        (PP (IN in)
                          (NP (JJ hyperTaxodionemic) (NNS patients)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
csubj(strategy-15, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, potential-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
compound(risk-19, CHD-18)
dobj(reducing-17, risk-19)
case(patients-22, in-20)
amod(patients-22, hyperTaxodionemic-21)
nmod:in(risk-19, patients-22)

However/RB ,/, further/JJ research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN specific/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ specific) (NNS populations))))))))))
    (. .)))

advmod(needed-6, However-1)
amod(research-4, further-3)
nsubjpass(needed-6, research-4)
auxpass(needed-6, is-5)
root(ROOT-0, needed-6)
mark(understand-9, to-7)
advmod(understand-9, fully-8)
ccomp(needed-6, understand-9)
det(mechanisms-11, the-10)
dobj(understand-9, mechanisms-11)
acl(mechanisms-11, underlying-12)
det(effects-14, these-13)
dobj(underlying-12, effects-14)
cc(understand-9, and-15)
mark(determine-17, to-16)
ccomp(needed-6, determine-17)
conj:and(understand-9, determine-17)
amod(dosages-19, optimal-18)
dobj(determine-17, dosages-19)
case(populations-22, for-20)
amod(populations-22, specific-21)
nmod:for(dosages-19, populations-22)

The/DT effects/NNS of/IN HN-11500/NNP administration/NN on/IN the/DT TXA2_receptor/JJ reduction/NN were/VBD studied/VBN during/IN low/JJ and/CC high-intensity/JJ exercise/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (NP (NNP HN-11500) (NN administration)))
      (PP (IN on)
        (NP (DT the) (JJ TXA2_receptor) (NN reduction))))
    (VP (VBD were)
      (VP (VBN studied)
        (PP (IN during)
          (NP
            (ADJP (JJ low)
              (CC and)
              (JJ high-intensity))
            (NN exercise)))))
    (. .)))

det(effects-2, The-1)
nsubjpass(studied-11, effects-2)
case(administration-5, of-3)
compound(administration-5, HN-11500-4)
nmod:of(effects-2, administration-5)
case(reduction-9, on-6)
det(reduction-9, the-7)
amod(reduction-9, TXA2_receptor-8)
nmod:on(effects-2, reduction-9)
auxpass(studied-11, were-10)
root(ROOT-0, studied-11)
case(exercise-16, during-12)
amod(exercise-16, low-13)
cc(low-13, and-14)
conj:and(low-13, high-intensity-15)
amod(exercise-16, high-intensity-15)
nmod:during(studied-11, exercise-16)

The/DT results/NNS showed/VBD that/IN the/DT reduction/NN in/IN TXA2_receptor/NNS after/IN HN-11500/NNP administration/NN was/VBD attenuated/VBN during/IN low-intensity/JJ exercise/NN ,/, with/IN a/DT decrease/NN of/IN 5/CD %/NN -LRB-/-LRB- P/NNP </CD 0.001/CD -RRB-/-RRB- ,/, and/CC abolished/VBN during/IN high-intensity/JJ exercise/NN ,/, with/IN a/DT decrease/NN of/IN 3/CD %/NN -LRB-/-LRB- P/NNP =/SYM not/RB significant/JJ -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN reduction))
              (PP (IN in)
                (NP
                  (NP (NNS TXA2_receptor))
                  (PP (IN after)
                    (NP (NNP HN-11500) (NN administration))))))
            (VP (VBD was)
              (VP (VBN attenuated)
                (PP (IN during)
                  (NP (JJ low-intensity) (NN exercise)))
                (, ,)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (NN decrease))
                      (PP (IN of)
                        (NP (CD 5) (NN %))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.001)))
                      (-RRB- -RRB-))))))))))
    (, ,)
    (CC and)
    (S
      (VP (VBN abolished)
        (PP (IN during)
          (NP (JJ high-intensity) (NN exercise)))
        (, ,)
        (PP (IN with)
          (NP
            (NP
              (NP (DT a) (NN decrease))
              (PP (IN of)
                (NP (CD 3) (NN %))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP P))
                (SBAR
                  (FRAG
                    (X (SYM =))
                    (NP (RB not) (JJ significant)))))
              (-RRB- -RRB-))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
nsubj(abolished-31, results-2)
root(ROOT-0, showed-3)
mark(attenuated-13, that-4)
det(reduction-6, the-5)
nsubjpass(attenuated-13, reduction-6)
case(TXA2_receptor-8, in-7)
nmod:in(reduction-6, TXA2_receptor-8)
case(administration-11, after-9)
compound(administration-11, HN-11500-10)
nmod:after(TXA2_receptor-8, administration-11)
auxpass(attenuated-13, was-12)
ccomp(showed-3, attenuated-13)
case(exercise-16, during-14)
amod(exercise-16, low-intensity-15)
nmod:during(attenuated-13, exercise-16)
case(decrease-20, with-18)
det(decrease-20, a-19)
nmod:with(attenuated-13, decrease-20)
case(%-23, of-21)
nummod(%-23, 5-22)
nmod:of(decrease-20, %-23)
appos(decrease-20, P-25)
compound(0.001-27, <-26)
nummod(P-25, 0.001-27)
cc(showed-3, and-30)
conj:and(showed-3, abolished-31)
case(exercise-34, during-32)
amod(exercise-34, high-intensity-33)
nmod:during(abolished-31, exercise-34)
case(decrease-38, with-36)
det(decrease-38, a-37)
nmod:with(abolished-31, decrease-38)
case(%-41, of-39)
nummod(%-41, 3-40)
nmod:of(decrease-38, %-41)
dep(decrease-38, P-43)
dep(significant-46, =-44)
neg(significant-46, not-45)
dep(P-43, significant-46)

Furthermore/RB ,/, the/DT study/NN found/VBD that/IN PaCO2/NNS decreased/VBD by/IN 7/CD %/NN -LRB-/-LRB- P/NNP </VBP 0.05/CD -RRB-/-RRB- and/CC CMRO2/NNP increased/VBD by/IN 17/CD %/NN -LRB-/-LRB- P/NNP </CD 0.05/CD -RRB-/-RRB- during/IN the/DT exercise/NN period/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (S
      (NP (DT the) (NN study))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP (NNS PaCO2))
            (VP (VBD decreased)
              (PP (IN by)
                (NP (CD 7) (NN %))))))))
    (PRN (-LRB- -LRB-)
      (S
        (NP (NNP P))
        (VP (VBP <)
          (NP (CD 0.05))))
      (-RRB- -RRB-))
    (CC and)
    (S
      (NP (NNP CMRO2))
      (VP (VBD increased)
        (PP
          (PP (IN by)
            (NP (CD 17) (NN %)))
          (PRN (-LRB- -LRB-)
            (NP (NNP P)
              (QP (CD <) (CD 0.05)))
            (-RRB- -RRB-)))
        (PP (IN during)
          (NP (DT the) (NN exercise) (NN period)))))
    (. .)))

advmod(found-5, Furthermore-1)
det(study-4, the-3)
nsubj(found-5, study-4)
root(ROOT-0, found-5)
mark(decreased-8, that-6)
nsubj(decreased-8, PaCO2-7)
ccomp(found-5, decreased-8)
case(%-11, by-9)
nummod(%-11, 7-10)
nmod:by(decreased-8, %-11)
nsubj(<-14, P-13)
dep(found-5, <-14)
dobj(<-14, 0.05-15)
cc(found-5, and-17)
nsubj(increased-19, CMRO2-18)
conj:and(found-5, increased-19)
case(%-22, by-20)
nummod(%-22, 17-21)
advcl(increased-19, %-22)
dep(%-22, P-24)
compound(0.05-26, <-25)
nummod(P-24, 0.05-26)
case(period-31, during-28)
det(period-31, the-29)
compound(period-31, exercise-30)
nmod:during(increased-19, period-31)

These/DT findings/NNS suggest/VBP that/IN HN-11500/NNP may/MD have/VB differential/NN effects/NNS on/IN TXA2_receptor/JJ reduction/NN depending/VBG on/IN the/DT intensity/NN of/IN exercise/NN ,/, and/CC that/IN these/DT effects/NNS may/MD be/VB related/VBN to/TO changes/NNS in/IN PaCO2/NNS and/CC CMRO2/CD levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (NNP HN-11500))
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (NN differential) (NNS effects))
                  (PP (IN on)
                    (NP (JJ TXA2_receptor) (NN reduction))))
                (PP (VBG depending)
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN intensity))
                      (PP (IN of)
                        (NP (NN exercise))))))))))
        (, ,)
        (CC and)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS effects))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN related)
                  (PP (TO to)
                    (NP
                      (NP (NNS changes))
                      (PP (IN in)
                        (NP
                          (NP (NNS PaCO2))
                          (CC and)
                          (NP (CD CMRO2) (NNS levels)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, HN-11500-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
compound(effects-9, differential-8)
dobj(have-7, effects-9)
case(reduction-12, on-10)
amod(reduction-12, TXA2_receptor-11)
nmod:on(effects-9, reduction-12)
case(intensity-16, depending-13)
case(intensity-16, on-14)
det(intensity-16, the-15)
advcl(have-7, intensity-16)
case(exercise-18, of-17)
nmod:of(intensity-16, exercise-18)
cc(have-7, and-20)
mark(related-26, that-21)
det(effects-23, these-22)
nsubjpass(related-26, effects-23)
aux(related-26, may-24)
auxpass(related-26, be-25)
ccomp(suggest-3, related-26)
conj:and(have-7, related-26)
case(changes-28, to-27)
nmod:to(related-26, changes-28)
case(PaCO2-30, in-29)
nmod:in(changes-28, PaCO2-30)
cc(PaCO2-30, and-31)
nummod(levels-33, CMRO2-32)
nmod:in(changes-28, levels-33)
conj:and(PaCO2-30, levels-33)

Further/JJ investigation/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT observations/NNS and/CC their/PRP$ potential/JJ clinical/JJ implications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NN investigation))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS observations))
                    (CC and)
                    (NP (PRP$ their) (JJ potential) (JJ clinical) (NNS implications))))))))))
    (. .)))

amod(investigation-2, Further-1)
nsubjpass(needed-4, investigation-2)
nsubj:xsubj(understand-7, investigation-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
case(observations-12, underlying-10)
det(observations-12, these-11)
nmod:underlying(mechanisms-9, observations-12)
cc(observations-12, and-13)
nmod:poss(implications-17, their-14)
amod(implications-17, potential-15)
amod(implications-17, clinical-16)
nmod:underlying(mechanisms-9, implications-17)
conj:and(observations-12, implications-17)

Opioid-induced/JJ constipation/NN -LRB-/-LRB- OIC/NNP -RRB-/-RRB- is_a/VBZ common/JJ side/NN effect/NN of/IN opioid/JJ therapy/NN for/IN chronic_pain/JJ management/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Opioid-induced) (NN constipation))
      (PRN (-LRB- -LRB-)
        (NP (NNP OIC))
        (-RRB- -RRB-)))
    (VP (VBZ is_a)
      (NP
        (NP (JJ common) (NN side) (NN effect))
        (PP (IN of)
          (NP
            (NP (JJ opioid) (NN therapy))
            (PP (IN for)
              (NP (JJ chronic_pain) (NN management)))))))
    (. .)))

amod(constipation-2, Opioid-induced-1)
nsubj(is_a-6, constipation-2)
appos(constipation-2, OIC-4)
root(ROOT-0, is_a-6)
amod(effect-9, common-7)
compound(effect-9, side-8)
dobj(is_a-6, effect-9)
case(therapy-12, of-10)
amod(therapy-12, opioid-11)
nmod:of(effect-9, therapy-12)
case(management-15, for-13)
amod(management-15, chronic_pain-14)
nmod:for(therapy-12, management-15)

Naloxegol/JJ is_a/NN peripherally/VBP acting/VBG μ-opioid/JJ receptor_antagonist/NN that/WDT has_been/VBP approved/VBN for/IN the/DT treatment/NN of/IN OIC/NNP ./.

(ROOT
  (S
    (NP (JJ Naloxegol) (NN is_a))
    (VP (VBP peripherally)
      (VP (VBG acting)
        (NP
          (NP (JJ μ-opioid) (NN receptor_antagonist))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP has_been)
                (VP (VBN approved)
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP (NNP OIC))))))))))))
    (. .)))

amod(is_a-2, Naloxegol-1)
nsubj(peripherally-3, is_a-2)
root(ROOT-0, peripherally-3)
xcomp(peripherally-3, acting-4)
amod(receptor_antagonist-6, μ-opioid-5)
dobj(acting-4, receptor_antagonist-6)
nsubj(has_been-8, receptor_antagonist-6)
ref(receptor_antagonist-6, that-7)
acl:relcl(receptor_antagonist-6, has_been-8)
dep(has_been-8, approved-9)
case(treatment-12, for-10)
det(treatment-12, the-11)
nmod:for(approved-9, treatment-12)
case(OIC-14, of-13)
nmod:of(treatment-12, OIC-14)

In/IN this/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ,/, we/PRP evaluated/VBN the/DT efficacy/NN of/IN naloxegol/NN in/IN reducing/VBG the/DT risk/NN of/IN colonic_inertia/NN and/CC associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBN evaluated)
        (NP
          (NP (DT the) (NN efficacy))
          (PP (IN of)
            (NP (NN naloxegol))))
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NN colonic_inertia))))))))
      (CC and)
      (VP (VBN associated)
        (NP
          (NP (NNS symptoms))
          (PP (JJ such) (IN as)
            (NP (NN photophobia)
              (CC and)
              (NN phonophobia))))))
    (. .)))

case(trial-8, In-1)
det(trial-8, this-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(evaluated-11, trial-8)
nsubj(evaluated-11, we-10)
nsubj(associated-23, we-10)
root(ROOT-0, evaluated-11)
det(efficacy-13, the-12)
dobj(evaluated-11, efficacy-13)
case(naloxegol-15, of-14)
nmod:of(efficacy-13, naloxegol-15)
mark(reducing-17, in-16)
advcl(evaluated-11, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
case(colonic_inertia-21, of-20)
nmod:of(risk-19, colonic_inertia-21)
cc(evaluated-11, and-22)
conj:and(evaluated-11, associated-23)
dobj(associated-23, symptoms-24)
case(photophobia-27, such-25)
mwe(such-25, as-26)
nmod:such_as(symptoms-24, photophobia-27)
cc(photophobia-27, and-28)
nmod:such_as(symptoms-24, phonophobia-29)
conj:and(photophobia-27, phonophobia-29)

A/DT total/NN of/IN 500/CD patients/NNS were/VBD enrolled/VBN in/IN the/DT study/NN and/CC received/VBN either/DT naloxegol/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (NN total))
      (PP (IN of)
        (NP (CD 500) (NNS patients))))
    (VP (VBD were)
      (VP
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study))))
        (CC and)
        (VP (VBN received)
          (NP (DT either) (NN naloxegol)
            (CC or)
            (NN placebo)))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-7, total-2)
nsubjpass(received-12, total-2)
case(patients-5, of-3)
nummod(patients-5, 500-4)
nmod:of(total-2, patients-5)
auxpass(enrolled-7, were-6)
root(ROOT-0, enrolled-7)
case(study-10, in-8)
det(study-10, the-9)
nmod:in(enrolled-7, study-10)
cc(enrolled-7, and-11)
conj:and(enrolled-7, received-12)
cc:preconj(naloxegol-14, either-13)
dobj(received-12, naloxegol-14)
cc(naloxegol-14, or-15)
dobj(received-12, placebo-16)
conj:or(naloxegol-14, placebo-16)

At_2/JJ h/NN after/IN dosing/VBG ,/, naloxegol/NN reduced/VBD the/DT risk/NN of/IN colonic_inertia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN naloxegol))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN colonic_inertia))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, naloxegol-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(colonic_inertia-11, of-10)
nmod:of(risk-9, colonic_inertia-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN naloxegol/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN OIC/NNP and/CC its/PRP$ associated/VBN symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN naloxegol))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNP OIC))
                    (CC and)
                    (NP (PRP$ its) (VBN associated) (NNS symptoms))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, naloxegol-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(OIC-13, for-12)
nmod:for(option-11, OIC-13)
cc(OIC-13, and-14)
nmod:poss(symptoms-17, its-15)
amod(symptoms-17, associated-16)
nmod:for(option-11, symptoms-17)
conj:and(OIC-13, symptoms-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN naloxegol/NN in/IN this/DT patient/JJ population/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB evaluate)
              (NP
                (NP (DT the) (JJ long-term) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN of)
                  (NP
                    (NP (NN naloxegol))
                    (PP (IN in)
                      (NP (DT this) (JJ patient) (NN population)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(evaluate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(evaluate-6, to-5)
xcomp(needed-4, evaluate-6)
det(safety-9, the-7)
amod(safety-9, long-term-8)
dobj(evaluate-6, safety-9)
cc(safety-9, and-10)
dobj(evaluate-6, efficacy-11)
conj:and(safety-9, efficacy-11)
case(naloxegol-13, of-12)
nmod:of(safety-9, naloxegol-13)
case(population-17, in-14)
det(population-17, this-15)
amod(population-17, patient-16)
nmod:in(naloxegol-13, population-17)

Obesity/JJ is_a/NN multifactorial_disease/VBD that/DT results/NNS from/IN an/DT imbalance/NN between/IN energy/NN intake/NN and/CC expenditure/NN ./.

(ROOT
  (S
    (NP (JJ Obesity) (NN is_a))
    (VP (VBD multifactorial_disease)
      (NP (DT that) (NNS results))
      (PP (IN from)
        (NP
          (NP (DT an) (NN imbalance))
          (PP (IN between)
            (NP (NN energy) (NN intake)
              (CC and)
              (NN expenditure))))))
    (. .)))

amod(is_a-2, Obesity-1)
nsubj(multifactorial_disease-3, is_a-2)
root(ROOT-0, multifactorial_disease-3)
det(results-5, that-4)
dobj(multifactorial_disease-3, results-5)
case(imbalance-8, from-6)
det(imbalance-8, an-7)
nmod:from(multifactorial_disease-3, imbalance-8)
case(intake-11, between-9)
compound(intake-11, energy-10)
nmod:between(imbalance-8, intake-11)
cc(intake-11, and-12)
nmod:between(imbalance-8, expenditure-13)
conj:and(intake-11, expenditure-13)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT ubiquitin-proteasome/JJ system/NN may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ ubiquitin-proteasome) (NN system))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-10, that-5)
det(system-8, the-6)
amod(system-8, ubiquitin-proteasome-7)
nsubj(play-10, system-8)
aux(play-10, may-9)
ccomp(suggested-4, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
case(development-15, in-13)
det(development-15, the-14)
nmod:in(role-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN e3_ubiquitin_ligase/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS e3_ubiquitin_ligase)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(e3_ubiquitin_ligase-20, of-19)
nmod:of(hypersecretion-18, e3_ubiquitin_ligase-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ indisulam/NN on/IN the/DT secretion/NN of/IN e3_ubiquitin_ligase/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN indisulam)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ e3_ubiquitin_ligase) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(indisulam-16, 10-14)
amod(indisulam-16, mmol/L-15)
nmod:of(effects-8, indisulam-16)
conj:and(glucose-12, indisulam-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
amod(and_insulin-22, e3_ubiquitin_ligase-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(rats-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, rats-39)
conj:and(genetically_obese-28, rats-39)

Our/PRP$ results/NNS showed/VBD that/IN e3_ubiquitin_ligase/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS when/WRB exposed/VBN to/TO high/JJ glucose/NN levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ e3_ubiquitin_ligase) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (SBAR
                      (WHADVP (WRB when))
                      (S
                        (VP (VBN exposed)
                          (PP (TO to)
                            (NP (JJ high) (NN glucose) (NNS levels))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-13, that-4)
amod(secretion-6, e3_ubiquitin_ligase-5)
nsubjpass(compared-13, secretion-6)
nsubj:xsubj(lean-15, secretion-6)
auxpass(compared-13, was-7)
advmod(higher-9, significantly-8)
advmod(compared-13, higher-9)
case(rats-12, in-10)
amod(rats-12, obese-11)
nmod:in(higher-9, rats-12)
ccomp(showed-3, compared-13)
mark(lean-15, to-14)
xcomp(compared-13, lean-15)
dobj(lean-15, rats-16)
advmod(exposed-18, when-17)
advcl(lean-15, exposed-18)
case(levels-22, to-19)
amod(levels-22, high-20)
compound(levels-22, glucose-21)
nmod:to(exposed-18, levels-22)

Interestingly/RB ,/, indisulam/NN treatment/NN significantly/RB reduced/VBD e3_ubiquitin_ligase/JJ secretion/NN in/IN both/DT obese/JJ and/CC lean/JJ rats/NNS without/IN affecting/VBG insulin_secretion/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NN indisulam) (NN treatment))
    (ADVP (RB significantly))
    (VP (VBD reduced)
      (NP (JJ e3_ubiquitin_ligase) (NN secretion))
      (PP (IN in)
        (NP (DT both) (JJ obese)
          (CC and)
          (JJ lean) (NNS rats)))
      (PP (IN without)
        (S
          (VP (VBG affecting)
            (NP (NN insulin_secretion))))))
    (. .)))

advmod(reduced-6, Interestingly-1)
compound(treatment-4, indisulam-3)
nsubj(reduced-6, treatment-4)
advmod(reduced-6, significantly-5)
root(ROOT-0, reduced-6)
amod(secretion-8, e3_ubiquitin_ligase-7)
dobj(reduced-6, secretion-8)
case(rats-14, in-9)
det(rats-14, both-10)
amod(rats-14, obese-11)
cc(obese-11, and-12)
conj:and(obese-11, lean-13)
amod(rats-14, lean-13)
nmod:in(reduced-6, rats-14)
mark(affecting-16, without-15)
advcl(reduced-6, affecting-16)
dobj(affecting-16, insulin_secretion-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN e3_ubiquitin_ligase/NNS by/IN the/DT pancreas/NN may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/NN ,/, and/CC that/IN targeting/VBG this/DT pathway/NN could/MD be/VB a/DT potential/JJ therapeutic/JJ strategy/NN for/IN treating/VBG obesity-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NNS e3_ubiquitin_ligase))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB contribute)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))))))
        (, ,)
        (CC and)
        (SBAR (IN that)
          (S
            (S
              (VP (VBG targeting)
                (NP (DT this) (NN pathway))))
            (VP (MD could)
              (VP (VB be)
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG treating)
                      (NP (NNS obesity-related_disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-12, that-4)
nsubj(contribute-12, hypersecretion-5)
case(e3_ubiquitin_ligase-7, of-6)
nmod:of(hypersecretion-5, e3_ubiquitin_ligase-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(e3_ubiquitin_ligase-7, pancreas-10)
aux(contribute-12, may-11)
ccomp(suggest-3, contribute-12)
case(development-15, to-13)
det(development-15, the-14)
nmod:to(contribute-12, development-15)
case(obesity-17, of-16)
nmod:of(development-15, obesity-17)
cc(contribute-12, and-19)
mark(strategy-29, that-20)
csubj(strategy-29, targeting-21)
det(pathway-23, this-22)
dobj(targeting-21, pathway-23)
aux(strategy-29, could-24)
cop(strategy-29, be-25)
det(strategy-29, a-26)
amod(strategy-29, potential-27)
amod(strategy-29, therapeutic-28)
ccomp(suggest-3, strategy-29)
conj:and(contribute-12, strategy-29)
mark(treating-31, for-30)
advcl(strategy-29, treating-31)
dobj(treating-31, obesity-related_disorders-32)

Hypericum/NNP perforatum/NNP ,/, commonly/RB known/VBN as/IN St./NNP John/NNP 's/POS wort/NN ,/, has_been/VBP used/VBN for/IN centuries/NNS to/TO treat/VB various/JJ ailments/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Hypericum) (NNP perforatum))
      (, ,)
      (VP
        (ADVP (RB commonly))
        (VBN known)
        (PP (IN as)
          (NP
            (NP (NNP St.) (NNP John) (POS 's))
            (NN wort))))
      (, ,))
    (VP (VBP has_been)
      (VP (VBN used)
        (PP (IN for)
          (NP (NNS centuries)))
        (S
          (VP (TO to)
            (VP (VB treat)
              (NP (JJ various) (NNS ailments)))))))
    (. .)))

compound(perforatum-2, Hypericum-1)
nsubj(has_been-12, perforatum-2)
advmod(known-5, commonly-4)
acl(perforatum-2, known-5)
case(wort-10, as-6)
compound(John-8, St.-7)
nmod:poss(wort-10, John-8)
case(John-8, 's-9)
nmod:as(known-5, wort-10)
root(ROOT-0, has_been-12)
dep(has_been-12, used-13)
case(centuries-15, for-14)
nmod:for(used-13, centuries-15)
mark(treat-17, to-16)
xcomp(used-13, treat-17)
amod(ailments-19, various-18)
dobj(treat-17, ailments-19)

One/CD of/IN its/PRP$ active/JJ components/NNS ,/, pseudohypericin/NN ,/, has/VBZ shown/VBN potential/JJ in/IN reducing/VBG the/DT risk/NN of/IN phototoxic_reactions/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (CD One))
        (PP (IN of)
          (NP (PRP$ its) (JJ active) (NNS components))))
      (, ,)
      (NP (NN pseudohypericin))
      (, ,))
    (VP (VBZ has)
      (VP (VBN shown)
        (ADJP (JJ potential))
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NNS phototoxic_reactions)))))))))
    (. .)))

nsubj(shown-10, One-1)
case(components-5, of-2)
nmod:poss(components-5, its-3)
amod(components-5, active-4)
nmod:of(One-1, components-5)
appos(One-1, pseudohypericin-7)
aux(shown-10, has-9)
root(ROOT-0, shown-10)
xcomp(shown-10, potential-11)
mark(reducing-13, in-12)
advcl(shown-10, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
case(phototoxic_reactions-17, of-16)
nmod:of(risk-15, phototoxic_reactions-17)

In/IN a/DT randomized_controlled_trial/NN ,/, patients/NNS were/VBD given/VBN a/DT single/JJ dose/NN of/IN pseudohypericin/NN and/CC monitored/VBN for/IN adverse_reactions/NNS to/TO light/JJ exposure/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (NN randomized_controlled_trial)))
    (, ,)
    (NP (NNS patients))
    (VP (VBD were)
      (VP
        (VP (VBN given)
          (NP
            (NP (DT a) (JJ single) (NN dose))
            (PP (IN of)
              (NP (NN pseudohypericin)))))
        (CC and)
        (VP (VBN monitored)
          (PP (IN for)
            (NP (NNS adverse_reactions)))
          (PP (TO to)
            (NP (JJ light) (NN exposure))))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, a-2)
nmod:in(given-7, randomized_controlled_trial-3)
nsubjpass(given-7, patients-5)
nsubjpass(monitored-14, patients-5)
auxpass(given-7, were-6)
root(ROOT-0, given-7)
det(dose-10, a-8)
amod(dose-10, single-9)
dobj(given-7, dose-10)
case(pseudohypericin-12, of-11)
nmod:of(dose-10, pseudohypericin-12)
cc(given-7, and-13)
conj:and(given-7, monitored-14)
case(adverse_reactions-16, for-15)
nmod:for(monitored-14, adverse_reactions-16)
case(exposure-19, to-17)
amod(exposure-19, light-18)
nmod:to(monitored-14, exposure-19)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, pseudohypericin/NN reduced/VBD the/DT risk/NN of/IN phototoxic_reactions/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN pseudohypericin))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS phototoxic_reactions))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, pseudohypericin-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(phototoxic_reactions-11, of-10)
nmod:of(risk-9, phototoxic_reactions-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN pseudohypericin/NN may/MD have/VB clinical/JJ applications/NNS in/IN reducing/VBG the/DT risk/NN of/IN adverse_reactions/NNS to/TO light/JJ exposure/NN in/IN patients/NNS with/IN photosensitive/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN pseudohypericin))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ clinical) (NNS applications))
              (PP (IN in)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (NP (NNS adverse_reactions))))
                    (PP (TO to)
                      (NP
                        (NP (JJ light) (NN exposure))
                        (PP (IN in)
                          (NP (NNS patients)))))
                    (PP (IN with)
                      (NP (JJ photosensitive) (NNS disorders)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, pseudohypericin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(applications-9, clinical-8)
dobj(have-7, applications-9)
mark(reducing-11, in-10)
advcl(have-7, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(adverse_reactions-15, of-14)
nmod:of(risk-13, adverse_reactions-15)
case(exposure-18, to-16)
amod(exposure-18, light-17)
nmod:to(reducing-11, exposure-18)
case(patients-20, in-19)
nmod:in(exposure-18, patients-20)
case(disorders-23, with-21)
amod(disorders-23, photosensitive-22)
nmod:with(reducing-11, disorders-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN and/CC long-term/JJ safety/NN profile/NN of/IN this/DT compound/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                (CC and)
                (NP
                  (NP (JJ long-term) (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (DT this) (NN compound))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(determine-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(determine-6, to-5)
xcomp(needed-4, determine-6)
det(regimen-10, the-7)
amod(regimen-10, optimal-8)
amod(regimen-10, dosing-9)
dobj(determine-6, regimen-10)
cc(regimen-10, and-11)
amod(profile-14, long-term-12)
compound(profile-14, safety-13)
dobj(determine-6, profile-14)
conj:and(regimen-10, profile-14)
case(compound-17, of-15)
det(compound-17, this-16)
nmod:of(profile-14, compound-17)

Eicosapentaenoic_acid/NNP -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- are/VBP long-chain/JJ omega-3_fatty_acids/NNS that/WDT have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP Eicosapentaenoic_acid))
          (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (JJ long-chain) (NNS omega-3_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP
                  (ADVP (RB extensively))
                  (VBN studied)
                  (PP (IN for)
                    (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(omega-3_fatty_acids-12, Eicosapentaenoic_acid-1)
dep(Eicosapentaenoic_acid-1, EPA-3)
cc(Eicosapentaenoic_acid-1, and-5)
conj:and(Eicosapentaenoic_acid-1, docosahexaenoic_acid-6)
nsubj(omega-3_fatty_acids-12, docosahexaenoic_acid-6)
appos(Eicosapentaenoic_acid-1, DHA-8)
cop(omega-3_fatty_acids-12, are-10)
amod(omega-3_fatty_acids-12, long-chain-11)
root(ROOT-0, omega-3_fatty_acids-12)
nsubjpass(studied-17, omega-3_fatty_acids-12)
ref(omega-3_fatty_acids-12, that-13)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
acl:relcl(omega-3_fatty_acids-12, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

One/CD of/IN the/DT observed/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP is_a/VBD decrease/NN in/IN sulcotrione/JJ levels/NNS in/IN hypersulcotrionemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ observed) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))))
    (VP (VBD is_a)
      (NP
        (NP (NN decrease))
        (PP (IN in)
          (NP
            (NP (JJ sulcotrione) (NNS levels))
            (PP (IN in)
              (NP (JJ hypersulcotrionemic) (NNS patients)))))))
    (. .)))

nsubj(is_a-10, One-1)
case(effects-5, of-2)
det(effects-5, the-3)
amod(effects-5, observed-4)
nmod:of(One-1, effects-5)
case(EPA-7, of-6)
nmod:of(effects-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(effects-5, DHA-9)
conj:and(EPA-7, DHA-9)
root(ROOT-0, is_a-10)
dobj(is_a-10, decrease-11)
case(levels-14, in-12)
amod(levels-14, sulcotrione-13)
nmod:in(decrease-11, levels-14)
case(patients-17, in-15)
amod(patients-17, hypersulcotrionemic-16)
nmod:in(levels-14, patients-17)

Moreover/RB ,/, these/DT fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN reduced) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(associated-7, Moreover-1)
det(fatty_acids-4, these-3)
nsubjpass(associated-7, fatty_acids-4)
aux(associated-7, have-5)
auxpass(associated-7, been-6)
root(ROOT-0, associated-7)
case(risk-11, with-8)
det(risk-11, a-9)
amod(risk-11, reduced-10)
nmod:with(associated-7, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

There/EX is/VBZ evidence/NN that/IN EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS by/IN reducing/VBG inflammation/NN ,/, improving/VBG endothelial/JJ function/NN ,/, and/CC modulating/VBG lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP (EX There))
    (VP (VBZ is)
      (NP
        (NP (NN evidence))
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBD exert)
              (NP (PRP$ their) (JJ cardioprotective) (NNS effects))
              (PP (IN by)
                (S
                  (VP
                    (VP (VBG reducing)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VBG improving)
                      (NP (JJ endothelial) (NN function)))
                    (, ,)
                    (CC and)
                    (VP (VBG modulating)
                      (NP (NN lipid) (NN metabolism)))))))))))
    (. .)))

expl(is-2, There-1)
root(ROOT-0, is-2)
nsubj(is-2, evidence-3)
mark(exert-8, that-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
dep(evidence-3, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, cardioprotective-10)
dobj(exert-8, effects-11)
mark(reducing-13, by-12)
advcl(exert-8, reducing-13)
dobj(reducing-13, inflammation-14)
advcl(exert-8, improving-16)
conj:and(reducing-13, improving-16)
amod(function-18, endothelial-17)
dobj(improving-16, function-18)
cc(reducing-13, and-20)
advcl(exert-8, modulating-21)
conj:and(reducing-13, modulating-21)
compound(metabolism-23, lipid-22)
dobj(modulating-21, metabolism-23)

Despite/IN the/DT promising/JJ results/NNS from/IN preclinical/JJ and/CC clinical/JJ studies/NNS ,/, the/DT optimal/JJ dose/NN and/CC duration/NN of/IN EPA/NNP and/CC DHA/NNP supplementation/NN for/IN CHD/NNP prevention/NN remain/VBP to_be/JJ determined/VBN ./.

(ROOT
  (S
    (PP (IN Despite)
      (NP
        (NP (DT the) (JJ promising) (NNS results))
        (PP (IN from)
          (NP
            (ADJP (JJ preclinical)
              (CC and)
              (JJ clinical))
            (NNS studies)))))
    (, ,)
    (NP
      (NP (DT the) (JJ optimal) (NN dose)
        (CC and)
        (NN duration))
      (PP (IN of)
        (NP
          (NP
            (ADJP (NNP EPA)
              (CC and)
              (NNP DHA))
            (NN supplementation))
          (PP (IN for)
            (NP (NNP CHD) (NN prevention))))))
    (VP (VBP remain)
      (ADVP (JJ to_be))
      (VP (VBN determined)))
    (. .)))

case(results-4, Despite-1)
det(results-4, the-2)
amod(results-4, promising-3)
nmod:despite(remain-24, results-4)
case(studies-9, from-5)
amod(studies-9, preclinical-6)
cc(preclinical-6, and-7)
conj:and(preclinical-6, clinical-8)
amod(studies-9, clinical-8)
nmod:from(results-4, studies-9)
det(dose-13, the-11)
amod(dose-13, optimal-12)
nsubj(remain-24, dose-13)
cc(dose-13, and-14)
conj:and(dose-13, duration-15)
nsubj(remain-24, duration-15)
case(supplementation-20, of-16)
amod(supplementation-20, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
amod(supplementation-20, DHA-19)
nmod:of(dose-13, supplementation-20)
case(prevention-23, for-21)
compound(prevention-23, CHD-22)
nmod:for(supplementation-20, prevention-23)
root(ROOT-0, remain-24)
advmod(remain-24, to_be-25)
xcomp(remain-24, determined-26)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN these/DT fatty_acids/NNS on/IN cardiovascular_health/NN and/CC to/TO identify/VB individuals/NNS who/WP may/MD benefit/VB the/DT most/JJS from/IN their/PRP$ supplementation/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ beneficial) (NNS effects))
                      (PP (IN of)
                        (NP (DT these) (NNS fatty_acids))))))
                (PP (IN on)
                  (NP (NN cardiovascular_health)))))
            (CC and)
            (VP (TO to)
              (VP (VB identify)
                (NP
                  (NP (NNS individuals))
                  (SBAR
                    (WHNP (WP who))
                    (S
                      (VP (MD may)
                        (VP (VB benefit)
                          (NP (DT the) (JJS most))
                          (PP (IN from)
                            (NP (PRP$ their) (NN supplementation))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-12, the-10)
amod(effects-12, beneficial-11)
dobj(underlying-9, effects-12)
case(fatty_acids-15, of-13)
det(fatty_acids-15, these-14)
nmod:of(effects-12, fatty_acids-15)
case(cardiovascular_health-17, on-16)
nmod:on(elucidate-6, cardiovascular_health-17)
cc(elucidate-6, and-18)
mark(identify-20, to-19)
ccomp(needed-4, identify-20)
conj:and(elucidate-6, identify-20)
dobj(identify-20, individuals-21)
nsubj(benefit-24, individuals-21)
ref(individuals-21, who-22)
aux(benefit-24, may-23)
acl:relcl(individuals-21, benefit-24)
det(most-26, the-25)
dobj(benefit-24, most-26)
case(supplementation-29, from-27)
nmod:poss(supplementation-29, their-28)
nmod:from(benefit-24, supplementation-29)

Malaria/NNP remains/VBZ a/DT significant/JJ public_health/NN concern/NN ,/, particularly/RB in/IN sub-Saharan_Africa/NN where/WRB it/PRP is/VBZ responsible/JJ for/IN a/DT high/JJ number/NN of/IN deaths/NNS annually/RB ./.

(ROOT
  (S
    (NP (NNP Malaria))
    (VP (VBZ remains)
      (NP (DT a) (JJ significant) (NN public_health) (NN concern))
      (, ,)
      (PP
        (ADVP (RB particularly))
        (IN in)
        (NP
          (NP (NN sub-Saharan_Africa))
          (SBAR
            (WHADVP (WRB where))
            (S
              (NP (PRP it))
              (VP (VBZ is)
                (ADJP (JJ responsible)
                  (PP (IN for)
                    (NP
                      (NP (DT a) (JJ high) (NN number))
                      (PP (IN of)
                        (NP (NNS deaths))))))
                (ADVP (RB annually))))))))
    (. .)))

nsubj(remains-2, Malaria-1)
root(ROOT-0, remains-2)
det(concern-6, a-3)
amod(concern-6, significant-4)
compound(concern-6, public_health-5)
xcomp(remains-2, concern-6)
advmod(sub-Saharan_Africa-10, particularly-8)
case(sub-Saharan_Africa-10, in-9)
nmod:in(remains-2, sub-Saharan_Africa-10)
advmod(responsible-14, where-11)
nsubj(responsible-14, it-12)
cop(responsible-14, is-13)
acl:relcl(sub-Saharan_Africa-10, responsible-14)
case(number-18, for-15)
det(number-18, a-16)
amod(number-18, high-17)
nmod:for(responsible-14, number-18)
case(deaths-20, of-19)
nmod:of(number-18, deaths-20)
advmod(responsible-14, annually-21)

The/DT emergence/NN of/IN drug-resistant/JJ strains/NNS of/IN Plasmodium_falciparum/NNP ,/, the/DT most/RBS lethal/JJ species/NN of/IN malaria/NN ,/, has/VBZ made/VBN treatment/NN and/CC prevention/NN more/RBR challenging/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN emergence))
      (PP (IN of)
        (NP
          (NP (JJ drug-resistant) (NNS strains))
          (PP (IN of)
            (NP
              (NP (NNP Plasmodium_falciparum))
              (, ,)
              (NP
                (NP (DT the)
                  (ADJP (RBS most) (JJ lethal))
                  (NN species))
                (PP (IN of)
                  (NP (NN malaria))))
              (, ,))))))
    (VP (VBZ has)
      (VP (VBN made)
        (S
          (NP (NN treatment)
            (CC and)
            (NN prevention))
          (ADJP (RBR more) (JJ challenging)))))
    (. .)))

det(emergence-2, The-1)
nsubj(made-17, emergence-2)
case(strains-5, of-3)
amod(strains-5, drug-resistant-4)
nmod:of(emergence-2, strains-5)
case(Plasmodium_falciparum-7, of-6)
nmod:of(strains-5, Plasmodium_falciparum-7)
det(species-12, the-9)
advmod(lethal-11, most-10)
amod(species-12, lethal-11)
appos(Plasmodium_falciparum-7, species-12)
case(malaria-14, of-13)
nmod:of(species-12, malaria-14)
aux(made-17, has-16)
root(ROOT-0, made-17)
nsubj(challenging-22, treatment-18)
cc(treatment-18, and-19)
conj:and(treatment-18, prevention-20)
nsubj(challenging-22, prevention-20)
advmod(challenging-22, more-21)
xcomp(made-17, challenging-22)

In/IN this/DT study/NN ,/, the/DT efficacy/NN of/IN ferroquine/NN was/VBD evaluated/VBN in/IN patients/NNS with/IN heart_failure/NN -LRB-/-LRB- HF/NNP -RRB-/-RRB- who/WP are/VBP at/IN higher/JJR risk/NN of/IN severe/JJ malaria_infection/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN efficacy))
      (PP (IN of)
        (NP (NN ferroquine))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN in)
          (NP
            (NP
              (NP (NNS patients))
              (PP (IN with)
                (NP (NN heart_failure))))
            (PRN (-LRB- -LRB-)
              (NP (NNP HF))
              (-RRB- -RRB-))
            (SBAR
              (WHNP (WP who))
              (S
                (VP (VBP are)
                  (PP (IN at)
                    (NP
                      (NP (JJR higher) (NN risk))
                      (PP (IN of)
                        (NP (JJ severe) (NN malaria_infection))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-10, study-3)
det(efficacy-6, the-5)
nsubjpass(evaluated-10, efficacy-6)
case(ferroquine-8, of-7)
nmod:of(efficacy-6, ferroquine-8)
auxpass(evaluated-10, was-9)
root(ROOT-0, evaluated-10)
case(patients-12, in-11)
nmod:in(evaluated-10, patients-12)
nsubj(risk-22, patients-12)
case(heart_failure-14, with-13)
nmod:with(patients-12, heart_failure-14)
appos(patients-12, HF-16)
ref(patients-12, who-18)
cop(risk-22, are-19)
case(risk-22, at-20)
amod(risk-22, higher-21)
acl:relcl(patients-12, risk-22)
case(malaria_infection-25, of-23)
amod(malaria_infection-25, severe-24)
nmod:of(risk-22, malaria_infection-25)

The/DT results/NNS showed/VBD that/IN ferroquine/NN reduced/VBD the/DT risk/NN of/IN Falciparum_Malaria/NNP by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN ferroquine))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNP Falciparum_Malaria))))
            (PP (IN by)
              (NP
                (NP (CD 21) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                      (: :)
                      (NP
                        (QP (CD 0.67-0) (CD .93)))))
                  (-RRB- -RRB-))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, ferroquine-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(Falciparum_Malaria-10, of-9)
nmod:of(risk-8, Falciparum_Malaria-10)
case(%-13, by-11)
nummod(%-13, 21-12)
nmod:by(reduced-6, %-13)
amod(-RSB--19, relative-15)
compound(-RSB--19, risk-16)
compound(-RSB--19, -LSB--17)
compound(-RSB--19, RR-18)
dep(%-13, -RSB--19)
nummod(-RSB--29, 0.79-21)
nummod(-RSB--29, 95-23)
compound(-RSB--29, %-24)
compound(-RSB--29, confidence-25)
amod(-RSB--29, interval-26)
amod(-RSB--29, -LSB--27)
compound(-RSB--29, CI-28)
dep(-RSB--19, -RSB--29)
compound(.93-32, 0.67-0-31)
dep(-RSB--29, .93-32)

This/DT finding/NN suggests/VBZ that/IN ferroquine/NN could/MD be/VB a/DT promising/JJ prophylactic/JJ treatment/NN for/IN individuals/NNS with/IN HF/NNP living/VBG in/IN malaria-endemic/JJ areas/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN ferroquine))
          (VP (MD could)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ prophylactic) (NN treatment))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP (NNP HF)))
                    (VP (VBG living)
                      (PP (IN in)
                        (NP (JJ malaria-endemic) (NNS areas))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(treatment-11, that-4)
nsubj(treatment-11, ferroquine-5)
aux(treatment-11, could-6)
cop(treatment-11, be-7)
det(treatment-11, a-8)
amod(treatment-11, promising-9)
amod(treatment-11, prophylactic-10)
ccomp(suggests-3, treatment-11)
case(individuals-13, for-12)
nmod:for(treatment-11, individuals-13)
case(HF-15, with-14)
nmod:with(individuals-13, HF-15)
acl(individuals-13, living-16)
case(areas-19, in-17)
amod(areas-19, malaria-endemic-18)
nmod:in(living-16, areas-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO evaluate/VB the/DT safety/NN and/CC effectiveness/NN of/IN ferroquine/NN in/IN larger/JJR populations/NNS and/CC to/TO determine/VB its/PRP$ potential/NN as/IN an/DT alternative/NN or/CC adjunctive/JJ therapy/NN for/IN malaria/NN prevention/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (NN safety)
                    (CC and)
                    (NN effectiveness))
                  (PP (IN of)
                    (NP
                      (NP (NN ferroquine))
                      (PP (IN in)
                        (NP (JJR larger) (NNS populations))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (PRP$ its) (NN potential))
                (PP (IN as)
                  (NP
                    (NP (DT an) (NN alternative))
                    (CC or)
                    (NP
                      (NP (JJ adjunctive) (NN therapy))
                      (PP (IN for)
                        (NP (NN malaria) (NN prevention))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(evaluate-6, to-5)
ccomp(needed-4, evaluate-6)
det(safety-8, the-7)
dobj(evaluate-6, safety-8)
cc(safety-8, and-9)
dobj(evaluate-6, effectiveness-10)
conj:and(safety-8, effectiveness-10)
case(ferroquine-12, of-11)
nmod:of(safety-8, ferroquine-12)
case(populations-15, in-13)
amod(populations-15, larger-14)
nmod:in(ferroquine-12, populations-15)
cc(evaluate-6, and-16)
mark(determine-18, to-17)
ccomp(needed-4, determine-18)
conj:and(evaluate-6, determine-18)
nmod:poss(potential-20, its-19)
dobj(determine-18, potential-20)
case(alternative-23, as-21)
det(alternative-23, an-22)
nmod:as(determine-18, alternative-23)
cc(alternative-23, or-24)
amod(therapy-26, adjunctive-25)
nmod:as(determine-18, therapy-26)
conj:or(alternative-23, therapy-26)
case(prevention-29, for-27)
compound(prevention-29, malaria-28)
nmod:for(therapy-26, prevention-29)

The/DT metabolism/NN of/IN glycodeoxycholic_acid/JJ has_been/NN shown/VBN to_be/VBD activated/VBN by/IN enterokinase/NN in/IN the/DT endothelium/NN of/IN the/DT bovine/JJ pulmonary_artery/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN metabolism))
      (PP (IN of)
        (NP (JJ glycodeoxycholic_acid) (NN has_been)))
      (VP (VBN shown)))
    (VP (VBD to_be)
      (VP (VBN activated)
        (PP (IN by)
          (NP (NN enterokinase)))
        (PP (IN in)
          (NP
            (NP (DT the) (NN endothelium))
            (PP (IN of)
              (NP (DT the) (JJ bovine) (NN pulmonary_artery)))))))
    (. .)))

det(metabolism-2, The-1)
nsubj(to_be-7, metabolism-2)
case(has_been-5, of-3)
amod(has_been-5, glycodeoxycholic_acid-4)
nmod:of(metabolism-2, has_been-5)
acl(metabolism-2, shown-6)
root(ROOT-0, to_be-7)
dep(to_be-7, activated-8)
case(enterokinase-10, by-9)
nmod:by(activated-8, enterokinase-10)
case(endothelium-13, in-11)
det(endothelium-13, the-12)
nmod:in(activated-8, endothelium-13)
case(pulmonary_artery-17, of-14)
det(pulmonary_artery-17, the-15)
amod(pulmonary_artery-17, bovine-16)
nmod:of(endothelium-13, pulmonary_artery-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN pertussis/NN toxin/NN and/CC botulinum/NN toxin/NN on/IN this/DT activation/NN process/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NN pertussis) (NN toxin))
            (CC and)
            (NP (NN botulinum) (NN toxin)))))
      (PP (IN on)
        (NP (DT this) (NN activation) (NN process))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(toxin-11, of-9)
compound(toxin-11, pertussis-10)
nmod:of(effect-8, toxin-11)
cc(toxin-11, and-12)
compound(toxin-14, botulinum-13)
nmod:of(effect-8, toxin-14)
conj:and(toxin-11, toxin-14)
case(process-18, on-15)
det(process-18, this-16)
compound(process-18, activation-17)
nmod:on(investigated-6, process-18)

Pertussis/JJ toxin/NN ,/, which/WDT ADP-ribosylates/VBZ a/DT membrane_protein/NN of/IN molecular/JJ mass/NN 40/CD kDa/NN ,/, did/VBD not/RB block/VB the/DT activation/NN of/IN glycodeoxycholic_acid/JJ metabolism/NN by/IN enterokinase/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Pertussis) (NN toxin))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ ADP-ribosylates)
            (NP
              (NP (DT a) (NN membrane_protein))
              (PP (IN of)
                (NP (JJ molecular) (NN mass) (CD 40) (NN kDa)))))))
      (, ,))
    (VP (VBD did) (RB not)
      (VP (VB block)
        (NP
          (NP (DT the) (NN activation))
          (PP (IN of)
            (NP (JJ glycodeoxycholic_acid) (NN metabolism))))
        (PP (IN by)
          (NP (NN enterokinase)))))
    (. .)))

amod(toxin-2, Pertussis-1)
nsubj(ADP-ribosylates-5, toxin-2)
nsubj(block-16, toxin-2)
ref(toxin-2, which-4)
acl:relcl(toxin-2, ADP-ribosylates-5)
det(membrane_protein-7, a-6)
dobj(ADP-ribosylates-5, membrane_protein-7)
case(kDa-12, of-8)
amod(kDa-12, molecular-9)
compound(kDa-12, mass-10)
nummod(kDa-12, 40-11)
nmod:of(membrane_protein-7, kDa-12)
aux(block-16, did-14)
neg(block-16, not-15)
root(ROOT-0, block-16)
det(activation-18, the-17)
dobj(block-16, activation-18)
case(metabolism-21, of-19)
amod(metabolism-21, glycodeoxycholic_acid-20)
nmod:of(activation-18, metabolism-21)
case(enterokinase-23, by-22)
nmod:by(block-16, enterokinase-23)

However/RB ,/, botulinum/NN toxin/NN ,/, which/WDT ADP-ribosylates/VBZ a/DT membrane_protein/NN of/IN molecular/JJ mass/NN 24/CD kDa/NN ,/, fully/RB blocked/VBD enterokinase-stimulated/JJ glycodeoxycholic_acid/JJ metabolism/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (NN botulinum) (NN toxin))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBZ ADP-ribosylates)
            (NP
              (NP (DT a) (NN membrane_protein))
              (PP (IN of)
                (NP (JJ molecular) (NN mass) (CD 24) (NN kDa)))))))
      (, ,))
    (ADVP (RB fully))
    (VP (VBD blocked)
      (NP (JJ enterokinase-stimulated) (JJ glycodeoxycholic_acid) (NN metabolism)))
    (. .)))

advmod(blocked-17, However-1)
compound(toxin-4, botulinum-3)
nsubj(ADP-ribosylates-7, toxin-4)
nsubj(blocked-17, toxin-4)
ref(toxin-4, which-6)
acl:relcl(toxin-4, ADP-ribosylates-7)
det(membrane_protein-9, a-8)
dobj(ADP-ribosylates-7, membrane_protein-9)
case(kDa-14, of-10)
amod(kDa-14, molecular-11)
compound(kDa-14, mass-12)
nummod(kDa-14, 24-13)
nmod:of(membrane_protein-9, kDa-14)
advmod(blocked-17, fully-16)
root(ROOT-0, blocked-17)
amod(metabolism-20, enterokinase-stimulated-18)
amod(metabolism-20, glycodeoxycholic_acid-19)
dobj(blocked-17, metabolism-20)

These/DT findings/NNS suggest/VBP that/IN the/DT activation/NN of/IN glycodeoxycholic_acid/JJ metabolism/NN by/IN enterokinase/NN in/IN the/DT endothelium/NN of/IN the/DT bovine/JJ pulmonary_artery/NN is/VBZ mediated/VBN by/IN a/DT membrane_protein/NN with/IN a/DT molecular/JJ mass/NN of/IN 24/CD kDa/NN and/CC is/VBZ not/RB dependent/JJ on/IN pertussis/NN toxin-sensitive/NN G/NNP proteins/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP
                (NP (JJ glycodeoxycholic_acid) (NN metabolism))
                (PP (IN by)
                  (NP
                    (NP (NN enterokinase))
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN endothelium))
                        (PP (IN of)
                          (NP (DT the) (JJ bovine) (NN pulmonary_artery))))))))))
          (VP
            (VP (VBZ is)
              (VP (VBN mediated)
                (PP (IN by)
                  (NP (DT a) (NN membrane_protein)))
                (PP (IN with)
                  (NP
                    (NP (DT a) (JJ molecular) (NN mass))
                    (PP (IN of)
                      (NP (CD 24) (NN kDa)))))))
            (CC and)
            (VP (VBZ is) (RB not)
              (ADJP (JJ dependent)
                (PP (IN on)
                  (NP (NN pertussis) (NN toxin-sensitive) (NNP G) (NNS proteins)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(mediated-20, that-4)
det(activation-6, the-5)
nsubjpass(mediated-20, activation-6)
nsubj(dependent-34, activation-6)
case(metabolism-9, of-7)
amod(metabolism-9, glycodeoxycholic_acid-8)
nmod:of(activation-6, metabolism-9)
case(enterokinase-11, by-10)
nmod:by(metabolism-9, enterokinase-11)
case(endothelium-14, in-12)
det(endothelium-14, the-13)
nmod:in(enterokinase-11, endothelium-14)
case(pulmonary_artery-18, of-15)
det(pulmonary_artery-18, the-16)
amod(pulmonary_artery-18, bovine-17)
nmod:of(endothelium-14, pulmonary_artery-18)
auxpass(mediated-20, is-19)
ccomp(suggest-3, mediated-20)
case(membrane_protein-23, by-21)
det(membrane_protein-23, a-22)
nmod:by(mediated-20, membrane_protein-23)
case(mass-27, with-24)
det(mass-27, a-25)
amod(mass-27, molecular-26)
nmod:with(mediated-20, mass-27)
case(kDa-30, of-28)
nummod(kDa-30, 24-29)
nmod:of(mass-27, kDa-30)
cc(mediated-20, and-31)
cop(dependent-34, is-32)
neg(dependent-34, not-33)
ccomp(suggest-3, dependent-34)
conj:and(mediated-20, dependent-34)
case(proteins-39, on-35)
compound(proteins-39, pertussis-36)
compound(proteins-39, toxin-sensitive-37)
compound(proteins-39, G-38)
nmod:on(dependent-34, proteins-39)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanism/NN underlying/VBG this/DT process/NN and/CC its/PRP$ potential/JJ therapeutic/JJ implications/NNS for/IN pulmonary_artery-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ precise) (NN mechanism))
                (PP (VBG underlying)
                  (NP
                    (NP (DT this) (NN process))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS implications))
                      (PP (IN for)
                        (NP (NNS pulmonary_artery-related_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanism-9, the-7)
amod(mechanism-9, precise-8)
dobj(elucidate-6, mechanism-9)
case(process-12, underlying-10)
det(process-12, this-11)
nmod:underlying(mechanism-9, process-12)
cc(process-12, and-13)
nmod:poss(implications-17, its-14)
amod(implications-17, potential-15)
amod(implications-17, therapeutic-16)
nmod:underlying(mechanism-9, implications-17)
conj:and(process-12, implications-17)
case(pulmonary_artery-related_disorders-19, for-18)
nmod:for(implications-17, pulmonary_artery-related_disorders-19)

Lauroylethanolamide/NNP -LRB-/-LRB- LAE/NNP -RRB-/-RRB- is/VBZ an/DT endogenous/JJ bioactive/JJ lipid/NN that/IN exhibits/VBZ anti-inflammatory/JJ and/CC analgesic/JJ properties/NNS ./.

(ROOT
  (S
    (NP (NNP Lauroylethanolamide) (-LRB- -LRB-)
      (NP (NNP LAE))
      (-RRB- -RRB-))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ endogenous) (JJ bioactive) (NN lipid))
        (SBAR
          (WHNP (IN that))
          (S
            (VP (VBZ exhibits)
              (NP (JJ anti-inflammatory)
                (CC and)
                (JJ analgesic) (NNS properties)))))))
    (. .)))

nsubj(lipid-9, Lauroylethanolamide-1)
dep(Lauroylethanolamide-1, LAE-3)
cop(lipid-9, is-5)
det(lipid-9, an-6)
amod(lipid-9, endogenous-7)
amod(lipid-9, bioactive-8)
root(ROOT-0, lipid-9)
nsubj(exhibits-11, lipid-9)
ref(lipid-9, that-10)
acl:relcl(lipid-9, exhibits-11)
amod(properties-15, anti-inflammatory-12)
cc(anti-inflammatory-12, and-13)
conj:and(anti-inflammatory-12, analgesic-14)
amod(properties-15, analgesic-14)
dobj(exhibits-11, properties-15)

12-lipoxygenase/JJ -LRB-/-LRB- 12-LOX/CD -RRB-/-RRB- has_been/VBP shown/VBN to/TO inhibit/VB LAE/NNP production/NN ,/, but/CC the/DT underlying/VBG mechanisms/NNS are/VBP not/RB fully/RB understood/VBN ./.

(ROOT
  (S
    (S
      (NP
        (NP (JJ 12-lipoxygenase))
        (PRN (-LRB- -LRB-)
          (NP (CD 12-LOX))
          (-RRB- -RRB-)))
      (VP (VBP has_been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB inhibit)
                (NP (NNP LAE) (NN production))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT the) (VBG underlying) (NNS mechanisms))
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (. .)))

nsubj(has_been-5, 12-lipoxygenase-1)
appos(12-lipoxygenase-1, 12-LOX-3)
root(ROOT-0, has_been-5)
dep(has_been-5, shown-6)
mark(inhibit-8, to-7)
xcomp(shown-6, inhibit-8)
compound(production-10, LAE-9)
dobj(inhibit-8, production-10)
cc(has_been-5, but-12)
det(mechanisms-15, the-13)
amod(mechanisms-15, underlying-14)
nsubjpass(understood-19, mechanisms-15)
auxpass(understood-19, are-16)
neg(understood-19, not-17)
advmod(understood-19, fully-18)
conj:but(has_been-5, understood-19)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT role/NN of/IN protein_kinase_A/NN -LRB-/-LRB- PKA/NNP -RRB-/-RRB- in/IN the/DT regulation/NN of/IN 12-LOX-mediated/JJ inhibition/NN of/IN LAE/NNP production/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP (NN protein_kinase_A))))
        (PRN (-LRB- -LRB-)
          (NP (NNP PKA))
          (-RRB- -RRB-)))
      (PP (IN in)
        (NP
          (NP (DT the) (NN regulation))
          (PP (IN of)
            (NP
              (NP (JJ 12-LOX-mediated) (NN inhibition))
              (PP (IN of)
                (NP (NNP LAE) (NN production))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(role-8, the-7)
dobj(investigated-6, role-8)
case(protein_kinase_A-10, of-9)
nmod:of(role-8, protein_kinase_A-10)
appos(role-8, PKA-12)
case(regulation-16, in-14)
det(regulation-16, the-15)
nmod:in(investigated-6, regulation-16)
case(inhibition-19, of-17)
amod(inhibition-19, 12-LOX-mediated-18)
nmod:of(regulation-16, inhibition-19)
case(production-22, of-20)
compound(production-22, LAE-21)
nmod:of(inhibition-19, production-22)

Our/PRP$ results/NNS show/VBP that/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT PKA/NNP inhibitor/NN ,/, or/CC mutating/VBG S730A/NNP ,/, the/DT PKA-dependent/JJ phosphorylation/NN site/NN in/IN the/DT 12-LOX/JJ sequence/NN ,/, reversed/VBD the/DT inhibitory/JJ effect/NN of/IN 12-LOX/CD on/IN LAE/NNP production/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (S
            (VP
              (VP (VBG pretreating)
                (NP (NNS cells))
                (PP (IN with)
                  (NP
                    (NP (NN staurosporin))
                    (, ,)
                    (NP (DT a) (NNP PKA) (NN inhibitor))
                    (, ,))))
              (CC or)
              (VP (VBG mutating)
                (NP
                  (NP (NNP S730A))
                  (, ,)
                  (NP
                    (NP (DT the) (JJ PKA-dependent) (NN phosphorylation) (NN site))
                    (PP (IN in)
                      (NP (DT the) (JJ 12-LOX) (NN sequence))))
                  (, ,)))))
          (VP (VBD reversed)
            (NP
              (NP (DT the) (JJ inhibitory) (NN effect))
              (PP (IN of)
                (NP (CD 12-LOX))))
            (PP (IN on)
              (NP (NNP LAE) (NN production)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(reversed-27, that-4)
csubj(reversed-27, pretreating-5)
dobj(pretreating-5, cells-6)
case(staurosporin-8, with-7)
nmod:with(pretreating-5, staurosporin-8)
det(inhibitor-12, a-10)
compound(inhibitor-12, PKA-11)
appos(staurosporin-8, inhibitor-12)
cc(pretreating-5, or-14)
conj:or(pretreating-5, mutating-15)
csubj(reversed-27, mutating-15)
dobj(mutating-15, S730A-16)
det(site-21, the-18)
amod(site-21, PKA-dependent-19)
compound(site-21, phosphorylation-20)
appos(S730A-16, site-21)
case(sequence-25, in-22)
det(sequence-25, the-23)
amod(sequence-25, 12-LOX-24)
nmod:in(site-21, sequence-25)
ccomp(show-3, reversed-27)
det(effect-30, the-28)
amod(effect-30, inhibitory-29)
dobj(reversed-27, effect-30)
case(12-LOX-32, of-31)
nmod:of(effect-30, 12-LOX-32)
case(production-35, on-33)
compound(production-35, LAE-34)
nmod:on(reversed-27, production-35)

These/DT findings/NNS suggest/VBP that/IN PKA/NNP signaling/VBG plays/VBZ a/DT critical/JJ role/NN in/IN regulating/VBG LAE/NNP biosynthesis/NNS and/CC may/MD have/VB implications/NNS for/IN developing/VBG new/JJ therapeutic/JJ strategies/NNS for/IN inflammatory/JJ and/CC painful_conditions/JJ ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNP PKA))
            (VP (VBG signaling)))
          (VP
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ critical) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (NNP LAE) (NNS biosynthesis)))))))
            (CC and)
            (VP (MD may)
              (VP (VB have)
                (NP
                  (NP (NNS implications))
                  (PP (IN for)
                    (S
                      (VP (VBG developing)
                        (NP (JJ new) (JJ therapeutic) (NNS strategies))
                        (PP (IN for)
                          (ADJP (JJ inflammatory)
                            (CC and)
                            (JJ painful_conditions)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(plays-7, that-4)
nsubj(plays-7, PKA-5)
nsubj(have-17, PKA-5)
acl(PKA-5, signaling-6)
ccomp(suggest-3, plays-7)
det(role-10, a-8)
amod(role-10, critical-9)
dobj(plays-7, role-10)
mark(regulating-12, in-11)
acl(role-10, regulating-12)
compound(biosynthesis-14, LAE-13)
dobj(regulating-12, biosynthesis-14)
cc(plays-7, and-15)
aux(have-17, may-16)
ccomp(suggest-3, have-17)
conj:and(plays-7, have-17)
dobj(have-17, implications-18)
mark(developing-20, for-19)
acl(implications-18, developing-20)
amod(strategies-23, new-21)
amod(strategies-23, therapeutic-22)
dobj(developing-20, strategies-23)
case(inflammatory-25, for-24)
advcl(developing-20, inflammatory-25)
cc(inflammatory-25, and-26)
advcl(developing-20, painful_conditions-27)
conj:and(inflammatory-25, painful_conditions-27)

The/DT search/NN for/IN effective/JJ treatments/NNS for/IN ischemic_brain_damage/JJ and/CC associated/VBN symptoms/NNS has_been/VBZ a/DT major/JJ focus/NN in/IN biomedical/JJ research/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN search))
      (PP (IN for)
        (NP
          (NP (JJ effective) (NNS treatments))
          (PP (IN for)
            (NP
              (ADJP (JJ ischemic_brain_damage)
                (CC and)
                (VBN associated))
              (NNS symptoms))))))
    (VP (VBZ has_been)
      (NP
        (NP (DT a) (JJ major) (NN focus))
        (PP (IN in)
          (NP (JJ biomedical) (NN research)))))
    (. .)))

det(search-2, The-1)
nsubj(has_been-11, search-2)
case(treatments-5, for-3)
amod(treatments-5, effective-4)
nmod:for(search-2, treatments-5)
case(symptoms-10, for-6)
amod(symptoms-10, ischemic_brain_damage-7)
cc(ischemic_brain_damage-7, and-8)
conj:and(ischemic_brain_damage-7, associated-9)
amod(symptoms-10, associated-9)
nmod:for(treatments-5, symptoms-10)
root(ROOT-0, has_been-11)
det(focus-14, a-12)
amod(focus-14, major-13)
dobj(has_been-11, focus-14)
case(research-17, in-15)
amod(research-17, biomedical-16)
nmod:in(focus-14, research-17)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN FR247304/NNP on/IN ischemic_brain_damage/JJ and/CC related/VBN symptoms/NNS were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP FR247304)))
      (PP (IN on)
        (NP
          (ADJP (JJ ischemic_brain_damage)
            (CC and)
            (VBN related))
          (NNS symptoms))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-15, study-3)
det(effects-6, the-5)
nsubjpass(investigated-15, effects-6)
case(FR247304-8, of-7)
nmod:of(effects-6, FR247304-8)
case(symptoms-13, on-9)
amod(symptoms-13, ischemic_brain_damage-10)
cc(ischemic_brain_damage-10, and-11)
conj:and(ischemic_brain_damage-10, related-12)
amod(symptoms-13, related-12)
nmod:on(effects-6, symptoms-13)
auxpass(investigated-15, were-14)
root(ROOT-0, investigated-15)

At_2/JJ h/NN after/IN dosing/VBG ,/, FR247304/NNP was/VBD found/VBN to/TO significantly/RB reduce/VB the/DT risk/NN of/IN ischemic_brain_damage/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NN 6-20/CD %/NN ,/, P/RB =/SYM 0.0005/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NNP FR247304))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB significantly))
              (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (NN ischemic_brain_damage))))
              (PP (IN by)
                (NP
                  (NP (CD 14) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (NP
                          (NP (CD 95) (NN %))
                          (NP (NN CI)))
                        (ADJP (CD 6-20) (NN %)))
                      (, ,)
                      (ADVP (RB P))
                      (NP
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.0005)))))
                    (-RRB- -RRB-)))))))))
    (. .)))

amod(h-2, At_2-1)
dep(found-8, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubjpass(found-8, FR247304-6)
nsubj:xsubj(reduce-11, FR247304-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(ischemic_brain_damage-15, of-14)
nmod:of(risk-13, ischemic_brain_damage-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
dep(%-18, %-21)
dep(%-21, CI-22)
compound(%-24, 6-20-23)
amod(%-21, %-24)
appos(%-21, P-26)
dep(0.0005-28, =-27)
dep(P-26, 0.0005-28)

Moreover/RB ,/, the/DT compound/NN also/RB demonstrated/VBD efficacy/RB in/IN reducing/VBG photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (DT the) (NN compound))
    (ADVP (RB also))
    (VP
      (VP (VBD demonstrated)
        (ADVP (RB efficacy))
        (PP (IN in)
          (S
            (VP (VBG reducing)
              (NP (NN photophobia))
              (PP (IN by)
                (NP (CD 17) (NN %)))))))
      (PRN (-LRB- -LRB-)
        (S
          (NP (CD 95) (NN %))
          (VP (VBP CI)
            (NP (CD 12-22) (NN %))
            (, ,)
            (SBAR
              (S
                (NP (NNP P))
                (VP (VBP <)
                  (NP (CD 0.0001)))))))
        (-RRB- -RRB-))
      (CC and)
      (VP (NN phonophobia)
        (PP (IN by)
          (NP
            (NP (CD 14) (NN %))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 95) (NN %))
                (PP (NNP CI)
                  (NP (CD 17-20) (NN %))))
              (, ,)
              (NP (NNP P)
                (QP (CD <) (CD 0.0001)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(demonstrated-6, Moreover-1)
det(compound-4, the-3)
nsubj(demonstrated-6, compound-4)
advmod(demonstrated-6, also-5)
root(ROOT-0, demonstrated-6)
advmod(demonstrated-6, efficacy-7)
mark(reducing-9, in-8)
advcl(demonstrated-6, reducing-9)
dobj(reducing-9, photophobia-10)
case(%-13, by-11)
nummod(%-13, 17-12)
nmod:by(reducing-9, %-13)
nummod(%-16, 95-15)
nsubj(CI-17, %-16)
parataxis(demonstrated-6, CI-17)
nummod(%-19, 12-22-18)
dobj(CI-17, %-19)
nsubj(<-22, P-21)
dep(CI-17, <-22)
dobj(<-22, 0.0001-23)
cc(demonstrated-6, and-25)
conj:and(demonstrated-6, phonophobia-26)
case(%-29, by-27)
nummod(%-29, 14-28)
nmod:by(phonophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 17-20-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)

These/DT findings/NNS suggest/VBP that/IN FR247304/NNP may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN the/DT treatment/NN of/IN ischemic_brain_damage/JJ and/CC associated/VBN symptoms/NNS ,/, although/IN further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC evaluate/VB its/PRP$ safety/NN and/CC efficacy/NN in/IN clinical/JJ settings/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP FR247304))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN treatment))
                      (PP (IN of)
                        (NP
                          (ADJP (JJ ischemic_brain_damage)
                            (CC and)
                            (VBN associated))
                          (NNS symptoms)))))))))))
      (, ,)
      (SBAR (IN although)
        (S
          (NP (JJ further) (NNS studies))
          (VP (VBP are)
            (VP (VBN needed)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB confirm)
                      (NP (DT these) (NNS results)))
                    (CC and)
                    (VP (VB evaluate)
                      (NP (PRP$ its) (NN safety)
                        (CC and)
                        (NN efficacy))
                      (PP (IN in)
                        (NP (JJ clinical) (NNS settings))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, FR247304-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(have-7, agent-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(agent-12, treatment-15)
case(symptoms-20, of-16)
amod(symptoms-20, ischemic_brain_damage-17)
cc(ischemic_brain_damage-17, and-18)
conj:and(ischemic_brain_damage-17, associated-19)
amod(symptoms-20, associated-19)
nmod:of(treatment-15, symptoms-20)
mark(needed-26, although-22)
amod(studies-24, further-23)
nsubjpass(needed-26, studies-24)
nsubj:xsubj(confirm-28, studies-24)
nsubj:xsubj(evaluate-32, studies-24)
auxpass(needed-26, are-25)
advcl(suggest-3, needed-26)
mark(confirm-28, to-27)
xcomp(needed-26, confirm-28)
det(results-30, these-29)
dobj(confirm-28, results-30)
cc(confirm-28, and-31)
xcomp(needed-26, evaluate-32)
conj:and(confirm-28, evaluate-32)
nmod:poss(safety-34, its-33)
dobj(evaluate-32, safety-34)
cc(safety-34, and-35)
dobj(evaluate-32, efficacy-36)
conj:and(safety-34, efficacy-36)
case(settings-39, in-37)
amod(settings-39, clinical-38)
nmod:in(evaluate-32, settings-39)

Somatostatin/NNP is_a/NNP peptide/VBD hormone/NN that/WDT regulates/VBZ various/JJ physiological/JJ functions/NNS ,/, including/VBG the/DT inhibition/NN of/IN growth_hormone/JJ release/NN ,/, insulin_secretion/NN ,/, and/CC gut/NN motility/NN ./.

(ROOT
  (S
    (NP (NNP Somatostatin) (NNP is_a))
    (VP (VBD peptide)
      (NP
        (NP (NN hormone))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ regulates)
              (NP
                (NP (JJ various) (JJ physiological) (NNS functions))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (DT the) (NN inhibition))
                    (PP (IN of)
                      (NP
                        (NP (JJ growth_hormone) (NN release))
                        (, ,)
                        (NP (NN insulin_secretion))
                        (, ,)
                        (CC and)
                        (NP (NN gut) (NN motility))))))))))))
    (. .)))

compound(is_a-2, Somatostatin-1)
nsubj(peptide-3, is_a-2)
root(ROOT-0, peptide-3)
dobj(peptide-3, hormone-4)
nsubj(regulates-6, hormone-4)
ref(hormone-4, that-5)
acl:relcl(hormone-4, regulates-6)
amod(functions-9, various-7)
amod(functions-9, physiological-8)
dobj(regulates-6, functions-9)
acl(functions-9, including-11)
det(inhibition-13, the-12)
dobj(including-11, inhibition-13)
case(release-16, of-14)
amod(release-16, growth_hormone-15)
nmod:of(inhibition-13, release-16)
nmod:of(inhibition-13, insulin_secretion-18)
conj:and(release-16, insulin_secretion-18)
cc(release-16, and-20)
compound(motility-22, gut-21)
nmod:of(inhibition-13, motility-22)
conj:and(release-16, motility-22)

The/DT somatostatin_receptor_4/NNP -LRB-/-LRB- SSTR-4/NNP -RRB-/-RRB- is/VBZ expressed/VBN in/IN several/JJ tissues/NNS ,/, including/VBG the/DT gastrointestinal/JJ tract/NN ,/, pancreas/NN ,/, and/CC brain/NN ./.

(ROOT
  (S
    (NP (DT The) (NNP somatostatin_receptor_4) (-LRB- -LRB-) (NNP SSTR-4) (-RRB- -RRB-))
    (VP (VBZ is)
      (VP (VBN expressed)
        (PP (IN in)
          (NP
            (NP (JJ several) (NNS tissues))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (DT the) (JJ gastrointestinal) (NN tract))
                (, ,)
                (NP (NN pancreas))
                (, ,)
                (CC and)
                (NP (NN brain))))))))
    (. .)))

det(SSTR-4-4, The-1)
compound(SSTR-4-4, somatostatin_receptor_4-2)
nsubjpass(expressed-7, SSTR-4-4)
auxpass(expressed-7, is-6)
root(ROOT-0, expressed-7)
case(tissues-10, in-8)
amod(tissues-10, several-9)
nmod:in(expressed-7, tissues-10)
acl(tissues-10, including-12)
det(tract-15, the-13)
amod(tract-15, gastrointestinal-14)
dobj(including-12, tract-15)
dobj(including-12, pancreas-17)
conj:and(tract-15, pancreas-17)
cc(tract-15, and-19)
dobj(including-12, brain-20)
conj:and(tract-15, brain-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT plasma/NN concentration/NN of/IN rSSTR-4/JJ during/IN intraduodenal/JJ administration/NN of/IN J-2156/NN or/CC long-chain/NN triglyceride/NN compared/VBN to/TO IV/NNP administration/NN of/IN rSSTR-4/JJ at/IN 100/CD pmol/kg-h/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN plasma) (NN concentration))
        (PP (IN of)
          (NP
            (ADJP (JJ rSSTR-4)
              (PP (IN during)
                (NP
                  (NP (JJ intraduodenal) (NN administration))
                  (PP (IN of)
                    (NP (NN J-2156)
                      (CC or)
                      (NN long-chain))))))
            (NN triglyceride))))
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP (NNP IV) (NN administration))
            (PP (IN of)
              (NP
                (ADJP (JJ rSSTR-4)
                  (PP (IN at)
                    (NP (CD 100))))
                (NN pmol/kg-h)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(concentration-9, the-7)
compound(concentration-9, plasma-8)
dobj(investigated-6, concentration-9)
case(triglyceride-19, of-10)
amod(triglyceride-19, rSSTR-4-11)
case(administration-14, during-12)
amod(administration-14, intraduodenal-13)
nmod:during(rSSTR-4-11, administration-14)
case(J-2156-16, of-15)
nmod:of(administration-14, J-2156-16)
cc(J-2156-16, or-17)
nmod:of(administration-14, long-chain-18)
conj:or(J-2156-16, long-chain-18)
nmod:of(concentration-9, triglyceride-19)
case(administration-23, compared-20)
mwe(compared-20, to-21)
compound(administration-23, IV-22)
advcl(investigated-6, administration-23)
case(pmol/kg-h-28, of-24)
amod(pmol/kg-h-28, rSSTR-4-25)
case(100-27, at-26)
nmod:at(rSSTR-4-25, 100-27)
nmod:of(administration-23, pmol/kg-h-28)

The/DT results/NNS showed/VBD that/IN the/DT plasma/NN concentration/NN of/IN rSSTR-4/JJ during/IN intraduodenal/NN administration/NN of/IN J-2156/NN -LRB-/-LRB- 150/CD +/NNS //: -/:

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (FRAG
          (NP
            (NP (DT the) (NN plasma) (NN concentration))
            (PP (IN of)
              (NP
                (ADJP (JJ rSSTR-4)
                  (PP (IN during)
                    (NP (NN intraduodenal))))
                (NN administration)))
            (PP (IN of)
              (NP
                (NP (NN J-2156))
                (-LRB- -LRB-)
                (NP (CD 150) (NNS +))
                (: /)))))))
    (: -)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(concentration-7, that-4)
det(concentration-7, the-5)
compound(concentration-7, plasma-6)
dep(showed-3, concentration-7)
case(administration-12, of-8)
amod(administration-12, rSSTR-4-9)
case(intraduodenal-11, during-10)
nmod:during(rSSTR-4-9, intraduodenal-11)
nmod:of(concentration-7, administration-12)
case(J-2156-14, of-13)
nmod:of(concentration-7, J-2156-14)
nummod(+-17, 150-16)
dep(J-2156-14, +-17)

20/CD pg/ml/JJ -RRB-/-RRB- or/CC long-chain/JJ triglyceride/NN -LRB-/-LRB- 187/CD +/CD //: -/:

(ROOT
  (NP
    (NP
      (NP
        (NP (CD 20))
        (PRN
          (NP (JJ pg/ml)))
        (-RRB- -RRB-))
      (CC or)
      (NP
        (NP (JJ long-chain) (NN triglyceride))
        (-LRB- -LRB-)
        (NP
          (QP (CD 187) (CD +)))
        (: /)))
    (: -)))

root(ROOT-0, 20-1)
dep(20-1, pg/ml-2)
cc(20-1, or-4)
amod(triglyceride-6, long-chain-5)
conj:or(20-1, triglyceride-6)
compound(+-9, 187-8)
dep(triglyceride-6, +-9)

37/CD pg/ml/CD -RRB-/-RRB- was/VBD similar/JJ to/TO the/DT plasma/NN concentration/NN of/IN rSSTR-4/JJ obtained/VBN during/IN IV/NNP administration/NN ./.

(ROOT
  (S
    (S
      (ADVP
        (NP
          (QP (CD 37)))
        (PRN
          (NP
            (QP (CD pg/ml)))
          (-RRB- -RRB-))))
    (VP (VBD was)
      (ADJP (JJ similar)
        (PP (TO to)
          (NP
            (NP (DT the) (NN plasma) (NN concentration))
            (PP (IN of)
              (NP (JJ rSSTR-4))))))
      (PP (VBN obtained)
        (PP (IN during)
          (NP (NNP IV) (NN administration)))))
    (. .)))

csubj(similar-5, 37-1)
dep(37-1, pg/ml-2)
cop(similar-5, was-4)
root(ROOT-0, similar-5)
case(concentration-9, to-6)
det(concentration-9, the-7)
compound(concentration-9, plasma-8)
nmod:to(similar-5, concentration-9)
case(rSSTR-4-11, of-10)
nmod:of(concentration-9, rSSTR-4-11)
case(administration-15, obtained-12)
case(administration-15, during-13)
compound(administration-15, IV-14)
advcl(similar-5, administration-15)

These/DT findings/NNS suggest/VBP that/IN intraduodenal/JJ administration/NN of/IN J-2156/JJ or/CC long-chain/JJ triglyceride/NN does/VBZ not/RB affect/VB the/DT circulating/VBG levels/NNS of/IN rSSTR-4/JJ and/CC may/MD be/VB a/DT viable/JJ alternative/NN to/TO IV/NNP administration/NN for/IN future/JJ studies/NNS investigating/VBG SSTR-4/JJ function/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ intraduodenal) (NN administration))
            (PP (IN of)
              (NP
                (ADJP (JJ J-2156)
                  (CC or)
                  (JJ long-chain))
                (NN triglyceride))))
          (VP
            (VP (VBZ does) (RB not)
              (VP (VB affect)
                (NP
                  (NP (DT the) (VBG circulating) (NNS levels))
                  (PP (IN of)
                    (NP (JJ rSSTR-4))))))
            (CC and)
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ viable) (NN alternative))
                  (PP (TO to)
                    (NP (NNP IV) (NN administration))))
                (PP (IN for)
                  (NP
                    (NP (JJ future) (NNS studies))
                    (VP (VBG investigating)
                      (NP (JJ SSTR-4) (NN function)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(affect-14, that-4)
amod(administration-6, intraduodenal-5)
nsubj(affect-14, administration-6)
case(triglyceride-11, of-7)
amod(triglyceride-11, J-2156-8)
cc(J-2156-8, or-9)
conj:or(J-2156-8, long-chain-10)
amod(triglyceride-11, long-chain-10)
nmod:of(administration-6, triglyceride-11)
aux(affect-14, does-12)
neg(affect-14, not-13)
ccomp(suggest-3, affect-14)
det(levels-17, the-15)
amod(levels-17, circulating-16)
dobj(affect-14, levels-17)
case(rSSTR-4-19, of-18)
nmod:of(levels-17, rSSTR-4-19)
cc(affect-14, and-20)
aux(alternative-25, may-21)
cop(alternative-25, be-22)
det(alternative-25, a-23)
amod(alternative-25, viable-24)
ccomp(suggest-3, alternative-25)
conj:and(affect-14, alternative-25)
case(administration-28, to-26)
compound(administration-28, IV-27)
nmod:to(alternative-25, administration-28)
case(studies-31, for-29)
amod(studies-31, future-30)
nmod:for(alternative-25, studies-31)
acl(studies-31, investigating-32)
amod(function-34, SSTR-4-33)
dobj(investigating-32, function-34)

Social_phobia/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN are/VBP common/JJ anxiety_disorders/NNS that/WDT can/MD significantly/RB impair/VB an/DT individual/NN 's/POS quality_of_life/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Social_phobia))
      (, ,)
      (NP (NN photophobia))
      (, ,)
      (CC and)
      (NP (NN phonophobia)))
    (VP (VBP are)
      (NP
        (NP (JJ common) (NNS anxiety_disorders))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (MD can) (RB significantly)
              (VP (VB impair)
                (NP
                  (NP (DT an) (NN individual) (POS 's))
                  (NN quality_of_life))))))))
    (. .)))

nsubj(anxiety_disorders-9, Social_phobia-1)
conj:and(Social_phobia-1, photophobia-3)
nsubj(anxiety_disorders-9, photophobia-3)
cc(Social_phobia-1, and-5)
conj:and(Social_phobia-1, phonophobia-6)
nsubj(anxiety_disorders-9, phonophobia-6)
cop(anxiety_disorders-9, are-7)
amod(anxiety_disorders-9, common-8)
root(ROOT-0, anxiety_disorders-9)
nsubj(impair-13, anxiety_disorders-9)
ref(anxiety_disorders-9, that-10)
aux(impair-13, can-11)
advmod(impair-13, significantly-12)
acl:relcl(anxiety_disorders-9, impair-13)
det(individual-15, an-14)
nmod:poss(quality_of_life-17, individual-15)
case(individual-15, 's-16)
dobj(impair-13, quality_of_life-17)

Various/JJ pharmacological/JJ interventions/NNS have/VBP been/VBN developed/VBN to/TO alleviate/VB the/DT symptoms/NNS of/IN these/DT disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Various) (JJ pharmacological) (NNS interventions))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN developed)
          (S
            (VP (TO to)
              (VP (VB alleviate)
                (NP
                  (NP (DT the) (NNS symptoms))
                  (PP (IN of)
                    (NP (DT these) (NNS disorders))))))))))
    (. .)))

amod(interventions-3, Various-1)
amod(interventions-3, pharmacological-2)
nsubjpass(developed-6, interventions-3)
nsubj:xsubj(alleviate-8, interventions-3)
aux(developed-6, have-4)
auxpass(developed-6, been-5)
root(ROOT-0, developed-6)
mark(alleviate-8, to-7)
xcomp(developed-6, alleviate-8)
det(symptoms-10, the-9)
dobj(alleviate-8, symptoms-10)
case(disorders-13, of-11)
det(disorders-13, these-12)
nmod:of(symptoms-10, disorders-13)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN CL285032/NNP ,/, a/DT novel/JJ anxiolytic/JJ drug/NN ,/, on/IN social_phobia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NNP CL285032))
          (, ,)
          (NP (DT a) (JJ novel) (JJ anxiolytic) (NN drug))
          (, ,)))
      (PP (IN on)
        (NP
          (NP (NN social_phobia))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-23, study-3)
det(effects-6, the-5)
nsubjpass(investigated-23, effects-6)
case(CL285032-8, of-7)
nmod:of(effects-6, CL285032-8)
det(drug-13, a-10)
amod(drug-13, novel-11)
amod(drug-13, anxiolytic-12)
appos(CL285032-8, drug-13)
case(social_phobia-16, on-15)
nmod:on(effects-6, social_phobia-16)
nmod:on(effects-6, photophobia-18)
conj:and(social_phobia-16, photophobia-18)
cc(social_phobia-16, and-20)
nmod:on(effects-6, phonophobia-21)
conj:and(social_phobia-16, phonophobia-21)
auxpass(investigated-23, were-22)
root(ROOT-0, investigated-23)

The/DT randomized_controlled_trial/NN involved/VBD administering/VBG a/DT single/JJ dose/NN of/IN CL285032/NNP to/TO a/DT group/NN of/IN participants/NNS suffering/VBG from/IN these/DT anxiety_disorders/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN randomized_controlled_trial))
    (VP (VBD involved)
      (VP (VBG administering)
        (NP
          (NP (DT a) (JJ single) (NN dose))
          (PP (IN of)
            (NP (NNP CL285032))))
        (PP (TO to)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP (NNS participants)))))
        (S
          (VP (VBG suffering)
            (PP (IN from)
              (NP (DT these) (NNS anxiety_disorders)))))))
    (. .)))

det(randomized_controlled_trial-2, The-1)
nsubj(involved-3, randomized_controlled_trial-2)
root(ROOT-0, involved-3)
xcomp(involved-3, administering-4)
det(dose-7, a-5)
amod(dose-7, single-6)
dobj(administering-4, dose-7)
case(CL285032-9, of-8)
nmod:of(dose-7, CL285032-9)
case(group-12, to-10)
det(group-12, a-11)
nmod:to(administering-4, group-12)
case(participants-14, of-13)
nmod:of(group-12, participants-14)
advcl(administering-4, suffering-15)
case(anxiety_disorders-18, from-16)
det(anxiety_disorders-18, these-17)
nmod:from(suffering-15, anxiety_disorders-18)

At_2/JJ h/NN after/IN dosing/VBG ,/, the/DT drug/NN was/VBD found/VBD to/TO reduce/VB the/DT risk/NN of/IN social_phobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (DT the) (NN drug))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NN social_phobia))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(h-2, At_2-1)
dep(found-9, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
det(drug-7, the-6)
nsubjpass(found-9, drug-7)
nsubj:xsubj(reduce-11, drug-7)
nsubj(photophobia-31, drug-7)
nsubj(phonophobia-48, drug-7)
auxpass(found-9, was-8)
root(ROOT-0, found-9)
mark(reduce-11, to-10)
xcomp(found-9, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(social_phobia-15, of-14)
nmod:of(risk-13, social_phobia-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-9, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-9, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-9, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-9, and-47)
conj:and(found-9, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-9, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT results/NNS suggest/VBP that/IN CL285032/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN individuals/NNS with/IN social_phobia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP CL285032))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP
                        (NP (NN social_phobia))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, CL285032-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
case(social_phobia-15, with-14)
nmod:with(individuals-13, social_phobia-15)
nmod:with(individuals-13, photophobia-17)
conj:and(social_phobia-15, photophobia-17)
cc(social_phobia-15, and-19)
nmod:with(individuals-13, phonophobia-20)
conj:and(social_phobia-15, phonophobia-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ efficacy/NN and/CC safety/NN profile/NN of/IN this/DT drug/NN in/IN treating/VBG anxiety_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NN efficacy))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (DT this) (NN drug)))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP (NNS anxiety_disorders))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(efficacy-9, the-7)
amod(efficacy-9, long-term-8)
dobj(investigate-6, efficacy-9)
cc(efficacy-9, and-10)
compound(profile-12, safety-11)
dobj(investigate-6, profile-12)
conj:and(efficacy-9, profile-12)
case(drug-15, of-13)
det(drug-15, this-14)
nmod:of(profile-12, drug-15)
mark(treating-17, in-16)
advcl(investigate-6, treating-17)
dobj(treating-17, anxiety_disorders-18)

Cell/JJ differentiation/NN is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN various/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN programs/NNS ./.

(ROOT
  (S
    (NP (JJ Cell) (NN differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ various) (VBG signaling) (NNS pathways))
                    (CC and)
                    (NP (NN gene) (NN expression) (NNS programs))))))))))
    (. .)))

amod(differentiation-2, Cell-1)
nsubj(is_a-3, differentiation-2)
root(ROOT-0, is_a-3)
amod(process-5, complex-4)
dobj(is_a-3, process-5)
nsubj(involves-7, process-5)
ref(process-5, that-6)
acl:relcl(process-5, involves-7)
det(activation-9, the-8)
dobj(involves-7, activation-9)
case(pathways-13, of-10)
amod(pathways-13, various-11)
amod(pathways-13, signaling-12)
nmod:of(activation-9, pathways-13)
cc(pathways-13, and-14)
compound(programs-17, gene-15)
compound(programs-17, expression-16)
nmod:of(activation-9, programs-17)
conj:and(pathways-13, programs-17)

AVN-944/NNP ,/, a/DT small/JJ molecule/NN inhibitor/NN of/IN inosine_monophosphate/JJ dehydrogenase/NN ,/, has_been/NN shown/VBN to/TO modulate/VBP cell/NN death/NN pathways/NNS and/CC promote/VB cell/NN survival/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP AVN-944))
      (, ,)
      (NP
        (NP (DT a) (JJ small) (NN molecule) (NN inhibitor))
        (PP (IN of)
          (NP
            (NP (JJ inosine_monophosphate) (NN dehydrogenase))
            (, ,)
            (NP
              (NP (NN has_been))
              (VP (VBN shown)
                (PP (TO to))))))))
    (VP
      (VP (VBP modulate)
        (NP (NN cell) (NN death) (NNS pathways)))
      (CC and)
      (VP (VB promote)
        (NP (NN cell) (NN survival))))
    (. .)))

nsubj(modulate-14, AVN-944-1)
nsubj(promote-19, AVN-944-1)
det(inhibitor-6, a-3)
amod(inhibitor-6, small-4)
compound(inhibitor-6, molecule-5)
appos(AVN-944-1, inhibitor-6)
case(dehydrogenase-9, of-7)
amod(dehydrogenase-9, inosine_monophosphate-8)
nmod:of(inhibitor-6, dehydrogenase-9)
appos(dehydrogenase-9, has_been-11)
acl(has_been-11, shown-12)
nmod(shown-12, to-13)
root(ROOT-0, modulate-14)
compound(pathways-17, cell-15)
compound(pathways-17, death-16)
dobj(modulate-14, pathways-17)
cc(modulate-14, and-18)
conj:and(modulate-14, promote-19)
compound(survival-21, cell-20)
dobj(promote-19, survival-21)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN AVN-944/JJ on/IN the/DT expression/NN and/CC stability/NN of/IN Bcl-2-related_ovarian_killer/NNS -LRB-/-LRB- Bok/NNP -RRB-/-RRB- protein/NN during/IN C2C12/NNP cell/NN differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (ADJP (JJ AVN-944)
              (PP (IN on)
                (NP
                  (NP
                    (NP (DT the) (NN expression)
                      (CC and)
                      (NN stability))
                    (PP (IN of)
                      (NP (NNS Bcl-2-related_ovarian_killer))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Bok))
                    (-RRB- -RRB-)))))
            (NN protein))))
      (PP (IN during)
        (NP (NNP C2C12) (NN cell) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(protein-21, of-9)
amod(protein-21, AVN-944-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(AVN-944-10, expression-13)
cc(expression-13, and-14)
nmod:on(AVN-944-10, stability-15)
conj:and(expression-13, stability-15)
case(Bcl-2-related_ovarian_killer-17, of-16)
nmod:of(expression-13, Bcl-2-related_ovarian_killer-17)
appos(expression-13, Bok-19)
nmod:of(effect-8, protein-21)
case(differentiation-25, during-22)
compound(differentiation-25, C2C12-23)
compound(differentiation-25, cell-24)
nmod:during(investigated-6, differentiation-25)

When/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, AVN-944/NNP up-regulated/JJ Bok/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ Bok/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNP C2C12) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (NP
              (NP (NN in_a) (NN medium))
              (PP (VBG favoring)
                (NP
                  (NP (NN differentiation))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Dulbecco))
                      (VP (VBN modified)
                        (NP (NNP Eagle) (NN medium))
                        (S
                          (VP (VBG containing)
                            (NP
                              (ADJP (CD 2) (NN %))
                              (NN horse) (NN serum))))))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (NP (NNP AVN-944)
      (NX
        (NX
          (NX (JJ up-regulated) (NNP Bok) (NN protein) (NNS levels) (NN in_a))
          (NP (JJ time-dependent) (NN manner)))
        (CC and)
        (NX (JJ prolonged) (NNP Bok) (NN protein))))
    (VP (NN half-life)
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
advcl(half-life-34, cultured-5)
compound(medium-7, in_a-6)
dobj(cultured-5, medium-7)
case(differentiation-9, favoring-8)
nmod:favoring(medium-7, differentiation-9)
dep(differentiation-9, Dulbecco-11)
acl(Dulbecco-11, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
xcomp(modified-12, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
dep(in_a-27, AVN-944-22)
amod(in_a-27, up-regulated-23)
compound(in_a-27, Bok-24)
compound(in_a-27, protein-25)
compound(in_a-27, levels-26)
nsubj(half-life-34, in_a-27)
amod(manner-29, time-dependent-28)
dep(in_a-27, manner-29)
cc(in_a-27, and-30)
amod(protein-33, prolonged-31)
compound(protein-33, Bok-32)
conj:and(in_a-27, protein-33)
nsubj(half-life-34, protein-33)
root(ROOT-0, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(half-life-34, hours-39)

These/DT findings/NNS suggest/VBP that/IN AVN-944/NNP may/MD play/VB a/DT role/NN in/IN promoting/VBG muscle/NN cell/NN survival/NN during/IN differentiation/NN by/IN modulating/VBG the/DT expression/NN and/CC stability/NN of/IN Bok/NNP protein/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP AVN-944))
          (VP (MD may)
            (VP (VB play)
              (NP (DT a) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG promoting)
                    (NP (NN muscle) (NN cell) (NN survival))
                    (PP (IN during)
                      (NP (NN differentiation))))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (DT the) (NN expression)
                        (CC and)
                        (NN stability))
                      (PP (IN of)
                        (NP (NNP Bok) (NN protein))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, AVN-944-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(promoting-11, in-10)
advcl(play-7, promoting-11)
compound(survival-14, muscle-12)
compound(survival-14, cell-13)
dobj(promoting-11, survival-14)
case(differentiation-16, during-15)
nmod:during(promoting-11, differentiation-16)
mark(modulating-18, by-17)
advcl(play-7, modulating-18)
det(expression-20, the-19)
dobj(modulating-18, expression-20)
cc(expression-20, and-21)
dobj(modulating-18, stability-22)
conj:and(expression-20, stability-22)
case(protein-25, of-23)
compound(protein-25, Bok-24)
nmod:of(expression-20, protein-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/JJ molecular/JJ mechanisms/NNS and/CC potential/JJ therapeutic/JJ applications/NNS of/IN AVN-944/NN in/IN muscle_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ underlying) (JJ molecular) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP
                      (NP (NN AVN-944))
                      (PP (IN in)
                        (NP (NNS muscle_disorders))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-10, the-7)
amod(mechanisms-10, underlying-8)
amod(mechanisms-10, molecular-9)
dobj(elucidate-6, mechanisms-10)
cc(mechanisms-10, and-11)
amod(applications-14, potential-12)
amod(applications-14, therapeutic-13)
dobj(elucidate-6, applications-14)
conj:and(mechanisms-10, applications-14)
case(AVN-944-16, of-15)
nmod:of(applications-14, AVN-944-16)
case(muscle_disorders-18, in-17)
nmod:in(AVN-944-16, muscle_disorders-18)

Abstract/NNP :/: Atiprimod/NNP is_a/NNP small/JJ molecule/NN drug/NN that/WDT has_been/VBP shown/VBN to/TO have/VB therapeutic/JJ potential/NN for/IN various_diseases/NNS ,/, including/VBG cancer/NN and/CC autoimmune_disorders/NNS ./.

(ROOT
  (NP
    (NP (NNP Abstract))
    (: :)
    (NP
      (NP (NNP Atiprimod) (NNP is_a) (JJ small) (NN molecule) (NN drug))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB have)
                    (NP
                      (NP (JJ therapeutic) (NN potential))
                      (PP (IN for)
                        (NP
                          (NP (NNS various_diseases))
                          (, ,)
                          (VP (VBG including)
                            (NP (NN cancer)
                              (CC and)
                              (NNS autoimmune_disorders))))))))))))))
    (. .)))

root(ROOT-0, Abstract-1)
compound(drug-7, Atiprimod-3)
compound(drug-7, is_a-4)
amod(drug-7, small-5)
compound(drug-7, molecule-6)
dep(Abstract-1, drug-7)
nsubj(has_been-9, drug-7)
ref(drug-7, that-8)
acl:relcl(drug-7, has_been-9)
dep(has_been-9, shown-10)
mark(have-12, to-11)
xcomp(shown-10, have-12)
amod(potential-14, therapeutic-13)
dobj(have-12, potential-14)
case(various_diseases-16, for-15)
nmod:for(potential-14, various_diseases-16)
acl(various_diseases-16, including-18)
dobj(including-18, cancer-19)
cc(cancer-19, and-20)
dobj(including-18, autoimmune_disorders-21)
conj:and(cancer-19, autoimmune_disorders-21)

The/DT synthesis/NN of/IN Atiprimod/NNP involves/VBZ the/DT expression/NN of/IN several/JJ genes/NNS ,/, including/VBG peroxisome_proliferator-activated_receptor-y/JJ -LRB-/-LRB- PPAR-y/NNP -RRB-/-RRB- ,/, CCAAT/enhancer/NNP binding_protein-a/NNP -LRB-/-LRB- CEBP-a/JJ -RRB-/-RRB- ,/, adipocyte_protein_2/JJ -LRB-/-LRB- aP2/JJ -RRB-/-RRB- ,/, acetyl-CoA_carboxylase/JJ -LRB-/-LRB- ACC/NNP -RRB-/-RRB- ,/, Atiprimod/JJ synthase/JJ -LRB-/-LRB- phosphoribosylformylglycinamidine_synthase/JJ -RRB-/-RRB- ,/, and/CC stearoylcoenzyme_A/NN desaturase-1/JJ -LRB-/-LRB- SCD-1/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN synthesis))
      (PP (IN of)
        (NP (NNP Atiprimod))))
    (VP (VBZ involves)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP (JJ several) (NNS genes))))
      (, ,)
      (S
        (VP (VBG including)
          (ADJP
            (ADJP (JJ peroxisome_proliferator-activated_receptor-y))
            (PRN (-LRB- -LRB-)
              (NP (NNP PPAR-y))
              (-RRB- -RRB-))
            (, ,)
            (ADJP (NNP CCAAT/enhancer) (NNP binding_protein-a))
            (PRN (-LRB- -LRB-)
              (ADJP (JJ CEBP-a))
              (-RRB- -RRB-))
            (, ,)
            (ADJP (JJ adipocyte_protein_2))
            (PRN (-LRB- -LRB-)
              (ADJP (JJ aP2))
              (-RRB- -RRB-))
            (, ,)
            (ADJP (JJ acetyl-CoA_carboxylase))
            (PRN (-LRB- -LRB-)
              (NP (NNP ACC))
              (-RRB- -RRB-))
            (, ,)
            (ADJP (JJ Atiprimod) (JJ synthase))
            (PRN (-LRB- -LRB-)
              (ADJP (JJ phosphoribosylformylglycinamidine_synthase))
              (-RRB- -RRB-))
            (, ,)
            (CC and)
            (ADJP (NN stearoylcoenzyme_A) (JJ desaturase-1))
            (PRN (-LRB- -LRB-)
              (NP (NNP SCD-1))
              (-RRB- -RRB-))))))
    (. .)))

det(synthesis-2, The-1)
nsubj(involves-5, synthesis-2)
case(Atiprimod-4, of-3)
nmod:of(synthesis-2, Atiprimod-4)
root(ROOT-0, involves-5)
det(expression-7, the-6)
dobj(involves-5, expression-7)
case(genes-10, of-8)
amod(genes-10, several-9)
nmod:of(expression-7, genes-10)
advcl(involves-5, including-12)
xcomp(including-12, peroxisome_proliferator-activated_receptor-y-13)
dep(peroxisome_proliferator-activated_receptor-y-13, PPAR-y-15)
amod(binding_protein-a-19, CCAAT/enhancer-18)
xcomp(including-12, binding_protein-a-19)
conj:and(peroxisome_proliferator-activated_receptor-y-13, binding_protein-a-19)
dep(peroxisome_proliferator-activated_receptor-y-13, CEBP-a-21)
xcomp(including-12, adipocyte_protein_2-24)
conj:and(peroxisome_proliferator-activated_receptor-y-13, adipocyte_protein_2-24)
dep(peroxisome_proliferator-activated_receptor-y-13, aP2-26)
xcomp(including-12, acetyl-CoA_carboxylase-29)
conj:and(peroxisome_proliferator-activated_receptor-y-13, acetyl-CoA_carboxylase-29)
dep(peroxisome_proliferator-activated_receptor-y-13, ACC-31)
amod(synthase-35, Atiprimod-34)
xcomp(including-12, synthase-35)
conj:and(peroxisome_proliferator-activated_receptor-y-13, synthase-35)
dep(peroxisome_proliferator-activated_receptor-y-13, phosphoribosylformylglycinamidine_synthase-37)
cc(peroxisome_proliferator-activated_receptor-y-13, and-40)
nmod:npmod(desaturase-1-42, stearoylcoenzyme_A-41)
xcomp(including-12, desaturase-1-42)
conj:and(peroxisome_proliferator-activated_receptor-y-13, desaturase-1-42)
dep(peroxisome_proliferator-activated_receptor-y-13, SCD-1-44)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN TBEs/NNP on/IN the/DT mRNA/JJ levels/NNS of/IN these/DT genes/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP TBEs))))
      (PP (IN on)
        (NP
          (NP (DT the) (JJ mRNA) (NNS levels))
          (PP (IN of)
            (NP (DT these) (NNS genes))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(TBEs-10, of-9)
nmod:of(effect-8, TBEs-10)
case(levels-14, on-11)
det(levels-14, the-12)
amod(levels-14, mRNA-13)
nmod:on(investigated-6, levels-14)
case(genes-17, of-15)
det(genes-17, these-16)
nmod:of(levels-14, genes-17)

Our/PRP$ results/NNS showed/VBD that/IN TBEs/NNP suppressed/VBD the/DT expression/NN of/IN these/DT genes/NNS involved/VBN in/IN Atiprimod/NNP synthesis/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP TBEs))
          (VP (VBD suppressed)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (NP (DT these) (NNS genes))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (NNP Atiprimod) (NN synthesis)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(suppressed-6, that-4)
nsubj(suppressed-6, TBEs-5)
ccomp(showed-3, suppressed-6)
det(expression-8, the-7)
dobj(suppressed-6, expression-8)
case(genes-11, of-9)
det(genes-11, these-10)
nmod:of(expression-8, genes-11)
acl(genes-11, involved-12)
case(synthesis-15, in-13)
compound(synthesis-15, Atiprimod-14)
nmod:in(involved-12, synthesis-15)

These/DT findings/NNS suggest/VBP that/IN TBEs/NNP may/MD have/VB potential/JJ as/IN a/DT natural/JJ product-based/JJ therapeutic/JJ agent/NN for/IN diseases/NNS that/WDT can/MD be/VB treated/VBN with/IN Atiprimod/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP TBEs))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ natural) (JJ product-based) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP
                      (NP (NNS diseases))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (MD can)
                            (VP (VB be)
                              (VP (VBN treated)
                                (PP (IN with)
                                  (NP (NNP Atiprimod)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, TBEs-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
xcomp(have-7, potential-8)
case(agent-14, as-9)
det(agent-14, a-10)
amod(agent-14, natural-11)
amod(agent-14, product-based-12)
amod(agent-14, therapeutic-13)
nmod:as(have-7, agent-14)
case(diseases-16, for-15)
nmod:for(agent-14, diseases-16)
nsubjpass(treated-20, diseases-16)
ref(diseases-16, that-17)
aux(treated-20, can-18)
auxpass(treated-20, be-19)
acl:relcl(diseases-16, treated-20)
case(Atiprimod-22, with-21)
nmod:with(treated-20, Atiprimod-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG the/DT effects/NNS of/IN TBEs/NNP on/IN gene/NN expression/NN and/CC their/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ molecular) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP (NNP TBEs))))))
              (PP (IN on)
                (NP
                  (NP (NN gene) (NN expression))
                  (CC and)
                  (NP (PRP$ their) (JJ potential) (JJ clinical) (NNS applications)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, the-11)
dobj(underlying-10, effects-12)
case(TBEs-14, of-13)
nmod:of(effects-12, TBEs-14)
case(expression-17, on-15)
compound(expression-17, gene-16)
nmod:on(elucidate-6, expression-17)
cc(expression-17, and-18)
nmod:poss(applications-22, their-19)
amod(applications-22, potential-20)
amod(applications-22, clinical-21)
nmod:on(elucidate-6, applications-22)
conj:and(expression-17, applications-22)

Heart_failure/NNP -LRB-/-LRB- HF/NNP -RRB-/-RRB- is_a/VBD common/JJ and/CC serious/JJ condition/NN that/WDT can/MD lead/VB to/TO the/DT development/NN of/IN life-threatening/JJ complications/NNS such/JJ as/IN coronary_artery_thrombosis/NNS ./.

(ROOT
  (S
    (NP (NNP Heart_failure) (-LRB- -LRB-)
      (NP (NNP HF))
      (-RRB- -RRB-))
    (VP (VBD is_a)
      (NP
        (ADJP (JJ common)
          (CC and)
          (JJ serious))
        (NN condition)
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (MD can)
              (VP (VB lead)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (JJ life-threatening) (NNS complications))
                        (PP (JJ such) (IN as)
                          (NP (NNS coronary_artery_thrombosis)))))))))))))
    (. .)))

nsubj(is_a-5, Heart_failure-1)
dep(Heart_failure-1, HF-3)
root(ROOT-0, is_a-5)
amod(condition-9, common-6)
cc(common-6, and-7)
conj:and(common-6, serious-8)
amod(condition-9, serious-8)
dobj(is_a-5, condition-9)
nsubj(lead-12, that-10)
aux(lead-12, can-11)
ccomp(condition-9, lead-12)
case(development-15, to-13)
det(development-15, the-14)
nmod:to(lead-12, development-15)
case(complications-18, of-16)
amod(complications-18, life-threatening-17)
nmod:of(development-15, complications-18)
case(coronary_artery_thrombosis-21, such-19)
mwe(such-19, as-20)
nmod:such_as(complications-18, coronary_artery_thrombosis-21)

HS-6/NNP is_a/VBZ novel/JJ therapeutic/JJ agent/NN that/WDT has_been/VBP shown/VBN to/TO reduce/VB the/DT risk/NN of/IN coronary_artery_thrombosis/NNS in/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (NP (NNP HS-6))
    (VP (VBZ is_a)
      (NP
        (NP (JJ novel) (JJ therapeutic) (NN agent))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB reduce)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (NNS coronary_artery_thrombosis))
                            (PP (IN in)
                              (NP (NNS patients))))))
                      (PP (IN with)
                        (NP (NNP HF))))))))))))
    (. .)))

nsubj(is_a-2, HS-6-1)
root(ROOT-0, is_a-2)
amod(agent-5, novel-3)
amod(agent-5, therapeutic-4)
dobj(is_a-2, agent-5)
nsubj(has_been-7, agent-5)
ref(agent-5, that-6)
acl:relcl(agent-5, has_been-7)
dep(has_been-7, shown-8)
mark(reduce-10, to-9)
xcomp(shown-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
case(coronary_artery_thrombosis-14, of-13)
nmod:of(risk-12, coronary_artery_thrombosis-14)
case(patients-16, in-15)
nmod:in(coronary_artery_thrombosis-14, patients-16)
case(HF-18, with-17)
nmod:with(reduce-10, HF-18)

In/IN a/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN ,/, HS-6/NNP was/VBD administered/VBN to/TO patients/NNS with/IN HF/NNP over/IN a/DT period/NN of/IN 12/CD months/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled) (NN trial)))
    (, ,)
    (NP (NNP HS-6))
    (VP (VBD was)
      (VP (VBN administered)
        (PP (TO to)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (NNP HF)))))
        (PP (IN over)
          (NP
            (NP (DT a) (NN period))
            (PP (IN of)
              (NP (CD 12) (NNS months)))))))
    (. .)))

case(trial-8, In-1)
det(trial-8, a-2)
amod(trial-8, randomized-3)
amod(trial-8, double-blind-5)
amod(trial-8, placebo-controlled-7)
nmod:in(administered-12, trial-8)
nsubjpass(administered-12, HS-6-10)
auxpass(administered-12, was-11)
root(ROOT-0, administered-12)
case(patients-14, to-13)
nmod:to(administered-12, patients-14)
case(HF-16, with-15)
nmod:with(patients-14, HF-16)
case(period-19, over-17)
det(period-19, a-18)
nmod:over(administered-12, period-19)
case(months-22, of-20)
nummod(months-22, 12-21)
nmod:of(period-19, months-22)

The/DT results/NNS showed/VBD that/IN HS-6/NNP reduced/VBD the/DT risk/NN of/IN coronary_artery_thrombosis/NNS by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP HS-6))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS coronary_artery_thrombosis))))
            (PP (IN by)
              (NP
                (NP (CD 21) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                    (: :)
                    (NP
                      (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                      (: :)
                      (NP
                        (QP (CD 0.67-0) (CD .93)))))
                  (-RRB- -RRB-))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, HS-6-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(coronary_artery_thrombosis-10, of-9)
nmod:of(risk-8, coronary_artery_thrombosis-10)
case(%-13, by-11)
nummod(%-13, 21-12)
nmod:by(reduced-6, %-13)
amod(-RSB--19, relative-15)
compound(-RSB--19, risk-16)
compound(-RSB--19, -LSB--17)
compound(-RSB--19, RR-18)
dep(%-13, -RSB--19)
nummod(-RSB--29, 0.79-21)
nummod(-RSB--29, 95-23)
compound(-RSB--29, %-24)
compound(-RSB--29, confidence-25)
amod(-RSB--29, interval-26)
amod(-RSB--29, -LSB--27)
compound(-RSB--29, CI-28)
dep(-RSB--19, -RSB--29)
compound(.93-32, 0.67-0-31)
dep(-RSB--29, .93-32)

These/DT findings/NNS suggest/VBP that/IN HS-6/NNP may/MD be/VB an/DT effective/JJ therapeutic/JJ option/NN for/IN the/DT prevention/NN of/IN coronary_artery_thrombosis/NNS in/IN patients/NNS with/IN HF/NNP and/CC warrant/VB further/JJ investigation/NN in/IN larger/JJR clinical/JJ trials/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP HS-6))
          (VP
            (VP (MD may)
              (VP (VB be)
                (NP
                  (NP (DT an) (JJ effective) (JJ therapeutic) (NN option))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN prevention))
                      (PP (IN of)
                        (NP
                          (NP (NNS coronary_artery_thrombosis))
                          (PP (IN in)
                            (NP
                              (NP (NNS patients))
                              (PP (IN with)
                                (NP (NNP HF))))))))))))
            (CC and)
            (VP (VB warrant)
              (NP
                (NP (JJ further) (NN investigation))
                (PP (IN in)
                  (NP (JJR larger) (JJ clinical) (NNS trials)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, HS-6-5)
nsubj(warrant-22, HS-6-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, an-8)
amod(option-11, effective-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(prevention-14, for-12)
det(prevention-14, the-13)
nmod:for(option-11, prevention-14)
case(coronary_artery_thrombosis-16, of-15)
nmod:of(prevention-14, coronary_artery_thrombosis-16)
case(patients-18, in-17)
nmod:in(coronary_artery_thrombosis-16, patients-18)
case(HF-20, with-19)
nmod:with(patients-18, HF-20)
cc(option-11, and-21)
ccomp(suggest-3, warrant-22)
conj:and(option-11, warrant-22)
amod(investigation-24, further-23)
dobj(warrant-22, investigation-24)
case(trials-28, in-25)
amod(trials-28, larger-26)
amod(trials-28, clinical-27)
nmod:in(investigation-24, trials-28)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN shown/VBN to/TO have/VB several/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP (JJ several) (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(shown-20, nutrients-16)
nsubj:xsubj(have-22, nutrients-16)
ref(nutrients-16, that-17)
aux(shown-20, have-18)
auxpass(shown-20, been-19)
acl:relcl(nutrients-16, shown-20)
mark(have-22, to-21)
xcomp(shown-20, have-22)
amod(benefits-25, several-23)
compound(benefits-25, health-24)
dobj(have-22, benefits-25)

Recent/JJ studies/NNS have/VBP demonstrated/VBN a/DT significant/JJ association/NN between/IN long-chain/JJ omega-3_fatty_acids/JJ and/CC decreased/VBN levels/NNS of/IN IST-622/NN in/IN hyperIST-622mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (NP
          (NP (DT a) (JJ significant) (NN association))
          (PP (IN between)
            (NP
              (NP (JJ long-chain)
                (ADJP (JJ omega-3_fatty_acids)
                  (CC and)
                  (VBN decreased))
                (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NN IST-622))
                  (PP (IN in)
                    (NP (JJ hyperIST-622mic) (NNS patients))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
det(association-7, a-5)
amod(association-7, significant-6)
dobj(demonstrated-4, association-7)
case(levels-13, between-8)
amod(levels-13, long-chain-9)
amod(levels-13, omega-3_fatty_acids-10)
cc(omega-3_fatty_acids-10, and-11)
conj:and(omega-3_fatty_acids-10, decreased-12)
amod(levels-13, decreased-12)
nmod:between(association-7, levels-13)
case(IST-622-15, of-14)
nmod:of(levels-13, IST-622-15)
case(patients-18, in-16)
amod(patients-18, hyperIST-622mic-17)
nmod:in(IST-622-15, patients-18)

Furthermore/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP
              (NP (DT a) (VBN reduced) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(has_been-9, Furthermore-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, reduced-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

The/DT mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS exert/VBP their/PRP$ beneficial/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN they/PRP may/MD modulate/VBP inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC enhance/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (WHPP (IN by)
        (WHNP (WDT which)
          (S
            (S
              (NP (DT these) (NNS fatty_acids))
              (VP (VBP exert)
                (SBAR
                  (S
                    (NP (PRP$ their) (JJ beneficial) (NNS effects))
                    (VP (VBP are)
                      (ADJP (RB not) (RB fully) (VBN understood)))))))
            (, ,)
            (CC but)
            (S
              (NP (PRP it))
              (VP (VBZ is)
                (VP (VBN believed)
                  (SBAR (IN that)
                    (S
                      (NP (PRP they))
                      (VP (MD may)))))))))))
    (VP (VBP modulate)
      (NP (NN inflammation))
      (, ,)
      (S
        (VP
          (VP (VB improve)
            (NP (NN lipid) (NN metabolism)))
          (, ,)
          (CC and)
          (VP (VB enhance)
            (NP (JJ endothelial) (NN function))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(modulate-23, mechanisms-2)
case(which-4, by-3)
nmod:by(mechanisms-2, which-4)
det(fatty_acids-6, these-5)
nsubj(exert-7, fatty_acids-6)
dep(which-4, exert-7)
nmod:poss(effects-10, their-8)
amod(effects-10, beneficial-9)
nsubjpass(understood-14, effects-10)
auxpass(understood-14, are-11)
neg(understood-14, not-12)
advmod(understood-14, fully-13)
ccomp(exert-7, understood-14)
cc(exert-7, but-16)
nsubjpass(believed-19, it-17)
auxpass(believed-19, is-18)
dep(which-4, believed-19)
conj:but(exert-7, believed-19)
mark(may-22, that-20)
nsubj(may-22, they-21)
ccomp(believed-19, may-22)
root(ROOT-0, modulate-23)
dobj(modulate-23, inflammation-24)
dep(modulate-23, improve-26)
compound(metabolism-28, lipid-27)
dobj(improve-26, metabolism-28)
cc(improve-26, and-30)
dep(modulate-23, enhance-31)
conj:and(improve-26, enhance-31)
amod(function-33, endothelial-32)
dobj(enhance-31, function-33)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN preventing/VBG or/CC managing/VBG hyperIST-622mia/JJ and/CC CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT an) (JJ effective) (NN strategy))
              (PP (IN for)
                (S
                  (VP
                    (VP (VBG preventing))
                    (CC or)
                    (VP (VBG managing)
                      (UCP (JJ hyperIST-622mia)
                        (CC and)
                        (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(preventing-18, for-17)
advcl(strategy-16, preventing-18)
cc(preventing-18, or-19)
advcl(strategy-16, managing-20)
conj:or(preventing-18, managing-20)
xcomp(managing-20, hyperIST-622mia-21)
cc(hyperIST-622mia-21, and-22)
xcomp(managing-20, CHD-23)
conj:and(hyperIST-622mia-21, CHD-23)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB beneficial/JJ effects/NNS on/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ beneficial) (NNS effects))
                  (PP (IN on)
                    (NP (JJ human) (NN health))))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(effects-20, beneficial-19)
dobj(have-18, effects-20)
case(health-23, on-21)
amod(health-23, human-22)
nmod:on(effects-20, health-23)

In/IN particular/JJ ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN colchicine/JJ levels/NNS in/IN hypercolchicinmic/JJ patients/NNS and/CC a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (JJ colchicine) (NNS levels))
              (PP (IN in)
                (NP
                  (NP (JJ hypercolchicinmic) (NNS patients))
                  (CC and)
                  (NP
                    (NP
                      (NP (DT a) (VBN reduced) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

case(particular-2, In-1)
advcl(associated-9, particular-2)
det(omega-3_fatty_acids-6, these-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(associated-9, omega-3_fatty_acids-6)
aux(associated-9, have-7)
auxpass(associated-9, been-8)
root(ROOT-0, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, colchicine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hypercolchicinmic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
det(risk-20, a-18)
amod(risk-20, reduced-19)
nmod:in(levels-13, risk-20)
conj:and(patients-16, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, coronary_heart_disease-23)
appos(risk-20, CHD-25)

The/DT mechanism/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ protective/JJ effects/NNS is/VBZ not/RB fully/RB understood/VBN ;/: however/RB ,/, it/PRP has_been/VBP proposed/VBN that/IN they/PRP may/MD modulate/VBP inflammation/NN ,/, improve/VB lipid/NN metabolism/NN ,/, and/CC reduce/VB oxidative_stress/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBD exert)
              (NP (PRP$ their) (JJ protective) (NNS effects))))))
      (VP (VBZ is)
        (ADJP (RB not) (RB fully) (VBN understood))))
    (: ;)
    (S
      (ADVP (RB however))
      (, ,)
      (NP (PRP it))
      (VP (VBP has_been)
        (VP (VBN proposed)
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP (NN inflammation))
                  (, ,)
                  (S
                    (VP
                      (VP (VB improve)
                        (NP (NN lipid) (NN metabolism)))
                      (, ,)
                      (CC and)
                      (VP (VB reduce)
                        (NP (NNS oxidative_stress))))))))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(exert-8, mechanism-2)
nsubjpass(understood-15, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
acl:relcl(mechanism-2, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, protective-10)
dobj(exert-8, effects-11)
auxpass(understood-15, is-12)
neg(understood-15, not-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
advmod(has_been-20, however-17)
nsubj(has_been-20, it-19)
parataxis(understood-15, has_been-20)
dep(has_been-20, proposed-21)
mark(modulate-25, that-22)
nsubj(modulate-25, they-23)
aux(modulate-25, may-24)
ccomp(proposed-21, modulate-25)
dobj(modulate-25, inflammation-26)
dep(modulate-25, improve-28)
compound(metabolism-30, lipid-29)
dobj(improve-28, metabolism-30)
cc(improve-28, and-32)
dep(modulate-25, reduce-33)
conj:and(improve-28, reduce-33)
dobj(reduce-33, oxidative_stress-34)

Studies/NNPS have/VBP also/RB suggested/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD have/VB therapeutic/JJ potential/NN in/IN the/DT management/NN of/IN other/JJ chronic_diseases/NNS such/JJ as/IN rheumatoid_arthritis/NNS ,/, diabetes/NN ,/, and/CC cancer/NN ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP
        (ADVP (RB also))
        (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may)
              (VP (VB have)
                (NP (JJ therapeutic) (NN potential))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN management))
                    (PP (IN of)
                      (NP
                        (NP (JJ other) (NNS chronic_diseases))
                        (PP (JJ such) (IN as)
                          (NP
                            (NP (NNS rheumatoid_arthritis))
                            (, ,)
                            (NP (NN diabetes))
                            (, ,)
                            (CC and)
                            (NP (NN cancer))))))))))))))
    (. .)))

nsubj(suggested-4, Studies-1)
aux(suggested-4, have-2)
advmod(suggested-4, also-3)
root(ROOT-0, suggested-4)
mark(have-10, that-5)
nsubj(have-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(have-10, DHA-8)
aux(have-10, may-9)
ccomp(suggested-4, have-10)
amod(potential-12, therapeutic-11)
dobj(have-10, potential-12)
case(management-15, in-13)
det(management-15, the-14)
nmod:in(have-10, management-15)
case(chronic_diseases-18, of-16)
amod(chronic_diseases-18, other-17)
nmod:of(management-15, chronic_diseases-18)
case(rheumatoid_arthritis-21, such-19)
mwe(such-19, as-20)
nmod:such_as(chronic_diseases-18, rheumatoid_arthritis-21)
nmod:such_as(chronic_diseases-18, diabetes-23)
conj:and(rheumatoid_arthritis-21, diabetes-23)
cc(rheumatoid_arthritis-21, and-25)
nmod:such_as(chronic_diseases-18, cancer-26)
conj:and(rheumatoid_arthritis-21, cancer-26)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN these/DT fatty_acids/NNS and/CC to/TO determine/VB optimal/JJ doses/NNS for/IN specific/JJ health/NN outcomes/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ beneficial) (NNS effects))
                      (PP (IN of)
                        (NP (DT these) (NNS fatty_acids))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS doses))
                  (PP (IN for)
                    (NP (JJ specific) (NN health) (NNS outcomes))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-12, the-10)
amod(effects-12, beneficial-11)
dobj(underlying-9, effects-12)
case(fatty_acids-15, of-13)
det(fatty_acids-15, these-14)
nmod:of(effects-12, fatty_acids-15)
cc(elucidate-6, and-16)
mark(determine-18, to-17)
ccomp(needed-4, determine-18)
conj:and(elucidate-6, determine-18)
amod(doses-20, optimal-19)
dobj(determine-18, doses-20)
case(outcomes-24, for-21)
amod(outcomes-24, specific-22)
compound(outcomes-24, health-23)
nmod:for(doses-20, outcomes-24)

Metallothioneins/NNS -LRB-/-LRB- MTs/NNP -RRB-/-RRB- are/VBP a/DT group/NN of/IN small/JJ ,/, cysteine-rich/JJ proteins/NNS that/WDT play/VBP a/DT crucial/JJ role/NN in/IN protecting/VBG cells/NNS from/IN heavy/JJ metal_toxicity/NN and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Metallothioneins))
      (PRN (-LRB- -LRB-)
        (NP (NNP MTs))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (DT a) (NN group))
        (PP (IN of)
          (NP
            (NP (JJ small) (, ,) (JJ cysteine-rich) (NNS proteins))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP play)
                  (NP
                    (NP (DT a) (JJ crucial) (NN role))
                    (PP (IN in)
                      (S
                        (VP (VBG protecting)
                          (NP (NNS cells))
                          (PP (IN from)
                            (NP (JJ heavy) (NN metal_toxicity)
                              (CC and)
                              (NNS oxidative_stress))))))))))))))
    (. .)))

nsubj(group-7, Metallothioneins-1)
appos(Metallothioneins-1, MTs-3)
cop(group-7, are-5)
det(group-7, a-6)
root(ROOT-0, group-7)
case(proteins-12, of-8)
amod(proteins-12, small-9)
amod(proteins-12, cysteine-rich-11)
nmod:of(group-7, proteins-12)
nsubj(play-14, proteins-12)
ref(proteins-12, that-13)
acl:relcl(proteins-12, play-14)
det(role-17, a-15)
amod(role-17, crucial-16)
dobj(play-14, role-17)
mark(protecting-19, in-18)
acl(role-17, protecting-19)
dobj(protecting-19, cells-20)
case(metal_toxicity-23, from-21)
amod(metal_toxicity-23, heavy-22)
nmod:from(protecting-19, metal_toxicity-23)
cc(metal_toxicity-23, and-24)
nmod:from(protecting-19, oxidative_stress-25)
conj:and(metal_toxicity-23, oxidative_stress-25)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN BBR3464/NNP ,/, a/DT novel/JJ platinum-based/JJ anticancer/JJ agent/NN ,/, on/IN the/DT expression/NN and/CC stability/NN of/IN MTs/NNP in/IN C2C12/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP BBR3464))
            (, ,)
            (NP (DT a) (JJ novel) (JJ platinum-based) (JJ anticancer) (NN agent))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (CC and)
          (NP
            (NP (NN stability))
            (PP (IN of)
              (NP (NNP MTs))))))
      (PP (IN in)
        (NP (CD C2C12) (NNS cells))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(BBR3464-10, of-9)
nmod:of(effect-8, BBR3464-10)
det(agent-16, a-12)
amod(agent-16, novel-13)
amod(agent-16, platinum-based-14)
amod(agent-16, anticancer-15)
appos(BBR3464-10, agent-16)
case(expression-20, on-18)
det(expression-20, the-19)
nmod:on(investigated-6, expression-20)
cc(expression-20, and-21)
nmod:on(investigated-6, stability-22)
conj:and(expression-20, stability-22)
case(MTs-24, of-23)
nmod:of(stability-22, MTs-24)
case(cells-27, in-25)
nummod(cells-27, C2C12-26)
nmod:in(investigated-6, cells-27)

We/PRP found/VBD that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, BBR3464/CD up-regulated/JJ metallothionein-1E/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ metallothionein-1E/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-))
                    (, ,)
                    (NP
                      (NP (CD BBR3464) (JJ up-regulated) (JJ metallothionein-1E) (NN protein) (NNS levels))
                      (NP (NN in_a) (JJ time-dependent) (NN manner))))
                  (CC and)
                  (NX (JJ prolonged) (JJ metallothionein-1E) (NN protein)))
                (NX (NN half-life)))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(cultured-8, that-3)
advmod(cultured-8, when-4)
compound(cells-6, C2C12-5)
nsubjpass(cultured-8, cells-6)
auxpass(cultured-8, were-7)
ccomp(found-2, cultured-8)
dep(half-life-37, in_a-9)
compound(differentiation-12, medium-10)
amod(differentiation-12, favoring-11)
dep(half-life-37, differentiation-12)
dep(differentiation-12, Dulbecco-14)
case(medium-17, modified-15)
compound(medium-17, Eagle-16)
nmod:modified(Dulbecco-14, medium-17)
acl(medium-17, containing-18)
compound(%-20, 2-19)
amod(serum-22, %-20)
compound(serum-22, horse-21)
dobj(containing-18, serum-22)
nummod(levels-29, BBR3464-25)
amod(levels-29, up-regulated-26)
amod(levels-29, metallothionein-1E-27)
compound(levels-29, protein-28)
dep(differentiation-12, levels-29)
compound(manner-32, in_a-30)
amod(manner-32, time-dependent-31)
dep(levels-29, manner-32)
cc(differentiation-12, and-33)
amod(protein-36, prolonged-34)
amod(protein-36, metallothionein-1E-35)
conj:and(differentiation-12, protein-36)
dep(half-life-37, protein-36)
dobj(cultured-8, half-life-37)
case(hours-42, from-38)
compound(18-41, 10-39)
dep(18-41, to-40)
nummod(hours-42, 18-41)
nmod:from(cultured-8, hours-42)

This/DT suggests/VBZ that/IN BBR3464/NNP may/MD have/VB potential/JJ therapeutic/JJ applications/NNS beyond/IN its/PRP$ known/VBN anticancer/JJ effects/NNS ,/, particularly/RB in/IN conditions/NNS associated/VBN with/IN heavy/JJ metal_toxicity/NN or/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NNP BBR3464))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ potential) (JJ therapeutic) (NNS applications))
              (PP (IN beyond)
                (NP
                  (NP (PRP$ its) (VBN known) (JJ anticancer) (NNS effects))
                  (, ,)
                  (ADVP (RB particularly))))
              (PP (IN in)
                (NP
                  (NP (NNS conditions))
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP (JJ heavy) (NN metal_toxicity)
                        (CC or)
                        (NNS oxidative_stress)))))))))))
    (. .)))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
mark(have-6, that-3)
nsubj(have-6, BBR3464-4)
aux(have-6, may-5)
ccomp(suggests-2, have-6)
amod(applications-9, potential-7)
amod(applications-9, therapeutic-8)
dobj(have-6, applications-9)
case(effects-14, beyond-10)
nmod:poss(effects-14, its-11)
amod(effects-14, known-12)
amod(effects-14, anticancer-13)
nmod:beyond(have-6, effects-14)
advmod(effects-14, particularly-16)
case(conditions-18, in-17)
nmod:in(have-6, conditions-18)
acl(conditions-18, associated-19)
case(metal_toxicity-22, with-20)
amod(metal_toxicity-22, heavy-21)
nmod:with(associated-19, metal_toxicity-22)
cc(metal_toxicity-22, or-23)
nmod:with(associated-19, oxidative_stress-24)
conj:or(metal_toxicity-22, oxidative_stress-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN BBR3464-induced/JJ MT/NNP upregulation/NNS and/CC stabilization/NN ,/, as/RB well/RB as/IN its/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (JJ BBR3464-induced) (NNP MT) (NNS upregulation))
                    (CC and)
                    (NP
                      (NP (NN stabilization))
                      (, ,)
                      (ADVP (RB as) (RB well)
                        (PP (IN as)
                          (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS applications)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(upregulation-13, of-10)
amod(upregulation-13, BBR3464-induced-11)
compound(upregulation-13, MT-12)
nmod:of(mechanisms-9, upregulation-13)
cc(upregulation-13, and-14)
nmod:of(mechanisms-9, stabilization-15)
conj:and(upregulation-13, stabilization-15)
advmod(well-18, as-17)
advmod(stabilization-15, well-18)
case(applications-23, as-19)
nmod:poss(applications-23, its-20)
amod(applications-23, potential-21)
amod(applications-23, clinical-22)
nmod:as(well-18, applications-23)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN Alanosyl-AICOR/JJ intervention/NN on/IN body/NN weight/NN ,/, villus/JJ height/NN ,/, villus/JJ surface/NN area/NN ,/, plasma/NN Alanosyl-AICOR/JJ concentration/NN and/CC Adenylosuccinase/JJ expression/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (JJ Alanosyl-AICOR) (NN intervention))
          (PP (IN on)
            (NP
              (NP (NN body) (NN weight))
              (, ,)
              (NP (JJ villus) (NN height))
              (, ,)
              (NP (JJ villus) (NN surface) (NN area))
              (, ,)
              (NP (NN plasma) (JJ Alanosyl-AICOR) (NN concentration))
              (CC and)
              (NP (JJ Adenylosuccinase) (NN expression)))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-28, study-3)
det(effects-6, the-5)
nsubjpass(investigated-28, effects-6)
case(intervention-9, of-7)
amod(intervention-9, Alanosyl-AICOR-8)
nmod:of(effects-6, intervention-9)
case(weight-12, on-10)
compound(weight-12, body-11)
nmod:on(intervention-9, weight-12)
amod(height-15, villus-14)
nmod:on(intervention-9, height-15)
conj:and(weight-12, height-15)
amod(area-19, villus-17)
compound(area-19, surface-18)
nmod:on(intervention-9, area-19)
conj:and(weight-12, area-19)
compound(concentration-23, plasma-21)
amod(concentration-23, Alanosyl-AICOR-22)
nmod:on(intervention-9, concentration-23)
conj:and(weight-12, concentration-23)
cc(weight-12, and-24)
amod(expression-26, Adenylosuccinase-25)
nmod:on(intervention-9, expression-26)
conj:and(weight-12, expression-26)
auxpass(investigated-28, were-27)
root(ROOT-0, investigated-28)

The/DT results/NNS showed/VBD that/IN the/DT Alanosyl-AICOR-intervened/JJ group/NN had/VBD a/DT significant/JJ decrease/NN in/IN body/NN weight/NN ,/, villus/JJ height/NN and/CC villus/JJ surface/NN area/NN compared/VBN to/TO the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (DT the) (JJ Alanosyl-AICOR-intervened) (NN group))
          (VP (VBD had)
            (NP
              (NP (DT a) (JJ significant) (NN decrease))
              (PP (IN in)
                (NP
                  (NP (NN body) (NN weight))
                  (, ,)
                  (NP
                    (NP (JJ villus) (NN height))
                    (CC and)
                    (NP (JJ villus) (NN surface) (NN area))))))
            (PP (VBN compared)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN control) (NN group))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP P)
                      (QP (CD <) (CD 0.01)))
                    (-RRB- -RRB-)))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-8, that-4)
det(group-7, the-5)
amod(group-7, Alanosyl-AICOR-intervened-6)
nsubj(had-8, group-7)
ccomp(showed-3, had-8)
det(decrease-11, a-9)
amod(decrease-11, significant-10)
dobj(had-8, decrease-11)
case(weight-14, in-12)
compound(weight-14, body-13)
nmod:in(decrease-11, weight-14)
amod(height-17, villus-16)
appos(weight-14, height-17)
cc(height-17, and-18)
amod(area-21, villus-19)
compound(area-21, surface-20)
appos(weight-14, area-21)
conj:and(height-17, area-21)
case(group-26, compared-22)
mwe(compared-22, to-23)
det(group-26, the-24)
compound(group-26, control-25)
advcl(had-8, group-26)
appos(group-26, P-28)
compound(0.01-30, <-29)
nummod(P-28, 0.01-30)

However/RB ,/, the/DT plasma/NN Alanosyl-AICOR/JJ concentration/NN and/CC Adenylosuccinase/JJ expression/NN in/IN the/DT Alanosyl-AICOR-intervened/JJ group/NN had/VBD recovered/VBN to/TO normal/JJ levels/NNS -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (NN plasma) (JJ Alanosyl-AICOR) (NN concentration))
      (CC and)
      (NP
        (NP (JJ Adenylosuccinase) (NN expression))
        (PP (IN in)
          (NP (DT the) (JJ Alanosyl-AICOR-intervened) (NN group)))))
    (VP (VBD had)
      (VP (VBN recovered)
        (PP (TO to)
          (NP
            (NP (JJ normal) (NNS levels))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD >) (CD 0.05)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(recovered-15, However-1)
det(concentration-6, the-3)
compound(concentration-6, plasma-4)
amod(concentration-6, Alanosyl-AICOR-5)
nsubj(recovered-15, concentration-6)
cc(concentration-6, and-7)
amod(expression-9, Adenylosuccinase-8)
conj:and(concentration-6, expression-9)
nsubj(recovered-15, expression-9)
case(group-13, in-10)
det(group-13, the-11)
amod(group-13, Alanosyl-AICOR-intervened-12)
nmod:in(expression-9, group-13)
aux(recovered-15, had-14)
root(ROOT-0, recovered-15)
case(levels-18, to-16)
amod(levels-18, normal-17)
nmod:to(recovered-15, levels-18)
appos(levels-18, P-20)
compound(0.05-22, >-21)
nummod(P-20, 0.05-22)

These/DT findings/NNS suggest/VBP that/IN Alanosyl-AICOR/NNP may/MD have/VB potential/JJ therapeutic/JJ effects/NNS on/IN certain/JJ conditions/NNS associated/VBN with/IN decreased_body_weight/JJ and/CC intestinal/JJ villus_atrophy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Alanosyl-AICOR))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS effects))
                (PP (IN on)
                  (NP
                    (NP (JJ certain) (NNS conditions))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP
                          (ADJP (JJ decreased_body_weight)
                            (CC and)
                            (JJ intestinal))
                          (NN villus_atrophy))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, Alanosyl-AICOR-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(effects-10, potential-8)
amod(effects-10, therapeutic-9)
dobj(have-7, effects-10)
case(conditions-13, on-11)
amod(conditions-13, certain-12)
nmod:on(effects-10, conditions-13)
acl(conditions-13, associated-14)
case(villus_atrophy-19, with-15)
amod(villus_atrophy-19, decreased_body_weight-16)
cc(decreased_body_weight-16, and-17)
conj:and(decreased_body_weight-16, intestinal-18)
amod(villus_atrophy-19, intestinal-18)
nmod:with(associated-14, villus_atrophy-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB its/PRP$ mechanism/NN of/IN action/NN and/CC potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (PRP$ its) (NN mechanism))
                (PP (IN of)
                  (NP
                    (NP (NN action))
                    (CC and)
                    (NP (JJ potential) (JJ clinical) (NNS applications))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
nmod:poss(mechanism-8, its-7)
dobj(explore-6, mechanism-8)
case(action-10, of-9)
nmod:of(mechanism-8, action-10)
cc(action-10, and-11)
amod(applications-14, potential-12)
amod(applications-14, clinical-13)
nmod:of(mechanism-8, applications-14)
conj:and(action-10, applications-14)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ for/IN human/JJ health/NN and/CC have/VBP been/VBN found/VBN to/TO have/VB numerous/JJ beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (ADJP (JJ essential)
          (PP (IN for)
            (NP (JJ human) (NN health)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN found)
            (S
              (VP (TO to)
                (VP (VB have)
                  (NP
                    (NP (JJ numerous) (JJ beneficial) (NNS effects))
                    (PP (IN on)
                      (NP (NN cardiovascular_health)))))))))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
nsubjpass(found-22, Omega-3_fatty_acids-1)
nsubj:xsubj(have-24, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, for-16)
amod(health-18, human-17)
nmod:for(essential-15, health-18)
cc(essential-15, and-19)
aux(found-22, have-20)
auxpass(found-22, been-21)
conj:and(essential-15, found-22)
mark(have-24, to-23)
xcomp(found-22, have-24)
amod(effects-27, numerous-25)
amod(effects-27, beneficial-26)
dobj(have-24, effects-27)
case(cardiovascular_health-29, on-28)
nmod:on(effects-27, cardiovascular_health-29)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN CAT-8015/NN levels/NNS in/IN hyperCAT-8015mic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO the/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN CAT-8015) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperCAT-8015mic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB contribute)
                                (PP (TO to)
                                  (NP
                                    (NP
                                      (NP (DT the) (VBN decreased) (NN risk))
                                      (PP (IN of)
                                        (S
                                          (VP (VBG developing)
                                            (NP (NN coronary_heart_disease))))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-9, omega-3_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, CAT-8015-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperCAT-8015mic-15)
nmod:in(levels-13, patients-16)
nsubj(contribute-20, patients-16)
ref(patients-16, which-18)
aux(contribute-20, may-19)
acl:relcl(patients-16, contribute-20)
case(risk-24, to-21)
det(risk-24, the-22)
amod(risk-24, decreased-23)
nmod:to(contribute-20, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

EPA/NNP and/CC DHA/NNP are/VBP believed/VBN to/TO exert/VB their/PRP$ protective/JJ effects/NNS through/IN multiple/JJ mechanisms/NNS ,/, including/VBG anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN believed)
        (S
          (VP (TO to)
            (VP (VB exert)
              (NP (PRP$ their) (JJ protective) (NNS effects))
              (PP (IN through)
                (NP (JJ multiple) (NNS mechanisms))))))
        (, ,)
        (S
          (VP (VBG including)
            (NP (JJ anti-inflammatory)
              (CC and)
              (JJ anti-thrombotic) (NNS properties))))))
    (. .)))

nsubjpass(believed-5, EPA-1)
nsubj:xsubj(exert-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(believed-5, DHA-3)
nsubj:xsubj(exert-7, DHA-3)
auxpass(believed-5, are-4)
root(ROOT-0, believed-5)
mark(exert-7, to-6)
xcomp(believed-5, exert-7)
nmod:poss(effects-10, their-8)
amod(effects-10, protective-9)
dobj(exert-7, effects-10)
case(mechanisms-13, through-11)
amod(mechanisms-13, multiple-12)
nmod:through(exert-7, mechanisms-13)
xcomp(believed-5, including-15)
amod(properties-19, anti-inflammatory-16)
cc(anti-inflammatory-16, and-17)
conj:and(anti-inflammatory-16, anti-thrombotic-18)
amod(properties-19, anti-thrombotic-18)
dobj(including-15, properties-19)

Additionally/RB ,/, they/PRP have/VBP been/VBN shown/VBN to/TO improve/VB lipid/NN profiles/NNS and/CC reduce/VB blood_pressure/NN ,/, both/DT of/IN which/WDT are/VBP major/JJ risk/NN factors/NNS for/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP (NN blood_pressure))
                    (, ,)
                    (SBAR
                      (WHNP (DT both)
                        (WHPP (IN of)
                          (WHNP (WDT which))))
                      (S
                        (VP (VBP are)
                          (NP
                            (NP (JJ major) (NN risk) (NNS factors))
                            (PP (IN for)
                              (NP (NNP CHD)))))))))))))))
    (. .)))

advmod(shown-6, Additionally-1)
nsubjpass(shown-6, they-3)
nsubj:xsubj(improve-8, they-3)
nsubj:xsubj(reduce-12, they-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
mark(improve-8, to-7)
xcomp(shown-6, improve-8)
compound(profiles-10, lipid-9)
dobj(improve-8, profiles-10)
cc(improve-8, and-11)
xcomp(shown-6, reduce-12)
conj:and(improve-8, reduce-12)
dobj(reduce-12, blood_pressure-13)
nsubj(factors-21, blood_pressure-13)
dep(which-17, both-15)
case(which-17, of-16)
ref(blood_pressure-13, which-17)
cop(factors-21, are-18)
amod(factors-21, major-19)
compound(factors-21, risk-20)
acl:relcl(blood_pressure-13, factors-21)
case(CHD-23, for-22)
nmod:for(factors-21, CHD-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN reducing/VBG the/DT incidence/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN incidence))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN cardiovascular_health))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-15, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, a-13)
amod(strategy-15, promising-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(incidence-19, the-18)
dobj(reducing-17, incidence-19)
case(CHD-21, of-20)
nmod:of(incidence-19, CHD-21)
cc(reducing-17, and-22)
acl(strategy-15, improving-23)
conj:and(reducing-17, improving-23)
amod(cardiovascular_health-25, overall-24)
dobj(improving-23, cardiovascular_health-25)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN several/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP (JJ several) (VBG signaling) (NNS pathways)))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, several-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)

Prostaglandin_E2/JJ -LRB-/-LRB- PGE2/NNP -RRB-/-RRB- is_a/NNS bioactive/VBD lipid/NN mediator/NN that/WDT plays/VBZ an/DT important/JJ role/NN in/IN skeletal_muscle/JJ differentiation/NN by/IN binding/VBG to/TO its/PRP$ receptor/NN ,/, PTGER4/NNP ./.

(ROOT
  (S
    (NP (JJ Prostaglandin_E2)
      (PRN (-LRB- -LRB-)
        (NP (NNP PGE2))
        (-RRB- -RRB-))
      (NNS is_a))
    (VP (VBD bioactive)
      (NP
        (NP (NN lipid) (NN mediator))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP (JJ skeletal_muscle) (NN differentiation))))))))
      (PP (IN by)
        (S
          (VP (VBG binding)
            (PP (TO to)
              (NP
                (NP (PRP$ its) (NN receptor))
                (, ,)
                (NP (NNP PTGER4))))))))
    (. .)))

amod(is_a-5, Prostaglandin_E2-1)
appos(is_a-5, PGE2-3)
nsubj(bioactive-6, is_a-5)
root(ROOT-0, bioactive-6)
compound(mediator-8, lipid-7)
dobj(bioactive-6, mediator-8)
nsubj(plays-10, mediator-8)
ref(mediator-8, that-9)
acl:relcl(mediator-8, plays-10)
det(role-13, an-11)
amod(role-13, important-12)
dobj(plays-10, role-13)
case(differentiation-16, in-14)
amod(differentiation-16, skeletal_muscle-15)
nmod:in(role-13, differentiation-16)
mark(binding-18, by-17)
advcl(bioactive-6, binding-18)
case(receptor-21, to-19)
nmod:poss(receptor-21, its-20)
nmod:to(binding-18, receptor-21)
appos(receptor-21, PTGER4-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN L-161982/NNP ,/, a/DT selective/JJ PTGER4/NNP agonist/NN ,/, on/IN PTGER4/NNP protein/NN levels/NNS and/CC stability/NN in/IN C2C12/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP L-161982))
            (, ,)
            (NP (DT a) (JJ selective) (NNP PTGER4) (NN agonist))
            (, ,))))
      (PP (IN on)
        (NP (NNP PTGER4) (NN protein) (NNS levels)
          (CC and)
          (NN stability)))
      (PP (IN in)
        (NP (CD C2C12) (NNS cells))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(L-161982-10, of-9)
nmod:of(effect-8, L-161982-10)
det(agonist-15, a-12)
amod(agonist-15, selective-13)
compound(agonist-15, PTGER4-14)
appos(L-161982-10, agonist-15)
case(levels-20, on-17)
compound(levels-20, PTGER4-18)
compound(levels-20, protein-19)
nmod:on(investigated-6, levels-20)
cc(levels-20, and-21)
nmod:on(investigated-6, stability-22)
conj:and(levels-20, stability-22)
case(cells-25, in-23)
nummod(cells-25, C2C12-24)
nmod:in(investigated-6, cells-25)

Our/PRP$ results/NNS showed/VBD that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, L-161982/NN up-regulated/JJ PTGER4/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ PTGER4/CD protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NX (NN L-161982)))
                (NX
                  (NX
                    (NX (JJ up-regulated) (NNP PTGER4) (NN protein) (NNS levels) (NN in_a))
                    (NP (JJ time-dependent) (NN manner)))
                  (CC and)
                  (NX
                    (ADJP (JJ prolonged)
                      (NP-TMP (CD PTGER4)))
                    (NN protein) (NN half-life))))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(cultured-9, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
ccomp(showed-3, cultured-9)
dep(in_a-31, in_a-10)
compound(differentiation-13, medium-11)
amod(differentiation-13, favoring-12)
dep(L-161982-26, differentiation-13)
dep(differentiation-13, Dulbecco-15)
case(medium-18, modified-16)
compound(medium-18, Eagle-17)
nmod:modified(Dulbecco-15, medium-18)
acl(medium-18, containing-19)
compound(%-21, 2-20)
amod(serum-23, %-21)
compound(serum-23, horse-22)
dobj(containing-19, serum-23)
dep(in_a-31, L-161982-26)
amod(in_a-31, up-regulated-27)
compound(in_a-31, PTGER4-28)
compound(in_a-31, protein-29)
compound(in_a-31, levels-30)
dobj(cultured-9, in_a-31)
amod(manner-33, time-dependent-32)
dep(in_a-31, manner-33)
cc(in_a-31, and-34)
amod(half-life-38, prolonged-35)
nmod:tmod(prolonged-35, PTGER4-36)
compound(half-life-38, protein-37)
dobj(cultured-9, half-life-38)
conj:and(in_a-31, half-life-38)
case(hours-43, from-39)
compound(18-42, 10-40)
dep(18-42, to-41)
nummod(hours-43, 18-42)
nmod:from(cultured-9, hours-43)

These/DT findings/NNS suggest/VBP that/IN PTGER4/CD activation/NN by/IN L-161982/NNP may/MD play/VB an/DT important/JJ role/NN in/IN skeletal_muscle/JJ differentiation_and/NN could/MD be/VB a/DT potential/JJ therapeutic/JJ target/NN for/IN muscle_wasting_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (CD PTGER4) (NN activation))
            (PP (IN by)
              (NP (NNP L-161982))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (JJ skeletal_muscle) (NN differentiation_and))
                    (SBAR
                      (S
                        (VP (MD could)
                          (VP (VB be)
                            (NP
                              (NP (DT a) (JJ potential) (JJ therapeutic) (NN target))
                              (PP (IN for)
                                (NP (NNS muscle_wasting_disorders))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-10, that-4)
nummod(activation-6, PTGER4-5)
nsubj(play-10, activation-6)
case(L-161982-8, by-7)
nmod:by(activation-6, L-161982-8)
aux(play-10, may-9)
ccomp(suggest-3, play-10)
det(role-13, an-11)
amod(role-13, important-12)
dobj(play-10, role-13)
case(differentiation_and-16, in-14)
amod(differentiation_and-16, skeletal_muscle-15)
nmod:in(role-13, differentiation_and-16)
aux(target-22, could-17)
cop(target-22, be-18)
det(target-22, a-19)
amod(target-22, potential-20)
amod(target-22, therapeutic-21)
acl:relcl(differentiation_and-16, target-22)
case(muscle_wasting_disorders-24, for-23)
nmod:for(target-22, muscle_wasting_disorders-24)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN L-161982-mediated/JJ PTGER4/NN up-regulation/NN and/CC its/PRP$ effects/NNS on/IN skeletal_muscle/JJ development/NN and/CC function/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (JJ L-161982-mediated) (NN PTGER4) (NN up-regulation))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (NNS effects))
                      (PP (IN on)
                        (NP (JJ skeletal_muscle) (NN development)
                          (CC and)
                          (NN function))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(up-regulation-13, of-10)
amod(up-regulation-13, L-161982-mediated-11)
compound(up-regulation-13, PTGER4-12)
nmod:of(mechanisms-9, up-regulation-13)
cc(up-regulation-13, and-14)
nmod:poss(effects-16, its-15)
nmod:of(mechanisms-9, effects-16)
conj:and(up-regulation-13, effects-16)
case(development-19, on-17)
amod(development-19, skeletal_muscle-18)
nmod:on(effects-16, development-19)
cc(development-19, and-20)
nmod:on(effects-16, function-21)
conj:and(development-19, function-21)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-17, omega-3_fatty_acids-2)
nsubj:xsubj(have-19, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
mark(have-19, to-18)
xcomp(shown-17, have-19)
amod(benefits-22, various-20)
compound(benefits-22, health-21)
dobj(have-19, benefits-22)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN benzoylecgonine/JJ levels/NNS in/IN hyperbenzoylecgoninemic/JJ patients/NNS ,/, suggesting/VBG a/DT potential/JJ role/NN in/IN the/DT treatment/NN of/IN drug_addiction/NN ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ benzoylecgonine) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperbenzoylecgoninemic) (NNS patients)))))
                (, ,)
                (S
                  (VP (VBG suggesting)
                    (NP
                      (NP (DT a) (JJ potential) (NN role))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN treatment))
                          (PP (IN of)
                            (NP (NN drug_addiction))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(demonstrated-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, benzoylecgonine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperbenzoylecgoninemic-15)
nmod:in(levels-13, patients-16)
xcomp(associated-9, suggesting-18)
det(role-21, a-19)
amod(role-21, potential-20)
dobj(suggesting-18, role-21)
case(treatment-24, in-22)
det(treatment-24, the-23)
nmod:in(role-21, treatment-24)
case(drug_addiction-26, of-25)
nmod:of(treatment-24, drug_addiction-26)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, which/WDT is_a/NN leading/VBG cause/NN of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP (DT a) (VBN reduced) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP
                      (NP
                        (NP (NN coronary_heart_disease))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-)))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (NP
                            (NP (NN is_a) (VBG leading) (NN cause))
                            (PP (IN of)
                              (NP (NN death))))
                          (ADVP (RB worldwide)))))))))))))
    (. .)))

advmod(linked-8, Additionally-1)
nsubjpass(linked-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(linked-8, DHA-5)
aux(linked-8, have-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, reduced-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
dep(cause-23, coronary_heart_disease-15)
appos(coronary_heart_disease-15, CHD-17)
ref(coronary_heart_disease-15, which-20)
compound(cause-23, is_a-21)
amod(cause-23, leading-22)
acl:relcl(coronary_heart_disease-15, cause-23)
case(death-25, of-24)
nmod:of(cause-23, death-25)
advmod(cause-23, worldwide-26)

The/DT mechanisms/NNS behind/IN these/DT protective/JJ effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD include/VB anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS ,/, as/RB well/RB as/IN improvements/NNS in/IN lipid/NN profiles/NNS and/CC endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (PP (IN behind)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB include)
          (NP
            (NP
              (ADJP (JJ anti-inflammatory)
                (CC and)
                (JJ anti-thrombotic))
              (NNS properties))
            (, ,)
            (CONJP (RB as) (RB well) (IN as))
            (NP
              (NP (NNS improvements))
              (PP (IN in)
                (NP
                  (NP (NN lipid) (NNS profiles))
                  (CC and)
                  (NP (JJ endothelial) (NN function)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-11, mechanisms-2)
nsubj(include-15, mechanisms-2)
case(effects-6, behind-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
nmod:behind(mechanisms-2, effects-6)
auxpass(understood-11, are-7)
neg(understood-11, not-8)
advmod(understood-11, yet-9)
advmod(understood-11, fully-10)
root(ROOT-0, understood-11)
cc(understood-11, but-13)
aux(include-15, may-14)
conj:but(understood-11, include-15)
amod(properties-19, anti-inflammatory-16)
cc(anti-inflammatory-16, and-17)
conj:and(anti-inflammatory-16, anti-thrombotic-18)
amod(properties-19, anti-thrombotic-18)
dobj(include-15, properties-19)
cc(properties-19, as-21)
mwe(as-21, well-22)
mwe(as-21, as-23)
dobj(include-15, improvements-24)
conj:and(properties-19, improvements-24)
case(profiles-27, in-25)
compound(profiles-27, lipid-26)
nmod:in(improvements-24, profiles-27)
cc(profiles-27, and-28)
amod(function-30, endothelial-29)
nmod:in(improvements-24, function-30)
conj:and(profiles-27, function-30)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP and_drug/JJ addiction/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN prevention)
                    (CC and)
                    (NN treatment))
                  (PP (IN of)
                    (NP (NNP CHD) (JJ and_drug) (NN addiction))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(applications-11, the-8)
amod(applications-11, potential-9)
amod(applications-11, therapeutic-10)
dobj(elucidate-7, applications-11)
case(EPA-13, of-12)
nmod:of(applications-11, EPA-13)
cc(EPA-13, and-14)
nmod:of(applications-11, DHA-15)
conj:and(EPA-13, DHA-15)
case(prevention-18, in-16)
det(prevention-18, the-17)
nmod:in(elucidate-7, prevention-18)
cc(prevention-18, and-19)
nmod:in(elucidate-7, treatment-20)
conj:and(prevention-18, treatment-20)
case(addiction-24, of-21)
compound(addiction-24, CHD-22)
amod(addiction-24, and_drug-23)
nmod:of(prevention-18, addiction-24)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(found-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
mark(have-18, to-17)
xcomp(found-16, have-18)
amod(benefits-21, various-19)
compound(benefits-21, health-20)
dobj(have-18, benefits-21)

Previous/JJ research/NN has/VBZ suggested/VBN that/IN these/DT long-chain_fatty_acids/NNS may/MD decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Previous) (NN research))
    (VP (VBZ has)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (MD may)
              (VP (VB decrease)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

amod(research-2, Previous-1)
nsubj(suggested-4, research-2)
aux(suggested-4, has-3)
root(ROOT-0, suggested-4)
mark(decrease-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubj(decrease-9, long-chain_fatty_acids-7)
aux(decrease-9, may-8)
ccomp(suggested-4, decrease-9)
det(risk-11, the-10)
dobj(decrease-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, coronary_heart_disease-14)
appos(risk-11, CHD-16)

Additionally/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN associated/VBN with/IN decreased/VBN methylestrenolone/JJ levels/NNS in/IN hypermethylestrenolonemic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (JJ methylestrenolone) (NNS levels))
              (PP (IN in)
                (NP (JJ hypermethylestrenolonemic) (NNS patients))))))))
    (. .)))

advmod(associated-8, Additionally-1)
nsubjpass(associated-8, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(associated-8, DHA-5)
aux(associated-8, have-6)
auxpass(associated-8, been-7)
root(ROOT-0, associated-8)
case(levels-12, with-9)
amod(levels-12, decreased-10)
amod(levels-12, methylestrenolone-11)
nmod:with(associated-8, levels-12)
case(patients-15, in-13)
amod(patients-15, hypermethylestrenolonemic-14)
nmod:in(levels-12, patients-15)

This/DT finding/NN suggests/VBZ that/IN omega-3_fatty_acids/NN may/MD play/VB a/DT role/NN in/IN the/DT regulation/NN of/IN steroid_hormones/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (NNS steroid_hormones)))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(play-7, that-4)
nsubj(play-7, omega-3_fatty_acids-5)
aux(play-7, may-6)
ccomp(suggests-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
case(regulation-12, in-10)
det(regulation-12, the-11)
nmod:in(role-9, regulation-12)
case(steroid_hormones-14, of-13)
nmod:of(regulation-12, steroid_hormones-14)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS behind/IN these/DT associations/NNS ,/, but/CC these/DT findings/NNS highlight/VB the/DT potential/JJ health/NN benefits/NNS of/IN consuming/VBG foods/NNS rich/JJ in/IN EPA/NNP and/CC DHA/NNP or/CC taking/VBG supplements/NNS containing/VBG these/DT long-chain/JJ omega-3_fatty_acids/NN ./.

(ROOT
  (S
    (S
      (NP (JJ Further) (NNS studies))
      (VP (VBP are)
        (VP (VBN needed)
          (S
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP (DT the) (NNS mechanisms))
                (PP (IN behind)
                  (NP (DT these) (NNS associations)))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT these) (NNS findings))
      (VP (VB highlight)
        (NP
          (NP (DT the) (JJ potential) (NN health) (NNS benefits))
          (PP (IN of)
            (S
              (VP
                (VP (VBG consuming)
                  (NP
                    (NP (NNS foods))
                    (ADJP (JJ rich)
                      (PP (IN in)
                        (NP (NNP EPA)
                          (CC and)
                          (NNP DHA))))))
                (CC or)
                (VP (VBG taking)
                  (NP
                    (NP (NNS supplements))
                    (VP (VBG containing)
                      (NP (DT these) (JJ long-chain) (NN omega-3_fatty_acids)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(understand-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
case(associations-12, behind-10)
det(associations-12, these-11)
nmod:behind(understand-7, associations-12)
cc(needed-4, but-14)
det(findings-16, these-15)
nsubj(highlight-17, findings-16)
conj:but(needed-4, highlight-17)
det(benefits-21, the-18)
amod(benefits-21, potential-19)
compound(benefits-21, health-20)
dobj(highlight-17, benefits-21)
mark(consuming-23, of-22)
acl(benefits-21, consuming-23)
dobj(consuming-23, foods-24)
amod(foods-24, rich-25)
case(EPA-27, in-26)
nmod:in(rich-25, EPA-27)
cc(EPA-27, and-28)
nmod:in(rich-25, DHA-29)
conj:and(EPA-27, DHA-29)
cc(consuming-23, or-30)
acl(benefits-21, taking-31)
conj:or(consuming-23, taking-31)
dobj(taking-31, supplements-32)
acl(supplements-32, containing-33)
det(omega-3_fatty_acids-36, these-34)
amod(omega-3_fatty_acids-36, long-chain-35)
dobj(containing-33, omega-3_fatty_acids-36)

Migraine/JJ is_a/JJ common/JJ neurological_disorder/NN characterized/VBD by/IN recurrent/JJ episodes/NNS of/IN headache/NN ./.

(ROOT
  (S
    (NP (JJ Migraine) (JJ is_a) (JJ common) (NN neurological_disorder))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ recurrent) (NNS episodes))
          (PP (IN of)
            (NP (NN headache))))))
    (. .)))

amod(neurological_disorder-4, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
nsubj(characterized-5, neurological_disorder-4)
root(ROOT-0, characterized-5)
case(episodes-8, by-6)
amod(episodes-8, recurrent-7)
nmod:by(characterized-5, episodes-8)
case(headache-10, of-9)
nmod:of(episodes-8, headache-10)

The/DT pathophysiology/NN of/IN migraine/NN is/VBZ complex/JJ and/CC involves/VBZ the/DT activation/NN of/IN trigeminovascular/NN system/NN and/CC release/NN of/IN inflammatory/JJ mediators/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathophysiology))
      (PP (IN of)
        (NP (NN migraine))))
    (VP
      (VP (VBZ is)
        (ADJP (JJ complex)))
      (CC and)
      (VP (VBZ involves)
        (NP
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (NN trigeminovascular) (NN system))))
          (CC and)
          (NP
            (NP (NN release))
            (PP (IN of)
              (NP (JJ inflammatory) (NNS mediators)))))))
    (. .)))

det(pathophysiology-2, The-1)
nsubj(complex-6, pathophysiology-2)
nsubj(involves-8, pathophysiology-2)
case(migraine-4, of-3)
nmod:of(pathophysiology-2, migraine-4)
cop(complex-6, is-5)
root(ROOT-0, complex-6)
cc(complex-6, and-7)
conj:and(complex-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(system-13, of-11)
compound(system-13, trigeminovascular-12)
nmod:of(activation-10, system-13)
cc(activation-10, and-14)
dobj(involves-8, release-15)
conj:and(activation-10, release-15)
case(mediators-18, of-16)
amod(mediators-18, inflammatory-17)
nmod:of(release-15, mediators-18)

Nitric_oxide/JJ -LRB-/-LRB- NO/UH -RRB-/-RRB- has_been/NN implicated/VBN in/IN the/DT pathogenesis/NNS of/IN migraine/NN ,/, and/CC its/PRP$ inhibition/JJ has_been/NN proposed/VBD as/IN a/DT therapeutic/JJ strategy/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Nitric_oxide)
        (PRN (-LRB- -LRB-)
          (INTJ (UH NO))
          (-RRB- -RRB-))
        (NN has_been))
      (VP (VBN implicated)
        (PP (IN in)
          (NP
            (NP (DT the) (NNS pathogenesis))
            (PP (IN of)
              (NP (NN migraine))))))
      (, ,)
      (CC and)
      (NP (PRP$ its) (JJ inhibition) (NN has_been)))
    (VP (VBD proposed)
      (PP (IN as)
        (NP (DT a) (JJ therapeutic) (NN strategy))))
    (. .)))

amod(has_been-5, Nitric_oxide-1)
discourse(has_been-5, NO-3)
nsubj(proposed-17, has_been-5)
acl(has_been-5, implicated-6)
case(pathogenesis-9, in-7)
det(pathogenesis-9, the-8)
nmod:in(implicated-6, pathogenesis-9)
case(migraine-11, of-10)
nmod:of(pathogenesis-9, migraine-11)
cc(has_been-5, and-13)
nmod:poss(has_been-16, its-14)
amod(has_been-16, inhibition-15)
conj:and(has_been-5, has_been-16)
nsubj(proposed-17, has_been-16)
root(ROOT-0, proposed-17)
case(strategy-21, as-18)
det(strategy-21, a-19)
amod(strategy-21, therapeutic-20)
nmod:as(proposed-17, strategy-21)

In/IN this/DT randomized_clinical_trial/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN 7-nitroindazole/JJ ,/, a/DT selective/JJ inhibitor/NN of/IN neuronal/JJ NO_synthase/NN -LRB-/-LRB- nNOS/NNS -RRB-/-RRB- ,/, on/IN migraine_symptoms/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN randomized_clinical_trial)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP
              (LST (JJ 7-nitroindazole))
              (, ,)
              (NP
                (NP (DT a) (JJ selective) (NN inhibitor))
                (PP (IN of)
                  (NP (JJ neuronal) (NN NO_synthase)))))
            (PRN (-LRB- -LRB-) (NNS nNOS) (-RRB- -RRB-)))))
      (, ,)
      (PP (IN on)
        (NP (NNS migraine_symptoms))))
    (. .)))

case(randomized_clinical_trial-3, In-1)
det(randomized_clinical_trial-3, this-2)
nmod:in(investigated-6, randomized_clinical_trial-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(inhibitor-14, of-9)
dep(inhibitor-14, 7-nitroindazole-10)
det(inhibitor-14, a-12)
amod(inhibitor-14, selective-13)
nmod:of(effect-8, inhibitor-14)
case(NO_synthase-17, of-15)
amod(NO_synthase-17, neuronal-16)
nmod:of(inhibitor-14, NO_synthase-17)
dep(inhibitor-14, nNOS-19)
case(migraine_symptoms-23, on-22)
nmod:on(investigated-6, migraine_symptoms-23)

A/DT total/NN of/IN 100/CD patients/NNS with/IN migraine/NN were/VBD enrolled/VBN in/IN the/DT study/NN and/CC randomly/RB assigned/VBN to/TO receive/VB either/DT 7-nitroindazole/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP
      (NP (DT A) (NN total))
      (PP (IN of)
        (NP
          (NP (CD 100) (NNS patients))
          (PP (IN with)
            (NP (NN migraine))))))
    (VP (VBD were)
      (VP
        (VP (VBN enrolled)
          (PP (IN in)
            (NP (DT the) (NN study))))
        (CC and)
        (VP
          (ADVP (RB randomly))
          (VBN assigned)
          (S
            (VP (TO to)
              (VP (VB receive)
                (NP (DT either) (NN 7-nitroindazole)
                  (CC or)
                  (NN placebo))))))))
    (. .)))

det(total-2, A-1)
nsubjpass(enrolled-9, total-2)
nsubjpass(assigned-15, total-2)
nsubj:xsubj(receive-17, total-2)
case(patients-5, of-3)
nummod(patients-5, 100-4)
nmod:of(total-2, patients-5)
case(migraine-7, with-6)
nmod:with(patients-5, migraine-7)
auxpass(enrolled-9, were-8)
root(ROOT-0, enrolled-9)
case(study-12, in-10)
det(study-12, the-11)
nmod:in(enrolled-9, study-12)
cc(enrolled-9, and-13)
advmod(assigned-15, randomly-14)
conj:and(enrolled-9, assigned-15)
mark(receive-17, to-16)
xcomp(assigned-15, receive-17)
cc:preconj(7-nitroindazole-19, either-18)
dobj(receive-17, 7-nitroindazole-19)
cc(7-nitroindazole-19, or-20)
dobj(receive-17, placebo-21)
conj:or(7-nitroindazole-19, placebo-21)

At_2/NNP h/VBP after/IN dosing/VBG ,/, 7-nitroindazole/JJ reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP At_2))
    (VP (VBP h)
      (ADJP
        (ADJP
          (ADJP
            (PP (IN after)
              (S
                (VP (VBG dosing))))
            (, ,) (JJ 7-nitroindazole))
          (SBAR
            (S
              (VP (VBD reduced)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNS bronchospasms))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

nsubj(h-2, At_2-1)
root(ROOT-0, h-2)
mark(dosing-4, after-3)
advcl(7-nitroindazole-6, dosing-4)
xcomp(h-2, 7-nitroindazole-6)
ccomp(7-nitroindazole-6, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(bronchospasms-11, of-10)
nmod:of(risk-9, bronchospasms-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
nsubj(CI-18, %-17)
dep(7-nitroindazole-6, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(h-2, photophobia-27)
conj:and(7-nitroindazole-6, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
nsubj(CI-34, %-33)
dep(7-nitroindazole-6, CI-34)
nummod(%-36, 12-22-35)
dobj(CI-34, %-36)
nsubj(<-39, P-38)
dep(CI-34, <-39)
dobj(<-39, 0.0001-40)
cc(7-nitroindazole-6, and-43)
xcomp(h-2, phonophobia-44)
conj:and(7-nitroindazole-6, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
nsubj(CI-51, %-50)
dep(7-nitroindazole-6, CI-51)
nummod(%-53, 17-20-52)
dobj(CI-51, %-53)
nsubj(<-56, P-55)
dep(CI-51, <-56)
dobj(<-56, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN inhibition/NN of/IN nNOS/NNS may/MD be/VB a/DT promising/JJ therapeutic/JJ approach/NN for/IN the/DT treatment/NN of/IN migraine_symptoms/NNS ,/, particularly/RB those/DT associated/VBN with/IN photophobia/NN ,/, phonophobia/NN ,/, and/CC bronchospasms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN inhibition))
            (PP (IN of)
              (NP (NNS nNOS))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (JJ therapeutic) (NN approach))
              (PP (IN for)
                (NP
                  (NP (DT the) (NN treatment))
                  (PP (IN of)
                    (NP
                      (NP (NNS migraine_symptoms))
                      (, ,)
                      (NP
                        (NP (RB particularly) (DT those))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP
                              (NP (NN photophobia))
                              (, ,)
                              (NP (NN phonophobia))
                              (, ,)
                              (CC and)
                              (NP (NNS bronchospasms)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(approach-13, that-4)
nsubj(approach-13, inhibition-5)
case(nNOS-7, of-6)
nmod:of(inhibition-5, nNOS-7)
aux(approach-13, may-8)
cop(approach-13, be-9)
det(approach-13, a-10)
amod(approach-13, promising-11)
amod(approach-13, therapeutic-12)
ccomp(suggest-3, approach-13)
case(treatment-16, for-14)
det(treatment-16, the-15)
nmod:for(approach-13, treatment-16)
case(migraine_symptoms-18, of-17)
nmod:of(treatment-16, migraine_symptoms-18)
advmod(those-21, particularly-20)
appos(migraine_symptoms-18, those-21)
acl(those-21, associated-22)
case(photophobia-24, with-23)
nmod:with(associated-22, photophobia-24)
nmod:with(associated-22, phonophobia-26)
conj:and(photophobia-24, phonophobia-26)
cc(photophobia-24, and-28)
nmod:with(associated-22, bronchospasms-29)
conj:and(photophobia-24, bronchospasms-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN nNOS/JJ inhibitors/NNS in/IN migraine/JJ therapy/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ long-term) (NN safety)
                  (CC and)
                  (NN efficacy))
                (PP (IN of)
                  (NP (JJ nNOS) (NNS inhibitors))))
              (PP (IN in)
                (NP (JJ migraine) (NN therapy))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(safety-9, the-7)
amod(safety-9, long-term-8)
dobj(investigate-6, safety-9)
cc(safety-9, and-10)
dobj(investigate-6, efficacy-11)
conj:and(safety-9, efficacy-11)
case(inhibitors-14, of-12)
amod(inhibitors-14, nNOS-13)
nmod:of(safety-9, inhibitors-14)
case(therapy-17, in-15)
amod(therapy-17, migraine-16)
nmod:in(investigate-6, therapy-17)

Methoxyflurane/JJ has_been/NN used/VBD as/IN an/DT analgesic/JJ agent/NN for/IN decades/NNS ,/, but/CC its/PRP$ impact/NN on/IN the/DT incidence/NN of/IN hypoventilation_syndrome/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN has/VBZ not/RB been/VBN thoroughly/RB studied/VBN ./.

(ROOT
  (S
    (S
      (NP (JJ Methoxyflurane) (NN has_been))
      (VP (VBD used)
        (PP (IN as)
          (NP (DT an) (JJ analgesic) (NN agent)))
        (PP (IN for)
          (NP (NNS decades)))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (PRP$ its) (NN impact))
        (PP (IN on)
          (NP
            (NP (DT the) (NN incidence))
            (PP (IN of)
              (NP
                (NP (NN hypoventilation_syndrome))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia)))))))
      (VP (VBZ has) (RB not)
        (VP (VBN been)
          (VP
            (ADVP (RB thoroughly))
            (VBN studied)))))
    (. .)))

amod(has_been-2, Methoxyflurane-1)
nsubj(used-3, has_been-2)
root(ROOT-0, used-3)
case(agent-7, as-4)
det(agent-7, an-5)
amod(agent-7, analgesic-6)
nmod:as(used-3, agent-7)
case(decades-9, for-8)
nmod:for(used-3, decades-9)
cc(used-3, but-11)
nmod:poss(impact-13, its-12)
nsubjpass(studied-28, impact-13)
case(incidence-16, on-14)
det(incidence-16, the-15)
nmod:on(impact-13, incidence-16)
case(hypoventilation_syndrome-18, of-17)
nmod:of(incidence-16, hypoventilation_syndrome-18)
nmod:of(incidence-16, photophobia-20)
conj:and(hypoventilation_syndrome-18, photophobia-20)
cc(hypoventilation_syndrome-18, and-22)
nmod:of(incidence-16, phonophobia-23)
conj:and(hypoventilation_syndrome-18, phonophobia-23)
aux(studied-28, has-24)
neg(studied-28, not-25)
auxpass(studied-28, been-26)
advmod(studied-28, thoroughly-27)
conj:but(used-3, studied-28)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO investigate/VB the/DT effects/NNS of/IN methoxyflurane/NN on/IN the/DT incidence/NN of/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP (NN methoxyflurane))))
            (PP (IN on)
              (NP
                (NP (DT the) (NN incidence))
                (PP (IN of)
                  (NP (DT these) (NNS conditions)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(investigate-8, we-5)
root(ROOT-0, aimed-6)
mark(investigate-8, to-7)
xcomp(aimed-6, investigate-8)
det(effects-10, the-9)
dobj(investigate-8, effects-10)
case(methoxyflurane-12, of-11)
nmod:of(effects-10, methoxyflurane-12)
case(incidence-15, on-13)
det(incidence-15, the-14)
nmod:on(investigate-8, incidence-15)
case(conditions-18, of-16)
det(conditions-18, these-17)
nmod:of(incidence-15, conditions-18)

Our/PRP$ results/NNS showed/VBD that/IN at/IN 2/CD h/VBP after/IN dosing/VBG ,/, methoxyflurane/VB reduced/VBN the/DT risk/NN of/IN hypoventilation_syndrome/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (QP (IN at) (CD 2)))
          (VP (VBP h)
            (PP (IN after)
              (S
                (VP (VBG dosing))))
            (, ,)
            (S
              (VP (VB methoxyflurane)
                (VP (VBN reduced)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NN hypoventilation_syndrome))))
                  (PP (IN by)
                    (NP (CD 14) (NN %))))))
            (PRN (-LRB- -LRB-)
              (S
                (NP (CD 95) (NN %))
                (VP (VBP CI)
                  (NP
                    (NP
                      (NP (CD 6-20) (NN %))
                      (, ,)
                      (NP (NNP P)))
                    (X
                      (X (SYM =))
                      (NP (CD 0.0005))))))
              (-RRB- -RRB-))
            (, ,)
            (ADJP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP (CD 17) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 12-22) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-))
              (, ,)
              (CC and)
              (ADJP (JJ phonophobia)
                (PP (IN by)
                  (NP (CD 14) (NN %))))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 95) (NN %))
                  (VP (VBP CI)
                    (NP (CD 17-20) (NN %))
                    (, ,)
                    (SBAR
                      (S
                        (NP (NNP P))
                        (VP (VBP <)
                          (NP (CD 0.0001)))))))
                (-RRB- -RRB-)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(h-7, that-4)
advmod(2-6, at-5)
nsubj(h-7, 2-6)
ccomp(showed-3, h-7)
mark(dosing-9, after-8)
advcl(h-7, dosing-9)
ccomp(h-7, methoxyflurane-11)
dep(methoxyflurane-11, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(hypoventilation_syndrome-16, of-15)
nmod:of(risk-14, hypoventilation_syndrome-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
nsubj(CI-23, %-22)
parataxis(h-7, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(h-7, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
nsubj(CI-39, %-38)
dep(photophobia-32, CI-39)
nummod(%-41, 12-22-40)
dobj(CI-39, %-41)
nsubj(<-44, P-43)
dep(CI-39, <-44)
dobj(<-44, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(h-7, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
nsubj(CI-56, %-55)
dep(photophobia-32, CI-56)
nummod(%-58, 17-20-57)
dobj(CI-56, %-58)
nsubj(<-61, P-60)
dep(CI-56, <-61)
dobj(<-61, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN methoxyflurane/NN could/MD be/VB a/DT promising/JJ option/NN for/IN managing/VBG pain/NN while/IN reducing/VBG the/DT risk/NN of/IN hypoventilation_syndrome/JJ and/CC associated/VBN symptoms/NNS such/JJ as/IN photophobia/NN and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN methoxyflurane))
          (VP (MD could)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN option))
                (PP (IN for)
                  (NP (VBG managing) (NN pain)
                    (SBAR
                      (WHNP (IN while))
                      (S
                        (VP (VBG reducing)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP
                                (NP
                                  (ADJP (JJ hypoventilation_syndrome)
                                    (CC and)
                                    (VBN associated))
                                  (NNS symptoms))
                                (PP (JJ such) (IN as)
                                  (NP (NN photophobia)
                                    (CC and)
                                    (NN phonophobia)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-10, that-4)
nsubj(option-10, methoxyflurane-5)
aux(option-10, could-6)
cop(option-10, be-7)
det(option-10, a-8)
amod(option-10, promising-9)
ccomp(suggest-3, option-10)
case(pain-13, for-11)
amod(pain-13, managing-12)
nmod:for(option-10, pain-13)
nsubj(reducing-15, while-14)
ccomp(pain-13, reducing-15)
det(risk-17, the-16)
dobj(reducing-15, risk-17)
case(symptoms-22, of-18)
amod(symptoms-22, hypoventilation_syndrome-19)
cc(hypoventilation_syndrome-19, and-20)
conj:and(hypoventilation_syndrome-19, associated-21)
amod(symptoms-22, associated-21)
nmod:of(risk-17, symptoms-22)
case(photophobia-25, such-23)
mwe(such-23, as-24)
nmod:such_as(symptoms-22, photophobia-25)
cc(photophobia-25, and-26)
nmod:such_as(symptoms-22, phonophobia-27)
conj:and(photophobia-25, phonophobia-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN methoxyflurane/NN in/IN pain/NN management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (NN methoxyflurane))
                      (PP (IN in)
                        (NP (NN pain) (NN management))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(determine-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, determine-10)
conj:and(confirm-6, determine-10)
det(regimen-14, the-11)
amod(regimen-14, optimal-12)
amod(regimen-14, dosing-13)
dobj(determine-10, regimen-14)
case(methoxyflurane-16, for-15)
nmod:for(regimen-14, methoxyflurane-16)
case(management-19, in-17)
compound(management-19, pain-18)
nmod:in(methoxyflurane-16, management-19)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, belong/VBP to/TO the/DT group/NN of/IN essential/JJ fatty_acids/NNS that/WDT are/VBP required/VBN for/IN maintaining/VBG optimal/JJ health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP belong)
      (PP (TO to)
        (NP
          (NP (DT the) (NN group))
          (PP (IN of)
            (NP
              (NP (JJ essential) (NNS fatty_acids))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP are)
                    (VP (VBN required)
                      (PP (IN for)
                        (S
                          (VP (VBG maintaining)
                            (NP (JJ optimal) (NN health))))))))))))))
    (. .)))

nsubj(belong-14, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
root(ROOT-0, belong-14)
case(group-17, to-15)
det(group-17, the-16)
nmod:to(belong-14, group-17)
case(fatty_acids-20, of-18)
amod(fatty_acids-20, essential-19)
nmod:of(group-17, fatty_acids-20)
nsubjpass(required-23, fatty_acids-20)
ref(fatty_acids-20, that-21)
auxpass(required-23, are-22)
acl:relcl(fatty_acids-20, required-23)
mark(maintaining-25, for-24)
advcl(required-23, maintaining-25)
amod(health-27, optimal-26)
dobj(maintaining-25, health-27)

These/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN associated/VBN with/IN a/DT variety/NN of/IN health/NN benefits/NNS ,/, including/VBG decreased/VBN meclozine/JJ levels/NNS in/IN hypermeclozinemic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (DT a) (NN variety))
              (PP (IN of)
                (NP (NN health) (NNS benefits)))
              (, ,)
              (VP (VBG including)
                (NP
                  (NP (VBN decreased) (JJ meclozine) (NNS levels))
                  (PP (IN in)
                    (NP
                      (NP (JJ hypermeclozinemic) (NNS patients))
                      (CC and)
                      (NP
                        (NP
                          (NP (VBN decreased) (NN risk))
                          (PP (IN of)
                            (S
                              (VP (VBG developing)
                                (NP (NN coronary_heart_disease))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

det(omega-3_fatty_acids-3, These-1)
amod(omega-3_fatty_acids-3, long-chain-2)
nsubjpass(associated-6, omega-3_fatty_acids-3)
aux(associated-6, have-4)
auxpass(associated-6, been-5)
root(ROOT-0, associated-6)
case(variety-9, with-7)
det(variety-9, a-8)
nmod:with(associated-6, variety-9)
case(benefits-12, of-10)
compound(benefits-12, health-11)
nmod:of(variety-9, benefits-12)
acl(variety-9, including-14)
amod(levels-17, decreased-15)
amod(levels-17, meclozine-16)
dobj(including-14, levels-17)
case(patients-20, in-18)
amod(patients-20, hypermeclozinemic-19)
nmod:in(levels-17, patients-20)
cc(patients-20, and-21)
amod(risk-23, decreased-22)
nmod:in(levels-17, risk-23)
conj:and(patients-20, risk-23)
mark(developing-25, of-24)
acl(risk-23, developing-25)
dobj(developing-25, coronary_heart_disease-26)
appos(risk-23, CHD-28)

In/IN hypermeclozinemic/JJ patients/NNS ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO decrease/VB meclozine/JJ levels/NNS ,/, which/WDT is_a/JJ potential/JJ marker/NN for/IN cardiovascular_disease/JJ risk/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ hypermeclozinemic) (NNS patients)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (JJ meclozine) (NNS levels))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP
                        (NP (JJ is_a) (JJ potential) (NN marker))
                        (PP (IN for)
                          (NP (JJ cardiovascular_disease) (NN risk)))))))))))))
    (. .)))

case(patients-3, In-1)
amod(patients-3, hypermeclozinemic-2)
nmod:in(shown-10, patients-3)
nsubjpass(shown-10, EPA-5)
nsubj:xsubj(decrease-12, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubjpass(shown-10, DHA-7)
nsubj:xsubj(decrease-12, DHA-7)
aux(shown-10, have-8)
auxpass(shown-10, been-9)
root(ROOT-0, shown-10)
mark(decrease-12, to-11)
xcomp(shown-10, decrease-12)
amod(levels-14, meclozine-13)
dobj(decrease-12, levels-14)
dep(marker-19, levels-14)
ref(levels-14, which-16)
amod(marker-19, is_a-17)
amod(marker-19, potential-18)
acl:relcl(levels-14, marker-19)
case(risk-22, for-20)
amod(risk-22, cardiovascular_disease-21)
nmod:for(marker-19, risk-22)

Additionally/RB ,/, long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN found/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG CHD/NNP by/IN improving/VBG lipid/NN profiles/NNS ,/, reducing/VBG inflammation/NN ,/, and/CC decreasing/VBG platelet_aggregation/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NNP CHD))
                        (PP (IN by)
                          (S
                            (VP
                              (VP (VBG improving)
                                (NP (NN lipid) (NNS profiles)))
                              (, ,)
                              (VP (VBG reducing)
                                (NP (NN inflammation)))
                              (, ,)
                              (CC and)
                              (VP (VBG decreasing)
                                (NP (NN platelet_aggregation))))))))))))))))
    (. .)))

advmod(found-7, Additionally-1)
amod(omega-3_fatty_acids-4, long-chain-3)
nsubjpass(found-7, omega-3_fatty_acids-4)
nsubj:xsubj(reduce-9, omega-3_fatty_acids-4)
aux(found-7, have-5)
auxpass(found-7, been-6)
root(ROOT-0, found-7)
mark(reduce-9, to-8)
xcomp(found-7, reduce-9)
det(risk-11, the-10)
dobj(reduce-9, risk-11)
mark(developing-13, of-12)
acl(risk-11, developing-13)
dobj(developing-13, CHD-14)
mark(improving-16, by-15)
advcl(developing-13, improving-16)
compound(profiles-18, lipid-17)
dobj(improving-16, profiles-18)
advcl(developing-13, reducing-20)
conj:and(improving-16, reducing-20)
dobj(reducing-20, inflammation-21)
cc(improving-16, and-23)
advcl(developing-13, decreasing-24)
conj:and(improving-16, decreasing-24)
dobj(decreasing-24, platelet_aggregation-25)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN cardiovascular_disease/NN in/IN susceptible/JJ populations/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (NN cardiovascular_disease))
                            (PP (IN in)
                              (NP (JJ susceptible) (NNS populations)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-21, that-4)
csubj(strategy-21, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(sources-14, through-12)
amod(sources-14, dietary-13)
nmod:through(increasing-5, sources-14)
cc(sources-14, or-15)
nmod:through(increasing-5, supplementation-16)
conj:or(sources-14, supplementation-16)
aux(strategy-21, may-17)
cop(strategy-21, be-18)
det(strategy-21, an-19)
amod(strategy-21, effective-20)
ccomp(suggest-3, strategy-21)
mark(reducing-23, for-22)
acl(strategy-21, reducing-23)
det(risk-25, the-24)
dobj(reducing-23, risk-25)
case(cardiovascular_disease-27, of-26)
nmod:of(risk-25, cardiovascular_disease-27)
case(populations-30, in-28)
amod(populations-30, susceptible-29)
nmod:in(cardiovascular_disease-27, populations-30)

The/DT placenta/NN plays/VBZ a/DT critical/JJ role/NN in/IN the/DT metabolism/NN of/IN drugs/NNS ,/, including/VBG Peretinoin/NNP ,/, which/WDT is_a/NN synthetic/NN retinoid/VBD that/IN has_been/VBP shown/VBN to/TO have/VB potent/JJ anticancer/JJ properties/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN placenta))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ critical) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN metabolism))
            (PP (IN of)
              (NP
                (NP (NNS drugs))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (NNP Peretinoin))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (NP (NN is_a) (NN synthetic))
                        (VP (VBD retinoid)
                          (SBAR (IN that)
                            (S
                              (VP (VBP has_been)
                                (VP (VBN shown)
                                  (S
                                    (VP (TO to)
                                      (VP (VB have)
                                        (NP (JJ potent) (JJ anticancer) (NNS properties))))))))))))))))))))
    (. .)))

det(placenta-2, The-1)
nsubj(plays-3, placenta-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, critical-5)
dobj(plays-3, role-6)
case(metabolism-9, in-7)
det(metabolism-9, the-8)
nmod:in(role-6, metabolism-9)
case(drugs-11, of-10)
nmod:of(metabolism-9, drugs-11)
acl(drugs-11, including-13)
dobj(including-13, Peretinoin-14)
dobj(retinoid-19, Peretinoin-14)
ref(Peretinoin-14, which-16)
compound(synthetic-18, is_a-17)
nsubj(retinoid-19, synthetic-18)
acl:relcl(Peretinoin-14, retinoid-19)
mark(has_been-21, that-20)
ccomp(retinoid-19, has_been-21)
dep(has_been-21, shown-22)
mark(have-24, to-23)
xcomp(shown-22, have-24)
amod(properties-27, potent-25)
amod(properties-27, anticancer-26)
dobj(have-24, properties-27)

Real-time/JJ quantitative/JJ reverse_transcriptase-polymerase/JJ chain/NN reaction/NN -LRB-/-LRB- Q-RT-PCR/NNP -RRB-/-RRB- analysis/NN was/VBD performed/VBN to/TO investigate/VB the/DT mRNA/JJ levels/NNS of/IN placental/JJ Peretinoin/NNP metabolism/NN enzymes/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Real-time) (JJ quantitative) (JJ reverse_transcriptase-polymerase) (NN chain))
        (NN reaction))
      (PRN (-LRB- -LRB-)
        (NP (NNP Q-RT-PCR))
        (-RRB- -RRB-))
      (NP (NN analysis)))
    (VP (VBD was)
      (VP (VBN performed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ mRNA) (NNS levels))
                (PP (IN of)
                  (NP (JJ placental) (NNP Peretinoin) (NN metabolism) (NNS enzymes)))))))))
    (. .)))

amod(chain-4, Real-time-1)
amod(chain-4, quantitative-2)
amod(chain-4, reverse_transcriptase-polymerase-3)
compound(reaction-5, chain-4)
nsubjpass(performed-11, reaction-5)
nsubj:xsubj(investigate-13, reaction-5)
appos(reaction-5, Q-RT-PCR-7)
dep(reaction-5, analysis-9)
auxpass(performed-11, was-10)
root(ROOT-0, performed-11)
mark(investigate-13, to-12)
xcomp(performed-11, investigate-13)
det(levels-16, the-14)
amod(levels-16, mRNA-15)
dobj(investigate-13, levels-16)
case(enzymes-21, of-17)
amod(enzymes-21, placental-18)
compound(enzymes-21, Peretinoin-19)
compound(enzymes-21, metabolism-20)
nmod:of(levels-16, enzymes-21)

The/DT results/NNS revealed/VBD a/DT significant/JJ increase/NN in/IN mRNA/NN levels/NNS for/IN UDP-glucuronosyltransferase_1A1/NNS -LRB-/-LRB- UGT1A1/NNP -RRB-/-RRB- ,/, estrogen_sulfotransferase/NN 1E1/CD -LRB-/-LRB- SULT1E1/NNP -RRB-/-RRB- ,/, Peretinoin/NNP 5a-reductase_1/JJ -LRB-/-LRB- Huh-7-Luc/NNS -RRB-/-RRB- and/CC Peretinoin/NNP 5a-reductase/JJ 2/CD -LRB-/-LRB- SRD5A2/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD revealed)
      (NP (DT a) (JJ significant) (NN increase))
      (PP (IN in)
        (NP (NN mRNA) (NNS levels)))
      (PP (IN for)
        (NP
          (NP
            (NP
              (NP (NNS UDP-glucuronosyltransferase_1A1))
              (PRN (-LRB- -LRB-)
                (NP (NNP UGT1A1))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NN estrogen_sulfotransferase) (CD 1E1))
              (PRN (-LRB- -LRB-)
                (NP (NNP SULT1E1))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (NNP Peretinoin))
              (NP (JJ 5a-reductase_1) (-LRB- -LRB-) (NNS Huh-7-Luc) (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (NNP Peretinoin))
              (ADJP (JJ 5a-reductase)
                (NP-TMP (CD 2)))))
          (PRN (-LRB- -LRB-)
            (NP (NNP SRD5A2))
            (-RRB- -RRB-)))))
    (. .)))

det(results-2, The-1)
nsubj(revealed-3, results-2)
root(ROOT-0, revealed-3)
det(increase-6, a-4)
amod(increase-6, significant-5)
dobj(revealed-3, increase-6)
case(levels-9, in-7)
compound(levels-9, mRNA-8)
nmod:in(revealed-3, levels-9)
case(UDP-glucuronosyltransferase_1A1-11, for-10)
nmod:for(revealed-3, UDP-glucuronosyltransferase_1A1-11)
appos(UDP-glucuronosyltransferase_1A1-11, UGT1A1-13)
nmod:for(revealed-3, estrogen_sulfotransferase-16)
conj:and(UDP-glucuronosyltransferase_1A1-11, estrogen_sulfotransferase-16)
nummod(estrogen_sulfotransferase-16, 1E1-17)
appos(estrogen_sulfotransferase-16, SULT1E1-19)
nmod:for(revealed-3, Peretinoin-22)
conj:and(UDP-glucuronosyltransferase_1A1-11, Peretinoin-22)
amod(Huh-7-Luc-25, 5a-reductase_1-23)
dep(Peretinoin-22, Huh-7-Luc-25)
cc(UDP-glucuronosyltransferase_1A1-11, and-27)
nmod:for(revealed-3, Peretinoin-28)
conj:and(UDP-glucuronosyltransferase_1A1-11, Peretinoin-28)
amod(Peretinoin-28, 5a-reductase-29)
nmod:tmod(5a-reductase-29, 2-30)
appos(UDP-glucuronosyltransferase_1A1-11, SRD5A2-32)

These/DT findings/NNS suggest/VBP that/IN the/DT placenta/NN may/MD play/VB a/DT crucial/JJ role/NN in/IN the/DT metabolism/NN of/IN Peretinoin/NNP and/CC that/IN alterations/NNS in/IN these/DT enzymes/NNS may/MD impact/VB the/DT efficacy/NN and/CC toxicity/NN of/IN this/DT drug/NN during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (DT the) (NN placenta))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (JJ crucial) (NN role))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN metabolism))
                      (PP (IN of)
                        (NP (NNP Peretinoin))))))))))
        (CC and)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS alterations))
              (PP (IN in)
                (NP (DT these) (NNS enzymes))))
            (VP (MD may)
              (VP (VB impact)
                (NP
                  (NP (DT the) (NN efficacy)
                    (CC and)
                    (NN toxicity))
                  (PP (IN of)
                    (NP (DT this) (NN drug))))
                (PP (IN during)
                  (NP (NN pregnancy)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-8, that-4)
det(placenta-6, the-5)
nsubj(play-8, placenta-6)
aux(play-8, may-7)
ccomp(suggest-3, play-8)
det(role-11, a-9)
amod(role-11, crucial-10)
dobj(play-8, role-11)
case(metabolism-14, in-12)
det(metabolism-14, the-13)
nmod:in(role-11, metabolism-14)
case(Peretinoin-16, of-15)
nmod:of(metabolism-14, Peretinoin-16)
cc(play-8, and-17)
mark(impact-24, that-18)
nsubj(impact-24, alterations-19)
case(enzymes-22, in-20)
det(enzymes-22, these-21)
nmod:in(alterations-19, enzymes-22)
aux(impact-24, may-23)
ccomp(suggest-3, impact-24)
conj:and(play-8, impact-24)
det(efficacy-26, the-25)
dobj(impact-24, efficacy-26)
cc(efficacy-26, and-27)
dobj(impact-24, toxicity-28)
conj:and(efficacy-26, toxicity-28)
case(drug-31, of-29)
det(drug-31, this-30)
nmod:of(efficacy-26, drug-31)
case(pregnancy-33, during-32)
nmod:during(impact-24, pregnancy-33)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT changes/NNS and/CC their/PRP$ potential/JJ implications/NNS for/IN clinical/JJ practice/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS changes))
                    (CC and)
                    (NP
                      (NP (PRP$ their) (JJ potential) (NNS implications))
                      (PP (IN for)
                        (NP (JJ clinical) (NN practice))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
case(changes-11, underlying-9)
det(changes-11, these-10)
nmod:underlying(mechanisms-8, changes-11)
cc(changes-11, and-12)
nmod:poss(implications-15, their-13)
amod(implications-15, potential-14)
nmod:underlying(mechanisms-8, implications-15)
conj:and(changes-11, implications-15)
case(practice-18, for-16)
amod(practice-18, clinical-17)
nmod:for(implications-15, practice-18)

Transient_receptor_potential_melastatin_7/NNP -LRB-/-LRB- TRPM7/NNP -RRB-/-RRB- is_a/VBZ unique/JJ ion/NN channel/NN that/WDT plays/VBZ an/DT important/JJ role/NN in/IN regulating/VBG various/JJ physiological/JJ processes/NNS ,/, including/VBG cell/NN proliferation/NN ,/, differentiation/NN ,/, and/CC migration/NN ./.

(ROOT
  (S
    (NP (NNP Transient_receptor_potential_melastatin_7) (-LRB- -LRB-)
      (NP (NNP TRPM7))
      (-RRB- -RRB-))
    (VP (VBZ is_a)
      (NP
        (NP (JJ unique) (NN ion) (NN channel))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP
                        (NP (JJ various) (JJ physiological) (NNS processes))
                        (, ,)
                        (VP (VBG including)
                          (NP
                            (NP (NN cell) (NN proliferation))
                            (, ,)
                            (NP (NN differentiation))
                            (, ,)
                            (CC and)
                            (NP (NN migration))))))))))))))
    (. .)))

nsubj(is_a-5, Transient_receptor_potential_melastatin_7-1)
dep(Transient_receptor_potential_melastatin_7-1, TRPM7-3)
root(ROOT-0, is_a-5)
amod(channel-8, unique-6)
compound(channel-8, ion-7)
dobj(is_a-5, channel-8)
nsubj(plays-10, channel-8)
ref(channel-8, that-9)
acl:relcl(channel-8, plays-10)
det(role-13, an-11)
amod(role-13, important-12)
dobj(plays-10, role-13)
mark(regulating-15, in-14)
acl(role-13, regulating-15)
amod(processes-18, various-16)
amod(processes-18, physiological-17)
dobj(regulating-15, processes-18)
acl(processes-18, including-20)
compound(proliferation-22, cell-21)
dobj(including-20, proliferation-22)
dobj(including-20, differentiation-24)
conj:and(proliferation-22, differentiation-24)
cc(proliferation-22, and-26)
dobj(including-20, migration-27)
conj:and(proliferation-22, migration-27)

The/DT TRPM7/NNP channel/NN has_been/VBP shown/VBN to_be/NN involved/VBN in/IN the/DT pathogenesis/NNS of/IN several_diseases/NNS ,/, including/VBG hypertension/NN and/CC cancer/NN ./.

(ROOT
  (S
    (NP (DT The) (NNP TRPM7) (NN channel))
    (VP (VBP has_been)
      (VP (VBN shown)
        (NP
          (NP (NN to_be))
          (VP (VBN involved)
            (PP (IN in)
              (NP
                (NP (DT the) (NNS pathogenesis))
                (PP (IN of)
                  (NP
                    (NP (NNS several_diseases))
                    (, ,)
                    (VP (VBG including)
                      (NP (NN hypertension)
                        (CC and)
                        (NN cancer)))))))))))
    (. .)))

det(channel-3, The-1)
compound(channel-3, TRPM7-2)
nsubj(has_been-4, channel-3)
root(ROOT-0, has_been-4)
dep(has_been-4, shown-5)
dobj(shown-5, to_be-6)
acl(to_be-6, involved-7)
case(pathogenesis-10, in-8)
det(pathogenesis-10, the-9)
nmod:in(involved-7, pathogenesis-10)
case(several_diseases-12, of-11)
nmod:of(pathogenesis-10, several_diseases-12)
acl(several_diseases-12, including-14)
dobj(including-14, hypertension-15)
cc(hypertension-15, and-16)
dobj(including-14, cancer-17)
conj:and(hypertension-15, cancer-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN pertussis/NN toxin/NN on/IN the/DT response/NN of/IN TRPM7/NNP to/TO SKF-96365/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN pertussis) (NN toxin))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN response))
          (PP (IN of)
            (NP (NNP TRPM7)))))
      (PP (TO to)
        (NP (NN SKF-96365))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(toxin-11, of-9)
compound(toxin-11, pertussis-10)
nmod:of(effect-8, toxin-11)
case(response-14, on-12)
det(response-14, the-13)
nmod:on(investigated-6, response-14)
case(TRPM7-16, of-15)
nmod:of(response-14, TRPM7-16)
case(SKF-96365-18, to-17)
nmod:to(investigated-6, SKF-96365-18)

Our/PRP$ results/NNS showed/VBD that/IN treatment/NN with/IN pertussis/NN toxin/NN did/VBD not/RB affect/VB the/DT response/NN of/IN TRPM7/NNP to/TO SKF-96365/NN ,/, suggesting/VBG that/IN this/DT response/NN may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN treatment))
            (PP (IN with)
              (NP (NN pertussis) (NN toxin))))
          (VP (VBD did) (RB not)
            (VP (VB affect)
              (NP
                (NP (DT the) (NN response))
                (PP (IN of)
                  (NP (NNP TRPM7))))
              (PP (TO to)
                (NP (NN SKF-96365)))))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (SBAR (IN that)
            (S
              (NP (DT this) (NN response))
              (VP (MD may)
                (VP (VB be)
                  (VP (VBN mediated)
                    (PP (IN via)
                      (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(affect-11, that-4)
nsubj(affect-11, treatment-5)
case(toxin-8, with-6)
compound(toxin-8, pertussis-7)
nmod:with(treatment-5, toxin-8)
aux(affect-11, did-9)
neg(affect-11, not-10)
ccomp(showed-3, affect-11)
det(response-13, the-12)
dobj(affect-11, response-13)
case(TRPM7-15, of-14)
nmod:of(response-13, TRPM7-15)
case(SKF-96365-17, to-16)
nmod:to(affect-11, SKF-96365-17)
xcomp(showed-3, suggesting-19)
mark(mediated-25, that-20)
det(response-22, this-21)
nsubjpass(mediated-25, response-22)
aux(mediated-25, may-23)
auxpass(mediated-25, be-24)
ccomp(suggesting-19, mediated-25)
case(G_protein-30, via-26)
det(G_protein-30, a-27)
compound(G_protein-30, pertussis-28)
amod(G_protein-30, toxin-insensitive-29)
nmod:via(mediated-25, G_protein-30)

These/DT findings/NNS provide/VBP new/JJ insights/NNS into/IN the/DT signaling/VBG pathways/NNS involved/VBN in/IN TRPM7-mediated/JJ responses/NNS and/CC may/MD have/VB important/JJ implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN diseases/NNS associated/VBN with/IN TRPM7/NNP dysfunction/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (VBG signaling) (NNS pathways))
            (VP (VBN involved)
              (PP (IN in)
                (NP (JJ TRPM7-mediated) (NNS responses)))))))
      (CC and)
      (VP (MD may)
        (VP (VB have)
          (NP
            (NP (JJ important) (NNS implications))
            (PP (IN for)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                    (PP (IN for)
                      (NP
                        (NP (NNS diseases))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (NNP TRPM7) (NN dysfunction))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
nsubj(have-16, findings-2)
root(ROOT-0, provide-3)
amod(insights-5, new-4)
dobj(provide-3, insights-5)
case(pathways-9, into-6)
det(pathways-9, the-7)
amod(pathways-9, signaling-8)
nmod:into(provide-3, pathways-9)
acl(pathways-9, involved-10)
case(responses-13, in-11)
amod(responses-13, TRPM7-mediated-12)
nmod:in(involved-10, responses-13)
cc(provide-3, and-14)
aux(have-16, may-15)
conj:and(provide-3, have-16)
amod(implications-18, important-17)
dobj(have-16, implications-18)
case(development-21, for-19)
det(development-21, the-20)
nmod:for(implications-18, development-21)
case(strategies-25, of-22)
amod(strategies-25, novel-23)
amod(strategies-25, therapeutic-24)
nmod:of(development-21, strategies-25)
case(diseases-27, for-26)
nmod:for(strategies-25, diseases-27)
acl(diseases-27, associated-28)
case(dysfunction-31, with-29)
compound(dysfunction-31, TRPM7-30)
nmod:with(associated-28, dysfunction-31)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanism/NN underlying/VBG this/DT observation/NN and/CC to/TO explore/VB its/PRP$ potential/JJ clinical/JJ applications/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ precise) (NN mechanism))
                  (VP (VBG underlying)
                    (NP (DT this) (NN observation))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (PRP$ its) (JJ potential) (JJ clinical) (NNS applications))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanism-9, the-7)
amod(mechanism-9, precise-8)
dobj(elucidate-6, mechanism-9)
acl(mechanism-9, underlying-10)
det(observation-12, this-11)
dobj(underlying-10, observation-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
nmod:poss(applications-19, its-16)
amod(applications-19, potential-17)
amod(applications-19, clinical-18)
dobj(explore-15, applications-19)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (JJ cardioprotective) (NNS effects))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(effects-10, for-6)
nmod:poss(effects-10, their-7)
amod(effects-10, potential-8)
amod(effects-10, cardioprotective-9)
nmod:for(studied-5, effects-10)

The/DT long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to_be/VB associated/VBN with/IN decreased/VBN halofuginone/NN levels/NNS in/IN hyperhalofuginonemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (VB to_be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (VBN decreased) (NN halofuginone) (NNS levels)))
                (PP (IN in)
                  (NP (JJ hyperhalofuginonemic) (NNS patients)))))))))
    (. .)))

det(omega-3_fatty_acids-3, The-1)
amod(omega-3_fatty_acids-3, long-chain-2)
nsubjpass(found-25, omega-3_fatty_acids-3)
dep(omega-3_fatty_acids-3, eicosapentaenoic_acid-5)
dobj(eicosapentaenoic_acid-5, EPA-7)
compound(n-3-11, 20:5-10)
dep(EPA-7, n-3-11)
cc(eicosapentaenoic_acid-5, and-13)
dep(omega-3_fatty_acids-3, docosahexaenoic_acid-14)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-14)
dobj(docosahexaenoic_acid-14, DHA-16)
compound(n-3-20, 22:6-19)
dep(DHA-16, n-3-20)
aux(found-25, have-23)
auxpass(found-25, been-24)
root(ROOT-0, found-25)
ccomp(found-25, to_be-26)
dep(to_be-26, associated-27)
case(levels-31, with-28)
amod(levels-31, decreased-29)
compound(levels-31, halofuginone-30)
nmod:with(associated-27, levels-31)
case(patients-34, in-32)
amod(patients-34, hyperhalofuginonemic-33)
nmod:in(associated-27, patients-34)

Halofuginone/JJ is_a/NN naturally/RB occurring/VBG alkaloid/VBD that/IN has_been/VBP shown/VBN to/TO inhibit/VB collagen/NN synthesis/NN and/CC angiogenesis/NNS ,/, which/WDT may/MD contribute/VB to/TO the/DT development/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Halofuginone) (NN is_a))
      (ADJP (RB naturally) (VBG occurring)))
    (VP (VBD alkaloid)
      (SBAR (IN that)
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB inhibit)
                    (NP
                      (NP (NN collagen) (NN synthesis)
                        (CC and)
                        (NNS angiogenesis))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD may)
                            (VP (VB contribute)
                              (PP (TO to)
                                (NP
                                  (NP (DT the) (NN development))
                                  (PP (IN of)
                                    (NP (NN cardiovascular_disease))))))))))))))))))
    (. .)))

amod(is_a-2, Halofuginone-1)
nsubj(alkaloid-5, is_a-2)
advmod(occurring-4, naturally-3)
amod(is_a-2, occurring-4)
root(ROOT-0, alkaloid-5)
mark(has_been-7, that-6)
ccomp(alkaloid-5, has_been-7)
dep(has_been-7, shown-8)
mark(inhibit-10, to-9)
xcomp(shown-8, inhibit-10)
compound(synthesis-12, collagen-11)
dobj(inhibit-10, synthesis-12)
nsubj(contribute-18, synthesis-12)
cc(synthesis-12, and-13)
dobj(inhibit-10, angiogenesis-14)
conj:and(synthesis-12, angiogenesis-14)
nsubj(contribute-18, angiogenesis-14)
ref(synthesis-12, which-16)
aux(contribute-18, may-17)
acl:relcl(synthesis-12, contribute-18)
case(development-21, to-19)
det(development-21, the-20)
nmod:to(contribute-18, development-21)
case(cardiovascular_disease-23, of-22)
nmod:of(development-21, cardiovascular_disease-23)

In/IN addition/NN ,/, EPA/NNP and/CC DHA/NNP have/VBP also/RB been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(associated-10, addition-2)
nsubjpass(associated-10, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(associated-10, DHA-6)
aux(associated-10, have-7)
advmod(associated-10, also-8)
auxpass(associated-10, been-9)
root(ROOT-0, associated-10)
case(risk-14, with-11)
det(risk-14, a-12)
amod(risk-14, decreased-13)
nmod:with(associated-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD have/VB beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ beneficial) (NNS effects))
                (PP (IN on)
                  (NP (NN cardiovascular_health)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-18, that-4)
csubj(have-18, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
case(sources-14, through-12)
amod(sources-14, dietary-13)
nmod:through(increasing-5, sources-14)
cc(sources-14, or-15)
nmod:through(increasing-5, supplementation-16)
conj:or(sources-14, supplementation-16)
aux(have-18, may-17)
ccomp(suggest-3, have-18)
amod(effects-20, beneficial-19)
dobj(have-18, effects-20)
case(cardiovascular_health-22, on-21)
nmod:on(effects-20, cardiovascular_health-22)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS by/IN which/WDT these/DT fatty_acids/NNS exert/VBP their/PRP$ cardioprotective/JJ effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN various/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN by)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (DT these) (NNS fatty_acids))
                      (VP (VBP exert)
                        (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ various) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
mark(exert-14, by-10)
dobj(exert-14, which-11)
det(fatty_acids-13, these-12)
nsubj(exert-14, fatty_acids-13)
advcl(elucidate-6, exert-14)
nmod:poss(effects-17, their-15)
amod(effects-17, cardioprotective-16)
dobj(exert-14, effects-17)
cc(elucidate-6, and-18)
mark(determine-20, to-19)
ccomp(needed-4, determine-20)
conj:and(elucidate-6, determine-20)
amod(dosages-22, optimal-21)
dobj(determine-20, dosages-22)
case(populations-26, for-23)
amod(populations-26, various-24)
amod(populations-26, patient-25)
nmod:for(dosages-22, populations-26)

This/DT study/NN aimed/VBD to/TO investigate/VB the/DT efficacy/NN of/IN Docusate/NNP in/IN reducing/VBG the/DT risk/NN of/IN colonic_inertia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN efficacy))
              (PP (IN of)
                (NP (NNP Docusate))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NN colonic_inertia))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(efficacy-7, the-6)
dobj(investigate-5, efficacy-7)
case(Docusate-9, of-8)
nmod:of(efficacy-7, Docusate-9)
mark(reducing-11, in-10)
advcl(investigate-5, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(colonic_inertia-15, of-14)
nmod:of(risk-13, colonic_inertia-15)
nmod:of(risk-13, photophobia-17)
conj:and(colonic_inertia-15, photophobia-17)
cc(colonic_inertia-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(colonic_inertia-15, phonophobia-20)

The/DT study/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN patients/NNS who/WP were/VBD administered/VBN Docusate/NNP and/CC monitored/VBN for/IN 2/CD hours/NNS after/IN dosing/VBG ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP
                (NP (NNS patients))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD were)
                      (VP
                        (VP (VBN administered)
                          (NP (NNP Docusate)))
                        (CC and)
                        (VP (VBN monitored)
                          (PP (IN for)
                            (NP (CD 2) (NNS hours)))
                          (PP (IN after)
                            (S
                              (VP (VBG dosing)))))))))))))))
    (. .)))

det(study-2, The-1)
nsubjpass(conducted-4, study-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(group-7, on-5)
det(group-7, a-6)
nmod:on(conducted-4, group-7)
case(patients-9, of-8)
nmod:of(group-7, patients-9)
nsubjpass(administered-12, patients-9)
nsubjpass(monitored-15, patients-9)
ref(patients-9, who-10)
auxpass(administered-12, were-11)
acl:relcl(patients-9, administered-12)
dobj(administered-12, Docusate-13)
cc(administered-12, and-14)
acl:relcl(patients-9, monitored-15)
conj:and(administered-12, monitored-15)
case(hours-18, for-16)
nummod(hours-18, 2-17)
nmod:for(monitored-15, hours-18)
mark(dosing-20, after-19)
advcl(monitored-15, dosing-20)

The/DT results/NNS showed/VBD that/IN Docusate/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN colonic_inertia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP Docusate))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN colonic_inertia))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-7, that-4)
nsubj(reduced-7, Docusate-5)
advmod(reduced-7, significantly-6)
ccomp(showed-3, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(colonic_inertia-11, of-10)
nmod:of(risk-9, colonic_inertia-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN Docusate/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN patients/NNS suffering/VBG from/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Docusate))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP (DT these) (NNS conditions))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Docusate-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, suffering-14)
case(conditions-17, from-15)
det(conditions-17, these-16)
nmod:from(suffering-14, conditions-17)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG the/DT observed/JJ effects/NNS of/IN Docusate/NNP on/IN colonic_inertia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP
                      (NP (DT the) (JJ observed) (NNS effects))
                      (PP (IN of)
                        (NP (NNP Docusate)))
                      (PP (IN on)
                        (NP
                          (NP (NN colonic_inertia))
                          (, ,)
                          (NP (NN photophobia))
                          (, ,)
                          (CC and)
                          (NP (NN phonophobia)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(confirm-6, to-5)
ccomp(warranted-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(explore-11, to-10)
ccomp(warranted-4, explore-11)
conj:and(confirm-6, explore-11)
det(mechanisms-14, the-12)
amod(mechanisms-14, potential-13)
dobj(explore-11, mechanisms-14)
acl(mechanisms-14, underlying-15)
det(effects-18, the-16)
amod(effects-18, observed-17)
dobj(underlying-15, effects-18)
case(Docusate-20, of-19)
nmod:of(effects-18, Docusate-20)
case(colonic_inertia-22, on-21)
nmod:on(effects-18, colonic_inertia-22)
nmod:on(effects-18, photophobia-24)
conj:and(colonic_inertia-22, photophobia-24)
cc(colonic_inertia-22, and-26)
nmod:on(effects-18, phonophobia-27)
conj:and(colonic_inertia-22, phonophobia-27)

In/IN vitro/NN studies/NNS were/VBD conducted/VBN to/TO investigate/VB the/DT effect/NN of/IN DMNH/NNP on/IN Lumican/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN vitro)))
    (NP (NNS studies))
    (VP (VBD were)
      (VP (VBN conducted)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN effect))
                (PP (IN of)
                  (NP (NNP DMNH))))
              (PP (IN on)
                (NP (JJ Lumican) (NNS levels))))))))
    (. .)))

case(vitro-2, In-1)
nmod:in(conducted-5, vitro-2)
nsubjpass(conducted-5, studies-3)
nsubj:xsubj(investigate-7, studies-3)
auxpass(conducted-5, were-4)
root(ROOT-0, conducted-5)
mark(investigate-7, to-6)
xcomp(conducted-5, investigate-7)
det(effect-9, the-8)
dobj(investigate-7, effect-9)
case(DMNH-11, of-10)
nmod:of(effect-9, DMNH-11)
case(levels-14, on-12)
amod(levels-14, Lumican-13)
nmod:on(investigate-7, levels-14)

The/DT Lumican/NNP level/NN of/IN the/DT non-transfected/JJ DMNH/NNP group/NN was/VBD found/VBN to_be/NN significantly/RB lower/JJR than/IN that/DT of/IN the/DT non-transfected/JJ non-DMNH/JJ group/NN -LRB-/-LRB- 352/CD ±/VBP 26/CD vs/NN 765/CD ±/VBP 22/CD ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNP Lumican) (NN level))
      (PP (IN of)
        (NP (DT the) (JJ non-transfected) (NNP DMNH) (NN group))))
    (VP (VBD was)
      (VP (VBN found)
        (NP (NN to_be))
        (ADVP (RB significantly))
        (NP
          (NP
            (QP (JJR lower) (IN than) (DT that)))
          (PP (IN of)
            (NP
              (NP (DT the) (JJ non-transfected) (JJ non-DMNH) (NN group))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 352))
                  (VP (VBP ±)
                    (NP
                      (NP (CD 26) (NN vs))
                      (SBAR
                        (S
                          (NP (CD 765))
                          (VP (VBP ±)
                            (ADJP
                              (NP (CD 22))
                              (JJ ng/L))
                            (, ,)
                            (SBAR
                              (S
                                (NP (NNP P))
                                (VP (VBP <)
                                  (NP (CD 0.001)))))))))))
                (-RRB- -RRB-)))))))
    (. .)))

det(level-3, The-1)
compound(level-3, Lumican-2)
nsubjpass(found-10, level-3)
case(group-8, of-4)
det(group-8, the-5)
amod(group-8, non-transfected-6)
compound(group-8, DMNH-7)
nmod:of(level-3, group-8)
auxpass(found-10, was-9)
root(ROOT-0, found-10)
dobj(found-10, to_be-11)
advmod(found-10, significantly-12)
advmod(that-15, lower-13)
advmod(that-15, than-14)
dobj(found-10, that-15)
case(group-20, of-16)
det(group-20, the-17)
amod(group-20, non-transfected-18)
amod(group-20, non-DMNH-19)
nmod:of(that-15, group-20)
nsubj(±-23, 352-22)
dep(group-20, ±-23)
nummod(vs-25, 26-24)
dobj(±-23, vs-25)
nsubj(±-27, 765-26)
acl:relcl(vs-25, ±-27)
nmod:npmod(ng/L-29, 22-28)
xcomp(±-27, ng/L-29)
nsubj(<-32, P-31)
ccomp(±-27, <-32)
dobj(<-32, 0.001-33)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN Lumican/JJ levels/NNS between/IN the/DT transfected/JJ DMNH/NNS and/CC transfected/JJ non-DMNH/JJ groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (JJ Lumican) (NNS levels)))
        (PP (IN between)
          (NP
            (NP (DT the) (JJ transfected) (NNS DMNH))
            (CC and)
            (NP (JJ transfected) (JJ non-DMNH) (NNS groups))))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(levels-10, in-8)
amod(levels-10, Lumican-9)
nmod:in(difference-7, levels-10)
case(DMNH-14, between-11)
det(DMNH-14, the-12)
amod(DMNH-14, transfected-13)
nmod:between(difference-7, DMNH-14)
cc(DMNH-14, and-15)
amod(groups-18, transfected-16)
amod(groups-18, non-DMNH-17)
nmod:between(difference-7, groups-18)
conj:and(DMNH-14, groups-18)

These/DT findings/NNS suggest/VBP that/IN DMNH/NNP may/MD play/VB a/DT role/NN in/IN regulating/VBG Lumican/JJ expression/NN and/CC could/MD potentially/RB be/VB used/VBN as/IN a/DT therapeutic/JJ target/NN for/IN diseases/NNS associated/VBN with/IN altered/JJ Lumican/NNP levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP DMNH))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (JJ Lumican) (NN expression))))))))
            (CC and)
            (VP (MD could) (RB potentially)
              (VP (VB be)
                (VP (VBN used)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN target))
                      (PP (IN for)
                        (NP
                          (NP (NNS diseases))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP (JJ altered) (NNP Lumican) (NNS levels)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, DMNH-5)
nsubjpass(used-18, DMNH-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
amod(expression-13, Lumican-12)
dobj(regulating-11, expression-13)
cc(play-7, and-14)
aux(used-18, could-15)
advmod(used-18, potentially-16)
auxpass(used-18, be-17)
ccomp(suggest-3, used-18)
conj:and(play-7, used-18)
case(target-22, as-19)
det(target-22, a-20)
amod(target-22, therapeutic-21)
nmod:as(used-18, target-22)
case(diseases-24, for-23)
nmod:for(target-22, diseases-24)
acl(diseases-24, associated-25)
case(levels-29, with-26)
amod(levels-29, altered-27)
compound(levels-29, Lumican-28)
nmod:with(associated-25, levels-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT regulation/NN and/CC to/TO explore/VB the/DT clinical/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT this) (NN regulation))
                      (CC and)
                      (S
                        (VP (TO to)
                          (VP (VB explore)
                            (NP
                              (NP (DT the) (JJ clinical) (NNS implications))
                              (PP (IN of)
                                (NP (DT these) (NNS findings))))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(regulation-13, in-11)
det(regulation-13, this-12)
nmod:in(involved-10, regulation-13)
cc(regulation-13, and-14)
mark(explore-16, to-15)
acl(regulation-13, explore-16)
det(implications-19, the-17)
amod(implications-19, clinical-18)
dobj(explore-16, implications-19)
case(findings-22, of-20)
det(findings-22, these-21)
nmod:of(implications-19, findings-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB a/DT significant/JJ impact/NN on/IN the/DT health/NN of/IN hyperTEI-4120mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (DT a) (JJ significant) (NN impact))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN health))
                      (PP (IN of)
                        (NP (JJ hyperTEI-4120mic) (NNS patients))))))))))))
    (. .)))

nsubjpass(shown-24, Omega-3_fatty_acids-1)
nsubj:xsubj(have-26, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
dep(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(Omega-3_fatty_acids-1, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(have-26, to-25)
xcomp(shown-24, have-26)
det(impact-29, a-27)
amod(impact-29, significant-28)
dobj(have-26, impact-29)
case(health-32, on-30)
det(health-32, the-31)
nmod:on(impact-29, health-32)
case(patients-35, of-33)
amod(patients-35, hyperTEI-4120mic-34)
nmod:of(health-32, patients-35)

These/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN TEI-4120/NN levels/NNS ,/, indicating/VBG their/PRP$ potential/JJ therapeutic/JJ value/NN in/IN managing/VBG this/DT condition/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS long-chain_fatty_acids))
    (VP (VBP are)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (VBN decreased) (NN TEI-4120) (NNS levels))
            (, ,)
            (VP (VBG indicating)
              (NP (PRP$ their) (JJ potential) (JJ therapeutic) (NN value))
              (PP (IN in)
                (S
                  (VP (VBG managing)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

det(long-chain_fatty_acids-2, These-1)
nsubjpass(associated-4, long-chain_fatty_acids-2)
auxpass(associated-4, are-3)
root(ROOT-0, associated-4)
case(levels-8, with-5)
amod(levels-8, decreased-6)
compound(levels-8, TEI-4120-7)
nmod:with(associated-4, levels-8)
acl(levels-8, indicating-10)
nmod:poss(value-14, their-11)
amod(value-14, potential-12)
amod(value-14, therapeutic-13)
dobj(indicating-10, value-14)
mark(managing-16, in-15)
advcl(indicating-10, managing-16)
det(condition-18, this-17)
dobj(managing-16, condition-18)

Furthermore/RB ,/, studies/NNS have/VBP demonstrated/VBN that/IN increased/VBN consumption/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, which/WDT highlights/VBZ the/DT importance/NN of/IN these/DT nutrients/NNS in/IN maintaining/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (VBN increased) (NN consumption))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP (DT a) (VBN reduced) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP
                            (NP
                              (NP (NN coronary_heart_disease))
                              (PRN (-LRB- -LRB-)
                                (NP (NNP CHD))
                                (-RRB- -RRB-)))
                            (, ,)
                            (SBAR
                              (WHNP (WDT which))
                              (S
                                (VP (VBZ highlights)
                                  (NP
                                    (NP (DT the) (NN importance))
                                    (PP (IN of)
                                      (NP (DT these) (NNS nutrients)))))))))))))
                (PP (IN in)
                  (S
                    (VP (VBG maintaining)
                      (NP (NN cardiovascular_health)))))))))))
    (. .)))

advmod(demonstrated-5, Furthermore-1)
nsubj(demonstrated-5, studies-3)
aux(demonstrated-5, have-4)
root(ROOT-0, demonstrated-5)
mark(linked-14, that-6)
amod(consumption-8, increased-7)
nsubjpass(linked-14, consumption-8)
case(EPA-10, of-9)
nmod:of(consumption-8, EPA-10)
cc(EPA-10, and-11)
nmod:of(consumption-8, DHA-12)
conj:and(EPA-10, DHA-12)
auxpass(linked-14, is-13)
ccomp(demonstrated-5, linked-14)
case(risk-18, to-15)
det(risk-18, a-16)
amod(risk-18, reduced-17)
nmod:to(linked-14, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, coronary_heart_disease-21)
nsubj(highlights-27, coronary_heart_disease-21)
appos(coronary_heart_disease-21, CHD-23)
ref(coronary_heart_disease-21, which-26)
acl:relcl(coronary_heart_disease-21, highlights-27)
det(importance-29, the-28)
dobj(highlights-27, importance-29)
case(nutrients-32, of-30)
det(nutrients-32, these-31)
nmod:of(importance-29, nutrients-32)
mark(maintaining-34, in-33)
advcl(linked-14, maintaining-34)
dobj(maintaining-34, cardiovascular_health-35)

Overall/RB ,/, the/DT findings/NNS suggest/VBP that/IN incorporating/VBG EPA/NNP and/CC DHA/NNP into/IN one/CD 's/POS diet/NN may/MD have/VB significant/JJ benefits/NNS for/IN individuals/NNS with/IN hyperTEI-4120mia/NNS or/CC those/DT at/IN risk/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT the) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG incorporating)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (PP (IN into)
                (NP
                  (NP (CD one) (POS 's))
                  (NN diet)))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ significant) (NNS benefits))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP
                        (NP (NNS hyperTEI-4120mia))
                        (CC or)
                        (NP (DT those)))))))
              (PP (IN at)
                (NP
                  (NP (NN risk))
                  (PP (IN for)
                    (NP (NNP CHD))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, the-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(have-16, that-6)
csubj(have-16, incorporating-7)
dobj(incorporating-7, EPA-8)
cc(EPA-8, and-9)
dobj(incorporating-7, DHA-10)
conj:and(EPA-8, DHA-10)
case(diet-14, into-11)
nmod:poss(diet-14, one-12)
case(one-12, 's-13)
nmod:into(incorporating-7, diet-14)
aux(have-16, may-15)
ccomp(suggest-5, have-16)
amod(benefits-18, significant-17)
dobj(have-16, benefits-18)
case(individuals-20, for-19)
nmod:for(benefits-18, individuals-20)
case(hyperTEI-4120mia-22, with-21)
nmod:with(individuals-20, hyperTEI-4120mia-22)
cc(hyperTEI-4120mia-22, or-23)
nmod:with(individuals-20, those-24)
conj:or(hyperTEI-4120mia-22, those-24)
case(risk-26, at-25)
nmod:at(have-16, risk-26)
case(CHD-28, for-27)
nmod:for(risk-26, CHD-28)

The/DT neurotransmitter/NN dopamine/NN plays/VBZ a/DT crucial/JJ role/NN in/IN modulating/VBG various/JJ physiological/JJ functions/NNS ,/, including/VBG motor/NN control/NN ,/, cognition/NN ,/, and/CC reward/NN ./.

(ROOT
  (S
    (NP (DT The) (NN neurotransmitter) (NN dopamine))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (S
            (VP (VBG modulating)
              (NP
                (NP (JJ various) (JJ physiological) (NNS functions))
                (, ,)
                (VP (VBG including)
                  (NP
                    (NP (NN motor) (NN control))
                    (, ,)
                    (NP (NN cognition))
                    (, ,)
                    (CC and)
                    (NP (NN reward))))))))))
    (. .)))

det(dopamine-3, The-1)
compound(dopamine-3, neurotransmitter-2)
nsubj(plays-4, dopamine-3)
root(ROOT-0, plays-4)
det(role-7, a-5)
amod(role-7, crucial-6)
dobj(plays-4, role-7)
mark(modulating-9, in-8)
acl(role-7, modulating-9)
amod(functions-12, various-10)
amod(functions-12, physiological-11)
dobj(modulating-9, functions-12)
acl(functions-12, including-14)
compound(control-16, motor-15)
dobj(including-14, control-16)
dobj(including-14, cognition-18)
conj:and(control-16, cognition-18)
cc(control-16, and-20)
dobj(including-14, reward-21)
conj:and(control-16, reward-21)

Dopaminergic/JJ dysfunction/NN is/VBZ associated/VBN with/IN several/JJ neurological_disorders/NNS ,/, such/JJ as/IN Parkinson/NNP 's/POS _/JJ disease/NN and/CC schizophrenia/NN ./.

(ROOT
  (S
    (NP (JJ Dopaminergic) (NN dysfunction))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ several) (NNS neurological_disorders))
            (, ,)
            (PP (JJ such) (IN as)
              (NP
                (NP (NNP Parkinson) (POS 's))
                (NX
                  (NX (JJ _) (NN disease))
                  (CC and)
                  (NX (NN schizophrenia)))))))))
    (. .)))

amod(dysfunction-2, Dopaminergic-1)
nsubjpass(associated-4, dysfunction-2)
auxpass(associated-4, is-3)
root(ROOT-0, associated-4)
case(neurological_disorders-7, with-5)
amod(neurological_disorders-7, several-6)
nmod:with(associated-4, neurological_disorders-7)
case(disease-14, such-9)
mwe(such-9, as-10)
nmod:poss(disease-14, Parkinson-11)
case(Parkinson-11, 's-12)
amod(disease-14, _-13)
nmod:such_as(neurological_disorders-7, disease-14)
cc(disease-14, and-15)
nmod:such_as(neurological_disorders-7, schizophrenia-16)
conj:and(disease-14, schizophrenia-16)

Piribedil/JJ is_a/NN dopamine/NN agonist/VBD that/IN has_been/NN used/VBD to/TO treat/VB these/DT disorders/NNS due/JJ to/TO its/PRP$ ability/NN to/TO stimulate/VB dopamine/JJ receptors/NNS ./.

(ROOT
  (S
    (NP (JJ Piribedil) (NN is_a) (NN dopamine))
    (VP (VBD agonist)
      (SBAR (IN that)
        (S
          (NP (NN has_been))
          (VP (VBD used)
            (S
              (VP (TO to)
                (VP (VB treat)
                  (NP
                    (NP (DT these) (NNS disorders))
                    (ADJP (JJ due)
                      (PP (TO to)
                        (NP (PRP$ its) (NN ability)
                          (S
                            (VP (TO to)
                              (VP (VB stimulate)
                                (NP (JJ dopamine) (NNS receptors))))))))))))))))
    (. .)))

amod(dopamine-3, Piribedil-1)
compound(dopamine-3, is_a-2)
nsubj(agonist-4, dopamine-3)
root(ROOT-0, agonist-4)
mark(used-7, that-5)
nsubj(used-7, has_been-6)
nsubj:xsubj(treat-9, has_been-6)
ccomp(agonist-4, used-7)
mark(treat-9, to-8)
xcomp(used-7, treat-9)
det(disorders-11, these-10)
dobj(treat-9, disorders-11)
amod(disorders-11, due-12)
case(ability-15, to-13)
nmod:poss(ability-15, its-14)
nmod:to(due-12, ability-15)
mark(stimulate-17, to-16)
acl(ability-15, stimulate-17)
amod(receptors-19, dopamine-18)
dobj(stimulate-17, receptors-19)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN Piribedil/NNP on/IN the/DT expression/NN of/IN specific/JJ receptors/NNS and/CC transporters/NNS in/IN the/DT brain/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP Piribedil)))
        (PP (IN on)
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (JJ specific) (NNS receptors)
                (CC and)
                (NNS transporters))))))
      (PP (IN in)
        (NP (DT the) (NN brain))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(Piribedil-10, of-9)
nmod:of(effects-8, Piribedil-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(effects-8, expression-13)
case(receptors-16, of-14)
amod(receptors-16, specific-15)
nmod:of(expression-13, receptors-16)
cc(receptors-16, and-17)
nmod:of(expression-13, transporters-18)
conj:and(receptors-16, transporters-18)
case(brain-21, in-19)
det(brain-21, the-20)
nmod:in(investigated-6, brain-21)

We/PRP found/VBD that/IN Piribedil/NNP treatment/NN resulted/VBD in/IN increased/VBN levels/NNS of/IN alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic_acid/JJ and_N-methyl-D-aspartate/JJ receptors/NNS ,/, which/WDT are/VBP known/VBN to_be/NN involved/VBN in/IN excitatory/JJ neurotransmission/NN ./.

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NNP Piribedil) (NN treatment))
          (VP (VBD resulted)
            (PP (IN in)
              (NP
                (NP (VBN increased) (NNS levels))
                (PP (IN of)
                  (NP
                    (NP (JJ alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic_acid) (JJ and_N-methyl-D-aspartate) (NNS receptors))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP are)
                          (VP (VBN known)
                            (NP
                              (NP (NN to_be))
                              (VP (VBN involved)
                                (PP (IN in)
                                  (NP (JJ excitatory) (NN neurotransmission)))))))))))))))))
    (. .)))

nsubj(found-2, We-1)
root(ROOT-0, found-2)
mark(resulted-6, that-3)
compound(treatment-5, Piribedil-4)
nsubj(resulted-6, treatment-5)
ccomp(found-2, resulted-6)
case(levels-9, in-7)
amod(levels-9, increased-8)
nmod:in(resulted-6, levels-9)
case(receptors-13, of-10)
amod(receptors-13, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic_acid-11)
amod(receptors-13, and_N-methyl-D-aspartate-12)
nmod:of(levels-9, receptors-13)
nsubjpass(known-17, receptors-13)
ref(receptors-13, which-15)
auxpass(known-17, are-16)
acl:relcl(receptors-13, known-17)
dobj(known-17, to_be-18)
acl(to_be-18, involved-19)
case(neurotransmission-22, in-20)
amod(neurotransmission-22, excitatory-21)
nmod:in(involved-19, neurotransmission-22)

Additionally/RB ,/, we/PRP observed/VBD an/DT upregulation/NN of/IN the/DT dopamine_D3_receptor/NN ,/, which/WDT serves/VBZ as/IN a/DT transporter/NN for/IN Piribedil/NNP ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT an) (NN upregulation))
        (PP (IN of)
          (NP
            (NP (DT the) (NN dopamine_D3_receptor))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ serves)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (NN transporter))
                      (PP (IN for)
                        (NP (NNP Piribedil))))))))))))
    (. .)))

advmod(observed-4, Additionally-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(upregulation-6, an-5)
dobj(observed-4, upregulation-6)
case(dopamine_D3_receptor-9, of-7)
det(dopamine_D3_receptor-9, the-8)
nmod:of(upregulation-6, dopamine_D3_receptor-9)
nsubj(serves-12, dopamine_D3_receptor-9)
ref(dopamine_D3_receptor-9, which-11)
acl:relcl(dopamine_D3_receptor-9, serves-12)
case(transporter-15, as-13)
det(transporter-15, a-14)
nmod:as(serves-12, transporter-15)
case(Piribedil-17, for-16)
nmod:for(transporter-15, Piribedil-17)

Interestingly/RB ,/, we/PRP also/RB detected/VBD elevated/JJ levels/NNS of/IN Piribedil/NNP itself/PRP in/IN the/DT brain/NN following/VBG treatment/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (PRP we))
    (ADVP (RB also))
    (VP (VBD detected)
      (NP
        (NP (JJ elevated) (NNS levels))
        (PP (IN of)
          (NP
            (NP (NNP Piribedil))
            (NP (PRP itself)))))
      (PP (IN in)
        (NP (DT the) (NN brain)))
      (S
        (VP (VBG following)
          (NP (NN treatment)))))
    (. .)))

advmod(detected-5, Interestingly-1)
nsubj(detected-5, we-3)
advmod(detected-5, also-4)
root(ROOT-0, detected-5)
amod(levels-7, elevated-6)
dobj(detected-5, levels-7)
case(Piribedil-9, of-8)
nmod:of(levels-7, Piribedil-9)
nmod:npmod(Piribedil-9, itself-10)
case(brain-13, in-11)
det(brain-13, the-12)
nmod:in(detected-5, brain-13)
xcomp(detected-5, following-14)
dobj(following-14, treatment-15)

These/DT findings/NNS suggest/VBP that/IN Piribedil/NNP may/MD exert/VB its/PRP$ therapeutic/JJ effects/NNS by/IN modulating/VBG the/DT expression/NN of/IN specific/JJ receptors/NNS and/CC transporters/NNS involved/VBN in/IN dopaminergic/JJ signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Piribedil))
          (VP (MD may)
            (VP (VB exert)
              (NP (PRP$ its) (JJ therapeutic) (NNS effects))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP
                          (NP (JJ specific) (NNS receptors))
                          (CC and)
                          (NP
                            (NP (NNS transporters))
                            (VP (VBN involved)
                              (PP (IN in)
                                (NP (JJ dopaminergic) (VBG signaling) (NNS pathways))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(exert-7, that-4)
nsubj(exert-7, Piribedil-5)
aux(exert-7, may-6)
ccomp(suggest-3, exert-7)
nmod:poss(effects-10, its-8)
amod(effects-10, therapeutic-9)
dobj(exert-7, effects-10)
mark(modulating-12, by-11)
advcl(exert-7, modulating-12)
det(expression-14, the-13)
dobj(modulating-12, expression-14)
case(receptors-17, of-15)
amod(receptors-17, specific-16)
nmod:of(expression-14, receptors-17)
cc(receptors-17, and-18)
nmod:of(expression-14, transporters-19)
conj:and(receptors-17, transporters-19)
acl(transporters-19, involved-20)
case(pathways-24, in-21)
amod(pathways-24, dopaminergic-22)
amod(pathways-24, signaling-23)
nmod:in(involved-20, pathways-24)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC their/PRP$ potential/JJ clinical/JJ implications/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ precise) (NNS mechanisms))
                (PP (VBG underlying)
                  (NP
                    (NP (DT these) (NNS effects))
                    (CC and)
                    (NP (PRP$ their) (JJ potential) (JJ clinical) (NNS implications))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
case(effects-12, underlying-10)
det(effects-12, these-11)
nmod:underlying(mechanisms-9, effects-12)
cc(effects-12, and-13)
nmod:poss(implications-17, their-14)
amod(implications-17, potential-15)
amod(implications-17, clinical-16)
nmod:underlying(mechanisms-9, implications-17)
conj:and(effects-12, implications-17)

Sirtuins/NNS are/VBP a/DT family/NN of/IN NAD/NNP -LRB-/-LRB- +/NNP -RRB-/-RRB- -/: dependent/JJ deacetylases/NNS that/WDT play/VB crucial/JJ roles/NNS in/IN cellular/JJ metabolism/NN ,/, stress/NN response/NN ,/, and/CC aging/VBG ./.

(ROOT
  (S
    (NP (NNS Sirtuins))
    (VP (VBP are)
      (NP
        (NP
          (NP (DT a) (NN family))
          (PP (IN of)
            (NP (NNP NAD))))
        (PRN (-LRB- -LRB-)
          (NP (NNP +))
          (-RRB- -RRB-)))
      (: -)
      (NP
        (NP (JJ dependent) (NNS deacetylases))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VB play)
              (NP (JJ crucial) (NNS roles))
              (PP (IN in)
                (NP
                  (NP (JJ cellular) (NN metabolism))
                  (, ,)
                  (NP (NN stress) (NN response))
                  (, ,)
                  (CC and)
                  (NP (VBG aging)))))))))
    (. .)))

nsubj(family-4, Sirtuins-1)
cop(family-4, are-2)
det(family-4, a-3)
root(ROOT-0, family-4)
case(NAD-6, of-5)
nmod:of(family-4, NAD-6)
appos(family-4, +-8)
amod(deacetylases-12, dependent-11)
parataxis(family-4, deacetylases-12)
nsubj(play-14, deacetylases-12)
ref(deacetylases-12, that-13)
acl:relcl(deacetylases-12, play-14)
amod(roles-16, crucial-15)
dobj(play-14, roles-16)
case(metabolism-19, in-17)
amod(metabolism-19, cellular-18)
nmod:in(play-14, metabolism-19)
compound(response-22, stress-21)
nmod:in(play-14, response-22)
conj:and(metabolism-19, response-22)
cc(metabolism-19, and-24)
nmod:in(play-14, aging-25)
conj:and(metabolism-19, aging-25)

Cambinol/NNP is_a/VBZ small/JJ molecule/NN inhibitor/NN of/IN sirtuins/NNS that/WDT has_been/VBP shown/VBN to/TO have/VB potential/JJ therapeutic/JJ effects/NNS in/IN various_diseases/NNS ./.

(ROOT
  (S
    (NP (NNP Cambinol))
    (VP (VBZ is_a)
      (NP
        (NP (JJ small) (NN molecule) (NN inhibitor))
        (PP (IN of)
          (NP
            (NP (NNS sirtuins))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP has_been)
                  (VP (VBN shown)
                    (S
                      (VP (TO to)
                        (VP (VB have)
                          (NP
                            (NP (JJ potential) (JJ therapeutic) (NNS effects))
                            (PP (IN in)
                              (NP (NNS various_diseases)))))))))))))))
    (. .)))

nsubj(is_a-2, Cambinol-1)
root(ROOT-0, is_a-2)
amod(inhibitor-5, small-3)
compound(inhibitor-5, molecule-4)
dobj(is_a-2, inhibitor-5)
case(sirtuins-7, of-6)
nmod:of(inhibitor-5, sirtuins-7)
nsubj(has_been-9, sirtuins-7)
ref(sirtuins-7, that-8)
acl:relcl(sirtuins-7, has_been-9)
dep(has_been-9, shown-10)
mark(have-12, to-11)
xcomp(shown-10, have-12)
amod(effects-15, potential-13)
amod(effects-15, therapeutic-14)
dobj(have-12, effects-15)
case(various_diseases-17, in-16)
nmod:in(effects-15, various_diseases-17)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN cambinol/JJ on/IN sirtuin_6/JJ protein/NN levels/NNS and/CC half-life/NN in/IN C2C12/CD cells/NNS cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (ADJP (JJ cambinol)
              (PP (IN on)
                (NP (JJ sirtuin_6) (NN protein))))
            (NNS levels)
            (CC and)
            (NN half-life))))
      (PP (IN in)
        (NP
          (NP (CD C2C12) (NNS cells))
          (VP (VBN cultured)
            (NP (JJ in_a) (NN medium))
            (S
              (VP (VBG favoring)
                (NP (NN differentiation))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(levels-14, of-9)
amod(levels-14, cambinol-10)
case(protein-13, on-11)
amod(protein-13, sirtuin_6-12)
nmod:on(cambinol-10, protein-13)
nmod:of(effect-8, levels-14)
cc(levels-14, and-15)
nmod:of(effect-8, half-life-16)
conj:and(levels-14, half-life-16)
case(cells-19, in-17)
nummod(cells-19, C2C12-18)
nmod:in(investigated-6, cells-19)
acl(cells-19, cultured-20)
amod(medium-22, in_a-21)
dobj(cultured-20, medium-22)
xcomp(cultured-20, favoring-23)
dobj(favoring-23, differentiation-24)

Our/PRP$ results/NNS showed/VBD that/IN cambinol/JJ up-regulated/JJ sirtuin_6/JJ protein/NN levels/NNS in_a/VBD time-dependent/JJ manner/NN and/CC prolonged/JJ sirtuin_6/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ cambinol) (JJ up-regulated) (JJ sirtuin_6) (NN protein) (NNS levels))
          (VP (VBD in_a)
            (NP
              (NP (JJ time-dependent) (NN manner))
              (CC and)
              (NP (JJ prolonged) (JJ sirtuin_6) (NN protein) (NN half-life)))
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(in_a-10, that-4)
amod(levels-9, cambinol-5)
amod(levels-9, up-regulated-6)
amod(levels-9, sirtuin_6-7)
compound(levels-9, protein-8)
nsubj(in_a-10, levels-9)
ccomp(showed-3, in_a-10)
amod(manner-12, time-dependent-11)
dobj(in_a-10, manner-12)
cc(manner-12, and-13)
amod(half-life-17, prolonged-14)
amod(half-life-17, sirtuin_6-15)
compound(half-life-17, protein-16)
dobj(in_a-10, half-life-17)
conj:and(manner-12, half-life-17)
case(hours-22, from-18)
compound(18-21, 10-19)
dep(18-21, to-20)
nummod(hours-22, 18-21)
nmod:from(in_a-10, hours-22)

These/DT findings/NNS suggest/VBP that/IN cambinol/NN may/MD have/VB a/DT beneficial/JJ effect/NN on/IN cellular/JJ metabolism/NN and/CC stress/NN response/NN by/IN modulating/VBG sirtuin_6/JJ activity/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN cambinol))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ beneficial) (NN effect))
                (PP (IN on)
                  (NP
                    (NP (JJ cellular) (NN metabolism))
                    (CC and)
                    (NP (NN stress) (NN response)))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP (JJ sirtuin_6) (NN activity))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, cambinol-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, beneficial-9)
dobj(have-7, effect-10)
case(metabolism-13, on-11)
amod(metabolism-13, cellular-12)
nmod:on(effect-10, metabolism-13)
cc(metabolism-13, and-14)
compound(response-16, stress-15)
nmod:on(effect-10, response-16)
conj:and(metabolism-13, response-16)
mark(modulating-18, by-17)
advcl(have-7, modulating-18)
amod(activity-20, sirtuin_6-19)
dobj(modulating-18, activity-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN cambinol/NN in/IN diseases/NNS associated/VBN with/IN dysregulated/JJ sirtuin/NN activity/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN of)
                  (NP
                    (NP (NN cambinol))
                    (PP (IN in)
                      (NP
                        (NP (NNS diseases))
                        (VP (VBN associated)
                          (PP (IN with)
                            (NP (JJ dysregulated) (NN sirtuin) (NN activity))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(applications-10, the-7)
amod(applications-10, potential-8)
amod(applications-10, therapeutic-9)
dobj(explore-6, applications-10)
case(cambinol-12, of-11)
nmod:of(applications-10, cambinol-12)
case(diseases-14, in-13)
nmod:in(cambinol-12, diseases-14)
acl(diseases-14, associated-15)
case(activity-19, with-16)
amod(activity-19, dysregulated-17)
compound(activity-19, sirtuin-18)
nmod:with(associated-15, activity-19)

Omega-3_fatty_acids/NNP have/VBP gained/VBN considerable/JJ attention/NN in/IN recent/JJ years/NNS due/JJ to/TO their/PRP$ potential/JJ health/NN benefits/NNS ,/, specifically/RB in/IN the/DT prevention/NN of/IN cardiovascular_disease/NN ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN gained)
        (NP (JJ considerable) (NN attention))
        (PP (IN in)
          (NP
            (NP (JJ recent) (NNS years))
            (ADJP (JJ due)
              (PP (TO to)
                (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
        (, ,)
        (ADVP (RB specifically))
        (PP (IN in)
          (NP
            (NP (DT the) (NN prevention))
            (PP (IN of)
              (NP (NN cardiovascular_disease)))))))
    (. .)))

nsubj(gained-3, Omega-3_fatty_acids-1)
aux(gained-3, have-2)
root(ROOT-0, gained-3)
amod(attention-5, considerable-4)
dobj(gained-3, attention-5)
case(years-8, in-6)
amod(years-8, recent-7)
nmod:in(gained-3, years-8)
amod(years-8, due-9)
case(benefits-14, to-10)
nmod:poss(benefits-14, their-11)
amod(benefits-14, potential-12)
compound(benefits-14, health-13)
nmod:to(due-9, benefits-14)
advmod(prevention-19, specifically-16)
case(prevention-19, in-17)
det(prevention-19, the-18)
nmod:in(gained-3, prevention-19)
case(cardiovascular_disease-21, of-20)
nmod:of(prevention-19, cardiovascular_disease-21)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN for/IN their/PRP$ anti-inflammatory/JJ properties/NNS and/CC have/VBP been/VBN shown/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (VP (VBN known)
          (PP (IN for)
            (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB decrease)
                  (NP
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-15, omega-3_fatty_acids-2)
nsubjpass(shown-23, omega-3_fatty_acids-2)
nsubj:xsubj(decrease-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
case(properties-19, for-16)
nmod:poss(properties-19, their-17)
amod(properties-19, anti-inflammatory-18)
nmod:for(known-15, properties-19)
cc(known-15, and-20)
aux(shown-23, have-21)
auxpass(shown-23, been-22)
conj:and(known-15, shown-23)
mark(decrease-25, to-24)
xcomp(shown-23, decrease-25)
det(risk-27, the-26)
dobj(decrease-25, risk-27)
mark(developing-29, of-28)
acl(risk-27, developing-29)
dobj(developing-29, coronary_heart_disease-30)
appos(risk-27, CHD-32)

One/CD possible/JJ mechanism/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VBD their/PRP$ cardioprotective/JJ effects/NNS is/VBZ through/IN the/DT modulation/NN of/IN octadeca-9/JJ ,12/CD -/: diynoic_acid/JJ levels/NNS ./.

(ROOT
  (S
    (NP (CD One) (JJ possible) (NN mechanism)
      (SBAR
        (WHPP (IN by)
          (WHNP (WDT which)))
        (S
          (NP (NNP EPA)
            (CC and)
            (NNP DHA))
          (VP (VBD exert)
            (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))
    (VP (VBZ is)
      (PP (IN through)
        (NP
          (NP
            (NP (DT the) (NN modulation))
            (PP (IN of)
              (NP (JJ octadeca-9) (CD ,12))))
          (: -)
          (NP (JJ diynoic_acid) (NNS levels)))))
    (. .)))

nummod(mechanism-3, One-1)
amod(mechanism-3, possible-2)
nsubj(modulation-16, mechanism-3)
case(which-5, by-4)
nmod:by(exert-9, which-5)
nsubj(exert-9, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(exert-9, DHA-8)
ccomp(mechanism-3, exert-9)
nmod:poss(effects-12, their-10)
amod(effects-12, cardioprotective-11)
dobj(exert-9, effects-12)
cop(modulation-16, is-13)
case(modulation-16, through-14)
det(modulation-16, the-15)
root(ROOT-0, modulation-16)
case(,12-19, of-17)
amod(,12-19, octadeca-9-18)
nmod:of(modulation-16, ,12-19)
amod(levels-22, diynoic_acid-21)
dep(modulation-16, levels-22)

Hyperoctadeca-9/NNP ,12/CD -/: diynoic/JJ acidmia/NN has_been/NN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN CHD/NNP ./.

(ROOT
  (NP
    (NP (NNP Hyperoctadeca-9) (CD ,12))
    (: -)
    (NP
      (NP (JJ diynoic) (NN acidmia) (NN has_been))
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT an) (VBN increased) (NN risk))
            (PP (IN of)
              (NP (NNP CHD)))))))
    (. .)))

root(ROOT-0, Hyperoctadeca-9-1)
nummod(Hyperoctadeca-9-1, ,12-2)
amod(has_been-6, diynoic-4)
compound(has_been-6, acidmia-5)
dep(Hyperoctadeca-9-1, has_been-6)
acl(has_been-6, associated-7)
case(risk-11, with-8)
det(risk-11, an-9)
amod(risk-11, increased-10)
nmod:with(associated-7, risk-11)
case(CHD-13, of-12)
nmod:of(risk-11, CHD-13)

Studies/NNPS have/VBP demonstrated/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN octadeca-9/NN ,12/CD -/: diynoic_acid/JJ levels/NNS in/IN hyperoctadeca-9/JJ ,12/CD -/: diynoic/JJ acidmic/JJ patients/NNS and/CC a/DT decreased/VBN risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (VBN decreased) (NN octadeca-9))
                      (NP (CD ,12)))
                    (: -)
                    (NP
                      (NP (JJ diynoic_acid) (NNS levels))
                      (PP (IN in)
                        (NP (JJ hyperoctadeca-9) (CD ,12))))
                    (: -)
                    (NP (JJ diynoic) (JJ acidmic) (NNS patients))
                    (CC and)
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NNP CHD))))))))))))))
    (. .)))

nsubj(demonstrated-3, Studies-1)
aux(demonstrated-3, have-2)
root(ROOT-0, demonstrated-3)
mark(associated-8, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(associated-8, omega-3_fatty_acids-6)
auxpass(associated-8, are-7)
ccomp(demonstrated-3, associated-8)
case(octadeca-9-11, with-9)
amod(octadeca-9-11, decreased-10)
nmod:with(associated-8, octadeca-9-11)
dep(octadeca-9-11, ,12-12)
amod(levels-15, diynoic_acid-14)
nmod:with(associated-8, levels-15)
conj:and(octadeca-9-11, levels-15)
case(,12-18, in-16)
amod(,12-18, hyperoctadeca-9-17)
nmod:in(levels-15, ,12-18)
amod(patients-22, diynoic-20)
amod(patients-22, acidmic-21)
nmod:with(associated-8, patients-22)
conj:and(octadeca-9-11, patients-22)
cc(octadeca-9-11, and-23)
det(risk-26, a-24)
amod(risk-26, decreased-25)
nmod:with(associated-8, risk-26)
conj:and(octadeca-9-11, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, CHD-29)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS by/IN which/WDT omega-3_fatty_acids/JJ provide/VBP cardiovascular/JJ protection/NN and/CC how/WRB they/PRP can/MD be/VB incorporated/VBN into/IN preventive/JJ strategies/NNS for/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP (DT the) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (NP (JJ omega-3_fatty_acids))
                      (VP (VBP provide)
                        (NP (JJ cardiovascular) (NN protection)))))
                  (CC and)
                  (SBAR
                    (WHADVP (WRB how))
                    (S
                      (NP (PRP they))
                      (VP (MD can)
                        (VP (VB be)
                          (VP (VBN incorporated)
                            (PP (IN into)
                              (NP
                                (NP (JJ preventive) (NNS strategies))
                                (PP (IN for)
                                  (NP (NNP CHD)))))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
mark(provide-13, by-10)
dobj(provide-13, which-11)
nsubj(provide-13, omega-3_fatty_acids-12)
advcl(understand-7, provide-13)
amod(protection-15, cardiovascular-14)
dobj(provide-13, protection-15)
cc(provide-13, and-16)
advmod(incorporated-21, how-17)
nsubjpass(incorporated-21, they-18)
aux(incorporated-21, can-19)
auxpass(incorporated-21, be-20)
advcl(understand-7, incorporated-21)
conj:and(provide-13, incorporated-21)
case(strategies-24, into-22)
amod(strategies-24, preventive-23)
nmod:into(incorporated-21, strategies-24)
case(CHD-26, for-25)
nmod:for(strategies-24, CHD-26)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB beneficial/JJ effects/NNS on/IN cardiovascular_health/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ beneficial) (NNS effects))
                  (PP (IN on)
                    (NP (NN cardiovascular_health))))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(have-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
amod(effects-20, beneficial-19)
dobj(have-18, effects-20)
case(cardiovascular_health-22, on-21)
nmod:on(effects-20, cardiovascular_health-22)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN Potassium_Oxonate/NNP in/IN hyperPotassium/JJ Oxonatemic/JJ patients/NNS ,/, which/WDT may/MD contribute/VB to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
          (VP (VBP are)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NNP Potassium_Oxonate))
                        (PP (IN in)
                          (NP
                            (NP (JJ hyperPotassium) (JJ Oxonatemic) (NNS patients))
                            (, ,)
                            (SBAR
                              (WHNP (WDT which))
                              (S
                                (VP (MD may)
                                  (VP (VB contribute)
                                    (PP (TO to)
                                      (NP
                                        (NP (DT a) (VBN decreased) (NN risk))
                                        (PP (IN of)
                                          (S
                                            (VP (VBG developing)
                                              (NP (NN coronary_heart_disease))))))))))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(associated-9, that-4)
det(omega-3_fatty_acids-7, these-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-9, omega-3_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(suggest-3, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(Potassium_Oxonate-14, of-13)
nmod:of(levels-12, Potassium_Oxonate-14)
case(patients-18, in-15)
amod(patients-18, hyperPotassium-16)
amod(patients-18, Oxonatemic-17)
nmod:in(Potassium_Oxonate-14, patients-18)
nsubj(contribute-22, patients-18)
ref(patients-18, which-20)
aux(contribute-22, may-21)
acl:relcl(patients-18, contribute-22)
case(risk-26, to-23)
det(risk-26, a-24)
amod(risk-26, decreased-25)
nmod:to(contribute-22, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, coronary_heart_disease-29)
appos(Potassium_Oxonate-14, CHD-31)

EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO have/VB anti-inflammatory/JJ properties/NNS that/WDT can/MD reduce/VB the/DT risk/NN of/IN developing/VBG CHD/NNP by/IN decreasing/VBG inflammation/NN in/IN the/DT blood/NN vessels/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ anti-inflammatory) (NNS properties))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (MD can)
                        (VP (VB reduce)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NNP CHD))
                                  (PP (IN by)
                                    (S
                                      (VP (VBG decreasing)
                                        (NP (NN inflammation))
                                        (PP (IN in)
                                          (NP (DT the) (NN blood) (NNS vessels)))))))))))))))))))))
    (. .)))

nsubjpass(found-6, EPA-1)
nsubj:xsubj(have-8, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(found-6, DHA-3)
nsubj:xsubj(have-8, DHA-3)
aux(found-6, have-4)
auxpass(found-6, been-5)
root(ROOT-0, found-6)
mark(have-8, to-7)
xcomp(found-6, have-8)
amod(properties-10, anti-inflammatory-9)
dobj(have-8, properties-10)
nsubj(reduce-13, properties-10)
ref(properties-10, that-11)
aux(reduce-13, can-12)
acl:relcl(properties-10, reduce-13)
det(risk-15, the-14)
dobj(reduce-13, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, CHD-18)
mark(decreasing-20, by-19)
advcl(developing-17, decreasing-20)
dobj(decreasing-20, inflammation-21)
case(vessels-25, in-22)
det(vessels-25, the-23)
compound(vessels-25, blood-24)
nmod:in(decreasing-20, vessels-25)

In/IN addition/NN ,/, they/PRP can/MD also/RB lower/VB triglyceride_levels/NNS in/IN the/DT blood/NN ,/, which/WDT is/VBZ another/DT risk/NN factor/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP they))
    (VP (MD can) (RB also)
      (VP (VB lower)
        (NP
          (NP (NNS triglyceride_levels))
          (PP (IN in)
            (NP
              (NP (DT the) (NN blood))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ is)
                    (NP
                      (NP (DT another) (NN risk) (NN factor))
                      (PP (IN for)
                        (NP (NNP CHD))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(lower-7, addition-2)
nsubj(lower-7, they-4)
aux(lower-7, can-5)
advmod(lower-7, also-6)
root(ROOT-0, lower-7)
dobj(lower-7, triglyceride_levels-8)
case(blood-11, in-9)
det(blood-11, the-10)
nmod:in(triglyceride_levels-8, blood-11)
nsubj(factor-17, blood-11)
ref(blood-11, which-13)
cop(factor-17, is-14)
det(factor-17, another-15)
compound(factor-17, risk-16)
acl:relcl(blood-11, factor-17)
case(CHD-19, for-18)
nmod:for(factor-17, CHD-19)

These/DT findings/NNS provide/VBP further/JJ evidence/NN for/IN the/DT importance/NN of/IN consuming/VBG adequate/JJ amounts/NNS of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN to/TO promote/VB cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP provide)
      (NP
        (NP (JJ further) (NN evidence))
        (PP (IN for)
          (NP
            (NP (DT the) (NN importance))
            (PP (IN of)
              (S
                (VP (VBG consuming)
                  (NP
                    (NP (JJ adequate) (NNS amounts))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA))))
                  (PP (IN through)
                    (NP (JJ dietary) (NNS sources)
                      (CC or)
                      (NN supplementation)))))))))
      (S
        (VP (TO to)
          (VP (VB promote)
            (NP (NN cardiovascular_health))))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
root(ROOT-0, provide-3)
amod(evidence-5, further-4)
dobj(provide-3, evidence-5)
case(importance-8, for-6)
det(importance-8, the-7)
nmod:for(evidence-5, importance-8)
mark(consuming-10, of-9)
acl(importance-8, consuming-10)
amod(amounts-12, adequate-11)
dobj(consuming-10, amounts-12)
case(EPA-14, of-13)
nmod:of(amounts-12, EPA-14)
cc(EPA-14, and-15)
nmod:of(amounts-12, DHA-16)
conj:and(EPA-14, DHA-16)
case(sources-19, through-17)
amod(sources-19, dietary-18)
nmod:through(consuming-10, sources-19)
cc(sources-19, or-20)
nmod:through(consuming-10, supplementation-21)
conj:or(sources-19, supplementation-21)
mark(promote-23, to-22)
advcl(provide-3, promote-23)
dobj(promote-23, cardiovascular_health-24)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ,/, particularly/RB in/IN relation/NN to/TO cardiovascular_disease/VB ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
          (, ,)
          (PP
            (ADVP (RB particularly))
            (IN in)
            (NP (NN relation)
              (S
                (VP (TO to)
                  (VP (VB cardiovascular_disease)))))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)
advmod(relation-14, particularly-12)
case(relation-14, in-13)
nmod:in(studied-5, relation-14)
mark(cardiovascular_disease-16, to-15)
acl(relation-14, cardiovascular_disease-16)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP known/VBN to/TO have/VB a/DT range/NN of/IN anti-inflammatory/JJ and/CC anti-atherogenic/JJ effects/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB have)
              (NP
                (NP (DT a) (NN range))
                (PP (IN of)
                  (NP
                    (ADJP (JJ anti-inflammatory)
                      (CC and)
                      (JJ anti-atherogenic))
                    (NNS effects)))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(known-15, omega-3_fatty_acids-2)
nsubj:xsubj(have-17, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
auxpass(known-15, are-14)
root(ROOT-0, known-15)
mark(have-17, to-16)
xcomp(known-15, have-17)
det(range-19, a-18)
dobj(have-17, range-19)
case(effects-24, of-20)
amod(effects-24, anti-inflammatory-21)
cc(anti-inflammatory-21, and-22)
conj:and(anti-inflammatory-21, anti-atherogenic-23)
amod(effects-24, anti-atherogenic-23)
nmod:of(range-19, effects-24)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN KW-3635/NN levels/NNS in/IN hyperKW-3635mic/JJ patients/NNS ,/, which/WDT suggests/VBZ a/DT potential/JJ mechanism/NN for/IN their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN KW-3635) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperKW-3635mic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (VBZ suggests)
                              (NP
                                (NP (DT a) (JJ potential) (NN mechanism))
                                (PP (IN for)
                                  (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
compound(levels-13, KW-3635-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hyperKW-3635mic-15)
nmod:in(levels-13, patients-16)
nsubj(suggests-19, patients-16)
ref(patients-16, which-18)
acl:relcl(patients-16, suggests-19)
det(mechanism-22, a-20)
amod(mechanism-22, potential-21)
dobj(suggests-19, mechanism-22)
case(effects-26, for-23)
nmod:poss(effects-26, their-24)
amod(effects-26, cardioprotective-25)
nmod:for(mechanism-22, effects-26)

In/IN addition/NN ,/, several/JJ epidemiological/JJ studies/NNS have/VBP demonstrated/VBN an/DT inverse/JJ relationship/NN between/IN omega-3/JJ intake/NN and/CC the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ several) (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (NP
          (NP (DT an) (JJ inverse) (NN relationship))
          (PP (IN between)
            (NP
              (NP
                (NP (JJ omega-3) (NN intake))
                (CC and)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease)))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

case(addition-2, In-1)
nmod:in(demonstrated-8, addition-2)
amod(studies-6, several-4)
amod(studies-6, epidemiological-5)
nsubj(demonstrated-8, studies-6)
aux(demonstrated-8, have-7)
root(ROOT-0, demonstrated-8)
det(relationship-11, an-9)
amod(relationship-11, inverse-10)
dobj(demonstrated-8, relationship-11)
case(intake-14, between-12)
amod(intake-14, omega-3-13)
nmod:between(relationship-11, intake-14)
cc(intake-14, and-15)
det(risk-17, the-16)
nmod:between(relationship-11, risk-17)
conj:and(intake-14, risk-17)
mark(developing-19, of-18)
acl(risk-17, developing-19)
dobj(developing-19, coronary_heart_disease-20)
appos(intake-14, CHD-22)

This/DT has/VBZ led/VBN to/TO recommendations/NNS for/IN increased/VBN consumption/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN as/IN a/DT means/NN of/IN reducing/VBG CHD/NNP risk/NN ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ has)
      (VP (VBN led)
        (PP (TO to)
          (NP
            (NP (NNS recommendations))
            (PP (IN for)
              (NP
                (NP (VBN increased) (NN consumption))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA)))))))
        (PP (IN through)
          (NP
            (NP (JJ dietary) (NNS sources))
            (CC or)
            (NP
              (NP (NN supplementation))
              (PP (IN as)
                (NP
                  (NP (DT a) (NN means))
                  (PP (IN of)
                    (S
                      (VP (VBG reducing)
                        (NP (NNP CHD) (NN risk))))))))))))
    (. .)))

nsubj(led-3, This-1)
aux(led-3, has-2)
root(ROOT-0, led-3)
case(recommendations-5, to-4)
nmod:to(led-3, recommendations-5)
case(consumption-8, for-6)
amod(consumption-8, increased-7)
nmod:for(recommendations-5, consumption-8)
case(EPA-10, of-9)
nmod:of(consumption-8, EPA-10)
cc(EPA-10, and-11)
nmod:of(consumption-8, DHA-12)
conj:and(EPA-10, DHA-12)
case(sources-15, through-13)
amod(sources-15, dietary-14)
nmod:through(led-3, sources-15)
cc(sources-15, or-16)
nmod:through(led-3, supplementation-17)
conj:or(sources-15, supplementation-17)
case(means-20, as-18)
det(means-20, a-19)
nmod:as(supplementation-17, means-20)
mark(reducing-22, of-21)
acl(means-20, reducing-22)
compound(risk-24, CHD-23)
dobj(reducing-22, risk-24)

However/RB ,/, further/JJ research/NN is/VBZ needed/VBN to/TO determine/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN omega-3/JJ supplementation/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (JJ further) (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (JJ optimal) (NN dose)
                  (CC and)
                  (NN duration))
                (PP (IN of)
                  (NP
                    (NP (JJ omega-3) (NN supplementation))
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN prevention)
                          (CC and)
                          (NN treatment))
                        (PP (IN of)
                          (NP (NNP CHD)))))))))))))
    (. .)))

advmod(needed-6, However-1)
amod(research-4, further-3)
nsubjpass(needed-6, research-4)
nsubj:xsubj(determine-8, research-4)
auxpass(needed-6, is-5)
root(ROOT-0, needed-6)
mark(determine-8, to-7)
xcomp(needed-6, determine-8)
det(dose-11, the-9)
amod(dose-11, optimal-10)
dobj(determine-8, dose-11)
cc(dose-11, and-12)
dobj(determine-8, duration-13)
conj:and(dose-11, duration-13)
case(supplementation-16, of-14)
amod(supplementation-16, omega-3-15)
nmod:of(dose-11, supplementation-16)
case(prevention-19, for-17)
det(prevention-19, the-18)
nmod:for(supplementation-16, prevention-19)
cc(prevention-19, and-20)
nmod:for(supplementation-16, treatment-21)
conj:and(prevention-19, treatment-21)
case(CHD-23, of-22)
nmod:of(prevention-19, CHD-23)

Obesity/RB is_a/JJ major/JJ public_health/NN concern/NN worldwide/RB ,/, and/CC its/PRP$ association/NN with/IN various/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes_mellitus/NNS ,/, is/VBZ well-established/JJ ./.

(ROOT
  (S
    (ADVP (RB Obesity))
    (NP
      (NP
        (NP (JJ is_a) (JJ major) (NN public_health) (NN concern))
        (ADVP (RB worldwide)))
      (, ,)
      (CC and)
      (NP
        (NP (PRP$ its) (NN association))
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes_mellitus)))
            (, ,)))))
    (VP (VBZ is)
      (ADJP (JJ well-established)))
    (. .)))

advmod(well-established-19, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
nsubj(well-established-19, concern-5)
advmod(concern-5, worldwide-6)
cc(concern-5, and-8)
nmod:poss(association-10, its-9)
conj:and(concern-5, association-10)
nsubj(well-established-19, association-10)
case(metabolic_disorders-13, with-11)
amod(metabolic_disorders-13, various-12)
nmod:with(association-10, metabolic_disorders-13)
acl(metabolic_disorders-13, including-15)
dobj(including-15, type_2_diabetes_mellitus-16)
cop(well-established-19, is-18)
root(ROOT-0, well-established-19)

The/DT pancreas/NN plays/VBZ a/DT crucial/JJ role/NN in/IN glucose_homeostasis/NNS by/IN secreting/VBG insulin/NN and/CC other/JJ hormones/NNS ,/, including/VBG C-1300/NN ./.

(ROOT
  (S
    (NP (DT The) (NN pancreas))
    (VP (VBZ plays)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP (NNS glucose_homeostasis))))
      (PP (IN by)
        (S
          (VP (VBG secreting)
            (NP
              (NP (NN insulin)
                (CC and)
                (JJ other) (NNS hormones))
              (, ,)
              (VP (VBG including)
                (NP (NN C-1300))))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, crucial-5)
dobj(plays-3, role-6)
case(glucose_homeostasis-8, in-7)
nmod:in(role-6, glucose_homeostasis-8)
mark(secreting-10, by-9)
advcl(plays-3, secreting-10)
compound(hormones-14, insulin-11)
cc(insulin-11, and-12)
conj:and(insulin-11, other-13)
compound(hormones-14, other-13)
dobj(secreting-10, hormones-14)
acl(hormones-14, including-16)
dobj(including-16, C-1300-17)

Hypersecretion/NN of/IN C-1300/JJ has_been/NN implicated/VBN in/IN the/DT development/NN of/IN obesity/NN ;/: however/RB ,/, the/DT exact/JJ relationship/NN between/IN C-1300/NN and/CC obesity/NN remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (NP
      (NP (NN Hypersecretion))
      (PP (IN of)
        (NP
          (NP (JJ C-1300) (NN has_been))
          (VP (VBN implicated)
            (PP (IN in)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (NN obesity))
                    (: ;)
                    (ADVP (RB however))
                    (, ,)
                    (NP
                      (NP (DT the) (JJ exact) (NN relationship))
                      (PP (IN between)
                        (NP (NN C-1300)
                          (CC and)
                          (NN obesity))))))))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

nsubj(remains-21, Hypersecretion-1)
case(has_been-4, of-2)
amod(has_been-4, C-1300-3)
nmod:of(Hypersecretion-1, has_been-4)
acl(has_been-4, implicated-5)
case(development-8, in-6)
det(development-8, the-7)
nmod:in(implicated-5, development-8)
case(obesity-10, of-9)
nmod:of(development-8, obesity-10)
advmod(obesity-10, however-12)
det(relationship-16, the-14)
amod(relationship-16, exact-15)
appos(obesity-10, relationship-16)
case(C-1300-18, between-17)
nmod:between(relationship-16, C-1300-18)
cc(C-1300-18, and-19)
nmod:between(relationship-16, obesity-20)
conj:and(C-1300-18, obesity-20)
root(ROOT-0, remains-21)
xcomp(remains-21, unclear-22)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN C-1300/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN C-1300)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(C-1300-20, of-19)
nmod:of(hypersecretion-18, C-1300-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT objective/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN L-dopa_methyl_ester/NNP on/IN the/DT secretion/NN of/IN C-1300/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- animals/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN objective)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP L-dopa_methyl_ester)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN C-1300) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS animals)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(objective-4, this-3)
dobj(achieve-2, objective-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(L-dopa_methyl_ester-17, 10-15)
compound(L-dopa_methyl_ester-17, mmol/L-16)
nmod:of(effects-9, L-dopa_methyl_ester-17)
conj:and(glucose-13, L-dopa_methyl_ester-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
compound(and_insulin-23, C-1300-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(animals-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, animals-40)
conj:and(genetically_obese-29, animals-40)

Our/PRP$ results/NNS showed/VBD that/IN the/DT secretion/NN of/IN C-1300/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ animals/NNS compared/VBN to/TO lean/VB animals/NNS under/IN both/DT basal/JJ conditions/NNS and/CC after/IN stimulation/NN with/IN glucose/NN or/CC L-dopa_methyl_ester/NNP ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP (NN C-1300))))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS animals))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB lean)
                      (NP (NNS animals))
                      (PP (IN under)
                        (NP (DT both) (JJ basal) (NNS conditions))))
                    (CC and)
                    (VP
                      (PP (IN after)
                        (NP (NN stimulation)))
                      (PP (IN with)
                        (NP
                          (NP (NN glucose))
                          (CC or)
                          (NP (NNP L-dopa_methyl_ester)))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-15, that-4)
det(secretion-6, the-5)
nsubjpass(compared-15, secretion-6)
nsubj:xsubj(lean-17, secretion-6)
case(C-1300-8, of-7)
nmod:of(secretion-6, C-1300-8)
auxpass(compared-15, was-9)
advmod(higher-11, significantly-10)
advmod(compared-15, higher-11)
case(animals-14, in-12)
amod(animals-14, obese-13)
nmod:in(higher-11, animals-14)
ccomp(showed-3, compared-15)
mark(lean-17, to-16)
xcomp(compared-15, lean-17)
dobj(lean-17, animals-18)
case(conditions-22, under-19)
det(conditions-22, both-20)
amod(conditions-22, basal-21)
nmod:under(lean-17, conditions-22)
cc(lean-17, and-23)
case(stimulation-25, after-24)
xcomp(compared-15, stimulation-25)
conj:and(lean-17, stimulation-25)
case(glucose-27, with-26)
nmod:with(stimulation-25, glucose-27)
cc(glucose-27, or-28)
nmod:with(stimulation-25, L-dopa_methyl_ester-29)
conj:or(glucose-27, L-dopa_methyl_ester-29)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN insulin_secretion/NN between/IN obese/JJ and/CC lean/JJ animals/NNS under/IN either/DT condition/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (NN insulin_secretion)))
        (PP (IN between)
          (NP (JJ obese)
            (CC and)
            (JJ lean) (NNS animals))))
      (PP (IN under)
        (NP (DT either) (NN condition))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(insulin_secretion-9, in-8)
nmod:in(difference-7, insulin_secretion-9)
case(animals-14, between-10)
amod(animals-14, obese-11)
cc(obese-11, and-12)
conj:and(obese-11, lean-13)
amod(animals-14, lean-13)
nmod:between(difference-7, animals-14)
case(condition-17, under-15)
det(condition-17, either-16)
nmod:under(was-4, condition-17)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN C-1300/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, independent/JJ of/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NN C-1300))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))
                    (, ,)
                    (PP (JJ independent) (IN of)
                      (NP
                        (NP (PRP$ its) (NNS effects))
                        (PP (IN on)
                          (NP (NN insulin_secretion)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-10, that-4)
nsubjpass(involved-10, hypersecretion-5)
case(C-1300-7, of-6)
nmod:of(hypersecretion-5, C-1300-7)
aux(involved-10, may-8)
auxpass(involved-10, be-9)
ccomp(suggest-3, involved-10)
case(development-13, in-11)
det(development-13, the-12)
nmod:in(involved-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
case(effects-20, independent-17)
case(effects-20, of-18)
nmod:poss(effects-20, its-19)
nmod:of(development-13, effects-20)
case(insulin_secretion-22, on-21)
nmod:on(effects-20, insulin_secretion-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS linking/VBG C-1300/JJ hypersecretion/NN to/TO obesity/NN and/CC its/PRP$ associated/VBN metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (VP (VBG linking)
                  (NP (JJ C-1300) (NN hypersecretion))
                  (PP (TO to)
                    (NP
                      (NP (NN obesity))
                      (CC and)
                      (NP (PRP$ its) (VBN associated) (NNS metabolic_disorders)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, linking-10)
amod(hypersecretion-12, C-1300-11)
dobj(linking-10, hypersecretion-12)
case(obesity-14, to-13)
nmod:to(linking-10, obesity-14)
cc(obesity-14, and-15)
nmod:poss(metabolic_disorders-18, its-16)
amod(metabolic_disorders-18, associated-17)
nmod:to(linking-10, metabolic_disorders-18)
conj:and(obesity-14, metabolic_disorders-18)

The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO investigate/VB the/DT expression/NN of/IN various/JJ genes/NNS involved/VBN in/IN transport/NN and/CC metabolism/NN of/IN 2-mercaptobenzothiazole/JJ -LRB-/-LRB- MBT/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN aim))
      (PP (IN of)
        (NP (DT this) (NN study))))
    (VP (VBD was)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (NP (JJ various) (NNS genes))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (NN transport)
                            (CC and)
                            (NN metabolism))
                          (PP (IN of)
                            (NP (JJ 2-mercaptobenzothiazole))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP MBT))
                          (-RRB- -RRB-))))))))))))
    (. .)))

det(aim-2, The-1)
nsubj(was-6, aim-2)
nsubj:xsubj(investigate-8, aim-2)
case(study-5, of-3)
det(study-5, this-4)
nmod:of(aim-2, study-5)
root(ROOT-0, was-6)
mark(investigate-8, to-7)
xcomp(was-6, investigate-8)
det(expression-10, the-9)
dobj(investigate-8, expression-10)
case(genes-13, of-11)
amod(genes-13, various-12)
nmod:of(expression-10, genes-13)
acl(genes-13, involved-14)
case(transport-16, in-15)
nmod:in(involved-14, transport-16)
cc(transport-16, and-17)
nmod:in(involved-14, metabolism-18)
conj:and(transport-16, metabolism-18)
case(2-mercaptobenzothiazole-20, of-19)
nmod:of(transport-16, 2-mercaptobenzothiazole-20)
appos(transport-16, MBT-22)

Using/VBG quantitative/JJ polymerase/NN chain/NN reaction/NN -LRB-/-LRB- qPCR/NN -RRB-/-RRB- ,/, we/PRP analyzed/VBD the/DT expression/NN of/IN CAT-2B/NN -LRB-/-LRB- SLC10A1/NNP -RRB-/-RRB- ,/, MCT8/NNP -LRB-/-LRB- SLC16A2/NNP -RRB-/-RRB- ,/, and/CC OATP1C1/NNP -LRB-/-LRB- SLCO1C1/NNP -RRB-/-RRB- transporters/NNS ,/, as/RB well/RB as/IN MBT/NNP receptor/NN genes/NNS THRA/NNP and/CC THRB/NNP ,/, and/CC deiodinase/JJ type_I/NNS ,/, II/NNP ,/, and/CC III/NNP -LRB-/-LRB- DIO1/NNP ,/, DIO2/NNP ,/, DIO3/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP
          (NP (JJ quantitative) (NN polymerase) (NN chain) (NN reaction))
          (PRN (-LRB- -LRB-)
            (NP (NN qPCR))
            (-RRB- -RRB-)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD analyzed)
      (NP
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP
                (NP
                  (NP (NN CAT-2B))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP SLC10A1))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP MCT8))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP SLC16A2))
                    (-RRB- -RRB-)))
                (, ,)
                (CC and)
                (NP
                  (NP (NNP OATP1C1))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP SLCO1C1))
                    (-RRB- -RRB-))
                  (NP (NNS transporters))))
              (, ,)
              (CONJP (RB as) (RB well) (IN as))
              (NP
                (NP (NNP MBT) (NN receptor) (NNS genes))
                (NP (NNP THRA)
                  (CC and)
                  (NNP THRB))))))
        (, ,)
        (CC and)
        (NP
          (NP (JJ deiodinase) (NNS type_I))
          (, ,)
          (NP (NNP II)))
        (, ,)
        (CC and)
        (NP
          (NP (NNP III))
          (PRN (-LRB- -LRB-)
            (NP (NNP DIO1))
            (, ,)
            (NP (NNP DIO2))
            (, ,)
            (NP (NNP DIO3))
            (-RRB- -RRB-)))))
    (. .)))

advcl(analyzed-11, Using-1)
amod(reaction-5, quantitative-2)
compound(reaction-5, polymerase-3)
compound(reaction-5, chain-4)
dobj(Using-1, reaction-5)
appos(reaction-5, qPCR-7)
nsubj(analyzed-11, we-10)
root(ROOT-0, analyzed-11)
det(expression-13, the-12)
dobj(analyzed-11, expression-13)
case(CAT-2B-15, of-14)
nmod:of(expression-13, CAT-2B-15)
appos(CAT-2B-15, SLC10A1-17)
nmod:of(expression-13, MCT8-20)
conj:and(CAT-2B-15, MCT8-20)
appos(MCT8-20, SLC16A2-22)
cc(CAT-2B-15, and-25)
nmod:of(expression-13, OATP1C1-26)
conj:and(CAT-2B-15, OATP1C1-26)
appos(OATP1C1-26, SLCO1C1-28)
dep(OATP1C1-26, transporters-30)
cc(CAT-2B-15, as-32)
mwe(as-32, well-33)
mwe(as-32, as-34)
compound(genes-37, MBT-35)
compound(genes-37, receptor-36)
nmod:of(expression-13, genes-37)
conj:and(CAT-2B-15, genes-37)
dep(genes-37, THRA-38)
cc(THRA-38, and-39)
dep(genes-37, THRB-40)
conj:and(THRA-38, THRB-40)
cc(expression-13, and-42)
amod(type_I-44, deiodinase-43)
dobj(analyzed-11, type_I-44)
conj:and(expression-13, type_I-44)
appos(type_I-44, II-46)
cc(expression-13, and-48)
dobj(analyzed-11, III-49)
conj:and(expression-13, III-49)
appos(III-49, DIO1-51)
dep(DIO1-51, DIO2-53)
dep(DIO1-51, DIO3-55)

Our/PRP$ results/NNS showed/VBD that/IN all/PDT the/DT analyzed/VBN genes/NNS were/VBD expressed/VBN in/IN the/DT studied/VBN tissue/NN samples/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (PDT all) (DT the) (VBN analyzed) (NNS genes))
          (VP (VBD were)
            (VP (VBN expressed)
              (PP (IN in)
                (NP (DT the) (VBN studied) (NN tissue) (NNS samples))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(expressed-10, that-4)
det:predet(genes-8, all-5)
det(genes-8, the-6)
amod(genes-8, analyzed-7)
nsubjpass(expressed-10, genes-8)
auxpass(expressed-10, were-9)
ccomp(showed-3, expressed-10)
case(samples-15, in-11)
det(samples-15, the-12)
amod(samples-15, studied-13)
compound(samples-15, tissue-14)
nmod:in(expressed-10, samples-15)

Interestingly/RB ,/, we/PRP observed/VBD a/DT significant/JJ upregulation/NN of/IN CAT-2B/NN and/CC OATP1C1/CD transporters/NNS in/IN response/NN to/TO MBT/NNP exposure/NN ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN upregulation))
        (PP (IN of)
          (NP
            (NP (NN CAT-2B))
            (CC and)
            (NP (CD OATP1C1) (NNS transporters)))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NNP MBT) (NN exposure))))))
    (. .)))

advmod(observed-4, Interestingly-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(upregulation-7, a-5)
amod(upregulation-7, significant-6)
dobj(observed-4, upregulation-7)
case(CAT-2B-9, of-8)
nmod:of(upregulation-7, CAT-2B-9)
cc(CAT-2B-9, and-10)
nummod(transporters-12, OATP1C1-11)
nmod:of(upregulation-7, transporters-12)
conj:and(CAT-2B-9, transporters-12)
case(response-14, in-13)
nmod:in(observed-4, response-14)
case(exposure-17, to-15)
compound(exposure-17, MBT-16)
nmod:to(response-14, exposure-17)

Additionally/RB ,/, we/PRP found/VBD that/IN the/DT expression/NN of/IN DIO3/NNP was/VBD significantly/RB decreased/VBN in/IN response/NN to/TO MBT/NNP exposure/NN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (NNP DIO3))))
          (VP (VBD was)
            (VP
              (ADVP (RB significantly))
              (VBN decreased)
              (PP (IN in)
                (NP
                  (NP (NN response))
                  (PP (TO to)
                    (NP (NNP MBT) (NN exposure))))))))))
    (. .)))

advmod(found-4, Additionally-1)
nsubj(found-4, we-3)
root(ROOT-0, found-4)
mark(decreased-12, that-5)
det(expression-7, the-6)
nsubjpass(decreased-12, expression-7)
case(DIO3-9, of-8)
nmod:of(expression-7, DIO3-9)
auxpass(decreased-12, was-10)
advmod(decreased-12, significantly-11)
ccomp(found-4, decreased-12)
case(response-14, in-13)
nmod:in(decreased-12, response-14)
case(exposure-17, to-15)
compound(exposure-17, MBT-16)
nmod:to(response-14, exposure-17)

These/DT findings/NNS suggest/VBP that/IN MBT/NNP may/MD have/VB a/DT significant/JJ impact/NN on/IN the/DT regulation/NN of/IN thyroid_hormone/JJ metabolism/NN and/CC transport/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP MBT))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ significant) (NN impact))
                (PP (IN on)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP (JJ thyroid_hormone) (NN metabolism)
                        (CC and)
                        (NN transport)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, MBT-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(impact-10, a-8)
amod(impact-10, significant-9)
dobj(have-7, impact-10)
case(regulation-13, on-11)
det(regulation-13, the-12)
nmod:on(impact-10, regulation-13)
case(metabolism-16, of-14)
amod(metabolism-16, thyroid_hormone-15)
nmod:of(regulation-13, metabolism-16)
cc(metabolism-16, and-17)
nmod:of(regulation-13, transport-18)
conj:and(metabolism-16, transport-18)

Further/JJ studies/NNS are/VBP needed/VBN to/TO investigate/VB the/DT potential/JJ implications/NNS of/IN these/DT findings/NNS for/IN human/JJ health/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (JJ potential) (NNS implications))
                (PP (IN of)
                  (NP (DT these) (NNS findings))))
              (PP (IN for)
                (NP (JJ human) (NN health))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(investigate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(investigate-6, to-5)
xcomp(needed-4, investigate-6)
det(implications-9, the-7)
amod(implications-9, potential-8)
dobj(investigate-6, implications-9)
case(findings-12, of-10)
det(findings-12, these-11)
nmod:of(implications-9, findings-12)
case(health-15, for-13)
amod(health-15, human-14)
nmod:for(investigate-6, health-15)

In/IN the/DT field/NN of/IN pharmacology/NN ,/, the/DT search/NN for/IN effective/JJ treatments/NNS of/IN allergic_contact_dermatitis/NNS is/VBZ ongoing/JJ ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN field))
        (PP (IN of)
          (NP (NN pharmacology)))))
    (, ,)
    (NP
      (NP (DT the) (NN search))
      (PP (IN for)
        (NP
          (NP (JJ effective) (NNS treatments))
          (PP (IN of)
            (NP (NNS allergic_contact_dermatitis))))))
    (VP (VBZ is)
      (ADJP (JJ ongoing)))
    (. .)))

case(field-3, In-1)
det(field-3, the-2)
nmod:in(ongoing-15, field-3)
case(pharmacology-5, of-4)
nmod:of(field-3, pharmacology-5)
det(search-8, the-7)
nsubj(ongoing-15, search-8)
case(treatments-11, for-9)
amod(treatments-11, effective-10)
nmod:for(search-8, treatments-11)
case(allergic_contact_dermatitis-13, of-12)
nmod:of(treatments-11, allergic_contact_dermatitis-13)
cop(ongoing-15, is-14)
root(ROOT-0, ongoing-15)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN JM335/NNP on/IN systemic/JJ allergic_contact_dermatitis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP (NNP JM335)))
      (PP (IN on)
        (NP
          (NP (JJ systemic) (NNS allergic_contact_dermatitis))
          (, ,)
          (NP (NN photophobia))
          (, ,)
          (CC and)
          (NP (NN phonophobia)))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-18, study-3)
det(effects-6, the-5)
nsubjpass(investigated-18, effects-6)
case(JM335-8, of-7)
nmod:of(effects-6, JM335-8)
case(allergic_contact_dermatitis-11, on-9)
amod(allergic_contact_dermatitis-11, systemic-10)
nmod:on(effects-6, allergic_contact_dermatitis-11)
nmod:on(effects-6, photophobia-13)
conj:and(allergic_contact_dermatitis-11, photophobia-13)
cc(allergic_contact_dermatitis-11, and-15)
nmod:on(effects-6, phonophobia-16)
conj:and(allergic_contact_dermatitis-11, phonophobia-16)
auxpass(investigated-18, were-17)
root(ROOT-0, investigated-18)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, JM335/NNP reduced/VBD the/DT risk/NN of/IN systemic/JJ allergic_contact_dermatitis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NNP JM335))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (JJ systemic)
                  (NX
                    (NX
                      (NX
                        (NX (NNS allergic_contact_dermatitis))
                        (PP (IN by)
                          (NP (CD 14) (NN %))))
                      (PRN (-LRB- -LRB-)
                        (S
                          (NP (CD 95) (NN %))
                          (VP (VBP CI)
                            (NP
                              (NP
                                (NP (CD 6-20) (NN %))
                                (, ,)
                                (NP (NNP P)))
                              (X
                                (X (SYM =))
                                (NP (CD 0.0005))))))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NX
                      (NX
                        (NX (NN photophobia))
                        (PP (IN by)
                          (NP (CD 17) (NN %))))
                      (PRN (-LRB- -LRB-)
                        (S
                          (NP (CD 95) (NN %))
                          (VP (VBP CI)
                            (NP (CD 12-22) (NN %))
                            (, ,)
                            (SBAR
                              (S
                                (NP (NNP P))
                                (VP (VBP <)
                                  (NP (CD 0.0001)))))))
                        (-RRB- -RRB-)))
                    (, ,)
                    (CC and)
                    (NX (NN phonophobia))))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (PP (NNP CI)
                      (NP (CD 17-20) (NN %))))
                  (, ,)
                  (NP (NNP P)
                    (QP (CD <) (CD 0.0001)))
                  (-RRB- -RRB-))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-12, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-12, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-12, JM335-11)
ccomp(showed-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(allergic_contact_dermatitis-17, of-15)
amod(allergic_contact_dermatitis-17, systemic-16)
nmod:of(risk-14, allergic_contact_dermatitis-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(allergic_contact_dermatitis-17, %-20)
nummod(%-23, 95-22)
nsubj(CI-24, %-23)
dep(allergic_contact_dermatitis-17, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
nmod:of(risk-14, photophobia-33)
conj:and(allergic_contact_dermatitis-17, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
nsubj(CI-40, %-39)
dep(photophobia-33, CI-40)
nummod(%-42, 12-22-41)
dobj(CI-40, %-42)
nsubj(<-45, P-44)
dep(CI-40, <-45)
dobj(<-45, 0.0001-46)
cc(allergic_contact_dermatitis-17, and-49)
nmod:of(risk-14, phonophobia-50)
conj:and(allergic_contact_dermatitis-17, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(reduced-12, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN JM335/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS suffering/VBG from/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP JM335))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP (DT these) (NNS conditions))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, JM335-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(conditions-17, from-15)
det(conditions-17, these-16)
nmod:from(suffering-14, conditions-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN maximum/JJ efficacy/NN and/CC safety/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP (JJ maximum) (NN efficacy)
                      (CC and)
                      (NN safety))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(efficacy-18, for-16)
amod(efficacy-18, maximum-17)
nmod:for(regimen-15, efficacy-18)
cc(efficacy-18, and-19)
nmod:for(regimen-15, safety-20)
conj:and(efficacy-18, safety-20)

In/IN vitro/NN studies/NNS have/VBP shown/VBN that/IN the/DT expression/NN of/IN solute/JJ carrier/NN family/NN 47/CD member_1/NNS -LRB-/-LRB- SLC47A1/NNP -RRB-/-RRB- is/VBZ significantly/RB lower/JJR in/IN non-transfected/JJ cells/NNS treated/VBN with/IN isorhamnetin/NN compared/VBN to/TO those/DT without/IN isorhamnetin/NN treatment/NN -LRB-/-LRB- 352/CD ±/VBP 26/CD ng/L/NN vs./FW 765/CD ±/VBP 22/CD ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN vitro)))
    (NP (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP
                  (NP
                    (NP (JJ solute) (NN carrier) (NN family))
                    (NP (CD 47) (NNS member_1)))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP SLC47A1))
                    (-RRB- -RRB-)))))
            (VP (VBZ is)
              (ADJP
                (ADJP (RB significantly) (JJR lower)
                  (PP (IN in)
                    (NP
                      (NP (JJ non-transfected) (NNS cells))
                      (VP (VBN treated)
                        (PP (IN with)
                          (NP
                            (NP (NN isorhamnetin))
                            (VP (VBN compared)
                              (PP (TO to)
                                (NP (DT those)))
                              (PP (IN without)
                                (NP (NN isorhamnetin) (NN treatment))))))))))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (CD 352))
                    (VP (VBP ±)
                      (SBAR
                        (S
                          (NP
                            (NP (CD 26) (NN ng/L))
                            (PP (FW vs.)
                              (NP (CD 765))))
                          (VP (VBP ±)
                            (ADJP
                              (NP (CD 22))
                              (JJ ng/L))
                            (, ,)
                            (SBAR
                              (S
                                (NP (NNP P))
                                (VP (VBP <)
                                  (NP (CD 0.001))))))))))
                  (-RRB- -RRB-))))))))
    (. .)))

case(vitro-2, In-1)
nmod:in(shown-5, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
mark(lower-20, that-6)
det(expression-8, the-7)
nsubj(lower-20, expression-8)
case(family-12, of-9)
amod(family-12, solute-10)
compound(family-12, carrier-11)
nmod:of(expression-8, family-12)
nummod(member_1-14, 47-13)
dep(family-12, member_1-14)
appos(family-12, SLC47A1-16)
cop(lower-20, is-18)
advmod(lower-20, significantly-19)
ccomp(shown-5, lower-20)
case(cells-23, in-21)
amod(cells-23, non-transfected-22)
nmod:in(lower-20, cells-23)
acl(cells-23, treated-24)
case(isorhamnetin-26, with-25)
nmod:with(treated-24, isorhamnetin-26)
acl(isorhamnetin-26, compared-27)
case(those-29, to-28)
nmod:to(compared-27, those-29)
case(treatment-32, without-30)
compound(treatment-32, isorhamnetin-31)
nmod:without(compared-27, treatment-32)
nsubj(±-35, 352-34)
dep(lower-20, ±-35)
nummod(ng/L-37, 26-36)
nsubj(±-40, ng/L-37)
dep(765-39, vs.-38)
nmod(ng/L-37, 765-39)
ccomp(±-35, ±-40)
nmod:npmod(ng/L-42, 22-41)
xcomp(±-40, ng/L-42)
nsubj(<-45, P-44)
ccomp(±-40, <-45)
dobj(<-45, 0.001-46)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN SLC47A1/CD levels/NNS between/IN transfected/JJ cells/NNS treated/VBN with/IN isorhamnetin/NN and/CC those/DT without/IN isorhamnetin/JJ treatment/NN ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (CD SLC47A1) (NNS levels)))
        (PP (IN between)
          (NP
            (NP (JJ transfected) (NNS cells))
            (VP (VBN treated)
              (PP (IN with)
                (NP
                  (NP (NN isorhamnetin))
                  (CC and)
                  (NP (DT those))))
              (PP (IN without)
                (NP (JJ isorhamnetin) (NN treatment))))))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(levels-10, in-8)
nummod(levels-10, SLC47A1-9)
nmod:in(difference-7, levels-10)
case(cells-13, between-11)
amod(cells-13, transfected-12)
nmod:between(difference-7, cells-13)
acl(cells-13, treated-14)
case(isorhamnetin-16, with-15)
nmod:with(treated-14, isorhamnetin-16)
cc(isorhamnetin-16, and-17)
nmod:with(treated-14, those-18)
conj:and(isorhamnetin-16, those-18)
case(treatment-21, without-19)
amod(treatment-21, isorhamnetin-20)
nmod:without(treated-14, treatment-21)

These/DT findings/NNS suggest/VBP that/IN isorhamnetin/NN may/MD play/VB a/DT role/NN in/IN regulating/VBG the/DT expression/NN of/IN SLC47A1/NNP and/CC could/MD have/VB potential/JJ therapeutic/JJ applications/NNS in/IN diseases/NNS associated/VBN with/IN altered/JJ SLC47A1/NN expression/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN isorhamnetin))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP
                          (NP (DT the) (NN expression))
                          (PP (IN of)
                            (NP (NNP SLC47A1))))))))))
            (CC and)
            (VP (MD could)
              (VP (VB have)
                (NP (JJ potential) (JJ therapeutic) (NNS applications))
                (PP (IN in)
                  (NP
                    (NP (NNS diseases))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP (JJ altered) (NN SLC47A1) (NN expression))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, isorhamnetin-5)
nsubj(have-18, isorhamnetin-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
det(expression-13, the-12)
dobj(regulating-11, expression-13)
case(SLC47A1-15, of-14)
nmod:of(expression-13, SLC47A1-15)
cc(play-7, and-16)
aux(have-18, could-17)
ccomp(suggest-3, have-18)
conj:and(play-7, have-18)
amod(applications-21, potential-19)
amod(applications-21, therapeutic-20)
dobj(have-18, applications-21)
case(diseases-23, in-22)
nmod:in(have-18, diseases-23)
acl(diseases-23, associated-24)
case(expression-28, with-25)
amod(expression-28, altered-26)
compound(expression-28, SLC47A1-27)
nmod:with(associated-24, expression-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO evaluate/VB the/DT efficacy/NN of/IN isorhamnetin/NN as/IN a/DT therapeutic/JJ agent/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (NN efficacy))
                  (PP (IN of)
                    (NP (NN isorhamnetin))))
                (PP (IN as)
                  (NP (DT a) (JJ therapeutic) (NN agent)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(mechanisms-8, the-7)
dobj(explore-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(explore-6, and-12)
mark(evaluate-14, to-13)
ccomp(needed-4, evaluate-14)
conj:and(explore-6, evaluate-14)
det(efficacy-16, the-15)
dobj(evaluate-14, efficacy-16)
case(isorhamnetin-18, of-17)
nmod:of(efficacy-16, isorhamnetin-18)
case(agent-22, as-19)
det(agent-22, a-20)
amod(agent-22, therapeutic-21)
nmod:as(evaluate-14, agent-22)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN found/VBN to_be/VB associated/VBN with/IN decreased/VBN theobromine/NN levels/NNS in/IN hypertheobrominemic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN found)
            (S
              (VP (VB to_be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (VBN decreased) (NN theobromine) (NNS levels)))
                  (PP (IN in)
                    (NP (JJ hypertheobrominemic) (NNS patients)))))))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(found-16, omega-3_fatty_acids-2)
nsubjpass(decreased-27, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
aux(found-16, have-14)
auxpass(found-16, been-15)
root(ROOT-0, found-16)
ccomp(found-16, to_be-17)
dep(to_be-17, associated-18)
case(levels-22, with-19)
amod(levels-22, decreased-20)
compound(levels-22, theobromine-21)
nmod:with(associated-18, levels-22)
case(patients-25, in-23)
amod(patients-25, hypertheobrominemic-24)
nmod:in(associated-18, patients-25)
cc(found-16, and-26)
conj:and(found-16, decreased-27)
dobj(decreased-27, risk-28)
case(coronary_heart_disease-31, of-29)
amod(coronary_heart_disease-31, developing-30)
nmod:of(risk-28, coronary_heart_disease-31)
appos(coronary_heart_disease-31, CHD-33)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB fully/RB understood/VBN ,/, but/CC may/MD involve/VB their/PRP$ ability/NN to/TO modulate/VBP lipid/NN metabolism/NN ,/, reduce/VB inflammation/NN and/CC oxidative_stress/NNS ,/, improve/VB endothelial/JJ function/NN ,/, and/CC enhance/VB insulin_sensitivity/RB ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (NNS effects))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP (PRP$ their) (NN ability)
            (S
              (VP (TO to)
                (VP
                  (VP
                    (SBAR
                      (S
                        (VP (VBP modulate)
                          (NP (NN lipid) (NN metabolism)))))
                    (, ,)
                    (VP (VB reduce)
                      (NP (NN inflammation)
                        (CC and)
                        (NNS oxidative_stress))))
                  (, ,)
                  (VP (VB improve)
                    (NP (JJ endothelial) (NN function)))
                  (, ,)
                  (CC and)
                  (VP (VB enhance)
                    (ADVP (RB insulin_sensitivity))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-9, mechanisms-2)
nsubj(involve-13, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-9, are-6)
neg(understood-9, not-7)
advmod(understood-9, fully-8)
root(ROOT-0, understood-9)
cc(understood-9, but-11)
aux(involve-13, may-12)
conj:but(understood-9, involve-13)
nmod:poss(ability-15, their-14)
dobj(involve-13, ability-15)
mark(reduce-21, to-16)
ccomp(reduce-21, modulate-17)
compound(metabolism-19, lipid-18)
dobj(modulate-17, metabolism-19)
acl(ability-15, reduce-21)
dobj(reduce-21, inflammation-22)
cc(inflammation-22, and-23)
dobj(reduce-21, oxidative_stress-24)
conj:and(inflammation-22, oxidative_stress-24)
acl(ability-15, improve-26)
conj:and(reduce-21, improve-26)
amod(function-28, endothelial-27)
dobj(improve-26, function-28)
cc(reduce-21, and-30)
acl(ability-15, enhance-31)
conj:and(reduce-21, enhance-31)
advmod(enhance-31, insulin_sensitivity-32)

Several/JJ epidemiological/JJ studies/NNS have/VBP shown/VBN that/IN increased/VBN intake/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT lower/JJR risk/NN of/IN CHD/NNP ,/, while/IN clinical/JJ trials/NNS have/VBP demonstrated/VBN their/PRP$ beneficial/JJ effects/NNS on/IN various/JJ cardiovascular_risk/NN factors/NNS ,/, such/JJ as/IN triglycerides/NNPS ,/, blood_pressure/NN ,/, and/CC platelet_aggregation/NN ./.

(ROOT
  (S
    (NP (JJ Several) (JJ epidemiological) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (VBN increased) (NN intake))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT a) (JJR lower) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (, ,)
                (SBAR (IN while)
                  (S
                    (NP (JJ clinical) (NNS trials))
                    (VP (VBP have)
                      (VP (VBN demonstrated)
                        (NP (PRP$ their) (JJ beneficial) (NNS effects))
                        (PP (IN on)
                          (NP
                            (NP (JJ various) (NN cardiovascular_risk) (NNS factors))
                            (, ,)
                            (PP (JJ such) (IN as)
                              (NP
                                (NP (NNPS triglycerides))
                                (, ,)
                                (NP (NN blood_pressure))
                                (, ,)
                                (CC and)
                                (NP (NN platelet_aggregation))))))))))))))))
    (. .)))

amod(studies-3, Several-1)
amod(studies-3, epidemiological-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
mark(associated-14, that-6)
amod(intake-8, increased-7)
nsubjpass(associated-14, intake-8)
case(EPA-10, of-9)
nmod:of(intake-8, EPA-10)
cc(EPA-10, and-11)
nmod:of(intake-8, DHA-12)
conj:and(EPA-10, DHA-12)
auxpass(associated-14, is-13)
ccomp(shown-5, associated-14)
case(risk-18, with-15)
det(risk-18, a-16)
amod(risk-18, lower-17)
nmod:with(associated-14, risk-18)
case(CHD-20, of-19)
nmod:of(risk-18, CHD-20)
mark(demonstrated-26, while-22)
amod(trials-24, clinical-23)
nsubj(demonstrated-26, trials-24)
aux(demonstrated-26, have-25)
advcl(associated-14, demonstrated-26)
nmod:poss(effects-29, their-27)
amod(effects-29, beneficial-28)
dobj(demonstrated-26, effects-29)
case(factors-33, on-30)
amod(factors-33, various-31)
compound(factors-33, cardiovascular_risk-32)
nmod:on(demonstrated-26, factors-33)
case(triglycerides-37, such-35)
mwe(such-35, as-36)
nmod:such_as(factors-33, triglycerides-37)
nmod:such_as(factors-33, blood_pressure-39)
conj:and(triglycerides-37, blood_pressure-39)
cc(triglycerides-37, and-41)
nmod:such_as(factors-33, platelet_aggregation-42)
conj:and(triglycerides-37, platelet_aggregation-42)

The/DT American/NNP Heart/NNP Association/NNP recommends/VBZ consuming/VBG at/IN least/JJS two/CD servings/NNS of/IN fish/NN per/IN week/NN to/TO obtain/VB sufficient/JJ amounts/NNS of/IN EPA/NNP and/CC DHA/NNP ./.

(ROOT
  (S
    (NP (DT The) (NNP American) (NNP Heart) (NNP Association))
    (VP (VBZ recommends)
      (VP (VBG consuming)
        (NP
          (NP
            (QP (IN at) (JJS least) (CD two))
            (NNS servings))
          (PP (IN of)
            (NP
              (NP (NN fish))
              (PP (IN per)
                (NP (NN week))))))
        (S
          (VP (TO to)
            (VP (VB obtain)
              (NP
                (NP (JJ sufficient) (NNS amounts))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA)))))))))
    (. .)))

det(Association-4, The-1)
compound(Association-4, American-2)
compound(Association-4, Heart-3)
nsubj(recommends-5, Association-4)
root(ROOT-0, recommends-5)
xcomp(recommends-5, consuming-6)
case(least-8, at-7)
nmod:npmod(two-9, least-8)
nummod(servings-10, two-9)
dobj(consuming-6, servings-10)
case(fish-12, of-11)
nmod:of(servings-10, fish-12)
case(week-14, per-13)
nmod:per(fish-12, week-14)
mark(obtain-16, to-15)
advcl(consuming-6, obtain-16)
amod(amounts-18, sufficient-17)
dobj(obtain-16, amounts-18)
case(EPA-20, of-19)
nmod:of(amounts-18, EPA-20)
cc(EPA-20, and-21)
nmod:of(amounts-18, DHA-22)
conj:and(EPA-20, DHA-22)

Supplementation/NN with/IN fish/NN oil/NN capsules/NNS may/MD also/RB be/VB considered/VBN for/IN individuals/NNS who/WP do/VBP not/RB consume/VB fish/NN regularly/RB or/CC have/VB elevated/JJ cardiovascular_risk/NN ./.

(ROOT
  (S
    (NP
      (NP (NN Supplementation))
      (PP (IN with)
        (NP (NN fish) (NN oil) (NNS capsules))))
    (VP (MD may) (RB also)
      (VP (VB be)
        (VP (VBN considered)
          (PP (IN for)
            (NP
              (NP (NNS individuals))
              (SBAR
                (WHNP (WP who))
                (S
                  (VP (VBP do) (RB not)
                    (VP
                      (VP (VB consume)
                        (NP (NN fish))
                        (ADVP (RB regularly)))
                      (CC or)
                      (VP (VB have)
                        (NP (JJ elevated) (NN cardiovascular_risk))))))))))))
    (. .)))

nsubjpass(considered-9, Supplementation-1)
case(capsules-5, with-2)
compound(capsules-5, fish-3)
compound(capsules-5, oil-4)
nmod:with(Supplementation-1, capsules-5)
aux(considered-9, may-6)
advmod(considered-9, also-7)
auxpass(considered-9, be-8)
root(ROOT-0, considered-9)
case(individuals-11, for-10)
nmod:for(considered-9, individuals-11)
nsubj(consume-15, individuals-11)
nsubj(have-19, individuals-11)
ref(individuals-11, who-12)
aux(consume-15, do-13)
neg(consume-15, not-14)
acl:relcl(individuals-11, consume-15)
dobj(consume-15, fish-16)
advmod(consume-15, regularly-17)
cc(consume-15, or-18)
acl:relcl(individuals-11, have-19)
conj:or(consume-15, have-19)
amod(cardiovascular_risk-21, elevated-20)
dobj(have-19, cardiovascular_risk-21)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT optimal/JJ dose/NN and/CC duration/NN of/IN omega-3_fatty_acid/JJ supplementation/NN for/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ optimal) (NN dose)
                  (CC and)
                  (NN duration))
                (PP (IN of)
                  (NP
                    (NP (JJ omega-3_fatty_acid) (NN supplementation))
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN prevention)
                          (CC and)
                          (NN treatment))
                        (PP (IN of)
                          (NP (NNP CHD)))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(dose-9, the-7)
amod(dose-9, optimal-8)
dobj(elucidate-6, dose-9)
cc(dose-9, and-10)
dobj(elucidate-6, duration-11)
conj:and(dose-9, duration-11)
case(supplementation-14, of-12)
amod(supplementation-14, omega-3_fatty_acid-13)
nmod:of(dose-9, supplementation-14)
case(prevention-17, for-15)
det(prevention-17, the-16)
nmod:for(supplementation-14, prevention-17)
cc(prevention-17, and-18)
nmod:for(supplementation-14, treatment-19)
conj:and(prevention-17, treatment-19)
case(CHD-21, of-20)
nmod:of(prevention-17, CHD-21)

Tetrahydrobiopterin/NNP -LRB-/-LRB- BH4/NNP -RRB-/-RRB- is/VBZ an/DT essential/JJ cofactor/NN for/IN the/DT synthesis/NN of/IN catecholamines/NNS ,/, nitric_oxide/NN ,/, and/CC serotonin/NN ./.

(ROOT
  (S
    (NP (NNP Tetrahydrobiopterin) (-LRB- -LRB-)
      (NP (NNP BH4))
      (-RRB- -RRB-))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ essential) (NN cofactor))
        (PP (IN for)
          (NP
            (NP (DT the) (NN synthesis))
            (PP (IN of)
              (NP
                (NP (NNS catecholamines))
                (, ,)
                (NP (NN nitric_oxide))
                (, ,)
                (CC and)
                (NP (NN serotonin))))))))
    (. .)))

nsubj(cofactor-8, Tetrahydrobiopterin-1)
dep(Tetrahydrobiopterin-1, BH4-3)
cop(cofactor-8, is-5)
det(cofactor-8, an-6)
amod(cofactor-8, essential-7)
root(ROOT-0, cofactor-8)
case(synthesis-11, for-9)
det(synthesis-11, the-10)
nmod:for(cofactor-8, synthesis-11)
case(catecholamines-13, of-12)
nmod:of(synthesis-11, catecholamines-13)
nmod:of(synthesis-11, nitric_oxide-15)
conj:and(catecholamines-13, nitric_oxide-15)
cc(catecholamines-13, and-17)
nmod:of(synthesis-11, serotonin-18)
conj:and(catecholamines-13, serotonin-18)

The/DT rate-limiting/JJ enzyme/NN in/IN BH4/CD biosynthesis/NNS is/VBZ GTP_cyclohydrolase_I/NNP -LRB-/-LRB- GTP-CH/NNP -RRB-/-RRB- ,/, which/WDT is/VBZ regulated/VBN by/IN feedback/NN inhibition/NN via/IN end/NN products/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ rate-limiting) (NN enzyme))
      (PP (IN in)
        (NP (CD BH4) (NNS biosynthesis))))
    (VP (VBZ is)
      (NP
        (NP
          (NP (NNP GTP_cyclohydrolase_I))
          (-LRB- -LRB-)
          (NP (NNP GTP-CH))
          (-RRB- -RRB-))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBZ is)
              (VP (VBN regulated)
                (PP (IN by)
                  (NP
                    (NP (NN feedback) (NN inhibition))
                    (PP (IN via)
                      (NP (NN end) (NNS products)))))))))))
    (. .)))

det(enzyme-3, The-1)
amod(enzyme-3, rate-limiting-2)
nsubj(GTP_cyclohydrolase_I-8, enzyme-3)
case(biosynthesis-6, in-4)
nummod(biosynthesis-6, BH4-5)
nmod:in(enzyme-3, biosynthesis-6)
cop(GTP_cyclohydrolase_I-8, is-7)
root(ROOT-0, GTP_cyclohydrolase_I-8)
nsubjpass(regulated-15, GTP_cyclohydrolase_I-8)
dep(GTP_cyclohydrolase_I-8, GTP-CH-10)
ref(GTP_cyclohydrolase_I-8, which-13)
auxpass(regulated-15, is-14)
acl:relcl(GTP_cyclohydrolase_I-8, regulated-15)
case(inhibition-18, by-16)
compound(inhibition-18, feedback-17)
nmod:by(regulated-15, inhibition-18)
case(products-21, via-19)
compound(products-21, end-20)
nmod:via(inhibition-18, products-21)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN 2,4-diamino-6-hydroxypyrimidine/JJ -LRB-/-LRB- DAHP/NNS -RRB-/-RRB- ,/, an/DT inhibitor/NN of/IN GTP-CH/NNP ,/, can/MD stimulate/VB BH4/NNP synthesis/NN by/IN activating/VBG GTP-CH/NN through/IN a/DT yet/RB unknown/JJ mechanism/NN ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ 2,4-diamino-6-hydroxypyrimidine) (-LRB- -LRB-) (NNS DAHP) (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (DT an) (NN inhibitor))
                (PP (IN of)
                  (NP (NNP GTP-CH))))
              (, ,))
            (VP (MD can)
              (VP (VB stimulate)
                (NP (NNP BH4) (NN synthesis))
                (PP (IN by)
                  (S
                    (VP (VBG activating)
                      (NP (NN GTP-CH))
                      (PP (IN through)
                        (NP (DT a)
                          (ADJP (RB yet) (JJ unknown))
                          (NN mechanism))))))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(stimulate-17, that-5)
amod(DAHP-8, 2,4-diamino-6-hydroxypyrimidine-6)
nsubj(stimulate-17, DAHP-8)
det(inhibitor-12, an-11)
appos(DAHP-8, inhibitor-12)
case(GTP-CH-14, of-13)
nmod:of(inhibitor-12, GTP-CH-14)
aux(stimulate-17, can-16)
ccomp(shown-4, stimulate-17)
compound(synthesis-19, BH4-18)
dobj(stimulate-17, synthesis-19)
mark(activating-21, by-20)
advcl(stimulate-17, activating-21)
dobj(activating-21, GTP-CH-22)
case(mechanism-27, through-23)
det(mechanism-27, a-24)
advmod(unknown-26, yet-25)
amod(mechanism-27, unknown-26)
nmod:through(activating-21, mechanism-27)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT involvement/NN of/IN pertussis/NN toxin-sensitive/NN and/CC -/: insensitive/JJ G/NNP proteins/NNS in/IN DAHP-induced/JJ activation/NN of/IN GTP-CH/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN involvement))
        (PP (IN of)
          (NP
            (NP (NN pertussis) (NN toxin-sensitive))
            (CC and)
            (NP (: -)
              (NP (JJ insensitive) (NNP G) (NNS proteins))
              (PP (IN in)
                (NP
                  (NP (JJ DAHP-induced) (NN activation))
                  (PP (IN of)
                    (NP (NNP GTP-CH))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(involvement-8, the-7)
dobj(investigated-6, involvement-8)
case(toxin-sensitive-11, of-9)
compound(toxin-sensitive-11, pertussis-10)
nmod:of(involvement-8, toxin-sensitive-11)
cc(toxin-sensitive-11, and-12)
amod(proteins-16, insensitive-14)
compound(proteins-16, G-15)
nmod:of(involvement-8, proteins-16)
conj:and(toxin-sensitive-11, proteins-16)
case(activation-19, in-17)
amod(activation-19, DAHP-induced-18)
nmod:in(proteins-16, activation-19)
case(GTP-CH-21, of-20)
nmod:of(activation-19, GTP-CH-21)

Treatment/NNP with/IN pertussis/NN toxin/NN ,/, which/WDT selectively/RB ADP-ribosylates/NNS and/CC inactivates/JJ Gi/Go/NNP proteins/NNS ,/, did/VBD not/RB affect/VB the/DT DAHP-induced/JJ increase/NN in/IN GTP-CH/JJ activity/NN ./.

(ROOT
  (S
    (NP
      (NP (NNP Treatment))
      (PP (IN with)
        (NP (NN pertussis) (NN toxin)))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (ADVP (RB selectively))
          (NP
            (NP (NNS ADP-ribosylates))
            (CC and)
            (NP (JJ inactivates) (NNP Gi/Go) (NNS proteins)))))
      (, ,))
    (VP (VBD did) (RB not)
      (VP (VB affect)
        (NP
          (NP (DT the) (JJ DAHP-induced) (NN increase))
          (PP (IN in)
            (NP (JJ GTP-CH) (NN activity))))))
    (. .)))

dep(ADP-ribosylates-8, Treatment-1)
nsubj(affect-16, Treatment-1)
case(toxin-4, with-2)
compound(toxin-4, pertussis-3)
nmod:with(Treatment-1, toxin-4)
ref(Treatment-1, which-6)
advmod(ADP-ribosylates-8, selectively-7)
acl:relcl(Treatment-1, ADP-ribosylates-8)
cc(ADP-ribosylates-8, and-9)
amod(proteins-12, inactivates-10)
compound(proteins-12, Gi/Go-11)
acl:relcl(Treatment-1, proteins-12)
conj:and(ADP-ribosylates-8, proteins-12)
aux(affect-16, did-14)
neg(affect-16, not-15)
root(ROOT-0, affect-16)
det(increase-19, the-17)
amod(increase-19, DAHP-induced-18)
dobj(affect-16, increase-19)
case(activity-22, in-20)
amod(activity-22, GTP-CH-21)
nmod:in(increase-19, activity-22)

This/DT suggests/VBZ that/IN DAHP/NNP responses/NNS may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NNP DAHP) (NNS responses))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN mediated)
                (PP (IN via)
                  (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein)))))))))
    (. .)))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
mark(mediated-8, that-3)
compound(responses-5, DAHP-4)
nsubjpass(mediated-8, responses-5)
aux(mediated-8, may-6)
auxpass(mediated-8, be-7)
ccomp(suggests-2, mediated-8)
case(G_protein-13, via-9)
det(G_protein-13, a-10)
compound(G_protein-13, pertussis-11)
amod(G_protein-13, toxin-insensitive-12)
nmod:via(mediated-8, G_protein-13)

Further/JJ studies/NNS are/VBP needed/VBN to/TO identify/VB the/DT specific/JJ G_protein/NN involved/VBN in/IN this/DT process/NN and/CC to/TO elucidate/VB the/DT downstream/JJ signaling/VBG pathway/NN leading/VBG to/TO increased/VBN BH4/NNP synthesis/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB identify)
                (NP
                  (NP (DT the) (JJ specific) (NN G_protein))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN process)))))))
            (CC and)
            (VP (TO to)
              (VP (VB elucidate)
                (NP (DT the) (JJ downstream) (VBG signaling) (NN pathway))
                (PP (VBG leading)
                  (PP (TO to)
                    (NP (VBN increased) (NNP BH4) (NN synthesis))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(identify-6, to-5)
ccomp(needed-4, identify-6)
det(G_protein-9, the-7)
amod(G_protein-9, specific-8)
dobj(identify-6, G_protein-9)
acl(G_protein-9, involved-10)
case(process-13, in-11)
det(process-13, this-12)
nmod:in(involved-10, process-13)
cc(identify-6, and-14)
mark(elucidate-16, to-15)
ccomp(needed-4, elucidate-16)
conj:and(identify-6, elucidate-16)
det(pathway-20, the-17)
amod(pathway-20, downstream-18)
amod(pathway-20, signaling-19)
dobj(elucidate-16, pathway-20)
case(synthesis-25, leading-21)
case(synthesis-25, to-22)
amod(synthesis-25, increased-23)
compound(synthesis-25, BH4-24)
advcl(elucidate-16, synthesis-25)

Understanding/VBG the/DT mechanisms/NNS of/IN DAHP-induced/JJ activation/NN of/IN GTP-CH/NNP may/MD have/VB important/JJ implications/NNS for/IN the/DT treatment/NN of/IN disorders/NNS associated/VBN with/IN BH4_deficiency/NNS such/JJ as/IN phenylketonuria/JJ and_Parkinson/NN 's/POS _/JJ disease/NN ./.

(ROOT
  (S
    (S
      (VP (VBG Understanding)
        (NP
          (NP (DT the) (NNS mechanisms))
          (PP (IN of)
            (NP
              (NP (JJ DAHP-induced) (NN activation))
              (PP (IN of)
                (NP (NNP GTP-CH))))))))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN treatment))
              (PP (IN of)
                (NP
                  (NP (NNS disorders))
                  (VP (VBN associated)
                    (PP (IN with)
                      (NP
                        (NP (NNS BH4_deficiency))
                        (PP (JJ such) (IN as)
                          (NP
                            (NP (JJ phenylketonuria) (NN and_Parkinson) (POS 's))
                            (JJ _) (NN disease)))))))))))))
    (. .)))

csubj(have-10, Understanding-1)
det(mechanisms-3, the-2)
dobj(Understanding-1, mechanisms-3)
case(activation-6, of-4)
amod(activation-6, DAHP-induced-5)
nmod:of(mechanisms-3, activation-6)
case(GTP-CH-8, of-7)
nmod:of(activation-6, GTP-CH-8)
aux(have-10, may-9)
root(ROOT-0, have-10)
amod(implications-12, important-11)
dobj(have-10, implications-12)
case(treatment-15, for-13)
det(treatment-15, the-14)
nmod:for(implications-12, treatment-15)
case(disorders-17, of-16)
nmod:of(treatment-15, disorders-17)
acl(disorders-17, associated-18)
case(BH4_deficiency-20, with-19)
nmod:with(associated-18, BH4_deficiency-20)
case(disease-27, such-21)
mwe(such-21, as-22)
amod(and_Parkinson-24, phenylketonuria-23)
nmod:poss(disease-27, and_Parkinson-24)
case(and_Parkinson-24, 's-25)
amod(disease-27, _-26)
nmod:such_as(BH4_deficiency-20, disease-27)

This/DT study/NN aimed/VBD to/TO investigate/VB the/DT effect/NN of/IN PF-3845/NN on/IN the/DT risk/NN of/IN developing/VBG migraine_symptoms/NNS such/JJ as/IN nausea/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN PF-3845))))
            (PP (IN on)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (VBG developing) (NNS migraine_symptoms))
                    (PP (JJ such) (IN as)
                      (NP
                        (NP (NN nausea))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effect-7, the-6)
dobj(investigate-5, effect-7)
case(PF-3845-9, of-8)
nmod:of(effect-7, PF-3845-9)
case(risk-12, on-10)
det(risk-12, the-11)
nmod:on(investigate-5, risk-12)
case(migraine_symptoms-15, of-13)
amod(migraine_symptoms-15, developing-14)
nmod:of(risk-12, migraine_symptoms-15)
case(nausea-18, such-16)
mwe(such-16, as-17)
nmod:such_as(migraine_symptoms-15, nausea-18)
nmod:such_as(migraine_symptoms-15, photophobia-20)
conj:and(nausea-18, photophobia-20)
cc(nausea-18, and-22)
nmod:such_as(migraine_symptoms-15, phonophobia-23)
conj:and(nausea-18, phonophobia-23)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT sample/NN of/IN migraine/JJ patients/NNS who/WP received/VBD a/DT single/JJ dose/NN of/IN PF-3845/NN or/CC placebo/NN ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN sample))
            (PP (IN of)
              (NP
                (NP (JJ migraine) (NNS patients))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD received)
                      (NP
                        (NP (DT a) (JJ single) (NN dose))
                        (PP (IN of)
                          (NP (NN PF-3845)
                            (CC or)
                            (NN placebo)))))))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(sample-12, on-10)
det(sample-12, a-11)
nmod:on(conducted-9, sample-12)
case(patients-15, of-13)
amod(patients-15, migraine-14)
nmod:of(sample-12, patients-15)
nsubj(received-17, patients-15)
ref(patients-15, who-16)
acl:relcl(patients-15, received-17)
det(dose-20, a-18)
amod(dose-20, single-19)
dobj(received-17, dose-20)
case(PF-3845-22, of-21)
nmod:of(dose-20, PF-3845-22)
cc(PF-3845-22, or-23)
nmod:of(dose-20, placebo-24)
conj:or(PF-3845-22, placebo-24)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, PF-3845/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN nausea/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- compared/VBN to/TO placebo/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP PF-3845))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN nausea))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))
                    (VP (VBN compared)
                      (PP (TO to)
                        (NP (NN placebo))))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, PF-3845-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(nausea-17, of-16)
nmod:of(risk-15, nausea-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)
acl(%-53, compared-65)
case(placebo-67, to-66)
nmod:to(compared-65, placebo-67)

These/DT findings/NNS suggest/VBP that/IN PF-3845/NNP may/MD be/VB a/DT potential/JJ therapeutic/JJ option/NN for/IN migraine/JJ patients/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP PF-3845))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (JJ migraine) (NNS patients))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, PF-3845-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, potential-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(patients-14, for-12)
amod(patients-14, migraine-13)
nmod:for(option-11, patients-14)
acl(patients-14, experiencing-15)
det(symptoms-17, these-16)
dobj(experiencing-15, symptoms-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC evaluate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN PF-3845/NN in/IN the/DT treatment/NN of/IN migraines/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB evaluate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP
                      (NP (NN PF-3845))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN treatment))
                          (PP (IN of)
                            (NP (NNS migraines))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(confirm-6, studies-2)
nsubj:xsubj(evaluate-10, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, evaluate-10)
conj:and(confirm-6, evaluate-10)
det(safety-13, the-11)
amod(safety-13, long-term-12)
dobj(evaluate-10, safety-13)
cc(safety-13, and-14)
dobj(evaluate-10, efficacy-15)
conj:and(safety-13, efficacy-15)
case(PF-3845-17, of-16)
nmod:of(safety-13, PF-3845-17)
case(treatment-20, in-18)
det(treatment-20, the-19)
nmod:in(PF-3845-17, treatment-20)
case(migraines-22, of-21)
nmod:of(treatment-20, migraines-22)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO possess/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB possess)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-16, Omega-3_fatty_acids-1)
nsubj:xsubj(possess-18, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
mark(possess-18, to-17)
xcomp(shown-16, possess-18)
amod(benefits-21, numerous-19)
compound(benefits-21, health-20)
dobj(possess-18, benefits-21)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD be/VB associated/VBN with/IN decreased/VBN levels/NNS of/IN PA-824/NN in/IN hyperPA-824mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (VBN decreased) (NNS levels))
                      (PP (IN of)
                        (NP
                          (NP (NN PA-824))
                          (PP (IN in)
                            (NP (JJ hyperPA-824mic) (NNS patients))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(associated-11, that-5)
nsubjpass(associated-11, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubjpass(associated-11, DHA-8)
aux(associated-11, may-9)
auxpass(associated-11, be-10)
ccomp(suggested-4, associated-11)
case(levels-14, with-12)
amod(levels-14, decreased-13)
nmod:with(associated-11, levels-14)
case(PA-824-16, of-15)
nmod:of(levels-14, PA-824-16)
case(patients-19, in-17)
amod(patients-19, hyperPA-824mic-18)
nmod:in(PA-824-16, patients-19)

Additionally/RB ,/, these/DT long-chain/JJ omega-3_fatty_acids/NNS have/VBP been/VBN linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN reduced) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(linked-8, Additionally-1)
det(omega-3_fatty_acids-5, these-3)
amod(omega-3_fatty_acids-5, long-chain-4)
nsubjpass(linked-8, omega-3_fatty_acids-5)
aux(linked-8, have-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, reduced-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

The/DT mechanisms/NNS underlying/VBG these/DT effects/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD modulate/VBP inflammation/NN ,/, lipid/NN metabolism/NN ,/, and/CC other/JJ pathways/NNS involved/VBN in/IN CHD/NNP development/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (VP (VBG underlying)
          (NP (DT these) (NNS effects))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (MD may)
                (VP (VBP modulate)
                  (NP
                    (NP (NN inflammation))
                    (, ,)
                    (NP (NN lipid) (NN metabolism))
                    (, ,)
                    (CC and)
                    (NP
                      (NP (JJ other) (NNS pathways))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NNP CHD) (NN development)))))))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-5, these-4)
dobj(underlying-3, effects-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(modulate-21, that-16)
nsubj(modulate-21, EPA-17)
cc(EPA-17, and-18)
conj:and(EPA-17, DHA-19)
nsubj(modulate-21, DHA-19)
aux(modulate-21, may-20)
ccomp(believed-15, modulate-21)
dobj(modulate-21, inflammation-22)
compound(metabolism-25, lipid-24)
dobj(modulate-21, metabolism-25)
conj:and(inflammation-22, metabolism-25)
cc(inflammation-22, and-27)
amod(pathways-29, other-28)
dobj(modulate-21, pathways-29)
conj:and(inflammation-22, pathways-29)
acl(pathways-29, involved-30)
case(development-33, in-31)
compound(development-33, CHD-32)
nmod:in(involved-30, development-33)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS of/IN action/NN of/IN EPA/NNP and/CC DHA/NNP in/IN the/DT context/NN of/IN PA-824/JJ levels/NNS and/CC CHD/NNP risk/NN reduction/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (JJ precise) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (NN action))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA))))))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN context))
                  (PP (IN of)
                    (NP
                      (NP (JJ PA-824) (NNS levels))
                      (CC and)
                      (NP (NNP CHD) (NN risk) (NN reduction)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-6, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
case(action-11, of-10)
nmod:of(mechanisms-9, action-11)
case(EPA-13, of-12)
nmod:of(action-11, EPA-13)
cc(EPA-13, and-14)
nmod:of(action-11, DHA-15)
conj:and(EPA-13, DHA-15)
case(context-18, in-16)
det(context-18, the-17)
nmod:in(elucidate-6, context-18)
case(levels-21, of-19)
amod(levels-21, PA-824-20)
nmod:of(context-18, levels-21)
cc(levels-21, and-22)
compound(reduction-25, CHD-23)
compound(reduction-25, risk-24)
nmod:of(context-18, reduction-25)
conj:and(levels-21, reduction-25)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT a) (JJ healthy) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS have/VBP a/DT significant/JJ impact/NN on/IN the/DT prevention/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP have)
              (NP
                (NP (DT a) (JJ significant) (NN impact))
                (PP (IN on)
                  (NP
                    (NP
                      (NP (DT the) (NN prevention))
                      (PP (IN of)
                        (NP (NN coronary_heart_disease))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(have-8, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubj(have-8, long-chain_fatty_acids-7)
ccomp(shown-4, have-8)
det(impact-11, a-9)
amod(impact-11, significant-10)
dobj(have-8, impact-11)
case(prevention-14, on-12)
det(prevention-14, the-13)
nmod:on(impact-11, prevention-14)
case(coronary_heart_disease-16, of-15)
nmod:of(prevention-14, coronary_heart_disease-16)
appos(prevention-14, CHD-18)

Interestingly/RB ,/, they/PRP have/VBP also/RB been/VBN associated/VBN with/IN decreased/VBN levels/NNS of/IN Gyromitrin/NNP in/IN hyperGyromitrinmic/JJ patients/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (VBN decreased) (NNS levels))
              (PP (IN of)
                (NP (NNP Gyromitrin)))
              (PP (IN in)
                (NP (JJ hyperGyromitrinmic) (NNS patients))))))))
    (. .)))

advmod(associated-7, Interestingly-1)
nsubjpass(associated-7, they-3)
aux(associated-7, have-4)
advmod(associated-7, also-5)
auxpass(associated-7, been-6)
root(ROOT-0, associated-7)
case(levels-10, with-8)
amod(levels-10, decreased-9)
nmod:with(associated-7, levels-10)
case(Gyromitrin-12, of-11)
nmod:of(levels-10, Gyromitrin-12)
case(patients-15, in-13)
amod(patients-15, hyperGyromitrinmic-14)
nmod:in(levels-10, patients-15)

Gyromitrin/JJ is_a/JJ toxic/JJ compound/NN found/VBD in/IN certain/JJ mushrooms/NNS and/CC has_been/NN linked/VBN to/TO liver_damage/JJ and/CC other/JJ health/NN issues/NNS ./.

(ROOT
  (S
    (NP (JJ Gyromitrin) (JJ is_a) (JJ toxic) (NN compound))
    (VP (VBD found)
      (PP (IN in)
        (NP
          (NP (JJ certain) (NNS mushrooms)
            (CC and)
            (NN has_been))
          (VP (VBN linked)
            (PP (TO to)
              (NP
                (ADJP (JJ liver_damage)
                  (CC and)
                  (JJ other))
                (NN health) (NNS issues)))))))
    (. .)))

amod(compound-4, Gyromitrin-1)
amod(compound-4, is_a-2)
amod(compound-4, toxic-3)
nsubj(found-5, compound-4)
root(ROOT-0, found-5)
case(mushrooms-8, in-6)
amod(mushrooms-8, certain-7)
nmod:in(found-5, mushrooms-8)
cc(mushrooms-8, and-9)
nmod:in(found-5, has_been-10)
conj:and(mushrooms-8, has_been-10)
acl(mushrooms-8, linked-11)
case(issues-17, to-12)
amod(issues-17, liver_damage-13)
cc(liver_damage-13, and-14)
conj:and(liver_damage-13, other-15)
amod(issues-17, other-15)
compound(issues-17, health-16)
nmod:to(linked-11, issues-17)

The/DT mechanism/NN by/IN which/WDT omega-3_fatty_acids/JJ reduce/VB Gyromitrin/JJ levels/NNS is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN to_be/JJ related/VBN to/TO their/PRP$ anti-inflammatory/JJ properties/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (JJ omega-3_fatty_acids))
            (VP (VB reduce)
              (NP (JJ Gyromitrin) (NNS levels))))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (ADJP (JJ to_be))
          (PP (VBN related)
            (PP (TO to)
              (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties)))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(reduce-6, mechanism-2)
nsubjpass(understood-13, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(reduce-6, omega-3_fatty_acids-5)
acl:relcl(mechanism-2, reduce-6)
amod(levels-8, Gyromitrin-7)
dobj(reduce-6, levels-8)
auxpass(understood-13, is-9)
neg(understood-13, not-10)
advmod(understood-13, yet-11)
advmod(understood-13, fully-12)
root(ROOT-0, understood-13)
cc(understood-13, but-15)
nsubjpass(believed-18, it-16)
auxpass(believed-18, is-17)
conj:but(understood-13, believed-18)
xcomp(believed-18, to_be-19)
case(properties-24, related-20)
case(properties-24, to-21)
nmod:poss(properties-24, their-22)
amod(properties-24, anti-inflammatory-23)
advcl(believed-18, properties-24)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN developing/VBG CHD/NNP and/CC preventing/VBG the/DT harmful/JJ effects/NNS of/IN Gyromitrin/NNP in/IN hyperGyromitrinmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (S
                            (VP
                              (VP (VBG developing)
                                (NP (NNP CHD)))
                              (CC and)
                              (VP (VBG preventing)
                                (NP
                                  (NP (DT the) (JJ harmful) (NNS effects))
                                  (PP (IN of)
                                    (NP (NNP Gyromitrin))))
                                (PP (IN in)
                                  (NP (JJ hyperGyromitrinmic) (NNS patients)))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
mark(developing-22, of-21)
acl(risk-20, developing-22)
dobj(developing-22, CHD-23)
cc(developing-22, and-24)
acl(risk-20, preventing-25)
conj:and(developing-22, preventing-25)
det(effects-28, the-26)
amod(effects-28, harmful-27)
dobj(preventing-25, effects-28)
case(Gyromitrin-30, of-29)
nmod:of(effects-28, Gyromitrin-30)
case(patients-33, in-31)
amod(patients-33, hyperGyromitrinmic-32)
nmod:in(preventing-25, patients-33)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT relationship/NN between/IN omega-3_fatty_acids/JJ and/CC these/DT health/NN outcomes/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NN relationship))
                (PP (IN between)
                  (NP
                    (ADJP (JJ omega-3_fatty_acids)
                      (CC and)
                      (DT these))
                    (NN health) (NNS outcomes)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(relationship-9, the-8)
dobj(understand-7, relationship-9)
case(outcomes-15, between-10)
amod(outcomes-15, omega-3_fatty_acids-11)
cc(omega-3_fatty_acids-11, and-12)
conj:and(omega-3_fatty_acids-11, these-13)
amod(outcomes-15, these-13)
compound(outcomes-15, health-14)
nmod:between(relationship-9, outcomes-15)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(associated-20, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, numerous-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD decrease/VB plenosol/JJ levels/NNS in/IN hyperplenosolmic/JJ patients/NNS ,/, which/WDT could/MD potentially/RB reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may)
              (VP (VB decrease)
                (NP
                  (NP (JJ plenosol) (NNS levels))
                  (PP (IN in)
                    (NP
                      (NP (JJ hyperplenosolmic) (NNS patients))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (MD could) (RB potentially)
                            (VP (VB reduce)
                              (NP
                                (NP
                                  (NP (DT the) (NN risk))
                                  (PP (IN of)
                                    (S
                                      (VP (VBG developing)
                                        (NP (NN coronary_heart_disease))))))
                                (PRN (-LRB- -LRB-)
                                  (NP (NNP CHD))
                                  (-RRB- -RRB-))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(decrease-10, that-5)
nsubj(decrease-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubj(decrease-10, DHA-8)
aux(decrease-10, may-9)
ccomp(suggested-4, decrease-10)
amod(levels-12, plenosol-11)
dobj(decrease-10, levels-12)
case(patients-15, in-13)
amod(patients-15, hyperplenosolmic-14)
nmod:in(levels-12, patients-15)
nsubj(reduce-20, patients-15)
ref(patients-15, which-17)
aux(reduce-20, could-18)
advmod(reduce-20, potentially-19)
acl:relcl(patients-15, reduce-20)
det(risk-22, the-21)
dobj(reduce-20, risk-22)
mark(developing-24, of-23)
acl(risk-22, developing-24)
dobj(developing-24, coronary_heart_disease-25)
appos(risk-22, CHD-27)

The/DT mechanism/NN by/IN which/WDT EPA/NNP and/CC DHA/NNP exert/VB their/PRP$ protective/JJ effects/NNS on/IN cardiovascular_health/NN is/VBZ still/RB under/IN investigation/NN ,/, but/CC it/PRP is/VBZ believed/VBN to/TO involve/VB their/PRP$ ability/NN to/TO modulate/VBP inflammation/NN ,/, blood/NN lipid/NN levels/NNS ,/, and/CC endothelial/JJ function/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VB exert)
              (NP (PRP$ their) (JJ protective) (NNS effects))
              (PP (IN on)
                (NP (NN cardiovascular_health)))))))
      (VP (VBZ is)
        (ADVP (RB still))
        (PP (IN under)
          (NP (NN investigation)))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (S
            (VP (TO to)
              (VP (VB involve)
                (NP (PRP$ their) (NN ability))
                (PP (TO to)
                  (NP
                    (NP (VBP modulate) (NN inflammation))
                    (, ,)
                    (NP (NN blood) (NN lipid) (NNS levels))
                    (, ,)
                    (CC and)
                    (NP (JJ endothelial) (NN function))))))))))
    (. .)))

det(mechanism-2, The-1)
nmod:by(exert-8, mechanism-2)
nsubj(investigation-17, mechanism-2)
case(which-4, by-3)
ref(mechanism-2, which-4)
nsubj(exert-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(exert-8, DHA-7)
acl:relcl(mechanism-2, exert-8)
nmod:poss(effects-11, their-9)
amod(effects-11, protective-10)
dobj(exert-8, effects-11)
case(cardiovascular_health-13, on-12)
nmod:on(exert-8, cardiovascular_health-13)
cop(investigation-17, is-14)
advmod(investigation-17, still-15)
case(investigation-17, under-16)
root(ROOT-0, investigation-17)
cc(investigation-17, but-19)
nsubjpass(believed-22, it-20)
nsubj:xsubj(involve-24, it-20)
auxpass(believed-22, is-21)
conj:but(investigation-17, believed-22)
mark(involve-24, to-23)
xcomp(believed-22, involve-24)
nmod:poss(ability-26, their-25)
dobj(involve-24, ability-26)
case(inflammation-29, to-27)
dep(inflammation-29, modulate-28)
nmod:to(involve-24, inflammation-29)
compound(levels-33, blood-31)
compound(levels-33, lipid-32)
nmod:to(involve-24, levels-33)
conj:and(inflammation-29, levels-33)
cc(inflammation-29, and-35)
amod(function-37, endothelial-36)
nmod:to(involve-24, function-37)
conj:and(inflammation-29, function-37)

In/IN addition/NN to/TO their/PRP$ cardiovascular_benefits/NNS ,/, omega-3_fatty_acids/JJ have/VBP also/RB been/VBN shown/VBN to/TO improve/VB cognitive/JJ function/NN ,/, mood_disorders/NNS ,/, and/CC joint/JJ health/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (NNS cardiovascular_benefits)))))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB improve)
                (NP
                  (NP (JJ cognitive) (NN function))
                  (, ,)
                  (NP (NNS mood_disorders))
                  (, ,)
                  (CC and)
                  (NP (JJ joint) (NN health)))))))))
    (. .)))

case(cardiovascular_benefits-5, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(cardiovascular_benefits-5, their-4)
nmod:in_addition_to(shown-11, cardiovascular_benefits-5)
nsubjpass(shown-11, omega-3_fatty_acids-7)
nsubj:xsubj(improve-13, omega-3_fatty_acids-7)
aux(shown-11, have-8)
advmod(shown-11, also-9)
auxpass(shown-11, been-10)
root(ROOT-0, shown-11)
mark(improve-13, to-12)
xcomp(shown-11, improve-13)
amod(function-15, cognitive-14)
dobj(improve-13, function-15)
dobj(improve-13, mood_disorders-17)
conj:and(function-15, mood_disorders-17)
cc(function-15, and-19)
amod(health-21, joint-20)
dobj(improve-13, health-21)
conj:and(function-15, health-21)

Therefore/RB ,/, increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ health/NN outcomes/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NN supplementation)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (CC and)
                (VP (VBG improving)
                  (NP (JJ overall) (NN health) (NNS outcomes)))))))))
    (. .)))

advmod(strategy-19, Therefore-1)
csubj(strategy-19, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(EPA-7, of-6)
nmod:of(intake-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(intake-5, DHA-9)
conj:and(EPA-7, DHA-9)
case(sources-12, through-10)
amod(sources-12, dietary-11)
nmod:through(increasing-3, sources-12)
cc(sources-12, or-13)
nmod:through(increasing-3, supplementation-14)
conj:or(sources-12, supplementation-14)
aux(strategy-19, may-15)
cop(strategy-19, be-16)
det(strategy-19, an-17)
amod(strategy-19, effective-18)
root(ROOT-0, strategy-19)
mark(reducing-21, for-20)
acl(strategy-19, reducing-21)
det(risk-23, the-22)
dobj(reducing-21, risk-23)
case(CHD-25, of-24)
nmod:of(risk-23, CHD-25)
cc(reducing-21, and-26)
acl(strategy-19, improving-27)
conj:and(reducing-21, improving-27)
amod(outcomes-30, overall-28)
compound(outcomes-30, health-29)
dobj(improving-27, outcomes-30)

Migraine/VB is_a/JJ common/JJ neurological_disorder/NN that/WDT affects/VBZ millions/NNS of/IN people/NNS worldwide/RB ./.

(ROOT
  (S
    (VP (VB Migraine)
      (NP
        (NP (JJ is_a) (JJ common) (NN neurological_disorder))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP
                (NP (NNS millions))
                (PP (IN of)
                  (NP (NNS people))))))))
      (ADVP (RB worldwide)))
    (. .)))

root(ROOT-0, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
dobj(Migraine-1, neurological_disorder-4)
nsubj(affects-6, neurological_disorder-4)
ref(neurological_disorder-4, that-5)
acl:relcl(neurological_disorder-4, affects-6)
dobj(affects-6, millions-7)
case(people-9, of-8)
nmod:of(millions-7, people-9)
advmod(Migraine-1, worldwide-10)

The/DT current/JJ treatment/NN options/NNS for/IN migraine/NN are/VBP limited/VBN ,/, and/CC there/EX is_a/RB need/VBP for/IN more/RBR effective/JJ and/CC safer/JJR treatments/NNS ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ current) (NN treatment) (NNS options))
        (PP (IN for)
          (NP (NN migraine))))
      (VP (VBP are)
        (VP (VBN limited))))
    (, ,)
    (CC and)
    (S
      (NP (EX there))
      (ADVP (RB is_a))
      (VP (VBP need)
        (PP (IN for)
          (NP
            (ADJP
              (ADJP (RBR more) (JJ effective))
              (CC and)
              (ADJP (JJR safer)))
            (NNS treatments)))))
    (. .)))

det(options-4, The-1)
amod(options-4, current-2)
compound(options-4, treatment-3)
nsubjpass(limited-8, options-4)
nsubj(need-13, options-4)
case(migraine-6, for-5)
nmod:for(options-4, migraine-6)
auxpass(limited-8, are-7)
root(ROOT-0, limited-8)
cc(limited-8, and-10)
expl(need-13, there-11)
advmod(need-13, is_a-12)
conj:and(limited-8, need-13)
case(treatments-19, for-14)
advmod(effective-16, more-15)
amod(treatments-19, effective-16)
cc(effective-16, and-17)
conj:and(effective-16, safer-18)
amod(treatments-19, safer-18)
nmod:for(need-13, treatments-19)

L-652/NNP ,731/CD is_a/JJ new/JJ drug/NN that/WDT has/VBZ shown/VBN promising/JJ results/NNS in/IN the/DT treatment/NN of/IN migraine/NN ./.

(ROOT
  (NP
    (NP (NNP L-652) (CD ,731))
    (NP
      (NP (JJ is_a) (JJ new) (NN drug))
      (SBAR
        (WHNP (WDT that))
        (S
          (VP (VBZ has)
            (VP (VBN shown)
              (NP (JJ promising) (NNS results))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN treatment))
                  (PP (IN of)
                    (NP (NN migraine))))))))))
    (. .)))

root(ROOT-0, L-652-1)
nummod(L-652-1, ,731-2)
amod(drug-5, is_a-3)
amod(drug-5, new-4)
dep(L-652-1, drug-5)
nsubj(shown-8, drug-5)
ref(drug-5, that-6)
aux(shown-8, has-7)
acl:relcl(drug-5, shown-8)
amod(results-10, promising-9)
dobj(shown-8, results-10)
case(treatment-13, in-11)
det(treatment-13, the-12)
nmod:in(shown-8, treatment-13)
case(migraine-15, of-14)
nmod:of(treatment-13, migraine-15)

In/IN a/DT randomized_controlled_trial/NN ,/, L-652/NNP ,731/CD was/VBD administered/VBN to/TO patients/NNS with/IN migraine/JJ attacks/NNS at/IN 2/CD hours/NNS after/IN dosing/VBG ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (NN randomized_controlled_trial)))
    (, ,)
    (NP (NNP L-652) (CD ,731))
    (VP (VBD was)
      (VP (VBN administered)
        (PP (TO to)
          (NP (NNS patients)))
        (PP (IN with)
          (NP (JJ migraine) (NNS attacks)))
        (PP (IN at)
          (NP (CD 2) (NNS hours)))
        (PP (IN after)
          (S
            (VP (VBG dosing))))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, a-2)
nmod:in(administered-8, randomized_controlled_trial-3)
nsubjpass(administered-8, L-652-5)
nummod(L-652-5, ,731-6)
auxpass(administered-8, was-7)
root(ROOT-0, administered-8)
case(patients-10, to-9)
nmod:to(administered-8, patients-10)
case(attacks-13, with-11)
amod(attacks-13, migraine-12)
nmod:with(administered-8, attacks-13)
case(hours-16, at-14)
nummod(hours-16, 2-15)
nmod:at(administered-8, hours-16)
mark(dosing-18, after-17)
advcl(administered-8, dosing-18)

The/DT results/NNS showed/VBD that/IN L-652/NN ,731/CD reduced/VBD the/DT risk/NN of/IN leukocytopenia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN L-652) (CD ,731))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN leukocytopenia))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-7, that-4)
nsubj(reduced-7, L-652-5)
nummod(L-652-5, ,731-6)
ccomp(showed-3, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(leukocytopenia-11, of-10)
nmod:of(risk-9, leukocytopenia-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN L-652/NNP ,731/CD may/MD be/VB an/DT effective/JJ and/CC safe/JJ treatment/NN option/NN for/IN patients/NNS with/IN migraine/JJ attacks/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP L-652) (CD ,731))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an)
                  (ADJP (JJ effective)
                    (CC and)
                    (JJ safe))
                  (NN treatment) (NN option))
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP (JJ migraine) (NNS attacks))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-14, that-4)
nsubj(option-14, L-652-5)
nummod(L-652-5, ,731-6)
aux(option-14, may-7)
cop(option-14, be-8)
det(option-14, an-9)
amod(option-14, effective-10)
cc(effective-10, and-11)
conj:and(effective-10, safe-12)
amod(option-14, safe-12)
compound(option-14, treatment-13)
ccomp(suggest-3, option-14)
case(patients-16, for-15)
nmod:for(option-14, patients-16)
case(attacks-19, with-17)
amod(attacks-19, migraine-18)
nmod:with(option-14, attacks-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO investigate/VB the/DT long-term/JJ safety/NN and/CC efficacy/NN of/IN L-652/NNP ,731/CD in/IN the/DT treatment/NN of/IN migraine/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (JJ long-term) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP (NNP L-652) (CD ,731))))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN treatment))
                    (PP (IN of)
                      (NP (NN migraine)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(investigate-11, to-10)
ccomp(needed-4, investigate-11)
conj:and(confirm-6, investigate-11)
det(safety-14, the-12)
amod(safety-14, long-term-13)
dobj(investigate-11, safety-14)
cc(safety-14, and-15)
dobj(investigate-11, efficacy-16)
conj:and(safety-14, efficacy-16)
case(L-652-18, of-17)
nmod:of(safety-14, L-652-18)
nummod(L-652-18, ,731-19)
case(treatment-22, in-20)
det(treatment-22, the-21)
nmod:in(investigate-11, treatment-22)
case(migraine-24, of-23)
nmod:of(treatment-22, migraine-24)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP (JJ numerous) (NN health) (NNS benefits))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubj(polyunsaturated_fatty_acids-24, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
cop(polyunsaturated_fatty_acids-24, are-22)
amod(polyunsaturated_fatty_acids-24, essential-23)
root(ROOT-0, polyunsaturated_fatty_acids-24)
nsubjpass(shown-28, polyunsaturated_fatty_acids-24)
nsubj:xsubj(have-30, polyunsaturated_fatty_acids-24)
ref(polyunsaturated_fatty_acids-24, that-25)
aux(shown-28, have-26)
auxpass(shown-28, been-27)
acl:relcl(polyunsaturated_fatty_acids-24, shown-28)
mark(have-30, to-29)
xcomp(shown-28, have-30)
amod(benefits-33, numerous-31)
compound(benefits-33, health-32)
dobj(have-30, benefits-33)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN these/DT fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG reducing)
                        (NP
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-9, that-5)
det(fatty_acids-7, these-6)
nsubj(play-9, fatty_acids-7)
aux(play-9, may-8)
ccomp(suggested-4, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(reducing-13, in-12)
acl(role-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

In/IN addition/NN ,/, there/EX is/VBZ evidence/NN to/TO suggest/VB that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB associated/VBN with/IN decreased/VBN Pandemrix/NN levels/NNS in/IN hyperPandemrixmic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (NP (NN evidence)
        (S
          (VP (TO to)
            (VP (VB suggest)
              (SBAR (IN that)
                (S
                  (NP (JJ long-chain) (NN omega-3_fatty_acids))
                  (VP (MD may)
                    (VP (VB be)
                      (VP (VBN associated)
                        (PP (IN with)
                          (NP
                            (NP (VBN decreased) (NN Pandemrix) (NNS levels))
                            (PP (IN in)
                              (NP (JJ hyperPandemrixmic) (NNS patients)))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(is-5, addition-2)
expl(is-5, there-4)
root(ROOT-0, is-5)
nsubj(is-5, evidence-6)
mark(suggest-8, to-7)
acl(evidence-6, suggest-8)
mark(associated-14, that-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nsubjpass(associated-14, omega-3_fatty_acids-11)
aux(associated-14, may-12)
auxpass(associated-14, be-13)
ccomp(suggest-8, associated-14)
case(levels-18, with-15)
amod(levels-18, decreased-16)
compound(levels-18, Pandemrix-17)
nmod:with(associated-14, levels-18)
case(patients-21, in-19)
amod(patients-21, hyperPandemrixmic-20)
nmod:in(levels-18, patients-21)

Pandemrix/NNP is_a/NN vaccine/NN used/VBD to/TO protect/VB against/IN influenza_A/NN -LRB-/-LRB- H1N1/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Pandemrix) (NN is_a) (NN vaccine))
    (VP (VBD used)
      (S
        (VP (TO to)
          (VP (VB protect)
            (PP (IN against)
              (NP
                (NP (NN influenza_A))
                (PRN (-LRB- -LRB-)
                  (NP (NNP H1N1))
                  (-RRB- -RRB-))))))))
    (. .)))

compound(vaccine-3, Pandemrix-1)
compound(vaccine-3, is_a-2)
nsubj(used-4, vaccine-3)
nsubj:xsubj(protect-6, vaccine-3)
root(ROOT-0, used-4)
mark(protect-6, to-5)
xcomp(used-4, protect-6)
case(influenza_A-8, against-7)
nmod:against(protect-6, influenza_A-8)
appos(influenza_A-8, H1N1-10)

This/DT finding/NN suggests/VBZ that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD have/VB immunomodulatory/JJ effects/NNS that/WDT could/MD be/VB beneficial/JJ for/IN individuals/NNS with/IN hyperPandemrixmia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ immunomodulatory) (NNS effects))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD could)
                      (VP (VB be)
                        (ADJP (JJ beneficial)
                          (PP (IN for)
                            (NP
                              (NP (NNS individuals))
                              (PP (IN with)
                                (NP (NN hyperPandemrixmia))))))))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(have-8, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubj(have-8, omega-3_fatty_acids-6)
aux(have-8, may-7)
ccomp(suggests-3, have-8)
amod(effects-10, immunomodulatory-9)
dobj(have-8, effects-10)
nsubj(beneficial-14, effects-10)
ref(effects-10, that-11)
aux(beneficial-14, could-12)
cop(beneficial-14, be-13)
acl:relcl(effects-10, beneficial-14)
case(individuals-16, for-15)
nmod:for(beneficial-14, individuals-16)
case(hyperPandemrixmia-18, with-17)
nmod:with(individuals-16, hyperPandemrixmia-18)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB the/DT optimal/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN for/IN disease/NN prevention/NN and/CC management/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (NN intake))
                  (PP (IN of)
                    (NP
                      (NP (JJ long-chain) (NN omega-3_fatty_acids))
                      (PP (IN for)
                        (NP (NN disease) (NN prevention)
                          (CC and)
                          (NN management))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
det(intake-18, the-16)
amod(intake-18, optimal-17)
dobj(determine-15, intake-18)
case(omega-3_fatty_acids-21, of-19)
amod(omega-3_fatty_acids-21, long-chain-20)
nmod:of(intake-18, omega-3_fatty_acids-21)
case(prevention-24, for-22)
compound(prevention-24, disease-23)
nmod:for(omega-3_fatty_acids-21, prevention-24)
cc(prevention-24, and-25)
nmod:for(omega-3_fatty_acids-21, management-26)
conj:and(prevention-24, management-26)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN various/JJ signaling/VBG pathways/NNS and/CC the/DT expression/NN of/IN specific/JJ genes/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP
                  (NP (DT the) (NN activation))
                  (PP (IN of)
                    (NP (JJ various) (VBG signaling) (NNS pathways))))
                (CC and)
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP (JJ specific) (NNS genes))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-14, of-11)
amod(pathways-14, various-12)
amod(pathways-14, signaling-13)
nmod:of(activation-10, pathways-14)
cc(activation-10, and-15)
det(expression-17, the-16)
dobj(involves-8, expression-17)
conj:and(activation-10, expression-17)
case(genes-20, of-18)
amod(genes-20, specific-19)
nmod:of(expression-17, genes-20)

Previous/JJ studies/NNS have/VBP shown/VBN that/IN spindlin/NN ,/, a/DT protein/NN involved/VBN in/IN chromatin/NN remodeling/NN and/CC gene/NN expression/NN ,/, plays/VBZ a/DT crucial/JJ role/NN in/IN myogenesis/NNS ./.

(ROOT
  (S
    (NP (JJ Previous) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN spindlin))
              (, ,)
              (NP
                (NP (DT a) (NN protein))
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (NN chromatin) (NN remodeling))
                      (CC and)
                      (NP (NN gene) (NN expression))))))
              (, ,))
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP (NNS myogenesis)))))))))
    (. .)))

amod(studies-2, Previous-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(plays-18, that-5)
nsubj(plays-18, spindlin-6)
det(protein-9, a-8)
appos(spindlin-6, protein-9)
acl(protein-9, involved-10)
case(remodeling-13, in-11)
compound(remodeling-13, chromatin-12)
nmod:in(involved-10, remodeling-13)
cc(remodeling-13, and-14)
compound(expression-16, gene-15)
nmod:in(involved-10, expression-16)
conj:and(remodeling-13, expression-16)
ccomp(shown-4, plays-18)
det(role-21, a-19)
amod(role-21, crucial-20)
dobj(plays-18, role-21)
case(myogenesis-23, in-22)
nmod:in(role-21, myogenesis-23)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN UNC0638/NNP ,/, a/DT small/JJ molecule/NN inhibitor/NN of/IN histone_methyltransferase/JJ G9a/NNS ,/, on/IN spindlin/JJ protein/NN levels/NNS in/IN C2C12/CD cells/NNS during/IN differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP UNC0638))
            (, ,)
            (NP
              (NP (DT a) (JJ small) (NN molecule) (NN inhibitor))
              (PP (IN of)
                (NP (JJ histone_methyltransferase) (NNS G9a))))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (JJ spindlin) (NN protein) (NNS levels))
          (PP (IN in)
            (NP (CD C2C12) (NNS cells)))))
      (PP (IN during)
        (NP (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(UNC0638-10, of-9)
nmod:of(effect-8, UNC0638-10)
det(inhibitor-15, a-12)
amod(inhibitor-15, small-13)
compound(inhibitor-15, molecule-14)
appos(UNC0638-10, inhibitor-15)
case(G9a-18, of-16)
amod(G9a-18, histone_methyltransferase-17)
nmod:of(inhibitor-15, G9a-18)
case(levels-23, on-20)
amod(levels-23, spindlin-21)
compound(levels-23, protein-22)
nmod:on(investigated-6, levels-23)
case(cells-26, in-24)
nummod(cells-26, C2C12-25)
nmod:in(levels-23, cells-26)
case(differentiation-28, during-27)
nmod:during(investigated-6, differentiation-28)

When/WRB C2C12/JJ cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, UNC0638/CD up-regulated/JJ spindlin/NN protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ spindlin/NN protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (SBARQ
    (WHNP
      (WHADJP (WRB When) (JJ C2C12))
      (NNS cells))
    (SQ (VBD were)
      (VP (VBN cultured)
        (NP (NN in_a)
          (NX
            (NX
              (NX (NN medium) (VBG favoring) (NN differentiation))
              (PRN (-LRB- -LRB-)
                (NAC (NNP Dulbecco)
                  (PP (VBN modified)
                    (NP
                      (NP (NNP Eagle) (NN medium))
                      (VP (VBG containing)
                        (NP
                          (ADJP (CD 2) (NN %))
                          (NN horse) (NN serum))))))
                (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (CD UNC0638) (JJ up-regulated) (NN spindlin) (NN protein) (NNS levels))
                (NP (NN in_a) (JJ time-dependent) (NN manner))))
            (CC and)
            (NX (JJ prolonged) (NN spindlin)))
          (NX (NN protein) (NN half-life)))
        (PP (IN from)
          (NP
            (QP (CD 10) (TO to) (CD 18))
            (NNS hours)))))
    (. .)))

advmod(C2C12-2, When-1)
amod(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
dep(half-life-34, in_a-6)
compound(differentiation-9, medium-7)
amod(differentiation-9, favoring-8)
dep(half-life-34, differentiation-9)
dep(differentiation-9, Dulbecco-11)
case(medium-14, modified-12)
compound(medium-14, Eagle-13)
nmod:modified(Dulbecco-11, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)
nummod(levels-26, UNC0638-22)
amod(levels-26, up-regulated-23)
compound(levels-26, spindlin-24)
compound(levels-26, protein-25)
dep(differentiation-9, levels-26)
compound(manner-29, in_a-27)
amod(manner-29, time-dependent-28)
dep(levels-26, manner-29)
cc(differentiation-9, and-30)
amod(spindlin-32, prolonged-31)
conj:and(differentiation-9, spindlin-32)
dep(half-life-34, spindlin-32)
compound(half-life-34, protein-33)
dobj(cultured-5, half-life-34)
case(hours-39, from-35)
compound(18-38, 10-36)
dep(18-38, to-37)
nummod(hours-39, 18-38)
nmod:from(cultured-5, hours-39)

These/DT findings/NNS suggest/VBP that/IN UNC0638/NNP may/MD enhance/VB myogenic/JJ differentiation/NN by/IN promoting/VBG the/DT expression/NN of/IN spindlin/NN and/CC its/PRP$ downstream/JJ targets/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP UNC0638))
          (VP (MD may)
            (VP (VB enhance)
              (NP (JJ myogenic) (NN differentiation))
              (PP (IN by)
                (S
                  (VP (VBG promoting)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP
                          (NP (NN spindlin))
                          (CC and)
                          (NP (PRP$ its) (JJ downstream) (NNS targets)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(enhance-7, that-4)
nsubj(enhance-7, UNC0638-5)
aux(enhance-7, may-6)
ccomp(suggest-3, enhance-7)
amod(differentiation-9, myogenic-8)
dobj(enhance-7, differentiation-9)
mark(promoting-11, by-10)
advcl(enhance-7, promoting-11)
det(expression-13, the-12)
dobj(promoting-11, expression-13)
case(spindlin-15, of-14)
nmod:of(expression-13, spindlin-15)
cc(spindlin-15, and-16)
nmod:poss(targets-19, its-17)
amod(targets-19, downstream-18)
nmod:of(expression-13, targets-19)
conj:and(spindlin-15, targets-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG this/DT effect/NN and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN UNC0638/NNP in/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN effect))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP UNC0638))))
                (PP (IN in)
                  (NP (NNS muscle-related_disorders)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effect-12, this-11)
dobj(underlying-10, effect-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
det(applications-19, the-16)
amod(applications-19, potential-17)
amod(applications-19, therapeutic-18)
dobj(explore-15, applications-19)
case(UNC0638-21, of-20)
nmod:of(applications-19, UNC0638-21)
case(muscle-related_disorders-23, in-22)
nmod:in(explore-15, muscle-related_disorders-23)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN that/WDT involves/VBZ the/DT activation/NN of/IN multiple/JJ pathways/NNS and/CC regulatory/JJ factors/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ involves)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ multiple) (NNS pathways))
                    (CC and)
                    (NP (JJ regulatory) (NNS factors))))))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
nsubj(involves-8, process-6)
ref(process-6, that-7)
acl:relcl(process-6, involves-8)
det(activation-10, the-9)
dobj(involves-8, activation-10)
case(pathways-13, of-11)
amod(pathways-13, multiple-12)
nmod:of(activation-10, pathways-13)
cc(pathways-13, and-14)
amod(factors-16, regulatory-15)
nmod:of(activation-10, factors-16)
conj:and(pathways-13, factors-16)

Isocitrate_dehydrogenase_2/NNP -LRB-/-LRB- IDH2/NNP -RRB-/-RRB- is_a/VBZ key/JJ enzyme/NN in/IN the/DT tricarboxylic_acid/JJ cycle/NN that/WDT plays/VBZ an/DT important/JJ role/NN in/IN energy/NN metabolism/NN and/CC redox/NN homeostasis/NNS ./.

(ROOT
  (S
    (NP (NNP Isocitrate_dehydrogenase_2) (-LRB- -LRB-)
      (NP (NNP IDH2))
      (-RRB- -RRB-))
    (VP (VBZ is_a)
      (NP
        (NP (JJ key) (NN enzyme))
        (PP (IN in)
          (NP (DT the) (JJ tricarboxylic_acid) (NN cycle)))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP (NN energy) (NN metabolism)
                    (CC and)
                    (NN redox) (NNS homeostasis)))))))))
    (. .)))

nsubj(is_a-5, Isocitrate_dehydrogenase_2-1)
dep(Isocitrate_dehydrogenase_2-1, IDH2-3)
root(ROOT-0, is_a-5)
amod(enzyme-7, key-6)
dobj(is_a-5, enzyme-7)
nsubj(plays-13, enzyme-7)
case(cycle-11, in-8)
det(cycle-11, the-9)
amod(cycle-11, tricarboxylic_acid-10)
nmod:in(enzyme-7, cycle-11)
ref(enzyme-7, that-12)
acl:relcl(enzyme-7, plays-13)
det(role-16, an-14)
amod(role-16, important-15)
dobj(plays-13, role-16)
case(metabolism-19, in-17)
compound(metabolism-19, energy-18)
nmod:in(role-16, metabolism-19)
cc(metabolism-19, and-20)
compound(homeostasis-22, redox-21)
nmod:in(role-16, homeostasis-22)
conj:and(metabolism-19, homeostasis-22)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN AGI-6780/NN on/IN IDH2/NNP protein/NN levels/NNS and/CC half-life/NN during/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NN AGI-6780))
            (PP (IN on)
              (NP (NNP IDH2) (NN protein) (NNS levels)
                (CC and)
                (NN half-life))))))
      (PP (IN during)
        (NP (JJ skeletal_muscle) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(AGI-6780-10, of-9)
nmod:of(effect-8, AGI-6780-10)
case(levels-14, on-11)
compound(levels-14, IDH2-12)
compound(levels-14, protein-13)
nmod:on(AGI-6780-10, levels-14)
cc(levels-14, and-15)
nmod:on(AGI-6780-10, half-life-16)
conj:and(levels-14, half-life-16)
case(differentiation-19, during-17)
amod(differentiation-19, skeletal_muscle-18)
nmod:during(investigated-6, differentiation-19)

C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN ,/, and/CC treated/VBN with/IN AGI-6780/NN at/IN different/JJ time/NN points/NNS ./.

(ROOT
  (S
    (NP (NN C2C12) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP (NN differentiation)))))
        (, ,)
        (CC and)
        (VP (VBN treated)
          (PP (IN with)
            (NP (NN AGI-6780)))
          (PP (IN at)
            (NP (JJ different) (NN time) (NNS points))))))
    (. .)))

compound(cells-2, C2C12-1)
nsubjpass(cultured-4, cells-2)
nsubjpass(treated-11, cells-2)
auxpass(cultured-4, were-3)
root(ROOT-0, cultured-4)
amod(medium-6, in_a-5)
dobj(cultured-4, medium-6)
xcomp(cultured-4, favoring-7)
dobj(favoring-7, differentiation-8)
cc(cultured-4, and-10)
conj:and(cultured-4, treated-11)
case(AGI-6780-13, with-12)
nmod:with(treated-11, AGI-6780-13)
case(points-17, at-14)
amod(points-17, different-15)
compound(points-17, time-16)
nmod:at(treated-11, points-17)

Our/PRP$ results/NNS showed/VBD that/IN AGI-6780/NNP up-regulated/JJ IDH2/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN ,/, and/CC prolonged/JJ IDH2/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP AGI-6780)
            (NX
              (NX
                (NX (JJ up-regulated) (NNP IDH2) (NN protein) (NNS levels) (NN in_a))
                (NP (JJ time-dependent) (NN manner)))
              (, ,)
              (CC and)
              (NX (JJ prolonged) (NNP IDH2) (NN protein))))
          (VP (NN half-life)
            (PP (IN from)
              (NP
                (QP (CD 10) (TO to) (CD 18))
                (NNS hours)))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(half-life-18, that-4)
dep(in_a-10, AGI-6780-5)
amod(in_a-10, up-regulated-6)
compound(in_a-10, IDH2-7)
compound(in_a-10, protein-8)
compound(in_a-10, levels-9)
nsubj(half-life-18, in_a-10)
amod(manner-12, time-dependent-11)
dep(in_a-10, manner-12)
cc(in_a-10, and-14)
amod(protein-17, prolonged-15)
compound(protein-17, IDH2-16)
conj:and(in_a-10, protein-17)
nsubj(half-life-18, protein-17)
ccomp(showed-3, half-life-18)
case(hours-23, from-19)
compound(18-22, 10-20)
dep(18-22, to-21)
nummod(hours-23, 18-22)
nmod:from(half-life-18, hours-23)

These/DT findings/NNS suggest/VBP that/IN AGI-6780/NNP may/MD play/VB a/DT role/NN in/IN regulating/VBG energy/NN metabolism/NN during/IN skeletal_muscle/JJ differentiation/NN ,/, and/CC provide/VB new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG skeletal_muscle/JJ development/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP AGI-6780))
          (VP (MD may)
            (VP
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (NN energy) (NN metabolism))
                        (PP (IN during)
                          (NP (JJ skeletal_muscle) (NN differentiation))))))))
              (, ,)
              (CC and)
              (VP (VB provide)
                (NP (JJ new) (NNS insights))
                (PP (IN into)
                  (NP
                    (NP (DT the) (JJ molecular) (NNS mechanisms))
                    (VP (VBG underlying)
                      (NP (JJ skeletal_muscle) (NN development)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, AGI-6780-5)
nsubj(provide-19, AGI-6780-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
compound(metabolism-13, energy-12)
dobj(regulating-11, metabolism-13)
case(differentiation-16, during-14)
amod(differentiation-16, skeletal_muscle-15)
nmod:during(regulating-11, differentiation-16)
cc(play-7, and-18)
ccomp(suggest-3, provide-19)
conj:and(play-7, provide-19)
amod(insights-21, new-20)
dobj(provide-19, insights-21)
case(mechanisms-25, into-22)
det(mechanisms-25, the-23)
amod(mechanisms-25, molecular-24)
nmod:into(provide-19, mechanisms-25)
acl(mechanisms-25, underlying-26)
amod(development-28, skeletal_muscle-27)
dobj(underlying-26, development-28)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT precise/JJ mechanisms/NNS by/IN which/WDT AGI-6780/NNP regulates/VBZ IDH2/JJ expression/NN and/CC function/NN during/IN skeletal_muscle/JJ differentiation/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP (DT the) (JJ precise) (NNS mechanisms))
              (PP (IN by)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (NP (NNP AGI-6780))
                    (VP (VBZ regulates)
                      (NP (JJ IDH2) (NN expression)
                        (CC and)
                        (NN function))
                      (PP (IN during)
                        (NP (JJ skeletal_muscle) (NN differentiation))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, precise-8)
dobj(elucidate-6, mechanisms-9)
mark(regulates-13, by-10)
dobj(regulates-13, which-11)
nsubj(regulates-13, AGI-6780-12)
advcl(elucidate-6, regulates-13)
amod(expression-15, IDH2-14)
dobj(regulates-13, expression-15)
cc(expression-15, and-16)
dobj(regulates-13, function-17)
conj:and(expression-15, function-17)
case(differentiation-20, during-18)
amod(differentiation-20, skeletal_muscle-19)
nmod:during(regulates-13, differentiation-20)

Obesity/RB is_a/JJ complex/JJ metabolic_disorder/NN that/WDT results/VBZ from/IN an/DT imbalance/NN between/IN energy/NN intake/NN and/CC expenditure/NN ./.

(ROOT
  (NP
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (JJ complex) (NN metabolic_disorder))
    (SBAR
      (WHNP (WDT that))
      (S
        (VP (VBZ results)
          (PP (IN from)
            (NP
              (NP (DT an) (NN imbalance))
              (PP (IN between)
                (NP (NN energy) (NN intake)
                  (CC and)
                  (NN expenditure))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(metabolic_disorder-4, is_a-2)
amod(metabolic_disorder-4, complex-3)
root(ROOT-0, metabolic_disorder-4)
nsubj(results-6, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
acl:relcl(metabolic_disorder-4, results-6)
case(imbalance-9, from-7)
det(imbalance-9, an-8)
nmod:from(results-6, imbalance-9)
case(intake-12, between-10)
compound(intake-12, energy-11)
nmod:between(imbalance-9, intake-12)
cc(intake-12, and-13)
nmod:between(imbalance-9, expenditure-14)
conj:and(intake-12, expenditure-14)

The/DT role/NN of/IN pancreatic/JJ hormones/NNS in/IN the/DT development/NN of/IN obesity/JJ has_been/NN extensively/RB studied/VBN ,/, but/CC the/DT involvement/NN of/IN sterolin-2/NN ,/, a/DT protein/NN secreted/VBN by/IN the/DT pancreas/NN ,/, remains/VBZ unclear/JJ ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN role))
      (PP (IN of)
        (NP
          (NP (JJ pancreatic) (NNS hormones))
          (PP (IN in)
            (NP
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP
                    (NP (JJ obesity) (NN has_been))
                    (ADJP (RB extensively) (VBN studied)))))
              (, ,)
              (CC but)
              (NP
                (NP (DT the) (NN involvement))
                (PP (IN of)
                  (NP
                    (NP (NN sterolin-2))
                    (, ,)
                    (NP
                      (NP (DT a) (NN protein))
                      (VP (VBN secreted)
                        (PP (IN by)
                          (NP (DT the) (NN pancreas)))))
                    (, ,)))))))))
    (VP (VBZ remains)
      (ADJP (JJ unclear)))
    (. .)))

det(role-2, The-1)
nsubj(remains-28, role-2)
case(hormones-5, of-3)
amod(hormones-5, pancreatic-4)
nmod:of(role-2, hormones-5)
case(development-8, in-6)
det(development-8, the-7)
nmod:in(hormones-5, development-8)
case(has_been-11, of-9)
amod(has_been-11, obesity-10)
nmod:of(development-8, has_been-11)
advmod(studied-13, extensively-12)
amod(has_been-11, studied-13)
cc(development-8, but-15)
det(involvement-17, the-16)
nmod:in(hormones-5, involvement-17)
conj:but(development-8, involvement-17)
case(sterolin-2-19, of-18)
nmod:of(involvement-17, sterolin-2-19)
det(protein-22, a-21)
appos(sterolin-2-19, protein-22)
acl(protein-22, secreted-23)
case(pancreas-26, by-24)
det(pancreas-26, the-25)
nmod:by(secreted-23, pancreas-26)
root(ROOT-0, remains-28)
xcomp(remains-28, unclear-29)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB the/DT relationship/NN between/IN obesity/NN and/CC hypersecretion/NN of/IN sterolin-2/JJ by/IN examining/VBG its/PRP$ secretion/NN in/IN response/NN to/TO glucose/NN and/CC Xanthohumol/NNP in/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/NNP //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP (NN obesity)
                  (CC and)
                  (NN hypersecretion)))
              (PP (IN of)
                (NP
                  (ADJP (JJ sterolin-2)
                    (PP (IN by)
                      (S
                        (VP (VBG examining)
                          (NP (PRP$ its) (NN secretion))
                          (PP (IN in)
                            (NP (NN response)))
                          (PP (TO to)
                            (NP
                              (NP (NN glucose))
                              (CC and)
                              (NP
                                (NP (NNP Xanthohumol))
                                (PRN
                                  (PP (IN in)
                                    (NP
                                      (NP (VBN isolated)
                                        (NX
                                          (NX
                                            (NX
                                              (NX (JJ perfused) (NN pancreata))
                                              (PP (IN from)
                                                (NP (NN genetically_obese))))
                                            (PRN (-LRB- -LRB-) (NN fa/fa) (-RRB- -RRB-)))
                                          (CC and)
                                          (NX (JJ lean))))
                                      (-LRB- -LRB-)
                                      (NP (NNP Fa))
                                      (: /))
                                    (. ?)))
                                (-RRB- -RRB-))))))))
                  (NNS rats))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(obesity-12, between-11)
nmod:between(relationship-10, obesity-12)
cc(obesity-12, and-13)
nmod:between(relationship-10, hypersecretion-14)
conj:and(obesity-12, hypersecretion-14)
case(rats-43, of-15)
amod(rats-43, sterolin-2-16)
mark(examining-18, by-17)
advcl(sterolin-2-16, examining-18)
nmod:poss(secretion-20, its-19)
dobj(examining-18, secretion-20)
case(response-22, in-21)
nmod:in(examining-18, response-22)
case(glucose-24, to-23)
nmod:to(examining-18, glucose-24)
cc(glucose-24, and-25)
nmod:to(examining-18, Xanthohumol-26)
conj:and(glucose-24, Xanthohumol-26)
case(pancreata-30, in-27)
amod(pancreata-30, isolated-28)
amod(pancreata-30, perfused-29)
nmod:in(Xanthohumol-26, pancreata-30)
case(genetically_obese-32, from-31)
nmod:from(pancreata-30, genetically_obese-32)
dep(pancreata-30, fa/fa-34)
cc(pancreata-30, and-36)
nmod:in(Xanthohumol-26, lean-37)
conj:and(pancreata-30, lean-37)
dep(pancreata-30, Fa-39)
nmod:of(relationship-10, rats-43)

Our/PRP$ results/NNS showed/VBD that/IN both/DT glucose/NN and/CC Xanthohumol/NNP stimulated/VBN the/DT secretion/NN of/IN insulin/NN and/CC sterolin-2/JJ in_a/JJ dose-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT both) (NN glucose))
            (CC and)
            (NP (NNP Xanthohumol)))
          (VP (VBN stimulated)
            (NP
              (NP (DT the) (NN secretion))
              (PP (IN of)
                (NP
                  (NP (NN insulin))
                  (CC and)
                  (NP (JJ sterolin-2) (JJ in_a) (JJ dose-dependent) (NN manner)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(stimulated-9, that-4)
det(glucose-6, both-5)
nsubj(stimulated-9, glucose-6)
cc(glucose-6, and-7)
conj:and(glucose-6, Xanthohumol-8)
nsubj(stimulated-9, Xanthohumol-8)
ccomp(showed-3, stimulated-9)
det(secretion-11, the-10)
dobj(stimulated-9, secretion-11)
case(insulin-13, of-12)
nmod:of(secretion-11, insulin-13)
cc(insulin-13, and-14)
amod(manner-18, sterolin-2-15)
amod(manner-18, in_a-16)
amod(manner-18, dose-dependent-17)
nmod:of(secretion-11, manner-18)
conj:and(insulin-13, manner-18)

Interestingly/RB ,/, we/PRP observed/VBD a/DT significant/JJ increase/NN in/IN the/DT secretion/NN of/IN sterolin-2/JJ in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS ,/, while/IN insulin_secretion/NN was/VBD similar/JJ between/IN the/DT two/CD groups/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP
            (NP (DT the) (NN secretion))
            (PP (IN of)
              (NP
                (ADJP (JJ sterolin-2)
                  (PP (IN in)
                    (NP
                      (NP (JJ obese) (NNS rats))
                      (VP (VBN compared)
                        (S
                          (VP (TO to)
                            (VP (VB lean))))))))
                (NNS rats))))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (NN insulin_secretion))
          (VP (VBD was)
            (ADJP (JJ similar))
            (PP (IN between)
              (NP (DT the) (CD two) (NNS groups)))))))
    (. .)))

advmod(observed-4, Interestingly-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
det(increase-7, a-5)
amod(increase-7, significant-6)
dobj(observed-4, increase-7)
case(secretion-10, in-8)
det(secretion-10, the-9)
nmod:in(increase-7, secretion-10)
case(rats-19, of-11)
amod(rats-19, sterolin-2-12)
case(rats-15, in-13)
amod(rats-15, obese-14)
nmod:in(sterolin-2-12, rats-15)
acl(rats-15, compared-16)
mark(lean-18, to-17)
xcomp(compared-16, lean-18)
nmod:of(secretion-10, rats-19)
mark(similar-24, while-21)
nsubj(similar-24, insulin_secretion-22)
cop(similar-24, was-23)
advcl(observed-4, similar-24)
case(groups-28, between-25)
det(groups-28, the-26)
nummod(groups-28, two-27)
nmod:between(similar-24, groups-28)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN sterolin-2/JJ may/MD play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN lipid/NN metabolism/NN or/CC appetite/NN regulation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (JJ sterolin-2))))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))))
              (, ,)
              (PP
                (ADVP (RB possibly))
                (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP
                      (NP (NN lipid) (NN metabolism))
                      (CC or)
                      (NP (NN appetite) (NN regulation)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, hypersecretion-5)
case(sterolin-2-7, of-6)
nmod:of(hypersecretion-5, sterolin-2-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(obesity-16, of-15)
nmod:of(development-14, obesity-16)
advmod(effects-21, possibly-18)
case(effects-21, through-19)
nmod:poss(effects-21, its-20)
nmod:through(play-9, effects-21)
case(metabolism-24, on-22)
compound(metabolism-24, lipid-23)
nmod:on(effects-21, metabolism-24)
cc(metabolism-24, or-25)
compound(regulation-27, appetite-26)
nmod:on(effects-21, regulation-27)
conj:or(metabolism-24, regulation-27)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG this/DT relationship/NN and/CC explore/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity/JJ management/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (RB fully)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN relationship)))))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (JJ obesity) (NN management))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
nsubj:xsubj(explore-14, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(relationship-12, this-11)
dobj(underlying-10, relationship-12)
cc(elucidate-7, and-13)
xcomp(needed-4, explore-14)
conj:and(elucidate-7, explore-14)
amod(targets-17, potential-15)
amod(targets-17, therapeutic-16)
dobj(explore-14, targets-17)
case(management-20, for-18)
amod(management-20, obesity-19)
nmod:for(targets-17, management-20)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN found/VBN to/TO play/VB a/DT role/NN in/IN various/JJ physiological/JJ processes/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN found)
                  (S
                    (VP (TO to)
                      (VP (VB play)
                        (NP
                          (NP (DT a) (NN role))
                          (PP (IN in)
                            (NP (JJ various) (JJ physiological) (NNS processes))))))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(found-20, polyunsaturated_fatty_acids-16)
nsubj:xsubj(play-22, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(found-20, have-18)
auxpass(found-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, found-20)
mark(play-22, to-21)
xcomp(found-20, play-22)
det(role-24, a-23)
dobj(play-22, role-24)
case(processes-28, in-25)
amod(processes-28, various-26)
amod(processes-28, physiological-27)
nmod:in(role-24, processes-28)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN mexiletine/JJ levels/NNS in/IN hypermexiletinemic/JJ patients/NNS ,/, which/WDT suggests/VBZ a/DT potential/JJ interaction/NN between/IN these/DT compounds/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ mexiletine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hypermexiletinemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (VBZ suggests)
                              (NP
                                (NP (DT a) (JJ potential) (NN interaction))
                                (PP (IN between)
                                  (NP (DT these) (NNS compounds)))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, mexiletine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hypermexiletinemic-16)
nmod:in(levels-14, patients-17)
nsubj(suggests-20, patients-17)
ref(patients-17, which-19)
acl:relcl(patients-17, suggests-20)
det(interaction-23, a-21)
amod(interaction-23, potential-22)
dobj(suggests-20, interaction-23)
case(compounds-26, between-24)
det(compounds-26, these-25)
nmod:between(interaction-23, compounds-26)

Furthermore/RB ,/, epidemiological/JJ evidence/NN has/VBZ suggested/VBN that/IN the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP is/VBZ associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (JJ epidemiological) (NN evidence))
    (VP (VBZ has)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN consumption))
              (PP (IN of)
                (NP (NNP EPA)
                  (CC and)
                  (NNP DHA))))
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (DT a) (VBN decreased) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

advmod(suggested-6, Furthermore-1)
amod(evidence-4, epidemiological-3)
nsubj(suggested-6, evidence-4)
aux(suggested-6, has-5)
root(ROOT-0, suggested-6)
mark(associated-15, that-7)
det(consumption-9, the-8)
nsubjpass(associated-15, consumption-9)
case(EPA-11, of-10)
nmod:of(consumption-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(consumption-9, DHA-13)
conj:and(EPA-11, DHA-13)
auxpass(associated-15, is-14)
ccomp(suggested-6, associated-15)
case(risk-19, with-16)
det(risk-19, a-17)
amod(risk-19, decreased-18)
nmod:with(associated-15, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

This/DT association/NN may/MD be/VB attributed/VBN to/TO the/DT ability/NN of/IN these/DT fatty_acids/NNS to/TO modulate/VBP lipid/NN metabolism/NN ,/, reduce/VB inflammation/NN ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (NP (DT This) (NN association))
    (VP (MD may)
      (VP (VB be)
        (VP (VBN attributed)
          (PP (TO to)
            (NP
              (NP (DT the) (NN ability))
              (PP (IN of)
                (NP (DT these) (NNS fatty_acids)))
              (S
                (VP (TO to)
                  (VP
                    (VP
                      (SBAR
                        (S
                          (VP (VBP modulate)
                            (NP (NN lipid) (NN metabolism)))))
                      (, ,)
                      (VP (VB reduce)
                        (NP (NN inflammation))))
                    (, ,)
                    (CC and)
                    (VP (VB improve)))))))
          (NP-TMP (JJ endothelial) (NN function)))))
    (. .)))

det(association-2, This-1)
nsubjpass(attributed-5, association-2)
aux(attributed-5, may-3)
auxpass(attributed-5, be-4)
root(ROOT-0, attributed-5)
case(ability-8, to-6)
det(ability-8, the-7)
nmod:to(attributed-5, ability-8)
case(fatty_acids-11, of-9)
det(fatty_acids-11, these-10)
nmod:of(ability-8, fatty_acids-11)
mark(reduce-17, to-12)
ccomp(reduce-17, modulate-13)
compound(metabolism-15, lipid-14)
dobj(modulate-13, metabolism-15)
acl(ability-8, reduce-17)
dobj(reduce-17, inflammation-18)
cc(reduce-17, and-20)
acl(ability-8, improve-21)
conj:and(reduce-17, improve-21)
amod(function-23, endothelial-22)
nmod:tmod(attributed-5, function-23)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD have/VB therapeutic/JJ implications/NNS for/IN patients/NNS with/IN hypermexiletinemia/NN and/CC those/DT at/IN risk/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ therapeutic) (NNS implications))
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP
                  (NP (NN hypermexiletinemia))
                  (CC and)
                  (NP (DT those))))
              (PP (IN at)
                (NP
                  (NP (NN risk))
                  (PP (IN for)
                    (NP (NNP CHD))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-13, that-4)
csubj(have-13, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(have-13, may-12)
ccomp(suggest-3, have-13)
amod(implications-15, therapeutic-14)
dobj(have-13, implications-15)
case(patients-17, for-16)
nmod:for(implications-15, patients-17)
case(hypermexiletinemia-19, with-18)
nmod:with(have-13, hypermexiletinemia-19)
cc(hypermexiletinemia-19, and-20)
nmod:with(have-13, those-21)
conj:and(hypermexiletinemia-19, those-21)
case(risk-23, at-22)
nmod:at(have-13, risk-23)
case(CHD-25, for-24)
nmod:for(risk-23, CHD-25)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN this/DT association/NN and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN clinical/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT this) (NN association))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ clinical) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(association-12, of-10)
det(association-12, this-11)
nmod:of(mechanisms-9, association-12)
cc(elucidate-6, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-6, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(use-20, for-18)
amod(use-20, clinical-19)
nmod:for(determine-15, use-20)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-17, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(studied-17, have-14)
auxpass(studied-17, been-15)
advmod(studied-17, extensively-16)
root(ROOT-0, studied-17)
case(benefits-22, for-18)
nmod:poss(benefits-22, their-19)
amod(benefits-22, potential-20)
compound(benefits-22, health-21)
nmod:for(studied-17, benefits-22)

Recent/JJ research/NN has/VBZ shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN phosphocreatine/JJ levels/NNS in/IN hyperphosphocreatinemic/JJ patients/NNS and/CC a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ phosphocreatine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperphosphocreatinemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (DT a) (VBN reduced) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(research-2, Recent-1)
nsubj(shown-4, research-2)
aux(shown-4, has-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, phosphocreatine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperphosphocreatinemic-16)
nmod:in(levels-14, patients-17)
cc(patients-17, and-18)
det(risk-21, a-19)
amod(risk-21, reduced-20)
nmod:in(levels-14, risk-21)
conj:and(patients-17, risk-21)
mark(developing-23, of-22)
acl(risk-21, developing-23)
dobj(developing-23, coronary_heart_disease-24)
appos(risk-21, CHD-26)

In/IN particular/JJ ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO have/VB anti-inflammatory/JJ effects/NNS ,/, which/WDT may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ anti-inflammatory) (NNS effects))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB contribute)
                          (PP (TO to)
                            (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))))))))))
    (. .)))

case(particular-2, In-1)
advcl(shown-9, particular-2)
nsubjpass(shown-9, EPA-4)
nsubj:xsubj(have-11, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(shown-9, DHA-6)
nsubj:xsubj(have-11, DHA-6)
aux(shown-9, have-7)
auxpass(shown-9, been-8)
root(ROOT-0, shown-9)
mark(have-11, to-10)
xcomp(shown-9, have-11)
amod(effects-13, anti-inflammatory-12)
dobj(have-11, effects-13)
nsubj(contribute-17, effects-13)
ref(effects-13, which-15)
aux(contribute-17, may-16)
acl:relcl(effects-13, contribute-17)
case(effects-21, to-18)
nmod:poss(effects-21, their-19)
amod(effects-21, cardioprotective-20)
nmod:to(contribute-17, effects-21)

Additionally/RB ,/, these/DT fatty_acids/NNS may/MD improve/VB lipid/NN profiles/NNS by/IN reducing/VBG triglyceride_levels/NNS and/CC increasing/VBG HDL_cholesterol/JJ levels/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (MD may)
      (VP (VB improve)
        (NP (NN lipid) (NNS profiles))
        (PP (IN by)
          (S
            (VP
              (VP (VBG reducing)
                (NP (NNS triglyceride_levels)))
              (CC and)
              (VP (VBG increasing)
                (NP (JJ HDL_cholesterol) (NNS levels))))))))
    (. .)))

advmod(improve-6, Additionally-1)
det(fatty_acids-4, these-3)
nsubj(improve-6, fatty_acids-4)
aux(improve-6, may-5)
root(ROOT-0, improve-6)
compound(profiles-8, lipid-7)
dobj(improve-6, profiles-8)
mark(reducing-10, by-9)
advcl(improve-6, reducing-10)
dobj(reducing-10, triglyceride_levels-11)
cc(reducing-10, and-12)
advcl(improve-6, increasing-13)
conj:and(reducing-10, increasing-13)
amod(levels-15, HDL_cholesterol-14)
dobj(increasing-13, levels-15)

The/DT mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP risk/NN are/VBP not/RB fully/RB understood/VBN but/CC may/MD involve/VB modulation/NN of/IN cellular/JJ signaling/VBG pathways/NNS or/CC changes/NNS in/IN gene/NN expression/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ beneficial) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA)))
          (PP (IN on)
            (NP (NNP CHD) (NN risk))))))
    (VP
      (VP (VBP are)
        (ADJP (RB not) (RB fully) (VBN understood)))
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (JJ cellular) (VBG signaling) (NNS pathways))
                (CC or)
                (NP (NNS changes)))))
          (PP (IN in)
            (NP (NN gene) (NN expression))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-17, mechanisms-2)
nsubj(involve-20, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, beneficial-5)
dobj(underlying-3, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(risk-13, on-11)
compound(risk-13, CHD-12)
nmod:on(effects-6, risk-13)
auxpass(understood-17, are-14)
neg(understood-17, not-15)
advmod(understood-17, fully-16)
root(ROOT-0, understood-17)
cc(understood-17, but-18)
aux(involve-20, may-19)
conj:but(understood-17, involve-20)
dobj(involve-20, modulation-21)
case(pathways-25, of-22)
amod(pathways-25, cellular-23)
amod(pathways-25, signaling-24)
nmod:of(modulation-21, pathways-25)
cc(pathways-25, or-26)
nmod:of(modulation-21, changes-27)
conj:or(pathways-25, changes-27)
case(expression-30, in-28)
compound(expression-30, gene-29)
nmod:in(involve-20, expression-30)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG the/DT cardioprotective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP ,/, as/RB well/RB as/IN their/PRP$ potential/JJ use/NN in/IN the/DT prevention/NN and/CC treatment/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT the) (JJ cardioprotective) (NNS effects))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA)))
                    (, ,)
                    (ADVP (RB as) (RB well)
                      (PP (IN as)
                        (NP
                          (NP (PRP$ their) (JJ potential) (NN use))
                          (PP (IN in)
                            (NP
                              (NP (DT the) (NN prevention)
                                (CC and)
                                (NN treatment))
                              (PP (IN of)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(elucidate-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-13, the-11)
amod(effects-13, cardioprotective-12)
dobj(underlying-10, effects-13)
case(EPA-15, of-14)
nmod:of(effects-13, EPA-15)
cc(EPA-15, and-16)
nmod:of(effects-13, DHA-17)
conj:and(EPA-15, DHA-17)
advmod(well-20, as-19)
advmod(effects-13, well-20)
case(use-24, as-21)
nmod:poss(use-24, their-22)
amod(use-24, potential-23)
nmod:as(well-20, use-24)
case(prevention-27, in-25)
det(prevention-27, the-26)
nmod:in(use-24, prevention-27)
cc(prevention-27, and-28)
nmod:in(use-24, treatment-29)
conj:and(prevention-27, treatment-29)
case(CHD-31, of-30)
nmod:of(prevention-27, CHD-31)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN associated/VBN with/IN a/DT variety/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP (DT a) (NN variety))
                      (PP (IN of)
                        (NP (NN health) (NNS benefits))))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(associated-20, nutrients-16)
ref(nutrients-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(nutrients-16, associated-20)
case(variety-23, with-21)
det(variety-23, a-22)
nmod:with(associated-20, variety-23)
case(benefits-26, of-24)
compound(benefits-26, health-25)
nmod:of(variety-23, benefits-26)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NNS ,/, specifically/RB EPA/NNP and/CC DHA/NNP ,/, are/VBP associated/VBN with/IN decreased/VBN decasilate/JJ levels/NNS in/IN hyperdecasilatemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (NNS omega-3_fatty_acids))
              (, ,) (RB specifically)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (, ,))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ decasilate) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperdecasilatemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-15, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubjpass(associated-15, omega-3_fatty_acids-7)
advmod(omega-3_fatty_acids-7, specifically-9)
dep(omega-3_fatty_acids-7, EPA-10)
cc(EPA-10, and-11)
dep(omega-3_fatty_acids-7, DHA-12)
conj:and(EPA-10, DHA-12)
auxpass(associated-15, are-14)
ccomp(shown-4, associated-15)
case(levels-19, with-16)
amod(levels-19, decreased-17)
amod(levels-19, decasilate-18)
nmod:with(associated-15, levels-19)
case(patients-22, in-20)
amod(patients-22, hyperdecasilatemic-21)
nmod:in(levels-19, patients-22)

Furthermore/RB ,/, the/DT consumption/NN of/IN these/DT fatty_acids/VBZ has_been/VBN linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (DT these))))
    (VP (VBZ fatty_acids)
      (VP (VBN has_been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(fatty_acids-7, Furthermore-1)
det(consumption-4, the-3)
nsubj(fatty_acids-7, consumption-4)
case(these-6, of-5)
nmod:of(consumption-4, these-6)
root(ROOT-0, fatty_acids-7)
dep(fatty_acids-7, has_been-8)
dep(has_been-8, linked-9)
case(risk-13, to-10)
det(risk-13, a-11)
amod(risk-13, decreased-12)
nmod:to(linked-9, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
dobj(developing-15, coronary_heart_disease-16)
appos(risk-13, CHD-18)

The/DT mechanisms/NNS by/IN which/WDT EPA/NNP and/CC DHA/NNP confer/VBP their/PRP$ cardioprotective/JJ effects/NNS are/VBP not/RB fully/RB understood/VBN but/CC may/MD involve/VB their/PRP$ anti-inflammatory/JJ properties/NNS ,/, modulation/NN of/IN lipid/NN metabolism/NN ,/, and/CC regulation/NN of/IN blood_pressure/NN ./.

(ROOT
  (S
    (NP (DT The) (NNS mechanisms))
    (VP
      (VP
        (PP (IN by)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))
              (VP (VBP confer)
                (NP (PRP$ their) (JJ cardioprotective) (NNS effects))))))
        (VBP are)
        (ADVP (RB not))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (PRP$ their) (JJ anti-inflammatory) (NNS properties))
            (, ,)
            (NP
              (NP
                (NP (NN modulation))
                (PP (IN of)
                  (NP (NN lipid) (NN metabolism))))
              (, ,)
              (CC and)
              (NP
                (NP (NN regulation))
                (PP (IN of)
                  (NP (NN blood_pressure)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-15, mechanisms-2)
nsubj(involve-18, mechanisms-2)
mark(confer-8, by-3)
dobj(confer-8, which-4)
nsubj(confer-8, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(confer-8, DHA-7)
advcl(understood-15, confer-8)
nmod:poss(effects-11, their-9)
amod(effects-11, cardioprotective-10)
dobj(confer-8, effects-11)
auxpass(understood-15, are-12)
neg(understood-15, not-13)
advmod(understood-15, fully-14)
root(ROOT-0, understood-15)
cc(understood-15, but-16)
aux(involve-18, may-17)
conj:but(understood-15, involve-18)
nmod:poss(properties-21, their-19)
amod(properties-21, anti-inflammatory-20)
dobj(involve-18, properties-21)
appos(properties-21, modulation-23)
case(metabolism-26, of-24)
compound(metabolism-26, lipid-25)
nmod:of(modulation-23, metabolism-26)
cc(modulation-23, and-28)
appos(properties-21, regulation-29)
conj:and(modulation-23, regulation-29)
case(blood_pressure-31, of-30)
nmod:of(regulation-29, blood_pressure-31)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ strategy/NN for/IN preventing/VBG or/CC managing/VBG CHD/NNP and/CC hyperdecasilatemia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (CC or)
                    (VBG managing)
                    (NP
                      (NP (NNP CHD))
                      (CC and)
                      (NP (NN hyperdecasilatemia)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-14, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-14, intake-6)
case(omega-3_fatty_acids-9, of-7)
amod(omega-3_fatty_acids-9, long-chain-8)
nmod:of(intake-6, omega-3_fatty_acids-9)
aux(strategy-14, may-10)
cop(strategy-14, be-11)
det(strategy-14, a-12)
amod(strategy-14, promising-13)
ccomp(suggest-3, strategy-14)
mark(preventing-16, for-15)
advcl(strategy-14, preventing-16)
cc(preventing-16, or-17)
advcl(strategy-14, managing-18)
conj:or(preventing-16, managing-18)
dobj(preventing-16, CHD-19)
cc(CHD-19, and-20)
dobj(preventing-16, hyperdecasilatemia-21)
conj:and(CHD-19, hyperdecasilatemia-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC optimal/JJ dosages/NNS for/IN these/DT therapeutic/JJ effects/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP (JJ optimal) (NNS dosages)))
              (PP (IN for)
                (NP (DT these) (JJ therapeutic) (NNS effects))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(dosages-12, optimal-11)
dobj(elucidate-6, dosages-12)
conj:and(mechanisms-9, dosages-12)
case(effects-16, for-13)
det(effects-16, these-14)
amod(effects-16, therapeutic-15)
nmod:for(elucidate-6, effects-16)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBD complex/JJ process/NN involving/VBG various/JJ signaling/VBG pathways/NNS and/CC regulatory/JJ molecules/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBD is_a)
      (NP
        (NP (JJ complex) (NN process))
        (PP (VBG involving)
          (NP
            (NP (JJ various) (VBG signaling) (NNS pathways))
            (CC and)
            (NP (JJ regulatory) (NNS molecules))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
case(pathways-10, involving-7)
amod(pathways-10, various-8)
amod(pathways-10, signaling-9)
nmod:involving(process-6, pathways-10)
cc(pathways-10, and-11)
amod(molecules-13, regulatory-12)
nmod:involving(process-6, molecules-13)
conj:and(pathways-10, molecules-13)

Thymalin/NNP ,/, a/DT thymic/JJ peptide/NN ,/, has_been/NN shown/VBN to/TO modulate/VBP immune/JJ responses/NNS and/CC exert/JJ cytoprotective/JJ effects/NNS in/IN various/JJ cell/NN types/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNP Thymalin))
      (, ,)
      (NP (DT a) (JJ thymic) (NN peptide))
      (, ,)
      (VP (NN has_been)
        (VP (VBN shown)
          (PP (TO to)))))
    (VP (VBP modulate)
      (NP
        (NP (JJ immune) (NNS responses))
        (CC and)
        (NP
          (NP (JJ exert) (JJ cytoprotective) (NNS effects))
          (PP (IN in)
            (NP (JJ various) (NN cell) (NNS types))))))
    (. .)))

nsubj(modulate-10, Thymalin-1)
det(peptide-5, a-3)
amod(peptide-5, thymic-4)
appos(Thymalin-1, peptide-5)
dep(shown-8, has_been-7)
dep(Thymalin-1, shown-8)
nmod(shown-8, to-9)
root(ROOT-0, modulate-10)
amod(responses-12, immune-11)
dobj(modulate-10, responses-12)
cc(responses-12, and-13)
amod(effects-16, exert-14)
amod(effects-16, cytoprotective-15)
dobj(modulate-10, effects-16)
conj:and(responses-12, effects-16)
case(types-20, in-17)
amod(types-20, various-18)
compound(types-20, cell-19)
nmod:in(effects-16, types-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN Thymalin/NNP on/IN Fused_Toes_Homolog/VBG -LRB-/-LRB- FTO/NNP -RRB-/-RRB- protein/NN levels/NNS during/IN C2C12/NNP myoblast/JJ differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP Thymalin))))
      (PP (IN on)
        (S
          (VP (VBG Fused_Toes_Homolog)
            (S (-LRB- -LRB-)
              (NP (NNP FTO))
              (-RRB- -RRB-)
              (NP (NN protein) (NNS levels))))))
      (PP (IN during)
        (NP (NNP C2C12) (JJ myoblast) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(Thymalin-10, of-9)
nmod:of(effect-8, Thymalin-10)
mark(Fused_Toes_Homolog-12, on-11)
advcl(investigated-6, Fused_Toes_Homolog-12)
dep(levels-17, FTO-14)
compound(levels-17, protein-16)
xcomp(Fused_Toes_Homolog-12, levels-17)
case(differentiation-21, during-18)
compound(differentiation-21, C2C12-19)
amod(differentiation-21, myoblast-20)
nmod:during(investigated-6, differentiation-21)

Our/PRP$ results/NNS showed/VBD that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, Thymalin/NNP up-regulated/JJ FTO/NNP protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ FTO/NNP protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NX (NNP Thymalin)))
                (NX
                  (NX
                    (NX (JJ up-regulated) (NNP FTO) (NN protein) (NNS levels) (NN in_a))
                    (NP (JJ time-dependent) (NN manner)))
                  (CC and)
                  (NX (JJ prolonged) (NNP FTO) (NN protein))
                  (NX (NN half-life))))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(cultured-9, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
ccomp(showed-3, cultured-9)
dep(half-life-38, in_a-10)
compound(differentiation-13, medium-11)
amod(differentiation-13, favoring-12)
dep(Thymalin-26, differentiation-13)
dep(differentiation-13, Dulbecco-15)
case(medium-18, modified-16)
compound(medium-18, Eagle-17)
nmod:modified(Dulbecco-15, medium-18)
acl(medium-18, containing-19)
compound(%-21, 2-20)
amod(serum-23, %-21)
compound(serum-23, horse-22)
dobj(containing-19, serum-23)
dep(half-life-38, Thymalin-26)
amod(in_a-31, up-regulated-27)
compound(in_a-31, FTO-28)
compound(in_a-31, protein-29)
compound(in_a-31, levels-30)
dep(half-life-38, in_a-31)
amod(manner-33, time-dependent-32)
dep(in_a-31, manner-33)
cc(half-life-38, and-34)
amod(protein-37, prolonged-35)
compound(protein-37, FTO-36)
dobj(cultured-9, protein-37)
conj:and(half-life-38, protein-37)
dobj(cultured-9, half-life-38)
case(hours-43, from-39)
compound(18-42, 10-40)
dep(18-42, to-41)
nummod(hours-43, 18-42)
nmod:from(cultured-9, hours-43)

These/DT findings/NNS suggest/VBP that/IN Thymalin/NNP may/MD play/VB a/DT role/NN in/IN regulating/VBG skeletal_muscle/JJ differentiation/NN through/IN modulation/NN of/IN FTO/NNP protein/NN levels/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Thymalin))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ skeletal_muscle) (NN differentiation))
                      (PP (IN through)
                        (NP
                          (NP (NN modulation))
                          (PP (IN of)
                            (NP (NNP FTO) (NN protein) (NNS levels))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, Thymalin-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
amod(differentiation-13, skeletal_muscle-12)
dobj(regulating-11, differentiation-13)
case(modulation-15, through-14)
nmod:through(regulating-11, modulation-15)
case(levels-19, of-16)
compound(levels-19, FTO-17)
compound(levels-19, protein-18)
nmod:of(modulation-15, levels-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/JJ molecular/JJ mechanisms/NNS involved/VBN in/IN this/DT process/NN and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ applications/NNS of/IN Thymalin/NNP in/IN muscle-related_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ underlying) (JJ molecular) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN process)))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP Thymalin))))
                (PP (IN in)
                  (NP (NNS muscle-related_disorders)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-10, the-7)
amod(mechanisms-10, underlying-8)
amod(mechanisms-10, molecular-9)
dobj(elucidate-6, mechanisms-10)
acl(mechanisms-10, involved-11)
case(process-14, in-12)
det(process-14, this-13)
nmod:in(involved-11, process-14)
cc(elucidate-6, and-15)
mark(explore-17, to-16)
ccomp(needed-4, explore-17)
conj:and(elucidate-6, explore-17)
det(applications-21, the-18)
amod(applications-21, potential-19)
amod(applications-21, therapeutic-20)
dobj(explore-17, applications-21)
case(Thymalin-23, of-22)
nmod:of(applications-21, Thymalin-23)
case(muscle-related_disorders-25, in-24)
nmod:in(explore-17, muscle-related_disorders-25)

In/IN recent/JJ years/NNS ,/, there/EX has_been/VBP an/DT increasing/VBG interest/NN in/IN the/DT potential/JJ role/NN of/IN alkaline_phosphatase/NN -LRB-/-LRB- ALP/NNP -RRB-/-RRB- in/IN various/JJ pathological/JJ conditions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ recent) (NNS years)))
    (, ,)
    (NP (EX there))
    (VP (VBP has_been)
      (NP
        (NP (DT an) (VBG increasing) (NN interest))
        (PP (IN in)
          (NP
            (NP
              (NP (DT the) (JJ potential) (NN role))
              (PP (IN of)
                (NP (NN alkaline_phosphatase))))
            (PRN (-LRB- -LRB-)
              (NP (NNP ALP))
              (-RRB- -RRB-))
            (PP (IN in)
              (NP (JJ various) (JJ pathological) (NNS conditions)))))))
    (. .)))

case(years-3, In-1)
amod(years-3, recent-2)
nmod:in(has_been-6, years-3)
expl(has_been-6, there-5)
root(ROOT-0, has_been-6)
det(interest-9, an-7)
amod(interest-9, increasing-8)
dobj(has_been-6, interest-9)
case(role-13, in-10)
det(role-13, the-11)
amod(role-13, potential-12)
nmod:in(interest-9, role-13)
case(alkaline_phosphatase-15, of-14)
nmod:of(role-13, alkaline_phosphatase-15)
appos(role-13, ALP-17)
case(conditions-22, in-19)
amod(conditions-22, various-20)
amod(conditions-22, pathological-21)
nmod:in(role-13, conditions-22)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP and/CC a/DT chemokine_receptor/NN ,/, CCR5/NNP ,/, which/WDT plays/VBZ a/DT crucial/JJ role/NN in/IN inflammation/NN and/CC immune/JJ response/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NNP ALP))
                (CC and)
                (NP (DT a) (NN chemokine_receptor))
                (, ,)
                (NP (NNP CCR5))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ plays)
                      (NP
                        (NP (DT a) (JJ crucial) (NN role))
                        (PP (IN in)
                          (NP
                            (NP (NN inflammation))
                            (CC and)
                            (NP (JJ immune) (NN response))))))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(correlation-8, the-7)
dobj(investigated-6, correlation-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(correlation-8, levels-11)
case(ALP-13, of-12)
nmod:of(levels-11, ALP-13)
cc(ALP-13, and-14)
det(chemokine_receptor-16, a-15)
nmod:of(levels-11, chemokine_receptor-16)
conj:and(ALP-13, chemokine_receptor-16)
nmod:of(levels-11, CCR5-18)
conj:and(ALP-13, CCR5-18)
nsubj(plays-21, which-20)
nmod:of(levels-11, plays-21)
conj:and(ALP-13, plays-21)
det(role-24, a-22)
amod(role-24, crucial-23)
dobj(plays-21, role-24)
case(inflammation-26, in-25)
nmod:in(role-24, inflammation-26)
cc(inflammation-26, and-27)
amod(response-29, immune-28)
nmod:in(role-24, response-29)
conj:and(inflammation-26, response-29)

We/PRP also/RB examined/VBD the/DT relationship/NN between/IN serum/NN levels/NNS of/IN RO5657/NNP ,/, a/DT known/VBN inhibitor/NN of/IN CCR5/NNP ,/, and/CC serum/NN CCR5/NN levels/NNS ./.

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB also))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NN relationship))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP (NNP RO5657))
                (, ,)
                (NP
                  (NP (DT a) (VBN known) (NN inhibitor))
                  (PP (IN of)
                    (NP (NNP CCR5))))
                (, ,)
                (CC and)
                (NP (NN serum) (NN CCR5) (NNS levels))))))))
    (. .)))

nsubj(examined-3, We-1)
advmod(examined-3, also-2)
root(ROOT-0, examined-3)
det(relationship-5, the-4)
dobj(examined-3, relationship-5)
case(levels-8, between-6)
compound(levels-8, serum-7)
nmod:between(relationship-5, levels-8)
case(RO5657-10, of-9)
nmod:of(levels-8, RO5657-10)
det(inhibitor-14, a-12)
amod(inhibitor-14, known-13)
nmod:of(levels-8, inhibitor-14)
conj:and(RO5657-10, inhibitor-14)
case(CCR5-16, of-15)
nmod:of(inhibitor-14, CCR5-16)
cc(RO5657-10, and-18)
compound(levels-21, serum-19)
compound(levels-21, CCR5-20)
nmod:of(levels-8, levels-21)
conj:and(RO5657-10, levels-21)

Our/PRP$ results/NNS showed/VBD a/DT significant/JJ correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- and/CC RO5657/NNP -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- with/IN serum/NN CCR5/NN levels/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN serum) (NNS levels))
            (PP (IN of)
              (NP
                (NP
                  (NP (NNP ALP))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.3)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NNP RO5657))
                  (PRN (-LRB- -LRB-)
                    (SBAR
                      (X (SYM r))
                      (S
                        (FRAG
                          (X (SYM =))
                          (NP (CD 0.42)))
                        (, ,)
                        (NP (NN p))
                        (VP (VBP <)
                          (NP (CD 0.01)))))
                    (-RRB- -RRB-))))))))
      (PP (IN with)
        (NP (NN serum) (NN CCR5) (NNS levels))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-6, a-4)
amod(correlation-6, significant-5)
dobj(showed-3, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(ALP-11, of-10)
nmod:of(levels-9, ALP-11)
dep(<-18, r-13)
dep(0.3-15, =-14)
dep(<-18, 0.3-15)
nsubj(<-18, p-17)
dep(ALP-11, <-18)
dobj(<-18, 0.01-19)
cc(ALP-11, and-21)
nmod:of(levels-9, RO5657-22)
conj:and(ALP-11, RO5657-22)
dep(<-29, r-24)
dep(0.42-26, =-25)
dep(<-29, 0.42-26)
nsubj(<-29, p-28)
dep(RO5657-22, <-29)
dobj(<-29, 0.01-30)
case(levels-35, with-32)
compound(levels-35, serum-33)
compound(levels-35, CCR5-34)
nmod:with(showed-3, levels-35)

These/DT findings/NNS suggest/VBP that/IN ALP/NNP and/CC RO5657/NNP may/MD play/VB important/JJ roles/NNS in/IN regulating/VBG the/DT expression/NN of/IN CCR5/NNP and/CC may/MD have/VB potential/JJ therapeutic/JJ implications/NNS in/IN diseases/NNS associated/VBN with/IN inflammation/NN and/CC immune_dysregulation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP ALP)
            (CC and)
            (NNP RO5657))
          (VP
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (JJ important) (NNS roles))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP
                          (NP (DT the) (NN expression))
                          (PP (IN of)
                            (NP (NNP CCR5))))))))))
            (CC and)
            (VP (MD may)
              (VP (VB have)
                (NP (JJ potential) (JJ therapeutic) (NNS implications))
                (PP (IN in)
                  (NP
                    (NP (NNS diseases))
                    (VP (VBN associated)
                      (PP (IN with)
                        (NP (NN inflammation)
                          (CC and)
                          (NN immune_dysregulation))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
nsubj(play-9, ALP-5)
nsubj(have-20, ALP-5)
cc(ALP-5, and-6)
conj:and(ALP-5, RO5657-7)
nsubj(play-9, RO5657-7)
aux(play-9, may-8)
ccomp(suggest-3, play-9)
amod(roles-11, important-10)
dobj(play-9, roles-11)
mark(regulating-13, in-12)
acl(roles-11, regulating-13)
det(expression-15, the-14)
dobj(regulating-13, expression-15)
case(CCR5-17, of-16)
nmod:of(expression-15, CCR5-17)
cc(play-9, and-18)
aux(have-20, may-19)
ccomp(suggest-3, have-20)
conj:and(play-9, have-20)
amod(implications-23, potential-21)
amod(implications-23, therapeutic-22)
dobj(have-20, implications-23)
case(diseases-25, in-24)
nmod:in(have-20, diseases-25)
acl(diseases-25, associated-26)
case(inflammation-28, with-27)
nmod:with(associated-26, inflammation-28)
cc(inflammation-28, and-29)
nmod:with(associated-26, immune_dysregulation-30)
conj:and(inflammation-28, immune_dysregulation-30)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT correlation/NN and/CC to/TO explore/VB the/DT clinical/JJ utility/NN of/IN targeting/VBG these/DT molecules/NNS for/IN therapeutic/JJ interventions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN correlation)))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ clinical) (NN utility))
                  (PP (IN of)
                    (S
                      (VP (VBG targeting)
                        (NP (DT these) (NNS molecules))
                        (PP (IN for)
                          (NP (JJ therapeutic) (NNS interventions)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(correlation-13, in-11)
det(correlation-13, this-12)
nmod:in(involved-10, correlation-13)
cc(elucidate-6, and-14)
mark(explore-16, to-15)
ccomp(needed-4, explore-16)
conj:and(elucidate-6, explore-16)
det(utility-19, the-17)
amod(utility-19, clinical-18)
dobj(explore-16, utility-19)
mark(targeting-21, of-20)
acl(utility-19, targeting-21)
det(molecules-23, these-22)
dobj(targeting-21, molecules-23)
case(interventions-26, for-24)
amod(interventions-26, therapeutic-25)
nmod:for(targeting-21, interventions-26)

Obesity/NNP is_a/VBZ complex/JJ metabolic_disorder/NN that/WDT has/VBZ become/VBN a/DT major/JJ public_health/NN concern/NN worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Obesity))
    (VP (VBZ is_a)
      (NP
        (NP (JJ complex) (NN metabolic_disorder))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ has)
              (VP (VBN become)
                (NP (DT a) (JJ major) (NN public_health) (NN concern))
                (ADVP (RB worldwide))))))))
    (. .)))

nsubj(is_a-2, Obesity-1)
root(ROOT-0, is_a-2)
amod(metabolic_disorder-4, complex-3)
dobj(is_a-2, metabolic_disorder-4)
nsubj(become-7, metabolic_disorder-4)
ref(metabolic_disorder-4, that-5)
aux(become-7, has-6)
acl:relcl(metabolic_disorder-4, become-7)
det(concern-11, a-8)
amod(concern-11, major-9)
compound(concern-11, public_health-10)
xcomp(become-7, concern-11)
advmod(become-7, worldwide-12)

While/IN the/DT etiology/NN of/IN obesity/NN is/VBZ multifactorial/JJ ,/, it/PRP has_been/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN ADH-A2/NN by/IN the/DT pancreas/NN may/MD play/VB a/DT role/NN in/IN its/PRP$ development/NN ./.

(ROOT
  (S
    (SBAR (IN While)
      (S
        (NP
          (NP (DT the) (NN etiology))
          (PP (IN of)
            (NP (NN obesity))))
        (VP (VBZ is)
          (ADJP (JJ multifactorial)))))
    (, ,)
    (NP (PRP it))
    (VP (VBP has_been)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN ADH-A2))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (NP (PRP$ its) (NN development))))))))))
    (. .)))

mark(multifactorial-7, While-1)
det(etiology-3, the-2)
nsubj(multifactorial-7, etiology-3)
case(obesity-5, of-4)
nmod:of(etiology-3, obesity-5)
cop(multifactorial-7, is-6)
advcl(has_been-10, multifactorial-7)
nsubj(has_been-10, it-9)
root(ROOT-0, has_been-10)
dep(has_been-10, suggested-11)
mark(play-21, that-12)
det(hypersecretion-14, the-13)
nsubj(play-21, hypersecretion-14)
case(ADH-A2-16, of-15)
nmod:of(hypersecretion-14, ADH-A2-16)
case(pancreas-19, by-17)
det(pancreas-19, the-18)
nmod:by(ADH-A2-16, pancreas-19)
aux(play-21, may-20)
ccomp(suggested-11, play-21)
det(role-23, a-22)
dobj(play-21, role-23)
case(development-26, in-24)
nmod:poss(development-26, its-25)
nmod:in(role-23, development-26)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN ADH-A2/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN ADH-A2)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(ADH-A2-20, of-19)
nmod:of(hypersecretion-18, ADH-A2-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ ICI-128436/NN on/IN the/DT secretion/NN of/IN ADH-A2/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- individuals/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN ICI-128436)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN ADH-A2) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS individuals)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-6, achieve-2)
dobj(achieve-2, this-3)
nsubj(examined-6, we-5)
root(ROOT-0, examined-6)
det(effects-8, the-7)
dobj(examined-6, effects-8)
case(glucose-12, of-9)
nummod(glucose-12, 16.7-10)
amod(glucose-12, mmol/L-11)
nmod:of(effects-8, glucose-12)
cc(glucose-12, and-13)
nummod(ICI-128436-16, 10-14)
amod(ICI-128436-16, mmol/L-15)
nmod:of(effects-8, ICI-128436-16)
conj:and(glucose-12, ICI-128436-16)
case(secretion-19, on-17)
det(secretion-19, the-18)
nmod:on(examined-6, secretion-19)
case(and_insulin-22, of-20)
compound(and_insulin-22, ADH-A2-21)
nmod:of(secretion-19, and_insulin-22)
case(pancreata-26, by-23)
amod(pancreata-26, isolated-24)
amod(pancreata-26, perfused-25)
nmod:by(examined-6, pancreata-26)
case(genetically_obese-28, from-27)
nmod:from(pancreata-26, genetically_obese-28)
appos(genetically_obese-28, fa/fa-30)
cc(genetically_obese-28, and-32)
amod(individuals-39, lean-33)
dep(lean-33, Fa-35)
nmod:from(pancreata-26, individuals-39)
conj:and(genetically_obese-28, individuals-39)

Our/PRP$ results/NNS showed/VBD that/IN obese/JJ individuals/NNS had/VBD significantly/RB higher/JJR levels/NNS of/IN ADH-A2/JJ secretion/NN compared/VBN to/TO lean/JJ individuals/NNS in/IN response/NN to/TO both/DT glucose/NN and/CC ICI-128436/NN stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ obese) (NNS individuals))
          (VP (VBD had)
            (NP
              (NP
                (ADJP (RB significantly) (JJR higher))
                (NNS levels))
              (PP (IN of)
                (NP (JJ ADH-A2) (NN secretion))))
            (PP (VBN compared)
              (PP (TO to)
                (NP (JJ lean) (NNS individuals))))
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP (DT both)
                    (ADJP (NN glucose)
                      (CC and)
                      (NN ICI-128436))
                    (NN stimulation)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(had-7, that-4)
amod(individuals-6, obese-5)
nsubj(had-7, individuals-6)
ccomp(showed-3, had-7)
advmod(higher-9, significantly-8)
amod(levels-10, higher-9)
dobj(had-7, levels-10)
case(secretion-13, of-11)
amod(secretion-13, ADH-A2-12)
nmod:of(levels-10, secretion-13)
case(individuals-17, compared-14)
mwe(compared-14, to-15)
amod(individuals-17, lean-16)
advcl(had-7, individuals-17)
case(response-19, in-18)
nmod:in(had-7, response-19)
case(stimulation-25, to-20)
det(stimulation-25, both-21)
amod(stimulation-25, glucose-22)
cc(glucose-22, and-23)
conj:and(glucose-22, ICI-128436-24)
amod(stimulation-25, ICI-128436-24)
nmod:to(response-19, stimulation-25)

Additionally/RB ,/, we/PRP observed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN ADH-A2/JJ secretion/NN and/CC body/NN weight/NN in/IN obese/JJ individuals/NNS but/CC not/RB in/IN lean/JJ individuals/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
        (PP (IN between)
          (NP
            (NP (JJ ADH-A2) (NN secretion))
            (CC and)
            (NP (NN body) (NN weight)))))
      (PP
        (PP (IN in)
          (NP (JJ obese) (NNS individuals)))
        (CONJP (CC but)
          (RB not))
        (PP (IN in)
          (NP (JJ lean) (NNS individuals)))))
    (. .)))

advmod(observed-4, Additionally-1)
nsubj(observed-4, we-3)
nsubj(observed-4', we-3)
root(ROOT-0, observed-4)
conj:negcc(observed-4, observed-4')
det(correlation-8, a-5)
amod(correlation-8, significant-6)
amod(correlation-8, positive-7)
dobj(observed-4, correlation-8)
case(secretion-11, between-9)
amod(secretion-11, ADH-A2-10)
nmod:between(correlation-8, secretion-11)
cc(secretion-11, and-12)
compound(weight-14, body-13)
nmod:between(correlation-8, weight-14)
conj:and(secretion-11, weight-14)
case(individuals-17, in-15)
amod(individuals-17, obese-16)
nmod:in(observed-4, individuals-17)
cc(not-19, but-18)
cc(observed-4, not-19)
case(individuals-22, in-20)
amod(individuals-22, lean-21)
nmod:in(observed-4', individuals-22)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN ADH-A2/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT pathogenesis/NNS of/IN obesity/NN ,/, highlighting/VBG a/DT potential/JJ target/NN for/IN therapeutic/JJ intervention/NN in/IN this/DT disease/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NN ADH-A2))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (S
                  (VP (VBG highlighting)
                    (NP
                      (NP (DT a) (JJ potential) (NN target))
                      (PP (IN for)
                        (NP
                          (NP (JJ therapeutic) (NN intervention))
                          (PP (IN in)
                            (NP (DT this) (NN disease))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(ADH-A2-7, of-6)
nmod:of(hypersecretion-5, ADH-A2-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(ADH-A2-7, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(pathogenesis-16, in-14)
det(pathogenesis-16, the-15)
nmod:in(involved-13, pathogenesis-16)
case(obesity-18, of-17)
nmod:of(pathogenesis-16, obesity-18)
xcomp(involved-13, highlighting-20)
det(target-23, a-21)
amod(target-23, potential-22)
dobj(highlighting-20, target-23)
case(intervention-26, for-24)
amod(intervention-26, therapeutic-25)
nmod:for(target-23, intervention-26)
case(disease-29, in-27)
det(disease-29, this-28)
nmod:in(intervention-26, disease-29)

The/DT use/NN of/IN N-propionyl-4-S-cysteaminylphenol/NNS -LRB-/-LRB- NPrCAP/NNP -RRB-/-RRB- and/CC its/PRP$ derivatives/NNS has_been/VBP explored/VBN as/IN a/DT potential/JJ therapeutic/JJ strategy/NN for/IN activating/JJ H2_receptors/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP
          (NP
            (NP (NNS N-propionyl-4-S-cysteaminylphenol))
            (PRN (-LRB- -LRB-)
              (NP (NNP NPrCAP))
              (-RRB- -RRB-)))
          (CC and)
          (NP (PRP$ its) (NNS derivatives)))))
    (VP (VBP has_been)
      (VP (VBN explored)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ potential) (JJ therapeutic) (NN strategy))
            (PP (IN for)
              (NP (JJ activating) (NNS H2_receptors)))))))
    (. .)))

det(use-2, The-1)
nsubj(has_been-11, use-2)
case(N-propionyl-4-S-cysteaminylphenol-4, of-3)
nmod:of(use-2, N-propionyl-4-S-cysteaminylphenol-4)
appos(N-propionyl-4-S-cysteaminylphenol-4, NPrCAP-6)
cc(N-propionyl-4-S-cysteaminylphenol-4, and-8)
nmod:poss(derivatives-10, its-9)
nmod:of(use-2, derivatives-10)
conj:and(N-propionyl-4-S-cysteaminylphenol-4, derivatives-10)
root(ROOT-0, has_been-11)
dep(has_been-11, explored-12)
case(strategy-17, as-13)
det(strategy-17, a-14)
amod(strategy-17, potential-15)
amod(strategy-17, therapeutic-16)
nmod:as(explored-12, strategy-17)
case(H2_receptors-20, for-18)
amod(H2_receptors-20, activating-19)
nmod:for(strategy-17, H2_receptors-20)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN NPrCAP/NNP and/CC its/PRP$ derivatives/NNS ,/, N-propionyl-4-S-cysteaminylphenol/JJ monochloramine/NN -LRB-/-LRB- NPrCAP-MC/NNP -RRB-/-RRB- and_N-propionyl-4-S-cysteaminylphenol/JJ dichloramine/NN -LRB-/-LRB- NPrCAP-DC/NNP -RRB-/-RRB- ,/, on/IN H2_receptor/JJ activation/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (NNP NPrCAP))))
        (CC and)
        (NP
          (NP (PRP$ its) (NNS derivatives))
          (, ,)
          (NP
            (NP
              (NP (JJ N-propionyl-4-S-cysteaminylphenol) (NN monochloramine))
              (PRN (-LRB- -LRB-)
                (NP (NNP NPrCAP-MC))
                (-RRB- -RRB-))
              (NP (JJ and_N-propionyl-4-S-cysteaminylphenol) (NN dichloramine)))
            (PRN (-LRB- -LRB-)
              (NP (NNP NPrCAP-DC))
              (-RRB- -RRB-)))
          (, ,)))
      (PP (IN on)
        (NP (JJ H2_receptor) (NN activation))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-28, study-3)
det(effects-6, the-5)
nsubjpass(investigated-28, effects-6)
case(NPrCAP-8, of-7)
nmod:of(effects-6, NPrCAP-8)
cc(effects-6, and-9)
nmod:poss(derivatives-11, its-10)
conj:and(effects-6, derivatives-11)
nsubjpass(investigated-28, derivatives-11)
amod(monochloramine-14, N-propionyl-4-S-cysteaminylphenol-13)
appos(derivatives-11, monochloramine-14)
appos(monochloramine-14, NPrCAP-MC-16)
amod(dichloramine-19, and_N-propionyl-4-S-cysteaminylphenol-18)
dep(monochloramine-14, dichloramine-19)
appos(monochloramine-14, NPrCAP-DC-21)
case(activation-26, on-24)
amod(activation-26, H2_receptor-25)
nmod:on(effects-6, activation-26)
auxpass(investigated-28, were-27)
root(ROOT-0, investigated-28)

Unlike/IN the/DT effects/NNS of/IN NPrCAP/NNP ,/, the/DT H2_receptor/JJ agonist/JJ effects/NNS of/IN NPrCAP-MC/NNP and/CC NPrCAP-DC/NNP did/VBD not/RB disappear/VB after/IN repeated/VBN washout/NN ./.

(ROOT
  (S
    (PP (IN Unlike)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NNP NPrCAP)))))
    (, ,)
    (NP
      (NP (DT the) (JJ H2_receptor) (JJ agonist) (NNS effects))
      (PP (IN of)
        (NP (NNP NPrCAP-MC)
          (CC and)
          (NNP NPrCAP-DC))))
    (VP (VBD did) (RB not)
      (VP (VB disappear)
        (PP (IN after)
          (NP (VBN repeated) (NN washout)))))
    (. .)))

case(effects-3, Unlike-1)
det(effects-3, the-2)
nmod:unlike(disappear-17, effects-3)
case(NPrCAP-5, of-4)
nmod:of(effects-3, NPrCAP-5)
det(effects-10, the-7)
amod(effects-10, H2_receptor-8)
amod(effects-10, agonist-9)
nsubj(disappear-17, effects-10)
case(NPrCAP-MC-12, of-11)
nmod:of(effects-10, NPrCAP-MC-12)
cc(NPrCAP-MC-12, and-13)
nmod:of(effects-10, NPrCAP-DC-14)
conj:and(NPrCAP-MC-12, NPrCAP-DC-14)
aux(disappear-17, did-15)
neg(disappear-17, not-16)
root(ROOT-0, disappear-17)
case(washout-20, after-18)
amod(washout-20, repeated-19)
nmod:after(disappear-17, washout-20)

These/DT results/NNS suggest/VBP that/IN the/DT derivatives/NNS of/IN NPrCAP/NNP may/MD have/VB potential/JJ as/IN long-lasting/JJ H2_receptor/NNS agonists/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NNS derivatives))
            (PP (IN of)
              (NP (NNP NPrCAP))))
          (VP (MD may)
            (VP (VB have)
              (NP
                (ADJP (JJ potential)
                  (PP (IN as)
                    (NP (JJ long-lasting) (NNS H2_receptor))))
                (NNS agonists))
              (PP (IN for)
                (NP (JJ therapeutic) (NN use))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(have-10, that-4)
det(derivatives-6, the-5)
nsubj(have-10, derivatives-6)
case(NPrCAP-8, of-7)
nmod:of(derivatives-6, NPrCAP-8)
aux(have-10, may-9)
ccomp(suggest-3, have-10)
amod(agonists-15, potential-11)
case(H2_receptor-14, as-12)
amod(H2_receptor-14, long-lasting-13)
nmod:as(potential-11, H2_receptor-14)
dobj(have-10, agonists-15)
case(use-18, for-16)
amod(use-18, therapeutic-17)
nmod:for(have-10, use-18)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT clinical/JJ implications/NNS of/IN these/DT findings/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ clinical) (NNS implications))
                (PP (IN of)
                  (NP (DT these) (NNS findings)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(implications-9, the-7)
amod(implications-9, clinical-8)
dobj(explore-6, implications-9)
case(findings-12, of-10)
det(findings-12, these-11)
nmod:of(implications-9, findings-12)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ nutrients/NNS that/WDT have/VBP been/VBN associated/VBN with/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS nutrients))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubj(nutrients-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(nutrients-16, are-14)
amod(nutrients-16, essential-15)
root(ROOT-0, nutrients-16)
nsubjpass(associated-20, nutrients-16)
ref(nutrients-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(nutrients-16, associated-20)
case(risk-24, with-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:with(associated-20, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP also/RB linked/VBN to/TO decreased/VBN Glubran/JJ levels/NNS in/IN hyperGlubranemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (ADVP (RB also))
              (VP (VBN linked)
                (PP (TO to)
                  (NP
                    (NP (VBN decreased) (JJ Glubran) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperGlubranemic) (NNS patients)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(linked-11, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(linked-11, omega-3_fatty_acids-8)
auxpass(linked-11, are-9)
advmod(linked-11, also-10)
ccomp(shown-4, linked-11)
case(levels-15, to-12)
amod(levels-15, decreased-13)
amod(levels-15, Glubran-14)
nmod:to(linked-11, levels-15)
case(patients-18, in-16)
amod(patients-18, hyperGlubranemic-17)
nmod:in(levels-15, patients-18)

The/DT mechanism/NN behind/IN this/DT association/NN is/VBZ not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN the/DT anti-inflammatory/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP may/MD play/VB a/DT role/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN mechanism))
        (PP (IN behind)
          (NP (DT this) (NN association))))
      (VP (VBZ is) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ anti-inflammatory) (NNS properties))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (VP (MD may)
                (VP (VB play)
                  (NP (DT a) (NN role)))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(understood-10, mechanism-2)
case(association-5, behind-3)
det(association-5, this-4)
nmod:behind(mechanism-2, association-5)
auxpass(understood-10, is-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(play-25, that-16)
det(properties-19, the-17)
amod(properties-19, anti-inflammatory-18)
nsubj(play-25, properties-19)
case(EPA-21, of-20)
nmod:of(properties-19, EPA-21)
cc(EPA-21, and-22)
nmod:of(properties-19, DHA-23)
conj:and(EPA-21, DHA-23)
aux(play-25, may-24)
ccomp(believed-15, play-25)
det(role-27, a-26)
dobj(play-25, role-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS may/MD be/VB a/DT potential/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC managing/VBG hyperGlubranemia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NNS supplements)))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG managing)
                        (NP (NN hyperGlubranemia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-20, that-4)
csubj(strategy-20, increasing-5)
dobj(increasing-5, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(sources-13, through-11)
amod(sources-13, dietary-12)
nmod:through(increasing-5, sources-13)
cc(sources-13, or-14)
nmod:through(increasing-5, supplements-15)
conj:or(sources-13, supplements-15)
aux(strategy-20, may-16)
cop(strategy-20, be-17)
det(strategy-20, a-18)
amod(strategy-20, potential-19)
ccomp(suggest-3, strategy-20)
mark(reducing-22, for-21)
acl(strategy-20, reducing-22)
det(risk-24, the-23)
dobj(reducing-22, risk-24)
case(CHD-26, of-25)
nmod:of(risk-24, CHD-26)
cc(reducing-22, and-27)
acl(strategy-20, managing-28)
conj:and(reducing-22, managing-28)
dobj(managing-28, hyperGlubranemia-29)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ therapeutic) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(use-20, for-18)
amod(use-20, therapeutic-19)
nmod:for(determine-15, use-20)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT play/VBP a/DT crucial/JJ role/NN in/IN maintaining/VBG human/JJ health/NN ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP play)
              (NP (DT a) (JJ crucial) (NN role))
              (PP (IN in)
                (S
                  (VP (VBG maintaining)
                    (NP (JJ human) (NN health))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubj(play-6, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
acl:relcl(polyunsaturated_fatty_acids-4, play-6)
det(role-9, a-7)
amod(role-9, crucial-8)
dobj(play-6, role-9)
mark(maintaining-11, in-10)
advcl(play-6, maintaining-11)
amod(health-13, human-12)
dobj(maintaining-11, health-13)

Among/IN them/PRP ,/, eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- have/VBP been/VBN associated/VBN with/IN various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (PRP them)))
    (, ,)
    (NP
      (NP
        (ADVP (JJ eicosapentaenoic_acid))
        (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP (JJ various) (NN health) (NNS benefits))))))
    (. .)))

case(them-2, Among-1)
nmod:among(associated-15, them-2)
advmod(EPA-6, eicosapentaenoic_acid-4)
nsubjpass(associated-15, EPA-6)
cc(EPA-6, and-8)
conj:and(EPA-6, docosahexaenoic_acid-9)
nsubjpass(associated-15, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(associated-15, have-13)
auxpass(associated-15, been-14)
root(ROOT-0, associated-15)
case(benefits-19, with-16)
amod(benefits-19, various-17)
compound(benefits-19, health-18)
nmod:with(associated-15, benefits-19)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN fenspiride/JJ levels/NNS in/IN hyperfenspiridemic/JJ patients/NNS ,/, which/WDT may/MD be/VB beneficial/JJ for/IN the/DT treatment/NN of/IN respiratory_diseases/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ fenspiride) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperfenspiridemic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP (MD may)
                              (VP (VB be)
                                (ADJP (JJ beneficial)
                                  (PP (IN for)
                                    (NP
                                      (NP (DT the) (NN treatment))
                                      (PP (IN of)
                                        (NP (NNS respiratory_diseases))))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, fenspiride-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperfenspiridemic-16)
nmod:in(levels-14, patients-17)
nsubj(beneficial-22, patients-17)
ref(patients-17, which-19)
aux(beneficial-22, may-20)
cop(beneficial-22, be-21)
acl:relcl(patients-17, beneficial-22)
case(treatment-25, for-23)
det(treatment-25, the-24)
nmod:for(beneficial-22, treatment-25)
case(respiratory_diseases-27, of-26)
nmod:of(treatment-25, respiratory_diseases-27)

Moreover/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, one/CD of/IN the/DT leading/VBG causes/NNS of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NN coronary_heart_disease))
                        (NP
                          (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                          (, ,)
                          (NP
                            (NP (CD one))
                            (PP (IN of)
                              (NP
                                (NP (DT the) (VBG leading) (NNS causes))
                                (PP (IN of)
                                  (NP (NN death)))))))))))
                (ADVP (RB worldwide))))))))
    (. .)))

advmod(found-8, Moreover-1)
nsubjpass(found-8, EPA-3)
nsubj:xsubj(reduce-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(found-8, DHA-5)
nsubj:xsubj(reduce-10, DHA-5)
aux(found-8, have-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
mark(reduce-10, to-9)
xcomp(found-8, reduce-10)
det(risk-12, the-11)
dobj(reduce-10, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
iobj(developing-14, coronary_heart_disease-15)
dobj(developing-14, CHD-17)
appos(CHD-17, one-20)
case(causes-24, of-21)
det(causes-24, the-22)
amod(causes-24, leading-23)
nmod:of(one-20, causes-24)
case(death-26, of-25)
nmod:of(causes-24, death-26)
advmod(reduce-10, worldwide-27)

The/DT mechanisms/NNS underlying/VBG these/DT protective/JJ effects/NNS are/VBP complex/JJ and/CC multifactorial/JJ ,/, involving/VBG modulation/NN of/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, oxidative_stress/NNS ,/, and/CC platelet_aggregation/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP (DT these) (JJ protective) (NNS effects))))
    (VP (VBP are)
      (ADJP (JJ complex)
        (CC and)
        (JJ multifactorial))
      (, ,)
      (S
        (VP (VBG involving)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (NP (NN inflammation))
                (, ,)
                (NP (NNS oxidative_stress))
                (, ,)
                (CC and)
                (NP (NN platelet_aggregation))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(complex-8, mechanisms-2)
nsubj(multifactorial-10, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, these-4)
amod(effects-6, protective-5)
dobj(underlying-3, effects-6)
cop(complex-8, are-7)
root(ROOT-0, complex-8)
cc(complex-8, and-9)
conj:and(complex-8, multifactorial-10)
xcomp(complex-8, involving-12)
dobj(involving-12, modulation-13)
case(metabolism-16, of-14)
compound(metabolism-16, lipid-15)
nmod:of(modulation-13, metabolism-16)
nmod:of(modulation-13, inflammation-18)
conj:and(metabolism-16, inflammation-18)
nmod:of(modulation-13, oxidative_stress-20)
conj:and(metabolism-16, oxidative_stress-20)
cc(metabolism-16, and-22)
nmod:of(modulation-13, platelet_aggregation-23)
conj:and(metabolism-16, platelet_aggregation-23)

Therefore/RB ,/, increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ or/CC supplement/NN sources/NNS may/MD have/VB important/JJ implications/NNS for/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP and/CC other/JJ related_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP (JJ dietary)
            (CC or)
            (NN supplement) (NNS sources)))))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (JJ important) (NNS implications))
          (PP (IN for)
            (NP
              (NP (DT the) (NN prevention)
                (CC and)
                (NN management))
              (PP (IN of)
                (NP (NNP CHD)
                  (CC and)
                  (JJ other) (NNS related_disorders))))))))
    (. .)))

advmod(have-16, Therefore-1)
csubj(have-16, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(EPA-7, of-6)
nmod:of(intake-5, EPA-7)
cc(EPA-7, and-8)
nmod:of(intake-5, DHA-9)
conj:and(EPA-7, DHA-9)
case(sources-14, through-10)
amod(sources-14, dietary-11)
cc(dietary-11, or-12)
conj:or(dietary-11, supplement-13)
amod(sources-14, supplement-13)
nmod:through(increasing-3, sources-14)
aux(have-16, may-15)
root(ROOT-0, have-16)
amod(implications-18, important-17)
dobj(have-16, implications-18)
case(prevention-21, for-19)
det(prevention-21, the-20)
nmod:for(implications-18, prevention-21)
cc(prevention-21, and-22)
nmod:for(implications-18, management-23)
conj:and(prevention-21, management-23)
case(related_disorders-28, of-24)
compound(related_disorders-28, CHD-25)
cc(CHD-25, and-26)
conj:and(CHD-25, other-27)
compound(related_disorders-28, other-27)
nmod:of(prevention-21, related_disorders-28)

Skeletal/JJ muscle/NN development/NN is_a/VBZ highly/RB regulated/VBN process/NN involving/VBG various/JJ signaling/VBG pathways/NNS and/CC transcription/JJ factors/NNS ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NN development))
    (VP (VBZ is_a)
      (NP
        (NP
          (ADJP (RB highly) (VBN regulated))
          (NN process))
        (PP (VBG involving)
          (NP
            (NP (JJ various) (VBG signaling) (NNS pathways))
            (CC and)
            (NP (JJ transcription) (NNS factors))))))
    (. .)))

amod(development-3, Skeletal-1)
compound(development-3, muscle-2)
nsubj(is_a-4, development-3)
root(ROOT-0, is_a-4)
advmod(regulated-6, highly-5)
amod(process-7, regulated-6)
dobj(is_a-4, process-7)
case(pathways-11, involving-8)
amod(pathways-11, various-9)
amod(pathways-11, signaling-10)
nmod:involving(process-7, pathways-11)
cc(pathways-11, and-12)
amod(factors-14, transcription-13)
nmod:involving(process-7, factors-14)
conj:and(pathways-11, factors-14)

The/DT CD24c-m/JJ protein/NN has_been/VBP identified/VBN as/IN a/DT potential/JJ regulator/NN of/IN myogenic/JJ differentiation/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ CD24c-m) (NN protein))
    (VP (VBP has_been)
      (VP (VBN identified)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ potential) (NN regulator))
            (PP (IN of)
              (NP (JJ myogenic) (NN differentiation)))))))
    (. .)))

det(protein-3, The-1)
amod(protein-3, CD24c-m-2)
nsubj(has_been-4, protein-3)
root(ROOT-0, has_been-4)
dep(has_been-4, identified-5)
case(regulator-9, as-6)
det(regulator-9, a-7)
amod(regulator-9, potential-8)
nmod:as(identified-5, regulator-9)
case(differentiation-12, of-10)
amod(differentiation-12, myogenic-11)
nmod:of(regulator-9, differentiation-12)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN PG11047/NNP on/IN CD24c-m/JJ protein/NN levels/NNS in/IN differentiating/VBG C2C12/CD cells/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NNP PG11047))))
      (PP (IN on)
        (NP (JJ CD24c-m) (NN protein) (NNS levels)))
      (PP (IN in)
        (S
          (VP (VBG differentiating)
            (NP (CD C2C12) (NNS cells))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(PG11047-10, of-9)
nmod:of(effect-8, PG11047-10)
case(levels-14, on-11)
amod(levels-14, CD24c-m-12)
compound(levels-14, protein-13)
nmod:on(investigated-6, levels-14)
mark(differentiating-16, in-15)
advcl(investigated-6, differentiating-16)
nummod(cells-18, C2C12-17)
dobj(differentiating-16, cells-18)

When/WRB C2C12/NN cells/NNS were/VBD cultured/VBN in_a/JJ medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/,

(ROOT
  (SBARQ
    (WHADVP (WRB When))
    (S
      (NP (NN C2C12) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (NP (JJ in_a) (NN medium))
          (S
            (VP (VBG favoring)
              (NP
                (NP (NN differentiation))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NNP Dulbecco))
                    (VP (VBN modified)
                      (NP
                        (NP (NNP Eagle) (NN medium))
                        (VP (VBG containing)
                          (NP
                            (ADJP (CD 2) (NN %))
                            (NN horse) (NN serum))))))
                  (-RRB- -RRB-)))))
          (, ,))))))

advmod(cultured-5, When-1)
compound(cells-3, C2C12-2)
nsubjpass(cultured-5, cells-3)
auxpass(cultured-5, were-4)
root(ROOT-0, cultured-5)
amod(medium-7, in_a-6)
dobj(cultured-5, medium-7)
xcomp(cultured-5, favoring-8)
dobj(favoring-8, differentiation-9)
nsubj(modified-12, Dulbecco-11)
dep(differentiation-9, modified-12)
compound(medium-14, Eagle-13)
dobj(modified-12, medium-14)
acl(medium-14, containing-15)
compound(%-17, 2-16)
amod(serum-19, %-17)
compound(serum-19, horse-18)
dobj(containing-15, serum-19)

PG11047/NNP up-regulated/VBD CD24c-m/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ CD24c-m/JJ protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (NNP PG11047))
    (VP (VBD up-regulated)
      (NP (JJ CD24c-m) (NN protein) (NNS levels))
      (NP (NN in_a)
        (NX
          (NX (JJ time-dependent) (NN manner))
          (CC and)
          (NX (JJ prolonged) (JJ CD24c-m) (NN protein)))
        (NX (NN half-life)))
      (PP (IN from)
        (NP
          (QP (CD 10) (TO to) (CD 18))
          (NNS hours))))
    (. .)))

nsubj(up-regulated-2, PG11047-1)
root(ROOT-0, up-regulated-2)
amod(levels-5, CD24c-m-3)
compound(levels-5, protein-4)
iobj(up-regulated-2, levels-5)
dep(half-life-13, in_a-6)
amod(manner-8, time-dependent-7)
dep(half-life-13, manner-8)
cc(manner-8, and-9)
amod(protein-12, prolonged-10)
amod(protein-12, CD24c-m-11)
conj:and(manner-8, protein-12)
dep(half-life-13, protein-12)
dobj(up-regulated-2, half-life-13)
case(hours-18, from-14)
compound(18-17, 10-15)
dep(18-17, to-16)
nummod(hours-18, 18-17)
nmod:from(up-regulated-2, hours-18)

These/DT findings/NNS suggest/VBP that/IN PG11047/NNP may/MD play/VB a/DT role/NN in/IN regulating/VBG myogenic/JJ differentiation/NN by/IN modulating/VBG the/DT expression/NN and/CC stability/NN of/IN the/DT CD24c-m/JJ protein/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP PG11047))
          (VP (MD may)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG regulating)
                      (NP (JJ myogenic) (NN differentiation))
                      (PP (IN by)
                        (S
                          (VP (VBG modulating)
                            (NP
                              (NP (DT the) (NN expression)
                                (CC and)
                                (NN stability))
                              (PP (IN of)
                                (NP (DT the) (JJ CD24c-m) (NN protein))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, PG11047-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(regulating-11, in-10)
acl(role-9, regulating-11)
amod(differentiation-13, myogenic-12)
dobj(regulating-11, differentiation-13)
mark(modulating-15, by-14)
advcl(regulating-11, modulating-15)
det(expression-17, the-16)
dobj(modulating-15, expression-17)
cc(expression-17, and-18)
dobj(modulating-15, stability-19)
conj:and(expression-17, stability-19)
case(protein-23, of-20)
det(protein-23, the-21)
amod(protein-23, CD24c-m-22)
nmod:of(expression-17, protein-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ applications/NNS of/IN PG11047/NNP in/IN skeletal_muscle/JJ disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS applications))
                  (PP (IN of)
                    (NP (NNP PG11047)))))
              (PP (IN in)
                (NP (JJ skeletal_muscle) (NNS disorders))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(applications-13, potential-11)
amod(applications-13, therapeutic-12)
dobj(elucidate-6, applications-13)
conj:and(mechanisms-9, applications-13)
case(PG11047-15, of-14)
nmod:of(applications-13, PG11047-15)
case(disorders-18, in-16)
amod(disorders-18, skeletal_muscle-17)
nmod:in(elucidate-6, disorders-18)

The/DT present/JJ study/NN investigated/VBD the/DT efficacy/NN of/IN ciclobendazole/NN in/IN reducing/VBG the/DT risk/NN of/IN biliary_ascariasis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN efficacy))
        (PP (IN of)
          (NP (NN ciclobendazole))))
      (PP (IN in)
        (S
          (VP (VBG reducing)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNS biliary_ascariasis))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP (NN phonophobia)))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(investigated-4, study-3)
root(ROOT-0, investigated-4)
det(efficacy-6, the-5)
dobj(investigated-4, efficacy-6)
case(ciclobendazole-8, of-7)
nmod:of(efficacy-6, ciclobendazole-8)
mark(reducing-10, in-9)
advcl(investigated-4, reducing-10)
det(risk-12, the-11)
dobj(reducing-10, risk-12)
case(biliary_ascariasis-14, of-13)
nmod:of(risk-12, biliary_ascariasis-14)
nmod:of(risk-12, photophobia-16)
conj:and(biliary_ascariasis-14, photophobia-16)
cc(biliary_ascariasis-14, and-18)
nmod:of(risk-12, phonophobia-19)
conj:and(biliary_ascariasis-14, phonophobia-19)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN on/IN a/DT sample/NN population/NN ,/, and/CC the/DT results/NNS showed/VBD that/WDT 2/CD hours/NNS after/IN dosing/VBG with/IN ciclobendazole/NN ,/, there/EX was/VBD a/DT significant/JJ reduction/NN in/IN the/DT risk/NN of/IN biliary_ascariasis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (S
      (NP (DT A) (NN randomized_controlled_trial))
      (VP (VBD was)
        (VP (VBN conducted)
          (PP (IN on)
            (NP (DT a) (NN sample) (NN population))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NNS results))
      (VP (VBD showed)
        (NP
          (NP (WDT that)
            (NX
              (NX
                (NX
                  (NP (CD 2) (NNS hours))
                  (SBAR (IN after)
                    (S
                      (PP (VBG dosing)
                        (PP (IN with)
                          (NP (NN ciclobendazole))))
                      (, ,)
                      (NP (EX there))
                      (VP (VBD was)
                        (NP (DT a) (JJ significant) (NN reduction))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP (NNS biliary_ascariasis)))))
                        (PP (IN by)
                          (NP (CD 14) (NN %)))))))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (CD 95) (NN %))
                    (VP (VBP CI)
                      (NP
                        (NP
                          (NP (CD 6-20) (NN %))
                          (, ,)
                          (NP (NNP P)))
                        (X
                          (X (SYM =))
                          (NP (CD 0.0005))))))
                  (-RRB- -RRB-)))
              (, ,)
              (NX
                (NX
                  (NX (NN photophobia))
                  (PP (IN by)
                    (NP (CD 17) (NN %))))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (CD 95) (NN %))
                    (VP (VBP CI)
                      (NP (CD 12-22) (NN %))
                      (, ,)
                      (SBAR
                        (S
                          (NP (NNP P))
                          (VP (VBP <)
                            (NP (CD 0.0001)))))))
                  (-RRB- -RRB-)))
              (, ,)
              (CC and)
              (NX
                (NX (NN phonophobia))
                (PP (IN by)
                  (NP (CD 14) (NN %))))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (PP (NNP CI)
                (NP (CD 17-20) (NN %))))
            (, ,)
            (NP (NNP P)
              (QP (CD <) (CD 0.0001)))
            (-RRB- -RRB-)))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
case(population-8, on-5)
det(population-8, a-6)
compound(population-8, sample-7)
nmod:on(conducted-4, population-8)
cc(conducted-4, and-10)
det(results-12, the-11)
nsubj(showed-13, results-12)
conj:and(conducted-4, showed-13)
dep(hours-16, that-14)
nummod(hours-16, 2-15)
dobj(showed-13, hours-16)
mark(was-23, after-17)
case(ciclobendazole-20, dosing-18)
case(ciclobendazole-20, with-19)
advcl(was-23, ciclobendazole-20)
expl(was-23, there-22)
dep(hours-16, was-23)
det(reduction-26, a-24)
amod(reduction-26, significant-25)
nsubj(was-23, reduction-26)
case(risk-29, in-27)
det(risk-29, the-28)
nmod:in(was-23, risk-29)
case(biliary_ascariasis-31, of-30)
nmod:of(risk-29, biliary_ascariasis-31)
case(%-34, by-32)
nummod(%-34, 14-33)
nmod:by(was-23, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(hours-16, CI-38)
nummod(%-40, 6-20-39)
dobj(CI-38, %-40)
appos(%-40, P-42)
dep(0.0005-44, =-43)
dep(%-40, 0.0005-44)
dobj(showed-13, photophobia-47)
conj:and(hours-16, photophobia-47)
case(%-50, by-48)
nummod(%-50, 17-49)
nmod:by(photophobia-47, %-50)
nummod(%-53, 95-52)
nsubj(CI-54, %-53)
dep(photophobia-47, CI-54)
nummod(%-56, 12-22-55)
dobj(CI-54, %-56)
nsubj(<-59, P-58)
dep(CI-54, <-59)
dobj(<-59, 0.0001-60)
cc(hours-16, and-63)
dobj(showed-13, phonophobia-64)
conj:and(hours-16, phonophobia-64)
case(%-67, by-65)
nummod(%-67, 14-66)
nmod:by(phonophobia-64, %-67)
nummod(%-70, 95-69)
appos(hours-16, %-70)
dep(%-73, CI-71)
nummod(%-73, 17-20-72)
nmod(%-70, %-73)
dep(%-70, P-75)
compound(0.0001-77, <-76)
nummod(P-75, 0.0001-77)

These/DT findings/NNS suggest/VBP that/IN ciclobendazole/NN may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN individuals/NNS with/IN biliary_ascariasis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN ciclobendazole))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP
                        (NP (NNS biliary_ascariasis))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, ciclobendazole-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
case(biliary_ascariasis-15, with-14)
nmod:with(individuals-13, biliary_ascariasis-15)
nmod:with(individuals-13, photophobia-17)
conj:and(biliary_ascariasis-15, photophobia-17)
cc(biliary_ascariasis-15, and-19)
nmod:with(individuals-13, phonophobia-20)
conj:and(biliary_ascariasis-15, phonophobia-20)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT long-term/JJ effects/NNS of/IN ciclobendazole/NN and/CC its/PRP$ safety/NN profile/NN in/IN different/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (PP (IN of)
                  (NP
                    (NP (NN ciclobendazole))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (NN safety) (NN profile))
                      (PP (IN in)
                        (NP (JJ different) (NNS populations))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(explore-6, effects-9)
case(ciclobendazole-11, of-10)
nmod:of(effects-9, ciclobendazole-11)
cc(ciclobendazole-11, and-12)
nmod:poss(profile-15, its-13)
compound(profile-15, safety-14)
nmod:of(effects-9, profile-15)
conj:and(ciclobendazole-11, profile-15)
case(populations-18, in-16)
amod(populations-18, different-17)
nmod:in(profile-15, populations-18)

The/DT use/NN of/IN Fludarabine/NNP has_been/VBP shown/VBN to_be/NN effective/JJ in/IN reducing/VBG the/DT risk/NN of/IN leukocytopenia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (NNP Fludarabine))))
    (VP (VBP has_been)
      (VP (VBN shown)
        (NP (NN to_be))
        (S
          (ADJP (JJ effective)
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NN leukocytopenia))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(use-2, The-1)
nsubj(has_been-5, use-2)
case(Fludarabine-4, of-3)
nmod:of(use-2, Fludarabine-4)
root(ROOT-0, has_been-5)
dep(has_been-5, shown-6)
dobj(shown-6, to_be-7)
xcomp(shown-6, effective-8)
mark(reducing-10, in-9)
advcl(effective-8, reducing-10)
det(risk-12, the-11)
dobj(reducing-10, risk-12)
case(leukocytopenia-14, of-13)
nmod:of(risk-12, leukocytopenia-14)
nmod:of(risk-12, photophobia-16)
conj:and(leukocytopenia-14, photophobia-16)
cc(leukocytopenia-14, and-18)
nmod:of(risk-12, phonophobia-19)
conj:and(leukocytopenia-14, phonophobia-19)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN to/TO investigate/VB the/DT efficacy/NN of/IN Fludarabine/NNP in/IN patients/NNS suffering/VBG from/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN efficacy))
                (PP (IN of)
                  (NP (NNP Fludarabine)))
                (PP (IN in)
                  (NP
                    (NP (NNS patients))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP (DT these) (NNS conditions))))))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
nsubj:xsubj(investigate-6, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
mark(investigate-6, to-5)
xcomp(conducted-4, investigate-6)
det(efficacy-8, the-7)
dobj(investigate-6, efficacy-8)
case(Fludarabine-10, of-9)
nmod:of(efficacy-8, Fludarabine-10)
case(patients-12, in-11)
nmod:in(efficacy-8, patients-12)
acl(patients-12, suffering-13)
case(conditions-16, from-14)
det(conditions-16, these-15)
nmod:from(suffering-13, conditions-16)

The/DT study/NN found/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, Fludarabine/NNP reduced/VBD the/DT risk/NN of/IN leukocytopenia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NNP Fludarabine))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN leukocytopenia))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(study-2, The-1)
nsubj(found-3, study-2)
root(ROOT-0, found-3)
mark(reduced-12, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-12, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-12, Fludarabine-11)
ccomp(found-3, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(leukocytopenia-16, of-15)
nmod:of(risk-14, leukocytopenia-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
xcomp(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
appos(%-35, %-38)
dep(%-41, CI-39)
nummod(%-41, 12-22-40)
nmod(%-38, %-41)
dep(%-38, P-43)
compound(0.0001-45, <-44)
nummod(P-43, 0.0001-45)
cc(photophobia-32, and-48)
xcomp(reduced-12, phonophobia-49)
conj:and(photophobia-32, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT results/NNS suggest/VBP that/IN Fludarabine/NNP may/MD be/VB a/DT useful/JJ treatment/NN option/NN for/IN patients/NNS with/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Fludarabine))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ useful) (NN treatment) (NN option))
                (PP (IN for)
                  (NP (NNS patients))))
              (PP (IN with)
                (NP (DT these) (NNS conditions))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Fludarabine-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, useful-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
case(conditions-16, with-14)
det(conditions-16, these-15)
nmod:with(option-11, conditions-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN Fludarabine/NNP in/IN these/DT patient/JJ populations/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (NNP Fludarabine)))))
              (PP (IN in)
                (NP (DT these) (JJ patient) (NNS populations))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(explore-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(explore-6, profile-12)
conj:and(effects-9, profile-12)
case(Fludarabine-14, of-13)
nmod:of(profile-12, Fludarabine-14)
case(populations-18, in-15)
det(populations-18, these-16)
amod(populations-18, patient-17)
nmod:in(explore-6, populations-18)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB various/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ various) (NN health) (NNS benefits))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-18, omega-3_fatty_acids-2)
nsubj:xsubj(have-20, omega-3_fatty_acids-2)
case(EPA-8, such-4)
mwe(such-4, as-5)
advmod(EPA-8, eicosapentaenoic_acid-6)
nmod:such_as(omega-3_fatty_acids-2, EPA-8)
cc(EPA-8, and-10)
nmod:such_as(omega-3_fatty_acids-2, docosahexaenoic_acid-11)
conj:and(EPA-8, docosahexaenoic_acid-11)
appos(EPA-8, DHA-13)
aux(shown-18, have-16)
auxpass(shown-18, been-17)
root(ROOT-0, shown-18)
mark(have-20, to-19)
xcomp(shown-18, have-20)
amod(benefits-23, various-21)
compound(benefits-23, health-22)
dobj(have-20, benefits-23)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN EPA/NNP and/CC DHA/NNP are/VBP associated/VBN with/IN decreased/VBN Flupirtine/JJ levels/NNS in/IN hyperFlupirtinemic/JJ patients/NNS ,/, suggesting/VBG a/DT potential/JJ role/NN in/IN managing/VBG Flupirtine/NNP levels/NNS in/IN these/DT patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ Flupirtine) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperFlupirtinemic) (NNS patients)))))
                (, ,)
                (S
                  (VP (VBG suggesting)
                    (NP
                      (NP (DT a) (JJ potential) (NN role))
                      (PP (IN in)
                        (NP (VBG managing) (NNP Flupirtine) (NNS levels)))
                      (PP (IN in)
                        (NP (DT these) (NNS patients))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-10, that-5)
nsubjpass(associated-10, EPA-6)
cc(EPA-6, and-7)
conj:and(EPA-6, DHA-8)
nsubjpass(associated-10, DHA-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
amod(levels-14, Flupirtine-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperFlupirtinemic-16)
nmod:in(levels-14, patients-17)
xcomp(associated-10, suggesting-19)
det(role-22, a-20)
amod(role-22, potential-21)
dobj(suggesting-19, role-22)
case(levels-26, in-23)
amod(levels-26, managing-24)
compound(levels-26, Flupirtine-25)
nmod:in(role-22, levels-26)
case(patients-29, in-27)
det(patients-29, these-28)
nmod:in(role-22, patients-29)

Furthermore/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/VB -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ,/, which/WDT is/VBZ one/CD of/IN the/DT leading/VBG causes/NNS of/IN death/NN worldwide/RB ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP (DT a) (VBN decreased) (NN risk))
            (PP (IN of)
              (S
                (VP (VBG developing)
                  (VP (VB coronary_heart_disease)
                    (NP
                      (NP (-LRB- -LRB-) (NNP CHD) (-RRB- -RRB-))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (VBZ is)
                            (NP
                              (NP (CD one))
                              (PP (IN of)
                                (NP
                                  (NP (DT the) (VBG leading) (NNS causes))
                                  (PP (IN of)
                                    (NP (NN death))))))))))
                    (ADVP (RB worldwide))))))))))
    (. .)))

advmod(has_been-9, Furthermore-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, decreased-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
xcomp(developing-16, coronary_heart_disease-17)
dobj(coronary_heart_disease-17, CHD-19)
nsubj(one-24, CHD-19)
ref(CHD-19, which-22)
cop(one-24, is-23)
acl:relcl(CHD-19, one-24)
case(causes-28, of-25)
det(causes-28, the-26)
amod(causes-28, leading-27)
nmod:of(one-24, causes-28)
case(death-30, of-29)
nmod:of(causes-28, death-30)
advmod(coronary_heart_disease-17, worldwide-31)

These/DT findings/NNS highlight/VB the/DT importance/NN of/IN incorporating/VBG long-chain/JJ omega-3_fatty_acids/JJ into/IN the/DT diet/NN for/IN maintaining/VBG optimal/JJ cardiovascular_health/NN and/CC managing/VBG Flupirtine/NNP levels/NNS in/IN hyperFlupirtinemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (NN importance))
        (PP (IN of)
          (S
            (VP (VBG incorporating)
              (NP
                (NP (JJ long-chain)
                  (ADJP (JJ omega-3_fatty_acids)
                    (PP (IN into)
                      (NP
                        (NP (DT the) (NN diet))
                        (PP (IN for)
                          (S
                            (VP
                              (VP (VBG maintaining)
                                (NP (JJ optimal) (NN cardiovascular_health)))
                              (CC and)
                              (VP (VBG managing)
                                (NP (NNP Flupirtine)))))))))
                  (NNS levels))
                (PP (IN in)
                  (NP (JJ hyperFlupirtinemic) (NNS patients)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(highlight-3, findings-2)
root(ROOT-0, highlight-3)
det(importance-5, the-4)
dobj(highlight-3, importance-5)
mark(incorporating-7, of-6)
acl(importance-5, incorporating-7)
amod(levels-20, long-chain-8)
amod(levels-20, omega-3_fatty_acids-9)
case(diet-12, into-10)
det(diet-12, the-11)
nmod:into(omega-3_fatty_acids-9, diet-12)
mark(maintaining-14, for-13)
acl(diet-12, maintaining-14)
amod(cardiovascular_health-16, optimal-15)
dobj(maintaining-14, cardiovascular_health-16)
cc(maintaining-14, and-17)
acl(diet-12, managing-18)
conj:and(maintaining-14, managing-18)
dobj(managing-18, Flupirtine-19)
dobj(incorporating-7, levels-20)
case(patients-23, in-21)
amod(patients-23, hyperFlupirtinemic-22)
nmod:in(levels-20, patients-23)

Further/RB research/NN is/VBZ warranted/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO explore/VB potential/JJ therapeutic/JJ applications/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP (JJ potential) (JJ therapeutic) (NNS applications))))))))
    (. .)))

advmod(warranted-4, Further-1)
nsubjpass(warranted-4, research-2)
auxpass(warranted-4, is-3)
root(ROOT-0, warranted-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(warranted-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(understand-7, and-13)
mark(explore-15, to-14)
ccomp(warranted-4, explore-15)
conj:and(understand-7, explore-15)
amod(applications-18, potential-16)
amod(applications-18, therapeutic-17)
dobj(explore-15, applications-18)

The/DT study/NN aimed/VBN to/TO investigate/VB the/DT effects/NNS of/IN TV3279/NNP intervention/NN on/IN body/NN weight/NN ,/, villus/NNS height/NN ,/, villus/JJ surface/NN area/NN ,/, plasma/NN TV3279/NN concentration/NN and/CC expression/NN of/IN cholinesterase/JJ in_a/NN mouse/NN model/NN ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (NNP TV3279)
                    (NX
                      (NX
                        (NX (NN intervention))
                        (PP (IN on)
                          (NP (NN body) (NN weight))))
                      (, ,)
                      (NX (NNS villus) (NN height))
                      (, ,)
                      (NX (JJ villus) (NN surface) (NN area))
                      (, ,)
                      (NX (NN plasma) (NN TV3279) (NN concentration))
                      (CC and)
                      (NX (NN expression))))
                  (PP (IN of)
                    (NP (JJ cholinesterase) (NN in_a) (NN mouse) (NN model))))))))))
    (. .)))

det(study-2, The-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effects-7, the-6)
dobj(investigate-5, effects-7)
case(intervention-10, of-8)
dep(intervention-10, TV3279-9)
nmod:of(effects-7, intervention-10)
case(weight-13, on-11)
compound(weight-13, body-12)
nmod:on(intervention-10, weight-13)
compound(height-16, villus-15)
nmod:of(effects-7, height-16)
conj:and(intervention-10, height-16)
amod(area-20, villus-18)
compound(area-20, surface-19)
nmod:of(effects-7, area-20)
conj:and(intervention-10, area-20)
compound(concentration-24, plasma-22)
compound(concentration-24, TV3279-23)
nmod:of(effects-7, concentration-24)
conj:and(intervention-10, concentration-24)
cc(intervention-10, and-25)
nmod:of(effects-7, expression-26)
conj:and(intervention-10, expression-26)
case(model-31, of-27)
amod(model-31, cholinesterase-28)
compound(model-31, in_a-29)
compound(model-31, mouse-30)
nmod:of(intervention-10, model-31)

The/DT results/NNS showed/VBD a/DT significant/JJ decrease/NN in/IN body/NN weight/NN ,/, villus/JJ height/NN and/CC villus/JJ surface/NN area/NN in/IN the/DT TV3279-intervened/JJ group/NN compared/VBN with/IN the/DT control/NN group/NN -LRB-/-LRB- P/NNP </CD 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP
            (NP (NN body) (NN weight))
            (, ,)
            (NP
              (NP (JJ villus) (NN height))
              (CC and)
              (NP (JJ villus) (NN surface) (NN area))))))
      (PP (IN in)
        (NP
          (NP (DT the) (JJ TV3279-intervened) (NN group))
          (VP (VBN compared)
            (PP (IN with)
              (NP
                (NP (DT the) (NN control) (NN group))
                (PRN (-LRB- -LRB-)
                  (NP (NNP P)
                    (QP (CD <) (CD 0.01)))
                  (-RRB- -RRB-))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(decrease-6, a-4)
amod(decrease-6, significant-5)
dobj(showed-3, decrease-6)
case(weight-9, in-7)
compound(weight-9, body-8)
nmod:in(decrease-6, weight-9)
amod(height-12, villus-11)
appos(weight-9, height-12)
cc(height-12, and-13)
amod(area-16, villus-14)
compound(area-16, surface-15)
appos(weight-9, area-16)
conj:and(height-12, area-16)
case(group-20, in-17)
det(group-20, the-18)
amod(group-20, TV3279-intervened-19)
nmod:in(showed-3, group-20)
acl(group-20, compared-21)
case(group-25, with-22)
det(group-25, the-23)
compound(group-25, control-24)
nmod:with(compared-21, group-25)
appos(group-25, P-27)
compound(0.01-29, <-28)
nummod(P-27, 0.01-29)

However/RB ,/, plasma/NN TV3279/NN concentration/NN and/CC expression/NN of/IN cholinesterase/NN in/IN the/DT TV3279-intervened/JJ group/NN had/VBD recovered/VBN to/TO normal/JJ levels/NNS -LRB-/-LRB- P/NNP >/CD 0.05/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (NN plasma) (NN TV3279) (NN concentration))
      (CC and)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP
            (NP (NN cholinesterase))
            (PP (IN in)
              (NP (DT the) (JJ TV3279-intervened) (NN group)))))))
    (VP (VBD had)
      (VP (VBN recovered)
        (PP (TO to)
          (NP
            (NP (JJ normal) (NNS levels))
            (PRN (-LRB- -LRB-)
              (NP (NNP P)
                (QP (CD >) (CD 0.05)))
              (-RRB- -RRB-))))))
    (. .)))

advmod(recovered-15, However-1)
compound(concentration-5, plasma-3)
compound(concentration-5, TV3279-4)
nsubj(recovered-15, concentration-5)
cc(concentration-5, and-6)
conj:and(concentration-5, expression-7)
nsubj(recovered-15, expression-7)
case(cholinesterase-9, of-8)
nmod:of(expression-7, cholinesterase-9)
case(group-13, in-10)
det(group-13, the-11)
amod(group-13, TV3279-intervened-12)
nmod:in(cholinesterase-9, group-13)
aux(recovered-15, had-14)
root(ROOT-0, recovered-15)
case(levels-18, to-16)
amod(levels-18, normal-17)
nmod:to(recovered-15, levels-18)
appos(levels-18, P-20)
compound(0.05-22, >-21)
nummod(P-20, 0.05-22)

These/DT findings/NNS suggest/VBP that/IN TV3279/NNP intervention/NN may/MD have/VB potential/JJ therapeutic/JJ effects/NNS on/IN certain/JJ disorders/NNS related/VBN to/TO body/NN weight/NN and/CC intestinal/JJ function/NN while/IN maintaining/VBG normal/JJ plasma/NN TV3279/NN concentration/NN and/CC cholinesterase/JJ expression/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP TV3279) (NN intervention))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS effects))
                (PP (IN on)
                  (NP
                    (NP (JJ certain) (NNS disorders))
                    (VP (VBN related)
                      (PP (TO to)
                        (NP
                          (NP (NN body) (NN weight))
                          (CC and)
                          (NP (JJ intestinal) (NN function))))))))
              (SBAR (IN while)
                (S
                  (VP (VBG maintaining)
                    (NP (JJ normal) (NN plasma) (NN TV3279)))
                  (NP-TMP
                    (NP (NN concentration))
                    (CC and)
                    (NP (JJ cholinesterase) (NN expression))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-8, that-4)
compound(intervention-6, TV3279-5)
nsubj(have-8, intervention-6)
aux(have-8, may-7)
ccomp(suggest-3, have-8)
amod(effects-11, potential-9)
amod(effects-11, therapeutic-10)
dobj(have-8, effects-11)
case(disorders-14, on-12)
amod(disorders-14, certain-13)
nmod:on(effects-11, disorders-14)
acl(disorders-14, related-15)
case(weight-18, to-16)
compound(weight-18, body-17)
nmod:to(related-15, weight-18)
cc(weight-18, and-19)
amod(function-21, intestinal-20)
nmod:to(related-15, function-21)
conj:and(weight-18, function-21)
mark(maintaining-23, while-22)
advcl(have-8, maintaining-23)
amod(TV3279-26, normal-24)
compound(TV3279-26, plasma-25)
dobj(maintaining-23, TV3279-26)
dep(maintaining-23, concentration-27)
cc(concentration-27, and-28)
amod(expression-30, cholinesterase-29)
dep(maintaining-23, expression-30)
conj:and(concentration-27, expression-30)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT underlying/VBG mechanisms/NNS of/IN these/DT effects/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN of)
                  (NP (DT these) (NNS effects)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(explore-6, mechanisms-9)
case(effects-12, of-10)
det(effects-12, these-11)
nmod:of(mechanisms-9, effects-12)

The/DT regulation/NN of/IN lactose/NN biosynthesis/VBZ is_a/JJ critical/JJ aspect/NN of/IN mammary_gland/JJ function/NN during/IN pregnancy/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN regulation))
      (PP (IN of)
        (NP (NN lactose))))
    (VP (VBZ biosynthesis)
      (NP
        (NP (JJ is_a) (JJ critical) (NN aspect))
        (PP (IN of)
          (NP (JJ mammary_gland) (NN function))))
      (PP (IN during)
        (NP (NN pregnancy))))
    (. .)))

det(regulation-2, The-1)
nsubj(biosynthesis-5, regulation-2)
case(lactose-4, of-3)
nmod:of(regulation-2, lactose-4)
root(ROOT-0, biosynthesis-5)
amod(aspect-8, is_a-6)
amod(aspect-8, critical-7)
dobj(biosynthesis-5, aspect-8)
case(function-11, of-9)
amod(function-11, mammary_gland-10)
nmod:of(aspect-8, function-11)
case(pregnancy-13, during-12)
nmod:during(biosynthesis-5, pregnancy-13)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT possible/JJ roles/NNS of/IN adenosine_3/NNS '/POS ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cAMP/NN -RRB-/-RRB- and/CC guanosine_3/JJ '/: ,5/CD '/'' -/: cyclic_monophosphate/NN -LRB-/-LRB- cGMP/NN -RRB-/-RRB- as/RB well/RB as/IN TPPO/NNP on/IN the/DT early/JJ effect/NN of/IN Mel_1a/NNS -LRB-/-LRB- PRL/NNP -RRB-/-RRB- on/IN lactose/JJ biosynthesis/NNS in/IN cultured/JJ mammary_gland/JJ explants/NNS derived/VBN from/IN mice/NNS 12-14/CD days/NNS pregnant/JJ ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP
          (NP
            (NP (DT the) (JJ possible) (NNS roles))
            (PP (IN of)
              (NP
                (NP (NNS adenosine_3) (POS '))
                (CD ,5)))
            ('' '))
          (: -)
          (NP
            (NP (NN cyclic_monophosphate))
            (PRN (-LRB- -LRB-)
              (NP (NN cAMP))
              (-RRB- -RRB-)))
          (CC and)
          (NP (JJ guanosine_3)
            (PRN (: ')
              (NP (CD ,5))
              ('' ') (: -))
            (NN cyclic_monophosphate)))
        (PRN (-LRB- -LRB-)
          (NP (NN cGMP))
          (-RRB- -RRB-))
        (CONJP (RB as) (RB well) (IN as))
        (NP
          (NP (NNP TPPO))
          (PP (IN on)
            (NP
              (NP (DT the) (JJ early) (NN effect))
              (PP (IN of)
                (NP
                  (NP (NNS Mel_1a))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP PRL))
                    (-RRB- -RRB-))))))))
      (PP (IN on)
        (NP (JJ lactose) (NNS biosynthesis)))
      (PP (IN in)
        (NP
          (NP (JJ cultured) (JJ mammary_gland) (NNS explants))
          (VP (VBN derived)
            (PP (IN from)
              (NP
                (NP (NNS mice))
                (NP-TMP (CD 12-14) (NNS days))))
            (S
              (ADJP (JJ pregnant)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(roles-9, the-7)
amod(roles-9, possible-8)
dobj(investigated-6, roles-9)
case(adenosine_3-11, of-10)
nmod:'(roles-9, adenosine_3-11)
case(adenosine_3-11, '-12)
nummod(adenosine_3-11, ,5-13)
dobj(investigated-6, cyclic_monophosphate-16)
conj:and(roles-9, cyclic_monophosphate-16)
appos(cyclic_monophosphate-16, cAMP-18)
cc(roles-9, and-20)
amod(cyclic_monophosphate-26, guanosine_3-21)
dep(cyclic_monophosphate-26, ,5-23)
dobj(investigated-6, cyclic_monophosphate-26)
conj:and(roles-9, cyclic_monophosphate-26)
appos(roles-9, cGMP-28)
cc(roles-9, as-30)
mwe(as-30, well-31)
mwe(as-30, as-32)
dobj(investigated-6, TPPO-33)
conj:and(roles-9, TPPO-33)
case(effect-37, on-34)
det(effect-37, the-35)
amod(effect-37, early-36)
nmod:on(TPPO-33, effect-37)
case(Mel_1a-39, of-38)
nmod:of(effect-37, Mel_1a-39)
appos(Mel_1a-39, PRL-41)
case(biosynthesis-45, on-43)
amod(biosynthesis-45, lactose-44)
nmod:on(investigated-6, biosynthesis-45)
case(explants-49, in-46)
amod(explants-49, cultured-47)
amod(explants-49, mammary_gland-48)
nmod:in(investigated-6, explants-49)
acl(explants-49, derived-50)
case(mice-52, from-51)
nmod:from(derived-50, mice-52)
nummod(days-54, 12-14-53)
nmod:tmod(mice-52, days-54)
xcomp(derived-50, pregnant-55)

Our/PRP$ results/NNS demonstrate/VBP that/IN Mel_1a/JJ stimulates/JJ lactose/NN biosynthesis/VBZ in_a/JJ dose-dependent/JJ manner/NN ,/, and/CC this/DT effect/NN is/VBZ significantly/RB inhibited/VBD by/IN cAMP/NN and/CC cGMP/NN analogues/NNS ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBP demonstrate)
        (SBAR (IN that)
          (S
            (NP (JJ Mel_1a) (JJ stimulates) (NN lactose))
            (VP (VBZ biosynthesis)
              (NP (JJ in_a) (JJ dose-dependent) (NN manner)))))))
    (, ,)
    (CC and)
    (S
      (NP (DT this) (NN effect))
      (VP (VBZ is) (RB significantly)
        (VP (VBD inhibited)
          (PP (IN by)
            (NP (NN cAMP)
              (CC and)
              (NN cGMP) (NNS analogues))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(biosynthesis-8, that-4)
amod(lactose-7, Mel_1a-5)
amod(lactose-7, stimulates-6)
nsubj(biosynthesis-8, lactose-7)
ccomp(demonstrate-3, biosynthesis-8)
amod(manner-11, in_a-9)
amod(manner-11, dose-dependent-10)
dobj(biosynthesis-8, manner-11)
cc(demonstrate-3, and-13)
det(effect-15, this-14)
nsubjpass(inhibited-18, effect-15)
auxpass(inhibited-18, is-16)
advmod(inhibited-18, significantly-17)
conj:and(demonstrate-3, inhibited-18)
case(analogues-23, by-19)
compound(analogues-23, cAMP-20)
cc(cAMP-20, and-21)
conj:and(cAMP-20, cGMP-22)
compound(analogues-23, cGMP-22)
nmod:by(inhibited-18, analogues-23)

Furthermore/RB ,/, we/PRP observed/VBD that/IN TPPO/NNP enhances/VBZ the/DT inhibitory/JJ effect/NN of/IN cAMP/NN and/CC cGMP/NN analogues/NNS on/IN PRL-induced/JJ lactose/JJ biosynthesis/NNS ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (SBAR (IN that)
        (S
          (NP (NNP TPPO))
          (VP (VBZ enhances)
            (NP
              (NP (DT the) (JJ inhibitory) (NN effect))
              (PP (IN of)
                (NP
                  (NP (NN cAMP)
                    (CC and)
                    (NN cGMP) (NNS analogues))
                  (PP (IN on)
                    (NP (JJ PRL-induced) (JJ lactose) (NNS biosynthesis))))))))))
    (. .)))

advmod(observed-4, Furthermore-1)
nsubj(observed-4, we-3)
root(ROOT-0, observed-4)
mark(enhances-7, that-5)
nsubj(enhances-7, TPPO-6)
ccomp(observed-4, enhances-7)
det(effect-10, the-8)
amod(effect-10, inhibitory-9)
dobj(enhances-7, effect-10)
case(analogues-15, of-11)
compound(analogues-15, cAMP-12)
cc(cAMP-12, and-13)
conj:and(cAMP-12, cGMP-14)
compound(analogues-15, cGMP-14)
nmod:of(effect-10, analogues-15)
case(biosynthesis-19, on-16)
amod(biosynthesis-19, PRL-induced-17)
amod(biosynthesis-19, lactose-18)
nmod:on(analogues-15, biosynthesis-19)

These/DT findings/NNS suggest/VBP that/IN both/DT cAMP/NN and/CC cGMP/NN play/VB important/JJ roles/NNS in/IN the/DT early/JJ effect/NN of/IN PRL/NNP on/IN lactose/JJ biosynthesis/NNS ,/, and/CC that/IN TPPO/NNP may/MD act/VB as/IN an/DT enhancer/NN of/IN their/PRP$ inhibitory/JJ effects/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR
        (SBAR (IN that)
          (S
            (NP (DT both) (NN cAMP)
              (CC and)
              (NN cGMP))
            (VP (VB play)
              (NP (JJ important) (NNS roles))
              (PP (IN in)
                (NP
                  (NP (DT the) (JJ early) (NN effect))
                  (PP (IN of)
                    (NP (NNP PRL)))))
              (PP (IN on)
                (NP (JJ lactose) (NNS biosynthesis))))))
        (, ,)
        (CC and)
        (SBAR (IN that)
          (S
            (NP (NNP TPPO))
            (VP (MD may)
              (VP (VB act)
                (PP (IN as)
                  (NP
                    (NP (DT an) (NN enhancer))
                    (PP (IN of)
                      (NP (PRP$ their) (JJ inhibitory) (NNS effects)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
cc:preconj(cAMP-6, both-5)
nsubj(play-9, cAMP-6)
cc(cAMP-6, and-7)
conj:and(cAMP-6, cGMP-8)
nsubj(play-9, cGMP-8)
ccomp(suggest-3, play-9)
amod(roles-11, important-10)
dobj(play-9, roles-11)
case(effect-15, in-12)
det(effect-15, the-13)
amod(effect-15, early-14)
nmod:in(play-9, effect-15)
case(PRL-17, of-16)
nmod:of(effect-15, PRL-17)
case(biosynthesis-20, on-18)
amod(biosynthesis-20, lactose-19)
nmod:on(play-9, biosynthesis-20)
cc(play-9, and-22)
mark(act-26, that-23)
nsubj(act-26, TPPO-24)
aux(act-26, may-25)
ccomp(suggest-3, act-26)
conj:and(play-9, act-26)
case(enhancer-29, as-27)
det(enhancer-29, an-28)
nmod:as(act-26, enhancer-29)
case(effects-33, of-30)
nmod:poss(effects-33, their-31)
amod(effects-33, inhibitory-32)
nmod:of(enhancer-29, effects-33)

This/DT study/NN provides/VBZ new/JJ insights/NNS into/IN the/DT molecular/JJ mechanisms/NNS underlying/VBG mammary_gland/JJ function/NN during/IN pregnancy/NN ,/, which/WDT may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/JJ therapeutic/JJ strategies/NNS for/IN lactation-related_disorders/NNS ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBZ provides)
      (NP
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (JJ molecular) (NNS mechanisms))
            (VP (VBG underlying)
              (NP (JJ mammary_gland) (NN function))
              (PP (IN during)
                (NP
                  (NP (NN pregnancy))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB have)
                          (NP
                            (NP (NNS implications))
                            (PP (IN for)
                              (NP
                                (NP (DT the) (NN development))
                                (PP (IN of)
                                  (NP
                                    (NP (JJ novel) (JJ therapeutic) (NNS strategies))
                                    (PP (IN for)
                                      (NP (NNS lactation-related_disorders)))))))))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(provides-3, study-2)
root(ROOT-0, provides-3)
amod(insights-5, new-4)
dobj(provides-3, insights-5)
case(mechanisms-9, into-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
nmod:into(insights-5, mechanisms-9)
acl(mechanisms-9, underlying-10)
amod(function-12, mammary_gland-11)
dobj(underlying-10, function-12)
case(pregnancy-14, during-13)
nmod:during(underlying-10, pregnancy-14)
nsubj(have-18, pregnancy-14)
ref(pregnancy-14, which-16)
aux(have-18, may-17)
acl:relcl(pregnancy-14, have-18)
dobj(have-18, implications-19)
case(development-22, for-20)
det(development-22, the-21)
nmod:for(implications-19, development-22)
case(strategies-26, of-23)
amod(strategies-26, novel-24)
amod(strategies-26, therapeutic-25)
nmod:of(development-22, strategies-26)
case(lactation-related_disorders-28, for-27)
nmod:for(strategies-26, lactation-related_disorders-28)

Eicosapentaenoic_acid/NNP -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- are/VBP long-chain/JJ omega-3_fatty_acids/NNS that/WDT have/VBP been/VBN shown/VBN to/TO have/VB a/DT protective/JJ effect/NN against/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP Eicosapentaenoic_acid))
          (-LRB- -LRB-)
          (NP (NNP EPA))
          (-RRB- -RRB-))
        (CC and)
        (NP (NN docosahexaenoic_acid)))
      (PRN (-LRB- -LRB-)
        (NP (NNP DHA))
        (-RRB- -RRB-)))
    (VP (VBP are)
      (NP
        (NP (JJ long-chain) (NNS omega-3_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN shown)
                  (S
                    (VP (TO to)
                      (VP (VB have)
                        (NP
                          (NP
                            (NP (DT a) (JJ protective) (NN effect))
                            (PP (IN against)
                              (NP (NN coronary_heart_disease))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

nsubj(omega-3_fatty_acids-12, Eicosapentaenoic_acid-1)
dep(Eicosapentaenoic_acid-1, EPA-3)
cc(Eicosapentaenoic_acid-1, and-5)
conj:and(Eicosapentaenoic_acid-1, docosahexaenoic_acid-6)
nsubj(omega-3_fatty_acids-12, docosahexaenoic_acid-6)
appos(Eicosapentaenoic_acid-1, DHA-8)
cop(omega-3_fatty_acids-12, are-10)
amod(omega-3_fatty_acids-12, long-chain-11)
root(ROOT-0, omega-3_fatty_acids-12)
nsubjpass(shown-16, omega-3_fatty_acids-12)
nsubj:xsubj(have-18, omega-3_fatty_acids-12)
ref(omega-3_fatty_acids-12, that-13)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
acl:relcl(omega-3_fatty_acids-12, shown-16)
mark(have-18, to-17)
xcomp(shown-16, have-18)
det(effect-21, a-19)
amod(effect-21, protective-20)
dobj(have-18, effect-21)
case(coronary_heart_disease-23, against-22)
nmod:against(effect-21, coronary_heart_disease-23)
appos(effect-21, CHD-25)

The/DT mechanism/NN underlying/VBG this/DT protection/NN has_been/NN linked/VBD to/TO their/PRP$ ability/NN to/TO decrease/VB A-72517/JJ levels/NNS in/IN hyperA-72517mic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN mechanism))
      (VP (VBG underlying)
        (NP (DT this) (NN protection) (NN has_been))))
    (VP (VBD linked)
      (PP (TO to)
        (NP (PRP$ their) (NN ability)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (JJ A-72517) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperA-72517mic) (NNS patients))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubj(linked-7, mechanism-2)
acl(mechanism-2, underlying-3)
det(has_been-6, this-4)
compound(has_been-6, protection-5)
dobj(underlying-3, has_been-6)
root(ROOT-0, linked-7)
case(ability-10, to-8)
nmod:poss(ability-10, their-9)
nmod:to(linked-7, ability-10)
mark(decrease-12, to-11)
acl(ability-10, decrease-12)
amod(levels-14, A-72517-13)
dobj(decrease-12, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperA-72517mic-16)
nmod:in(levels-14, patients-17)

A-72517/JJ is_a/NN known/VBN risk/NN factor/NN for/IN CHD/NNP ,/, and/CC its/PRP$ reduction/NN by/IN EPA/NNP and/CC DHA/NNP is/VBZ thought/VBN to_be/RB responsible/JJ for/IN the/DT observed/JJ cardiovascular_benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ A-72517) (NN is_a))
      (VP (VBN known)
        (NP
          (NP
            (NP (NN risk) (NN factor))
            (PP (IN for)
              (NP (NNP CHD))))
          (, ,)
          (CC and)
          (NP
            (NP (PRP$ its) (NN reduction))
            (PP (IN by)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA)))))))
    (VP (VBZ is)
      (VP (VBN thought)
        (ADJP (RB to_be) (JJ responsible)
          (PP (IN for)
            (NP (DT the) (JJ observed) (NNS cardiovascular_benefits))))))
    (. .)))

amod(is_a-2, A-72517-1)
nsubjpass(thought-17, is_a-2)
acl(is_a-2, known-3)
compound(factor-5, risk-4)
dobj(known-3, factor-5)
case(CHD-7, for-6)
nmod:for(factor-5, CHD-7)
cc(factor-5, and-9)
nmod:poss(reduction-11, its-10)
dobj(known-3, reduction-11)
conj:and(factor-5, reduction-11)
case(EPA-13, by-12)
nmod:by(reduction-11, EPA-13)
cc(EPA-13, and-14)
nmod:by(reduction-11, DHA-15)
conj:and(EPA-13, DHA-15)
auxpass(thought-17, is-16)
root(ROOT-0, thought-17)
advmod(responsible-19, to_be-18)
xcomp(thought-17, responsible-19)
case(cardiovascular_benefits-23, for-20)
det(cardiovascular_benefits-23, the-21)
amod(cardiovascular_benefits-23, observed-22)
nmod:for(responsible-19, cardiovascular_benefits-23)

Several/JJ studies/NNS have/VBP investigated/VBN the/DT relationship/NN between/IN omega-3_fatty_acids/NNP and/CC CHD/NNP ,/, with/IN consistent/JJ findings/NNS of/IN a/DT decreased/VBN risk/NN of/IN developing/VBG CHD/NNP in/IN individuals/NNS with/IN higher/JJR levels/NNS of/IN EPA/NNP and/CC DHA/NNP ./.

(ROOT
  (S
    (NP (JJ Several) (NNS studies))
    (VP (VBP have)
      (VP (VBN investigated)
        (NP
          (NP (DT the) (NN relationship))
          (PP (IN between)
            (NP (NNP omega-3_fatty_acids)
              (CC and)
              (NNP CHD))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (JJ consistent) (NNS findings))
            (PP (IN of)
              (NP
                (NP (DT a) (VBN decreased) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NNP CHD))
                      (PP (IN in)
                        (NP
                          (NP (NNS individuals))
                          (PP (IN with)
                            (NP
                              (NP (JJR higher) (NNS levels))
                              (PP (IN of)
                                (NP (NNP EPA)
                                  (CC and)
                                  (NNP DHA))))))))))))))))
    (. .)))

amod(studies-2, Several-1)
nsubj(investigated-4, studies-2)
aux(investigated-4, have-3)
root(ROOT-0, investigated-4)
det(relationship-6, the-5)
dobj(investigated-4, relationship-6)
case(omega-3_fatty_acids-8, between-7)
nmod:between(relationship-6, omega-3_fatty_acids-8)
cc(omega-3_fatty_acids-8, and-9)
nmod:between(relationship-6, CHD-10)
conj:and(omega-3_fatty_acids-8, CHD-10)
case(findings-14, with-12)
amod(findings-14, consistent-13)
nmod:with(investigated-4, findings-14)
case(risk-18, of-15)
det(risk-18, a-16)
amod(risk-18, decreased-17)
nmod:of(findings-14, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, CHD-21)
case(individuals-23, in-22)
nmod:in(developing-20, individuals-23)
case(levels-26, with-24)
amod(levels-26, higher-25)
nmod:with(individuals-23, levels-26)
case(EPA-28, of-27)
nmod:of(levels-26, EPA-28)
cc(EPA-28, and-29)
nmod:of(levels-26, DHA-30)
conj:and(EPA-28, DHA-30)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN preventing/VBG CHD/NNP in/IN high-risk/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP (DT an) (JJ effective) (NN strategy))
              (PP (IN for)
                (S
                  (VP (VBG preventing)
                    (NP (NNP CHD))
                    (PP (IN in)
                      (NP (JJ high-risk) (NNS patients)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-6, increasing-5)
nsubj(strategy-15, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(preventing-17, for-16)
advcl(strategy-15, preventing-17)
dobj(preventing-17, CHD-18)
case(patients-21, in-19)
amod(patients-21, high-risk-20)
nmod:in(preventing-17, patients-21)

Skeletal/JJ muscle/NN differentiation/NNS is_a/VBP complex/JJ process/NN regulated/VBN by/IN various/JJ signaling/VBG pathways/NNS and/CC gene/NN expression/NN ./.

(ROOT
  (S
    (NP (JJ Skeletal) (NN muscle) (NNS differentiation))
    (VP (VBP is_a)
      (NP (JJ complex) (NN process))
      (PP (VBN regulated)
        (PP (IN by)
          (NP
            (NP (JJ various) (VBG signaling) (NNS pathways))
            (CC and)
            (NP (NN gene) (NN expression))))))
    (. .)))

amod(differentiation-3, Skeletal-1)
compound(differentiation-3, muscle-2)
nsubj(is_a-4, differentiation-3)
root(ROOT-0, is_a-4)
amod(process-6, complex-5)
dobj(is_a-4, process-6)
case(pathways-11, regulated-7)
case(pathways-11, by-8)
amod(pathways-11, various-9)
amod(pathways-11, signaling-10)
advcl(is_a-4, pathways-11)
cc(pathways-11, and-12)
compound(expression-14, gene-13)
advcl(is_a-4, expression-14)
conj:and(pathways-11, expression-14)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN verticillin_A/NN on/IN the/DT expression/NN of/IN Suv39H1/JJ protein/NN during/IN C2C12/NNP cell/NN differentiation/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN verticillin_A))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP (JJ Suv39H1) (NN protein)))))
      (PP (IN during)
        (NP (NNP C2C12) (NN cell) (NN differentiation))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(verticillin_A-10, of-9)
nmod:of(effect-8, verticillin_A-10)
case(expression-13, on-11)
det(expression-13, the-12)
nmod:on(investigated-6, expression-13)
case(protein-16, of-14)
amod(protein-16, Suv39H1-15)
nmod:of(expression-13, protein-16)
case(differentiation-20, during-17)
compound(differentiation-20, C2C12-18)
compound(differentiation-20, cell-19)
nmod:during(investigated-6, differentiation-20)

Our/PRP$ results/NNS show/VBP that/IN when/WRB C2C12/NNP cells/NNS were/VBD cultured/VBN in_a/NN medium/NN favoring/VBG differentiation/NN -LRB-/-LRB- Dulbecco/NNP modified/VBN Eagle/NNP medium/NN containing/VBG 2/CD %/NN horse/NN serum/NN -RRB-/-RRB- ,/, verticillin_A/JJ up-regulated/JJ Suv39H1/JJ protein/NN levels/NNS in_a/NN time-dependent/JJ manner/NN and/CC prolonged/JJ Suv39H1/NNS protein/NN half-life/NN from/IN 10/CD to/TO 18/CD hours/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP show)
      (SBAR (IN that)
        (WHADVP (WRB when))
        (S
          (NP (NNP C2C12) (NNS cells))
          (VP (VBD were)
            (VP (VBN cultured)
              (NP (NN in_a)
                (NX
                  (NX
                    (NX (NN medium) (VBG favoring) (NN differentiation))
                    (PRN (-LRB- -LRB-)
                      (NAC (NNP Dulbecco)
                        (PP (VBN modified)
                          (NP
                            (NP (NNP Eagle) (NN medium))
                            (VP (VBG containing)
                              (NP
                                (ADJP (CD 2) (NN %))
                                (NN horse) (NN serum))))))
                      (-RRB- -RRB-))
                    (, ,)
                    (NP
                      (NP (JJ verticillin_A) (JJ up-regulated) (JJ Suv39H1) (NN protein) (NNS levels))
                      (NP (NN in_a) (JJ time-dependent) (NN manner))))
                  (CC and)
                  (NX (JJ prolonged) (NNS Suv39H1)))
                (NX (NN protein) (NN half-life)))
              (PP (IN from)
                (NP
                  (QP (CD 10) (TO to) (CD 18))
                  (NNS hours))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(show-3, results-2)
root(ROOT-0, show-3)
mark(cultured-9, that-4)
advmod(cultured-9, when-5)
compound(cells-7, C2C12-6)
nsubjpass(cultured-9, cells-7)
auxpass(cultured-9, were-8)
ccomp(show-3, cultured-9)
dep(half-life-38, in_a-10)
compound(differentiation-13, medium-11)
amod(differentiation-13, favoring-12)
dep(half-life-38, differentiation-13)
dep(differentiation-13, Dulbecco-15)
case(medium-18, modified-16)
compound(medium-18, Eagle-17)
nmod:modified(Dulbecco-15, medium-18)
acl(medium-18, containing-19)
compound(%-21, 2-20)
amod(serum-23, %-21)
compound(serum-23, horse-22)
dobj(containing-19, serum-23)
amod(levels-30, verticillin_A-26)
amod(levels-30, up-regulated-27)
amod(levels-30, Suv39H1-28)
compound(levels-30, protein-29)
dep(differentiation-13, levels-30)
compound(manner-33, in_a-31)
amod(manner-33, time-dependent-32)
dep(levels-30, manner-33)
cc(differentiation-13, and-34)
amod(Suv39H1-36, prolonged-35)
conj:and(differentiation-13, Suv39H1-36)
dep(half-life-38, Suv39H1-36)
compound(half-life-38, protein-37)
dobj(cultured-9, half-life-38)
case(hours-43, from-39)
compound(18-42, 10-40)
dep(18-42, to-41)
nummod(hours-43, 18-42)
nmod:from(cultured-9, hours-43)

Suv39H1/NNP is/VBZ known/VBN to/TO play/VB an/DT important/JJ role/NN in/IN muscle/NN differentiation/NN by/IN regulating/VBG chromatin/NN structure/NN and/CC gene/NN expression/NN ./.

(ROOT
  (S
    (NP (NNP Suv39H1))
    (VP (VBZ is)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB play)
              (NP
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP (NN muscle) (NN differentiation))))
              (PP (IN by)
                (S
                  (VP (VBG regulating)
                    (NP
                      (NP (NN chromatin) (NN structure))
                      (CC and)
                      (NP (NN gene) (NN expression)))))))))))
    (. .)))

nsubjpass(known-3, Suv39H1-1)
nsubj:xsubj(play-5, Suv39H1-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
mark(play-5, to-4)
xcomp(known-3, play-5)
det(role-8, an-6)
amod(role-8, important-7)
dobj(play-5, role-8)
case(differentiation-11, in-9)
compound(differentiation-11, muscle-10)
nmod:in(role-8, differentiation-11)
mark(regulating-13, by-12)
advcl(play-5, regulating-13)
compound(structure-15, chromatin-14)
dobj(regulating-13, structure-15)
cc(structure-15, and-16)
compound(expression-18, gene-17)
dobj(regulating-13, expression-18)
conj:and(structure-15, expression-18)

Therefore/RB ,/, our/PRP$ findings/NNS suggest/VBP that/IN verticillin_A/NN may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN muscle-related_disorders/NNS by/IN modulating/VBG the/DT expression/NN of/IN Suv39H1/JJ protein/NN ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP (PRP$ our) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN verticillin_A))
          (VP (MD may)
            (VP (VB have)
              (ADJP (JJ potential))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP (NNS muscle-related_disorders)))))
              (PP (IN by)
                (S
                  (VP (VBG modulating)
                    (NP
                      (NP (DT the) (NN expression))
                      (PP (IN of)
                        (NP (JJ Suv39H1) (NN protein))))))))))))
    (. .)))

advmod(suggest-5, Therefore-1)
nmod:poss(findings-4, our-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(have-9, that-6)
nsubj(have-9, verticillin_A-7)
aux(have-9, may-8)
ccomp(suggest-5, have-9)
xcomp(have-9, potential-10)
case(agent-14, as-11)
det(agent-14, a-12)
amod(agent-14, therapeutic-13)
nmod:as(have-9, agent-14)
case(muscle-related_disorders-16, for-15)
nmod:for(agent-14, muscle-related_disorders-16)
mark(modulating-18, by-17)
advcl(have-9, modulating-18)
det(expression-20, the-19)
dobj(modulating-18, expression-20)
case(protein-23, of-21)
amod(protein-23, Suv39H1-22)
nmod:of(expression-20, protein-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN this/DT effect/NN and/CC to/TO evaluate/VB its/PRP$ therapeutic/JJ potential/NN in/IN vivo/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (PP (IN of)
                    (NP (DT this) (NN effect))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP (PRP$ its) (JJ therapeutic) (NN potential))
                (PP (IN in)
                  (NP (NN vivo)))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(effect-12, of-10)
det(effect-12, this-11)
nmod:of(mechanisms-9, effect-12)
cc(elucidate-6, and-13)
mark(evaluate-15, to-14)
ccomp(needed-4, evaluate-15)
conj:and(elucidate-6, evaluate-15)
nmod:poss(potential-18, its-16)
amod(potential-18, therapeutic-17)
dobj(evaluate-15, potential-18)
case(vivo-20, in-19)
nmod:in(evaluate-15, vivo-20)

In/IN the/DT context/NN of/IN phototoxic_reactions/NNS ,/, pseudourea/NN has_been/NN investigated/VBD for/IN its/PRP$ potential/NN to/TO reduce/VB the/DT risk/NN of/IN such/JJ reactions/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN context))
        (PP (IN of)
          (NP (NNS phototoxic_reactions)))))
    (, ,)
    (NP (NN pseudourea) (NN has_been))
    (VP (VBD investigated)
      (PP (IN for)
        (NP (PRP$ its) (NN potential)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (JJ such) (NNS reactions))))))))))
    (. .)))

case(context-3, In-1)
det(context-3, the-2)
nmod:in(investigated-9, context-3)
case(phototoxic_reactions-5, of-4)
nmod:of(context-3, phototoxic_reactions-5)
compound(has_been-8, pseudourea-7)
nsubj(investigated-9, has_been-8)
root(ROOT-0, investigated-9)
case(potential-12, for-10)
nmod:poss(potential-12, its-11)
nmod:for(investigated-9, potential-12)
mark(reduce-14, to-13)
acl(potential-12, reduce-14)
det(risk-16, the-15)
dobj(reduce-14, risk-16)
case(reactions-19, of-17)
amod(reactions-19, such-18)
nmod:of(risk-16, reactions-19)

In/IN a/DT randomized_controlled_trial/NN ,/, participants/NNS were/VBD administered/VBN pseudourea/NN and/CC observed/VBN for/IN any/DT phototoxic_reactions/NNS at/IN 2/CD hours/NNS post-dosing/JJ ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (NN randomized_controlled_trial)))
    (, ,)
    (NP (NNS participants))
    (VP (VBD were)
      (VP
        (VP (VBN administered)
          (NP (NN pseudourea)))
        (CC and)
        (VP (VBN observed)
          (PP (IN for)
            (NP (DT any) (NNS phototoxic_reactions)))
          (PP (IN at)
            (NP (CD 2) (NNS hours)))
          (S
            (ADJP (JJ post-dosing))))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, a-2)
nmod:in(administered-7, randomized_controlled_trial-3)
nsubjpass(administered-7, participants-5)
nsubjpass(observed-10, participants-5)
auxpass(administered-7, were-6)
root(ROOT-0, administered-7)
dobj(administered-7, pseudourea-8)
cc(administered-7, and-9)
conj:and(administered-7, observed-10)
case(phototoxic_reactions-13, for-11)
det(phototoxic_reactions-13, any-12)
nmod:for(observed-10, phototoxic_reactions-13)
case(hours-16, at-14)
nummod(hours-16, 2-15)
nmod:at(observed-10, hours-16)
xcomp(observed-10, post-dosing-17)

The/DT results/NNS showed/VBD that/IN pseudourea/NN reduced/VBD the/DT risk/NN of/IN phototoxic_reactions/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN pseudourea))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS phototoxic_reactions))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, pseudourea-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
case(phototoxic_reactions-10, of-9)
nmod:of(risk-8, phototoxic_reactions-10)
case(%-13, by-11)
nummod(%-13, 14-12)
nmod:by(reduced-6, %-13)
nummod(%-16, 95-15)
dep(%-13, %-16)
acl:relcl(%-16, CI-17)
nummod(%-19, 6-20-18)
dobj(CI-17, %-19)
appos(%-19, P-21)
dep(0.0005-23, =-22)
dep(%-19, 0.0005-23)
xcomp(reduced-6, photophobia-26)
case(%-29, by-27)
nummod(%-29, 17-28)
nmod:by(photophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(photophobia-26, and-42)
xcomp(reduced-6, phonophobia-43)
conj:and(photophobia-26, phonophobia-43)
case(%-46, by-44)
nummod(%-46, 14-45)
nmod:by(phonophobia-43, %-46)
nummod(%-49, 95-48)
appos(%-46, %-49)
dep(%-52, CI-50)
nummod(%-52, 17-20-51)
nmod(%-49, %-52)
dep(%-49, P-54)
compound(0.0001-56, <-55)
nummod(P-54, 0.0001-56)

These/DT findings/NNS suggest/VBP that/IN pseudourea/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN phototoxicity/JJ and/CC related/VBN symptoms/NNS ,/, which/WDT could/MD have/VB important/JJ implications/NNS for/IN the/DT prevention/NN and/CC treatment/NN of/IN conditions/NNS associated/VBN with/IN these/DT reactions/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN pseudourea))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP
                    (NP
                      (ADJP (JJ phototoxicity)
                        (CC and)
                        (VBN related))
                      (NNS symptoms))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (MD could)
                          (VP (VB have)
                            (NP
                              (NP (JJ important) (NNS implications))
                              (PP (IN for)
                                (NP
                                  (NP (DT the) (NN prevention)
                                    (CC and)
                                    (NN treatment))
                                  (PP (IN of)
                                    (NP
                                      (NP (NNS conditions))
                                      (VP (VBN associated)
                                        (PP (IN with)
                                          (NP (DT these) (NNS reactions)))))))))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, pseudourea-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
det(effect-10, a-8)
amod(effect-10, protective-9)
dobj(have-7, effect-10)
case(symptoms-15, against-11)
amod(symptoms-15, phototoxicity-12)
cc(phototoxicity-12, and-13)
conj:and(phototoxicity-12, related-14)
amod(symptoms-15, related-14)
nmod:against(effect-10, symptoms-15)
nsubj(have-19, symptoms-15)
ref(symptoms-15, which-17)
aux(have-19, could-18)
acl:relcl(symptoms-15, have-19)
amod(implications-21, important-20)
dobj(have-19, implications-21)
case(prevention-24, for-22)
det(prevention-24, the-23)
nmod:for(implications-21, prevention-24)
cc(prevention-24, and-25)
nmod:for(implications-21, treatment-26)
conj:and(prevention-24, treatment-26)
case(conditions-28, of-27)
nmod:of(prevention-24, conditions-28)
acl(conditions-28, associated-29)
case(reactions-32, with-30)
det(reactions-32, these-31)
nmod:with(associated-29, reactions-32)

Further/RB research/NN is/VBZ needed/VBN to/TO confirm/VB these/DT results/NNS and/CC explore/VB the/DT mechanisms/NNS underlying/VBG this/DT potential/JJ protective/JJ effect/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB confirm)
                (NP (DT these) (NNS results)))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (JJ potential) (JJ protective) (NN effect))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(confirm-6, research-2)
nsubj:xsubj(explore-10, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
xcomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
xcomp(needed-4, explore-10)
conj:and(confirm-6, explore-10)
det(mechanisms-12, the-11)
dobj(explore-10, mechanisms-12)
acl(mechanisms-12, underlying-13)
det(effect-17, this-14)
amod(effect-17, potential-15)
amod(effect-17, protective-16)
dobj(underlying-13, effect-17)

MicroRNAs/NNP -LRB-/-LRB- miRNAs/NNS -RRB-/-RRB- are/VBP small/JJ non-coding/JJ RNAs/NNS that/WDT regulate/VB gene/NN expression/NN at/IN the/DT post-transcriptional/JJ level/NN ./.

(ROOT
  (S
    (NP (NNP MicroRNAs) (-LRB- -LRB-)
      (NP (NNS miRNAs))
      (-RRB- -RRB-))
    (VP (VBP are)
      (NP
        (NP (JJ small) (JJ non-coding) (NNS RNAs))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VB regulate)
              (NP (NN gene) (NN expression))
              (PP (IN at)
                (NP (DT the) (JJ post-transcriptional) (NN level))))))))
    (. .)))

nsubj(RNAs-8, MicroRNAs-1)
dep(MicroRNAs-1, miRNAs-3)
cop(RNAs-8, are-5)
amod(RNAs-8, small-6)
amod(RNAs-8, non-coding-7)
root(ROOT-0, RNAs-8)
nsubj(regulate-10, RNAs-8)
ref(RNAs-8, that-9)
acl:relcl(RNAs-8, regulate-10)
compound(expression-12, gene-11)
dobj(regulate-10, expression-12)
case(level-16, at-13)
det(level-16, the-14)
amod(level-16, post-transcriptional-15)
nmod:at(regulate-10, level-16)

miR-145/JJ has_been/NN identified/VBD as/IN a/DT tumor_suppressor/NN in/IN several/JJ types/NNS of/IN cancer/NN ,/, including/VBG colorectal_cancer/NN ./.

(ROOT
  (S
    (NP (JJ miR-145) (NN has_been))
    (VP (VBD identified)
      (PP (IN as)
        (NP
          (NP (DT a) (NN tumor_suppressor))
          (PP (IN in)
            (NP
              (NP (JJ several) (NNS types))
              (PP (IN of)
                (NP (NN cancer)))
              (, ,)
              (VP (VBG including)
                (NP (NN colorectal_cancer))))))))
    (. .)))

amod(has_been-2, miR-145-1)
nsubj(identified-3, has_been-2)
root(ROOT-0, identified-3)
case(tumor_suppressor-6, as-4)
det(tumor_suppressor-6, a-5)
nmod:as(identified-3, tumor_suppressor-6)
case(types-9, in-7)
amod(types-9, several-8)
nmod:in(tumor_suppressor-6, types-9)
case(cancer-11, of-10)
nmod:of(types-9, cancer-11)
acl(types-9, including-13)
dobj(including-13, colorectal_cancer-14)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN miR-145/JJ inhibition/NN on/IN the/DT methylation/JJ levels/NNS of/IN several/JJ genes/NNS involved/VBN in/IN cancer_progression/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (JJ miR-145) (NN inhibition))))
      (PP (IN on)
        (NP
          (NP (DT the) (JJ methylation) (NNS levels))
          (PP (IN of)
            (NP
              (NP (JJ several) (NNS genes))
              (VP (VBN involved)
                (PP (IN in)
                  (NP (NN cancer_progression)))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(inhibition-11, of-9)
amod(inhibition-11, miR-145-10)
nmod:of(effect-8, inhibition-11)
case(levels-15, on-12)
det(levels-15, the-13)
amod(levels-15, methylation-14)
nmod:on(investigated-6, levels-15)
case(genes-18, of-16)
amod(genes-18, several-17)
nmod:of(levels-15, genes-18)
acl(genes-18, involved-19)
case(cancer_progression-21, in-20)
nmod:in(involved-19, cancer_progression-21)

Our/PRP$ results/NNS showed/VBD that/IN inhibition/NN of/IN miR-145/JJ increased/VBD methylation/NN levels/NNS of/IN d-Glucuronolactone/JJ synthase/NN -LRB-/-LRB- SLC23A2/NNP -RRB-/-RRB- ,/, stearoyl-CoA_desaturase_1/JJ -LRB-/-LRB- SCD1/NNP -RRB-/-RRB- ,/, peroxisome_proliferator-activated_receptor_gamma/NN -LRB-/-LRB- PPARG/NNP -RRB-/-RRB- ,/, and/CC sterol_regulatory_element_binding_transcription_factor_1/NNS -LRB-/-LRB- SREBF1/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN inhibition))
            (PP (IN of)
              (NP (JJ miR-145))))
          (VP (VBD increased)
            (NP
              (NP (NN methylation) (NNS levels))
              (PP (IN of)
                (NP
                  (NP
                    (NP (JJ d-Glucuronolactone) (NN synthase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP SLC23A2))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ stearoyl-CoA_desaturase_1))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP SCD1))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN peroxisome_proliferator-activated_receptor_gamma))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PPARG))
                      (-RRB- -RRB-)))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (NNS sterol_regulatory_element_binding_transcription_factor_1))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP SREBF1))
                      (-RRB- -RRB-))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-8, that-4)
nsubj(increased-8, inhibition-5)
case(miR-145-7, of-6)
nmod:of(inhibition-5, miR-145-7)
ccomp(showed-3, increased-8)
compound(levels-10, methylation-9)
dobj(increased-8, levels-10)
case(synthase-13, of-11)
amod(synthase-13, d-Glucuronolactone-12)
nmod:of(levels-10, synthase-13)
appos(synthase-13, SLC23A2-15)
nmod:of(levels-10, stearoyl-CoA_desaturase_1-18)
conj:and(synthase-13, stearoyl-CoA_desaturase_1-18)
appos(stearoyl-CoA_desaturase_1-18, SCD1-20)
nmod:of(levels-10, peroxisome_proliferator-activated_receptor_gamma-23)
conj:and(synthase-13, peroxisome_proliferator-activated_receptor_gamma-23)
appos(peroxisome_proliferator-activated_receptor_gamma-23, PPARG-25)
cc(synthase-13, and-28)
nmod:of(levels-10, sterol_regulatory_element_binding_transcription_factor_1-29)
conj:and(synthase-13, sterol_regulatory_element_binding_transcription_factor_1-29)
appos(sterol_regulatory_element_binding_transcription_factor_1-29, SREBF1-31)

These/DT genes/NNS have/VBP been/VBN previously/RB implicated/VBN in/IN cancer/NN development/NN and/CC progression/NN ,/, and/CC our/PRP$ findings/NNS suggest/VBP that/IN miR-145/JJ may/MD play/VB a/DT role/NN in/IN regulating/VBG their/PRP$ expression/NN through/IN epigenetic/JJ mechanisms/NNS ./.

(ROOT
  (S
    (S
      (NP (DT These) (NNS genes))
      (VP (VBP have)
        (VP (VBN been)
          (VP
            (ADVP (RB previously))
            (VBN implicated)
            (PP (IN in)
              (NP (NN cancer) (NN development)
                (CC and)
                (NN progression)))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP$ our) (NNS findings))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (JJ miR-145))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP (VBG regulating)
                        (NP (PRP$ their) (NN expression))
                        (PP (IN through)
                          (NP (JJ epigenetic) (NNS mechanisms)))))))))))))
    (. .)))

det(genes-2, These-1)
nsubjpass(implicated-6, genes-2)
aux(implicated-6, have-3)
auxpass(implicated-6, been-4)
advmod(implicated-6, previously-5)
root(ROOT-0, implicated-6)
case(development-9, in-7)
compound(development-9, cancer-8)
nmod:in(implicated-6, development-9)
cc(development-9, and-10)
nmod:in(implicated-6, progression-11)
conj:and(development-9, progression-11)
cc(implicated-6, and-13)
nmod:poss(findings-15, our-14)
nsubj(suggest-16, findings-15)
conj:and(implicated-6, suggest-16)
mark(play-20, that-17)
nsubj(play-20, miR-145-18)
aux(play-20, may-19)
ccomp(suggest-16, play-20)
det(role-22, a-21)
dobj(play-20, role-22)
mark(regulating-24, in-23)
acl(role-22, regulating-24)
nmod:poss(expression-26, their-25)
dobj(regulating-24, expression-26)
case(mechanisms-29, through-27)
amod(mechanisms-29, epigenetic-28)
nmod:through(regulating-24, mechanisms-29)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT molecular/JJ mechanisms/NNS underlying/VBG these/DT observations/NNS and/CC to/TO explore/VB the/DT potential/JJ therapeutic/JJ implications/NNS of/IN targeting/VBG miR-145/JJ in/IN cancer/NN treatment/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (JJ molecular) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS observations))))))
            (CC and)
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (JJ therapeutic) (NNS implications))
                  (PP (IN of)
                    (S
                      (VP (VBG targeting)
                        (ADJP (JJ miR-145))
                        (PP (IN in)
                          (NP (NN cancer) (NN treatment)))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, molecular-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(observations-12, these-11)
dobj(underlying-10, observations-12)
cc(elucidate-6, and-13)
mark(explore-15, to-14)
ccomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
det(implications-19, the-16)
amod(implications-19, potential-17)
amod(implications-19, therapeutic-18)
dobj(explore-15, implications-19)
mark(targeting-21, of-20)
acl(implications-19, targeting-21)
xcomp(targeting-21, miR-145-22)
case(treatment-25, in-23)
compound(treatment-25, cancer-24)
nmod:in(targeting-21, treatment-25)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN linked/VBN to/TO numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP (JJ numerous) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(linked-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
aux(linked-16, have-14)
auxpass(linked-16, been-15)
root(ROOT-0, linked-16)
case(benefits-20, to-17)
amod(benefits-20, numerous-18)
compound(benefits-20, health-19)
nmod:to(linked-16, benefits-20)

Recent/JJ studies/NNS suggest/VBP that/IN these/DT long-chain_fatty_acids/NNS may/MD also/RB play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS long-chain_fatty_acids))
          (VP (MD may) (RB also)
            (VP (VB play)
              (NP
                (NP (DT a) (NN role))
                (PP (IN in)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (S
                              (VP (VBG developing)
                                (NP (NN coronary_heart_disease))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggest-3, studies-2)
root(ROOT-0, suggest-3)
mark(play-9, that-4)
det(long-chain_fatty_acids-6, these-5)
nsubj(play-9, long-chain_fatty_acids-6)
aux(play-9, may-7)
advmod(play-9, also-8)
ccomp(suggest-3, play-9)
det(role-11, a-10)
dobj(play-9, role-11)
mark(reducing-13, in-12)
acl(role-11, reducing-13)
det(risk-15, the-14)
dobj(reducing-13, risk-15)
mark(developing-17, of-16)
acl(risk-15, developing-17)
dobj(developing-17, coronary_heart_disease-18)
appos(risk-15, CHD-20)

In/IN hyperaminoacetonitrilemic/JJ patients/NNS ,/, EPA/NNP and/CC DHA/NNP were/VBD found/VBN to_be/NN associated/VBN with/IN decreased/VBN aminoacetonitrile/JJ levels/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ hyperaminoacetonitrilemic) (NNS patients)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBD were)
      (VP (VBN found)
        (NP
          (NP (NN to_be))
          (VP (VBN associated)
            (PP (IN with)
              (NP (VBN decreased) (JJ aminoacetonitrile) (NNS levels)))))))
    (. .)))

case(patients-3, In-1)
amod(patients-3, hyperaminoacetonitrilemic-2)
nmod:in(found-9, patients-3)
nsubjpass(found-9, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubjpass(found-9, DHA-7)
auxpass(found-9, were-8)
root(ROOT-0, found-9)
dobj(found-9, to_be-10)
acl(to_be-10, associated-11)
case(levels-15, with-12)
amod(levels-15, decreased-13)
amod(levels-15, aminoacetonitrile-14)
nmod:with(associated-11, levels-15)

This/DT suggests/VBZ that/IN omega-3_fatty_acids/NN may/MD have/VB a/DT protective/JJ effect/NN against/IN CHD/NNP by/IN reducing/VBG the/DT levels/NNS of/IN this/DT compound/NN ./.

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ protective) (NN effect))
                (PP (IN against)
                  (NP (NNP CHD))))
              (PP (IN by)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NNS levels))
                      (PP (IN of)
                        (NP (DT this) (NN compound))))))))))))
    (. .)))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
mark(have-6, that-3)
nsubj(have-6, omega-3_fatty_acids-4)
aux(have-6, may-5)
ccomp(suggests-2, have-6)
det(effect-9, a-7)
amod(effect-9, protective-8)
dobj(have-6, effect-9)
case(CHD-11, against-10)
nmod:against(effect-9, CHD-11)
mark(reducing-13, by-12)
advcl(have-6, reducing-13)
det(levels-15, the-14)
dobj(reducing-13, levels-15)
case(compound-18, of-16)
det(compound-18, this-17)
nmod:of(levels-15, compound-18)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS behind/IN this/DT association/NN ,/, but/CC these/DT findings/NNS highlight/VB the/DT potential/JJ importance/NN of/IN consuming/VBG adequate/JJ amounts/NNS of/IN EPA/NNP and/CC DHA/NNP in/IN promoting/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (S
      (ADVP (RB Further))
      (NP (NN research))
      (VP (VBZ is)
        (VP (VBN needed)
          (S
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (PP (IN behind)
                    (NP (DT this) (NN association))))))))))
    (, ,)
    (CC but)
    (S
      (NP (DT these) (NNS findings))
      (VP (VB highlight)
        (NP
          (NP (DT the) (JJ potential) (NN importance))
          (PP (IN of)
            (S
              (VP (VBG consuming)
                (NP
                  (NP (JJ adequate) (NNS amounts))
                  (PP (IN of)
                    (NP (NNP EPA)
                      (CC and)
                      (NNP DHA))))
                (PP (IN in)
                  (S
                    (VP (VBG promoting)
                      (NP (NN cardiovascular_health)))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
case(association-12, behind-10)
det(association-12, this-11)
nmod:behind(mechanisms-9, association-12)
cc(needed-4, but-14)
det(findings-16, these-15)
nsubj(highlight-17, findings-16)
conj:but(needed-4, highlight-17)
det(importance-20, the-18)
amod(importance-20, potential-19)
dobj(highlight-17, importance-20)
mark(consuming-22, of-21)
acl(importance-20, consuming-22)
amod(amounts-24, adequate-23)
dobj(consuming-22, amounts-24)
case(EPA-26, of-25)
nmod:of(amounts-24, EPA-26)
cc(EPA-26, and-27)
nmod:of(amounts-24, DHA-28)
conj:and(EPA-26, DHA-28)
mark(promoting-30, in-29)
advcl(consuming-22, promoting-30)
dobj(promoting-30, cardiovascular_health-31)

Panthenyl/NNP ethyl_ether/VBP is_a/NN compound/NN that/WDT has/VBZ shown/VBN potential/JJ in/IN reducing/VBG the/DT risk/NN of/IN systemic/JJ allergic_contact_dermatitis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (NNP Panthenyl))
    (VP (VBP ethyl_ether)
      (NP
        (NP (NN is_a) (NN compound))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ has)
              (VP (VBN shown)
                (ADJP (JJ potential))
                (PP (IN in)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP
                            (NP (JJ systemic) (NNS allergic_contact_dermatitis))
                            (, ,)
                            (NP (NN photophobia))
                            (, ,)
                            (CC and)
                            (NP (NN phonophobia))))))))))))))
    (. .)))

nsubj(ethyl_ether-2, Panthenyl-1)
root(ROOT-0, ethyl_ether-2)
compound(compound-4, is_a-3)
dobj(ethyl_ether-2, compound-4)
nsubj(shown-7, compound-4)
ref(compound-4, that-5)
aux(shown-7, has-6)
acl:relcl(compound-4, shown-7)
xcomp(shown-7, potential-8)
mark(reducing-10, in-9)
advcl(shown-7, reducing-10)
det(risk-12, the-11)
dobj(reducing-10, risk-12)
case(allergic_contact_dermatitis-15, of-13)
amod(allergic_contact_dermatitis-15, systemic-14)
nmod:of(risk-12, allergic_contact_dermatitis-15)
nmod:of(risk-12, photophobia-17)
conj:and(allergic_contact_dermatitis-15, photophobia-17)
cc(allergic_contact_dermatitis-15, and-19)
nmod:of(risk-12, phonophobia-20)
conj:and(allergic_contact_dermatitis-15, phonophobia-20)

In/IN a/DT clinical/JJ trial/NN ,/, participants/NNS were/VBD administered/VBN with/IN panthenyl_ethyl_ether/NN and/CC monitored/VBN for/IN 2/CD hours/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ clinical) (NN trial)))
    (, ,)
    (NP (NNS participants))
    (VP (VBD were)
      (VP
        (VP (VBN administered)
          (PP (IN with)
            (NP (NN panthenyl_ethyl_ether))))
        (CC and)
        (VP (VBN monitored)
          (PP (IN for)
            (NP (CD 2) (NNS hours))))))
    (. .)))

case(trial-4, In-1)
det(trial-4, a-2)
amod(trial-4, clinical-3)
nmod:in(administered-8, trial-4)
nsubjpass(administered-8, participants-6)
nsubjpass(monitored-12, participants-6)
auxpass(administered-8, were-7)
root(ROOT-0, administered-8)
case(panthenyl_ethyl_ether-10, with-9)
nmod:with(administered-8, panthenyl_ethyl_ether-10)
cc(administered-8, and-11)
conj:and(administered-8, monitored-12)
case(hours-15, for-13)
nummod(hours-15, 2-14)
nmod:for(monitored-12, hours-15)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, panthenyl_ethyl_ether/NN significantly/RB reduced/VBD the/DT risk/NN of/IN systemic/JJ allergic_contact_dermatitis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN panthenyl_ethyl_ether))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (JJ systemic)
                  (NX
                    (NX
                      (NX
                        (NX (NNS allergic_contact_dermatitis))
                        (PP (IN by)
                          (NP (CD 14) (NN %))))
                      (PRN (-LRB- -LRB-)
                        (S
                          (NP (CD 95) (NN %))
                          (VP (VBP CI)
                            (NP
                              (NP
                                (NP (CD 6-20) (NN %))
                                (, ,)
                                (NP (NNP P)))
                              (X
                                (X (SYM =))
                                (NP (CD 0.0005))))))
                        (-RRB- -RRB-)))
                    (, ,)
                    (NX
                      (NX
                        (NX (NN photophobia))
                        (PP (IN by)
                          (NP (CD 17) (NN %))))
                      (PRN (-LRB- -LRB-)
                        (S
                          (NP (CD 95) (NN %))
                          (VP (VBP CI)
                            (NP (CD 12-22) (NN %))
                            (, ,)
                            (SBAR
                              (S
                                (NP (NNP P))
                                (VP (VBP <)
                                  (NP (CD 0.0001)))))))
                        (-RRB- -RRB-)))
                    (, ,)
                    (CC and)
                    (NX (NN phonophobia))))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (PP (NNP CI)
                      (NP (CD 17-20) (NN %))))
                  (, ,)
                  (NP (NNP P)
                    (QP (CD <) (CD 0.0001)))
                  (-RRB- -RRB-))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, panthenyl_ethyl_ether-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(allergic_contact_dermatitis-18, of-16)
amod(allergic_contact_dermatitis-18, systemic-17)
nmod:of(risk-15, allergic_contact_dermatitis-18)
case(%-21, by-19)
nummod(%-21, 14-20)
nmod:by(allergic_contact_dermatitis-18, %-21)
nummod(%-24, 95-23)
nsubj(CI-25, %-24)
dep(allergic_contact_dermatitis-18, CI-25)
nummod(%-27, 6-20-26)
dobj(CI-25, %-27)
appos(%-27, P-29)
dep(0.0005-31, =-30)
dep(%-27, 0.0005-31)
nmod:of(risk-15, photophobia-34)
conj:and(allergic_contact_dermatitis-18, photophobia-34)
case(%-37, by-35)
nummod(%-37, 17-36)
nmod:by(photophobia-34, %-37)
nummod(%-40, 95-39)
nsubj(CI-41, %-40)
dep(photophobia-34, CI-41)
nummod(%-43, 12-22-42)
dobj(CI-41, %-43)
nsubj(<-46, P-45)
dep(CI-41, <-46)
dobj(<-46, 0.0001-47)
cc(allergic_contact_dermatitis-18, and-50)
nmod:of(risk-15, phonophobia-51)
conj:and(allergic_contact_dermatitis-18, phonophobia-51)
case(%-54, by-52)
nummod(%-54, 14-53)
nmod:by(reduced-13, %-54)
nummod(%-57, 95-56)
appos(%-54, %-57)
dep(%-60, CI-58)
nummod(%-60, 17-20-59)
nmod(%-57, %-60)
dep(%-57, P-62)
compound(0.0001-64, <-63)
nummod(P-62, 0.0001-64)

These/DT findings/NNS suggest/VBP that/IN panthenyl_ethyl_ether/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS who/WP suffer/VBP from/IN allergic_contact_dermatitis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN panthenyl_ethyl_ether))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (SBAR
                      (WHNP (WP who))
                      (S
                        (VP (VBP suffer)
                          (PP (IN from)
                            (NP
                              (NP (NNS allergic_contact_dermatitis))
                              (, ,)
                              (NP (NN photophobia))
                              (, ,)
                              (CC and)
                              (NP (NN phonophobia)))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, panthenyl_ethyl_ether-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
nsubj(suffer-15, individuals-13)
ref(individuals-13, who-14)
acl:relcl(individuals-13, suffer-15)
case(allergic_contact_dermatitis-17, from-16)
nmod:from(suffer-15, allergic_contact_dermatitis-17)
nmod:from(suffer-15, photophobia-19)
conj:and(allergic_contact_dermatitis-17, photophobia-19)
cc(allergic_contact_dermatitis-17, and-21)
nmod:from(suffer-15, phonophobia-22)
conj:and(allergic_contact_dermatitis-17, phonophobia-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN this/DT compound/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (DT this) (NN compound))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(explore-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(explore-6, profile-12)
conj:and(effects-9, profile-12)
case(compound-15, of-13)
det(compound-15, this-14)
nmod:of(profile-12, compound-15)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effects/NNS of/IN serotonin/NN -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- on/IN GPR-32/NN and/CC COOH-terminal/NNP MAG-DHA/NNP extended/VBD proGPR-32/JJ -LRB-/-LRB- GPR-32-G/NNP -RRB-/-RRB- secretion/NN ,/, biosynthesis/NNS of/IN GPR-32/NNP and/CC GPR-32-G/NNP ,/, and/CC the/DT effects/NNS of/IN GPR-32-G/NN on/IN gastric_acid/JJ secretion/NN in/IN rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (S
      (NP (PRP we))
      (VP (VBD investigated)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP
              (NP (NN serotonin))
              (PRN (-LRB- -LRB-)
                (NP (CD 5-HT))
                (-RRB- -RRB-)))))
        (PP (IN on)
          (NP (NN GPR-32)))))
    (CC and)
    (S
      (NP (NNP COOH-terminal) (NNP MAG-DHA))
      (VP (VBD extended)
        (NP
          (NP (JJ proGPR-32)
            (PRN (-LRB- -LRB-)
              (NP (NNP GPR-32-G))
              (-RRB- -RRB-))
            (NN secretion))
          (, ,)
          (NP
            (NP (NNS biosynthesis))
            (PP (IN of)
              (NP (NNP GPR-32)
                (CC and)
                (NNP GPR-32-G))))
          (, ,)
          (CC and)
          (NP
            (NP (DT the) (NNS effects))
            (PP (IN of)
              (NP (NN GPR-32-G)))
            (PP (IN on)
              (NP (JJ gastric_acid) (NN secretion)))))
        (PP (IN in)
          (NP (NNS rats)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effects-8, the-7)
dobj(investigated-6, effects-8)
case(serotonin-10, of-9)
nmod:of(effects-8, serotonin-10)
appos(serotonin-10, 5-HT-12)
case(GPR-32-15, on-14)
nmod:on(investigated-6, GPR-32-15)
cc(investigated-6, and-16)
compound(MAG-DHA-18, COOH-terminal-17)
nsubj(extended-19, MAG-DHA-18)
conj:and(investigated-6, extended-19)
amod(secretion-24, proGPR-32-20)
appos(secretion-24, GPR-32-G-22)
dobj(extended-19, secretion-24)
dobj(extended-19, biosynthesis-26)
conj:and(secretion-24, biosynthesis-26)
case(GPR-32-28, of-27)
nmod:of(biosynthesis-26, GPR-32-28)
cc(GPR-32-28, and-29)
nmod:of(biosynthesis-26, GPR-32-G-30)
conj:and(GPR-32-28, GPR-32-G-30)
cc(secretion-24, and-32)
det(effects-34, the-33)
dobj(extended-19, effects-34)
conj:and(secretion-24, effects-34)
case(GPR-32-G-36, of-35)
nmod:of(effects-34, GPR-32-G-36)
case(secretion-39, on-37)
amod(secretion-39, gastric_acid-38)
nmod:on(effects-34, secretion-39)
case(rats-41, in-40)
nmod:in(extended-19, rats-41)

Our/PRP$ results/NNS showed/VBD that/IN 5-HT/NNP significantly/RB increased/VBD the/DT secretion/NN of/IN GPR-32-G/JJ in_a/JJ dose-dependent/JJ manner/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP 5-HT))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP
              (NP (DT the) (NN secretion))
              (PP (IN of)
                (NP (JJ GPR-32-G) (JJ in_a) (JJ dose-dependent) (NN manner))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(increased-7, that-4)
nsubj(increased-7, 5-HT-5)
advmod(increased-7, significantly-6)
ccomp(showed-3, increased-7)
det(secretion-9, the-8)
dobj(increased-7, secretion-9)
case(manner-14, of-10)
amod(manner-14, GPR-32-G-11)
amod(manner-14, in_a-12)
amod(manner-14, dose-dependent-13)
nmod:of(secretion-9, manner-14)

Furthermore/RB ,/, 5-HT/CD also/RB enhanced/VBD the/DT biosynthesis/NNS of/IN GPR-32/JJ and/CC GPR-32-G/JJ in_a/JJ time-dependent/JJ manner/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (CD 5-HT))
    (ADVP (RB also))
    (VP (VBD enhanced)
      (NP
        (NP (DT the) (NNS biosynthesis))
        (PP (IN of)
          (NP
            (ADJP (JJ GPR-32)
              (CC and)
              (JJ GPR-32-G))
            (JJ in_a) (JJ time-dependent) (NN manner)))))
    (. .)))

advmod(enhanced-5, Furthermore-1)
nsubj(enhanced-5, 5-HT-3)
advmod(enhanced-5, also-4)
root(ROOT-0, enhanced-5)
det(biosynthesis-7, the-6)
dobj(enhanced-5, biosynthesis-7)
case(manner-14, of-8)
amod(manner-14, GPR-32-9)
cc(GPR-32-9, and-10)
conj:and(GPR-32-9, GPR-32-G-11)
amod(manner-14, GPR-32-G-11)
amod(manner-14, in_a-12)
amod(manner-14, time-dependent-13)
nmod:of(biosynthesis-7, manner-14)

The/DT administration/NN of/IN exogenous/JJ GPR-32-G/NN resulted/VBD in_a/JJ significant/JJ reduction/NN in/IN gastric_acid/JJ secretion/NN ,/, indicating/VBG that/IN it/PRP may/MD have/VB potential/JJ therapeutic/JJ implications/NNS for/IN the/DT treatment/NN of/IN gastric_acid-related_disorders/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN administration))
      (PP (IN of)
        (NP (JJ exogenous) (NN GPR-32-G))))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN reduction))
        (PP (IN in)
          (NP (JJ gastric_acid) (NN secretion))))
      (, ,)
      (S
        (VP (VBG indicating)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (MD may)
                (VP (VB have)
                  (NP
                    (NP (JJ potential) (JJ therapeutic) (NNS implications))
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN treatment))
                        (PP (IN of)
                          (NP (NNS gastric_acid-related_disorders)))))))))))))
    (. .)))

det(administration-2, The-1)
nsubj(resulted-6, administration-2)
case(GPR-32-G-5, of-3)
amod(GPR-32-G-5, exogenous-4)
nmod:of(administration-2, GPR-32-G-5)
root(ROOT-0, resulted-6)
amod(reduction-9, in_a-7)
amod(reduction-9, significant-8)
dobj(resulted-6, reduction-9)
case(secretion-12, in-10)
amod(secretion-12, gastric_acid-11)
nmod:in(reduction-9, secretion-12)
advcl(resulted-6, indicating-14)
mark(have-18, that-15)
nsubj(have-18, it-16)
aux(have-18, may-17)
ccomp(indicating-14, have-18)
amod(implications-21, potential-19)
amod(implications-21, therapeutic-20)
dobj(have-18, implications-21)
case(treatment-24, for-22)
det(treatment-24, the-23)
nmod:for(implications-21, treatment-24)
case(gastric_acid-related_disorders-26, of-25)
nmod:of(treatment-24, gastric_acid-related_disorders-26)

Overall/RB ,/, these/DT findings/NNS highlight/VB the/DT important/JJ role/NN of/IN 5-HT/CD in/IN regulating/VBG the/DT secretion/NN and/CC biosynthesis/NNS of/IN GPR-32/NN and/CC its/PRP$ extended/JJ form/NN ,/, as/RB well/RB as/IN their/PRP$ potential/JJ therapeutic/JJ applications/NNS for/IN gastric_acid-related_disorders/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VB highlight)
      (NP
        (NP (DT the) (JJ important) (NN role))
        (PP (IN of)
          (NP (CD 5-HT)))
        (PP (IN in)
          (S
            (VP (VBG regulating)
              (NP
                (NP (DT the) (NN secretion))
                (CC and)
                (NP
                  (NP (NNS biosynthesis))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NN GPR-32))
                        (CC and)
                        (NP (PRP$ its) (JJ extended) (NN form)))
                      (, ,)
                      (CONJP (RB as) (RB well) (IN as))
                      (NP
                        (NP (PRP$ their) (JJ potential) (JJ therapeutic) (NNS applications))
                        (PP (IN for)
                          (NP (NNS gastric_acid-related_disorders)))))))))))))
    (. .)))

advmod(highlight-5, Overall-1)
det(findings-4, these-3)
nsubj(highlight-5, findings-4)
root(ROOT-0, highlight-5)
det(role-8, the-6)
amod(role-8, important-7)
dobj(highlight-5, role-8)
case(5-HT-10, of-9)
nmod:of(role-8, 5-HT-10)
mark(regulating-12, in-11)
acl(role-8, regulating-12)
det(secretion-14, the-13)
dobj(regulating-12, secretion-14)
cc(secretion-14, and-15)
dobj(regulating-12, biosynthesis-16)
conj:and(secretion-14, biosynthesis-16)
case(GPR-32-18, of-17)
nmod:of(biosynthesis-16, GPR-32-18)
cc(GPR-32-18, and-19)
nmod:poss(form-22, its-20)
amod(form-22, extended-21)
nmod:of(biosynthesis-16, form-22)
conj:and(GPR-32-18, form-22)
cc(GPR-32-18, as-24)
mwe(as-24, well-25)
mwe(as-24, as-26)
nmod:poss(applications-30, their-27)
amod(applications-30, potential-28)
amod(applications-30, therapeutic-29)
nmod:of(biosynthesis-16, applications-30)
conj:and(GPR-32-18, applications-30)
case(gastric_acid-related_disorders-32, for-31)
nmod:for(applications-30, gastric_acid-related_disorders-32)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT a) (JJ healthy) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)

These/DT long-chain_fatty_acids/NNS have/VBP been/VBN shown/VBN to_be/NN associated/VBN with/IN decreased/VBN levels/NNS of/IN NXY-059/NN in/IN hyperNXY-059mic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT These) (NNS long-chain_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NN NXY-059))
                        (PP (IN in)
                          (NP
                            (NP (JJ hyperNXY-059mic) (NNS patients))
                            (, ,)
                            (ADVP (RB as) (RB well)
                              (PP (IN as)
                                (NP
                                  (NP (DT a) (VBN decreased) (NN risk))
                                  (PP (IN of)
                                    (S
                                      (VP (VBG developing)
                                        (NP (NN coronary_heart_disease)))))))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

det(long-chain_fatty_acids-2, These-1)
nsubjpass(shown-5, long-chain_fatty_acids-2)
aux(shown-5, have-3)
auxpass(shown-5, been-4)
root(ROOT-0, shown-5)
dobj(shown-5, to_be-6)
acl(to_be-6, associated-7)
case(levels-10, with-8)
amod(levels-10, decreased-9)
nmod:with(associated-7, levels-10)
case(NXY-059-12, of-11)
nmod:of(levels-10, NXY-059-12)
case(patients-15, in-13)
amod(patients-15, hyperNXY-059mic-14)
nmod:in(NXY-059-12, patients-15)
advmod(well-18, as-17)
advmod(patients-15, well-18)
case(risk-22, as-19)
det(risk-22, a-20)
amod(risk-22, decreased-21)
nmod:as(well-18, risk-22)
mark(developing-24, of-23)
acl(risk-22, developing-24)
dobj(developing-24, coronary_heart_disease-25)
appos(NXY-059-12, CHD-27)

The/DT beneficial/JJ effects/NNS of/IN these/DT omega-3_fatty_acids/NN on/IN cardiovascular_health/NN are/VBP thought/VBN to_be/RB due/JJ to/TO their/PRP$ ability/NN to/TO reduce/VB inflammation/NN and/CC improve/VB lipid/NN metabolism/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ beneficial) (NNS effects))
      (PP (IN of)
        (NP
          (NP (DT these) (NN omega-3_fatty_acids))
          (PP (IN on)
            (NP (NN cardiovascular_health))))))
    (VP (VBP are)
      (VP (VBN thought)
        (ADJP (RB to_be) (JJ due)
          (PP (TO to)
            (NP (PRP$ their) (NN ability)
              (S
                (VP (TO to)
                  (VP
                    (VP (VB reduce)
                      (NP (NN inflammation)))
                    (CC and)
                    (VP (VB improve)
                      (NP (NN lipid) (NN metabolism)))))))))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, beneficial-2)
nsubjpass(thought-10, effects-3)
case(omega-3_fatty_acids-6, of-4)
det(omega-3_fatty_acids-6, these-5)
nmod:of(effects-3, omega-3_fatty_acids-6)
case(cardiovascular_health-8, on-7)
nmod:on(omega-3_fatty_acids-6, cardiovascular_health-8)
auxpass(thought-10, are-9)
root(ROOT-0, thought-10)
advmod(due-12, to_be-11)
xcomp(thought-10, due-12)
case(ability-15, to-13)
nmod:poss(ability-15, their-14)
nmod:to(due-12, ability-15)
mark(reduce-17, to-16)
acl(ability-15, reduce-17)
dobj(reduce-17, inflammation-18)
cc(reduce-17, and-19)
acl(ability-15, improve-20)
conj:and(reduce-17, improve-20)
compound(metabolism-22, lipid-21)
dobj(improve-20, metabolism-22)

In/IN addition/NN ,/, recent/JJ studies/NNS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP may/MD also/RB have/VB neuroprotective/JJ properties/NNS ,/, making/VBG them/PRP potentially/RB useful/JJ in/IN the/DT prevention/NN and/CC treatment/NN of/IN neurological_disorders/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (JJ recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD may) (RB also)
              (VP (VB have)
                (NP (JJ neuroprotective) (NNS properties))
                (, ,)
                (S
                  (VP (VBG making)
                    (S
                      (NP (PRP them))
                      (ADJP (RB potentially) (JJ useful)
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN prevention)
                              (CC and)
                              (NN treatment))
                            (PP (IN of)
                              (NP (NNS neurological_disorders)))))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-7, addition-2)
amod(studies-5, recent-4)
nsubj(shown-7, studies-5)
aux(shown-7, have-6)
root(ROOT-0, shown-7)
mark(have-14, that-8)
nsubj(have-14, EPA-9)
cc(EPA-9, and-10)
conj:and(EPA-9, DHA-11)
nsubj(have-14, DHA-11)
aux(have-14, may-12)
advmod(have-14, also-13)
ccomp(shown-7, have-14)
amod(properties-16, neuroprotective-15)
dobj(have-14, properties-16)
advcl(have-14, making-18)
nsubj(useful-21, them-19)
advmod(useful-21, potentially-20)
xcomp(making-18, useful-21)
case(prevention-24, in-22)
det(prevention-24, the-23)
nmod:in(useful-21, prevention-24)
cc(prevention-24, and-25)
nmod:in(useful-21, treatment-26)
conj:and(prevention-24, treatment-26)
case(neurological_disorders-28, of-27)
nmod:of(prevention-24, neurological_disorders-28)

Overall/RB ,/, the/DT evidence/NN suggests/VBZ that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN improving/VBG overall/JJ health/NN and/CC reducing/VBG the/DT risk/NN of/IN chronic_diseases/NNS such/JJ as/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT the) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG improving)
                        (NP (JJ overall) (NN health)))
                      (CC and)
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP
                              (NP (NNS chronic_diseases))
                              (PP (JJ such) (IN as)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

advmod(suggests-5, Overall-1)
det(evidence-4, the-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
mark(strategy-16, that-6)
amod(intake-8, increasing-7)
nsubj(strategy-16, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggests-5, strategy-16)
mark(improving-18, for-17)
acl(strategy-16, improving-18)
amod(health-20, overall-19)
dobj(improving-18, health-20)
cc(improving-18, and-21)
acl(strategy-16, reducing-22)
conj:and(improving-18, reducing-22)
det(risk-24, the-23)
dobj(reducing-22, risk-24)
case(chronic_diseases-26, of-25)
nmod:of(risk-24, chronic_diseases-26)
case(CHD-29, such-27)
mwe(such-27, as-28)
nmod:such_as(chronic_diseases-26, CHD-29)

Migraine/JJ is_a/JJ common/JJ neurological_disorder/NN characterized/VBD by/IN recurrent/JJ headache/NN attacks/NN and/CC associated/VBN symptoms/NNS such/JJ as/IN nausea/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (JJ Migraine) (JJ is_a) (JJ common) (NN neurological_disorder))
    (VP (VBD characterized)
      (PP (IN by)
        (NP
          (NP (JJ recurrent) (NN headache) (NN attacks))
          (CC and)
          (NP
            (NP (VBN associated) (NNS symptoms))
            (PP (JJ such) (IN as)
              (NP
                (NP (NN nausea))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

amod(neurological_disorder-4, Migraine-1)
amod(neurological_disorder-4, is_a-2)
amod(neurological_disorder-4, common-3)
nsubj(characterized-5, neurological_disorder-4)
root(ROOT-0, characterized-5)
case(attacks-9, by-6)
amod(attacks-9, recurrent-7)
compound(attacks-9, headache-8)
nmod:by(characterized-5, attacks-9)
cc(attacks-9, and-10)
amod(symptoms-12, associated-11)
nmod:by(characterized-5, symptoms-12)
conj:and(attacks-9, symptoms-12)
case(nausea-15, such-13)
mwe(such-13, as-14)
nmod:such_as(symptoms-12, nausea-15)
nmod:such_as(symptoms-12, photophobia-17)
conj:and(nausea-15, photophobia-17)
cc(nausea-15, and-19)
nmod:such_as(symptoms-12, phonophobia-20)
conj:and(nausea-15, phonophobia-20)

Metoclopramide_hydrochloride/JJ has_been/NN used/VBD to/TO manage/VB migraine-associated_symptoms/NNS ./.

(ROOT
  (S
    (NP (JJ Metoclopramide_hydrochloride) (NN has_been))
    (VP (VBD used)
      (S
        (VP (TO to)
          (VP (VB manage)
            (NP (NNS migraine-associated_symptoms))))))
    (. .)))

amod(has_been-2, Metoclopramide_hydrochloride-1)
nsubj(used-3, has_been-2)
nsubj:xsubj(manage-5, has_been-2)
root(ROOT-0, used-3)
mark(manage-5, to-4)
xcomp(used-3, manage-5)
dobj(manage-5, migraine-associated_symptoms-6)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN metoclopramide_hydrochloride/NN on/IN the/DT risk/NN of/IN migraine-associated_symptoms/NNS was/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP
          (NP (NN metoclopramide_hydrochloride))
          (PP (IN on)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS migraine-associated_symptoms))))))))
    (VP (VBD was)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-15, study-3)
det(effect-6, the-5)
nsubjpass(evaluated-15, effect-6)
case(metoclopramide_hydrochloride-8, of-7)
nmod:of(effect-6, metoclopramide_hydrochloride-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(metoclopramide_hydrochloride-8, risk-11)
case(migraine-associated_symptoms-13, of-12)
nmod:of(risk-11, migraine-associated_symptoms-13)
auxpass(evaluated-15, was-14)
root(ROOT-0, evaluated-15)

At_2/JJ h/NN after/IN dosing/VBG ,/, metoclopramide_hydrochloride/NN reduced/VBD the/DT risk/NN of/IN nausea_reduction/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN metoclopramide_hydrochloride))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NN nausea_reduction))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(h-2, At_2-1)
dep(reduced-7, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubj(reduced-7, metoclopramide_hydrochloride-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(nausea_reduction-11, of-10)
nmod:of(risk-9, nausea_reduction-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT results/NNS suggest/VBP that/IN metoclopramide_hydrochloride/NN may/MD be/VB an/DT effective/JJ treatment/NN for/IN managing/VBG migraine-associated_symptoms/NNS ,/, particularly/RB nausea/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN metoclopramide_hydrochloride))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP
                  (NP (DT an) (JJ effective) (NN treatment))
                  (PP (IN for)
                    (NP (VBG managing) (NNS migraine-associated_symptoms))))
                (, ,) (RB particularly)
                (NP (NN nausea))
                (, ,)
                (NP (NN photophobia))
                (, ,)
                (CC and)
                (NP (NN phonophobia))))))))
    (. .)))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
mark(treatment-10, that-4)
nsubj(treatment-10, metoclopramide_hydrochloride-5)
aux(treatment-10, may-6)
cop(treatment-10, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
ccomp(suggest-3, treatment-10)
case(migraine-associated_symptoms-13, for-11)
amod(migraine-associated_symptoms-13, managing-12)
nmod:for(treatment-10, migraine-associated_symptoms-13)
advmod(treatment-10, particularly-15)
dep(treatment-10, nausea-16)
ccomp(suggest-3, photophobia-18)
conj:and(treatment-10, photophobia-18)
cc(treatment-10, and-20)
ccomp(suggest-3, phonophobia-21)
conj:and(treatment-10, phonophobia-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO confirm/VB these/DT findings/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN metoclopramide_hydrochloride/NN in/IN the/DT management/NN of/IN migraine-associated_symptoms/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS findings))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (NN metoclopramide_hydrochloride))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN management))
                          (PP (IN of)
                            (NP (NNS migraine-associated_symptoms))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(findings-8, these-7)
dobj(confirm-6, findings-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(metoclopramide_hydrochloride-17, for-16)
nmod:for(regimen-15, metoclopramide_hydrochloride-17)
case(management-20, in-18)
det(management-20, the-19)
nmod:in(metoclopramide_hydrochloride-17, management-20)
case(migraine-associated_symptoms-22, of-21)
nmod:of(management-20, migraine-associated_symptoms-22)

In/IN this/DT study/NN ,/, the/DT effects/NNS of/IN penbutolol/NN on/IN the/DT risk/NN of/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN were/VBD investigated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NNS effects))
      (PP (IN of)
        (NP
          (NP (NN penbutolol))
          (PP (IN on)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNS bronchospasms))
                  (, ,)
                  (NP (NN photophobia))
                  (, ,)
                  (CC and)
                  (NP (NN phonophobia)))))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-20, study-3)
det(effects-6, the-5)
nsubjpass(investigated-20, effects-6)
case(penbutolol-8, of-7)
nmod:of(effects-6, penbutolol-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(penbutolol-8, risk-11)
case(bronchospasms-13, of-12)
nmod:of(risk-11, bronchospasms-13)
nmod:of(risk-11, photophobia-15)
conj:and(bronchospasms-13, photophobia-15)
cc(bronchospasms-13, and-17)
nmod:of(risk-11, phonophobia-18)
conj:and(bronchospasms-13, phonophobia-18)
auxpass(investigated-20, were-19)
root(ROOT-0, investigated-20)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, penbutolol/NN significantly/RB reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP (IN at)
            (NP
              (NP (CD 2) (NNS hours))
              (PP (IN after)
                (NP (VBG dosing)))))
          (, ,)
          (NP (NN penbutolol))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNS bronchospasms))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(hours-7, at-5)
nummod(hours-7, 2-6)
nmod:at(reduced-13, hours-7)
case(dosing-9, after-8)
nmod:after(hours-7, dosing-9)
nsubj(reduced-13, penbutolol-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(bronchospasms-17, of-16)
nmod:of(risk-15, bronchospasms-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN penbutolol/NN may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN individuals/NNS suffering/VBG from/IN these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN penbutolol))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP (DT these) (NNS symptoms))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, penbutolol-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, suffering-14)
case(symptoms-17, from-15)
det(symptoms-17, these-16)
nmod:from(suffering-14, symptoms-17)

Further/RB research/NN is/VBZ needed/VBN to/TO confirm/VB these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN penbutolol/NN in/IN this/DT context/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB confirm)
                (NP (DT these) (NNS results))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP (NN penbutolol))))
                (PP (IN in)
                  (NP (DT this) (NN context)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(confirm-6, to-5)
ccomp(needed-4, confirm-6)
det(results-8, these-7)
dobj(confirm-6, results-8)
cc(confirm-6, and-9)
mark(determine-11, to-10)
ccomp(needed-4, determine-11)
conj:and(confirm-6, determine-11)
det(regimen-15, the-12)
amod(regimen-15, optimal-13)
amod(regimen-15, dosing-14)
dobj(determine-11, regimen-15)
case(penbutolol-17, for-16)
nmod:for(regimen-15, penbutolol-17)
case(context-20, in-18)
det(context-20, this-19)
nmod:in(determine-11, context-20)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/VB associated/VBN with/IN decreased/VBN Diosmetin/NNP levels/NNS in/IN hyperDiosmetinmic/JJ patients/NNS and/CC decreased/VBD risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (VB to_be)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (VBN decreased) (NNP Diosmetin) (NNS levels)))
                  (PP (IN in)
                    (NP (JJ hyperDiosmetinmic) (NNS patients)))))))))
      (CC and)
      (VP (VBD decreased)
        (NP
          (NP (NN risk))
          (PP (IN of)
            (NP
              (NP (VBG developing) (NN coronary_heart_disease))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-24, omega-3_fatty_acids-2)
nsubjpass(decreased-35, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
ccomp(shown-24, to_be-25)
dep(to_be-25, associated-26)
case(levels-30, with-27)
amod(levels-30, decreased-28)
compound(levels-30, Diosmetin-29)
nmod:with(associated-26, levels-30)
case(patients-33, in-31)
amod(patients-33, hyperDiosmetinmic-32)
nmod:in(associated-26, patients-33)
cc(shown-24, and-34)
conj:and(shown-24, decreased-35)
dobj(decreased-35, risk-36)
case(coronary_heart_disease-39, of-37)
amod(coronary_heart_disease-39, developing-38)
nmod:of(risk-36, coronary_heart_disease-39)
appos(coronary_heart_disease-39, CHD-41)

The/DT mechanism/NN behind/IN this/DT association/NN is/VBZ thought/VBN to_be/JJ related/VBN to/TO the/DT anti-inflammatory/JJ effects/NNS of/IN omega-3_fatty_acids/NN ,/, which/WDT can/MD reduce/VB the/DT production/NN of/IN pro-inflammatory/JJ cytokines/NNS and/CC chemokines/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN mechanism))
      (PP (IN behind)
        (NP (DT this) (NN association))))
    (VP (VBZ is)
      (VP (VBN thought)
        (ADJP (JJ to_be))
        (PP (VBN related)
          (PP (TO to)
            (NP
              (NP (DT the) (JJ anti-inflammatory) (NNS effects))
              (PP (IN of)
                (NP
                  (NP (NN omega-3_fatty_acids))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD can)
                        (VP (VB reduce)
                          (NP
                            (NP (DT the) (NN production))
                            (PP (IN of)
                              (NP (JJ pro-inflammatory) (NNS cytokines)
                                (CC and)
                                (NNS chemokines)))))))))))))))
    (. .)))

det(mechanism-2, The-1)
nsubjpass(thought-7, mechanism-2)
case(association-5, behind-3)
det(association-5, this-4)
nmod:behind(mechanism-2, association-5)
auxpass(thought-7, is-6)
root(ROOT-0, thought-7)
xcomp(thought-7, to_be-8)
case(effects-13, related-9)
case(effects-13, to-10)
det(effects-13, the-11)
amod(effects-13, anti-inflammatory-12)
advcl(thought-7, effects-13)
case(omega-3_fatty_acids-15, of-14)
nmod:of(effects-13, omega-3_fatty_acids-15)
nsubj(reduce-19, omega-3_fatty_acids-15)
ref(omega-3_fatty_acids-15, which-17)
aux(reduce-19, can-18)
acl:relcl(omega-3_fatty_acids-15, reduce-19)
det(production-21, the-20)
dobj(reduce-19, production-21)
case(cytokines-24, of-22)
amod(cytokines-24, pro-inflammatory-23)
nmod:of(production-21, cytokines-24)
cc(cytokines-24, and-25)
nmod:of(production-21, chemokines-26)
conj:and(cytokines-24, chemokines-26)

Additionally/RB ,/, omega-3_fatty_acids/NN may/MD improve/VB lipid/NN metabolism/NN by/IN reducing/VBG triglyceride_levels/NNS and/CC increasing/VBG high-density_lipoprotein_cholesterol/JJ levels/NNS ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP (NN omega-3_fatty_acids))
    (VP (MD may)
      (VP (VB improve)
        (NP (NN lipid) (NN metabolism))
        (PP (IN by)
          (S
            (VP
              (VP (VBG reducing)
                (NP (NNS triglyceride_levels)))
              (CC and)
              (VP (VBG increasing)
                (NP (JJ high-density_lipoprotein_cholesterol) (NNS levels))))))))
    (. .)))

advmod(improve-5, Additionally-1)
nsubj(improve-5, omega-3_fatty_acids-3)
aux(improve-5, may-4)
root(ROOT-0, improve-5)
compound(metabolism-7, lipid-6)
dobj(improve-5, metabolism-7)
mark(reducing-9, by-8)
advcl(improve-5, reducing-9)
dobj(reducing-9, triglyceride_levels-10)
cc(reducing-9, and-11)
advcl(improve-5, increasing-12)
conj:and(reducing-9, increasing-12)
amod(levels-14, high-density_lipoprotein_cholesterol-13)
dobj(increasing-12, levels-14)

The/DT evidence/NN supporting/VBG the/DT beneficial/JJ effects/NNS of/IN omega-3_fatty_acids/JJ on/IN cardiovascular_health/NN has/VBZ led/VBN to/TO recommendations/NNS for/IN increased/VBN consumption/NN of/IN these/DT nutrients/NNS through/IN dietary/JJ sources/NNS or/CC supplementation/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN evidence))
      (VP (VBG supporting)
        (NP
          (NP (DT the) (JJ beneficial) (NNS effects))
          (PP (IN of)
            (NP (JJ omega-3_fatty_acids)))
          (PP (IN on)
            (NP (NN cardiovascular_health))))))
    (VP (VBZ has)
      (VP (VBN led)
        (PP (TO to)
          (NP
            (NP (NNS recommendations))
            (PP (IN for)
              (NP
                (NP (VBN increased) (NN consumption))
                (PP (IN of)
                  (NP (DT these) (NNS nutrients)))))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NN supplementation)))))
    (. .)))

det(evidence-2, The-1)
nsubj(led-12, evidence-2)
acl(evidence-2, supporting-3)
det(effects-6, the-4)
amod(effects-6, beneficial-5)
dobj(supporting-3, effects-6)
case(omega-3_fatty_acids-8, of-7)
nmod:of(effects-6, omega-3_fatty_acids-8)
case(cardiovascular_health-10, on-9)
nmod:on(effects-6, cardiovascular_health-10)
aux(led-12, has-11)
root(ROOT-0, led-12)
case(recommendations-14, to-13)
nmod:to(led-12, recommendations-14)
case(consumption-17, for-15)
amod(consumption-17, increased-16)
nmod:for(recommendations-14, consumption-17)
case(nutrients-20, of-18)
det(nutrients-20, these-19)
nmod:of(consumption-17, nutrients-20)
case(sources-23, through-21)
amod(sources-23, dietary-22)
nmod:through(led-12, sources-23)
cc(sources-23, or-24)
nmod:through(led-12, supplementation-25)
conj:or(sources-23, supplementation-25)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ doses/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS doses))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(doses-17, optimal-16)
dobj(determine-15, doses-17)
case(populations-21, for-18)
amod(populations-21, different-19)
amod(populations-21, patient-20)
nmod:for(doses-17, populations-21)

Obesity/RB is_a/JJ major/JJ health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN various/JJ metabolic_disorders/NNS ,/, including/VBG type_2_diabetes/NNS ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS metabolic_disorders))
            (, ,)
            (VP (VBG including)
              (NP (NNS type_2_diabetes)))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(metabolic_disorders-12, with-10)
amod(metabolic_disorders-12, various-11)
nmod:with(associated-9, metabolic_disorders-12)
acl(metabolic_disorders-12, including-14)
dobj(including-14, type_2_diabetes-15)

Recent/JJ studies/NNS have/VBP suggested/VBN that/IN epigenetic/JJ modifications/NNS play/VBP a/DT key/JJ role/NN in/IN the/DT development/NN of/IN obesity/JJ and/CC associated/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP (JJ epigenetic) (NNS modifications))
            (VP (VBP play)
              (NP
                (NP (DT a) (JJ key) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (JJ obesity)
                        (CC and)
                        (JJ associated) (NNS metabolic_disorders)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(suggested-4, studies-2)
aux(suggested-4, have-3)
root(ROOT-0, suggested-4)
mark(play-8, that-5)
amod(modifications-7, epigenetic-6)
nsubj(play-8, modifications-7)
ccomp(suggested-4, play-8)
det(role-11, a-9)
amod(role-11, key-10)
dobj(play-8, role-11)
case(development-14, in-12)
det(development-14, the-13)
nmod:in(role-11, development-14)
case(metabolic_disorders-19, of-15)
amod(metabolic_disorders-19, obesity-16)
cc(obesity-16, and-17)
conj:and(obesity-16, associated-18)
amod(metabolic_disorders-19, associated-18)
nmod:of(development-14, metabolic_disorders-19)

DOT1-like/JJ protein/NN is_a/NN histone_methyltransferase/VBD that/DT has_been/NN implicated/VBN in/IN the/DT regulation/NN of/IN gene/NN expression/NN through/IN epigenetic/JJ modifications/NNS ./.

(ROOT
  (S
    (NP (JJ DOT1-like) (NN protein) (NN is_a))
    (VP (VBD histone_methyltransferase)
      (NP
        (NP (DT that) (NN has_been))
        (VP (VBN implicated)
          (PP (IN in)
            (NP
              (NP (DT the) (NN regulation))
              (PP (IN of)
                (NP (NN gene) (NN expression)))))))
      (PP (IN through)
        (NP (JJ epigenetic) (NNS modifications))))
    (. .)))

amod(is_a-3, DOT1-like-1)
compound(is_a-3, protein-2)
nsubj(histone_methyltransferase-4, is_a-3)
root(ROOT-0, histone_methyltransferase-4)
det(has_been-6, that-5)
dobj(histone_methyltransferase-4, has_been-6)
acl(has_been-6, implicated-7)
case(regulation-10, in-8)
det(regulation-10, the-9)
nmod:in(implicated-7, regulation-10)
case(expression-13, of-11)
compound(expression-13, gene-12)
nmod:of(regulation-10, expression-13)
case(modifications-16, through-14)
amod(modifications-16, epigenetic-15)
nmod:through(histone_methyltransferase-4, modifications-16)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN DOT1-like/NNS by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNS DOT1-like)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(DOT1-like-20, of-19)
nmod:of(hypersecretion-18, DOT1-like-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO investigate/VB this/DT relationship/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ EPZ-5676/NN on/IN the/DT secretion/NN of/IN DOT1-like/JJ and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB investigate)
          (NP (DT this) (NN relationship)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (JJ mmol/L) (NN EPZ-5676)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (JJ DOT1-like) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(investigate-2, To-1)
advcl(examined-7, investigate-2)
det(relationship-4, this-3)
dobj(investigate-2, relationship-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(EPZ-5676-17, 10-15)
amod(EPZ-5676-17, mmol/L-16)
nmod:of(effects-9, EPZ-5676-17)
conj:and(glucose-13, EPZ-5676-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
amod(and_insulin-23, DOT1-like-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN obese/JJ rats/NNS exhibited/VBD hypersecretion/NN of/IN DOT1-like/NNS compared/VBN to/TO lean/VB rats/NNS in/IN response/NN to/TO glucose/NN stimulation/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ obese) (NNS rats))
          (VP (VBD exhibited)
            (NP
              (NP (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NNS DOT1-like))
                  (VP (VBN compared)
                    (S
                      (VP (TO to)
                        (VP (VB lean)
                          (NP (NNS rats))
                          (PP (IN in)
                            (NP
                              (NP (NN response))
                              (PP (TO to)
                                (NP (NN glucose) (NN stimulation))))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(exhibited-7, that-4)
amod(rats-6, obese-5)
nsubj(exhibited-7, rats-6)
ccomp(showed-3, exhibited-7)
dobj(exhibited-7, hypersecretion-8)
case(DOT1-like-10, of-9)
nmod:of(hypersecretion-8, DOT1-like-10)
acl(DOT1-like-10, compared-11)
mark(lean-13, to-12)
xcomp(compared-11, lean-13)
dobj(lean-13, rats-14)
case(response-16, in-15)
nmod:in(lean-13, response-16)
case(stimulation-19, to-17)
compound(stimulation-19, glucose-18)
nmod:to(response-16, stimulation-19)

Treatment/NNP with/IN EPZ-5676/NNP ,/, a/DT specific/JJ inhibitor/NN of/IN DOT1-like/NNS ,/, resulted/VBD in_a/JJ significant/JJ decrease/NN in/IN insulin_secretion/NN in/IN both/DT lean/JJ and/CC obese/JJ rats/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Treatment))
        (PP (IN with)
          (NP (NNP EPZ-5676))))
      (, ,)
      (NP
        (NP (DT a) (JJ specific) (NN inhibitor))
        (PP (IN of)
          (NP (NNS DOT1-like))))
      (, ,))
    (VP (VBD resulted)
      (NP
        (NP (JJ in_a) (JJ significant) (NN decrease))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP (DT both)
          (ADJP (JJ lean)
            (CC and)
            (JJ obese))
          (NNS rats))))
    (. .)))

nsubj(resulted-11, Treatment-1)
case(EPZ-5676-3, with-2)
nmod:with(Treatment-1, EPZ-5676-3)
det(inhibitor-7, a-5)
amod(inhibitor-7, specific-6)
appos(Treatment-1, inhibitor-7)
case(DOT1-like-9, of-8)
nmod:of(inhibitor-7, DOT1-like-9)
root(ROOT-0, resulted-11)
amod(decrease-14, in_a-12)
amod(decrease-14, significant-13)
dobj(resulted-11, decrease-14)
case(insulin_secretion-16, in-15)
nmod:in(decrease-14, insulin_secretion-16)
case(rats-22, in-17)
det(rats-22, both-18)
amod(rats-22, lean-19)
cc(lean-19, and-20)
conj:and(lean-19, obese-21)
amod(rats-22, obese-21)
nmod:in(resulted-11, rats-22)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN DOT1-like/NNS may/MD contribute/VB to/TO the/DT development/NN of/IN obesity/JJ and/CC associated/JJ metabolic_disorders/NNS through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNS DOT1-like))))
          (VP (MD may)
            (VP (VB contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (JJ obesity)
                      (CC and)
                      (JJ associated) (NNS metabolic_disorders)))))
              (PP (IN through)
                (NP
                  (NP (PRP$ its) (NNS effects))
                  (PP (IN on)
                    (NP (NN insulin_secretion))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(contribute-9, that-4)
nsubj(contribute-9, hypersecretion-5)
case(DOT1-like-7, of-6)
nmod:of(hypersecretion-5, DOT1-like-7)
aux(contribute-9, may-8)
ccomp(suggest-3, contribute-9)
case(development-12, to-10)
det(development-12, the-11)
nmod:to(contribute-9, development-12)
case(metabolic_disorders-17, of-13)
amod(metabolic_disorders-17, obesity-14)
cc(obesity-14, and-15)
conj:and(obesity-14, associated-16)
amod(metabolic_disorders-17, associated-16)
nmod:of(development-12, metabolic_disorders-17)
case(effects-20, through-18)
nmod:poss(effects-20, its-19)
nmod:through(contribute-9, effects-20)
case(insulin_secretion-22, on-21)
nmod:on(effects-20, insulin_secretion-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS involved/VBN in/IN this/DT relationship/NN and/CC explore/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity-related/JJ metabolic_disorders/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (VBG underlying) (NNS mechanisms))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP (DT this) (NN relationship))))))
              (CC and)
              (VP (VB explore)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (JJ obesity-related) (NNS metabolic_disorders))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
nsubj:xsubj(explore-15, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, involved-10)
case(relationship-13, in-11)
det(relationship-13, this-12)
nmod:in(involved-10, relationship-13)
cc(elucidate-6, and-14)
xcomp(needed-4, explore-15)
conj:and(elucidate-6, explore-15)
amod(targets-18, potential-16)
amod(targets-18, therapeutic-17)
dobj(explore-15, targets-18)
case(metabolic_disorders-21, for-19)
amod(metabolic_disorders-21, obesity-related-20)
nmod:for(targets-18, metabolic_disorders-21)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/JJ -LRB-/-LRB- ALP/NNP -RRB-/-RRB- ,/, ambenonium_chloride/NN ,/, and/CC serum/NN DmAChE/NNP levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN correlation))
              (PP (IN between)
                (NP
                  (NP (NN serum) (NNS levels))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ alkaline_phosphatase)
                        (PP
                          (NP
                            (NP (-LRB- -LRB-) (NNP ALP) (-RRB- -RRB-))
                            (, ,)
                            (NP (NN ambenonium_chloride))
                            (, ,)
                            (CC and)
                            (NP (NN serum)))
                          (NP (NNP DmAChE))))
                      (NNS levels))))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(correlation-8, the-7)
dobj(investigate-6, correlation-8)
case(levels-11, between-9)
compound(levels-11, serum-10)
nmod:between(correlation-8, levels-11)
case(levels-23, of-12)
amod(levels-23, alkaline_phosphatase-13)
nmod(alkaline_phosphatase-13, ALP-15)
nmod(alkaline_phosphatase-13, ambenonium_chloride-18)
conj:and(ALP-15, ambenonium_chloride-18)
cc(ALP-15, and-20)
nmod(alkaline_phosphatase-13, serum-21)
conj:and(ALP-15, serum-21)
dep(ALP-15, DmAChE-22)
nmod:of(levels-11, levels-23)

A/DT total/NN of/IN 100/CD subjects/NNS were/VBD recruited/VBN for/IN the/DT study/NN ,/, and/CC their/PRP$ serum/NN levels/NNS of/IN ALP/NNP ,/, ambenonium_chloride/NN ,/, and/CC DmAChE/NNP were/VBD measured/VBN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN total))
        (PP (IN of)
          (NP (CD 100) (NNS subjects))))
      (VP (VBD were)
        (VP (VBN recruited)
          (PP (IN for)
            (NP (DT the) (NN study))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (PRP$ their) (NN serum) (NNS levels))
        (PP (IN of)
          (NP
            (NP (NNP ALP))
            (, ,)
            (NP (NN ambenonium_chloride))
            (, ,)
            (CC and)
            (NP (NNP DmAChE)))))
      (VP (VBD were)
        (VP (VBN measured))))
    (. .)))

det(total-2, A-1)
nsubjpass(recruited-7, total-2)
case(subjects-5, of-3)
nummod(subjects-5, 100-4)
nmod:of(total-2, subjects-5)
auxpass(recruited-7, were-6)
root(ROOT-0, recruited-7)
case(study-10, for-8)
det(study-10, the-9)
nmod:for(recruited-7, study-10)
cc(recruited-7, and-12)
nmod:poss(levels-15, their-13)
compound(levels-15, serum-14)
nsubjpass(measured-24, levels-15)
case(ALP-17, of-16)
nmod:of(levels-15, ALP-17)
nmod:of(levels-15, ambenonium_chloride-19)
conj:and(ALP-17, ambenonium_chloride-19)
cc(ALP-17, and-21)
nmod:of(levels-15, DmAChE-22)
conj:and(ALP-17, DmAChE-22)
auxpass(measured-24, were-23)
conj:and(recruited-7, measured-24)

The/DT results/NNS showed/VBD a/DT significant/JJ positive/JJ correlation/NN between/IN serum/NN levels/NNS of/IN ALP/NNP and/CC ambenonium_chloride/VBP with/IN serum/NN DmAChE/NNP levels/NNS -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/RB </VBP 0.01/CD ;/: r/SYM =/SYM 0.42/CD ,/, p/RB </VBP 0.01/CD respectively/RB -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP
      (VP (VBD showed)
        (NP
          (NP (DT a) (JJ significant) (JJ positive) (NN correlation))
          (PP (IN between)
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NNP ALP)))))))
      (CC and)
      (VP (VBP ambenonium_chloride)
        (PP (IN with)
          (NP
            (NP (NN serum) (NNP DmAChE) (NNS levels))
            (PRN (-LRB- -LRB-)
              (SBAR
                (X
                  (X (SYM r))
                  (NP (SYM =)))
                (S
                  (NP (CD 0.3))
                  (, ,)
                  (S
                    (SINV
                      (ADVP (RB p))
                      (VP (VBP <))
                      (NP (CD 0.01)))
                    (: ;)
                    (FRAG
                      (X
                        (X (SYM r))
                        (NP (SYM =)))
                      (NP (CD 0.42))))
                  (, ,)
                  (VP
                    (ADVP (RB p))
                    (VBP <)
                    (NP (CD 0.01))
                    (ADVP (RB respectively)))))
              (-RRB- -RRB-))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
nsubj(ambenonium_chloride-14, results-2)
root(ROOT-0, showed-3)
det(correlation-7, a-4)
amod(correlation-7, significant-5)
amod(correlation-7, positive-6)
dobj(showed-3, correlation-7)
case(levels-10, between-8)
compound(levels-10, serum-9)
nmod:between(correlation-7, levels-10)
case(ALP-12, of-11)
nmod:of(levels-10, ALP-12)
cc(showed-3, and-13)
conj:and(showed-3, ambenonium_chloride-14)
case(levels-18, with-15)
compound(levels-18, serum-16)
compound(levels-18, DmAChE-17)
nmod:with(ambenonium_chloride-14, levels-18)
dep(=-21, r-20)
dep(<-33, =-21)
nsubj(<-33, 0.3-22)
advmod(<-25, p-24)
dep(0.42-30, <-25)
nsubj(<-25, 0.01-26)
dep(=-29, r-28)
dep(0.42-30, =-29)
ccomp(<-33, 0.42-30)
advmod(<-33, p-32)
dep(levels-18, <-33)
dobj(<-33, 0.01-34)
advmod(<-33, respectively-35)

These/DT findings/NNS suggest/VBP that/IN there/EX may/MD be/VB a/DT potential/JJ link/NN between/IN these/DT biomarkers/NNS and/CC cholinergic/JJ activity/NN in/IN the/DT body/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (EX there))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ potential) (NN link))
                (PP (IN between)
                  (NP
                    (NP (DT these) (NNS biomarkers))
                    (CC and)
                    (NP (JJ cholinergic) (NN activity))))
                (PP (IN in)
                  (NP (DT the) (NN body)))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(link-10, that-4)
expl(link-10, there-5)
aux(link-10, may-6)
cop(link-10, be-7)
det(link-10, a-8)
amod(link-10, potential-9)
ccomp(suggest-3, link-10)
case(biomarkers-13, between-11)
det(biomarkers-13, these-12)
nmod:between(link-10, biomarkers-13)
cc(biomarkers-13, and-14)
amod(activity-16, cholinergic-15)
nmod:between(link-10, activity-16)
conj:and(biomarkers-13, activity-16)
case(body-19, in-17)
det(body-19, the-18)
nmod:in(link-10, body-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS of/IN this/DT association/NN and/CC its/PRP$ clinical/JJ implications/NNS for/IN diseases/NNS associated/VBN with/IN cholinergic_dysfunction/NN such/JJ as/IN Alzheimer/NNP 's/POS _/JJ disease/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (PP (IN of)
                  (NP
                    (NP (DT this) (NN association))
                    (CC and)
                    (NP
                      (NP (PRP$ its) (JJ clinical) (NNS implications))
                      (PP (IN for)
                        (NP
                          (NP (NNS diseases))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP
                                (NP (NN cholinergic_dysfunction))
                                (PP (JJ such) (IN as)
                                  (NP
                                    (NP (NNP Alzheimer) (POS 's))
                                    (JJ _) (NN disease)))))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
case(association-12, of-10)
det(association-12, this-11)
nmod:of(mechanisms-9, association-12)
cc(association-12, and-13)
nmod:poss(implications-16, its-14)
amod(implications-16, clinical-15)
nmod:of(mechanisms-9, implications-16)
conj:and(association-12, implications-16)
case(diseases-18, for-17)
nmod:for(implications-16, diseases-18)
acl(diseases-18, associated-19)
case(cholinergic_dysfunction-21, with-20)
nmod:with(associated-19, cholinergic_dysfunction-21)
case(disease-27, such-22)
mwe(such-22, as-23)
nmod:poss(disease-27, Alzheimer-24)
case(Alzheimer-24, 's-25)
amod(disease-27, _-26)
nmod:such_as(cholinergic_dysfunction-21, disease-27)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(fatty_acids-16, are-14)
amod(fatty_acids-16, essential-15)
root(ROOT-0, fatty_acids-16)
nsubjpass(associated-20, fatty_acids-16)
ref(fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(fatty_acids-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, numerous-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN RO5101576/NN levels/NNS in/IN hyperRO5101576mic/JJ patients/NNS ,/, which/WDT is_a/RB known/VBN risk/NN factor/NN for/IN the/DT development/NN of/IN coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN RO5101576) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hyperRO5101576mic) (NNS patients))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (ADVP (RB is_a))
                            (VP (VBN known)
                              (NP
                                (NP (NN risk) (NN factor))
                                (PP (IN for)
                                  (NP
                                    (NP
                                      (NP (DT the) (NN development))
                                      (PP (IN of)
                                        (NP (NN coronary_heart_disease))))
                                    (PRN (-LRB- -LRB-)
                                      (NP (NNP CHD))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(shown-4, associated-10)
case(levels-14, with-11)
amod(levels-14, decreased-12)
compound(levels-14, RO5101576-13)
nmod:with(associated-10, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperRO5101576mic-16)
nmod:in(levels-14, patients-17)
nsubj(known-21, patients-17)
ref(patients-17, which-19)
advmod(known-21, is_a-20)
acl:relcl(patients-17, known-21)
compound(factor-23, risk-22)
dobj(known-21, factor-23)
case(development-26, for-24)
det(development-26, the-25)
nmod:for(factor-23, development-26)
case(coronary_heart_disease-28, of-27)
nmod:of(development-26, coronary_heart_disease-28)
appos(development-26, CHD-30)

In/IN addition/NN ,/, diets/NNS rich/JJ in/IN EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO decrease/VB the/DT risk/NN of/IN developing/VBG CHD/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (NNS diets))
      (ADJP (JJ rich)
        (PP (IN in)
          (NP (NNP EPA)
            (CC and)
            (NNP DHA)))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB decrease)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (S
                      (VP (VBG developing)
                        (NP (NNP CHD))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-12, addition-2)
nsubjpass(found-12, diets-4)
nsubj:xsubj(decrease-14, diets-4)
amod(diets-4, rich-5)
case(EPA-7, in-6)
nmod:in(rich-5, EPA-7)
cc(EPA-7, and-8)
nmod:in(rich-5, DHA-9)
conj:and(EPA-7, DHA-9)
aux(found-12, have-10)
auxpass(found-12, been-11)
root(ROOT-0, found-12)
mark(decrease-14, to-13)
xcomp(found-12, decrease-14)
det(risk-16, the-15)
dobj(decrease-14, risk-16)
mark(developing-18, of-17)
acl(risk-16, developing-18)
dobj(developing-18, CHD-19)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC managing/VBG hyperRO5101576mia/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG managing)
                        (NP (NNS hyperRO5101576mia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(reducing-18, for-17)
acl(strategy-16, reducing-18)
det(risk-20, the-19)
dobj(reducing-18, risk-20)
case(CHD-22, of-21)
nmod:of(risk-20, CHD-22)
cc(reducing-18, and-23)
acl(strategy-16, managing-24)
conj:and(reducing-18, managing-24)
dobj(managing-24, hyperRO5101576mia-25)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ doses/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS doses))
                  (PP (IN for)
                    (NP (JJ therapeutic) (NN use))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
amod(doses-17, optimal-16)
dobj(determine-15, doses-17)
case(use-20, for-18)
amod(use-20, therapeutic-19)
nmod:for(doses-17, use-20)

This/DT study/NN investigated/VBD the/DT effects/NNS of/IN dirhamnolipid/NN on/IN tracheomalacia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (NN dirhamnolipid)))
        (PP (IN on)
          (NP
            (NP (NN tracheomalacia))
            (, ,)
            (NP (NN photophobia))
            (, ,)
            (CC and)
            (NP (NN phonophobia))))))
    (. .)))

det(study-2, This-1)
nsubj(investigated-3, study-2)
root(ROOT-0, investigated-3)
det(effects-5, the-4)
dobj(investigated-3, effects-5)
case(dirhamnolipid-7, of-6)
nmod:of(effects-5, dirhamnolipid-7)
case(tracheomalacia-9, on-8)
nmod:on(effects-5, tracheomalacia-9)
nmod:on(effects-5, photophobia-11)
conj:and(tracheomalacia-9, photophobia-11)
cc(tracheomalacia-9, and-13)
nmod:on(effects-5, phonophobia-14)
conj:and(tracheomalacia-9, phonophobia-14)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN in/IN which/WDT participants/NNS were/VBD administered/VBN a/DT single/JJ dose/NN of/IN dirhamnolipid/NN ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNS participants))
              (VP (VBD were)
                (VP (VBN administered)
                  (NP
                    (NP (DT a) (JJ single) (NN dose))
                    (PP (IN of)
                      (NP (NN dirhamnolipid)))))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
mark(administered-9, in-5)
dobj(administered-9, which-6)
nsubjpass(administered-9, participants-7)
auxpass(administered-9, were-8)
advcl(conducted-4, administered-9)
det(dose-12, a-10)
amod(dose-12, single-11)
dobj(administered-9, dose-12)
case(dirhamnolipid-14, of-13)
nmod:of(dose-12, dirhamnolipid-14)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD hours/NNS after/IN dosing/VBG ,/, dirhamnolipid/VBD reduced/VBN the/DT risk/NN of/IN tracheomalacia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/NN by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP
            (QP (IN at) (CD 2))
            (NNS hours))
          (VP
            (VP
              (PP (IN after)
                (S
                  (VP (VBG dosing))))
              (, ,) (VBD dirhamnolipid)
              (VP (VBN reduced)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NN tracheomalacia))))
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (SBAR
                          (S
                            (VP (VBP CI)
                              (NP
                                (NP
                                  (NP (CD 6-20) (NN %))
                                  (, ,)
                                  (NP (NNP P)))
                                (X
                                  (X (SYM =))
                                  (NP (CD 0.0005))))))))
                      (-RRB- -RRB-))))
                (, ,)
                (PP
                  (NP (NN photophobia))
                  (PP (IN by)
                    (NP (CD 17) (NN %)))
                  (PRN (-LRB- -LRB-)
                    (S
                      (NP (CD 95) (NN %))
                      (VP (VBP CI)
                        (NP (CD 12-22) (NN %))
                        (, ,)
                        (SBAR
                          (S
                            (NP (NNP P))
                            (VP (VBP <)
                              (NP (CD 0.0001)))))))
                    (-RRB- -RRB-)))))
            (, ,)
            (CC and)
            (VP (NN phonophobia)
              (PP (IN by)
                (NP
                  (NP (CD 14) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 95) (NN %))
                      (PP (NNP CI)
                        (NP (CD 17-20) (NN %))))
                    (, ,)
                    (NP (NNP P)
                      (QP (CD <) (CD 0.0001)))
                    (-RRB- -RRB-)))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(dirhamnolipid-11, that-4)
advmod(2-6, at-5)
nummod(hours-7, 2-6)
nsubj(dirhamnolipid-11, hours-7)
mark(dosing-9, after-8)
advcl(dirhamnolipid-11, dosing-9)
ccomp(showed-3, dirhamnolipid-11)
dep(dirhamnolipid-11, reduced-12)
det(risk-14, the-13)
dobj(reduced-12, risk-14)
case(tracheomalacia-16, of-15)
nmod:of(risk-14, tracheomalacia-16)
case(%-19, by-17)
nummod(%-19, 14-18)
nmod:by(reduced-12, %-19)
nummod(%-22, 95-21)
dep(%-19, %-22)
acl:relcl(%-22, CI-23)
nummod(%-25, 6-20-24)
dobj(CI-23, %-25)
appos(%-25, P-27)
dep(0.0005-29, =-28)
dep(%-25, 0.0005-29)
nmod(reduced-12, photophobia-32)
case(%-35, by-33)
nummod(%-35, 17-34)
nmod:by(photophobia-32, %-35)
nummod(%-38, 95-37)
nsubj(CI-39, %-38)
dep(photophobia-32, CI-39)
nummod(%-41, 12-22-40)
dobj(CI-39, %-41)
nsubj(<-44, P-43)
dep(CI-39, <-44)
dobj(<-44, 0.0001-45)
cc(dirhamnolipid-11, and-48)
ccomp(showed-3, phonophobia-49)
conj:and(dirhamnolipid-11, phonophobia-49)
case(%-52, by-50)
nummod(%-52, 14-51)
nmod:by(phonophobia-49, %-52)
nummod(%-55, 95-54)
appos(%-52, %-55)
dep(%-58, CI-56)
nummod(%-58, 17-20-57)
nmod(%-55, %-58)
dep(%-55, P-60)
compound(0.0001-62, <-61)
nummod(P-60, 0.0001-62)

These/DT findings/NNS suggest/VBP that/IN dirhamnolipid/NN may/MD have/VB potential/JJ therapeutic/JJ benefits/NNS for/IN individuals/NNS with/IN tracheomalacia/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN dirhamnolipid))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ potential) (JJ therapeutic) (NNS benefits))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP
                        (NP (NN tracheomalacia))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, dirhamnolipid-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(benefits-10, potential-8)
amod(benefits-10, therapeutic-9)
dobj(have-7, benefits-10)
case(individuals-12, for-11)
nmod:for(benefits-10, individuals-12)
case(tracheomalacia-14, with-13)
nmod:with(individuals-12, tracheomalacia-14)
nmod:with(individuals-12, photophobia-16)
conj:and(tracheomalacia-14, photophobia-16)
cc(tracheomalacia-14, and-18)
nmod:with(individuals-12, phonophobia-19)
conj:and(tracheomalacia-14, phonophobia-19)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO explore/VB the/DT clinical/JJ implications/NNS of/IN these/DT results/NNS and/CC to/TO determine/VB the/DT optimal/JJ dosing/JJ regimen/NN for/IN dirhamnolipid/NN in/IN these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ clinical) (NNS implications))
                  (PP (IN of)
                    (NP (DT these) (NNS results))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (JJ optimal) (JJ dosing) (NN regimen))
                  (PP (IN for)
                    (NP
                      (NP (NN dirhamnolipid))
                      (PP (IN in)
                        (NP (DT these) (NNS conditions))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(explore-6, to-5)
ccomp(warranted-4, explore-6)
det(implications-9, the-7)
amod(implications-9, clinical-8)
dobj(explore-6, implications-9)
case(results-12, of-10)
det(results-12, these-11)
nmod:of(implications-9, results-12)
cc(explore-6, and-13)
mark(determine-15, to-14)
ccomp(warranted-4, determine-15)
conj:and(explore-6, determine-15)
det(regimen-19, the-16)
amod(regimen-19, optimal-17)
amod(regimen-19, dosing-18)
dobj(determine-15, regimen-19)
case(dirhamnolipid-21, for-20)
nmod:for(regimen-19, dirhamnolipid-21)
case(conditions-24, in-22)
det(conditions-24, these-23)
nmod:in(dirhamnolipid-21, conditions-24)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT plasma/NN concentration/NN of/IN ISG12a/NNS during/IN intraduodenal/JJ administration/NN of/IN HS-113/JJ or/CC long-chain/JJ triglyceride/NN and/CC compare/VB it/PRP with/IN the/DT plasma/NN concentration/NN of/IN ISG12a/NNS during/IN intravenous/JJ administration/NN of/IN ISG12a/NNS at/IN 100/CD pmol/kg-h/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN plasma) (NN concentration))
                (PP (IN of)
                  (NP (NNS ISG12a))))
              (PP (IN during)
                (NP
                  (NP (JJ intraduodenal) (NN administration))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ HS-113)
                        (CC or)
                        (JJ long-chain))
                      (NN triglyceride))))))
            (CC and)
            (VP (VB compare)
              (NP (PRP it))
              (PP (IN with)
                (NP
                  (NP (DT the) (NN plasma) (NN concentration))
                  (PP (IN of)
                    (NP (NNS ISG12a)))))
              (PP (IN during)
                (NP
                  (NP (JJ intravenous) (NN administration))
                  (PP (IN of)
                    (NP (NNS ISG12a)))))))))
      (PP (IN at)
        (NP (CD 100) (NNS pmol/kg-h))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
nsubj:xsubj(compare-21, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(concentration-9, the-7)
compound(concentration-9, plasma-8)
dobj(investigate-6, concentration-9)
case(ISG12a-11, of-10)
nmod:of(concentration-9, ISG12a-11)
case(administration-14, during-12)
amod(administration-14, intraduodenal-13)
nmod:during(investigate-6, administration-14)
case(triglyceride-19, of-15)
amod(triglyceride-19, HS-113-16)
cc(HS-113-16, or-17)
conj:or(HS-113-16, long-chain-18)
amod(triglyceride-19, long-chain-18)
nmod:of(administration-14, triglyceride-19)
cc(investigate-6, and-20)
xcomp(aimed-4, compare-21)
conj:and(investigate-6, compare-21)
dobj(compare-21, it-22)
case(concentration-26, with-23)
det(concentration-26, the-24)
compound(concentration-26, plasma-25)
nmod:with(compare-21, concentration-26)
case(ISG12a-28, of-27)
nmod:of(concentration-26, ISG12a-28)
case(administration-31, during-29)
amod(administration-31, intravenous-30)
nmod:during(compare-21, administration-31)
case(ISG12a-33, of-32)
nmod:of(administration-31, ISG12a-33)
case(pmol/kg-h-36, at-34)
nummod(pmol/kg-h-36, 100-35)
nmod:at(aimed-4, pmol/kg-h-36)

The/DT results/NNS showed/VBD that/IN the/DT plasma/NN concentration/NN of/IN ISG12a/NNS during/IN intraduodenal/JJ administration/NN of/IN HS-113/NN -LRB-/-LRB- 150/CD +/NNS //: -/:

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (FRAG
          (NP
            (NP (DT the) (NN plasma) (NN concentration))
            (PP (IN of)
              (NP
                (NP (NNS ISG12a))
                (PP (IN during)
                  (NP (JJ intraduodenal) (NN administration)))))
            (PP (IN of)
              (NP
                (NP (NN HS-113))
                (-LRB- -LRB-)
                (NP (CD 150) (NNS +))
                (: /)))))))
    (: -)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(concentration-7, that-4)
det(concentration-7, the-5)
compound(concentration-7, plasma-6)
dep(showed-3, concentration-7)
case(ISG12a-9, of-8)
nmod:of(concentration-7, ISG12a-9)
case(administration-12, during-10)
amod(administration-12, intraduodenal-11)
nmod:during(ISG12a-9, administration-12)
case(HS-113-14, of-13)
nmod:of(concentration-7, HS-113-14)
nummod(+-17, 150-16)
dep(HS-113-14, +-17)

20/CD pg/ml/JJ -RRB-/-RRB- or/CC long-chain/JJ triglyceride/NN -LRB-/-LRB- 187/CD +/CD //: -/:

(ROOT
  (NP
    (NP
      (NP
        (NP (CD 20))
        (PRN
          (NP (JJ pg/ml)))
        (-RRB- -RRB-))
      (CC or)
      (NP
        (NP (JJ long-chain) (NN triglyceride))
        (-LRB- -LRB-)
        (NP
          (QP (CD 187) (CD +)))
        (: /)))
    (: -)))

root(ROOT-0, 20-1)
dep(20-1, pg/ml-2)
cc(20-1, or-4)
amod(triglyceride-6, long-chain-5)
conj:or(20-1, triglyceride-6)
compound(+-9, 187-8)
dep(triglyceride-6, +-9)

37/CD pg/ml/CD -RRB-/-RRB- was/VBD similar/JJ to/TO the/DT plasma/NN concentration/NN obtained/VBN during/IN intravenous/JJ administration/NN of/IN ISG12a/NNS at/IN 100/CD pmol/kg-h/NN ./.

(ROOT
  (S
    (VP
      (ADVP
        (ADVP (CD 37))
        (PRN
          (NP
            (QP (CD pg/ml)))
          (-RRB- -RRB-)))
      (VBD was)
      (NP
        (ADJP (JJ similar)
          (PP (TO to)
            (NP
              (NP (DT the) (NN plasma) (NN concentration))
              (VP (VBN obtained)
                (PP (IN during)
                  (NP
                    (NP (JJ intravenous) (NN administration))
                    (PP (IN of)
                      (NP (NNS ISG12a)))))
                (PP (IN at)
                  (NP (CD 100)))))))
        (NN pmol/kg-h)))
    (. .)))

advmod(pmol/kg-h-18, 37-1)
dep(37-1, pg/ml-2)
cop(pmol/kg-h-18, was-4)
amod(pmol/kg-h-18, similar-5)
case(concentration-9, to-6)
det(concentration-9, the-7)
compound(concentration-9, plasma-8)
nmod:to(similar-5, concentration-9)
acl(concentration-9, obtained-10)
case(administration-13, during-11)
amod(administration-13, intravenous-12)
nmod:during(obtained-10, administration-13)
case(ISG12a-15, of-14)
nmod:of(administration-13, ISG12a-15)
case(100-17, at-16)
nmod:at(obtained-10, 100-17)
root(ROOT-0, pmol/kg-h-18)

These/DT findings/NNS suggest/VBP that/IN intraduodenal/JJ administration/NN of/IN HS-113/JJ or/CC long-chain/JJ triglyceride/NN may/MD be/VB a/DT promising/JJ alternative/NN to/TO intravenous/JJ administration/NN for/IN achieving/VBG therapeutic/JJ levels/NNS of/IN ISG12a/NNS in/IN the/DT bloodstream/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ intraduodenal) (NN administration))
            (PP (IN of)
              (NP
                (ADJP (JJ HS-113)
                  (CC or)
                  (JJ long-chain))
                (NN triglyceride))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN alternative))
                (PP (TO to)
                  (NP (JJ intravenous) (NN administration))))
              (PP (IN for)
                (S
                  (VP (VBG achieving)
                    (NP
                      (NP (JJ therapeutic) (NNS levels))
                      (PP (IN of)
                        (NP
                          (NP (NNS ISG12a))
                          (PP (IN in)
                            (NP (DT the) (NN bloodstream))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(alternative-16, that-4)
amod(administration-6, intraduodenal-5)
nsubj(alternative-16, administration-6)
case(triglyceride-11, of-7)
amod(triglyceride-11, HS-113-8)
cc(HS-113-8, or-9)
conj:or(HS-113-8, long-chain-10)
amod(triglyceride-11, long-chain-10)
nmod:of(administration-6, triglyceride-11)
aux(alternative-16, may-12)
cop(alternative-16, be-13)
det(alternative-16, a-14)
amod(alternative-16, promising-15)
ccomp(suggest-3, alternative-16)
case(administration-19, to-17)
amod(administration-19, intravenous-18)
nmod:to(alternative-16, administration-19)
mark(achieving-21, for-20)
advcl(alternative-16, achieving-21)
amod(levels-23, therapeutic-22)
dobj(achieving-21, levels-23)
case(ISG12a-25, of-24)
nmod:of(levels-23, ISG12a-25)
case(bloodstream-28, in-26)
det(bloodstream-28, the-27)
nmod:in(ISG12a-25, bloodstream-28)

Further/JJ studies/NNS are/VBP warranted/VBN to/TO explore/VB the/DT potential/JJ clinical/JJ applications/NNS of/IN these/DT alternative/JJ routes/NNS of/IN drug/NN administration/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN warranted)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ potential) (JJ clinical) (NNS applications))
                (PP (IN of)
                  (NP
                    (NP (DT these) (JJ alternative) (NNS routes))
                    (PP (IN of)
                      (NP (NN drug) (NN administration)))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(warranted-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(warranted-4, are-3)
root(ROOT-0, warranted-4)
mark(explore-6, to-5)
xcomp(warranted-4, explore-6)
det(applications-10, the-7)
amod(applications-10, potential-8)
amod(applications-10, clinical-9)
dobj(explore-6, applications-10)
case(routes-14, of-11)
det(routes-14, these-12)
amod(routes-14, alternative-13)
nmod:of(applications-10, routes-14)
case(administration-17, of-15)
compound(administration-17, drug-16)
nmod:of(routes-14, administration-17)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ to/TO human/JJ health/NN and/CC have/VBP been/VBN linked/VBN to/TO a/DT range/NN of/IN health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP
      (VP (VBP are)
        (ADJP (JJ essential)
          (PP (TO to)
            (NP (JJ human) (NN health)))))
      (CC and)
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN linked)
            (PP (TO to)
              (NP
                (NP (DT a) (NN range))
                (PP (IN of)
                  (NP (NN health) (NNS benefits)))))))))
    (. .)))

nsubj(essential-15, Omega-3_fatty_acids-1)
nsubjpass(linked-22, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(essential-15, are-14)
root(ROOT-0, essential-15)
case(health-18, to-16)
amod(health-18, human-17)
nmod:to(essential-15, health-18)
cc(essential-15, and-19)
aux(linked-22, have-20)
auxpass(linked-22, been-21)
conj:and(essential-15, linked-22)
case(range-25, to-23)
det(range-25, a-24)
nmod:to(linked-22, range-25)
case(benefits-28, of-26)
compound(benefits-28, health-27)
nmod:of(range-25, benefits-28)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/JJ EPA/NNP and/CC DHA/NNP are/VBP associated/VBN with/IN decreased/VBN DHEC/NN levels/NNS in/IN hyperDHECmic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ long-chain) (JJ omega-3_fatty_acids) (NNP EPA))
              (CC and)
              (NP (NNP DHA)))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NN DHEC) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperDHECmic) (NNS patients)))))
                (, ,)
                (ADVP
                  (ADVP (RB as) (RB well))
                  (PP (IN as)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-12, that-5)
amod(EPA-8, long-chain-6)
amod(EPA-8, omega-3_fatty_acids-7)
nsubjpass(associated-12, EPA-8)
cc(EPA-8, and-9)
conj:and(EPA-8, DHA-10)
nsubjpass(associated-12, DHA-10)
auxpass(associated-12, are-11)
ccomp(shown-4, associated-12)
case(levels-16, with-13)
amod(levels-16, decreased-14)
compound(levels-16, DHEC-15)
nmod:with(associated-12, levels-16)
case(patients-19, in-17)
amod(patients-19, hyperDHECmic-18)
nmod:in(levels-16, patients-19)
advmod(associated-12, as-21)
mwe(as-21, well-22)
case(risk-26, as-23)
det(risk-26, a-24)
amod(risk-26, decreased-25)
nmod:as(as-21, risk-26)
mark(developing-28, of-27)
acl(risk-26, developing-28)
dobj(developing-28, coronary_heart_disease-29)
appos(risk-26, CHD-31)

The/DT mechanisms/NNS by/IN which/WDT these/DT effects/NNS occur/VBP are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC may/MD be/VB related/VBN to/TO the/DT anti-inflammatory/JJ properties/NNS of/IN omega-3_fatty_acids/JJ ./.

(ROOT
  (S
    (NP (DT The) (NNS mechanisms))
    (VP
      (VP
        (PP (IN by)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (DT these) (NNS effects))
              (VP (VBP occur)))))
        (VBP are)
        (ADVP (RB not) (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB be)
          (VP (VBN related)
            (PP (TO to)
              (NP
                (NP (DT the) (JJ anti-inflammatory) (NNS properties))
                (PP (IN of)
                  (NP (JJ omega-3_fatty_acids)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-12, mechanisms-2)
nsubjpass(related-17, mechanisms-2)
mark(occur-7, by-3)
dobj(occur-7, which-4)
det(effects-6, these-5)
nsubj(occur-7, effects-6)
advcl(understood-12, occur-7)
auxpass(understood-12, are-8)
dep(yet-10, not-9)
advmod(understood-12, yet-10)
advmod(understood-12, fully-11)
root(ROOT-0, understood-12)
cc(understood-12, but-14)
aux(related-17, may-15)
auxpass(related-17, be-16)
conj:but(understood-12, related-17)
case(properties-21, to-18)
det(properties-21, the-19)
amod(properties-21, anti-inflammatory-20)
nmod:to(related-17, properties-21)
case(omega-3_fatty_acids-23, of-22)
nmod:of(properties-21, omega-3_fatty_acids-23)

These/DT findings/NNS suggest/VBP that/IN increased/VBN intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN in/IN hyperDHECmic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBN increased) (NN intake))
            (PP (IN of)
              (NP (NNP EPA)
                (CC and)
                (NNP DHA))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP
                          (NP (JJ overall) (NN cardiovascular_health))
                          (PP (IN in)
                            (NP (JJ hyperDHECmic) (NNS patients))))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-6, increased-5)
nsubj(strategy-15, intake-6)
case(EPA-8, of-7)
nmod:of(intake-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(intake-6, DHA-10)
conj:and(EPA-8, DHA-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(risk-19, the-18)
dobj(reducing-17, risk-19)
case(CHD-21, of-20)
nmod:of(risk-19, CHD-21)
cc(reducing-17, and-22)
acl(strategy-15, improving-23)
conj:and(reducing-17, improving-23)
amod(cardiovascular_health-25, overall-24)
dobj(improving-23, cardiovascular_health-25)
case(patients-28, in-26)
amod(patients-28, hyperDHECmic-27)
nmod:in(cardiovascular_health-25, patients-28)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB understand)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ therapeutic) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
ccomp(needed-4, understand-7)
det(mechanisms-9, the-8)
dobj(understand-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(understand-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(understand-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(use-20, for-18)
amod(use-20, therapeutic-19)
nmod:for(determine-15, use-20)

In/IN this/DT study/NN ,/, the/DT effect/NN of/IN Azaperone/NNP on/IN the/DT risk/NN of/IN Tachypnea/NNP ,/, photophobia/NN ,/, and/CC phonophobia/NN was/VBD evaluated/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP
      (NP (DT the) (NN effect))
      (PP (IN of)
        (NP (NNP Azaperone)))
      (PP (IN on)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (NP
              (NP (NNP Tachypnea))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (VP (VBD was)
      (VP (VBN evaluated)))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(evaluated-20, study-3)
det(effect-6, the-5)
nsubjpass(evaluated-20, effect-6)
case(Azaperone-8, of-7)
nmod:of(effect-6, Azaperone-8)
case(risk-11, on-9)
det(risk-11, the-10)
nmod:on(effect-6, risk-11)
case(Tachypnea-13, of-12)
nmod:of(risk-11, Tachypnea-13)
nmod:of(risk-11, photophobia-15)
conj:and(Tachypnea-13, photophobia-15)
cc(Tachypnea-13, and-17)
nmod:of(risk-11, phonophobia-18)
conj:and(Tachypnea-13, phonophobia-18)
auxpass(evaluated-20, was-19)
root(ROOT-0, evaluated-20)

The/DT results/NNS showed/VBD that/IN at/IN 2/CD h/NN after/IN dosing/VBG ,/, Azaperone/NNP significantly/RB reduced/VBD the/DT risk/NN of/IN Tachypnea/NNP by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (PP
            (PP (IN at)
              (NP (CD 2) (NN h)))
            (PP (IN after)
              (S
                (VP (VBG dosing)))))
          (, ,)
          (NP (NNP Azaperone))
          (ADVP (RB significantly))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NNP Tachypnea))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-13, that-4)
case(h-7, at-5)
nummod(h-7, 2-6)
nmod:at(reduced-13, h-7)
mark(dosing-9, after-8)
nmod(h-7, dosing-9)
nsubj(reduced-13, Azaperone-11)
advmod(reduced-13, significantly-12)
ccomp(showed-3, reduced-13)
det(risk-15, the-14)
dobj(reduced-13, risk-15)
case(Tachypnea-17, of-16)
nmod:of(risk-15, Tachypnea-17)
case(%-20, by-18)
nummod(%-20, 14-19)
nmod:by(reduced-13, %-20)
nummod(%-23, 95-22)
dep(%-20, %-23)
acl:relcl(%-23, CI-24)
nummod(%-26, 6-20-25)
dobj(CI-24, %-26)
appos(%-26, P-28)
dep(0.0005-30, =-29)
dep(%-26, 0.0005-30)
xcomp(reduced-13, photophobia-33)
case(%-36, by-34)
nummod(%-36, 17-35)
nmod:by(photophobia-33, %-36)
nummod(%-39, 95-38)
appos(%-36, %-39)
dep(%-42, CI-40)
nummod(%-42, 12-22-41)
nmod(%-39, %-42)
dep(%-39, P-44)
compound(0.0001-46, <-45)
nummod(P-44, 0.0001-46)
cc(photophobia-33, and-49)
xcomp(reduced-13, phonophobia-50)
conj:and(photophobia-33, phonophobia-50)
case(%-53, by-51)
nummod(%-53, 14-52)
nmod:by(phonophobia-50, %-53)
nummod(%-56, 95-55)
appos(%-53, %-56)
dep(%-59, CI-57)
nummod(%-59, 17-20-58)
nmod(%-56, %-59)
dep(%-56, P-61)
compound(0.0001-63, <-62)
nummod(P-61, 0.0001-63)

These/DT findings/NNS suggest/VBP that/IN Azaperone/NNP may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS experiencing/VBG these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Azaperone))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Azaperone-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, experiencing-14)
det(symptoms-16, these-15)
dobj(experiencing-14, symptoms-16)

Further/JJ studies/NNS are/VBP needed/VBN to/TO evaluate/VB the/DT long-term/JJ efficacy/NN and/CC safety/NN of/IN Azaperone/NNP in/IN treating/VBG these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB evaluate)
              (NP
                (NP (DT the) (JJ long-term) (NN efficacy)
                  (CC and)
                  (NN safety))
                (PP (IN of)
                  (NP (NNP Azaperone))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(evaluate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(evaluate-6, to-5)
xcomp(needed-4, evaluate-6)
det(efficacy-9, the-7)
amod(efficacy-9, long-term-8)
dobj(evaluate-6, efficacy-9)
cc(efficacy-9, and-10)
dobj(evaluate-6, safety-11)
conj:and(efficacy-9, safety-11)
case(Azaperone-13, of-12)
nmod:of(efficacy-9, Azaperone-13)
mark(treating-15, in-14)
advcl(evaluate-6, treating-15)
det(conditions-17, these-16)
dobj(treating-15, conditions-17)

Omega-3_fatty_acids/NNS ,/, such/JJ as/IN eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-17, Omega-3_fatty_acids-1)
nsubj:xsubj(have-19, Omega-3_fatty_acids-1)
case(EPA-7, such-3)
mwe(such-3, as-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
nmod:such_as(Omega-3_fatty_acids-1, EPA-7)
cc(EPA-7, and-9)
nmod:such_as(Omega-3_fatty_acids-1, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
mark(have-19, to-18)
xcomp(shown-17, have-19)
amod(benefits-22, numerous-20)
compound(benefits-22, health-21)
dobj(have-19, benefits-22)

One/CD of/IN these/DT benefits/NNS is/VBZ the/DT potential/NN to/TO decrease/VB nicotinamide_riboside/JJ -LRB-/-LRB- niceritrol/JJ -RRB-/-RRB- levels/NNS in/IN hyperniceritrolemic/JJ patients/NNS ,/, as/RB well/RB as/IN reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP (DT these) (NNS benefits))))
    (VP (VBZ is)
      (NP (DT the) (NN potential)
        (S
          (VP (TO to)
            (VP
              (VP (VB decrease)
                (NP (JJ nicotinamide_riboside)
                  (PRN (-LRB- -LRB-) (JJ niceritrol) (-RRB- -RRB-))
                  (NNS levels))
                (PP (IN in)
                  (NP (JJ hyperniceritrolemic) (NNS patients))))
              (, ,)
              (CONJP (RB as) (RB well) (IN as))
              (VP (VB reduce)
                (NP
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (S
                        (VP (VBG developing)
                          (NP (NN coronary_heart_disease))))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP CHD))
                    (-RRB- -RRB-)))))))))
    (. .)))

nsubj(potential-7, One-1)
case(benefits-4, of-2)
det(benefits-4, these-3)
nmod:of(One-1, benefits-4)
cop(potential-7, is-5)
det(potential-7, the-6)
root(ROOT-0, potential-7)
mark(decrease-9, to-8)
acl(potential-7, decrease-9)
amod(levels-14, nicotinamide_riboside-10)
dep(levels-14, niceritrol-12)
dobj(decrease-9, levels-14)
case(patients-17, in-15)
amod(patients-17, hyperniceritrolemic-16)
nmod:in(decrease-9, patients-17)
cc(decrease-9, as-19)
mwe(as-19, well-20)
mwe(as-19, as-21)
acl(potential-7, reduce-22)
conj:and(decrease-9, reduce-22)
det(risk-24, the-23)
dobj(reduce-22, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

EPA/NNP and/CC DHA/NNP are/VBP long-chain/JJ omega-3_fatty_acids/NN that/WDT have/VBP been/VBN found/VBN to_be/JJ particularly/RB effective/JJ in/IN improving/VBG cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (S
        (NP
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP have)
                (VP (VBN been)
                  (VP (VBN found)
                    (ADJP (JJ to_be))))))))
        (ADJP (RB particularly) (JJ effective)
          (PP (IN in)
            (S
              (VP (VBG improving)
                (NP (NN cardiovascular_health))))))))
    (. .)))

nsubj(are-4, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubj(are-4, DHA-3)
root(ROOT-0, are-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubjpass(found-10, omega-3_fatty_acids-6)
nsubj(effective-13, omega-3_fatty_acids-6)
ref(omega-3_fatty_acids-6, that-7)
aux(found-10, have-8)
auxpass(found-10, been-9)
acl:relcl(omega-3_fatty_acids-6, found-10)
xcomp(found-10, to_be-11)
advmod(effective-13, particularly-12)
xcomp(are-4, effective-13)
mark(improving-15, in-14)
advcl(effective-13, improving-15)
dobj(improving-15, cardiovascular_health-16)

Studies/NNPS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS can/MD help/VB lower/JJR blood_pressure/NN ,/, reduce/VB inflammation/NN ,/, and/CC improve/VB lipid/NN profiles/NNS ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD can)
              (VP
                (VP (VB help)
                  (NP (JJR lower) (NN blood_pressure)))
                (, ,)
                (VP
                  (VP (VB reduce)
                    (NP (NN inflammation)))
                  (, ,)
                  (CC and)
                  (VP (VB improve)
                    (NP (NN lipid) (NNS profiles))))))))))
    (. .)))

nsubj(shown-3, Studies-1)
aux(shown-3, have-2)
root(ROOT-0, shown-3)
mark(help-8, that-4)
det(fatty_acids-6, these-5)
nsubj(help-8, fatty_acids-6)
aux(help-8, can-7)
ccomp(shown-3, help-8)
amod(blood_pressure-10, lower-9)
dobj(help-8, blood_pressure-10)
dep(help-8, reduce-12)
dobj(reduce-12, inflammation-13)
cc(reduce-12, and-15)
dep(help-8, improve-16)
conj:and(reduce-12, improve-16)
compound(profiles-18, lipid-17)
dobj(improve-16, profiles-18)

In/IN addition/NN ,/, they/PRP may/MD also/RB play/VB a/DT role/NN in/IN reducing/VBG the/DT risk/NN of/IN other/JJ chronic_diseases/NNS such/JJ as/IN diabetes/NN ,/, cancer/NN ,/, and/CC Alzheimer/NNP 's/POS _/JJ disease/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP they))
    (VP (MD may) (RB also)
      (VP (VB play)
        (NP
          (NP (DT a) (NN role))
          (PP (IN in)
            (S
              (VP (VBG reducing)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP
                      (NP (JJ other) (NNS chronic_diseases))
                      (PP (JJ such) (IN as)
                        (NP
                          (NP (NN diabetes))
                          (, ,)
                          (NP (NN cancer))
                          (, ,)
                          (CC and)
                          (NP
                            (NP (NNP Alzheimer) (POS 's))
                            (JJ _) (NN disease)))))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(play-7, addition-2)
nsubj(play-7, they-4)
aux(play-7, may-5)
advmod(play-7, also-6)
root(ROOT-0, play-7)
det(role-9, a-8)
dobj(play-7, role-9)
mark(reducing-11, in-10)
acl(role-9, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(chronic_diseases-16, of-14)
amod(chronic_diseases-16, other-15)
nmod:of(risk-13, chronic_diseases-16)
case(diabetes-19, such-17)
mwe(such-17, as-18)
nmod:such_as(chronic_diseases-16, diabetes-19)
nmod:such_as(chronic_diseases-16, cancer-21)
conj:and(diabetes-19, cancer-21)
cc(diabetes-19, and-23)
nmod:poss(disease-27, Alzheimer-24)
case(Alzheimer-24, 's-25)
amod(disease-27, _-26)
nmod:such_as(chronic_diseases-16, disease-27)
conj:and(diabetes-19, disease-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB an/DT effective/JJ strategy/NN for/IN improving/VBG overall/JJ health/NN outcomes/NNS and/CC reducing/VBG the/DT risk/NN of/IN CHD/NNP in/IN high-risk/JJ patients/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG improving)
                        (NP (JJ overall) (NN health) (NNS outcomes)))
                      (CC and)
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN risk))
                          (PP (IN of)
                            (NP (NNP CHD))))
                        (PP (IN in)
                          (NP (JJ high-risk) (NNS patients)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-16, that-4)
csubj(strategy-16, increasing-5)
det(intake-7, the-6)
dobj(increasing-5, intake-7)
case(EPA-9, of-8)
nmod:of(intake-7, EPA-9)
cc(EPA-9, and-10)
nmod:of(intake-7, DHA-11)
conj:and(EPA-9, DHA-11)
aux(strategy-16, may-12)
cop(strategy-16, be-13)
det(strategy-16, an-14)
amod(strategy-16, effective-15)
ccomp(suggest-3, strategy-16)
mark(improving-18, for-17)
acl(strategy-16, improving-18)
amod(outcomes-21, overall-19)
compound(outcomes-21, health-20)
dobj(improving-18, outcomes-21)
cc(improving-18, and-22)
acl(strategy-16, reducing-23)
conj:and(improving-18, reducing-23)
det(risk-25, the-24)
dobj(reducing-23, risk-25)
case(CHD-27, of-26)
nmod:of(risk-25, CHD-27)
case(patients-30, in-28)
amod(patients-30, high-risk-29)
nmod:in(reducing-23, patients-30)

The/DT present/JJ study/NN aimed/VBD to/TO investigate/VB the/DT potential/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN ,/, pyridoxine_phosphate/NN ,/, and/CC serum/JJ pyridoxal_kinase/JJ levels/NNS ./.

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (JJ potential) (NN correlation))
              (PP (IN between)
                (NP
                  (NP (NN serum) (NNS levels))
                  (PP (IN of)
                    (NP
                      (NP (NN alkaline_phosphatase))
                      (, ,)
                      (NP (NN pyridoxine_phosphate))
                      (, ,)
                      (CC and)
                      (NP (JJ serum) (JJ pyridoxal_kinase) (NNS levels)))))))))))
    (. .)))

det(study-3, The-1)
amod(study-3, present-2)
nsubj(aimed-4, study-3)
nsubj:xsubj(investigate-6, study-3)
root(ROOT-0, aimed-4)
mark(investigate-6, to-5)
xcomp(aimed-4, investigate-6)
det(correlation-9, the-7)
amod(correlation-9, potential-8)
dobj(investigate-6, correlation-9)
case(levels-12, between-10)
compound(levels-12, serum-11)
nmod:between(correlation-9, levels-12)
case(alkaline_phosphatase-14, of-13)
nmod:of(levels-12, alkaline_phosphatase-14)
nmod:of(levels-12, pyridoxine_phosphate-16)
conj:and(alkaline_phosphatase-14, pyridoxine_phosphate-16)
cc(alkaline_phosphatase-14, and-18)
amod(levels-21, serum-19)
amod(levels-21, pyridoxal_kinase-20)
nmod:of(levels-12, levels-21)
conj:and(alkaline_phosphatase-14, levels-21)

The/DT study/NN involved/VBD a/DT sample/NN of/IN 100/CD participants/NNS with/IN varying/VBG medical/JJ conditions/NNS ./.

(ROOT
  (S
    (NP (DT The) (NN study))
    (VP (VBD involved)
      (NP
        (NP (DT a) (NN sample))
        (PP (IN of)
          (NP (CD 100) (NNS participants))))
      (PP (IN with)
        (S
          (VP (VBG varying)
            (NP (JJ medical) (NNS conditions))))))
    (. .)))

det(study-2, The-1)
nsubj(involved-3, study-2)
root(ROOT-0, involved-3)
det(sample-5, a-4)
dobj(involved-3, sample-5)
case(participants-8, of-6)
nummod(participants-8, 100-7)
nmod:of(sample-5, participants-8)
mark(varying-10, with-9)
advcl(involved-3, varying-10)
amod(conditions-12, medical-11)
dobj(varying-10, conditions-12)

The/DT results/NNS showed/VBD a/DT significant/JJ correlation/NN between/IN serum/NN levels/NNS of/IN alkaline_phosphatase/NN and/CC pyridoxine_phosphate/NN -LRB-/-LRB- r/SYM =/SYM 0.3/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- as/IN well/RB as/RB between/IN pyridoxine_phosphate/JJ and/CC serum/NN pyridoxal_kinase/NN levels/NNS -LRB-/-LRB- r/SYM =/SYM 0.42/CD ,/, p/NN </VBP 0.01/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN correlation))
        (PP (IN between)
          (NP
            (NP
              (NP (NN serum) (NNS levels))
              (PP (IN of)
                (NP (NN alkaline_phosphatase)
                  (CC and)
                  (NN pyridoxine_phosphate))))
            (PRN (-LRB- -LRB-)
              (SBAR
                (X (SYM r))
                (S
                  (FRAG
                    (X (SYM =))
                    (NP (CD 0.3)))
                  (, ,)
                  (NP (NN p))
                  (VP (VBP <)
                    (NP (CD 0.01)))))
              (-RRB- -RRB-)))))
      (PP (IN as)
        (NP
          (NP
            (QP (RB well) (RB as) (IN between) (JJ pyridoxine_phosphate)))
          (CC and)
          (NP
            (NP (NN serum) (NN pyridoxal_kinase) (NNS levels))
            (PRN (-LRB- -LRB-)
              (SBAR
                (X (SYM r))
                (S
                  (FRAG
                    (X (SYM =))
                    (NP (CD 0.42)))
                  (, ,)
                  (NP (NN p))
                  (VP (VBP <)
                    (NP (CD 0.01)))))
              (-RRB- -RRB-))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
det(correlation-6, a-4)
amod(correlation-6, significant-5)
dobj(showed-3, correlation-6)
case(levels-9, between-7)
compound(levels-9, serum-8)
nmod:between(correlation-6, levels-9)
case(alkaline_phosphatase-11, of-10)
nmod:of(levels-9, alkaline_phosphatase-11)
cc(alkaline_phosphatase-11, and-12)
nmod:of(levels-9, pyridoxine_phosphate-13)
conj:and(alkaline_phosphatase-11, pyridoxine_phosphate-13)
dep(<-20, r-15)
dep(0.3-17, =-16)
dep(<-20, 0.3-17)
nsubj(<-20, p-19)
dep(levels-9, <-20)
dobj(<-20, 0.01-21)
case(pyridoxine_phosphate-27, as-23)
advmod(pyridoxine_phosphate-27, well-24)
advmod(pyridoxine_phosphate-27, as-25)
advmod(pyridoxine_phosphate-27, between-26)
nmod:as(showed-3, pyridoxine_phosphate-27)
cc(pyridoxine_phosphate-27, and-28)
compound(levels-31, serum-29)
compound(levels-31, pyridoxal_kinase-30)
nmod:as(showed-3, levels-31)
conj:and(pyridoxine_phosphate-27, levels-31)
dep(<-38, r-33)
dep(0.42-35, =-34)
dep(<-38, 0.42-35)
nsubj(<-38, p-37)
dep(levels-31, <-38)
dobj(<-38, 0.01-39)

These/DT findings/NNS suggest/VBP that/IN changes/NNS in/IN serum_alkaline_phosphatase/JJ and/CC pyridoxine_phosphate/JJ levels/NNS may/MD be/VB indicative/JJ of/IN altered/JJ metabolism/NN or/CC disease/NN processes/NNS affecting/VBG vitamin_B6/JJ status/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNS changes))
            (PP (IN in)
              (NP
                (ADJP (JJ serum_alkaline_phosphatase)
                  (CC and)
                  (JJ pyridoxine_phosphate))
                (NNS levels))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (JJ indicative))
                (PP (IN of)
                  (NP
                    (NP (JJ altered) (NN metabolism)
                      (CC or)
                      (NN disease) (NNS processes))
                    (VP (VBG affecting)
                      (NP (JJ vitamin_B6) (NN status)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(indicative-13, that-4)
nsubj(indicative-13, changes-5)
case(levels-10, in-6)
amod(levels-10, serum_alkaline_phosphatase-7)
cc(serum_alkaline_phosphatase-7, and-8)
conj:and(serum_alkaline_phosphatase-7, pyridoxine_phosphate-9)
amod(levels-10, pyridoxine_phosphate-9)
nmod:in(changes-5, levels-10)
aux(indicative-13, may-11)
cop(indicative-13, be-12)
ccomp(suggest-3, indicative-13)
case(metabolism-16, of-14)
amod(metabolism-16, altered-15)
nmod:of(indicative-13, metabolism-16)
cc(metabolism-16, or-17)
compound(processes-19, disease-18)
nmod:of(indicative-13, processes-19)
conj:or(metabolism-16, processes-19)
acl(metabolism-16, affecting-20)
amod(status-22, vitamin_B6-21)
dobj(affecting-20, status-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT clinical/JJ significance/NN of/IN these/DT correlations/NNS in/IN specific/JJ patient/JJ populations/NNS and/CC to/TO determine/VB whether/IN interventions/NNS targeting/VBG these/DT biomarkers/NNS can/MD improve/VB health/NN outcomes/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ clinical) (NN significance))
                  (PP (IN of)
                    (NP
                      (NP (DT these) (NNS correlations))
                      (PP (IN in)
                        (NP (JJ specific) (JJ patient) (NNS populations))))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (SBAR (IN whether)
                  (S
                    (NP
                      (NP (NNS interventions))
                      (VP (VBG targeting)
                        (NP (DT these) (NNS biomarkers))))
                    (VP (MD can)
                      (VP (VB improve)
                        (NP (NN health) (NNS outcomes))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(significance-9, the-7)
amod(significance-9, clinical-8)
dobj(explore-6, significance-9)
case(correlations-12, of-10)
det(correlations-12, these-11)
nmod:of(significance-9, correlations-12)
case(populations-16, in-13)
amod(populations-16, specific-14)
amod(populations-16, patient-15)
nmod:in(correlations-12, populations-16)
cc(explore-6, and-17)
mark(determine-19, to-18)
ccomp(needed-4, determine-19)
conj:and(explore-6, determine-19)
mark(improve-26, whether-20)
nsubj(improve-26, interventions-21)
acl(interventions-21, targeting-22)
det(biomarkers-24, these-23)
dobj(targeting-22, biomarkers-24)
aux(improve-26, can-25)
ccomp(determine-19, improve-26)
compound(outcomes-28, health-27)
dobj(improve-26, outcomes-28)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT have/VBP been/VBN associated/VBN with/IN numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (ADVP (RB specifically))
        (VBN eicosapentaenoic_acid)
        (NP
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN associated)
                  (PP (IN with)
                    (NP (JJ numerous) (NN health) (NNS benefits))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-16, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
acl(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
cc(EPA-6, and-8)
dobj(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(polyunsaturated_fatty_acids-16, are-14)
amod(polyunsaturated_fatty_acids-16, essential-15)
root(ROOT-0, polyunsaturated_fatty_acids-16)
nsubjpass(associated-20, polyunsaturated_fatty_acids-16)
ref(polyunsaturated_fatty_acids-16, that-17)
aux(associated-20, have-18)
auxpass(associated-20, been-19)
acl:relcl(polyunsaturated_fatty_acids-16, associated-20)
case(benefits-24, with-21)
amod(benefits-24, numerous-22)
compound(benefits-24, health-23)
nmod:with(associated-20, benefits-24)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN long-chain/JJ omega-3_fatty_acids/NN can/MD decrease/VB Topiroxostat/JJ levels/NNS in/IN hyperTopiroxostatmic/JJ patients/NNS and/CC reduce/VB the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (JJ long-chain) (NN omega-3_fatty_acids))
            (VP (MD can)
              (VP
                (VP (VB decrease)
                  (NP
                    (NP (JJ Topiroxostat) (NNS levels))
                    (PP (IN in)
                      (NP (JJ hyperTopiroxostatmic) (NNS patients)))))
                (CC and)
                (VP (VB reduce)
                  (NP
                    (NP
                      (NP (DT the) (NN risk))
                      (PP (IN of)
                        (S
                          (VP (VBG developing)
                            (NP (NN coronary_heart_disease))))))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CHD))
                      (-RRB- -RRB-))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(decrease-9, that-5)
amod(omega-3_fatty_acids-7, long-chain-6)
nsubj(decrease-9, omega-3_fatty_acids-7)
nsubj(reduce-16, omega-3_fatty_acids-7)
aux(decrease-9, can-8)
ccomp(shown-4, decrease-9)
amod(levels-11, Topiroxostat-10)
dobj(decrease-9, levels-11)
case(patients-14, in-12)
amod(patients-14, hyperTopiroxostatmic-13)
nmod:in(levels-11, patients-14)
cc(decrease-9, and-15)
ccomp(shown-4, reduce-16)
conj:and(decrease-9, reduce-16)
det(risk-18, the-17)
dobj(reduce-16, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, coronary_heart_disease-21)
appos(risk-18, CHD-23)

EPA/NNP and/CC DHA/NNP are/VBP believed/VBN to/TO exert/VB their/PRP$ cardioprotective/JJ effects/NNS by/IN reducing/VBG inflammation/NN ,/, improving/VBG lipid/NN metabolism/NN ,/, decreasing/VBG blood_pressure/NN ,/, and/CC reducing/VBG the/DT risk/NN of/IN arrhythmias/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN believed)
        (S
          (VP (TO to)
            (VP (VB exert)
              (NP (PRP$ their) (JJ cardioprotective) (NNS effects))
              (PP (IN by)
                (S
                  (VP
                    (VP (VBG reducing)
                      (NP (NN inflammation)))
                    (, ,)
                    (VP (VBG improving)
                      (NP (NN lipid) (NN metabolism)))
                    (, ,)
                    (VP (VBG decreasing)
                      (NP (NN blood_pressure)))
                    (, ,)
                    (CC and)
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (NP (NNS arrhythmias)))))))))))))
    (. .)))

nsubjpass(believed-5, EPA-1)
nsubj:xsubj(exert-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(believed-5, DHA-3)
nsubj:xsubj(exert-7, DHA-3)
auxpass(believed-5, are-4)
root(ROOT-0, believed-5)
mark(exert-7, to-6)
xcomp(believed-5, exert-7)
nmod:poss(effects-10, their-8)
amod(effects-10, cardioprotective-9)
dobj(exert-7, effects-10)
mark(reducing-12, by-11)
advcl(exert-7, reducing-12)
dobj(reducing-12, inflammation-13)
advcl(exert-7, improving-15)
conj:and(reducing-12, improving-15)
compound(metabolism-17, lipid-16)
dobj(improving-15, metabolism-17)
advcl(exert-7, decreasing-19)
conj:and(reducing-12, decreasing-19)
dobj(decreasing-19, blood_pressure-20)
cc(reducing-12, and-22)
advcl(exert-7, reducing-23)
conj:and(reducing-12, reducing-23)
det(risk-25, the-24)
dobj(reducing-23, risk-25)
case(arrhythmias-27, of-26)
nmod:of(risk-25, arrhythmias-27)

These/DT findings/NNS suggest/VBP that/IN increasing/VBG dietary/JJ intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT incidence/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (JJ dietary) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN strategy))
                (PP (IN for)
                  (S
                    (VP
                      (VP (VBG reducing)
                        (NP
                          (NP (DT the) (NN incidence))
                          (PP (IN of)
                            (NP (NNP CHD)))))
                      (CC and)
                      (VP (VBG improving)
                        (NP (JJ overall) (NN cardiovascular_health))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(strategy-15, that-4)
amod(intake-7, increasing-5)
amod(intake-7, dietary-6)
nsubj(strategy-15, intake-7)
case(omega-3_fatty_acids-10, of-8)
amod(omega-3_fatty_acids-10, long-chain-9)
nmod:of(intake-7, omega-3_fatty_acids-10)
aux(strategy-15, may-11)
cop(strategy-15, be-12)
det(strategy-15, an-13)
amod(strategy-15, effective-14)
ccomp(suggest-3, strategy-15)
mark(reducing-17, for-16)
acl(strategy-15, reducing-17)
det(incidence-19, the-18)
dobj(reducing-17, incidence-19)
case(CHD-21, of-20)
nmod:of(incidence-19, CHD-21)
cc(reducing-17, and-22)
acl(strategy-15, improving-23)
conj:and(reducing-17, improving-23)
amod(cardiovascular_health-25, overall-24)
dobj(improving-23, cardiovascular_health-25)

Further/RB research/NN is/VBZ needed/VBN to/TO elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN different/JJ patient/JJ populations/NNS ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (JJ optimal) (NNS dosages))
                  (PP (IN for)
                    (NP (JJ different) (JJ patient) (NNS populations))))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
ccomp(needed-4, elucidate-6)
det(mechanisms-8, the-7)
dobj(elucidate-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effects-11, these-10)
dobj(underlying-9, effects-11)
cc(elucidate-6, and-12)
mark(determine-14, to-13)
ccomp(needed-4, determine-14)
conj:and(elucidate-6, determine-14)
amod(dosages-16, optimal-15)
dobj(determine-14, dosages-16)
case(populations-20, for-17)
amod(populations-20, different-18)
amod(populations-20, patient-19)
nmod:for(dosages-16, populations-20)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-18, omega-3_fatty_acids-2)
acl(omega-3_fatty_acids-2, including-4)
advmod(EPA-7, eicosapentaenoic_acid-5)
dobj(including-4, EPA-7)
cc(EPA-7, and-9)
dobj(including-4, docosahexaenoic_acid-10)
conj:and(EPA-7, docosahexaenoic_acid-10)
appos(EPA-7, DHA-12)
aux(studied-18, have-15)
auxpass(studied-18, been-16)
advmod(studied-18, extensively-17)
root(ROOT-0, studied-18)
case(benefits-23, for-19)
nmod:poss(benefits-23, their-20)
amod(benefits-23, potential-21)
compound(benefits-23, health-22)
nmod:for(studied-18, benefits-23)

In/IN particular/JJ ,/, research/NN has/VBZ shown/VBN that/IN these/DT fatty_acids/NNS may/MD play/VB a/DT role/NN in/IN decreasing/VBG clozapine/JJ levels/NNS in/IN hyperclozapinmic/JJ patients/NNS and/CC reducing/VBG the/DT risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (NP (NN research))
    (VP (VBZ has)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (MD may)
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN in)
                    (S
                      (VP
                        (VP (VBG decreasing)
                          (NP
                            (NP (JJ clozapine) (NNS levels))
                            (PP (IN in)
                              (NP (JJ hyperclozapinmic) (NNS patients)))))
                        (CC and)
                        (VP (VBG reducing)
                          (NP
                            (NP
                              (NP (DT the) (NN risk))
                              (PP (IN of)
                                (S
                                  (VP (VBG developing)
                                    (NP (NN coronary_heart_disease))))))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP CHD))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

case(particular-2, In-1)
advcl(shown-6, particular-2)
nsubj(shown-6, research-4)
aux(shown-6, has-5)
root(ROOT-0, shown-6)
mark(play-11, that-7)
det(fatty_acids-9, these-8)
nsubj(play-11, fatty_acids-9)
aux(play-11, may-10)
ccomp(shown-6, play-11)
det(role-13, a-12)
dobj(play-11, role-13)
mark(decreasing-15, in-14)
acl(role-13, decreasing-15)
amod(levels-17, clozapine-16)
dobj(decreasing-15, levels-17)
case(patients-20, in-18)
amod(patients-20, hyperclozapinmic-19)
nmod:in(levels-17, patients-20)
cc(decreasing-15, and-21)
acl(role-13, reducing-22)
conj:and(decreasing-15, reducing-22)
det(risk-24, the-23)
dobj(reducing-22, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(risk-24, CHD-29)

EPA/NNP and/CC DHA/NNP are/VBP known/VBN to/TO possess/VB anti-inflammatory/JJ properties/NNS that/WDT may/MD contribute/VB to/TO their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB possess)
              (NP
                (NP (JJ anti-inflammatory) (NNS properties))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD may)
                      (VP (VB contribute)
                        (PP (TO to)
                          (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))))
    (. .)))

nsubjpass(known-5, EPA-1)
nsubj:xsubj(possess-7, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(known-5, DHA-3)
nsubj:xsubj(possess-7, DHA-3)
auxpass(known-5, are-4)
root(ROOT-0, known-5)
mark(possess-7, to-6)
xcomp(known-5, possess-7)
amod(properties-9, anti-inflammatory-8)
dobj(possess-7, properties-9)
nsubj(contribute-12, properties-9)
ref(properties-9, that-10)
aux(contribute-12, may-11)
acl:relcl(properties-9, contribute-12)
case(effects-16, to-13)
nmod:poss(effects-16, their-14)
amod(effects-16, cardioprotective-15)
nmod:to(contribute-12, effects-16)

Moreover/RB ,/, they/PRP have/VBP been/VBN shown/VBN to/TO modulate/VBP lipid/NN metabolism/NN ,/, reduce/VB triglyceride_levels/NNS ,/, and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (PRP they))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (PP (TO to))
          (SBAR
            (S
              (VP (VBP modulate)
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (S
                  (VP
                    (VP (VB reduce)
                      (NP (NNS triglyceride_levels)))
                    (, ,)
                    (CC and)
                    (VP (VB improve)
                      (NP (JJ endothelial) (NN function)))))))))))
    (. .)))

advmod(shown-6, Moreover-1)
nsubjpass(shown-6, they-3)
aux(shown-6, have-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
nmod(shown-6, to-7)
ccomp(shown-6, modulate-8)
compound(metabolism-10, lipid-9)
dobj(modulate-8, metabolism-10)
dep(modulate-8, reduce-12)
dobj(reduce-12, triglyceride_levels-13)
cc(reduce-12, and-15)
dep(modulate-8, improve-16)
conj:and(reduce-12, improve-16)
amod(function-18, endothelial-17)
dobj(improve-16, function-18)

These/DT findings/NNS suggest/VBP that/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS with/IN hyperclozapinemia/NN or/CC at/IN risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ long-chain) (NN omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB be)
              (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
              (PP
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (PP (IN with)
                      (NP (NN hyperclozapinemia)))))
                (CC or)
                (PP (IN at)
                  (NP
                    (NP (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-12, that-4)
amod(omega-3_fatty_acids-6, long-chain-5)
nsubj(option-12, omega-3_fatty_acids-6)
aux(option-12, may-7)
cop(option-12, be-8)
det(option-12, a-9)
amod(option-12, promising-10)
amod(option-12, therapeutic-11)
ccomp(suggest-3, option-12)
ccomp(suggest-3, option-12')
conj:or(option-12, option-12')
case(individuals-14, for-13)
nmod:for(option-12, individuals-14)
case(hyperclozapinemia-16, with-15)
nmod:with(individuals-14, hyperclozapinemia-16)
cc(option-12, or-17)
case(risk-19, at-18)
nmod:at(option-12', risk-19)
case(CHD-21, of-20)
nmod:of(risk-19, CHD-21)

Further/JJ studies/NNS are/VBP needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG the/DT observed/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN clozapine/JJ levels/NNS and/CC CHD/NNP risk/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB elucidate)
              (NP
                (NP (DT the) (NNS mechanisms))
                (VP (VBG underlying)
                  (NP
                    (NP (DT the) (JJ observed) (NNS effects))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA)))
                    (PP (IN on)
                      (NP
                        (NP (JJ clozapine) (NNS levels))
                        (CC and)
                        (NP (NNP CHD) (NN risk))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-7, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
xcomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-13, the-11)
amod(effects-13, observed-12)
dobj(underlying-10, effects-13)
case(EPA-15, of-14)
nmod:of(effects-13, EPA-15)
cc(EPA-15, and-16)
nmod:of(effects-13, DHA-17)
conj:and(EPA-15, DHA-17)
case(levels-20, on-18)
amod(levels-20, clozapine-19)
nmod:on(effects-13, levels-20)
cc(levels-20, and-21)
compound(risk-23, CHD-22)
nmod:on(effects-13, risk-23)
conj:and(levels-20, risk-23)

Omega-3_fatty_acids/NNP have/VBP been/VBN found/VBN to/TO have/VB several/JJ health/NN benefits/NNS ,/, including/VBG a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNP Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ several) (NN health) (NNS benefits))
                  (, ,)
                  (VP (VBG including)
                    (NP
                      (NP
                        (NP (DT a) (VBN decreased) (NN risk))
                        (PP (IN of)
                          (S
                            (VP (VBG developing)
                              (NP (NN coronary_heart_disease))))))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP CHD))
                        (-RRB- -RRB-)))))))))))
    (. .)))

nsubjpass(found-4, Omega-3_fatty_acids-1)
nsubj:xsubj(have-6, Omega-3_fatty_acids-1)
aux(found-4, have-2)
auxpass(found-4, been-3)
root(ROOT-0, found-4)
mark(have-6, to-5)
xcomp(found-4, have-6)
amod(benefits-9, several-7)
compound(benefits-9, health-8)
dobj(have-6, benefits-9)
acl(benefits-9, including-11)
det(risk-14, a-12)
amod(risk-14, decreased-13)
dobj(including-11, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

Two/CD long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/NN particularly/RB effective/JJ in/IN reducing/VBG the/DT levels/NNS of/IN Astemizole/NNP in/IN hyperAstemizolemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP
      (NP (CD Two) (JJ long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP (NN to_be))
          (S
            (ADJP (RB particularly) (JJ effective)
              (PP (IN in)
                (S
                  (VP (VBG reducing)
                    (NP
                      (NP (DT the) (NNS levels))
                      (PP (IN of)
                        (NP (NNP Astemizole)))
                      (PP (IN in)
                        (NP (JJ hyperAstemizolemic) (NNS patients))))))))))))
    (. .)))

nummod(omega-3_fatty_acids-3, Two-1)
amod(omega-3_fatty_acids-3, long-chain-2)
nsubjpass(shown-17, omega-3_fatty_acids-3)
dep(omega-3_fatty_acids-3, eicosapentaenoic_acid-5)
dep(eicosapentaenoic_acid-5, EPA-7)
cc(eicosapentaenoic_acid-5, and-9)
dep(omega-3_fatty_acids-3, docosahexaenoic_acid-10)
conj:and(eicosapentaenoic_acid-5, docosahexaenoic_acid-10)
dep(docosahexaenoic_acid-10, DHA-12)
aux(shown-17, have-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
dobj(shown-17, to_be-18)
advmod(effective-20, particularly-19)
xcomp(shown-17, effective-20)
mark(reducing-22, in-21)
advcl(effective-20, reducing-22)
det(levels-24, the-23)
dobj(reducing-22, levels-24)
case(Astemizole-26, of-25)
nmod:of(levels-24, Astemizole-26)
case(patients-29, in-27)
amod(patients-29, hyperAstemizolemic-28)
nmod:in(levels-24, patients-29)

In/IN addition/NN ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO reduce/VB inflammation/NN ,/, improve/VB blood/NN lipid/NN profiles/NNS ,/, and/CC lower/JJR blood_pressure/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP
                (VP (VB reduce)
                  (NP (NN inflammation)))
                (, ,)
                (VP (VB improve)
                  (NP
                    (NP (NN blood) (NN lipid) (NNS profiles))
                    (, ,)
                    (CC and)
                    (NP (JJR lower) (NN blood_pressure))))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(found-9, addition-2)
nsubjpass(found-9, EPA-4)
nsubj:xsubj(reduce-11, EPA-4)
cc(EPA-4, and-5)
conj:and(EPA-4, DHA-6)
nsubjpass(found-9, DHA-6)
nsubj:xsubj(reduce-11, DHA-6)
aux(found-9, have-7)
auxpass(found-9, been-8)
root(ROOT-0, found-9)
mark(reduce-11, to-10)
xcomp(found-9, reduce-11)
dobj(reduce-11, inflammation-12)
dep(reduce-11, improve-14)
compound(profiles-17, blood-15)
compound(profiles-17, lipid-16)
dobj(improve-14, profiles-17)
cc(profiles-17, and-19)
amod(blood_pressure-21, lower-20)
dobj(improve-14, blood_pressure-21)
conj:and(profiles-17, blood_pressure-21)

These/DT beneficial/JJ effects/NNS are/VBP thought/VBN to_be/NN due/JJ to/TO the/DT ability/NN of/IN EPA/NNP and/CC DHA/NNP to/TO modulate/VBP gene/NN expression/NN and/CC regulate/VB cell/NN signaling/VBG pathways/NNS ./.

(ROOT
  (S
    (NP (DT These) (JJ beneficial) (NNS effects))
    (VP (VBP are)
      (VP (VBN thought)
        (SBAR
          (S
            (NP
              (NP (NN to_be))
              (ADJP (JJ due)
                (PP (TO to)
                  (NP
                    (NP (DT the) (NN ability))
                    (PP (IN of)
                      (NP (NNP EPA)
                        (CC and)
                        (NNP DHA)))
                    (S
                      (VP (TO to)))))))
            (VP
              (VP (VBP modulate)
                (NP (NN gene) (NN expression)))
              (CC and)
              (VP (VB regulate)
                (NP (NN cell))
                (S
                  (VP (VBG signaling)
                    (NP (NNS pathways))))))))))
    (. .)))

det(effects-3, These-1)
amod(effects-3, beneficial-2)
nsubjpass(thought-5, effects-3)
auxpass(thought-5, are-4)
root(ROOT-0, thought-5)
nsubj(modulate-16, to_be-6)
nsubj(regulate-20, to_be-6)
amod(to_be-6, due-7)
case(ability-10, to-8)
det(ability-10, the-9)
nmod:to(due-7, ability-10)
case(EPA-12, of-11)
nmod:of(ability-10, EPA-12)
cc(EPA-12, and-13)
nmod:of(ability-10, DHA-14)
conj:and(EPA-12, DHA-14)
acl(ability-10, to-15)
ccomp(thought-5, modulate-16)
compound(expression-18, gene-17)
dobj(modulate-16, expression-18)
cc(modulate-16, and-19)
ccomp(thought-5, regulate-20)
conj:and(modulate-16, regulate-20)
dobj(regulate-20, cell-21)
xcomp(regulate-20, signaling-22)
dobj(signaling-22, pathways-23)

Given/VBN their/PRP$ potential/JJ health/NN benefits/NNS ,/, increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplements/NNS may/MD be/VB an/DT effective/JJ strategy/NN for/IN reducing/VBG the/DT risk/NN of/IN CHD/NNP and/CC improving/VBG overall/JJ health/NN ./.

(ROOT
  (S
    (PP (VBN Given)
      (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits)))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NNS supplements)))))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT an) (JJ effective) (NN strategy))
          (PP (IN for)
            (S
              (VP
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (CC and)
                (VP (VBG improving)
                  (NP (JJ overall) (NN health)))))))))
    (. .)))

case(benefits-5, Given-1)
nmod:poss(benefits-5, their-2)
amod(benefits-5, potential-3)
compound(benefits-5, health-4)
nmod:given(strategy-23, benefits-5)
csubj(strategy-23, increasing-7)
det(intake-9, the-8)
dobj(increasing-7, intake-9)
case(EPA-11, of-10)
nmod:of(intake-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(intake-9, DHA-13)
conj:and(EPA-11, DHA-13)
case(sources-16, through-14)
amod(sources-16, dietary-15)
nmod:through(increasing-7, sources-16)
cc(sources-16, or-17)
nmod:through(increasing-7, supplements-18)
conj:or(sources-16, supplements-18)
aux(strategy-23, may-19)
cop(strategy-23, be-20)
det(strategy-23, an-21)
amod(strategy-23, effective-22)
root(ROOT-0, strategy-23)
mark(reducing-25, for-24)
acl(strategy-23, reducing-25)
det(risk-27, the-26)
dobj(reducing-25, risk-27)
case(CHD-29, of-28)
nmod:of(risk-27, CHD-29)
cc(reducing-25, and-30)
acl(strategy-23, improving-31)
conj:and(reducing-25, improving-31)
amod(health-33, overall-32)
dobj(improving-31, health-33)

Obesity/JJ is_a/NN growing/VBG public_health/JJ concern/NN worldwide/RB ,/, and/CC its/PRP$ development/NN is/VBZ influenced/VBN by/IN various/JJ factors/NNS ,/, including/VBG genetics/NNS and/CC environmental/JJ factors/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Obesity) (NN is_a))
      (VP (VBG growing)
        (NP (JJ public_health) (NN concern))
        (ADVP (RB worldwide)))
      (, ,)
      (CC and)
      (NP (PRP$ its) (NN development)))
    (VP (VBZ is)
      (VP (VBN influenced)
        (PP (IN by)
          (NP
            (NP (JJ various) (NNS factors))
            (, ,)
            (VP (VBG including)
              (NP
                (NP (NNS genetics))
                (CC and)
                (NP (JJ environmental) (NNS factors))))))))
    (. .)))

amod(is_a-2, Obesity-1)
nsubjpass(influenced-12, is_a-2)
acl(is_a-2, growing-3)
amod(concern-5, public_health-4)
dobj(growing-3, concern-5)
advmod(growing-3, worldwide-6)
cc(is_a-2, and-8)
nmod:poss(development-10, its-9)
conj:and(is_a-2, development-10)
nsubjpass(influenced-12, development-10)
auxpass(influenced-12, is-11)
root(ROOT-0, influenced-12)
case(factors-15, by-13)
amod(factors-15, various-14)
nmod:by(influenced-12, factors-15)
acl(factors-15, including-17)
dobj(including-17, genetics-18)
cc(genetics-18, and-19)
amod(factors-21, environmental-20)
dobj(including-17, factors-21)
conj:and(genetics-18, factors-21)

One/CD potential/JJ factor/NN that/WDT has_been/NN suggested/VBD to/TO play/VB a/DT role/NN in/IN the/DT development/NN of/IN obesity/NN is/VBZ the/DT hypersecretion/NN of/IN ANGPTL7/NNP by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (NP (CD One) (JJ potential) (NN factor)
      (SBAR
        (WHNP (WDT that))
        (S
          (NP (NN has_been))
          (VP (VBD suggested)
            (S
              (VP (TO to)
                (VP (VB play)
                  (NP
                    (NP (DT a) (NN role))
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (NN obesity)))))))))))))
    (VP (VBZ is)
      (NP
        (NP (DT the) (NN hypersecretion))
        (PP (IN of)
          (NP (NNP ANGPTL7))))
      (PP (IN by)
        (NP (DT the) (NN pancreas))))
    (. .)))

nummod(factor-3, One-1)
amod(factor-3, potential-2)
nsubj(hypersecretion-18, factor-3)
dobj(suggested-6, that-4)
nsubj:xsubj(play-8, that-4)
nsubj(suggested-6, has_been-5)
ccomp(factor-3, suggested-6)
mark(play-8, to-7)
xcomp(suggested-6, play-8)
det(role-10, a-9)
dobj(play-8, role-10)
case(development-13, in-11)
det(development-13, the-12)
nmod:in(role-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cop(hypersecretion-18, is-16)
det(hypersecretion-18, the-17)
root(ROOT-0, hypersecretion-18)
case(ANGPTL7-20, of-19)
nmod:of(hypersecretion-18, ANGPTL7-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(hypersecretion-18, pancreas-23)

In/IN this/DT study/NN ,/, we/PRP aimed/VBN to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN ANGPTL7/NNP by/IN examining/VBG the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/JJ flavylium/NN on/IN the/DT secretion/NN of/IN ANGPTL7/NNP and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBN aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NNP ANGPTL7)))))))
            (PP (IN by)
              (S
                (VP (VBG examining)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP
                        (NP (CD 16.7) (JJ mmol/L) (NN glucose))
                        (CC and)
                        (NP (CD 10) (JJ mmol/L) (NN flavylium)))))
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN secretion))
                      (PP (IN of)
                        (NP (NNP ANGPTL7) (NN and_insulin))))))))
            (PP (IN by)
              (NP (VBN isolated) (JJ perfused) (NN pancreata))))))
      (PP (IN from)
        (NP
          (NP
            (NP (NN genetically_obese))
            (PRN (-LRB- -LRB-)
              (NP (NN fa/fa))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (ADJP
              (ADJP (JJ lean))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (ADVP (RB Fa) (: /))
                  (. ?))
                (-RRB- -RRB-)))
            (NNS rats)))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(ANGPTL7-20, of-19)
nmod:of(hypersecretion-18, ANGPTL7-20)
mark(examining-22, by-21)
advcl(evaluate-8, examining-22)
det(effects-24, the-23)
dobj(examining-22, effects-24)
case(glucose-28, of-25)
nummod(glucose-28, 16.7-26)
amod(glucose-28, mmol/L-27)
nmod:of(effects-24, glucose-28)
cc(glucose-28, and-29)
nummod(flavylium-32, 10-30)
amod(flavylium-32, mmol/L-31)
nmod:of(effects-24, flavylium-32)
conj:and(glucose-28, flavylium-32)
case(secretion-35, on-33)
det(secretion-35, the-34)
nmod:on(examining-22, secretion-35)
case(and_insulin-38, of-36)
compound(and_insulin-38, ANGPTL7-37)
nmod:of(secretion-35, and_insulin-38)
case(pancreata-42, by-39)
amod(pancreata-42, isolated-40)
amod(pancreata-42, perfused-41)
nmod:by(evaluate-8, pancreata-42)
case(genetically_obese-44, from-43)
nmod:from(aimed-6, genetically_obese-44)
appos(genetically_obese-44, fa/fa-46)
cc(genetically_obese-44, and-48)
amod(rats-55, lean-49)
dep(lean-49, Fa-51)
nmod:from(aimed-6, rats-55)
conj:and(genetically_obese-44, rats-55)

Our/PRP$ results/NNS showed/VBD that/IN ANGPTL7/NNP secretion/NN was/VBD significantly/RB higher/JJR in/IN pancreata/NN from/IN genetically_obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS ,/, while/IN insulin_secretion/NN was/VBD similar/JJ between/IN the/DT two/CD groups/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP ANGPTL7) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP
                  (NP (NN pancreata))
                  (PP (IN from)
                    (NP (JJ genetically_obese) (NNS rats))))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (, ,)
                    (SBAR (IN while)
                      (S
                        (NP (NN insulin_secretion))
                        (VP (VBD was)
                          (ADJP (JJ similar))
                          (PP (IN between)
                            (NP (DT the) (CD two) (NNS groups))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-15, that-4)
compound(secretion-6, ANGPTL7-5)
nsubjpass(compared-15, secretion-6)
nsubj:xsubj(lean-17, secretion-6)
auxpass(compared-15, was-7)
advmod(higher-9, significantly-8)
advmod(compared-15, higher-9)
case(pancreata-11, in-10)
nmod:in(higher-9, pancreata-11)
case(rats-14, from-12)
amod(rats-14, genetically_obese-13)
nmod:from(pancreata-11, rats-14)
ccomp(showed-3, compared-15)
mark(lean-17, to-16)
xcomp(compared-15, lean-17)
dobj(lean-17, rats-18)
mark(similar-23, while-20)
nsubj(similar-23, insulin_secretion-21)
cop(similar-23, was-22)
advcl(lean-17, similar-23)
case(groups-27, between-24)
det(groups-27, the-25)
nummod(groups-27, two-26)
nmod:between(similar-23, groups-27)

Furthermore/RB ,/, exposure/NN to/TO high/JJ glucose/NN or/CC flavylium/NN did/VBD not/RB significantly/RB affect/VB ANGPTL7/NNP or_insulin/NN secretion/NN in/IN either/DT group/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN exposure))
      (PP (TO to)
        (NP (JJ high) (NN glucose)
          (CC or)
          (NN flavylium))))
    (VP (VBD did) (RB not)
      (VP
        (ADVP (RB significantly))
        (VB affect)
        (NP
          (NP (NNP ANGPTL7) (NN or_insulin) (NN secretion))
          (PP (IN in)
            (NP (DT either) (NN group))))))
    (. .)))

advmod(affect-12, Furthermore-1)
nsubj(affect-12, exposure-3)
case(glucose-6, to-4)
amod(glucose-6, high-5)
nmod:to(exposure-3, glucose-6)
cc(glucose-6, or-7)
nmod:to(exposure-3, flavylium-8)
conj:or(glucose-6, flavylium-8)
aux(affect-12, did-9)
neg(affect-12, not-10)
advmod(affect-12, significantly-11)
root(ROOT-0, affect-12)
compound(secretion-15, ANGPTL7-13)
compound(secretion-15, or_insulin-14)
dobj(affect-12, secretion-15)
case(group-18, in-16)
det(group-18, either-17)
nmod:in(secretion-15, group-18)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN ANGPTL7/NNP may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, independent/JJ of/IN glucose/NN or/CC flavylium/NN stimulation/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP (NNP ANGPTL7))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP
                        (NP (NN obesity))
                        (, ,)
                        (NP
                          (ADJP (JJ independent)
                            (PP (IN of)
                              (NP (NN glucose)
                                (CC or)
                                (NN flavylium))))
                          (NN stimulation))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-10, that-4)
nsubjpass(involved-10, hypersecretion-5)
case(ANGPTL7-7, of-6)
nmod:of(hypersecretion-5, ANGPTL7-7)
aux(involved-10, may-8)
auxpass(involved-10, be-9)
ccomp(suggest-3, involved-10)
case(development-13, in-11)
det(development-13, the-12)
nmod:in(involved-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
amod(stimulation-22, independent-17)
case(glucose-19, of-18)
nmod:of(independent-17, glucose-19)
cc(glucose-19, or-20)
nmod:of(independent-17, flavylium-21)
conj:or(glucose-19, flavylium-21)
appos(obesity-15, stimulation-22)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS linking/VBG ANGPTL7/NNP hypersecretion/NN to/TO obesity/VB development/NN and/CC identify/VB potential/JJ therapeutic/JJ targets/NNS for/IN obesity/JJ prevention/NN and/CC treatment/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (VP (VBG linking)
                  (NP (NNP ANGPTL7) (NN hypersecretion))
                  (S
                    (VP (TO to)
                      (VP
                        (VP (VB obesity)
                          (NP (NN development)))
                        (CC and)
                        (VP (VB identify)
                          (NP
                            (NP (JJ potential) (JJ therapeutic) (NNS targets))
                            (PP (IN for)
                              (NP (JJ obesity) (NN prevention)
                                (CC and)
                                (NN treatment)))))))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
acl(mechanisms-9, linking-10)
compound(hypersecretion-12, ANGPTL7-11)
dobj(linking-10, hypersecretion-12)
mark(obesity-14, to-13)
advcl(linking-10, obesity-14)
dobj(obesity-14, development-15)
cc(obesity-14, and-16)
advcl(linking-10, identify-17)
conj:and(obesity-14, identify-17)
amod(targets-20, potential-18)
amod(targets-20, therapeutic-19)
dobj(identify-17, targets-20)
case(prevention-23, for-21)
amod(prevention-23, obesity-22)
nmod:for(targets-20, prevention-23)
cc(prevention-23, and-24)
nmod:for(targets-20, treatment-25)
conj:and(prevention-23, treatment-25)

The/DT production/NN of/IN ferulate/NN ,/, a/DT key/JJ component/NN of/IN plant/NN cell/NN walls/NNS ,/, is/VBZ regulated/VBN by/IN various/JJ enzymes/NNS and/CC pathways/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NN production))
        (PP (IN of)
          (NP (NN ferulate))))
      (, ,)
      (NP
        (NP (DT a) (JJ key) (NN component))
        (PP (IN of)
          (NP (NN plant) (NN cell) (NNS walls))))
      (, ,))
    (VP (VBZ is)
      (VP (VBN regulated)
        (PP (IN by)
          (NP (JJ various) (NNS enzymes)
            (CC and)
            (NNS pathways)))))
    (. .)))

det(production-2, The-1)
nsubjpass(regulated-15, production-2)
case(ferulate-4, of-3)
nmod:of(production-2, ferulate-4)
det(component-8, a-6)
amod(component-8, key-7)
appos(production-2, component-8)
case(walls-12, of-9)
compound(walls-12, plant-10)
compound(walls-12, cell-11)
nmod:of(component-8, walls-12)
auxpass(regulated-15, is-14)
root(ROOT-0, regulated-15)
case(enzymes-18, by-16)
amod(enzymes-18, various-17)
nmod:by(regulated-15, enzymes-18)
cc(enzymes-18, and-19)
nmod:by(regulated-15, pathways-20)
conj:and(enzymes-18, pathways-20)

One/CD such/JJ enzyme/NN is/VBZ AtFAH1/NN ,/, which/WDT has_been/VBP shown/VBN to/TO inhibit/VB ferulate/JJ production/NN in/IN Arabidopsis_thaliana/NNP ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN enzyme))
    (VP (VBZ is)
      (NP
        (NP (NN AtFAH1))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP has_been)
              (VP (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB inhibit)
                      (NP (JJ ferulate) (NN production))
                      (PP (IN in)
                        (NP (NNP Arabidopsis_thaliana))))))))))))
    (. .)))

nummod(enzyme-3, One-1)
amod(enzyme-3, such-2)
nsubj(AtFAH1-5, enzyme-3)
cop(AtFAH1-5, is-4)
root(ROOT-0, AtFAH1-5)
nsubj(has_been-8, AtFAH1-5)
ref(AtFAH1-5, which-7)
acl:relcl(AtFAH1-5, has_been-8)
dep(has_been-8, shown-9)
mark(inhibit-11, to-10)
xcomp(shown-9, inhibit-11)
amod(production-13, ferulate-12)
dobj(inhibit-11, production-13)
case(Arabidopsis_thaliana-15, in-14)
nmod:in(inhibit-11, Arabidopsis_thaliana-15)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT underlying/JJ mechanism/NN of/IN AtFAH1-mediated/JJ inhibition/NN of/IN ferulate/JJ production/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (JJ underlying) (NN mechanism))
        (PP (IN of)
          (NP
            (NP (JJ AtFAH1-mediated) (NN inhibition))
            (PP (IN of)
              (NP (JJ ferulate) (NN production)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(mechanism-9, the-7)
amod(mechanism-9, underlying-8)
dobj(investigated-6, mechanism-9)
case(inhibition-12, of-10)
amod(inhibition-12, AtFAH1-mediated-11)
nmod:of(mechanism-9, inhibition-12)
case(production-15, of-13)
amod(production-15, ferulate-14)
nmod:of(inhibition-12, production-15)

Our/PRP$ results/NNS indicate/VBP that/IN this/DT inhibition/NN can/MD be/VB reversed/VBN by/IN pretreating/VBG cells/NNS with/IN staurosporin/NN ,/, a/DT protein_kinase_A/NN -LRB-/-LRB- PKA/NNP -RRB-/-RRB- inhibitor/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (DT this) (NN inhibition))
          (VP (MD can)
            (VP (VB be)
              (VP (VBN reversed)
                (PP (IN by)
                  (S
                    (VP (VBG pretreating)
                      (NP (NNS cells))
                      (PP (IN with)
                        (NP
                          (NP (NN staurosporin))
                          (, ,)
                          (NP (DT a) (NN protein_kinase_A))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP PKA))
                            (-RRB- -RRB-))
                          (NP (NN inhibitor)))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(indicate-3, results-2)
root(ROOT-0, indicate-3)
mark(reversed-9, that-4)
det(inhibition-6, this-5)
nsubjpass(reversed-9, inhibition-6)
aux(reversed-9, can-7)
auxpass(reversed-9, be-8)
ccomp(indicate-3, reversed-9)
mark(pretreating-11, by-10)
advcl(reversed-9, pretreating-11)
dobj(pretreating-11, cells-12)
case(staurosporin-14, with-13)
nmod:with(pretreating-11, staurosporin-14)
det(protein_kinase_A-17, a-16)
appos(staurosporin-14, protein_kinase_A-17)
appos(staurosporin-14, PKA-19)
dep(staurosporin-14, inhibitor-21)

Furthermore/RB ,/, mutation/NN of/IN the/DT PKA-dependent/JJ phosphorylation/JJ site/NN S730A/NN in/IN the/DT AtFAH1/JJ sequence/NN also/RB restored/VBD ferulate/JJ production/NN ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN mutation))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ PKA-dependent) (JJ phosphorylation) (NN site) (NN S730A))
          (PP (IN in)
            (NP (DT the) (JJ AtFAH1) (NN sequence))))))
    (ADVP (RB also))
    (VP (VBD restored)
      (NP (JJ ferulate) (NN production)))
    (. .)))

advmod(restored-15, Furthermore-1)
nsubj(restored-15, mutation-3)
case(S730A-9, of-4)
det(S730A-9, the-5)
amod(S730A-9, PKA-dependent-6)
amod(S730A-9, phosphorylation-7)
compound(S730A-9, site-8)
nmod:of(mutation-3, S730A-9)
case(sequence-13, in-10)
det(sequence-13, the-11)
amod(sequence-13, AtFAH1-12)
nmod:in(S730A-9, sequence-13)
advmod(restored-15, also-14)
root(ROOT-0, restored-15)
amod(production-17, ferulate-16)
dobj(restored-15, production-17)

These/DT findings/NNS suggest/VBP that/IN AtFAH1-mediated/JJ inhibition/NN of/IN ferulate/JJ production/NN is/VBZ dependent/JJ on/IN PKA/NNP signaling/VBG and/CC provide/VB insight/NN into/IN the/DT regulation/NN of/IN plant/NN cell/NN wall/NN biosynthesis/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ AtFAH1-mediated) (NN inhibition))
              (PP (IN of)
                (NP (JJ ferulate) (NN production))))
            (VP (VBZ is)
              (ADJP (JJ dependent)
                (PP (IN on)
                  (NP (NNP PKA))))
              (S
                (VP (VBG signaling)))))))
      (CC and)
      (VP (VB provide)
        (NP (NN insight))
        (PP (IN into)
          (NP
            (NP (DT the) (NN regulation))
            (PP (IN of)
              (NP (NN plant) (NN cell) (NN wall) (NNS biosynthesis)))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
nsubj(provide-16, findings-2)
root(ROOT-0, suggest-3)
mark(dependent-11, that-4)
amod(inhibition-6, AtFAH1-mediated-5)
nsubj(dependent-11, inhibition-6)
case(production-9, of-7)
amod(production-9, ferulate-8)
nmod:of(inhibition-6, production-9)
cop(dependent-11, is-10)
ccomp(suggest-3, dependent-11)
case(PKA-13, on-12)
nmod:on(dependent-11, PKA-13)
xcomp(dependent-11, signaling-14)
cc(suggest-3, and-15)
conj:and(suggest-3, provide-16)
dobj(provide-16, insight-17)
case(regulation-20, into-18)
det(regulation-20, the-19)
nmod:into(provide-16, regulation-20)
case(biosynthesis-25, of-21)
compound(biosynthesis-25, plant-22)
compound(biosynthesis-25, cell-23)
compound(biosynthesis-25, wall-24)
nmod:of(regulation-20, biosynthesis-25)

Heart_failure/NNP -LRB-/-LRB- HF/NNP -RRB-/-RRB- is_a/VBZ common/JJ and/CC debilitating/JJ condition/NN that/WDT affects/VBZ millions/NNS of/IN people/NNS worldwide/RB ./.

(ROOT
  (S
    (NP (NNP Heart_failure) (-LRB- -LRB-)
      (NP (NNP HF))
      (-RRB- -RRB-))
    (VP (VBZ is_a)
      (NP
        (ADJP (JJ common)
          (CC and)
          (JJ debilitating))
        (NN condition)
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ affects)
              (NP
                (NP (NNS millions))
                (PP (IN of)
                  (NP (NNS people))))
              (ADVP (RB worldwide)))))))
    (. .)))

nsubj(is_a-5, Heart_failure-1)
dep(Heart_failure-1, HF-3)
root(ROOT-0, is_a-5)
amod(condition-9, common-6)
cc(common-6, and-7)
conj:and(common-6, debilitating-8)
amod(condition-9, debilitating-8)
dobj(is_a-5, condition-9)
nsubj(affects-11, that-10)
ccomp(condition-9, affects-11)
dobj(affects-11, millions-12)
case(people-14, of-13)
nmod:of(millions-12, people-14)
advmod(affects-11, worldwide-15)

Despite/IN advances/NNS in/IN medical/JJ therapy/NN ,/, the/DT prognosis/NN for/IN patients/NNS with/IN HF/NNP remains/VBZ poor/JJ ,/, highlighting/VBG the/DT need/NN for/IN novel/JJ therapeutic/JJ approaches/NNS ./.

(ROOT
  (S
    (PP (IN Despite)
      (NP
        (NP (NNS advances))
        (PP (IN in)
          (NP (JJ medical) (NN therapy)))))
    (, ,)
    (NP
      (NP (DT the) (NN prognosis))
      (PP (IN for)
        (NP
          (NP (NNS patients))
          (PP (IN with)
            (NP (NNP HF))))))
    (VP (VBZ remains)
      (ADJP (JJ poor))
      (, ,)
      (PP (VBG highlighting)
        (NP
          (NP (DT the) (NN need))
          (PP (IN for)
            (NP (JJ novel) (JJ therapeutic) (NNS approaches))))))
    (. .)))

case(advances-2, Despite-1)
nmod:despite(remains-13, advances-2)
case(therapy-5, in-3)
amod(therapy-5, medical-4)
nmod:in(advances-2, therapy-5)
det(prognosis-8, the-7)
nsubj(remains-13, prognosis-8)
case(patients-10, for-9)
nmod:for(prognosis-8, patients-10)
case(HF-12, with-11)
nmod:with(patients-10, HF-12)
root(ROOT-0, remains-13)
xcomp(remains-13, poor-14)
case(need-18, highlighting-16)
det(need-18, the-17)
nmod:highlighting(remains-13, need-18)
case(approaches-22, for-19)
amod(approaches-22, novel-20)
amod(approaches-22, therapeutic-21)
nmod:for(need-18, approaches-22)

In/IN recent/JJ years/NNS ,/, there/EX has_been/VBP growing/VBG interest/NN in/IN the/DT potential/JJ role/NN of/IN natural/JJ compounds/NNS in/IN the/DT management/NN of/IN HF/NNP ./.

(ROOT
  (S
    (PP (IN In)
      (NP (JJ recent) (NNS years)))
    (, ,)
    (NP (EX there))
    (VP (VBP has_been)
      (NP
        (NP (VBG growing) (NN interest))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ potential) (NN role))
            (PP (IN of)
              (NP
                (NP (JJ natural) (NNS compounds))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN management))
                    (PP (IN of)
                      (NP (NNP HF)))))))))))
    (. .)))

case(years-3, In-1)
amod(years-3, recent-2)
nmod:in(has_been-6, years-3)
expl(has_been-6, there-5)
root(ROOT-0, has_been-6)
amod(interest-8, growing-7)
dobj(has_been-6, interest-8)
case(role-12, in-9)
det(role-12, the-10)
amod(role-12, potential-11)
nmod:in(interest-8, role-12)
case(compounds-15, of-13)
amod(compounds-15, natural-14)
nmod:of(role-12, compounds-15)
case(management-18, in-16)
det(management-18, the-17)
nmod:in(compounds-15, management-18)
case(HF-20, of-19)
nmod:of(management-18, HF-20)

One/CD such/JJ compound/NN is/VBZ citral/JJ ,/, a/DT natural/JJ flavoring/JJ agent/NN found/VBN in/IN many/JJ fruits/NNS and/CC vegetables/NNS ./.

(ROOT
  (S
    (NP (CD One) (JJ such) (NN compound))
    (VP (VBZ is)
      (ADJP (JJ citral))
      (, ,)
      (NP
        (NP (DT a) (JJ natural) (JJ flavoring) (NN agent))
        (VP (VBN found)
          (PP (IN in)
            (NP (JJ many) (NNS fruits)
              (CC and)
              (NNS vegetables))))))
    (. .)))

nummod(compound-3, One-1)
amod(compound-3, such-2)
nsubj(citral-5, compound-3)
cop(citral-5, is-4)
root(ROOT-0, citral-5)
det(agent-10, a-7)
amod(agent-10, natural-8)
amod(agent-10, flavoring-9)
dep(citral-5, agent-10)
acl(agent-10, found-11)
case(fruits-14, in-12)
amod(fruits-14, many-13)
nmod:in(found-11, fruits-14)
cc(fruits-14, and-15)
nmod:in(found-11, vegetables-16)
conj:and(fruits-14, vegetables-16)

In/IN a/DT randomized_controlled_trial/JJ involving/VBG patients/NNS with/IN HF/NNP ,/, citral/NN was/VBD found/VBN to/TO reduce/VB the/DT risk/NN of/IN non-community-acquired_pneumonia/JJ -LRB-/-LRB- CAP/NNP -RRB-/-RRB- controls/NNS by/IN 21/CD %/NN -LRB-/-LRB- relative/JJ risk/NN -LSB-/NNP RR/NNP -RSB-/NNP :/: 0.79/CD ,/, 95/CD %/NN confidence/NN interval/JJ -LSB-/JJ CI/NNP -RSB-/NNS :/: 0.67-0/CD .93/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT a) (JJ randomized_controlled_trial) (VBG involving) (NNS patients))
        (PP (IN with)
          (NP (NNP HF)))))
    (, ,)
    (NP (NN citral))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB reduce)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP (JJ non-community-acquired_pneumonia)
                    (PRN (-LRB- -LRB-)
                      (NP (NNP CAP))
                      (-RRB- -RRB-))
                    (NNS controls))))
              (PP (IN by)
                (NP
                  (NP (CD 21) (NN %))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (JJ relative) (NN risk) (NNP -LSB-) (NNP RR) (NNP -RSB-))
                      (: :)
                      (NP
                        (NP (CD 0.79) (, ,) (CD 95) (NN %) (NN confidence) (JJ interval) (JJ -LSB-) (NNP CI) (NNS -RSB-))
                        (: :)
                        (NP
                          (QP (CD 0.67-0) (CD .93)))))
                    (-RRB- -RRB-)))))))))
    (. .)))

case(patients-5, In-1)
det(patients-5, a-2)
amod(patients-5, randomized_controlled_trial-3)
amod(patients-5, involving-4)
nmod:in(found-11, patients-5)
case(HF-7, with-6)
nmod:with(patients-5, HF-7)
nsubjpass(found-11, citral-9)
nsubj:xsubj(reduce-13, citral-9)
auxpass(found-11, was-10)
root(ROOT-0, found-11)
mark(reduce-13, to-12)
xcomp(found-11, reduce-13)
det(risk-15, the-14)
dobj(reduce-13, risk-15)
case(controls-21, of-16)
amod(controls-21, non-community-acquired_pneumonia-17)
appos(controls-21, CAP-19)
nmod:of(risk-15, controls-21)
case(%-24, by-22)
nummod(%-24, 21-23)
nmod:by(reduce-13, %-24)
amod(-RSB--30, relative-26)
compound(-RSB--30, risk-27)
compound(-RSB--30, -LSB--28)
compound(-RSB--30, RR-29)
dep(%-24, -RSB--30)
nummod(-RSB--40, 0.79-32)
nummod(-RSB--40, 95-34)
compound(-RSB--40, %-35)
compound(-RSB--40, confidence-36)
amod(-RSB--40, interval-37)
amod(-RSB--40, -LSB--38)
compound(-RSB--40, CI-39)
dep(-RSB--30, -RSB--40)
compound(.93-43, 0.67-0-42)
dep(-RSB--40, .93-43)

This/DT finding/NN suggests/VBZ that/IN citral/NN may/MD have/VB a/DT beneficial/JJ effect/NN on/IN respiratory_infections/NNS in/IN patients/NNS with/IN HF/NNP and/CC warrants/NNS further/JJ investigation/NN into/IN its/PRP$ potential/NN as/IN a/DT therapeutic/JJ agent/NN for/IN this/DT population/NN ./.

(ROOT
  (S
    (NP (DT This) (NN finding))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (NN citral))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (DT a) (JJ beneficial) (NN effect))
                (PP (IN on)
                  (NP
                    (NP (NNS respiratory_infections))
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (NNS patients))
                          (PP (IN with)
                            (NP (NNP HF))))
                        (CC and)
                        (NP
                          (NP (NNS warrants))
                          (NP (JJ further) (NN investigation))))))))
              (PP (IN into)
                (NP (PRP$ its) (NN potential)))
              (PP (IN as)
                (NP
                  (NP (DT a) (JJ therapeutic) (NN agent))
                  (PP (IN for)
                    (NP (DT this) (NN population))))))))))
    (. .)))

det(finding-2, This-1)
nsubj(suggests-3, finding-2)
root(ROOT-0, suggests-3)
mark(have-7, that-4)
nsubj(have-7, citral-5)
aux(have-7, may-6)
ccomp(suggests-3, have-7)
det(effect-10, a-8)
amod(effect-10, beneficial-9)
dobj(have-7, effect-10)
case(respiratory_infections-12, on-11)
nmod:on(effect-10, respiratory_infections-12)
case(patients-14, in-13)
nmod:in(respiratory_infections-12, patients-14)
case(HF-16, with-15)
nmod:with(patients-14, HF-16)
cc(patients-14, and-17)
nmod:in(respiratory_infections-12, warrants-18)
conj:and(patients-14, warrants-18)
amod(investigation-20, further-19)
dep(warrants-18, investigation-20)
case(potential-23, into-21)
nmod:poss(potential-23, its-22)
nmod:into(have-7, potential-23)
case(agent-27, as-24)
det(agent-27, a-25)
amod(agent-27, therapeutic-26)
nmod:as(have-7, agent-27)
case(population-30, for-28)
det(population-30, this-29)
nmod:for(agent-27, population-30)

Future/JJ studies/NNS should/MD focus/VB on/IN elucidating/VBG the/DT mechanisms/NNS underlying/VBG this/DT effect/NN and/CC exploring/VBG the/DT safety/NN and/CC efficacy/NN of/IN citral/NN in/IN larger/JJR populations/NNS of/IN patients/NNS with/IN HF/NNP ./.

(ROOT
  (S
    (NP (JJ Future) (NNS studies))
    (VP (MD should)
      (VP (VB focus)
        (PP (IN on)
          (S
            (VP
              (VP (VBG elucidating)
                (NP (DT the) (NNS mechanisms))
                (S
                  (VP (VBG underlying)
                    (NP (DT this) (NN effect)))))
              (CC and)
              (VP (VBG exploring)
                (NP
                  (NP (DT the) (NN safety)
                    (CC and)
                    (NN efficacy))
                  (PP (IN of)
                    (NP
                      (NP (NN citral))
                      (PP (IN in)
                        (NP
                          (NP (JJR larger) (NNS populations))
                          (PP (IN of)
                            (NP (NNS patients))))))))
                (PP (IN with)
                  (NP (NNP HF)))))))))
    (. .)))

amod(studies-2, Future-1)
nsubj(focus-4, studies-2)
aux(focus-4, should-3)
root(ROOT-0, focus-4)
mark(elucidating-6, on-5)
advcl(focus-4, elucidating-6)
det(mechanisms-8, the-7)
dobj(elucidating-6, mechanisms-8)
advcl(elucidating-6, underlying-9)
det(effect-11, this-10)
dobj(underlying-9, effect-11)
cc(elucidating-6, and-12)
advcl(focus-4, exploring-13)
conj:and(elucidating-6, exploring-13)
det(safety-15, the-14)
dobj(exploring-13, safety-15)
cc(safety-15, and-16)
dobj(exploring-13, efficacy-17)
conj:and(safety-15, efficacy-17)
case(citral-19, of-18)
nmod:of(safety-15, citral-19)
case(populations-22, in-20)
amod(populations-22, larger-21)
nmod:in(citral-19, populations-22)
case(patients-24, of-23)
nmod:of(populations-22, patients-24)
case(HF-26, with-25)
nmod:with(exploring-13, HF-26)

Omega-3_fatty_acids/NNS ,/, including/VBG eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, are/VBP essential/JJ components/NNS of/IN a/DT healthy/JJ diet/NN ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP (VBG including)
        (NP
          (NP
            (ADVP (JJ eicosapentaenoic_acid))
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (CC and)
            (NP (NN docosahexaenoic_acid)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS components))
        (PP (IN of)
          (NP (DT a) (JJ healthy) (NN diet)))))
    (. .)))

nsubj(components-16, Omega-3_fatty_acids-1)
acl(Omega-3_fatty_acids-1, including-3)
advmod(EPA-6, eicosapentaenoic_acid-4)
dobj(including-3, EPA-6)
cc(EPA-6, and-8)
dobj(including-3, docosahexaenoic_acid-9)
conj:and(EPA-6, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
cop(components-16, are-14)
amod(components-16, essential-15)
root(ROOT-0, components-16)
case(diet-20, of-17)
det(diet-20, a-18)
amod(diet-20, healthy-19)
nmod:of(components-16, diet-20)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT long-chain_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN OSI-211/NN in/IN hyperOSI-211mic/JJ patients/NNS ,/, as/RB well/RB as/IN a/DT decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS long-chain_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN OSI-211))
                          (PP (IN in)
                            (NP
                              (NP (JJ hyperOSI-211mic) (NNS patients))
                              (, ,)
                              (ADVP (RB as) (RB well)
                                (PP (IN as)
                                  (NP
                                    (NP (DT a) (VBN decreased) (NN risk))
                                    (PP (IN of)
                                      (S
                                        (VP (VBG developing)
                                          (NP (NN coronary_heart_disease)))))))))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP CHD))
                          (-RRB- -RRB-))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(long-chain_fatty_acids-7, these-6)
nsubjpass(associated-9, long-chain_fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-12, with-10)
amod(levels-12, decreased-11)
nmod:with(associated-9, levels-12)
case(OSI-211-14, of-13)
nmod:of(levels-12, OSI-211-14)
case(patients-17, in-15)
amod(patients-17, hyperOSI-211mic-16)
nmod:in(OSI-211-14, patients-17)
advmod(well-20, as-19)
advmod(patients-17, well-20)
case(risk-24, as-21)
det(risk-24, a-22)
amod(risk-24, decreased-23)
nmod:as(well-20, risk-24)
mark(developing-26, of-25)
acl(risk-24, developing-26)
dobj(developing-26, coronary_heart_disease-27)
appos(OSI-211-14, CHD-29)

EPA/NNP and/CC DHA/NNP have/VBP been/VBN found/VBN to/TO have/VB anti-inflammatory/JJ properties/NNS ,/, which/WDT may/MD explain/VB their/PRP$ cardioprotective/JJ effects/NNS ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB have)
                (NP
                  (NP (JJ anti-inflammatory) (NNS properties))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (MD may)
                        (VP (VB explain)
                          (NP (PRP$ their) (JJ cardioprotective) (NNS effects)))))))))))))
    (. .)))

nsubjpass(found-6, EPA-1)
nsubj:xsubj(have-8, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubjpass(found-6, DHA-3)
nsubj:xsubj(have-8, DHA-3)
aux(found-6, have-4)
auxpass(found-6, been-5)
root(ROOT-0, found-6)
mark(have-8, to-7)
xcomp(found-6, have-8)
amod(properties-10, anti-inflammatory-9)
dobj(have-8, properties-10)
nsubj(explain-14, properties-10)
ref(properties-10, which-12)
aux(explain-14, may-13)
acl:relcl(properties-10, explain-14)
nmod:poss(effects-17, their-15)
amod(effects-17, cardioprotective-16)
dobj(explain-14, effects-17)

In/IN addition/NN ,/, these/DT fatty_acids/NNS have/VBP been/VBN shown/VBN to/TO reduce/VB triglyceride_levels/NNS and/CC improve/VB endothelial/JJ function/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP
                (VP (VB reduce)
                  (NP (NNS triglyceride_levels)))
                (CC and)
                (VP (VB improve)
                  (NP-TMP (JJ endothelial) (NN function)))))))))
    (. .)))

case(addition-2, In-1)
nmod:in(shown-8, addition-2)
det(fatty_acids-5, these-4)
nsubjpass(shown-8, fatty_acids-5)
nsubj:xsubj(reduce-10, fatty_acids-5)
nsubj:xsubj(improve-13, fatty_acids-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(reduce-10, to-9)
xcomp(shown-8, reduce-10)
dobj(reduce-10, triglyceride_levels-11)
cc(reduce-10, and-12)
xcomp(shown-8, improve-13)
conj:and(reduce-10, improve-13)
amod(function-15, endothelial-14)
nmod:tmod(improve-13, function-15)

The/DT mechanisms/NNS underlying/VBG the/DT beneficial/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP on/IN CHD/NNP risk/NN remain/VBP unclear/JJ ,/, but/CC may/MD involve/VB modulation/NN of/IN lipid/NN metabolism/NN ,/, inflammation/NN ,/, and/CC oxidative_stress/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NNS mechanisms))
      (VP (VBG underlying)
        (NP
          (NP (DT the) (JJ beneficial) (NNS effects))
          (PP (IN of)
            (NP (NNP EPA)
              (CC and)
              (NNP DHA)))
          (PP (IN on)
            (NP (NNP CHD) (NN risk))))))
    (VP
      (VP (VBP remain)
        (ADJP (JJ unclear)))
      (, ,)
      (CC but)
      (VP (MD may)
        (VP (VB involve)
          (NP
            (NP (NN modulation))
            (PP (IN of)
              (NP
                (NP (NN lipid) (NN metabolism))
                (, ,)
                (NP (NN inflammation))
                (, ,)
                (CC and)
                (NP (NNS oxidative_stress))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubj(remain-14, mechanisms-2)
nsubj(involve-19, mechanisms-2)
acl(mechanisms-2, underlying-3)
det(effects-6, the-4)
amod(effects-6, beneficial-5)
dobj(underlying-3, effects-6)
case(EPA-8, of-7)
nmod:of(effects-6, EPA-8)
cc(EPA-8, and-9)
nmod:of(effects-6, DHA-10)
conj:and(EPA-8, DHA-10)
case(risk-13, on-11)
compound(risk-13, CHD-12)
nmod:on(effects-6, risk-13)
root(ROOT-0, remain-14)
xcomp(remain-14, unclear-15)
cc(remain-14, but-17)
aux(involve-19, may-18)
conj:but(remain-14, involve-19)
dobj(involve-19, modulation-20)
case(metabolism-23, of-21)
compound(metabolism-23, lipid-22)
nmod:of(modulation-20, metabolism-23)
nmod:of(modulation-20, inflammation-25)
conj:and(metabolism-23, inflammation-25)
cc(metabolism-23, and-27)
nmod:of(modulation-20, oxidative_stress-28)
conj:and(metabolism-23, oxidative_stress-28)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB understand/VB the/DT role/NN of/IN omega-3_fatty_acids/JJ in/IN cardiovascular_health/JJ and_disease/NN prevention/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB fully))
              (VB understand)
              (NP
                (NP (DT the) (NN role))
                (PP (IN of)
                  (NP
                    (ADJP (JJ omega-3_fatty_acids)
                      (PP (IN in)
                        (NP (JJ cardiovascular_health) (NN and_disease))))
                    (NN prevention)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
nsubj:xsubj(understand-7, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(understand-7, to-5)
advmod(understand-7, fully-6)
xcomp(needed-4, understand-7)
det(role-9, the-8)
dobj(understand-7, role-9)
case(prevention-15, of-10)
amod(prevention-15, omega-3_fatty_acids-11)
case(and_disease-14, in-12)
amod(and_disease-14, cardiovascular_health-13)
nmod:in(omega-3_fatty_acids-11, and_disease-14)
nmod:of(role-9, prevention-15)

Omega-3_fatty_acids/NNS have/VBP been/VBN extensively/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB extensively))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

nsubjpass(studied-5, Omega-3_fatty_acids-1)
aux(studied-5, have-2)
auxpass(studied-5, been-3)
advmod(studied-5, extensively-4)
root(ROOT-0, studied-5)
case(benefits-10, for-6)
nmod:poss(benefits-10, their-7)
amod(benefits-10, potential-8)
compound(benefits-10, health-9)
nmod:for(studied-5, benefits-10)

Among/IN them/PRP ,/, eicosapentaenoic_acid/JJ -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/NN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, which/WDT are/VBP long-chain/JJ omega-3_fatty_acids/JJ ,/, have/VBP been/VBN shown/VBN to_be/NN associated/VBN with/IN decreased/VBN TJ-23/NN levels/NNS in/IN hyperTJ-23mic/JJ patients/NNS ./.

(ROOT
  (S
    (PP (IN Among)
      (NP (PRP them)))
    (, ,)
    (NP
      (NP
        (NP
          (ADVP (JJ eicosapentaenoic_acid))
          (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
          (CC and)
          (NP (NN docosahexaenoic_acid)))
        (PRN (-LRB- -LRB-)
          (NP (NNP DHA))
          (-RRB- -RRB-)))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBP are)
            (ADVP (JJ long-chain))
            (ADJP (JJ omega-3_fatty_acids)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (NP
            (NP (NN to_be))
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (VBN decreased) (NN TJ-23) (NNS levels))
                  (PP (IN in)
                    (NP (JJ hyperTJ-23mic) (NNS patients))))))))))
    (. .)))

case(them-2, Among-1)
nmod:among(shown-21, them-2)
advmod(EPA-6, eicosapentaenoic_acid-4)
nsubj(omega-3_fatty_acids-17, EPA-6)
nsubjpass(shown-21, EPA-6)
cc(EPA-6, and-8)
conj:and(EPA-6, docosahexaenoic_acid-9)
nsubj(omega-3_fatty_acids-17, docosahexaenoic_acid-9)
nsubjpass(shown-21, docosahexaenoic_acid-9)
appos(EPA-6, DHA-11)
ref(EPA-6, which-14)
cop(omega-3_fatty_acids-17, are-15)
advmod(omega-3_fatty_acids-17, long-chain-16)
acl:relcl(EPA-6, omega-3_fatty_acids-17)
aux(shown-21, have-19)
auxpass(shown-21, been-20)
root(ROOT-0, shown-21)
dobj(shown-21, to_be-22)
acl(to_be-22, associated-23)
case(levels-27, with-24)
amod(levels-27, decreased-25)
compound(levels-27, TJ-23-26)
nmod:with(associated-23, levels-27)
case(patients-30, in-28)
amod(patients-30, hyperTJ-23mic-29)
nmod:in(levels-27, patients-30)

Furthermore/RB ,/, these/DT fatty_acids/NNS have/VBP also/RB been/VBN linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (DT these) (NNS fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN linked)
          (PP (TO to)
            (NP
              (NP
                (NP (DT a) (VBN reduced) (NN risk))
                (PP (IN of)
                  (S
                    (VP (VBG developing)
                      (NP (NN coronary_heart_disease))))))
              (PRN (-LRB- -LRB-)
                (NP (NNP CHD))
                (-RRB- -RRB-)))))))
    (. .)))

advmod(linked-8, Furthermore-1)
det(fatty_acids-4, these-3)
nsubjpass(linked-8, fatty_acids-4)
aux(linked-8, have-5)
advmod(linked-8, also-6)
auxpass(linked-8, been-7)
root(ROOT-0, linked-8)
case(risk-12, to-9)
det(risk-12, a-10)
amod(risk-12, reduced-11)
nmod:to(linked-8, risk-12)
mark(developing-14, of-13)
acl(risk-12, developing-14)
dobj(developing-14, coronary_heart_disease-15)
appos(risk-12, CHD-17)

The/DT mechanisms/NNS behind/IN these/DT associations/NNS are/VBP not/RB yet/RB fully/RB understood/VBN ,/, but/CC it/PRP is/VBZ believed/VBN that/IN the/DT anti-inflammatory/JJ and/CC anti-thrombotic/JJ properties/NNS of/IN EPA/NNP and/CC DHA/NNP may/MD play/VB a/DT role/NN ./.

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NNS mechanisms))
        (PP (IN behind)
          (NP (DT these) (NNS associations))))
      (VP (VBP are) (RB not)
        (ADVP (RB yet))
        (VP
          (ADVP (RB fully))
          (VBN understood))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ anti-inflammatory)
                  (CC and)
                  (JJ anti-thrombotic) (NNS properties))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (VP (MD may)
                (VP (VB play)
                  (NP (DT a) (NN role)))))))))
    (. .)))

det(mechanisms-2, The-1)
nsubjpass(understood-10, mechanisms-2)
case(associations-5, behind-3)
det(associations-5, these-4)
nmod:behind(mechanisms-2, associations-5)
auxpass(understood-10, are-6)
neg(understood-10, not-7)
advmod(understood-10, yet-8)
advmod(understood-10, fully-9)
root(ROOT-0, understood-10)
cc(understood-10, but-12)
nsubjpass(believed-15, it-13)
auxpass(believed-15, is-14)
conj:but(understood-10, believed-15)
mark(play-27, that-16)
det(properties-21, the-17)
amod(properties-21, anti-inflammatory-18)
cc(anti-inflammatory-18, and-19)
conj:and(anti-inflammatory-18, anti-thrombotic-20)
amod(properties-21, anti-thrombotic-20)
nsubj(play-27, properties-21)
case(EPA-23, of-22)
nmod:of(properties-21, EPA-23)
cc(EPA-23, and-24)
nmod:of(properties-21, DHA-25)
conj:and(EPA-23, DHA-25)
aux(play-27, may-26)
ccomp(believed-15, play-27)
det(role-29, a-28)
dobj(play-27, role-29)

In/IN addition/NN to/TO their/PRP$ potential/JJ cardiovascular_benefits/NNS ,/, omega-3_fatty_acids/JJ have/VBP also/RB been/VBN investigated/VBN for/IN their/PRP$ effects/NNS on/IN other/JJ health/NN conditions/NNS such/JJ as/IN cognitive/JJ function/NN and/CC mood_disorders/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP (PRP$ their) (JJ potential) (NNS cardiovascular_benefits)))))
    (, ,)
    (NP (JJ omega-3_fatty_acids))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN been)
        (VP (VBN investigated)
          (PP (IN for)
            (NP (PRP$ their) (NNS effects)))
          (PP (IN on)
            (NP
              (NP (JJ other) (NN health) (NNS conditions))
              (PP (JJ such) (IN as)
                (NP (JJ cognitive) (NN function)
                  (CC and)
                  (NNS mood_disorders))))))))
    (. .)))

case(cardiovascular_benefits-6, In-1)
mwe(In-1, addition-2)
mwe(In-1, to-3)
nmod:poss(cardiovascular_benefits-6, their-4)
amod(cardiovascular_benefits-6, potential-5)
nmod:in_addition_to(investigated-12, cardiovascular_benefits-6)
nsubjpass(investigated-12, omega-3_fatty_acids-8)
aux(investigated-12, have-9)
advmod(investigated-12, also-10)
auxpass(investigated-12, been-11)
root(ROOT-0, investigated-12)
case(effects-15, for-13)
nmod:poss(effects-15, their-14)
nmod:for(investigated-12, effects-15)
case(conditions-19, on-16)
amod(conditions-19, other-17)
compound(conditions-19, health-18)
nmod:on(investigated-12, conditions-19)
case(function-23, such-20)
mwe(such-20, as-21)
amod(function-23, cognitive-22)
nmod:such_as(conditions-19, function-23)
cc(function-23, and-24)
nmod:such_as(conditions-19, mood_disorders-25)
conj:and(function-23, mood_disorders-25)

Overall/RB ,/, the/DT evidence/NN suggests/VBZ that/IN increasing/VBG the/DT intake/NN of/IN EPA/NNP and/CC DHA/NNP through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD have/VB important/JJ health/NN implications/NNS ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT the) (NN evidence))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (S
            (VP (VBG increasing)
              (NP
                (NP (DT the) (NN intake))
                (PP (IN of)
                  (NP (NNP EPA)
                    (CC and)
                    (NNP DHA))))
              (PP (IN through)
                (NP (JJ dietary) (NNS sources)
                  (CC or)
                  (NN supplementation)))))
          (VP (MD may)
            (VP (VB have)
              (NP (JJ important) (NN health) (NNS implications)))))))
    (. .)))

advmod(suggests-5, Overall-1)
det(evidence-4, the-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
mark(have-20, that-6)
csubj(have-20, increasing-7)
det(intake-9, the-8)
dobj(increasing-7, intake-9)
case(EPA-11, of-10)
nmod:of(intake-9, EPA-11)
cc(EPA-11, and-12)
nmod:of(intake-9, DHA-13)
conj:and(EPA-11, DHA-13)
case(sources-16, through-14)
amod(sources-16, dietary-15)
nmod:through(increasing-7, sources-16)
cc(sources-16, or-17)
nmod:through(increasing-7, supplementation-18)
conj:or(sources-16, supplementation-18)
aux(have-20, may-19)
ccomp(suggests-5, have-20)
amod(implications-23, important-21)
compound(implications-23, health-22)
dobj(have-20, implications-23)

Omega-3_fatty_acids/NNS ,/, specifically/RB eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to/TO exhibit/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (NNS Omega-3_fatty_acids))
      (, ,)
      (VP
        (VP
          (ADVP (RB specifically))
          (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB exhibit)
                (NP (JJ numerous) (NN health) (NNS benefits))))))))
    (. .)))

nsubjpass(shown-24, Omega-3_fatty_acids-1)
nsubj:xsubj(exhibit-26, Omega-3_fatty_acids-1)
advmod(eicosapentaenoic_acid-4, specifically-3)
dep(Omega-3_fatty_acids-1, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(Omega-3_fatty_acids-1, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(shown-24, have-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
mark(exhibit-26, to-25)
xcomp(shown-24, exhibit-26)
amod(benefits-29, numerous-27)
compound(benefits-29, health-28)
dobj(exhibit-26, benefits-29)

Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN these/DT long-chain/JJ omega-3_fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN levels/NNS of/IN tenofovir_diphosphate/NN in/IN hypertenofovir/JJ diphosphatemic/JJ patients/NNS ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN demonstrated)
        (SBAR (IN that)
          (S
            (NP (DT these) (JJ long-chain) (NNS omega-3_fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (NNS levels))
                    (PP (IN of)
                      (NP
                        (NP (NN tenofovir_diphosphate))
                        (PP (IN in)
                          (NP (JJ hypertenofovir) (JJ diphosphatemic) (NNS patients)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
mark(associated-10, that-5)
det(omega-3_fatty_acids-8, these-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nsubjpass(associated-10, omega-3_fatty_acids-8)
auxpass(associated-10, are-9)
ccomp(demonstrated-4, associated-10)
case(levels-13, with-11)
amod(levels-13, decreased-12)
nmod:with(associated-10, levels-13)
case(tenofovir_diphosphate-15, of-14)
nmod:of(levels-13, tenofovir_diphosphate-15)
case(patients-19, in-16)
amod(patients-19, hypertenofovir-17)
amod(patients-19, diphosphatemic-18)
nmod:in(tenofovir_diphosphate-15, patients-19)

Furthermore/RB ,/, the/DT consumption/NN of/IN EPA/NNP and/CC DHA/NNP has_been/VBP linked/VBN to/TO a/DT reduced/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (NN consumption))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA))))
    (VP (VBP has_been)
      (VP (VBN linked)
        (PP (TO to)
          (NP
            (NP
              (NP (DT a) (VBN reduced) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG developing)
                    (NP (NN coronary_heart_disease))))))
            (PRN (-LRB- -LRB-)
              (NP (NNP CHD))
              (-RRB- -RRB-))))))
    (. .)))

advmod(has_been-9, Furthermore-1)
det(consumption-4, the-3)
nsubj(has_been-9, consumption-4)
case(EPA-6, of-5)
nmod:of(consumption-4, EPA-6)
cc(EPA-6, and-7)
nmod:of(consumption-4, DHA-8)
conj:and(EPA-6, DHA-8)
root(ROOT-0, has_been-9)
dep(has_been-9, linked-10)
case(risk-14, to-11)
det(risk-14, a-12)
amod(risk-14, reduced-13)
nmod:to(linked-10, risk-14)
mark(developing-16, of-15)
acl(risk-14, developing-16)
dobj(developing-16, coronary_heart_disease-17)
appos(risk-14, CHD-19)

These/DT findings/NNS suggest/VBP that/IN omega-3_fatty_acids/JJ may/MD play/VB a/DT crucial/JJ role/NN in/IN the/DT prevention/NN and/CC management/NN of/IN CHD/NNP ,/, as/RB well/RB as/IN in/IN improving/VBG the/DT efficacy/NN of/IN antiretroviral/JJ therapy/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (JJ omega-3_fatty_acids))
          (VP (MD may)
            (VP (VB play)
              (NP (DT a) (JJ crucial) (NN role))
              (PP
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN prevention)
                      (CC and)
                      (NN management))
                    (PP (IN of)
                      (NP (NNP CHD)))))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (PP (IN in)
                  (S
                    (VP (VBG improving)
                      (NP
                        (NP (DT the) (NN efficacy))
                        (PP (IN of)
                          (NP (JJ antiretroviral) (NN therapy)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(play-7, that-4)
nsubj(play-7, omega-3_fatty_acids-5)
aux(play-7, may-6)
ccomp(suggest-3, play-7)
det(role-10, a-8)
amod(role-10, crucial-9)
dobj(play-7, role-10)
case(prevention-13, in-11)
det(prevention-13, the-12)
nmod:in(play-7, prevention-13)
cc(prevention-13, and-14)
nmod:in(play-7, management-15)
conj:and(prevention-13, management-15)
case(CHD-17, of-16)
nmod:of(prevention-13, CHD-17)
cc(prevention-13, as-19)
mwe(as-19, well-20)
mwe(as-19, as-21)
mark(improving-23, in-22)
nmod:in(play-7, improving-23)
conj:and(prevention-13, improving-23)
det(efficacy-25, the-24)
dobj(improving-23, efficacy-25)
case(therapy-28, of-26)
amod(therapy-28, antiretroviral-27)
nmod:of(efficacy-25, therapy-28)

Further/RB research/NN is/VBZ needed/VBN to/TO fully/RB elucidate/VB the/DT mechanisms/NNS underlying/VBG these/DT associations/NNS and/CC to/TO determine/VB optimal/JJ dosages/NNS for/IN therapeutic/JJ use/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP
                (ADVP (RB fully))
                (VB elucidate)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS associations))))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (JJ optimal) (NNS dosages))
                (PP (IN for)
                  (NP (JJ therapeutic) (NN use)))))))))
    (. .)))

advmod(needed-4, Further-1)
nsubjpass(needed-4, research-2)
auxpass(needed-4, is-3)
root(ROOT-0, needed-4)
mark(elucidate-7, to-5)
advmod(elucidate-7, fully-6)
ccomp(needed-4, elucidate-7)
det(mechanisms-9, the-8)
dobj(elucidate-7, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(associations-12, these-11)
dobj(underlying-10, associations-12)
cc(elucidate-7, and-13)
mark(determine-15, to-14)
ccomp(needed-4, determine-15)
conj:and(elucidate-7, determine-15)
amod(dosages-17, optimal-16)
dobj(determine-15, dosages-17)
case(use-20, for-18)
amod(use-20, therapeutic-19)
nmod:for(determine-15, use-20)

In/IN order/NN to/TO investigate/VB the/DT localization/NN and/CC distribution/NN of/IN key/JJ neurotransmitters/NNS and/CC transporters/NNS in/IN the/DT nervous/JJ system/NN ,/, a/DT panel/NN of/IN antibodies/NNS was/VBD employed/VBN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (NN order)
        (S
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NN localization)
                  (CC and)
                  (NN distribution))
                (PP (IN of)
                  (NP (JJ key) (NNS neurotransmitters)
                    (CC and)
                    (NNS transporters))))
              (PP (IN in)
                (NP (DT the) (JJ nervous) (NN system))))))))
    (, ,)
    (NP
      (NP (DT a) (NN panel))
      (PP (IN of)
        (NP (NNS antibodies))))
    (VP (VBD was)
      (VP (VBN employed)))
    (. .)))

case(order-2, In-1)
nmod:in(employed-24, order-2)
mark(investigate-4, to-3)
acl(order-2, investigate-4)
det(localization-6, the-5)
dobj(investigate-4, localization-6)
cc(localization-6, and-7)
dobj(investigate-4, distribution-8)
conj:and(localization-6, distribution-8)
case(neurotransmitters-11, of-9)
amod(neurotransmitters-11, key-10)
nmod:of(localization-6, neurotransmitters-11)
cc(neurotransmitters-11, and-12)
nmod:of(localization-6, transporters-13)
conj:and(neurotransmitters-11, transporters-13)
case(system-17, in-14)
det(system-17, the-15)
amod(system-17, nervous-16)
nmod:in(investigate-4, system-17)
det(panel-20, a-19)
nsubjpass(employed-24, panel-20)
case(antibodies-22, of-21)
nmod:of(panel-20, antibodies-22)
auxpass(employed-24, was-23)
root(ROOT-0, employed-24)

These/DT antibodies/NNS targeted/VBD a/DT variety/NN of/IN vesicular/NN transporters/NNS ,/, including/VBG DNMDAR-I/NNS for/IN vesicular/JJ eliprodil/JJ transporters/NNS and/CC VAChT/NNP for/IN acetylcholine/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS antibodies))
    (VP (VBD targeted)
      (NP
        (NP (DT a) (NN variety))
        (PP (IN of)
          (NP (NN vesicular) (NNS transporters)))
        (, ,)
        (VP (VBG including)
          (NP
            (NP (NNS DNMDAR-I))
            (PP (IN for)
              (NP
                (NP (JJ vesicular) (JJ eliprodil) (NNS transporters))
                (CC and)
                (NP (NNP VAChT)))))))
      (PP (IN for)
        (NP (NN acetylcholine))))
    (. .)))

det(antibodies-2, These-1)
nsubj(targeted-3, antibodies-2)
root(ROOT-0, targeted-3)
det(variety-5, a-4)
dobj(targeted-3, variety-5)
case(transporters-8, of-6)
compound(transporters-8, vesicular-7)
nmod:of(variety-5, transporters-8)
acl(variety-5, including-10)
dobj(including-10, DNMDAR-I-11)
case(transporters-15, for-12)
amod(transporters-15, vesicular-13)
amod(transporters-15, eliprodil-14)
nmod:for(DNMDAR-I-11, transporters-15)
cc(transporters-15, and-16)
nmod:for(DNMDAR-I-11, VAChT-17)
conj:and(transporters-15, VAChT-17)
case(acetylcholine-19, for-18)
nmod:for(targeted-3, acetylcholine-19)

Additionally/RB ,/, antibodies/NNS against/IN enzymes/NNS involved/VBN in/IN neurotransmitter/NN synthesis/NN ,/, such/JJ as/IN tyrosine_hydroxylase/JJ -LRB-/-LRB- TH/NNP -RRB-/-RRB- and/CC dopamine_beta-hydroxylase/NN -LRB-/-LRB- DBH/NNP -RRB-/-RRB- ,/, were/VBD utilized/VBN ./.

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (NNS antibodies))
      (PP (IN against)
        (NP
          (NP (NNS enzymes))
          (VP (VBN involved)
            (PP (IN in)
              (NP (NN neurotransmitter) (NN synthesis))))))
      (, ,)
      (PP (JJ such) (IN as)
        (NP
          (NP
            (ADVP (JJ tyrosine_hydroxylase))
            (NP (-LRB- -LRB-) (NNP TH) (-RRB- -RRB-))
            (CC and)
            (NP (NN dopamine_beta-hydroxylase)))
          (PRN (-LRB- -LRB-)
            (NP (NNP DBH))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBD were)
      (VP (VBN utilized)))
    (. .)))

advmod(utilized-24, Additionally-1)
nsubjpass(utilized-24, antibodies-3)
case(enzymes-5, against-4)
nmod:against(antibodies-3, enzymes-5)
acl(enzymes-5, involved-6)
case(synthesis-9, in-7)
compound(synthesis-9, neurotransmitter-8)
nmod:in(involved-6, synthesis-9)
case(TH-15, such-11)
mwe(such-11, as-12)
advmod(TH-15, tyrosine_hydroxylase-13)
nmod:such_as(antibodies-3, TH-15)
cc(TH-15, and-17)
nmod:such_as(antibodies-3, dopamine_beta-hydroxylase-18)
conj:and(TH-15, dopamine_beta-hydroxylase-18)
appos(TH-15, DBH-20)
auxpass(utilized-24, were-23)
root(ROOT-0, utilized-24)

Serotonin/NNP -LRB-/-LRB- 5-HT/CD -RRB-/-RRB- ,/, vasoactive_intestinal_peptide/NN -LRB-/-LRB- VIP/NNP -RRB-/-RRB- ,/, and/CC protein_gene_product_9/CD .5/CD -LRB-/-LRB- PGP_9/NNP .5/CD -RRB-/-RRB- were/VBD also/RB targeted/VBN by/IN specific/JJ antibodies/NNS ./.

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (NNP Serotonin))
          (-LRB- -LRB-)
          (NP (CD 5-HT))
          (-RRB- -RRB-))
        (, ,)
        (NP
          (NP (NN vasoactive_intestinal_peptide))
          (PRN (-LRB- -LRB-)
            (NP (NNP VIP))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (NP
          (QP (CD protein_gene_product_9) (CD .5))))
      (PRN (-LRB- -LRB-)
        (NP (NNP PGP_9) (CD .5))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP
        (ADVP (RB also))
        (VBN targeted)
        (PP (IN by)
          (NP (JJ specific) (NNS antibodies)))))
    (. .)))

nsubjpass(targeted-20, Serotonin-1)
dep(Serotonin-1, 5-HT-3)
conj:and(Serotonin-1, vasoactive_intestinal_peptide-6)
nsubjpass(targeted-20, vasoactive_intestinal_peptide-6)
appos(vasoactive_intestinal_peptide-6, VIP-8)
cc(Serotonin-1, and-11)
compound(.5-13, protein_gene_product_9-12)
conj:and(Serotonin-1, .5-13)
nsubjpass(targeted-20, .5-13)
appos(Serotonin-1, PGP_9-15)
nummod(PGP_9-15, .5-16)
auxpass(targeted-20, were-18)
advmod(targeted-20, also-19)
root(ROOT-0, targeted-20)
case(antibodies-23, by-21)
amod(antibodies-23, specific-22)
nmod:by(targeted-20, antibodies-23)

The/DT use/NN of/IN these/DT antibodies/NNS allowed/VBD for/IN detailed/JJ analysis/NN of/IN the/DT localization/NN and/CC distribution/NN of/IN these/DT key/JJ molecules/NNS in/IN the/DT nervous/JJ system/NN ,/, providing/VBG important/JJ insights/NNS into/IN their/PRP$ roles/NNS in/IN neural/JJ function/NN and_disease/NN states/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (DT these) (NNS antibodies))))
    (VP (VBD allowed)
      (PP (IN for)
        (NP
          (NP (JJ detailed) (NN analysis))
          (PP (IN of)
            (NP
              (NP (DT the) (NN localization))
              (CC and)
              (NP
                (NP (NN distribution))
                (PP (IN of)
                  (NP (DT these) (JJ key) (NNS molecules))))))))
      (PP (IN in)
        (NP (DT the) (JJ nervous) (NN system)))
      (, ,)
      (S
        (VP (VBG providing)
          (NP (JJ important) (NNS insights))
          (PP (IN into)
            (NP
              (NP (PRP$ their) (NNS roles))
              (PP (IN in)
                (NP (JJ neural) (NN function) (NN and_disease) (NNS states))))))))
    (. .)))

det(use-2, The-1)
nsubj(allowed-6, use-2)
case(antibodies-5, of-3)
det(antibodies-5, these-4)
nmod:of(use-2, antibodies-5)
root(ROOT-0, allowed-6)
case(analysis-9, for-7)
amod(analysis-9, detailed-8)
nmod:for(allowed-6, analysis-9)
case(localization-12, of-10)
det(localization-12, the-11)
nmod:of(analysis-9, localization-12)
cc(localization-12, and-13)
nmod:of(analysis-9, distribution-14)
conj:and(localization-12, distribution-14)
case(molecules-18, of-15)
det(molecules-18, these-16)
amod(molecules-18, key-17)
nmod:of(distribution-14, molecules-18)
case(system-22, in-19)
det(system-22, the-20)
amod(system-22, nervous-21)
nmod:in(allowed-6, system-22)
xcomp(allowed-6, providing-24)
amod(insights-26, important-25)
dobj(providing-24, insights-26)
case(roles-29, into-27)
nmod:poss(roles-29, their-28)
nmod:into(providing-24, roles-29)
case(states-34, in-30)
amod(states-34, neural-31)
compound(states-34, function-32)
compound(states-34, and_disease-33)
nmod:in(roles-29, states-34)

Adenosine/JJ A3/NN receptor/NN is_a/VBZ G_protein-coupled_receptor/JJ that/IN has_been/VBP shown/VBN to/TO play/VB a/DT role/NN in/IN various/JJ physiological/JJ processes/NNS ./.

(ROOT
  (S
    (NP (JJ Adenosine) (NN A3) (NN receptor))
    (VP (VBZ is_a)
      (ADJP (JJ G_protein-coupled_receptor))
      (SBAR (IN that)
        (S
          (VP (VBP has_been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB play)
                    (NP
                      (NP (DT a) (NN role))
                      (PP (IN in)
                        (NP (JJ various) (JJ physiological) (NNS processes))))))))))))
    (. .)))

amod(receptor-3, Adenosine-1)
compound(receptor-3, A3-2)
nsubj(is_a-4, receptor-3)
root(ROOT-0, is_a-4)
xcomp(is_a-4, G_protein-coupled_receptor-5)
mark(has_been-7, that-6)
ccomp(is_a-4, has_been-7)
dep(has_been-7, shown-8)
mark(play-10, to-9)
xcomp(shown-8, play-10)
det(role-12, a-11)
dobj(play-10, role-12)
case(processes-16, in-13)
amod(processes-16, various-14)
amod(processes-16, physiological-15)
nmod:in(role-12, processes-16)

The/DT activation/NN of/IN this/DT receptor/NN by/IN 2-Cl-IB-MECA/JJ has_been/NN previously/RB reported/VBD to/TO elicit/VB a/DT response/NN that/WDT is/VBZ mediated/VBN via/IN G/NNP proteins/NNS ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN activation))
      (PP (IN of)
        (NP
          (NP (DT this) (NN receptor))
          (PP (IN by)
            (NP (JJ 2-Cl-IB-MECA) (NN has_been))))))
    (ADVP (RB previously))
    (VP (VBD reported)
      (S
        (VP (TO to)
          (VP (VB elicit)
            (NP
              (NP (DT a) (NN response))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBZ is)
                    (VP (VBN mediated)
                      (PP (IN via)
                        (NP (NNP G) (NNS proteins))))))))))))
    (. .)))

det(activation-2, The-1)
nsubj(reported-10, activation-2)
nsubj:xsubj(elicit-12, activation-2)
case(receptor-5, of-3)
det(receptor-5, this-4)
nmod:of(activation-2, receptor-5)
case(has_been-8, by-6)
amod(has_been-8, 2-Cl-IB-MECA-7)
nmod:by(receptor-5, has_been-8)
advmod(reported-10, previously-9)
root(ROOT-0, reported-10)
mark(elicit-12, to-11)
xcomp(reported-10, elicit-12)
det(response-14, a-13)
dobj(elicit-12, response-14)
nsubjpass(mediated-17, response-14)
ref(response-14, that-15)
auxpass(mediated-17, is-16)
acl:relcl(response-14, mediated-17)
case(proteins-20, via-18)
compound(proteins-20, G-19)
nmod:via(mediated-17, proteins-20)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN pertussis/NN toxin/NN treatment/NN on/IN the/DT response/NN of/IN adenosine_A3_receptor/JJ to/TO 2-Cl-IB-MECA/JJ ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (SBAR
        (S
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP (NN pertussis) (NN toxin))))
          (VP (NN treatment)
            (PP (IN on)
              (NP
                (NP (DT the) (NN response))
                (PP (IN of)
                  (NP
                    (QP (JJ adenosine_A3_receptor) (TO to) (JJ 2-Cl-IB-MECA))))))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
nsubj(treatment-12, effect-8)
case(toxin-11, of-9)
compound(toxin-11, pertussis-10)
nmod:of(effect-8, toxin-11)
ccomp(investigated-6, treatment-12)
case(response-15, on-13)
det(response-15, the-14)
nmod:on(treatment-12, response-15)
case(2-Cl-IB-MECA-19, of-16)
advmod(2-Cl-IB-MECA-19, adenosine_A3_receptor-17)
dep(2-Cl-IB-MECA-19, to-18)
nmod:of(response-15, 2-Cl-IB-MECA-19)

Our/PRP$ results/NNS demonstrate/VBP that/IN treatment/NN with/IN pertussis/NN toxin/NN did/VBD not/RB affect/VB the/DT response/NN of/IN adenosine_A3_receptor/JJ to/TO 2-Cl-IB-MECA/JJ ,/, suggesting/VBG that/IN this/DT response/NN may/MD be/VB mediated/VBN via/IN a/DT pertussis/NN toxin-insensitive/JJ G_protein/NN ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBP demonstrate)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN treatment))
            (PP (IN with)
              (NP (NN pertussis) (NN toxin))))
          (VP (VBD did) (RB not)
            (VP (VB affect)
              (NP
                (NP (DT the) (NN response))
                (PP (IN of)
                  (NP
                    (QP (JJ adenosine_A3_receptor) (TO to) (JJ 2-Cl-IB-MECA))))
                (, ,)
                (VP (VBG suggesting)
                  (SBAR (IN that)
                    (S
                      (NP (DT this) (NN response))
                      (VP (MD may)
                        (VP (VB be)
                          (VP (VBN mediated)
                            (PP (IN via)
                              (NP (DT a) (NN pertussis) (JJ toxin-insensitive) (NN G_protein)))))))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(demonstrate-3, results-2)
root(ROOT-0, demonstrate-3)
mark(affect-11, that-4)
nsubj(affect-11, treatment-5)
case(toxin-8, with-6)
compound(toxin-8, pertussis-7)
nmod:with(treatment-5, toxin-8)
aux(affect-11, did-9)
neg(affect-11, not-10)
ccomp(demonstrate-3, affect-11)
det(response-13, the-12)
dobj(affect-11, response-13)
case(2-Cl-IB-MECA-17, of-14)
advmod(2-Cl-IB-MECA-17, adenosine_A3_receptor-15)
dep(2-Cl-IB-MECA-17, to-16)
nmod:of(response-13, 2-Cl-IB-MECA-17)
acl(response-13, suggesting-19)
mark(mediated-25, that-20)
det(response-22, this-21)
nsubjpass(mediated-25, response-22)
aux(mediated-25, may-23)
auxpass(mediated-25, be-24)
ccomp(suggesting-19, mediated-25)
case(G_protein-30, via-26)
det(G_protein-30, a-27)
compound(G_protein-30, pertussis-28)
amod(G_protein-30, toxin-insensitive-29)
nmod:via(mediated-25, G_protein-30)

These/DT findings/NNS provide/VBP insights/NNS into/IN the/DT mechanism/NN of/IN action/NN of/IN adenosine_A3_receptor/JJ and/CC may/MD have/VB implications/NNS for/IN the/DT development/NN of/IN novel/NN therapeutic/JJ agents/NNS targeting/VBG this/DT receptor/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP provide)
      (NP
        (NP (NNS insights))
        (PP (IN into)
          (NP
            (NP (DT the) (NN mechanism))
            (PP (IN of)
              (NP
                (NP (NN action))
                (PP (IN of)
                  (NP
                    (UCP
                      (ADJP (JJ adenosine_A3_receptor))
                      (CC and)
                      (VP (MD may)
                        (VP (VB have)
                          (NP
                            (NP (NNS implications))
                            (PP (IN for)
                              (NP
                                (NP (DT the) (NN development))
                                (PP (IN of)
                                  (NP (NN novel)))))))))
                    (JJ therapeutic) (NNS agents)))))))
        (VP (VBG targeting)
          (NP (DT this) (NN receptor)))))
    (. .)))

det(findings-2, These-1)
nsubj(provide-3, findings-2)
root(ROOT-0, provide-3)
dobj(provide-3, insights-4)
case(mechanism-7, into-5)
det(mechanism-7, the-6)
nmod:into(insights-4, mechanism-7)
case(action-9, of-8)
nmod:of(mechanism-7, action-9)
case(agents-22, of-10)
amod(agents-22, adenosine_A3_receptor-11)
cc(adenosine_A3_receptor-11, and-12)
aux(have-14, may-13)
conj:and(adenosine_A3_receptor-11, have-14)
amod(agents-22, have-14)
dobj(have-14, implications-15)
case(development-18, for-16)
det(development-18, the-17)
nmod:for(implications-15, development-18)
case(novel-20, of-19)
nmod:of(development-18, novel-20)
amod(agents-22, therapeutic-21)
nmod:of(action-9, agents-22)
acl(insights-4, targeting-23)
det(receptor-25, this-24)
dobj(targeting-23, receptor-25)

This/DT study/NN aimed/VBD to/TO investigate/VB the/DT effect/NN of/IN fenicaberan/NN on/IN the/DT risk/NN of/IN calculous_cholecystitis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN fenicaberan))))
            (PP (IN on)
              (NP
                (NP (DT the) (NN risk))
                (PP (IN of)
                  (NP
                    (NP (NNS calculous_cholecystitis))
                    (, ,)
                    (NP (NN photophobia))
                    (, ,)
                    (CC and)
                    (NP (NN phonophobia))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(investigate-5, study-2)
root(ROOT-0, aimed-3)
mark(investigate-5, to-4)
xcomp(aimed-3, investigate-5)
det(effect-7, the-6)
dobj(investigate-5, effect-7)
case(fenicaberan-9, of-8)
nmod:of(effect-7, fenicaberan-9)
case(risk-12, on-10)
det(risk-12, the-11)
nmod:on(investigate-5, risk-12)
case(calculous_cholecystitis-14, of-13)
nmod:of(risk-12, calculous_cholecystitis-14)
nmod:of(risk-12, photophobia-16)
conj:and(calculous_cholecystitis-14, photophobia-16)
cc(calculous_cholecystitis-14, and-18)
nmod:of(risk-12, phonophobia-19)
conj:and(calculous_cholecystitis-14, phonophobia-19)

A/DT randomized_controlled_trial/NN was/VBD conducted/VBN in/IN which/WDT participants/NNS were/VBD administered/VBN fenicaberan/NN and/CC placebo/NN at/IN different/JJ time/NN points/NNS ./.

(ROOT
  (S
    (NP (DT A) (NN randomized_controlled_trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NNS participants))
              (VP (VBD were)
                (VP (VBN administered)
                  (NP (NN fenicaberan)
                    (CC and)
                    (NN placebo))
                  (PP (IN at)
                    (NP (JJ different) (NN time) (NNS points))))))))))
    (. .)))

det(randomized_controlled_trial-2, A-1)
nsubjpass(conducted-4, randomized_controlled_trial-2)
auxpass(conducted-4, was-3)
root(ROOT-0, conducted-4)
mark(administered-9, in-5)
dobj(administered-9, which-6)
nsubjpass(administered-9, participants-7)
auxpass(administered-9, were-8)
advcl(conducted-4, administered-9)
dobj(administered-9, fenicaberan-10)
cc(fenicaberan-10, and-11)
dobj(administered-9, placebo-12)
conj:and(fenicaberan-10, placebo-12)
case(points-16, at-13)
amod(points-16, different-14)
compound(points-16, time-15)
nmod:at(administered-9, points-16)

At_2/JJ h/NN after/IN dosing/VBG ,/, fenicaberan/NN was/VBD found/VBD to/TO significantly/RB reduce/VB the/DT risk/NN of/IN calculous_cholecystitis/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 12-22/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/JJ by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NN h))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN fenicaberan))
    (VP (VBD was)
      (ADJP
        (ADJP (VBD found)
          (S
            (VP (TO to)
              (ADVP (RB significantly))
              (VP (VB reduce)
                (NP
                  (NP (DT the) (NN risk))
                  (PP (IN of)
                    (NP (NNS calculous_cholecystitis))))
                (PP (IN by)
                  (NP (CD 14) (NN %)))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP
                (NP
                  (NP (CD 6-20) (NN %))
                  (, ,)
                  (NP (NNP P)))
                (X
                  (X (SYM =))
                  (NP (CD 0.0005))))))
          (-RRB- -RRB-))
        (, ,)
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP (CD 17) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 12-22) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))
        (, ,)
        (CC and)
        (ADJP (JJ phonophobia)
          (PP (IN by)
            (NP (CD 14) (NN %))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (CD 95) (NN %))
            (VP (VBP CI)
              (NP (CD 17-20) (NN %))
              (, ,)
              (SBAR
                (S
                  (NP (NNP P))
                  (VP (VBP <)
                    (NP (CD 0.0001)))))))
          (-RRB- -RRB-))))
    (. .)))

amod(h-2, At_2-1)
dep(found-8, h-2)
mark(h-2, after-3)
dep(h-2, dosing-4)
nsubjpass(found-8, fenicaberan-6)
nsubj:xsubj(reduce-11, fenicaberan-6)
nsubj(photophobia-31, fenicaberan-6)
nsubj(phonophobia-48, fenicaberan-6)
auxpass(found-8, was-7)
root(ROOT-0, found-8)
mark(reduce-11, to-9)
advmod(reduce-11, significantly-10)
xcomp(found-8, reduce-11)
det(risk-13, the-12)
dobj(reduce-11, risk-13)
case(calculous_cholecystitis-15, of-14)
nmod:of(risk-13, calculous_cholecystitis-15)
case(%-18, by-16)
nummod(%-18, 14-17)
nmod:by(reduce-11, %-18)
nummod(%-21, 95-20)
nsubj(CI-22, %-21)
dep(found-8, CI-22)
nummod(%-24, 6-20-23)
dobj(CI-22, %-24)
appos(%-24, P-26)
dep(0.0005-28, =-27)
dep(%-24, 0.0005-28)
conj:and(found-8, photophobia-31)
case(%-34, by-32)
nummod(%-34, 17-33)
nmod:by(photophobia-31, %-34)
nummod(%-37, 95-36)
nsubj(CI-38, %-37)
dep(found-8, CI-38)
nummod(%-40, 12-22-39)
dobj(CI-38, %-40)
nsubj(<-43, P-42)
dep(CI-38, <-43)
dobj(<-43, 0.0001-44)
cc(found-8, and-47)
conj:and(found-8, phonophobia-48)
case(%-51, by-49)
nummod(%-51, 14-50)
nmod:by(phonophobia-48, %-51)
nummod(%-54, 95-53)
nsubj(CI-55, %-54)
dep(found-8, CI-55)
nummod(%-57, 17-20-56)
dobj(CI-55, %-57)
nsubj(<-60, P-59)
dep(CI-55, <-60)
dobj(<-60, 0.0001-61)

These/DT findings/NNS suggest/VBP that/IN fenicaberan/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS at/IN risk/NN of/IN developing/VBG calculous_cholecystitis/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN fenicaberan))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP (NNS individuals)))
                (PP (IN at)
                  (NP
                    (NP (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (VBG developing) (NNS calculous_cholecystitis))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, fenicaberan-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
case(risk-15, at-14)
nmod:at(option-11, risk-15)
case(calculous_cholecystitis-18, of-16)
amod(calculous_cholecystitis-18, developing-17)
nmod:of(risk-15, calculous_cholecystitis-18)
nmod:of(risk-15, photophobia-20)
conj:and(calculous_cholecystitis-18, photophobia-20)
cc(calculous_cholecystitis-18, and-22)
nmod:of(risk-15, phonophobia-23)
conj:and(calculous_cholecystitis-18, phonophobia-23)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT long-term/JJ effects/NNS of/IN fenicaberan/NN on/IN these/DT conditions/NNS and/CC to/TO determine/VB its/PRP$ safety/NN profile/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ long-term) (NNS effects))
                  (PP (IN of)
                    (NP (NN fenicaberan))))
                (PP (IN on)
                  (NP (DT these) (NNS conditions)))))
            (CC and)
            (VP (TO to)
              (VP (VB determine)
                (NP (PRP$ its) (NN safety) (NN profile))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(explore-6, effects-9)
case(fenicaberan-11, of-10)
nmod:of(effects-9, fenicaberan-11)
case(conditions-14, on-12)
det(conditions-14, these-13)
nmod:on(explore-6, conditions-14)
cc(explore-6, and-15)
mark(determine-17, to-16)
ccomp(needed-4, determine-17)
conj:and(explore-6, determine-17)
nmod:poss(profile-20, its-18)
compound(profile-20, safety-19)
dobj(determine-17, profile-20)

The/DT use/NN of/IN diaminopyridine/JJ has_been/NN investigated/VBD for/IN its/PRP$ potential/JJ therapeutic/JJ effects/NNS on/IN bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (JJ diaminopyridine) (NN has_been))))
    (VP (VBD investigated)
      (PP (IN for)
        (NP
          (NP (PRP$ its) (JJ potential) (JJ therapeutic) (NNS effects))
          (PP (IN on)
            (NP
              (NP (NNS bronchospasms))
              (, ,)
              (NP (NN photophobia))
              (, ,)
              (CC and)
              (NP (NN phonophobia)))))))
    (. .)))

det(use-2, The-1)
nsubj(investigated-6, use-2)
case(has_been-5, of-3)
amod(has_been-5, diaminopyridine-4)
nmod:of(use-2, has_been-5)
root(ROOT-0, investigated-6)
case(effects-11, for-7)
nmod:poss(effects-11, its-8)
amod(effects-11, potential-9)
amod(effects-11, therapeutic-10)
nmod:for(investigated-6, effects-11)
case(bronchospasms-13, on-12)
nmod:on(effects-11, bronchospasms-13)
nmod:on(effects-11, photophobia-15)
conj:and(bronchospasms-13, photophobia-15)
cc(bronchospasms-13, and-17)
nmod:on(effects-11, phonophobia-18)
conj:and(bronchospasms-13, phonophobia-18)

In/IN a/DT randomized_controlled_trial/NN ,/, subjects/NNS were/VBD administered/VBN diaminopyridine/JJ and/CC monitored/VBN for/IN adverse/JJ effects/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (NN randomized_controlled_trial)))
    (, ,)
    (NP (NNS subjects))
    (VP (VBD were)
      (VP
        (VP (VBN administered)
          (ADJP (JJ diaminopyridine)))
        (CC and)
        (VP (VBN monitored)
          (PP (IN for)
            (NP (JJ adverse) (NNS effects))))))
    (. .)))

case(randomized_controlled_trial-3, In-1)
det(randomized_controlled_trial-3, a-2)
nmod:in(administered-7, randomized_controlled_trial-3)
nsubjpass(administered-7, subjects-5)
nsubjpass(monitored-10, subjects-5)
auxpass(administered-7, were-6)
root(ROOT-0, administered-7)
xcomp(administered-7, diaminopyridine-8)
cc(administered-7, and-9)
conj:and(administered-7, monitored-10)
case(effects-13, for-11)
amod(effects-13, adverse-12)
nmod:for(monitored-10, effects-13)

At_2/JJ hours/NNS after/IN dosing/VBG ,/, diaminopyridine/NN reduced/VBD the/DT risk/NN of/IN bronchospasms/NNS by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (PP
      (NP (JJ At_2) (NNS hours))
      (IN after)
      (S
        (VP (VBG dosing))))
    (, ,)
    (NP (NN diaminopyridine))
    (VP (VBD reduced)
      (NP
        (NP (DT the) (NN risk))
        (PP (IN of)
          (NP (NNS bronchospasms))))
      (PP (IN by)
        (NP
          (NP (CD 14) (NN %))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 95) (NN %))
              (SBAR
                (S
                  (VP (VBP CI)
                    (NP
                      (NP
                        (NP (CD 6-20) (NN %))
                        (, ,)
                        (NP (NNP P)))
                      (X
                        (X (SYM =))
                        (NP (CD 0.0005))))))))
            (-RRB- -RRB-))))
      (, ,)
      (UCP
        (ADJP (JJ photophobia)
          (PP (IN by)
            (NP
              (NP (CD 17) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 12-22) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (NN phonophobia)
          (PP (IN by)
            (NP
              (NP (CD 14) (NN %))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 95) (NN %))
                  (PP (NNP CI)
                    (NP (CD 17-20) (NN %))))
                (, ,)
                (NP (NNP P)
                  (QP (CD <) (CD 0.0001)))
                (-RRB- -RRB-)))))))
    (. .)))

amod(hours-2, At_2-1)
dep(reduced-7, hours-2)
mark(hours-2, after-3)
dep(hours-2, dosing-4)
nsubj(reduced-7, diaminopyridine-6)
root(ROOT-0, reduced-7)
det(risk-9, the-8)
dobj(reduced-7, risk-9)
case(bronchospasms-11, of-10)
nmod:of(risk-9, bronchospasms-11)
case(%-14, by-12)
nummod(%-14, 14-13)
nmod:by(reduced-7, %-14)
nummod(%-17, 95-16)
dep(%-14, %-17)
acl:relcl(%-17, CI-18)
nummod(%-20, 6-20-19)
dobj(CI-18, %-20)
appos(%-20, P-22)
dep(0.0005-24, =-23)
dep(%-20, 0.0005-24)
xcomp(reduced-7, photophobia-27)
case(%-30, by-28)
nummod(%-30, 17-29)
nmod:by(photophobia-27, %-30)
nummod(%-33, 95-32)
appos(%-30, %-33)
dep(%-36, CI-34)
nummod(%-36, 12-22-35)
nmod(%-33, %-36)
dep(%-33, P-38)
compound(0.0001-40, <-39)
nummod(P-38, 0.0001-40)
cc(photophobia-27, and-43)
xcomp(reduced-7, phonophobia-44)
conj:and(photophobia-27, phonophobia-44)
case(%-47, by-45)
nummod(%-47, 14-46)
nmod:by(phonophobia-44, %-47)
nummod(%-50, 95-49)
appos(%-47, %-50)
dep(%-53, CI-51)
nummod(%-53, 17-20-52)
nmod(%-50, %-53)
dep(%-50, P-55)
compound(0.0001-57, <-56)
nummod(P-55, 0.0001-57)

These/DT findings/NNS suggest/VBP that/IN diaminopyridine/NN may/MD be/VB a/DT promising/JJ therapeutic/JJ option/NN for/IN individuals/NNS experiencing/VBG bronchospasms/NNS ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NN diaminopyridine))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (JJ therapeutic) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS individuals))
                    (VP (VBG experiencing)
                      (NP
                        (NP (NNS bronchospasms))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, diaminopyridine-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
amod(option-11, therapeutic-10)
ccomp(suggest-3, option-11)
case(individuals-13, for-12)
nmod:for(option-11, individuals-13)
acl(individuals-13, experiencing-14)
dobj(experiencing-14, bronchospasms-15)
dobj(experiencing-14, photophobia-17)
conj:and(bronchospasms-15, photophobia-17)
cc(bronchospasms-15, and-19)
dobj(experiencing-14, phonophobia-20)
conj:and(bronchospasms-15, phonophobia-20)

Further/RB research/NN is/VBZ warranted/VBN to/TO explore/VB the/DT potential/JJ mechanisms/NNS underlying/VBG these/DT effects/NNS and/CC to/TO optimize/VB dosing/JJ regimens/NNS for/IN maximal/JJ clinical/JJ benefit/NN ./.

(ROOT
  (S
    (ADVP (RB Further))
    (NP (NN research))
    (VP (VBZ is)
      (VP (VBN warranted)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (JJ potential) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT these) (NNS effects))))))
            (CC and)
            (VP (TO to)
              (VP (VB optimize)
                (NP (JJ dosing) (NNS regimens))
                (PP (IN for)
                  (NP (JJ maximal) (JJ clinical) (NN benefit)))))))))
    (. .)))

advmod(warranted-4, Further-1)
nsubjpass(warranted-4, research-2)
auxpass(warranted-4, is-3)
root(ROOT-0, warranted-4)
mark(explore-6, to-5)
ccomp(warranted-4, explore-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, potential-8)
dobj(explore-6, mechanisms-9)
acl(mechanisms-9, underlying-10)
det(effects-12, these-11)
dobj(underlying-10, effects-12)
cc(explore-6, and-13)
mark(optimize-15, to-14)
ccomp(warranted-4, optimize-15)
conj:and(explore-6, optimize-15)
amod(regimens-17, dosing-16)
dobj(optimize-15, regimens-17)
case(benefit-21, for-18)
amod(benefit-21, maximal-19)
amod(benefit-21, clinical-20)
nmod:for(optimize-15, benefit-21)

Adenylosuccinate/JJ synthase/NN like-1/JJ -LRB-/-LRB- AdSSL1/NNP -RRB-/-RRB- is/VBZ an/DT enzyme/NN that/WDT plays/VBZ a/DT crucial/JJ role/NN in/IN purine/JJ metabolism/NN and/CC has_been/NN implicated/VBN in/IN several_diseases/NNS ,/, including/VBG cancer/NN ./.

(ROOT
  (S
    (NP
      (NP (JJ Adenylosuccinate) (NN synthase) (JJ like-1))
      (PRN (-LRB- -LRB-)
        (NP (NNP AdSSL1))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (NP
        (NP (DT an) (NN enzyme))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ plays)
              (NP
                (NP (DT a) (JJ crucial) (NN role))
                (PP (IN in)
                  (NP
                    (NP (JJ purine) (NN metabolism)
                      (CC and)
                      (NN has_been))
                    (VP (VBN implicated)
                      (PP (IN in)
                        (NP
                          (NP (NNS several_diseases))
                          (, ,)
                          (VP (VBG including)
                            (NP (NN cancer))))))))))))))
    (. .)))

amod(synthase-2, Adenylosuccinate-1)
nsubj(enzyme-9, synthase-2)
amod(synthase-2, like-1-3)
appos(synthase-2, AdSSL1-5)
cop(enzyme-9, is-7)
det(enzyme-9, an-8)
root(ROOT-0, enzyme-9)
nsubj(plays-11, enzyme-9)
ref(enzyme-9, that-10)
acl:relcl(enzyme-9, plays-11)
det(role-14, a-12)
amod(role-14, crucial-13)
dobj(plays-11, role-14)
case(metabolism-17, in-15)
amod(metabolism-17, purine-16)
nmod:in(role-14, metabolism-17)
cc(metabolism-17, and-18)
nmod:in(role-14, has_been-19)
conj:and(metabolism-17, has_been-19)
acl(metabolism-17, implicated-20)
case(several_diseases-22, in-21)
nmod:in(implicated-20, several_diseases-22)
acl(several_diseases-22, including-24)
dobj(including-24, cancer-25)

In/IN this/DT study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN Hydantocidin/NNP ,/, a/DT natural/JJ product/NN with/IN antitumor/NN properties/NNS ,/, on/IN AdSSL1/JJ levels/NNS in/IN vitro/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP
            (NP (NNP Hydantocidin))
            (, ,)
            (NP
              (NP (DT a) (JJ natural) (NN product))
              (PP (IN with)
                (NP (NN antitumor) (NNS properties))))
            (, ,))))
      (PP (IN on)
        (NP
          (NP (JJ AdSSL1) (NNS levels))
          (PP (IN in)
            (NP (NN vitro))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(investigated-6, study-3)
nsubj(investigated-6, we-5)
root(ROOT-0, investigated-6)
det(effect-8, the-7)
dobj(investigated-6, effect-8)
case(Hydantocidin-10, of-9)
nmod:of(effect-8, Hydantocidin-10)
det(product-14, a-12)
amod(product-14, natural-13)
appos(Hydantocidin-10, product-14)
case(properties-17, with-15)
compound(properties-17, antitumor-16)
nmod:with(product-14, properties-17)
case(levels-21, on-19)
amod(levels-21, AdSSL1-20)
nmod:on(investigated-6, levels-21)
case(vitro-23, in-22)
nmod:in(levels-21, vitro-23)

Our/PRP$ results/NNS showed/VBD that/IN the/DT AdSSL1/JJ level/NN of/IN the/DT non-transfected/JJ Hydantocidin/NNP group/NN was/VBD significantly/RB lower/JJR than/IN the/DT non-transfected/JJ non-Hydantocidin/JJ group/NN -LSB-/NN -LRB-/-LRB- 352/CD ±/VBP 26/CD -RRB-/-RRB- vs/NN -LRB-/-LRB- 765/CD ±/VBP 22/CD -RRB-/-RRB- ng/L/JJ ,/, P/NNP </VBP 0.001/CD -RSB-/CD ,/, indicating/VBG that/IN Hydantocidin/NNP can/MD reduce/VB AdSSL1/JJ expression/NN ./.

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS results))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ AdSSL1) (NN level))
              (PP (IN of)
                (NP (DT the) (JJ non-transfected) (NNP Hydantocidin) (NN group))))
            (VP (VBD was)
              (NP
                (ADJP
                  (ADJP (RB significantly) (JJR lower)
                    (PP (IN than)
                      (NP (DT the) (JJ non-transfected) (JJ non-Hydantocidin) (NN group) (NN -LSB-))))
                  (PRN (-LRB- -LRB-)
                    (S
                      (NP (CD 352))
                      (VP (VBP ±)
                        (NP (CD 26))))
                    (-RRB- -RRB-)))
                (NN vs))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (CD 765))
                  (VP (VBP ±)
                    (NP (CD 22))))
                (-RRB- -RRB-))
              (ADJP (JJ ng/L)))))))
    (, ,)
    (NP (NNP P))
    (VP (VBP <)
      (NP
        (QP (CD 0.001) (CD -RSB-)))
      (, ,)
      (S
        (VP (VBG indicating)
          (SBAR (IN that)
            (S
              (NP (NNP Hydantocidin))
              (VP (MD can)
                (VP (VB reduce)
                  (NP (JJ AdSSL1) (NN expression)))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
ccomp(<-36, showed-3)
mark(ng/L-33, that-4)
det(level-7, the-5)
amod(level-7, AdSSL1-6)
nsubj(ng/L-33, level-7)
case(group-12, of-8)
det(group-12, the-9)
amod(group-12, non-transfected-10)
compound(group-12, Hydantocidin-11)
nmod:of(level-7, group-12)
cop(ng/L-33, was-13)
advmod(lower-15, significantly-14)
amod(vs-27, lower-15)
case(-LSB--21, than-16)
det(-LSB--21, the-17)
amod(-LSB--21, non-transfected-18)
amod(-LSB--21, non-Hydantocidin-19)
compound(-LSB--21, group-20)
nmod:than(lower-15, -LSB--21)
nsubj(±-24, 352-23)
dep(lower-15, ±-24)
dobj(±-24, 26-25)
dep(ng/L-33, vs-27)
nsubj(±-30, 765-29)
parataxis(ng/L-33, ±-30)
dobj(±-30, 22-31)
ccomp(showed-3, ng/L-33)
nsubj(<-36, P-35)
root(ROOT-0, <-36)
compound(-RSB--38, 0.001-37)
dobj(<-36, -RSB--38)
advcl(<-36, indicating-40)
mark(reduce-44, that-41)
nsubj(reduce-44, Hydantocidin-42)
aux(reduce-44, can-43)
ccomp(indicating-40, reduce-44)
amod(expression-46, AdSSL1-45)
dobj(reduce-44, expression-46)

However/RB ,/, there/EX was/VBD no/DT significant/JJ difference/NN in/IN AdSSL1/JJ levels/NNS between/IN the/DT transfected/JJ Hydantocidin/NNP and/CC transfected/JJ non-Hydantocidin/JJ groups/NNS ./.

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP (DT no) (JJ significant) (NN difference))
        (PP (IN in)
          (NP (JJ AdSSL1) (NNS levels)))
        (PP (IN between)
          (NP (DT the) (JJ transfected) (NNP Hydantocidin)
            (CC and)
            (JJ transfected) (JJ non-Hydantocidin) (NNS groups)))))
    (. .)))

advmod(was-4, However-1)
expl(was-4, there-3)
root(ROOT-0, was-4)
neg(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
case(levels-10, in-8)
amod(levels-10, AdSSL1-9)
nmod:in(difference-7, levels-10)
case(Hydantocidin-14, between-11)
det(Hydantocidin-14, the-12)
amod(Hydantocidin-14, transfected-13)
nmod:between(difference-7, Hydantocidin-14)
cc(Hydantocidin-14, and-15)
amod(groups-18, transfected-16)
amod(groups-18, non-Hydantocidin-17)
nmod:between(difference-7, groups-18)
conj:and(Hydantocidin-14, groups-18)

These/DT findings/NNS suggest/VBP that/IN Hydantocidin/NNP may/MD have/VB potential/JJ as/IN a/DT therapeutic/JJ agent/NN for/IN diseases/NNS associated/VBN with/IN elevated/JJ AdSSL1/NNS expression/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Hydantocidin))
          (VP (MD may)
            (VP (VB have)
              (NP
                (ADJP (JJ potential)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (JJ therapeutic) (NN agent))
                      (PP (IN for)
                        (NP
                          (NP (NNS diseases))
                          (VP (VBN associated)
                            (PP (IN with)
                              (NP (JJ elevated) (NNS AdSSL1)))))))))
                (NN expression)))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(have-7, that-4)
nsubj(have-7, Hydantocidin-5)
aux(have-7, may-6)
ccomp(suggest-3, have-7)
amod(expression-19, potential-8)
case(agent-12, as-9)
det(agent-12, a-10)
amod(agent-12, therapeutic-11)
nmod:as(potential-8, agent-12)
case(diseases-14, for-13)
nmod:for(agent-12, diseases-14)
acl(diseases-14, associated-15)
case(AdSSL1-18, with-16)
amod(AdSSL1-18, elevated-17)
nmod:with(associated-15, AdSSL1-18)
dobj(have-7, expression-19)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT mechanisms/NNS underlying/VBG this/DT effect/NN and/CC to/TO evaluate/VB its/PRP$ clinical/JJ significance/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP
            (VP (TO to)
              (VP (VB explore)
                (NP
                  (NP (DT the) (NNS mechanisms))
                  (VP (VBG underlying)
                    (NP (DT this) (NN effect))))))
            (CC and)
            (VP (TO to)
              (VP (VB evaluate)
                (NP (PRP$ its) (JJ clinical) (NN significance))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
ccomp(needed-4, explore-6)
det(mechanisms-8, the-7)
dobj(explore-6, mechanisms-8)
acl(mechanisms-8, underlying-9)
det(effect-11, this-10)
dobj(underlying-9, effect-11)
cc(explore-6, and-12)
mark(evaluate-14, to-13)
ccomp(needed-4, evaluate-14)
conj:and(explore-6, evaluate-14)
nmod:poss(significance-17, its-15)
amod(significance-17, clinical-16)
dobj(evaluate-14, significance-17)

Omega-3_fatty_acids/NNS are/VBP essential/JJ polyunsaturated_fatty_acids/NNS that/WDT are/VBP known/VBN to/TO have/VB numerous/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP (NNS Omega-3_fatty_acids))
    (VP (VBP are)
      (NP
        (NP (JJ essential) (NNS polyunsaturated_fatty_acids))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP are)
              (VP (VBN known)
                (S
                  (VP (TO to)
                    (VP (VB have)
                      (NP (JJ numerous) (NN health) (NNS benefits)))))))))))
    (. .)))

nsubj(polyunsaturated_fatty_acids-4, Omega-3_fatty_acids-1)
cop(polyunsaturated_fatty_acids-4, are-2)
amod(polyunsaturated_fatty_acids-4, essential-3)
root(ROOT-0, polyunsaturated_fatty_acids-4)
nsubjpass(known-7, polyunsaturated_fatty_acids-4)
nsubj:xsubj(have-9, polyunsaturated_fatty_acids-4)
ref(polyunsaturated_fatty_acids-4, that-5)
auxpass(known-7, are-6)
acl:relcl(polyunsaturated_fatty_acids-4, known-7)
mark(have-9, to-8)
xcomp(known-7, have-9)
amod(benefits-12, numerous-10)
compound(benefits-12, health-11)
dobj(have-9, benefits-12)

Long-chain/JJ omega-3_fatty_acids/JJ ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- ,/, have/VBP been/VBN shown/VBN to_be/VB associated/VBN with/IN decreased/VBN BG9928/NNP levels/NNS in/IN hyperBG9928mic/JJ patients/NNS ,/, which/WDT is_a/NN significant/JJ risk/NN factor/NN for/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (JJ omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP EPA))
            (-RRB- -RRB-)))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (PRN (-LRB- -LRB-)
            (NP (NNP DHA))
            (-RRB- -RRB-))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (VB to_be)
              (VP (VBN associated)
                (PP (IN with)
                  (NP (VBN decreased) (NNP BG9928) (NNS levels)))
                (PP (IN in)
                  (NP
                    (NP (JJ hyperBG9928mic) (NNS patients))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (NN is_a)
                          (NP (JJ significant) (NN risk) (NN factor))
                          (PP (IN for)
                            (NP
                              (NP (VBG developing) (NN coronary_heart_disease))
                              (PRN (-LRB- -LRB-)
                                (NP (NNP CHD))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(shown-16, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dep(eicosapentaenoic_acid-4, EPA-6)
cc(eicosapentaenoic_acid-4, and-8)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-9)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-9)
dep(docosahexaenoic_acid-9, DHA-11)
aux(shown-16, have-14)
auxpass(shown-16, been-15)
root(ROOT-0, shown-16)
ccomp(shown-16, to_be-17)
dep(to_be-17, associated-18)
case(levels-22, with-19)
amod(levels-22, decreased-20)
compound(levels-22, BG9928-21)
nmod:with(associated-18, levels-22)
case(patients-25, in-23)
amod(patients-25, hyperBG9928mic-24)
nmod:in(associated-18, patients-25)
nsubj(is_a-28, patients-25)
ref(patients-25, which-27)
acl:relcl(patients-25, is_a-28)
amod(factor-31, significant-29)
compound(factor-31, risk-30)
dobj(is_a-28, factor-31)
case(coronary_heart_disease-34, for-32)
amod(coronary_heart_disease-34, developing-33)
nmod:for(is_a-28, coronary_heart_disease-34)
appos(coronary_heart_disease-34, CHD-36)

Studies/NNPS have/VBP shown/VBN that/IN EPA/NNP and/CC DHA/NNP can/MD reduce/VB inflammation/NN ,/, lower/JJR blood_pressure/NN ,/, improve/VB lipid/NN profiles/NNS ,/, and/CC decrease/VB the/DT risk/NN of/IN CHD/NNP ./.

(ROOT
  (S
    (NP (NNPS Studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (NNP EPA)
              (CC and)
              (NNP DHA))
            (VP (MD can)
              (VP
                (VP (VB reduce)
                  (NP (NN inflammation) (, ,) (JJR lower) (NN blood_pressure)))
                (, ,)
                (VP (VB improve)
                  (NP (NN lipid) (NNS profiles)))
                (, ,)
                (CC and)
                (VP (VB decrease)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP (NNP CHD)))))))))))
    (. .)))

nsubj(shown-3, Studies-1)
aux(shown-3, have-2)
root(ROOT-0, shown-3)
mark(reduce-9, that-4)
nsubj(reduce-9, EPA-5)
nsubj(improve-15, EPA-5)
nsubj(decrease-20, EPA-5)
cc(EPA-5, and-6)
conj:and(EPA-5, DHA-7)
nsubj(reduce-9, DHA-7)
aux(reduce-9, can-8)
ccomp(shown-3, reduce-9)
compound(blood_pressure-13, inflammation-10)
amod(blood_pressure-13, lower-12)
dobj(reduce-9, blood_pressure-13)
ccomp(shown-3, improve-15)
conj:and(reduce-9, improve-15)
compound(profiles-17, lipid-16)
dobj(improve-15, profiles-17)
cc(reduce-9, and-19)
ccomp(shown-3, decrease-20)
conj:and(reduce-9, decrease-20)
det(risk-22, the-21)
dobj(decrease-20, risk-22)
case(CHD-24, of-23)
nmod:of(risk-22, CHD-24)

The/DT cardioprotective/JJ effects/NNS of/IN EPA/NNP and/CC DHA/NNP may/MD be/VB due/JJ to/TO their/PRP$ ability/NN to/TO modulate/VBP various/JJ physiological/JJ processes/NNS such/JJ as/IN platelet_aggregation/NN ,/, endothelial/JJ function/NN ,/, and/CC cardiac/JJ electrophysiology/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (JJ cardioprotective) (NNS effects))
      (PP (IN of)
        (NP (NNP EPA)
          (CC and)
          (NNP DHA)))
      (SBAR
        (S
          (VP (MD may)
            (VP (VB be)
              (ADJP (JJ due)
                (PP (TO to)
                  (NP (PRP$ their) (NN ability)
                    (S
                      (VP (TO to)))))))))))
    (VP (VBP modulate)
      (NP
        (NP (JJ various) (JJ physiological) (NNS processes))
        (PP (JJ such) (IN as)
          (NP
            (NP (NN platelet_aggregation))
            (, ,)
            (NP (JJ endothelial) (NN function))
            (, ,)
            (CC and)
            (NP (JJ cardiac) (NN electrophysiology))))))
    (. .)))

det(effects-3, The-1)
amod(effects-3, cardioprotective-2)
nsubj(modulate-15, effects-3)
case(EPA-5, of-4)
nmod:of(effects-3, EPA-5)
cc(EPA-5, and-6)
nmod:of(effects-3, DHA-7)
conj:and(EPA-5, DHA-7)
aux(due-10, may-8)
cop(due-10, be-9)
acl:relcl(effects-3, due-10)
case(ability-13, to-11)
nmod:poss(ability-13, their-12)
nmod:to(due-10, ability-13)
acl(ability-13, to-14)
root(ROOT-0, modulate-15)
amod(processes-18, various-16)
amod(processes-18, physiological-17)
dobj(modulate-15, processes-18)
case(platelet_aggregation-21, such-19)
mwe(such-19, as-20)
nmod:such_as(processes-18, platelet_aggregation-21)
amod(function-24, endothelial-23)
nmod:such_as(processes-18, function-24)
conj:and(platelet_aggregation-21, function-24)
cc(platelet_aggregation-21, and-26)
amod(electrophysiology-28, cardiac-27)
nmod:such_as(processes-18, electrophysiology-28)
conj:and(platelet_aggregation-21, electrophysiology-28)

Therefore/RB ,/, increasing/VBG the/DT intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN through/IN dietary/JJ sources/NNS or/CC supplementation/NN may/MD be/VB a/DT promising/JJ approach/NN for/IN preventing/VBG or/CC managing/VBG CHD/NNP in/IN high-risk/JJ individuals/NNS ./.

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (S
      (VP (VBG increasing)
        (NP
          (NP (DT the) (NN intake))
          (PP (IN of)
            (NP (JJ long-chain) (NN omega-3_fatty_acids))))
        (PP (IN through)
          (NP (JJ dietary) (NNS sources)
            (CC or)
            (NN supplementation)))))
    (VP (MD may)
      (VP (VB be)
        (NP (DT a) (JJ promising) (NN approach))
        (PP (IN for)
          (S
            (VP (VBG preventing)
              (CC or)
              (VBG managing)
              (NP (NNP CHD))
              (PP (IN in)
                (NP (JJ high-risk) (NNS individuals))))))))
    (. .)))

advmod(approach-18, Therefore-1)
csubj(approach-18, increasing-3)
det(intake-5, the-4)
dobj(increasing-3, intake-5)
case(omega-3_fatty_acids-8, of-6)
amod(omega-3_fatty_acids-8, long-chain-7)
nmod:of(intake-5, omega-3_fatty_acids-8)
case(sources-11, through-9)
amod(sources-11, dietary-10)
nmod:through(increasing-3, sources-11)
cc(sources-11, or-12)
nmod:through(increasing-3, supplementation-13)
conj:or(sources-11, supplementation-13)
aux(approach-18, may-14)
cop(approach-18, be-15)
det(approach-18, a-16)
amod(approach-18, promising-17)
root(ROOT-0, approach-18)
mark(preventing-20, for-19)
advcl(approach-18, preventing-20)
cc(preventing-20, or-21)
advcl(approach-18, managing-22)
conj:or(preventing-20, managing-22)
dobj(preventing-20, CHD-23)
case(individuals-26, in-24)
amod(individuals-26, high-risk-25)
nmod:in(preventing-20, individuals-26)

This/DT study/NN aimed/VBD to/TO evaluate/VB the/DT effectiveness/NN of/IN DP/NNP in/IN reducing/VBG the/DT risk/NN of/IN abnormal_uterine_bleeding/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP (DT This) (NN study))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN effectiveness))
              (PP (IN of)
                (NP (NNP DP))))
            (PP (IN in)
              (S
                (VP (VBG reducing)
                  (NP
                    (NP (DT the) (NN risk))
                    (PP (IN of)
                      (NP
                        (NP (NN abnormal_uterine_bleeding))
                        (, ,)
                        (NP (NN photophobia))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))))))))))
    (. .)))

det(study-2, This-1)
nsubj(aimed-3, study-2)
nsubj:xsubj(evaluate-5, study-2)
root(ROOT-0, aimed-3)
mark(evaluate-5, to-4)
xcomp(aimed-3, evaluate-5)
det(effectiveness-7, the-6)
dobj(evaluate-5, effectiveness-7)
case(DP-9, of-8)
nmod:of(effectiveness-7, DP-9)
mark(reducing-11, in-10)
advcl(evaluate-5, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(abnormal_uterine_bleeding-15, of-14)
nmod:of(risk-13, abnormal_uterine_bleeding-15)
nmod:of(risk-13, photophobia-17)
conj:and(abnormal_uterine_bleeding-15, photophobia-17)
cc(abnormal_uterine_bleeding-15, and-19)
nmod:of(risk-13, phonophobia-20)
conj:and(abnormal_uterine_bleeding-15, phonophobia-20)

A/DT randomized/JJ ,/, double-blind/JJ ,/, placebo-controlled/JJ trial/NN was/VBD conducted/VBN on/IN a/DT group/NN of/IN women/NNS who/WP experienced/VBD these/DT symptoms/NNS ./.

(ROOT
  (S
    (NP (DT A)
      (ADJP (JJ randomized) (, ,) (JJ double-blind) (, ,) (JJ placebo-controlled))
      (NN trial))
    (VP (VBD was)
      (VP (VBN conducted)
        (PP (IN on)
          (NP
            (NP (DT a) (NN group))
            (PP (IN of)
              (NP
                (NP (NNS women))
                (SBAR
                  (WHNP (WP who))
                  (S
                    (VP (VBD experienced)
                      (NP (DT these) (NNS symptoms)))))))))))
    (. .)))

det(trial-7, A-1)
amod(placebo-controlled-6, randomized-2)
amod(placebo-controlled-6, double-blind-4)
amod(trial-7, placebo-controlled-6)
nsubjpass(conducted-9, trial-7)
auxpass(conducted-9, was-8)
root(ROOT-0, conducted-9)
case(group-12, on-10)
det(group-12, a-11)
nmod:on(conducted-9, group-12)
case(women-14, of-13)
nmod:of(group-12, women-14)
nsubj(experienced-16, women-14)
ref(women-14, who-15)
acl:relcl(women-14, experienced-16)
det(symptoms-18, these-17)
dobj(experienced-16, symptoms-18)

The/DT participants/NNS were/VBD administered/VBN DP/NNP and/CC the/DT effects/NNS were/VBD measured/VBN at/IN 2/CD hours/NNS post-dosing/JJ ./.

(ROOT
  (S
    (S
      (NP (DT The) (NNS participants))
      (VP (VBD were)
        (VP (VBN administered)
          (NP (NNP DP)))))
    (CC and)
    (S
      (NP (DT the) (NNS effects))
      (VP (VBD were)
        (VP (VBN measured)
          (PP (IN at)
            (NP (CD 2) (NNS hours)))
          (S
            (ADJP (JJ post-dosing))))))
    (. .)))

det(participants-2, The-1)
nsubjpass(administered-4, participants-2)
auxpass(administered-4, were-3)
root(ROOT-0, administered-4)
dobj(administered-4, DP-5)
cc(administered-4, and-6)
det(effects-8, the-7)
nsubjpass(measured-10, effects-8)
auxpass(measured-10, were-9)
conj:and(administered-4, measured-10)
case(hours-13, at-11)
nummod(hours-13, 2-12)
nmod:at(measured-10, hours-13)
xcomp(measured-10, post-dosing-14)

The/DT results/NNS showed/VBD that/IN DP/NNP reduced/VBD the/DT risk/NN of/IN abnormal_uterine_bleeding/VBG by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 17-20/CD %/NN ,/, P/NNP </VBP 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP DP))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (S
                  (VP (VBG abnormal_uterine_bleeding)
                    (PP (IN by)
                      (NP
                        (NP (CD 14) (NN %))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (CD 95) (NN %))
                            (SBAR
                              (S
                                (VP (VBP CI)
                                  (NP
                                    (NP
                                      (NP (CD 6-20) (NN %))
                                      (, ,)
                                      (NP (NNP P)))
                                    (X
                                      (X (SYM =))
                                      (NP (CD 0.0005))))))))
                          (-RRB- -RRB-))
                        (, ,)
                        (ADJP (JJ photophobia)
                          (PP (IN by)
                            (NP
                              (NP (CD 17) (NN %))
                              (PRN (-LRB- -LRB-)
                                (NP
                                  (NP (CD 95) (NN %))
                                  (PP (NNP CI)
                                    (NP (CD 12-22) (NN %))))
                                (, ,)
                                (NP (NNP P)
                                  (QP (CD <) (CD 0.0001)))
                                (-RRB- -RRB-)))))
                        (, ,)
                        (CC and)
                        (NP (NN phonophobia))))
                    (PP (IN by)
                      (NP (CD 14) (NN %)))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (CD 95) (NN %))
                        (VP (VBP CI)
                          (NP (CD 17-20) (NN %))
                          (, ,)
                          (SBAR
                            (S
                              (NP (NNP P))
                              (VP (VBP <)
                                (NP (CD 0.0001)))))))
                      (-RRB- -RRB-))))))))))
    (. .)))

det(results-2, The-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(reduced-6, that-4)
nsubj(reduced-6, DP-5)
ccomp(showed-3, reduced-6)
det(risk-8, the-7)
dobj(reduced-6, risk-8)
mark(abnormal_uterine_bleeding-10, of-9)
acl(risk-8, abnormal_uterine_bleeding-10)
case(%-13, by-11)
nummod(%-13, 14-12)
nmod:by(abnormal_uterine_bleeding-10, %-13)
nummod(%-16, 95-15)
dep(%-13, %-16)
acl:relcl(%-16, CI-17)
nummod(%-19, 6-20-18)
dobj(CI-17, %-19)
appos(%-19, P-21)
dep(0.0005-23, =-22)
dep(%-19, 0.0005-23)
amod(%-13, photophobia-26)
case(%-29, by-27)
nummod(%-29, 17-28)
nmod:by(photophobia-26, %-29)
nummod(%-32, 95-31)
appos(%-29, %-32)
dep(%-35, CI-33)
nummod(%-35, 12-22-34)
nmod(%-32, %-35)
dep(%-32, P-37)
compound(0.0001-39, <-38)
nummod(P-37, 0.0001-39)
cc(%-13, and-42)
nmod:by(abnormal_uterine_bleeding-10, phonophobia-43)
conj:and(%-13, phonophobia-43)
case(%-46, by-44)
nummod(%-46, 14-45)
nmod:by(abnormal_uterine_bleeding-10, %-46)
nummod(%-49, 95-48)
nsubj(CI-50, %-49)
parataxis(abnormal_uterine_bleeding-10, CI-50)
nummod(%-52, 17-20-51)
dobj(CI-50, %-52)
nsubj(<-55, P-54)
dep(CI-50, <-55)
dobj(<-55, 0.0001-56)

These/DT findings/NNS suggest/VBP that/IN DP/NNP may/MD be/VB an/DT effective/JJ treatment/NN option/NN for/IN women/NNS experiencing/VBG these/DT symptoms/NNS and/CC warrants/NNS further/JJ investigation/NN in/IN larger/JJR clinical/JJ trials/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP DP))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ effective) (NN treatment))
                (NN option)
                (PP (IN for)
                  (NP
                    (NP (NNS women))
                    (VP (VBG experiencing)
                      (NP (DT these) (NNS symptoms)
                        (CC and)
                        (NNS warrants))
                      (NP
                        (NP (JJ further) (NN investigation))
                        (PP (IN in)
                          (NP (JJR larger) (JJ clinical) (NNS trials)))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, DP-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(treatment-10, an-8)
amod(treatment-10, effective-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(women-13, for-12)
nmod:for(option-11, women-13)
acl(women-13, experiencing-14)
det(symptoms-16, these-15)
iobj(experiencing-14, symptoms-16)
cc(symptoms-16, and-17)
iobj(experiencing-14, warrants-18)
conj:and(symptoms-16, warrants-18)
amod(investigation-20, further-19)
dobj(experiencing-14, investigation-20)
case(trials-24, in-21)
amod(trials-24, larger-22)
amod(trials-24, clinical-23)
nmod:in(investigation-20, trials-24)

The/DT use/NN of/IN Lithium_citrate/NNP has_been/NN explored/VBD for/IN its/PRP$ potential/NN in/IN reducing/VBG the/DT risk/NN of/IN neurological_disorders/NNS such/JJ as/IN catatonia_syndrome/NN ,/, photophobia/NN ,/, and/CC phonophobia/NN ./.

(ROOT
  (S
    (NP
      (NP (DT The) (NN use))
      (PP (IN of)
        (NP (NNP Lithium_citrate) (NN has_been))))
    (VP (VBD explored)
      (PP (IN for)
        (NP (PRP$ its) (NN potential)))
      (PP (IN in)
        (S
          (VP (VBG reducing)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP
                  (NP (NNS neurological_disorders))
                  (PP (JJ such) (IN as)
                    (NP
                      (NP (NN catatonia_syndrome))
                      (, ,)
                      (NP (NN photophobia))
                      (, ,)
                      (CC and)
                      (NP (NN phonophobia)))))))))))
    (. .)))

det(use-2, The-1)
nsubj(explored-6, use-2)
case(has_been-5, of-3)
compound(has_been-5, Lithium_citrate-4)
nmod:of(use-2, has_been-5)
root(ROOT-0, explored-6)
case(potential-9, for-7)
nmod:poss(potential-9, its-8)
nmod:for(explored-6, potential-9)
mark(reducing-11, in-10)
advcl(explored-6, reducing-11)
det(risk-13, the-12)
dobj(reducing-11, risk-13)
case(neurological_disorders-15, of-14)
nmod:of(risk-13, neurological_disorders-15)
case(catatonia_syndrome-18, such-16)
mwe(such-16, as-17)
nmod:such_as(neurological_disorders-15, catatonia_syndrome-18)
nmod:such_as(neurological_disorders-15, photophobia-20)
conj:and(catatonia_syndrome-18, photophobia-20)
cc(catatonia_syndrome-18, and-22)
nmod:such_as(neurological_disorders-15, phonophobia-23)
conj:and(catatonia_syndrome-18, phonophobia-23)

In/IN this/DT study/NN ,/, Lithium_citrate/NNP was/VBD administered/VBN to/TO a/DT group/NN of/IN patients/NNS and/CC its/PRP$ effects/NNS were/VBD measured/VBN after/IN 2/CD hours/NNS ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (S
      (NP (NNP Lithium_citrate))
      (VP (VBD was)
        (VP (VBN administered)
          (PP (TO to)
            (NP
              (NP (DT a) (NN group))
              (PP (IN of)
                (NP (NNS patients))))))))
    (CC and)
    (S
      (NP (PRP$ its) (NNS effects))
      (VP (VBD were)
        (VP (VBN measured)
          (PP (IN after)
            (NP (CD 2) (NNS hours))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(administered-7, study-3)
nsubjpass(administered-7, Lithium_citrate-5)
auxpass(administered-7, was-6)
root(ROOT-0, administered-7)
case(group-10, to-8)
det(group-10, a-9)
nmod:to(administered-7, group-10)
case(patients-12, of-11)
nmod:of(group-10, patients-12)
cc(administered-7, and-13)
nmod:poss(effects-15, its-14)
nsubjpass(measured-17, effects-15)
auxpass(measured-17, were-16)
conj:and(administered-7, measured-17)
case(hours-20, after-18)
nummod(hours-20, 2-19)
nmod:after(measured-17, hours-20)

Results/NNS showed/VBD that/IN Lithium_citrate/NNP reduced/VBD the/DT risk/NN of/IN catatonia_syndrome/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/VBP 6-20/CD %/NN ,/, P/NNP =/SYM 0.0005/CD -RRB-/-RRB- ,/, photophobia/JJ by/IN 17/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 12-22/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ,/, and/CC phonophobia/NN by/IN 14/CD %/NN -LRB-/-LRB- 95/CD %/NN CI/NNP 17-20/CD %/NN ,/, P/NNP </CD 0.0001/CD -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP Lithium_citrate))
          (VP (VBD reduced)
            (NP
              (NP (DT the) (NN risk))
              (PP (IN of)
                (NP (NN catatonia_syndrome))))
            (PP (IN by)
              (NP
                (NP (CD 14) (NN %))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 95) (NN %))
                    (SBAR
                      (S
                        (VP (VBP CI)
                          (NP
                            (NP
                              (NP (CD 6-20) (NN %))
                              (, ,)
                              (NP (NNP P)))
                            (X
                              (X (SYM =))
                              (NP (CD 0.0005))))))))
                  (-RRB- -RRB-))))
            (, ,)
            (UCP
              (ADJP (JJ photophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 17) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 12-22) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-)))))
              (, ,)
              (CC and)
              (VP (NN phonophobia)
                (PP (IN by)
                  (NP
                    (NP (CD 14) (NN %))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (CD 95) (NN %))
                        (PP (NNP CI)
                          (NP (CD 17-20) (NN %))))
                      (, ,)
                      (NP (NNP P)
                        (QP (CD <) (CD 0.0001)))
                      (-RRB- -RRB-))))))))))
    (. .)))

nsubj(showed-2, Results-1)
root(ROOT-0, showed-2)
mark(reduced-5, that-3)
nsubj(reduced-5, Lithium_citrate-4)
ccomp(showed-2, reduced-5)
det(risk-7, the-6)
dobj(reduced-5, risk-7)
case(catatonia_syndrome-9, of-8)
nmod:of(risk-7, catatonia_syndrome-9)
case(%-12, by-10)
nummod(%-12, 14-11)
nmod:by(reduced-5, %-12)
nummod(%-15, 95-14)
dep(%-12, %-15)
acl:relcl(%-15, CI-16)
nummod(%-18, 6-20-17)
dobj(CI-16, %-18)
appos(%-18, P-20)
dep(0.0005-22, =-21)
dep(%-18, 0.0005-22)
xcomp(reduced-5, photophobia-25)
case(%-28, by-26)
nummod(%-28, 17-27)
nmod:by(photophobia-25, %-28)
nummod(%-31, 95-30)
appos(%-28, %-31)
dep(%-34, CI-32)
nummod(%-34, 12-22-33)
nmod(%-31, %-34)
dep(%-31, P-36)
compound(0.0001-38, <-37)
nummod(P-36, 0.0001-38)
cc(photophobia-25, and-41)
xcomp(reduced-5, phonophobia-42)
conj:and(photophobia-25, phonophobia-42)
case(%-45, by-43)
nummod(%-45, 14-44)
nmod:by(phonophobia-42, %-45)
nummod(%-48, 95-47)
appos(%-45, %-48)
dep(%-51, CI-49)
nummod(%-51, 17-20-50)
nmod(%-48, %-51)
dep(%-48, P-53)
compound(0.0001-55, <-54)
nummod(P-53, 0.0001-55)

These/DT findings/NNS suggest/VBP that/IN Lithium_citrate/NNP may/MD be/VB a/DT promising/JJ treatment/NN option/NN for/IN patients/NNS suffering/VBG from/IN these/DT neurological_disorders/NNS ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP (NNP Lithium_citrate))
          (VP (MD may)
            (VP (VB be)
              (NP
                (NP (DT a) (JJ promising) (NN treatment) (NN option))
                (PP (IN for)
                  (NP
                    (NP (NNS patients))
                    (VP (VBG suffering)
                      (PP (IN from)
                        (NP (DT these) (NNS neurological_disorders))))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(option-11, that-4)
nsubj(option-11, Lithium_citrate-5)
aux(option-11, may-6)
cop(option-11, be-7)
det(option-11, a-8)
amod(option-11, promising-9)
compound(option-11, treatment-10)
ccomp(suggest-3, option-11)
case(patients-13, for-12)
nmod:for(option-11, patients-13)
acl(patients-13, suffering-14)
case(neurological_disorders-17, from-15)
det(neurological_disorders-17, these-16)
nmod:from(suffering-14, neurological_disorders-17)

Further/JJ studies/NNS are/VBP needed/VBN to/TO explore/VB the/DT long-term/JJ effects/NNS and/CC safety/NN profile/NN of/IN Lithium_citrate/NNP in/IN treating/VBG these/DT conditions/NNS ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (JJ long-term) (NNS effects))
                (CC and)
                (NP
                  (NP (NN safety) (NN profile))
                  (PP (IN of)
                    (NP (NNP Lithium_citrate)))))
              (PP (IN in)
                (S
                  (VP (VBG treating)
                    (NP (DT these) (NNS conditions))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(explore-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(explore-6, to-5)
xcomp(needed-4, explore-6)
det(effects-9, the-7)
amod(effects-9, long-term-8)
dobj(explore-6, effects-9)
cc(effects-9, and-10)
compound(profile-12, safety-11)
dobj(explore-6, profile-12)
conj:and(effects-9, profile-12)
case(Lithium_citrate-14, of-13)
nmod:of(profile-12, Lithium_citrate-14)
mark(treating-16, in-15)
advcl(explore-6, treating-16)
det(conditions-18, these-17)
dobj(treating-16, conditions-18)

Long-chain/JJ omega-3_fatty_acids/NNS ,/, eicosapentaenoic_acid/VBN -LRB-/-LRB- EPA/NNP -RRB-/-RRB- -LRB-/-LRB- 20:5/CD n-3/CD -RRB-/-RRB- and/CC docosahexaenoic_acid/VBN -LRB-/-LRB- DHA/NNP -RRB-/-RRB- -LRB-/-LRB- 22:6/CD n-3/CD -RRB-/-RRB- ,/, have/VBP been/VBN widely/RB studied/VBN for/IN their/PRP$ potential/JJ health/NN benefits/NNS ./.

(ROOT
  (S
    (NP
      (NP (JJ Long-chain) (NNS omega-3_fatty_acids))
      (, ,)
      (VP
        (VP (VBN eicosapentaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP EPA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 20:5) (CD n-3)))
              (-RRB- -RRB-))))
        (CC and)
        (VP (VBN docosahexaenoic_acid)
          (NP
            (NP (-LRB- -LRB-) (NNP DHA) (-RRB- -RRB-))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD 22:6) (CD n-3)))
              (-RRB- -RRB-)))))
      (, ,))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB widely))
          (VBN studied)
          (PP (IN for)
            (NP (PRP$ their) (JJ potential) (NN health) (NNS benefits))))))
    (. .)))

amod(omega-3_fatty_acids-2, Long-chain-1)
nsubjpass(studied-25, omega-3_fatty_acids-2)
dep(omega-3_fatty_acids-2, eicosapentaenoic_acid-4)
dobj(eicosapentaenoic_acid-4, EPA-6)
compound(n-3-10, 20:5-9)
dep(EPA-6, n-3-10)
cc(eicosapentaenoic_acid-4, and-12)
dep(omega-3_fatty_acids-2, docosahexaenoic_acid-13)
conj:and(eicosapentaenoic_acid-4, docosahexaenoic_acid-13)
dobj(docosahexaenoic_acid-13, DHA-15)
compound(n-3-19, 22:6-18)
dep(DHA-15, n-3-19)
aux(studied-25, have-22)
auxpass(studied-25, been-23)
advmod(studied-25, widely-24)
root(ROOT-0, studied-25)
case(benefits-30, for-26)
nmod:poss(benefits-30, their-27)
amod(benefits-30, potential-28)
compound(benefits-30, health-29)
nmod:for(studied-25, benefits-30)

Recent/JJ studies/NNS have/VBP shown/VBN that/IN these/DT fatty_acids/NNS are/VBP associated/VBN with/IN decreased/VBN cyclocreatine/JJ levels/NNS in/IN hypercyclocreatinemic/JJ patients/NNS and/CC decreased/VBN risk/NN of/IN developing/VBG coronary_heart_disease/NN -LRB-/-LRB- CHD/NNP -RRB-/-RRB- ./.

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP have)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS fatty_acids))
            (VP (VBP are)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (VBN decreased) (JJ cyclocreatine) (NNS levels))
                    (PP (IN in)
                      (NP
                        (NP (JJ hypercyclocreatinemic) (NNS patients))
                        (CC and)
                        (NP
                          (NP
                            (NP (VBN decreased) (NN risk))
                            (PP (IN of)
                              (S
                                (VP (VBG developing)
                                  (NP (NN coronary_heart_disease))))))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP CHD))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

amod(studies-2, Recent-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
mark(associated-9, that-5)
det(fatty_acids-7, these-6)
nsubjpass(associated-9, fatty_acids-7)
auxpass(associated-9, are-8)
ccomp(shown-4, associated-9)
case(levels-13, with-10)
amod(levels-13, decreased-11)
amod(levels-13, cyclocreatine-12)
nmod:with(associated-9, levels-13)
case(patients-16, in-14)
amod(patients-16, hypercyclocreatinemic-15)
nmod:in(levels-13, patients-16)
cc(patients-16, and-17)
amod(risk-19, decreased-18)
nmod:in(levels-13, risk-19)
conj:and(patients-16, risk-19)
mark(developing-21, of-20)
acl(risk-19, developing-21)
dobj(developing-21, coronary_heart_disease-22)
appos(risk-19, CHD-24)

EPA/NNP and/CC DHA/NNP are/VBP essential/JJ components/NNS of/IN cell/NN membranes/NNS and/CC play/VB a/DT crucial/JJ role/NN in/IN maintaining/VBG membrane/NN fluidity/NN ,/, which/WDT is/VBZ important/JJ for/IN proper/JJ cellular/JJ function/NN ./.

(ROOT
  (S
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP
      (VP (VBP are)
        (NP
          (NP (JJ essential) (NNS components))
          (PP (IN of)
            (NP (NN cell) (NNS membranes)))))
      (CC and)
      (VP (VB play)
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (S
            (VP (VBG maintaining)
              (NP
                (NP (NN membrane) (NN fluidity))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ is)
                      (ADJP (JJ important)
                        (PP (IN for)
                          (NP (JJ proper) (JJ cellular) (NN function)))))))))))))
    (. .)))

nsubj(components-6, EPA-1)
nsubj(play-11, EPA-1)
cc(EPA-1, and-2)
conj:and(EPA-1, DHA-3)
nsubj(components-6, DHA-3)
cop(components-6, are-4)
amod(components-6, essential-5)
root(ROOT-0, components-6)
case(membranes-9, of-7)
compound(membranes-9, cell-8)
nmod:of(components-6, membranes-9)
cc(components-6, and-10)
conj:and(components-6, play-11)
det(role-14, a-12)
amod(role-14, crucial-13)
dobj(play-11, role-14)
mark(maintaining-16, in-15)
advcl(play-11, maintaining-16)
compound(fluidity-18, membrane-17)
dobj(maintaining-16, fluidity-18)
nsubj(important-22, fluidity-18)
ref(fluidity-18, which-20)
cop(important-22, is-21)
acl:relcl(fluidity-18, important-22)
case(function-26, for-23)
amod(function-26, proper-24)
amod(function-26, cellular-25)
nmod:for(important-22, function-26)

These/DT fatty_acids/NNS also/RB have/VBP anti-inflammatory/JJ properties/NNS and/CC may/MD help/VB to/TO reduce/VB inflammation/NN in/IN the/DT body/NN ,/, which/WDT is_a/RB known/VBN risk/NN factor/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (NP (DT These) (NNS fatty_acids))
    (ADVP (RB also))
    (VP
      (VP (VBP have)
        (NP (JJ anti-inflammatory) (NNS properties)))
      (CC and)
      (VP (MD may)
        (VP (VB help)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (NN inflammation))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN body))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (ADVP (RB is_a))
                          (VP (VBN known)
                            (NP
                              (NP (NN risk) (NN factor))
                              (PP (IN for)
                                (NP (NNP CHD))))))))))))))))
    (. .)))

det(fatty_acids-2, These-1)
nsubj(have-4, fatty_acids-2)
nsubj(help-9, fatty_acids-2)
nsubj:xsubj(reduce-11, fatty_acids-2)
advmod(have-4, also-3)
root(ROOT-0, have-4)
amod(properties-6, anti-inflammatory-5)
dobj(have-4, properties-6)
cc(have-4, and-7)
aux(help-9, may-8)
conj:and(have-4, help-9)
mark(reduce-11, to-10)
xcomp(help-9, reduce-11)
dobj(reduce-11, inflammation-12)
case(body-15, in-13)
det(body-15, the-14)
nmod:in(inflammation-12, body-15)
nsubj(known-19, body-15)
ref(body-15, which-17)
advmod(known-19, is_a-18)
acl:relcl(body-15, known-19)
compound(factor-21, risk-20)
dobj(known-19, factor-21)
case(CHD-23, for-22)
nmod:for(factor-21, CHD-23)

Furthermore/RB ,/, EPA/NNP and/CC DHA/NNP have/VBP been/VBN shown/VBN to/TO reduce/VB triglyceride_levels/NNS ,/, which/WDT is/VBZ another/DT risk/NN factor/NN for/IN CHD/NNP ./.

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NNP EPA)
      (CC and)
      (NNP DHA))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB reduce)
                (NP
                  (NP (NNS triglyceride_levels))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBZ is)
                        (NP
                          (NP (DT another) (NN risk) (NN factor))
                          (PP (IN for)
                            (NP (NNP CHD))))))))))))))
    (. .)))

advmod(shown-8, Furthermore-1)
nsubjpass(shown-8, EPA-3)
nsubj:xsubj(reduce-10, EPA-3)
cc(EPA-3, and-4)
conj:and(EPA-3, DHA-5)
nsubjpass(shown-8, DHA-5)
nsubj:xsubj(reduce-10, DHA-5)
aux(shown-8, have-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
mark(reduce-10, to-9)
xcomp(shown-8, reduce-10)
dobj(reduce-10, triglyceride_levels-11)
nsubj(factor-17, triglyceride_levels-11)
ref(triglyceride_levels-11, which-13)
cop(factor-17, is-14)
det(factor-17, another-15)
compound(factor-17, risk-16)
acl:relcl(triglyceride_levels-11, factor-17)
case(CHD-19, for-18)
nmod:for(factor-17, CHD-19)

Overall/RB ,/, these/DT findings/NNS suggest/VBP that/IN increasing/VBG intake/NN of/IN long-chain/JJ omega-3_fatty_acids/NN may/MD be/VB beneficial/JJ for/IN reducing/VBG the/DT risk/NN of/IN developing/VBG CHD/NNP and/CC improving/VBG overall/JJ cardiovascular_health/NN ./.

(ROOT
  (S
    (ADVP (RB Overall))
    (, ,)
    (NP (DT these) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (VBG increasing) (NN intake))
            (PP (IN of)
              (NP (JJ long-chain) (NN omega-3_fatty_acids))))
          (VP (MD may)
            (VP (VB be)
              (ADJP (JJ beneficial)
                (PP (IN for)
                  (S
                    (VP (VBG reducing)
                      (NP
                        (NP (DT the) (NN risk))
                        (PP (IN of)
                          (S
                            (VP
                              (VP (VBG developing)
                                (NP (NNP CHD)))
                              (CC and)
                              (VP (VBG improving)
                                (NP (JJ overall) (NN cardiovascular_health))))))))))))))))
    (. .)))

advmod(suggest-5, Overall-1)
det(findings-4, these-3)
nsubj(suggest-5, findings-4)
root(ROOT-0, suggest-5)
mark(beneficial-14, that-6)
amod(intake-8, increasing-7)
nsubj(beneficial-14, intake-8)
case(omega-3_fatty_acids-11, of-9)
amod(omega-3_fatty_acids-11, long-chain-10)
nmod:of(intake-8, omega-3_fatty_acids-11)
aux(beneficial-14, may-12)
cop(beneficial-14, be-13)
ccomp(suggest-5, beneficial-14)
mark(reducing-16, for-15)
advcl(beneficial-14, reducing-16)
det(risk-18, the-17)
dobj(reducing-16, risk-18)
mark(developing-20, of-19)
acl(risk-18, developing-20)
dobj(developing-20, CHD-21)
cc(developing-20, and-22)
acl(risk-18, improving-23)
conj:and(developing-20, improving-23)
amod(cardiovascular_health-25, overall-24)
dobj(improving-23, cardiovascular_health-25)

Obesity/RB is_a/JJ major/JJ public_health/NN concern/NN worldwide/RB and/CC is/VBZ associated/VBN with/IN an/DT increased/VBN risk/NN of/IN developing/VBG various/JJ metabolic_disorders/NNS ,/, including/VBG diabetes/NN ./.

(ROOT
  (S
    (NP
      (ADJP (RB Obesity) (JJ is_a))
      (NX
        (NX
          (NX (JJ major) (NN public_health) (NN concern))
          (ADJP (RB worldwide)))
        (CC and)))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (DT an) (VBN increased) (NN risk))
            (PP (IN of)
              (S
                (VP (VBG developing)
                  (NP
                    (NP (JJ various) (NNS metabolic_disorders))
                    (, ,)
                    (VP (VBG including)
                      (NP (NN diabetes)))))))))))
    (. .)))

advmod(is_a-2, Obesity-1)
amod(concern-5, is_a-2)
amod(concern-5, major-3)
compound(concern-5, public_health-4)
nsubjpass(associated-9, concern-5)
amod(concern-5, worldwide-6)
cc(concern-5, and-7)
auxpass(associated-9, is-8)
root(ROOT-0, associated-9)
case(risk-13, with-10)
det(risk-13, an-11)
amod(risk-13, increased-12)
nmod:with(associated-9, risk-13)
mark(developing-15, of-14)
acl(risk-13, developing-15)
amod(metabolic_disorders-17, various-16)
dobj(developing-15, metabolic_disorders-17)
acl(metabolic_disorders-17, including-19)
dobj(including-19, diabetes-20)

The/DT pancreas/NN plays/VBZ a/DT critical/JJ role/NN in/IN regulating/VBG glucose/NN and/CC lipid/NN homeostasis/NNS ,/, and/CC dysfunction/NN of/IN this/DT organ/NN is/VBZ often/RB observed/VBN in/IN obesity/NN ./.

(ROOT
  (S
    (S
      (NP (DT The) (NN pancreas))
      (VP (VBZ plays)
        (NP
          (NP (DT a) (JJ critical) (NN role))
          (PP (IN in)
            (S
              (VP (VBG regulating)
                (NP (NN glucose)
                  (CC and)
                  (NN lipid) (NNS homeostasis))))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (NN dysfunction))
        (PP (IN of)
          (NP (DT this) (NN organ))))
      (VP (VBZ is)
        (VP
          (ADVP (RB often))
          (VBN observed)
          (PP (IN in)
            (NP (NN obesity))))))
    (. .)))

det(pancreas-2, The-1)
nsubj(plays-3, pancreas-2)
root(ROOT-0, plays-3)
det(role-6, a-4)
amod(role-6, critical-5)
dobj(plays-3, role-6)
mark(regulating-8, in-7)
acl(role-6, regulating-8)
compound(homeostasis-12, glucose-9)
cc(glucose-9, and-10)
conj:and(glucose-9, lipid-11)
compound(homeostasis-12, lipid-11)
dobj(regulating-8, homeostasis-12)
cc(plays-3, and-14)
nsubjpass(observed-21, dysfunction-15)
case(organ-18, of-16)
det(organ-18, this-17)
nmod:of(dysfunction-15, organ-18)
auxpass(observed-21, is-19)
advmod(observed-21, often-20)
conj:and(plays-3, observed-21)
case(obesity-23, in-22)
nmod:in(observed-21, obesity-23)

Recently/RB ,/, it/PRP has_been/VBP suggested/VBN that/IN the/DT hypersecretion/NN of/IN CPT-11/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ./.

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP (PRP it))
    (VP (VBP has_been)
      (VP (VBN suggested)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN hypersecretion))
              (PP (IN of)
                (NP
                  (NP (NN CPT-11))
                  (PP (IN by)
                    (NP (DT the) (NN pancreas))))))
            (VP (MD may)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN development))
                      (PP (IN of)
                        (NP (NN obesity))))))))))))
    (. .)))

advmod(has_been-4, Recently-1)
nsubj(has_been-4, it-3)
root(ROOT-0, has_been-4)
dep(has_been-4, suggested-5)
mark(involved-16, that-6)
det(hypersecretion-8, the-7)
nsubjpass(involved-16, hypersecretion-8)
case(CPT-11-10, of-9)
nmod:of(hypersecretion-8, CPT-11-10)
case(pancreas-13, by-11)
det(pancreas-13, the-12)
nmod:by(CPT-11-10, pancreas-13)
aux(involved-16, may-14)
auxpass(involved-16, be-15)
ccomp(suggested-5, involved-16)
case(development-19, in-17)
det(development-19, the-18)
nmod:in(involved-16, development-19)
case(obesity-21, of-20)
nmod:of(development-19, obesity-21)

In/IN this/DT study/NN ,/, we/PRP aimed/VBD to/TO evaluate/VB the/DT relationship/NN between/IN the/DT development/NN of/IN obesity/NN and/CC the/DT hypersecretion/NN of/IN CPT-11/NN by/IN the/DT pancreas/NN ./.

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD aimed)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN relationship))
              (PP (IN between)
                (NP
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity))))
                  (CC and)
                  (NP
                    (NP (DT the) (NN hypersecretion))
                    (PP (IN of)
                      (NP (NN CPT-11)))))))
            (PP (IN by)
              (NP (DT the) (NN pancreas)))))))
    (. .)))

case(study-3, In-1)
det(study-3, this-2)
nmod:in(aimed-6, study-3)
nsubj(aimed-6, we-5)
nsubj:xsubj(evaluate-8, we-5)
root(ROOT-0, aimed-6)
mark(evaluate-8, to-7)
xcomp(aimed-6, evaluate-8)
det(relationship-10, the-9)
dobj(evaluate-8, relationship-10)
case(development-13, between-11)
det(development-13, the-12)
nmod:between(relationship-10, development-13)
case(obesity-15, of-14)
nmod:of(development-13, obesity-15)
cc(development-13, and-16)
det(hypersecretion-18, the-17)
nmod:between(relationship-10, hypersecretion-18)
conj:and(development-13, hypersecretion-18)
case(CPT-11-20, of-19)
nmod:of(hypersecretion-18, CPT-11-20)
case(pancreas-23, by-21)
det(pancreas-23, the-22)
nmod:by(evaluate-8, pancreas-23)

To/TO achieve/VB this/DT goal/NN ,/, we/PRP examined/VBD the/DT effects/NNS of/IN 16.7/CD mmol/L/JJ glucose/NN and/CC 10/CD mmol/L/NN ETP/NNP on/IN the/DT secretion/NN of/IN CPT-11/NN and_insulin/NN by/IN isolated/VBN perfused/JJ pancreata/NN from/IN genetically_obese/NN -LRB-/-LRB- fa/fa/NN -RRB-/-RRB- and/CC lean/JJ -LRB-/-LRB- Fa/RB //: ?/. -RRB-/-RRB- rats/NNS ./.

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB achieve)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP
            (NP (CD 16.7) (JJ mmol/L) (NN glucose))
            (CC and)
            (NP (CD 10) (NN mmol/L) (NNP ETP)))))
      (PP (IN on)
        (NP
          (NP (DT the) (NN secretion))
          (PP (IN of)
            (NP (NN CPT-11) (NN and_insulin)))))
      (PP (IN by)
        (NP
          (NP (VBN isolated) (JJ perfused) (NN pancreata))
          (PP (IN from)
            (NP
              (NP
                (NP (NN genetically_obese))
                (PRN (-LRB- -LRB-)
                  (NP (NN fa/fa))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (ADJP
                  (ADJP (JJ lean))
                  (PRN (-LRB- -LRB-)
                    (FRAG
                      (ADVP (RB Fa) (: /))
                      (. ?))
                    (-RRB- -RRB-)))
                (NNS rats)))))))
    (. .)))

mark(achieve-2, To-1)
advcl(examined-7, achieve-2)
det(goal-4, this-3)
dobj(achieve-2, goal-4)
nsubj(examined-7, we-6)
root(ROOT-0, examined-7)
det(effects-9, the-8)
dobj(examined-7, effects-9)
case(glucose-13, of-10)
nummod(glucose-13, 16.7-11)
amod(glucose-13, mmol/L-12)
nmod:of(effects-9, glucose-13)
cc(glucose-13, and-14)
nummod(ETP-17, 10-15)
compound(ETP-17, mmol/L-16)
nmod:of(effects-9, ETP-17)
conj:and(glucose-13, ETP-17)
case(secretion-20, on-18)
det(secretion-20, the-19)
nmod:on(examined-7, secretion-20)
case(and_insulin-23, of-21)
compound(and_insulin-23, CPT-11-22)
nmod:of(secretion-20, and_insulin-23)
case(pancreata-27, by-24)
amod(pancreata-27, isolated-25)
amod(pancreata-27, perfused-26)
nmod:by(examined-7, pancreata-27)
case(genetically_obese-29, from-28)
nmod:from(pancreata-27, genetically_obese-29)
appos(genetically_obese-29, fa/fa-31)
cc(genetically_obese-29, and-33)
amod(rats-40, lean-34)
dep(lean-34, Fa-36)
nmod:from(pancreata-27, rats-40)
conj:and(genetically_obese-29, rats-40)

Our/PRP$ results/NNS showed/VBD that/IN CPT-11/JJ secretion/NN was/VBD significantly/RB higher/JJR in/IN obese/JJ rats/NNS compared/VBN to/TO lean/VB rats/NNS under/IN both/DT basal/JJ and/CC stimulated/VBN conditions/NNS ./.

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (JJ CPT-11) (NN secretion))
          (VP (VBD was)
            (ADVP
              (ADVP (RB significantly) (JJR higher))
              (PP (IN in)
                (NP (JJ obese) (NNS rats))))
            (VP (VBN compared)
              (S
                (VP (TO to)
                  (VP (VB lean)
                    (NP (NNS rats))
                    (PP (IN under)
                      (NP (DT both)
                        (ADJP (JJ basal)
                          (CC and)
                          (VBN stimulated))
                        (NNS conditions)))))))))))
    (. .)))

nmod:poss(results-2, Our-1)
nsubj(showed-3, results-2)
root(ROOT-0, showed-3)
mark(compared-13, that-4)
amod(secretion-6, CPT-11-5)
nsubjpass(compared-13, secretion-6)
nsubj:xsubj(lean-15, secretion-6)
auxpass(compared-13, was-7)
advmod(higher-9, significantly-8)
advmod(compared-13, higher-9)
case(rats-12, in-10)
amod(rats-12, obese-11)
nmod:in(higher-9, rats-12)
ccomp(showed-3, compared-13)
mark(lean-15, to-14)
xcomp(compared-13, lean-15)
dobj(lean-15, rats-16)
case(conditions-22, under-17)
det(conditions-22, both-18)
amod(conditions-22, basal-19)
cc(basal-19, and-20)
conj:and(basal-19, stimulated-21)
amod(conditions-22, stimulated-21)
nmod:under(lean-15, conditions-22)

Interestingly/RB ,/, we/PRP also/RB observed/VBD a/DT significant/JJ increase/NN in/IN insulin_secretion/NN in/IN response/NN to/TO glucose/NN stimulation/NN in/IN obese/JJ rats/NNS compared/VBN to/TO lean/JJ rats/NNS ./.

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (PRP we))
    (ADVP (RB also))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN in)
          (NP (NN insulin_secretion))))
      (PP (IN in)
        (NP
          (NP (NN response))
          (PP (TO to)
            (NP (NN glucose) (NN stimulation)))))
      (PP (IN in)
        (NP
          (NP (JJ obese) (NNS rats))
          (VP (VBN compared)
            (PP (TO to)
              (NP (JJ lean) (NNS rats)))))))
    (. .)))

advmod(observed-5, Interestingly-1)
nsubj(observed-5, we-3)
advmod(observed-5, also-4)
root(ROOT-0, observed-5)
det(increase-8, a-6)
amod(increase-8, significant-7)
dobj(observed-5, increase-8)
case(insulin_secretion-10, in-9)
nmod:in(increase-8, insulin_secretion-10)
case(response-12, in-11)
nmod:in(observed-5, response-12)
case(stimulation-15, to-13)
compound(stimulation-15, glucose-14)
nmod:to(response-12, stimulation-15)
case(rats-18, in-16)
amod(rats-18, obese-17)
nmod:in(observed-5, rats-18)
acl(rats-18, compared-19)
case(rats-22, to-20)
amod(rats-22, lean-21)
nmod:to(compared-19, rats-22)

These/DT findings/NNS suggest/VBP that/IN hypersecretion/NN of/IN CPT-11/NN by/IN the/DT pancreas/NN may/MD be/VB involved/VBN in/IN the/DT development/NN of/IN obesity/NN ,/, possibly/RB through/IN its/PRP$ effects/NNS on/IN insulin_secretion/NN ./.

(ROOT
  (S
    (NP (DT These) (NNS findings))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN hypersecretion))
            (PP (IN of)
              (NP
                (NP (NN CPT-11))
                (PP (IN by)
                  (NP (DT the) (NN pancreas))))))
          (VP (MD may)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN development))
                    (PP (IN of)
                      (NP (NN obesity)))))
                (, ,)
                (PP
                  (ADVP (RB possibly))
                  (IN through)
                  (NP
                    (NP (PRP$ its) (NNS effects))
                    (PP (IN on)
                      (NP (NN insulin_secretion)))))))))))
    (. .)))

det(findings-2, These-1)
nsubj(suggest-3, findings-2)
root(ROOT-0, suggest-3)
mark(involved-13, that-4)
nsubjpass(involved-13, hypersecretion-5)
case(CPT-11-7, of-6)
nmod:of(hypersecretion-5, CPT-11-7)
case(pancreas-10, by-8)
det(pancreas-10, the-9)
nmod:by(CPT-11-7, pancreas-10)
aux(involved-13, may-11)
auxpass(involved-13, be-12)
ccomp(suggest-3, involved-13)
case(development-16, in-14)
det(development-16, the-15)
nmod:in(involved-13, development-16)
case(obesity-18, of-17)
nmod:of(development-16, obesity-18)
advmod(effects-23, possibly-20)
case(effects-23, through-21)
nmod:poss(effects-23, its-22)
nmod:through(involved-13, effects-23)
case(insulin_secretion-25, on-24)
nmod:on(effects-23, insulin_secretion-25)

Further/JJ studies/NNS are/VBP needed/VBN to/TO elucidate/VB the/DT underlying/VBG mechanisms/NNS and/CC potential/JJ therapeutic/JJ targets/NNS for/IN this/DT condition/NN ./.

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (VP (VBP are)
      (VP (VBN needed)
        (S
          (VP (TO to)
            (VP (VB elucidate)
              (NP
                (NP (DT the) (VBG underlying) (NNS mechanisms))
                (CC and)
                (NP
                  (NP (JJ potential) (JJ therapeutic) (NNS targets))
                  (PP (IN for)
                    (NP (DT this) (NN condition))))))))))
    (. .)))

amod(studies-2, Further-1)
nsubjpass(needed-4, studies-2)
nsubj:xsubj(elucidate-6, studies-2)
auxpass(needed-4, are-3)
root(ROOT-0, needed-4)
mark(elucidate-6, to-5)
xcomp(needed-4, elucidate-6)
det(mechanisms-9, the-7)
amod(mechanisms-9, underlying-8)
dobj(elucidate-6, mechanisms-9)
cc(mechanisms-9, and-10)
amod(targets-13, potential-11)
amod(targets-13, therapeutic-12)
dobj(elucidate-6, targets-13)
conj:and(mechanisms-9, targets-13)
case(condition-16, for-14)
det(condition-16, this-15)
nmod:for(targets-13, condition-16)

